# newdoc_id = 00c862a6402381a8541bcffe843696e059095300
1	In	_	_	_	_	_	_	_	BeginSeg=Yes
2	this	_	_	_	_	_	_	_	_
3	study	_	_	_	_	_	_	_	_
4	,	_	_	_	_	_	_	_	_
5	we	_	_	_	_	_	_	_	_
6	investigated	_	_	_	_	_	_	_	_
7	turkey	_	_	_	_	_	_	_	_
8	reovirus	_	_	_	_	_	_	_	_
9	(	_	_	_	_	_	_	_	_
10	TReoV	_	_	_	_	_	_	_	_
11	)	_	_	_	_	_	_	_	_
12	in	_	_	_	_	_	_	_	_
13	tissue	_	_	_	_	_	_	_	_
14	samples	_	_	_	_	_	_	_	_
15	from	_	_	_	_	_	_	_	_
16	young	_	_	_	_	_	_	_	_
17	birds	_	_	_	_	_	_	_	_
18	,	_	_	_	_	_	_	_	_
19	aged	_	_	_	_	_	_	_	BeginSeg=Yes
20	15	_	_	_	_	_	_	_	_
21	days	_	_	_	_	_	_	_	_
22	.	_	_	_	_	_	_	_	_
23	RT	_	_	_	_	_	_	_	BeginSeg=Yes
24	-	_	_	_	_	_	_	_	_
25	PCR	_	_	_	_	_	_	_	_
26	for	_	_	_	_	_	_	_	_
27	TReoV	_	_	_	_	_	_	_	_
28	detected	_	_	_	_	_	_	_	_
29	3.3	_	_	_	_	_	_	_	_
30	%	_	_	_	_	_	_	_	_
31	positive	_	_	_	_	_	_	_	_
32	samples	_	_	_	_	_	_	_	_
33	and	_	_	_	_	_	_	_	BeginSeg=Yes
34	TReoV	_	_	_	_	_	_	_	_
35	was	_	_	_	_	_	_	_	_
36	successfully	_	_	_	_	_	_	_	_
37	isolated	_	_	_	_	_	_	_	_
38	in	_	_	_	_	_	_	_	_
39	Vero	_	_	_	_	_	_	_	_
40	cells	_	_	_	_	_	_	_	_
41	.	_	_	_	_	_	_	_	_
42	Histological	_	_	_	_	_	_	_	BeginSeg=Yes
43	analysis	_	_	_	_	_	_	_	_
44	of	_	_	_	_	_	_	_	_
45	positive	_	_	_	_	_	_	_	_
46	bursa	_	_	_	_	_	_	_	_
47	of	_	_	_	_	_	_	_	_
48	Fabricius	_	_	_	_	_	_	_	_
49	(	_	_	_	_	_	_	_	_
50	BF	_	_	_	_	_	_	_	_
51	)	_	_	_	_	_	_	_	_
52	revealed	_	_	_	_	_	_	_	_
53	atrophied	_	_	_	_	_	_	_	_
54	follicles	_	_	_	_	_	_	_	_
55	and	_	_	_	_	_	_	_	_
56	lymphocyte	_	_	_	_	_	_	_	_
57	depletion	_	_	_	_	_	_	_	_
58	.	_	_	_	_	_	_	_	_
59	The	_	_	_	_	_	_	_	BeginSeg=Yes
60	number	_	_	_	_	_	_	_	_
61	of	_	_	_	_	_	_	_	_
62	CD8	_	_	_	_	_	_	_	_
63	?	_	_	_	_	_	_	_	_
64	,	_	_	_	_	_	_	_	_
65	CD4	_	_	_	_	_	_	_	_
66	?	_	_	_	_	_	_	_	_
67	and	_	_	_	_	_	_	_	_
68	IgM	_	_	_	_	_	_	_	_
69	?	_	_	_	_	_	_	_	_
70	cells	_	_	_	_	_	_	_	_
71	was	_	_	_	_	_	_	_	_
72	lower	_	_	_	_	_	_	_	_
73	in	_	_	_	_	_	_	_	_
74	infected	_	_	_	_	_	_	_	_
75	BF	_	_	_	_	_	_	_	_
76	.	_	_	_	_	_	_	_	_
77	Phylogenetic	_	_	_	_	_	_	_	BeginSeg=Yes
78	analysis	_	_	_	_	_	_	_	_
79	based	_	_	_	_	_	_	_	BeginSeg=Yes
80	on	_	_	_	_	_	_	_	_
81	S3	_	_	_	_	_	_	_	_
82	gene	_	_	_	_	_	_	_	_
83	showed	_	_	_	_	_	_	_	BeginSeg=Yes
84	that	_	_	_	_	_	_	_	BeginSeg=Yes
85	the	_	_	_	_	_	_	_	_
86	Brazilian	_	_	_	_	_	_	_	_
87	TReoV	_	_	_	_	_	_	_	_
88	isolates	_	_	_	_	_	_	_	_
89	clustered	_	_	_	_	_	_	_	_
90	in	_	_	_	_	_	_	_	_
91	a	_	_	_	_	_	_	_	_
92	single	_	_	_	_	_	_	_	_
93	group	_	_	_	_	_	_	_	_
94	with	_	_	_	_	_	_	_	_
95	98	_	_	_	_	_	_	_	_
96	-	_	_	_	_	_	_	_	_
97	100	_	_	_	_	_	_	_	_
98	%	_	_	_	_	_	_	_	_
99	similarity	_	_	_	_	_	_	_	_
100	to	_	_	_	_	_	_	_	_
101	TReoV	_	_	_	_	_	_	_	_
102	strains	_	_	_	_	_	_	_	_
103	circulating	_	_	_	_	_	_	_	BeginSeg=Yes
104	in	_	_	_	_	_	_	_	_
105	the	_	_	_	_	_	_	_	_
106	United	_	_	_	_	_	_	_	_
107	States	_	_	_	_	_	_	_	_
108	.	_	_	_	_	_	_	_	_
109	This	_	_	_	_	_	_	_	BeginSeg=Yes
110	is	_	_	_	_	_	_	_	_
111	the	_	_	_	_	_	_	_	_
112	first	_	_	_	_	_	_	_	_
113	indication	_	_	_	_	_	_	_	_
114	that	_	_	_	_	_	_	_	BeginSeg=Yes
115	TReoV	_	_	_	_	_	_	_	_
116	infection	_	_	_	_	_	_	_	_
117	may	_	_	_	_	_	_	_	_
118	be	_	_	_	_	_	_	_	_
119	a	_	_	_	_	_	_	_	_
120	contributing	_	_	_	_	_	_	_	_
121	factor	_	_	_	_	_	_	_	_
122	to	_	_	_	_	_	_	_	_
123	immunosuppression	_	_	_	_	_	_	_	_
124	in	_	_	_	_	_	_	_	_
125	young	_	_	_	_	_	_	_	_
126	birds	_	_	_	_	_	_	_	_
127	.	_	_	_	_	_	_	_	_

# newdoc_id = 0146a0b36f80ebcb868c7e16fb60c1a9d2afbf83
1	This	_	_	_	_	_	_	_	BeginSeg=Yes
2	is	_	_	_	_	_	_	_	_
3	an	_	_	_	_	_	_	_	_
4	extensive	_	_	_	_	_	_	_	_
5	review	_	_	_	_	_	_	_	_
6	on	_	_	_	_	_	_	_	_
7	epiphytic	_	_	_	_	_	_	_	_
8	plants	_	_	_	_	_	_	_	_
9	that	_	_	_	_	_	_	_	BeginSeg=Yes
10	have	_	_	_	_	_	_	_	_
11	been	_	_	_	_	_	_	_	_
12	used	_	_	_	_	_	_	_	_
13	traditionally	_	_	_	_	_	_	_	_
14	as	_	_	_	_	_	_	_	_
15	medicines	_	_	_	_	_	_	_	_
16	.	_	_	_	_	_	_	_	_
17	It	_	_	_	_	_	_	_	BeginSeg=Yes
18	provides	_	_	_	_	_	_	_	_
19	information	_	_	_	_	_	_	_	_
20	on	_	_	_	_	_	_	_	_
21	185	_	_	_	_	_	_	_	_
22	epiphytes	_	_	_	_	_	_	_	_
23	and	_	_	_	_	_	_	_	_
24	their	_	_	_	_	_	_	_	_
25	traditional	_	_	_	_	_	_	_	_
26	medicinal	_	_	_	_	_	_	_	_
27	uses	_	_	_	_	_	_	_	_
28	,	_	_	_	_	_	_	_	_
29	regions	_	_	_	_	_	_	_	_
30	where	_	_	_	_	_	_	_	BeginSeg=Yes
31	Indigenous	_	_	_	_	_	_	_	_
32	people	_	_	_	_	_	_	_	_
33	use	_	_	_	_	_	_	_	_
34	the	_	_	_	_	_	_	_	_
35	plants	_	_	_	_	_	_	_	_
36	,	_	_	_	_	_	_	_	_
37	parts	_	_	_	_	_	_	_	BeginSeg=Yes
38	of	_	_	_	_	_	_	_	_
39	the	_	_	_	_	_	_	_	_
40	plants	_	_	_	_	_	_	_	_
41	used	_	_	_	_	_	_	_	BeginSeg=Yes
42	as	_	_	_	_	_	_	_	_
43	medicines	_	_	_	_	_	_	_	_
44	and	_	_	_	_	_	_	_	BeginSeg=Yes
45	their	_	_	_	_	_	_	_	_
46	preparation	_	_	_	_	_	_	_	_
47	,	_	_	_	_	_	_	_	_
48	and	_	_	_	_	_	_	_	_
49	their	_	_	_	_	_	_	_	_
50	reported	_	_	_	_	_	_	_	_
51	phytochemical	_	_	_	_	_	_	_	_
52	properties	_	_	_	_	_	_	_	_
53	and	_	_	_	_	_	_	_	_
54	pharmacological	_	_	_	_	_	_	_	_
55	properties	_	_	_	_	_	_	_	_
56	aligned	_	_	_	_	_	_	_	BeginSeg=Yes
57	with	_	_	_	_	_	_	_	_
58	their	_	_	_	_	_	_	_	_
59	traditional	_	_	_	_	_	_	_	_
60	uses	_	_	_	_	_	_	_	_
61	.	_	_	_	_	_	_	_	_
62	These	_	_	_	_	_	_	_	BeginSeg=Yes
63	epiphytic	_	_	_	_	_	_	_	_
64	medicinal	_	_	_	_	_	_	_	_
65	plants	_	_	_	_	_	_	_	_
66	are	_	_	_	_	_	_	_	_
67	able	_	_	_	_	_	_	_	_
68	to	_	_	_	_	_	_	_	_
69	produce	_	_	_	_	_	_	_	_
70	a	_	_	_	_	_	_	_	_
71	range	_	_	_	_	_	_	_	_
72	of	_	_	_	_	_	_	_	_
73	secondary	_	_	_	_	_	_	_	_
74	metabolites	_	_	_	_	_	_	_	_
75	,	_	_	_	_	_	_	_	_
76	including	_	_	_	_	_	_	_	BeginSeg=Yes
77	alkaloids	_	_	_	_	_	_	_	_
78	,	_	_	_	_	_	_	_	_
79	and	_	_	_	_	_	_	_	BeginSeg=Yes
80	a	_	_	_	_	_	_	_	_
81	total	_	_	_	_	_	_	_	_
82	of	_	_	_	_	_	_	_	_
83	842	_	_	_	_	_	_	_	_
84	phytochemicals	_	_	_	_	_	_	_	_
85	have	_	_	_	_	_	_	_	_
86	been	_	_	_	_	_	_	_	_
87	identified	_	_	_	_	_	_	_	_
88	to	_	_	_	_	_	_	_	_
89	date	_	_	_	_	_	_	_	_
90	.	_	_	_	_	_	_	_	_
91	As	_	_	_	_	_	_	_	BeginSeg=Yes
92	many	_	_	_	_	_	_	_	_
93	as	_	_	_	_	_	_	_	_
94	71	_	_	_	_	_	_	_	_
95	epiphytic	_	_	_	_	_	_	_	_
96	medicinal	_	_	_	_	_	_	_	_
97	plants	_	_	_	_	_	_	_	_
98	were	_	_	_	_	_	_	_	_
99	studied	_	_	_	_	_	_	_	_
100	for	_	_	_	_	_	_	_	_
101	their	_	_	_	_	_	_	_	_
102	biological	_	_	_	_	_	_	_	_
103	activities	_	_	_	_	_	_	_	_
104	,	_	_	_	_	_	_	_	_
105	showing	_	_	_	_	_	_	_	BeginSeg=Yes
106	promising	_	_	_	_	_	_	_	_
107	pharmacological	_	_	_	_	_	_	_	_
108	activities	_	_	_	_	_	_	_	_
109	,	_	_	_	_	_	_	_	_
110	including	_	_	_	_	_	_	_	BeginSeg=Yes
111	as	_	_	_	_	_	_	_	_
112	anti	_	_	_	_	_	_	_	_
113	-	_	_	_	_	_	_	_	_
114	inflammatory	_	_	_	_	_	_	_	_
115	,	_	_	_	_	_	_	_	_
116	antimicrobial	_	_	_	_	_	_	_	_
117	,	_	_	_	_	_	_	_	_
118	and	_	_	_	_	_	_	_	_
119	anticancer	_	_	_	_	_	_	_	_
120	agents	_	_	_	_	_	_	_	_
121	.	_	_	_	_	_	_	_	_
122	There	_	_	_	_	_	_	_	BeginSeg=Yes
123	are	_	_	_	_	_	_	_	_
124	several	_	_	_	_	_	_	_	_
125	species	_	_	_	_	_	_	_	_
126	that	_	_	_	_	_	_	_	BeginSeg=Yes
127	were	_	_	_	_	_	_	_	_
128	not	_	_	_	_	_	_	_	_
129	investigated	_	_	_	_	_	_	_	_
130	for	_	_	_	_	_	_	_	_
131	their	_	_	_	_	_	_	_	_
132	activities	_	_	_	_	_	_	_	_
133	and	_	_	_	_	_	_	_	BeginSeg=Yes
134	are	_	_	_	_	_	_	_	_
135	worthy	_	_	_	_	_	_	_	_
136	of	_	_	_	_	_	_	_	_
137	exploration	_	_	_	_	_	_	_	_
138	.	_	_	_	_	_	_	_	_
139	These	_	_	_	_	_	_	_	BeginSeg=Yes
140	epipythes	_	_	_	_	_	_	_	_
141	have	_	_	_	_	_	_	_	_
142	the	_	_	_	_	_	_	_	_
143	potential	_	_	_	_	_	_	_	_
144	to	_	_	_	_	_	_	_	BeginSeg=Yes
145	furnish	_	_	_	_	_	_	_	_
146	drug	_	_	_	_	_	_	_	_
147	lead	_	_	_	_	_	_	_	_
148	compounds	_	_	_	_	_	_	_	_
149	,	_	_	_	_	_	_	_	_
150	especially	_	_	_	_	_	_	_	BeginSeg=Yes
151	for	_	_	_	_	_	_	_	_
152	treating	_	_	_	_	_	_	_	_
153	cancers	_	_	_	_	_	_	_	_
154	,	_	_	_	_	_	_	_	_
155	and	_	_	_	_	_	_	_	BeginSeg=Yes
156	thus	_	_	_	_	_	_	_	_
157	warrant	_	_	_	_	_	_	_	_
158	indepth	_	_	_	_	_	_	_	_
159	investigations	_	_	_	_	_	_	_	_
160	.	_	_	_	_	_	_	_	_

# newdoc_id = 0232f18e7bbf3192e9e34da1c0abe2a20b2ba1e4
1	Herein	_	_	_	_	_	_	_	BeginSeg=Yes
2	,	_	_	_	_	_	_	_	_
3	the	_	_	_	_	_	_	_	_
4	LASSBio	_	_	_	_	_	_	_	_
5	Chemical	_	_	_	_	_	_	_	_
6	Library	_	_	_	_	_	_	_	_
7	is	_	_	_	_	_	_	_	_
8	presented	_	_	_	_	_	_	_	_
9	as	_	_	_	_	_	_	_	_
10	a	_	_	_	_	_	_	_	_
11	valuable	_	_	_	_	_	_	_	_
12	source	_	_	_	_	_	_	_	_
13	of	_	_	_	_	_	_	_	_
14	compounds	_	_	_	_	_	_	_	_
15	for	_	_	_	_	_	_	_	_
16	screening	_	_	_	_	_	_	_	_
17	to	_	_	_	_	_	_	_	BeginSeg=Yes
18	identify	_	_	_	_	_	_	_	_
19	hits	_	_	_	_	_	_	_	_
20	suitable	_	_	_	_	_	_	_	_
21	for	_	_	_	_	_	_	_	_
22	subsequent	_	_	_	_	_	_	_	_
23	hit	_	_	_	_	_	_	_	_
24	-	_	_	_	_	_	_	_	_
25	to	_	_	_	_	_	_	_	_
26	-	_	_	_	_	_	_	_	_
27	lead	_	_	_	_	_	_	_	_
28	optimization	_	_	_	_	_	_	_	_
29	stages	_	_	_	_	_	_	_	_
30	.	_	_	_	_	_	_	_	_
31	A	_	_	_	_	_	_	_	BeginSeg=Yes
32	feature	_	_	_	_	_	_	_	_
33	of	_	_	_	_	_	_	_	_
34	the	_	_	_	_	_	_	_	_
35	LASSBio	_	_	_	_	_	_	_	_
36	Chemical	_	_	_	_	_	_	_	_
37	Library	_	_	_	_	_	_	_	_
38	worth	_	_	_	_	_	_	_	_
39	highlighting	_	_	_	_	_	_	_	_
40	is	_	_	_	_	_	_	_	_
41	the	_	_	_	_	_	_	_	_
42	fact	_	_	_	_	_	_	_	_
43	that	_	_	_	_	_	_	_	BeginSeg=Yes
44	it	_	_	_	_	_	_	_	_
45	is	_	_	_	_	_	_	_	_
46	a	_	_	_	_	_	_	_	_
47	smart	_	_	_	_	_	_	_	_
48	library	_	_	_	_	_	_	_	_
49	designed	_	_	_	_	_	_	_	BeginSeg=Yes
50	by	_	_	_	_	_	_	_	_
51	medicinal	_	_	_	_	_	_	_	_
52	chemists	_	_	_	_	_	_	_	_
53	with	_	_	_	_	_	_	_	_
54	pharmacological	_	_	_	_	_	_	_	_
55	activity	_	_	_	_	_	_	_	_
56	as	_	_	_	_	_	_	_	_
57	the	_	_	_	_	_	_	_	_
58	main	_	_	_	_	_	_	_	_
59	priority	_	_	_	_	_	_	_	_
60	.	_	_	_	_	_	_	_	_
61	The	_	_	_	_	_	_	_	BeginSeg=Yes
62	great	_	_	_	_	_	_	_	_
63	majority	_	_	_	_	_	_	_	_
64	of	_	_	_	_	_	_	_	_
65	the	_	_	_	_	_	_	_	_
66	compounds	_	_	_	_	_	_	_	_
67	part	_	_	_	_	_	_	_	_
68	of	_	_	_	_	_	_	_	_
69	this	_	_	_	_	_	_	_	_
70	library	_	_	_	_	_	_	_	_
71	have	_	_	_	_	_	_	_	_
72	shown	_	_	_	_	_	_	_	_
73	in	_	_	_	_	_	_	_	_
74	vivo	_	_	_	_	_	_	_	_
75	activity	_	_	_	_	_	_	_	_
76	in	_	_	_	_	_	_	_	_
77	animal	_	_	_	_	_	_	_	_
78	models	_	_	_	_	_	_	_	_
79	,	_	_	_	_	_	_	_	_
80	which	_	_	_	_	_	_	_	BeginSeg=Yes
81	is	_	_	_	_	_	_	_	_
82	an	_	_	_	_	_	_	_	_
83	indication	_	_	_	_	_	_	_	_
84	that	_	_	_	_	_	_	_	BeginSeg=Yes
85	they	_	_	_	_	_	_	_	_
86	possess	_	_	_	_	_	_	_	_
87	overall	_	_	_	_	_	_	_	_
88	favorable	_	_	_	_	_	_	_	_
89	bioavailability	_	_	_	_	_	_	_	_
90	properties	_	_	_	_	_	_	_	_
91	and	_	_	_	_	_	_	_	_
92	,	_	_	_	_	_	_	_	_
93	hence	_	_	_	_	_	_	_	_
94	,	_	_	_	_	_	_	_	_
95	adequate	_	_	_	_	_	_	_	_
96	pharmacokinetic	_	_	_	_	_	_	_	_
97	profiles	_	_	_	_	_	_	_	_
98	.	_	_	_	_	_	_	_	_
99	This	_	_	_	_	_	_	_	BeginSeg=Yes
100	,	_	_	_	_	_	_	_	_
101	in	_	_	_	_	_	_	_	_
102	turn	_	_	_	_	_	_	_	_
103	,	_	_	_	_	_	_	_	_
104	is	_	_	_	_	_	_	_	_
105	supported	_	_	_	_	_	_	_	_
106	by	_	_	_	_	_	_	_	_
107	the	_	_	_	_	_	_	_	_
108	fact	_	_	_	_	_	_	_	_
109	that	_	_	_	_	_	_	_	BeginSeg=Yes
110	approximately	_	_	_	_	_	_	_	_
111	85	_	_	_	_	_	_	_	_
112	%	_	_	_	_	_	_	_	_
113	of	_	_	_	_	_	_	_	_
114	the	_	_	_	_	_	_	_	_
115	compounds	_	_	_	_	_	_	_	_
116	are	_	_	_	_	_	_	_	_
117	compliant	_	_	_	_	_	_	_	_
118	with	_	_	_	_	_	_	_	_
119-120	Lipinski's	_	_	_	_	_	_	_	_
119	Lipinski	_	_	_	_	_	_	_	_
120	's	_	_	_	_	_	_	_	_
121	rule	_	_	_	_	_	_	_	_
122	of	_	_	_	_	_	_	_	_
123	five	_	_	_	_	_	_	_	_
124	and	_	_	_	_	_	_	_	_
125	ca	_	_	_	_	_	_	_	_
126	.	_	_	_	_	_	_	_	_
127	95	_	_	_	_	_	_	_	BeginSeg=Yes
128	%	_	_	_	_	_	_	_	_
129	are	_	_	_	_	_	_	_	_
130	compliant	_	_	_	_	_	_	_	_
131	with	_	_	_	_	_	_	_	_
132-133	Veber's	_	_	_	_	_	_	_	_
132	Veber	_	_	_	_	_	_	_	_
133	's	_	_	_	_	_	_	_	_
134	rules	_	_	_	_	_	_	_	_
135	,	_	_	_	_	_	_	_	_
136	two	_	_	_	_	_	_	_	_
137	important	_	_	_	_	_	_	_	_
138	guidelines	_	_	_	_	_	_	_	_
139	for	_	_	_	_	_	_	_	_
140	oral	_	_	_	_	_	_	_	_
141	bioavailability	_	_	_	_	_	_	_	_
142	.	_	_	_	_	_	_	_	_
143	In	_	_	_	_	_	_	_	BeginSeg=Yes
144	this	_	_	_	_	_	_	_	_
145	work	_	_	_	_	_	_	_	_
146	it	_	_	_	_	_	_	_	_
147	is	_	_	_	_	_	_	_	_
148	presented	_	_	_	_	_	_	_	_
149	a	_	_	_	_	_	_	_	_
150	virtual	_	_	_	_	_	_	_	_
151	screening	_	_	_	_	_	_	_	_
152	methodology	_	_	_	_	_	_	_	_
153	combining	_	_	_	_	_	_	_	BeginSeg=Yes
154	a	_	_	_	_	_	_	_	_
155	pharmacophore	_	_	_	_	_	_	_	_
156	-	_	_	_	_	_	_	_	_
157	based	_	_	_	_	_	_	_	_
158	model	_	_	_	_	_	_	_	_
159	and	_	_	_	_	_	_	_	_
160	an	_	_	_	_	_	_	_	_
161	empirical	_	_	_	_	_	_	_	_
162	Gibbs	_	_	_	_	_	_	_	_
163	free	_	_	_	_	_	_	_	_
164	energy	_	_	_	_	_	_	_	_
165	-	_	_	_	_	_	_	_	_
166	based	_	_	_	_	_	_	_	_
167	model	_	_	_	_	_	_	_	_
168	for	_	_	_	_	_	_	_	_
169	the	_	_	_	_	_	_	_	_
170	ligand	_	_	_	_	_	_	_	_
171	-	_	_	_	_	_	_	_	_
172	protein	_	_	_	_	_	_	_	_
173	interaction	_	_	_	_	_	_	_	_
174	to	_	_	_	_	_	_	_	BeginSeg=Yes
175	explore	_	_	_	_	_	_	_	_
176	the	_	_	_	_	_	_	_	_
177	LASSBio	_	_	_	_	_	_	_	_
178	Chemical	_	_	_	_	_	_	_	_
179	Library	_	_	_	_	_	_	_	_
180	as	_	_	_	_	_	_	_	_
181	a	_	_	_	_	_	_	_	_
182	source	_	_	_	_	_	_	_	_
183	of	_	_	_	_	_	_	_	_
184	new	_	_	_	_	_	_	_	_
185	hits	_	_	_	_	_	_	_	_
186	for	_	_	_	_	_	_	_	_
187	the	_	_	_	_	_	_	_	_
188	inhibition	_	_	_	_	_	_	_	_
189	of	_	_	_	_	_	_	_	_
190	the	_	_	_	_	_	_	_	_
191	phosphatidylinositol	_	_	_	_	_	_	_	_
192	4-kinase	_	_	_	_	_	_	_	_
193	IIIβ	_	_	_	_	_	_	_	_
194	(	_	_	_	_	_	_	_	_
195	PI4KIIIβ	_	_	_	_	_	_	_	_
196	)	_	_	_	_	_	_	_	_
197	enzyme	_	_	_	_	_	_	_	_
198	,	_	_	_	_	_	_	_	_
199	which	_	_	_	_	_	_	_	BeginSeg=Yes
200	is	_	_	_	_	_	_	_	_
201	related	_	_	_	_	_	_	_	_
202	to	_	_	_	_	_	_	_	_
203	the	_	_	_	_	_	_	_	_
204	development	_	_	_	_	_	_	_	_
205	of	_	_	_	_	_	_	_	_
206	viral	_	_	_	_	_	_	_	_
207	infections	_	_	_	_	_	_	_	_
208	(	_	_	_	_	_	_	_	BeginSeg=Yes
209	including	_	_	_	_	_	_	_	_
210	enteroviruses	_	_	_	_	_	_	_	_
211	,	_	_	_	_	_	_	_	_
212	SARS	_	_	_	_	_	_	_	_
213	coronavirus	_	_	_	_	_	_	_	_
214	,	_	_	_	_	_	_	_	_
215	and	_	_	_	_	_	_	_	_
216	hepatitis	_	_	_	_	_	_	_	_
217	C	_	_	_	_	_	_	_	_
218	virus	_	_	_	_	_	_	_	_
219	)	_	_	_	_	_	_	_	_
220	,	_	_	_	_	_	_	_	_
221	cancers	_	_	_	_	_	_	_	BeginSeg=Yes
222	and	_	_	_	_	_	_	_	_
223	neurological	_	_	_	_	_	_	_	_
224	diseases	_	_	_	_	_	_	_	_
225	.	_	_	_	_	_	_	_	_
226	The	_	_	_	_	_	_	_	BeginSeg=Yes
227	approach	_	_	_	_	_	_	_	_
228	resulted	_	_	_	_	_	_	_	_
229	in	_	_	_	_	_	_	_	_
230	the	_	_	_	_	_	_	_	_
231	identification	_	_	_	_	_	_	_	_
232	of	_	_	_	_	_	_	_	_
233	two	_	_	_	_	_	_	_	_
234	hits	_	_	_	_	_	_	_	_
235	,	_	_	_	_	_	_	_	_
236	LASSBio-1799	_	_	_	_	_	_	_	_
237	(	_	_	_	_	_	_	_	_
238	7	_	_	_	_	_	_	_	_
239	)	_	_	_	_	_	_	_	_
240	and	_	_	_	_	_	_	_	_
241	LASSBio-1814	_	_	_	_	_	_	_	_
242	(	_	_	_	_	_	_	_	_
243	10	_	_	_	_	_	_	_	_
244	)	_	_	_	_	_	_	_	_
245	,	_	_	_	_	_	_	_	_
246	which	_	_	_	_	_	_	_	BeginSeg=Yes
247	inhibited	_	_	_	_	_	_	_	_
248	the	_	_	_	_	_	_	_	_
249	target	_	_	_	_	_	_	_	_
250	enzyme	_	_	_	_	_	_	_	_
251	with	_	_	_	_	_	_	_	_
252	IC	_	_	_	_	_	_	_	_
253	50	_	_	_	_	_	_	_	_
254	values	_	_	_	_	_	_	_	_
255	of	_	_	_	_	_	_	_	_
256	3.66	_	_	_	_	_	_	_	_
257	μM	_	_	_	_	_	_	_	_
258	and	_	_	_	_	_	_	_	_
259	IC	_	_	_	_	_	_	_	_
260	50	_	_	_	_	_	_	_	_
261	and	_	_	_	_	_	_	_	_
262	6.09	_	_	_	_	_	_	_	_
263	μM	_	_	_	_	_	_	_	_
264	,	_	_	_	_	_	_	_	_
265	respectively	_	_	_	_	_	_	_	_
266	.	_	_	_	_	_	_	_	_
267	This	_	_	_	_	_	_	_	BeginSeg=Yes
268	study	_	_	_	_	_	_	_	_
269	also	_	_	_	_	_	_	_	_
270	enabled	_	_	_	_	_	_	_	_
271	the	_	_	_	_	_	_	_	_
272	determination	_	_	_	_	_	_	_	_
273	of	_	_	_	_	_	_	_	_
274	the	_	_	_	_	_	_	_	_
275	structural	_	_	_	_	_	_	_	_
276	requirements	_	_	_	_	_	_	_	_
277	for	_	_	_	_	_	_	_	_
278	interactions	_	_	_	_	_	_	_	_
279	with	_	_	_	_	_	_	_	_
280	the	_	_	_	_	_	_	_	_
281	active	_	_	_	_	_	_	_	_
282	site	_	_	_	_	_	_	_	_
283	of	_	_	_	_	_	_	_	_
284	PI4KIIIβ	_	_	_	_	_	_	_	_
285	,	_	_	_	_	_	_	_	_
286	demonstrating	_	_	_	_	_	_	_	BeginSeg=Yes
287	the	_	_	_	_	_	_	_	_
288	importance	_	_	_	_	_	_	_	_
289	of	_	_	_	_	_	_	_	_
290	both	_	_	_	_	_	_	_	_
291	acceptor	_	_	_	_	_	_	_	_
292	and	_	_	_	_	_	_	_	_
293	donor	_	_	_	_	_	_	_	_
294	hydrogen	_	_	_	_	_	_	_	_
295	bonding	_	_	_	_	_	_	_	_
296	groups	_	_	_	_	_	_	_	_
297	for	_	_	_	_	_	_	_	BeginSeg=Yes
298	forming	_	_	_	_	_	_	_	_
299	interactions	_	_	_	_	_	_	_	_
300	with	_	_	_	_	_	_	_	_
301	binding	_	_	_	_	_	_	_	_
302	site	_	_	_	_	_	_	_	_
303	residues	_	_	_	_	_	_	_	_
304	Val598	_	_	_	_	_	_	_	_
305	and	_	_	_	_	_	_	_	_
306	Lys549	_	_	_	_	_	_	_	_
307	.	_	_	_	_	_	_	_	_

# newdoc_id = 09bdbea1700a3826acc33484ed51e2fa8c23f047
1	Data	_	_	_	_	_	_	_	BeginSeg=Yes
2	-	_	_	_	_	_	_	_	_
3	centric	_	_	_	_	_	_	_	_
4	models	_	_	_	_	_	_	_	_
5	of	_	_	_	_	_	_	_	_
6	COVID-19	_	_	_	_	_	_	_	_
7	have	_	_	_	_	_	_	_	_
8	been	_	_	_	_	_	_	_	_
9	tried	_	_	_	_	_	_	_	_
10	,	_	_	_	_	_	_	_	_
11	but	_	_	_	_	_	_	_	BeginSeg=Yes
12	have	_	_	_	_	_	_	_	_
13	certain	_	_	_	_	_	_	_	_
14	limitations	_	_	_	_	_	_	_	_
15	.	_	_	_	_	_	_	_	_
16	In	_	_	_	_	_	_	_	BeginSeg=Yes
17	this	_	_	_	_	_	_	_	_
18	work	_	_	_	_	_	_	_	_
19	,	_	_	_	_	_	_	_	_
20	we	_	_	_	_	_	_	_	_
21	propose	_	_	_	_	_	_	_	_
22	an	_	_	_	_	_	_	_	_
23	agent	_	_	_	_	_	_	_	_
24	-	_	_	_	_	_	_	_	_
25	based	_	_	_	_	_	_	_	_
26	model	_	_	_	_	_	_	_	_
27	of	_	_	_	_	_	_	_	_
28	the	_	_	_	_	_	_	_	_
29	epidemic	_	_	_	_	_	_	_	_
30	in	_	_	_	_	_	_	_	_
31	a	_	_	_	_	_	_	_	_
32	confined	_	_	_	_	_	_	_	_
33	space	_	_	_	_	_	_	_	_
34	of	_	_	_	_	_	_	_	_
35	agents	_	_	_	_	_	_	_	_
36	representing	_	_	_	_	_	_	_	_
37	humans	_	_	_	_	_	_	_	_
38	.	_	_	_	_	_	_	_	_
39	An	_	_	_	_	_	_	_	BeginSeg=Yes
40	extension	_	_	_	_	_	_	_	_
41	to	_	_	_	_	_	_	_	_
42	the	_	_	_	_	_	_	_	_
43	SEIR	_	_	_	_	_	_	_	_
44	model	_	_	_	_	_	_	_	_
45	allows	_	_	_	_	_	_	_	_
46	us	_	_	_	_	_	_	_	_
47	to	_	_	_	_	_	_	_	_
48	consider	_	_	_	_	_	_	_	_
49	the	_	_	_	_	_	_	_	_
50	difference	_	_	_	_	_	_	_	_
51	between	_	_	_	_	_	_	_	_
52	the	_	_	_	_	_	_	_	_
53	appearance	_	_	_	_	_	_	_	_
54	(	_	_	_	_	_	_	_	_
55	black	_	_	_	_	_	_	_	_
56	-	_	_	_	_	_	_	_	_
57	box	_	_	_	_	_	_	_	_
58	view	_	_	_	_	_	_	_	_
59	)	_	_	_	_	_	_	_	_
60	of	_	_	_	_	_	_	_	_
61	the	_	_	_	_	_	_	_	_
62	spread	_	_	_	_	_	_	_	_
63	of	_	_	_	_	_	_	_	_
64	disease	_	_	_	_	_	_	_	_
65	,	_	_	_	_	_	_	_	_
66	and	_	_	_	_	_	_	_	_
67	the	_	_	_	_	_	_	_	_
68	real	_	_	_	_	_	_	_	_
69	situation	_	_	_	_	_	_	_	_
70	(	_	_	_	_	_	_	_	_
71	glass	_	_	_	_	_	_	_	_
72	-	_	_	_	_	_	_	_	_
73	box	_	_	_	_	_	_	_	_
74	view	_	_	_	_	_	_	_	_
75	)	_	_	_	_	_	_	_	_
76	.	_	_	_	_	_	_	_	_
77	Our	_	_	_	_	_	_	_	BeginSeg=Yes
78	model	_	_	_	_	_	_	_	_
79	allows	_	_	_	_	_	_	_	_
80	for	_	_	_	_	_	_	_	_
81	simulations	_	_	_	_	_	_	_	_
82	of	_	_	_	_	_	_	_	_
83	lockdowns	_	_	_	_	_	_	_	_
84	,	_	_	_	_	_	_	_	_
85	social	_	_	_	_	_	_	_	_
86	distancing	_	_	_	_	_	_	_	_
87	,	_	_	_	_	_	_	_	_
88	personal	_	_	_	_	_	_	_	_
89	hygiene	_	_	_	_	_	_	_	_
90	,	_	_	_	_	_	_	_	_
91	quarantine	_	_	_	_	_	_	_	_
92	,	_	_	_	_	_	_	_	_
93	and	_	_	_	_	_	_	_	_
94	hospitalization	_	_	_	_	_	_	_	_
95	,	_	_	_	_	_	_	_	_
96	with	_	_	_	_	_	_	_	_
97	further	_	_	_	_	_	_	_	_
98	considerations	_	_	_	_	_	_	_	_
99	of	_	_	_	_	_	_	_	_
100	different	_	_	_	_	_	_	_	_
101	parameters	_	_	_	_	_	_	_	_
102	such	_	_	_	_	_	_	_	BeginSeg=Yes
103	as	_	_	_	_	_	_	_	_
104	the	_	_	_	_	_	_	_	_
105	extent	_	_	_	_	_	_	_	_
106	to	_	_	_	_	_	_	_	BeginSeg=Yes
107	which	_	_	_	_	_	_	_	_
108	hygiene	_	_	_	_	_	_	_	_
109	and	_	_	_	_	_	_	_	_
110	social	_	_	_	_	_	_	_	_
111	distancing	_	_	_	_	_	_	_	_
112	are	_	_	_	_	_	_	_	_
113	observed	_	_	_	_	_	_	_	_
114	in	_	_	_	_	_	_	_	_
115	a	_	_	_	_	_	_	_	_
116	population	_	_	_	_	_	_	_	_
117	.	_	_	_	_	_	_	_	_
118	Our	_	_	_	_	_	_	_	BeginSeg=Yes
119	results	_	_	_	_	_	_	_	_
120	give	_	_	_	_	_	_	_	_
121	qualitative	_	_	_	_	_	_	_	_
122	indications	_	_	_	_	_	_	_	_
123	of	_	_	_	_	_	_	_	_
124	the	_	_	_	_	_	_	_	_
125	effects	_	_	_	_	_	_	_	_
126	of	_	_	_	_	_	_	_	_
127	various	_	_	_	_	_	_	_	_
128	policies	_	_	_	_	_	_	_	_
129	and	_	_	_	_	_	_	_	_
130	parameters	_	_	_	_	_	_	_	_
131	;	_	_	_	_	_	_	_	_
132	for	_	_	_	_	_	_	_	BeginSeg=Yes
133	instance	_	_	_	_	_	_	_	_
134	,	_	_	_	_	_	_	_	_
135	that	_	_	_	_	_	_	_	_
136	lockdowns	_	_	_	_	_	_	_	_
137	by	_	_	_	_	_	_	_	_
138	themselves	_	_	_	_	_	_	_	_
139	are	_	_	_	_	_	_	_	_
140	extremely	_	_	_	_	_	_	_	_
141	unlikely	_	_	_	_	_	_	_	_
142	to	_	_	_	_	_	_	_	_
143	bring	_	_	_	_	_	_	_	_
144	an	_	_	_	_	_	_	_	_
145	end	_	_	_	_	_	_	_	_
146	to	_	_	_	_	_	_	_	_
147	an	_	_	_	_	_	_	_	_
148	epidemic	_	_	_	_	_	_	_	_
149	and	_	_	_	_	_	_	_	BeginSeg=Yes
150	may	_	_	_	_	_	_	_	_
151	indeed	_	_	_	_	_	_	_	_
152	make	_	_	_	_	_	_	_	_
153	things	_	_	_	_	_	_	_	_
154	worse	_	_	_	_	_	_	_	_
155	,	_	_	_	_	_	_	_	_
156	that	_	_	_	_	_	_	_	BeginSeg=Yes
157	social	_	_	_	_	_	_	_	_
158	distancing	_	_	_	_	_	_	_	_
159	matters	_	_	_	_	_	_	_	_
160	more	_	_	_	_	_	_	_	_
161	than	_	_	_	_	_	_	_	_
162	personal	_	_	_	_	_	_	_	_
163	hygiene	_	_	_	_	_	_	_	_
164	,	_	_	_	_	_	_	_	_
165	and	_	_	_	_	_	_	_	BeginSeg=Yes
166	that	_	_	_	_	_	_	_	_
167	the	_	_	_	_	_	_	_	_
168	growth	_	_	_	_	_	_	_	_
169	of	_	_	_	_	_	_	_	_
170	infection	_	_	_	_	_	_	_	_
171	comes	_	_	_	_	_	_	_	_
172	down	_	_	_	_	_	_	_	_
173	significantly	_	_	_	_	_	_	_	_
174	for	_	_	_	_	_	_	_	_
175	moderately	_	_	_	_	_	_	_	_
176	high	_	_	_	_	_	_	_	_
177	levels	_	_	_	_	_	_	_	_
178	of	_	_	_	_	_	_	_	_
179	social	_	_	_	_	_	_	_	_
180	distancing	_	_	_	_	_	_	_	_
181	and	_	_	_	_	_	_	_	_
182	hygiene	_	_	_	_	_	_	_	_
183	,	_	_	_	_	_	_	_	_
184	even	_	_	_	_	_	_	_	_
185	in	_	_	_	_	_	_	_	_
186	the	_	_	_	_	_	_	_	_
187	absence	_	_	_	_	_	_	_	_
188	of	_	_	_	_	_	_	_	_
189	herd	_	_	_	_	_	_	_	_
190	immunity	_	_	_	_	_	_	_	_
191	.	_	_	_	_	_	_	_	_

# newdoc_id = 0b362bc7e9278b56c2740ab7bc10e91c036f835a
1	We	_	_	_	_	_	_	_	BeginSeg=Yes
2	study	_	_	_	_	_	_	_	_
3	seasonal	_	_	_	_	_	_	_	_
4	epidemic	_	_	_	_	_	_	_	_
5	spreading	_	_	_	_	_	_	_	_
6	in	_	_	_	_	_	_	_	_
7	a	_	_	_	_	_	_	_	_
8	susceptible	_	_	_	_	_	_	_	_
9	-	_	_	_	_	_	_	_	_
10	infected	_	_	_	_	_	_	_	_
11	-	_	_	_	_	_	_	_	_
12	removed	_	_	_	_	_	_	_	_
13	-	_	_	_	_	_	_	_	_
14	susceptible	_	_	_	_	_	_	_	_
15	(	_	_	_	_	_	_	_	_
16	SIRS	_	_	_	_	_	_	_	_
17	)	_	_	_	_	_	_	_	_
18	model	_	_	_	_	_	_	_	_
19	on	_	_	_	_	_	_	_	_
20	smallworld	_	_	_	_	_	_	_	_
21	graphs	_	_	_	_	_	_	_	_
22	.	_	_	_	_	_	_	_	_
23	We	_	_	_	_	_	_	_	BeginSeg=Yes
24	derive	_	_	_	_	_	_	_	_
25	a	_	_	_	_	_	_	_	_
26	mean	_	_	_	_	_	_	_	_
27	-	_	_	_	_	_	_	_	_
28	field	_	_	_	_	_	_	_	_
29	description	_	_	_	_	_	_	_	_
30	that	_	_	_	_	_	_	_	BeginSeg=Yes
31	accurately	_	_	_	_	_	_	_	_
32	captures	_	_	_	_	_	_	_	_
33	the	_	_	_	_	_	_	_	_
34	salient	_	_	_	_	_	_	_	_
35	features	_	_	_	_	_	_	_	_
36	of	_	_	_	_	_	_	_	_
37	the	_	_	_	_	_	_	_	_
38	model	_	_	_	_	_	_	_	_
39	,	_	_	_	_	_	_	_	_
40	most	_	_	_	_	_	_	_	_
41	notably	_	_	_	_	_	_	_	_
42	a	_	_	_	_	_	_	_	_
43	phase	_	_	_	_	_	_	_	_
44	transition	_	_	_	_	_	_	_	_
45	between	_	_	_	_	_	_	_	_
46	annual	_	_	_	_	_	_	_	_
47	and	_	_	_	_	_	_	_	_
48	biennial	_	_	_	_	_	_	_	_
49	outbreaks	_	_	_	_	_	_	_	_
50	.	_	_	_	_	_	_	_	_
51	A	_	_	_	_	_	_	_	BeginSeg=Yes
52	numerical	_	_	_	_	_	_	_	_
53	scaling	_	_	_	_	_	_	_	_
54	analysis	_	_	_	_	_	_	_	_
55	exhibits	_	_	_	_	_	_	_	_
56	a	_	_	_	_	_	_	_	_
57	diverging	_	_	_	_	_	_	_	_
58	autocorrelation	_	_	_	_	_	_	_	_
59	time	_	_	_	_	_	_	_	_
60	in	_	_	_	_	_	_	_	_
61	the	_	_	_	_	_	_	_	_
62	thermodynamic	_	_	_	_	_	_	_	_
63	limit	_	_	_	_	_	_	_	_
64	,	_	_	_	_	_	_	_	_
65	which	_	_	_	_	_	_	_	BeginSeg=Yes
66	confirms	_	_	_	_	_	_	_	_
67	the	_	_	_	_	_	_	_	_
68	presence	_	_	_	_	_	_	_	_
69	of	_	_	_	_	_	_	_	_
70	a	_	_	_	_	_	_	_	_
71	classical	_	_	_	_	_	_	_	_
72	discrete	_	_	_	_	_	_	_	_
73	time	_	_	_	_	_	_	_	_
74	crystalline	_	_	_	_	_	_	_	_
75	phase	_	_	_	_	_	_	_	_
76	.	_	_	_	_	_	_	_	_
77	We	_	_	_	_	_	_	_	BeginSeg=Yes
78	derive	_	_	_	_	_	_	_	_
79	the	_	_	_	_	_	_	_	_
80	phase	_	_	_	_	_	_	_	_
81	diagram	_	_	_	_	_	_	_	_
82	of	_	_	_	_	_	_	_	_
83	the	_	_	_	_	_	_	_	_
84	model	_	_	_	_	_	_	_	_
85	both	_	_	_	_	_	_	_	_
86	from	_	_	_	_	_	_	_	_
87	mean	_	_	_	_	_	_	_	_
88	-	_	_	_	_	_	_	_	_
89	field	_	_	_	_	_	_	_	_
90	theory	_	_	_	_	_	_	_	_
91	and	_	_	_	_	_	_	_	_
92	from	_	_	_	_	_	_	_	_
93	numerics	_	_	_	_	_	_	_	_
94	.	_	_	_	_	_	_	_	_
95	Our	_	_	_	_	_	_	_	BeginSeg=Yes
96	work	_	_	_	_	_	_	_	_
97	offers	_	_	_	_	_	_	_	_
98	new	_	_	_	_	_	_	_	_
99	perspectives	_	_	_	_	_	_	_	_
100	by	_	_	_	_	_	_	_	BeginSeg=Yes
101	demonstrating	_	_	_	_	_	_	_	_
102	that	_	_	_	_	_	_	_	BeginSeg=Yes
103	small	_	_	_	_	_	_	_	_
104	-	_	_	_	_	_	_	_	_
105	worldness	_	_	_	_	_	_	_	_
106	and	_	_	_	_	_	_	_	_
107	non	_	_	_	_	_	_	_	_
108	-	_	_	_	_	_	_	_	_
109	Markovianity	_	_	_	_	_	_	_	_
110	can	_	_	_	_	_	_	_	_
111	stabilize	_	_	_	_	_	_	_	_
112	a	_	_	_	_	_	_	_	_
113	classical	_	_	_	_	_	_	_	_
114	discrete	_	_	_	_	_	_	_	_
115	time	_	_	_	_	_	_	_	_
116	crystal	_	_	_	_	_	_	_	_
117	,	_	_	_	_	_	_	_	_
118	and	_	_	_	_	_	_	_	BeginSeg=Yes
119	by	_	_	_	_	_	_	_	_
120	linking	_	_	_	_	_	_	_	_
121	recent	_	_	_	_	_	_	_	_
122	efforts	_	_	_	_	_	_	_	_
123	to	_	_	_	_	_	_	_	BeginSeg=Yes
124	understand	_	_	_	_	_	_	_	_
125	such	_	_	_	_	_	_	_	_
126	dynamical	_	_	_	_	_	_	_	_
127	phases	_	_	_	_	_	_	_	_
128	of	_	_	_	_	_	_	_	_
129	matter	_	_	_	_	_	_	_	_
130	to	_	_	_	_	_	_	_	BeginSeg=Yes
131	the	_	_	_	_	_	_	_	_
132	century	_	_	_	_	_	_	_	_
133	-	_	_	_	_	_	_	_	_
134	old	_	_	_	_	_	_	_	_
135	problem	_	_	_	_	_	_	_	_
136	of	_	_	_	_	_	_	_	_
137	biennial	_	_	_	_	_	_	_	_
138	epidemics	_	_	_	_	_	_	_	_
139	.	_	_	_	_	_	_	_	_

# newdoc_id = 0b6936373351a029b06b8784ff8077d755e7ee96
1	Ebola	_	_	_	_	_	_	_	BeginSeg=Yes
2	virus	_	_	_	_	_	_	_	_
3	(	_	_	_	_	_	_	_	_
4	EBOV	_	_	_	_	_	_	_	_
5	)	_	_	_	_	_	_	_	_
6	,	_	_	_	_	_	_	_	_
7	a	_	_	_	_	_	_	_	_
8	non	_	_	_	_	_	_	_	_
9	-	_	_	_	_	_	_	_	_
10	segmented	_	_	_	_	_	_	_	_
11	single	_	_	_	_	_	_	_	_
12	-	_	_	_	_	_	_	_	_
13	stranded	_	_	_	_	_	_	_	_
14	RNA	_	_	_	_	_	_	_	_
15	virus	_	_	_	_	_	_	_	_
16	,	_	_	_	_	_	_	_	_
17	is	_	_	_	_	_	_	_	_
18	often	_	_	_	_	_	_	_	_
19	-	_	_	_	_	_	_	_	_
20	most	_	_	_	_	_	_	_	_
21	transmitted	_	_	_	_	_	_	_	_
22	through	_	_	_	_	_	_	_	_
23	body	_	_	_	_	_	_	_	_
24	fluids	_	_	_	_	_	_	_	_
25	like	_	_	_	_	_	_	_	_
26	sweat	_	_	_	_	_	_	_	_
27	,	_	_	_	_	_	_	_	_
28	tears	_	_	_	_	_	_	_	_
29	,	_	_	_	_	_	_	_	_
30	saliva	_	_	_	_	_	_	_	_
31	,	_	_	_	_	_	_	_	_
32	and	_	_	_	_	_	_	_	_
33	nasal	_	_	_	_	_	_	_	_
34	secretions	_	_	_	_	_	_	_	_
35	.	_	_	_	_	_	_	_	_
36	Till	_	_	_	_	_	_	_	BeginSeg=Yes
37	date	_	_	_	_	_	_	_	_
38	,	_	_	_	_	_	_	_	_
39	there	_	_	_	_	_	_	_	_
40	is	_	_	_	_	_	_	_	_
41	no	_	_	_	_	_	_	_	_
42	licensed	_	_	_	_	_	_	_	_
43	vaccine	_	_	_	_	_	_	_	_
44	of	_	_	_	_	_	_	_	_
45	EBOV	_	_	_	_	_	_	_	_
46	is	_	_	_	_	_	_	_	_
47	available	_	_	_	_	_	_	_	_
48	in	_	_	_	_	_	_	_	_
49	the	_	_	_	_	_	_	_	_
50	market	_	_	_	_	_	_	_	_
51	;	_	_	_	_	_	_	_	_
52	however	_	_	_	_	_	_	_	BeginSeg=Yes
53	,	_	_	_	_	_	_	_	_
54	the	_	_	_	_	_	_	_	_
55	world	_	_	_	_	_	_	_	_
56	is	_	_	_	_	_	_	_	_
57	increasingly	_	_	_	_	_	_	_	_
58	vulnerable	_	_	_	_	_	_	_	_
59	to	_	_	_	_	_	_	_	_
60	this	_	_	_	_	_	_	_	_
61	emerging	_	_	_	_	_	_	_	_
62	threat	_	_	_	_	_	_	_	_
63	.	_	_	_	_	_	_	_	_
64	Hence	_	_	_	_	_	_	_	BeginSeg=Yes
65	,	_	_	_	_	_	_	_	_
66	it	_	_	_	_	_	_	_	_
67	is	_	_	_	_	_	_	_	_
68	the	_	_	_	_	_	_	_	_
69	need	_	_	_	_	_	_	_	_
70	of	_	_	_	_	_	_	_	_
71	time	_	_	_	_	_	_	_	_
72	to	_	_	_	_	_	_	_	_
73	develop	_	_	_	_	_	_	_	_
74	a	_	_	_	_	_	_	_	_
75	vaccine	_	_	_	_	_	_	_	_
76	for	_	_	_	_	_	_	_	_
77	EBOV	_	_	_	_	_	_	_	_
78	to	_	_	_	_	_	_	_	BeginSeg=Yes
79	hinder	_	_	_	_	_	_	_	_
80	its	_	_	_	_	_	_	_	_
81	dissemination	_	_	_	_	_	_	_	_
82	.	_	_	_	_	_	_	_	_
83	The	_	_	_	_	_	_	_	BeginSeg=Yes
84	current	_	_	_	_	_	_	_	_
85	study	_	_	_	_	_	_	_	_
86	has	_	_	_	_	_	_	_	_
87	been	_	_	_	_	_	_	_	_
88	designed	_	_	_	_	_	_	_	_
89	for	_	_	_	_	_	_	_	_
90	identification	_	_	_	_	_	_	_	_
91	and	_	_	_	_	_	_	_	_
92	characterization	_	_	_	_	_	_	_	_
93	of	_	_	_	_	_	_	_	_
94	the	_	_	_	_	_	_	_	_
95	potential	_	_	_	_	_	_	_	_
96	B	_	_	_	_	_	_	_	_
97	and	_	_	_	_	_	_	_	_
98	T	_	_	_	_	_	_	_	_
99	-	_	_	_	_	_	_	_	_
100	cell	_	_	_	_	_	_	_	_
101	epitopes	_	_	_	_	_	_	_	_
102	using	_	_	_	_	_	_	_	BeginSeg=Yes
103	the	_	_	_	_	_	_	_	_
104	Immuno	_	_	_	_	_	_	_	_
105	-	_	_	_	_	_	_	_	_
106	informatics	_	_	_	_	_	_	_	_
107	tools	_	_	_	_	_	_	_	_
108	,	_	_	_	_	_	_	_	_
109	and	_	_	_	_	_	_	_	BeginSeg=Yes
110	it	_	_	_	_	_	_	_	_
111	helped	_	_	_	_	_	_	_	_
112	in	_	_	_	_	_	_	_	_
113	finding	_	_	_	_	_	_	_	_
114	the	_	_	_	_	_	_	_	_
115	potent	_	_	_	_	_	_	_	_
116	vaccine	_	_	_	_	_	_	_	_
117	candidates	_	_	_	_	_	_	_	_
118	against	_	_	_	_	_	_	_	_
119	EBOV	_	_	_	_	_	_	_	_
120	.	_	_	_	_	_	_	_	_
121	Prediction	_	_	_	_	_	_	_	BeginSeg=Yes
122	,	_	_	_	_	_	_	_	_
123	antigenicity	_	_	_	_	_	_	_	_
124	and	_	_	_	_	_	_	_	_
125	allergenicity	_	_	_	_	_	_	_	_
126	testing	_	_	_	_	_	_	_	_
127	of	_	_	_	_	_	_	_	_
128	predicted	_	_	_	_	_	_	_	_
129	B	_	_	_	_	_	_	_	_
130	and	_	_	_	_	_	_	_	_
131	T	_	_	_	_	_	_	_	_
132-133	cells'	_	_	_	_	_	_	_	_
132	cells	_	_	_	_	_	_	_	_
133	'	_	_	_	_	_	_	_	_
134	epitopes	_	_	_	_	_	_	_	_
135	was	_	_	_	_	_	_	_	_
136	done	_	_	_	_	_	_	_	_
137	as	_	_	_	_	_	_	_	BeginSeg=Yes
138	well	_	_	_	_	_	_	_	_
139	to	_	_	_	_	_	_	_	_
140	identify	_	_	_	_	_	_	_	_
141	their	_	_	_	_	_	_	_	_
142	potential	_	_	_	_	_	_	_	_
143	as	_	_	_	_	_	_	_	_
144	a	_	_	_	_	_	_	_	_
145	vaccine	_	_	_	_	_	_	_	_
146	candidate	_	_	_	_	_	_	_	_
147	and	_	_	_	_	_	_	_	BeginSeg=Yes
148	to	_	_	_	_	_	_	_	_
149	measure	_	_	_	_	_	_	_	_
150	their	_	_	_	_	_	_	_	_
151	safety	_	_	_	_	_	_	_	_
152	level	_	_	_	_	_	_	_	_
153	respectively	_	_	_	_	_	_	_	_
154	.	_	_	_	_	_	_	_	_
155	Among	_	_	_	_	_	_	_	BeginSeg=Yes
156	B	_	_	_	_	_	_	_	_
157	-	_	_	_	_	_	_	_	_
158	cell	_	_	_	_	_	_	_	_
159	epitopes	_	_	_	_	_	_	_	_
160	"	_	_	_	_	_	_	_	_
161	WIPAGIGVTGVIIA	_	_	_	_	_	_	_	_
162	"	_	_	_	_	_	_	_	_
163	showed	_	_	_	_	_	_	_	_
164	a	_	_	_	_	_	_	_	_
165	high	_	_	_	_	_	_	_	_
166	antigenicity	_	_	_	_	_	_	_	_
167	score	_	_	_	_	_	_	_	_
168	and	_	_	_	_	_	_	_	BeginSeg=Yes
169	it	_	_	_	_	_	_	_	_
170	would	_	_	_	_	_	_	_	_
171	play	_	_	_	_	_	_	_	_
172	an	_	_	_	_	_	_	_	_
173	important	_	_	_	_	_	_	_	_
174	role	_	_	_	_	_	_	_	_
175	in	_	_	_	_	_	_	_	BeginSeg=Yes
176	evoking	_	_	_	_	_	_	_	_
177	the	_	_	_	_	_	_	_	_
178	immune	_	_	_	_	_	_	_	_
179	response	_	_	_	_	_	_	_	_
180	.	_	_	_	_	_	_	_	_
181	In	_	_	_	_	_	_	_	BeginSeg=Yes
182	T	_	_	_	_	_	_	_	_
183	-	_	_	_	_	_	_	_	_
184	cell	_	_	_	_	_	_	_	_
185	epitopes	_	_	_	_	_	_	_	_
186	,	_	_	_	_	_	_	_	_
187	peptides	_	_	_	_	_	_	_	_
188	"	_	_	_	_	_	_	_	_
189	AIGLAWIPY	_	_	_	_	_	_	_	_
190	"	_	_	_	_	_	_	_	_
191	and	_	_	_	_	_	_	_	_
192	"	_	_	_	_	_	_	_	_
193	IRGFPRCRY	_	_	_	_	_	_	_	_
194	"	_	_	_	_	_	_	_	_
195	presented	_	_	_	_	_	_	_	_
196	high	_	_	_	_	_	_	_	_
197	antigenicity	_	_	_	_	_	_	_	_
198	score	_	_	_	_	_	_	_	_
199	,	_	_	_	_	_	_	_	_
200	which	_	_	_	_	_	_	_	BeginSeg=Yes
201	binds	_	_	_	_	_	_	_	_
202	to	_	_	_	_	_	_	_	_
203	MHC	_	_	_	_	_	_	_	_
204	class	_	_	_	_	_	_	_	_
205	-	_	_	_	_	_	_	_	_
206	I	_	_	_	_	_	_	_	_
207	and	_	_	_	_	_	_	_	_
208	MHC	_	_	_	_	_	_	_	_
209	class	_	_	_	_	_	_	_	_
210	-	_	_	_	_	_	_	_	_
211	II	_	_	_	_	_	_	_	_
212	alleles	_	_	_	_	_	_	_	_
213	respectively	_	_	_	_	_	_	_	_
214	.	_	_	_	_	_	_	_	_
215	All	_	_	_	_	_	_	_	BeginSeg=Yes
216	predicted	_	_	_	_	_	_	_	_
217	epitopes	_	_	_	_	_	_	_	_
218	were	_	_	_	_	_	_	_	_
219	analyzed	_	_	_	_	_	_	_	_
220	and	_	_	_	_	_	_	_	BeginSeg=Yes
221	compared	_	_	_	_	_	_	_	_
222	with	_	_	_	_	_	_	_	_
223	already	_	_	_	_	_	_	_	_
224	reported	_	_	_	_	_	_	_	_
225	peptides	_	_	_	_	_	_	_	_
226	carefully	_	_	_	_	_	_	_	_
227	.	_	_	_	_	_	_	_	_
228	Comparatively	_	_	_	_	_	_	_	BeginSeg=Yes
229	,	_	_	_	_	_	_	_	_
230	Peptides	_	_	_	_	_	_	_	_
231	predicted	_	_	_	_	_	_	_	BeginSeg=Yes
232	in	_	_	_	_	_	_	_	_
233	the	_	_	_	_	_	_	_	_
234	present	_	_	_	_	_	_	_	_
235	study	_	_	_	_	_	_	_	_
236	showed	_	_	_	_	_	_	_	BeginSeg=Yes
237	more	_	_	_	_	_	_	_	_
238	immunogenicity	_	_	_	_	_	_	_	_
239	score	_	_	_	_	_	_	_	_
240	than	_	_	_	_	_	_	_	_
241	already	_	_	_	_	_	_	_	_
242	reported	_	_	_	_	_	_	_	_
243	peptides	_	_	_	_	_	_	_	_
244	,	_	_	_	_	_	_	_	_
245	used	_	_	_	_	_	_	_	BeginSeg=Yes
246	as	_	_	_	_	_	_	_	_
247	positive	_	_	_	_	_	_	_	_
248	control	_	_	_	_	_	_	_	_
249	,	_	_	_	_	_	_	_	_
250	and	_	_	_	_	_	_	_	BeginSeg=Yes
251	are	_	_	_	_	_	_	_	_
252	more	_	_	_	_	_	_	_	_
253	immunogenic	_	_	_	_	_	_	_	_
254	as	_	_	_	_	_	_	_	BeginSeg=Yes
255	compared	_	_	_	_	_	_	_	_
256	to	_	_	_	_	_	_	_	_
257	them	_	_	_	_	_	_	_	_
258	.	_	_	_	_	_	_	_	_

# newdoc_id = 0b7581ab8ae5da78a11692b4c7d9399ec6dea283
1	Background	_	_	_	_	_	_	_	BeginSeg=Yes
2	:	_	_	_	_	_	_	_	_
3	In	_	_	_	_	_	_	_	BeginSeg=Yes
4	this	_	_	_	_	_	_	_	_
5	study	_	_	_	_	_	_	_	_
6	we	_	_	_	_	_	_	_	_
7	evaluated	_	_	_	_	_	_	_	_
8	the	_	_	_	_	_	_	_	_
9	RespoCheck	_	_	_	_	_	_	_	_
10	Mycoplasma	_	_	_	_	_	_	_	_
11	triplex	_	_	_	_	_	_	_	_
12	real	_	_	_	_	_	_	_	_
13	-	_	_	_	_	_	_	_	_
14	time	_	_	_	_	_	_	_	_
15	PCR	_	_	_	_	_	_	_	_
16	for	_	_	_	_	_	_	_	_
17	the	_	_	_	_	_	_	_	_
18	detection	_	_	_	_	_	_	_	_
19	in	_	_	_	_	_	_	_	_
20	bronchoalveolar	_	_	_	_	_	_	_	_
21	lavage	_	_	_	_	_	_	_	_
22	fluid	_	_	_	_	_	_	_	_
23	(	_	_	_	_	_	_	_	_
24	BALF	_	_	_	_	_	_	_	_
25	)	_	_	_	_	_	_	_	_
26	of	_	_	_	_	_	_	_	_
27	Mycoplasma	_	_	_	_	_	_	_	_
28	(	_	_	_	_	_	_	_	_
29	M.	_	_	_	_	_	_	_	_
30	)	_	_	_	_	_	_	_	_
31	dispar	_	_	_	_	_	_	_	_
32	,	_	_	_	_	_	_	_	_
33	M.	_	_	_	_	_	_	_	_
34	bovis	_	_	_	_	_	_	_	_
35	and	_	_	_	_	_	_	_	_
36	M.	_	_	_	_	_	_	_	_
37	bovirhinis	_	_	_	_	_	_	_	_
38	,	_	_	_	_	_	_	_	_
39	all	_	_	_	_	_	_	_	BeginSeg=Yes
40	three	_	_	_	_	_	_	_	_
41	associated	_	_	_	_	_	_	_	_
42	with	_	_	_	_	_	_	_	_
43	bovine	_	_	_	_	_	_	_	_
44	respiratory	_	_	_	_	_	_	_	_
45	disease	_	_	_	_	_	_	_	_
46	(	_	_	_	_	_	_	_	_
47	BRD	_	_	_	_	_	_	_	_
48	)	_	_	_	_	_	_	_	_
49	.	_	_	_	_	_	_	_	_
50	Primers	_	_	_	_	_	_	_	BeginSeg=Yes
51	and	_	_	_	_	_	_	_	_
52	probes	_	_	_	_	_	_	_	_
53	of	_	_	_	_	_	_	_	_
54	the	_	_	_	_	_	_	_	_
55	RespoCheck	_	_	_	_	_	_	_	_
56	Mycoplasma	_	_	_	_	_	_	_	_
57	triplex	_	_	_	_	_	_	_	_
58	real	_	_	_	_	_	_	_	_
59	-	_	_	_	_	_	_	_	_
60	time	_	_	_	_	_	_	_	_
61	PCR	_	_	_	_	_	_	_	_
62	are	_	_	_	_	_	_	_	_
63	based	_	_	_	_	_	_	_	_
64	on	_	_	_	_	_	_	_	_
65	the	_	_	_	_	_	_	_	_
66	V3	_	_	_	_	_	_	_	_
67	/	_	_	_	_	_	_	_	_
68	V4	_	_	_	_	_	_	_	_
69	region	_	_	_	_	_	_	_	_
70	of	_	_	_	_	_	_	_	_
71	the	_	_	_	_	_	_	_	_
72	16S	_	_	_	_	_	_	_	_
73	rRNA	_	_	_	_	_	_	_	_
74	gene	_	_	_	_	_	_	_	_
75	of	_	_	_	_	_	_	_	_
76	the	_	_	_	_	_	_	_	_
77	three	_	_	_	_	_	_	_	_
78	Mycoplasma	_	_	_	_	_	_	_	_
79	species	_	_	_	_	_	_	_	_
80	.	_	_	_	_	_	_	_	_
81	Results	_	_	_	_	_	_	_	BeginSeg=Yes
82	:	_	_	_	_	_	_	_	_
83	The	_	_	_	_	_	_	_	BeginSeg=Yes
84	analytical	_	_	_	_	_	_	_	_
85	sensitivity	_	_	_	_	_	_	_	_
86	of	_	_	_	_	_	_	_	_
87	the	_	_	_	_	_	_	_	_
88	RespoCheck	_	_	_	_	_	_	_	_
89	triplex	_	_	_	_	_	_	_	_
90	real	_	_	_	_	_	_	_	_
91	-	_	_	_	_	_	_	_	_
92	time	_	_	_	_	_	_	_	_
93	PCR	_	_	_	_	_	_	_	_
94	was	_	_	_	_	_	_	_	_
95	,	_	_	_	_	_	_	_	_
96	as	_	_	_	_	_	_	_	BeginSeg=Yes
97	determined	_	_	_	_	_	_	_	_
98	by	_	_	_	_	_	_	_	_
99	spiking	_	_	_	_	_	_	_	_
100	experiments	_	_	_	_	_	_	_	_
101	of	_	_	_	_	_	_	_	_
102	the	_	_	_	_	_	_	_	_
103	Mycoplasma	_	_	_	_	_	_	_	_
104	strains	_	_	_	_	_	_	_	_
105	in	_	_	_	_	_	_	_	_
106	Phosphate	_	_	_	_	_	_	_	_
107	Buffered	_	_	_	_	_	_	_	_
108	Saline	_	_	_	_	_	_	_	_
109	,	_	_	_	_	_	_	_	_
110	300	_	_	_	_	_	_	_	BeginSeg=Yes
111	colony	_	_	_	_	_	_	_	_
112	forming	_	_	_	_	_	_	_	_
113	units	_	_	_	_	_	_	_	_
114	(	_	_	_	_	_	_	_	_
115	cfu)/mL	_	_	_	_	_	_	_	_
116	for	_	_	_	_	_	_	_	_
117	M.	_	_	_	_	_	_	_	_
118	dispar	_	_	_	_	_	_	_	_
119	,	_	_	_	_	_	_	_	_
120	and	_	_	_	_	_	_	_	_
121	30	_	_	_	_	_	_	_	_
122	cfu	_	_	_	_	_	_	_	_
123	/	_	_	_	_	_	_	_	_
124	mL	_	_	_	_	_	_	_	_
125	for	_	_	_	_	_	_	_	_
126	M.	_	_	_	_	_	_	_	_
127	bovis	_	_	_	_	_	_	_	_
128	or	_	_	_	_	_	_	_	_
129	M.	_	_	_	_	_	_	_	_
130	bovirhinis	_	_	_	_	_	_	_	_
131	.	_	_	_	_	_	_	_	_
132	The	_	_	_	_	_	_	_	BeginSeg=Yes
133	analytical	_	_	_	_	_	_	_	_
134	sensitivity	_	_	_	_	_	_	_	_
135	of	_	_	_	_	_	_	_	_
136	the	_	_	_	_	_	_	_	_
137	RespoCheck	_	_	_	_	_	_	_	_
138	Mycoplasma	_	_	_	_	_	_	_	_
139	triplex	_	_	_	_	_	_	_	_
140	real	_	_	_	_	_	_	_	_
141	-	_	_	_	_	_	_	_	_
142	time	_	_	_	_	_	_	_	_
143	PCR	_	_	_	_	_	_	_	_
144	was	_	_	_	_	_	_	_	_
145	,	_	_	_	_	_	_	_	_
146	as	_	_	_	_	_	_	_	BeginSeg=Yes
147	determined	_	_	_	_	_	_	_	_
148	on	_	_	_	_	_	_	_	_
149	purified	_	_	_	_	_	_	_	_
150	DNA	_	_	_	_	_	_	_	_
151	,	_	_	_	_	_	_	_	_
152	10	_	_	_	_	_	_	_	BeginSeg=Yes
153	fg	_	_	_	_	_	_	_	_
154	DNA	_	_	_	_	_	_	_	_
155	per	_	_	_	_	_	_	_	_
156	assay	_	_	_	_	_	_	_	_
157	for	_	_	_	_	_	_	_	_
158	M.	_	_	_	_	_	_	_	_
159	dispar	_	_	_	_	_	_	_	_
160	and	_	_	_	_	_	_	_	_
161	100	_	_	_	_	_	_	_	_
162	fg	_	_	_	_	_	_	_	_
163	fo	_	_	_	_	_	_	_	_
164	rM.	_	_	_	_	_	_	_	_
165	bovis	_	_	_	_	_	_	_	_
166	and	_	_	_	_	_	_	_	_
167	M.	_	_	_	_	_	_	_	_
168	bovirhinis	_	_	_	_	_	_	_	_
169	.	_	_	_	_	_	_	_	_
170	The	_	_	_	_	_	_	_	BeginSeg=Yes
171	analytical	_	_	_	_	_	_	_	_
172	specificity	_	_	_	_	_	_	_	_
173	of	_	_	_	_	_	_	_	_
174	the	_	_	_	_	_	_	_	_
175	RespoCheck	_	_	_	_	_	_	_	_
176	Mycoplasma	_	_	_	_	_	_	_	_
177	triplex	_	_	_	_	_	_	_	_
178	real	_	_	_	_	_	_	_	_
179	-	_	_	_	_	_	_	_	_
180	time	_	_	_	_	_	_	_	_
181	PCR	_	_	_	_	_	_	_	_
182	was	_	_	_	_	_	_	_	_
183	,	_	_	_	_	_	_	_	_
184	as	_	_	_	_	_	_	_	BeginSeg=Yes
185	determined	_	_	_	_	_	_	_	_
186	by	_	_	_	_	_	_	_	_
187	testing	_	_	_	_	_	_	_	_
188	Mycoplasmas	_	_	_	_	_	_	_	_
189	strains	_	_	_	_	_	_	_	_
190	(	_	_	_	_	_	_	_	BeginSeg=Yes
191	n	_	_	_	_	_	_	_	_
192	=	_	_	_	_	_	_	_	_
193	17	_	_	_	_	_	_	_	_
194	)	_	_	_	_	_	_	_	_
195	and	_	_	_	_	_	_	_	BeginSeg=Yes
196	other	_	_	_	_	_	_	_	_
197	bacterial	_	_	_	_	_	_	_	_
198	strains	_	_	_	_	_	_	_	_
199	(	_	_	_	_	_	_	_	BeginSeg=Yes
200	n	_	_	_	_	_	_	_	_
201	=	_	_	_	_	_	_	_	_
202	107	_	_	_	_	_	_	_	_
203	)	_	_	_	_	_	_	_	_
204	,	_	_	_	_	_	_	_	_
205	100	_	_	_	_	_	_	_	BeginSeg=Yes
206	,	_	_	_	_	_	_	_	_
207	98.2	_	_	_	_	_	_	_	_
208	and	_	_	_	_	_	_	_	_
209	99.1	_	_	_	_	_	_	_	_
210	%	_	_	_	_	_	_	_	_
211	for	_	_	_	_	_	_	_	_
212	M.	_	_	_	_	_	_	_	_
213	bovis	_	_	_	_	_	_	_	_
214	,	_	_	_	_	_	_	_	_
215	M.	_	_	_	_	_	_	_	_
216	dispar	_	_	_	_	_	_	_	_
217	and	_	_	_	_	_	_	_	_
218	M.	_	_	_	_	_	_	_	_
219	bovirhinis	_	_	_	_	_	_	_	_
220	respectively	_	_	_	_	_	_	_	_
221	.	_	_	_	_	_	_	_	_
222	The	_	_	_	_	_	_	_	BeginSeg=Yes
223	RespoCheck	_	_	_	_	_	_	_	_
224	Mycoplasma	_	_	_	_	_	_	_	_
225	triplex	_	_	_	_	_	_	_	_
226	real	_	_	_	_	_	_	_	_
227	-	_	_	_	_	_	_	_	_
228	time	_	_	_	_	_	_	_	_
229	PCR	_	_	_	_	_	_	_	_
230	was	_	_	_	_	_	_	_	_
231	compared	_	_	_	_	_	_	_	_
232	with	_	_	_	_	_	_	_	_
233	the	_	_	_	_	_	_	_	_
234	PCR	_	_	_	_	_	_	_	_
235	/	_	_	_	_	_	_	_	_
236	DGGE	_	_	_	_	_	_	_	_
237	analysis	_	_	_	_	_	_	_	_
238	for	_	_	_	_	_	_	_	_
239	M.	_	_	_	_	_	_	_	_
240	bovis	_	_	_	_	_	_	_	_
241	,	_	_	_	_	_	_	_	_
242	M.	_	_	_	_	_	_	_	_
243	dispar	_	_	_	_	_	_	_	_
244	and	_	_	_	_	_	_	_	_
245	M.	_	_	_	_	_	_	_	_
246	bovirhinis	_	_	_	_	_	_	_	_
247	respectively	_	_	_	_	_	_	_	_
248	by	_	_	_	_	_	_	_	BeginSeg=Yes
249	testing	_	_	_	_	_	_	_	_
250	44	_	_	_	_	_	_	_	_
251	BALF	_	_	_	_	_	_	_	_
252	samples	_	_	_	_	_	_	_	_
253	from	_	_	_	_	_	_	_	_
254	calves	_	_	_	_	_	_	_	_
255	.	_	_	_	_	_	_	_	_
256	Conclusion	_	_	_	_	_	_	_	BeginSeg=Yes
257	:	_	_	_	_	_	_	_	_
258	In	_	_	_	_	_	_	_	BeginSeg=Yes
259	conclusion	_	_	_	_	_	_	_	_
260	,	_	_	_	_	_	_	_	_
261	the	_	_	_	_	_	_	_	_
262	RespoCheck	_	_	_	_	_	_	_	_
263	PCR	_	_	_	_	_	_	_	_
264	assay	_	_	_	_	_	_	_	_
265	can	_	_	_	_	_	_	_	_
266	be	_	_	_	_	_	_	_	_
267	a	_	_	_	_	_	_	_	_
268	valuable	_	_	_	_	_	_	_	_
269	tool	_	_	_	_	_	_	_	_
270	for	_	_	_	_	_	_	_	_
271	timely	_	_	_	_	_	_	_	_
272	and	_	_	_	_	_	_	_	_
273	accurate	_	_	_	_	_	_	_	_
274	detection	_	_	_	_	_	_	_	_
275	of	_	_	_	_	_	_	_	_
276	three	_	_	_	_	_	_	_	_
277	Mycoplasma	_	_	_	_	_	_	_	_
278	species	_	_	_	_	_	_	_	_
279	associated	_	_	_	_	_	_	_	BeginSeg=Yes
280	with	_	_	_	_	_	_	_	_
281	in	_	_	_	_	_	_	_	_
282	bovine	_	_	_	_	_	_	_	_
283	respiratory	_	_	_	_	_	_	_	_
284	disease	_	_	_	_	_	_	_	_
285	.	_	_	_	_	_	_	_	_

# newdoc_id = 0c44f901baca3850ff6e79e5f26ee898faa9b68d
1	Emerging	_	_	_	_	_	_	_	BeginSeg=Yes
2	and	_	_	_	_	_	_	_	_
3	re	_	_	_	_	_	_	_	_
4	-	_	_	_	_	_	_	_	_
5	emerging	_	_	_	_	_	_	_	_
6	infectious	_	_	_	_	_	_	_	_
7	diseases	_	_	_	_	_	_	_	_
8	,	_	_	_	_	_	_	_	_
9	and	_	_	_	_	_	_	_	_
10	their	_	_	_	_	_	_	_	_
11	determinants	_	_	_	_	_	_	_	_
12	,	_	_	_	_	_	_	_	_
13	have	_	_	_	_	_	_	_	_
14	recently	_	_	_	_	_	_	_	_
15	attracted	_	_	_	_	_	_	_	_
16	substantial	_	_	_	_	_	_	_	_
17	scientific	_	_	_	_	_	_	_	_
18	and	_	_	_	_	_	_	_	_
19	popular	_	_	_	_	_	_	_	_
20	attention	_	_	_	_	_	_	_	_
21	.	_	_	_	_	_	_	_	_
22	HIV	_	_	_	_	_	_	_	BeginSeg=Yes
23	/	_	_	_	_	_	_	_	_
24	AIDS	_	_	_	_	_	_	_	_
25	,	_	_	_	_	_	_	_	_
26	severe	_	_	_	_	_	_	_	_
27	acute	_	_	_	_	_	_	_	_
28	respiratory	_	_	_	_	_	_	_	_
29	syndrome	_	_	_	_	_	_	_	_
30	,	_	_	_	_	_	_	_	_
31	H5N1	_	_	_	_	_	_	_	_
32	avian	_	_	_	_	_	_	_	_
33	influenza	_	_	_	_	_	_	_	_
34	,	_	_	_	_	_	_	_	_
35	and	_	_	_	_	_	_	_	_
36	many	_	_	_	_	_	_	_	_
37	other	_	_	_	_	_	_	_	_
38	emerging	_	_	_	_	_	_	_	_
39	diseases	_	_	_	_	_	_	_	_
40	have	_	_	_	_	_	_	_	_
41	either	_	_	_	_	_	_	_	_
42	proved	_	_	_	_	_	_	_	_
43	fatal	_	_	_	_	_	_	_	_
44	or	_	_	_	_	_	_	_	BeginSeg=Yes
45	caused	_	_	_	_	_	_	_	_
46	international	_	_	_	_	_	_	_	_
47	alarm	_	_	_	_	_	_	_	_
48	.	_	_	_	_	_	_	_	_
49	Common	_	_	_	_	_	_	_	BeginSeg=Yes
50	and	_	_	_	_	_	_	_	_
51	interactive	_	_	_	_	_	_	_	_
52	co	_	_	_	_	_	_	_	_
53	-	_	_	_	_	_	_	_	_
54	determinants	_	_	_	_	_	_	_	_
55	of	_	_	_	_	_	_	_	_
56	disease	_	_	_	_	_	_	_	_
57	emergence	_	_	_	_	_	_	_	_
58	,	_	_	_	_	_	_	_	_
59	including	_	_	_	_	_	_	_	BeginSeg=Yes
60	population	_	_	_	_	_	_	_	_
61	growth	_	_	_	_	_	_	_	_
62	,	_	_	_	_	_	_	_	_
63	travel	_	_	_	_	_	_	_	_
64	,	_	_	_	_	_	_	_	_
65	and	_	_	_	_	_	_	_	_
66	environmental	_	_	_	_	_	_	_	_
67	disruption	_	_	_	_	_	_	_	_
68	,	_	_	_	_	_	_	_	_
69	have	_	_	_	_	_	_	_	BeginSeg=Yes
70	been	_	_	_	_	_	_	_	_
71	increasingly	_	_	_	_	_	_	_	_
72	documented	_	_	_	_	_	_	_	_
73	and	_	_	_	_	_	_	_	BeginSeg=Yes
74	studied	_	_	_	_	_	_	_	_
75	.	_	_	_	_	_	_	_	_
76	Are	_	_	_	_	_	_	_	BeginSeg=Yes
77	emerging	_	_	_	_	_	_	_	_
78	infections	_	_	_	_	_	_	_	_
79	a	_	_	_	_	_	_	_	_
80	new	_	_	_	_	_	_	_	_
81	phenomenon	_	_	_	_	_	_	_	_
82	related	_	_	_	_	_	_	_	BeginSeg=Yes
83	to	_	_	_	_	_	_	_	_
84	modern	_	_	_	_	_	_	_	_
85	life	_	_	_	_	_	_	_	_
86	,	_	_	_	_	_	_	_	_
87	or	_	_	_	_	_	_	_	BeginSeg=Yes
88	do	_	_	_	_	_	_	_	_
89	more	_	_	_	_	_	_	_	_
90	basic	_	_	_	_	_	_	_	_
91	determinants	_	_	_	_	_	_	_	_
92	,	_	_	_	_	_	_	_	_
93	transcending	_	_	_	_	_	_	_	BeginSeg=Yes
94	time	_	_	_	_	_	_	_	_
95	,	_	_	_	_	_	_	_	_
96	place	_	_	_	_	_	_	_	_
97	,	_	_	_	_	_	_	_	_
98	and	_	_	_	_	_	_	_	_
99	human	_	_	_	_	_	_	_	_
100	progress	_	_	_	_	_	_	_	_
101	,	_	_	_	_	_	_	_	_
102	govern	_	_	_	_	_	_	_	BeginSeg=Yes
103	disease	_	_	_	_	_	_	_	_
104	generation	_	_	_	_	_	_	_	_
105	?	_	_	_	_	_	_	_	_
106	By	_	_	_	_	_	_	_	BeginSeg=Yes
107	examining	_	_	_	_	_	_	_	_
108	a	_	_	_	_	_	_	_	_
109	number	_	_	_	_	_	_	_	_
110	of	_	_	_	_	_	_	_	_
111	historically	_	_	_	_	_	_	_	_
112	notable	_	_	_	_	_	_	_	_
113	epidemics	_	_	_	_	_	_	_	_
114	,	_	_	_	_	_	_	_	_
115	we	_	_	_	_	_	_	_	BeginSeg=Yes
116	suggest	_	_	_	_	_	_	_	_
117	that	_	_	_	_	_	_	_	BeginSeg=Yes
118	emerging	_	_	_	_	_	_	_	_
119	diseases	_	_	_	_	_	_	_	_
120	,	_	_	_	_	_	_	_	_
121	similar	_	_	_	_	_	_	_	BeginSeg=Yes
122	in	_	_	_	_	_	_	_	_
123	their	_	_	_	_	_	_	_	_
124	novelty	_	_	_	_	_	_	_	_
125	,	_	_	_	_	_	_	_	_
126	impact	_	_	_	_	_	_	_	_
127	,	_	_	_	_	_	_	_	_
128	and	_	_	_	_	_	_	_	_
129	elicitation	_	_	_	_	_	_	_	_
130	of	_	_	_	_	_	_	_	_
131	control	_	_	_	_	_	_	_	_
132	responses	_	_	_	_	_	_	_	_
133	,	_	_	_	_	_	_	_	_
134	have	_	_	_	_	_	_	_	BeginSeg=Yes
135	occurred	_	_	_	_	_	_	_	_
136	throughout	_	_	_	_	_	_	_	_
137	recorded	_	_	_	_	_	_	_	_
138	history	_	_	_	_	_	_	_	_
139	.	_	_	_	_	_	_	_	_
140	Fundamental	_	_	_	_	_	_	_	BeginSeg=Yes
141	determinants	_	_	_	_	_	_	_	_
142	,	_	_	_	_	_	_	_	_
143	typically	_	_	_	_	_	_	_	BeginSeg=Yes
144	acting	_	_	_	_	_	_	_	_
145	in	_	_	_	_	_	_	_	_
146	concert	_	_	_	_	_	_	_	_
147	,	_	_	_	_	_	_	_	_
148	seem	_	_	_	_	_	_	_	BeginSeg=Yes
149	to	_	_	_	_	_	_	_	_
150	underlie	_	_	_	_	_	_	_	_
151	their	_	_	_	_	_	_	_	_
152	emergence	_	_	_	_	_	_	_	_
153	,	_	_	_	_	_	_	_	_
154	and	_	_	_	_	_	_	_	BeginSeg=Yes
155	infections	_	_	_	_	_	_	_	_
156	such	_	_	_	_	_	_	_	_
157	as	_	_	_	_	_	_	_	_
158	these	_	_	_	_	_	_	_	_
159	are	_	_	_	_	_	_	_	_
160	likely	_	_	_	_	_	_	_	_
161	to	_	_	_	_	_	_	_	_
162	continue	_	_	_	_	_	_	_	_
163	to	_	_	_	_	_	_	_	_
164	remain	_	_	_	_	_	_	_	_
165	challenges	_	_	_	_	_	_	_	_
166	to	_	_	_	_	_	_	_	_
167	human	_	_	_	_	_	_	_	_
168	survival	_	_	_	_	_	_	_	_
169	.	_	_	_	_	_	_	_	_

# newdoc_id = 1399e34d62b515e482ccde6c4cae500b19546909
1	Influenza	_	_	_	_	_	_	_	BeginSeg=Yes
2	viruses	_	_	_	_	_	_	_	_
3	are	_	_	_	_	_	_	_	_
4	among	_	_	_	_	_	_	_	_
5	the	_	_	_	_	_	_	_	_
6	major	_	_	_	_	_	_	_	_
7	infectious	_	_	_	_	_	_	_	_
8	disease	_	_	_	_	_	_	_	_
9	threats	_	_	_	_	_	_	_	_
10	of	_	_	_	_	_	_	_	_
11	animal	_	_	_	_	_	_	_	_
12	and	_	_	_	_	_	_	_	_
13	human	_	_	_	_	_	_	_	_
14	health	_	_	_	_	_	_	_	_
15	.	_	_	_	_	_	_	_	_
16	This	_	_	_	_	_	_	_	BeginSeg=Yes
17	review	_	_	_	_	_	_	_	_
18	examines	_	_	_	_	_	_	_	_
19	the	_	_	_	_	_	_	_	_
20	recent	_	_	_	_	_	_	_	_
21	discovery	_	_	_	_	_	_	_	_
22	of	_	_	_	_	_	_	_	_
23	novel	_	_	_	_	_	_	_	_
24	influenza	_	_	_	_	_	_	_	_
25	viruses	_	_	_	_	_	_	_	_
26	in	_	_	_	_	_	_	_	_
27	bats	_	_	_	_	_	_	_	_
28	and	_	_	_	_	_	_	_	_
29	cattle	_	_	_	_	_	_	_	_
30	,	_	_	_	_	_	_	_	_
31	the	_	_	_	_	_	_	_	_
32	evolving	_	_	_	_	_	_	_	_
33	complexity	_	_	_	_	_	_	_	_
34	of	_	_	_	_	_	_	_	_
35	influenza	_	_	_	_	_	_	_	_
36	virus	_	_	_	_	_	_	_	_
37	host	_	_	_	_	_	_	_	_
38	range	_	_	_	_	_	_	_	_
39	including	_	_	_	_	_	_	_	BeginSeg=Yes
40	the	_	_	_	_	_	_	_	_
41	ability	_	_	_	_	_	_	_	_
42	to	_	_	_	_	_	_	_	BeginSeg=Yes
43	cross	_	_	_	_	_	_	_	_
44	species	_	_	_	_	_	_	_	_
45	barriers	_	_	_	_	_	_	_	_
46	and	_	_	_	_	_	_	_	_
47	geographic	_	_	_	_	_	_	_	_
48	boundaries	_	_	_	_	_	_	_	_
49	,	_	_	_	_	_	_	_	_
50	and	_	_	_	_	_	_	_	BeginSeg=Yes
51	implications	_	_	_	_	_	_	_	_
52	to	_	_	_	_	_	_	_	_
53	animal	_	_	_	_	_	_	_	_
54	and	_	_	_	_	_	_	_	_
55	human	_	_	_	_	_	_	_	_
56	health	_	_	_	_	_	_	_	_
57	.	_	_	_	_	_	_	_	_

# newdoc_id = 13e4291652008b528006f89f67d55955c2aac729
1	Hepatitis	_	_	_	_	_	_	_	BeginSeg=Yes
2	B	_	_	_	_	_	_	_	_
3	virus	_	_	_	_	_	_	_	_
4	(	_	_	_	_	_	_	_	_
5	HBV	_	_	_	_	_	_	_	_
6	)	_	_	_	_	_	_	_	_
7	is	_	_	_	_	_	_	_	_
8	a	_	_	_	_	_	_	_	_
9	DNA	_	_	_	_	_	_	_	_
10	virus	_	_	_	_	_	_	_	_
11	that	_	_	_	_	_	_	_	BeginSeg=Yes
12	infects	_	_	_	_	_	_	_	_
13	the	_	_	_	_	_	_	_	_
14	liver	_	_	_	_	_	_	_	_
15	as	_	_	_	_	_	_	_	_
16	primary	_	_	_	_	_	_	_	_
17	target	_	_	_	_	_	_	_	_
18	.	_	_	_	_	_	_	_	_
19	Currently	_	_	_	_	_	_	_	BeginSeg=Yes
20	,	_	_	_	_	_	_	_	_
21	a	_	_	_	_	_	_	_	_
22	high	_	_	_	_	_	_	_	_
23	affinity	_	_	_	_	_	_	_	_
24	receptor	_	_	_	_	_	_	_	_
25	for	_	_	_	_	_	_	_	_
26	HBV	_	_	_	_	_	_	_	_
27	is	_	_	_	_	_	_	_	_
28	still	_	_	_	_	_	_	_	_
29	unknown	_	_	_	_	_	_	_	_
30	.	_	_	_	_	_	_	_	_
31	The	_	_	_	_	_	_	_	BeginSeg=Yes
32	dendritic	_	_	_	_	_	_	_	_
33	cell	_	_	_	_	_	_	_	_
34	specific	_	_	_	_	_	_	_	_
35	C	_	_	_	_	_	_	_	_
36	-	_	_	_	_	_	_	_	_
37	type	_	_	_	_	_	_	_	_
38	lectin	_	_	_	_	_	_	_	_
39	DC	_	_	_	_	_	_	_	_
40	-	_	_	_	_	_	_	_	_
41	SIGN	_	_	_	_	_	_	_	_
42	is	_	_	_	_	_	_	_	_
43	involved	_	_	_	_	_	_	_	_
44	in	_	_	_	_	_	_	_	_
45	pathogen	_	_	_	_	_	_	_	_
46	recognition	_	_	_	_	_	_	_	_
47	through	_	_	_	_	_	_	_	_
48	mannose	_	_	_	_	_	_	_	_
49	and	_	_	_	_	_	_	_	_
50	fucose	_	_	_	_	_	_	_	_
51	containing	_	_	_	_	_	_	_	BeginSeg=Yes
52	carbohydrates	_	_	_	_	_	_	_	_
53	leading	_	_	_	_	_	_	_	BeginSeg=Yes
54	to	_	_	_	_	_	_	_	_
55	the	_	_	_	_	_	_	_	_
56	induction	_	_	_	_	_	_	_	_
57	of	_	_	_	_	_	_	_	_
58	an	_	_	_	_	_	_	_	_
59	anti	_	_	_	_	_	_	_	_
60	-	_	_	_	_	_	_	_	_
61	viral	_	_	_	_	_	_	_	_
62	immune	_	_	_	_	_	_	_	_
63	response	_	_	_	_	_	_	_	_
64	.	_	_	_	_	_	_	_	_
65	Many	_	_	_	_	_	_	_	BeginSeg=Yes
66	glycosylated	_	_	_	_	_	_	_	_
67	viruses	_	_	_	_	_	_	_	_
68	subvert	_	_	_	_	_	_	_	_
69	this	_	_	_	_	_	_	_	_
70	immune	_	_	_	_	_	_	_	_
71	surveillance	_	_	_	_	_	_	_	_
72	function	_	_	_	_	_	_	_	_
73	and	_	_	_	_	_	_	_	BeginSeg=Yes
74	exploit	_	_	_	_	_	_	_	_
75	DC	_	_	_	_	_	_	_	_
76	-	_	_	_	_	_	_	_	_
77	SIGN	_	_	_	_	_	_	_	_
78	as	_	_	_	_	_	_	_	_
79	a	_	_	_	_	_	_	_	_
80	port	_	_	_	_	_	_	_	_
81	of	_	_	_	_	_	_	_	_
82	entry	_	_	_	_	_	_	_	_
83	and	_	_	_	_	_	_	_	_
84	for	_	_	_	_	_	_	_	_
85	trans	_	_	_	_	_	_	_	_
86	-	_	_	_	_	_	_	_	_
87	infection	_	_	_	_	_	_	_	_
88	of	_	_	_	_	_	_	_	_
89	target	_	_	_	_	_	_	_	_
90	cells	_	_	_	_	_	_	_	_
91	.	_	_	_	_	_	_	_	_
92	The	_	_	_	_	_	_	_	BeginSeg=Yes
93	glycosylation	_	_	_	_	_	_	_	_
94	pattern	_	_	_	_	_	_	_	_
95	on	_	_	_	_	_	_	_	_
96	HBV	_	_	_	_	_	_	_	_
97	surface	_	_	_	_	_	_	_	_
98	antigens	_	_	_	_	_	_	_	_
99	(	_	_	_	_	_	_	_	_
100	HBsAg	_	_	_	_	_	_	_	_
101	)	_	_	_	_	_	_	_	_
102	together	_	_	_	_	_	_	_	_
103	with	_	_	_	_	_	_	_	_
104	the	_	_	_	_	_	_	_	_
105	tissue	_	_	_	_	_	_	_	_
106	distribution	_	_	_	_	_	_	_	_
107	of	_	_	_	_	_	_	_	_
108	HBV	_	_	_	_	_	_	_	_
109	would	_	_	_	_	_	_	_	_
110	allow	_	_	_	_	_	_	_	_
111	interaction	_	_	_	_	_	_	_	_
112	between	_	_	_	_	_	_	_	_
113	HBV	_	_	_	_	_	_	_	_
114	and	_	_	_	_	_	_	_	_
115	DC	_	_	_	_	_	_	_	_
116	-	_	_	_	_	_	_	_	_
117	SIGN	_	_	_	_	_	_	_	_
118	and	_	_	_	_	_	_	_	_
119	its	_	_	_	_	_	_	_	_
120	liver	_	_	_	_	_	_	_	_
121	-	_	_	_	_	_	_	_	_
122	expressed	_	_	_	_	_	_	_	_
123	homologue	_	_	_	_	_	_	_	_
124	L	_	_	_	_	_	_	_	_
125	-	_	_	_	_	_	_	_	_
126	SIGN	_	_	_	_	_	_	_	_
127	.	_	_	_	_	_	_	_	_
128	Therefore	_	_	_	_	_	_	_	BeginSeg=Yes
129	,	_	_	_	_	_	_	_	_
130	a	_	_	_	_	_	_	_	_
131	detailed	_	_	_	_	_	_	_	_
132	study	_	_	_	_	_	_	_	_
133	to	_	_	_	_	_	_	_	BeginSeg=Yes
134	investigate	_	_	_	_	_	_	_	_
135	the	_	_	_	_	_	_	_	_
136	binding	_	_	_	_	_	_	_	_
137	of	_	_	_	_	_	_	_	_
138	HBV	_	_	_	_	_	_	_	_
139	to	_	_	_	_	_	_	_	_
140	DC	_	_	_	_	_	_	_	_
141	-	_	_	_	_	_	_	_	_
142	SIGN	_	_	_	_	_	_	_	_
143	and	_	_	_	_	_	_	_	_
144	L	_	_	_	_	_	_	_	_
145	-	_	_	_	_	_	_	_	_
146	SIGN	_	_	_	_	_	_	_	_
147	was	_	_	_	_	_	_	_	BeginSeg=Yes
148	performed	_	_	_	_	_	_	_	_
149	.	_	_	_	_	_	_	_	_
150	For	_	_	_	_	_	_	_	BeginSeg=Yes
151	HCV	_	_	_	_	_	_	_	_
152	,	_	_	_	_	_	_	_	_
153	both	_	_	_	_	_	_	_	_
154	DC	_	_	_	_	_	_	_	_
155	-	_	_	_	_	_	_	_	_
156	SIGN	_	_	_	_	_	_	_	_
157	and	_	_	_	_	_	_	_	_
158	L	_	_	_	_	_	_	_	_
159	-	_	_	_	_	_	_	_	_
160	SIGN	_	_	_	_	_	_	_	_
161	are	_	_	_	_	_	_	_	_
162	known	_	_	_	_	_	_	_	_
163	to	_	_	_	_	_	_	_	_
164	bind	_	_	_	_	_	_	_	_
165	envelope	_	_	_	_	_	_	_	_
166	glycoproteins	_	_	_	_	_	_	_	_
167	E1	_	_	_	_	_	_	_	_
168	and	_	_	_	_	_	_	_	_
169	E2	_	_	_	_	_	_	_	_
170	.	_	_	_	_	_	_	_	_
171	Soluble	_	_	_	_	_	_	_	BeginSeg=Yes
172	DC	_	_	_	_	_	_	_	_
173	-	_	_	_	_	_	_	_	_
174	SIGN	_	_	_	_	_	_	_	_
175	and	_	_	_	_	_	_	_	_
176	L	_	_	_	_	_	_	_	_
177	-	_	_	_	_	_	_	_	_
178	SIGN	_	_	_	_	_	_	_	_
179	specifically	_	_	_	_	_	_	_	_
180	bound	_	_	_	_	_	_	_	_
181	HCV	_	_	_	_	_	_	_	_
182	virus	_	_	_	_	_	_	_	_
183	-	_	_	_	_	_	_	_	_
184	like	_	_	_	_	_	_	_	_
185	particles	_	_	_	_	_	_	_	_
186	,	_	_	_	_	_	_	_	_
187	but	_	_	_	_	_	_	_	BeginSeg=Yes
188	no	_	_	_	_	_	_	_	_
189	interaction	_	_	_	_	_	_	_	_
190	with	_	_	_	_	_	_	_	_
191	either	_	_	_	_	_	_	_	_
192	HBsAg	_	_	_	_	_	_	_	_
193	or	_	_	_	_	_	_	_	_
194	HepG2.2.15-derived	_	_	_	_	_	_	_	_
195	HBV	_	_	_	_	_	_	_	_
196	was	_	_	_	_	_	_	_	_
197	detected	_	_	_	_	_	_	_	_
198	.	_	_	_	_	_	_	_	_
199	Also	_	_	_	_	_	_	_	BeginSeg=Yes
200	,	_	_	_	_	_	_	_	_
201	neither	_	_	_	_	_	_	_	_
202	DC	_	_	_	_	_	_	_	_
203	-	_	_	_	_	_	_	_	_
204	SIGN	_	_	_	_	_	_	_	_
205	nor	_	_	_	_	_	_	_	_
206	L	_	_	_	_	_	_	_	_
207	-	_	_	_	_	_	_	_	_
208	SIGN	_	_	_	_	_	_	_	_
209	transfected	_	_	_	_	_	_	_	_
210	Raji	_	_	_	_	_	_	_	_
211	cells	_	_	_	_	_	_	_	_
212	bound	_	_	_	_	_	_	_	_
213	HBsAg	_	_	_	_	_	_	_	_
214	.	_	_	_	_	_	_	_	_
215	In	_	_	_	_	_	_	_	BeginSeg=Yes
216	contrast	_	_	_	_	_	_	_	_
217	,	_	_	_	_	_	_	_	_
218	highly	_	_	_	_	_	_	_	_
219	mannosylated	_	_	_	_	_	_	_	_
220	HBV	_	_	_	_	_	_	_	_
221	,	_	_	_	_	_	_	_	_
222	obtained	_	_	_	_	_	_	_	BeginSeg=Yes
223	by	_	_	_	_	_	_	_	BeginSeg=Yes
224	treating	_	_	_	_	_	_	_	_
225	HBV	_	_	_	_	_	_	_	_
226	producing	_	_	_	_	_	_	_	_
227	HepG2.2.15	_	_	_	_	_	_	_	_
228	cells	_	_	_	_	_	_	_	_
229	with	_	_	_	_	_	_	_	_
230	the	_	_	_	_	_	_	_	_
231	a	_	_	_	_	_	_	_	_
232	-	_	_	_	_	_	_	_	_
233	mannosidase	_	_	_	_	_	_	_	_
234	I	_	_	_	_	_	_	_	_
235	inhibitor	_	_	_	_	_	_	_	_
236	kifunensine	_	_	_	_	_	_	_	_
237	,	_	_	_	_	_	_	_	_
238	is	_	_	_	_	_	_	_	BeginSeg=Yes
239	recognized	_	_	_	_	_	_	_	_
240	by	_	_	_	_	_	_	_	_
241	DC	_	_	_	_	_	_	_	_
242	-	_	_	_	_	_	_	_	_
243	SIGN	_	_	_	_	_	_	_	_
244	.	_	_	_	_	_	_	_	_
245	The	_	_	_	_	_	_	_	BeginSeg=Yes
246	a	_	_	_	_	_	_	_	_
247	-	_	_	_	_	_	_	_	_
248	mannosidase	_	_	_	_	_	_	_	_
249	I	_	_	_	_	_	_	_	_
250	trimming	_	_	_	_	_	_	_	_
251	of	_	_	_	_	_	_	_	_
252	N	_	_	_	_	_	_	_	_
253	-	_	_	_	_	_	_	_	_
254	linked	_	_	_	_	_	_	_	_
255	oligosaccharide	_	_	_	_	_	_	_	_
256	structures	_	_	_	_	_	_	_	_
257	thus	_	_	_	_	_	_	_	_
258	prevents	_	_	_	_	_	_	_	_
259	recognition	_	_	_	_	_	_	_	_
260	by	_	_	_	_	_	_	_	_
261	DC	_	_	_	_	_	_	_	_
262	-	_	_	_	_	_	_	_	_
263	SIGN	_	_	_	_	_	_	_	_
264	.	_	_	_	_	_	_	_	_
265	On	_	_	_	_	_	_	_	BeginSeg=Yes
266	the	_	_	_	_	_	_	_	_
267	basis	_	_	_	_	_	_	_	_
268	of	_	_	_	_	_	_	_	_
269	these	_	_	_	_	_	_	_	_
270	findings	_	_	_	_	_	_	_	_
271	,	_	_	_	_	_	_	_	_
272	it	_	_	_	_	_	_	_	_
273	is	_	_	_	_	_	_	_	_
274	tempting	_	_	_	_	_	_	_	_
275	to	_	_	_	_	_	_	_	_
276	speculate	_	_	_	_	_	_	_	_
277	that	_	_	_	_	_	_	_	_
278	HBV	_	_	_	_	_	_	_	_
279	exploits	_	_	_	_	_	_	_	_
280	mannose	_	_	_	_	_	_	_	_
281	trimming	_	_	_	_	_	_	_	_
282	as	_	_	_	_	_	_	_	_
283	a	_	_	_	_	_	_	_	_
284	way	_	_	_	_	_	_	_	_
285	to	_	_	_	_	_	_	_	BeginSeg=Yes
286	escape	_	_	_	_	_	_	_	_
287	recognition	_	_	_	_	_	_	_	_
288	by	_	_	_	_	_	_	_	_
289	DC	_	_	_	_	_	_	_	_
290	-	_	_	_	_	_	_	_	_
291	SIGN	_	_	_	_	_	_	_	_
292	and	_	_	_	_	_	_	_	BeginSeg=Yes
293	thereby	_	_	_	_	_	_	_	_
294	subvert	_	_	_	_	_	_	_	_
295	a	_	_	_	_	_	_	_	_
296	possible	_	_	_	_	_	_	_	_
297	immune	_	_	_	_	_	_	_	_
298	activation	_	_	_	_	_	_	_	_
299	response	_	_	_	_	_	_	_	_
300	.	_	_	_	_	_	_	_	_

# newdoc_id = 1723e7c27aadbc83619fd69629fcc089e700418b
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	COVID-19	_	_	_	_	_	_	_	_
3	pandemic	_	_	_	_	_	_	_	_
4	has	_	_	_	_	_	_	_	_
5	forced	_	_	_	_	_	_	_	_
6	us	_	_	_	_	_	_	_	_
7	to	_	_	_	_	_	_	_	_
8	consider	_	_	_	_	_	_	_	_
9	the	_	_	_	_	_	_	_	_
10	physiologic	_	_	_	_	_	_	_	_
11	role	_	_	_	_	_	_	_	_
12	of	_	_	_	_	_	_	_	_
13	obesity	_	_	_	_	_	_	_	_
14	in	_	_	_	_	_	_	_	_
15	the	_	_	_	_	_	_	_	_
16	response	_	_	_	_	_	_	_	_
17	to	_	_	_	_	_	_	_	_
18	infectious	_	_	_	_	_	_	_	_
19	disease	_	_	_	_	_	_	_	_
20	.	_	_	_	_	_	_	_	_
21	There	_	_	_	_	_	_	_	BeginSeg=Yes
22	are	_	_	_	_	_	_	_	_
23	significant	_	_	_	_	_	_	_	_
24	disparities	_	_	_	_	_	_	_	_
25	in	_	_	_	_	_	_	_	_
26	morbidity	_	_	_	_	_	_	_	_
27	and	_	_	_	_	_	_	_	_
28	mortality	_	_	_	_	_	_	_	_
29	by	_	_	_	_	_	_	_	_
30	sex	_	_	_	_	_	_	_	_
31	,	_	_	_	_	_	_	_	_
32	weight	_	_	_	_	_	_	_	_
33	and	_	_	_	_	_	_	_	_
34	diabetes	_	_	_	_	_	_	_	_
35	status	_	_	_	_	_	_	_	_
36	.	_	_	_	_	_	_	_	_
37	Numerous	_	_	_	_	_	_	_	BeginSeg=Yes
38	endocrine	_	_	_	_	_	_	_	_
39	changes	_	_	_	_	_	_	_	_
40	might	_	_	_	_	_	_	_	_
41	drive	_	_	_	_	_	_	_	_
42	these	_	_	_	_	_	_	_	_
43	varied	_	_	_	_	_	_	_	_
44	responses	_	_	_	_	_	_	_	_
45	to	_	_	_	_	_	_	_	_
46	SARS	_	_	_	_	_	_	_	_
47	-	_	_	_	_	_	_	_	_
48	CoV-2	_	_	_	_	_	_	_	_
49	infection	_	_	_	_	_	_	_	_
50	including	_	_	_	_	_	_	_	BeginSeg=Yes
51	hormone	_	_	_	_	_	_	_	_
52	and	_	_	_	_	_	_	_	_
53	immune	_	_	_	_	_	_	_	_
54	mediators	_	_	_	_	_	_	_	_
55	,	_	_	_	_	_	_	_	_
56	hyperglycemia	_	_	_	_	_	_	_	_
57	,	_	_	_	_	_	_	_	_
58	leukocyte	_	_	_	_	_	_	_	_
59	responses	_	_	_	_	_	_	_	_
60	,	_	_	_	_	_	_	_	_
61	cytokine	_	_	_	_	_	_	_	_
62	secretion	_	_	_	_	_	_	_	_
63	,	_	_	_	_	_	_	_	_
64	and	_	_	_	_	_	_	_	_
65	tissue	_	_	_	_	_	_	_	_
66	dysfunction	_	_	_	_	_	_	_	_
67	.	_	_	_	_	_	_	_	_
68	Studies	_	_	_	_	_	_	_	BeginSeg=Yes
69	of	_	_	_	_	_	_	_	_
70	patients	_	_	_	_	_	_	_	_
71	with	_	_	_	_	_	_	_	_
72	severe	_	_	_	_	_	_	_	_
73	COVID-19	_	_	_	_	_	_	_	_
74	disease	_	_	_	_	_	_	_	_
75	have	_	_	_	_	_	_	_	_
76	revealed	_	_	_	_	_	_	_	_
77	the	_	_	_	_	_	_	_	_
78	importance	_	_	_	_	_	_	_	_
79	of	_	_	_	_	_	_	_	_
80	innate	_	_	_	_	_	_	_	_
81	immune	_	_	_	_	_	_	_	_
82	responses	_	_	_	_	_	_	_	_
83	in	_	_	_	_	_	_	_	BeginSeg=Yes
84	driving	_	_	_	_	_	_	_	_
85	immunopathology	_	_	_	_	_	_	_	_
86	and	_	_	_	_	_	_	_	_
87	tissue	_	_	_	_	_	_	_	_
88	injury	_	_	_	_	_	_	_	_
89	.	_	_	_	_	_	_	_	_
90	In	_	_	_	_	_	_	_	BeginSeg=Yes
91	this	_	_	_	_	_	_	_	_
92	review	_	_	_	_	_	_	_	_
93	we	_	_	_	_	_	_	_	_
94	will	_	_	_	_	_	_	_	_
95	describe	_	_	_	_	_	_	_	_
96	the	_	_	_	_	_	_	_	_
97	impact	_	_	_	_	_	_	_	_
98	of	_	_	_	_	_	_	_	_
99	the	_	_	_	_	_	_	_	_
100	metabolically	_	_	_	_	_	_	_	_
101	induced	_	_	_	_	_	_	_	_
102	inflammation	_	_	_	_	_	_	_	_
103	(	_	_	_	_	_	_	_	_
104	meta	_	_	_	_	_	_	_	_
105	-	_	_	_	_	_	_	_	_
106	inflammation	_	_	_	_	_	_	_	_
107	)	_	_	_	_	_	_	_	_
108	that	_	_	_	_	_	_	_	BeginSeg=Yes
109	characterizes	_	_	_	_	_	_	_	_
110	obesity	_	_	_	_	_	_	_	_
111	on	_	_	_	_	_	_	_	_
112	innate	_	_	_	_	_	_	_	_
113	immunity	_	_	_	_	_	_	_	_
114	.	_	_	_	_	_	_	_	_
115	We	_	_	_	_	_	_	_	BeginSeg=Yes
116	consider	_	_	_	_	_	_	_	_
117	that	_	_	_	_	_	_	_	BeginSeg=Yes
118	obesity	_	_	_	_	_	_	_	_
119	-	_	_	_	_	_	_	_	_
120	driven	_	_	_	_	_	_	_	_
121	dysregulation	_	_	_	_	_	_	_	_
122	of	_	_	_	_	_	_	_	_
123	innate	_	_	_	_	_	_	_	_
124	immune	_	_	_	_	_	_	_	_
125	responses	_	_	_	_	_	_	_	_
126	may	_	_	_	_	_	_	_	_
127	drive	_	_	_	_	_	_	_	_
128	organ	_	_	_	_	_	_	_	_
129	injury	_	_	_	_	_	_	_	_
130	in	_	_	_	_	_	_	_	_
131	development	_	_	_	_	_	_	_	_
132	of	_	_	_	_	_	_	_	_
133	severe	_	_	_	_	_	_	_	_
134	COVID-19	_	_	_	_	_	_	_	_
135	and	_	_	_	_	_	_	_	_
136	impair	_	_	_	_	_	_	_	_
137	viral	_	_	_	_	_	_	_	_
138	clearance	_	_	_	_	_	_	_	_
139	.	_	_	_	_	_	_	_	_

# newdoc_id = 17c5d5036721bc5935b23a9e23f69fde366ecc20
1	We	_	_	_	_	_	_	_	BeginSeg=Yes
2	investigate	_	_	_	_	_	_	_	_
3	the	_	_	_	_	_	_	_	_
4	difference	_	_	_	_	_	_	_	_
5	in	_	_	_	_	_	_	_	_
6	the	_	_	_	_	_	_	_	_
7	spread	_	_	_	_	_	_	_	_
8	of	_	_	_	_	_	_	_	_
9	COVID-19	_	_	_	_	_	_	_	_
10	between	_	_	_	_	_	_	_	_
11	the	_	_	_	_	_	_	_	_
12	states	_	_	_	_	_	_	_	_
13	won	_	_	_	_	_	_	_	BeginSeg=Yes
14	by	_	_	_	_	_	_	_	_
15	Donald	_	_	_	_	_	_	_	_
16	Trump	_	_	_	_	_	_	_	_
17	(	_	_	_	_	_	_	_	_
18	Red	_	_	_	_	_	_	_	_
19	)	_	_	_	_	_	_	_	_
20	and	_	_	_	_	_	_	_	BeginSeg=Yes
21	the	_	_	_	_	_	_	_	_
22	states	_	_	_	_	_	_	_	_
23	won	_	_	_	_	_	_	_	BeginSeg=Yes
24	by	_	_	_	_	_	_	_	_
25	Hillary	_	_	_	_	_	_	_	_
26	Clinton	_	_	_	_	_	_	_	_
27	(	_	_	_	_	_	_	_	_
28	Blue	_	_	_	_	_	_	_	_
29	)	_	_	_	_	_	_	_	_
30	in	_	_	_	_	_	_	_	_
31	the	_	_	_	_	_	_	_	_
32	2016	_	_	_	_	_	_	_	_
33	presidential	_	_	_	_	_	_	_	_
34	election	_	_	_	_	_	_	_	_
35	,	_	_	_	_	_	_	_	_
36	by	_	_	_	_	_	_	_	BeginSeg=Yes
37	mining	_	_	_	_	_	_	_	_
38	transportation	_	_	_	_	_	_	_	_
39	patterns	_	_	_	_	_	_	_	_
40	of	_	_	_	_	_	_	_	_
41	US	_	_	_	_	_	_	_	_
42	residents	_	_	_	_	_	_	_	_
43	from	_	_	_	_	_	_	_	_
44	March	_	_	_	_	_	_	_	_
45	2020	_	_	_	_	_	_	_	_
46	to	_	_	_	_	_	_	_	_
47	July	_	_	_	_	_	_	_	_
48	2020	_	_	_	_	_	_	_	_
49	.	_	_	_	_	_	_	_	_
50	To	_	_	_	_	_	_	_	BeginSeg=Yes
51	ensure	_	_	_	_	_	_	_	_
52	a	_	_	_	_	_	_	_	_
53	fair	_	_	_	_	_	_	_	_
54	comparison	_	_	_	_	_	_	_	_
55	,	_	_	_	_	_	_	_	_
56	we	_	_	_	_	_	_	_	BeginSeg=Yes
57	first	_	_	_	_	_	_	_	_
58	use	_	_	_	_	_	_	_	_
59	a	_	_	_	_	_	_	_	_
60	K	_	_	_	_	_	_	_	_
61	-	_	_	_	_	_	_	_	_
62	means	_	_	_	_	_	_	_	_
63	clustering	_	_	_	_	_	_	_	_
64	method	_	_	_	_	_	_	_	_
65	to	_	_	_	_	_	_	_	BeginSeg=Yes
66	group	_	_	_	_	_	_	_	_
67	the	_	_	_	_	_	_	_	_
68	50	_	_	_	_	_	_	_	_
69	states	_	_	_	_	_	_	_	_
70	into	_	_	_	_	_	_	_	_
71	five	_	_	_	_	_	_	_	_
72	clusters	_	_	_	_	_	_	_	_
73	according	_	_	_	_	_	_	_	_
74	to	_	_	_	_	_	_	_	_
75	their	_	_	_	_	_	_	_	_
76	population	_	_	_	_	_	_	_	_
77	,	_	_	_	_	_	_	_	_
78	area	_	_	_	_	_	_	_	_
79	and	_	_	_	_	_	_	_	_
80	population	_	_	_	_	_	_	_	_
81	density	_	_	_	_	_	_	_	_
82	.	_	_	_	_	_	_	_	_
83	We	_	_	_	_	_	_	_	BeginSeg=Yes
84	then	_	_	_	_	_	_	_	_
85	characterize	_	_	_	_	_	_	_	_
86	daily	_	_	_	_	_	_	_	_
87	transportation	_	_	_	_	_	_	_	_
88	patterns	_	_	_	_	_	_	_	_
89	of	_	_	_	_	_	_	_	_
90	the	_	_	_	_	_	_	_	_
91	residents	_	_	_	_	_	_	_	_
92	of	_	_	_	_	_	_	_	_
93	different	_	_	_	_	_	_	_	_
94	states	_	_	_	_	_	_	_	_
95	using	_	_	_	_	_	_	_	BeginSeg=Yes
96	the	_	_	_	_	_	_	_	_
97	mean	_	_	_	_	_	_	_	_
98	percentage	_	_	_	_	_	_	_	_
99	of	_	_	_	_	_	_	_	_
100	residents	_	_	_	_	_	_	_	_
101	traveling	_	_	_	_	_	_	_	BeginSeg=Yes
102	and	_	_	_	_	_	_	_	BeginSeg=Yes
103	the	_	_	_	_	_	_	_	_
104	number	_	_	_	_	_	_	_	_
105	of	_	_	_	_	_	_	_	_
106	trips	_	_	_	_	_	_	_	_
107	per	_	_	_	_	_	_	_	_
108	person	_	_	_	_	_	_	_	_
109	.	_	_	_	_	_	_	_	_
110	For	_	_	_	_	_	_	_	BeginSeg=Yes
111	each	_	_	_	_	_	_	_	_
112	state	_	_	_	_	_	_	_	_
113	,	_	_	_	_	_	_	_	_
114	we	_	_	_	_	_	_	_	_
115	study	_	_	_	_	_	_	_	_
116	the	_	_	_	_	_	_	_	_
117	correlations	_	_	_	_	_	_	_	_
118	between	_	_	_	_	_	_	_	_
119	travel	_	_	_	_	_	_	_	_
120	patterns	_	_	_	_	_	_	_	_
121	and	_	_	_	_	_	_	_	_
122	infection	_	_	_	_	_	_	_	_
123	rate	_	_	_	_	_	_	_	_
124	for	_	_	_	_	_	_	_	_
125	a	_	_	_	_	_	_	_	_
126	2-month	_	_	_	_	_	_	_	_
127	period	_	_	_	_	_	_	_	_
128	before	_	_	_	_	_	_	_	_
129	and	_	_	_	_	_	_	_	_
130	after	_	_	_	_	_	_	_	_
131	the	_	_	_	_	_	_	_	_
132	official	_	_	_	_	_	_	_	_
133	states	_	_	_	_	_	_	_	_
134	reopening	_	_	_	_	_	_	_	_
135	dates	_	_	_	_	_	_	_	_
136	.	_	_	_	_	_	_	_	_
137	We	_	_	_	_	_	_	_	BeginSeg=Yes
138	observe	_	_	_	_	_	_	_	_
139	that	_	_	_	_	_	_	_	BeginSeg=Yes
140	during	_	_	_	_	_	_	_	_
141	the	_	_	_	_	_	_	_	_
142	lock	_	_	_	_	_	_	_	_
143	-	_	_	_	_	_	_	_	_
144	down	_	_	_	_	_	_	_	_
145	,	_	_	_	_	_	_	_	_
146	Red	_	_	_	_	_	_	_	_
147	and	_	_	_	_	_	_	_	_
148	Blue	_	_	_	_	_	_	_	_
149	states	_	_	_	_	_	_	_	_
150	both	_	_	_	_	_	_	_	_
151	displayed	_	_	_	_	_	_	_	_
152	strong	_	_	_	_	_	_	_	_
153	positive	_	_	_	_	_	_	_	_
154	correlations	_	_	_	_	_	_	_	_
155	between	_	_	_	_	_	_	_	_
156	their	_	_	_	_	_	_	_	_
157	travel	_	_	_	_	_	_	_	_
158	patterns	_	_	_	_	_	_	_	_
159	and	_	_	_	_	_	_	_	_
160	infection	_	_	_	_	_	_	_	_
161	rates	_	_	_	_	_	_	_	_
162	.	_	_	_	_	_	_	_	_
163	However	_	_	_	_	_	_	_	BeginSeg=Yes
164	,	_	_	_	_	_	_	_	_
165	after	_	_	_	_	_	_	_	BeginSeg=Yes
166	states	_	_	_	_	_	_	_	_
167	reopened	_	_	_	_	_	_	_	_
168	we	_	_	_	_	_	_	_	BeginSeg=Yes
169	find	_	_	_	_	_	_	_	_
170	that	_	_	_	_	_	_	_	BeginSeg=Yes
171	Red	_	_	_	_	_	_	_	_
172	states	_	_	_	_	_	_	_	_
173	had	_	_	_	_	_	_	_	_
174	higher	_	_	_	_	_	_	_	_
175	travel	_	_	_	_	_	_	_	_
176	-	_	_	_	_	_	_	_	_
177	infection	_	_	_	_	_	_	_	_
178	correlations	_	_	_	_	_	_	_	_
179	than	_	_	_	_	_	_	_	_
180	Blue	_	_	_	_	_	_	_	_
181	states	_	_	_	_	_	_	_	_
182	in	_	_	_	_	_	_	_	_
183	all	_	_	_	_	_	_	_	_
184	five	_	_	_	_	_	_	_	_
185	state	_	_	_	_	_	_	_	_
186	clusters	_	_	_	_	_	_	_	_
187	.	_	_	_	_	_	_	_	_
188	We	_	_	_	_	_	_	_	BeginSeg=Yes
189	find	_	_	_	_	_	_	_	_
190	that	_	_	_	_	_	_	_	BeginSeg=Yes
191	the	_	_	_	_	_	_	_	_
192	residents	_	_	_	_	_	_	_	_
193	of	_	_	_	_	_	_	_	_
194	both	_	_	_	_	_	_	_	_
195	Red	_	_	_	_	_	_	_	_
196	and	_	_	_	_	_	_	_	_
197	Blue	_	_	_	_	_	_	_	_
198	states	_	_	_	_	_	_	_	_
199	displayed	_	_	_	_	_	_	_	_
200	similar	_	_	_	_	_	_	_	_
201	travel	_	_	_	_	_	_	_	_
202	patterns	_	_	_	_	_	_	_	_
203	during	_	_	_	_	_	_	_	_
204	the	_	_	_	_	_	_	_	_
205	period	_	_	_	_	_	_	_	_
206	post	_	_	_	_	_	_	_	_
207	the	_	_	_	_	_	_	_	_
208	reopening	_	_	_	_	_	_	_	_
209	of	_	_	_	_	_	_	_	_
210	states	_	_	_	_	_	_	_	_
211	,	_	_	_	_	_	_	_	_
212	leading	_	_	_	_	_	_	_	BeginSeg=Yes
213	us	_	_	_	_	_	_	_	_
214	to	_	_	_	_	_	_	_	_
215	conclude	_	_	_	_	_	_	_	_
216	that	_	_	_	_	_	_	_	BeginSeg=Yes
217	,	_	_	_	_	_	_	_	_
218	on	_	_	_	_	_	_	_	_
219	average	_	_	_	_	_	_	_	_
220	,	_	_	_	_	_	_	_	_
221	the	_	_	_	_	_	_	_	_
222	residents	_	_	_	_	_	_	_	_
223	in	_	_	_	_	_	_	_	_
224	Red	_	_	_	_	_	_	_	_
225	states	_	_	_	_	_	_	_	_
226	might	_	_	_	_	_	_	_	_
227	be	_	_	_	_	_	_	_	_
228	mobilizing	_	_	_	_	_	_	_	_
229	less	_	_	_	_	_	_	_	_
230	safely	_	_	_	_	_	_	_	_
231	than	_	_	_	_	_	_	_	_
232	the	_	_	_	_	_	_	_	_
233	residents	_	_	_	_	_	_	_	_
234	in	_	_	_	_	_	_	_	_
235	Blue	_	_	_	_	_	_	_	_
236	states	_	_	_	_	_	_	_	_
237	.	_	_	_	_	_	_	_	_
238	Furthermore	_	_	_	_	_	_	_	BeginSeg=Yes
239	,	_	_	_	_	_	_	_	_
240	we	_	_	_	_	_	_	_	_
241	use	_	_	_	_	_	_	_	_
242	temperature	_	_	_	_	_	_	_	_
243	data	_	_	_	_	_	_	_	_
244	to	_	_	_	_	_	_	_	BeginSeg=Yes
245	attempt	_	_	_	_	_	_	_	_
246	to	_	_	_	_	_	_	_	_
247	explain	_	_	_	_	_	_	_	_
248	the	_	_	_	_	_	_	_	_
249	difference	_	_	_	_	_	_	_	_
250	in	_	_	_	_	_	_	_	_
251	the	_	_	_	_	_	_	_	_
252	way	_	_	_	_	_	_	_	_
253	residents	_	_	_	_	_	_	_	BeginSeg=Yes
254	travel	_	_	_	_	_	_	_	_
255	and	_	_	_	_	_	_	_	_
256	practice	_	_	_	_	_	_	_	_
257	safety	_	_	_	_	_	_	_	_
258	measures	_	_	_	_	_	_	_	_
259	.	_	_	_	_	_	_	_	_

# newdoc_id = 1b7c700ee3a33c0a675a5f7e71a20ce62467b900
1	Background	_	_	_	_	_	_	_	BeginSeg=Yes
2	:	_	_	_	_	_	_	_	_
3	Human	_	_	_	_	_	_	_	BeginSeg=Yes
4	immunodeficiency	_	_	_	_	_	_	_	_
5	virus	_	_	_	_	_	_	_	_
6	type	_	_	_	_	_	_	_	_
7	1	_	_	_	_	_	_	_	_
8	(	_	_	_	_	_	_	_	_
9	HIV-1	_	_	_	_	_	_	_	_
10	)	_	_	_	_	_	_	_	_
11	has	_	_	_	_	_	_	_	_
12	infected	_	_	_	_	_	_	_	_
13	more	_	_	_	_	_	_	_	_
14	than	_	_	_	_	_	_	_	_
15	40	_	_	_	_	_	_	_	_
16	million	_	_	_	_	_	_	_	_
17	people	_	_	_	_	_	_	_	_
18	worldwide	_	_	_	_	_	_	_	_
19	,	_	_	_	_	_	_	_	_
20	mainly	_	_	_	_	_	_	_	_
21	in	_	_	_	_	_	_	_	_
22	sub	_	_	_	_	_	_	_	_
23	-	_	_	_	_	_	_	_	_
24	Saharan	_	_	_	_	_	_	_	_
25	Africa	_	_	_	_	_	_	_	_
26	.	_	_	_	_	_	_	_	_
27	The	_	_	_	_	_	_	_	BeginSeg=Yes
28	high	_	_	_	_	_	_	_	_
29	prevalence	_	_	_	_	_	_	_	_
30	of	_	_	_	_	_	_	_	_
31	HIV-1	_	_	_	_	_	_	_	_
32	subtype	_	_	_	_	_	_	_	_
33	C	_	_	_	_	_	_	_	_
34	in	_	_	_	_	_	_	_	_
35	southern	_	_	_	_	_	_	_	_
36	Africa	_	_	_	_	_	_	_	_
37	necessitates	_	_	_	_	_	_	_	_
38	the	_	_	_	_	_	_	_	_
39	development	_	_	_	_	_	_	_	_
40	of	_	_	_	_	_	_	_	_
41	cheap	_	_	_	_	_	_	_	_
42	,	_	_	_	_	_	_	_	_
43	effective	_	_	_	_	_	_	_	_
44	vaccines	_	_	_	_	_	_	_	_
45	.	_	_	_	_	_	_	_	_
46	One	_	_	_	_	_	_	_	BeginSeg=Yes
47	means	_	_	_	_	_	_	_	_
48	of	_	_	_	_	_	_	_	_
49	production	_	_	_	_	_	_	_	_
50	is	_	_	_	_	_	_	_	_
51	the	_	_	_	_	_	_	_	_
52	use	_	_	_	_	_	_	_	_
53	of	_	_	_	_	_	_	_	_
54	plants	_	_	_	_	_	_	_	_
55	,	_	_	_	_	_	_	_	_
56	for	_	_	_	_	_	_	_	BeginSeg=Yes
57	which	_	_	_	_	_	_	_	_
58	a	_	_	_	_	_	_	_	_
59	number	_	_	_	_	_	_	_	_
60	of	_	_	_	_	_	_	_	_
61	different	_	_	_	_	_	_	_	_
62	techniques	_	_	_	_	_	_	_	_
63	have	_	_	_	_	_	_	_	_
64	been	_	_	_	_	_	_	_	_
65	successfully	_	_	_	_	_	_	_	_
66	developed	_	_	_	_	_	_	_	_
67	.	_	_	_	_	_	_	_	_
68	HIV-1	_	_	_	_	_	_	_	BeginSeg=Yes
69	Pr55Gag	_	_	_	_	_	_	_	_
70	is	_	_	_	_	_	_	_	_
71	a	_	_	_	_	_	_	_	_
72	promising	_	_	_	_	_	_	_	_
73	HIV-1	_	_	_	_	_	_	_	_
74	vaccine	_	_	_	_	_	_	_	_
75	candidate	_	_	_	_	_	_	_	_
76	:	_	_	_	_	_	_	_	_
77	we	_	_	_	_	_	_	_	BeginSeg=Yes
78	compared	_	_	_	_	_	_	_	_
79	the	_	_	_	_	_	_	_	_
80	expression	_	_	_	_	_	_	_	_
81	of	_	_	_	_	_	_	_	_
82	this	_	_	_	_	_	_	_	_
83	and	_	_	_	_	_	_	_	_
84	a	_	_	_	_	_	_	_	_
85	truncated	_	_	_	_	_	_	_	_
86	Gag	_	_	_	_	_	_	_	_
87	(	_	_	_	_	_	_	_	_
88	p17	_	_	_	_	_	_	_	_
89	/	_	_	_	_	_	_	_	_
90	p24	_	_	_	_	_	_	_	_
91	)	_	_	_	_	_	_	_	_
92	and	_	_	_	_	_	_	_	_
93	the	_	_	_	_	_	_	_	_
94	p24	_	_	_	_	_	_	_	_
95	capsid	_	_	_	_	_	_	_	_
96	subunit	_	_	_	_	_	_	_	_
97	in	_	_	_	_	_	_	_	_
98	Nicotiana	_	_	_	_	_	_	_	_
99	spp	_	_	_	_	_	_	_	_
100	.	_	_	_	_	_	_	_	_
101	using	_	_	_	_	_	_	_	BeginSeg=Yes
102	transgenic	_	_	_	_	_	_	_	_
103	plants	_	_	_	_	_	_	_	_
104	and	_	_	_	_	_	_	_	_
105	transient	_	_	_	_	_	_	_	_
106	expression	_	_	_	_	_	_	_	_
107	via	_	_	_	_	_	_	_	_
108	Agrobacterium	_	_	_	_	_	_	_	_
109	tumefaciens	_	_	_	_	_	_	_	_
110	and	_	_	_	_	_	_	_	_
111	recombinant	_	_	_	_	_	_	_	_
112	tobamovirus	_	_	_	_	_	_	_	_
113	vectors	_	_	_	_	_	_	_	_
114	.	_	_	_	_	_	_	_	_
115	We	_	_	_	_	_	_	_	BeginSeg=Yes
116	also	_	_	_	_	_	_	_	_
117	investigated	_	_	_	_	_	_	_	_
118	the	_	_	_	_	_	_	_	_
119	influence	_	_	_	_	_	_	_	_
120	of	_	_	_	_	_	_	_	_
121	subcellular	_	_	_	_	_	_	_	_
122	localisation	_	_	_	_	_	_	_	_
123	of	_	_	_	_	_	_	_	_
124	recombinant	_	_	_	_	_	_	_	_
125	protein	_	_	_	_	_	_	_	_
126	to	_	_	_	_	_	_	_	_
127	the	_	_	_	_	_	_	_	_
128	chloroplast	_	_	_	_	_	_	_	_
129	and	_	_	_	_	_	_	_	_
130	the	_	_	_	_	_	_	_	_
131	endoplasmic	_	_	_	_	_	_	_	_
132	reticulum	_	_	_	_	_	_	_	_
133	(	_	_	_	_	_	_	_	_
134	ER	_	_	_	_	_	_	_	_
135	)	_	_	_	_	_	_	_	_
136	on	_	_	_	_	_	_	_	_
137	protein	_	_	_	_	_	_	_	_
138	yield	_	_	_	_	_	_	_	_
139	.	_	_	_	_	_	_	_	_
140	We	_	_	_	_	_	_	_	BeginSeg=Yes
141	partially	_	_	_	_	_	_	_	_
142	purified	_	_	_	_	_	_	_	_
143	a	_	_	_	_	_	_	_	_
144	selected	_	_	_	_	_	_	_	_
145	vaccine	_	_	_	_	_	_	_	_
146	candidate	_	_	_	_	_	_	_	_
147	and	_	_	_	_	_	_	_	BeginSeg=Yes
148	tested	_	_	_	_	_	_	_	_
149	its	_	_	_	_	_	_	_	_
150	stimulation	_	_	_	_	_	_	_	_
151	of	_	_	_	_	_	_	_	_
152	a	_	_	_	_	_	_	_	_
153	humoral	_	_	_	_	_	_	_	_
154	and	_	_	_	_	_	_	_	_
155	cellular	_	_	_	_	_	_	_	_
156	immune	_	_	_	_	_	_	_	_
157	response	_	_	_	_	_	_	_	_
158	in	_	_	_	_	_	_	_	_
159	mice	_	_	_	_	_	_	_	_
160	.	_	_	_	_	_	_	_	_
161	Both	_	_	_	_	_	_	_	BeginSeg=Yes
162	transient	_	_	_	_	_	_	_	_
163	and	_	_	_	_	_	_	_	_
164	transgenic	_	_	_	_	_	_	_	_
165	expression	_	_	_	_	_	_	_	_
166	of	_	_	_	_	_	_	_	_
167	the	_	_	_	_	_	_	_	_
168	HIV	_	_	_	_	_	_	_	_
169	antigens	_	_	_	_	_	_	_	_
170	were	_	_	_	_	_	_	_	_
171	successful	_	_	_	_	_	_	_	_
172	,	_	_	_	_	_	_	_	_
173	although	_	_	_	_	_	_	_	BeginSeg=Yes
174	expression	_	_	_	_	_	_	_	_
175	of	_	_	_	_	_	_	_	_
176	Pr55Gag	_	_	_	_	_	_	_	_
177	was	_	_	_	_	_	_	_	_
178	low	_	_	_	_	_	_	_	_
179	in	_	_	_	_	_	_	_	_
180	all	_	_	_	_	_	_	_	_
181	systems	_	_	_	_	_	_	_	_
182	;	_	_	_	_	_	_	_	_
183	however	_	_	_	_	_	_	_	BeginSeg=Yes
184	,	_	_	_	_	_	_	_	_
185	the	_	_	_	_	_	_	_	_
186	Agrobacterium	_	_	_	_	_	_	_	_
187	-	_	_	_	_	_	_	_	_
188	mediated	_	_	_	_	_	_	_	_
189	transient	_	_	_	_	_	_	_	_
190	expression	_	_	_	_	_	_	_	_
191	of	_	_	_	_	_	_	_	_
192	p24	_	_	_	_	_	_	_	_
193	and	_	_	_	_	_	_	_	_
194	p17	_	_	_	_	_	_	_	_
195	/	_	_	_	_	_	_	_	_
196	p24	_	_	_	_	_	_	_	_
197	yielded	_	_	_	_	_	_	_	_
198	best	_	_	_	_	_	_	_	_
199	,	_	_	_	_	_	_	_	_
200	to	_	_	_	_	_	_	_	_
201	more	_	_	_	_	_	_	_	_
202	than	_	_	_	_	_	_	_	_
203	1	_	_	_	_	_	_	_	_
204	mg	_	_	_	_	_	_	_	_
205	p24	_	_	_	_	_	_	_	_
206	/	_	_	_	_	_	_	_	_
207	kg	_	_	_	_	_	_	_	_
208	fresh	_	_	_	_	_	_	_	_
209	weight	_	_	_	_	_	_	_	_
210	.	_	_	_	_	_	_	_	_
211	Chloroplast	_	_	_	_	_	_	_	BeginSeg=Yes
212	targeted	_	_	_	_	_	_	_	_
213	protein	_	_	_	_	_	_	_	_
214	levels	_	_	_	_	_	_	_	_
215	were	_	_	_	_	_	_	_	_
216	highest	_	_	_	_	_	_	_	_
217	in	_	_	_	_	_	_	_	_
218	transient	_	_	_	_	_	_	_	_
219	and	_	_	_	_	_	_	_	_
220	transgenic	_	_	_	_	_	_	_	_
221	expression	_	_	_	_	_	_	_	_
222	of	_	_	_	_	_	_	_	_
223	p24	_	_	_	_	_	_	_	_
224	and	_	_	_	_	_	_	_	_
225	p17	_	_	_	_	_	_	_	_
226	/	_	_	_	_	_	_	_	_
227	p24	_	_	_	_	_	_	_	_
228	.	_	_	_	_	_	_	_	_
229	The	_	_	_	_	_	_	_	BeginSeg=Yes
230	transiently	_	_	_	_	_	_	_	_
231	-	_	_	_	_	_	_	_	_
232	expressed	_	_	_	_	_	_	_	_
233	p17	_	_	_	_	_	_	_	_
234	/	_	_	_	_	_	_	_	_
235	p24	_	_	_	_	_	_	_	_
236	was	_	_	_	_	_	_	_	_
237	not	_	_	_	_	_	_	_	_
238	immunogenic	_	_	_	_	_	_	_	_
239	in	_	_	_	_	_	_	_	_
240	mice	_	_	_	_	_	_	_	_
241	as	_	_	_	_	_	_	_	_
242	a	_	_	_	_	_	_	_	_
243	homologous	_	_	_	_	_	_	_	_
244	vaccine	_	_	_	_	_	_	_	_
245	,	_	_	_	_	_	_	_	_
246	but	_	_	_	_	_	_	_	BeginSeg=Yes
247	it	_	_	_	_	_	_	_	_
248	significantly	_	_	_	_	_	_	_	_
249	boosted	_	_	_	_	_	_	_	_
250	a	_	_	_	_	_	_	_	_
251	humoral	_	_	_	_	_	_	_	_
252	and	_	_	_	_	_	_	_	_
253	T	_	_	_	_	_	_	_	_
254	cell	_	_	_	_	_	_	_	_
255	immune	_	_	_	_	_	_	_	_
256	response	_	_	_	_	_	_	_	_
257	primed	_	_	_	_	_	_	_	BeginSeg=Yes
258	by	_	_	_	_	_	_	_	_
259	a	_	_	_	_	_	_	_	_
260	gag	_	_	_	_	_	_	_	_
261	DNA	_	_	_	_	_	_	_	_
262	vaccine	_	_	_	_	_	_	_	_
263	,	_	_	_	_	_	_	_	_
264	pTHGagC.	_	_	_	_	_	_	_	_
265	Conclusion	_	_	_	_	_	_	_	BeginSeg=Yes
266	:	_	_	_	_	_	_	_	_
267	Transient	_	_	_	_	_	_	_	BeginSeg=Yes
268	agroinfiltration	_	_	_	_	_	_	_	_
269	was	_	_	_	_	_	_	_	_
270	best	_	_	_	_	_	_	_	_
271	for	_	_	_	_	_	_	_	_
272	expression	_	_	_	_	_	_	_	_
273	of	_	_	_	_	_	_	_	_
274	all	_	_	_	_	_	_	_	_
275	of	_	_	_	_	_	_	_	_
276	the	_	_	_	_	_	_	_	_
277	recombinant	_	_	_	_	_	_	_	_
278	proteins	_	_	_	_	_	_	_	_
279	tested	_	_	_	_	_	_	_	_
280	,	_	_	_	_	_	_	_	_
281	and	_	_	_	_	_	_	_	BeginSeg=Yes
282	p24	_	_	_	_	_	_	_	_
283	and	_	_	_	_	_	_	_	_
284	p17	_	_	_	_	_	_	_	_
285	/	_	_	_	_	_	_	_	_
286	p24	_	_	_	_	_	_	_	_
287	were	_	_	_	_	_	_	_	_
288	expressed	_	_	_	_	_	_	_	_
289	at	_	_	_	_	_	_	_	_
290	much	_	_	_	_	_	_	_	_
291	higher	_	_	_	_	_	_	_	_
292	levels	_	_	_	_	_	_	_	_
293	than	_	_	_	_	_	_	_	_
294	Pr55Gag	_	_	_	_	_	_	_	_
295	.	_	_	_	_	_	_	_	_
296	Our	_	_	_	_	_	_	_	BeginSeg=Yes
297	results	_	_	_	_	_	_	_	_
298	highlight	_	_	_	_	_	_	_	_
299	the	_	_	_	_	_	_	_	_
300	usefulness	_	_	_	_	_	_	_	_
301	of	_	_	_	_	_	_	_	_
302	plastid	_	_	_	_	_	_	_	_
303	signal	_	_	_	_	_	_	_	_
304	peptides	_	_	_	_	_	_	_	_
305	in	_	_	_	_	_	_	_	BeginSeg=Yes
306	enhancing	_	_	_	_	_	_	_	_
307	the	_	_	_	_	_	_	_	_
308	production	_	_	_	_	_	_	_	_
309	of	_	_	_	_	_	_	_	_
310	recombinant	_	_	_	_	_	_	_	_
311	proteins	_	_	_	_	_	_	_	_
312	meant	_	_	_	_	_	_	_	BeginSeg=Yes
313	for	_	_	_	_	_	_	_	_
314	use	_	_	_	_	_	_	_	_
315	as	_	_	_	_	_	_	_	_
316	vaccines	_	_	_	_	_	_	_	_
317	.	_	_	_	_	_	_	_	_
318	The	_	_	_	_	_	_	_	BeginSeg=Yes
319	p17	_	_	_	_	_	_	_	_
320	/	_	_	_	_	_	_	_	_
321	p24	_	_	_	_	_	_	_	_
322	protein	_	_	_	_	_	_	_	_
323	effectively	_	_	_	_	_	_	_	_
324	boosted	_	_	_	_	_	_	_	_
325	T	_	_	_	_	_	_	_	_
326	cell	_	_	_	_	_	_	_	_
327	and	_	_	_	_	_	_	_	_
328	humoral	_	_	_	_	_	_	_	_
329	responses	_	_	_	_	_	_	_	_
330	in	_	_	_	_	_	_	_	_
331	mice	_	_	_	_	_	_	_	_
332	primed	_	_	_	_	_	_	_	BeginSeg=Yes
333	by	_	_	_	_	_	_	_	_
334	the	_	_	_	_	_	_	_	_
335	DNA	_	_	_	_	_	_	_	_
336	vaccine	_	_	_	_	_	_	_	_
337	pTHGagC	_	_	_	_	_	_	_	_
338	,	_	_	_	_	_	_	_	_
339	showing	_	_	_	_	_	_	_	BeginSeg=Yes
340	that	_	_	_	_	_	_	_	BeginSeg=Yes
341	this	_	_	_	_	_	_	_	_
342	plant	_	_	_	_	_	_	_	_
343	-	_	_	_	_	_	_	_	_
344	produced	_	_	_	_	_	_	_	_
345	protein	_	_	_	_	_	_	_	_
346	has	_	_	_	_	_	_	_	_
347	potential	_	_	_	_	_	_	_	_
348	for	_	_	_	_	_	_	_	_
349	use	_	_	_	_	_	_	_	_
350	as	_	_	_	_	_	_	_	_
351	a	_	_	_	_	_	_	_	_
352	vaccine	_	_	_	_	_	_	_	_
353	.	_	_	_	_	_	_	_	_

# newdoc_id = 1ca87acde2d673e129b4360d84dce19f2555438b
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	development	_	_	_	_	_	_	_	_
3	of	_	_	_	_	_	_	_	_
4	a	_	_	_	_	_	_	_	_
5	"	_	_	_	_	_	_	_	_
6	cold	_	_	_	_	_	_	_	_
7	-	_	_	_	_	_	_	_	_
8	like	_	_	_	_	_	_	_	_
9	illness	_	_	_	_	_	_	_	_
10	"	_	_	_	_	_	_	_	_
11	(	_	_	_	_	_	_	_	_
12	CLI	_	_	_	_	_	_	_	_
13	)	_	_	_	_	_	_	_	_
14	usually	_	_	_	_	_	_	_	_
15	requires	_	_	_	_	_	_	_	_
16	infection	_	_	_	_	_	_	_	_
17	with	_	_	_	_	_	_	_	_
18	an	_	_	_	_	_	_	_	_
19	upper	_	_	_	_	_	_	_	_
20	respiratory	_	_	_	_	_	_	_	_
21	virus	_	_	_	_	_	_	_	_
22	such	_	_	_	_	_	_	_	_
23	as	_	_	_	_	_	_	_	_
24	rhinovirus	_	_	_	_	_	_	_	_
25	,	_	_	_	_	_	_	_	_
26	influenza	_	_	_	_	_	_	_	_
27	virus	_	_	_	_	_	_	_	_
28	,	_	_	_	_	_	_	_	_
29	respiratory	_	_	_	_	_	_	_	_
30	syncytial	_	_	_	_	_	_	_	_
31	virus	_	_	_	_	_	_	_	_
32	,	_	_	_	_	_	_	_	_
33	parainfluenza	_	_	_	_	_	_	_	_
34	virus	_	_	_	_	_	_	_	_
35	,	_	_	_	_	_	_	_	_
36	coronavirus	_	_	_	_	_	_	_	_
37	or	_	_	_	_	_	_	_	_
38	adenovirus	_	_	_	_	_	_	_	_
39	,	_	_	_	_	_	_	_	_
40	among	_	_	_	_	_	_	_	_
41	others	_	_	_	_	_	_	_	_
42	,	_	_	_	_	_	_	_	_
43	and	_	_	_	_	_	_	_	_
44	the	_	_	_	_	_	_	_	_
45	development	_	_	_	_	_	_	_	_
46	of	_	_	_	_	_	_	_	_
47	sufficient	_	_	_	_	_	_	_	_
48	signs	_	_	_	_	_	_	_	_
49	,	_	_	_	_	_	_	_	_
50	symptoms	_	_	_	_	_	_	_	_
51	and	_	_	_	_	_	_	_	_
52	pathophysiologies	_	_	_	_	_	_	_	_
53	to	_	_	_	_	_	_	_	BeginSeg=Yes
54	qualify	_	_	_	_	_	_	_	_
55	as	_	_	_	_	_	_	_	_
56	being	_	_	_	_	_	_	_	_
57	ill	_	_	_	_	_	_	_	_
58	based	_	_	_	_	_	_	_	BeginSeg=Yes
59	on	_	_	_	_	_	_	_	_
60	personal	_	_	_	_	_	_	_	_
61	and	_	_	_	_	_	_	_	_
62	cultural	_	_	_	_	_	_	_	_
63	definitions	_	_	_	_	_	_	_	_
64	.	_	_	_	_	_	_	_	_
65	A	_	_	_	_	_	_	_	BeginSeg=Yes
66	viral	_	_	_	_	_	_	_	_
67	upper	_	_	_	_	_	_	_	_
68	respiratory	_	_	_	_	_	_	_	_
69	tract	_	_	_	_	_	_	_	_
70	infection	_	_	_	_	_	_	_	_
71	(	_	_	_	_	_	_	_	_
72	vURTI	_	_	_	_	_	_	_	_
73	)	_	_	_	_	_	_	_	_
74	in	_	_	_	_	_	_	_	_
75	the	_	_	_	_	_	_	_	_
76	absence	_	_	_	_	_	_	_	_
77	of	_	_	_	_	_	_	_	_
78	overt	_	_	_	_	_	_	_	_
79	illness	_	_	_	_	_	_	_	_
80	(	_	_	_	_	_	_	_	_
81	subclinical	_	_	_	_	_	_	_	_
82	vURTI	_	_	_	_	_	_	_	_
83	)	_	_	_	_	_	_	_	_
84	will	_	_	_	_	_	_	_	_
85	not	_	_	_	_	_	_	_	_
86	be	_	_	_	_	_	_	_	_
87	made	_	_	_	_	_	_	_	_
88	manifest	_	_	_	_	_	_	_	_
89	to	_	_	_	_	_	_	_	_
90	the	_	_	_	_	_	_	_	_
91	individual	_	_	_	_	_	_	_	_
92	or	_	_	_	_	_	_	_	_
93	to	_	_	_	_	_	_	_	_
94	observers	_	_	_	_	_	_	_	_
95	and	_	_	_	_	_	_	_	BeginSeg=Yes
96	,	_	_	_	_	_	_	_	_
97	therefore	_	_	_	_	_	_	_	_
98	,	_	_	_	_	_	_	_	_
99	will	_	_	_	_	_	_	_	_
100	not	_	_	_	_	_	_	_	_
101	be	_	_	_	_	_	_	_	_
102	diagnosed	_	_	_	_	_	_	_	_
103	as	_	_	_	_	_	_	_	_
104	a	_	_	_	_	_	_	_	_
105	CLI	_	_	_	_	_	_	_	_
106	.	_	_	_	_	_	_	_	_
107	The	_	_	_	_	_	_	_	BeginSeg=Yes
108	degree	_	_	_	_	_	_	_	_
109	of	_	_	_	_	_	_	_	_
110	illness	_	_	_	_	_	_	_	_
111	occurring	_	_	_	_	_	_	_	BeginSeg=Yes
112	during	_	_	_	_	_	_	_	_
113	a	_	_	_	_	_	_	_	_
114	vURTI	_	_	_	_	_	_	_	_
115	is	_	_	_	_	_	_	_	BeginSeg=Yes
116	directly	_	_	_	_	_	_	_	_
117	related	_	_	_	_	_	_	_	_
118	to	_	_	_	_	_	_	_	_
119	the	_	_	_	_	_	_	_	_
120	extent	_	_	_	_	_	_	_	_
121	of	_	_	_	_	_	_	_	_
122	provoked	_	_	_	_	_	_	_	_
123	inflammation	_	_	_	_	_	_	_	_
124	,	_	_	_	_	_	_	_	_
125	which	_	_	_	_	_	_	_	BeginSeg=Yes
126	in	_	_	_	_	_	_	_	_
127	turn	_	_	_	_	_	_	_	_
128	depends	_	_	_	_	_	_	_	_
129	on	_	_	_	_	_	_	_	_
130	the	_	_	_	_	_	_	_	_
131	engagement	_	_	_	_	_	_	_	_
132	of	_	_	_	_	_	_	_	_
133	antiviral	_	_	_	_	_	_	_	_
134	defense	_	_	_	_	_	_	_	_
135	systems	_	_	_	_	_	_	_	_
136	.	_	_	_	_	_	_	_	_
137	Thus	_	_	_	_	_	_	_	BeginSeg=Yes
138	,	_	_	_	_	_	_	_	_
139	risk	_	_	_	_	_	_	_	_
140	factors	_	_	_	_	_	_	_	_
141	for	_	_	_	_	_	_	_	_
142	CLI	_	_	_	_	_	_	_	_
143	can	_	_	_	_	_	_	_	_
144	modulate	_	_	_	_	_	_	_	_
145	either	_	_	_	_	_	_	_	_
146	the	_	_	_	_	_	_	_	_
147	vURTI	_	_	_	_	_	_	_	_
148	risk	_	_	_	_	_	_	_	_
149	by	_	_	_	_	_	_	_	BeginSeg=Yes
150	affecting	_	_	_	_	_	_	_	_
151	virus	_	_	_	_	_	_	_	_
152	exposure	_	_	_	_	_	_	_	_
153	and/or	_	_	_	_	_	_	_	_
154	susceptibility	_	_	_	_	_	_	_	_
155	to	_	_	_	_	_	_	_	_
156	infection	_	_	_	_	_	_	_	_
157	,	_	_	_	_	_	_	_	_
158	or	_	_	_	_	_	_	_	BeginSeg=Yes
159	the	_	_	_	_	_	_	_	_
160	CLI	_	_	_	_	_	_	_	_
161	risk	_	_	_	_	_	_	_	_
162	given	_	_	_	_	_	_	_	_
163	a	_	_	_	_	_	_	_	_
164	vURTI	_	_	_	_	_	_	_	_
165	by	_	_	_	_	_	_	_	BeginSeg=Yes
166	affecting	_	_	_	_	_	_	_	_
167	immunocompetence	_	_	_	_	_	_	_	_
168	,	_	_	_	_	_	_	_	_
169	the	_	_	_	_	_	_	_	_
170	provoked	_	_	_	_	_	_	_	_
171	inflammation	_	_	_	_	_	_	_	_
172	and/or	_	_	_	_	_	_	_	_
173	the	_	_	_	_	_	_	_	_
174	interpretation	_	_	_	_	_	_	_	_
175	of	_	_	_	_	_	_	_	_
176	illness	_	_	_	_	_	_	_	_
177	as	_	_	_	_	_	_	_	_
178	a	_	_	_	_	_	_	_	_
179	CLI	_	_	_	_	_	_	_	_
180	.	_	_	_	_	_	_	_	_
181	In	_	_	_	_	_	_	_	BeginSeg=Yes
182	this	_	_	_	_	_	_	_	_
183	chapter	_	_	_	_	_	_	_	_
184	,	_	_	_	_	_	_	_	_
185	we	_	_	_	_	_	_	_	_
186	review	_	_	_	_	_	_	_	_
187	published	_	_	_	_	_	_	_	_
188	studies	_	_	_	_	_	_	_	_
189	for	_	_	_	_	_	_	_	_
190	evidence	_	_	_	_	_	_	_	_
191	of	_	_	_	_	_	_	_	_
192	CLI	_	_	_	_	_	_	_	_
193	risk	_	_	_	_	_	_	_	_
194	-	_	_	_	_	_	_	_	_
195	modulating	_	_	_	_	_	_	_	_
196	factors	_	_	_	_	_	_	_	_
197	and	_	_	_	_	_	_	_	BeginSeg=Yes
198	report	_	_	_	_	_	_	_	_
199	that	_	_	_	_	_	_	_	BeginSeg=Yes
200	climate	_	_	_	_	_	_	_	_
201	,	_	_	_	_	_	_	_	_
202	crowding	_	_	_	_	_	_	_	_
203	and	_	_	_	_	_	_	_	_
204	perhaps	_	_	_	_	_	_	_	_
205	female	_	_	_	_	_	_	_	_
206	gender	_	_	_	_	_	_	_	_
207	can	_	_	_	_	_	_	_	_
208	affect	_	_	_	_	_	_	_	_
209	the	_	_	_	_	_	_	_	_
210	probability	_	_	_	_	_	_	_	_
211	of	_	_	_	_	_	_	_	_
212	exposure	_	_	_	_	_	_	_	_
213	to	_	_	_	_	_	_	_	_
214	vURTI	_	_	_	_	_	_	_	_
215	viruses	_	_	_	_	_	_	_	_
216	,	_	_	_	_	_	_	_	_
217	that	_	_	_	_	_	_	_	BeginSeg=Yes
218	extant	_	_	_	_	_	_	_	_
219	immunological	_	_	_	_	_	_	_	_
220	factors	_	_	_	_	_	_	_	_
221	and	_	_	_	_	_	_	_	_
222	age	_	_	_	_	_	_	_	_
223	can	_	_	_	_	_	_	_	_
224	affect	_	_	_	_	_	_	_	_
225	the	_	_	_	_	_	_	_	_
226	probability	_	_	_	_	_	_	_	_
227	of	_	_	_	_	_	_	_	_
228	virus	_	_	_	_	_	_	_	_
229	infection	_	_	_	_	_	_	_	_
230	given	_	_	_	_	_	_	_	BeginSeg=Yes
231	exposure	_	_	_	_	_	_	_	_
232	,	_	_	_	_	_	_	_	_
233	that	_	_	_	_	_	_	_	BeginSeg=Yes
234	stress	_	_	_	_	_	_	_	_
235	levels	_	_	_	_	_	_	_	_
236	(	_	_	_	_	_	_	_	BeginSeg=Yes
237	moderated	_	_	_	_	_	_	_	_
238	by	_	_	_	_	_	_	_	_
239	social	_	_	_	_	_	_	_	_
240	environment	_	_	_	_	_	_	_	_
241	)	_	_	_	_	_	_	_	_
242	,	_	_	_	_	_	_	_	_
243	health	_	_	_	_	_	_	_	BeginSeg=Yes
244	practices	_	_	_	_	_	_	_	_
245	(	_	_	_	_	_	_	_	BeginSeg=Yes
246	exercise	_	_	_	_	_	_	_	_
247	,	_	_	_	_	_	_	_	_
248	tobacco	_	_	_	_	_	_	_	_
249	and	_	_	_	_	_	_	_	_
250	alcohol	_	_	_	_	_	_	_	_
251	consumption	_	_	_	_	_	_	_	_
252	,	_	_	_	_	_	_	_	_
253	sleep	_	_	_	_	_	_	_	_
254	efficiency	_	_	_	_	_	_	_	_
255	)	_	_	_	_	_	_	_	_
256	and	_	_	_	_	_	_	_	BeginSeg=Yes
257	genetics	_	_	_	_	_	_	_	_
258	contribute	_	_	_	_	_	_	_	_
259	to	_	_	_	_	_	_	_	_
260	CLI	_	_	_	_	_	_	_	_
261	risk	_	_	_	_	_	_	_	_
262	most	_	_	_	_	_	_	_	BeginSeg=Yes
263	probably	_	_	_	_	_	_	_	_
264	by	_	_	_	_	_	_	_	_
265	modulating	_	_	_	_	_	_	_	_
266	the	_	_	_	_	_	_	_	_
267	immune	_	_	_	_	_	_	_	_
268	-	_	_	_	_	_	_	_	_
269	inflammatory	_	_	_	_	_	_	_	_
270	response	_	_	_	_	_	_	_	_
271	to	_	_	_	_	_	_	_	_
272	infection	_	_	_	_	_	_	_	_
273	,	_	_	_	_	_	_	_	_
274	and	_	_	_	_	_	_	_	BeginSeg=Yes
275	that	_	_	_	_	_	_	_	_
276	other	_	_	_	_	_	_	_	_
277	factors	_	_	_	_	_	_	_	_
278	such	_	_	_	_	_	_	_	BeginSeg=Yes
279	as	_	_	_	_	_	_	_	_
280	pollution	_	_	_	_	_	_	_	_
281	,	_	_	_	_	_	_	_	_
282	home	_	_	_	_	_	_	_	_
283	environment	_	_	_	_	_	_	_	_
284	and	_	_	_	_	_	_	_	_
285	certain	_	_	_	_	_	_	_	_
286	personality	_	_	_	_	_	_	_	_
287	traits	_	_	_	_	_	_	_	_
288	affect	_	_	_	_	_	_	_	BeginSeg=Yes
289	CLI	_	_	_	_	_	_	_	_
290	risk	_	_	_	_	_	_	_	_
291	by	_	_	_	_	_	_	_	BeginSeg=Yes
292	biasing	_	_	_	_	_	_	_	_
293	illness	_	_	_	_	_	_	_	_
294	interpretation	_	_	_	_	_	_	_	_
295	for	_	_	_	_	_	_	_	_
296	a	_	_	_	_	_	_	_	_
297	given	_	_	_	_	_	_	_	_
298	set	_	_	_	_	_	_	_	_
299	of	_	_	_	_	_	_	_	_
300	symptoms	_	_	_	_	_	_	_	_
301	and	_	_	_	_	_	_	_	_
302	signs	_	_	_	_	_	_	_	_
303	.	_	_	_	_	_	_	_	_

# newdoc_id = 1d5a95f805753e4ae9c605845a395adf47cabce8
1	Newcastle	_	_	_	_	_	_	_	BeginSeg=Yes
2	disease	_	_	_	_	_	_	_	_
3	(	_	_	_	_	_	_	_	_
4	Paramyxoviridae	_	_	_	_	_	_	_	_
5	)	_	_	_	_	_	_	_	_
6	is	_	_	_	_	_	_	_	_
7	a	_	_	_	_	_	_	_	_
8	highly	_	_	_	_	_	_	_	_
9	infectious	_	_	_	_	_	_	_	_
10	virus	_	_	_	_	_	_	_	_
11	shed	_	_	_	_	_	_	_	BeginSeg=Yes
12	in	_	_	_	_	_	_	_	_
13	the	_	_	_	_	_	_	_	_
14	faeces	_	_	_	_	_	_	_	_
15	of	_	_	_	_	_	_	_	_
16	infected	_	_	_	_	_	_	_	_
17	birds	_	_	_	_	_	_	_	_
18	.	_	_	_	_	_	_	_	_
19	Non	_	_	_	_	_	_	_	BeginSeg=Yes
20	-	_	_	_	_	_	_	_	_
21	biting	_	_	_	_	_	_	_	_
22	Muscid	_	_	_	_	_	_	_	_
23	flies	_	_	_	_	_	_	_	_
24	characteristically	_	_	_	_	_	_	_	_
25	visit	_	_	_	_	_	_	_	_
26	manure	_	_	_	_	_	_	_	_
27	and	_	_	_	_	_	_	_	_
28	decaying	_	_	_	_	_	_	_	_
29	organic	_	_	_	_	_	_	_	_
30	material	_	_	_	_	_	_	_	_
31	to	_	_	_	_	_	_	_	BeginSeg=Yes
32	feed	_	_	_	_	_	_	_	_
33	and	_	_	_	_	_	_	_	BeginSeg=Yes
34	oviposit	_	_	_	_	_	_	_	_
35	,	_	_	_	_	_	_	_	_
36	and	_	_	_	_	_	_	_	BeginSeg=Yes
37	may	_	_	_	_	_	_	_	_
38	contribute	_	_	_	_	_	_	_	_
39	to	_	_	_	_	_	_	_	_
40	disease	_	_	_	_	_	_	_	_
41	transmission	_	_	_	_	_	_	_	_
42	.	_	_	_	_	_	_	_	_
43	The	_	_	_	_	_	_	_	BeginSeg=Yes
44	housefly	_	_	_	_	_	_	_	_
45	,	_	_	_	_	_	_	_	_
46	Musca	_	_	_	_	_	_	_	_
47	domestica	_	_	_	_	_	_	_	_
48	(	_	_	_	_	_	_	_	_
49	Linnaeus	_	_	_	_	_	_	_	_
50	,	_	_	_	_	_	_	_	_
51	1758	_	_	_	_	_	_	_	_
52	)	_	_	_	_	_	_	_	_
53	(	_	_	_	_	_	_	_	_
54	Diptera	_	_	_	_	_	_	_	_
55	:	_	_	_	_	_	_	_	_
56	Muscidae	_	_	_	_	_	_	_	_
57	)	_	_	_	_	_	_	_	_
58	,	_	_	_	_	_	_	_	_
59	has	_	_	_	_	_	_	_	_
60	been	_	_	_	_	_	_	_	_
61	implicated	_	_	_	_	_	_	_	_
62	as	_	_	_	_	_	_	_	_
63	a	_	_	_	_	_	_	_	_
64	mechanical	_	_	_	_	_	_	_	_
65	vector	_	_	_	_	_	_	_	_
66	of	_	_	_	_	_	_	_	_
67	numerous	_	_	_	_	_	_	_	_
68	pathogens	_	_	_	_	_	_	_	_
69	.	_	_	_	_	_	_	_	_
70	In	_	_	_	_	_	_	_	BeginSeg=Yes
71	this	_	_	_	_	_	_	_	_
72	study	_	_	_	_	_	_	_	_
73	2000	_	_	_	_	_	_	_	_
74	aerial	_	_	_	_	_	_	_	_
75	net	_	_	_	_	_	_	_	_
76	-	_	_	_	_	_	_	_	_
77	captured	_	_	_	_	_	_	_	_
78	houseflies	_	_	_	_	_	_	_	_
79	were	_	_	_	_	_	_	_	_
80	examined	_	_	_	_	_	_	_	_
81	for	_	_	_	_	_	_	_	_
82	their	_	_	_	_	_	_	_	_
83	ability	_	_	_	_	_	_	_	_
84	to	_	_	_	_	_	_	_	BeginSeg=Yes
85	harbour	_	_	_	_	_	_	_	_
86	Newcastle	_	_	_	_	_	_	_	_
87	disease	_	_	_	_	_	_	_	_
88	virus	_	_	_	_	_	_	_	_
89	(	_	_	_	_	_	_	_	_
90	NDV	_	_	_	_	_	_	_	_
91	)	_	_	_	_	_	_	_	_
92	.	_	_	_	_	_	_	_	_
93	In	_	_	_	_	_	_	_	BeginSeg=Yes
94	an	_	_	_	_	_	_	_	_
95	adjacent	_	_	_	_	_	_	_	_
96	study	_	_	_	_	_	_	_	_
97	,	_	_	_	_	_	_	_	_
98	laboratory	_	_	_	_	_	_	_	_
99	-	_	_	_	_	_	_	_	_
100	reared	_	_	_	_	_	_	_	_
101	flies	_	_	_	_	_	_	_	_
102	were	_	_	_	_	_	_	_	_
103	experimentally	_	_	_	_	_	_	_	_
104	exposed	_	_	_	_	_	_	_	_
105	to	_	_	_	_	_	_	_	_
106	NDV	_	_	_	_	_	_	_	_
107	La	_	_	_	_	_	_	_	_
108	Sota	_	_	_	_	_	_	_	_
109	strain	_	_	_	_	_	_	_	_
110	.	_	_	_	_	_	_	_	_
111	The	_	_	_	_	_	_	_	BeginSeg=Yes
112	virus	_	_	_	_	_	_	_	_
113	was	_	_	_	_	_	_	_	_
114	detected	_	_	_	_	_	_	_	_
115	in	_	_	_	_	_	_	_	_
116	the	_	_	_	_	_	_	_	_
117	dissected	_	_	_	_	_	_	_	_
118	gastrointestinal	_	_	_	_	_	_	_	_
119	tract	_	_	_	_	_	_	_	_
120	of	_	_	_	_	_	_	_	_
121	laboratory	_	_	_	_	_	_	_	_
122	-	_	_	_	_	_	_	_	_
123	exposed	_	_	_	_	_	_	_	_
124	flies	_	_	_	_	_	_	_	_
125	for	_	_	_	_	_	_	_	_
126	up	_	_	_	_	_	_	_	_
127	to	_	_	_	_	_	_	_	_
128	72	_	_	_	_	_	_	_	_
129	h	_	_	_	_	_	_	_	_
130	post	_	_	_	_	_	_	_	_
131	-	_	_	_	_	_	_	_	_
132	exposure	_	_	_	_	_	_	_	_
133	,	_	_	_	_	_	_	_	_
134	whereas	_	_	_	_	_	_	_	BeginSeg=Yes
135	the	_	_	_	_	_	_	_	_
136	untreated	_	_	_	_	_	_	_	_
137	control	_	_	_	_	_	_	_	_
138	flies	_	_	_	_	_	_	_	_
139	were	_	_	_	_	_	_	_	_
140	negative	_	_	_	_	_	_	_	_
141	.	_	_	_	_	_	_	_	_

# newdoc_id = 1dc818a92b31dc871d7020ec659faaeb38e519c6
1	Respiratory	_	_	_	_	_	_	_	BeginSeg=Yes
2	viral	_	_	_	_	_	_	_	_
3	infections	_	_	_	_	_	_	_	_
4	in	_	_	_	_	_	_	_	_
5	infants	_	_	_	_	_	_	_	_
6	and	_	_	_	_	_	_	_	_
7	young	_	_	_	_	_	_	_	_
8	children	_	_	_	_	_	_	_	_
9	frequently	_	_	_	_	_	_	_	_
10	cause	_	_	_	_	_	_	_	_
11	illness	_	_	_	_	_	_	_	_
12	that	_	_	_	_	_	_	_	BeginSeg=Yes
13	can	_	_	_	_	_	_	_	_
14	easily	_	_	_	_	_	_	_	_
15	progress	_	_	_	_	_	_	_	_
16	to	_	_	_	_	_	_	_	_
17	hospitalization	_	_	_	_	_	_	_	_
18	and	_	_	_	_	_	_	_	_
19	death	_	_	_	_	_	_	_	_
20	.	_	_	_	_	_	_	_	_
21	There	_	_	_	_	_	_	_	BeginSeg=Yes
22	are	_	_	_	_	_	_	_	_
23	currently	_	_	_	_	_	_	_	_
24	no	_	_	_	_	_	_	_	_
25	licensed	_	_	_	_	_	_	_	_
26	vaccines	_	_	_	_	_	_	_	_
27	to	_	_	_	_	_	_	_	BeginSeg=Yes
28	prevent	_	_	_	_	_	_	_	_
29	respiratory	_	_	_	_	_	_	_	_
30	viral	_	_	_	_	_	_	_	_
31	disease	_	_	_	_	_	_	_	_
32	in	_	_	_	_	_	_	_	_
33	children	_	_	_	_	_	_	_	_
34	younger	_	_	_	_	_	_	_	_
35	than	_	_	_	_	_	_	_	_
36	6	_	_	_	_	_	_	_	_
37	months	_	_	_	_	_	_	_	_
38	,	_	_	_	_	_	_	_	_
39	reflecting	_	_	_	_	_	_	_	BeginSeg=Yes
40	safety	_	_	_	_	_	_	_	_
41	concerns	_	_	_	_	_	_	_	_
42	and	_	_	_	_	_	_	_	_
43	the	_	_	_	_	_	_	_	_
44	difficulty	_	_	_	_	_	_	_	_
45	in	_	_	_	_	_	_	_	BeginSeg=Yes
46	inducing	_	_	_	_	_	_	_	_
47	effective	_	_	_	_	_	_	_	_
48	immune	_	_	_	_	_	_	_	_
49	responses	_	_	_	_	_	_	_	_
50	in	_	_	_	_	_	_	_	_
51	infants	_	_	_	_	_	_	_	_
52	.	_	_	_	_	_	_	_	_
53	This	_	_	_	_	_	_	_	BeginSeg=Yes
54	review	_	_	_	_	_	_	_	_
55	discusses	_	_	_	_	_	_	_	_
56	vaccines	_	_	_	_	_	_	_	_
57	that	_	_	_	_	_	_	_	BeginSeg=Yes
58	have	_	_	_	_	_	_	_	_
59	been	_	_	_	_	_	_	_	_
60	developed	_	_	_	_	_	_	_	_
61	,	_	_	_	_	_	_	_	_
62	or	_	_	_	_	_	_	_	_
63	are	_	_	_	_	_	_	_	_
64	currently	_	_	_	_	_	_	_	_
65	being	_	_	_	_	_	_	_	_
66	developed	_	_	_	_	_	_	_	_
67	,	_	_	_	_	_	_	_	_
68	against	_	_	_	_	_	_	_	_
69	influenza	_	_	_	_	_	_	_	_
70	and	_	_	_	_	_	_	_	_
71	respiratory	_	_	_	_	_	_	_	_
72	syncytial	_	_	_	_	_	_	_	_
73	virus	_	_	_	_	_	_	_	_
74	,	_	_	_	_	_	_	_	_
75	with	_	_	_	_	_	_	_	_
76	a	_	_	_	_	_	_	_	_
77	focus	_	_	_	_	_	_	_	_
78	on	_	_	_	_	_	_	_	_
79	studies	_	_	_	_	_	_	_	_
80	performed	_	_	_	_	_	_	_	BeginSeg=Yes
81	to	_	_	_	_	_	_	_	BeginSeg=Yes
82	demonstrate	_	_	_	_	_	_	_	_
83	their	_	_	_	_	_	_	_	_
84	safety	_	_	_	_	_	_	_	_
85	and	_	_	_	_	_	_	_	_
86	efficacy	_	_	_	_	_	_	_	_
87	,	_	_	_	_	_	_	_	_
88	and	_	_	_	_	_	_	_	_
89	the	_	_	_	_	_	_	_	_
90	impact	_	_	_	_	_	_	_	_
91	of	_	_	_	_	_	_	_	_
92	immunologic	_	_	_	_	_	_	_	_
93	immaturity	_	_	_	_	_	_	_	_
94	and	_	_	_	_	_	_	_	_
95	maternal	_	_	_	_	_	_	_	_
96	antibodies	_	_	_	_	_	_	_	_
97	on	_	_	_	_	_	_	_	_
98	the	_	_	_	_	_	_	_	_
99	infant	_	_	_	_	_	_	_	_
100	response	_	_	_	_	_	_	_	_
101	to	_	_	_	_	_	_	_	_
102	vaccines	_	_	_	_	_	_	_	_
103	.	_	_	_	_	_	_	_	_

# newdoc_id = 1ea771012595cf18bfe22d4933e45b8a190881fc
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	novel	_	_	_	_	_	_	_	_
3	Coronavirus	_	_	_	_	_	_	_	_
4	has	_	_	_	_	_	_	_	_
5	caused	_	_	_	_	_	_	_	_
6	a	_	_	_	_	_	_	_	_
7	global	_	_	_	_	_	_	_	_
8	crisis	_	_	_	_	_	_	_	_
9	and	_	_	_	_	_	_	_	BeginSeg=Yes
10	many	_	_	_	_	_	_	_	_
11	governments	_	_	_	_	_	_	_	_
12	have	_	_	_	_	_	_	_	_
13	taken	_	_	_	_	_	_	_	_
14	social	_	_	_	_	_	_	_	_
15	measures	_	_	_	_	_	_	_	_
16	,	_	_	_	_	_	_	_	_
17	such	_	_	_	_	_	_	_	BeginSeg=Yes
18	as	_	_	_	_	_	_	_	_
19	home	_	_	_	_	_	_	_	_
20	quarantine	_	_	_	_	_	_	_	_
21	and	_	_	_	_	_	_	_	_
22	maintaining	_	_	_	_	_	_	_	_
23	social	_	_	_	_	_	_	_	_
24	distance	_	_	_	_	_	_	_	_
25	.	_	_	_	_	_	_	_	_
26	Many	_	_	_	_	_	_	_	BeginSeg=Yes
27	recent	_	_	_	_	_	_	_	_
28	studies	_	_	_	_	_	_	_	_
29	show	_	_	_	_	_	_	_	_
30	that	_	_	_	_	_	_	_	BeginSeg=Yes
31	network	_	_	_	_	_	_	_	_
32	structure	_	_	_	_	_	_	_	_
33	and	_	_	_	_	_	_	_	_
34	human	_	_	_	_	_	_	_	_
35	mobility	_	_	_	_	_	_	_	_
36	greatly	_	_	_	_	_	_	_	_
37	influence	_	_	_	_	_	_	_	_
38	the	_	_	_	_	_	_	_	_
39	dynamics	_	_	_	_	_	_	_	_
40	of	_	_	_	_	_	_	_	_
41	epidemic	_	_	_	_	_	_	_	_
42	spreading	_	_	_	_	_	_	_	_
43	.	_	_	_	_	_	_	_	_
44	In	_	_	_	_	_	_	_	BeginSeg=Yes
45	this	_	_	_	_	_	_	_	_
46	paper	_	_	_	_	_	_	_	_
47	,	_	_	_	_	_	_	_	_
48	we	_	_	_	_	_	_	_	_
49	utilize	_	_	_	_	_	_	_	_
50	a	_	_	_	_	_	_	_	_
51	discrete	_	_	_	_	_	_	_	_
52	-	_	_	_	_	_	_	_	_
53	time	_	_	_	_	_	_	_	_
54	Markov	_	_	_	_	_	_	_	_
55	chain	_	_	_	_	_	_	_	_
56	approach	_	_	_	_	_	_	_	_
57	and	_	_	_	_	_	_	_	BeginSeg=Yes
58	propose	_	_	_	_	_	_	_	_
59	an	_	_	_	_	_	_	_	_
60	epidemic	_	_	_	_	_	_	_	_
61	model	_	_	_	_	_	_	_	_
62	to	_	_	_	_	_	_	_	BeginSeg=Yes
63	describe	_	_	_	_	_	_	_	_
64	virus	_	_	_	_	_	_	_	_
65	propagation	_	_	_	_	_	_	_	_
66	in	_	_	_	_	_	_	_	_
67	the	_	_	_	_	_	_	_	_
68	heterogeneous	_	_	_	_	_	_	_	_
69	graph	_	_	_	_	_	_	_	_
70	,	_	_	_	_	_	_	_	_
71	which	_	_	_	_	_	_	_	BeginSeg=Yes
72	is	_	_	_	_	_	_	_	_
73	used	_	_	_	_	_	_	_	_
74	to	_	_	_	_	_	_	_	BeginSeg=Yes
75	represent	_	_	_	_	_	_	_	_
76	individuals	_	_	_	_	_	_	_	_
77	with	_	_	_	_	_	_	_	_
78	intra	_	_	_	_	_	_	_	_
79	social	_	_	_	_	_	_	_	_
80	connections	_	_	_	_	_	_	_	_
81	and	_	_	_	_	_	_	_	_
82	mobility	_	_	_	_	_	_	_	_
83	between	_	_	_	_	_	_	_	_
84	individuals	_	_	_	_	_	_	_	_
85	and	_	_	_	_	_	_	_	_
86	common	_	_	_	_	_	_	_	_
87	locations	_	_	_	_	_	_	_	_
88	.	_	_	_	_	_	_	_	_
89	There	_	_	_	_	_	_	_	BeginSeg=Yes
90	are	_	_	_	_	_	_	_	_
91	two	_	_	_	_	_	_	_	_
92	types	_	_	_	_	_	_	_	_
93	of	_	_	_	_	_	_	_	_
94	nodes	_	_	_	_	_	_	_	_
95	,	_	_	_	_	_	_	_	_
96	individuals	_	_	_	_	_	_	_	_
97	and	_	_	_	_	_	_	_	_
98	public	_	_	_	_	_	_	_	_
99	places	_	_	_	_	_	_	_	_
100	,	_	_	_	_	_	_	_	_
101	and	_	_	_	_	_	_	_	BeginSeg=Yes
102	disease	_	_	_	_	_	_	_	_
103	can	_	_	_	_	_	_	_	_
104	spread	_	_	_	_	_	_	_	_
105	by	_	_	_	_	_	_	_	_
106	social	_	_	_	_	_	_	_	_
107	contacts	_	_	_	_	_	_	_	_
108	among	_	_	_	_	_	_	_	_
109	individuals	_	_	_	_	_	_	_	_
110	and	_	_	_	_	_	_	_	_
111	people	_	_	_	_	_	_	_	_
112	gathering	_	_	_	_	_	_	_	BeginSeg=Yes
113	in	_	_	_	_	_	_	_	_
114	common	_	_	_	_	_	_	_	_
115	areas	_	_	_	_	_	_	_	_
116	.	_	_	_	_	_	_	_	_
117	We	_	_	_	_	_	_	_	BeginSeg=Yes
118	give	_	_	_	_	_	_	_	_
119	theoretical	_	_	_	_	_	_	_	_
120	results	_	_	_	_	_	_	_	_
121	about	_	_	_	_	_	_	_	_
122	epidemic	_	_	_	_	_	_	_	_
123	threshold	_	_	_	_	_	_	_	_
124	and	_	_	_	_	_	_	_	_
125	influence	_	_	_	_	_	_	_	_
126	of	_	_	_	_	_	_	_	_
127	isolation	_	_	_	_	_	_	_	_
128	factor	_	_	_	_	_	_	_	_
129	.	_	_	_	_	_	_	_	_
130	Several	_	_	_	_	_	_	_	BeginSeg=Yes
131	numerical	_	_	_	_	_	_	_	_
132	simulations	_	_	_	_	_	_	_	_
133	are	_	_	_	_	_	_	_	_
134	performed	_	_	_	_	_	_	_	_
135	and	_	_	_	_	_	_	_	BeginSeg=Yes
136	experimental	_	_	_	_	_	_	_	_
137	results	_	_	_	_	_	_	_	_
138	further	_	_	_	_	_	_	_	_
139	demonstrate	_	_	_	_	_	_	_	_
140	the	_	_	_	_	_	_	_	_
141	correctness	_	_	_	_	_	_	_	_
142	of	_	_	_	_	_	_	_	_
143	proposed	_	_	_	_	_	_	_	_
144	model	_	_	_	_	_	_	_	_
145	.	_	_	_	_	_	_	_	_
146	Non	_	_	_	_	_	_	_	BeginSeg=Yes
147	-	_	_	_	_	_	_	_	_
148	monotonic	_	_	_	_	_	_	_	_
149	relationship	_	_	_	_	_	_	_	_
150	between	_	_	_	_	_	_	_	_
151	mobility	_	_	_	_	_	_	_	_
152	possibility	_	_	_	_	_	_	_	_
153	and	_	_	_	_	_	_	_	_
154	epidemic	_	_	_	_	_	_	_	_
155	threshold	_	_	_	_	_	_	_	_
156	and	_	_	_	_	_	_	_	_
157	differences	_	_	_	_	_	_	_	_
158	between	_	_	_	_	_	_	_	_
159	Erdös	_	_	_	_	_	_	_	_
160	-	_	_	_	_	_	_	_	_
161	Rényi	_	_	_	_	_	_	_	_
162	and	_	_	_	_	_	_	_	_
163	power	_	_	_	_	_	_	_	_
164	-	_	_	_	_	_	_	_	_
165	law	_	_	_	_	_	_	_	_
166	social	_	_	_	_	_	_	_	_
167	connections	_	_	_	_	_	_	_	_
168	are	_	_	_	_	_	_	_	_
169	revealed	_	_	_	_	_	_	_	_
170	.	_	_	_	_	_	_	_	_
171	In	_	_	_	_	_	_	_	BeginSeg=Yes
172	summary	_	_	_	_	_	_	_	_
173	,	_	_	_	_	_	_	_	_
174	our	_	_	_	_	_	_	_	_
175	proposed	_	_	_	_	_	_	_	_
176	approach	_	_	_	_	_	_	_	_
177	and	_	_	_	_	_	_	_	_
178	findings	_	_	_	_	_	_	_	_
179	are	_	_	_	_	_	_	_	_
180	helpful	_	_	_	_	_	_	_	_
181	to	_	_	_	_	_	_	_	_
182	analyse	_	_	_	_	_	_	_	_
183	and	_	_	_	_	_	_	_	_
184	prevent	_	_	_	_	_	_	_	_
185	the	_	_	_	_	_	_	_	_
186	epidemic	_	_	_	_	_	_	_	_
187	spreading	_	_	_	_	_	_	_	_
188	in	_	_	_	_	_	_	_	_
189	networked	_	_	_	_	_	_	_	_
190	population	_	_	_	_	_	_	_	_
191	with	_	_	_	_	_	_	_	_
192	recurrent	_	_	_	_	_	_	_	_
193	mobility	_	_	_	_	_	_	_	_
194	pattern	_	_	_	_	_	_	_	_
195	.	_	_	_	_	_	_	_	_

# newdoc_id = 2074781d7ca96edc1ef37f4cc7196856653a14e0
1	This	_	_	_	_	_	_	_	BeginSeg=Yes
2	paper	_	_	_	_	_	_	_	_
3	presents	_	_	_	_	_	_	_	_
4	the	_	_	_	_	_	_	_	_
5	dataset	_	_	_	_	_	_	_	_
6	of	_	_	_	_	_	_	_	_
7	a	_	_	_	_	_	_	_	_
8	survey	_	_	_	_	_	_	_	_
9	on	_	_	_	_	_	_	_	_
10	workplace	_	_	_	_	_	_	_	_
11	health	_	_	_	_	_	_	_	_
12	and	_	_	_	_	_	_	_	_
13	safety	_	_	_	_	_	_	_	_
14	training	_	_	_	_	_	_	_	_
15	,	_	_	_	_	_	_	_	_
16-17	employees'	_	_	_	_	_	_	_	_
16	employees	_	_	_	_	_	_	_	_
17	'	_	_	_	_	_	_	_	_
18	risk	_	_	_	_	_	_	_	_
19	perceptions	_	_	_	_	_	_	_	_
20	,	_	_	_	_	_	_	_	_
21	behavioral	_	_	_	_	_	_	_	_
22	safety	_	_	_	_	_	_	_	_
23	compliance	_	_	_	_	_	_	_	_
24	,	_	_	_	_	_	_	_	_
25	and	_	_	_	_	_	_	_	_
26	perceived	_	_	_	_	_	_	_	_
27	job	_	_	_	_	_	_	_	_
28	insecurity	_	_	_	_	_	_	_	_
29	in	_	_	_	_	_	_	_	_
30	Vietnam	_	_	_	_	_	_	_	_
31	during	_	_	_	_	_	_	_	_
32	COVID-19	_	_	_	_	_	_	_	_
33	pandemic	_	_	_	_	_	_	_	_
34	.	_	_	_	_	_	_	_	_
35	The	_	_	_	_	_	_	_	BeginSeg=Yes
36	data	_	_	_	_	_	_	_	_
37	were	_	_	_	_	_	_	_	_
38	collected	_	_	_	_	_	_	_	_
39	through	_	_	_	_	_	_	_	_
40	an	_	_	_	_	_	_	_	_
41	online	_	_	_	_	_	_	_	_
42	questionnaire	_	_	_	_	_	_	_	_
43	completed	_	_	_	_	_	_	_	BeginSeg=Yes
44	by	_	_	_	_	_	_	_	_
45	Vietnamese	_	_	_	_	_	_	_	_
46	full	_	_	_	_	_	_	_	_
47	-	_	_	_	_	_	_	_	_
48	time	_	_	_	_	_	_	_	_
49	employees	_	_	_	_	_	_	_	_
50	between	_	_	_	_	_	_	_	_
51	April	_	_	_	_	_	_	_	_
52	and	_	_	_	_	_	_	_	_
53	June	_	_	_	_	_	_	_	_
54	2020	_	_	_	_	_	_	_	_
55	.	_	_	_	_	_	_	_	_
56	Using	_	_	_	_	_	_	_	BeginSeg=Yes
57	E	_	_	_	_	_	_	_	_
58	-	_	_	_	_	_	_	_	_
59	mail	_	_	_	_	_	_	_	_
60	,	_	_	_	_	_	_	_	_
61	LinkedIn	_	_	_	_	_	_	_	_
62	,	_	_	_	_	_	_	_	_
63	and	_	_	_	_	_	_	_	_
64	Facebook	_	_	_	_	_	_	_	_
65	,	_	_	_	_	_	_	_	_
66	the	_	_	_	_	_	_	_	BeginSeg=Yes
67	online	_	_	_	_	_	_	_	_
68	questionnaire	_	_	_	_	_	_	_	_
69	was	_	_	_	_	_	_	_	_
70	sent	_	_	_	_	_	_	_	_
71	to	_	_	_	_	_	_	_	_
72	respondents	_	_	_	_	_	_	_	_
73	who	_	_	_	_	_	_	_	BeginSeg=Yes
74	filled	_	_	_	_	_	_	_	_
75	it	_	_	_	_	_	_	_	_
76	out	_	_	_	_	_	_	_	_
77	voluntarily	_	_	_	_	_	_	_	_
78	.	_	_	_	_	_	_	_	_
79	A	_	_	_	_	_	_	_	BeginSeg=Yes
80	twowave	_	_	_	_	_	_	_	_
81	survey	_	_	_	_	_	_	_	_
82	was	_	_	_	_	_	_	_	_
83	conducted	_	_	_	_	_	_	_	_
84	in	_	_	_	_	_	_	_	BeginSeg=Yes
85	order	_	_	_	_	_	_	_	_
86	to	_	_	_	_	_	_	_	_
87	lessen	_	_	_	_	_	_	_	_
88	the	_	_	_	_	_	_	_	_
89	common	_	_	_	_	_	_	_	_
90	method	_	_	_	_	_	_	_	_
91	bias	_	_	_	_	_	_	_	_
92	.	_	_	_	_	_	_	_	_
93	Totally	_	_	_	_	_	_	_	BeginSeg=Yes
94	,	_	_	_	_	_	_	_	_
95	we	_	_	_	_	_	_	_	_
96	received	_	_	_	_	_	_	_	_
97	complete	_	_	_	_	_	_	_	_
98	matched	_	_	_	_	_	_	_	_
99	data	_	_	_	_	_	_	_	_
100	for	_	_	_	_	_	_	_	_
101	732	_	_	_	_	_	_	_	_
102	full	_	_	_	_	_	_	_	_
103	-	_	_	_	_	_	_	_	_
104	time	_	_	_	_	_	_	_	_
105	employees	_	_	_	_	_	_	_	_
106	.	_	_	_	_	_	_	_	_
107	All	_	_	_	_	_	_	_	BeginSeg=Yes
108	data	_	_	_	_	_	_	_	_
109	were	_	_	_	_	_	_	_	_
110	processed	_	_	_	_	_	_	_	_
111	through	_	_	_	_	_	_	_	_
112	SPSS	_	_	_	_	_	_	_	_
113	22.0	_	_	_	_	_	_	_	_
114	,	_	_	_	_	_	_	_	_
115	AMOS	_	_	_	_	_	_	_	_
116	23.0	_	_	_	_	_	_	_	_
117	and	_	_	_	_	_	_	_	_
118	Smart	_	_	_	_	_	_	_	_
119	PLS	_	_	_	_	_	_	_	_
120	3.0	_	_	_	_	_	_	_	_
121	.	_	_	_	_	_	_	_	_
122	Besides	_	_	_	_	_	_	_	BeginSeg=Yes
123	descriptive	_	_	_	_	_	_	_	_
124	statistics	_	_	_	_	_	_	_	_
125	,	_	_	_	_	_	_	_	_
126	the	_	_	_	_	_	_	_	_
127	results	_	_	_	_	_	_	_	_
128	of	_	_	_	_	_	_	_	_
129	the	_	_	_	_	_	_	_	_
130	explanatory	_	_	_	_	_	_	_	_
131	factor	_	_	_	_	_	_	_	_
132	analysis	_	_	_	_	_	_	_	_
133	and	_	_	_	_	_	_	_	_
134	the	_	_	_	_	_	_	_	_
135	confirmation	_	_	_	_	_	_	_	_
136	factor	_	_	_	_	_	_	_	_
137	analysis	_	_	_	_	_	_	_	_
138	were	_	_	_	_	_	_	_	_
139	included	_	_	_	_	_	_	_	_
140	in	_	_	_	_	_	_	_	_
141	this	_	_	_	_	_	_	_	_
142	paper	_	_	_	_	_	_	_	_
143	,	_	_	_	_	_	_	_	_
144	which	_	_	_	_	_	_	_	BeginSeg=Yes
145	may	_	_	_	_	_	_	_	_
146	serve	_	_	_	_	_	_	_	_
147	as	_	_	_	_	_	_	_	_
148	a	_	_	_	_	_	_	_	_
149	good	_	_	_	_	_	_	_	_
150	reference	_	_	_	_	_	_	_	_
151	for	_	_	_	_	_	_	_	_
152	future	_	_	_	_	_	_	_	_
153	studies	_	_	_	_	_	_	_	_
154	.	_	_	_	_	_	_	_	_

# newdoc_id = 20ec367d459abe3e88b7db18a359f087c37bd90e
1	Enteroviruses	_	_	_	_	_	_	_	BeginSeg=Yes
2	are	_	_	_	_	_	_	_	_
3	common	_	_	_	_	_	_	_	_
4	human	_	_	_	_	_	_	_	_
5	pathogens	_	_	_	_	_	_	_	_
6	,	_	_	_	_	_	_	_	_
7	and	_	_	_	_	_	_	_	BeginSeg=Yes
8	infections	_	_	_	_	_	_	_	_
9	are	_	_	_	_	_	_	_	_
10	particularly	_	_	_	_	_	_	_	_
11	frequent	_	_	_	_	_	_	_	_
12	in	_	_	_	_	_	_	_	_
13	children	_	_	_	_	_	_	_	_
14	.	_	_	_	_	_	_	_	_
15	Severe	_	_	_	_	_	_	_	BeginSeg=Yes
16	infections	_	_	_	_	_	_	_	_
17	can	_	_	_	_	_	_	_	_
18	lead	_	_	_	_	_	_	_	_
19	to	_	_	_	_	_	_	_	_
20	a	_	_	_	_	_	_	_	_
21	variety	_	_	_	_	_	_	_	_
22	of	_	_	_	_	_	_	_	_
23	diseases	_	_	_	_	_	_	_	_
24	,	_	_	_	_	_	_	_	_
25	including	_	_	_	_	_	_	_	BeginSeg=Yes
26	poliomyelitis	_	_	_	_	_	_	_	_
27	,	_	_	_	_	_	_	_	_
28	aseptic	_	_	_	_	_	_	_	_
29	meningitis	_	_	_	_	_	_	_	_
30	,	_	_	_	_	_	_	_	_
31	myocarditis	_	_	_	_	_	_	_	_
32	and	_	_	_	_	_	_	_	_
33	neonatal	_	_	_	_	_	_	_	_
34	sepsis	_	_	_	_	_	_	_	_
35	.	_	_	_	_	_	_	_	_
36	Enterovirus	_	_	_	_	_	_	_	BeginSeg=Yes
37	infections	_	_	_	_	_	_	_	_
38	have	_	_	_	_	_	_	_	_
39	also	_	_	_	_	_	_	_	_
40	been	_	_	_	_	_	_	_	_
41	implicated	_	_	_	_	_	_	_	_
42	in	_	_	_	_	_	_	_	_
43	asthmatic	_	_	_	_	_	_	_	_
44	exacerbations	_	_	_	_	_	_	_	_
45	and	_	_	_	_	_	_	_	_
46	type	_	_	_	_	_	_	_	_
47	1	_	_	_	_	_	_	_	_
48	diabetes	_	_	_	_	_	_	_	_
49	.	_	_	_	_	_	_	_	_
50	The	_	_	_	_	_	_	_	BeginSeg=Yes
51	large	_	_	_	_	_	_	_	_
52	disease	_	_	_	_	_	_	_	_
53	spectrum	_	_	_	_	_	_	_	_
54	of	_	_	_	_	_	_	_	_
55	the	_	_	_	_	_	_	_	_
56	closely	_	_	_	_	_	_	_	_
57	related	_	_	_	_	_	_	_	_
58	enteroviruses	_	_	_	_	_	_	_	_
59	may	_	_	_	_	_	_	_	_
60	be	_	_	_	_	_	_	_	_
61	partially	_	_	_	_	_	_	_	_
62	,	_	_	_	_	_	_	_	_
63	but	_	_	_	_	_	_	_	_
64	not	_	_	_	_	_	_	_	_
65	fully	_	_	_	_	_	_	_	_
66	,	_	_	_	_	_	_	_	_
67	explained	_	_	_	_	_	_	_	_
68	by	_	_	_	_	_	_	_	_
69	differences	_	_	_	_	_	_	_	_
70	in	_	_	_	_	_	_	_	_
71	tissue	_	_	_	_	_	_	_	_
72	tropism	_	_	_	_	_	_	_	_
73	.	_	_	_	_	_	_	_	_
74	The	_	_	_	_	_	_	_	BeginSeg=Yes
75	molecular	_	_	_	_	_	_	_	_
76	mechanisms	_	_	_	_	_	_	_	_
77	by	_	_	_	_	_	_	_	BeginSeg=Yes
78	which	_	_	_	_	_	_	_	_
79	enteroviruses	_	_	_	_	_	_	_	_
80	cause	_	_	_	_	_	_	_	_
81	disease	_	_	_	_	_	_	_	_
82	are	_	_	_	_	_	_	_	BeginSeg=Yes
83	poorly	_	_	_	_	_	_	_	_
84	understood	_	_	_	_	_	_	_	_
85	,	_	_	_	_	_	_	_	_
86	but	_	_	_	_	_	_	_	BeginSeg=Yes
87	there	_	_	_	_	_	_	_	_
88	is	_	_	_	_	_	_	_	_
89	increasing	_	_	_	_	_	_	_	_
90	evidence	_	_	_	_	_	_	_	_
91	that	_	_	_	_	_	_	_	BeginSeg=Yes
92	the	_	_	_	_	_	_	_	_
93	two	_	_	_	_	_	_	_	_
94	enteroviral	_	_	_	_	_	_	_	_
95	proteases	_	_	_	_	_	_	_	_
96	,	_	_	_	_	_	_	_	_
97	2A	_	_	_	_	_	_	_	_
98	pro	_	_	_	_	_	_	_	_
99	and	_	_	_	_	_	_	_	_
100	3C	_	_	_	_	_	_	_	_
101	pro	_	_	_	_	_	_	_	_
102	,	_	_	_	_	_	_	_	_
103	are	_	_	_	_	_	_	_	_
104	important	_	_	_	_	_	_	_	_
105	mediators	_	_	_	_	_	_	_	_
106	of	_	_	_	_	_	_	_	_
107	pathology	_	_	_	_	_	_	_	_
108	.	_	_	_	_	_	_	_	_
109	These	_	_	_	_	_	_	_	BeginSeg=Yes
110	proteases	_	_	_	_	_	_	_	_
111	perform	_	_	_	_	_	_	_	_
112	the	_	_	_	_	_	_	_	_
113	posttranslational	_	_	_	_	_	_	_	_
114	proteolytic	_	_	_	_	_	_	_	_
115	processing	_	_	_	_	_	_	_	_
116	of	_	_	_	_	_	_	_	_
117	the	_	_	_	_	_	_	_	_
118	viral	_	_	_	_	_	_	_	_
119	polyprotein	_	_	_	_	_	_	_	_
120	,	_	_	_	_	_	_	_	_
121	but	_	_	_	_	_	_	_	BeginSeg=Yes
122	they	_	_	_	_	_	_	_	_
123	also	_	_	_	_	_	_	_	_
124	cleave	_	_	_	_	_	_	_	_
125	several	_	_	_	_	_	_	_	_
126	host	_	_	_	_	_	_	_	_
127	-	_	_	_	_	_	_	_	_
128	cell	_	_	_	_	_	_	_	_
129	proteins	_	_	_	_	_	_	_	_
130	in	_	_	_	_	_	_	_	BeginSeg=Yes
131	order	_	_	_	_	_	_	_	_
132	to	_	_	_	_	_	_	_	_
133	promote	_	_	_	_	_	_	_	_
134	the	_	_	_	_	_	_	_	_
135	production	_	_	_	_	_	_	_	_
136	of	_	_	_	_	_	_	_	_
137	new	_	_	_	_	_	_	_	_
138	virus	_	_	_	_	_	_	_	_
139	particles	_	_	_	_	_	_	_	_
140	,	_	_	_	_	_	_	_	_
141	as	_	_	_	_	_	_	_	BeginSeg=Yes
142	well	_	_	_	_	_	_	_	_
143	as	_	_	_	_	_	_	_	_
144	to	_	_	_	_	_	_	_	_
145	evade	_	_	_	_	_	_	_	_
146	the	_	_	_	_	_	_	_	_
147	cellular	_	_	_	_	_	_	_	_
148	antiviral	_	_	_	_	_	_	_	_
149	immune	_	_	_	_	_	_	_	_
150	responses	_	_	_	_	_	_	_	_
151	.	_	_	_	_	_	_	_	_
152	Enterovirus	_	_	_	_	_	_	_	BeginSeg=Yes
153	-	_	_	_	_	_	_	_	_
154	associated	_	_	_	_	_	_	_	_
155	processing	_	_	_	_	_	_	_	_
156	of	_	_	_	_	_	_	_	_
157	cellular	_	_	_	_	_	_	_	_
158	proteins	_	_	_	_	_	_	_	_
159	may	_	_	_	_	_	_	_	_
160	also	_	_	_	_	_	_	_	_
161	contribute	_	_	_	_	_	_	_	_
162	to	_	_	_	_	_	_	_	_
163	pathology	_	_	_	_	_	_	_	_
164	,	_	_	_	_	_	_	_	_
165	as	_	_	_	_	_	_	_	BeginSeg=Yes
166	elegantly	_	_	_	_	_	_	_	_
167	demonstrated	_	_	_	_	_	_	_	_
168	by	_	_	_	_	_	_	_	_
169	the	_	_	_	_	_	_	_	_
170	2A	_	_	_	_	_	_	_	_
171	pro	_	_	_	_	_	_	_	_
172	-mediated	_	_	_	_	_	_	_	_
173	cleavage	_	_	_	_	_	_	_	_
174	of	_	_	_	_	_	_	_	_
175	dystrophin	_	_	_	_	_	_	_	_
176	in	_	_	_	_	_	_	_	_
177	cardiomyocytes	_	_	_	_	_	_	_	_
178	contributing	_	_	_	_	_	_	_	BeginSeg=Yes
179	to	_	_	_	_	_	_	_	_
180	Coxsackievirus	_	_	_	_	_	_	_	_
181	-	_	_	_	_	_	_	_	_
182	induced	_	_	_	_	_	_	_	_
183	cardiomyopathy	_	_	_	_	_	_	_	_
184	.	_	_	_	_	_	_	_	_
185	It	_	_	_	_	_	_	_	BeginSeg=Yes
186	is	_	_	_	_	_	_	_	_
187	likely	_	_	_	_	_	_	_	_
188	that	_	_	_	_	_	_	_	_
189	improved	_	_	_	_	_	_	_	_
190	tools	_	_	_	_	_	_	_	_
191	to	_	_	_	_	_	_	_	BeginSeg=Yes
192	identify	_	_	_	_	_	_	_	_
193	targets	_	_	_	_	_	_	_	_
194	for	_	_	_	_	_	_	_	_
195	these	_	_	_	_	_	_	_	_
196	proteases	_	_	_	_	_	_	_	_
197	will	_	_	_	_	_	_	_	BeginSeg=Yes
198	reveal	_	_	_	_	_	_	_	_
199	additional	_	_	_	_	_	_	_	_
200	host	_	_	_	_	_	_	_	_
201	protein	_	_	_	_	_	_	_	_
202	substrates	_	_	_	_	_	_	_	_
203	that	_	_	_	_	_	_	_	BeginSeg=Yes
204	can	_	_	_	_	_	_	_	_
205	be	_	_	_	_	_	_	_	_
206	linked	_	_	_	_	_	_	_	_
207	to	_	_	_	_	_	_	_	_
208	specific	_	_	_	_	_	_	_	_
209	enterovirus	_	_	_	_	_	_	_	_
210	-	_	_	_	_	_	_	_	_
211	associated	_	_	_	_	_	_	_	_
212	diseases	_	_	_	_	_	_	_	_
213	.	_	_	_	_	_	_	_	_
214	Here	_	_	_	_	_	_	_	BeginSeg=Yes
215	,	_	_	_	_	_	_	_	_
216	we	_	_	_	_	_	_	_	_
217	discuss	_	_	_	_	_	_	_	_
218	the	_	_	_	_	_	_	_	_
219	function	_	_	_	_	_	_	_	_
220	of	_	_	_	_	_	_	_	_
221	the	_	_	_	_	_	_	_	_
222	enteroviral	_	_	_	_	_	_	_	_
223	proteases	_	_	_	_	_	_	_	_
224	in	_	_	_	_	_	_	_	_
225	the	_	_	_	_	_	_	_	_
226	virus	_	_	_	_	_	_	_	_
227	replication	_	_	_	_	_	_	_	_
228	cycle	_	_	_	_	_	_	_	_
229	and	_	_	_	_	_	_	_	BeginSeg=Yes
230	review	_	_	_	_	_	_	_	_
231	the	_	_	_	_	_	_	_	_
232	current	_	_	_	_	_	_	_	_
233	knowledge	_	_	_	_	_	_	_	_
234	regarding	_	_	_	_	_	_	_	BeginSeg=Yes
235	how	_	_	_	_	_	_	_	_
236	these	_	_	_	_	_	_	_	_
237	proteases	_	_	_	_	_	_	_	_
238	modulate	_	_	_	_	_	_	_	_
239	the	_	_	_	_	_	_	_	_
240	infected	_	_	_	_	_	_	_	_
241	cell	_	_	_	_	_	_	_	_
242	in	_	_	_	_	_	_	_	BeginSeg=Yes
243	order	_	_	_	_	_	_	_	_
244	to	_	_	_	_	_	_	_	_
245	favour	_	_	_	_	_	_	_	_
246	virus	_	_	_	_	_	_	_	_
247	replication	_	_	_	_	_	_	_	_
248	,	_	_	_	_	_	_	_	_
249	including	_	_	_	_	_	_	_	BeginSeg=Yes
250	ways	_	_	_	_	_	_	_	_
251	to	_	_	_	_	_	_	_	BeginSeg=Yes
252	avoid	_	_	_	_	_	_	_	_
253	detection	_	_	_	_	_	_	_	_
254	by	_	_	_	_	_	_	_	_
255	the	_	_	_	_	_	_	_	_
256	immune	_	_	_	_	_	_	_	_
257	system	_	_	_	_	_	_	_	_
258	.	_	_	_	_	_	_	_	_
259	We	_	_	_	_	_	_	_	BeginSeg=Yes
260	also	_	_	_	_	_	_	_	_
261	highlight	_	_	_	_	_	_	_	_
262	new	_	_	_	_	_	_	_	_
263	possibilities	_	_	_	_	_	_	_	_
264	for	_	_	_	_	_	_	_	_
265	the	_	_	_	_	_	_	_	_
266	identification	_	_	_	_	_	_	_	_
267	of	_	_	_	_	_	_	_	_
268	protease	_	_	_	_	_	_	_	_
269	-	_	_	_	_	_	_	_	_
270	specific	_	_	_	_	_	_	_	_
271	cellular	_	_	_	_	_	_	_	_
272	targets	_	_	_	_	_	_	_	_
273	and	_	_	_	_	_	_	_	_
274	thereby	_	_	_	_	_	_	_	_
275	a	_	_	_	_	_	_	_	_
276	way	_	_	_	_	_	_	_	_
277	to	_	_	_	_	_	_	_	BeginSeg=Yes
278	discover	_	_	_	_	_	_	_	_
279	novel	_	_	_	_	_	_	_	_
280	mechanisms	_	_	_	_	_	_	_	_
281	contributing	_	_	_	_	_	_	_	BeginSeg=Yes
282	to	_	_	_	_	_	_	_	_
283	disease	_	_	_	_	_	_	_	_
284	.	_	_	_	_	_	_	_	_

# newdoc_id = 2134f97f11e3c3aee6903f4971a2d1195f9620b0
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	study	_	_	_	_	_	_	_	_
3	of	_	_	_	_	_	_	_	_
4	infectious	_	_	_	_	_	_	_	_
5	disease	_	_	_	_	_	_	_	_
6	outbreaks	_	_	_	_	_	_	_	_
7	is	_	_	_	_	_	_	_	_
8	required	_	_	_	_	_	_	_	_
9	to	_	_	_	_	_	_	_	BeginSeg=Yes
10	train	_	_	_	_	_	_	_	_
11-12	today's	_	_	_	_	_	_	_	_
11	today	_	_	_	_	_	_	_	_
12	's	_	_	_	_	_	_	_	_
13	epidemiologists	_	_	_	_	_	_	_	_
14	.	_	_	_	_	_	_	_	_
15	A	_	_	_	_	_	_	_	BeginSeg=Yes
16	typical	_	_	_	_	_	_	_	_
17	way	_	_	_	_	_	_	_	_
18	to	_	_	_	_	_	_	_	BeginSeg=Yes
19	introduce	_	_	_	_	_	_	_	_
20	and	_	_	_	_	_	_	_	_
21	explain	_	_	_	_	_	_	_	_
22	key	_	_	_	_	_	_	_	_
23	epidemiological	_	_	_	_	_	_	_	_
24	concepts	_	_	_	_	_	_	_	_
25	is	_	_	_	_	_	_	_	BeginSeg=Yes
26	through	_	_	_	_	_	_	_	_
27	the	_	_	_	_	_	_	_	_
28	analysis	_	_	_	_	_	_	_	_
29	of	_	_	_	_	_	_	_	_
30	a	_	_	_	_	_	_	_	_
31	historical	_	_	_	_	_	_	_	_
32	outbreak	_	_	_	_	_	_	_	_
33	.	_	_	_	_	_	_	_	_
34	There	_	_	_	_	_	_	_	BeginSeg=Yes
35	are	_	_	_	_	_	_	_	_
36	,	_	_	_	_	_	_	_	_
37	however	_	_	_	_	_	_	_	_
38	,	_	_	_	_	_	_	_	_
39	few	_	_	_	_	_	_	_	_
40	training	_	_	_	_	_	_	_	_
41	options	_	_	_	_	_	_	_	_
42	that	_	_	_	_	_	_	_	BeginSeg=Yes
43	explicitly	_	_	_	_	_	_	_	_
44	utilise	_	_	_	_	_	_	_	_
45	real	_	_	_	_	_	_	_	_
46	-	_	_	_	_	_	_	_	_
47	time	_	_	_	_	_	_	_	_
48	simulated	_	_	_	_	_	_	_	_
49	stochastic	_	_	_	_	_	_	_	_
50	outbreaks	_	_	_	_	_	_	_	_
51	where	_	_	_	_	_	_	_	BeginSeg=Yes
52	the	_	_	_	_	_	_	_	_
53	participants	_	_	_	_	_	_	_	_
54	themselves	_	_	_	_	_	_	_	_
55	comprise	_	_	_	_	_	_	_	_
56	the	_	_	_	_	_	_	_	_
57	dataset	_	_	_	_	_	_	_	_
58	they	_	_	_	_	_	_	_	BeginSeg=Yes
59	subsequently	_	_	_	_	_	_	_	_
60	analyse	_	_	_	_	_	_	_	_
61	.	_	_	_	_	_	_	_	_
62	In	_	_	_	_	_	_	_	BeginSeg=Yes
63	this	_	_	_	_	_	_	_	_
64	paper	_	_	_	_	_	_	_	_
65	,	_	_	_	_	_	_	_	_
66	we	_	_	_	_	_	_	_	_
67	present	_	_	_	_	_	_	_	_
68	a	_	_	_	_	_	_	_	_
69	teaching	_	_	_	_	_	_	_	_
70	exercise	_	_	_	_	_	_	_	_
71	in	_	_	_	_	_	_	_	BeginSeg=Yes
72	which	_	_	_	_	_	_	_	_
73	an	_	_	_	_	_	_	_	_
74	infectious	_	_	_	_	_	_	_	_
75	disease	_	_	_	_	_	_	_	_
76	outbreak	_	_	_	_	_	_	_	_
77	is	_	_	_	_	_	_	_	_
78	simulated	_	_	_	_	_	_	_	_
79	over	_	_	_	_	_	_	_	_
80	a	_	_	_	_	_	_	_	_
81	five	_	_	_	_	_	_	_	_
82	-	_	_	_	_	_	_	_	_
83	day	_	_	_	_	_	_	_	_
84	period	_	_	_	_	_	_	_	_
85	and	_	_	_	_	_	_	_	BeginSeg=Yes
86	subsequently	_	_	_	_	_	_	_	_
87	analysed	_	_	_	_	_	_	_	_
88	.	_	_	_	_	_	_	_	_
89	We	_	_	_	_	_	_	_	BeginSeg=Yes
90	iteratively	_	_	_	_	_	_	_	_
91	developed	_	_	_	_	_	_	_	_
92	the	_	_	_	_	_	_	_	_
93	teaching	_	_	_	_	_	_	_	_
94	exercise	_	_	_	_	_	_	_	_
95	to	_	_	_	_	_	_	_	BeginSeg=Yes
96	offer	_	_	_	_	_	_	_	_
97	additional	_	_	_	_	_	_	_	_
98	insight	_	_	_	_	_	_	_	_
99	into	_	_	_	_	_	_	_	_
100	analysing	_	_	_	_	_	_	_	_
101	an	_	_	_	_	_	_	_	_
102	outbreak	_	_	_	_	_	_	_	_
103	.	_	_	_	_	_	_	_	_
104	An	_	_	_	_	_	_	_	BeginSeg=Yes
105	R	_	_	_	_	_	_	_	_
106	package	_	_	_	_	_	_	_	_
107	for	_	_	_	_	_	_	_	_
108	visualisation	_	_	_	_	_	_	_	_
109	,	_	_	_	_	_	_	_	_
110	analysis	_	_	_	_	_	_	_	_
111	and	_	_	_	_	_	_	_	_
112	simulation	_	_	_	_	_	_	_	_
113	of	_	_	_	_	_	_	_	_
114	the	_	_	_	_	_	_	_	_
115	outbreak	_	_	_	_	_	_	_	_
116	data	_	_	_	_	_	_	_	_
117	was	_	_	_	_	_	_	_	_
118	developed	_	_	_	_	_	_	_	_
119	to	_	_	_	_	_	_	_	BeginSeg=Yes
120	accompany	_	_	_	_	_	_	_	_
121	the	_	_	_	_	_	_	_	_
122	practical	_	_	_	_	_	_	_	_
123	to	_	_	_	_	_	_	_	BeginSeg=Yes
124	reinforce	_	_	_	_	_	_	_	_
125	learning	_	_	_	_	_	_	_	_
126	outcomes	_	_	_	_	_	_	_	_
127	.	_	_	_	_	_	_	_	_
128	Computer	_	_	_	_	_	_	_	BeginSeg=Yes
129	simulations	_	_	_	_	_	_	_	_
130	of	_	_	_	_	_	_	_	_
131	the	_	_	_	_	_	_	_	_
132	outbreak	_	_	_	_	_	_	_	_
133	revealed	_	_	_	_	_	_	_	_
134	deviations	_	_	_	_	_	_	_	_
135	from	_	_	_	_	_	_	_	_
136	observed	_	_	_	_	_	_	_	_
137	dynamics	_	_	_	_	_	_	_	_
138	,	_	_	_	_	_	_	_	_
139	highlighting	_	_	_	_	_	_	_	BeginSeg=Yes
140	how	_	_	_	_	_	_	_	BeginSeg=Yes
141	simplifying	_	_	_	_	_	_	_	_
142	assumptions	_	_	_	_	_	_	_	_
143	conventionally	_	_	_	_	_	_	_	BeginSeg=Yes
144	made	_	_	_	_	_	_	_	_
145	in	_	_	_	_	_	_	_	_
146	mathematical	_	_	_	_	_	_	_	_
147	models	_	_	_	_	_	_	_	_
148	often	_	_	_	_	_	_	_	BeginSeg=Yes
149	differ	_	_	_	_	_	_	_	_
150	from	_	_	_	_	_	_	_	_
151	reality	_	_	_	_	_	_	_	_
152	.	_	_	_	_	_	_	_	_
153	Here	_	_	_	_	_	_	_	BeginSeg=Yes
154	we	_	_	_	_	_	_	_	_
155	provide	_	_	_	_	_	_	_	_
156	a	_	_	_	_	_	_	_	_
157	pedagogical	_	_	_	_	_	_	_	_
158	tool	_	_	_	_	_	_	_	_
159	for	_	_	_	_	_	_	_	_
160	others	_	_	_	_	_	_	_	_
161	to	_	_	_	_	_	_	_	BeginSeg=Yes
162	use	_	_	_	_	_	_	_	_
163	and	_	_	_	_	_	_	_	_
164	adapt	_	_	_	_	_	_	_	_
165	in	_	_	_	_	_	_	_	_
166	their	_	_	_	_	_	_	_	_
167	own	_	_	_	_	_	_	_	_
168	settings	_	_	_	_	_	_	_	_
169	.	_	_	_	_	_	_	_	_

# newdoc_id = 21a551af356295ada6e657054646444bca9d202b
1	This	_	_	_	_	_	_	_	BeginSeg=Yes
2	review	_	_	_	_	_	_	_	_
3	summarizes	_	_	_	_	_	_	_	_
4	the	_	_	_	_	_	_	_	_
5	current	_	_	_	_	_	_	_	_
6	knowledge	_	_	_	_	_	_	_	_
7	on	_	_	_	_	_	_	_	_
8	the	_	_	_	_	_	_	_	_
9	physiological	_	_	_	_	_	_	_	_
10	action	_	_	_	_	_	_	_	_
11	of	_	_	_	_	_	_	_	_
12	endogenous	_	_	_	_	_	_	_	_
13	and	_	_	_	_	_	_	_	_
14	exogenous	_	_	_	_	_	_	_	_
15	pulmonary	_	_	_	_	_	_	_	_
16	surfactant	_	_	_	_	_	_	_	_
17	,	_	_	_	_	_	_	_	_
18	the	_	_	_	_	_	_	_	_
19	role	_	_	_	_	_	_	_	_
20	of	_	_	_	_	_	_	_	_
21	different	_	_	_	_	_	_	_	_
22	types	_	_	_	_	_	_	_	_
23	of	_	_	_	_	_	_	_	_
24	animal	_	_	_	_	_	_	_	_
25	-	_	_	_	_	_	_	_	_
26	derived	_	_	_	_	_	_	_	_
27	and	_	_	_	_	_	_	_	_
28	synthetic	_	_	_	_	_	_	_	_
29	surfactants	_	_	_	_	_	_	_	_
30	for	_	_	_	_	_	_	_	_
31	RDS	_	_	_	_	_	_	_	_
32	therapy	_	_	_	_	_	_	_	_
33	,	_	_	_	_	_	_	_	_
34	different	_	_	_	_	_	_	_	_
35	modes	_	_	_	_	_	_	_	_
36	of	_	_	_	_	_	_	_	_
37	administration	_	_	_	_	_	_	_	_
38	,	_	_	_	_	_	_	_	_
39	potential	_	_	_	_	_	_	_	_
40	risks	_	_	_	_	_	_	_	_
41	and	_	_	_	_	_	_	_	_
42	strategies	_	_	_	_	_	_	_	_
43	of	_	_	_	_	_	_	_	_
44	ventilation	_	_	_	_	_	_	_	_
45	,	_	_	_	_	_	_	_	_
46	and	_	_	_	_	_	_	_	BeginSeg=Yes
47	highlights	_	_	_	_	_	_	_	_
48	the	_	_	_	_	_	_	_	_
49	most	_	_	_	_	_	_	_	_
50	promising	_	_	_	_	_	_	_	_
51	aims	_	_	_	_	_	_	_	_
52	for	_	_	_	_	_	_	_	_
53	future	_	_	_	_	_	_	_	_
54	development	_	_	_	_	_	_	_	_
55	.	_	_	_	_	_	_	_	_
56	Scientists	_	_	_	_	_	_	_	BeginSeg=Yes
57	have	_	_	_	_	_	_	_	_
58	clarified	_	_	_	_	_	_	_	_
59	the	_	_	_	_	_	_	_	_
60	physicochemical	_	_	_	_	_	_	_	_
61	properties	_	_	_	_	_	_	_	_
62	and	_	_	_	_	_	_	_	_
63	functions	_	_	_	_	_	_	_	_
64	of	_	_	_	_	_	_	_	_
65	the	_	_	_	_	_	_	_	_
66	different	_	_	_	_	_	_	_	_
67	components	_	_	_	_	_	_	_	_
68	of	_	_	_	_	_	_	_	_
69	surfactant	_	_	_	_	_	_	_	_
70	,	_	_	_	_	_	_	_	_
71	and	_	_	_	_	_	_	_	BeginSeg=Yes
72	part	_	_	_	_	_	_	_	_
73	of	_	_	_	_	_	_	_	_
74	this	_	_	_	_	_	_	_	_
75	successful	_	_	_	_	_	_	_	_
76	research	_	_	_	_	_	_	_	_
77	is	_	_	_	_	_	_	_	_
78	derived	_	_	_	_	_	_	_	_
79	from	_	_	_	_	_	_	_	_
80	the	_	_	_	_	_	_	_	_
81	characterization	_	_	_	_	_	_	_	_
82	of	_	_	_	_	_	_	_	_
83	genetic	_	_	_	_	_	_	_	_
84	diseases	_	_	_	_	_	_	_	_
85	affecting	_	_	_	_	_	_	_	BeginSeg=Yes
86	surfactant	_	_	_	_	_	_	_	_
87	composition	_	_	_	_	_	_	_	_
88	or	_	_	_	_	_	_	_	_
89	function	_	_	_	_	_	_	_	_
90	.	_	_	_	_	_	_	_	_
91	Knowledge	_	_	_	_	_	_	_	BeginSeg=Yes
92	from	_	_	_	_	_	_	_	_
93	functional	_	_	_	_	_	_	_	_
94	tests	_	_	_	_	_	_	_	_
95	of	_	_	_	_	_	_	_	_
96	surfactant	_	_	_	_	_	_	_	_
97	action	_	_	_	_	_	_	_	_
98	,	_	_	_	_	_	_	_	_
99	its	_	_	_	_	_	_	_	_
100	immunochemistry	_	_	_	_	_	_	_	_
101	,	_	_	_	_	_	_	_	_
102	kinetics	_	_	_	_	_	_	_	_
103	and	_	_	_	_	_	_	_	_
104	homeostasis	_	_	_	_	_	_	_	_
105	are	_	_	_	_	_	_	_	_
106	important	_	_	_	_	_	_	_	_
107	also	_	_	_	_	_	_	_	BeginSeg=Yes
108	for	_	_	_	_	_	_	_	_
109	improving	_	_	_	_	_	_	_	_
110	therapy	_	_	_	_	_	_	_	_
111	with	_	_	_	_	_	_	_	_
112	animal	_	_	_	_	_	_	_	_
113	-	_	_	_	_	_	_	_	_
114	derived	_	_	_	_	_	_	_	_
115	surfactant	_	_	_	_	_	_	_	_
116	preparations	_	_	_	_	_	_	_	_
117	and	_	_	_	_	_	_	_	_
118	for	_	_	_	_	_	_	_	_
119	the	_	_	_	_	_	_	_	_
120	development	_	_	_	_	_	_	_	_
121	of	_	_	_	_	_	_	_	_
122	modified	_	_	_	_	_	_	_	_
123	surfactants	_	_	_	_	_	_	_	_
124	.	_	_	_	_	_	_	_	_
125	In	_	_	_	_	_	_	_	BeginSeg=Yes
126	the	_	_	_	_	_	_	_	_
127	past	_	_	_	_	_	_	_	_
128	decade	_	_	_	_	_	_	_	_
129	newly	_	_	_	_	_	_	_	_
130	designed	_	_	_	_	_	_	_	_
131	artificial	_	_	_	_	_	_	_	_
132	surfactants	_	_	_	_	_	_	_	_
133	and	_	_	_	_	_	_	_	_
134	additives	_	_	_	_	_	_	_	_
135	have	_	_	_	_	_	_	_	_
136	gained	_	_	_	_	_	_	_	_
137	much	_	_	_	_	_	_	_	_
138	attention	_	_	_	_	_	_	_	_
139	and	_	_	_	_	_	_	_	BeginSeg=Yes
140	have	_	_	_	_	_	_	_	_
141	proven	_	_	_	_	_	_	_	_
142	different	_	_	_	_	_	_	_	_
143	advantages	_	_	_	_	_	_	_	_
144	,	_	_	_	_	_	_	_	_
145	but	_	_	_	_	_	_	_	BeginSeg=Yes
146	their	_	_	_	_	_	_	_	_
147	particular	_	_	_	_	_	_	_	_
148	role	_	_	_	_	_	_	_	_
149	still	_	_	_	_	_	_	_	_
150	has	_	_	_	_	_	_	_	_
151	to	_	_	_	_	_	_	_	_
152	be	_	_	_	_	_	_	_	_
153	defined	_	_	_	_	_	_	_	_
154	.	_	_	_	_	_	_	_	_

# newdoc_id = 21a572a6c0f75baa745480e28b596d73d4492cc8
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	COVID-19	_	_	_	_	_	_	_	_
3	pandemic	_	_	_	_	_	_	_	_
4	has	_	_	_	_	_	_	_	_
5	resulted	_	_	_	_	_	_	_	_
6	in	_	_	_	_	_	_	_	_
7	a	_	_	_	_	_	_	_	_
8	proliferation	_	_	_	_	_	_	_	_
9	of	_	_	_	_	_	_	_	_
10	clinical	_	_	_	_	_	_	_	_
11	trials	_	_	_	_	_	_	_	_
12	that	_	_	_	_	_	_	_	BeginSeg=Yes
13	are	_	_	_	_	_	_	_	_
14	designed	_	_	_	_	_	_	_	_
15	to	_	_	_	_	_	_	_	BeginSeg=Yes
16	slow	_	_	_	_	_	_	_	_
17	the	_	_	_	_	_	_	_	_
18	spread	_	_	_	_	_	_	_	_
19	of	_	_	_	_	_	_	_	_
20	SARS	_	_	_	_	_	_	_	_
21	-	_	_	_	_	_	_	_	_
22	CoV-2	_	_	_	_	_	_	_	_
23	,	_	_	_	_	_	_	_	_
24	the	_	_	_	_	_	_	_	_
25	virus	_	_	_	_	_	_	_	_
26	that	_	_	_	_	_	_	_	BeginSeg=Yes
27	causes	_	_	_	_	_	_	_	_
28	COVID-19	_	_	_	_	_	_	_	_
29	.	_	_	_	_	_	_	_	_
30	The	_	_	_	_	_	_	_	BeginSeg=Yes
31	overwhelming	_	_	_	_	_	_	_	_
32	majority	_	_	_	_	_	_	_	_
33	of	_	_	_	_	_	_	_	_
34	cardiovascular	_	_	_	_	_	_	_	_
35	and	_	_	_	_	_	_	_	_
36	cancer	_	_	_	_	_	_	_	_
37	patients	_	_	_	_	_	_	_	_
38	are	_	_	_	_	_	_	_	_
39	at	_	_	_	_	_	_	_	_
40	increased	_	_	_	_	_	_	_	_
41	risk	_	_	_	_	_	_	_	_
42	for	_	_	_	_	_	_	_	_
43	SARS	_	_	_	_	_	_	_	_
44	-	_	_	_	_	_	_	_	_
45	CoV-2	_	_	_	_	_	_	_	_
46	infection	_	_	_	_	_	_	_	_
47	;	_	_	_	_	_	_	_	_
48	accordingly	_	_	_	_	_	_	_	BeginSeg=Yes
49	,	_	_	_	_	_	_	_	_
50	the	_	_	_	_	_	_	_	_
51	cardiovascular	_	_	_	_	_	_	_	_
52	and	_	_	_	_	_	_	_	_
53	cardio	_	_	_	_	_	_	_	_
54	-	_	_	_	_	_	_	_	_
55	oncology	_	_	_	_	_	_	_	_
56	communities	_	_	_	_	_	_	_	_
57	are	_	_	_	_	_	_	_	_
58	playing	_	_	_	_	_	_	_	_
59	a	_	_	_	_	_	_	_	_
60	major	_	_	_	_	_	_	_	_
61	role	_	_	_	_	_	_	_	_
62	in	_	_	_	_	_	_	_	BeginSeg=Yes
63	caring	_	_	_	_	_	_	_	_
64	for	_	_	_	_	_	_	_	_
65	COVID-19	_	_	_	_	_	_	_	_
66	patients	_	_	_	_	_	_	_	_
67	.	_	_	_	_	_	_	_	_
68	Many	_	_	_	_	_	_	_	BeginSeg=Yes
69	of	_	_	_	_	_	_	_	_
70	the	_	_	_	_	_	_	_	_
71	therapeutic	_	_	_	_	_	_	_	_
72	agents	_	_	_	_	_	_	_	_
73	that	_	_	_	_	_	_	_	BeginSeg=Yes
74	are	_	_	_	_	_	_	_	_
75	being	_	_	_	_	_	_	_	_
76	used	_	_	_	_	_	_	_	_
77	to	_	_	_	_	_	_	_	BeginSeg=Yes
78	treat	_	_	_	_	_	_	_	_
79	patients	_	_	_	_	_	_	_	_
80	with	_	_	_	_	_	_	_	_
81	COVID-19	_	_	_	_	_	_	_	_
82	are	_	_	_	_	_	_	_	BeginSeg=Yes
83	repurposed	_	_	_	_	_	_	_	_
84	treatments	_	_	_	_	_	_	_	_
85	for	_	_	_	_	_	_	_	_
86	influenza	_	_	_	_	_	_	_	_
87	,	_	_	_	_	_	_	_	_
88	drugs	_	_	_	_	_	_	_	_
89	that	_	_	_	_	_	_	_	BeginSeg=Yes
90	were	_	_	_	_	_	_	_	_
91	not	_	_	_	_	_	_	_	_
92	effective	_	_	_	_	_	_	_	_
93	in	_	_	_	_	_	_	_	_
94	Ebola	_	_	_	_	_	_	_	_
95	patients	_	_	_	_	_	_	_	_
96	,	_	_	_	_	_	_	_	_
97	or	_	_	_	_	_	_	_	BeginSeg=Yes
98	treatments	_	_	_	_	_	_	_	_
99	for	_	_	_	_	_	_	_	_
100	malaria	_	_	_	_	_	_	_	_
101	that	_	_	_	_	_	_	_	BeginSeg=Yes
102	were	_	_	_	_	_	_	_	_
103	developed	_	_	_	_	_	_	_	_
104	decades	_	_	_	_	_	_	_	_
105	ago	_	_	_	_	_	_	_	_
106	,	_	_	_	_	_	_	_	_
107	and	_	_	_	_	_	_	_	BeginSeg=Yes
108	are	_	_	_	_	_	_	_	_
109	unlikely	_	_	_	_	_	_	_	_
110	to	_	_	_	_	_	_	_	_
111	be	_	_	_	_	_	_	_	_
112	familiar	_	_	_	_	_	_	_	_
113	to	_	_	_	_	_	_	_	_
114	the	_	_	_	_	_	_	_	_
115	cardiovascular	_	_	_	_	_	_	_	_
116	and	_	_	_	_	_	_	_	_
117	cardio	_	_	_	_	_	_	_	_
118	-	_	_	_	_	_	_	_	_
119	oncology	_	_	_	_	_	_	_	_
120	communities	_	_	_	_	_	_	_	_
121	.	_	_	_	_	_	_	_	_
122	Here	_	_	_	_	_	_	_	BeginSeg=Yes
123	we	_	_	_	_	_	_	_	_
124	have	_	_	_	_	_	_	_	_
125	provided	_	_	_	_	_	_	_	_
126	a	_	_	_	_	_	_	_	_
127	foundation	_	_	_	_	_	_	_	_
128	for	_	_	_	_	_	_	_	_
129	cardiovascular	_	_	_	_	_	_	_	_
130	and	_	_	_	_	_	_	_	_
131	cardio	_	_	_	_	_	_	_	_
132	-	_	_	_	_	_	_	_	_
133	oncology	_	_	_	_	_	_	_	_
134	physicians	_	_	_	_	_	_	_	_
135	who	_	_	_	_	_	_	_	BeginSeg=Yes
136	are	_	_	_	_	_	_	_	_
137	on	_	_	_	_	_	_	_	_
138	the	_	_	_	_	_	_	_	_
139	frontline	_	_	_	_	_	_	_	_
140	providing	_	_	_	_	_	_	_	BeginSeg=Yes
141	care	_	_	_	_	_	_	_	_
142	to	_	_	_	_	_	_	_	_
143	COVID-19	_	_	_	_	_	_	_	_
144	patients	_	_	_	_	_	_	_	_
145	,	_	_	_	_	_	_	_	_
146	so	_	_	_	_	_	_	_	BeginSeg=Yes
147	that	_	_	_	_	_	_	_	_
148	they	_	_	_	_	_	_	_	_
149	can	_	_	_	_	_	_	_	_
150	better	_	_	_	_	_	_	_	_
151	understand	_	_	_	_	_	_	_	_
152	the	_	_	_	_	_	_	_	_
153	emerging	_	_	_	_	_	_	_	_
154	cardiovascular	_	_	_	_	_	_	_	_
155	epidemiology	_	_	_	_	_	_	_	_
156	of	_	_	_	_	_	_	_	_
157	COVID-19	_	_	_	_	_	_	_	_
158	,	_	_	_	_	_	_	_	_
159	as	_	_	_	_	_	_	_	_
160	well	_	_	_	_	_	_	_	_
161	as	_	_	_	_	_	_	_	_
162	the	_	_	_	_	_	_	_	_
163	biological	_	_	_	_	_	_	_	_
164	rationale	_	_	_	_	_	_	_	_
165	for	_	_	_	_	_	_	_	_
166	the	_	_	_	_	_	_	_	_
167	clinical	_	_	_	_	_	_	_	_
168	trials	_	_	_	_	_	_	_	_
169	that	_	_	_	_	_	_	_	BeginSeg=Yes
170	are	_	_	_	_	_	_	_	_
171	ongoing	_	_	_	_	_	_	_	_
172	for	_	_	_	_	_	_	_	_
173	the	_	_	_	_	_	_	_	_
174	treatment	_	_	_	_	_	_	_	_
175	of	_	_	_	_	_	_	_	_
176	COVID-19	_	_	_	_	_	_	_	_
177	patients	_	_	_	_	_	_	_	_
178	.	_	_	_	_	_	_	_	_

# newdoc_id = 23d06bd7a12e6e729f5b2b06bbe825eb9a91270e
1	Severe	_	_	_	_	_	_	_	BeginSeg=Yes
2	acute	_	_	_	_	_	_	_	_
3	respiratory	_	_	_	_	_	_	_	_
4	syndrome	_	_	_	_	_	_	_	_
5	(	_	_	_	_	_	_	_	_
6	SARS	_	_	_	_	_	_	_	_
7	)	_	_	_	_	_	_	_	_
8	is	_	_	_	_	_	_	_	_
9	a	_	_	_	_	_	_	_	_
10	recently	_	_	_	_	_	_	_	_
11	described	_	_	_	_	_	_	_	_
12	infectious	_	_	_	_	_	_	_	_
13	entity	_	_	_	_	_	_	_	_
14	with	_	_	_	_	_	_	_	_
15	salient	_	_	_	_	_	_	_	_
16	features	_	_	_	_	_	_	_	_
17	of	_	_	_	_	_	_	_	_
18	fever	_	_	_	_	_	_	_	_
19	,	_	_	_	_	_	_	_	_
20	headache	_	_	_	_	_	_	_	_
21	and	_	_	_	_	_	_	_	_
22	malaise	_	_	_	_	_	_	_	_
23	,	_	_	_	_	_	_	_	_
24	with	_	_	_	_	_	_	_	_
25	rapid	_	_	_	_	_	_	_	_
26	progression	_	_	_	_	_	_	_	_
27	to	_	_	_	_	_	_	_	_
28	pneumonitis	_	_	_	_	_	_	_	_
29	.	_	_	_	_	_	_	_	_
30	The	_	_	_	_	_	_	_	BeginSeg=Yes
31	etiology	_	_	_	_	_	_	_	_
32	of	_	_	_	_	_	_	_	_
33	SARS	_	_	_	_	_	_	_	_
34	is	_	_	_	_	_	_	_	_
35	likely	_	_	_	_	_	_	_	_
36	a	_	_	_	_	_	_	_	_
37	novel	_	_	_	_	_	_	_	_
38	coronavirus	_	_	_	_	_	_	_	_
39	.	_	_	_	_	_	_	_	_
40	During	_	_	_	_	_	_	_	BeginSeg=Yes
41	the	_	_	_	_	_	_	_	_
42	winter	_	_	_	_	_	_	_	_
43	of	_	_	_	_	_	_	_	_
44	2003	_	_	_	_	_	_	_	_
45	,	_	_	_	_	_	_	_	_
46	an	_	_	_	_	_	_	_	_
47	outbreak	_	_	_	_	_	_	_	_
48	of	_	_	_	_	_	_	_	_
49	SARS	_	_	_	_	_	_	_	_
50	involving	_	_	_	_	_	_	_	BeginSeg=Yes
51	several	_	_	_	_	_	_	_	_
52	hospitals	_	_	_	_	_	_	_	_
53	occurred	_	_	_	_	_	_	_	BeginSeg=Yes
54	in	_	_	_	_	_	_	_	_
55	Toronto	_	_	_	_	_	_	_	_
56	,	_	_	_	_	_	_	_	_
57	Canada	_	_	_	_	_	_	_	_
58	.	_	_	_	_	_	_	_	_
59	We	_	_	_	_	_	_	_	BeginSeg=Yes
60	describe	_	_	_	_	_	_	_	_
61	a	_	_	_	_	_	_	_	_
62	patient	_	_	_	_	_	_	_	_
63	post	_	_	_	_	_	_	_	_
64	liver	_	_	_	_	_	_	_	_
65	transplant	_	_	_	_	_	_	_	_
66	who	_	_	_	_	_	_	_	BeginSeg=Yes
67	contracted	_	_	_	_	_	_	_	_
68	SARS	_	_	_	_	_	_	_	_
69	and	_	_	_	_	_	_	_	BeginSeg=Yes
70	died	_	_	_	_	_	_	_	_
71	during	_	_	_	_	_	_	_	_
72	the	_	_	_	_	_	_	_	_
73	outbreak	_	_	_	_	_	_	_	_
74	,	_	_	_	_	_	_	_	_
75	with	_	_	_	_	_	_	_	_
76	subsequent	_	_	_	_	_	_	_	_
77	infection	_	_	_	_	_	_	_	_
78	of	_	_	_	_	_	_	_	_
79	family	_	_	_	_	_	_	_	_
80	and	_	_	_	_	_	_	_	_
81	several	_	_	_	_	_	_	_	_
82	health	_	_	_	_	_	_	_	_
83	-	_	_	_	_	_	_	_	_
84	care	_	_	_	_	_	_	_	_
85	workers	_	_	_	_	_	_	_	_
86	.	_	_	_	_	_	_	_	_
87	A	_	_	_	_	_	_	_	BeginSeg=Yes
88	novel	_	_	_	_	_	_	_	_
89	coronavirus	_	_	_	_	_	_	_	_
90	was	_	_	_	_	_	_	_	_
91	detected	_	_	_	_	_	_	_	_
92	in	_	_	_	_	_	_	_	_
93	respiratory	_	_	_	_	_	_	_	_
94	specimens	_	_	_	_	_	_	_	_
95	by	_	_	_	_	_	_	_	_
96	PCR	_	_	_	_	_	_	_	_
97	.	_	_	_	_	_	_	_	_
98	Due	_	_	_	_	_	_	_	BeginSeg=Yes
99	to	_	_	_	_	_	_	_	_
100	the	_	_	_	_	_	_	_	_
101	potential	_	_	_	_	_	_	_	_
102	severity	_	_	_	_	_	_	_	_
103	of	_	_	_	_	_	_	_	_
104	SARS	_	_	_	_	_	_	_	_
105	in	_	_	_	_	_	_	_	_
106	transplant	_	_	_	_	_	_	_	_
107	recipients	_	_	_	_	_	_	_	_
108	and	_	_	_	_	_	_	_	_
109	the	_	_	_	_	_	_	_	_
110	large	_	_	_	_	_	_	_	_
111	number	_	_	_	_	_	_	_	_
112	of	_	_	_	_	_	_	_	_
113	cases	_	_	_	_	_	_	_	_
114	of	_	_	_	_	_	_	_	_
115	SARS	_	_	_	_	_	_	_	_
116	in	_	_	_	_	_	_	_	_
117	the	_	_	_	_	_	_	_	_
118	community	_	_	_	_	_	_	_	_
119	,	_	_	_	_	_	_	_	_
120	in	_	_	_	_	_	_	_	BeginSeg=Yes
121	order	_	_	_	_	_	_	_	_
122	to	_	_	_	_	_	_	_	_
123	avoid	_	_	_	_	_	_	_	_
124	transmission	_	_	_	_	_	_	_	_
125	of	_	_	_	_	_	_	_	_
126	SARS	_	_	_	_	_	_	_	_
127	from	_	_	_	_	_	_	_	_
128	a	_	_	_	_	_	_	_	_
129	donor	_	_	_	_	_	_	_	_
130	,	_	_	_	_	_	_	_	_
131	we	_	_	_	_	_	_	_	BeginSeg=Yes
132	developed	_	_	_	_	_	_	_	_
133	guidelines	_	_	_	_	_	_	_	_
134	for	_	_	_	_	_	_	_	_
135	SARS	_	_	_	_	_	_	_	_
136	screening	_	_	_	_	_	_	_	_
137	of	_	_	_	_	_	_	_	_
138	organ	_	_	_	_	_	_	_	_
139	donors	_	_	_	_	_	_	_	_
140	.	_	_	_	_	_	_	_	_
141	A	_	_	_	_	_	_	_	BeginSeg=Yes
142	screening	_	_	_	_	_	_	_	_
143	tool	_	_	_	_	_	_	_	_
144	based	_	_	_	_	_	_	_	BeginSeg=Yes
145	on	_	_	_	_	_	_	_	_
146	potential	_	_	_	_	_	_	_	_
147	hospital	_	_	_	_	_	_	_	_
148	SARS	_	_	_	_	_	_	_	_
149	exposure	_	_	_	_	_	_	_	_
150	,	_	_	_	_	_	_	_	_
151	clinical	_	_	_	_	_	_	_	_
152	symptoms	_	_	_	_	_	_	_	_
153	,	_	_	_	_	_	_	_	_
154	and	_	_	_	_	_	_	_	_
155	epidemiological	_	_	_	_	_	_	_	_
156	exposure	_	_	_	_	_	_	_	_
157	was	_	_	_	_	_	_	_	BeginSeg=Yes
158	used	_	_	_	_	_	_	_	_
159	to	_	_	_	_	_	_	_	BeginSeg=Yes
160	stratify	_	_	_	_	_	_	_	_
161	donors	_	_	_	_	_	_	_	_
162	as	_	_	_	_	_	_	_	_
163	high	_	_	_	_	_	_	_	_
164	,	_	_	_	_	_	_	_	_
165	intermediate	_	_	_	_	_	_	_	_
166	or	_	_	_	_	_	_	_	_
167	low	_	_	_	_	_	_	_	_
168	risk	_	_	_	_	_	_	_	_
169	for	_	_	_	_	_	_	_	_
170	SARS	_	_	_	_	_	_	_	_
171	.	_	_	_	_	_	_	_	_
172	As	_	_	_	_	_	_	_	BeginSeg=Yes
173	SARS	_	_	_	_	_	_	_	_
174	spreads	_	_	_	_	_	_	_	_
175	throughout	_	_	_	_	_	_	_	_
176	the	_	_	_	_	_	_	_	_
177	world	_	_	_	_	_	_	_	_
178	,	_	_	_	_	_	_	_	_
179	it	_	_	_	_	_	_	_	BeginSeg=Yes
180	may	_	_	_	_	_	_	_	_
181	become	_	_	_	_	_	_	_	_
182	an	_	_	_	_	_	_	_	_
183	increasingly	_	_	_	_	_	_	_	_
184	significant	_	_	_	_	_	_	_	_
185	problem	_	_	_	_	_	_	_	_
186	for	_	_	_	_	_	_	_	_
187	transplant	_	_	_	_	_	_	_	_
188	patients	_	_	_	_	_	_	_	_
189	and	_	_	_	_	_	_	_	_
190	programs	_	_	_	_	_	_	_	_
191	.	_	_	_	_	_	_	_	_

# newdoc_id = 247d3262ad1b15f331a89f70eec56b34dbe6b8b5
1	Background	_	_	_	_	_	_	_	BeginSeg=Yes
2	.	_	_	_	_	_	_	_	_
3	The	_	_	_	_	_	_	_	BeginSeg=Yes
4	negative	_	_	_	_	_	_	_	_
5	binomial	_	_	_	_	_	_	_	_
6	distribution	_	_	_	_	_	_	_	_
7	is	_	_	_	_	_	_	_	_
8	used	_	_	_	_	_	_	_	_
9	commonly	_	_	_	_	_	_	_	_
10	throughout	_	_	_	_	_	_	_	_
11	biology	_	_	_	_	_	_	_	_
12	as	_	_	_	_	_	_	_	_
13	a	_	_	_	_	_	_	_	_
14	model	_	_	_	_	_	_	_	_
15	for	_	_	_	_	_	_	_	_
16	overdispersed	_	_	_	_	_	_	_	_
17	count	_	_	_	_	_	_	_	_
18	data	_	_	_	_	_	_	_	_
19	,	_	_	_	_	_	_	_	_
20	with	_	_	_	_	_	_	_	_
21	attention	_	_	_	_	_	_	_	_
22	focused	_	_	_	_	_	_	_	BeginSeg=Yes
23	on	_	_	_	_	_	_	_	_
24	the	_	_	_	_	_	_	_	_
25	negative	_	_	_	_	_	_	_	_
26	binomial	_	_	_	_	_	_	_	_
27	dispersion	_	_	_	_	_	_	_	_
28	parameter	_	_	_	_	_	_	_	_
29	,	_	_	_	_	_	_	_	_
30	k.	_	_	_	_	_	_	_	_
31	A	_	_	_	_	_	_	_	BeginSeg=Yes
32	substantial	_	_	_	_	_	_	_	_
33	literature	_	_	_	_	_	_	_	_
34	exists	_	_	_	_	_	_	_	_
35	on	_	_	_	_	_	_	_	_
36	the	_	_	_	_	_	_	_	_
37	estimation	_	_	_	_	_	_	_	_
38	of	_	_	_	_	_	_	_	_
39	k	_	_	_	_	_	_	_	_
40	,	_	_	_	_	_	_	_	_
41	but	_	_	_	_	_	_	_	BeginSeg=Yes
42	most	_	_	_	_	_	_	_	_
43	attention	_	_	_	_	_	_	_	_
44	has	_	_	_	_	_	_	_	_
45	focused	_	_	_	_	_	_	_	_
46	on	_	_	_	_	_	_	_	_
47	datasets	_	_	_	_	_	_	_	_
48	that	_	_	_	_	_	_	_	BeginSeg=Yes
49	are	_	_	_	_	_	_	_	_
50	not	_	_	_	_	_	_	_	_
51	highly	_	_	_	_	_	_	_	_
52	overdispersed	_	_	_	_	_	_	_	_
53	(	_	_	_	_	_	_	_	BeginSeg=Yes
54	i.e.	_	_	_	_	_	_	_	_
55	,	_	_	_	_	_	_	_	_
56	those	_	_	_	_	_	_	_	_
57	with	_	_	_	_	_	_	_	_
58	k$1	_	_	_	_	_	_	_	_
59	)	_	_	_	_	_	_	_	_
60	,	_	_	_	_	_	_	_	_
61	and	_	_	_	_	_	_	_	BeginSeg=Yes
62	the	_	_	_	_	_	_	_	_
63	accuracy	_	_	_	_	_	_	_	_
64	of	_	_	_	_	_	_	_	_
65	confidence	_	_	_	_	_	_	_	_
66	intervals	_	_	_	_	_	_	_	_
67	estimated	_	_	_	_	_	_	_	BeginSeg=Yes
68	for	_	_	_	_	_	_	_	_
69	k	_	_	_	_	_	_	_	_
70	is	_	_	_	_	_	_	_	BeginSeg=Yes
71	typically	_	_	_	_	_	_	_	_
72	not	_	_	_	_	_	_	_	_
73	explored	_	_	_	_	_	_	_	_
74	.	_	_	_	_	_	_	_	_
75	Methodology	_	_	_	_	_	_	_	BeginSeg=Yes
76	.	_	_	_	_	_	_	_	_
77	This	_	_	_	_	_	_	_	BeginSeg=Yes
78	article	_	_	_	_	_	_	_	_
79	presents	_	_	_	_	_	_	_	_
80	a	_	_	_	_	_	_	_	_
81	simulation	_	_	_	_	_	_	_	_
82	study	_	_	_	_	_	_	_	_
83	exploring	_	_	_	_	_	_	_	BeginSeg=Yes
84	the	_	_	_	_	_	_	_	_
85	bias	_	_	_	_	_	_	_	_
86	,	_	_	_	_	_	_	_	_
87	precision	_	_	_	_	_	_	_	_
88	,	_	_	_	_	_	_	_	_
89	and	_	_	_	_	_	_	_	_
90	confidence	_	_	_	_	_	_	_	_
91	interval	_	_	_	_	_	_	_	_
92	coverage	_	_	_	_	_	_	_	_
93	of	_	_	_	_	_	_	_	_
94	maximum	_	_	_	_	_	_	_	_
95	-	_	_	_	_	_	_	_	_
96	likelihood	_	_	_	_	_	_	_	_
97	estimates	_	_	_	_	_	_	_	_
98	of	_	_	_	_	_	_	_	_
99	k	_	_	_	_	_	_	_	_
100	from	_	_	_	_	_	_	_	_
101	highly	_	_	_	_	_	_	_	_
102	overdispersed	_	_	_	_	_	_	_	_
103	distributions	_	_	_	_	_	_	_	_
104	.	_	_	_	_	_	_	_	_
105	In	_	_	_	_	_	_	_	BeginSeg=Yes
106	addition	_	_	_	_	_	_	_	_
107	to	_	_	_	_	_	_	_	_
108	exploring	_	_	_	_	_	_	_	_
109	small	_	_	_	_	_	_	_	_
110	-	_	_	_	_	_	_	_	_
111	sample	_	_	_	_	_	_	_	_
112	bias	_	_	_	_	_	_	_	_
113	on	_	_	_	_	_	_	_	_
114	negative	_	_	_	_	_	_	_	_
115	binomial	_	_	_	_	_	_	_	_
116	estimates	_	_	_	_	_	_	_	_
117	,	_	_	_	_	_	_	_	_
118	the	_	_	_	_	_	_	_	_
119	study	_	_	_	_	_	_	_	_
120	addresses	_	_	_	_	_	_	_	_
121	estimation	_	_	_	_	_	_	_	_
122	from	_	_	_	_	_	_	_	_
123	datasets	_	_	_	_	_	_	_	_
124	influenced	_	_	_	_	_	_	_	BeginSeg=Yes
125	by	_	_	_	_	_	_	_	_
126	two	_	_	_	_	_	_	_	_
127	types	_	_	_	_	_	_	_	_
128	of	_	_	_	_	_	_	_	_
129	event	_	_	_	_	_	_	_	_
130	under	_	_	_	_	_	_	_	_
131	-	_	_	_	_	_	_	_	_
132	counting	_	_	_	_	_	_	_	_
133	,	_	_	_	_	_	_	_	_
134	and	_	_	_	_	_	_	_	BeginSeg=Yes
135	from	_	_	_	_	_	_	_	_
136	disease	_	_	_	_	_	_	_	_
137	transmission	_	_	_	_	_	_	_	_
138	data	_	_	_	_	_	_	_	_
139	subject	_	_	_	_	_	_	_	_
140	to	_	_	_	_	_	_	_	_
141	selection	_	_	_	_	_	_	_	_
142	bias	_	_	_	_	_	_	_	_
143	for	_	_	_	_	_	_	_	_
144	successful	_	_	_	_	_	_	_	_
145	outbreaks	_	_	_	_	_	_	_	_
146	.	_	_	_	_	_	_	_	_
147	Conclusions	_	_	_	_	_	_	_	BeginSeg=Yes
148	.	_	_	_	_	_	_	_	_
149	Results	_	_	_	_	_	_	_	BeginSeg=Yes
150	show	_	_	_	_	_	_	_	_
151	that	_	_	_	_	_	_	_	BeginSeg=Yes
152	maximum	_	_	_	_	_	_	_	_
153	likelihood	_	_	_	_	_	_	_	_
154	estimates	_	_	_	_	_	_	_	_
155	of	_	_	_	_	_	_	_	_
156	k	_	_	_	_	_	_	_	_
157	can	_	_	_	_	_	_	_	_
158	be	_	_	_	_	_	_	_	_
159	biased	_	_	_	_	_	_	_	_
160	upward	_	_	_	_	_	_	_	_
161	by	_	_	_	_	_	_	_	_
162	small	_	_	_	_	_	_	_	_
163	sample	_	_	_	_	_	_	_	_
164	size	_	_	_	_	_	_	_	_
165	or	_	_	_	_	_	_	_	_
166	under	_	_	_	_	_	_	_	_
167	-	_	_	_	_	_	_	_	_
168	reporting	_	_	_	_	_	_	_	_
169	of	_	_	_	_	_	_	_	_
170	zero	_	_	_	_	_	_	_	_
171	-	_	_	_	_	_	_	_	_
172	class	_	_	_	_	_	_	_	_
173	events	_	_	_	_	_	_	_	_
174	,	_	_	_	_	_	_	_	_
175	but	_	_	_	_	_	_	_	BeginSeg=Yes
176	are	_	_	_	_	_	_	_	_
177	not	_	_	_	_	_	_	_	_
178	biased	_	_	_	_	_	_	_	_
179	downward	_	_	_	_	_	_	_	_
180	by	_	_	_	_	_	_	_	_
181	any	_	_	_	_	_	_	_	_
182	of	_	_	_	_	_	_	_	_
183	the	_	_	_	_	_	_	_	_
184	factors	_	_	_	_	_	_	_	_
185	considered	_	_	_	_	_	_	_	_
186	.	_	_	_	_	_	_	_	_
187	Confidence	_	_	_	_	_	_	_	BeginSeg=Yes
188	intervals	_	_	_	_	_	_	_	_
189	estimated	_	_	_	_	_	_	_	BeginSeg=Yes
190	from	_	_	_	_	_	_	_	_
191	the	_	_	_	_	_	_	_	_
192	asymptotic	_	_	_	_	_	_	_	_
193	sampling	_	_	_	_	_	_	_	_
194	variance	_	_	_	_	_	_	_	_
195	tend	_	_	_	_	_	_	_	BeginSeg=Yes
196	to	_	_	_	_	_	_	_	_
197	exhibit	_	_	_	_	_	_	_	_
198	coverage	_	_	_	_	_	_	_	_
199	below	_	_	_	_	_	_	_	_
200	the	_	_	_	_	_	_	_	_
201	nominal	_	_	_	_	_	_	_	_
202	level	_	_	_	_	_	_	_	_
203	,	_	_	_	_	_	_	_	_
204	with	_	_	_	_	_	_	_	_
205	overestimates	_	_	_	_	_	_	_	_
206	of	_	_	_	_	_	_	_	_
207	k	_	_	_	_	_	_	_	_
208	comprising	_	_	_	_	_	_	_	BeginSeg=Yes
209	the	_	_	_	_	_	_	_	_
210	great	_	_	_	_	_	_	_	_
211	majority	_	_	_	_	_	_	_	_
212	of	_	_	_	_	_	_	_	_
213	coverage	_	_	_	_	_	_	_	_
214	errors	_	_	_	_	_	_	_	_
215	.	_	_	_	_	_	_	_	_
216	Estimation	_	_	_	_	_	_	_	BeginSeg=Yes
217	from	_	_	_	_	_	_	_	_
218	outbreak	_	_	_	_	_	_	_	_
219	datasets	_	_	_	_	_	_	_	_
220	does	_	_	_	_	_	_	_	_
221	not	_	_	_	_	_	_	_	_
222	increase	_	_	_	_	_	_	_	_
223	the	_	_	_	_	_	_	_	_
224	bias	_	_	_	_	_	_	_	_
225	of	_	_	_	_	_	_	_	_
226	k	_	_	_	_	_	_	_	_
227	estimates	_	_	_	_	_	_	_	_
228	,	_	_	_	_	_	_	_	_
229	but	_	_	_	_	_	_	_	BeginSeg=Yes
230	can	_	_	_	_	_	_	_	_
231	add	_	_	_	_	_	_	_	_
232	significant	_	_	_	_	_	_	_	_
233	upward	_	_	_	_	_	_	_	_
234	bias	_	_	_	_	_	_	_	_
235	to	_	_	_	_	_	_	_	_
236	estimates	_	_	_	_	_	_	_	_
237	of	_	_	_	_	_	_	_	_
238	the	_	_	_	_	_	_	_	_
239	mean	_	_	_	_	_	_	_	_
240	.	_	_	_	_	_	_	_	_
241	Because	_	_	_	_	_	_	_	BeginSeg=Yes
242	k	_	_	_	_	_	_	_	_
243	varies	_	_	_	_	_	_	_	_
244	inversely	_	_	_	_	_	_	_	_
245	with	_	_	_	_	_	_	_	_
246	the	_	_	_	_	_	_	_	_
247	degree	_	_	_	_	_	_	_	_
248	of	_	_	_	_	_	_	_	_
249	overdispersion	_	_	_	_	_	_	_	_
250	,	_	_	_	_	_	_	_	_
251	these	_	_	_	_	_	_	_	BeginSeg=Yes
252	findings	_	_	_	_	_	_	_	_
253	show	_	_	_	_	_	_	_	_
254	that	_	_	_	_	_	_	_	BeginSeg=Yes
255	overestimation	_	_	_	_	_	_	_	_
256	of	_	_	_	_	_	_	_	_
257	the	_	_	_	_	_	_	_	_
258	degree	_	_	_	_	_	_	_	_
259	of	_	_	_	_	_	_	_	_
260	overdispersion	_	_	_	_	_	_	_	_
261	is	_	_	_	_	_	_	_	_
262	very	_	_	_	_	_	_	_	_
263	rare	_	_	_	_	_	_	_	_
264	for	_	_	_	_	_	_	_	_
265	these	_	_	_	_	_	_	_	_
266	datasets	_	_	_	_	_	_	_	_
267	.	_	_	_	_	_	_	_	_

# newdoc_id = 25aad84c22269cf7221d0c22737e2e01a36ec51b
1	RNA	_	_	_	_	_	_	_	BeginSeg=Yes
2	dependent	_	_	_	_	_	_	_	_
3	DNA	_	_	_	_	_	_	_	_
4	-	_	_	_	_	_	_	_	_
5	polymerases	_	_	_	_	_	_	_	_
6	,	_	_	_	_	_	_	_	_
7	reverse	_	_	_	_	_	_	_	_
8	transcriptases	_	_	_	_	_	_	_	_
9	,	_	_	_	_	_	_	_	_
10	are	_	_	_	_	_	_	_	_
11	key	_	_	_	_	_	_	_	_
12	enzymes	_	_	_	_	_	_	_	_
13	for	_	_	_	_	_	_	_	_
14	retroviruses	_	_	_	_	_	_	_	_
15	and	_	_	_	_	_	_	_	_
16	retroelements	_	_	_	_	_	_	_	_
17	.	_	_	_	_	_	_	_	_
18	Their	_	_	_	_	_	_	_	BeginSeg=Yes
19	fidelity	_	_	_	_	_	_	_	_
20	,	_	_	_	_	_	_	_	_
21	including	_	_	_	_	_	_	_	BeginSeg=Yes
22	indel	_	_	_	_	_	_	_	_
23	generation	_	_	_	_	_	_	_	_
24	,	_	_	_	_	_	_	_	_
25	is	_	_	_	_	_	_	_	BeginSeg=Yes
26	significant	_	_	_	_	_	_	_	_
27	for	_	_	_	_	_	_	_	_
28	their	_	_	_	_	_	_	_	_
29	use	_	_	_	_	_	_	_	_
30	as	_	_	_	_	_	_	_	_
31	reagents	_	_	_	_	_	_	_	_
32	including	_	_	_	_	_	_	_	BeginSeg=Yes
33	for	_	_	_	_	_	_	_	_
34	deep	_	_	_	_	_	_	_	_
35	sequencing	_	_	_	_	_	_	_	_
36	.	_	_	_	_	_	_	_	_
37	Here	_	_	_	_	_	_	_	BeginSeg=Yes
38	,	_	_	_	_	_	_	_	_
39	we	_	_	_	_	_	_	_	_
40	report	_	_	_	_	_	_	_	_
41	that	_	_	_	_	_	_	_	BeginSeg=Yes
42	certain	_	_	_	_	_	_	_	_
43	RNA	_	_	_	_	_	_	_	_
44	template	_	_	_	_	_	_	_	_
45	structures	_	_	_	_	_	_	_	_
46	and	_	_	_	_	_	_	_	_
47	G	_	_	_	_	_	_	_	_
48	-	_	_	_	_	_	_	_	_
49	rich	_	_	_	_	_	_	_	_
50	sequences	_	_	_	_	_	_	_	_
51	,	_	_	_	_	_	_	_	_
52	ahead	_	_	_	_	_	_	_	_
53	of	_	_	_	_	_	_	_	_
54	diverse	_	_	_	_	_	_	_	_
55	reverse	_	_	_	_	_	_	_	_
56	transcriptases	_	_	_	_	_	_	_	_
57	can	_	_	_	_	_	_	_	_
58	be	_	_	_	_	_	_	_	_
59	strong	_	_	_	_	_	_	_	_
60	stimulators	_	_	_	_	_	_	_	_
61	for	_	_	_	_	_	_	_	_
62	slippage	_	_	_	_	_	_	_	_
63	at	_	_	_	_	_	_	_	_
64	slippageprone	_	_	_	_	_	_	_	_
65	template	_	_	_	_	_	_	_	_
66	motif	_	_	_	_	_	_	_	_
67	sequence	_	_	_	_	_	_	_	_
68	3	_	_	_	_	_	_	_	_
69	of	_	_	_	_	_	_	_	_
70	such	_	_	_	_	_	_	_	_
71	'	_	_	_	_	_	_	_	_
72	slippagestimulatory	_	_	_	_	_	_	_	_
73	'	_	_	_	_	_	_	_	_
74	structures	_	_	_	_	_	_	_	_
75	.	_	_	_	_	_	_	_	_
76	Where	_	_	_	_	_	_	_	BeginSeg=Yes
77	slippage	_	_	_	_	_	_	_	_
78	is	_	_	_	_	_	_	_	_
79	stimulated	_	_	_	_	_	_	_	_
80	,	_	_	_	_	_	_	_	_
81	the	_	_	_	_	_	_	_	BeginSeg=Yes
82	resulting	_	_	_	_	_	_	_	_
83	products	_	_	_	_	_	_	_	_
84	have	_	_	_	_	_	_	_	_
85	one	_	_	_	_	_	_	_	_
86	or	_	_	_	_	_	_	_	_
87	more	_	_	_	_	_	_	_	_
88	additional	_	_	_	_	_	_	_	_
89	base(s	_	_	_	_	_	_	_	_
90	)	_	_	_	_	_	_	_	_
91	compared	_	_	_	_	_	_	_	BeginSeg=Yes
92	to	_	_	_	_	_	_	_	_
93	the	_	_	_	_	_	_	_	_
94	corresponding	_	_	_	_	_	_	_	_
95	template	_	_	_	_	_	_	_	_
96	motif	_	_	_	_	_	_	_	_
97	.	_	_	_	_	_	_	_	_
98	Such	_	_	_	_	_	_	_	BeginSeg=Yes
99	structures	_	_	_	_	_	_	_	_
100	also	_	_	_	_	_	_	_	_
101	inhibit	_	_	_	_	_	_	_	_
102	slippagemediated	_	_	_	_	_	_	_	_
103	base	_	_	_	_	_	_	_	_
104	omission	_	_	_	_	_	_	_	_
105	which	_	_	_	_	_	_	_	BeginSeg=Yes
106	can	_	_	_	_	_	_	_	_
107	be	_	_	_	_	_	_	_	_
108	more	_	_	_	_	_	_	_	_
109	frequent	_	_	_	_	_	_	_	_
110	in	_	_	_	_	_	_	_	_
111	the	_	_	_	_	_	_	_	_
112	absence	_	_	_	_	_	_	_	_
113	of	_	_	_	_	_	_	_	_
114	a	_	_	_	_	_	_	_	_
115	relevant	_	_	_	_	_	_	_	_
116	stem	_	_	_	_	_	_	_	_
117	-	_	_	_	_	_	_	_	_
118	loop	_	_	_	_	_	_	_	_
119	.	_	_	_	_	_	_	_	_
120	Slippage	_	_	_	_	_	_	_	BeginSeg=Yes
121	directionality	_	_	_	_	_	_	_	_
122	,	_	_	_	_	_	_	_	_
123	base	_	_	_	_	_	_	_	_
124	insertion	_	_	_	_	_	_	_	_
125	and	_	_	_	_	_	_	_	_
126	omission	_	_	_	_	_	_	_	_
127	,	_	_	_	_	_	_	_	_
128	is	_	_	_	_	_	_	_	_
129	sensitive	_	_	_	_	_	_	_	_
130	to	_	_	_	_	_	_	_	_
131	the	_	_	_	_	_	_	_	_
132	relative	_	_	_	_	_	_	_	_
133	concentration	_	_	_	_	_	_	_	_
134	ratio	_	_	_	_	_	_	_	_
135	of	_	_	_	_	_	_	_	_
136	dNTPs	_	_	_	_	_	_	_	_
137	specified	_	_	_	_	_	_	_	BeginSeg=Yes
138	by	_	_	_	_	_	_	_	_
139	the	_	_	_	_	_	_	_	_
140	RNA	_	_	_	_	_	_	_	_
141	template	_	_	_	_	_	_	_	_
142	slippage	_	_	_	_	_	_	_	_
143	-	_	_	_	_	_	_	_	_
144	prone	_	_	_	_	_	_	_	_
145	sequence	_	_	_	_	_	_	_	_
146	and	_	_	_	_	_	_	_	_
147	its	_	_	_	_	_	_	_	_
148	5	_	_	_	_	_	_	_	_
149	adjacent	_	_	_	_	_	_	_	_
150	base	_	_	_	_	_	_	_	_
151	.	_	_	_	_	_	_	_	_
152	The	_	_	_	_	_	_	_	BeginSeg=Yes
153	retrotransposon	_	_	_	_	_	_	_	_
154	-	_	_	_	_	_	_	_	_
155	derived	_	_	_	_	_	_	_	_
156	enzyme	_	_	_	_	_	_	_	_
157	TGIRT	_	_	_	_	_	_	_	_
158	exhibits	_	_	_	_	_	_	_	_
159	more	_	_	_	_	_	_	_	_
160	slippage	_	_	_	_	_	_	_	_
161	in	_	_	_	_	_	_	_	_
162	vitro	_	_	_	_	_	_	_	_
163	than	_	_	_	_	_	_	_	_
164	the	_	_	_	_	_	_	_	_
165	retroviral	_	_	_	_	_	_	_	_
166	enzymes	_	_	_	_	_	_	_	_
167	tested	_	_	_	_	_	_	_	BeginSeg=Yes
168	including	_	_	_	_	_	_	_	BeginSeg=Yes
169	that	_	_	_	_	_	_	_	_
170	from	_	_	_	_	_	_	_	_
171	HIV	_	_	_	_	_	_	_	_
172	.	_	_	_	_	_	_	_	_
173	Structure	_	_	_	_	_	_	_	BeginSeg=Yes
174	-	_	_	_	_	_	_	_	_
175	mediated	_	_	_	_	_	_	_	_
176	slippage	_	_	_	_	_	_	_	_
177	may	_	_	_	_	_	_	_	_
178	be	_	_	_	_	_	_	_	_
179	exhibited	_	_	_	_	_	_	_	_
180	by	_	_	_	_	_	_	_	_
181	other	_	_	_	_	_	_	_	_
182	polymerases	_	_	_	_	_	_	_	_
183	and	_	_	_	_	_	_	_	_
184	enrich	_	_	_	_	_	_	_	_
185	gene	_	_	_	_	_	_	_	_
186	expression	_	_	_	_	_	_	_	_
187	.	_	_	_	_	_	_	_	_
188	A	_	_	_	_	_	_	_	BeginSeg=Yes
189	cassette	_	_	_	_	_	_	_	_
190	from	_	_	_	_	_	_	_	_
191	Drosophila	_	_	_	_	_	_	_	_
192	retrotransposon	_	_	_	_	_	_	_	_
193	Dme1	_	_	_	_	_	_	_	_
194	chrX	_	_	_	_	_	_	_	_
195	2630566	_	_	_	_	_	_	_	_
196	,	_	_	_	_	_	_	_	_
197	a	_	_	_	_	_	_	_	_
198	candidate	_	_	_	_	_	_	_	_
199	for	_	_	_	_	_	_	_	BeginSeg=Yes
200	utilizing	_	_	_	_	_	_	_	_
201	slippage	_	_	_	_	_	_	_	_
202	for	_	_	_	_	_	_	_	_
203	its	_	_	_	_	_	_	_	_
204	GagPol	_	_	_	_	_	_	_	_
205	synthesis	_	_	_	_	_	_	_	_
206	,	_	_	_	_	_	_	_	_
207	exhibits	_	_	_	_	_	_	_	BeginSeg=Yes
208	strong	_	_	_	_	_	_	_	_
209	slippage	_	_	_	_	_	_	_	_
210	in	_	_	_	_	_	_	_	_
211	vitro	_	_	_	_	_	_	_	_
212	.	_	_	_	_	_	_	_	_
213	Given	_	_	_	_	_	_	_	BeginSeg=Yes
214	the	_	_	_	_	_	_	_	_
215	widespread	_	_	_	_	_	_	_	_
216	occurrence	_	_	_	_	_	_	_	_
217	and	_	_	_	_	_	_	_	_
218	importance	_	_	_	_	_	_	_	_
219	of	_	_	_	_	_	_	_	_
220	retrotransposons	_	_	_	_	_	_	_	_
221	,	_	_	_	_	_	_	_	_
222	systematic	_	_	_	_	_	_	_	BeginSeg=Yes
223	studies	_	_	_	_	_	_	_	_
224	to	_	_	_	_	_	_	_	BeginSeg=Yes
225	reveal	_	_	_	_	_	_	_	_
226	the	_	_	_	_	_	_	_	_
227	extent	_	_	_	_	_	_	_	_
228	of	_	_	_	_	_	_	_	_
229	their	_	_	_	_	_	_	_	_
230	functional	_	_	_	_	_	_	_	_
231	utilization	_	_	_	_	_	_	_	_
232	of	_	_	_	_	_	_	_	_
233	RT	_	_	_	_	_	_	_	_
234	slippage	_	_	_	_	_	_	_	_
235	are	_	_	_	_	_	_	_	BeginSeg=Yes
236	merited	_	_	_	_	_	_	_	_
237	.	_	_	_	_	_	_	_	_

# newdoc_id = 2a32218f7d0b647b6bebeb1526245a0dc8856546
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	cell	_	_	_	_	_	_	_	_
3	intrinsic	_	_	_	_	_	_	_	_
4	innate	_	_	_	_	_	_	_	_
5	immune	_	_	_	_	_	_	_	_
6	responses	_	_	_	_	_	_	_	_
7	provide	_	_	_	_	_	_	_	_
8	a	_	_	_	_	_	_	_	_
9	first	_	_	_	_	_	_	_	_
10	line	_	_	_	_	_	_	_	_
11	of	_	_	_	_	_	_	_	_
12	defense	_	_	_	_	_	_	_	_
13	against	_	_	_	_	_	_	_	_
14	viral	_	_	_	_	_	_	_	_
15	infection	_	_	_	_	_	_	_	_
16	,	_	_	_	_	_	_	_	_
17	and	_	_	_	_	_	_	_	BeginSeg=Yes
18	often	_	_	_	_	_	_	_	_
19	function	_	_	_	_	_	_	_	_
20	by	_	_	_	_	_	_	_	BeginSeg=Yes
21	targeting	_	_	_	_	_	_	_	_
22	cellular	_	_	_	_	_	_	_	_
23	pathways	_	_	_	_	_	_	_	_
24	usurped	_	_	_	_	_	_	_	BeginSeg=Yes
25	by	_	_	_	_	_	_	_	_
26	the	_	_	_	_	_	_	_	_
27	virus	_	_	_	_	_	_	_	_
28	during	_	_	_	_	_	_	_	_
29	infection	_	_	_	_	_	_	_	_
30	.	_	_	_	_	_	_	_	_
31	In	_	_	_	_	_	_	_	BeginSeg=Yes
32	particular	_	_	_	_	_	_	_	_
33	,	_	_	_	_	_	_	_	_
34	many	_	_	_	_	_	_	_	_
35	viruses	_	_	_	_	_	_	_	_
36	manipulate	_	_	_	_	_	_	_	_
37	cellular	_	_	_	_	_	_	_	_
38	lipids	_	_	_	_	_	_	_	_
39	to	_	_	_	_	_	_	_	BeginSeg=Yes
40	form	_	_	_	_	_	_	_	_
41	complex	_	_	_	_	_	_	_	_
42	structures	_	_	_	_	_	_	_	_
43	required	_	_	_	_	_	_	_	BeginSeg=Yes
44	for	_	_	_	_	_	_	_	_
45	viral	_	_	_	_	_	_	_	_
46	replication	_	_	_	_	_	_	_	_
47	,	_	_	_	_	_	_	_	_
48	many	_	_	_	_	_	_	_	BeginSeg=Yes
49	of	_	_	_	_	_	_	_	_
50	which	_	_	_	_	_	_	_	_
51	are	_	_	_	_	_	_	_	_
52	dependent	_	_	_	_	_	_	_	_
53	on	_	_	_	_	_	_	_	_
54	de	_	_	_	_	_	_	_	_
55	novo	_	_	_	_	_	_	_	_
56	fatty	_	_	_	_	_	_	_	_
57	acid	_	_	_	_	_	_	_	_
58	synthesis	_	_	_	_	_	_	_	_
59	.	_	_	_	_	_	_	_	_
60	We	_	_	_	_	_	_	_	BeginSeg=Yes
61	found	_	_	_	_	_	_	_	_
62	that	_	_	_	_	_	_	_	BeginSeg=Yes
63	the	_	_	_	_	_	_	_	_
64	energy	_	_	_	_	_	_	_	_
65	regulator	_	_	_	_	_	_	_	_
66	AMPK	_	_	_	_	_	_	_	_
67	,	_	_	_	_	_	_	_	_
68	which	_	_	_	_	_	_	_	BeginSeg=Yes
69	potently	_	_	_	_	_	_	_	_
70	inhibits	_	_	_	_	_	_	_	_
71	fatty	_	_	_	_	_	_	_	_
72	acid	_	_	_	_	_	_	_	_
73	synthesis	_	_	_	_	_	_	_	_
74	,	_	_	_	_	_	_	_	_
75	restricts	_	_	_	_	_	_	_	BeginSeg=Yes
76	infection	_	_	_	_	_	_	_	_
77	of	_	_	_	_	_	_	_	_
78	the	_	_	_	_	_	_	_	_
79	Bunyavirus	_	_	_	_	_	_	_	_
80	,	_	_	_	_	_	_	_	_
81	Rift	_	_	_	_	_	_	_	_
82	Valley	_	_	_	_	_	_	_	_
83	Fever	_	_	_	_	_	_	_	_
84	Virus	_	_	_	_	_	_	_	_
85	(	_	_	_	_	_	_	_	_
86	RVFV	_	_	_	_	_	_	_	_
87	)	_	_	_	_	_	_	_	_
88	,	_	_	_	_	_	_	_	_
89	an	_	_	_	_	_	_	_	_
90	important	_	_	_	_	_	_	_	_
91	re	_	_	_	_	_	_	_	_
92	-	_	_	_	_	_	_	_	_
93	emerging	_	_	_	_	_	_	_	_
94	arthropod	_	_	_	_	_	_	_	_
95	-	_	_	_	_	_	_	_	_
96	borne	_	_	_	_	_	_	_	_
97	human	_	_	_	_	_	_	_	_
98	pathogen	_	_	_	_	_	_	_	_
99	for	_	_	_	_	_	_	_	BeginSeg=Yes
100	which	_	_	_	_	_	_	_	_
101	there	_	_	_	_	_	_	_	_
102	are	_	_	_	_	_	_	_	_
103	no	_	_	_	_	_	_	_	_
104	effective	_	_	_	_	_	_	_	_
105	vaccines	_	_	_	_	_	_	_	_
106	or	_	_	_	_	_	_	_	_
107	therapeutics	_	_	_	_	_	_	_	_
108	.	_	_	_	_	_	_	_	_
109	We	_	_	_	_	_	_	_	BeginSeg=Yes
110	show	_	_	_	_	_	_	_	_
111	restriction	_	_	_	_	_	_	_	_
112	of	_	_	_	_	_	_	_	_
113	RVFV	_	_	_	_	_	_	_	_
114	both	_	_	_	_	_	_	_	_
115	by	_	_	_	_	_	_	_	_
116	AMPK	_	_	_	_	_	_	_	_
117	and	_	_	_	_	_	_	_	_
118	its	_	_	_	_	_	_	_	_
119	upstream	_	_	_	_	_	_	_	_
120	activator	_	_	_	_	_	_	_	_
121	LKB1	_	_	_	_	_	_	_	_
122	,	_	_	_	_	_	_	_	_
123	indicating	_	_	_	_	_	_	_	BeginSeg=Yes
124	an	_	_	_	_	_	_	_	_
125	antiviral	_	_	_	_	_	_	_	_
126	role	_	_	_	_	_	_	_	_
127	for	_	_	_	_	_	_	_	_
128	this	_	_	_	_	_	_	_	_
129	signaling	_	_	_	_	_	_	_	_
130	pathway	_	_	_	_	_	_	_	_
131	.	_	_	_	_	_	_	_	_
132	Furthermore	_	_	_	_	_	_	_	BeginSeg=Yes
133	,	_	_	_	_	_	_	_	_
134	we	_	_	_	_	_	_	_	_
135	found	_	_	_	_	_	_	_	_
136	that	_	_	_	_	_	_	_	BeginSeg=Yes
137	AMPK	_	_	_	_	_	_	_	_
138	is	_	_	_	_	_	_	_	_
139	activated	_	_	_	_	_	_	_	_
140	during	_	_	_	_	_	_	_	_
141	RVFV	_	_	_	_	_	_	_	_
142	infection	_	_	_	_	_	_	_	_
143	,	_	_	_	_	_	_	_	_
144	leading	_	_	_	_	_	_	_	BeginSeg=Yes
145	to	_	_	_	_	_	_	_	_
146	the	_	_	_	_	_	_	_	_
147	phosphorylation	_	_	_	_	_	_	_	_
148	and	_	_	_	_	_	_	_	_
149	inhibition	_	_	_	_	_	_	_	_
150	of	_	_	_	_	_	_	_	_
151	acetyl	_	_	_	_	_	_	_	_
152	-	_	_	_	_	_	_	_	_
153	CoA	_	_	_	_	_	_	_	_
154	carboxylase	_	_	_	_	_	_	_	_
155	,	_	_	_	_	_	_	_	_
156	the	_	_	_	_	_	_	_	_
157	first	_	_	_	_	_	_	_	_
158	rate	_	_	_	_	_	_	_	_
159	-	_	_	_	_	_	_	_	_
160	limiting	_	_	_	_	_	_	_	_
161	enzyme	_	_	_	_	_	_	_	_
162	in	_	_	_	_	_	_	_	_
163	fatty	_	_	_	_	_	_	_	_
164	acid	_	_	_	_	_	_	_	_
165	synthesis	_	_	_	_	_	_	_	_
166	.	_	_	_	_	_	_	_	_
167	Activating	_	_	_	_	_	_	_	BeginSeg=Yes
168	AMPK	_	_	_	_	_	_	_	_
169	pharmacologically	_	_	_	_	_	_	_	_
170	both	_	_	_	_	_	_	_	_
171	restricted	_	_	_	_	_	_	_	_
172	infection	_	_	_	_	_	_	_	_
173	and	_	_	_	_	_	_	_	BeginSeg=Yes
174	reduced	_	_	_	_	_	_	_	_
175	lipid	_	_	_	_	_	_	_	_
176	levels	_	_	_	_	_	_	_	_
177	.	_	_	_	_	_	_	_	_
178	This	_	_	_	_	_	_	_	BeginSeg=Yes
179	restriction	_	_	_	_	_	_	_	_
180	could	_	_	_	_	_	_	_	_
181	be	_	_	_	_	_	_	_	_
182	bypassed	_	_	_	_	_	_	_	_
183	by	_	_	_	_	_	_	_	_
184	treatment	_	_	_	_	_	_	_	_
185	with	_	_	_	_	_	_	_	_
186	the	_	_	_	_	_	_	_	_
187	fatty	_	_	_	_	_	_	_	_
188	acid	_	_	_	_	_	_	_	_
189	palmitate	_	_	_	_	_	_	_	_
190	,	_	_	_	_	_	_	_	_
191	demonstrating	_	_	_	_	_	_	_	BeginSeg=Yes
192	that	_	_	_	_	_	_	_	BeginSeg=Yes
193	AMPK	_	_	_	_	_	_	_	_
194	restricts	_	_	_	_	_	_	_	_
195	RVFV	_	_	_	_	_	_	_	_
196	infection	_	_	_	_	_	_	_	_
197	through	_	_	_	_	_	_	_	_
198	its	_	_	_	_	_	_	_	_
199	inhibition	_	_	_	_	_	_	_	_
200	of	_	_	_	_	_	_	_	_
201	fatty	_	_	_	_	_	_	_	_
202	acid	_	_	_	_	_	_	_	_
203	biosynthesis	_	_	_	_	_	_	_	_
204	.	_	_	_	_	_	_	_	_
205	Lastly	_	_	_	_	_	_	_	BeginSeg=Yes
206	,	_	_	_	_	_	_	_	_
207	we	_	_	_	_	_	_	_	_
208	found	_	_	_	_	_	_	_	_
209	that	_	_	_	_	_	_	_	BeginSeg=Yes
210	this	_	_	_	_	_	_	_	_
211	pathway	_	_	_	_	_	_	_	_
212	plays	_	_	_	_	_	_	_	_
213	a	_	_	_	_	_	_	_	_
214	broad	_	_	_	_	_	_	_	_
215	role	_	_	_	_	_	_	_	_
216	in	_	_	_	_	_	_	_	_
217	antiviral	_	_	_	_	_	_	_	_
218	defense	_	_	_	_	_	_	_	_
219	since	_	_	_	_	_	_	_	BeginSeg=Yes
220	additional	_	_	_	_	_	_	_	_
221	viruses	_	_	_	_	_	_	_	_
222	from	_	_	_	_	_	_	_	_
223	disparate	_	_	_	_	_	_	_	_
224	families	_	_	_	_	_	_	_	_
225	were	_	_	_	_	_	_	_	_
226	also	_	_	_	_	_	_	_	_
227	restricted	_	_	_	_	_	_	_	_
228	by	_	_	_	_	_	_	_	_
229	AMPK	_	_	_	_	_	_	_	_
230	and	_	_	_	_	_	_	_	_
231	LKB1	_	_	_	_	_	_	_	_
232	.	_	_	_	_	_	_	_	_
233	Therefore	_	_	_	_	_	_	_	BeginSeg=Yes
234	,	_	_	_	_	_	_	_	_
235	AMPK	_	_	_	_	_	_	_	_
236	is	_	_	_	_	_	_	_	_
237	an	_	_	_	_	_	_	_	_
238	important	_	_	_	_	_	_	_	_
239	component	_	_	_	_	_	_	_	_
240	of	_	_	_	_	_	_	_	_
241	the	_	_	_	_	_	_	_	_
242	cell	_	_	_	_	_	_	_	_
243	intrinsic	_	_	_	_	_	_	_	_
244	immune	_	_	_	_	_	_	_	_
245	response	_	_	_	_	_	_	_	_
246	that	_	_	_	_	_	_	_	BeginSeg=Yes
247	restricts	_	_	_	_	_	_	_	_
248	infection	_	_	_	_	_	_	_	_
249	through	_	_	_	_	_	_	_	_
250	a	_	_	_	_	_	_	_	_
251	novel	_	_	_	_	_	_	_	_
252	mechanism	_	_	_	_	_	_	_	_
253	involving	_	_	_	_	_	_	_	BeginSeg=Yes
254	the	_	_	_	_	_	_	_	_
255	inhibition	_	_	_	_	_	_	_	_
256	of	_	_	_	_	_	_	_	_
257	fatty	_	_	_	_	_	_	_	_
258	acid	_	_	_	_	_	_	_	_
259	metabolism	_	_	_	_	_	_	_	_
260	.	_	_	_	_	_	_	_	_

# newdoc_id = 2a6d03c2466a88098a79eb95b0bccd23d91168ff
1	Antimicrobial	_	_	_	_	_	_	_	BeginSeg=Yes
2	stewardship	_	_	_	_	_	_	_	_
3	program	_	_	_	_	_	_	_	_
4	aims	_	_	_	_	_	_	_	_
5	to	_	_	_	_	_	_	_	_
6	reduce	_	_	_	_	_	_	_	_
7	antibiotic	_	_	_	_	_	_	_	_
8	use	_	_	_	_	_	_	_	_
9	.	_	_	_	_	_	_	_	_
10	Periodic	_	_	_	_	_	_	_	BeginSeg=Yes
11	measurement	_	_	_	_	_	_	_	_
12	and	_	_	_	_	_	_	_	_
13	monitoring	_	_	_	_	_	_	_	_
14	of	_	_	_	_	_	_	_	_
15	antibiotic	_	_	_	_	_	_	_	_
16	use	_	_	_	_	_	_	_	_
17	and	_	_	_	_	_	_	_	_
18	comparison	_	_	_	_	_	_	_	_
19	within	_	_	_	_	_	_	_	_
20	the	_	_	_	_	_	_	_	_
21	institution	_	_	_	_	_	_	_	_
22	as	_	_	_	_	_	_	_	_
23	well	_	_	_	_	_	_	_	_
24	as	_	_	_	_	_	_	_	_
25	with	_	_	_	_	_	_	_	_
26	other	_	_	_	_	_	_	_	_
27	organizations	_	_	_	_	_	_	_	_
28	are	_	_	_	_	_	_	_	_
29	important	_	_	_	_	_	_	_	_
30	indicators	_	_	_	_	_	_	_	_
31	.	_	_	_	_	_	_	_	_
32	We	_	_	_	_	_	_	_	BeginSeg=Yes
33	analyzed	_	_	_	_	_	_	_	_
34	antibiotic	_	_	_	_	_	_	_	_
35	usage	_	_	_	_	_	_	_	_
36	in	_	_	_	_	_	_	_	_
37	a	_	_	_	_	_	_	_	_
38	general	_	_	_	_	_	_	_	_
39	hospital	_	_	_	_	_	_	_	_
40	in	_	_	_	_	_	_	_	_
41	Saudi	_	_	_	_	_	_	_	_
42	Arabia	_	_	_	_	_	_	_	_
43	.	_	_	_	_	_	_	_	_
44	Antibiotic	_	_	_	_	_	_	_	BeginSeg=Yes
45	data	_	_	_	_	_	_	_	_
46	were	_	_	_	_	_	_	_	_
47	collected	_	_	_	_	_	_	_	_
48	retrospectively	_	_	_	_	_	_	_	_
49	for	_	_	_	_	_	_	_	_
50	2011	_	_	_	_	_	_	_	_
51	and	_	_	_	_	_	_	_	_
52	from	_	_	_	_	_	_	_	_
53	2013	_	_	_	_	_	_	_	_
54	to	_	_	_	_	_	_	_	_
55	2015	_	_	_	_	_	_	_	_
56	,	_	_	_	_	_	_	_	_
57	and	_	_	_	_	_	_	_	BeginSeg=Yes
58	only	_	_	_	_	_	_	_	_
59	adult	_	_	_	_	_	_	_	_
60	patients	_	_	_	_	_	_	_	_
61	(	_	_	_	_	_	_	_	BeginSeg=Yes
62	>	_	_	_	_	_	_	_	_
63	15	_	_	_	_	_	_	_	_
64	year	_	_	_	_	_	_	_	_
65	of	_	_	_	_	_	_	_	_
66	age	_	_	_	_	_	_	_	_
67	)	_	_	_	_	_	_	_	_
68	were	_	_	_	_	_	_	_	BeginSeg=Yes
69	included	_	_	_	_	_	_	_	_
70	in	_	_	_	_	_	_	_	_
71	the	_	_	_	_	_	_	_	_
72	study	_	_	_	_	_	_	_	_
73	.	_	_	_	_	_	_	_	_
74	Data	_	_	_	_	_	_	_	BeginSeg=Yes
75	were	_	_	_	_	_	_	_	_
76	presented	_	_	_	_	_	_	_	_
77	as	_	_	_	_	_	_	_	_
78	days	_	_	_	_	_	_	_	_
79	of	_	_	_	_	_	_	_	_
80	therapy	_	_	_	_	_	_	_	_
81	(	_	_	_	_	_	_	_	_
82	DOT	_	_	_	_	_	_	_	_
83	)	_	_	_	_	_	_	_	_
84	and	_	_	_	_	_	_	_	_
85	defined	_	_	_	_	_	_	_	_
86	daily	_	_	_	_	_	_	_	_
87	dose	_	_	_	_	_	_	_	_
88	(	_	_	_	_	_	_	_	_
89	DDD	_	_	_	_	_	_	_	_
90	)	_	_	_	_	_	_	_	_
91	.	_	_	_	_	_	_	_	_
92	DDD	_	_	_	_	_	_	_	BeginSeg=Yes
93	was	_	_	_	_	_	_	_	_
94	adjusted	_	_	_	_	_	_	_	_
95	per	_	_	_	_	_	_	_	_
96	100	_	_	_	_	_	_	_	_
97	bed	_	_	_	_	_	_	_	_
98	-	_	_	_	_	_	_	_	_
99	days	_	_	_	_	_	_	_	_
100	and	_	_	_	_	_	_	_	_
101	according	_	_	_	_	_	_	_	_
102	to	_	_	_	_	_	_	_	_
103	the	_	_	_	_	_	_	_	_
104	case	_	_	_	_	_	_	_	_
105	mix	_	_	_	_	_	_	_	_
106	index	_	_	_	_	_	_	_	_
107	(	_	_	_	_	_	_	_	_
108	CMI	_	_	_	_	_	_	_	_
109	)	_	_	_	_	_	_	_	_
110	.	_	_	_	_	_	_	_	_
111	The	_	_	_	_	_	_	_	BeginSeg=Yes
112	total	_	_	_	_	_	_	_	_
113	DDD	_	_	_	_	_	_	_	_
114	was	_	_	_	_	_	_	_	_
115	37,557	_	_	_	_	_	_	_	_
116	in	_	_	_	_	_	_	_	_
117	2013	_	_	_	_	_	_	_	_
118	,	_	_	_	_	_	_	_	_
119	36,550	_	_	_	_	_	_	_	_
120	in	_	_	_	_	_	_	_	_
121	2014	_	_	_	_	_	_	_	_
122	and	_	_	_	_	_	_	_	_
123	38,738	_	_	_	_	_	_	_	_
124	in	_	_	_	_	_	_	_	_
125	2015	_	_	_	_	_	_	_	_
126	.	_	_	_	_	_	_	_	_
127	The	_	_	_	_	_	_	_	BeginSeg=Yes
128	DDD	_	_	_	_	_	_	_	_
129	per	_	_	_	_	_	_	_	_
130	100	_	_	_	_	_	_	_	_
131	patient	_	_	_	_	_	_	_	_
132	-	_	_	_	_	_	_	_	_
133	days	_	_	_	_	_	_	_	_
134	was	_	_	_	_	_	_	_	_
135	90.7	_	_	_	_	_	_	_	_
136	-	_	_	_	_	_	_	_	_
137	94.5	_	_	_	_	_	_	_	_
138	.	_	_	_	_	_	_	_	_
139	There	_	_	_	_	_	_	_	BeginSeg=Yes
140	was	_	_	_	_	_	_	_	_
141	a	_	_	_	_	_	_	_	_
142	discordant	_	_	_	_	_	_	_	_
143	findings	_	_	_	_	_	_	_	_
144	of	_	_	_	_	_	_	_	_
145	antibiotic	_	_	_	_	_	_	_	_
146	measurements	_	_	_	_	_	_	_	_
147	based	_	_	_	_	_	_	_	BeginSeg=Yes
148	on	_	_	_	_	_	_	_	_
149	the	_	_	_	_	_	_	_	_
150	DDD	_	_	_	_	_	_	_	_
151	compared	_	_	_	_	_	_	_	BeginSeg=Yes
152	to	_	_	_	_	_	_	_	_
153	DOT	_	_	_	_	_	_	_	_
154	,	_	_	_	_	_	_	_	_
155	and	_	_	_	_	_	_	_	BeginSeg=Yes
156	DDD/100	_	_	_	_	_	_	_	_
157	beddays	_	_	_	_	_	_	_	_
158	compared	_	_	_	_	_	_	_	BeginSeg=Yes
159	to	_	_	_	_	_	_	_	_
160	DOT/100	_	_	_	_	_	_	_	_
161	bed	_	_	_	_	_	_	_	_
162	-	_	_	_	_	_	_	_	_
163	days	_	_	_	_	_	_	_	_
164	.	_	_	_	_	_	_	_	_
165	There	_	_	_	_	_	_	_	BeginSeg=Yes
166	was	_	_	_	_	_	_	_	_
167	a	_	_	_	_	_	_	_	_
168	negative	_	_	_	_	_	_	_	_
169	correlation	_	_	_	_	_	_	_	_
170	between	_	_	_	_	_	_	_	_
171	CMI	_	_	_	_	_	_	_	_
172	and	_	_	_	_	_	_	_	_
173	DDD	_	_	_	_	_	_	_	_
174	per	_	_	_	_	_	_	_	_
175	100	_	_	_	_	_	_	_	_
176	bed	_	_	_	_	_	_	_	_
177	days	_	_	_	_	_	_	_	_
178	(	_	_	_	_	_	_	_	BeginSeg=Yes
179	r	_	_	_	_	_	_	_	_
180	−0.696	_	_	_	_	_	_	_	_
181	)	_	_	_	_	_	_	_	_
182	,	_	_	_	_	_	_	_	_
183	but	_	_	_	_	_	_	_	BeginSeg=Yes
184	a	_	_	_	_	_	_	_	_
185	positive	_	_	_	_	_	_	_	_
186	correlation	_	_	_	_	_	_	_	_
187	of	_	_	_	_	_	_	_	_
188	CMI	_	_	_	_	_	_	_	_
189	with	_	_	_	_	_	_	_	_
190	DOT	_	_	_	_	_	_	_	_
191	(	_	_	_	_	_	_	_	BeginSeg=Yes
192	r	_	_	_	_	_	_	_	_
193	+0.93	_	_	_	_	_	_	_	_
194	)	_	_	_	_	_	_	_	_
195	.	_	_	_	_	_	_	_	_
196	Adjusted	_	_	_	_	_	_	_	BeginSeg=Yes
197	DDD/100	_	_	_	_	_	_	_	_
198	bed	_	_	_	_	_	_	_	_
199	-	_	_	_	_	_	_	_	_
200	days	_	_	_	_	_	_	_	_
201	showed	_	_	_	_	_	_	_	_
202	decrease	_	_	_	_	_	_	_	_
203	in	_	_	_	_	_	_	_	_
204	the	_	_	_	_	_	_	_	_
205	usage	_	_	_	_	_	_	_	_
206	of	_	_	_	_	_	_	_	_
207	antibiotics	_	_	_	_	_	_	_	_
208	,	_	_	_	_	_	_	_	_
209	reflecting	_	_	_	_	_	_	_	BeginSeg=Yes
210	activities	_	_	_	_	_	_	_	_
211	of	_	_	_	_	_	_	_	_
212	the	_	_	_	_	_	_	_	_
213	antibiotic	_	_	_	_	_	_	_	_
214	stewardship	_	_	_	_	_	_	_	_
215	program	_	_	_	_	_	_	_	_
216	.	_	_	_	_	_	_	_	_
217	The	_	_	_	_	_	_	_	BeginSeg=Yes
218	increase	_	_	_	_	_	_	_	_
219	in	_	_	_	_	_	_	_	_
220	DOT/100	_	_	_	_	_	_	_	_
221	bed	_	_	_	_	_	_	_	_
222	-	_	_	_	_	_	_	_	_
223	days	_	_	_	_	_	_	_	_
224	may	_	_	_	_	_	_	_	_
225	indicate	_	_	_	_	_	_	_	_
226	the	_	_	_	_	_	_	_	_
227	favorable	_	_	_	_	_	_	_	_
228	utilization	_	_	_	_	_	_	_	_
229	of	_	_	_	_	_	_	_	_
230	combination	_	_	_	_	_	_	_	_
231	therapy	_	_	_	_	_	_	_	_
232	.	_	_	_	_	_	_	_	_
233	Antibiotic	_	_	_	_	_	_	_	BeginSeg=Yes
234	usage	_	_	_	_	_	_	_	_
235	needs	_	_	_	_	_	_	_	_
236	to	_	_	_	_	_	_	_	_
237	be	_	_	_	_	_	_	_	_
238	adjusted	_	_	_	_	_	_	_	_
239	per	_	_	_	_	_	_	_	_
240	100	_	_	_	_	_	_	_	_
241	bed	_	_	_	_	_	_	_	_
242	-	_	_	_	_	_	_	_	_
243	days	_	_	_	_	_	_	_	_
244	and	_	_	_	_	_	_	_	_
245	correlated	_	_	_	_	_	_	_	_
246	with	_	_	_	_	_	_	_	_
247	CMI	_	_	_	_	_	_	_	_
248	for	_	_	_	_	_	_	_	_
249	better	_	_	_	_	_	_	_	_
250	reflection	_	_	_	_	_	_	_	_
251	of	_	_	_	_	_	_	_	_
252	optimal	_	_	_	_	_	_	_	_
253	antibiotic	_	_	_	_	_	_	_	_
254	utilization	_	_	_	_	_	_	_	_
255	,	_	_	_	_	_	_	_	_
256	activities	_	_	_	_	_	_	_	_
257	of	_	_	_	_	_	_	_	_
258	the	_	_	_	_	_	_	_	_
259	antibiotic	_	_	_	_	_	_	_	_
260	stewardship	_	_	_	_	_	_	_	_
261	program	_	_	_	_	_	_	_	_
262	,	_	_	_	_	_	_	_	_
263	and	_	_	_	_	_	_	_	_
264	to	_	_	_	_	_	_	_	_
265	allow	_	_	_	_	_	_	_	_
266	benchmarking	_	_	_	_	_	_	_	_
267	.	_	_	_	_	_	_	_	_

# newdoc_id = 2bc85cf8715cbd57eb454b5a0d8966c787aca1e5
1	Pandemics	_	_	_	_	_	_	_	BeginSeg=Yes
2	and	_	_	_	_	_	_	_	_
3	other	_	_	_	_	_	_	_	_
4	crisis	_	_	_	_	_	_	_	_
5	situations	_	_	_	_	_	_	_	_
6	result	_	_	_	_	_	_	_	_
7	in	_	_	_	_	_	_	_	_
8	unsettled	_	_	_	_	_	_	_	_
9	times	_	_	_	_	_	_	_	_
10	,	_	_	_	_	_	_	_	_
11	or	_	_	_	_	_	_	_	_
12	ontologically	_	_	_	_	_	_	_	_
13	insecure	_	_	_	_	_	_	_	_
14	moments	_	_	_	_	_	_	_	_
15	when	_	_	_	_	_	_	_	BeginSeg=Yes
16	social	_	_	_	_	_	_	_	_
17	and	_	_	_	_	_	_	_	_
18	political	_	_	_	_	_	_	_	_
19	institutions	_	_	_	_	_	_	_	_
20	are	_	_	_	_	_	_	_	_
21	in	_	_	_	_	_	_	_	_
22	flux	_	_	_	_	_	_	_	_
23	.	_	_	_	_	_	_	_	_
24	During	_	_	_	_	_	_	_	BeginSeg=Yes
25	such	_	_	_	_	_	_	_	_
26	crises	_	_	_	_	_	_	_	_
27	,	_	_	_	_	_	_	_	_
28	the	_	_	_	_	_	_	_	_
29	ordinary	_	_	_	_	_	_	_	_
30	and	_	_	_	_	_	_	_	_
31	unnoticed	_	_	_	_	_	_	_	_
32	routines	_	_	_	_	_	_	_	_
33	that	_	_	_	_	_	_	_	BeginSeg=Yes
34	structure	_	_	_	_	_	_	_	_
35	everyday	_	_	_	_	_	_	_	_
36	life	_	_	_	_	_	_	_	_
37	are	_	_	_	_	_	_	_	BeginSeg=Yes
38	thrust	_	_	_	_	_	_	_	_
39	into	_	_	_	_	_	_	_	_
40	the	_	_	_	_	_	_	_	_
41	spotlight	_	_	_	_	_	_	_	_
42	as	_	_	_	_	_	_	_	BeginSeg=Yes
43	people	_	_	_	_	_	_	_	_
44	struggle	_	_	_	_	_	_	_	_
45	to	_	_	_	_	_	_	_	_
46	maintain	_	_	_	_	_	_	_	_
47	or	_	_	_	_	_	_	_	_
48	recreate	_	_	_	_	_	_	_	_
49	a	_	_	_	_	_	_	_	_
50	sense	_	_	_	_	_	_	_	_
51	of	_	_	_	_	_	_	_	_
52	normalcy	_	_	_	_	_	_	_	_
53	.	_	_	_	_	_	_	_	_
54	Drawing	_	_	_	_	_	_	_	BeginSeg=Yes
55	on	_	_	_	_	_	_	_	_
56	a	_	_	_	_	_	_	_	_
57	range	_	_	_	_	_	_	_	_
58	of	_	_	_	_	_	_	_	_
59	cases	_	_	_	_	_	_	_	_
60	including	_	_	_	_	_	_	_	BeginSeg=Yes
61	China	_	_	_	_	_	_	_	_
62	,	_	_	_	_	_	_	_	_
63	Russia	_	_	_	_	_	_	_	_
64	,	_	_	_	_	_	_	_	_
65	the	_	_	_	_	_	_	_	_
66	UK	_	_	_	_	_	_	_	_
67	,	_	_	_	_	_	_	_	_
68	and	_	_	_	_	_	_	_	_
69	USA	_	_	_	_	_	_	_	_
70	,	_	_	_	_	_	_	_	_
71	we	_	_	_	_	_	_	_	BeginSeg=Yes
72	examine	_	_	_	_	_	_	_	_
73	three	_	_	_	_	_	_	_	_
74	categories	_	_	_	_	_	_	_	_
75	of	_	_	_	_	_	_	_	_
76	everyday	_	_	_	_	_	_	_	_
77	practice	_	_	_	_	_	_	_	_
78	during	_	_	_	_	_	_	_	_
79	the	_	_	_	_	_	_	_	_
80	COVID-19	_	_	_	_	_	_	_	_
81	pandemic	_	_	_	_	_	_	_	_
82	that	_	_	_	_	_	_	_	BeginSeg=Yes
83	respond	_	_	_	_	_	_	_	_
84	to	_	_	_	_	_	_	_	_
85	disruptions	_	_	_	_	_	_	_	_
86	in	_	_	_	_	_	_	_	_
87	daily	_	_	_	_	_	_	_	_
88	routines	_	_	_	_	_	_	_	_
89	and	_	_	_	_	_	_	_	BeginSeg=Yes
90	seek	_	_	_	_	_	_	_	_
91	a	_	_	_	_	_	_	_	_
92	return	_	_	_	_	_	_	_	_
93	to	_	_	_	_	_	_	_	_
94	national	_	_	_	_	_	_	_	_
95	normality	_	_	_	_	_	_	_	_
96	:	_	_	_	_	_	_	_	_
97	performing	_	_	_	_	_	_	_	BeginSeg=Yes
98	national	_	_	_	_	_	_	_	_
99	solidarities	_	_	_	_	_	_	_	_
100	and	_	_	_	_	_	_	_	_
101	exclusions	_	_	_	_	_	_	_	_
102	by	_	_	_	_	_	_	_	BeginSeg=Yes
103	wearing	_	_	_	_	_	_	_	_
104	face	_	_	_	_	_	_	_	_
105	masks	_	_	_	_	_	_	_	_
106	;	_	_	_	_	_	_	_	_
107	consuming	_	_	_	_	_	_	_	BeginSeg=Yes
108	the	_	_	_	_	_	_	_	_
109	nation	_	_	_	_	_	_	_	_
110	in	_	_	_	_	_	_	_	_
111	the	_	_	_	_	_	_	_	_
112	form	_	_	_	_	_	_	_	_
113	of	_	_	_	_	_	_	_	_
114	panic	_	_	_	_	_	_	_	_
115	buying	_	_	_	_	_	_	_	_
116	and	_	_	_	_	_	_	_	_
117	conspiracy	_	_	_	_	_	_	_	_
118	theories	_	_	_	_	_	_	_	_
119	;	_	_	_	_	_	_	_	_
120	and	_	_	_	_	_	_	_	BeginSeg=Yes
121	enforcing	_	_	_	_	_	_	_	_
122	foreign	_	_	_	_	_	_	_	_
123	policies	_	_	_	_	_	_	_	_
124	through	_	_	_	_	_	_	_	_
125	social	_	_	_	_	_	_	_	_
126	media	_	_	_	_	_	_	_	_
127	and	_	_	_	_	_	_	_	_
128	embodiment	_	_	_	_	_	_	_	_
129	.	_	_	_	_	_	_	_	_
130	This	_	_	_	_	_	_	_	BeginSeg=Yes
131	analysis	_	_	_	_	_	_	_	_
132	thus	_	_	_	_	_	_	_	_
133	breaks	_	_	_	_	_	_	_	_
134	with	_	_	_	_	_	_	_	_
135	existing	_	_	_	_	_	_	_	_
136	works	_	_	_	_	_	_	_	_
137	on	_	_	_	_	_	_	_	_
138	everyday	_	_	_	_	_	_	_	_
139	nationalism	_	_	_	_	_	_	_	_
140	and	_	_	_	_	_	_	_	_
141	banal	_	_	_	_	_	_	_	_
142	nationalism	_	_	_	_	_	_	_	_
143	that	_	_	_	_	_	_	_	BeginSeg=Yes
144	typically	_	_	_	_	_	_	_	_
145	focus	_	_	_	_	_	_	_	_
146	on	_	_	_	_	_	_	_	_
147	pervasively	_	_	_	_	_	_	_	_
148	unnoticed	_	_	_	_	_	_	_	_
149	forms	_	_	_	_	_	_	_	_
150	of	_	_	_	_	_	_	_	_
151	nationalism	_	_	_	_	_	_	_	_
152	during	_	_	_	_	_	_	_	_
153	settled	_	_	_	_	_	_	_	_
154	times	_	_	_	_	_	_	_	_
155	,	_	_	_	_	_	_	_	_
156	and	_	_	_	_	_	_	_	BeginSeg=Yes
157	it	_	_	_	_	_	_	_	_
158	challenges	_	_	_	_	_	_	_	_
159	approaches	_	_	_	_	_	_	_	_
160	to	_	_	_	_	_	_	_	_
161	contentious	_	_	_	_	_	_	_	_
162	politics	_	_	_	_	_	_	_	_
163	that	_	_	_	_	_	_	_	BeginSeg=Yes
164	predict	_	_	_	_	_	_	_	_
165	protest	_	_	_	_	_	_	_	_
166	mobilization	_	_	_	_	_	_	_	_
167	for	_	_	_	_	_	_	_	_
168	change	_	_	_	_	_	_	_	_
169	rather	_	_	_	_	_	_	_	_
170	than	_	_	_	_	_	_	_	_
171	restoration	_	_	_	_	_	_	_	_
172	of	_	_	_	_	_	_	_	_
173	the	_	_	_	_	_	_	_	_
174	status	_	_	_	_	_	_	_	_
175	quo	_	_	_	_	_	_	_	_
176	ante	_	_	_	_	_	_	_	_
177	.	_	_	_	_	_	_	_	_
178	In	_	_	_	_	_	_	_	BeginSeg=Yes
179	highlighting	_	_	_	_	_	_	_	_
180	the	_	_	_	_	_	_	_	_
181	ways	_	_	_	_	_	_	_	_
182	that	_	_	_	_	_	_	_	BeginSeg=Yes
183	unsettled	_	_	_	_	_	_	_	_
184	times	_	_	_	_	_	_	_	_
185	disrupt	_	_	_	_	_	_	_	_
186	domestic	_	_	_	_	_	_	_	_
187	and	_	_	_	_	_	_	_	_
188	international	_	_	_	_	_	_	_	_
189	structures	_	_	_	_	_	_	_	_
190	,	_	_	_	_	_	_	_	_
191	this	_	_	_	_	_	_	_	BeginSeg=Yes
192	work	_	_	_	_	_	_	_	_
193	also	_	_	_	_	_	_	_	_
194	presents	_	_	_	_	_	_	_	_
195	a	_	_	_	_	_	_	_	_
196	first	_	_	_	_	_	_	_	_
197	attempt	_	_	_	_	_	_	_	_
198	to	_	_	_	_	_	_	_	BeginSeg=Yes
199	link	_	_	_	_	_	_	_	_
200	everyday	_	_	_	_	_	_	_	_
201	nationalism	_	_	_	_	_	_	_	_
202	with	_	_	_	_	_	_	_	_
203	growing	_	_	_	_	_	_	_	_
204	work	_	_	_	_	_	_	_	_
205	on	_	_	_	_	_	_	_	_
206	international	_	_	_	_	_	_	_	_
207	practices	_	_	_	_	_	_	_	_
208	.	_	_	_	_	_	_	_	_

# newdoc_id = 2c798963aaa2245c095624af78d5638bebf60c2f
1	Air	_	_	_	_	_	_	_	BeginSeg=Yes
2	sampling	_	_	_	_	_	_	_	_
3	as	_	_	_	_	_	_	_	_
4	an	_	_	_	_	_	_	_	_
5	aid	_	_	_	_	_	_	_	_
6	to	_	_	_	_	_	_	_	_
7	infection	_	_	_	_	_	_	_	_
8	control	_	_	_	_	_	_	_	_
9	is	_	_	_	_	_	_	_	_
10	still	_	_	_	_	_	_	_	_
11	in	_	_	_	_	_	_	_	_
12	an	_	_	_	_	_	_	_	_
13	experimental	_	_	_	_	_	_	_	_
14	stage	_	_	_	_	_	_	_	_
15	,	_	_	_	_	_	_	_	_
16	as	_	_	_	_	_	_	_	BeginSeg=Yes
17	there	_	_	_	_	_	_	_	_
18	is	_	_	_	_	_	_	_	_
19	no	_	_	_	_	_	_	_	_
20	consensus	_	_	_	_	_	_	_	_
21	about	_	_	_	_	_	_	_	BeginSeg=Yes
22	which	_	_	_	_	_	_	_	_
23	air	_	_	_	_	_	_	_	_
24	samplers	_	_	_	_	_	_	_	_
25	and	_	_	_	_	_	_	_	_
26	pathogen	_	_	_	_	_	_	_	_
27	detection	_	_	_	_	_	_	_	_
28	methods	_	_	_	_	_	_	_	_
29	should	_	_	_	_	_	_	_	_
30	be	_	_	_	_	_	_	_	_
31	used	_	_	_	_	_	_	_	_
32	,	_	_	_	_	_	_	_	_
33	and	_	_	_	_	_	_	_	_
34	what	_	_	_	_	_	_	_	_
35	thresholds	_	_	_	_	_	_	_	_
36	of	_	_	_	_	_	_	_	_
37	specific	_	_	_	_	_	_	_	_
38	pathogens	_	_	_	_	_	_	_	_
39	in	_	_	_	_	_	_	_	_
40	specific	_	_	_	_	_	_	_	_
41	exposed	_	_	_	_	_	_	_	_
42	populations	_	_	_	_	_	_	_	_
43	(	_	_	_	_	_	_	_	BeginSeg=Yes
44	staff	_	_	_	_	_	_	_	_
45	,	_	_	_	_	_	_	_	_
46	patients	_	_	_	_	_	_	_	_
47	,	_	_	_	_	_	_	_	_
48	or	_	_	_	_	_	_	_	_
49	visitors	_	_	_	_	_	_	_	_
50	)	_	_	_	_	_	_	_	_
51	constitutes	_	_	_	_	_	_	_	BeginSeg=Yes
52	a	_	_	_	_	_	_	_	_
53	true	_	_	_	_	_	_	_	_
54	clinical	_	_	_	_	_	_	_	_
55	risk	_	_	_	_	_	_	_	_
56	.	_	_	_	_	_	_	_	_
57	This	_	_	_	_	_	_	_	BeginSeg=Yes
58	case	_	_	_	_	_	_	_	_
59	report	_	_	_	_	_	_	_	_
60	used	_	_	_	_	_	_	_	_
61	a	_	_	_	_	_	_	_	_
62	button	_	_	_	_	_	_	_	_
63	sampler	_	_	_	_	_	_	_	_
64	,	_	_	_	_	_	_	_	_
65	worn	_	_	_	_	_	_	_	BeginSeg=Yes
66	or	_	_	_	_	_	_	_	_
67	held	_	_	_	_	_	_	_	_
68	by	_	_	_	_	_	_	_	_
69	staff	_	_	_	_	_	_	_	_
70	or	_	_	_	_	_	_	_	BeginSeg=Yes
71	left	_	_	_	_	_	_	_	_
72	free	_	_	_	_	_	_	_	_
73	-	_	_	_	_	_	_	_	_
74	standing	_	_	_	_	_	_	_	_
75	in	_	_	_	_	_	_	_	_
76	a	_	_	_	_	_	_	_	_
77	fixed	_	_	_	_	_	_	_	_
78	location	_	_	_	_	_	_	_	_
79	,	_	_	_	_	_	_	_	_
80	for	_	_	_	_	_	_	_	BeginSeg=Yes
81	environmental	_	_	_	_	_	_	_	_
82	sampling	_	_	_	_	_	_	_	_
83	around	_	_	_	_	_	_	_	_
84	a	_	_	_	_	_	_	_	_
85	child	_	_	_	_	_	_	_	_
86	who	_	_	_	_	_	_	_	BeginSeg=Yes
87	was	_	_	_	_	_	_	_	_
88	chronically	_	_	_	_	_	_	_	_
89	infected	_	_	_	_	_	_	_	_
90	by	_	_	_	_	_	_	_	_
91	a	_	_	_	_	_	_	_	_
92	respiratory	_	_	_	_	_	_	_	_
93	adenovirus	_	_	_	_	_	_	_	_
94	,	_	_	_	_	_	_	_	_
95	to	_	_	_	_	_	_	_	BeginSeg=Yes
96	determine	_	_	_	_	_	_	_	_
97	whether	_	_	_	_	_	_	_	_
98	there	_	_	_	_	_	_	_	_
99	was	_	_	_	_	_	_	_	_
100	any	_	_	_	_	_	_	_	_
101	risk	_	_	_	_	_	_	_	_
102	of	_	_	_	_	_	_	_	_
103	secondary	_	_	_	_	_	_	_	_
104	adenovirus	_	_	_	_	_	_	_	_
105	infection	_	_	_	_	_	_	_	_
106	to	_	_	_	_	_	_	_	_
107	the	_	_	_	_	_	_	_	_
108	staff	_	_	_	_	_	_	_	_
109	managing	_	_	_	_	_	_	_	_
110	the	_	_	_	_	_	_	_	_
111	patient	_	_	_	_	_	_	_	_
112	.	_	_	_	_	_	_	_	_
113	Despite	_	_	_	_	_	_	_	BeginSeg=Yes
114	multiple	_	_	_	_	_	_	_	_
115	air	_	_	_	_	_	_	_	_
116	samples	_	_	_	_	_	_	_	_
117	taken	_	_	_	_	_	_	_	BeginSeg=Yes
118	on	_	_	_	_	_	_	_	_
119	difference	_	_	_	_	_	_	_	_
120	days	_	_	_	_	_	_	_	_
121	,	_	_	_	_	_	_	_	_
122	coinciding	_	_	_	_	_	_	_	BeginSeg=Yes
123	with	_	_	_	_	_	_	_	_
124	high	_	_	_	_	_	_	_	_
125	levels	_	_	_	_	_	_	_	_
126	of	_	_	_	_	_	_	_	_
127	adenovirus	_	_	_	_	_	_	_	_
128	detectable	_	_	_	_	_	_	_	_
129	in	_	_	_	_	_	_	_	_
130	the	_	_	_	_	_	_	_	_
131-132	child's	_	_	_	_	_	_	_	_
131	child	_	_	_	_	_	_	_	_
132	's	_	_	_	_	_	_	_	_
133	nasopharyngeal	_	_	_	_	_	_	_	_
134	aspirates	_	_	_	_	_	_	_	_
135	(	_	_	_	_	_	_	_	_
136	NPAs	_	_	_	_	_	_	_	_
137	)	_	_	_	_	_	_	_	_
138	,	_	_	_	_	_	_	_	_
139	none	_	_	_	_	_	_	_	BeginSeg=Yes
140	of	_	_	_	_	_	_	_	_
141	the	_	_	_	_	_	_	_	_
142	air	_	_	_	_	_	_	_	_
143	samples	_	_	_	_	_	_	_	_
144	contained	_	_	_	_	_	_	_	_
145	any	_	_	_	_	_	_	_	_
146	detectable	_	_	_	_	_	_	_	_
147	adenovirus	_	_	_	_	_	_	_	_
148	DNA	_	_	_	_	_	_	_	_
149	using	_	_	_	_	_	_	_	BeginSeg=Yes
150	a	_	_	_	_	_	_	_	_
151	clinically	_	_	_	_	_	_	_	_
152	validated	_	_	_	_	_	_	_	_
153	diagnostic	_	_	_	_	_	_	_	_
154	polymerase	_	_	_	_	_	_	_	_
155	chain	_	_	_	_	_	_	_	_
156	reaction	_	_	_	_	_	_	_	_
157	(	_	_	_	_	_	_	_	_
158	PCR	_	_	_	_	_	_	_	_
159	)	_	_	_	_	_	_	_	_
160	assay	_	_	_	_	_	_	_	_
161	.	_	_	_	_	_	_	_	_
162	Although	_	_	_	_	_	_	_	BeginSeg=Yes
163	highly	_	_	_	_	_	_	_	_
164	sensitive	_	_	_	_	_	_	_	_
165	,	_	_	_	_	_	_	_	_
166	in	_	_	_	_	_	_	_	_
167	-	_	_	_	_	_	_	_	_
168	house	_	_	_	_	_	_	_	_
169	PCR	_	_	_	_	_	_	_	_
170	assays	_	_	_	_	_	_	_	_
171	have	_	_	_	_	_	_	_	_
172	been	_	_	_	_	_	_	_	_
173	developed	_	_	_	_	_	_	_	_
174	to	_	_	_	_	_	_	_	BeginSeg=Yes
175	detect	_	_	_	_	_	_	_	_
176	airborne	_	_	_	_	_	_	_	_
177	pathogen	_	_	_	_	_	_	_	_
178	RNA	_	_	_	_	_	_	_	_
179	/	_	_	_	_	_	_	_	_
180	DNA	_	_	_	_	_	_	_	_
181	,	_	_	_	_	_	_	_	_
182	it	_	_	_	_	_	_	_	BeginSeg=Yes
183	is	_	_	_	_	_	_	_	_
184	still	_	_	_	_	_	_	_	_
185	unclear	_	_	_	_	_	_	_	_
186	what	_	_	_	_	_	_	_	_
187	level	_	_	_	_	_	_	_	_
188	of	_	_	_	_	_	_	_	_
189	specific	_	_	_	_	_	_	_	_
190	pathogen	_	_	_	_	_	_	_	_
191	RNA	_	_	_	_	_	_	_	_
192	/	_	_	_	_	_	_	_	_
193	DNA	_	_	_	_	_	_	_	_
194	constitutes	_	_	_	_	_	_	_	_
195	a	_	_	_	_	_	_	_	_
196	true	_	_	_	_	_	_	_	_
197	clinical	_	_	_	_	_	_	_	_
198	risk	_	_	_	_	_	_	_	_
199	.	_	_	_	_	_	_	_	_
200	In	_	_	_	_	_	_	_	BeginSeg=Yes
201	this	_	_	_	_	_	_	_	_
202	case	_	_	_	_	_	_	_	_
203	,	_	_	_	_	_	_	_	_
204	the	_	_	_	_	_	_	_	_
205	absence	_	_	_	_	_	_	_	_
206	of	_	_	_	_	_	_	_	_
207	detectable	_	_	_	_	_	_	_	_
208	airborne	_	_	_	_	_	_	_	_
209	adenovirus	_	_	_	_	_	_	_	_
210	DNA	_	_	_	_	_	_	_	_
211	using	_	_	_	_	_	_	_	BeginSeg=Yes
212	a	_	_	_	_	_	_	_	_
213	conventional	_	_	_	_	_	_	_	_
214	diagnostic	_	_	_	_	_	_	_	_
215	assay	_	_	_	_	_	_	_	_
216	removed	_	_	_	_	_	_	_	BeginSeg=Yes
217	the	_	_	_	_	_	_	_	_
218	requirement	_	_	_	_	_	_	_	_
219	for	_	_	_	_	_	_	_	_
220	staff	_	_	_	_	_	_	_	_
221	to	_	_	_	_	_	_	_	_
222	wear	_	_	_	_	_	_	_	_
223	surgical	_	_	_	_	_	_	_	_
224	masks	_	_	_	_	_	_	_	_
225	and	_	_	_	_	_	_	_	_
226	face	_	_	_	_	_	_	_	_
227	visors	_	_	_	_	_	_	_	_
228	when	_	_	_	_	_	_	_	BeginSeg=Yes
229	they	_	_	_	_	_	_	_	_
230	entered	_	_	_	_	_	_	_	_
231	the	_	_	_	_	_	_	_	_
232-233	child's	_	_	_	_	_	_	_	_
232	child	_	_	_	_	_	_	_	_
233	's	_	_	_	_	_	_	_	_
234	room	_	_	_	_	_	_	_	_
235	.	_	_	_	_	_	_	_	_
236	No	_	_	_	_	_	_	_	BeginSeg=Yes
237	subsequent	_	_	_	_	_	_	_	_
238	staff	_	_	_	_	_	_	_	_
239	infections	_	_	_	_	_	_	_	_
240	or	_	_	_	_	_	_	_	_
241	outbreaks	_	_	_	_	_	_	_	_
242	of	_	_	_	_	_	_	_	_
243	adenovirus	_	_	_	_	_	_	_	_
244	have	_	_	_	_	_	_	_	_
245	so	_	_	_	_	_	_	_	_
246	far	_	_	_	_	_	_	_	_
247	been	_	_	_	_	_	_	_	_
248	identified	_	_	_	_	_	_	_	_
249	.	_	_	_	_	_	_	_	_

# newdoc_id = 2cd74646ef69d8ea8f04a046a88eb22dc7187dab
1	Transshipment	_	_	_	_	_	_	_	BeginSeg=Yes
2	hub	_	_	_	_	_	_	_	_
3	selection	_	_	_	_	_	_	_	_
4	becomes	_	_	_	_	_	_	_	_
5	increasingly	_	_	_	_	_	_	_	_
6	important	_	_	_	_	_	_	_	_
7	to	_	_	_	_	_	_	_	_
8	the	_	_	_	_	_	_	_	_
9	global	_	_	_	_	_	_	_	_
10	logistics	_	_	_	_	_	_	_	_
11	community	_	_	_	_	_	_	_	_
12	.	_	_	_	_	_	_	_	_
13	From	_	_	_	_	_	_	_	BeginSeg=Yes
14	the	_	_	_	_	_	_	_	_
15	perspectives	_	_	_	_	_	_	_	_
16	of	_	_	_	_	_	_	_	_
17	shippers	_	_	_	_	_	_	_	_
18	and	_	_	_	_	_	_	_	_
19	freight	_	_	_	_	_	_	_	_
20	forwarders	_	_	_	_	_	_	_	_
21	,	_	_	_	_	_	_	_	_
22	a	_	_	_	_	_	_	_	_
23	selection	_	_	_	_	_	_	_	_
24	must	_	_	_	_	_	_	_	_
25	align	_	_	_	_	_	_	_	_
26	with	_	_	_	_	_	_	_	_
27	cost	_	_	_	_	_	_	_	_
28	control	_	_	_	_	_	_	_	_
29	strategy	_	_	_	_	_	_	_	_
30	and	_	_	_	_	_	_	_	BeginSeg=Yes
31	sustain	_	_	_	_	_	_	_	_
32	service	_	_	_	_	_	_	_	_
33	reliability	_	_	_	_	_	_	_	_
34	across	_	_	_	_	_	_	_	_
35	cooperative	_	_	_	_	_	_	_	_
36	service	_	_	_	_	_	_	_	_
37	providers	_	_	_	_	_	_	_	_
38	.	_	_	_	_	_	_	_	_
39	This	_	_	_	_	_	_	_	BeginSeg=Yes
40	paper	_	_	_	_	_	_	_	_
41	assesses	_	_	_	_	_	_	_	_
42	the	_	_	_	_	_	_	_	_
43	selection	_	_	_	_	_	_	_	_
44	with	_	_	_	_	_	_	_	_
45	the	_	_	_	_	_	_	_	_
46	options	_	_	_	_	_	_	_	_
47	of	_	_	_	_	_	_	_	_
48	both	_	_	_	_	_	_	_	_
49	sea	_	_	_	_	_	_	_	_
50	and	_	_	_	_	_	_	_	_
51	air	_	_	_	_	_	_	_	_
52	transports	_	_	_	_	_	_	_	_
53	,	_	_	_	_	_	_	_	_
54	and	_	_	_	_	_	_	_	_
55	from	_	_	_	_	_	_	_	_
56	the	_	_	_	_	_	_	_	_
57	influence	_	_	_	_	_	_	_	_
58	of	_	_	_	_	_	_	_	_
59	country	_	_	_	_	_	_	_	_
60	of	_	_	_	_	_	_	_	_
61	origin	_	_	_	_	_	_	_	_
62	of	_	_	_	_	_	_	_	_
63	the	_	_	_	_	_	_	_	_
64	company	_	_	_	_	_	_	_	_
65	.	_	_	_	_	_	_	_	_
66	Critical	_	_	_	_	_	_	_	BeginSeg=Yes
67	factors	_	_	_	_	_	_	_	_
68	of	_	_	_	_	_	_	_	_
69	transshipment	_	_	_	_	_	_	_	_
70	hub	_	_	_	_	_	_	_	_
71	selection	_	_	_	_	_	_	_	_
72	,	_	_	_	_	_	_	_	_
73	both	_	_	_	_	_	_	_	_
74	qualitative	_	_	_	_	_	_	_	_
75	and	_	_	_	_	_	_	_	_
76	quantitative	_	_	_	_	_	_	_	_
77	,	_	_	_	_	_	_	_	_
78	are	_	_	_	_	_	_	_	_
79	identified	_	_	_	_	_	_	_	_
80	through	_	_	_	_	_	_	_	_
81	focus	_	_	_	_	_	_	_	_
82	group	_	_	_	_	_	_	_	_
83	discussions	_	_	_	_	_	_	_	_
84	.	_	_	_	_	_	_	_	_
85	Relative	_	_	_	_	_	_	_	BeginSeg=Yes
86	importance	_	_	_	_	_	_	_	_
87	of	_	_	_	_	_	_	_	_
88	these	_	_	_	_	_	_	_	_
89	factors	_	_	_	_	_	_	_	_
90	is	_	_	_	_	_	_	_	_
91	determined	_	_	_	_	_	_	_	_
92	based	_	_	_	_	_	_	_	BeginSeg=Yes
93	on	_	_	_	_	_	_	_	_
94	collective	_	_	_	_	_	_	_	_
95	views	_	_	_	_	_	_	_	_
96	of	_	_	_	_	_	_	_	_
97	logistics	_	_	_	_	_	_	_	_
98	stakeholders	_	_	_	_	_	_	_	_
99	.	_	_	_	_	_	_	_	_
100	The	_	_	_	_	_	_	_	BeginSeg=Yes
101	competitiveness	_	_	_	_	_	_	_	_
102	of	_	_	_	_	_	_	_	_
103	transshipment	_	_	_	_	_	_	_	_
104	hubs	_	_	_	_	_	_	_	_
105	is	_	_	_	_	_	_	_	_
106	then	_	_	_	_	_	_	_	_
107	assessed	_	_	_	_	_	_	_	_
108	using	_	_	_	_	_	_	_	BeginSeg=Yes
109	an	_	_	_	_	_	_	_	_
110	AHP	_	_	_	_	_	_	_	_
111	approach	_	_	_	_	_	_	_	_
112	.	_	_	_	_	_	_	_	_
113	Our	_	_	_	_	_	_	_	BeginSeg=Yes
114	analysis	_	_	_	_	_	_	_	_
115	is	_	_	_	_	_	_	_	_
116	based	_	_	_	_	_	_	_	_
117	on	_	_	_	_	_	_	_	_
118	the	_	_	_	_	_	_	_	_
119	historical	_	_	_	_	_	_	_	_
120	implementation	_	_	_	_	_	_	_	_
121	of	_	_	_	_	_	_	_	_
122	direct	_	_	_	_	_	_	_	_
123	transportation	_	_	_	_	_	_	_	_
124	link	_	_	_	_	_	_	_	_
125	policy	_	_	_	_	_	_	_	_
126	between	_	_	_	_	_	_	_	_
127	Mainland	_	_	_	_	_	_	_	_
128	China	_	_	_	_	_	_	_	_
129	and	_	_	_	_	_	_	_	_
130	Taiwan	_	_	_	_	_	_	_	_
131	.	_	_	_	_	_	_	_	_
132	With	_	_	_	_	_	_	_	BeginSeg=Yes
133	this	_	_	_	_	_	_	_	_
134	empirical	_	_	_	_	_	_	_	_
135	work	_	_	_	_	_	_	_	_
136	,	_	_	_	_	_	_	_	_
137	the	_	_	_	_	_	_	_	_
138	finding	_	_	_	_	_	_	_	_
139	suggests	_	_	_	_	_	_	_	_
140	that	_	_	_	_	_	_	_	BeginSeg=Yes
141	even	_	_	_	_	_	_	_	_
142	the	_	_	_	_	_	_	_	_
143	spawn	_	_	_	_	_	_	_	_
144	of	_	_	_	_	_	_	_	_
145	other	_	_	_	_	_	_	_	_
146	nearby	_	_	_	_	_	_	_	_
147	ports	_	_	_	_	_	_	_	_
148	with	_	_	_	_	_	_	_	_
149	shorter	_	_	_	_	_	_	_	_
150	transport	_	_	_	_	_	_	_	_
151	distance	_	_	_	_	_	_	_	_
152	and	_	_	_	_	_	_	_	_
153	closer	_	_	_	_	_	_	_	_
154	proximity	_	_	_	_	_	_	_	_
155	to	_	_	_	_	_	_	_	_
156	cargo	_	_	_	_	_	_	_	_
157	sources	_	_	_	_	_	_	_	_
158	,	_	_	_	_	_	_	_	_
159	there	_	_	_	_	_	_	_	_
160	remain	_	_	_	_	_	_	_	_
161	overriding	_	_	_	_	_	_	_	_
162	factors	_	_	_	_	_	_	_	_
163	such	_	_	_	_	_	_	_	BeginSeg=Yes
164	as	_	_	_	_	_	_	_	_
165	customs	_	_	_	_	_	_	_	_
166	regulations	_	_	_	_	_	_	_	_
167	&	_	_	_	_	_	_	_	_
168	government	_	_	_	_	_	_	_	_
169	policies	_	_	_	_	_	_	_	_
170	and	_	_	_	_	_	_	_	_
171	connectivity	_	_	_	_	_	_	_	_
172	that	_	_	_	_	_	_	_	BeginSeg=Yes
173	a	_	_	_	_	_	_	_	_
174	transshipment	_	_	_	_	_	_	_	_
175	hub	_	_	_	_	_	_	_	_
176	is	_	_	_	_	_	_	_	_
177	preferred	_	_	_	_	_	_	_	_
178	.	_	_	_	_	_	_	_	_

# newdoc_id = 2cfc9d870895fa21b90e90ab86d1343b0da35457
1	This	_	_	_	_	_	_	_	BeginSeg=Yes
2	study	_	_	_	_	_	_	_	_
3	explores	_	_	_	_	_	_	_	_
4	the	_	_	_	_	_	_	_	_
5	divergence	_	_	_	_	_	_	_	_
6	pattern	_	_	_	_	_	_	_	_
7	of	_	_	_	_	_	_	_	_
8	SARS	_	_	_	_	_	_	_	_
9	-	_	_	_	_	_	_	_	_
10	CoV-2	_	_	_	_	_	_	_	_
11	using	_	_	_	_	_	_	_	BeginSeg=Yes
12	whole	_	_	_	_	_	_	_	_
13	genome	_	_	_	_	_	_	_	_
14	sequences	_	_	_	_	_	_	_	_
15	of	_	_	_	_	_	_	_	_
16	the	_	_	_	_	_	_	_	_
17	isolates	_	_	_	_	_	_	_	_
18	from	_	_	_	_	_	_	_	_
19	various	_	_	_	_	_	_	_	_
20	COVID-19	_	_	_	_	_	_	_	_
21	affected	_	_	_	_	_	_	_	_
22	countries	_	_	_	_	_	_	_	_
23	.	_	_	_	_	_	_	_	_
24	The	_	_	_	_	_	_	_	BeginSeg=Yes
25	phylogenomic	_	_	_	_	_	_	_	_
26	analysis	_	_	_	_	_	_	_	_
27	indicates	_	_	_	_	_	_	_	_
28	the	_	_	_	_	_	_	_	_
29	presence	_	_	_	_	_	_	_	_
30	of	_	_	_	_	_	_	_	_
31	at	_	_	_	_	_	_	_	_
32	least	_	_	_	_	_	_	_	_
33	four	_	_	_	_	_	_	_	_
34	distinct	_	_	_	_	_	_	_	_
35	groups	_	_	_	_	_	_	_	_
36	of	_	_	_	_	_	_	_	_
37	the	_	_	_	_	_	_	_	_
38	SARS	_	_	_	_	_	_	_	_
39	-	_	_	_	_	_	_	_	_
40	CoV-2	_	_	_	_	_	_	_	_
41	genomes	_	_	_	_	_	_	_	_
42	.	_	_	_	_	_	_	_	_
43	The	_	_	_	_	_	_	_	BeginSeg=Yes
44	emergent	_	_	_	_	_	_	_	_
45	groups	_	_	_	_	_	_	_	_
46	have	_	_	_	_	_	_	_	_
47	been	_	_	_	_	_	_	_	_
48	found	_	_	_	_	_	_	_	_
49	to	_	_	_	_	_	_	_	_
50	be	_	_	_	_	_	_	_	_
51	associated	_	_	_	_	_	_	_	_
52	with	_	_	_	_	_	_	_	_
53	signature	_	_	_	_	_	_	_	_
54	structural	_	_	_	_	_	_	_	_
55	changes	_	_	_	_	_	_	_	_
56	in	_	_	_	_	_	_	_	_
57	specific	_	_	_	_	_	_	_	_
58	proteins	_	_	_	_	_	_	_	_
59	.	_	_	_	_	_	_	_	_
60	Also	_	_	_	_	_	_	_	BeginSeg=Yes
61	,	_	_	_	_	_	_	_	_
62	this	_	_	_	_	_	_	_	_
63	study	_	_	_	_	_	_	_	_
64	reveals	_	_	_	_	_	_	_	_
65	the	_	_	_	_	_	_	_	_
66	differential	_	_	_	_	_	_	_	_
67	levels	_	_	_	_	_	_	_	_
68	of	_	_	_	_	_	_	_	_
69	divergence	_	_	_	_	_	_	_	_
70	patterns	_	_	_	_	_	_	_	_
71	for	_	_	_	_	_	_	_	_
72	the	_	_	_	_	_	_	_	_
73	protein	_	_	_	_	_	_	_	_
74	coding	_	_	_	_	_	_	_	_
75	regions	_	_	_	_	_	_	_	_
76	.	_	_	_	_	_	_	_	_
77	Moreover	_	_	_	_	_	_	_	BeginSeg=Yes
78	,	_	_	_	_	_	_	_	_
79	we	_	_	_	_	_	_	_	_
80	have	_	_	_	_	_	_	_	_
81	predicted	_	_	_	_	_	_	_	_
82	the	_	_	_	_	_	_	_	_
83	impact	_	_	_	_	_	_	_	_
84	of	_	_	_	_	_	_	_	_
85	structural	_	_	_	_	_	_	_	_
86	changes	_	_	_	_	_	_	_	_
87	on	_	_	_	_	_	_	_	_
88	a	_	_	_	_	_	_	_	_
89	couple	_	_	_	_	_	_	_	_
90	of	_	_	_	_	_	_	_	_
91	important	_	_	_	_	_	_	_	_
92	viral	_	_	_	_	_	_	_	_
93	proteins	_	_	_	_	_	_	_	_
94	via	_	_	_	_	_	_	_	_
95	structural	_	_	_	_	_	_	_	_
96	modelling	_	_	_	_	_	_	_	_
97	techniques	_	_	_	_	_	_	_	_
98	.	_	_	_	_	_	_	_	_
99	This	_	_	_	_	_	_	_	BeginSeg=Yes
100	study	_	_	_	_	_	_	_	_
101	further	_	_	_	_	_	_	_	_
102	advocates	_	_	_	_	_	_	_	_
103	for	_	_	_	_	_	_	_	_
104	more	_	_	_	_	_	_	_	_
105	viral	_	_	_	_	_	_	_	_
106	genetic	_	_	_	_	_	_	_	_
107	studies	_	_	_	_	_	_	_	_
108	with	_	_	_	_	_	_	_	_
109	associated	_	_	_	_	_	_	_	_
110	clinical	_	_	_	_	_	_	_	_
111	outcomes	_	_	_	_	_	_	_	_
112	and	_	_	_	_	_	_	_	_
113-114	hosts'	_	_	_	_	_	_	_	_
113	hosts	_	_	_	_	_	_	_	_
114	'	_	_	_	_	_	_	_	_
115	response	_	_	_	_	_	_	_	_
116	for	_	_	_	_	_	_	_	_
117	better	_	_	_	_	_	_	_	_
118	understanding	_	_	_	_	_	_	_	_
119	of	_	_	_	_	_	_	_	_
120	SARS	_	_	_	_	_	_	_	_
121	-	_	_	_	_	_	_	_	_
122	CoV-2	_	_	_	_	_	_	_	_
123	pathogenesis	_	_	_	_	_	_	_	_
124	enabling	_	_	_	_	_	_	_	BeginSeg=Yes
125	better	_	_	_	_	_	_	_	_
126	mitigation	_	_	_	_	_	_	_	_
127	of	_	_	_	_	_	_	_	_
128	this	_	_	_	_	_	_	_	_
129	pandemic	_	_	_	_	_	_	_	_
130	situation	_	_	_	_	_	_	_	_
131	.	_	_	_	_	_	_	_	_

# newdoc_id = 2e6263111a76ff0d43e7e3cde2692df04533e4f7
1	It	_	_	_	_	_	_	_	BeginSeg=Yes
2	is	_	_	_	_	_	_	_	_
3	well	_	_	_	_	_	_	_	_
4	established	_	_	_	_	_	_	_	_
5	that	_	_	_	_	_	_	_	_
6	increasing	_	_	_	_	_	_	_	_
7	age	_	_	_	_	_	_	_	_
8	is	_	_	_	_	_	_	_	_
9	associated	_	_	_	_	_	_	_	_
10	with	_	_	_	_	_	_	_	_
11	a	_	_	_	_	_	_	_	_
12	decreased	_	_	_	_	_	_	_	_
13	capacity	_	_	_	_	_	_	_	_
14	of	_	_	_	_	_	_	_	_
15	the	_	_	_	_	_	_	_	_
16	immune	_	_	_	_	_	_	_	_
17	system	_	_	_	_	_	_	_	_
18	to	_	_	_	_	_	_	_	BeginSeg=Yes
19	mediate	_	_	_	_	_	_	_	_
20	effective	_	_	_	_	_	_	_	_
21	immune	_	_	_	_	_	_	_	_
22	responses	_	_	_	_	_	_	_	_
23	to	_	_	_	_	_	_	_	_
24	vaccination	_	_	_	_	_	_	_	_
25	and	_	_	_	_	_	_	_	_
26	invading	_	_	_	_	_	_	_	_
27	pathogens	_	_	_	_	_	_	_	_
28	.	_	_	_	_	_	_	_	_
29	Because	_	_	_	_	_	_	_	BeginSeg=Yes
30	of	_	_	_	_	_	_	_	_
31	the	_	_	_	_	_	_	_	_
32	inherent	_	_	_	_	_	_	_	_
33	limitations	_	_	_	_	_	_	_	_
34	of	_	_	_	_	_	_	_	BeginSeg=Yes
35	conducting	_	_	_	_	_	_	_	_
36	experiments	_	_	_	_	_	_	_	_
37	in	_	_	_	_	_	_	_	_
38	humans	_	_	_	_	_	_	_	_
39	,	_	_	_	_	_	_	_	_
40	much	_	_	_	_	_	_	_	BeginSeg=Yes
41	of	_	_	_	_	_	_	_	_
42	what	_	_	_	_	_	_	_	_
43	we	_	_	_	_	_	_	_	_
44	have	_	_	_	_	_	_	_	_
45	learned	_	_	_	_	_	_	_	_
46	is	_	_	_	_	_	_	_	_
47	owed	_	_	_	_	_	_	_	_
48	to	_	_	_	_	_	_	_	_
49	the	_	_	_	_	_	_	_	_
50	utility	_	_	_	_	_	_	_	_
51	of	_	_	_	_	_	_	_	_
52	experimental	_	_	_	_	_	_	_	_
53	mouse	_	_	_	_	_	_	_	_
54	models	_	_	_	_	_	_	_	_
55	of	_	_	_	_	_	_	_	_
56	aging	_	_	_	_	_	_	_	_
57	.	_	_	_	_	_	_	_	_
58	Recent	_	_	_	_	_	_	_	BeginSeg=Yes
59	studies	_	_	_	_	_	_	_	_
60	performed	_	_	_	_	_	_	_	BeginSeg=Yes
61	in	_	_	_	_	_	_	_	_
62	the	_	_	_	_	_	_	_	_
63	mouse	_	_	_	_	_	_	_	_
64	have	_	_	_	_	_	_	_	BeginSeg=Yes
65	demonstrated	_	_	_	_	_	_	_	_
66	mechanisms	_	_	_	_	_	_	_	_
67	responsible	_	_	_	_	_	_	_	_
68	for	_	_	_	_	_	_	_	_
69	age	_	_	_	_	_	_	_	_
70	-	_	_	_	_	_	_	_	_
71	related	_	_	_	_	_	_	_	_
72	declines	_	_	_	_	_	_	_	_
73	in	_	_	_	_	_	_	_	_
74	the	_	_	_	_	_	_	_	_
75	function	_	_	_	_	_	_	_	_
76	of	_	_	_	_	_	_	_	_
77	CD4	_	_	_	_	_	_	_	_
78	+	_	_	_	_	_	_	_	_
79	and	_	_	_	_	_	_	_	_
80	CD8	_	_	_	_	_	_	_	_
81	+	_	_	_	_	_	_	_	_
82	cells	_	_	_	_	_	_	_	_
83	.	_	_	_	_	_	_	_	_
84	This	_	_	_	_	_	_	_	BeginSeg=Yes
85	review	_	_	_	_	_	_	_	_
86	describes	_	_	_	_	_	_	_	_
87	key	_	_	_	_	_	_	_	_
88	findings	_	_	_	_	_	_	_	_
89	regarding	_	_	_	_	_	_	_	BeginSeg=Yes
90	age	_	_	_	_	_	_	_	_
91	-	_	_	_	_	_	_	_	_
92	related	_	_	_	_	_	_	_	_
93	defects	_	_	_	_	_	_	_	_
94	in	_	_	_	_	_	_	_	_
95	T	_	_	_	_	_	_	_	_
96	-	_	_	_	_	_	_	_	_
97	cell	_	_	_	_	_	_	_	_
98	function	_	_	_	_	_	_	_	_
99	and	_	_	_	_	_	_	_	BeginSeg=Yes
100	discusses	_	_	_	_	_	_	_	_
101	the	_	_	_	_	_	_	_	_
102	impact	_	_	_	_	_	_	_	_
103	these	_	_	_	_	_	_	_	BeginSeg=Yes
104	defects	_	_	_	_	_	_	_	_
105	have	_	_	_	_	_	_	_	_
106	on	_	_	_	_	_	_	_	_
107	vaccine	_	_	_	_	_	_	_	_
108	efficacy	_	_	_	_	_	_	_	_
109	and	_	_	_	_	_	_	_	_
110	immunity	_	_	_	_	_	_	_	_
111	.	_	_	_	_	_	_	_	_

# newdoc_id = 2ebd4ba5ce0c32a5c7ef6396e35262bd667f1dcc
1	Cytokine	_	_	_	_	_	_	_	BeginSeg=Yes
2	storm	_	_	_	_	_	_	_	_
3	during	_	_	_	_	_	_	_	_
4	viral	_	_	_	_	_	_	_	_
5	infection	_	_	_	_	_	_	_	_
6	is	_	_	_	_	_	_	_	_
7	a	_	_	_	_	_	_	_	_
8	prospective	_	_	_	_	_	_	_	_
9	predictor	_	_	_	_	_	_	_	_
10	of	_	_	_	_	_	_	_	_
11	morbidity	_	_	_	_	_	_	_	_
12	and	_	_	_	_	_	_	_	_
13	mortality	_	_	_	_	_	_	_	_
14	,	_	_	_	_	_	_	_	_
15	yet	_	_	_	_	_	_	_	BeginSeg=Yes
16	the	_	_	_	_	_	_	_	_
17	cellular	_	_	_	_	_	_	_	_
18	sources	_	_	_	_	_	_	_	_
19	remain	_	_	_	_	_	_	_	_
20	undefined	_	_	_	_	_	_	_	_
21	.	_	_	_	_	_	_	_	_
22	Here	_	_	_	_	_	_	_	BeginSeg=Yes
23	,	_	_	_	_	_	_	_	_
24	using	_	_	_	_	_	_	_	_
25	genetic	_	_	_	_	_	_	_	_
26	and	_	_	_	_	_	_	_	_
27	chemical	_	_	_	_	_	_	_	_
28	tools	_	_	_	_	_	_	_	_
29	to	_	_	_	_	_	_	_	BeginSeg=Yes
30	probe	_	_	_	_	_	_	_	_
31	functions	_	_	_	_	_	_	_	_
32	of	_	_	_	_	_	_	_	_
33	the	_	_	_	_	_	_	_	_
34	S1P	_	_	_	_	_	_	_	_
35	1	_	_	_	_	_	_	_	_
36	receptor	_	_	_	_	_	_	_	_
37	,	_	_	_	_	_	_	_	_
38	we	_	_	_	_	_	_	_	BeginSeg=Yes
39	elucidate	_	_	_	_	_	_	_	_
40	cellular	_	_	_	_	_	_	_	_
41	and	_	_	_	_	_	_	_	_
42	signaling	_	_	_	_	_	_	_	_
43	mechanisms	_	_	_	_	_	_	_	_
44	that	_	_	_	_	_	_	_	BeginSeg=Yes
45	are	_	_	_	_	_	_	_	_
46	important	_	_	_	_	_	_	_	_
47	in	_	_	_	_	_	_	_	_
48	initiating	_	_	_	_	_	_	_	_
49	cytokine	_	_	_	_	_	_	_	_
50	storm	_	_	_	_	_	_	_	_
51	.	_	_	_	_	_	_	_	_
52	Whereas	_	_	_	_	_	_	_	BeginSeg=Yes
53	S1P	_	_	_	_	_	_	_	_
54	1	_	_	_	_	_	_	_	_
55	receptor	_	_	_	_	_	_	_	_
56	is	_	_	_	_	_	_	_	_
57	expressed	_	_	_	_	_	_	_	_
58	on	_	_	_	_	_	_	_	_
59	endothelial	_	_	_	_	_	_	_	_
60	cells	_	_	_	_	_	_	_	_
61	and	_	_	_	_	_	_	_	_
62	lymphocytes	_	_	_	_	_	_	_	_
63	within	_	_	_	_	_	_	_	_
64	lung	_	_	_	_	_	_	_	_
65	tissue	_	_	_	_	_	_	_	_
66	,	_	_	_	_	_	_	_	_
67	S1P	_	_	_	_	_	_	_	BeginSeg=Yes
68	1	_	_	_	_	_	_	_	_
69	agonism	_	_	_	_	_	_	_	_
70	suppresses	_	_	_	_	_	_	_	_
71	cytokines	_	_	_	_	_	_	_	_
72	and	_	_	_	_	_	_	_	_
73	innate	_	_	_	_	_	_	_	_
74	immune	_	_	_	_	_	_	_	_
75	cell	_	_	_	_	_	_	_	_
76	recruitment	_	_	_	_	_	_	_	_
77	in	_	_	_	_	_	_	_	_
78	wild	_	_	_	_	_	_	_	_
79	-	_	_	_	_	_	_	_	_
80	type	_	_	_	_	_	_	_	_
81	and	_	_	_	_	_	_	_	_
82	lymphocyte	_	_	_	_	_	_	_	_
83	-	_	_	_	_	_	_	_	_
84	deficient	_	_	_	_	_	_	_	_
85	mice	_	_	_	_	_	_	_	_
86	,	_	_	_	_	_	_	_	_
87	identifying	_	_	_	_	_	_	_	BeginSeg=Yes
88	endothelial	_	_	_	_	_	_	_	_
89	cells	_	_	_	_	_	_	_	_
90	as	_	_	_	_	_	_	_	_
91	central	_	_	_	_	_	_	_	_
92	regulators	_	_	_	_	_	_	_	_
93	of	_	_	_	_	_	_	_	_
94	cytokine	_	_	_	_	_	_	_	_
95	storm	_	_	_	_	_	_	_	_
96	.	_	_	_	_	_	_	_	_
97	Furthermore	_	_	_	_	_	_	_	BeginSeg=Yes
98	,	_	_	_	_	_	_	_	_
99	our	_	_	_	_	_	_	_	_
100	data	_	_	_	_	_	_	_	_
101	reveal	_	_	_	_	_	_	_	_
102	immune	_	_	_	_	_	_	_	_
103	cell	_	_	_	_	_	_	_	_
104	infiltration	_	_	_	_	_	_	_	_
105	and	_	_	_	_	_	_	_	_
106	cytokine	_	_	_	_	_	_	_	_
107	production	_	_	_	_	_	_	_	_
108	as	_	_	_	_	_	_	_	_
109	distinct	_	_	_	_	_	_	_	_
110	events	_	_	_	_	_	_	_	_
111	that	_	_	_	_	_	_	_	BeginSeg=Yes
112	are	_	_	_	_	_	_	_	_
113	both	_	_	_	_	_	_	_	_
114	orchestrated	_	_	_	_	_	_	_	_
115	by	_	_	_	_	_	_	_	_
116	endothelial	_	_	_	_	_	_	_	_
117	cells	_	_	_	_	_	_	_	_
118	.	_	_	_	_	_	_	_	_
119	Moreover	_	_	_	_	_	_	_	BeginSeg=Yes
120	,	_	_	_	_	_	_	_	_
121	we	_	_	_	_	_	_	_	_
122	demonstrate	_	_	_	_	_	_	_	_
123	that	_	_	_	_	_	_	_	BeginSeg=Yes
124	suppression	_	_	_	_	_	_	_	_
125	of	_	_	_	_	_	_	_	_
126	early	_	_	_	_	_	_	_	_
127	innate	_	_	_	_	_	_	_	_
128	immune	_	_	_	_	_	_	_	_
129	responses	_	_	_	_	_	_	_	_
130	through	_	_	_	_	_	_	_	_
131	S1P	_	_	_	_	_	_	_	_
132	1	_	_	_	_	_	_	_	_
133	signaling	_	_	_	_	_	_	_	_
134	results	_	_	_	_	_	_	_	_
135	in	_	_	_	_	_	_	_	_
136	reduced	_	_	_	_	_	_	_	_
137	mortality	_	_	_	_	_	_	_	_
138	during	_	_	_	_	_	_	_	_
139	infection	_	_	_	_	_	_	_	_
140	with	_	_	_	_	_	_	_	_
141	a	_	_	_	_	_	_	_	_
142	human	_	_	_	_	_	_	_	_
143	pathogenic	_	_	_	_	_	_	_	_
144	strain	_	_	_	_	_	_	_	_
145	of	_	_	_	_	_	_	_	_
146	influenza	_	_	_	_	_	_	_	_
147	virus	_	_	_	_	_	_	_	_
148	.	_	_	_	_	_	_	_	_
149	Modulation	_	_	_	_	_	_	_	BeginSeg=Yes
150	of	_	_	_	_	_	_	_	_
151	endothelium	_	_	_	_	_	_	_	_
152	with	_	_	_	_	_	_	_	_
153	a	_	_	_	_	_	_	_	_
154	specific	_	_	_	_	_	_	_	_
155	agonist	_	_	_	_	_	_	_	_
156	suggests	_	_	_	_	_	_	_	_
157	that	_	_	_	_	_	_	_	BeginSeg=Yes
158	diseases	_	_	_	_	_	_	_	_
159	in	_	_	_	_	_	_	_	BeginSeg=Yes
160	which	_	_	_	_	_	_	_	_
161	amplification	_	_	_	_	_	_	_	_
162	of	_	_	_	_	_	_	_	_
163	cytokine	_	_	_	_	_	_	_	_
164	storm	_	_	_	_	_	_	_	_
165	is	_	_	_	_	_	_	_	_
166	a	_	_	_	_	_	_	_	_
167	significant	_	_	_	_	_	_	_	_
168	pathological	_	_	_	_	_	_	_	_
169	component	_	_	_	_	_	_	_	_
170	could	_	_	_	_	_	_	_	BeginSeg=Yes
171	be	_	_	_	_	_	_	_	_
172	chemically	_	_	_	_	_	_	_	_
173	tractable	_	_	_	_	_	_	_	_
174	.	_	_	_	_	_	_	_	_

# newdoc_id = 2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5
1	It	_	_	_	_	_	_	_	BeginSeg=Yes
2	is	_	_	_	_	_	_	_	_
3	normal	_	_	_	_	_	_	_	_
4	for	_	_	_	_	_	_	_	_
5	hosts	_	_	_	_	_	_	_	_
6	to	_	_	_	_	_	_	_	_
7	be	_	_	_	_	_	_	_	_
8	co	_	_	_	_	_	_	_	_
9	-	_	_	_	_	_	_	_	_
10	infected	_	_	_	_	_	_	_	_
11	by	_	_	_	_	_	_	_	_
12	parasites	_	_	_	_	_	_	_	_
13	.	_	_	_	_	_	_	_	_
14	Interactions	_	_	_	_	_	_	_	BeginSeg=Yes
15	among	_	_	_	_	_	_	_	_
16	co	_	_	_	_	_	_	_	_
17	-	_	_	_	_	_	_	_	_
18	infecting	_	_	_	_	_	_	_	_
19	species	_	_	_	_	_	_	_	_
20	can	_	_	_	_	_	_	_	_
21	have	_	_	_	_	_	_	_	_
22	profound	_	_	_	_	_	_	_	_
23	consequences	_	_	_	_	_	_	_	_
24	,	_	_	_	_	_	_	_	_
25	including	_	_	_	_	_	_	_	BeginSeg=Yes
26	changing	_	_	_	_	_	_	_	_
27	parasite	_	_	_	_	_	_	_	_
28	transmission	_	_	_	_	_	_	_	_
29	dynamics	_	_	_	_	_	_	_	_
30	,	_	_	_	_	_	_	_	_
31	altering	_	_	_	_	_	_	_	_
32	disease	_	_	_	_	_	_	_	_
33	severity	_	_	_	_	_	_	_	_
34	and	_	_	_	_	_	_	_	_
35	confounding	_	_	_	_	_	_	_	_
36	attempts	_	_	_	_	_	_	_	_
37	at	_	_	_	_	_	_	_	_
38	parasite	_	_	_	_	_	_	_	_
39	control	_	_	_	_	_	_	_	_
40	.	_	_	_	_	_	_	_	_
41	Despite	_	_	_	_	_	_	_	BeginSeg=Yes
42	the	_	_	_	_	_	_	_	_
43	importance	_	_	_	_	_	_	_	_
44	of	_	_	_	_	_	_	_	_
45	co	_	_	_	_	_	_	_	_
46	-	_	_	_	_	_	_	_	_
47	infection	_	_	_	_	_	_	_	_
48	,	_	_	_	_	_	_	_	_
49	there	_	_	_	_	_	_	_	BeginSeg=Yes
50	is	_	_	_	_	_	_	_	_
51	currently	_	_	_	_	_	_	_	_
52	no	_	_	_	_	_	_	_	_
53	way	_	_	_	_	_	_	_	_
54	to	_	_	_	_	_	_	_	BeginSeg=Yes
55	predict	_	_	_	_	_	_	_	_
56	how	_	_	_	_	_	_	_	_
57	different	_	_	_	_	_	_	_	_
58	parasite	_	_	_	_	_	_	_	_
59	species	_	_	_	_	_	_	_	_
60	may	_	_	_	_	_	_	_	_
61	interact	_	_	_	_	_	_	_	_
62	with	_	_	_	_	_	_	_	_
63	one	_	_	_	_	_	_	_	_
64	another	_	_	_	_	_	_	_	_
65	,	_	_	_	_	_	_	_	_
66	nor	_	_	_	_	_	_	_	_
67	the	_	_	_	_	_	_	_	_
68	consequences	_	_	_	_	_	_	_	_
69	of	_	_	_	_	_	_	_	_
70	those	_	_	_	_	_	_	_	_
71	interactions	_	_	_	_	_	_	_	_
72	.	_	_	_	_	_	_	_	_
73	Here	_	_	_	_	_	_	_	BeginSeg=Yes
74	,	_	_	_	_	_	_	_	_
75	we	_	_	_	_	_	_	_	_
76	demonstrate	_	_	_	_	_	_	_	_
77	a	_	_	_	_	_	_	_	_
78	method	_	_	_	_	_	_	_	_
79	that	_	_	_	_	_	_	_	BeginSeg=Yes
80	enables	_	_	_	_	_	_	_	_
81	such	_	_	_	_	_	_	_	_
82	prediction	_	_	_	_	_	_	_	_
83	by	_	_	_	_	_	_	_	BeginSeg=Yes
84	identifying	_	_	_	_	_	_	_	_
85	two	_	_	_	_	_	_	_	_
86	nematode	_	_	_	_	_	_	_	_
87	parasite	_	_	_	_	_	_	_	_
88	groups	_	_	_	_	_	_	_	_
89	based	_	_	_	_	_	_	_	BeginSeg=Yes
90	on	_	_	_	_	_	_	_	_
91	taxonomy	_	_	_	_	_	_	_	_
92	and	_	_	_	_	_	_	_	_
93	characteristics	_	_	_	_	_	_	_	_
94	of	_	_	_	_	_	_	_	_
95	the	_	_	_	_	_	_	_	_
96	parasitological	_	_	_	_	_	_	_	_
97	niche	_	_	_	_	_	_	_	_
98	.	_	_	_	_	_	_	_	_
99	From	_	_	_	_	_	_	_	BeginSeg=Yes
100	an	_	_	_	_	_	_	_	_
101	understanding	_	_	_	_	_	_	_	_
102	of	_	_	_	_	_	_	_	_
103	the	_	_	_	_	_	_	_	_
104	interactions	_	_	_	_	_	_	_	_
105	between	_	_	_	_	_	_	_	_
106	the	_	_	_	_	_	_	_	_
107	two	_	_	_	_	_	_	_	_
108	defined	_	_	_	_	_	_	_	_
109	groups	_	_	_	_	_	_	_	_
110	in	_	_	_	_	_	_	_	_
111	one	_	_	_	_	_	_	_	_
112	host	_	_	_	_	_	_	_	_
113	system	_	_	_	_	_	_	_	_
114	(	_	_	_	_	_	_	_	BeginSeg=Yes
115	wild	_	_	_	_	_	_	_	_
116	rabbits	_	_	_	_	_	_	_	_
117	)	_	_	_	_	_	_	_	_
118	,	_	_	_	_	_	_	_	_
119	we	_	_	_	_	_	_	_	BeginSeg=Yes
120	predict	_	_	_	_	_	_	_	_
121	how	_	_	_	_	_	_	_	_
122	two	_	_	_	_	_	_	_	_
123	different	_	_	_	_	_	_	_	_
124	nematode	_	_	_	_	_	_	_	_
125	species	_	_	_	_	_	_	_	_
126	,	_	_	_	_	_	_	_	_
127	from	_	_	_	_	_	_	_	_
128	the	_	_	_	_	_	_	_	_
129	same	_	_	_	_	_	_	_	_
130	defined	_	_	_	_	_	_	_	_
131	groups	_	_	_	_	_	_	_	_
132	,	_	_	_	_	_	_	_	_
133	will	_	_	_	_	_	_	_	_
134	interact	_	_	_	_	_	_	_	_
135	in	_	_	_	_	_	_	_	_
136	co	_	_	_	_	_	_	_	_
137	-	_	_	_	_	_	_	_	_
138	infections	_	_	_	_	_	_	_	_
139	in	_	_	_	_	_	_	_	_
140	a	_	_	_	_	_	_	_	_
141	different	_	_	_	_	_	_	_	_
142	host	_	_	_	_	_	_	_	_
143	system	_	_	_	_	_	_	_	_
144	(	_	_	_	_	_	_	_	BeginSeg=Yes
145	sheep	_	_	_	_	_	_	_	_
146	)	_	_	_	_	_	_	_	_
147	,	_	_	_	_	_	_	_	_
148	and	_	_	_	_	_	_	_	BeginSeg=Yes
149	then	_	_	_	_	_	_	_	_
150	we	_	_	_	_	_	_	_	_
151	test	_	_	_	_	_	_	_	_
152	this	_	_	_	_	_	_	_	_
153	experimentally	_	_	_	_	_	_	_	_
154	.	_	_	_	_	_	_	_	_
155	We	_	_	_	_	_	_	_	BeginSeg=Yes
156	show	_	_	_	_	_	_	_	_
157	that	_	_	_	_	_	_	_	BeginSeg=Yes
158	,	_	_	_	_	_	_	_	_
159	as	_	_	_	_	_	_	_	BeginSeg=Yes
160	predicted	_	_	_	_	_	_	_	_
161	,	_	_	_	_	_	_	_	_
162	in	_	_	_	_	_	_	_	BeginSeg=Yes
163	co	_	_	_	_	_	_	_	_
164	-	_	_	_	_	_	_	_	_
165	infections	_	_	_	_	_	_	_	_
166	,	_	_	_	_	_	_	_	_
167	the	_	_	_	_	_	_	_	_
168	blood	_	_	_	_	_	_	_	_
169	-	_	_	_	_	_	_	_	_
170	feeding	_	_	_	_	_	_	_	_
171	nematode	_	_	_	_	_	_	_	_
172	Haemonchus	_	_	_	_	_	_	_	_
173	contortus	_	_	_	_	_	_	_	_
174	suppresses	_	_	_	_	_	_	_	_
175	aspects	_	_	_	_	_	_	_	_
176	of	_	_	_	_	_	_	_	_
177	the	_	_	_	_	_	_	_	_
178	sheep	_	_	_	_	_	_	_	_
179	immune	_	_	_	_	_	_	_	_
180	response	_	_	_	_	_	_	_	_
181	,	_	_	_	_	_	_	_	_
182	thereby	_	_	_	_	_	_	_	BeginSeg=Yes
183	facilitating	_	_	_	_	_	_	_	_
184	the	_	_	_	_	_	_	_	_
185	establishment	_	_	_	_	_	_	_	_
186	and/or	_	_	_	_	_	_	_	_
187	survival	_	_	_	_	_	_	_	_
188	of	_	_	_	_	_	_	_	_
189	the	_	_	_	_	_	_	_	_
190	nematode	_	_	_	_	_	_	_	_
191	Trichostrongylus	_	_	_	_	_	_	_	_
192	colubriformis	_	_	_	_	_	_	_	_
193	;	_	_	_	_	_	_	_	_
194	and	_	_	_	_	_	_	_	BeginSeg=Yes
195	that	_	_	_	_	_	_	_	_
196	the	_	_	_	_	_	_	_	_
197	T.	_	_	_	_	_	_	_	_
198	colubriformis	_	_	_	_	_	_	_	_
199	-	_	_	_	_	_	_	_	_
200	induced	_	_	_	_	_	_	_	_
201	immune	_	_	_	_	_	_	_	_
202	response	_	_	_	_	_	_	_	_
203	negatively	_	_	_	_	_	_	_	_
204	affects	_	_	_	_	_	_	_	_
205	H.	_	_	_	_	_	_	_	_
206	contortus	_	_	_	_	_	_	_	_
207	.	_	_	_	_	_	_	_	_
208	This	_	_	_	_	_	_	_	BeginSeg=Yes
209	work	_	_	_	_	_	_	_	_
210	is	_	_	_	_	_	_	_	_
211	,	_	_	_	_	_	_	_	_
212	to	_	_	_	_	_	_	_	_
213	our	_	_	_	_	_	_	_	_
214	knowledge	_	_	_	_	_	_	_	_
215	,	_	_	_	_	_	_	_	_
216	the	_	_	_	_	_	_	_	_
217	first	_	_	_	_	_	_	_	_
218	to	_	_	_	_	_	_	_	BeginSeg=Yes
219	use	_	_	_	_	_	_	_	_
220	empirical	_	_	_	_	_	_	_	_
221	data	_	_	_	_	_	_	_	_
222	from	_	_	_	_	_	_	_	_
223	one	_	_	_	_	_	_	_	_
224	host	_	_	_	_	_	_	_	_
225	system	_	_	_	_	_	_	_	_
226	to	_	_	_	_	_	_	_	BeginSeg=Yes
227	successfully	_	_	_	_	_	_	_	_
228	predict	_	_	_	_	_	_	_	_
229	the	_	_	_	_	_	_	_	_
230	specific	_	_	_	_	_	_	_	_
231	outcome	_	_	_	_	_	_	_	_
232	of	_	_	_	_	_	_	_	_
233	a	_	_	_	_	_	_	_	_
234	different	_	_	_	_	_	_	_	_
235	co	_	_	_	_	_	_	_	_
236	-	_	_	_	_	_	_	_	_
237	infection	_	_	_	_	_	_	_	_
238	in	_	_	_	_	_	_	_	_
239	a	_	_	_	_	_	_	_	_
240	second	_	_	_	_	_	_	_	_
241	host	_	_	_	_	_	_	_	_
242	species	_	_	_	_	_	_	_	_
243	.	_	_	_	_	_	_	_	_
244	The	_	_	_	_	_	_	_	BeginSeg=Yes
245	study	_	_	_	_	_	_	_	_
246	therefore	_	_	_	_	_	_	_	_
247	takes	_	_	_	_	_	_	_	_
248	the	_	_	_	_	_	_	_	_
249	first	_	_	_	_	_	_	_	_
250	step	_	_	_	_	_	_	_	_
251	in	_	_	_	_	_	_	_	BeginSeg=Yes
252	defining	_	_	_	_	_	_	_	_
253	a	_	_	_	_	_	_	_	_
254	practical	_	_	_	_	_	_	_	_
255	framework	_	_	_	_	_	_	_	_
256	for	_	_	_	_	_	_	_	BeginSeg=Yes
257	predicting	_	_	_	_	_	_	_	_
258	interspecific	_	_	_	_	_	_	_	_
259	parasite	_	_	_	_	_	_	_	_
260	interactions	_	_	_	_	_	_	_	_
261	in	_	_	_	_	_	_	_	_
262	other	_	_	_	_	_	_	_	_
263	animal	_	_	_	_	_	_	_	_
264	systems	_	_	_	_	_	_	_	_
265	.	_	_	_	_	_	_	_	_

# newdoc_id = 2f6efc4edc0c9fffd3acc810efd8616e7772b28a
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	appearance	_	_	_	_	_	_	_	_
3	of	_	_	_	_	_	_	_	_
4	the	_	_	_	_	_	_	_	_
5	novel	_	_	_	_	_	_	_	_
6	betacoronavirus	_	_	_	_	_	_	_	_
7	SARS	_	_	_	_	_	_	_	_
8	-	_	_	_	_	_	_	_	_
9	CoV-2	_	_	_	_	_	_	_	_
10	represents	_	_	_	_	_	_	_	_
11	a	_	_	_	_	_	_	_	_
12	major	_	_	_	_	_	_	_	_
13	threat	_	_	_	_	_	_	_	_
14	to	_	_	_	_	_	_	_	_
15	human	_	_	_	_	_	_	_	_
16	health	_	_	_	_	_	_	_	_
17	,	_	_	_	_	_	_	_	_
18	and	_	_	_	_	_	_	_	BeginSeg=Yes
19	its	_	_	_	_	_	_	_	_
20	diffusion	_	_	_	_	_	_	_	_
21	around	_	_	_	_	_	_	_	_
22	the	_	_	_	_	_	_	_	_
23	world	_	_	_	_	_	_	_	_
24	is	_	_	_	_	_	_	_	_
25	causing	_	_	_	_	_	_	_	_
26	dramatic	_	_	_	_	_	_	_	_
27	consequences	_	_	_	_	_	_	_	_
28	.	_	_	_	_	_	_	_	_
29	The	_	_	_	_	_	_	_	BeginSeg=Yes
30	knowledge	_	_	_	_	_	_	_	_
31	of	_	_	_	_	_	_	_	_
32	the	_	_	_	_	_	_	_	_
33	3D	_	_	_	_	_	_	_	_
34	structures	_	_	_	_	_	_	_	_
35	of	_	_	_	_	_	_	_	_
36	SARS	_	_	_	_	_	_	_	_
37	-	_	_	_	_	_	_	_	_
38	CoV-2	_	_	_	_	_	_	_	_
39	proteins	_	_	_	_	_	_	_	_
40	can	_	_	_	_	_	_	_	_
41	facilitate	_	_	_	_	_	_	_	_
42	the	_	_	_	_	_	_	_	_
43	development	_	_	_	_	_	_	_	_
44	of	_	_	_	_	_	_	_	_
45	therapeutic	_	_	_	_	_	_	_	_
46	and	_	_	_	_	_	_	_	_
47	diagnostic	_	_	_	_	_	_	_	_
48	molecules	_	_	_	_	_	_	_	_
49	.	_	_	_	_	_	_	_	_
50	Specifically	_	_	_	_	_	_	_	BeginSeg=Yes
51	,	_	_	_	_	_	_	_	_
52	comparative	_	_	_	_	_	_	_	_
53	analyses	_	_	_	_	_	_	_	_
54	of	_	_	_	_	_	_	_	_
55	the	_	_	_	_	_	_	_	_
56	structures	_	_	_	_	_	_	_	_
57	of	_	_	_	_	_	_	_	_
58	SARS	_	_	_	_	_	_	_	_
59	-	_	_	_	_	_	_	_	_
60	CoV-2	_	_	_	_	_	_	_	_
61	proteins	_	_	_	_	_	_	_	_
62	and	_	_	_	_	_	_	_	_
63	homologous	_	_	_	_	_	_	_	_
64	proteins	_	_	_	_	_	_	_	_
65	from	_	_	_	_	_	_	_	_
66	previously	_	_	_	_	_	_	_	_
67	characterized	_	_	_	_	_	_	_	_
68	viruses	_	_	_	_	_	_	_	_
69	,	_	_	_	_	_	_	_	_
70	such	_	_	_	_	_	_	_	BeginSeg=Yes
71	as	_	_	_	_	_	_	_	_
72	SARS	_	_	_	_	_	_	_	_
73	-	_	_	_	_	_	_	_	_
74	CoV	_	_	_	_	_	_	_	_
75	,	_	_	_	_	_	_	_	_
76	can	_	_	_	_	_	_	_	BeginSeg=Yes
77	reveal	_	_	_	_	_	_	_	_
78	the	_	_	_	_	_	_	_	_
79	common	_	_	_	_	_	_	_	_
80	and/or	_	_	_	_	_	_	_	_
81	distinctive	_	_	_	_	_	_	_	_
82	traits	_	_	_	_	_	_	_	_
83	that	_	_	_	_	_	_	_	BeginSeg=Yes
84	underlie	_	_	_	_	_	_	_	_
85	the	_	_	_	_	_	_	_	_
86	mechanisms	_	_	_	_	_	_	_	_
87	of	_	_	_	_	_	_	_	_
88	recognition	_	_	_	_	_	_	_	_
89	of	_	_	_	_	_	_	_	_
90	cell	_	_	_	_	_	_	_	_
91	receptors	_	_	_	_	_	_	_	_
92	and	_	_	_	_	_	_	_	_
93	of	_	_	_	_	_	_	_	_
94	molecules	_	_	_	_	_	_	_	_
95	of	_	_	_	_	_	_	_	_
96	the	_	_	_	_	_	_	_	_
97	immune	_	_	_	_	_	_	_	_
98	system	_	_	_	_	_	_	_	_
99	.	_	_	_	_	_	_	_	_
100	Herein	_	_	_	_	_	_	_	BeginSeg=Yes
101	,	_	_	_	_	_	_	_	_
102	we	_	_	_	_	_	_	_	_
103	apply	_	_	_	_	_	_	_	_
104	our	_	_	_	_	_	_	_	_
105	recently	_	_	_	_	_	_	_	_
106	developed	_	_	_	_	_	_	_	_
107	energy	_	_	_	_	_	_	_	_
108	-	_	_	_	_	_	_	_	_
109	based	_	_	_	_	_	_	_	_
110	methods	_	_	_	_	_	_	_	_
111	for	_	_	_	_	_	_	_	_
112	the	_	_	_	_	_	_	_	_
113	prediction	_	_	_	_	_	_	_	_
114	of	_	_	_	_	_	_	_	_
115	antibodybinding	_	_	_	_	_	_	_	_
116	epitopes	_	_	_	_	_	_	_	_
117	and	_	_	_	_	_	_	_	_
118	protein	_	_	_	_	_	_	_	_
119	-	_	_	_	_	_	_	_	_
120	protein	_	_	_	_	_	_	_	_
121	interaction	_	_	_	_	_	_	_	_
122	regions	_	_	_	_	_	_	_	_
123	to	_	_	_	_	_	_	_	_
124	the	_	_	_	_	_	_	_	_
125	Receptor	_	_	_	_	_	_	_	_
126	Binding	_	_	_	_	_	_	_	_
127	Domain	_	_	_	_	_	_	_	_
128	(	_	_	_	_	_	_	_	_
129	RBD	_	_	_	_	_	_	_	_
130	)	_	_	_	_	_	_	_	_
131	of	_	_	_	_	_	_	_	_
132	the	_	_	_	_	_	_	_	_
133	Spike	_	_	_	_	_	_	_	_
134	proteins	_	_	_	_	_	_	_	_
135	from	_	_	_	_	_	_	_	_
136	SARS	_	_	_	_	_	_	_	_
137	-	_	_	_	_	_	_	_	_
138	CoV-2	_	_	_	_	_	_	_	_
139	and	_	_	_	_	_	_	_	_
140	SARS	_	_	_	_	_	_	_	_
141	-	_	_	_	_	_	_	_	_
142	CoV.	_	_	_	_	_	_	_	_
143	Our	_	_	_	_	_	_	_	BeginSeg=Yes
144	analysis	_	_	_	_	_	_	_	_
145	focusses	_	_	_	_	_	_	_	_
146	only	_	_	_	_	_	_	_	_
147	on	_	_	_	_	_	_	_	_
148	the	_	_	_	_	_	_	_	_
149	study	_	_	_	_	_	_	_	_
150	of	_	_	_	_	_	_	_	_
151	the	_	_	_	_	_	_	_	_
152	structure	_	_	_	_	_	_	_	_
153	of	_	_	_	_	_	_	_	_
154	RBDs	_	_	_	_	_	_	_	_
155	in	_	_	_	_	_	_	_	_
156	isolation	_	_	_	_	_	_	_	_
157	,	_	_	_	_	_	_	_	_
158	without	_	_	_	_	_	_	_	BeginSeg=Yes
159	making	_	_	_	_	_	_	_	_
160	use	_	_	_	_	_	_	_	_
161	of	_	_	_	_	_	_	_	_
162	any	_	_	_	_	_	_	_	_
163	previous	_	_	_	_	_	_	_	_
164	knowledge	_	_	_	_	_	_	_	_
165	of	_	_	_	_	_	_	_	_
166	binding	_	_	_	_	_	_	_	_
167	properties	_	_	_	_	_	_	_	_
168	.	_	_	_	_	_	_	_	_
169	Importantly	_	_	_	_	_	_	_	BeginSeg=Yes
170	,	_	_	_	_	_	_	_	_
171	our	_	_	_	_	_	_	_	_
172	results	_	_	_	_	_	_	_	_
173	highlight	_	_	_	_	_	_	_	_
174	structural	_	_	_	_	_	_	_	_
175	and	_	_	_	_	_	_	_	_
176	sequence	_	_	_	_	_	_	_	_
177	differences	_	_	_	_	_	_	_	_
178	among	_	_	_	_	_	_	_	_
179	the	_	_	_	_	_	_	_	_
180	regions	_	_	_	_	_	_	_	_
181	that	_	_	_	_	_	_	_	BeginSeg=Yes
182	are	_	_	_	_	_	_	_	_
183	predicted	_	_	_	_	_	_	_	_
184	to	_	_	_	_	_	_	_	_
185	be	_	_	_	_	_	_	_	_
186	immunoreactive	_	_	_	_	_	_	_	_
187	and	_	_	_	_	_	_	_	_
188	bind	_	_	_	_	_	_	_	_
189	/	_	_	_	_	_	_	_	_
190	elicit	_	_	_	_	_	_	_	_
191	antibodies	_	_	_	_	_	_	_	_
192	.	_	_	_	_	_	_	_	_
193	These	_	_	_	_	_	_	_	BeginSeg=Yes
194	results	_	_	_	_	_	_	_	_
195	provide	_	_	_	_	_	_	_	_
196	a	_	_	_	_	_	_	_	_
197	rational	_	_	_	_	_	_	_	_
198	basis	_	_	_	_	_	_	_	_
199	to	_	_	_	_	_	_	_	_
200	the	_	_	_	_	_	_	_	_
201	observation	_	_	_	_	_	_	_	_
202	that	_	_	_	_	_	_	_	BeginSeg=Yes
203	several	_	_	_	_	_	_	_	_
204	SARS	_	_	_	_	_	_	_	_
205	-	_	_	_	_	_	_	_	_
206	CoV	_	_	_	_	_	_	_	_
207	RDB	_	_	_	_	_	_	_	_
208	-	_	_	_	_	_	_	_	_
209	specific	_	_	_	_	_	_	_	_
210	monoclonal	_	_	_	_	_	_	_	_
211	antibodies	_	_	_	_	_	_	_	_
212	fail	_	_	_	_	_	_	_	_
213	to	_	_	_	_	_	_	_	_
214	appreciably	_	_	_	_	_	_	_	_
215	bind	_	_	_	_	_	_	_	_
216	the	_	_	_	_	_	_	_	_
217	SARS	_	_	_	_	_	_	_	_
218	-	_	_	_	_	_	_	_	_
219	CoV-2	_	_	_	_	_	_	_	_
220	counterpart	_	_	_	_	_	_	_	_
221	.	_	_	_	_	_	_	_	_
222	Furthermore	_	_	_	_	_	_	_	BeginSeg=Yes
223	,	_	_	_	_	_	_	_	_
224	we	_	_	_	_	_	_	_	_
225	correctly	_	_	_	_	_	_	_	_
226	identify	_	_	_	_	_	_	_	_
227	the	_	_	_	_	_	_	_	_
228	region	_	_	_	_	_	_	_	_
229	of	_	_	_	_	_	_	_	_
230	SARS	_	_	_	_	_	_	_	_
231	-	_	_	_	_	_	_	_	_
232	CoV-2	_	_	_	_	_	_	_	_
233	RBD	_	_	_	_	_	_	_	_
234	that	_	_	_	_	_	_	_	BeginSeg=Yes
235	is	_	_	_	_	_	_	_	_
236	engaged	_	_	_	_	_	_	_	_
237	by	_	_	_	_	_	_	_	_
238	the	_	_	_	_	_	_	_	_
239	cell	_	_	_	_	_	_	_	_
240	receptor	_	_	_	_	_	_	_	_
241	ACE2	_	_	_	_	_	_	_	_
242	during	_	_	_	_	_	_	_	_
243	viral	_	_	_	_	_	_	_	_
244	entry	_	_	_	_	_	_	_	_
245	into	_	_	_	_	_	_	_	_
246	host	_	_	_	_	_	_	_	_
247	cells	_	_	_	_	_	_	_	_
248	.	_	_	_	_	_	_	_	_
249	The	_	_	_	_	_	_	_	BeginSeg=Yes
250	data	_	_	_	_	_	_	_	_
251	,	_	_	_	_	_	_	_	_
252	sequences	_	_	_	_	_	_	_	_
253	and	_	_	_	_	_	_	_	_
254	structures	_	_	_	_	_	_	_	_
255	we	_	_	_	_	_	_	_	BeginSeg=Yes
256	present	_	_	_	_	_	_	_	_
257	here	_	_	_	_	_	_	_	_
258	can	_	_	_	_	_	_	_	BeginSeg=Yes
259	be	_	_	_	_	_	_	_	_
260	useful	_	_	_	_	_	_	_	_
261	for	_	_	_	_	_	_	_	_
262	the	_	_	_	_	_	_	_	_
263	development	_	_	_	_	_	_	_	_
264	of	_	_	_	_	_	_	_	_
265	novel	_	_	_	_	_	_	_	_
266	therapeutic	_	_	_	_	_	_	_	_
267	and	_	_	_	_	_	_	_	_
268	diagnostic	_	_	_	_	_	_	_	_
269	interventions	_	_	_	_	_	_	_	_
270	.	_	_	_	_	_	_	_	_

# newdoc_id = 2f8012db8f2100bb1876e19722d6c131849e2315
1	Viruses	_	_	_	_	_	_	_	BeginSeg=Yes
2	have	_	_	_	_	_	_	_	_
3	evolved	_	_	_	_	_	_	_	_
4	elaborate	_	_	_	_	_	_	_	_
5	mechanisms	_	_	_	_	_	_	_	_
6	to	_	_	_	_	_	_	_	BeginSeg=Yes
7	evade	_	_	_	_	_	_	_	_
8	or	_	_	_	_	_	_	_	_
9	inactivate	_	_	_	_	_	_	_	_
10	the	_	_	_	_	_	_	_	_
11	complex	_	_	_	_	_	_	_	_
12	system	_	_	_	_	_	_	_	_
13	of	_	_	_	_	_	_	_	_
14	sensors	_	_	_	_	_	_	_	_
15	and	_	_	_	_	_	_	_	_
16	signaling	_	_	_	_	_	_	_	_
17	molecules	_	_	_	_	_	_	_	_
18	that	_	_	_	_	_	_	_	BeginSeg=Yes
19	make	_	_	_	_	_	_	_	_
20	up	_	_	_	_	_	_	_	_
21	the	_	_	_	_	_	_	_	_
22	host	_	_	_	_	_	_	_	_
23	innate	_	_	_	_	_	_	_	_
24	immune	_	_	_	_	_	_	_	_
25	response	_	_	_	_	_	_	_	_
26	.	_	_	_	_	_	_	_	_
27	Here	_	_	_	_	_	_	_	BeginSeg=Yes
28	we	_	_	_	_	_	_	_	_
29	show	_	_	_	_	_	_	_	_
30	that	_	_	_	_	_	_	_	BeginSeg=Yes
31	human	_	_	_	_	_	_	_	_
32	coronavirus	_	_	_	_	_	_	_	_
33	(	_	_	_	_	_	_	_	_
34	HCoV	_	_	_	_	_	_	_	_
35	)	_	_	_	_	_	_	_	_
36	NL63	_	_	_	_	_	_	_	_
37	and	_	_	_	_	_	_	_	_
38	severe	_	_	_	_	_	_	_	_
39	acute	_	_	_	_	_	_	_	_
40	respiratory	_	_	_	_	_	_	_	_
41	syndrome	_	_	_	_	_	_	_	_
42	(	_	_	_	_	_	_	_	_
43	SARS	_	_	_	_	_	_	_	_
44	)	_	_	_	_	_	_	_	_
45	CoV	_	_	_	_	_	_	_	_
46	papain	_	_	_	_	_	_	_	_
47	-	_	_	_	_	_	_	_	_
48	like	_	_	_	_	_	_	_	_
49	proteases	_	_	_	_	_	_	_	_
50	(	_	_	_	_	_	_	_	_
51	PLP	_	_	_	_	_	_	_	_
52	)	_	_	_	_	_	_	_	_
53	antagonize	_	_	_	_	_	_	_	_
54	innate	_	_	_	_	_	_	_	_
55	immune	_	_	_	_	_	_	_	_
56	signaling	_	_	_	_	_	_	_	_
57	mediated	_	_	_	_	_	_	_	BeginSeg=Yes
58	by	_	_	_	_	_	_	_	_
59	STING	_	_	_	_	_	_	_	_
60	(	_	_	_	_	_	_	_	BeginSeg=Yes
61	stimulator	_	_	_	_	_	_	_	_
62	of	_	_	_	_	_	_	_	_
63	interferon	_	_	_	_	_	_	_	_
64	genes	_	_	_	_	_	_	_	_
65	,	_	_	_	_	_	_	_	_
66	also	_	_	_	_	_	_	_	_
67	known	_	_	_	_	_	_	_	_
68	as	_	_	_	_	_	_	_	_
69	MITA	_	_	_	_	_	_	_	_
70	/	_	_	_	_	_	_	_	_
71	ERIS	_	_	_	_	_	_	_	_
72	/	_	_	_	_	_	_	_	_
73	MYPS	_	_	_	_	_	_	_	_
74	)	_	_	_	_	_	_	_	_
75	.	_	_	_	_	_	_	_	_
76	STING	_	_	_	_	_	_	_	BeginSeg=Yes
77	resides	_	_	_	_	_	_	_	_
78	in	_	_	_	_	_	_	_	_
79	the	_	_	_	_	_	_	_	_
80	endoplasmic	_	_	_	_	_	_	_	_
81	reticulum	_	_	_	_	_	_	_	_
82	and	_	_	_	_	_	_	_	BeginSeg=Yes
83	upon	_	_	_	_	_	_	_	_
84	activation	_	_	_	_	_	_	_	_
85	,	_	_	_	_	_	_	_	_
86	forms	_	_	_	_	_	_	_	_
87	dimers	_	_	_	_	_	_	_	_
88	which	_	_	_	_	_	_	_	BeginSeg=Yes
89	assemble	_	_	_	_	_	_	_	_
90	with	_	_	_	_	_	_	_	_
91	MAVS	_	_	_	_	_	_	_	_
92	,	_	_	_	_	_	_	_	_
93	TBK-1	_	_	_	_	_	_	_	_
94	and	_	_	_	_	_	_	_	_
95	IKKe	_	_	_	_	_	_	_	_
96	,	_	_	_	_	_	_	_	_
97	leading	_	_	_	_	_	_	_	BeginSeg=Yes
98	to	_	_	_	_	_	_	_	_
99	IRF-3	_	_	_	_	_	_	_	_
100	activation	_	_	_	_	_	_	_	_
101	and	_	_	_	_	_	_	_	_
102	subsequent	_	_	_	_	_	_	_	_
103	induction	_	_	_	_	_	_	_	_
104	of	_	_	_	_	_	_	_	_
105	interferon	_	_	_	_	_	_	_	_
106	(	_	_	_	_	_	_	_	_
107	IFN	_	_	_	_	_	_	_	_
108	)	_	_	_	_	_	_	_	_
109	.	_	_	_	_	_	_	_	_
110	We	_	_	_	_	_	_	_	BeginSeg=Yes
111	found	_	_	_	_	_	_	_	_
112	that	_	_	_	_	_	_	_	BeginSeg=Yes
113	expression	_	_	_	_	_	_	_	_
114	of	_	_	_	_	_	_	_	_
115	the	_	_	_	_	_	_	_	_
116	membrane	_	_	_	_	_	_	_	_
117	anchored	_	_	_	_	_	_	_	_
118	PLP	_	_	_	_	_	_	_	_
119	domain	_	_	_	_	_	_	_	_
120	from	_	_	_	_	_	_	_	_
121	human	_	_	_	_	_	_	_	_
122	HCoV	_	_	_	_	_	_	_	_
123	-	_	_	_	_	_	_	_	_
124	NL63	_	_	_	_	_	_	_	_
125	(	_	_	_	_	_	_	_	_
126	PLP2-TM	_	_	_	_	_	_	_	_
127	)	_	_	_	_	_	_	_	_
128	or	_	_	_	_	_	_	_	_
129	SARS	_	_	_	_	_	_	_	_
130	-	_	_	_	_	_	_	_	_
131	CoV	_	_	_	_	_	_	_	_
132	(	_	_	_	_	_	_	_	_
133	PLpro	_	_	_	_	_	_	_	_
134	-	_	_	_	_	_	_	_	_
135	TM	_	_	_	_	_	_	_	_
136	)	_	_	_	_	_	_	_	_
137	inhibits	_	_	_	_	_	_	_	_
138	STING	_	_	_	_	_	_	_	_
139	-	_	_	_	_	_	_	_	_
140	mediated	_	_	_	_	_	_	_	_
141	activation	_	_	_	_	_	_	_	_
142	of	_	_	_	_	_	_	_	_
143	IRF-3	_	_	_	_	_	_	_	_
144	nuclear	_	_	_	_	_	_	_	_
145	translocation	_	_	_	_	_	_	_	_
146	and	_	_	_	_	_	_	_	_
147	induction	_	_	_	_	_	_	_	_
148	of	_	_	_	_	_	_	_	_
149	IRF-3	_	_	_	_	_	_	_	_
150	dependent	_	_	_	_	_	_	_	_
151	promoters	_	_	_	_	_	_	_	_
152	.	_	_	_	_	_	_	_	_
153	Both	_	_	_	_	_	_	_	BeginSeg=Yes
154	catalytically	_	_	_	_	_	_	_	_
155	active	_	_	_	_	_	_	_	_
156	and	_	_	_	_	_	_	_	_
157	inactive	_	_	_	_	_	_	_	_
158	forms	_	_	_	_	_	_	_	_
159	of	_	_	_	_	_	_	_	_
160	CoV	_	_	_	_	_	_	_	_
161	PLPs	_	_	_	_	_	_	_	_
162	co	_	_	_	_	_	_	_	_
163	-	_	_	_	_	_	_	_	_
164	immunoprecipitated	_	_	_	_	_	_	_	_
165	with	_	_	_	_	_	_	_	_
166	STING	_	_	_	_	_	_	_	_
167	,	_	_	_	_	_	_	_	_
168	and	_	_	_	_	_	_	_	BeginSeg=Yes
169	viral	_	_	_	_	_	_	_	_
170	replicase	_	_	_	_	_	_	_	_
171	proteins	_	_	_	_	_	_	_	_
172	co	_	_	_	_	_	_	_	_
173	-	_	_	_	_	_	_	_	_
174	localize	_	_	_	_	_	_	_	_
175	with	_	_	_	_	_	_	_	_
176	STING	_	_	_	_	_	_	_	_
177	in	_	_	_	_	_	_	_	_
178	HCoV	_	_	_	_	_	_	_	_
179	-	_	_	_	_	_	_	_	_
180	NL63-infected	_	_	_	_	_	_	_	_
181	cells	_	_	_	_	_	_	_	_
182	.	_	_	_	_	_	_	_	_
183	Ectopic	_	_	_	_	_	_	_	BeginSeg=Yes
184	expression	_	_	_	_	_	_	_	_
185	of	_	_	_	_	_	_	_	_
186	catalytically	_	_	_	_	_	_	_	_
187	active	_	_	_	_	_	_	_	_
188	PLP2-TM	_	_	_	_	_	_	_	_
189	blocks	_	_	_	_	_	_	_	_
190	STING	_	_	_	_	_	_	_	_
191	dimer	_	_	_	_	_	_	_	_
192	formation	_	_	_	_	_	_	_	_
193	and	_	_	_	_	_	_	_	BeginSeg=Yes
194	negatively	_	_	_	_	_	_	_	_
195	regulates	_	_	_	_	_	_	_	_
196	assembly	_	_	_	_	_	_	_	_
197	of	_	_	_	_	_	_	_	_
198	STING	_	_	_	_	_	_	_	_
199	-	_	_	_	_	_	_	_	_
200	MAVS	_	_	_	_	_	_	_	_
201	-	_	_	_	_	_	_	_	_
202	TBK1	_	_	_	_	_	_	_	_
203	/	_	_	_	_	_	_	_	_
204	IKKe	_	_	_	_	_	_	_	_
205	complexes	_	_	_	_	_	_	_	_
206	required	_	_	_	_	_	_	_	BeginSeg=Yes
207	for	_	_	_	_	_	_	_	_
208	activation	_	_	_	_	_	_	_	_
209	of	_	_	_	_	_	_	_	_
210	IRF-3	_	_	_	_	_	_	_	_
211	.	_	_	_	_	_	_	_	_
212	STING	_	_	_	_	_	_	_	BeginSeg=Yes
213	dimerization	_	_	_	_	_	_	_	_
214	was	_	_	_	_	_	_	_	_
215	also	_	_	_	_	_	_	_	_
216	substantially	_	_	_	_	_	_	_	_
217	reduced	_	_	_	_	_	_	_	_
218	in	_	_	_	_	_	_	_	_
219	cells	_	_	_	_	_	_	_	_
220	infected	_	_	_	_	_	_	_	BeginSeg=Yes
221	with	_	_	_	_	_	_	_	_
222	SARS	_	_	_	_	_	_	_	_
223	-	_	_	_	_	_	_	_	_
224	CoV.	_	_	_	_	_	_	_	_
225	Furthermore	_	_	_	_	_	_	_	BeginSeg=Yes
226	,	_	_	_	_	_	_	_	_
227	the	_	_	_	_	_	_	_	_
228	level	_	_	_	_	_	_	_	_
229	of	_	_	_	_	_	_	_	_
230	ubiquitinated	_	_	_	_	_	_	_	_
231	forms	_	_	_	_	_	_	_	_
232	of	_	_	_	_	_	_	_	_
233	STING	_	_	_	_	_	_	_	_
234	,	_	_	_	_	_	_	_	_
235	RIG	_	_	_	_	_	_	_	_
236	-	_	_	_	_	_	_	_	_
237	I	_	_	_	_	_	_	_	_
238	,	_	_	_	_	_	_	_	_
239	TBK1	_	_	_	_	_	_	_	_
240	and	_	_	_	_	_	_	_	_
241	IRF-3	_	_	_	_	_	_	_	_
242	are	_	_	_	_	_	_	_	_
243	reduced	_	_	_	_	_	_	_	_
244	in	_	_	_	_	_	_	_	_
245	cells	_	_	_	_	_	_	_	_
246	expressing	_	_	_	_	_	_	_	BeginSeg=Yes
247	wild	_	_	_	_	_	_	_	_
248	type	_	_	_	_	_	_	_	_
249	or	_	_	_	_	_	_	_	_
250	catalytic	_	_	_	_	_	_	_	_
251	mutants	_	_	_	_	_	_	_	_
252	of	_	_	_	_	_	_	_	_
253	PLP2-TM	_	_	_	_	_	_	_	_
254	,	_	_	_	_	_	_	_	_
255	likely	_	_	_	_	_	_	_	BeginSeg=Yes
256	contributing	_	_	_	_	_	_	_	_
257	to	_	_	_	_	_	_	_	_
258	disruption	_	_	_	_	_	_	_	_
259	of	_	_	_	_	_	_	_	_
260	signaling	_	_	_	_	_	_	_	_
261	required	_	_	_	_	_	_	_	BeginSeg=Yes
262	for	_	_	_	_	_	_	_	_
263	IFN	_	_	_	_	_	_	_	_
264	induction	_	_	_	_	_	_	_	_
265	.	_	_	_	_	_	_	_	_
266	These	_	_	_	_	_	_	_	BeginSeg=Yes
267	results	_	_	_	_	_	_	_	_
268	describe	_	_	_	_	_	_	_	_
269	a	_	_	_	_	_	_	_	_
270	new	_	_	_	_	_	_	_	_
271	mechanism	_	_	_	_	_	_	_	_
272	used	_	_	_	_	_	_	_	BeginSeg=Yes
273	by	_	_	_	_	_	_	_	_
274	CoVs	_	_	_	_	_	_	_	_
275	in	_	_	_	_	_	_	_	BeginSeg=Yes
276	which	_	_	_	_	_	_	_	_
277	CoV	_	_	_	_	_	_	_	_
278	PLPs	_	_	_	_	_	_	_	_
279	negatively	_	_	_	_	_	_	_	_
280	regulate	_	_	_	_	_	_	_	_
281	antiviral	_	_	_	_	_	_	_	_
282	defenses	_	_	_	_	_	_	_	_
283	by	_	_	_	_	_	_	_	BeginSeg=Yes
284	disrupting	_	_	_	_	_	_	_	_
285	the	_	_	_	_	_	_	_	_
286	STING	_	_	_	_	_	_	_	_
287	-	_	_	_	_	_	_	_	_
288	mediated	_	_	_	_	_	_	_	_
289	IFN	_	_	_	_	_	_	_	_
290	induction	_	_	_	_	_	_	_	_
291	.	_	_	_	_	_	_	_	_

# newdoc_id = 31fae2807695521804442fedcd3f7b9f17d0f9ea
1	BACKGROUND	_	_	_	_	_	_	_	BeginSeg=Yes
2	:	_	_	_	_	_	_	_	_
3	Evaluation	_	_	_	_	_	_	_	BeginSeg=Yes
4	of	_	_	_	_	_	_	_	_
5	interindividual	_	_	_	_	_	_	_	_
6	variability	_	_	_	_	_	_	_	_
7	is	_	_	_	_	_	_	_	_
8	a	_	_	_	_	_	_	_	_
9	challenging	_	_	_	_	_	_	_	_
10	step	_	_	_	_	_	_	_	_
11	in	_	_	_	_	_	_	_	_
12	risk	_	_	_	_	_	_	_	_
13	assessment	_	_	_	_	_	_	_	_
14	.	_	_	_	_	_	_	_	_
15	For	_	_	_	_	_	_	_	BeginSeg=Yes
16	most	_	_	_	_	_	_	_	_
17	environmental	_	_	_	_	_	_	_	_
18	pollutants	_	_	_	_	_	_	_	_
19	,	_	_	_	_	_	_	_	_
20	including	_	_	_	_	_	_	_	BeginSeg=Yes
21	perchloroethylene	_	_	_	_	_	_	_	_
22	(	_	_	_	_	_	_	_	_
23	PERC	_	_	_	_	_	_	_	_
24	)	_	_	_	_	_	_	_	_
25	,	_	_	_	_	_	_	_	_
26	experimental	_	_	_	_	_	_	_	BeginSeg=Yes
27	data	_	_	_	_	_	_	_	_
28	are	_	_	_	_	_	_	_	_
29	lacking	_	_	_	_	_	_	_	_
30	,	_	_	_	_	_	_	_	_
31	resulting	_	_	_	_	_	_	_	BeginSeg=Yes
32	in	_	_	_	_	_	_	_	_
33	default	_	_	_	_	_	_	_	_
34	assumptions	_	_	_	_	_	_	_	_
35	being	_	_	_	_	_	_	_	BeginSeg=Yes
36	used	_	_	_	_	_	_	_	_
37	to	_	_	_	_	_	_	_	BeginSeg=Yes
38	account	_	_	_	_	_	_	_	_
39	for	_	_	_	_	_	_	_	_
40	variability	_	_	_	_	_	_	_	_
41	in	_	_	_	_	_	_	_	_
42	toxicokinetics	_	_	_	_	_	_	_	_
43	and	_	_	_	_	_	_	_	_
44	toxicodynamics	_	_	_	_	_	_	_	_
45	.	_	_	_	_	_	_	_	_
46	OBJECTIVE	_	_	_	_	_	_	_	BeginSeg=Yes
47	:	_	_	_	_	_	_	_	_
48	We	_	_	_	_	_	_	_	BeginSeg=Yes
49	quantitatively	_	_	_	_	_	_	_	_
50	examined	_	_	_	_	_	_	_	_
51	the	_	_	_	_	_	_	_	_
52	relationship	_	_	_	_	_	_	_	_
53	between	_	_	_	_	_	_	_	_
54	PERC	_	_	_	_	_	_	_	_
55	toxicokinetics	_	_	_	_	_	_	_	_
56	and	_	_	_	_	_	_	_	_
57	toxicodynamics	_	_	_	_	_	_	_	_
58	at	_	_	_	_	_	_	_	_
59	the	_	_	_	_	_	_	_	_
60	population	_	_	_	_	_	_	_	_
61	level	_	_	_	_	_	_	_	_
62	to	_	_	_	_	_	_	_	BeginSeg=Yes
63	test	_	_	_	_	_	_	_	_
64	whether	_	_	_	_	_	_	_	_
65	individuals	_	_	_	_	_	_	_	_
66	with	_	_	_	_	_	_	_	_
67	increased	_	_	_	_	_	_	_	_
68	oxidative	_	_	_	_	_	_	_	_
69	metabolism	_	_	_	_	_	_	_	_
70	are	_	_	_	_	_	_	_	_
71	be	_	_	_	_	_	_	_	_
72	more	_	_	_	_	_	_	_	_
73	sensitive	_	_	_	_	_	_	_	_
74	to	_	_	_	_	_	_	_	_
75	hepatotoxicity	_	_	_	_	_	_	_	_
76	following	_	_	_	_	_	_	_	BeginSeg=Yes
77	PERC	_	_	_	_	_	_	_	_
78	exposure	_	_	_	_	_	_	_	_
79	.	_	_	_	_	_	_	_	_
80	METHODS	_	_	_	_	_	_	_	BeginSeg=Yes
81	:	_	_	_	_	_	_	_	_
82	Male	_	_	_	_	_	_	_	BeginSeg=Yes
83	mice	_	_	_	_	_	_	_	_
84	from	_	_	_	_	_	_	_	_
85	45	_	_	_	_	_	_	_	_
86	strains	_	_	_	_	_	_	_	_
87	of	_	_	_	_	_	_	_	_
88	the	_	_	_	_	_	_	_	_
89	Collaborative	_	_	_	_	_	_	_	_
90	Cross	_	_	_	_	_	_	_	_
91	(	_	_	_	_	_	_	_	_
92	CC	_	_	_	_	_	_	_	_
93	)	_	_	_	_	_	_	_	_
94	were	_	_	_	_	_	_	_	_
95	orally	_	_	_	_	_	_	_	_
96	administered	_	_	_	_	_	_	_	_
97	a	_	_	_	_	_	_	_	_
98	single	_	_	_	_	_	_	_	_
99	dose	_	_	_	_	_	_	_	_
100	of	_	_	_	_	_	_	_	_
101	PERC	_	_	_	_	_	_	_	_
102	(	_	_	_	_	_	_	_	BeginSeg=Yes
103	1,000	_	_	_	_	_	_	_	_
104	mg	_	_	_	_	_	_	_	_
105	/	_	_	_	_	_	_	_	_
106	kg	_	_	_	_	_	_	_	_
107	)	_	_	_	_	_	_	_	_
108	or	_	_	_	_	_	_	_	BeginSeg=Yes
109	vehicle	_	_	_	_	_	_	_	_
110	(	_	_	_	_	_	_	_	BeginSeg=Yes
111	Alkamuls	_	_	_	_	_	_	_	_
112	-	_	_	_	_	_	_	_	_
113	EL620	_	_	_	_	_	_	_	_
114	)	_	_	_	_	_	_	_	_
115	and	_	_	_	_	_	_	_	BeginSeg=Yes
116	euthanized	_	_	_	_	_	_	_	_
117	at	_	_	_	_	_	_	_	_
118	various	_	_	_	_	_	_	_	_
119	time	_	_	_	_	_	_	_	_
120	points	_	_	_	_	_	_	_	_
121	(	_	_	_	_	_	_	_	BeginSeg=Yes
122	n	_	_	_	_	_	_	_	_
123	=	_	_	_	_	_	_	_	_
124	1	_	_	_	_	_	_	_	_
125	=	_	_	_	_	_	_	_	_
126	strain	_	_	_	_	_	_	_	_
127	=	_	_	_	_	_	_	_	_
128	time	_	_	_	_	_	_	_	_
129	)	_	_	_	_	_	_	_	_
130	.	_	_	_	_	_	_	_	_
131	Concentration	_	_	_	_	_	_	_	BeginSeg=Yes
132	-	_	_	_	_	_	_	_	_
133	time	_	_	_	_	_	_	_	_
134	profiles	_	_	_	_	_	_	_	_
135	were	_	_	_	_	_	_	_	_
136	generated	_	_	_	_	_	_	_	_
137	for	_	_	_	_	_	_	_	_
138	PERC	_	_	_	_	_	_	_	_
139	and	_	_	_	_	_	_	_	_
140	its	_	_	_	_	_	_	_	_
141	primary	_	_	_	_	_	_	_	_
142	oxidative	_	_	_	_	_	_	_	_
143	metabolite	_	_	_	_	_	_	_	_
144	trichloroacetate	_	_	_	_	_	_	_	_
145	(	_	_	_	_	_	_	_	_
146	TCA	_	_	_	_	_	_	_	_
147	)	_	_	_	_	_	_	_	_
148	in	_	_	_	_	_	_	_	_
149	multiple	_	_	_	_	_	_	_	_
150	tissues	_	_	_	_	_	_	_	_
151	.	_	_	_	_	_	_	_	_
152	Toxicodynamic	_	_	_	_	_	_	_	BeginSeg=Yes
153	phenotyping	_	_	_	_	_	_	_	_
154	was	_	_	_	_	_	_	_	_
155	also	_	_	_	_	_	_	_	_
156	performed	_	_	_	_	_	_	_	_
157	.	_	_	_	_	_	_	_	_
158	RESULTS	_	_	_	_	_	_	_	BeginSeg=Yes
159	:	_	_	_	_	_	_	_	_
160	Significant	_	_	_	_	_	_	_	BeginSeg=Yes
161	variability	_	_	_	_	_	_	_	_
162	among	_	_	_	_	_	_	_	_
163	strains	_	_	_	_	_	_	_	_
164	was	_	_	_	_	_	_	_	_
165	observed	_	_	_	_	_	_	_	_
166	in	_	_	_	_	_	_	_	_
167	toxicokinetics	_	_	_	_	_	_	_	_
168	of	_	_	_	_	_	_	_	_
169	PERC	_	_	_	_	_	_	_	_
170	and	_	_	_	_	_	_	_	_
171	TCA	_	_	_	_	_	_	_	_
172	in	_	_	_	_	_	_	_	_
173	every	_	_	_	_	_	_	_	_
174	tissue	_	_	_	_	_	_	_	_
175	examined	_	_	_	_	_	_	_	_
176	.	_	_	_	_	_	_	_	_
177	Based	_	_	_	_	_	_	_	BeginSeg=Yes
178	on	_	_	_	_	_	_	_	_
179	area	_	_	_	_	_	_	_	_
180	under	_	_	_	_	_	_	_	_
181	the	_	_	_	_	_	_	_	_
182	curve	_	_	_	_	_	_	_	_
183	(	_	_	_	_	_	_	_	_
184	AUC	_	_	_	_	_	_	_	_
185	)	_	_	_	_	_	_	_	_
186	,	_	_	_	_	_	_	_	_
187	the	_	_	_	_	_	_	_	BeginSeg=Yes
188	range	_	_	_	_	_	_	_	_
189	of	_	_	_	_	_	_	_	_
190	liver	_	_	_	_	_	_	_	_
191	TCA	_	_	_	_	_	_	_	_
192	levels	_	_	_	_	_	_	_	_
193	spanned	_	_	_	_	_	_	_	_
194	nearly	_	_	_	_	_	_	_	_
195	an	_	_	_	_	_	_	_	_
196	order	_	_	_	_	_	_	_	_
197	of	_	_	_	_	_	_	_	_
198	magnitude	_	_	_	_	_	_	_	_
199	(	_	_	_	_	_	_	_	BeginSeg=Yes
200	∼	_	_	_	_	_	_	_	_
201	8-fold	_	_	_	_	_	_	_	_
202	)	_	_	_	_	_	_	_	_
203	.	_	_	_	_	_	_	_	_
204	Expression	_	_	_	_	_	_	_	BeginSeg=Yes
205	of	_	_	_	_	_	_	_	_
206	liver	_	_	_	_	_	_	_	_
207	cytochrome	_	_	_	_	_	_	_	_
208	P4502E1	_	_	_	_	_	_	_	_
209	did	_	_	_	_	_	_	_	_
210	not	_	_	_	_	_	_	_	_
211	correlate	_	_	_	_	_	_	_	_
212	with	_	_	_	_	_	_	_	_
213	TCA	_	_	_	_	_	_	_	_
214	levels	_	_	_	_	_	_	_	_
215	.	_	_	_	_	_	_	_	_
216	Toxicodynamic	_	_	_	_	_	_	_	BeginSeg=Yes
217	phenotyping	_	_	_	_	_	_	_	_
218	revealed	_	_	_	_	_	_	_	_
219	an	_	_	_	_	_	_	_	_
220	effect	_	_	_	_	_	_	_	_
221	of	_	_	_	_	_	_	_	_
222	PERC	_	_	_	_	_	_	_	_
223	on	_	_	_	_	_	_	_	_
224	bodyweight	_	_	_	_	_	_	_	_
225	loss	_	_	_	_	_	_	_	_
226	,	_	_	_	_	_	_	_	_
227	induction	_	_	_	_	_	_	_	_
228	of	_	_	_	_	_	_	_	_
229	peroxisome	_	_	_	_	_	_	_	_
230	proliferator	_	_	_	_	_	_	_	_
231	activated	_	_	_	_	_	_	_	_
232	receptor	_	_	_	_	_	_	_	_
233	-	_	_	_	_	_	_	_	_
234	alpha	_	_	_	_	_	_	_	_
235	(	_	_	_	_	_	_	_	_
236	PPARa)-regulated	_	_	_	_	_	_	_	_
237	genes	_	_	_	_	_	_	_	_
238	,	_	_	_	_	_	_	_	_
239	and	_	_	_	_	_	_	_	_
240	dysregulation	_	_	_	_	_	_	_	_
241	of	_	_	_	_	_	_	_	_
242	hepatic	_	_	_	_	_	_	_	_
243	lipid	_	_	_	_	_	_	_	_
244	homeostasis	_	_	_	_	_	_	_	_
245	.	_	_	_	_	_	_	_	_
246	Clustering	_	_	_	_	_	_	_	BeginSeg=Yes
247	was	_	_	_	_	_	_	_	_
248	observed	_	_	_	_	_	_	_	_
249	among	_	_	_	_	_	_	_	_
250	a	_	_	_	_	_	_	_	_
251	)	_	_	_	_	_	_	_	_
252	liver	_	_	_	_	_	_	_	_
253	levels	_	_	_	_	_	_	_	_
254	of	_	_	_	_	_	_	_	_
255	PERC	_	_	_	_	_	_	_	_
256	,	_	_	_	_	_	_	_	_
257	TCA	_	_	_	_	_	_	_	_
258	,	_	_	_	_	_	_	_	_
259	and	_	_	_	_	_	_	_	_
260	triglycerides	_	_	_	_	_	_	_	_
261	;	_	_	_	_	_	_	_	_
262	b	_	_	_	_	_	_	_	_
263	)	_	_	_	_	_	_	_	_
264	TCA	_	_	_	_	_	_	_	_
265	levels	_	_	_	_	_	_	_	_
266	in	_	_	_	_	_	_	_	_
267	liver	_	_	_	_	_	_	_	_
268	and	_	_	_	_	_	_	_	_
269	kidney	_	_	_	_	_	_	_	_
270	;	_	_	_	_	_	_	_	_
271	and	_	_	_	_	_	_	_	_
272	c	_	_	_	_	_	_	_	_
273	)	_	_	_	_	_	_	_	_
274	TCA	_	_	_	_	_	_	_	_
275	levels	_	_	_	_	_	_	_	_
276	in	_	_	_	_	_	_	_	_
277	serum	_	_	_	_	_	_	_	_
278	,	_	_	_	_	_	_	_	_
279	brain	_	_	_	_	_	_	_	_
280	,	_	_	_	_	_	_	_	_
281	fat	_	_	_	_	_	_	_	_
282	,	_	_	_	_	_	_	_	_
283	and	_	_	_	_	_	_	_	_
284	lung	_	_	_	_	_	_	_	_
285	.	_	_	_	_	_	_	_	_
286	CONCLUSIONS	_	_	_	_	_	_	_	BeginSeg=Yes
287	:	_	_	_	_	_	_	_	_
288	Using	_	_	_	_	_	_	_	BeginSeg=Yes
289	the	_	_	_	_	_	_	_	_
290	CC	_	_	_	_	_	_	_	_
291	mouse	_	_	_	_	_	_	_	_
292	population	_	_	_	_	_	_	_	_
293	model	_	_	_	_	_	_	_	_
294	,	_	_	_	_	_	_	_	_
295	we	_	_	_	_	_	_	_	BeginSeg=Yes
296	have	_	_	_	_	_	_	_	_
297	demonstrated	_	_	_	_	_	_	_	_
298	a	_	_	_	_	_	_	_	_
299	complex	_	_	_	_	_	_	_	_
300	and	_	_	_	_	_	_	_	_
301	highly	_	_	_	_	_	_	_	_
302	variable	_	_	_	_	_	_	_	_
303	relationship	_	_	_	_	_	_	_	_
304	between	_	_	_	_	_	_	_	_
305	PERC	_	_	_	_	_	_	_	_
306	and	_	_	_	_	_	_	_	_
307	TCA	_	_	_	_	_	_	_	_
308	toxicokinetics	_	_	_	_	_	_	_	_
309	and	_	_	_	_	_	_	_	_
310	toxicodynamics	_	_	_	_	_	_	_	_
311	at	_	_	_	_	_	_	_	_
312	the	_	_	_	_	_	_	_	_
313	population	_	_	_	_	_	_	_	_
314	level	_	_	_	_	_	_	_	_
315	.	_	_	_	_	_	_	_	_
316	https://doi	_	_	_	_	_	_	_	BeginSeg=Yes
317	.	_	_	_	_	_	_	_	_

# newdoc_id = 338d45deb88de8cc7f4cf5158c4752fb3533a0b7
1	A	_	_	_	_	_	_	_	BeginSeg=Yes
2	Resequencing	_	_	_	_	_	_	_	_
3	Pathogen	_	_	_	_	_	_	_	_
4	Microarray	_	_	_	_	_	_	_	_
5	(	_	_	_	_	_	_	_	_
6	RPM	_	_	_	_	_	_	_	_
7	)	_	_	_	_	_	_	_	_
8	is	_	_	_	_	_	_	_	_
9	a	_	_	_	_	_	_	_	_
10	single	_	_	_	_	_	_	_	_
11	,	_	_	_	_	_	_	_	_
12	highly	_	_	_	_	_	_	_	_
13	multiplexed	_	_	_	_	_	_	_	_
14	assay	_	_	_	_	_	_	_	_
15	for	_	_	_	_	_	_	_	BeginSeg=Yes
16	detecting	_	_	_	_	_	_	_	_
17	and	_	_	_	_	_	_	_	_
18	differentiating	_	_	_	_	_	_	_	_
19	similarly	_	_	_	_	_	_	_	_
20	related	_	_	_	_	_	_	_	_
21	pathogens	_	_	_	_	_	_	_	_
22	by	_	_	_	_	_	_	_	BeginSeg=Yes
23	using	_	_	_	_	_	_	_	_
24	closely	_	_	_	_	_	_	_	_
25	overlapping	_	_	_	_	_	_	_	_
26	probe	_	_	_	_	_	_	_	_
27	sets	_	_	_	_	_	_	_	_
28	to	_	_	_	_	_	_	_	BeginSeg=Yes
29	determine	_	_	_	_	_	_	_	_
30	a	_	_	_	_	_	_	_	_
31	target	_	_	_	_	_	_	_	_
32-33	organism's	_	_	_	_	_	_	_	_
32	organism	_	_	_	_	_	_	_	_
33	's	_	_	_	_	_	_	_	_
34	nucleotide	_	_	_	_	_	_	_	_
35	sequence	_	_	_	_	_	_	_	_
36	.	_	_	_	_	_	_	_	_
37	In	_	_	_	_	_	_	_	BeginSeg=Yes
38	this	_	_	_	_	_	_	_	_
39	study	_	_	_	_	_	_	_	_
40	,	_	_	_	_	_	_	_	_
41	a	_	_	_	_	_	_	_	_
42	new	_	_	_	_	_	_	_	_
43	RPM	_	_	_	_	_	_	_	_
44	(	_	_	_	_	_	_	_	_
45	RPM	_	_	_	_	_	_	_	_
46	-	_	_	_	_	_	_	_	_
47	IVDC1	_	_	_	_	_	_	_	_
48	)	_	_	_	_	_	_	_	_
49	that	_	_	_	_	_	_	_	BeginSeg=Yes
50	consisted	_	_	_	_	_	_	_	_
51	of	_	_	_	_	_	_	_	_
52	224-bp	_	_	_	_	_	_	_	_
53	detector	_	_	_	_	_	_	_	_
54	tiles	_	_	_	_	_	_	_	_
55	corresponding	_	_	_	_	_	_	_	BeginSeg=Yes
56	to	_	_	_	_	_	_	_	_
57	9	_	_	_	_	_	_	_	_
58	influenza	_	_	_	_	_	_	_	_
59	A	_	_	_	_	_	_	_	_
60	subtypes	_	_	_	_	_	_	_	_
61	,	_	_	_	_	_	_	_	_
62	11	_	_	_	_	_	_	_	_
63	rhinoviruses	_	_	_	_	_	_	_	_
64	,	_	_	_	_	_	_	_	_
65	28	_	_	_	_	_	_	_	_
66	enteroviruses	_	_	_	_	_	_	_	_
67	and	_	_	_	_	_	_	_	_
68	38	_	_	_	_	_	_	_	_
69	other	_	_	_	_	_	_	_	_
70	respiratory	_	_	_	_	_	_	_	_
71	viruses	_	_	_	_	_	_	_	_
72	was	_	_	_	_	_	_	_	BeginSeg=Yes
73	developed	_	_	_	_	_	_	_	_
74	and	_	_	_	_	_	_	_	_
75	optimized	_	_	_	_	_	_	_	_
76	to	_	_	_	_	_	_	_	BeginSeg=Yes
77	provide	_	_	_	_	_	_	_	_
78	individual	_	_	_	_	_	_	_	_
79	and	_	_	_	_	_	_	_	_
80	simultaneous	_	_	_	_	_	_	_	_
81	detection	_	_	_	_	_	_	_	_
82	sensitivities	_	_	_	_	_	_	_	_
83	ranging	_	_	_	_	_	_	_	BeginSeg=Yes
84	from	_	_	_	_	_	_	_	_
85	15	_	_	_	_	_	_	_	_
86	to	_	_	_	_	_	_	_	_
87	750	_	_	_	_	_	_	_	_
88	genomic	_	_	_	_	_	_	_	_
89	copies	_	_	_	_	_	_	_	_
90	for	_	_	_	_	_	_	_	_
91	16	_	_	_	_	_	_	_	_
92	common	_	_	_	_	_	_	_	_
93	respiratory	_	_	_	_	_	_	_	_
94	pathogens	_	_	_	_	_	_	_	_
95	.	_	_	_	_	_	_	_	_
96	A	_	_	_	_	_	_	_	BeginSeg=Yes
97	total	_	_	_	_	_	_	_	_
98	of	_	_	_	_	_	_	_	_
99	110	_	_	_	_	_	_	_	_
100	consecutive	_	_	_	_	_	_	_	_
101	patients	_	_	_	_	_	_	_	_
102	with	_	_	_	_	_	_	_	_
103	community	_	_	_	_	_	_	_	_
104	-	_	_	_	_	_	_	_	_
105	acquired	_	_	_	_	_	_	_	_
106	pneumonia	_	_	_	_	_	_	_	_
107	(	_	_	_	_	_	_	_	_
108	CAP	_	_	_	_	_	_	_	_
109	)	_	_	_	_	_	_	_	_
110	admitted	_	_	_	_	_	_	_	BeginSeg=Yes
111	to	_	_	_	_	_	_	_	_
112	5	_	_	_	_	_	_	_	_
113	district	_	_	_	_	_	_	_	_
114	general	_	_	_	_	_	_	_	_
115	hospitals	_	_	_	_	_	_	_	_
116	in	_	_	_	_	_	_	_	_
117	Beijing	_	_	_	_	_	_	_	_
118	during	_	_	_	_	_	_	_	_
119	a	_	_	_	_	_	_	_	_
120	1-year	_	_	_	_	_	_	_	_
121	period	_	_	_	_	_	_	_	_
122	were	_	_	_	_	_	_	_	BeginSeg=Yes
123	assessed	_	_	_	_	_	_	_	_
124	using	_	_	_	_	_	_	_	_
125	the	_	_	_	_	_	_	_	_
126	new	_	_	_	_	_	_	_	_
127	assay	_	_	_	_	_	_	_	_
128	.	_	_	_	_	_	_	_	_
129	Among	_	_	_	_	_	_	_	BeginSeg=Yes
130	the	_	_	_	_	_	_	_	_
131	children	_	_	_	_	_	_	_	_
132	(	_	_	_	_	_	_	_	_
133	under	_	_	_	_	_	_	_	_
134	age	_	_	_	_	_	_	_	_
135	5	_	_	_	_	_	_	_	_
136	)	_	_	_	_	_	_	_	_
137	and	_	_	_	_	_	_	_	_
138	adult	_	_	_	_	_	_	_	_
139	patients	_	_	_	_	_	_	_	_
140	(	_	_	_	_	_	_	_	_
141	above	_	_	_	_	_	_	_	_
142	age	_	_	_	_	_	_	_	_
143	18	_	_	_	_	_	_	_	_
144	)	_	_	_	_	_	_	_	_
145	,	_	_	_	_	_	_	_	_
146	respiratory	_	_	_	_	_	_	_	_
147	syncytial	_	_	_	_	_	_	_	_
148	virus	_	_	_	_	_	_	_	_
149	(	_	_	_	_	_	_	_	_
150	RSV	_	_	_	_	_	_	_	_
151	)	_	_	_	_	_	_	_	_
152	and	_	_	_	_	_	_	_	_
153	rhinovirus	_	_	_	_	_	_	_	_
154	(	_	_	_	_	_	_	_	_
155	RV	_	_	_	_	_	_	_	_
156	)	_	_	_	_	_	_	_	_
157	were	_	_	_	_	_	_	_	_
158	the	_	_	_	_	_	_	_	_
159	most	_	_	_	_	_	_	_	_
160	common	_	_	_	_	_	_	_	_
161	etiological	_	_	_	_	_	_	_	_
162	agents	_	_	_	_	_	_	_	_
163	,	_	_	_	_	_	_	_	_
164	respectively	_	_	_	_	_	_	_	_
165	,	_	_	_	_	_	_	_	_
166	which	_	_	_	_	_	_	_	BeginSeg=Yes
167	is	_	_	_	_	_	_	_	_
168	consistent	_	_	_	_	_	_	_	_
169	with	_	_	_	_	_	_	_	_
170	reference	_	_	_	_	_	_	_	_
171	assays	_	_	_	_	_	_	_	_
172	.	_	_	_	_	_	_	_	_
173	Atypical	_	_	_	_	_	_	_	BeginSeg=Yes
174	pathogens	_	_	_	_	_	_	_	_
175	that	_	_	_	_	_	_	_	BeginSeg=Yes
176	may	_	_	_	_	_	_	_	_
177	cause	_	_	_	_	_	_	_	_
178	CAP	_	_	_	_	_	_	_	_
179	-	_	_	_	_	_	_	_	_
180	like	_	_	_	_	_	_	_	_
181	illness	_	_	_	_	_	_	_	_
182	,	_	_	_	_	_	_	_	_
183	including	_	_	_	_	_	_	_	BeginSeg=Yes
184	rubella	_	_	_	_	_	_	_	_
185	virus	_	_	_	_	_	_	_	_
186	,	_	_	_	_	_	_	_	_
187	measles	_	_	_	_	_	_	_	_
188	virus	_	_	_	_	_	_	_	_
189	,	_	_	_	_	_	_	_	_
190	influenza	_	_	_	_	_	_	_	_
191	type	_	_	_	_	_	_	_	_
192	C	_	_	_	_	_	_	_	_
193	virus	_	_	_	_	_	_	_	_
194	,	_	_	_	_	_	_	_	_
195	human	_	_	_	_	_	_	_	_
196	herpesvirus	_	_	_	_	_	_	_	_
197	(	_	_	_	_	_	_	_	_
198	HHV	_	_	_	_	_	_	_	_
199	)	_	_	_	_	_	_	_	_
200	were	_	_	_	_	_	_	_	BeginSeg=Yes
201	also	_	_	_	_	_	_	_	_
202	detected	_	_	_	_	_	_	_	_
203	.	_	_	_	_	_	_	_	_
204	The	_	_	_	_	_	_	_	BeginSeg=Yes
205	results	_	_	_	_	_	_	_	_
206	show	_	_	_	_	_	_	_	_
207	the	_	_	_	_	_	_	_	_
208	capability	_	_	_	_	_	_	_	_
209	of	_	_	_	_	_	_	_	_
210	RPM	_	_	_	_	_	_	_	_
211	-	_	_	_	_	_	_	_	_
212	IVDC1	_	_	_	_	_	_	_	_
213	for	_	_	_	_	_	_	_	_
214	the	_	_	_	_	_	_	_	_
215	accurate	_	_	_	_	_	_	_	_
216	detection	_	_	_	_	_	_	_	_
217	and	_	_	_	_	_	_	_	_
218	identification	_	_	_	_	_	_	_	_
219	of	_	_	_	_	_	_	_	_
220	multiple	_	_	_	_	_	_	_	_
221	virus	_	_	_	_	_	_	_	_
222	types	_	_	_	_	_	_	_	_
223	,	_	_	_	_	_	_	_	_
224	which	_	_	_	_	_	_	_	BeginSeg=Yes
225	may	_	_	_	_	_	_	_	_
226	be	_	_	_	_	_	_	_	_
227	of	_	_	_	_	_	_	_	_
228	significant	_	_	_	_	_	_	_	_
229	use	_	_	_	_	_	_	_	_
230	in	_	_	_	_	_	_	_	_
231	epidemic	_	_	_	_	_	_	_	_
232	surveillance	_	_	_	_	_	_	_	_
233	and	_	_	_	_	_	_	_	_
234	outbreak	_	_	_	_	_	_	_	_
235	investigations	_	_	_	_	_	_	_	_
236	of	_	_	_	_	_	_	_	_
237	atypical	_	_	_	_	_	_	_	_
238	pathogens	_	_	_	_	_	_	_	_
239	.	_	_	_	_	_	_	_	_

# newdoc_id = 34694791cd158e785ad16404d5d34ad8559792c0
1	Recently	_	_	_	_	_	_	_	BeginSeg=Yes
2	a	_	_	_	_	_	_	_	_
3	number	_	_	_	_	_	_	_	_
4	of	_	_	_	_	_	_	_	_
5	publications	_	_	_	_	_	_	_	_
6	looked	_	_	_	_	_	_	_	_
7	at	_	_	_	_	_	_	_	_
8	the	_	_	_	_	_	_	_	_
9	association	_	_	_	_	_	_	_	_
10	between	_	_	_	_	_	_	_	_
11	COVID-19	_	_	_	_	_	_	_	_
12	morbidity	_	_	_	_	_	_	_	_
13	and	_	_	_	_	_	_	_	_
14	mortality	_	_	_	_	_	_	_	_
15	on	_	_	_	_	_	_	_	_
16	one	_	_	_	_	_	_	_	_
17	hand	_	_	_	_	_	_	_	_
18	and	_	_	_	_	_	_	_	_
19-20	countries'	_	_	_	_	_	_	_	_
19	countries	_	_	_	_	_	_	_	_
20	'	_	_	_	_	_	_	_	_
21	policies	_	_	_	_	_	_	_	_
22	with	_	_	_	_	_	_	_	_
23	respect	_	_	_	_	_	_	_	_
24	to	_	_	_	_	_	_	_	_
25	BCG	_	_	_	_	_	_	_	_
26	vaccination	_	_	_	_	_	_	_	_
27	on	_	_	_	_	_	_	_	_
28	the	_	_	_	_	_	_	_	_
29	other	_	_	_	_	_	_	_	_
30	.	_	_	_	_	_	_	_	_
31	This	_	_	_	_	_	_	_	BeginSeg=Yes
32	connection	_	_	_	_	_	_	_	_
33	arises	_	_	_	_	_	_	_	_
34	from	_	_	_	_	_	_	_	_
35	differences	_	_	_	_	_	_	_	_
36	in	_	_	_	_	_	_	_	_
37	the	_	_	_	_	_	_	_	_
38	rates	_	_	_	_	_	_	_	_
39	of	_	_	_	_	_	_	_	_
40	infection	_	_	_	_	_	_	_	_
41	in	_	_	_	_	_	_	_	_
42	countries	_	_	_	_	_	_	_	_
43	where	_	_	_	_	_	_	_	BeginSeg=Yes
44	BCG	_	_	_	_	_	_	_	_
45	vaccination	_	_	_	_	_	_	_	_
46	is	_	_	_	_	_	_	_	_
47	mandatory	_	_	_	_	_	_	_	_
48	compared	_	_	_	_	_	_	_	BeginSeg=Yes
49	to	_	_	_	_	_	_	_	_
50	countries	_	_	_	_	_	_	_	_
51	where	_	_	_	_	_	_	_	BeginSeg=Yes
52	mandatory	_	_	_	_	_	_	_	_
53	vaccination	_	_	_	_	_	_	_	_
54	no	_	_	_	_	_	_	_	_
55	longer	_	_	_	_	_	_	_	_
56	exists	_	_	_	_	_	_	_	_
57	or	_	_	_	_	_	_	_	BeginSeg=Yes
58	was	_	_	_	_	_	_	_	_
59	never	_	_	_	_	_	_	_	_
60	implemented	_	_	_	_	_	_	_	_
61	in	_	_	_	_	_	_	_	_
62	the	_	_	_	_	_	_	_	_
63	first	_	_	_	_	_	_	_	_
64	place	_	_	_	_	_	_	_	_
65	.	_	_	_	_	_	_	_	_
66	In	_	_	_	_	_	_	_	BeginSeg=Yes
67	at	_	_	_	_	_	_	_	_
68	least	_	_	_	_	_	_	_	_
69	2	_	_	_	_	_	_	_	_
70	preprint	_	_	_	_	_	_	_	_
71	publications	_	_	_	_	_	_	_	_
72	the	_	_	_	_	_	_	_	_
73	authors	_	_	_	_	_	_	_	_
74	expressed	_	_	_	_	_	_	_	_
75	the	_	_	_	_	_	_	_	_
76	view	_	_	_	_	_	_	_	_
77	that	_	_	_	_	_	_	_	BeginSeg=Yes
78	the	_	_	_	_	_	_	_	_
79	"	_	_	_	_	_	_	_	_
80	known	_	_	_	_	_	_	_	_
81	immunological	_	_	_	_	_	_	_	_
82	benefits	_	_	_	_	_	_	_	_
83	"	_	_	_	_	_	_	_	_
84	of	_	_	_	_	_	_	_	_
85	BCG	_	_	_	_	_	_	_	_
86	vaccination	_	_	_	_	_	_	_	_
87	may	_	_	_	_	_	_	_	_
88	be	_	_	_	_	_	_	_	_
89	behind	_	_	_	_	_	_	_	_
90	the	_	_	_	_	_	_	_	_
91	biological	_	_	_	_	_	_	_	_
92	mechanism	_	_	_	_	_	_	_	_
93	of	_	_	_	_	_	_	_	_
94	such	_	_	_	_	_	_	_	_
95	observation	_	_	_	_	_	_	_	_
96	.	_	_	_	_	_	_	_	_
97	One	_	_	_	_	_	_	_	BeginSeg=Yes
98	study	_	_	_	_	_	_	_	_
99	accounted	_	_	_	_	_	_	_	_
100	for	_	_	_	_	_	_	_	_
101	different	_	_	_	_	_	_	_	_
102	income	_	_	_	_	_	_	_	_
103	levels	_	_	_	_	_	_	_	_
104	in	_	_	_	_	_	_	_	_
105	different	_	_	_	_	_	_	_	_
106	groups	_	_	_	_	_	_	_	_
107	.	_	_	_	_	_	_	_	_
108	Another	_	_	_	_	_	_	_	BeginSeg=Yes
109	study	_	_	_	_	_	_	_	_
110	did	_	_	_	_	_	_	_	_
111	not	_	_	_	_	_	_	_	_
112	attempted	_	_	_	_	_	_	_	_
113	to	_	_	_	_	_	_	_	_
114	do	_	_	_	_	_	_	_	_
115	so	_	_	_	_	_	_	_	_
116	,	_	_	_	_	_	_	_	_
117	instead	_	_	_	_	_	_	_	BeginSeg=Yes
118	exploring	_	_	_	_	_	_	_	_
119	the	_	_	_	_	_	_	_	_
120	differences	_	_	_	_	_	_	_	_
121	between	_	_	_	_	_	_	_	_
122	countries	_	_	_	_	_	_	_	_
123	where	_	_	_	_	_	_	_	BeginSeg=Yes
124	a	_	_	_	_	_	_	_	_
125	booster	_	_	_	_	_	_	_	_
126	shot	_	_	_	_	_	_	_	_
127	is	_	_	_	_	_	_	_	_
128	given	_	_	_	_	_	_	_	_
129	vs	_	_	_	_	_	_	_	BeginSeg=Yes
130	others	_	_	_	_	_	_	_	_
131	where	_	_	_	_	_	_	_	BeginSeg=Yes
132	no	_	_	_	_	_	_	_	_
133	such	_	_	_	_	_	_	_	_
134	practice	_	_	_	_	_	_	_	_
135	exists	_	_	_	_	_	_	_	_
136	(	_	_	_	_	_	_	_	_
137	finding	_	_	_	_	_	_	_	_
138	no	_	_	_	_	_	_	_	_
139	connection	_	_	_	_	_	_	_	_
140	)	_	_	_	_	_	_	_	_
141	.	_	_	_	_	_	_	_	_
142	Both	_	_	_	_	_	_	_	BeginSeg=Yes
143	of	_	_	_	_	_	_	_	_
144	these	_	_	_	_	_	_	_	_
145	studies	_	_	_	_	_	_	_	_
146	did	_	_	_	_	_	_	_	_
147	not	_	_	_	_	_	_	_	_
148	explore	_	_	_	_	_	_	_	_
149	other	_	_	_	_	_	_	_	_
150	potential	_	_	_	_	_	_	_	_
151	confounding	_	_	_	_	_	_	_	_
152	factors	_	_	_	_	_	_	_	_
153	.	_	_	_	_	_	_	_	_
154	Meanwhile	_	_	_	_	_	_	_	BeginSeg=Yes
155	the	_	_	_	_	_	_	_	_
156	press	_	_	_	_	_	_	_	_
157	has	_	_	_	_	_	_	_	_
158	focused	_	_	_	_	_	_	_	_
159	on	_	_	_	_	_	_	_	_
160	these	_	_	_	_	_	_	_	_
161	headlines	_	_	_	_	_	_	_	_
162	and	_	_	_	_	_	_	_	BeginSeg=Yes
163	pushed	_	_	_	_	_	_	_	_
164	the	_	_	_	_	_	_	_	_
165	narrative	_	_	_	_	_	_	_	_
166	that	_	_	_	_	_	_	_	BeginSeg=Yes
167	BCG	_	_	_	_	_	_	_	_
168	vaccination	_	_	_	_	_	_	_	_
169	is	_	_	_	_	_	_	_	_
170	causally	_	_	_	_	_	_	_	_
171	linked	_	_	_	_	_	_	_	_
172	to	_	_	_	_	_	_	_	_
173	infection	_	_	_	_	_	_	_	_
174	and	_	_	_	_	_	_	_	_
175	mortality	_	_	_	_	_	_	_	_
176	rates	_	_	_	_	_	_	_	_
177	.	_	_	_	_	_	_	_	_
178	This	_	_	_	_	_	_	_	BeginSeg=Yes
179	poses	_	_	_	_	_	_	_	_
180	a	_	_	_	_	_	_	_	_
181	serious	_	_	_	_	_	_	_	_
182	challenge	_	_	_	_	_	_	_	_
183	,	_	_	_	_	_	_	_	_
184	demonstrated	_	_	_	_	_	_	_	BeginSeg=Yes
185	by	_	_	_	_	_	_	_	_
186	the	_	_	_	_	_	_	_	_
187	recently	_	_	_	_	_	_	_	_
188	initiated	_	_	_	_	_	_	_	_
189	clinical	_	_	_	_	_	_	_	_
190	trials	_	_	_	_	_	_	_	_
191	on	_	_	_	_	_	_	_	_
192	BCG	_	_	_	_	_	_	_	_
193	vaccination	_	_	_	_	_	_	_	_
194	within	_	_	_	_	_	_	_	_
195	the	_	_	_	_	_	_	_	_
196	COVID19	_	_	_	_	_	_	_	_
197	context	_	_	_	_	_	_	_	_
198	.	_	_	_	_	_	_	_	_
199	This	_	_	_	_	_	_	_	BeginSeg=Yes
200	study	_	_	_	_	_	_	_	_
201	shows	_	_	_	_	_	_	_	_
202	that	_	_	_	_	_	_	_	BeginSeg=Yes
203	population	_	_	_	_	_	_	_	_
204	age	_	_	_	_	_	_	_	_
205	is	_	_	_	_	_	_	_	_
206	a	_	_	_	_	_	_	_	_
207	very	_	_	_	_	_	_	_	_
208	significant	_	_	_	_	_	_	_	_
209	confounding	_	_	_	_	_	_	_	_
210	factor	_	_	_	_	_	_	_	_
211	that	_	_	_	_	_	_	_	BeginSeg=Yes
212	explains	_	_	_	_	_	_	_	_
213	the	_	_	_	_	_	_	_	_
214	rates	_	_	_	_	_	_	_	_
215	of	_	_	_	_	_	_	_	_
216	infections	_	_	_	_	_	_	_	_
217	much	_	_	_	_	_	_	_	_
218	better	_	_	_	_	_	_	_	_
219	and	_	_	_	_	_	_	_	BeginSeg=Yes
220	has	_	_	_	_	_	_	_	_
221	a	_	_	_	_	_	_	_	_
222	solid	_	_	_	_	_	_	_	_
223	biology	_	_	_	_	_	_	_	_
224	mechanism	_	_	_	_	_	_	_	_
225	which	_	_	_	_	_	_	_	BeginSeg=Yes
226	explains	_	_	_	_	_	_	_	_
227	this	_	_	_	_	_	_	_	_
228	correlation	_	_	_	_	_	_	_	_
229	.	_	_	_	_	_	_	_	_
230	It	_	_	_	_	_	_	_	BeginSeg=Yes
231	suggests	_	_	_	_	_	_	_	_
232	that	_	_	_	_	_	_	_	BeginSeg=Yes
233	BCG	_	_	_	_	_	_	_	_
234	vaccination	_	_	_	_	_	_	_	_
235	may	_	_	_	_	_	_	_	_
236	have	_	_	_	_	_	_	_	_
237	little	_	_	_	_	_	_	_	_
238	or	_	_	_	_	_	_	_	_
239	no	_	_	_	_	_	_	_	_
240	causal	_	_	_	_	_	_	_	_
241	link	_	_	_	_	_	_	_	_
242	to	_	_	_	_	_	_	_	_
243	infection	_	_	_	_	_	_	_	_
244	rates	_	_	_	_	_	_	_	_
245	and	_	_	_	_	_	_	_	BeginSeg=Yes
246	advises	_	_	_	_	_	_	_	_
247	that	_	_	_	_	_	_	_	BeginSeg=Yes
248	any	_	_	_	_	_	_	_	_
249	follow	_	_	_	_	_	_	_	_
250	up	_	_	_	_	_	_	_	_
251	studies	_	_	_	_	_	_	_	_
252	should	_	_	_	_	_	_	_	_
253	control	_	_	_	_	_	_	_	_
254	for	_	_	_	_	_	_	_	_
255	several	_	_	_	_	_	_	_	_
256	confounding	_	_	_	_	_	_	_	_
257	factors	_	_	_	_	_	_	_	_
258	,	_	_	_	_	_	_	_	_
259	such	_	_	_	_	_	_	_	BeginSeg=Yes
260	as	_	_	_	_	_	_	_	_
261	population	_	_	_	_	_	_	_	_
262	age	_	_	_	_	_	_	_	_
263	,	_	_	_	_	_	_	_	_
264	ethnicity	_	_	_	_	_	_	_	_
265	,	_	_	_	_	_	_	_	_
266	rates	_	_	_	_	_	_	_	_
267	of	_	_	_	_	_	_	_	_
268	certain	_	_	_	_	_	_	_	_
269	chronic	_	_	_	_	_	_	_	_
270	diseases	_	_	_	_	_	_	_	_
271	,	_	_	_	_	_	_	_	_
272	time	_	_	_	_	_	_	_	_
273	from	_	_	_	_	_	_	_	_
274	community	_	_	_	_	_	_	_	_
275	spread	_	_	_	_	_	_	_	_
276	start	_	_	_	_	_	_	_	_
277	date	_	_	_	_	_	_	_	_
278	,	_	_	_	_	_	_	_	_
279	major	_	_	_	_	_	_	_	_
280	public	_	_	_	_	_	_	_	_
281	policy	_	_	_	_	_	_	_	_
282	decisions	_	_	_	_	_	_	_	_
283	and	_	_	_	_	_	_	_	_
284	income	_	_	_	_	_	_	_	_
285	levels	_	_	_	_	_	_	_	_
286	.	_	_	_	_	_	_	_	_

# newdoc_id = 352657225f9b69e4693a466de17c2a4d55ccc1d3
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	integration	_	_	_	_	_	_	_	_
3	of	_	_	_	_	_	_	_	_
4	proteomic	_	_	_	_	_	_	_	_
5	methods	_	_	_	_	_	_	_	_
6	to	_	_	_	_	_	_	_	_
7	virology	_	_	_	_	_	_	_	_
8	has	_	_	_	_	_	_	_	_
9	facilitated	_	_	_	_	_	_	_	_
10	a	_	_	_	_	_	_	_	_
11	significant	_	_	_	_	_	_	_	_
12	breadth	_	_	_	_	_	_	_	_
13	of	_	_	_	_	_	_	_	_
14	biological	_	_	_	_	_	_	_	_
15	insight	_	_	_	_	_	_	_	_
16	into	_	_	_	_	_	_	_	_
17	mechanisms	_	_	_	_	_	_	_	_
18	of	_	_	_	_	_	_	_	_
19	virus	_	_	_	_	_	_	_	_
20	replication	_	_	_	_	_	_	_	_
21	,	_	_	_	_	_	_	_	_
22	antiviral	_	_	_	_	_	_	_	_
23	host	_	_	_	_	_	_	_	_
24	responses	_	_	_	_	_	_	_	_
25	and	_	_	_	_	_	_	_	_
26	viral	_	_	_	_	_	_	_	_
27	subversion	_	_	_	_	_	_	_	_
28	of	_	_	_	_	_	_	_	_
29	host	_	_	_	_	_	_	_	_
30	defenses	_	_	_	_	_	_	_	_
31	.	_	_	_	_	_	_	_	_
32	Throughout	_	_	_	_	_	_	_	BeginSeg=Yes
33	the	_	_	_	_	_	_	_	_
34	course	_	_	_	_	_	_	_	_
35	of	_	_	_	_	_	_	_	_
36	infection	_	_	_	_	_	_	_	_
37	,	_	_	_	_	_	_	_	_
38	these	_	_	_	_	_	_	_	_
39	cellular	_	_	_	_	_	_	_	_
40	mechanisms	_	_	_	_	_	_	_	_
41	rely	_	_	_	_	_	_	_	_
42	heavily	_	_	_	_	_	_	_	_
43	on	_	_	_	_	_	_	_	_
44	the	_	_	_	_	_	_	_	_
45	formation	_	_	_	_	_	_	_	_
46	of	_	_	_	_	_	_	_	_
47	temporally	_	_	_	_	_	_	_	_
48	and	_	_	_	_	_	_	_	_
49	spatially	_	_	_	_	_	_	_	_
50	regulated	_	_	_	_	_	_	_	_
51	virus	_	_	_	_	_	_	_	_
52	-	_	_	_	_	_	_	_	_
53	host	_	_	_	_	_	_	_	_
54	protein	_	_	_	_	_	_	_	_
55	-	_	_	_	_	_	_	_	_
56	protein	_	_	_	_	_	_	_	_
57	interactions	_	_	_	_	_	_	_	_
58	.	_	_	_	_	_	_	_	_
59	Reviewed	_	_	_	_	_	_	_	BeginSeg=Yes
60	here	_	_	_	_	_	_	_	_
61	are	_	_	_	_	_	_	_	_
62	proteomic	_	_	_	_	_	_	_	_
63	-	_	_	_	_	_	_	_	_
64	based	_	_	_	_	_	_	_	_
65	approaches	_	_	_	_	_	_	_	_
66	that	_	_	_	_	_	_	_	BeginSeg=Yes
67	have	_	_	_	_	_	_	_	_
68	been	_	_	_	_	_	_	_	_
69	used	_	_	_	_	_	_	_	_
70	to	_	_	_	_	_	_	_	BeginSeg=Yes
71	characterize	_	_	_	_	_	_	_	_
72	this	_	_	_	_	_	_	_	_
73	dynamic	_	_	_	_	_	_	_	_
74	virus	_	_	_	_	_	_	_	_
75	-	_	_	_	_	_	_	_	_
76	host	_	_	_	_	_	_	_	_
77	interplay	_	_	_	_	_	_	_	_
78	.	_	_	_	_	_	_	_	_
79	Specifically	_	_	_	_	_	_	_	BeginSeg=Yes
80	discussed	_	_	_	_	_	_	_	_
81	are	_	_	_	_	_	_	_	_
82	the	_	_	_	_	_	_	_	_
83	contribution	_	_	_	_	_	_	_	_
84	of	_	_	_	_	_	_	_	_
85	integrative	_	_	_	_	_	_	_	_
86	mass	_	_	_	_	_	_	_	_
87	spectrometry	_	_	_	_	_	_	_	_
88	,	_	_	_	_	_	_	_	_
89	antibodybased	_	_	_	_	_	_	_	_
90	affinity	_	_	_	_	_	_	_	_
91	purification	_	_	_	_	_	_	_	_
92	of	_	_	_	_	_	_	_	_
93	protein	_	_	_	_	_	_	_	_
94	complexes	_	_	_	_	_	_	_	_
95	,	_	_	_	_	_	_	_	_
96	cross	_	_	_	_	_	_	_	_
97	-	_	_	_	_	_	_	_	_
98	linking	_	_	_	_	_	_	_	_
99	and	_	_	_	_	_	_	_	_
100	protein	_	_	_	_	_	_	_	_
101	array	_	_	_	_	_	_	_	_
102	techniques	_	_	_	_	_	_	_	_
103	for	_	_	_	_	_	_	_	BeginSeg=Yes
104	elucidating	_	_	_	_	_	_	_	_
105	complex	_	_	_	_	_	_	_	_
106	networks	_	_	_	_	_	_	_	_
107	of	_	_	_	_	_	_	_	_
108	virus	_	_	_	_	_	_	_	_
109	-	_	_	_	_	_	_	_	_
110	host	_	_	_	_	_	_	_	_
111	protein	_	_	_	_	_	_	_	_
112	associations	_	_	_	_	_	_	_	_
113	during	_	_	_	_	_	_	_	_
114	infection	_	_	_	_	_	_	_	_
115	with	_	_	_	_	_	_	_	_
116	a	_	_	_	_	_	_	_	_
117	diverse	_	_	_	_	_	_	_	_
118	range	_	_	_	_	_	_	_	_
119	of	_	_	_	_	_	_	_	_
120	RNA	_	_	_	_	_	_	_	_
121	and	_	_	_	_	_	_	_	_
122	DNA	_	_	_	_	_	_	_	_
123	viruses	_	_	_	_	_	_	_	_
124	.	_	_	_	_	_	_	_	_
125	The	_	_	_	_	_	_	_	BeginSeg=Yes
126	benefits	_	_	_	_	_	_	_	_
127	and	_	_	_	_	_	_	_	_
128	limitations	_	_	_	_	_	_	_	_
129	of	_	_	_	_	_	_	_	BeginSeg=Yes
130	applying	_	_	_	_	_	_	_	_
131	proteomic	_	_	_	_	_	_	_	_
132	methods	_	_	_	_	_	_	_	_
133	to	_	_	_	_	_	_	_	_
134	virology	_	_	_	_	_	_	_	_
135	are	_	_	_	_	_	_	_	BeginSeg=Yes
136	explored	_	_	_	_	_	_	_	_
137	,	_	_	_	_	_	_	_	_
138	and	_	_	_	_	_	_	_	BeginSeg=Yes
139	the	_	_	_	_	_	_	_	_
140	contribution	_	_	_	_	_	_	_	_
141	of	_	_	_	_	_	_	_	_
142	these	_	_	_	_	_	_	_	_
143	approaches	_	_	_	_	_	_	_	_
144	to	_	_	_	_	_	_	_	_
145	important	_	_	_	_	_	_	_	_
146	biological	_	_	_	_	_	_	_	_
147	discoveries	_	_	_	_	_	_	_	_
148	and	_	_	_	_	_	_	_	_
149	to	_	_	_	_	_	_	_	_
150	inspiring	_	_	_	_	_	_	_	_
151	new	_	_	_	_	_	_	_	_
152	tractable	_	_	_	_	_	_	_	_
153	avenues	_	_	_	_	_	_	_	_
154	for	_	_	_	_	_	_	_	_
155	the	_	_	_	_	_	_	_	_
156	design	_	_	_	_	_	_	_	_
157	of	_	_	_	_	_	_	_	_
158	antiviral	_	_	_	_	_	_	_	_
159	therapeutics	_	_	_	_	_	_	_	_
160	is	_	_	_	_	_	_	_	_
161	highlighted	_	_	_	_	_	_	_	_
162	.	_	_	_	_	_	_	_	_

# newdoc_id = 36f9ee4d21bf47a3f9f504f7fca3a1db625899d2
1	Coronaviruses	_	_	_	_	_	_	_	BeginSeg=Yes
2	are	_	_	_	_	_	_	_	_
3	positive	_	_	_	_	_	_	_	_
4	stranded	_	_	_	_	_	_	_	_
5	RNA	_	_	_	_	_	_	_	_
6	viruses	_	_	_	_	_	_	_	_
7	that	_	_	_	_	_	_	_	BeginSeg=Yes
8	cause	_	_	_	_	_	_	_	_
9	respiratory	_	_	_	_	_	_	_	_
10	,	_	_	_	_	_	_	_	_
11	enteric	_	_	_	_	_	_	_	_
12	and	_	_	_	_	_	_	_	_
13	central	_	_	_	_	_	_	_	_
14	nervous	_	_	_	_	_	_	_	_
15	system	_	_	_	_	_	_	_	_
16	diseases	_	_	_	_	_	_	_	_
17	in	_	_	_	_	_	_	_	_
18	many	_	_	_	_	_	_	_	_
19	species	_	_	_	_	_	_	_	_
20	,	_	_	_	_	_	_	_	_
21	including	_	_	_	_	_	_	_	BeginSeg=Yes
22	humans	_	_	_	_	_	_	_	_
23	.	_	_	_	_	_	_	_	_
24	Until	_	_	_	_	_	_	_	BeginSeg=Yes
25	recently	_	_	_	_	_	_	_	_
26	,	_	_	_	_	_	_	_	_
27	the	_	_	_	_	_	_	_	_
28	relatively	_	_	_	_	_	_	_	_
29	low	_	_	_	_	_	_	_	_
30	burden	_	_	_	_	_	_	_	_
31	of	_	_	_	_	_	_	_	_
32	disease	_	_	_	_	_	_	_	_
33	in	_	_	_	_	_	_	_	_
34	humans	_	_	_	_	_	_	_	_
35	caused	_	_	_	_	_	_	_	BeginSeg=Yes
36	by	_	_	_	_	_	_	_	_
37	few	_	_	_	_	_	_	_	_
38	of	_	_	_	_	_	_	_	_
39	these	_	_	_	_	_	_	_	_
40	viruses	_	_	_	_	_	_	_	_
41	impeded	_	_	_	_	_	_	_	BeginSeg=Yes
42	the	_	_	_	_	_	_	_	_
43	development	_	_	_	_	_	_	_	_
44	of	_	_	_	_	_	_	_	_
45	coronavirus	_	_	_	_	_	_	_	_
46	specific	_	_	_	_	_	_	_	_
47	therapeutics	_	_	_	_	_	_	_	_
48	.	_	_	_	_	_	_	_	_
49	However	_	_	_	_	_	_	_	BeginSeg=Yes
50	,	_	_	_	_	_	_	_	_
51	the	_	_	_	_	_	_	_	_
52	emergence	_	_	_	_	_	_	_	_
53	of	_	_	_	_	_	_	_	_
54	severe	_	_	_	_	_	_	_	_
55	acute	_	_	_	_	_	_	_	_
56	respiratory	_	_	_	_	_	_	_	_
57	syndrome	_	_	_	_	_	_	_	_
58	coronavirus	_	_	_	_	_	_	_	_
59	(	_	_	_	_	_	_	_	_
60	SARS	_	_	_	_	_	_	_	_
61	-	_	_	_	_	_	_	_	_
62	CoV	_	_	_	_	_	_	_	_
63	)	_	_	_	_	_	_	_	_
64	,	_	_	_	_	_	_	_	_
65	and	_	_	_	_	_	_	_	_
66	more	_	_	_	_	_	_	_	_
67	recently	_	_	_	_	_	_	_	_
68	,	_	_	_	_	_	_	_	_
69	Middle	_	_	_	_	_	_	_	_
70	East	_	_	_	_	_	_	_	_
71	respiratory	_	_	_	_	_	_	_	_
72	syndrome	_	_	_	_	_	_	_	_
73	coronavirus	_	_	_	_	_	_	_	_
74	(	_	_	_	_	_	_	_	_
75	MERS	_	_	_	_	_	_	_	_
76	-	_	_	_	_	_	_	_	_
77	CoV	_	_	_	_	_	_	_	_
78	)	_	_	_	_	_	_	_	_
79	,	_	_	_	_	_	_	_	_
80	has	_	_	_	_	_	_	_	_
81	impelled	_	_	_	_	_	_	_	_
82	the	_	_	_	_	_	_	_	_
83	development	_	_	_	_	_	_	_	_
84	of	_	_	_	_	_	_	_	_
85	such	_	_	_	_	_	_	_	_
86	drugs	_	_	_	_	_	_	_	_
87	.	_	_	_	_	_	_	_	_
88	This	_	_	_	_	_	_	_	BeginSeg=Yes
89	review	_	_	_	_	_	_	_	_
90	focuses	_	_	_	_	_	_	_	_
91	on	_	_	_	_	_	_	_	_
92	some	_	_	_	_	_	_	_	_
93	newly	_	_	_	_	_	_	_	_
94	identified	_	_	_	_	_	_	_	_
95	SARS	_	_	_	_	_	_	_	_
96	-	_	_	_	_	_	_	_	_
97	CoV	_	_	_	_	_	_	_	_
98	inhibitors	_	_	_	_	_	_	_	_
99	,	_	_	_	_	_	_	_	_
100	with	_	_	_	_	_	_	_	_
101	known	_	_	_	_	_	_	_	_
102	mechanisms	_	_	_	_	_	_	_	_
103	of	_	_	_	_	_	_	_	_
104	action	_	_	_	_	_	_	_	_
105	and	_	_	_	_	_	_	_	_
106	their	_	_	_	_	_	_	_	_
107	potential	_	_	_	_	_	_	_	_
108	to	_	_	_	_	_	_	_	BeginSeg=Yes
109	inhibit	_	_	_	_	_	_	_	_
110	the	_	_	_	_	_	_	_	_
111	novel	_	_	_	_	_	_	_	_
112	MERS	_	_	_	_	_	_	_	_
113	-	_	_	_	_	_	_	_	_
114	CoV.	_	_	_	_	_	_	_	_
115	The	_	_	_	_	_	_	_	BeginSeg=Yes
116	clinical	_	_	_	_	_	_	_	_
117	development	_	_	_	_	_	_	_	_
118	of	_	_	_	_	_	_	_	_
119	optimized	_	_	_	_	_	_	_	_
120	versions	_	_	_	_	_	_	_	_
121	of	_	_	_	_	_	_	_	_
122	such	_	_	_	_	_	_	_	_
123	compounds	_	_	_	_	_	_	_	_
124	could	_	_	_	_	_	_	_	_
125	be	_	_	_	_	_	_	_	_
126	beneficial	_	_	_	_	_	_	_	_
127	for	_	_	_	_	_	_	_	_
128	the	_	_	_	_	_	_	_	_
129	treatment	_	_	_	_	_	_	_	_
130	and	_	_	_	_	_	_	_	_
131	control	_	_	_	_	_	_	_	_
132	of	_	_	_	_	_	_	_	_
133	SARS	_	_	_	_	_	_	_	_
134	-	_	_	_	_	_	_	_	_
135	CoV	_	_	_	_	_	_	_	_
136	,	_	_	_	_	_	_	_	_
137	the	_	_	_	_	_	_	_	_
138	current	_	_	_	_	_	_	_	_
139	MERS	_	_	_	_	_	_	_	_
140	-	_	_	_	_	_	_	_	_
141	CoV	_	_	_	_	_	_	_	_
142	and	_	_	_	_	_	_	_	_
143	other	_	_	_	_	_	_	_	_
144	future	_	_	_	_	_	_	_	_
145	SARS	_	_	_	_	_	_	_	_
146	-	_	_	_	_	_	_	_	_
147	like	_	_	_	_	_	_	_	_
148	epidemics	_	_	_	_	_	_	_	_
149	.	_	_	_	_	_	_	_	_

# newdoc_id = 393df9f3bd2b9ab0e100ab48688cebc9e86c5a60
1	Pandemics	_	_	_	_	_	_	_	BeginSeg=Yes
2	have	_	_	_	_	_	_	_	_
3	a	_	_	_	_	_	_	_	_
4	profound	_	_	_	_	_	_	_	_
5	impact	_	_	_	_	_	_	_	_
6	on	_	_	_	_	_	_	_	_
7	our	_	_	_	_	_	_	_	_
8	world	_	_	_	_	_	_	_	_
9	,	_	_	_	_	_	_	_	_
10	causing	_	_	_	_	_	_	_	BeginSeg=Yes
11	loss	_	_	_	_	_	_	_	_
12	of	_	_	_	_	_	_	_	_
13	life	_	_	_	_	_	_	_	_
14	,	_	_	_	_	_	_	_	_
15	affecting	_	_	_	_	_	_	_	BeginSeg=Yes
16	our	_	_	_	_	_	_	_	_
17	culture	_	_	_	_	_	_	_	_
18	and	_	_	_	_	_	_	_	BeginSeg=Yes
19	historically	_	_	_	_	_	_	_	_
20	shaping	_	_	_	_	_	_	_	_
21	our	_	_	_	_	_	_	_	_
22	genetics	_	_	_	_	_	_	_	_
23	.	_	_	_	_	_	_	_	_
24	The	_	_	_	_	_	_	_	BeginSeg=Yes
25	response	_	_	_	_	_	_	_	_
26	to	_	_	_	_	_	_	_	_
27	a	_	_	_	_	_	_	_	_
28	pandemic	_	_	_	_	_	_	_	_
29	requires	_	_	_	_	_	_	_	_
30	both	_	_	_	_	_	_	_	_
31	resilience	_	_	_	_	_	_	_	_
32	and	_	_	_	_	_	_	_	_
33	imagination	_	_	_	_	_	_	_	_
34	.	_	_	_	_	_	_	_	_
35	It	_	_	_	_	_	_	_	BeginSeg=Yes
36	has	_	_	_	_	_	_	_	_
37	been	_	_	_	_	_	_	_	_
38	clearly	_	_	_	_	_	_	_	_
39	documented	_	_	_	_	_	_	_	_
40	that	_	_	_	_	_	_	_	_
41	obtaining	_	_	_	_	_	_	_	_
42	an	_	_	_	_	_	_	_	_
43	accurate	_	_	_	_	_	_	_	_
44	estimate	_	_	_	_	_	_	_	_
45	and	_	_	_	_	_	_	_	_
46	trends	_	_	_	_	_	_	_	_
47	of	_	_	_	_	_	_	_	_
48	the	_	_	_	_	_	_	_	_
49	actual	_	_	_	_	_	_	_	_
50	infection	_	_	_	_	_	_	_	_
51	rate	_	_	_	_	_	_	_	_
52	and	_	_	_	_	_	_	_	_
53	mortality	_	_	_	_	_	_	_	_
54	risk	_	_	_	_	_	_	_	_
55	are	_	_	_	_	_	_	_	_
56	very	_	_	_	_	_	_	_	_
57	important	_	_	_	_	_	_	_	_
58	for	_	_	_	_	_	_	_	_
59	policy	_	_	_	_	_	_	_	_
60	makers	_	_	_	_	_	_	_	_
61	and	_	_	_	_	_	_	_	_
62	medical	_	_	_	_	_	_	_	_
63	professionals	_	_	_	_	_	_	_	_
64	.	_	_	_	_	_	_	_	_
65	One	_	_	_	_	_	_	_	BeginSeg=Yes
66	can	_	_	_	_	_	_	_	_
67	not	_	_	_	_	_	_	_	_
68	estimate	_	_	_	_	_	_	_	_
69	mortality	_	_	_	_	_	_	_	_
70	rates	_	_	_	_	_	_	_	_
71	without	_	_	_	_	_	_	_	BeginSeg=Yes
72	an	_	_	_	_	_	_	_	_
73	accurate	_	_	_	_	_	_	_	_
74	assessment	_	_	_	_	_	_	_	_
75	of	_	_	_	_	_	_	_	_
76	the	_	_	_	_	_	_	_	_
77	number	_	_	_	_	_	_	_	_
78	of	_	_	_	_	_	_	_	_
79	infected	_	_	_	_	_	_	_	_
80	individuals	_	_	_	_	_	_	_	_
81	in	_	_	_	_	_	_	_	_
82	the	_	_	_	_	_	_	_	_
83	population	_	_	_	_	_	_	_	_
84	.	_	_	_	_	_	_	_	_
85	This	_	_	_	_	_	_	_	BeginSeg=Yes
86	need	_	_	_	_	_	_	_	_
87	is	_	_	_	_	_	_	_	_
88	also	_	_	_	_	_	_	_	_
89	aligned	_	_	_	_	_	_	_	_
90	with	_	_	_	_	_	_	_	_
91	identifying	_	_	_	_	_	_	_	_
92	the	_	_	_	_	_	_	_	_
93	infected	_	_	_	_	_	_	_	_
94	individuals	_	_	_	_	_	_	_	_
95	so	_	_	_	_	_	_	_	BeginSeg=Yes
96	they	_	_	_	_	_	_	_	_
97	can	_	_	_	_	_	_	_	_
98	be	_	_	_	_	_	_	_	_
99	properly	_	_	_	_	_	_	_	_
100	treated	_	_	_	_	_	_	_	_
101	,	_	_	_	_	_	_	_	_
102	monitored	_	_	_	_	_	_	_	BeginSeg=Yes
103	and	_	_	_	_	_	_	_	BeginSeg=Yes
104	tracked	_	_	_	_	_	_	_	_
105	.	_	_	_	_	_	_	_	_
106	However	_	_	_	_	_	_	_	BeginSeg=Yes
107	,	_	_	_	_	_	_	_	_
108	accurate	_	_	_	_	_	_	_	_
109	estimation	_	_	_	_	_	_	_	_
110	of	_	_	_	_	_	_	_	_
111	the	_	_	_	_	_	_	_	_
112	infection	_	_	_	_	_	_	_	_
113	rate	_	_	_	_	_	_	_	_
114	,	_	_	_	_	_	_	_	_
115	locally	_	_	_	_	_	_	_	_
116	,	_	_	_	_	_	_	_	_
117	geographically	_	_	_	_	_	_	_	_
118	and	_	_	_	_	_	_	_	_
119	nationally	_	_	_	_	_	_	_	_
120	is	_	_	_	_	_	_	_	_
121	important	_	_	_	_	_	_	_	_
122	independently	_	_	_	_	_	_	_	_
123	.	_	_	_	_	_	_	_	_
124	These	_	_	_	_	_	_	_	BeginSeg=Yes
125	infection	_	_	_	_	_	_	_	_
126	rate	_	_	_	_	_	_	_	_
127	estimates	_	_	_	_	_	_	_	_
128	can	_	_	_	_	_	_	_	_
129	guide	_	_	_	_	_	_	_	_
130	policy	_	_	_	_	_	_	_	_
131	makers	_	_	_	_	_	_	_	_
132	at	_	_	_	_	_	_	_	_
133	both	_	_	_	_	_	_	_	_
134	state	_	_	_	_	_	_	_	_
135	,	_	_	_	_	_	_	_	_
136	national	_	_	_	_	_	_	_	_
137	or	_	_	_	_	_	_	_	_
138	world	_	_	_	_	_	_	_	_
139	level	_	_	_	_	_	_	_	_
140	to	_	_	_	_	_	_	_	_
141	achieve	_	_	_	_	_	_	_	_
142	a	_	_	_	_	_	_	_	_
143	better	_	_	_	_	_	_	_	_
144	management	_	_	_	_	_	_	_	_
145	of	_	_	_	_	_	_	_	_
146	risk	_	_	_	_	_	_	_	_
147	to	_	_	_	_	_	_	_	_
148	society	_	_	_	_	_	_	_	_
149	.	_	_	_	_	_	_	_	_
150	The	_	_	_	_	_	_	_	BeginSeg=Yes
151	decisions	_	_	_	_	_	_	_	_
152	facing	_	_	_	_	_	_	_	BeginSeg=Yes
153	policy	_	_	_	_	_	_	_	_
154	makers	_	_	_	_	_	_	_	_
155	are	_	_	_	_	_	_	_	BeginSeg=Yes
156	very	_	_	_	_	_	_	_	_
157	different	_	_	_	_	_	_	_	_
158	during	_	_	_	_	_	_	_	_
159	early	_	_	_	_	_	_	_	_
160	stages	_	_	_	_	_	_	_	_
161	of	_	_	_	_	_	_	_	_
162	an	_	_	_	_	_	_	_	_
163	emerging	_	_	_	_	_	_	_	_
164	epidemic	_	_	_	_	_	_	_	_
165	where	_	_	_	_	_	_	_	BeginSeg=Yes
166	the	_	_	_	_	_	_	_	_
167	infection	_	_	_	_	_	_	_	_
168	rate	_	_	_	_	_	_	_	_
169	is	_	_	_	_	_	_	_	_
170	low	_	_	_	_	_	_	_	_
171	,	_	_	_	_	_	_	_	_
172	middle	_	_	_	_	_	_	_	BeginSeg=Yes
173	stages	_	_	_	_	_	_	_	_
174	where	_	_	_	_	_	_	_	BeginSeg=Yes
175	the	_	_	_	_	_	_	_	_
176	rate	_	_	_	_	_	_	_	_
177	is	_	_	_	_	_	_	_	_
178	rapidly	_	_	_	_	_	_	_	_
179	climbing	_	_	_	_	_	_	_	_
180	,	_	_	_	_	_	_	_	_
181	and	_	_	_	_	_	_	_	BeginSeg=Yes
182	later	_	_	_	_	_	_	_	_
183	stages	_	_	_	_	_	_	_	_
184	where	_	_	_	_	_	_	_	BeginSeg=Yes
185	the	_	_	_	_	_	_	_	_
186	epidemic	_	_	_	_	_	_	_	_
187	curve	_	_	_	_	_	_	_	_
188	has	_	_	_	_	_	_	_	_
189	flattened	_	_	_	_	_	_	_	_
190	to	_	_	_	_	_	_	_	_
191	a	_	_	_	_	_	_	_	_
192	low	_	_	_	_	_	_	_	_
193	and	_	_	_	_	_	_	_	_
194	relatively	_	_	_	_	_	_	_	_
195	sustainable	_	_	_	_	_	_	_	_
196	rate	_	_	_	_	_	_	_	_
197	.	_	_	_	_	_	_	_	_
198	In	_	_	_	_	_	_	_	BeginSeg=Yes
199	this	_	_	_	_	_	_	_	_
200	paper	_	_	_	_	_	_	_	_
201	we	_	_	_	_	_	_	_	_
202	provide	_	_	_	_	_	_	_	_
203	relatively	_	_	_	_	_	_	_	_
204	efficient	_	_	_	_	_	_	_	_
205	pooling	_	_	_	_	_	_	_	_
206	methods	_	_	_	_	_	_	_	_
207	to	_	_	_	_	_	_	_	BeginSeg=Yes
208	both	_	_	_	_	_	_	_	_
209	estimate	_	_	_	_	_	_	_	_
210	infection	_	_	_	_	_	_	_	_
211	rates	_	_	_	_	_	_	_	_
212	and	_	_	_	_	_	_	_	BeginSeg=Yes
213	identify	_	_	_	_	_	_	_	_
214	infected	_	_	_	_	_	_	_	_
215	individuals	_	_	_	_	_	_	_	_
216	for	_	_	_	_	_	_	_	_
217	populations	_	_	_	_	_	_	_	_
218	with	_	_	_	_	_	_	_	_
219	low	_	_	_	_	_	_	_	_
220	infection	_	_	_	_	_	_	_	_
221	rates	_	_	_	_	_	_	_	_
222	.	_	_	_	_	_	_	_	_
223	These	_	_	_	_	_	_	_	BeginSeg=Yes
224	estimates	_	_	_	_	_	_	_	_
225	may	_	_	_	_	_	_	_	_
226	provide	_	_	_	_	_	_	_	_
227	significant	_	_	_	_	_	_	_	_
228	cost	_	_	_	_	_	_	_	_
229	reductions	_	_	_	_	_	_	_	_
230	for	_	_	_	_	_	_	_	BeginSeg=Yes
231	testing	_	_	_	_	_	_	_	_
232	in	_	_	_	_	_	_	_	_
233	rural	_	_	_	_	_	_	_	_
234	communities	_	_	_	_	_	_	_	_
235	,	_	_	_	_	_	_	_	_
236	third	_	_	_	_	_	_	_	_
237	world	_	_	_	_	_	_	_	_
238	countries	_	_	_	_	_	_	_	_
239	and	_	_	_	_	_	_	_	_
240	other	_	_	_	_	_	_	_	_
241	situations	_	_	_	_	_	_	_	_
242	where	_	_	_	_	_	_	_	BeginSeg=Yes
243	the	_	_	_	_	_	_	_	_
244	cost	_	_	_	_	_	_	_	_
245	of	_	_	_	_	_	_	_	_
246	testing	_	_	_	_	_	_	_	_
247	is	_	_	_	_	_	_	_	_
248	expensive	_	_	_	_	_	_	_	_
249	or	_	_	_	_	_	_	_	BeginSeg=Yes
250	testing	_	_	_	_	_	_	_	_
251	is	_	_	_	_	_	_	_	_
252	not	_	_	_	_	_	_	_	_
253	widely	_	_	_	_	_	_	_	_
254	available	_	_	_	_	_	_	_	_
255	.	_	_	_	_	_	_	_	_
256	As	_	_	_	_	_	_	_	BeginSeg=Yes
257	we	_	_	_	_	_	_	_	_
258	prepare	_	_	_	_	_	_	_	_
259	for	_	_	_	_	_	_	_	_
260	the	_	_	_	_	_	_	_	_
261	second	_	_	_	_	_	_	_	_
262	wave	_	_	_	_	_	_	_	_
263	of	_	_	_	_	_	_	_	_
264	the	_	_	_	_	_	_	_	_
265	pandemic	_	_	_	_	_	_	_	_
266	this	_	_	_	_	_	_	_	BeginSeg=Yes
267	line	_	_	_	_	_	_	_	_
268	of	_	_	_	_	_	_	_	_
269	work	_	_	_	_	_	_	_	_
270	may	_	_	_	_	_	_	_	_
271	provide	_	_	_	_	_	_	_	_
272	new	_	_	_	_	_	_	_	_
273	solutions	_	_	_	_	_	_	_	_
274	for	_	_	_	_	_	_	_	_
275	both	_	_	_	_	_	_	_	_
276	the	_	_	_	_	_	_	_	_
277	biomedical	_	_	_	_	_	_	_	_
278	community	_	_	_	_	_	_	_	_
279	and	_	_	_	_	_	_	_	_
280	policy	_	_	_	_	_	_	_	_
281	makers	_	_	_	_	_	_	_	_
282	at	_	_	_	_	_	_	_	_
283	all	_	_	_	_	_	_	_	_
284	levels	_	_	_	_	_	_	_	_
285	.	_	_	_	_	_	_	_	_

# newdoc_id = 3b2db322b3470bdbc2145b4b348b1dc2c8e054ec
1	Coronavirus	_	_	_	_	_	_	_	BeginSeg=Yes
2	disease	_	_	_	_	_	_	_	_
3	2019	_	_	_	_	_	_	_	_
4	caused	_	_	_	_	_	_	_	BeginSeg=Yes
5	by	_	_	_	_	_	_	_	_
6	severe	_	_	_	_	_	_	_	_
7	acute	_	_	_	_	_	_	_	_
8	respiratory	_	_	_	_	_	_	_	_
9	syndrome	_	_	_	_	_	_	_	_
10	coronavirus	_	_	_	_	_	_	_	_
11	2	_	_	_	_	_	_	_	_
12	has	_	_	_	_	_	_	_	BeginSeg=Yes
13	spread	_	_	_	_	_	_	_	_
14	rapidly	_	_	_	_	_	_	_	_
15	around	_	_	_	_	_	_	_	_
16	the	_	_	_	_	_	_	_	_
17	world	_	_	_	_	_	_	_	_
18	and	_	_	_	_	_	_	_	BeginSeg=Yes
19	is	_	_	_	_	_	_	_	_
20	a	_	_	_	_	_	_	_	_
21	significant	_	_	_	_	_	_	_	_
22	threat	_	_	_	_	_	_	_	_
23	to	_	_	_	_	_	_	_	_
24	global	_	_	_	_	_	_	_	_
25	health	_	_	_	_	_	_	_	_
26	.	_	_	_	_	_	_	_	_
27	Patients	_	_	_	_	_	_	_	BeginSeg=Yes
28	in	_	_	_	_	_	_	_	_
29	the	_	_	_	_	_	_	_	_
30	Neonatal	_	_	_	_	_	_	_	_
31	Surgery	_	_	_	_	_	_	_	_
32	Department	_	_	_	_	_	_	_	_
33	have	_	_	_	_	_	_	_	_
34	rapidly	_	_	_	_	_	_	_	_
35	progressing	_	_	_	_	_	_	_	_
36	diseases	_	_	_	_	_	_	_	_
37	and	_	_	_	_	_	_	_	_
38	immature	_	_	_	_	_	_	_	_
39	immunity	_	_	_	_	_	_	_	_
40	,	_	_	_	_	_	_	_	_
41	which	_	_	_	_	_	_	_	BeginSeg=Yes
42	makes	_	_	_	_	_	_	_	_
43	them	_	_	_	_	_	_	_	_
44	vulnerable	_	_	_	_	_	_	_	_
45	to	_	_	_	_	_	_	_	_
46	pulmonary	_	_	_	_	_	_	_	_
47	infection	_	_	_	_	_	_	_	_
48	and	_	_	_	_	_	_	_	_
49	a	_	_	_	_	_	_	_	_
50	relatively	_	_	_	_	_	_	_	_
51	higher	_	_	_	_	_	_	_	_
52	mortality	_	_	_	_	_	_	_	_
53	.	_	_	_	_	_	_	_	_
54	This	_	_	_	_	_	_	_	BeginSeg=Yes
55	means	_	_	_	_	_	_	_	_
56	that	_	_	_	_	_	_	_	BeginSeg=Yes
57	these	_	_	_	_	_	_	_	_
58	patients	_	_	_	_	_	_	_	_
59	require	_	_	_	_	_	_	_	_
60	multidisciplinary	_	_	_	_	_	_	_	_
61	treatment	_	_	_	_	_	_	_	_
62	including	_	_	_	_	_	_	_	BeginSeg=Yes
63	early	_	_	_	_	_	_	_	_
64	diagnosis	_	_	_	_	_	_	_	_
65	,	_	_	_	_	_	_	_	_
66	timely	_	_	_	_	_	_	_	_
67	transport	_	_	_	_	_	_	_	_
68	,	_	_	_	_	_	_	_	_
69	emergency	_	_	_	_	_	_	_	_
70	surgery	_	_	_	_	_	_	_	_
71	and	_	_	_	_	_	_	_	_
72	intensive	_	_	_	_	_	_	_	_
73	critical	_	_	_	_	_	_	_	_
74	care	_	_	_	_	_	_	_	_
75	.	_	_	_	_	_	_	_	_
76	The	_	_	_	_	_	_	_	BeginSeg=Yes
77	COVID-19	_	_	_	_	_	_	_	_
78	pandemic	_	_	_	_	_	_	_	_
79	poses	_	_	_	_	_	_	_	_
80	a	_	_	_	_	_	_	_	_
81	threat	_	_	_	_	_	_	_	_
82	to	_	_	_	_	_	_	_	_
83	carrying	_	_	_	_	_	_	_	_
84	out	_	_	_	_	_	_	_	_
85	these	_	_	_	_	_	_	_	_
86	treatments	_	_	_	_	_	_	_	_
87	.	_	_	_	_	_	_	_	_
88	To	_	_	_	_	_	_	_	BeginSeg=Yes
89	provide	_	_	_	_	_	_	_	_
90	support	_	_	_	_	_	_	_	_
91	for	_	_	_	_	_	_	_	_
92	the	_	_	_	_	_	_	_	_
93	health	_	_	_	_	_	_	_	_
94	protection	_	_	_	_	_	_	_	_
95	requirements	_	_	_	_	_	_	_	_
96	of	_	_	_	_	_	_	_	_
97	the	_	_	_	_	_	_	_	_
98	medical	_	_	_	_	_	_	_	_
99	services	_	_	_	_	_	_	_	_
100	in	_	_	_	_	_	_	_	_
101	the	_	_	_	_	_	_	_	_
102	Neonatal	_	_	_	_	_	_	_	_
103	Surgery	_	_	_	_	_	_	_	_
104	Department	_	_	_	_	_	_	_	_
105	,	_	_	_	_	_	_	_	_
106	we	_	_	_	_	_	_	_	BeginSeg=Yes
107	developed	_	_	_	_	_	_	_	_
108	recommendations	_	_	_	_	_	_	_	_
109	focusing	_	_	_	_	_	_	_	BeginSeg=Yes
110	on	_	_	_	_	_	_	_	_
111	patient	_	_	_	_	_	_	_	_
112	transport	_	_	_	_	_	_	_	_
113	,	_	_	_	_	_	_	_	_
114	surgery	_	_	_	_	_	_	_	_
115	selection	_	_	_	_	_	_	_	_
116	and	_	_	_	_	_	_	_	_
117	protection	_	_	_	_	_	_	_	_
118	requirements	_	_	_	_	_	_	_	_
119	with	_	_	_	_	_	_	_	BeginSeg=Yes
120	the	_	_	_	_	_	_	_	_
121	aim	_	_	_	_	_	_	_	_
122	of	_	_	_	_	_	_	_	BeginSeg=Yes
123	improving	_	_	_	_	_	_	_	_
124	treatment	_	_	_	_	_	_	_	_
125	strategies	_	_	_	_	_	_	_	_
126	for	_	_	_	_	_	_	_	_
127	patients	_	_	_	_	_	_	_	_
128	and	_	_	_	_	_	_	_	BeginSeg=Yes
129	preventing	_	_	_	_	_	_	_	_
130	infection	_	_	_	_	_	_	_	_
131	in	_	_	_	_	_	_	_	_
132	medical	_	_	_	_	_	_	_	_
133	staff	_	_	_	_	_	_	_	_
134	during	_	_	_	_	_	_	_	_
135	the	_	_	_	_	_	_	_	_
136	current	_	_	_	_	_	_	_	_
137	COVID-19	_	_	_	_	_	_	_	_
138	pandemic	_	_	_	_	_	_	_	_
139	.	_	_	_	_	_	_	_	_

# newdoc_id = 3d026627a1f1f6af6f6fbb07bbcb84d917c7c946
1	Identification	_	_	_	_	_	_	_	BeginSeg=Yes
2	of	_	_	_	_	_	_	_	_
3	regulatory	_	_	_	_	_	_	_	_
4	elements	_	_	_	_	_	_	_	_
5	is	_	_	_	_	_	_	_	_
6	essential	_	_	_	_	_	_	_	_
7	for	_	_	_	_	_	_	_	BeginSeg=Yes
8	understanding	_	_	_	_	_	_	_	_
9	the	_	_	_	_	_	_	_	_
10	mechanism	_	_	_	_	_	_	_	_
11	behind	_	_	_	_	_	_	_	_
12	regulating	_	_	_	_	_	_	_	_
13	gene	_	_	_	_	_	_	_	_
14	expression	_	_	_	_	_	_	_	_
15	.	_	_	_	_	_	_	_	_
16	These	_	_	_	_	_	_	_	BeginSeg=Yes
17	regulatory	_	_	_	_	_	_	_	_
18	elements	_	_	_	_	_	_	_	_
19	-	_	_	_	_	_	_	_	BeginSeg=Yes
20	located	_	_	_	_	_	_	_	_
21	in	_	_	_	_	_	_	_	_
22	or	_	_	_	_	_	_	_	_
23	near	_	_	_	_	_	_	_	_
24	gene	_	_	_	_	_	_	_	_
25	-	_	_	_	_	_	_	_	_
26	bind	_	_	_	_	_	_	_	BeginSeg=Yes
27	to	_	_	_	_	_	_	_	_
28	proteins	_	_	_	_	_	_	_	_
29	called	_	_	_	_	_	_	_	BeginSeg=Yes
30	transcription	_	_	_	_	_	_	_	_
31	factors	_	_	_	_	_	_	_	_
32	to	_	_	_	_	_	_	_	BeginSeg=Yes
33	initiate	_	_	_	_	_	_	_	_
34	the	_	_	_	_	_	_	_	_
35	transcription	_	_	_	_	_	_	_	_
36	process	_	_	_	_	_	_	_	_
37	.	_	_	_	_	_	_	_	_
38	Their	_	_	_	_	_	_	_	BeginSeg=Yes
39	occurrences	_	_	_	_	_	_	_	_
40	are	_	_	_	_	_	_	_	_
41	influenced	_	_	_	_	_	_	_	_
42	by	_	_	_	_	_	_	_	_
43	the	_	_	_	_	_	_	_	_
44	GC	_	_	_	_	_	_	_	_
45	-	_	_	_	_	_	_	_	_
46	content	_	_	_	_	_	_	_	_
47	or	_	_	_	_	_	_	_	_
48	nucleotide	_	_	_	_	_	_	_	_
49	composition	_	_	_	_	_	_	_	_
50	.	_	_	_	_	_	_	_	_
51	For	_	_	_	_	_	_	_	BeginSeg=Yes
52	generating	_	_	_	_	_	_	_	_
53	synthetic	_	_	_	_	_	_	_	_
54	coding	_	_	_	_	_	_	_	_
55	sequences	_	_	_	_	_	_	_	_
56	with	_	_	_	_	_	_	_	_
57	pre	_	_	_	_	_	_	_	_
58	-	_	_	_	_	_	_	_	_
59	specified	_	_	_	_	_	_	_	_
60	amino	_	_	_	_	_	_	_	_
61	acid	_	_	_	_	_	_	_	_
62	sequence	_	_	_	_	_	_	_	_
63	and	_	_	_	_	_	_	_	_
64	desired	_	_	_	_	_	_	_	_
65	GC	_	_	_	_	_	_	_	_
66	-	_	_	_	_	_	_	_	_
67	content	_	_	_	_	_	_	_	_
68	,	_	_	_	_	_	_	_	_
69	there	_	_	_	_	_	_	_	BeginSeg=Yes
70	exist	_	_	_	_	_	_	_	_
71	two	_	_	_	_	_	_	_	_
72	stochastic	_	_	_	_	_	_	_	_
73	methods	_	_	_	_	_	_	_	_
74	,	_	_	_	_	_	_	_	_
75	multinomial	_	_	_	_	_	_	_	_
76	and	_	_	_	_	_	_	_	_
77	maximum	_	_	_	_	_	_	_	_
78	entropy	_	_	_	_	_	_	_	_
79	.	_	_	_	_	_	_	_	_
80	Both	_	_	_	_	_	_	_	BeginSeg=Yes
81	methods	_	_	_	_	_	_	_	_
82	rely	_	_	_	_	_	_	_	_
83	on	_	_	_	_	_	_	_	_
84	the	_	_	_	_	_	_	_	_
85	probability	_	_	_	_	_	_	_	_
86	of	_	_	_	_	_	_	_	BeginSeg=Yes
87	choosing	_	_	_	_	_	_	_	_
88	the	_	_	_	_	_	_	_	_
89	codon	_	_	_	_	_	_	_	_
90	synonymous	_	_	_	_	_	_	_	_
91	for	_	_	_	_	_	_	_	_
92	usage	_	_	_	_	_	_	_	_
93	in	_	_	_	_	_	_	_	_
94	regard	_	_	_	_	_	_	_	_
95	to	_	_	_	_	_	_	_	_
96	a	_	_	_	_	_	_	_	_
97	specific	_	_	_	_	_	_	_	_
98	amino	_	_	_	_	_	_	_	_
99	acid	_	_	_	_	_	_	_	_
100	.	_	_	_	_	_	_	_	_
101	In	_	_	_	_	_	_	_	BeginSeg=Yes
102	spite	_	_	_	_	_	_	_	_
103	the	_	_	_	_	_	_	_	_
104	latter	_	_	_	_	_	_	_	_
105	exhibited	_	_	_	_	_	_	_	_
106	unbiased	_	_	_	_	_	_	_	_
107	manner	_	_	_	_	_	_	_	_
108	,	_	_	_	_	_	_	_	_
109	the	_	_	_	_	_	_	_	BeginSeg=Yes
110	produced	_	_	_	_	_	_	_	_
111	sequences	_	_	_	_	_	_	_	_
112	are	_	_	_	_	_	_	_	_
113	not	_	_	_	_	_	_	_	_
114	exactly	_	_	_	_	_	_	_	_
115	obeying	_	_	_	_	_	_	_	_
116	the	_	_	_	_	_	_	_	_
117	GC	_	_	_	_	_	_	_	_
118	-	_	_	_	_	_	_	_	_
119	content	_	_	_	_	_	_	_	_
120	constraint	_	_	_	_	_	_	_	_
121	.	_	_	_	_	_	_	_	_
122	In	_	_	_	_	_	_	_	BeginSeg=Yes
123	this	_	_	_	_	_	_	_	_
124	paper	_	_	_	_	_	_	_	_
125	,	_	_	_	_	_	_	_	_
126	we	_	_	_	_	_	_	_	_
127	present	_	_	_	_	_	_	_	_
128	an	_	_	_	_	_	_	_	_
129	algorithmic	_	_	_	_	_	_	_	_
130	solution	_	_	_	_	_	_	_	_
131	to	_	_	_	_	_	_	_	BeginSeg=Yes
132	produce	_	_	_	_	_	_	_	_
133	coding	_	_	_	_	_	_	_	_
134	sequences	_	_	_	_	_	_	_	_
135	that	_	_	_	_	_	_	_	BeginSeg=Yes
136	follow	_	_	_	_	_	_	_	_
137	exactly	_	_	_	_	_	_	_	_
138	a	_	_	_	_	_	_	_	_
139	primary	_	_	_	_	_	_	_	_
140	amino	_	_	_	_	_	_	_	_
141	acid	_	_	_	_	_	_	_	_
142	sequence	_	_	_	_	_	_	_	_
143	and	_	_	_	_	_	_	_	_
144	a	_	_	_	_	_	_	_	_
145	desired	_	_	_	_	_	_	_	_
146	GC	_	_	_	_	_	_	_	_
147	-	_	_	_	_	_	_	_	_
148	content	_	_	_	_	_	_	_	_
149	.	_	_	_	_	_	_	_	_
150	The	_	_	_	_	_	_	_	BeginSeg=Yes
151	proposed	_	_	_	_	_	_	_	_
152	tool	_	_	_	_	_	_	_	_
153	,	_	_	_	_	_	_	_	_
154	namely	_	_	_	_	_	_	_	_
155	CodSeqGen	_	_	_	_	_	_	_	_
156	,	_	_	_	_	_	_	_	_
157	depends	_	_	_	_	_	_	_	_
158	on	_	_	_	_	_	_	_	_
159	random	_	_	_	_	_	_	_	_
160	selection	_	_	_	_	_	_	_	_
161	for	_	_	_	_	_	_	_	_
162	smaller	_	_	_	_	_	_	_	_
163	subsets	_	_	_	_	_	_	_	_
164	to	_	_	_	_	_	_	_	BeginSeg=Yes
165	be	_	_	_	_	_	_	_	_
166	traversed	_	_	_	_	_	_	_	_
167	using	_	_	_	_	_	_	_	BeginSeg=Yes
168	the	_	_	_	_	_	_	_	_
169	backtracking	_	_	_	_	_	_	_	_
170	approach	_	_	_	_	_	_	_	_
171	.	_	_	_	_	_	_	_	_

# newdoc_id = 3db88b442b2c693d0783756c733c55bcec669df0
1	In	_	_	_	_	_	_	_	BeginSeg=Yes
2	this	_	_	_	_	_	_	_	_
3	paper	_	_	_	_	_	_	_	_
4	are	_	_	_	_	_	_	_	_
5	presented	_	_	_	_	_	_	_	_
6	mathematical	_	_	_	_	_	_	_	_
7	predictions	_	_	_	_	_	_	_	_
8	on	_	_	_	_	_	_	_	_
9	the	_	_	_	_	_	_	_	_
10	evolution	_	_	_	_	_	_	_	_
11	in	_	_	_	_	_	_	_	_
12	time	_	_	_	_	_	_	_	_
13	of	_	_	_	_	_	_	_	_
14	the	_	_	_	_	_	_	_	_
15	number	_	_	_	_	_	_	_	_
16	of	_	_	_	_	_	_	_	_
17	positive	_	_	_	_	_	_	_	_
18	cases	_	_	_	_	_	_	_	_
19	in	_	_	_	_	_	_	_	_
20	Italy	_	_	_	_	_	_	_	_
21	of	_	_	_	_	_	_	_	_
22	the	_	_	_	_	_	_	_	_
23	COVID-19	_	_	_	_	_	_	_	_
24	pandemic	_	_	_	_	_	_	_	_
25	based	_	_	_	_	_	_	_	BeginSeg=Yes
26	on	_	_	_	_	_	_	_	_
27	official	_	_	_	_	_	_	_	_
28	data	_	_	_	_	_	_	_	_
29	and	_	_	_	_	_	_	_	_
30	on	_	_	_	_	_	_	_	_
31	the	_	_	_	_	_	_	_	_
32	use	_	_	_	_	_	_	_	_
33	of	_	_	_	_	_	_	_	_
34	a	_	_	_	_	_	_	_	_
35	function	_	_	_	_	_	_	_	_
36	of	_	_	_	_	_	_	_	_
37	the	_	_	_	_	_	_	_	_
38	type	_	_	_	_	_	_	_	_
39	of	_	_	_	_	_	_	_	_
40	a	_	_	_	_	_	_	_	_
41	Gauss	_	_	_	_	_	_	_	_
42	error	_	_	_	_	_	_	_	_
43	function	_	_	_	_	_	_	_	_
44	,	_	_	_	_	_	_	_	_
45	with	_	_	_	_	_	_	_	_
46	four	_	_	_	_	_	_	_	_
47	parameters	_	_	_	_	_	_	_	_
48	,	_	_	_	_	_	_	_	_
49	as	_	_	_	_	_	_	_	_
50	a	_	_	_	_	_	_	_	_
51	cumulative	_	_	_	_	_	_	_	_
52	distribution	_	_	_	_	_	_	_	_
53	function	_	_	_	_	_	_	_	_
54	.	_	_	_	_	_	_	_	_
55	We	_	_	_	_	_	_	_	BeginSeg=Yes
56	have	_	_	_	_	_	_	_	_
57	analyzed	_	_	_	_	_	_	_	_
58	the	_	_	_	_	_	_	_	_
59	available	_	_	_	_	_	_	_	_
60	data	_	_	_	_	_	_	_	_
61	for	_	_	_	_	_	_	_	_
62	China	_	_	_	_	_	_	_	_
63	and	_	_	_	_	_	_	_	_
64	Italy	_	_	_	_	_	_	_	_
65	.	_	_	_	_	_	_	_	_
66	The	_	_	_	_	_	_	_	BeginSeg=Yes
67	evolution	_	_	_	_	_	_	_	_
68	in	_	_	_	_	_	_	_	_
69	time	_	_	_	_	_	_	_	_
70	of	_	_	_	_	_	_	_	_
71	the	_	_	_	_	_	_	_	_
72	number	_	_	_	_	_	_	_	_
73	of	_	_	_	_	_	_	_	_
74	cumulative	_	_	_	_	_	_	_	_
75	diagnosed	_	_	_	_	_	_	_	_
76	positive	_	_	_	_	_	_	_	_
77	cases	_	_	_	_	_	_	_	_
78	of	_	_	_	_	_	_	_	_
79	COVID-19	_	_	_	_	_	_	_	_
80	in	_	_	_	_	_	_	_	_
81	China	_	_	_	_	_	_	_	_
82	very	_	_	_	_	_	_	_	_
83	well	_	_	_	_	_	_	_	_
84	approximates	_	_	_	_	_	_	_	_
85	a	_	_	_	_	_	_	_	_
86	distribution	_	_	_	_	_	_	_	_
87	of	_	_	_	_	_	_	_	_
88	the	_	_	_	_	_	_	_	_
89	type	_	_	_	_	_	_	_	_
90	of	_	_	_	_	_	_	_	_
91	the	_	_	_	_	_	_	_	_
92	error	_	_	_	_	_	_	_	_
93	function	_	_	_	_	_	_	_	_
94	,	_	_	_	_	_	_	_	_
95	that	_	_	_	_	_	_	_	BeginSeg=Yes
96	is	_	_	_	_	_	_	_	_
97	,	_	_	_	_	_	_	_	_
98	the	_	_	_	_	_	_	_	_
99	integral	_	_	_	_	_	_	_	_
100	of	_	_	_	_	_	_	_	_
101	a	_	_	_	_	_	_	_	_
102	normal	_	_	_	_	_	_	_	_
103	,	_	_	_	_	_	_	_	_
104	Gaussian	_	_	_	_	_	_	_	_
105	distribution	_	_	_	_	_	_	_	_
106	.	_	_	_	_	_	_	_	_
107	We	_	_	_	_	_	_	_	BeginSeg=Yes
108	have	_	_	_	_	_	_	_	_
109	then	_	_	_	_	_	_	_	_
110	used	_	_	_	_	_	_	_	_
111	such	_	_	_	_	_	_	_	_
112	a	_	_	_	_	_	_	_	_
113	function	_	_	_	_	_	_	_	_
114	to	_	_	_	_	_	_	_	BeginSeg=Yes
115	study	_	_	_	_	_	_	_	_
116	the	_	_	_	_	_	_	_	_
117	potential	_	_	_	_	_	_	_	_
118	evolution	_	_	_	_	_	_	_	_
119	in	_	_	_	_	_	_	_	_
120	time	_	_	_	_	_	_	_	_
121	of	_	_	_	_	_	_	_	_
122	the	_	_	_	_	_	_	_	_
123	number	_	_	_	_	_	_	_	_
124	of	_	_	_	_	_	_	_	_
125	positive	_	_	_	_	_	_	_	_
126	cases	_	_	_	_	_	_	_	_
127	in	_	_	_	_	_	_	_	_
128	Italy	_	_	_	_	_	_	_	_
129	by	_	_	_	_	_	_	_	BeginSeg=Yes
130	performing	_	_	_	_	_	_	_	_
131	a	_	_	_	_	_	_	_	_
132	number	_	_	_	_	_	_	_	_
133	of	_	_	_	_	_	_	_	_
134	fits	_	_	_	_	_	_	_	_
135	of	_	_	_	_	_	_	_	_
136	the	_	_	_	_	_	_	_	_
137	official	_	_	_	_	_	_	_	_
138	data	_	_	_	_	_	_	_	_
139	so	_	_	_	_	_	_	_	_
140	far	_	_	_	_	_	_	_	_
141	available	_	_	_	_	_	_	_	_
142	.	_	_	_	_	_	_	_	_
143	We	_	_	_	_	_	_	_	BeginSeg=Yes
144	then	_	_	_	_	_	_	_	_
145	found	_	_	_	_	_	_	_	_
146	a	_	_	_	_	_	_	_	_
147	statistical	_	_	_	_	_	_	_	_
148	prediction	_	_	_	_	_	_	_	_
149	for	_	_	_	_	_	_	_	_
150	the	_	_	_	_	_	_	_	_
151	day	_	_	_	_	_	_	_	_
152	in	_	_	_	_	_	_	_	BeginSeg=Yes
153	which	_	_	_	_	_	_	_	_
154	the	_	_	_	_	_	_	_	_
155	peak	_	_	_	_	_	_	_	_
156	of	_	_	_	_	_	_	_	_
157	the	_	_	_	_	_	_	_	_
158	number	_	_	_	_	_	_	_	_
159	of	_	_	_	_	_	_	_	_
160	daily	_	_	_	_	_	_	_	_
161	positive	_	_	_	_	_	_	_	_
162	cases	_	_	_	_	_	_	_	_
163	in	_	_	_	_	_	_	_	_
164	Italy	_	_	_	_	_	_	_	_
165	occurs	_	_	_	_	_	_	_	_
166	,	_	_	_	_	_	_	_	_
167	corresponding	_	_	_	_	_	_	_	BeginSeg=Yes
168	to	_	_	_	_	_	_	_	_
169	the	_	_	_	_	_	_	_	_
170	flex	_	_	_	_	_	_	_	_
171	of	_	_	_	_	_	_	_	_
172	the	_	_	_	_	_	_	_	_
173	fit	_	_	_	_	_	_	_	_
174	,	_	_	_	_	_	_	_	_
175	that	_	_	_	_	_	_	_	BeginSeg=Yes
176	is	_	_	_	_	_	_	_	_
177	,	_	_	_	_	_	_	_	_
178	to	_	_	_	_	_	_	_	_
179	the	_	_	_	_	_	_	_	_
180	change	_	_	_	_	_	_	_	_
181	in	_	_	_	_	_	_	_	_
182	sign	_	_	_	_	_	_	_	_
183	of	_	_	_	_	_	_	_	_
184	its	_	_	_	_	_	_	_	_
185	second	_	_	_	_	_	_	_	_
186	derivative	_	_	_	_	_	_	_	_
187	(	_	_	_	_	_	_	_	BeginSeg=Yes
188	i.e.	_	_	_	_	_	_	_	_
189	,	_	_	_	_	_	_	_	_
190	the	_	_	_	_	_	_	_	_
191	change	_	_	_	_	_	_	_	_
192	from	_	_	_	_	_	_	_	_
193	acceleration	_	_	_	_	_	_	_	_
194	to	_	_	_	_	_	_	_	_
195	deceleration	_	_	_	_	_	_	_	_
196	)	_	_	_	_	_	_	_	_
197	,	_	_	_	_	_	_	_	_
198	as	_	_	_	_	_	_	_	BeginSeg=Yes
199	well	_	_	_	_	_	_	_	_
200	as	_	_	_	_	_	_	_	_
201	of	_	_	_	_	_	_	_	_
202	the	_	_	_	_	_	_	_	_
203	day	_	_	_	_	_	_	_	_
204	in	_	_	_	_	_	_	_	BeginSeg=Yes
205	which	_	_	_	_	_	_	_	_
206	a	_	_	_	_	_	_	_	_
207	substantial	_	_	_	_	_	_	_	_
208	attenuation	_	_	_	_	_	_	_	_
209	of	_	_	_	_	_	_	_	_
210	such	_	_	_	_	_	_	_	_
211	number	_	_	_	_	_	_	_	_
212	of	_	_	_	_	_	_	_	_
213	daily	_	_	_	_	_	_	_	_
214	cases	_	_	_	_	_	_	_	_
215	is	_	_	_	_	_	_	_	_
216	reached	_	_	_	_	_	_	_	_
217	.	_	_	_	_	_	_	_	_
218	We	_	_	_	_	_	_	_	BeginSeg=Yes
219	have	_	_	_	_	_	_	_	_
220	also	_	_	_	_	_	_	_	_
221	analyzed	_	_	_	_	_	_	_	_
222	the	_	_	_	_	_	_	_	_
223	predictions	_	_	_	_	_	_	_	_
224	of	_	_	_	_	_	_	_	_
225	the	_	_	_	_	_	_	_	_
226	cumulative	_	_	_	_	_	_	_	_
227	number	_	_	_	_	_	_	_	_
228	of	_	_	_	_	_	_	_	_
229	fatalities	_	_	_	_	_	_	_	_
230	in	_	_	_	_	_	_	_	_
231	both	_	_	_	_	_	_	_	_
232	China	_	_	_	_	_	_	_	_
233	and	_	_	_	_	_	_	_	_
234	Italy	_	_	_	_	_	_	_	_
235	,	_	_	_	_	_	_	_	_
236	obtaining	_	_	_	_	_	_	_	BeginSeg=Yes
237	consistent	_	_	_	_	_	_	_	_
238	results	_	_	_	_	_	_	_	_
239	.	_	_	_	_	_	_	_	_
240	We	_	_	_	_	_	_	_	BeginSeg=Yes
241	have	_	_	_	_	_	_	_	_
242	then	_	_	_	_	_	_	_	_
243	performed	_	_	_	_	_	_	_	_
244	150	_	_	_	_	_	_	_	_
245	Monte	_	_	_	_	_	_	_	_
246	Carlo	_	_	_	_	_	_	_	_
247	simulations	_	_	_	_	_	_	_	_
248	to	_	_	_	_	_	_	_	BeginSeg=Yes
249	have	_	_	_	_	_	_	_	_
250	a	_	_	_	_	_	_	_	_
251	more	_	_	_	_	_	_	_	_
252	robust	_	_	_	_	_	_	_	_
253	prediction	_	_	_	_	_	_	_	_
254	of	_	_	_	_	_	_	_	_
255	the	_	_	_	_	_	_	_	_
256	day	_	_	_	_	_	_	_	_
257	of	_	_	_	_	_	_	_	_
258	the	_	_	_	_	_	_	_	_
259	above	_	_	_	_	_	_	_	_
260	-	_	_	_	_	_	_	_	_
261	mentioned	_	_	_	_	_	_	_	_
262	peak	_	_	_	_	_	_	_	_
263	and	_	_	_	_	_	_	_	_
264	of	_	_	_	_	_	_	_	_
265	the	_	_	_	_	_	_	_	_
266	day	_	_	_	_	_	_	_	_
267	of	_	_	_	_	_	_	_	_
268	the	_	_	_	_	_	_	_	_
269	substantial	_	_	_	_	_	_	_	_
270	decrease	_	_	_	_	_	_	_	_
271	in	_	_	_	_	_	_	_	_
272	the	_	_	_	_	_	_	_	_
273	number	_	_	_	_	_	_	_	_
274	of	_	_	_	_	_	_	_	_
275	daily	_	_	_	_	_	_	_	_
276	positive	_	_	_	_	_	_	_	_
277	cases	_	_	_	_	_	_	_	_
278	and	_	_	_	_	_	_	_	_
279	fatalities	_	_	_	_	_	_	_	_
280	.	_	_	_	_	_	_	_	_
281	Although	_	_	_	_	_	_	_	BeginSeg=Yes
282	official	_	_	_	_	_	_	_	_
283	data	_	_	_	_	_	_	_	_
284	have	_	_	_	_	_	_	_	_
285	been	_	_	_	_	_	_	_	_
286	used	_	_	_	_	_	_	_	_
287	,	_	_	_	_	_	_	_	_
288	those	_	_	_	_	_	_	_	BeginSeg=Yes
289	predictions	_	_	_	_	_	_	_	_
290	are	_	_	_	_	_	_	_	_
291	obtained	_	_	_	_	_	_	_	_
292	with	_	_	_	_	_	_	_	_
293	a	_	_	_	_	_	_	_	_
294	heuristic	_	_	_	_	_	_	_	_
295	approach	_	_	_	_	_	_	_	_
296	since	_	_	_	_	_	_	_	BeginSeg=Yes
297	they	_	_	_	_	_	_	_	_
298	are	_	_	_	_	_	_	_	_
299	based	_	_	_	_	_	_	_	_
300	on	_	_	_	_	_	_	_	_
301	a	_	_	_	_	_	_	_	_
302	statistical	_	_	_	_	_	_	_	_
303	approach	_	_	_	_	_	_	_	_
304	and	_	_	_	_	_	_	_	BeginSeg=Yes
305	do	_	_	_	_	_	_	_	_
306	not	_	_	_	_	_	_	_	_
307	take	_	_	_	_	_	_	_	_
308	into	_	_	_	_	_	_	_	_
309	account	_	_	_	_	_	_	_	_
310	either	_	_	_	_	_	_	_	_
311	a	_	_	_	_	_	_	_	_
312	number	_	_	_	_	_	_	_	_
313	of	_	_	_	_	_	_	_	_
314	relevant	_	_	_	_	_	_	_	_
315	issues	_	_	_	_	_	_	_	_
316	(	_	_	_	_	_	_	_	BeginSeg=Yes
317	such	_	_	_	_	_	_	_	_
318	as	_	_	_	_	_	_	_	_
319	number	_	_	_	_	_	_	_	_
320	of	_	_	_	_	_	_	_	_
321	daily	_	_	_	_	_	_	_	_
322	nasopharyngeal	_	_	_	_	_	_	_	_
323	swabs	_	_	_	_	_	_	_	_
324	,	_	_	_	_	_	_	_	_
325	medical	_	_	_	_	_	_	_	_
326	,	_	_	_	_	_	_	_	_
327	social	_	_	_	_	_	_	_	_
328	distancing	_	_	_	_	_	_	_	_
329	,	_	_	_	_	_	_	_	_
330	virological	_	_	_	_	_	_	_	_
331	and	_	_	_	_	_	_	_	_
332	epidemiological	_	_	_	_	_	_	_	_
333	)	_	_	_	_	_	_	_	_
334	or	_	_	_	_	_	_	_	BeginSeg=Yes
335	models	_	_	_	_	_	_	_	_
336	of	_	_	_	_	_	_	_	_
337	contamination	_	_	_	_	_	_	_	_
338	diffusion	_	_	_	_	_	_	_	_
339	.	_	_	_	_	_	_	_	_

# newdoc_id = 3e8d0363f49f83917e0ddddf7b4322186da47dbc
1	Shotgun	_	_	_	_	_	_	_	BeginSeg=Yes
2	metagenomics	_	_	_	_	_	_	_	_
3	using	_	_	_	_	_	_	_	BeginSeg=Yes
4	next	_	_	_	_	_	_	_	_
5	generation	_	_	_	_	_	_	_	_
6	sequencing	_	_	_	_	_	_	_	_
7	(	_	_	_	_	_	_	_	_
8	NGS	_	_	_	_	_	_	_	_
9	)	_	_	_	_	_	_	_	_
10	is	_	_	_	_	_	_	_	BeginSeg=Yes
11	a	_	_	_	_	_	_	_	_
12	promising	_	_	_	_	_	_	_	_
13	technique	_	_	_	_	_	_	_	_
14	to	_	_	_	_	_	_	_	BeginSeg=Yes
15	analyze	_	_	_	_	_	_	_	_
16	both	_	_	_	_	_	_	_	_
17	DNA	_	_	_	_	_	_	_	_
18	and	_	_	_	_	_	_	_	_
19	RNA	_	_	_	_	_	_	_	_
20	microbial	_	_	_	_	_	_	_	_
21	material	_	_	_	_	_	_	_	_
22	from	_	_	_	_	_	_	_	_
23	patient	_	_	_	_	_	_	_	_
24	samples	_	_	_	_	_	_	_	_
25	.	_	_	_	_	_	_	_	_
26	Mostly	_	_	_	_	_	_	_	BeginSeg=Yes
27	used	_	_	_	_	_	_	_	_
28	in	_	_	_	_	_	_	_	_
29	a	_	_	_	_	_	_	_	_
30	research	_	_	_	_	_	_	_	_
31	setting	_	_	_	_	_	_	_	_
32	,	_	_	_	_	_	_	_	_
33	it	_	_	_	_	_	_	_	BeginSeg=Yes
34	is	_	_	_	_	_	_	_	_
35	now	_	_	_	_	_	_	_	_
36	increasingly	_	_	_	_	_	_	_	_
37	being	_	_	_	_	_	_	_	_
38	used	_	_	_	_	_	_	_	_
39	in	_	_	_	_	_	_	_	_
40	the	_	_	_	_	_	_	_	_
41	clinical	_	_	_	_	_	_	_	_
42	realm	_	_	_	_	_	_	_	_
43	as	_	_	_	_	_	_	_	_
44	well	_	_	_	_	_	_	_	_
45	,	_	_	_	_	_	_	_	_
46	notably	_	_	_	_	_	_	_	BeginSeg=Yes
47	to	_	_	_	_	_	_	_	_
48	support	_	_	_	_	_	_	_	_
49	diagnosis	_	_	_	_	_	_	_	_
50	of	_	_	_	_	_	_	_	_
51	viral	_	_	_	_	_	_	_	_
52	infections	_	_	_	_	_	_	_	_
53	,	_	_	_	_	_	_	_	_
54	thereby	_	_	_	_	_	_	_	BeginSeg=Yes
55	calling	_	_	_	_	_	_	_	_
56	for	_	_	_	_	_	_	_	_
57	quality	_	_	_	_	_	_	_	_
58	control	_	_	_	_	_	_	_	_
59	and	_	_	_	_	_	_	_	_
60	the	_	_	_	_	_	_	_	_
61	implementation	_	_	_	_	_	_	_	_
62	of	_	_	_	_	_	_	_	_
63	ring	_	_	_	_	_	_	_	_
64	trials	_	_	_	_	_	_	_	_
65	(	_	_	_	_	_	_	_	_
66	RT	_	_	_	_	_	_	_	_
67	)	_	_	_	_	_	_	_	_
68	to	_	_	_	_	_	_	_	BeginSeg=Yes
69	benchmark	_	_	_	_	_	_	_	_
70	pipelines	_	_	_	_	_	_	_	_
71	and	_	_	_	_	_	_	_	BeginSeg=Yes
72	ensure	_	_	_	_	_	_	_	_
73	comparable	_	_	_	_	_	_	_	_
74	results	_	_	_	_	_	_	_	_
75	.	_	_	_	_	_	_	_	_
76	The	_	_	_	_	_	_	_	BeginSeg=Yes
77	Swiss	_	_	_	_	_	_	_	_
78	NGS	_	_	_	_	_	_	_	_
79	clinical	_	_	_	_	_	_	_	_
80	virology	_	_	_	_	_	_	_	_
81	community	_	_	_	_	_	_	_	_
82	therefore	_	_	_	_	_	_	_	_
83	decided	_	_	_	_	_	_	_	_
84	to	_	_	_	_	_	_	_	_
85	conduct	_	_	_	_	_	_	_	_
86	a	_	_	_	_	_	_	_	_
87	RT	_	_	_	_	_	_	_	_
88	in	_	_	_	_	_	_	_	_
89	2018	_	_	_	_	_	_	_	_
90	,	_	_	_	_	_	_	_	_
91	in	_	_	_	_	_	_	_	BeginSeg=Yes
92	order	_	_	_	_	_	_	_	_
93	to	_	_	_	_	_	_	_	_
94	benchmark	_	_	_	_	_	_	_	_
95	current	_	_	_	_	_	_	_	_
96	metagenomic	_	_	_	_	_	_	_	_
97	workflows	_	_	_	_	_	_	_	_
98	used	_	_	_	_	_	_	_	BeginSeg=Yes
99	at	_	_	_	_	_	_	_	_
100	Swiss	_	_	_	_	_	_	_	_
101	clinical	_	_	_	_	_	_	_	_
102	virology	_	_	_	_	_	_	_	_
103	laboratories	_	_	_	_	_	_	_	_
104	,	_	_	_	_	_	_	_	_
105	and	_	_	_	_	_	_	_	BeginSeg=Yes
106	thereby	_	_	_	_	_	_	_	_
107	contribute	_	_	_	_	_	_	_	_
108	to	_	_	_	_	_	_	_	_
109	the	_	_	_	_	_	_	_	_
110	definition	_	_	_	_	_	_	_	_
111	of	_	_	_	_	_	_	_	_
112	common	_	_	_	_	_	_	_	_
113	best	_	_	_	_	_	_	_	_
114	practices	_	_	_	_	_	_	_	_
115	.	_	_	_	_	_	_	_	_
116	The	_	_	_	_	_	_	_	BeginSeg=Yes
117	RT	_	_	_	_	_	_	_	_
118	consisted	_	_	_	_	_	_	_	_
119	of	_	_	_	_	_	_	_	_
120	two	_	_	_	_	_	_	_	_
121	parts	_	_	_	_	_	_	_	_
122	(	_	_	_	_	_	_	_	BeginSeg=Yes
123	increments	_	_	_	_	_	_	_	_
124	)	_	_	_	_	_	_	_	_
125	,	_	_	_	_	_	_	_	_
126	in	_	_	_	_	_	_	_	BeginSeg=Yes
127	order	_	_	_	_	_	_	_	_
128	to	_	_	_	_	_	_	_	_
129	disentangle	_	_	_	_	_	_	_	_
130	the	_	_	_	_	_	_	_	_
131	variability	_	_	_	_	_	_	_	_
132	arising	_	_	_	_	_	_	_	BeginSeg=Yes
133	from	_	_	_	_	_	_	_	_
134	the	_	_	_	_	_	_	_	_
135	experimental	_	_	_	_	_	_	_	_
136	compared	_	_	_	_	_	_	_	BeginSeg=Yes
137	to	_	_	_	_	_	_	_	_
138	the	_	_	_	_	_	_	_	_
139	bioinformatics	_	_	_	_	_	_	_	_
140	parts	_	_	_	_	_	_	_	_
141	of	_	_	_	_	_	_	_	_
142	the	_	_	_	_	_	_	_	_
143	laboratory	_	_	_	_	_	_	_	_
144	pipeline	_	_	_	_	_	_	_	_
145	.	_	_	_	_	_	_	_	_
146	In	_	_	_	_	_	_	_	BeginSeg=Yes
147	addition	_	_	_	_	_	_	_	_
148	,	_	_	_	_	_	_	_	_
149	the	_	_	_	_	_	_	_	_
150	RT	_	_	_	_	_	_	_	_
151	was	_	_	_	_	_	_	_	_
152	also	_	_	_	_	_	_	_	_
153	designed	_	_	_	_	_	_	_	_
154	to	_	_	_	_	_	_	_	BeginSeg=Yes
155	assess	_	_	_	_	_	_	_	_
156	the	_	_	_	_	_	_	_	_
157	impact	_	_	_	_	_	_	_	_
158	of	_	_	_	_	_	_	_	_
159	databases	_	_	_	_	_	_	_	_
160	compared	_	_	_	_	_	_	_	BeginSeg=Yes
161	to	_	_	_	_	_	_	_	_
162	bioinformatics	_	_	_	_	_	_	_	_
163	algorithms	_	_	_	_	_	_	_	_
164	on	_	_	_	_	_	_	_	_
165	the	_	_	_	_	_	_	_	_
166	final	_	_	_	_	_	_	_	_
167	results	_	_	_	_	_	_	_	_
168	,	_	_	_	_	_	_	_	_
169	by	_	_	_	_	_	_	_	BeginSeg=Yes
170	asking	_	_	_	_	_	_	_	_
171	participants	_	_	_	_	_	_	_	_
172	to	_	_	_	_	_	_	_	_
173	perform	_	_	_	_	_	_	_	_
174	the	_	_	_	_	_	_	_	_
175	bioinformatics	_	_	_	_	_	_	_	_
176	analysis	_	_	_	_	_	_	_	_
177	with	_	_	_	_	_	_	_	_
178	a	_	_	_	_	_	_	_	_
179	common	_	_	_	_	_	_	_	_
180	database	_	_	_	_	_	_	_	_
181	,	_	_	_	_	_	_	_	_
182	in	_	_	_	_	_	_	_	BeginSeg=Yes
183	addition	_	_	_	_	_	_	_	_
184	to	_	_	_	_	_	_	_	_
185	using	_	_	_	_	_	_	_	_
186	their	_	_	_	_	_	_	_	_
187	own	_	_	_	_	_	_	_	_
188	in	_	_	_	_	_	_	_	_
189	-	_	_	_	_	_	_	_	_
190	house	_	_	_	_	_	_	_	_
191	database	_	_	_	_	_	_	_	_
192	.	_	_	_	_	_	_	_	_
193	Five	_	_	_	_	_	_	_	BeginSeg=Yes
194	laboratories	_	_	_	_	_	_	_	_
195	participated	_	_	_	_	_	_	_	_
196	in	_	_	_	_	_	_	_	_
197	the	_	_	_	_	_	_	_	_
198	RT	_	_	_	_	_	_	_	_
199	(	_	_	_	_	_	_	_	BeginSeg=Yes
200	seven	_	_	_	_	_	_	_	_
201	pipelines	_	_	_	_	_	_	_	_
202	were	_	_	_	_	_	_	_	_
203	tested	_	_	_	_	_	_	_	_
204	)	_	_	_	_	_	_	_	_
205	.	_	_	_	_	_	_	_	_
206	We	_	_	_	_	_	_	_	BeginSeg=Yes
207	observed	_	_	_	_	_	_	_	_
208	that	_	_	_	_	_	_	_	BeginSeg=Yes
209	the	_	_	_	_	_	_	_	_
210	algorithms	_	_	_	_	_	_	_	_
211	had	_	_	_	_	_	_	_	_
212	a	_	_	_	_	_	_	_	_
213	stronger	_	_	_	_	_	_	_	_
214	impact	_	_	_	_	_	_	_	_
215	on	_	_	_	_	_	_	_	_
216	the	_	_	_	_	_	_	_	_
217	overall	_	_	_	_	_	_	_	_
218	performance	_	_	_	_	_	_	_	_
219	than	_	_	_	_	_	_	_	_
220	the	_	_	_	_	_	_	_	_
221	choice	_	_	_	_	_	_	_	_
222	of	_	_	_	_	_	_	_	_
223	the	_	_	_	_	_	_	_	_
224	reference	_	_	_	_	_	_	_	_
225	database	_	_	_	_	_	_	_	_
226	.	_	_	_	_	_	_	_	_
227	Our	_	_	_	_	_	_	_	BeginSeg=Yes
228	results	_	_	_	_	_	_	_	_
229	also	_	_	_	_	_	_	_	_
230	suggest	_	_	_	_	_	_	_	_
231	that	_	_	_	_	_	_	_	BeginSeg=Yes
232	differences	_	_	_	_	_	_	_	_
233	in	_	_	_	_	_	_	_	_
234	sample	_	_	_	_	_	_	_	_
235	preparation	_	_	_	_	_	_	_	_
236	can	_	_	_	_	_	_	_	_
237	lead	_	_	_	_	_	_	_	_
238	to	_	_	_	_	_	_	_	_
239	significant	_	_	_	_	_	_	_	_
240	differences	_	_	_	_	_	_	_	_
241	in	_	_	_	_	_	_	_	_
242	the	_	_	_	_	_	_	_	_
243	performance	_	_	_	_	_	_	_	_
244	,	_	_	_	_	_	_	_	_
245	and	_	_	_	_	_	_	_	BeginSeg=Yes
246	that	_	_	_	_	_	_	_	_
247	laboratories	_	_	_	_	_	_	_	_
248	should	_	_	_	_	_	_	_	_
249	aim	_	_	_	_	_	_	_	_
250	for	_	_	_	_	_	_	_	_
251	at	_	_	_	_	_	_	_	_
252	least	_	_	_	_	_	_	_	_
253	5	_	_	_	_	_	_	_	_
254	-	_	_	_	_	_	_	_	_
255	10	_	_	_	_	_	_	_	_
256	Mio	_	_	_	_	_	_	_	_
257	reads	_	_	_	_	_	_	_	_
258	per	_	_	_	_	_	_	_	_
259	sample	_	_	_	_	_	_	_	_
260	and	_	_	_	_	_	_	_	BeginSeg=Yes
261	use	_	_	_	_	_	_	_	_
262	depth	_	_	_	_	_	_	_	_
263	of	_	_	_	_	_	_	_	_
264	coverage	_	_	_	_	_	_	_	_
265	in	_	_	_	_	_	_	_	_
266	addition	_	_	_	_	_	_	_	_
267	to	_	_	_	_	_	_	_	_
268	other	_	_	_	_	_	_	_	_
269	interpretation	_	_	_	_	_	_	_	_
270	metrics	_	_	_	_	_	_	_	_
271	such	_	_	_	_	_	_	_	BeginSeg=Yes
272	as	_	_	_	_	_	_	_	_
273	the	_	_	_	_	_	_	_	_
274	percent	_	_	_	_	_	_	_	_
275	of	_	_	_	_	_	_	_	_
276	coverage	_	_	_	_	_	_	_	_
277	.	_	_	_	_	_	_	_	_
278	Performance	_	_	_	_	_	_	_	BeginSeg=Yes
279	was	_	_	_	_	_	_	_	_
280	generally	_	_	_	_	_	_	_	_
281	lower	_	_	_	_	_	_	_	_
282	when	_	_	_	_	_	_	_	BeginSeg=Yes
283	increasing	_	_	_	_	_	_	_	_
284	the	_	_	_	_	_	_	_	_
285	number	_	_	_	_	_	_	_	_
286	of	_	_	_	_	_	_	_	_
287	viruses	_	_	_	_	_	_	_	_
288	per	_	_	_	_	_	_	_	_
289	sample	_	_	_	_	_	_	_	_
290	.	_	_	_	_	_	_	_	_
291	The	_	_	_	_	_	_	_	BeginSeg=Yes
292	lessons	_	_	_	_	_	_	_	_
293	learned	_	_	_	_	_	_	_	BeginSeg=Yes
294	from	_	_	_	_	_	_	_	_
295	this	_	_	_	_	_	_	_	_
296	pilot	_	_	_	_	_	_	_	_
297	study	_	_	_	_	_	_	_	_
298	will	_	_	_	_	_	_	_	BeginSeg=Yes
299	be	_	_	_	_	_	_	_	_
300	useful	_	_	_	_	_	_	_	_
301	for	_	_	_	_	_	_	_	_
302	the	_	_	_	_	_	_	_	_
303	development	_	_	_	_	_	_	_	_
304	of	_	_	_	_	_	_	_	_
305	larger	_	_	_	_	_	_	_	_
306	-	_	_	_	_	_	_	_	_
307	scale	_	_	_	_	_	_	_	_
308	RTs	_	_	_	_	_	_	_	_
309	to	_	_	_	_	_	_	_	BeginSeg=Yes
310	serve	_	_	_	_	_	_	_	_
311	as	_	_	_	_	_	_	_	_
312	regular	_	_	_	_	_	_	_	_
313	quality	_	_	_	_	_	_	_	_
314	control	_	_	_	_	_	_	_	_
315	tests	_	_	_	_	_	_	_	_
316	for	_	_	_	_	_	_	_	_
317	laboratories	_	_	_	_	_	_	_	_
318	performing	_	_	_	_	_	_	_	BeginSeg=Yes
319	NGS	_	_	_	_	_	_	_	_
320	analyses	_	_	_	_	_	_	_	_
321	of	_	_	_	_	_	_	_	_
322	viruses	_	_	_	_	_	_	_	_
323	in	_	_	_	_	_	_	_	_
324	a	_	_	_	_	_	_	_	_
325	clinical	_	_	_	_	_	_	_	_
326	setting	_	_	_	_	_	_	_	_
327	.	_	_	_	_	_	_	_	_

# newdoc_id = 3f8d61cff42f5714412479237e85de075e817fae
1	Porcine	_	_	_	_	_	_	_	BeginSeg=Yes
2	β	_	_	_	_	_	_	_	_
3	-	_	_	_	_	_	_	_	_
4	defensin	_	_	_	_	_	_	_	_
5	2	_	_	_	_	_	_	_	_
6	(	_	_	_	_	_	_	_	_
7	PBD-2	_	_	_	_	_	_	_	_
8	)	_	_	_	_	_	_	_	_
9	,	_	_	_	_	_	_	_	_
10	expressed	_	_	_	_	_	_	_	BeginSeg=Yes
11	by	_	_	_	_	_	_	_	_
12	different	_	_	_	_	_	_	_	_
13	tissues	_	_	_	_	_	_	_	_
14	of	_	_	_	_	_	_	_	_
15	pigs	_	_	_	_	_	_	_	_
16	,	_	_	_	_	_	_	_	_
17	is	_	_	_	_	_	_	_	BeginSeg=Yes
18	a	_	_	_	_	_	_	_	_
19	multifunctional	_	_	_	_	_	_	_	_
20	cationic	_	_	_	_	_	_	_	_
21	peptide	_	_	_	_	_	_	_	_
22	with	_	_	_	_	_	_	_	_
23	antimicrobial	_	_	_	_	_	_	_	_
24	,	_	_	_	_	_	_	_	_
25	immunomodulatory	_	_	_	_	_	_	_	_
26	and	_	_	_	_	_	_	_	_
27	growth	_	_	_	_	_	_	_	_
28	-	_	_	_	_	_	_	_	_
29	promoting	_	_	_	_	_	_	_	_
30	abilities	_	_	_	_	_	_	_	_
31	.	_	_	_	_	_	_	_	_
32	As	_	_	_	_	_	_	_	BeginSeg=Yes
33	the	_	_	_	_	_	_	_	_
34	latest	_	_	_	_	_	_	_	_
35	generation	_	_	_	_	_	_	_	_
36	of	_	_	_	_	_	_	_	_
37	genome	_	_	_	_	_	_	_	_
38	-	_	_	_	_	_	_	_	_
39	editing	_	_	_	_	_	_	_	_
40	tool	_	_	_	_	_	_	_	_
41	,	_	_	_	_	_	_	_	_
42	CRISPR	_	_	_	_	_	_	_	_
43	/	_	_	_	_	_	_	_	_
44	Cas9	_	_	_	_	_	_	_	_
45	system	_	_	_	_	_	_	_	_
46	makes	_	_	_	_	_	_	_	_
47	it	_	_	_	_	_	_	_	_
48	possible	_	_	_	_	_	_	_	_
49	to	_	_	_	_	_	_	_	_
50	enhance	_	_	_	_	_	_	_	_
51	the	_	_	_	_	_	_	_	_
52	expression	_	_	_	_	_	_	_	_
53	of	_	_	_	_	_	_	_	_
54	PBD-2	_	_	_	_	_	_	_	_
55	in	_	_	_	_	_	_	_	_
56	pigs	_	_	_	_	_	_	_	_
57	by	_	_	_	_	_	_	_	_
58	site	_	_	_	_	_	_	_	_
59	-	_	_	_	_	_	_	_	_
60	specific	_	_	_	_	_	_	_	_
61	knock	_	_	_	_	_	_	_	_
62	-	_	_	_	_	_	_	_	_
63	in	_	_	_	_	_	_	_	_
64	of	_	_	_	_	_	_	_	_
65	pbd-2	_	_	_	_	_	_	_	_
66	gene	_	_	_	_	_	_	_	_
67	into	_	_	_	_	_	_	_	_
68	the	_	_	_	_	_	_	_	_
69	pig	_	_	_	_	_	_	_	_
70	genome	_	_	_	_	_	_	_	_
71	.	_	_	_	_	_	_	_	_
72	In	_	_	_	_	_	_	_	BeginSeg=Yes
73	this	_	_	_	_	_	_	_	_
74	study	_	_	_	_	_	_	_	_
75	,	_	_	_	_	_	_	_	_
76	we	_	_	_	_	_	_	_	_
77	aimed	_	_	_	_	_	_	_	_
78	to	_	_	_	_	_	_	_	_
79	generate	_	_	_	_	_	_	_	_
80	marker	_	_	_	_	_	_	_	_
81	-	_	_	_	_	_	_	_	_
82	free	_	_	_	_	_	_	_	_
83	pbd-2	_	_	_	_	_	_	_	_
84	knock	_	_	_	_	_	_	_	_
85	-	_	_	_	_	_	_	_	_
86	in	_	_	_	_	_	_	_	_
87	pigs	_	_	_	_	_	_	_	_
88	using	_	_	_	_	_	_	_	BeginSeg=Yes
89	the	_	_	_	_	_	_	_	_
90	CRISPR	_	_	_	_	_	_	_	_
91	/	_	_	_	_	_	_	_	_
92	Cas9	_	_	_	_	_	_	_	_
93	and	_	_	_	_	_	_	_	_
94	Cre	_	_	_	_	_	_	_	_
95	/	_	_	_	_	_	_	_	_
96	loxP	_	_	_	_	_	_	_	_
97	systems	_	_	_	_	_	_	_	_
98	.	_	_	_	_	_	_	_	_
99	Two	_	_	_	_	_	_	_	BeginSeg=Yes
100	copies	_	_	_	_	_	_	_	_
101	of	_	_	_	_	_	_	_	_
102	pbd-2	_	_	_	_	_	_	_	_
103	gene	_	_	_	_	_	_	_	_
104	linked	_	_	_	_	_	_	_	BeginSeg=Yes
105	by	_	_	_	_	_	_	_	_
106	a	_	_	_	_	_	_	_	_
107	T2A	_	_	_	_	_	_	_	_
108	sequence	_	_	_	_	_	_	_	_
109	were	_	_	_	_	_	_	_	BeginSeg=Yes
110	inserted	_	_	_	_	_	_	_	_
111	into	_	_	_	_	_	_	_	_
112	the	_	_	_	_	_	_	_	_
113	porcine	_	_	_	_	_	_	_	_
114	Rosa26	_	_	_	_	_	_	_	_
115	locus	_	_	_	_	_	_	_	_
116	through	_	_	_	_	_	_	_	_
117	CRISPR	_	_	_	_	_	_	_	_
118	/	_	_	_	_	_	_	_	_
119	Cas9-mediated	_	_	_	_	_	_	_	_
120	homology	_	_	_	_	_	_	_	_
121	-	_	_	_	_	_	_	_	_
122	directed	_	_	_	_	_	_	_	_
123	repair	_	_	_	_	_	_	_	_
124	.	_	_	_	_	_	_	_	_
125	The	_	_	_	_	_	_	_	BeginSeg=Yes
126	floxed	_	_	_	_	_	_	_	_
127	selectable	_	_	_	_	_	_	_	_
128	marker	_	_	_	_	_	_	_	_
129	gene	_	_	_	_	_	_	_	_
130	neoR	_	_	_	_	_	_	_	_
131	,	_	_	_	_	_	_	_	_
132	used	_	_	_	_	_	_	_	BeginSeg=Yes
133	for	_	_	_	_	_	_	_	_
134	G418	_	_	_	_	_	_	_	_
135	screening	_	_	_	_	_	_	_	_
136	of	_	_	_	_	_	_	_	_
137	positive	_	_	_	_	_	_	_	_
138	cell	_	_	_	_	_	_	_	_
139	clones	_	_	_	_	_	_	_	_
140	,	_	_	_	_	_	_	_	_
141	was	_	_	_	_	_	_	_	BeginSeg=Yes
142	removed	_	_	_	_	_	_	_	_
143	by	_	_	_	_	_	_	_	_
144	cell	_	_	_	_	_	_	_	_
145	-	_	_	_	_	_	_	_	_
146	penetrating	_	_	_	_	_	_	_	_
147	Cre	_	_	_	_	_	_	_	_
148	recombinase	_	_	_	_	_	_	_	_
149	with	_	_	_	_	_	_	_	_
150	a	_	_	_	_	_	_	_	_
151	recombination	_	_	_	_	_	_	_	_
152	efficiency	_	_	_	_	_	_	_	_
153	of	_	_	_	_	_	_	_	_
154	48.3	_	_	_	_	_	_	_	_
155	%	_	_	_	_	_	_	_	_
156	.	_	_	_	_	_	_	_	_
157	Cloned	_	_	_	_	_	_	_	BeginSeg=Yes
158	piglets	_	_	_	_	_	_	_	_
159	were	_	_	_	_	_	_	_	_
160	produced	_	_	_	_	_	_	_	_
161	via	_	_	_	_	_	_	_	_
162	somatic	_	_	_	_	_	_	_	_
163	cell	_	_	_	_	_	_	_	_
164	nuclear	_	_	_	_	_	_	_	_
165	transfer	_	_	_	_	_	_	_	_
166	and	_	_	_	_	_	_	_	BeginSeg=Yes
167	correct	_	_	_	_	_	_	_	_
168	insertion	_	_	_	_	_	_	_	_
169	of	_	_	_	_	_	_	_	_
170	pbd-2	_	_	_	_	_	_	_	_
171	genes	_	_	_	_	_	_	_	_
172	was	_	_	_	_	_	_	_	_
173	confirmed	_	_	_	_	_	_	_	_
174	by	_	_	_	_	_	_	_	_
175	PCR	_	_	_	_	_	_	_	_
176	and	_	_	_	_	_	_	_	_
177	Southern	_	_	_	_	_	_	_	_
178	blot	_	_	_	_	_	_	_	_
179	.	_	_	_	_	_	_	_	_
180	Immunohistochemistry	_	_	_	_	_	_	_	BeginSeg=Yes
181	and	_	_	_	_	_	_	_	_
182	immunofluorescence	_	_	_	_	_	_	_	_
183	analyses	_	_	_	_	_	_	_	_
184	indicated	_	_	_	_	_	_	_	_
185	that	_	_	_	_	_	_	_	BeginSeg=Yes
186	expression	_	_	_	_	_	_	_	_
187	levels	_	_	_	_	_	_	_	_
188	of	_	_	_	_	_	_	_	_
189	PBD-2	_	_	_	_	_	_	_	_
190	in	_	_	_	_	_	_	_	_
191	different	_	_	_	_	_	_	_	_
192	tissues	_	_	_	_	_	_	_	_
193	of	_	_	_	_	_	_	_	_
194	transgenic	_	_	_	_	_	_	_	_
195	(	_	_	_	_	_	_	_	_
196	TG	_	_	_	_	_	_	_	_
197	)	_	_	_	_	_	_	_	_
198	piglets	_	_	_	_	_	_	_	_
199	were	_	_	_	_	_	_	_	_
200	significantly	_	_	_	_	_	_	_	_
201	higher	_	_	_	_	_	_	_	_
202	than	_	_	_	_	_	_	_	_
203	those	_	_	_	_	_	_	_	_
204	of	_	_	_	_	_	_	_	_
205	their	_	_	_	_	_	_	_	_
206	wild	_	_	_	_	_	_	_	_
207	-	_	_	_	_	_	_	_	_
208	type	_	_	_	_	_	_	_	_
209	(	_	_	_	_	_	_	_	_
210	WT	_	_	_	_	_	_	_	_
211	)	_	_	_	_	_	_	_	_
212	littermates	_	_	_	_	_	_	_	_
213	.	_	_	_	_	_	_	_	_
214	Bactericidal	_	_	_	_	_	_	_	BeginSeg=Yes
215	assays	_	_	_	_	_	_	_	_
216	demonstrated	_	_	_	_	_	_	_	_
217	that	_	_	_	_	_	_	_	BeginSeg=Yes
218	there	_	_	_	_	_	_	_	_
219	was	_	_	_	_	_	_	_	_
220	a	_	_	_	_	_	_	_	_
221	significant	_	_	_	_	_	_	_	_
222	increase	_	_	_	_	_	_	_	_
223	in	_	_	_	_	_	_	_	_
224	the	_	_	_	_	_	_	_	_
225	antimicrobial	_	_	_	_	_	_	_	_
226	properties	_	_	_	_	_	_	_	_
227	of	_	_	_	_	_	_	_	_
228	the	_	_	_	_	_	_	_	_
229	cell	_	_	_	_	_	_	_	_
230	culture	_	_	_	_	_	_	_	_
231	supernatants	_	_	_	_	_	_	_	_
232	of	_	_	_	_	_	_	_	_
233	porcine	_	_	_	_	_	_	_	_
234	ear	_	_	_	_	_	_	_	_
235	fibroblasts	_	_	_	_	_	_	_	_
236	from	_	_	_	_	_	_	_	_
237	the	_	_	_	_	_	_	_	_
238	TG	_	_	_	_	_	_	_	_
239	pigs	_	_	_	_	_	_	_	_
240	in	_	_	_	_	_	_	_	BeginSeg=Yes
241	comparison	_	_	_	_	_	_	_	_
242	to	_	_	_	_	_	_	_	_
243	those	_	_	_	_	_	_	_	_
244	from	_	_	_	_	_	_	_	_
245	the	_	_	_	_	_	_	_	_
246	WT	_	_	_	_	_	_	_	_
247	pigs	_	_	_	_	_	_	_	_
248	.	_	_	_	_	_	_	_	_
249	Altogether	_	_	_	_	_	_	_	BeginSeg=Yes
250	,	_	_	_	_	_	_	_	_
251	our	_	_	_	_	_	_	_	_
252	study	_	_	_	_	_	_	_	_
253	improved	_	_	_	_	_	_	_	_
254	the	_	_	_	_	_	_	_	_
255	protein	_	_	_	_	_	_	_	_
256	expression	_	_	_	_	_	_	_	_
257	level	_	_	_	_	_	_	_	_
258	of	_	_	_	_	_	_	_	_
259	PBD-2	_	_	_	_	_	_	_	_
260	in	_	_	_	_	_	_	_	_
261	pigs	_	_	_	_	_	_	_	_
262	by	_	_	_	_	_	_	_	_
263	site	_	_	_	_	_	_	_	_
264	-	_	_	_	_	_	_	_	_
265	specific	_	_	_	_	_	_	_	_
266	integration	_	_	_	_	_	_	_	_
267	of	_	_	_	_	_	_	_	_
268	pbd-2	_	_	_	_	_	_	_	_
269	into	_	_	_	_	_	_	_	_
270	the	_	_	_	_	_	_	_	_
271	pig	_	_	_	_	_	_	_	_
272	genome	_	_	_	_	_	_	_	_
273	,	_	_	_	_	_	_	_	_
274	which	_	_	_	_	_	_	_	BeginSeg=Yes
275	not	_	_	_	_	_	_	_	_
276	only	_	_	_	_	_	_	_	_
277	provided	_	_	_	_	_	_	_	_
278	an	_	_	_	_	_	_	_	_
279	effective	_	_	_	_	_	_	_	_
280	pig	_	_	_	_	_	_	_	_
281	model	_	_	_	_	_	_	_	_
282	to	_	_	_	_	_	_	_	BeginSeg=Yes
283	study	_	_	_	_	_	_	_	_
284	the	_	_	_	_	_	_	_	_
285	anti	_	_	_	_	_	_	_	_
286	-	_	_	_	_	_	_	_	_
287	infection	_	_	_	_	_	_	_	_
288	mechanisms	_	_	_	_	_	_	_	_
289	of	_	_	_	_	_	_	_	_
290	PBD-2	_	_	_	_	_	_	_	_
291	but	_	_	_	_	_	_	_	BeginSeg=Yes
292	also	_	_	_	_	_	_	_	_
293	a	_	_	_	_	_	_	_	_
294	promising	_	_	_	_	_	_	_	_
295	genetic	_	_	_	_	_	_	_	_
296	material	_	_	_	_	_	_	_	_
297	for	_	_	_	_	_	_	_	_
298	the	_	_	_	_	_	_	_	_
299	breeding	_	_	_	_	_	_	_	_
300	of	_	_	_	_	_	_	_	_
301	disease	_	_	_	_	_	_	_	_
302	-	_	_	_	_	_	_	_	_
303	resistant	_	_	_	_	_	_	_	_
304	pigs	_	_	_	_	_	_	_	_
305	.	_	_	_	_	_	_	_	_

# newdoc_id = 40276a234b15f83ca6f70b4956659025fd7b2ae5
1	Background	_	_	_	_	_	_	_	BeginSeg=Yes
2	:	_	_	_	_	_	_	_	_
3	HRV	_	_	_	_	_	_	_	BeginSeg=Yes
4	infections	_	_	_	_	_	_	_	_
5	are	_	_	_	_	_	_	_	_
6	generally	_	_	_	_	_	_	_	_
7	self	_	_	_	_	_	_	_	_
8	-	_	_	_	_	_	_	_	_
9	limiting	_	_	_	_	_	_	_	_
10	in	_	_	_	_	_	_	_	_
11	healthy	_	_	_	_	_	_	_	_
12	subjects	_	_	_	_	_	_	_	_
13	,	_	_	_	_	_	_	_	_
14	whereas	_	_	_	_	_	_	_	BeginSeg=Yes
15	in	_	_	_	_	_	_	_	_
16	immunocompromised	_	_	_	_	_	_	_	_
17	hosts	_	_	_	_	_	_	_	_
18	HRV	_	_	_	_	_	_	_	_
19	infections	_	_	_	_	_	_	_	_
20	can	_	_	_	_	_	_	_	_
21	lead	_	_	_	_	_	_	_	_
22	to	_	_	_	_	_	_	_	_
23	severe	_	_	_	_	_	_	_	_
24	complications	_	_	_	_	_	_	_	_
25	and	_	_	_	_	_	_	_	_
26	persistent	_	_	_	_	_	_	_	_
27	infections	_	_	_	_	_	_	_	_
28	.	_	_	_	_	_	_	_	_
29	The	_	_	_	_	_	_	_	BeginSeg=Yes
30	persistence	_	_	_	_	_	_	_	_
31	of	_	_	_	_	_	_	_	_
32	HRV	_	_	_	_	_	_	_	_
33	shedding	_	_	_	_	_	_	_	_
34	could	_	_	_	_	_	_	_	_
35	be	_	_	_	_	_	_	_	_
36	due	_	_	_	_	_	_	_	_
37	to	_	_	_	_	_	_	_	_
38	the	_	_	_	_	_	_	_	_
39	inefficient	_	_	_	_	_	_	_	_
40	immunological	_	_	_	_	_	_	_	_
41	control	_	_	_	_	_	_	_	_
42	of	_	_	_	_	_	_	_	_
43	a	_	_	_	_	_	_	_	_
44	single	_	_	_	_	_	_	_	_
45	infectious	_	_	_	_	_	_	_	_
46	episode	_	_	_	_	_	_	_	_
47	.	_	_	_	_	_	_	_	_
48	Objectives	_	_	_	_	_	_	_	BeginSeg=Yes
49	:	_	_	_	_	_	_	_	_
50	To	_	_	_	_	_	_	_	BeginSeg=Yes
51	investigate	_	_	_	_	_	_	_	_
52	the	_	_	_	_	_	_	_	_
53	clinical	_	_	_	_	_	_	_	_
54	,	_	_	_	_	_	_	_	_
55	virologic	_	_	_	_	_	_	_	_
56	and	_	_	_	_	_	_	_	_
57	immunologic	_	_	_	_	_	_	_	_
58	characteristics	_	_	_	_	_	_	_	_
59	of	_	_	_	_	_	_	_	_
60	pediatric	_	_	_	_	_	_	_	_
61	HSCT	_	_	_	_	_	_	_	_
62	recipients	_	_	_	_	_	_	_	_
63	with	_	_	_	_	_	_	_	_
64	HRV	_	_	_	_	_	_	_	_
65	-	_	_	_	_	_	_	_	_
66	PI	_	_	_	_	_	_	_	_
67	infection	_	_	_	_	_	_	_	_
68	.	_	_	_	_	_	_	_	_
69	Study	_	_	_	_	_	_	_	BeginSeg=Yes
70	design	_	_	_	_	_	_	_	_
71	:	_	_	_	_	_	_	_	_
72	During	_	_	_	_	_	_	_	BeginSeg=Yes
73	the	_	_	_	_	_	_	_	_
74	period	_	_	_	_	_	_	_	_
75	2006	_	_	_	_	_	_	_	_
76	-	_	_	_	_	_	_	_	_
77	2012	_	_	_	_	_	_	_	_
78	,	_	_	_	_	_	_	_	_
79	eight	_	_	_	_	_	_	_	_
80	hematopoietic	_	_	_	_	_	_	_	_
81	stem	_	_	_	_	_	_	_	_
82	cell	_	_	_	_	_	_	_	_
83	transplant	_	_	_	_	_	_	_	_
84	(	_	_	_	_	_	_	_	_
85	HSCT	_	_	_	_	_	_	_	_
86	)	_	_	_	_	_	_	_	_
87	recipients	_	_	_	_	_	_	_	_
88	presented	_	_	_	_	_	_	_	_
89	with	_	_	_	_	_	_	_	_
90	persistent	_	_	_	_	_	_	_	_
91	rhinovirus	_	_	_	_	_	_	_	_
92	infection	_	_	_	_	_	_	_	_
93	(	_	_	_	_	_	_	_	BeginSeg=Yes
94	HRV	_	_	_	_	_	_	_	_
95	-	_	_	_	_	_	_	_	_
96	PI	_	_	_	_	_	_	_	_
97	,	_	_	_	_	_	_	_	_
98	≥30	_	_	_	_	_	_	_	_
99	days	_	_	_	_	_	_	_	_
100	)	_	_	_	_	_	_	_	_
101	.	_	_	_	_	_	_	_	_
102	Viral	_	_	_	_	_	_	_	BeginSeg=Yes
103	load	_	_	_	_	_	_	_	_
104	and	_	_	_	_	_	_	_	_
105	T	_	_	_	_	_	_	_	_
106	-	_	_	_	_	_	_	_	_
107	CD4	_	_	_	_	_	_	_	_
108	+	_	_	_	_	_	_	_	_
109	,	_	_	_	_	_	_	_	_
110	T	_	_	_	_	_	_	_	_
111	-	_	_	_	_	_	_	_	_
112	CD8	_	_	_	_	_	_	_	_
113	+	_	_	_	_	_	_	_	_
114	,	_	_	_	_	_	_	_	_
115	B	_	_	_	_	_	_	_	_
116	and	_	_	_	_	_	_	_	_
117	NK	_	_	_	_	_	_	_	_
118	lymphocyte	_	_	_	_	_	_	_	_
119	counts	_	_	_	_	_	_	_	_
120	at	_	_	_	_	_	_	_	_
121	the	_	_	_	_	_	_	_	_
122	onset	_	_	_	_	_	_	_	_
123	of	_	_	_	_	_	_	_	_
124	infection	_	_	_	_	_	_	_	_
125	were	_	_	_	_	_	_	_	_
126	compared	_	_	_	_	_	_	_	_
127	with	_	_	_	_	_	_	_	_
128	those	_	_	_	_	_	_	_	_
129	of	_	_	_	_	_	_	_	_
130	fourteen	_	_	_	_	_	_	_	_
131	HSCT	_	_	_	_	_	_	_	_
132	recipients	_	_	_	_	_	_	_	_
133	with	_	_	_	_	_	_	_	_
134	acute	_	_	_	_	_	_	_	_
135	HRV	_	_	_	_	_	_	_	_
136	infection	_	_	_	_	_	_	_	_
137	(	_	_	_	_	_	_	_	BeginSeg=Yes
138	HRV	_	_	_	_	_	_	_	_
139	-	_	_	_	_	_	_	_	_
140	AI	_	_	_	_	_	_	_	_
141	,	_	_	_	_	_	_	_	_
142	≤15	_	_	_	_	_	_	_	_
143	days	_	_	_	_	_	_	_	_
144	)	_	_	_	_	_	_	_	_
145	.	_	_	_	_	_	_	_	_
146	Results	_	_	_	_	_	_	_	BeginSeg=Yes
147	:	_	_	_	_	_	_	_	_
148	The	_	_	_	_	_	_	_	BeginSeg=Yes
149	median	_	_	_	_	_	_	_	_
150	duration	_	_	_	_	_	_	_	_
151	of	_	_	_	_	_	_	_	_
152	HRV	_	_	_	_	_	_	_	_
153	positivity	_	_	_	_	_	_	_	_
154	in	_	_	_	_	_	_	_	_
155	patients	_	_	_	_	_	_	_	_
156	with	_	_	_	_	_	_	_	_
157	HRV	_	_	_	_	_	_	_	_
158	-	_	_	_	_	_	_	_	_
159	PI	_	_	_	_	_	_	_	_
160	was	_	_	_	_	_	_	_	_
161	61	_	_	_	_	_	_	_	_
162	days	_	_	_	_	_	_	_	_
163	(	_	_	_	_	_	_	_	BeginSeg=Yes
164	range	_	_	_	_	_	_	_	_
165	30	_	_	_	_	_	_	_	_
166	-	_	_	_	_	_	_	_	_
167	174	_	_	_	_	_	_	_	_
168	days	_	_	_	_	_	_	_	_
169	)	_	_	_	_	_	_	_	_
170	and	_	_	_	_	_	_	_	BeginSeg=Yes
171	phylogenetic	_	_	_	_	_	_	_	_
172	analysis	_	_	_	_	_	_	_	_
173	showed	_	_	_	_	_	_	_	_
174	the	_	_	_	_	_	_	_	_
175	persistence	_	_	_	_	_	_	_	_
176	of	_	_	_	_	_	_	_	_
177	a	_	_	_	_	_	_	_	_
178	single	_	_	_	_	_	_	_	_
179	HRV	_	_	_	_	_	_	_	_
180	type	_	_	_	_	_	_	_	_
181	in	_	_	_	_	_	_	_	_
182	all	_	_	_	_	_	_	_	_
183	patients	_	_	_	_	_	_	_	_
184	(	_	_	_	_	_	_	_	BeginSeg=Yes
185	100	_	_	_	_	_	_	_	_
186	%	_	_	_	_	_	_	_	_
187	)	_	_	_	_	_	_	_	_
188	.	_	_	_	_	_	_	_	_
189	In	_	_	_	_	_	_	_	BeginSeg=Yes
190	HSCT	_	_	_	_	_	_	_	_
191	recipients	_	_	_	_	_	_	_	_
192	with	_	_	_	_	_	_	_	_
193	HRV	_	_	_	_	_	_	_	_
194	-	_	_	_	_	_	_	_	_
195	PI	_	_	_	_	_	_	_	_
196	,	_	_	_	_	_	_	_	_
197	T	_	_	_	_	_	_	_	_
198	-	_	_	_	_	_	_	_	_
199	CD4	_	_	_	_	_	_	_	_
200	+	_	_	_	_	_	_	_	_
201	,	_	_	_	_	_	_	_	_
202	T	_	_	_	_	_	_	_	_
203	-	_	_	_	_	_	_	_	_
204	CD8	_	_	_	_	_	_	_	_
205	+	_	_	_	_	_	_	_	_
206	and	_	_	_	_	_	_	_	_
207	NK	_	_	_	_	_	_	_	_
208	cell	_	_	_	_	_	_	_	_
209	counts	_	_	_	_	_	_	_	_
210	at	_	_	_	_	_	_	_	_
211	the	_	_	_	_	_	_	_	_
212	onset	_	_	_	_	_	_	_	_
213	of	_	_	_	_	_	_	_	_
214	infection	_	_	_	_	_	_	_	_
215	were	_	_	_	_	_	_	_	_
216	significantly	_	_	_	_	_	_	_	_
217	lower	_	_	_	_	_	_	_	_
218	than	_	_	_	_	_	_	_	_
219	those	_	_	_	_	_	_	_	_
220	observed	_	_	_	_	_	_	_	BeginSeg=Yes
221	in	_	_	_	_	_	_	_	_
222	recipients	_	_	_	_	_	_	_	_
223	with	_	_	_	_	_	_	_	_
224	HRV	_	_	_	_	_	_	_	_
225	-	_	_	_	_	_	_	_	_
226	AI	_	_	_	_	_	_	_	_
227	(	_	_	_	_	_	_	_	BeginSeg=Yes
228	p	_	_	_	_	_	_	_	_
229	<	_	_	_	_	_	_	_	_
230	0.01	_	_	_	_	_	_	_	_
231	)	_	_	_	_	_	_	_	_
232	,	_	_	_	_	_	_	_	_
233	while	_	_	_	_	_	_	_	BeginSeg=Yes
234	B	_	_	_	_	_	_	_	_
235	cell	_	_	_	_	_	_	_	_
236	counts	_	_	_	_	_	_	_	_
237	were	_	_	_	_	_	_	_	_
238	similar	_	_	_	_	_	_	_	_
239	in	_	_	_	_	_	_	_	_
240	the	_	_	_	_	_	_	_	_
241	two	_	_	_	_	_	_	_	_
242	groups	_	_	_	_	_	_	_	_
243	(	_	_	_	_	_	_	_	BeginSeg=Yes
244	p	_	_	_	_	_	_	_	_
245	=	_	_	_	_	_	_	_	_
246	0.25	_	_	_	_	_	_	_	_
247	)	_	_	_	_	_	_	_	_
248	.	_	_	_	_	_	_	_	_
249	A	_	_	_	_	_	_	_	BeginSeg=Yes
250	decrease	_	_	_	_	_	_	_	_
251	in	_	_	_	_	_	_	_	_
252	HRV	_	_	_	_	_	_	_	_
253	load	_	_	_	_	_	_	_	_
254	was	_	_	_	_	_	_	_	_
255	associated	_	_	_	_	_	_	_	_
256	with	_	_	_	_	_	_	_	_
257	a	_	_	_	_	_	_	_	_
258	significant	_	_	_	_	_	_	_	_
259	increase	_	_	_	_	_	_	_	_
260	in	_	_	_	_	_	_	_	_
261	T	_	_	_	_	_	_	_	_
262	-	_	_	_	_	_	_	_	_
263	CD4	_	_	_	_	_	_	_	_
264	+	_	_	_	_	_	_	_	_
265	,	_	_	_	_	_	_	_	_
266	T	_	_	_	_	_	_	_	_
267	-	_	_	_	_	_	_	_	_
268	CD8	_	_	_	_	_	_	_	_
269	+	_	_	_	_	_	_	_	_
270	and	_	_	_	_	_	_	_	_
271	NK	_	_	_	_	_	_	_	_
272	lymphocyte	_	_	_	_	_	_	_	_
273	counts	_	_	_	_	_	_	_	_
274	in	_	_	_	_	_	_	_	_
275	HRV	_	_	_	_	_	_	_	_
276	-	_	_	_	_	_	_	_	_
277	PI	_	_	_	_	_	_	_	_
278	patients	_	_	_	_	_	_	_	_
279	(	_	_	_	_	_	_	_	BeginSeg=Yes
280	p	_	_	_	_	_	_	_	_
281	<	_	_	_	_	_	_	_	_
282	0.01	_	_	_	_	_	_	_	_
283	)	_	_	_	_	_	_	_	_
284	.	_	_	_	_	_	_	_	_
285	Conclusions	_	_	_	_	_	_	_	BeginSeg=Yes
286	:	_	_	_	_	_	_	_	_
287	This	_	_	_	_	_	_	_	BeginSeg=Yes
288	study	_	_	_	_	_	_	_	_
289	suggests	_	_	_	_	_	_	_	_
290	a	_	_	_	_	_	_	_	_
291	role	_	_	_	_	_	_	_	_
292	for	_	_	_	_	_	_	_	_
293	cellular	_	_	_	_	_	_	_	_
294	immunity	_	_	_	_	_	_	_	_
295	in	_	_	_	_	_	_	_	_
296	HRV	_	_	_	_	_	_	_	_
297	clearance	_	_	_	_	_	_	_	_
298	and	_	_	_	_	_	_	_	BeginSeg=Yes
299	highlights	_	_	_	_	_	_	_	_
300	the	_	_	_	_	_	_	_	_
301	importance	_	_	_	_	_	_	_	_
302	of	_	_	_	_	_	_	_	_
303	its	_	_	_	_	_	_	_	_
304	recovery	_	_	_	_	_	_	_	_
305	for	_	_	_	_	_	_	_	_
306	the	_	_	_	_	_	_	_	_
307	control	_	_	_	_	_	_	_	_
308	of	_	_	_	_	_	_	_	_
309	HRV	_	_	_	_	_	_	_	_
310	infection	_	_	_	_	_	_	_	_
311	in	_	_	_	_	_	_	_	_
312	HSCT	_	_	_	_	_	_	_	_
313	recipients	_	_	_	_	_	_	_	_
314	.	_	_	_	_	_	_	_	_

# newdoc_id = 414d4a7cbe08a1904b9b3c2716562f40983f1087
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	COVID-19	_	_	_	_	_	_	_	_
3	epidemic	_	_	_	_	_	_	_	_
4	,	_	_	_	_	_	_	_	_
5	which	_	_	_	_	_	_	_	BeginSeg=Yes
6	is	_	_	_	_	_	_	_	_
7	caused	_	_	_	_	_	_	_	_
8	by	_	_	_	_	_	_	_	_
9	the	_	_	_	_	_	_	_	_
10	novel	_	_	_	_	_	_	_	_
11	coronavirus	_	_	_	_	_	_	_	_
12	SARS	_	_	_	_	_	_	_	_
13	-	_	_	_	_	_	_	_	_
14	CoV-2	_	_	_	_	_	_	_	_
15	,	_	_	_	_	_	_	_	_
16	has	_	_	_	_	_	_	_	BeginSeg=Yes
17	spread	_	_	_	_	_	_	_	_
18	rapidly	_	_	_	_	_	_	_	_
19	to	_	_	_	_	_	_	_	BeginSeg=Yes
20	become	_	_	_	_	_	_	_	_
21	a	_	_	_	_	_	_	_	_
22	world	_	_	_	_	_	_	_	_
23	-	_	_	_	_	_	_	_	_
24	wide	_	_	_	_	_	_	_	_
25	pandemic	_	_	_	_	_	_	_	_
26	.	_	_	_	_	_	_	_	_
27	Chest	_	_	_	_	_	_	_	BeginSeg=Yes
28	radiography	_	_	_	_	_	_	_	_
29	and	_	_	_	_	_	_	_	_
30	chest	_	_	_	_	_	_	_	_
31	CT	_	_	_	_	_	_	_	_
32	are	_	_	_	_	_	_	_	_
33	frequently	_	_	_	_	_	_	_	_
34	used	_	_	_	_	_	_	_	_
35	to	_	_	_	_	_	_	_	BeginSeg=Yes
36	support	_	_	_	_	_	_	_	_
37	the	_	_	_	_	_	_	_	_
38	diagnosis	_	_	_	_	_	_	_	_
39	of	_	_	_	_	_	_	_	_
40	COVID-19	_	_	_	_	_	_	_	_
41	infection	_	_	_	_	_	_	_	_
42	.	_	_	_	_	_	_	_	_
43	However	_	_	_	_	_	_	_	BeginSeg=Yes
44	,	_	_	_	_	_	_	_	_
45	multiple	_	_	_	_	_	_	_	_
46	cases	_	_	_	_	_	_	_	_
47	of	_	_	_	_	_	_	_	_
48	COVID-19	_	_	_	_	_	_	_	_
49	transmission	_	_	_	_	_	_	_	_
50	in	_	_	_	_	_	_	_	_
51	radiology	_	_	_	_	_	_	_	_
52	department	_	_	_	_	_	_	_	_
53	have	_	_	_	_	_	_	_	_
54	been	_	_	_	_	_	_	_	_
55	reported	_	_	_	_	_	_	_	_
56	.	_	_	_	_	_	_	_	_
57	Here	_	_	_	_	_	_	_	BeginSeg=Yes
58	we	_	_	_	_	_	_	_	_
59	summarize	_	_	_	_	_	_	_	_
60	the	_	_	_	_	_	_	_	_
61	lessons	_	_	_	_	_	_	_	_
62	we	_	_	_	_	_	_	_	BeginSeg=Yes
63	learned	_	_	_	_	_	_	_	_
64	and	_	_	_	_	_	_	_	BeginSeg=Yes
65	provide	_	_	_	_	_	_	_	_
66	suggestions	_	_	_	_	_	_	_	_
67	to	_	_	_	_	_	_	_	BeginSeg=Yes
68	improve	_	_	_	_	_	_	_	_
69	the	_	_	_	_	_	_	_	_
70	infection	_	_	_	_	_	_	_	_
71	control	_	_	_	_	_	_	_	_
72	and	_	_	_	_	_	_	_	_
73	prevention	_	_	_	_	_	_	_	_
74	practices	_	_	_	_	_	_	_	_
75	of	_	_	_	_	_	_	_	_
76	healthcare	_	_	_	_	_	_	_	_
77	workers	_	_	_	_	_	_	_	_
78	in	_	_	_	_	_	_	_	_
79	departments	_	_	_	_	_	_	_	_
80	of	_	_	_	_	_	_	_	_
81	radiology	_	_	_	_	_	_	_	_
82	.	_	_	_	_	_	_	_	_

# newdoc_id = 422787d1a8391db8a23e809e861e477df0753c99
1	Background	_	_	_	_	_	_	_	BeginSeg=Yes
2	.	_	_	_	_	_	_	_	_
3	Brazil	_	_	_	_	_	_	_	BeginSeg=Yes
4	detected	_	_	_	_	_	_	_	_
5	community	_	_	_	_	_	_	_	_
6	transmission	_	_	_	_	_	_	_	_
7	of	_	_	_	_	_	_	_	_
8	COVID-19	_	_	_	_	_	_	_	_
9	on	_	_	_	_	_	_	_	_
10	March	_	_	_	_	_	_	_	_
11	13	_	_	_	_	_	_	_	_
12	,	_	_	_	_	_	_	_	_
13	2020	_	_	_	_	_	_	_	_
14	.	_	_	_	_	_	_	_	_
15	In	_	_	_	_	_	_	_	BeginSeg=Yes
16	this	_	_	_	_	_	_	_	_
17	study	_	_	_	_	_	_	_	_
18	we	_	_	_	_	_	_	_	_
19	identify	_	_	_	_	_	_	_	_
20	which	_	_	_	_	_	_	_	_
21	areas	_	_	_	_	_	_	_	_
22	in	_	_	_	_	_	_	_	_
23	the	_	_	_	_	_	_	_	_
24	country	_	_	_	_	_	_	_	_
25	are	_	_	_	_	_	_	_	_
26	most	_	_	_	_	_	_	_	_
27	vulnerable	_	_	_	_	_	_	_	_
28	for	_	_	_	_	_	_	_	_
29	COVID-19	_	_	_	_	_	_	_	_
30	,	_	_	_	_	_	_	_	_
31	both	_	_	_	_	_	_	_	_
32	in	_	_	_	_	_	_	_	_
33	terms	_	_	_	_	_	_	_	_
34	of	_	_	_	_	_	_	_	_
35	the	_	_	_	_	_	_	_	_
36	risk	_	_	_	_	_	_	_	_
37	of	_	_	_	_	_	_	_	_
38	arrival	_	_	_	_	_	_	_	_
39	of	_	_	_	_	_	_	_	_
40	COVID-19	_	_	_	_	_	_	_	_
41	cases	_	_	_	_	_	_	_	_
42	and	_	_	_	_	_	_	_	_
43	the	_	_	_	_	_	_	_	_
44	risk	_	_	_	_	_	_	_	_
45	of	_	_	_	_	_	_	_	_
46	sustained	_	_	_	_	_	_	_	_
47	transmission	_	_	_	_	_	_	_	_
48	.	_	_	_	_	_	_	_	_
49	The	_	_	_	_	_	_	_	BeginSeg=Yes
50	micro	_	_	_	_	_	_	_	_
51	-	_	_	_	_	_	_	_	_
52	regions	_	_	_	_	_	_	_	_
53	with	_	_	_	_	_	_	_	_
54	higher	_	_	_	_	_	_	_	_
55	social	_	_	_	_	_	_	_	_
56	vulnerability	_	_	_	_	_	_	_	_
57	are	_	_	_	_	_	_	_	_
58	also	_	_	_	_	_	_	_	_
59	identified	_	_	_	_	_	_	_	_
60	.	_	_	_	_	_	_	_	_
61	Methods	_	_	_	_	_	_	_	BeginSeg=Yes
62	.	_	_	_	_	_	_	_	_
63	Probabilistic	_	_	_	_	_	_	_	BeginSeg=Yes
64	models	_	_	_	_	_	_	_	_
65	were	_	_	_	_	_	_	_	_
66	used	_	_	_	_	_	_	_	_
67	to	_	_	_	_	_	_	_	BeginSeg=Yes
68	calculate	_	_	_	_	_	_	_	_
69	the	_	_	_	_	_	_	_	_
70	probability	_	_	_	_	_	_	_	_
71	of	_	_	_	_	_	_	_	_
72	COVID-19	_	_	_	_	_	_	_	_
73	spread	_	_	_	_	_	_	_	_
74	from	_	_	_	_	_	_	_	_
75	São	_	_	_	_	_	_	_	_
76	Paulo	_	_	_	_	_	_	_	_
77	and	_	_	_	_	_	_	_	_
78	Rio	_	_	_	_	_	_	_	_
79	de	_	_	_	_	_	_	_	_
80	Janeiro	_	_	_	_	_	_	_	_
81	,	_	_	_	_	_	_	_	_
82	according	_	_	_	_	_	_	_	_
83	to	_	_	_	_	_	_	_	_
84	previous	_	_	_	_	_	_	_	_
85	data	_	_	_	_	_	_	_	_
86	available	_	_	_	_	_	_	_	_
87	on	_	_	_	_	_	_	_	_
88	human	_	_	_	_	_	_	_	_
89	mobility	_	_	_	_	_	_	_	_
90	in	_	_	_	_	_	_	_	_
91	Brazil	_	_	_	_	_	_	_	_
92	.	_	_	_	_	_	_	_	_
93	We	_	_	_	_	_	_	_	BeginSeg=Yes
94	also	_	_	_	_	_	_	_	_
95	perform	_	_	_	_	_	_	_	_
96	a	_	_	_	_	_	_	_	_
97	multivariate	_	_	_	_	_	_	_	_
98	cluster	_	_	_	_	_	_	_	_
99	analysis	_	_	_	_	_	_	_	_
100	of	_	_	_	_	_	_	_	_
101	socio	_	_	_	_	_	_	_	_
102	-	_	_	_	_	_	_	_	_
103	economic	_	_	_	_	_	_	_	_
104	indices	_	_	_	_	_	_	_	_
105	to	_	_	_	_	_	_	_	BeginSeg=Yes
106	identify	_	_	_	_	_	_	_	_
107	areas	_	_	_	_	_	_	_	_
108	with	_	_	_	_	_	_	_	_
109	similar	_	_	_	_	_	_	_	_
110	social	_	_	_	_	_	_	_	_
111	vulnerability	_	_	_	_	_	_	_	_
112	.	_	_	_	_	_	_	_	_
113	Results	_	_	_	_	_	_	_	BeginSeg=Yes
114	.	_	_	_	_	_	_	_	_
115	The	_	_	_	_	_	_	_	BeginSeg=Yes
116	results	_	_	_	_	_	_	_	_
117	consist	_	_	_	_	_	_	_	_
118	of	_	_	_	_	_	_	_	_
119	a	_	_	_	_	_	_	_	_
120	series	_	_	_	_	_	_	_	_
121	of	_	_	_	_	_	_	_	_
122	maps	_	_	_	_	_	_	_	_
123	of	_	_	_	_	_	_	_	_
124	effective	_	_	_	_	_	_	_	_
125	distance	_	_	_	_	_	_	_	_
126	,	_	_	_	_	_	_	_	_
127	outbreak	_	_	_	_	_	_	_	_
128	probability	_	_	_	_	_	_	_	_
129	,	_	_	_	_	_	_	_	_
130	hospital	_	_	_	_	_	_	_	_
131	capacity	_	_	_	_	_	_	_	_
132	and	_	_	_	_	_	_	_	_
133	social	_	_	_	_	_	_	_	_
134	vulnerability	_	_	_	_	_	_	_	_
135	.	_	_	_	_	_	_	_	_
136	They	_	_	_	_	_	_	_	BeginSeg=Yes
137	show	_	_	_	_	_	_	_	_
138	areas	_	_	_	_	_	_	_	_
139	in	_	_	_	_	_	_	_	_
140	the	_	_	_	_	_	_	_	_
141	North	_	_	_	_	_	_	_	_
142	and	_	_	_	_	_	_	_	_
143	Northeast	_	_	_	_	_	_	_	_
144	with	_	_	_	_	_	_	_	_
145	high	_	_	_	_	_	_	_	_
146	risk	_	_	_	_	_	_	_	_
147	of	_	_	_	_	_	_	_	_
148	COVID-19	_	_	_	_	_	_	_	_
149	outbreak	_	_	_	_	_	_	_	_
150	that	_	_	_	_	_	_	_	BeginSeg=Yes
151	are	_	_	_	_	_	_	_	_
152	also	_	_	_	_	_	_	_	_
153	highly	_	_	_	_	_	_	_	_
154	vulnerable	_	_	_	_	_	_	_	_
155	.	_	_	_	_	_	_	_	_

# newdoc_id = 43568a4ba8221af0f87a1c7d1ddbd2a48eb27e79
1	Objectives	_	_	_	_	_	_	_	BeginSeg=Yes
2	of	_	_	_	_	_	_	_	_
3	this	_	_	_	_	_	_	_	_
4	study	_	_	_	_	_	_	_	_
5	were	_	_	_	_	_	_	_	_
6	to	_	_	_	_	_	_	_	_
7	determine	_	_	_	_	_	_	_	_
8	prevalence	_	_	_	_	_	_	_	_
9	of	_	_	_	_	_	_	_	_
10	infection	_	_	_	_	_	_	_	_
11	in	_	_	_	_	_	_	_	_
12	feral	_	_	_	_	_	_	_	_
13	cats	_	_	_	_	_	_	_	_
14	in	_	_	_	_	_	_	_	_
15	Northern	_	_	_	_	_	_	_	_
16	Florida	_	_	_	_	_	_	_	_
17	with	_	_	_	_	_	_	_	_
18	a	_	_	_	_	_	_	_	_
19	select	_	_	_	_	_	_	_	_
20	group	_	_	_	_	_	_	_	_
21	of	_	_	_	_	_	_	_	_
22	infectious	_	_	_	_	_	_	_	_
23	organisms	_	_	_	_	_	_	_	_
24	and	_	_	_	_	_	_	_	_
25	to	_	_	_	_	_	_	_	_
26	determine	_	_	_	_	_	_	_	_
27	risk	_	_	_	_	_	_	_	_
28	factors	_	_	_	_	_	_	_	_
29	for	_	_	_	_	_	_	_	_
30	infection	_	_	_	_	_	_	_	_
31	.	_	_	_	_	_	_	_	_
32	Blood	_	_	_	_	_	_	_	BeginSeg=Yes
33	samples	_	_	_	_	_	_	_	_
34	or	_	_	_	_	_	_	_	_
35	sera	_	_	_	_	_	_	_	_
36	from	_	_	_	_	_	_	_	_
37	553	_	_	_	_	_	_	_	_
38	cats	_	_	_	_	_	_	_	_
39	were	_	_	_	_	_	_	_	_
40	tested	_	_	_	_	_	_	_	_
41	with	_	_	_	_	_	_	_	_
42	a	_	_	_	_	_	_	_	_
43	panel	_	_	_	_	_	_	_	_
44	of	_	_	_	_	_	_	_	_
45	antibody	_	_	_	_	_	_	_	_
46	,	_	_	_	_	_	_	_	_
47	antigen	_	_	_	_	_	_	_	_
48	or	_	_	_	_	_	_	_	_
49	PCR	_	_	_	_	_	_	_	_
50	assays	_	_	_	_	_	_	_	_
51	.	_	_	_	_	_	_	_	_
52	Male	_	_	_	_	_	_	_	BeginSeg=Yes
53	cats	_	_	_	_	_	_	_	_
54	were	_	_	_	_	_	_	_	_
55	at	_	_	_	_	_	_	_	_
56	higher	_	_	_	_	_	_	_	_
57	risk	_	_	_	_	_	_	_	_
58	for	_	_	_	_	_	_	_	_
59	FIV	_	_	_	_	_	_	_	_
60	,	_	_	_	_	_	_	_	_
61	Mycoplasma	_	_	_	_	_	_	_	_
62	haemofelis	_	_	_	_	_	_	_	_
63	,	_	_	_	_	_	_	_	_
64	and	_	_	_	_	_	_	_	_
65	M.	_	_	_	_	_	_	_	_
66	haemominutum	_	_	_	_	_	_	_	_
67	.	_	_	_	_	_	_	_	_
68	Infection	_	_	_	_	_	_	_	BeginSeg=Yes
69	with	_	_	_	_	_	_	_	_
70	either	_	_	_	_	_	_	_	_
71	FeLV	_	_	_	_	_	_	_	_
72	or	_	_	_	_	_	_	_	_
73	FIV	_	_	_	_	_	_	_	_
74	was	_	_	_	_	_	_	_	_
75	associated	_	_	_	_	_	_	_	_
76	with	_	_	_	_	_	_	_	_
77	increased	_	_	_	_	_	_	_	_
78	risk	_	_	_	_	_	_	_	_
79	for	_	_	_	_	_	_	_	_
80	coinfection	_	_	_	_	_	_	_	_
81	with	_	_	_	_	_	_	_	_
82	the	_	_	_	_	_	_	_	_
83	other	_	_	_	_	_	_	_	_
84	retrovirus	_	_	_	_	_	_	_	_
85	,	_	_	_	_	_	_	_	_
86	M.	_	_	_	_	_	_	_	_
87	haemofelis	_	_	_	_	_	_	_	_
88	,	_	_	_	_	_	_	_	_
89	or	_	_	_	_	_	_	_	_
90	M.	_	_	_	_	_	_	_	_
91	haemominutum	_	_	_	_	_	_	_	_
92	.	_	_	_	_	_	_	_	_
93	Bartonella	_	_	_	_	_	_	_	BeginSeg=Yes
94	henselae	_	_	_	_	_	_	_	_
95	had	_	_	_	_	_	_	_	_
96	the	_	_	_	_	_	_	_	_
97	highest	_	_	_	_	_	_	_	_
98	prevalence	_	_	_	_	_	_	_	_
99	and	_	_	_	_	_	_	_	BeginSeg=Yes
100	was	_	_	_	_	_	_	_	_
101	the	_	_	_	_	_	_	_	_
102	only	_	_	_	_	_	_	_	_
103	organism	_	_	_	_	_	_	_	_
104	that	_	_	_	_	_	_	_	BeginSeg=Yes
105	did	_	_	_	_	_	_	_	_
106	not	_	_	_	_	_	_	_	_
107	have	_	_	_	_	_	_	_	_
108	any	_	_	_	_	_	_	_	_
109	associated	_	_	_	_	_	_	_	_
110	risk	_	_	_	_	_	_	_	_
111	for	_	_	_	_	_	_	_	_
112	coinfection	_	_	_	_	_	_	_	_
113	with	_	_	_	_	_	_	_	_
114	other	_	_	_	_	_	_	_	_
115	organisms	_	_	_	_	_	_	_	_
116	.	_	_	_	_	_	_	_	_
117	Feral	_	_	_	_	_	_	_	BeginSeg=Yes
118	cats	_	_	_	_	_	_	_	_
119	in	_	_	_	_	_	_	_	_
120	this	_	_	_	_	_	_	_	_
121	study	_	_	_	_	_	_	_	_
122	had	_	_	_	_	_	_	_	_
123	similar	_	_	_	_	_	_	_	_
124	or	_	_	_	_	_	_	_	_
125	lower	_	_	_	_	_	_	_	_
126	prevalence	_	_	_	_	_	_	_	_
127	rates	_	_	_	_	_	_	_	_
128	of	_	_	_	_	_	_	_	_
129	infections	_	_	_	_	_	_	_	_
130	than	_	_	_	_	_	_	_	_
131	those	_	_	_	_	_	_	_	_
132	published	_	_	_	_	_	_	_	BeginSeg=Yes
133	for	_	_	_	_	_	_	_	_
134	pet	_	_	_	_	_	_	_	_
135	cats	_	_	_	_	_	_	_	_
136	in	_	_	_	_	_	_	_	_
137	the	_	_	_	_	_	_	_	_
138	United	_	_	_	_	_	_	_	_
139	States	_	_	_	_	_	_	_	_
140	.	_	_	_	_	_	_	_	_
141	Thus	_	_	_	_	_	_	_	BeginSeg=Yes
142	,	_	_	_	_	_	_	_	_
143	feral	_	_	_	_	_	_	_	_
144	cats	_	_	_	_	_	_	_	_
145	assessed	_	_	_	_	_	_	_	BeginSeg=Yes
146	in	_	_	_	_	_	_	_	_
147	this	_	_	_	_	_	_	_	_
148	study	_	_	_	_	_	_	_	_
149	appear	_	_	_	_	_	_	_	BeginSeg=Yes
150	to	_	_	_	_	_	_	_	_
151	be	_	_	_	_	_	_	_	_
152	of	_	_	_	_	_	_	_	_
153	no	_	_	_	_	_	_	_	_
154	greater	_	_	_	_	_	_	_	_
155	risk	_	_	_	_	_	_	_	_
156	to	_	_	_	_	_	_	_	_
157	human	_	_	_	_	_	_	_	_
158	beings	_	_	_	_	_	_	_	_
159	or	_	_	_	_	_	_	_	_
160	other	_	_	_	_	_	_	_	_
161	cats	_	_	_	_	_	_	_	_
162	than	_	_	_	_	_	_	_	_
163	pet	_	_	_	_	_	_	_	_
164	cats	_	_	_	_	_	_	_	_
165	.	_	_	_	_	_	_	_	_

# newdoc_id = 4467298e39f2e2c43a48135ce26a887ea78b5706
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	ultimate	_	_	_	_	_	_	_	_
3	goal	_	_	_	_	_	_	_	_
4	of	_	_	_	_	_	_	_	_
5	proteomics	_	_	_	_	_	_	_	_
6	is	_	_	_	_	_	_	_	_
7	to	_	_	_	_	_	_	_	_
8	identify	_	_	_	_	_	_	_	_
9	biologically	_	_	_	_	_	_	_	_
10	active	_	_	_	_	_	_	_	_
11	proteins	_	_	_	_	_	_	_	_
12	and	_	_	_	_	_	_	_	_
13	to	_	_	_	_	_	_	_	_
14	produce	_	_	_	_	_	_	_	_
15	them	_	_	_	_	_	_	_	_
16	using	_	_	_	_	_	_	_	BeginSeg=Yes
17	biotechnology	_	_	_	_	_	_	_	_
18	tools	_	_	_	_	_	_	_	_
19	such	_	_	_	_	_	_	_	BeginSeg=Yes
20	as	_	_	_	_	_	_	_	_
21	bacterial	_	_	_	_	_	_	_	_
22	hosts	_	_	_	_	_	_	_	_
23	.	_	_	_	_	_	_	_	_
24	However	_	_	_	_	_	_	_	BeginSeg=Yes
25	,	_	_	_	_	_	_	_	_
26	proteins	_	_	_	_	_	_	_	_
27	produced	_	_	_	_	_	_	_	BeginSeg=Yes
28	by	_	_	_	_	_	_	_	_
29	Escherichia	_	_	_	_	_	_	_	_
30	coli	_	_	_	_	_	_	_	_
31	must	_	_	_	_	_	_	_	BeginSeg=Yes
32	be	_	_	_	_	_	_	_	_
33	refolded	_	_	_	_	_	_	_	_
34	to	_	_	_	_	_	_	_	_
35	their	_	_	_	_	_	_	_	_
36	native	_	_	_	_	_	_	_	_
37	state	_	_	_	_	_	_	_	_
38	.	_	_	_	_	_	_	_	_
39	Protein	_	_	_	_	_	_	_	BeginSeg=Yes
40	folding	_	_	_	_	_	_	_	_
41	liquid	_	_	_	_	_	_	_	_
42	chromatography	_	_	_	_	_	_	_	_
43	(	_	_	_	_	_	_	_	_
44	PFLC	_	_	_	_	_	_	_	_
45	)	_	_	_	_	_	_	_	_
46	is	_	_	_	_	_	_	_	_
47	a	_	_	_	_	_	_	_	_
48	new	_	_	_	_	_	_	_	_
49	method	_	_	_	_	_	_	_	_
50	developed	_	_	_	_	_	_	_	BeginSeg=Yes
51	in	_	_	_	_	_	_	_	_
52	recent	_	_	_	_	_	_	_	_
53	years	_	_	_	_	_	_	_	_
54	,	_	_	_	_	_	_	_	_
55	and	_	_	_	_	_	_	_	BeginSeg=Yes
56	it	_	_	_	_	_	_	_	_
57	is	_	_	_	_	_	_	_	_
58	widely	_	_	_	_	_	_	_	_
59	used	_	_	_	_	_	_	_	_
60	in	_	_	_	_	_	_	_	_
61	molecular	_	_	_	_	_	_	_	_
62	biology	_	_	_	_	_	_	_	_
63	and	_	_	_	_	_	_	_	_
64	biotechnology	_	_	_	_	_	_	_	_
65	.	_	_	_	_	_	_	_	_
66	In	_	_	_	_	_	_	_	BeginSeg=Yes
67	this	_	_	_	_	_	_	_	_
68	paper	_	_	_	_	_	_	_	_
69	,	_	_	_	_	_	_	_	_
70	the	_	_	_	_	_	_	_	_
71	new	_	_	_	_	_	_	_	_
72	method	_	_	_	_	_	_	_	_
73	,	_	_	_	_	_	_	_	_
74	PFLC	_	_	_	_	_	_	_	_
75	is	_	_	_	_	_	_	_	_
76	introduced	_	_	_	_	_	_	_	_
77	and	_	_	_	_	_	_	_	BeginSeg=Yes
78	its	_	_	_	_	_	_	_	_
79	recent	_	_	_	_	_	_	_	_
80	development	_	_	_	_	_	_	_	_
81	is	_	_	_	_	_	_	_	_
82	reviewed	_	_	_	_	_	_	_	_
83	.	_	_	_	_	_	_	_	_
84	In	_	_	_	_	_	_	_	BeginSeg=Yes
85	addition	_	_	_	_	_	_	_	_
86	the	_	_	_	_	_	_	_	_
87	paper	_	_	_	_	_	_	_	_
88	includes	_	_	_	_	_	_	_	_
89	definitions	_	_	_	_	_	_	_	_
90	,	_	_	_	_	_	_	_	_
91	advantages	_	_	_	_	_	_	_	_
92	,	_	_	_	_	_	_	_	_
93	principles	_	_	_	_	_	_	_	_
94	,	_	_	_	_	_	_	_	_
95	applications	_	_	_	_	_	_	_	_
96	for	_	_	_	_	_	_	_	_
97	both	_	_	_	_	_	_	_	_
98	laboratory	_	_	_	_	_	_	_	_
99	and	_	_	_	_	_	_	_	_
100	large	_	_	_	_	_	_	_	_
101	scales	_	_	_	_	_	_	_	_
102	,	_	_	_	_	_	_	_	_
103	apparatus	_	_	_	_	_	_	_	_
104	,	_	_	_	_	_	_	_	_
105	and	_	_	_	_	_	_	_	_
106	effecting	_	_	_	_	_	_	_	_
107	factors	_	_	_	_	_	_	_	_
108	of	_	_	_	_	_	_	_	_
109	PFLC	_	_	_	_	_	_	_	_
110	.	_	_	_	_	_	_	_	_
111	In	_	_	_	_	_	_	_	BeginSeg=Yes
112	addition	_	_	_	_	_	_	_	_
113	,	_	_	_	_	_	_	_	_
114	the	_	_	_	_	_	_	_	_
115	role	_	_	_	_	_	_	_	_
116	of	_	_	_	_	_	_	_	_
117	this	_	_	_	_	_	_	_	_
118	method	_	_	_	_	_	_	_	_
119	in	_	_	_	_	_	_	_	_
120	the	_	_	_	_	_	_	_	_
121	future	_	_	_	_	_	_	_	_
122	is	_	_	_	_	_	_	_	_
123	examined	_	_	_	_	_	_	_	_
124	.	_	_	_	_	_	_	_	_

# newdoc_id = 48356622cf00b854864f09f21cacca3c5f444225
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	novel	_	_	_	_	_	_	_	_
3	coronavirus	_	_	_	_	_	_	_	_
4	disease-2019	_	_	_	_	_	_	_	_
5	,	_	_	_	_	_	_	_	_
6	caused	_	_	_	_	_	_	_	BeginSeg=Yes
7	by	_	_	_	_	_	_	_	_
8	severe	_	_	_	_	_	_	_	_
9	acute	_	_	_	_	_	_	_	_
10	respiratory	_	_	_	_	_	_	_	_
11	syndrome	_	_	_	_	_	_	_	_
12	coronavirus-2	_	_	_	_	_	_	_	_
13	,	_	_	_	_	_	_	_	_
14	has	_	_	_	_	_	_	_	BeginSeg=Yes
15	spread	_	_	_	_	_	_	_	_
16	worldwide	_	_	_	_	_	_	_	_
17	from	_	_	_	_	_	_	_	_
18	China	_	_	_	_	_	_	_	_
19	.	_	_	_	_	_	_	_	_
20	There	_	_	_	_	_	_	_	BeginSeg=Yes
21	are	_	_	_	_	_	_	_	_
22	no	_	_	_	_	_	_	_	_
23	case	_	_	_	_	_	_	_	_
24	reports	_	_	_	_	_	_	_	_
25	from	_	_	_	_	_	_	_	_
26	Asia	_	_	_	_	_	_	_	_
27	of	_	_	_	_	_	_	_	_
28	COVID-19	_	_	_	_	_	_	_	_
29	with	_	_	_	_	_	_	_	_
30	facial	_	_	_	_	_	_	_	_
31	paralysis	_	_	_	_	_	_	_	_
32	and	_	_	_	_	_	_	_	_
33	olfactory	_	_	_	_	_	_	_	_
34	disturbance	_	_	_	_	_	_	_	_
35	.	_	_	_	_	_	_	_	_
36	We	_	_	_	_	_	_	_	BeginSeg=Yes
37	herein	_	_	_	_	_	_	_	_
38	report	_	_	_	_	_	_	_	_
39	a	_	_	_	_	_	_	_	_
40	case	_	_	_	_	_	_	_	_
41	of	_	_	_	_	_	_	_	_
42	COVID-19	_	_	_	_	_	_	_	_
43	pneumonia	_	_	_	_	_	_	_	_
44	in	_	_	_	_	_	_	_	_
45	a	_	_	_	_	_	_	_	_
46	Japanese	_	_	_	_	_	_	_	_
47	woman	_	_	_	_	_	_	_	_
48	who	_	_	_	_	_	_	_	BeginSeg=Yes
49	showed	_	_	_	_	_	_	_	_
50	facial	_	_	_	_	_	_	_	_
51	nerve	_	_	_	_	_	_	_	_
52	palsy	_	_	_	_	_	_	_	_
53	and	_	_	_	_	_	_	_	_
54	olfactory	_	_	_	_	_	_	_	_
55	disturbance	_	_	_	_	_	_	_	_
56	.	_	_	_	_	_	_	_	_

# newdoc_id = 4894e8b3062d3304ef9cc17f72efcea7e66bbe4d
1	Chemical	_	_	_	_	_	_	_	BeginSeg=Yes
2	denaturant	_	_	_	_	_	_	_	_
3	sensitivity	_	_	_	_	_	_	_	_
4	of	_	_	_	_	_	_	_	_
5	the	_	_	_	_	_	_	_	_
6	dimeric	_	_	_	_	_	_	_	_
7	main	_	_	_	_	_	_	_	_
8	protease	_	_	_	_	_	_	_	_
9	from	_	_	_	_	_	_	_	_
10	severe	_	_	_	_	_	_	_	_
11	acute	_	_	_	_	_	_	_	_
12	respiratory	_	_	_	_	_	_	_	_
13	syndrome	_	_	_	_	_	_	_	_
14	(	_	_	_	_	_	_	_	_
15	SARS	_	_	_	_	_	_	_	_
16	)	_	_	_	_	_	_	_	_
17	coronavirus	_	_	_	_	_	_	_	_
18	to	_	_	_	_	_	_	_	_
19	guanidinium	_	_	_	_	_	_	_	_
20	chloride	_	_	_	_	_	_	_	_
21	was	_	_	_	_	_	_	_	_
22	examined	_	_	_	_	_	_	_	_
23	in	_	_	_	_	_	_	_	_
24	terms	_	_	_	_	_	_	_	_
25	of	_	_	_	_	_	_	_	_
26	fluorescence	_	_	_	_	_	_	_	_
27	spectroscopy	_	_	_	_	_	_	_	_
28	,	_	_	_	_	_	_	_	_
29	circular	_	_	_	_	_	_	_	_
30	dichroism	_	_	_	_	_	_	_	_
31	,	_	_	_	_	_	_	_	_
32	analytical	_	_	_	_	_	_	_	_
33	ultracentrifuge	_	_	_	_	_	_	_	_
34	,	_	_	_	_	_	_	_	_
35	and	_	_	_	_	_	_	_	_
36	enzyme	_	_	_	_	_	_	_	_
37	activity	_	_	_	_	_	_	_	_
38	change	_	_	_	_	_	_	_	_
39	.	_	_	_	_	_	_	_	_
40	The	_	_	_	_	_	_	_	BeginSeg=Yes
41	dimeric	_	_	_	_	_	_	_	_
42	enzyme	_	_	_	_	_	_	_	_
43	dissociated	_	_	_	_	_	_	_	_
44	at	_	_	_	_	_	_	_	_
45	guanidinium	_	_	_	_	_	_	_	_
46	chloride	_	_	_	_	_	_	_	_
47	concentration	_	_	_	_	_	_	_	_
48	of	_	_	_	_	_	_	_	_
49	,	_	_	_	_	_	_	_	_
50	0.4	_	_	_	_	_	_	_	_
51	M	_	_	_	_	_	_	_	_
52	,	_	_	_	_	_	_	_	_
53	at	_	_	_	_	_	_	_	BeginSeg=Yes
54	which	_	_	_	_	_	_	_	_
55	the	_	_	_	_	_	_	_	_
56	enzymatic	_	_	_	_	_	_	_	_
57	activity	_	_	_	_	_	_	_	_
58	loss	_	_	_	_	_	_	_	_
59	showed	_	_	_	_	_	_	_	_
60	close	_	_	_	_	_	_	_	_
61	correlation	_	_	_	_	_	_	_	_
62	with	_	_	_	_	_	_	_	_
63	the	_	_	_	_	_	_	_	_
64	subunit	_	_	_	_	_	_	_	_
65	dissociation	_	_	_	_	_	_	_	_
66	.	_	_	_	_	_	_	_	_
67	Further	_	_	_	_	_	_	_	BeginSeg=Yes
68	increase	_	_	_	_	_	_	_	_
69	in	_	_	_	_	_	_	_	_
70	guanidinium	_	_	_	_	_	_	_	_
71	chloride	_	_	_	_	_	_	_	_
72	induced	_	_	_	_	_	_	_	_
73	a	_	_	_	_	_	_	_	_
74	reversible	_	_	_	_	_	_	_	_
75	biphasic	_	_	_	_	_	_	_	_
76	unfolding	_	_	_	_	_	_	_	_
77	of	_	_	_	_	_	_	_	_
78	the	_	_	_	_	_	_	_	_
79	enzyme	_	_	_	_	_	_	_	_
80	.	_	_	_	_	_	_	_	_
81	The	_	_	_	_	_	_	_	BeginSeg=Yes
82	unfolding	_	_	_	_	_	_	_	_
83	of	_	_	_	_	_	_	_	_
84	the	_	_	_	_	_	_	_	_
85	C	_	_	_	_	_	_	_	_
86	-	_	_	_	_	_	_	_	_
87	terminal	_	_	_	_	_	_	_	_
88	domain	_	_	_	_	_	_	_	_
89	-	_	_	_	_	_	_	_	_
90	truncated	_	_	_	_	_	_	_	_
91	enzyme	_	_	_	_	_	_	_	_
92	,	_	_	_	_	_	_	_	_
93	on	_	_	_	_	_	_	_	_
94	the	_	_	_	_	_	_	_	_
95	other	_	_	_	_	_	_	_	_
96	hand	_	_	_	_	_	_	_	_
97	,	_	_	_	_	_	_	_	_
98	followed	_	_	_	_	_	_	_	_
99	a	_	_	_	_	_	_	_	_
100	monophasic	_	_	_	_	_	_	_	_
101	unfolding	_	_	_	_	_	_	_	_
102	curve	_	_	_	_	_	_	_	_
103	.	_	_	_	_	_	_	_	_
104	Different	_	_	_	_	_	_	_	BeginSeg=Yes
105	mutants	_	_	_	_	_	_	_	_
106	of	_	_	_	_	_	_	_	_
107	the	_	_	_	_	_	_	_	_
108	full	_	_	_	_	_	_	_	_
109	-	_	_	_	_	_	_	_	_
110	length	_	_	_	_	_	_	_	_
111	protease	_	_	_	_	_	_	_	_
112	(	_	_	_	_	_	_	_	BeginSeg=Yes
113	W31	_	_	_	_	_	_	_	_
114	and	_	_	_	_	_	_	_	_
115	W207	_	_	_	_	_	_	_	_
116	/	_	_	_	_	_	_	_	_
117	W218	_	_	_	_	_	_	_	_
118	)	_	_	_	_	_	_	_	_
119	,	_	_	_	_	_	_	_	_
120	with	_	_	_	_	_	_	_	BeginSeg=Yes
121	tryptophanyl	_	_	_	_	_	_	_	_
122	residue(s	_	_	_	_	_	_	_	_
123	)	_	_	_	_	_	_	_	_
124	mutated	_	_	_	_	_	_	_	BeginSeg=Yes
125	to	_	_	_	_	_	_	_	_
126	phenylalanine	_	_	_	_	_	_	_	_
127	at	_	_	_	_	_	_	_	_
128	the	_	_	_	_	_	_	_	_
129	C	_	_	_	_	_	_	_	_
130	-	_	_	_	_	_	_	_	_
131	terminal	_	_	_	_	_	_	_	_
132	or	_	_	_	_	_	_	_	_
133	N	_	_	_	_	_	_	_	_
134	-	_	_	_	_	_	_	_	_
135	terminal	_	_	_	_	_	_	_	_
136	domain	_	_	_	_	_	_	_	_
137	,	_	_	_	_	_	_	_	_
138	respectively	_	_	_	_	_	_	_	_
139	,	_	_	_	_	_	_	_	_
140	were	_	_	_	_	_	_	_	BeginSeg=Yes
141	constructed	_	_	_	_	_	_	_	_
142	.	_	_	_	_	_	_	_	_
143	Unfolding	_	_	_	_	_	_	_	BeginSeg=Yes
144	curves	_	_	_	_	_	_	_	_
145	of	_	_	_	_	_	_	_	_
146	these	_	_	_	_	_	_	_	_
147	mutants	_	_	_	_	_	_	_	_
148	were	_	_	_	_	_	_	_	_
149	monophasic	_	_	_	_	_	_	_	_
150	but	_	_	_	_	_	_	_	BeginSeg=Yes
151	corresponded	_	_	_	_	_	_	_	_
152	to	_	_	_	_	_	_	_	_
153	the	_	_	_	_	_	_	_	_
154	first	_	_	_	_	_	_	_	_
155	and	_	_	_	_	_	_	_	_
156	second	_	_	_	_	_	_	_	_
157	phases	_	_	_	_	_	_	_	_
158	of	_	_	_	_	_	_	_	_
159	the	_	_	_	_	_	_	_	_
160	protease	_	_	_	_	_	_	_	_
161	,	_	_	_	_	_	_	_	_
162	respectively	_	_	_	_	_	_	_	_
163	.	_	_	_	_	_	_	_	_
164	The	_	_	_	_	_	_	_	BeginSeg=Yes
165	unfolding	_	_	_	_	_	_	_	_
166	intermediate	_	_	_	_	_	_	_	_
167	of	_	_	_	_	_	_	_	_
168	the	_	_	_	_	_	_	_	_
169	protease	_	_	_	_	_	_	_	_
170	thus	_	_	_	_	_	_	_	_
171	represented	_	_	_	_	_	_	_	_
172	a	_	_	_	_	_	_	_	_
173	folded	_	_	_	_	_	_	_	_
174	C	_	_	_	_	_	_	_	_
175	-	_	_	_	_	_	_	_	_
176	terminal	_	_	_	_	_	_	_	_
177	domain	_	_	_	_	_	_	_	_
178	but	_	_	_	_	_	_	_	_
179	an	_	_	_	_	_	_	_	_
180	unfolded	_	_	_	_	_	_	_	_
181	N	_	_	_	_	_	_	_	_
182	-	_	_	_	_	_	_	_	_
183	terminal	_	_	_	_	_	_	_	_
184	domain	_	_	_	_	_	_	_	_
185	,	_	_	_	_	_	_	_	_
186	which	_	_	_	_	_	_	_	BeginSeg=Yes
187	is	_	_	_	_	_	_	_	_
188	enzymatically	_	_	_	_	_	_	_	_
189	inactive	_	_	_	_	_	_	_	_
190	due	_	_	_	_	_	_	_	BeginSeg=Yes
191	to	_	_	_	_	_	_	_	_
192	loss	_	_	_	_	_	_	_	_
193	of	_	_	_	_	_	_	_	_
194	regulatory	_	_	_	_	_	_	_	_
195	properties	_	_	_	_	_	_	_	_
196	.	_	_	_	_	_	_	_	_
197	The	_	_	_	_	_	_	_	BeginSeg=Yes
198	various	_	_	_	_	_	_	_	_
199	enzyme	_	_	_	_	_	_	_	_
200	forms	_	_	_	_	_	_	_	_
201	were	_	_	_	_	_	_	_	_
202	characterized	_	_	_	_	_	_	_	_
203	in	_	_	_	_	_	_	_	_
204	terms	_	_	_	_	_	_	_	_
205	of	_	_	_	_	_	_	_	_
206	hydrophobicity	_	_	_	_	_	_	_	_
207	and	_	_	_	_	_	_	_	_
208	size	_	_	_	_	_	_	_	_
209	-	_	_	_	_	_	_	_	_
210	and	_	_	_	_	_	_	_	_
211	-	_	_	_	_	_	_	_	_
212	shape	_	_	_	_	_	_	_	_
213	distributions	_	_	_	_	_	_	_	_
214	.	_	_	_	_	_	_	_	_
215	We	_	_	_	_	_	_	_	BeginSeg=Yes
216	provide	_	_	_	_	_	_	_	_
217	direct	_	_	_	_	_	_	_	_
218	evidence	_	_	_	_	_	_	_	_
219	for	_	_	_	_	_	_	_	_
220	the	_	_	_	_	_	_	_	_
221	functional	_	_	_	_	_	_	_	_
222	role	_	_	_	_	_	_	_	_
223	of	_	_	_	_	_	_	_	_
224	C	_	_	_	_	_	_	_	_
225	-	_	_	_	_	_	_	_	_
226	terminal	_	_	_	_	_	_	_	_
227	domain	_	_	_	_	_	_	_	_
228	in	_	_	_	_	_	_	_	_
229	stabilization	_	_	_	_	_	_	_	_
230	of	_	_	_	_	_	_	_	_
231	the	_	_	_	_	_	_	_	_
232	catalytic	_	_	_	_	_	_	_	_
233	N	_	_	_	_	_	_	_	_
234	-	_	_	_	_	_	_	_	_
235	terminal	_	_	_	_	_	_	_	_
236	domain	_	_	_	_	_	_	_	_
237	of	_	_	_	_	_	_	_	_
238	SARS	_	_	_	_	_	_	_	_
239	coronavirus	_	_	_	_	_	_	_	_
240	main	_	_	_	_	_	_	_	_
241	protease	_	_	_	_	_	_	_	_
242	.	_	_	_	_	_	_	_	_

# newdoc_id = 492a1c000e859332a6e5d333aef1d74c4147b4e1
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	coronavirus	_	_	_	_	_	_	_	_
3	disease	_	_	_	_	_	_	_	_
4	2019	_	_	_	_	_	_	_	_
5	,	_	_	_	_	_	_	_	_
6	which	_	_	_	_	_	_	_	BeginSeg=Yes
7	emerged	_	_	_	_	_	_	_	_
8	from	_	_	_	_	_	_	_	_
9	Wuhan	_	_	_	_	_	_	_	_
10	,	_	_	_	_	_	_	_	_
11	China	_	_	_	_	_	_	_	_
12	,	_	_	_	_	_	_	_	_
13	is	_	_	_	_	_	_	_	BeginSeg=Yes
14	now	_	_	_	_	_	_	_	_
15	a	_	_	_	_	_	_	_	_
16	pandemic	_	_	_	_	_	_	_	_
17	,	_	_	_	_	_	_	_	_
18	affecting	_	_	_	_	_	_	_	BeginSeg=Yes
19	across	_	_	_	_	_	_	_	_
20	the	_	_	_	_	_	_	_	_
21	globe	_	_	_	_	_	_	_	_
22	.	_	_	_	_	_	_	_	_
23	Government	_	_	_	_	_	_	_	BeginSeg=Yes
24	of	_	_	_	_	_	_	_	_
25	different	_	_	_	_	_	_	_	_
26	countries	_	_	_	_	_	_	_	_
27	have	_	_	_	_	_	_	_	_
28	developed	_	_	_	_	_	_	_	_
29	and	_	_	_	_	_	_	_	_
30	adopted	_	_	_	_	_	_	_	_
31	various	_	_	_	_	_	_	_	_
32	policies	_	_	_	_	_	_	_	_
33	to	_	_	_	_	_	_	_	BeginSeg=Yes
34	contain	_	_	_	_	_	_	_	_
35	this	_	_	_	_	_	_	_	_
36	epidemic	_	_	_	_	_	_	_	_
37	and	_	_	_	_	_	_	_	BeginSeg=Yes
38	the	_	_	_	_	_	_	_	_
39	most	_	_	_	_	_	_	_	_
40	common	_	_	_	_	_	_	_	_
41	were	_	_	_	_	_	_	_	_
42	the	_	_	_	_	_	_	_	_
43	social	_	_	_	_	_	_	_	_
44	distancing	_	_	_	_	_	_	_	_
45	and	_	_	_	_	_	_	_	_
46	lockdown	_	_	_	_	_	_	_	_
47	.	_	_	_	_	_	_	_	_
48	We	_	_	_	_	_	_	_	BeginSeg=Yes
49	proposed	_	_	_	_	_	_	_	_
50	a	_	_	_	_	_	_	_	_
51	SEIR	_	_	_	_	_	_	_	_
52	epidemic	_	_	_	_	_	_	_	_
53	model	_	_	_	_	_	_	_	_
54	that	_	_	_	_	_	_	_	BeginSeg=Yes
55	accommodates	_	_	_	_	_	_	_	_
56	the	_	_	_	_	_	_	_	_
57	effects	_	_	_	_	_	_	_	_
58	of	_	_	_	_	_	_	_	_
59	lockdown	_	_	_	_	_	_	_	_
60	and	_	_	_	_	_	_	_	_
61	individual	_	_	_	_	_	_	_	_
62	based	_	_	_	_	_	_	_	_
63	precautionary	_	_	_	_	_	_	_	_
64	measures	_	_	_	_	_	_	_	_
65	and	_	_	_	_	_	_	_	BeginSeg=Yes
66	used	_	_	_	_	_	_	_	_
67	it	_	_	_	_	_	_	_	_
68	to	_	_	_	_	_	_	_	BeginSeg=Yes
69	estimate	_	_	_	_	_	_	_	_
70	model	_	_	_	_	_	_	_	_
71	parameters	_	_	_	_	_	_	_	_
72	from	_	_	_	_	_	_	_	_
73	the	_	_	_	_	_	_	_	_
74	epidemic	_	_	_	_	_	_	_	_
75	data	_	_	_	_	_	_	_	_
76	up	_	_	_	_	_	_	_	_
77	to	_	_	_	_	_	_	_	_
78	2nd	_	_	_	_	_	_	_	_
79	April	_	_	_	_	_	_	_	_
80	,	_	_	_	_	_	_	_	_
81	2020	_	_	_	_	_	_	_	_
82	,	_	_	_	_	_	_	_	_
83	freely	_	_	_	_	_	_	_	BeginSeg=Yes
84	available	_	_	_	_	_	_	_	_
85	in	_	_	_	_	_	_	_	_
86	GitHub	_	_	_	_	_	_	_	_
87	repository	_	_	_	_	_	_	_	_
88	for	_	_	_	_	_	_	_	_
89	COVID-19	_	_	_	_	_	_	_	_
90	,	_	_	_	_	_	_	_	_
91	for	_	_	_	_	_	_	_	_
92	nine	_	_	_	_	_	_	_	_
93	developed	_	_	_	_	_	_	_	_
94	and	_	_	_	_	_	_	_	_
95	developing	_	_	_	_	_	_	_	_
96	countries	_	_	_	_	_	_	_	_
97	.	_	_	_	_	_	_	_	_
98	We	_	_	_	_	_	_	_	BeginSeg=Yes
99	used	_	_	_	_	_	_	_	_
100	the	_	_	_	_	_	_	_	_
101	estimated	_	_	_	_	_	_	_	_
102	parameters	_	_	_	_	_	_	_	_
103	to	_	_	_	_	_	_	_	BeginSeg=Yes
104	predict	_	_	_	_	_	_	_	_
105	the	_	_	_	_	_	_	_	_
106	disease	_	_	_	_	_	_	_	_
107	burden	_	_	_	_	_	_	_	_
108	in	_	_	_	_	_	_	_	_
109	these	_	_	_	_	_	_	_	_
110	countries	_	_	_	_	_	_	_	_
111	with	_	_	_	_	_	_	_	_
112	special	_	_	_	_	_	_	_	_
113	emphasis	_	_	_	_	_	_	_	_
114	on	_	_	_	_	_	_	_	_
115	India	_	_	_	_	_	_	_	_
116	,	_	_	_	_	_	_	_	_
117	Bangladesh	_	_	_	_	_	_	_	_
118	and	_	_	_	_	_	_	_	_
119	Pakistan	_	_	_	_	_	_	_	_
120	.	_	_	_	_	_	_	_	_
121	Our	_	_	_	_	_	_	_	BeginSeg=Yes
122	analysis	_	_	_	_	_	_	_	_
123	revealed	_	_	_	_	_	_	_	_
124	that	_	_	_	_	_	_	_	BeginSeg=Yes
125	the	_	_	_	_	_	_	_	_
126	lockdown	_	_	_	_	_	_	_	_
127	and	_	_	_	_	_	_	_	_
128	recommended	_	_	_	_	_	_	_	_
129	individual	_	_	_	_	_	_	_	_
130	hygiene	_	_	_	_	_	_	_	_
131	can	_	_	_	_	_	_	_	_
132	slow	_	_	_	_	_	_	_	_
133	down	_	_	_	_	_	_	_	_
134	the	_	_	_	_	_	_	_	_
135	outbreak	_	_	_	_	_	_	_	_
136	but	_	_	_	_	_	_	_	BeginSeg=Yes
137	unable	_	_	_	_	_	_	_	_
138	to	_	_	_	_	_	_	_	_
139	eradicate	_	_	_	_	_	_	_	_
140	the	_	_	_	_	_	_	_	_
141	disease	_	_	_	_	_	_	_	_
142	from	_	_	_	_	_	_	_	_
143	the	_	_	_	_	_	_	_	_
144	society	_	_	_	_	_	_	_	_
145	.	_	_	_	_	_	_	_	_
146	With	_	_	_	_	_	_	_	BeginSeg=Yes
147	the	_	_	_	_	_	_	_	_
148	current	_	_	_	_	_	_	_	_
149	human	_	_	_	_	_	_	_	_
150	-	_	_	_	_	_	_	_	_
151	to	_	_	_	_	_	_	_	_
152	-	_	_	_	_	_	_	_	_
153	human	_	_	_	_	_	_	_	_
154	transmission	_	_	_	_	_	_	_	_
155	rate	_	_	_	_	_	_	_	_
156	and	_	_	_	_	_	_	_	_
157	existing	_	_	_	_	_	_	_	_
158	level	_	_	_	_	_	_	_	_
159	of	_	_	_	_	_	_	_	_
160	personal	_	_	_	_	_	_	_	_
161	precautionary	_	_	_	_	_	_	_	_
162	,	_	_	_	_	_	_	_	_
163	the	_	_	_	_	_	_	_	BeginSeg=Yes
164	number	_	_	_	_	_	_	_	_
165	of	_	_	_	_	_	_	_	_
166	infected	_	_	_	_	_	_	_	_
167	individuals	_	_	_	_	_	_	_	_
168	in	_	_	_	_	_	_	_	_
169	India	_	_	_	_	_	_	_	_
170	will	_	_	_	_	_	_	_	_
171	be	_	_	_	_	_	_	_	_
172	increasing	_	_	_	_	_	_	_	_
173	at	_	_	_	_	_	_	_	_
174	least	_	_	_	_	_	_	_	_
175	for	_	_	_	_	_	_	_	_
176	the	_	_	_	_	_	_	_	_
177	next	_	_	_	_	_	_	_	_
178	3	_	_	_	_	_	_	_	_
179	months	_	_	_	_	_	_	_	_
180	and	_	_	_	_	_	_	_	BeginSeg=Yes
181	the	_	_	_	_	_	_	_	_
182	peak	_	_	_	_	_	_	_	_
183	will	_	_	_	_	_	_	_	_
184	come	_	_	_	_	_	_	_	_
185	in	_	_	_	_	_	_	_	_
186	5	_	_	_	_	_	_	_	_
187	months	_	_	_	_	_	_	_	_
188	.	_	_	_	_	_	_	_	_
189	We	_	_	_	_	_	_	_	BeginSeg=Yes
190	can	_	_	_	_	_	_	_	_
191	,	_	_	_	_	_	_	_	_
192	however	_	_	_	_	_	_	_	_
193	,	_	_	_	_	_	_	_	_
194	reduce	_	_	_	_	_	_	_	_
195	the	_	_	_	_	_	_	_	_
196	epidemic	_	_	_	_	_	_	_	_
197	size	_	_	_	_	_	_	_	_
198	and	_	_	_	_	_	_	_	BeginSeg=Yes
199	prolong	_	_	_	_	_	_	_	_
200	the	_	_	_	_	_	_	_	_
201	time	_	_	_	_	_	_	_	_
202	to	_	_	_	_	_	_	_	BeginSeg=Yes
203	arrive	_	_	_	_	_	_	_	_
204	epidemic	_	_	_	_	_	_	_	_
205	peak	_	_	_	_	_	_	_	_
206	by	_	_	_	_	_	_	_	BeginSeg=Yes
207	seriously	_	_	_	_	_	_	_	_
208	following	_	_	_	_	_	_	_	_
209	the	_	_	_	_	_	_	_	_
210	measures	_	_	_	_	_	_	_	_
211	suggested	_	_	_	_	_	_	_	BeginSeg=Yes
212	by	_	_	_	_	_	_	_	_
213	the	_	_	_	_	_	_	_	_
214	authorities	_	_	_	_	_	_	_	_
215	.	_	_	_	_	_	_	_	_
216	We	_	_	_	_	_	_	_	BeginSeg=Yes
217	need	_	_	_	_	_	_	_	_
218	to	_	_	_	_	_	_	_	_
219	wait	_	_	_	_	_	_	_	_
220	for	_	_	_	_	_	_	_	_
221	another	_	_	_	_	_	_	_	_
222	one	_	_	_	_	_	_	_	_
223	month	_	_	_	_	_	_	_	_
224	to	_	_	_	_	_	_	_	BeginSeg=Yes
225	obtain	_	_	_	_	_	_	_	_
226	more	_	_	_	_	_	_	_	_
227	data	_	_	_	_	_	_	_	_
228	and	_	_	_	_	_	_	_	_
229	epidemiological	_	_	_	_	_	_	_	_
230	parameters	_	_	_	_	_	_	_	_
231	for	_	_	_	_	_	_	_	BeginSeg=Yes
232	giving	_	_	_	_	_	_	_	_
233	a	_	_	_	_	_	_	_	_
234	better	_	_	_	_	_	_	_	_
235	prediction	_	_	_	_	_	_	_	_
236	about	_	_	_	_	_	_	_	_
237	the	_	_	_	_	_	_	_	_
238	pandemic	_	_	_	_	_	_	_	_
239	.	_	_	_	_	_	_	_	_
240	It	_	_	_	_	_	_	_	BeginSeg=Yes
241	is	_	_	_	_	_	_	_	_
242	to	_	_	_	_	_	_	_	_
243	be	_	_	_	_	_	_	_	_
244	mentioned	_	_	_	_	_	_	_	_
245	that	_	_	_	_	_	_	_	_
246	research	_	_	_	_	_	_	_	_
247	community	_	_	_	_	_	_	_	_
248	is	_	_	_	_	_	_	_	_
249	working	_	_	_	_	_	_	_	_
250	for	_	_	_	_	_	_	_	_
251	drugs	_	_	_	_	_	_	_	_
252	and/	_	_	_	_	_	_	_	_
253	or	_	_	_	_	_	_	_	_
254	vaccines	_	_	_	_	_	_	_	_
255	against	_	_	_	_	_	_	_	_
256	COVID19	_	_	_	_	_	_	_	_
257	and	_	_	_	_	_	_	_	BeginSeg=Yes
258	the	_	_	_	_	_	_	_	_
259	presence	_	_	_	_	_	_	_	_
260	of	_	_	_	_	_	_	_	_
261	such	_	_	_	_	_	_	_	_
262	pharmaceutical	_	_	_	_	_	_	_	_
263	interventions	_	_	_	_	_	_	_	_
264	will	_	_	_	_	_	_	_	_
265	significantly	_	_	_	_	_	_	_	_
266	alter	_	_	_	_	_	_	_	_
267	the	_	_	_	_	_	_	_	_
268	results	_	_	_	_	_	_	_	_
269	.	_	_	_	_	_	_	_	_

# newdoc_id = 4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	current	_	_	_	_	_	_	_	_
3	Ebola	_	_	_	_	_	_	_	_
4	virus	_	_	_	_	_	_	_	_
5	outbreak	_	_	_	_	_	_	_	_
6	has	_	_	_	_	_	_	_	_
7	highlighted	_	_	_	_	_	_	_	_
8	the	_	_	_	_	_	_	_	_
9	uncertainties	_	_	_	_	_	_	_	_
10	surrounding	_	_	_	_	_	_	_	BeginSeg=Yes
11	many	_	_	_	_	_	_	_	_
12	aspects	_	_	_	_	_	_	_	_
13	of	_	_	_	_	_	_	_	_
14	Ebola	_	_	_	_	_	_	_	_
15	virus	_	_	_	_	_	_	_	_
16	virology	_	_	_	_	_	_	_	_
17	,	_	_	_	_	_	_	_	_
18	including	_	_	_	_	_	_	_	BeginSeg=Yes
19	routes	_	_	_	_	_	_	_	_
20	of	_	_	_	_	_	_	_	_
21	transmission	_	_	_	_	_	_	_	_
22	.	_	_	_	_	_	_	_	_
23	The	_	_	_	_	_	_	_	BeginSeg=Yes
24	scientific	_	_	_	_	_	_	_	_
25	community	_	_	_	_	_	_	_	_
26	played	_	_	_	_	_	_	_	_
27	a	_	_	_	_	_	_	_	_
28	leading	_	_	_	_	_	_	_	_
29	role	_	_	_	_	_	_	_	_
30	during	_	_	_	_	_	_	_	_
31	the	_	_	_	_	_	_	_	_
32	outbreak	_	_	_	_	_	_	_	_
33	-	_	_	_	_	_	_	_	BeginSeg=Yes
34	potentially	_	_	_	_	_	_	_	_
35	,	_	_	_	_	_	_	_	_
36	the	_	_	_	_	_	_	_	_
37	largest	_	_	_	_	_	_	_	_
38	of	_	_	_	_	_	_	_	_
39	its	_	_	_	_	_	_	_	_
40	kind	_	_	_	_	_	_	_	_
41	-	_	_	_	_	_	_	_	_
42	as	_	_	_	_	_	_	_	BeginSeg=Yes
43	many	_	_	_	_	_	_	_	_
44	of	_	_	_	_	_	_	_	_
45	the	_	_	_	_	_	_	_	_
46	questions	_	_	_	_	_	_	_	_
47	surrounding	_	_	_	_	_	_	_	BeginSeg=Yes
48	ebolaviruses	_	_	_	_	_	_	_	_
49	have	_	_	_	_	_	_	_	BeginSeg=Yes
50	only	_	_	_	_	_	_	_	_
51	been	_	_	_	_	_	_	_	_
52	interrogated	_	_	_	_	_	_	_	_
53	in	_	_	_	_	_	_	_	_
54	the	_	_	_	_	_	_	_	_
55	laboratory	_	_	_	_	_	_	_	_
56	.	_	_	_	_	_	_	_	_
57	Scientists	_	_	_	_	_	_	_	BeginSeg=Yes
58	provided	_	_	_	_	_	_	_	_
59	an	_	_	_	_	_	_	_	_
60	invaluable	_	_	_	_	_	_	_	_
61	resource	_	_	_	_	_	_	_	_
62	for	_	_	_	_	_	_	_	_
63	clinicians	_	_	_	_	_	_	_	_
64	,	_	_	_	_	_	_	_	_
65	public	_	_	_	_	_	_	_	_
66	health	_	_	_	_	_	_	_	_
67	officials	_	_	_	_	_	_	_	_
68	,	_	_	_	_	_	_	_	_
69	policy	_	_	_	_	_	_	_	_
70	makers	_	_	_	_	_	_	_	_
71	,	_	_	_	_	_	_	_	_
72	and	_	_	_	_	_	_	_	_
73	the	_	_	_	_	_	_	_	_
74	lay	_	_	_	_	_	_	_	_
75	public	_	_	_	_	_	_	_	_
76	in	_	_	_	_	_	_	_	BeginSeg=Yes
77	understanding	_	_	_	_	_	_	_	_
78	the	_	_	_	_	_	_	_	_
79	progress	_	_	_	_	_	_	_	_
80	of	_	_	_	_	_	_	_	_
81	Ebola	_	_	_	_	_	_	_	_
82	virus	_	_	_	_	_	_	_	_
83	disease	_	_	_	_	_	_	_	_
84	and	_	_	_	_	_	_	_	_
85	the	_	_	_	_	_	_	_	_
86	continuing	_	_	_	_	_	_	_	_
87	outbreak	_	_	_	_	_	_	_	_
88	.	_	_	_	_	_	_	_	_
89	Not	_	_	_	_	_	_	_	BeginSeg=Yes
90	all	_	_	_	_	_	_	_	_
91	of	_	_	_	_	_	_	_	_
92	the	_	_	_	_	_	_	_	_
93	scientific	_	_	_	_	_	_	_	_
94	communication	_	_	_	_	_	_	_	_
95	,	_	_	_	_	_	_	_	_
96	however	_	_	_	_	_	_	_	_
97	,	_	_	_	_	_	_	_	_
98	was	_	_	_	_	_	_	_	_
99	accurate	_	_	_	_	_	_	_	_
100	or	_	_	_	_	_	_	_	_
101	effective	_	_	_	_	_	_	_	_
102	.	_	_	_	_	_	_	_	_
103	There	_	_	_	_	_	_	_	BeginSeg=Yes
104	were	_	_	_	_	_	_	_	_
105	multiple	_	_	_	_	_	_	_	_
106	instances	_	_	_	_	_	_	_	_
107	of	_	_	_	_	_	_	_	_
108	published	_	_	_	_	_	_	_	_
109	articles	_	_	_	_	_	_	_	_
110	during	_	_	_	_	_	_	_	_
111	the	_	_	_	_	_	_	_	_
112	height	_	_	_	_	_	_	_	_
113	of	_	_	_	_	_	_	_	_
114	the	_	_	_	_	_	_	_	_
115	outbreak	_	_	_	_	_	_	_	_
116	containing	_	_	_	_	_	_	_	BeginSeg=Yes
117	potentially	_	_	_	_	_	_	_	_
118	misleading	_	_	_	_	_	_	_	_
119	scientific	_	_	_	_	_	_	_	_
120	language	_	_	_	_	_	_	_	_
121	that	_	_	_	_	_	_	_	BeginSeg=Yes
122	spurred	_	_	_	_	_	_	_	_
123	media	_	_	_	_	_	_	_	_
124	overreaction	_	_	_	_	_	_	_	_
125	and	_	_	_	_	_	_	_	BeginSeg=Yes
126	potentially	_	_	_	_	_	_	_	_
127	jeopardized	_	_	_	_	_	_	_	_
128	preparedness	_	_	_	_	_	_	_	_
129	and	_	_	_	_	_	_	_	_
130	policy	_	_	_	_	_	_	_	_
131	decisions	_	_	_	_	_	_	_	_
132	at	_	_	_	_	_	_	_	_
133	critical	_	_	_	_	_	_	_	_
134	points	_	_	_	_	_	_	_	_
135	.	_	_	_	_	_	_	_	_
136	Here	_	_	_	_	_	_	_	BeginSeg=Yes
137	,	_	_	_	_	_	_	_	_
138	we	_	_	_	_	_	_	_	_
139	use	_	_	_	_	_	_	_	_
140	articles	_	_	_	_	_	_	_	_
141	declaring	_	_	_	_	_	_	_	BeginSeg=Yes
142	the	_	_	_	_	_	_	_	_
143	potential	_	_	_	_	_	_	_	_
144	for	_	_	_	_	_	_	_	_
145	airborne	_	_	_	_	_	_	_	_
146	transmission	_	_	_	_	_	_	_	_
147	of	_	_	_	_	_	_	_	_
148	Ebola	_	_	_	_	_	_	_	_
149	virus	_	_	_	_	_	_	_	_
150	as	_	_	_	_	_	_	_	BeginSeg=Yes
151	a	_	_	_	_	_	_	_	_
152	case	_	_	_	_	_	_	_	_
153	study	_	_	_	_	_	_	_	_
154	in	_	_	_	_	_	_	_	_
155	the	_	_	_	_	_	_	_	_
156	inaccurate	_	_	_	_	_	_	_	_
157	reporting	_	_	_	_	_	_	_	_
158	of	_	_	_	_	_	_	_	_
159	basic	_	_	_	_	_	_	_	_
160	science	_	_	_	_	_	_	_	_
161	,	_	_	_	_	_	_	_	_
162	and	_	_	_	_	_	_	_	BeginSeg=Yes
163	we	_	_	_	_	_	_	_	_
164	provide	_	_	_	_	_	_	_	_
165	recommendations	_	_	_	_	_	_	_	_
166	for	_	_	_	_	_	_	_	BeginSeg=Yes
167	improving	_	_	_	_	_	_	_	_
168	the	_	_	_	_	_	_	_	_
169	communication	_	_	_	_	_	_	_	_
170	about	_	_	_	_	_	_	_	_
171	unknown	_	_	_	_	_	_	_	_
172	aspects	_	_	_	_	_	_	_	_
173	of	_	_	_	_	_	_	_	_
174	disease	_	_	_	_	_	_	_	_
175	during	_	_	_	_	_	_	_	_
176	public	_	_	_	_	_	_	_	_
177	health	_	_	_	_	_	_	_	_
178	crises	_	_	_	_	_	_	_	_
179	.	_	_	_	_	_	_	_	_
180	Basic	_	_	_	_	_	_	_	BeginSeg=Yes
181	scientific	_	_	_	_	_	_	_	_
182	research	_	_	_	_	_	_	_	_
183	is	_	_	_	_	_	_	_	_
184	now	_	_	_	_	_	_	_	_
185	considered	_	_	_	_	_	_	_	_
186	an	_	_	_	_	_	_	_	_
187	integral	_	_	_	_	_	_	_	_
188	component	_	_	_	_	_	_	_	_
189	of	_	_	_	_	_	_	_	_
190	the	_	_	_	_	_	_	_	_
191	fight	_	_	_	_	_	_	_	_
192	against	_	_	_	_	_	_	_	_
193	emerging	_	_	_	_	_	_	_	_
194	infectious	_	_	_	_	_	_	_	_
195	diseases	_	_	_	_	_	_	_	_
196	like	_	_	_	_	_	_	_	_
197	Ebola	_	_	_	_	_	_	_	_
198	virus	_	_	_	_	_	_	_	_
199	.	_	_	_	_	_	_	_	_
200	The	_	_	_	_	_	_	_	BeginSeg=Yes
201	recent	_	_	_	_	_	_	_	_
202	Ebola	_	_	_	_	_	_	_	_
203	outbreak	_	_	_	_	_	_	_	_
204	,	_	_	_	_	_	_	_	_
205	however	_	_	_	_	_	_	_	_
206	,	_	_	_	_	_	_	_	_
207	demonstrates	_	_	_	_	_	_	_	_
208	how	_	_	_	_	_	_	_	BeginSeg=Yes
209	the	_	_	_	_	_	_	_	_
210	ineffective	_	_	_	_	_	_	_	_
211	communication	_	_	_	_	_	_	_	_
212	of	_	_	_	_	_	_	_	_
213	basic	_	_	_	_	_	_	_	_
214	science	_	_	_	_	_	_	_	_
215	can	_	_	_	_	_	_	_	_
216	stoke	_	_	_	_	_	_	_	_
217	public	_	_	_	_	_	_	_	_
218	panic	_	_	_	_	_	_	_	_
219	more	_	_	_	_	_	_	_	_
220	than	_	_	_	_	_	_	_	BeginSeg=Yes
221	it	_	_	_	_	_	_	_	_
222	provides	_	_	_	_	_	_	_	_
223	helpful	_	_	_	_	_	_	_	_
224	tools	_	_	_	_	_	_	_	_
225	to	_	_	_	_	_	_	_	_
226	responders	_	_	_	_	_	_	_	_
227	;	_	_	_	_	_	_	_	_
228	basic	_	_	_	_	_	_	_	BeginSeg=Yes
229	science	_	_	_	_	_	_	_	_
230	trades	_	_	_	_	_	_	_	_
231	in	_	_	_	_	_	_	_	_
232	probabilities	_	_	_	_	_	_	_	_
233	and	_	_	_	_	_	_	_	_
234	uncertainty	_	_	_	_	_	_	_	_
235	,	_	_	_	_	_	_	_	_
236	while	_	_	_	_	_	_	_	BeginSeg=Yes
237	public	_	_	_	_	_	_	_	_
238	communication	_	_	_	_	_	_	_	_
239	tends	_	_	_	_	_	_	_	_
240	to	_	_	_	_	_	_	_	_
241	favor	_	_	_	_	_	_	_	_
242	more	_	_	_	_	_	_	_	_
243	categorical	_	_	_	_	_	_	_	_
244	claims	_	_	_	_	_	_	_	_
245	.	_	_	_	_	_	_	_	_
246	Here	_	_	_	_	_	_	_	BeginSeg=Yes
247	,	_	_	_	_	_	_	_	_
248	we	_	_	_	_	_	_	_	_
249	discuss	_	_	_	_	_	_	_	_
250	the	_	_	_	_	_	_	_	_
251	ethics	_	_	_	_	_	_	_	_
252	of	_	_	_	_	_	_	_	BeginSeg=Yes
253	communicating	_	_	_	_	_	_	_	_
254	scientific	_	_	_	_	_	_	_	_
255	results	_	_	_	_	_	_	_	_
256	,	_	_	_	_	_	_	_	_
257	using	_	_	_	_	_	_	_	BeginSeg=Yes
258	,	_	_	_	_	_	_	_	_
259	as	_	_	_	_	_	_	_	_
260	a	_	_	_	_	_	_	_	_
261	case	_	_	_	_	_	_	_	_
262	study	_	_	_	_	_	_	_	_
263	,	_	_	_	_	_	_	_	_
264	the	_	_	_	_	_	_	_	_
265	recent	_	_	_	_	_	_	_	_
266	controversy	_	_	_	_	_	_	_	_
267	over	_	_	_	_	_	_	_	BeginSeg=Yes
268	whether	_	_	_	_	_	_	_	_
269	basic	_	_	_	_	_	_	_	_
270	life	_	_	_	_	_	_	_	_
271	sciences	_	_	_	_	_	_	_	_
272	research	_	_	_	_	_	_	_	_
273	demonstrates	_	_	_	_	_	_	_	_
274	that	_	_	_	_	_	_	_	BeginSeg=Yes
275	Ebola	_	_	_	_	_	_	_	_
276	could	_	_	_	_	_	_	_	_
277	become	_	_	_	_	_	_	_	_
278	transmissible	_	_	_	_	_	_	_	_
279	via	_	_	_	_	_	_	_	_
280	airborne	_	_	_	_	_	_	_	_
281	respiratory	_	_	_	_	_	_	_	_
282	droplet	_	_	_	_	_	_	_	_
283	nuclei	_	_	_	_	_	_	_	_
284	-	_	_	_	_	_	_	_	BeginSeg=Yes
285	popularly	_	_	_	_	_	_	_	_
286	known	_	_	_	_	_	_	_	_
287	as	_	_	_	_	_	_	_	_
288	a	_	_	_	_	_	_	_	_
289	virus	_	_	_	_	_	_	_	_
290	becoming	_	_	_	_	_	_	_	BeginSeg=Yes
291	"	_	_	_	_	_	_	_	_
292	airborne	_	_	_	_	_	_	_	_
293	.	_	_	_	_	_	_	_	_
294	"	_	_	_	_	_	_	_	_
295	We	_	_	_	_	_	_	_	BeginSeg=Yes
296	show	_	_	_	_	_	_	_	_
297	how	_	_	_	_	_	_	_	BeginSeg=Yes
298	the	_	_	_	_	_	_	_	_
299	science	_	_	_	_	_	_	_	_
300	does	_	_	_	_	_	_	_	_
301	not	_	_	_	_	_	_	_	_
302	demonstrate	_	_	_	_	_	_	_	_
303	this	_	_	_	_	_	_	_	_
304	possibility	_	_	_	_	_	_	_	_
305	,	_	_	_	_	_	_	_	_
306	despite	_	_	_	_	_	_	_	BeginSeg=Yes
307	claims	_	_	_	_	_	_	_	_
308	made	_	_	_	_	_	_	_	BeginSeg=Yes
309	in	_	_	_	_	_	_	_	_
310	the	_	_	_	_	_	_	_	_
311	popular	_	_	_	_	_	_	_	_
312	and	_	_	_	_	_	_	_	_
313	scientific	_	_	_	_	_	_	_	_
314	press	_	_	_	_	_	_	_	_
315	.	_	_	_	_	_	_	_	_
316	We	_	_	_	_	_	_	_	BeginSeg=Yes
317	then	_	_	_	_	_	_	_	_
318	recommend	_	_	_	_	_	_	_	_
319	that	_	_	_	_	_	_	_	BeginSeg=Yes
320	uncertain	_	_	_	_	_	_	_	_
321	scientific	_	_	_	_	_	_	_	_
322	results	_	_	_	_	_	_	_	_
323	in	_	_	_	_	_	_	_	_
324	the	_	_	_	_	_	_	_	_
325	context	_	_	_	_	_	_	_	_
326	of	_	_	_	_	_	_	_	_
327	public	_	_	_	_	_	_	_	_
328	health	_	_	_	_	_	_	_	_
329	crises	_	_	_	_	_	_	_	_
330	ought	_	_	_	_	_	_	_	_
331	to	_	_	_	_	_	_	_	_
332	be	_	_	_	_	_	_	_	_
333	communicated	_	_	_	_	_	_	_	_
334	with	_	_	_	_	_	_	_	_
335	humility	_	_	_	_	_	_	_	_
336	,	_	_	_	_	_	_	_	_
337	an	_	_	_	_	_	_	_	_
338	emphasis	_	_	_	_	_	_	_	_
339	on	_	_	_	_	_	_	_	_
340	what	_	_	_	_	_	_	_	_
341	is	_	_	_	_	_	_	_	_
342	unknown	_	_	_	_	_	_	_	_
343	,	_	_	_	_	_	_	_	_
344	and	_	_	_	_	_	_	_	_
345	a	_	_	_	_	_	_	_	_
346	clear	_	_	_	_	_	_	_	_
347	outline	_	_	_	_	_	_	_	_
348	of	_	_	_	_	_	_	_	_
349	the	_	_	_	_	_	_	_	_
350	kinds	_	_	_	_	_	_	_	_
351	of	_	_	_	_	_	_	_	_
352	evidence	_	_	_	_	_	_	_	_
353	that	_	_	_	_	_	_	_	BeginSeg=Yes
354	would	_	_	_	_	_	_	_	_
355	give	_	_	_	_	_	_	_	_
356	proof	_	_	_	_	_	_	_	_
357	to	_	_	_	_	_	_	_	_
358	controversial	_	_	_	_	_	_	_	_
359	claims	_	_	_	_	_	_	_	_
360	.	_	_	_	_	_	_	_	_

# newdoc_id = 4cace95b9b4e1f4af324d1fa278274c53c2b00af
1	We	_	_	_	_	_	_	_	BeginSeg=Yes
2	report	_	_	_	_	_	_	_	_
3	the	_	_	_	_	_	_	_	_
4	design	_	_	_	_	_	_	_	_
5	and	_	_	_	_	_	_	_	_
6	synthesis	_	_	_	_	_	_	_	_
7	of	_	_	_	_	_	_	_	_
8	a	_	_	_	_	_	_	_	_
9	series	_	_	_	_	_	_	_	_
10	of	_	_	_	_	_	_	_	_
11	dipeptide	_	_	_	_	_	_	_	_
12	-	_	_	_	_	_	_	_	_
13	type	_	_	_	_	_	_	_	_
14	inhibitors	_	_	_	_	_	_	_	_
15	with	_	_	_	_	_	_	_	_
16	novel	_	_	_	_	_	_	_	_
17	P3	_	_	_	_	_	_	_	_
18	scaffolds	_	_	_	_	_	_	_	_
19	that	_	_	_	_	_	_	_	BeginSeg=Yes
20	display	_	_	_	_	_	_	_	_
21	potent	_	_	_	_	_	_	_	_
22	inhibitory	_	_	_	_	_	_	_	_
23	activity	_	_	_	_	_	_	_	_
24	against	_	_	_	_	_	_	_	_
25	SARS	_	_	_	_	_	_	_	_
26	-	_	_	_	_	_	_	_	_
27	CoV	_	_	_	_	_	_	_	_
28	3CL	_	_	_	_	_	_	_	_
29	pro	_	_	_	_	_	_	_	_
30	.	_	_	_	_	_	_	_	_
31	A	_	_	_	_	_	_	_	BeginSeg=Yes
32	docking	_	_	_	_	_	_	_	_
33	study	_	_	_	_	_	_	_	_
34	involving	_	_	_	_	_	_	_	BeginSeg=Yes
35	binding	_	_	_	_	_	_	_	_
36	between	_	_	_	_	_	_	_	_
37	the	_	_	_	_	_	_	_	_
38	dipeptidic	_	_	_	_	_	_	_	_
39	lead	_	_	_	_	_	_	_	_
40	compound	_	_	_	_	_	_	_	_
41	4	_	_	_	_	_	_	_	_
42	and	_	_	_	_	_	_	_	_
43	3CL	_	_	_	_	_	_	_	_
44	pro	_	_	_	_	_	_	_	_
45	suggested	_	_	_	_	_	_	_	BeginSeg=Yes
46	the	_	_	_	_	_	_	_	_
47	modification	_	_	_	_	_	_	_	_
48	of	_	_	_	_	_	_	_	_
49	a	_	_	_	_	_	_	_	_
50	structurally	_	_	_	_	_	_	_	_
51	flexible	_	_	_	_	_	_	_	_
52	P3	_	_	_	_	_	_	_	_
53	N-(3methoxyphenyl)glycine	_	_	_	_	_	_	_	_
54	with	_	_	_	_	_	_	_	_
55	various	_	_	_	_	_	_	_	_
56	rigid	_	_	_	_	_	_	_	_
57	P3	_	_	_	_	_	_	_	_
58	moieties	_	_	_	_	_	_	_	_
59	in	_	_	_	_	_	_	_	_
60	4	_	_	_	_	_	_	_	_
61	.	_	_	_	_	_	_	_	_
62	The	_	_	_	_	_	_	_	BeginSeg=Yes
63	modifications	_	_	_	_	_	_	_	_
64	led	_	_	_	_	_	_	_	_
65	to	_	_	_	_	_	_	_	_
66	the	_	_	_	_	_	_	_	_
67	identification	_	_	_	_	_	_	_	_
68	of	_	_	_	_	_	_	_	_
69	several	_	_	_	_	_	_	_	_
70	potent	_	_	_	_	_	_	_	_
71	derivatives	_	_	_	_	_	_	_	_
72	,	_	_	_	_	_	_	_	_
73	including	_	_	_	_	_	_	_	BeginSeg=Yes
74	5cek	_	_	_	_	_	_	_	_
75	and	_	_	_	_	_	_	_	_
76	5n	_	_	_	_	_	_	_	_
77	with	_	_	_	_	_	_	_	_
78	the	_	_	_	_	_	_	_	_
79	inhibitory	_	_	_	_	_	_	_	_
80	activities	_	_	_	_	_	_	_	_
81	(	_	_	_	_	_	_	_	_
82	K	_	_	_	_	_	_	_	_
83	i	_	_	_	_	_	_	_	_
84	or	_	_	_	_	_	_	_	_
85	IC	_	_	_	_	_	_	_	_
86	50	_	_	_	_	_	_	_	_
87	)	_	_	_	_	_	_	_	_
88	in	_	_	_	_	_	_	_	_
89	the	_	_	_	_	_	_	_	_
90	submicromolar	_	_	_	_	_	_	_	_
91	to	_	_	_	_	_	_	_	_
92	nanomolar	_	_	_	_	_	_	_	_
93	range	_	_	_	_	_	_	_	_
94	.	_	_	_	_	_	_	_	_
95	Compound	_	_	_	_	_	_	_	BeginSeg=Yes
96	5h	_	_	_	_	_	_	_	_
97	,	_	_	_	_	_	_	_	_
98	in	_	_	_	_	_	_	_	_
99	particular	_	_	_	_	_	_	_	_
100	,	_	_	_	_	_	_	_	_
101	displayed	_	_	_	_	_	_	_	_
102	the	_	_	_	_	_	_	_	_
103	most	_	_	_	_	_	_	_	_
104	potent	_	_	_	_	_	_	_	_
105	inhibitory	_	_	_	_	_	_	_	_
106	activity	_	_	_	_	_	_	_	_
107	,	_	_	_	_	_	_	_	_
108	with	_	_	_	_	_	_	_	_
109	a	_	_	_	_	_	_	_	_
110	K	_	_	_	_	_	_	_	_
111	i	_	_	_	_	_	_	_	_
112	value	_	_	_	_	_	_	_	_
113	of	_	_	_	_	_	_	_	_
114	0.006	_	_	_	_	_	_	_	_
115	mM.	_	_	_	_	_	_	_	_
116	This	_	_	_	_	_	_	_	BeginSeg=Yes
117	potency	_	_	_	_	_	_	_	_
118	was	_	_	_	_	_	_	_	_
119	65-fold	_	_	_	_	_	_	_	_
120	higher	_	_	_	_	_	_	_	_
121	than	_	_	_	_	_	_	_	_
122	the	_	_	_	_	_	_	_	_
123	potency	_	_	_	_	_	_	_	_
124	of	_	_	_	_	_	_	_	_
125	the	_	_	_	_	_	_	_	_
126	lead	_	_	_	_	_	_	_	_
127	compound	_	_	_	_	_	_	_	_
128	4	_	_	_	_	_	_	_	_
129	(	_	_	_	_	_	_	_	_
130	K	_	_	_	_	_	_	_	_
131	i	_	_	_	_	_	_	_	_
132	¼	_	_	_	_	_	_	_	_
133	0.39	_	_	_	_	_	_	_	_
134	mM	_	_	_	_	_	_	_	_
135	)	_	_	_	_	_	_	_	_
136	.	_	_	_	_	_	_	_	_
137	In	_	_	_	_	_	_	_	BeginSeg=Yes
138	addition	_	_	_	_	_	_	_	_
139	,	_	_	_	_	_	_	_	_
140	the	_	_	_	_	_	_	_	_
141	K	_	_	_	_	_	_	_	_
142	i	_	_	_	_	_	_	_	_
143	value	_	_	_	_	_	_	_	_
144	of	_	_	_	_	_	_	_	_
145	5h	_	_	_	_	_	_	_	_
146	was	_	_	_	_	_	_	_	_
147	in	_	_	_	_	_	_	_	_
148	very	_	_	_	_	_	_	_	_
149	good	_	_	_	_	_	_	_	_
150	agreement	_	_	_	_	_	_	_	_
151	with	_	_	_	_	_	_	_	_
152	the	_	_	_	_	_	_	_	_
153	binding	_	_	_	_	_	_	_	_
154	affinity	_	_	_	_	_	_	_	_
155	(	_	_	_	_	_	_	_	_
156	16	_	_	_	_	_	_	_	_
157	nM	_	_	_	_	_	_	_	_
158	)	_	_	_	_	_	_	_	_
159	observed	_	_	_	_	_	_	_	BeginSeg=Yes
160	in	_	_	_	_	_	_	_	_
161	isothermal	_	_	_	_	_	_	_	_
162	titration	_	_	_	_	_	_	_	_
163	calorimetry	_	_	_	_	_	_	_	_
164	(	_	_	_	_	_	_	_	_
165	ITC	_	_	_	_	_	_	_	_
166	)	_	_	_	_	_	_	_	_
167	.	_	_	_	_	_	_	_	_
168	A	_	_	_	_	_	_	_	BeginSeg=Yes
169	SAR	_	_	_	_	_	_	_	_
170	study	_	_	_	_	_	_	_	_
171	around	_	_	_	_	_	_	_	_
172	the	_	_	_	_	_	_	_	_
173	P3	_	_	_	_	_	_	_	_
174	group	_	_	_	_	_	_	_	_
175	in	_	_	_	_	_	_	_	_
176	the	_	_	_	_	_	_	_	_
177	lead	_	_	_	_	_	_	_	_
178	4	_	_	_	_	_	_	_	_
179	led	_	_	_	_	_	_	_	_
180	to	_	_	_	_	_	_	_	_
181	the	_	_	_	_	_	_	_	_
182	identification	_	_	_	_	_	_	_	_
183	of	_	_	_	_	_	_	_	_
184	a	_	_	_	_	_	_	_	_
185	rigid	_	_	_	_	_	_	_	_
186	indole-2-carbonyl	_	_	_	_	_	_	_	_
187	unit	_	_	_	_	_	_	_	_
188	as	_	_	_	_	_	_	_	_
189	one	_	_	_	_	_	_	_	_
190	of	_	_	_	_	_	_	_	_
191	the	_	_	_	_	_	_	_	_
192	best	_	_	_	_	_	_	_	_
193	P3	_	_	_	_	_	_	_	_
194	moieties	_	_	_	_	_	_	_	_
195	(	_	_	_	_	_	_	_	_
196	5c	_	_	_	_	_	_	_	_
197	)	_	_	_	_	_	_	_	_
198	.	_	_	_	_	_	_	_	_
199	Further	_	_	_	_	_	_	_	BeginSeg=Yes
200	optimization	_	_	_	_	_	_	_	_
201	showed	_	_	_	_	_	_	_	_
202	that	_	_	_	_	_	_	_	BeginSeg=Yes
203	a	_	_	_	_	_	_	_	_
204	methoxy	_	_	_	_	_	_	_	_
205	substitution	_	_	_	_	_	_	_	_
206	at	_	_	_	_	_	_	_	_
207	the	_	_	_	_	_	_	_	_
208	4-position	_	_	_	_	_	_	_	_
209	on	_	_	_	_	_	_	_	_
210	the	_	_	_	_	_	_	_	_
211	indole	_	_	_	_	_	_	_	_
212	unit	_	_	_	_	_	_	_	_
213	was	_	_	_	_	_	_	_	_
214	highly	_	_	_	_	_	_	_	_
215	favorable	_	_	_	_	_	_	_	_
216	for	_	_	_	_	_	_	_	_
217	enhancing	_	_	_	_	_	_	_	_
218	the	_	_	_	_	_	_	_	_
219	inhibitory	_	_	_	_	_	_	_	_
220	potency	_	_	_	_	_	_	_	_
221	.	_	_	_	_	_	_	_	_

# newdoc_id = 4d2366b0ee4d6b5ec8c8b7376e7b343fa15e0ff8
1	Until	_	_	_	_	_	_	_	BeginSeg=Yes
2	recently	_	_	_	_	_	_	_	_
3	,	_	_	_	_	_	_	_	_
4	conventional	_	_	_	_	_	_	_	_
5	culture	_	_	_	_	_	_	_	_
6	techniques	_	_	_	_	_	_	_	_
7	and	_	_	_	_	_	_	_	_
8	immunofluorecence	_	_	_	_	_	_	_	_
9	assays	_	_	_	_	_	_	_	_
10	were	_	_	_	_	_	_	_	_
11	considered	_	_	_	_	_	_	_	_
12	the	_	_	_	_	_	_	_	_
13	gold	_	_	_	_	_	_	_	_
14	standard	_	_	_	_	_	_	_	_
15	for	_	_	_	_	_	_	_	_
16	the	_	_	_	_	_	_	_	_
17	detection	_	_	_	_	_	_	_	_
18	of	_	_	_	_	_	_	_	_
19	respiratory	_	_	_	_	_	_	_	_
20	viruses	_	_	_	_	_	_	_	_
21	,	_	_	_	_	_	_	_	_
22	even	_	_	_	_	_	_	_	BeginSeg=Yes
23	though	_	_	_	_	_	_	_	_
24	results	_	_	_	_	_	_	_	_
25	are	_	_	_	_	_	_	_	_
26	mostly	_	_	_	_	_	_	_	_
27	available	_	_	_	_	_	_	_	_
28	too	_	_	_	_	_	_	_	_
29	late	_	_	_	_	_	_	_	_
30	or	_	_	_	_	_	_	_	BeginSeg=Yes
31	lacked	_	_	_	_	_	_	_	_
32	specificity	_	_	_	_	_	_	_	_
33	and	_	_	_	_	_	_	_	_
34	sensitivity	_	_	_	_	_	_	_	_
35	.	_	_	_	_	_	_	_	_
36	These	_	_	_	_	_	_	_	BeginSeg=Yes
37	methods	_	_	_	_	_	_	_	_
38	are	_	_	_	_	_	_	_	_
39	now	_	_	_	_	_	_	_	_
40	widely	_	_	_	_	_	_	_	_
41	replaced	_	_	_	_	_	_	_	_
42	with	_	_	_	_	_	_	_	_
43	appropriate	_	_	_	_	_	_	_	_
44	DNA	_	_	_	_	_	_	_	_
45	-	_	_	_	_	_	_	_	_
46	and	_	_	_	_	_	_	_	_
47	RNA	_	_	_	_	_	_	_	_
48	-	_	_	_	_	_	_	_	_
49	based	_	_	_	_	_	_	_	_
50	amplification	_	_	_	_	_	_	_	_
51	techniques	_	_	_	_	_	_	_	_
52	,	_	_	_	_	_	_	_	_
53	in	_	_	_	_	_	_	_	_
54	particular	_	_	_	_	_	_	_	_
55	real	_	_	_	_	_	_	_	_
56	time	_	_	_	_	_	_	_	_
57	PCR	_	_	_	_	_	_	_	_
58	amplification	_	_	_	_	_	_	_	_
59	,	_	_	_	_	_	_	_	_
60	for	_	_	_	_	_	_	_	_
61	the	_	_	_	_	_	_	_	_
62	detection	_	_	_	_	_	_	_	_
63	of	_	_	_	_	_	_	_	_
64	an	_	_	_	_	_	_	_	_
65	extended	_	_	_	_	_	_	_	_
66	number	_	_	_	_	_	_	_	_
67	of	_	_	_	_	_	_	_	_
68	agents	_	_	_	_	_	_	_	_
69	responsible	_	_	_	_	_	_	_	_
70	for	_	_	_	_	_	_	_	_
71	acute	_	_	_	_	_	_	_	_
72	respiratory	_	_	_	_	_	_	_	_
73	infections	_	_	_	_	_	_	_	_
74	.	_	_	_	_	_	_	_	_
75	Real	_	_	_	_	_	_	_	BeginSeg=Yes
76	-	_	_	_	_	_	_	_	_
77	time	_	_	_	_	_	_	_	_
78	PCR	_	_	_	_	_	_	_	_
79	offers	_	_	_	_	_	_	_	_
80	rapid	_	_	_	_	_	_	_	_
81	results	_	_	_	_	_	_	_	_
82	,	_	_	_	_	_	_	_	_
83	efficiencies	_	_	_	_	_	_	_	_
84	in	_	_	_	_	_	_	_	_
85	work	_	_	_	_	_	_	_	_
86	flow	_	_	_	_	_	_	_	_
87	and	_	_	_	_	_	_	_	_
88	a	_	_	_	_	_	_	_	_
89	reduced	_	_	_	_	_	_	_	_
90	risk	_	_	_	_	_	_	_	_
91	of	_	_	_	_	_	_	_	_
92	false	_	_	_	_	_	_	_	_
93	positive	_	_	_	_	_	_	_	_
94	results	_	_	_	_	_	_	_	_
95	due	_	_	_	_	_	_	_	BeginSeg=Yes
96	to	_	_	_	_	_	_	_	_
97	contamination	_	_	_	_	_	_	_	_
98	.	_	_	_	_	_	_	_	_
99	As	_	_	_	_	_	_	_	BeginSeg=Yes
100	a	_	_	_	_	_	_	_	_
101	result	_	_	_	_	_	_	_	_
102	,	_	_	_	_	_	_	_	_
103	better	_	_	_	_	_	_	_	_
104	patient	_	_	_	_	_	_	_	_
105	management	_	_	_	_	_	_	_	_
106	or	_	_	_	_	_	_	_	_
107	reduction	_	_	_	_	_	_	_	_
108	of	_	_	_	_	_	_	_	_
109	unnecessary	_	_	_	_	_	_	_	_
110	antibiotic	_	_	_	_	_	_	_	_
111	administration	_	_	_	_	_	_	_	_
112	will	_	_	_	_	_	_	_	_
113	be	_	_	_	_	_	_	_	_
114	possible	_	_	_	_	_	_	_	_
115	leading	_	_	_	_	_	_	_	BeginSeg=Yes
116	to	_	_	_	_	_	_	_	_
117	enhanced	_	_	_	_	_	_	_	_
118	efficiencies	_	_	_	_	_	_	_	_
119	in	_	_	_	_	_	_	_	_
120	health	_	_	_	_	_	_	_	_
121	care	_	_	_	_	_	_	_	_
122	.	_	_	_	_	_	_	_	_
123	In	_	_	_	_	_	_	_	BeginSeg=Yes
124	applying	_	_	_	_	_	_	_	_
125	molecular	_	_	_	_	_	_	_	_
126	methods	_	_	_	_	_	_	_	_
127	to	_	_	_	_	_	_	_	_
128	diagnostic	_	_	_	_	_	_	_	_
129	use	_	_	_	_	_	_	_	_
130	,	_	_	_	_	_	_	_	_
131	the	_	_	_	_	_	_	_	BeginSeg=Yes
132	laboratory	_	_	_	_	_	_	_	_
133	can	_	_	_	_	_	_	_	_
134	optimise	_	_	_	_	_	_	_	_
135	its	_	_	_	_	_	_	_	_
136	diagnostic	_	_	_	_	_	_	_	_
137	strategy	_	_	_	_	_	_	_	_
138	by	_	_	_	_	_	_	_	BeginSeg=Yes
139	applying	_	_	_	_	_	_	_	_
140	a	_	_	_	_	_	_	_	_
141	combination	_	_	_	_	_	_	_	_
142	of	_	_	_	_	_	_	_	_
143	real	_	_	_	_	_	_	_	_
144	-	_	_	_	_	_	_	_	_
145	time	_	_	_	_	_	_	_	_
146	amplification	_	_	_	_	_	_	_	_
147	tests	_	_	_	_	_	_	_	_
148	for	_	_	_	_	_	_	_	_
149	respiratory	_	_	_	_	_	_	_	_
150	viruses	_	_	_	_	_	_	_	_
151	and	_	_	_	_	_	_	_	_
152	the	_	_	_	_	_	_	_	_
153	non	_	_	_	_	_	_	_	_
154	-	_	_	_	_	_	_	_	_
155	viral	_	_	_	_	_	_	_	_
156	respiratory	_	_	_	_	_	_	_	_
157	bacterial	_	_	_	_	_	_	_	_
158	pathogens	_	_	_	_	_	_	_	_
159	.	_	_	_	_	_	_	_	_
160	However	_	_	_	_	_	_	_	BeginSeg=Yes
161	this	_	_	_	_	_	_	_	_
162	must	_	_	_	_	_	_	_	_
163	be	_	_	_	_	_	_	_	_
164	done	_	_	_	_	_	_	_	_
165	within	_	_	_	_	_	_	_	_
166	a	_	_	_	_	_	_	_	_
167	context	_	_	_	_	_	_	_	_
168	of	_	_	_	_	_	_	_	_
169	resource	_	_	_	_	_	_	_	_
170	availability	_	_	_	_	_	_	_	_
171	,	_	_	_	_	_	_	_	_
172	technical	_	_	_	_	_	_	_	_
173	expertise	_	_	_	_	_	_	_	_
174	available	_	_	_	_	_	_	_	_
175	and	_	_	_	_	_	_	_	_
176	clinical	_	_	_	_	_	_	_	_
177	utility	_	_	_	_	_	_	_	_
178	.	_	_	_	_	_	_	_	_
179	It	_	_	_	_	_	_	_	BeginSeg=Yes
180	seems	_	_	_	_	_	_	_	_
181	certain	_	_	_	_	_	_	_	_
182	that	_	_	_	_	_	_	_	_
183	molecular	_	_	_	_	_	_	_	_
184	microbiology	_	_	_	_	_	_	_	_
185	will	_	_	_	_	_	_	_	_
186	continue	_	_	_	_	_	_	_	_
187	to	_	_	_	_	_	_	_	_
188	develop	_	_	_	_	_	_	_	_
189	,	_	_	_	_	_	_	_	_
190	leading	_	_	_	_	_	_	_	BeginSeg=Yes
191	to	_	_	_	_	_	_	_	_
192	further	_	_	_	_	_	_	_	_
193	applications	_	_	_	_	_	_	_	_
194	in	_	_	_	_	_	_	_	_
195	diagnostic	_	_	_	_	_	_	_	_
196	technology	_	_	_	_	_	_	_	_
197	,	_	_	_	_	_	_	_	_
198	thereby	_	_	_	_	_	_	_	BeginSeg=Yes
199	improving	_	_	_	_	_	_	_	_
200	our	_	_	_	_	_	_	_	_
201	understanding	_	_	_	_	_	_	_	_
202	of	_	_	_	_	_	_	_	_
203	disease	_	_	_	_	_	_	_	_
204	processes	_	_	_	_	_	_	_	_
205	and	_	_	_	_	_	_	_	BeginSeg=Yes
206	enhancing	_	_	_	_	_	_	_	_
207	our	_	_	_	_	_	_	_	_
208	knowledge	_	_	_	_	_	_	_	_
209	of	_	_	_	_	_	_	_	_
210	the	_	_	_	_	_	_	_	_
211	pathogens	_	_	_	_	_	_	_	_
212	responsible	_	_	_	_	_	_	_	_
213	.	_	_	_	_	_	_	_	_

# newdoc_id = 50cde1e9f6887bf2ef3e41f30b17011e4e58aba8
1	In	_	_	_	_	_	_	_	BeginSeg=Yes
2	order	_	_	_	_	_	_	_	_
3	to	_	_	_	_	_	_	_	_
4	survey	_	_	_	_	_	_	_	_
5	the	_	_	_	_	_	_	_	_
6	infectious	_	_	_	_	_	_	_	_
7	situation	_	_	_	_	_	_	_	_
8	of	_	_	_	_	_	_	_	_
9	canine	_	_	_	_	_	_	_	_
10	coronavirus	_	_	_	_	_	_	_	_
11	(	_	_	_	_	_	_	_	_
12	CCV	_	_	_	_	_	_	_	_
13	)	_	_	_	_	_	_	_	_
14	in	_	_	_	_	_	_	_	_
15	giant	_	_	_	_	_	_	_	_
16	panda	_	_	_	_	_	_	_	_
17	population	_	_	_	_	_	_	_	_
18	,	_	_	_	_	_	_	_	_
19	a	_	_	_	_	_	_	_	BeginSeg=Yes
20	virus	_	_	_	_	_	_	_	_
21	neutralization	_	_	_	_	_	_	_	_
22	test	_	_	_	_	_	_	_	_
23	detecting	_	_	_	_	_	_	_	BeginSeg=Yes
24	specific	_	_	_	_	_	_	_	_
25	antibodies	_	_	_	_	_	_	_	_
26	against	_	_	_	_	_	_	_	_
27	CCV	_	_	_	_	_	_	_	_
28	in	_	_	_	_	_	_	_	_
29	giant	_	_	_	_	_	_	_	_
30-31	panda's	_	_	_	_	_	_	_	_
30	panda	_	_	_	_	_	_	_	_
31	's	_	_	_	_	_	_	_	_
32	sera	_	_	_	_	_	_	_	_
33	was	_	_	_	_	_	_	_	BeginSeg=Yes
34	established	_	_	_	_	_	_	_	_
35	by	_	_	_	_	_	_	_	BeginSeg=Yes
36	using	_	_	_	_	_	_	_	_
37	two	_	_	_	_	_	_	_	_
38	-	_	_	_	_	_	_	_	_
39	fold	_	_	_	_	_	_	_	_
40	dilutions	_	_	_	_	_	_	_	_
41	of	_	_	_	_	_	_	_	_
42	serum	_	_	_	_	_	_	_	_
43	and	_	_	_	_	_	_	_	_
44	100	_	_	_	_	_	_	_	_
45	TCIDso	_	_	_	_	_	_	_	_
46	of	_	_	_	_	_	_	_	_
47	the	_	_	_	_	_	_	_	_
48	virus	_	_	_	_	_	_	_	_
49	.	_	_	_	_	_	_	_	_
50	The	_	_	_	_	_	_	_	BeginSeg=Yes
51	62	_	_	_	_	_	_	_	_
52	sera	_	_	_	_	_	_	_	_
53	samples	_	_	_	_	_	_	_	_
54	of	_	_	_	_	_	_	_	_
55	giant	_	_	_	_	_	_	_	_
56	pandas	_	_	_	_	_	_	_	_
57	,	_	_	_	_	_	_	_	_
58	which	_	_	_	_	_	_	_	BeginSeg=Yes
59	were	_	_	_	_	_	_	_	_
60	gathered	_	_	_	_	_	_	_	_
61	from	_	_	_	_	_	_	_	_
62	zoos	_	_	_	_	_	_	_	_
63	and	_	_	_	_	_	_	_	_
64	reserve	_	_	_	_	_	_	_	_
65	region	_	_	_	_	_	_	_	_
66	of	_	_	_	_	_	_	_	_
67	Sichuan	_	_	_	_	_	_	_	_
68	Province	_	_	_	_	_	_	_	_
69	,	_	_	_	_	_	_	_	_
70	China	_	_	_	_	_	_	_	_
71	were	_	_	_	_	_	_	_	BeginSeg=Yes
72	detected	_	_	_	_	_	_	_	_
73	.	_	_	_	_	_	_	_	_
74	The	_	_	_	_	_	_	_	BeginSeg=Yes
75	neutralization	_	_	_	_	_	_	_	_
76	antibody	_	_	_	_	_	_	_	_
77	titer	_	_	_	_	_	_	_	_
78	of	_	_	_	_	_	_	_	_
79	1:4	_	_	_	_	_	_	_	_
80	was	_	_	_	_	_	_	_	_
81	recognized	_	_	_	_	_	_	_	_
82	as	_	_	_	_	_	_	_	_
83	the	_	_	_	_	_	_	_	_
84	positive	_	_	_	_	_	_	_	_
85	criterion	_	_	_	_	_	_	_	_
86	,	_	_	_	_	_	_	_	_
87	8	_	_	_	_	_	_	_	BeginSeg=Yes
88	sera	_	_	_	_	_	_	_	_
89	samples	_	_	_	_	_	_	_	_
90	were	_	_	_	_	_	_	_	_
91	detected	_	_	_	_	_	_	_	_
92	to	_	_	_	_	_	_	_	_
93	be	_	_	_	_	_	_	_	_
94	positive	_	_	_	_	_	_	_	_
95	,	_	_	_	_	_	_	_	_
96	and	_	_	_	_	_	_	_	BeginSeg=Yes
97	the	_	_	_	_	_	_	_	_
98	positive	_	_	_	_	_	_	_	_
99	rate	_	_	_	_	_	_	_	_
100	was	_	_	_	_	_	_	_	_
101	12.9	_	_	_	_	_	_	_	_
102	%	_	_	_	_	_	_	_	_
103	.	_	_	_	_	_	_	_	_
104	The	_	_	_	_	_	_	_	BeginSeg=Yes
105	titers	_	_	_	_	_	_	_	_
106	of	_	_	_	_	_	_	_	_
107	neutralizing	_	_	_	_	_	_	_	_
108	antibody	_	_	_	_	_	_	_	_
109	ranged	_	_	_	_	_	_	_	_
110	from	_	_	_	_	_	_	_	_
111	1:8	_	_	_	_	_	_	_	_
112	to	_	_	_	_	_	_	_	_
113	1:32	_	_	_	_	_	_	_	_
114	.	_	_	_	_	_	_	_	_
115	It	_	_	_	_	_	_	_	BeginSeg=Yes
116	was	_	_	_	_	_	_	_	_
117	the	_	_	_	_	_	_	_	_
118	first	_	_	_	_	_	_	_	_
119	comprehensive	_	_	_	_	_	_	_	_
120	investigation	_	_	_	_	_	_	_	_
121	on	_	_	_	_	_	_	_	_
122	neutralization	_	_	_	_	_	_	_	_
123	antibodies	_	_	_	_	_	_	_	_
124	against	_	_	_	_	_	_	_	_
125	CCV	_	_	_	_	_	_	_	_
126	in	_	_	_	_	_	_	_	_
127	giant	_	_	_	_	_	_	_	_
128	panda	_	_	_	_	_	_	_	_
129	population	_	_	_	_	_	_	_	_
130	in	_	_	_	_	_	_	_	_
131	China	_	_	_	_	_	_	_	_
132	.	_	_	_	_	_	_	_	_
133	The	_	_	_	_	_	_	_	BeginSeg=Yes
134	results	_	_	_	_	_	_	_	_
135	of	_	_	_	_	_	_	_	_
136	study	_	_	_	_	_	_	_	_
137	showed	_	_	_	_	_	_	_	_
138	that	_	_	_	_	_	_	_	BeginSeg=Yes
139	the	_	_	_	_	_	_	_	_
140	infection	_	_	_	_	_	_	_	_
141	of	_	_	_	_	_	_	_	_
142	CCV	_	_	_	_	_	_	_	_
143	in	_	_	_	_	_	_	_	_
144	giant	_	_	_	_	_	_	_	_
145	panda	_	_	_	_	_	_	_	_
146	population	_	_	_	_	_	_	_	_
147	was	_	_	_	_	_	_	_	_
148	universal	_	_	_	_	_	_	_	_
149	,	_	_	_	_	_	_	_	_
150	which	_	_	_	_	_	_	_	BeginSeg=Yes
151	has	_	_	_	_	_	_	_	_
152	posed	_	_	_	_	_	_	_	_
153	a	_	_	_	_	_	_	_	_
154	threat	_	_	_	_	_	_	_	_
155	to	_	_	_	_	_	_	_	_
156	the	_	_	_	_	_	_	_	_
157	health	_	_	_	_	_	_	_	_
158	of	_	_	_	_	_	_	_	_
159	giant	_	_	_	_	_	_	_	_
160	panda	_	_	_	_	_	_	_	_
161	.	_	_	_	_	_	_	_	_
162	Therefore	_	_	_	_	_	_	_	BeginSeg=Yes
163	,	_	_	_	_	_	_	_	_
164	it	_	_	_	_	_	_	_	_
165	is	_	_	_	_	_	_	_	_
166	incumbent	_	_	_	_	_	_	_	_
167	on	_	_	_	_	_	_	_	_
168	us	_	_	_	_	_	_	_	_
169	to	_	_	_	_	_	_	_	_
170	study	_	_	_	_	_	_	_	_
171	safe	_	_	_	_	_	_	_	_
172	and	_	_	_	_	_	_	_	_
173	effective	_	_	_	_	_	_	_	_
174	vaccines	_	_	_	_	_	_	_	_
175	to	_	_	_	_	_	_	_	BeginSeg=Yes
176	protect	_	_	_	_	_	_	_	_
177	giant	_	_	_	_	_	_	_	_
178	panda	_	_	_	_	_	_	_	_
179	against	_	_	_	_	_	_	_	_
180	CCV	_	_	_	_	_	_	_	_
181	infection	_	_	_	_	_	_	_	_
182	.	_	_	_	_	_	_	_	_

# newdoc_id = 5405330f85660bb35ec960a144e904c54c4c67a7
1	In	_	_	_	_	_	_	_	BeginSeg=Yes
2	this	_	_	_	_	_	_	_	_
3	demo	_	_	_	_	_	_	_	_
4	,	_	_	_	_	_	_	_	_
5	we	_	_	_	_	_	_	_	_
6	introduce	_	_	_	_	_	_	_	_
7	an	_	_	_	_	_	_	_	_
8	interactive	_	_	_	_	_	_	_	_
9	system	_	_	_	_	_	_	_	_
10	,	_	_	_	_	_	_	_	_
11	which	_	_	_	_	_	_	_	BeginSeg=Yes
12	effectively	_	_	_	_	_	_	_	_
13	applies	_	_	_	_	_	_	_	_
14	multiple	_	_	_	_	_	_	_	_
15	criteria	_	_	_	_	_	_	_	_
16	analysis	_	_	_	_	_	_	_	_
17	to	_	_	_	_	_	_	_	BeginSeg=Yes
18	rank	_	_	_	_	_	_	_	_
19	association	_	_	_	_	_	_	_	_
20	rules	_	_	_	_	_	_	_	_
21	.	_	_	_	_	_	_	_	_
22	We	_	_	_	_	_	_	_	BeginSeg=Yes
23	first	_	_	_	_	_	_	_	_
24	use	_	_	_	_	_	_	_	_
25	association	_	_	_	_	_	_	_	_
26	rules	_	_	_	_	_	_	_	_
27	techniques	_	_	_	_	_	_	_	_
28	to	_	_	_	_	_	_	_	BeginSeg=Yes
29	explore	_	_	_	_	_	_	_	_
30	the	_	_	_	_	_	_	_	_
31	correlations	_	_	_	_	_	_	_	_
32	between	_	_	_	_	_	_	_	_
33	variables	_	_	_	_	_	_	_	_
34	in	_	_	_	_	_	_	_	_
35	given	_	_	_	_	_	_	_	_
36	data	_	_	_	_	_	_	_	_
37	(	_	_	_	_	_	_	_	BeginSeg=Yes
38	i.e.	_	_	_	_	_	_	_	_
39	,	_	_	_	_	_	_	_	_
40	database	_	_	_	_	_	_	_	_
41	and	_	_	_	_	_	_	_	_
42	linked	_	_	_	_	_	_	_	_
43	data	_	_	_	_	_	_	_	_
44	(	_	_	_	_	_	_	_	_
45	LD	_	_	_	_	_	_	_	_
46	)	_	_	_	_	_	_	_	_
47	)	_	_	_	_	_	_	_	_
48	,	_	_	_	_	_	_	_	_
49	and	_	_	_	_	_	_	_	BeginSeg=Yes
50	secondly	_	_	_	_	_	_	_	_
51	apply	_	_	_	_	_	_	_	_
52	multiple	_	_	_	_	_	_	_	_
53	criteria	_	_	_	_	_	_	_	_
54	analysis	_	_	_	_	_	_	_	_
55	(	_	_	_	_	_	_	_	_
56	MCA	_	_	_	_	_	_	_	_
57	)	_	_	_	_	_	_	_	_
58	to	_	_	_	_	_	_	_	BeginSeg=Yes
59	select	_	_	_	_	_	_	_	_
60	the	_	_	_	_	_	_	_	_
61	most	_	_	_	_	_	_	_	_
62	relevant	_	_	_	_	_	_	_	_
63	rules	_	_	_	_	_	_	_	_
64	according	_	_	_	_	_	_	_	_
65	to	_	_	_	_	_	_	_	_
66	user	_	_	_	_	_	_	_	_
67	preferences	_	_	_	_	_	_	_	_
68	.	_	_	_	_	_	_	_	_
69	The	_	_	_	_	_	_	_	BeginSeg=Yes
70	developed	_	_	_	_	_	_	_	_
71	system	_	_	_	_	_	_	_	_
72	is	_	_	_	_	_	_	_	_
73	flexible	_	_	_	_	_	_	_	_
74	and	_	_	_	_	_	_	_	BeginSeg=Yes
75	allows	_	_	_	_	_	_	_	_
76	intuitive	_	_	_	_	_	_	_	_
77	creation	_	_	_	_	_	_	_	_
78	and	_	_	_	_	_	_	_	_
79	execution	_	_	_	_	_	_	_	_
80	of	_	_	_	_	_	_	_	_
81	different	_	_	_	_	_	_	_	_
82	algorithms	_	_	_	_	_	_	_	_
83	for	_	_	_	_	_	_	_	_
84	an	_	_	_	_	_	_	_	_
85	extensive	_	_	_	_	_	_	_	_
86	range	_	_	_	_	_	_	_	_
87	of	_	_	_	_	_	_	_	_
88	advanced	_	_	_	_	_	_	_	_
89	data	_	_	_	_	_	_	_	_
90	analysis	_	_	_	_	_	_	_	_
91	topics	_	_	_	_	_	_	_	_
92	.	_	_	_	_	_	_	_	_
93	Furthermore	_	_	_	_	_	_	_	BeginSeg=Yes
94	,	_	_	_	_	_	_	_	_
95	we	_	_	_	_	_	_	_	_
96	demonstrate	_	_	_	_	_	_	_	_
97	a	_	_	_	_	_	_	_	_
98	case	_	_	_	_	_	_	_	_
99	study	_	_	_	_	_	_	_	_
100	of	_	_	_	_	_	_	_	_
101	association	_	_	_	_	_	_	_	_
102	rule	_	_	_	_	_	_	_	_
103	mining	_	_	_	_	_	_	_	_
104	and	_	_	_	_	_	_	_	_
105	ranking	_	_	_	_	_	_	_	_
106	on	_	_	_	_	_	_	_	_
107	road	_	_	_	_	_	_	_	_
108	accident	_	_	_	_	_	_	_	_
109	data	_	_	_	_	_	_	_	_
110	.	_	_	_	_	_	_	_	_

# newdoc_id = 55cb2d0edd96f893cd0f5e11ef9b7052841eec3a
1	Tuberculosis	_	_	_	_	_	_	_	BeginSeg=Yes
2	is	_	_	_	_	_	_	_	_
3	the	_	_	_	_	_	_	_	_
4	deadliest	_	_	_	_	_	_	_	_
5	infection	_	_	_	_	_	_	_	_
6	of	_	_	_	_	_	_	_	_
7	our	_	_	_	_	_	_	_	_
8	time	_	_	_	_	_	_	_	_
9	.	_	_	_	_	_	_	_	_
10	In	_	_	_	_	_	_	_	BeginSeg=Yes
11	contrast	_	_	_	_	_	_	_	_
12	,	_	_	_	_	_	_	_	_
13	about	_	_	_	_	_	_	_	_
14	11,000	_	_	_	_	_	_	_	_
15	people	_	_	_	_	_	_	_	_
16	died	_	_	_	_	_	_	_	_
17	of	_	_	_	_	_	_	_	_
18	Ebola	_	_	_	_	_	_	_	_
19	between	_	_	_	_	_	_	_	_
20	2014	_	_	_	_	_	_	_	_
21	and	_	_	_	_	_	_	_	_
22	2016	_	_	_	_	_	_	_	_
23	.	_	_	_	_	_	_	_	_
24	Despite	_	_	_	_	_	_	_	BeginSeg=Yes
25	this	_	_	_	_	_	_	_	_
26	manifest	_	_	_	_	_	_	_	_
27	difference	_	_	_	_	_	_	_	_
28	in	_	_	_	_	_	_	_	_
29	mortality	_	_	_	_	_	_	_	_
30	,	_	_	_	_	_	_	_	_
31	there	_	_	_	_	_	_	_	BeginSeg=Yes
32	is	_	_	_	_	_	_	_	_
33	now	_	_	_	_	_	_	_	_
34	a	_	_	_	_	_	_	_	_
35	vaccine	_	_	_	_	_	_	_	_
36	licensed	_	_	_	_	_	_	_	BeginSeg=Yes
37	in	_	_	_	_	_	_	_	_
38	the	_	_	_	_	_	_	_	_
39	United	_	_	_	_	_	_	_	_
40	States	_	_	_	_	_	_	_	_
41	and	_	_	_	_	_	_	_	_
42	by	_	_	_	_	_	_	_	_
43	the	_	_	_	_	_	_	_	_
44	European	_	_	_	_	_	_	_	_
45	Medicines	_	_	_	_	_	_	_	_
46	Agency	_	_	_	_	_	_	_	_
47	,	_	_	_	_	_	_	_	_
48	with	_	_	_	_	_	_	_	BeginSeg=Yes
49	up	_	_	_	_	_	_	_	_
50	to	_	_	_	_	_	_	_	_
51	100	_	_	_	_	_	_	_	_
52	%	_	_	_	_	_	_	_	_
53	efficacy	_	_	_	_	_	_	_	_
54	against	_	_	_	_	_	_	_	_
55	Ebola	_	_	_	_	_	_	_	_
56	.	_	_	_	_	_	_	_	_
57	The	_	_	_	_	_	_	_	BeginSeg=Yes
58	developments	_	_	_	_	_	_	_	_
59	that	_	_	_	_	_	_	_	BeginSeg=Yes
60	led	_	_	_	_	_	_	_	_
61	to	_	_	_	_	_	_	_	_
62	the	_	_	_	_	_	_	_	_
63	trialing	_	_	_	_	_	_	_	_
64	of	_	_	_	_	_	_	_	_
65	the	_	_	_	_	_	_	_	_
66	Ebola	_	_	_	_	_	_	_	_
67	vaccine	_	_	_	_	_	_	_	_
68	were	_	_	_	_	_	_	_	BeginSeg=Yes
69	historic	_	_	_	_	_	_	_	_
70	and	_	_	_	_	_	_	_	_
71	unprecedented	_	_	_	_	_	_	_	_
72	.	_	_	_	_	_	_	_	_
73	The	_	_	_	_	_	_	_	BeginSeg=Yes
74	single	_	_	_	_	_	_	_	_
75	licensed	_	_	_	_	_	_	_	_
76	TB	_	_	_	_	_	_	_	_
77	vaccine	_	_	_	_	_	_	_	_
78	(	_	_	_	_	_	_	_	_
79	BCG	_	_	_	_	_	_	_	_
80	)	_	_	_	_	_	_	_	_
81	has	_	_	_	_	_	_	_	_
82	limited	_	_	_	_	_	_	_	_
83	efficacy	_	_	_	_	_	_	_	_
84	.	_	_	_	_	_	_	_	_
85	There	_	_	_	_	_	_	_	BeginSeg=Yes
86	is	_	_	_	_	_	_	_	_
87	a	_	_	_	_	_	_	_	_
88	dire	_	_	_	_	_	_	_	_
89	need	_	_	_	_	_	_	_	_
90	for	_	_	_	_	_	_	_	_
91	a	_	_	_	_	_	_	_	_
92	more	_	_	_	_	_	_	_	_
93	efficacious	_	_	_	_	_	_	_	_
94	TB	_	_	_	_	_	_	_	_
95	vaccine	_	_	_	_	_	_	_	_
96	.	_	_	_	_	_	_	_	_
97	To	_	_	_	_	_	_	_	BeginSeg=Yes
98	deploy	_	_	_	_	_	_	_	_
99	such	_	_	_	_	_	_	_	_
100	vaccines	_	_	_	_	_	_	_	_
101	,	_	_	_	_	_	_	_	_
102	trials	_	_	_	_	_	_	_	BeginSeg=Yes
103	are	_	_	_	_	_	_	_	_
104	needed	_	_	_	_	_	_	_	_
105	in	_	_	_	_	_	_	_	_
106	sites	_	_	_	_	_	_	_	_
107	that	_	_	_	_	_	_	_	BeginSeg=Yes
108	combine	_	_	_	_	_	_	_	_
109	high	_	_	_	_	_	_	_	_
110	disease	_	_	_	_	_	_	_	_
111	incidence	_	_	_	_	_	_	_	_
112	and	_	_	_	_	_	_	_	_
113	research	_	_	_	_	_	_	_	_
114	infrastructure	_	_	_	_	_	_	_	_
115	.	_	_	_	_	_	_	_	_
116	We	_	_	_	_	_	_	_	BeginSeg=Yes
117	describe	_	_	_	_	_	_	_	_
118	our	_	_	_	_	_	_	_	_
119	twelve	_	_	_	_	_	_	_	_
120	-	_	_	_	_	_	_	_	_
121	year	_	_	_	_	_	_	_	_
122	experience	_	_	_	_	_	_	_	_
123	building	_	_	_	_	_	_	_	BeginSeg=Yes
124	a	_	_	_	_	_	_	_	_
125	TB	_	_	_	_	_	_	_	_
126	vaccine	_	_	_	_	_	_	_	_
127	trial	_	_	_	_	_	_	_	_
128	site	_	_	_	_	_	_	_	_
129	in	_	_	_	_	_	_	_	BeginSeg=Yes
130	contrast	_	_	_	_	_	_	_	_
131	to	_	_	_	_	_	_	_	_
132	the	_	_	_	_	_	_	_	_
133	process	_	_	_	_	_	_	_	_
134	in	_	_	_	_	_	_	_	_
135	the	_	_	_	_	_	_	_	_
136	recent	_	_	_	_	_	_	_	_
137	Ebola	_	_	_	_	_	_	_	_
138	outbreak	_	_	_	_	_	_	_	_
139	.	_	_	_	_	_	_	_	_
140	There	_	_	_	_	_	_	_	BeginSeg=Yes
141	are	_	_	_	_	_	_	_	_
142	additional	_	_	_	_	_	_	_	_
143	differences	_	_	_	_	_	_	_	_
144	.	_	_	_	_	_	_	_	_
145	Relative	_	_	_	_	_	_	_	BeginSeg=Yes
146	to	_	_	_	_	_	_	_	_
147	the	_	_	_	_	_	_	_	_
148	Ebola	_	_	_	_	_	_	_	_
149	pipeline	_	_	_	_	_	_	_	_
150	,	_	_	_	_	_	_	_	_
151	TB	_	_	_	_	_	_	_	BeginSeg=Yes
152	vaccines	_	_	_	_	_	_	_	_
153	have	_	_	_	_	_	_	_	_
154	fewer	_	_	_	_	_	_	_	_
155	trials	_	_	_	_	_	_	_	_
156	and	_	_	_	_	_	_	_	_
157	a	_	_	_	_	_	_	_	_
158	paucity	_	_	_	_	_	_	_	_
159	of	_	_	_	_	_	_	_	_
160	government	_	_	_	_	_	_	_	_
161	and	_	_	_	_	_	_	_	_
162	industry	_	_	_	_	_	_	_	_
163	led	_	_	_	_	_	_	_	_
164	trials	_	_	_	_	_	_	_	_
165	.	_	_	_	_	_	_	_	_
166	While	_	_	_	_	_	_	_	BeginSeg=Yes
167	pathogens	_	_	_	_	_	_	_	_
168	have	_	_	_	_	_	_	_	_
169	varying	_	_	_	_	_	_	_	_
170	levels	_	_	_	_	_	_	_	_
171	of	_	_	_	_	_	_	_	_
172	difficulty	_	_	_	_	_	_	_	_
173	in	_	_	_	_	_	_	_	_
174	the	_	_	_	_	_	_	_	_
175	development	_	_	_	_	_	_	_	_
176	of	_	_	_	_	_	_	_	_
177	new	_	_	_	_	_	_	_	_
178	vaccine	_	_	_	_	_	_	_	_
179	candidates	_	_	_	_	_	_	_	_
180	,	_	_	_	_	_	_	_	_
181	there	_	_	_	_	_	_	_	BeginSeg=Yes
182	yet	_	_	_	_	_	_	_	_
183	appears	_	_	_	_	_	_	_	_
184	to	_	_	_	_	_	_	_	_
185	be	_	_	_	_	_	_	_	_
186	greater	_	_	_	_	_	_	_	_
187	interest	_	_	_	_	_	_	_	_
188	in	_	_	_	_	_	_	_	_
189	funding	_	_	_	_	_	_	_	_
190	and	_	_	_	_	_	_	_	_
191	coordinating	_	_	_	_	_	_	_	_
192	Ebola	_	_	_	_	_	_	_	_
193	interventions	_	_	_	_	_	_	_	_
194	.	_	_	_	_	_	_	_	_
195	TB	_	_	_	_	_	_	_	BeginSeg=Yes
196	is	_	_	_	_	_	_	_	_
197	a	_	_	_	_	_	_	_	_
198	global	_	_	_	_	_	_	_	_
199	threat	_	_	_	_	_	_	_	_
200	that	_	_	_	_	_	_	_	BeginSeg=Yes
201	requires	_	_	_	_	_	_	_	_
202	similar	_	_	_	_	_	_	_	_
203	concerted	_	_	_	_	_	_	_	_
204	effort	_	_	_	_	_	_	_	_
205	for	_	_	_	_	_	_	_	_
206	elimination	_	_	_	_	_	_	_	_
207	.	_	_	_	_	_	_	_	_

# newdoc_id = 59f5a1087f771959fc4d01b18ea5bf91bf95bb94
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	current	_	_	_	_	_	_	_	_
3	coronavirus	_	_	_	_	_	_	_	_
4	disease	_	_	_	_	_	_	_	_
5	pandemic	_	_	_	_	_	_	_	_
6	caused	_	_	_	_	_	_	_	BeginSeg=Yes
7	by	_	_	_	_	_	_	_	_
8	severe	_	_	_	_	_	_	_	_
9	acute	_	_	_	_	_	_	_	_
10	respiratory	_	_	_	_	_	_	_	_
11	syndrome	_	_	_	_	_	_	_	_
12	coronavirus	_	_	_	_	_	_	_	_
13	2	_	_	_	_	_	_	_	_
14	has	_	_	_	_	_	_	_	BeginSeg=Yes
15	led	_	_	_	_	_	_	_	_
16	to	_	_	_	_	_	_	_	_
17	immense	_	_	_	_	_	_	_	_
18	strain	_	_	_	_	_	_	_	_
19	on	_	_	_	_	_	_	_	_
20	healthcare	_	_	_	_	_	_	_	_
21	systems	_	_	_	_	_	_	_	_
22	and	_	_	_	_	_	_	_	_
23	workers	_	_	_	_	_	_	_	_
24	.	_	_	_	_	_	_	_	_
25	Patients	_	_	_	_	_	_	_	BeginSeg=Yes
26	with	_	_	_	_	_	_	_	_
27	severe	_	_	_	_	_	_	_	_
28	symptoms	_	_	_	_	_	_	_	_
29	of	_	_	_	_	_	_	_	_
30	COVID-19	_	_	_	_	_	_	_	_
31	may	_	_	_	_	_	_	_	_
32	also	_	_	_	_	_	_	_	_
33	present	_	_	_	_	_	_	_	_
34	with	_	_	_	_	_	_	_	_
35	acute	_	_	_	_	_	_	_	_
36	neurological	_	_	_	_	_	_	_	_
37	emergencies	_	_	_	_	_	_	_	_
38	such	_	_	_	_	_	_	_	BeginSeg=Yes
39	as	_	_	_	_	_	_	_	_
40	ischemic	_	_	_	_	_	_	_	_
41	stroke	_	_	_	_	_	_	_	_
42	.	_	_	_	_	_	_	_	_
43	Ischemic	_	_	_	_	_	_	_	BeginSeg=Yes
44	stroke	_	_	_	_	_	_	_	_
45	in	_	_	_	_	_	_	_	_
46	these	_	_	_	_	_	_	_	_
47	patients	_	_	_	_	_	_	_	_
48	may	_	_	_	_	_	_	_	_
49	result	_	_	_	_	_	_	_	_
50	from	_	_	_	_	_	_	_	_
51	COVID-19	_	_	_	_	_	_	_	_
52	related	_	_	_	_	_	_	_	_
53	complications	_	_	_	_	_	_	_	_
54	or	_	_	_	_	_	_	_	_
55	decompensation	_	_	_	_	_	_	_	_
56	of	_	_	_	_	_	_	_	_
57	previously	_	_	_	_	_	_	_	_
58	asymptomatic	_	_	_	_	_	_	_	_
59	cerebrovascular	_	_	_	_	_	_	_	_
60	disorders	_	_	_	_	_	_	_	_
61	,	_	_	_	_	_	_	_	_
62	or	_	_	_	_	_	_	_	_
63	concurrent	_	_	_	_	_	_	_	_
64	ischemic	_	_	_	_	_	_	_	_
65	stroke	_	_	_	_	_	_	_	_
66	from	_	_	_	_	_	_	_	_
67	common	_	_	_	_	_	_	_	_
68	stroke	_	_	_	_	_	_	_	_
69	risk	_	_	_	_	_	_	_	_
70	factors	_	_	_	_	_	_	_	_
71	in	_	_	_	_	_	_	_	_
72	a	_	_	_	_	_	_	_	_
73	patient	_	_	_	_	_	_	_	_
74	with	_	_	_	_	_	_	_	_
75	COVID-19	_	_	_	_	_	_	_	_
76	.	_	_	_	_	_	_	_	_
77	Acute	_	_	_	_	_	_	_	BeginSeg=Yes
78	ischemic	_	_	_	_	_	_	_	_
79	stroke	_	_	_	_	_	_	_	_
80	patients	_	_	_	_	_	_	_	_
81	with	_	_	_	_	_	_	_	_
82	large	_	_	_	_	_	_	_	_
83	vessel	_	_	_	_	_	_	_	_
84	occlusions	_	_	_	_	_	_	_	_
85	require	_	_	_	_	_	_	_	_
86	emergent	_	_	_	_	_	_	_	_
87	triage	_	_	_	_	_	_	_	_
88	,	_	_	_	_	_	_	_	_
89	intensive	_	_	_	_	_	_	_	_
90	care	_	_	_	_	_	_	_	_
91	,	_	_	_	_	_	_	_	_
92	and	_	_	_	_	_	_	_	_
93	mechanical	_	_	_	_	_	_	_	_
94	thrombectomy	_	_	_	_	_	_	_	_
95	.	_	_	_	_	_	_	_	_
96	Management	_	_	_	_	_	_	_	BeginSeg=Yes
97	of	_	_	_	_	_	_	_	_
98	patients	_	_	_	_	_	_	_	_
99	with	_	_	_	_	_	_	_	_
100	large	_	_	_	_	_	_	_	_
101	vessel	_	_	_	_	_	_	_	_
102	occlusions	_	_	_	_	_	_	_	_
103	(	_	_	_	_	_	_	_	_
104	LVO	_	_	_	_	_	_	_	_
105	)	_	_	_	_	_	_	_	_
106	requires	_	_	_	_	_	_	_	_
107	special	_	_	_	_	_	_	_	_
108	considerations	_	_	_	_	_	_	_	_
109	in	_	_	_	_	_	_	_	_
110	the	_	_	_	_	_	_	_	_
111	current	_	_	_	_	_	_	_	_
112	pandemic	_	_	_	_	_	_	_	_
113	.	_	_	_	_	_	_	_	_
114	Physicians	_	_	_	_	_	_	_	BeginSeg=Yes
115	must	_	_	_	_	_	_	_	_
116	now	_	_	_	_	_	_	_	_
117	account	_	_	_	_	_	_	_	_
118	for	_	_	_	_	_	_	_	_
119	prognosis	_	_	_	_	_	_	_	_
120	of	_	_	_	_	_	_	_	_
121	severe	_	_	_	_	_	_	_	_
122	COVID-19	_	_	_	_	_	_	_	_
123	,	_	_	_	_	_	_	_	_
124	resource	_	_	_	_	_	_	_	_
125	utilization	_	_	_	_	_	_	_	_
126	,	_	_	_	_	_	_	_	_
127	and	_	_	_	_	_	_	_	_
128	risk	_	_	_	_	_	_	_	_
129	of	_	_	_	_	_	_	_	_
130	infection	_	_	_	_	_	_	_	_
131	to	_	_	_	_	_	_	_	_
132	healthcare	_	_	_	_	_	_	_	_
133	workers	_	_	_	_	_	_	_	_
134	when	_	_	_	_	_	_	_	BeginSeg=Yes
135	determining	_	_	_	_	_	_	_	_
136	eligibility	_	_	_	_	_	_	_	_
137	for	_	_	_	_	_	_	_	_
138	mechanical	_	_	_	_	_	_	_	_
139	thrombectomy	_	_	_	_	_	_	_	_
140	(	_	_	_	_	_	_	_	_
141	MT	_	_	_	_	_	_	_	_
142	)	_	_	_	_	_	_	_	_
143	.	_	_	_	_	_	_	_	_
144	Here	_	_	_	_	_	_	_	BeginSeg=Yes
145	,	_	_	_	_	_	_	_	_
146	we	_	_	_	_	_	_	_	_
147	describe	_	_	_	_	_	_	_	_
148	important	_	_	_	_	_	_	_	_
149	prognostic	_	_	_	_	_	_	_	_
150	factors	_	_	_	_	_	_	_	_
151	including	_	_	_	_	_	_	_	BeginSeg=Yes
152	age	_	_	_	_	_	_	_	_
153	,	_	_	_	_	_	_	_	_
154	laboratory	_	_	_	_	_	_	_	_
155	,	_	_	_	_	_	_	_	_
156	and	_	_	_	_	_	_	_	_
157	imaging	_	_	_	_	_	_	_	_
158	findings	_	_	_	_	_	_	_	_
159	to	_	_	_	_	_	_	_	BeginSeg=Yes
160	consider	_	_	_	_	_	_	_	_
161	for	_	_	_	_	_	_	_	_
162	MT	_	_	_	_	_	_	_	_
163	selection	_	_	_	_	_	_	_	_
164	and	_	_	_	_	_	_	_	BeginSeg=Yes
165	provide	_	_	_	_	_	_	_	_
166	suggestions	_	_	_	_	_	_	_	_
167	for	_	_	_	_	_	_	_	BeginSeg=Yes
168	taking	_	_	_	_	_	_	_	_
169	care	_	_	_	_	_	_	_	_
170	of	_	_	_	_	_	_	_	_
171	patients	_	_	_	_	_	_	_	_
172	with	_	_	_	_	_	_	_	_
173	LVO	_	_	_	_	_	_	_	_
174	and	_	_	_	_	_	_	_	_
175	possible	_	_	_	_	_	_	_	_
176	or	_	_	_	_	_	_	_	_
177	confirmed	_	_	_	_	_	_	_	_
178	COVID-19	_	_	_	_	_	_	_	_
179	.	_	_	_	_	_	_	_	_
180	It	_	_	_	_	_	_	_	BeginSeg=Yes
181	is	_	_	_	_	_	_	_	_
182	recommended	_	_	_	_	_	_	_	_
183	to	_	_	_	_	_	_	_	_
184	perform	_	_	_	_	_	_	_	_
185	MT	_	_	_	_	_	_	_	_
186	in	_	_	_	_	_	_	_	_
187	patients	_	_	_	_	_	_	_	_
188	within	_	_	_	_	_	_	_	_
189	the	_	_	_	_	_	_	_	_
190	established	_	_	_	_	_	_	_	_
191	guidelines	_	_	_	_	_	_	_	_
192	,	_	_	_	_	_	_	_	_
193	and	_	_	_	_	_	_	_	_
194	consider	_	_	_	_	_	_	_	_
195	a	_	_	_	_	_	_	_	_
196	conservative	_	_	_	_	_	_	_	_
197	approach	_	_	_	_	_	_	_	_
198	in	_	_	_	_	_	_	_	_
199	cases	_	_	_	_	_	_	_	_
200	where	_	_	_	_	_	_	_	BeginSeg=Yes
201	there	_	_	_	_	_	_	_	_
202	is	_	_	_	_	_	_	_	_
203	clinical	_	_	_	_	_	_	_	_
204	equipoise	_	_	_	_	_	_	_	_
205	to	_	_	_	_	_	_	_	BeginSeg=Yes
206	minimize	_	_	_	_	_	_	_	_
207	futile	_	_	_	_	_	_	_	_
208	reperfusion	_	_	_	_	_	_	_	_
209	.	_	_	_	_	_	_	_	_
210	Lastly	_	_	_	_	_	_	_	BeginSeg=Yes
211	,	_	_	_	_	_	_	_	_
212	we	_	_	_	_	_	_	_	_
213	describe	_	_	_	_	_	_	_	_
214	an	_	_	_	_	_	_	_	_
215	illustrative	_	_	_	_	_	_	_	_
216	case	_	_	_	_	_	_	_	_
217	of	_	_	_	_	_	_	_	_
218	a	_	_	_	_	_	_	_	_
219	patient	_	_	_	_	_	_	_	_
220	with	_	_	_	_	_	_	_	_
221	ischemic	_	_	_	_	_	_	_	_
222	stroke	_	_	_	_	_	_	_	_
223	and	_	_	_	_	_	_	_	_
224	COVID-19	_	_	_	_	_	_	_	_
225	.	_	_	_	_	_	_	_	_

# newdoc_id = 5c2bd95f80ed7229802a7fd01731a2586702f8b3
1	Activation	_	_	_	_	_	_	_	BeginSeg=Yes
2	of	_	_	_	_	_	_	_	_
3	the	_	_	_	_	_	_	_	_
4	thrombotic	_	_	_	_	_	_	_	_
5	and	_	_	_	_	_	_	_	_
6	complement	_	_	_	_	_	_	_	_
7	systems	_	_	_	_	_	_	_	_
8	is	_	_	_	_	_	_	_	_
9	the	_	_	_	_	_	_	_	_
10	main	_	_	_	_	_	_	_	_
11	recognition	_	_	_	_	_	_	_	_
12	and	_	_	_	_	_	_	_	_
13	effector	_	_	_	_	_	_	_	_
14	mechanisms	_	_	_	_	_	_	_	_
15	in	_	_	_	_	_	_	_	_
16	the	_	_	_	_	_	_	_	_
17	multiple	_	_	_	_	_	_	_	_
18	adverse	_	_	_	_	_	_	_	_
19	biological	_	_	_	_	_	_	_	_
20	responses	_	_	_	_	_	_	_	_
21	triggered	_	_	_	_	_	_	_	BeginSeg=Yes
22	when	_	_	_	_	_	_	_	BeginSeg=Yes
23	biomaterials	_	_	_	_	_	_	_	_
24	or	_	_	_	_	_	_	_	_
25	therapeutic	_	_	_	_	_	_	_	_
26	cells	_	_	_	_	_	_	_	_
27	come	_	_	_	_	_	_	_	_
28	into	_	_	_	_	_	_	_	_
29	blood	_	_	_	_	_	_	_	_
30	contact	_	_	_	_	_	_	_	_
31	.	_	_	_	_	_	_	_	_
32	We	_	_	_	_	_	_	_	BeginSeg=Yes
33	have	_	_	_	_	_	_	_	_
34	created	_	_	_	_	_	_	_	_
35	a	_	_	_	_	_	_	_	_
36	surface	_	_	_	_	_	_	_	_
37	which	_	_	_	_	_	_	_	BeginSeg=Yes
38	is	_	_	_	_	_	_	_	_
39	auto	_	_	_	_	_	_	_	_
40	-	_	_	_	_	_	_	_	_
41	protective	_	_	_	_	_	_	_	_
42	to	_	_	_	_	_	_	_	_
43	human	_	_	_	_	_	_	_	_
44	innate	_	_	_	_	_	_	_	_
45	immunity	_	_	_	_	_	_	_	_
46	by	_	_	_	_	_	_	_	BeginSeg=Yes
47	combining	_	_	_	_	_	_	_	_
48	three	_	_	_	_	_	_	_	_
49	fundamentally	_	_	_	_	_	_	_	_
50	different	_	_	_	_	_	_	_	_
51	strategies	_	_	_	_	_	_	_	_
52	,	_	_	_	_	_	_	_	_
53	all	_	_	_	_	_	_	_	BeginSeg=Yes
54	developed	_	_	_	_	_	_	_	_
55	by	_	_	_	_	_	_	_	_
56	us	_	_	_	_	_	_	_	_
57	previously	_	_	_	_	_	_	_	_
58	,	_	_	_	_	_	_	_	_
59	which	_	_	_	_	_	_	_	BeginSeg=Yes
60	have	_	_	_	_	_	_	_	_
61	been	_	_	_	_	_	_	_	_
62	shown	_	_	_	_	_	_	_	_
63	to	_	_	_	_	_	_	_	_
64	induce	_	_	_	_	_	_	_	_
65	substantial	_	_	_	_	_	_	_	_
66	,	_	_	_	_	_	_	_	_
67	but	_	_	_	_	_	_	_	_
68	incomplete	_	_	_	_	_	_	_	_
69	hemocompatibility	_	_	_	_	_	_	_	_
70	when	_	_	_	_	_	_	_	BeginSeg=Yes
71	used	_	_	_	_	_	_	_	_
72	separately	_	_	_	_	_	_	_	_
73	.	_	_	_	_	_	_	_	_
74	In	_	_	_	_	_	_	_	BeginSeg=Yes
75	summary	_	_	_	_	_	_	_	_
76	,	_	_	_	_	_	_	_	_
77	we	_	_	_	_	_	_	_	_
78	have	_	_	_	_	_	_	_	_
79	conjugated	_	_	_	_	_	_	_	_
80	a	_	_	_	_	_	_	_	_
81	factor	_	_	_	_	_	_	_	_
82	Hebinding	_	_	_	_	_	_	_	_
83	peptide	_	_	_	_	_	_	_	_
84	;	_	_	_	_	_	_	_	_
85	and	_	_	_	_	_	_	_	_
86	an	_	_	_	_	_	_	_	_
87	ADP	_	_	_	_	_	_	_	_
88	-	_	_	_	_	_	_	_	_
89	degrading	_	_	_	_	_	_	_	_
90	enzyme	_	_	_	_	_	_	_	_
91	;	_	_	_	_	_	_	_	_
92	using	_	_	_	_	_	_	_	BeginSeg=Yes
93	a	_	_	_	_	_	_	_	_
94	PEG	_	_	_	_	_	_	_	_
95	linker	_	_	_	_	_	_	_	_
96	on	_	_	_	_	_	_	_	_
97	both	_	_	_	_	_	_	_	_
98	material	_	_	_	_	_	_	_	_
99	and	_	_	_	_	_	_	_	_
100	cellular	_	_	_	_	_	_	_	_
101	surfaces	_	_	_	_	_	_	_	_
102	.	_	_	_	_	_	_	_	_
103	When	_	_	_	_	_	_	_	BeginSeg=Yes
104	exposed	_	_	_	_	_	_	_	_
105	to	_	_	_	_	_	_	_	_
106	human	_	_	_	_	_	_	_	_
107	whole	_	_	_	_	_	_	_	_
108	blood	_	_	_	_	_	_	_	_
109	,	_	_	_	_	_	_	_	_
110	factor	_	_	_	_	_	_	_	BeginSeg=Yes
111	H	_	_	_	_	_	_	_	_
112	was	_	_	_	_	_	_	_	_
113	specifically	_	_	_	_	_	_	_	_
114	recruited	_	_	_	_	_	_	_	_
115	to	_	_	_	_	_	_	_	_
116	the	_	_	_	_	_	_	_	_
117	modified	_	_	_	_	_	_	_	_
118	surfaces	_	_	_	_	_	_	_	_
119	and	_	_	_	_	_	_	_	BeginSeg=Yes
120	inhibited	_	_	_	_	_	_	_	_
121	complement	_	_	_	_	_	_	_	_
122	attack	_	_	_	_	_	_	_	_
123	.	_	_	_	_	_	_	_	_
124	In	_	_	_	_	_	_	_	BeginSeg=Yes
125	addition	_	_	_	_	_	_	_	_
126	,	_	_	_	_	_	_	_	_
127	activation	_	_	_	_	_	_	_	_
128	of	_	_	_	_	_	_	_	_
129	platelets	_	_	_	_	_	_	_	_
130	and	_	_	_	_	_	_	_	_
131	coagulation	_	_	_	_	_	_	_	_
132	was	_	_	_	_	_	_	_	_
133	efficiently	_	_	_	_	_	_	_	_
134	attenuated	_	_	_	_	_	_	_	_
135	,	_	_	_	_	_	_	_	_
136	by	_	_	_	_	_	_	_	BeginSeg=Yes
137	degrading	_	_	_	_	_	_	_	_
138	ADP	_	_	_	_	_	_	_	_
139	.	_	_	_	_	_	_	_	_
140	Thus	_	_	_	_	_	_	_	BeginSeg=Yes
141	,	_	_	_	_	_	_	_	_
142	by	_	_	_	_	_	_	_	BeginSeg=Yes
143	inhibiting	_	_	_	_	_	_	_	_
144	thromboinflammation	_	_	_	_	_	_	_	_
145	using	_	_	_	_	_	_	_	BeginSeg=Yes
146	a	_	_	_	_	_	_	_	_
147	multicomponent	_	_	_	_	_	_	_	_
148	approach	_	_	_	_	_	_	_	_
149	,	_	_	_	_	_	_	_	_
150	we	_	_	_	_	_	_	_	BeginSeg=Yes
151	have	_	_	_	_	_	_	_	_
152	created	_	_	_	_	_	_	_	_
153	a	_	_	_	_	_	_	_	_
154	hybrid	_	_	_	_	_	_	_	_
155	surface	_	_	_	_	_	_	_	_
156	with	_	_	_	_	_	_	_	_
157	the	_	_	_	_	_	_	_	_
158	potential	_	_	_	_	_	_	_	_
159	to	_	_	_	_	_	_	_	BeginSeg=Yes
160	greatly	_	_	_	_	_	_	_	_
161	reduce	_	_	_	_	_	_	_	_
162	incompatibility	_	_	_	_	_	_	_	_
163	reactions	_	_	_	_	_	_	_	_
164	involving	_	_	_	_	_	_	_	BeginSeg=Yes
165	biomaterials	_	_	_	_	_	_	_	_
166	and	_	_	_	_	_	_	_	_
167	transplantation	_	_	_	_	_	_	_	_
168	.	_	_	_	_	_	_	_	_

# newdoc_id = 5cfb44ecdfb61b2898b6cf7315b1e810874a9560
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	2019-nCoV	_	_	_	_	_	_	_	_
3	outbreak	_	_	_	_	_	_	_	_
4	has	_	_	_	_	_	_	_	_
5	raised	_	_	_	_	_	_	_	_
6	concern	_	_	_	_	_	_	_	_
7	of	_	_	_	_	_	_	_	_
8	global	_	_	_	_	_	_	_	_
9	spread	_	_	_	_	_	_	_	_
10	.	_	_	_	_	_	_	_	_
11	While	_	_	_	_	_	_	_	BeginSeg=Yes
12	person	_	_	_	_	_	_	_	_
13	-	_	_	_	_	_	_	_	_
14	to	_	_	_	_	_	_	_	_
15	-	_	_	_	_	_	_	_	_
16	person	_	_	_	_	_	_	_	_
17	transmission	_	_	_	_	_	_	_	_
18	within	_	_	_	_	_	_	_	_
19	the	_	_	_	_	_	_	_	_
20	Wuhan	_	_	_	_	_	_	_	_
21	district	_	_	_	_	_	_	_	_
22	has	_	_	_	_	_	_	_	_
23	led	_	_	_	_	_	_	_	_
24	to	_	_	_	_	_	_	_	_
25	a	_	_	_	_	_	_	_	_
26	large	_	_	_	_	_	_	_	_
27	outbreak	_	_	_	_	_	_	_	_
28	,	_	_	_	_	_	_	_	_
29	the	_	_	_	_	_	_	_	BeginSeg=Yes
30	transmission	_	_	_	_	_	_	_	_
31	potential	_	_	_	_	_	_	_	_
32	outside	_	_	_	_	_	_	_	_
33	of	_	_	_	_	_	_	_	_
34	the	_	_	_	_	_	_	_	_
35	region	_	_	_	_	_	_	_	_
36	remains	_	_	_	_	_	_	_	_
37	unclear	_	_	_	_	_	_	_	_
38	.	_	_	_	_	_	_	_	_
39	Here	_	_	_	_	_	_	_	BeginSeg=Yes
40	we	_	_	_	_	_	_	_	_
41	present	_	_	_	_	_	_	_	_
42	a	_	_	_	_	_	_	_	_
43	simple	_	_	_	_	_	_	_	_
44	approach	_	_	_	_	_	_	_	_
45	for	_	_	_	_	_	_	_	BeginSeg=Yes
46	determining	_	_	_	_	_	_	_	_
47	whether	_	_	_	_	_	_	_	_
48	the	_	_	_	_	_	_	_	_
49	upper	_	_	_	_	_	_	_	_
50	limit	_	_	_	_	_	_	_	_
51	of	_	_	_	_	_	_	_	_
52	the	_	_	_	_	_	_	_	_
53	confidence	_	_	_	_	_	_	_	_
54	interval	_	_	_	_	_	_	_	_
55	for	_	_	_	_	_	_	_	_
56	the	_	_	_	_	_	_	_	_
57	reproduction	_	_	_	_	_	_	_	_
58	number	_	_	_	_	_	_	_	_
59	exceeds	_	_	_	_	_	_	_	_
60	one	_	_	_	_	_	_	_	_
61	for	_	_	_	_	_	_	_	_
62	transmission	_	_	_	_	_	_	_	_
63	in	_	_	_	_	_	_	_	_
64	the	_	_	_	_	_	_	_	_
65	United	_	_	_	_	_	_	_	_
66	States	_	_	_	_	_	_	_	_
67	,	_	_	_	_	_	_	_	_
68	which	_	_	_	_	_	_	_	BeginSeg=Yes
69	would	_	_	_	_	_	_	_	_
70	allow	_	_	_	_	_	_	_	_
71	endemic	_	_	_	_	_	_	_	_
72	transmission	_	_	_	_	_	_	_	_
73	.	_	_	_	_	_	_	_	_
74	As	_	_	_	_	_	_	_	BeginSeg=Yes
75	of	_	_	_	_	_	_	_	_
76	February	_	_	_	_	_	_	_	_
77	7	_	_	_	_	_	_	_	_
78	,	_	_	_	_	_	_	_	_
79	2020	_	_	_	_	_	_	_	_
80	,	_	_	_	_	_	_	_	_
81	the	_	_	_	_	_	_	_	_
82	number	_	_	_	_	_	_	_	_
83	of	_	_	_	_	_	_	_	_
84	cases	_	_	_	_	_	_	_	_
85	in	_	_	_	_	_	_	_	_
86	the	_	_	_	_	_	_	_	_
87	United	_	_	_	_	_	_	_	_
88	states	_	_	_	_	_	_	_	_
89	support	_	_	_	_	_	_	_	_
90	subcritical	_	_	_	_	_	_	_	_
91	transmission	_	_	_	_	_	_	_	_
92	,	_	_	_	_	_	_	_	_
93	rather	_	_	_	_	_	_	_	_
94	than	_	_	_	_	_	_	_	_
95	ongoing	_	_	_	_	_	_	_	_
96	transmission	_	_	_	_	_	_	_	_
97	.	_	_	_	_	_	_	_	_
98	However	_	_	_	_	_	_	_	BeginSeg=Yes
99	,	_	_	_	_	_	_	_	_
100	this	_	_	_	_	_	_	_	_
101	conclusion	_	_	_	_	_	_	_	_
102	can	_	_	_	_	_	_	_	_
103	change	_	_	_	_	_	_	_	_
104	if	_	_	_	_	_	_	_	BeginSeg=Yes
105	pre	_	_	_	_	_	_	_	_
106	-	_	_	_	_	_	_	_	_
107	symptomatic	_	_	_	_	_	_	_	_
108	cases	_	_	_	_	_	_	_	_
109	resulting	_	_	_	_	_	_	_	BeginSeg=Yes
110	from	_	_	_	_	_	_	_	_
111	human	_	_	_	_	_	_	_	_
112	-	_	_	_	_	_	_	_	_
113	to	_	_	_	_	_	_	_	_
114	-	_	_	_	_	_	_	_	_
115	human	_	_	_	_	_	_	_	_
116	transmission	_	_	_	_	_	_	_	_
117	have	_	_	_	_	_	_	_	BeginSeg=Yes
118	not	_	_	_	_	_	_	_	_
119	yet	_	_	_	_	_	_	_	_
120	been	_	_	_	_	_	_	_	_
121	identified	_	_	_	_	_	_	_	_
122	.	_	_	_	_	_	_	_	_
123	The	_	_	_	_	_	_	_	BeginSeg=Yes
124	2019-nCoV	_	_	_	_	_	_	_	_
125	outbreak	_	_	_	_	_	_	_	_
126	is	_	_	_	_	_	_	_	_
127	a	_	_	_	_	_	_	_	_
128	global	_	_	_	_	_	_	_	_
129	health	_	_	_	_	_	_	_	_
130	risk	_	_	_	_	_	_	_	_
131	,	_	_	_	_	_	_	_	_
132	especially	_	_	_	_	_	_	_	BeginSeg=Yes
133	considering	_	_	_	_	_	_	_	_
134	the	_	_	_	_	_	_	_	_
135	number	_	_	_	_	_	_	_	_
136	of	_	_	_	_	_	_	_	_
137	patients	_	_	_	_	_	_	_	_
138	who	_	_	_	_	_	_	_	BeginSeg=Yes
139	have	_	_	_	_	_	_	_	_
140	already	_	_	_	_	_	_	_	_
141	died	_	_	_	_	_	_	_	_
142	after	_	_	_	_	_	_	_	BeginSeg=Yes
143	becoming	_	_	_	_	_	_	_	_
144	infected	_	_	_	_	_	_	_	_
145	in	_	_	_	_	_	_	_	_
146	Wuhan	_	_	_	_	_	_	_	_
147	,	_	_	_	_	_	_	_	_
148	China	_	_	_	_	_	_	_	_
149	.	_	_	_	_	_	_	_	_
150	Many	_	_	_	_	_	_	_	BeginSeg=Yes
151	initial	_	_	_	_	_	_	_	_
152	characterizations	_	_	_	_	_	_	_	_
153	of	_	_	_	_	_	_	_	_
154	the	_	_	_	_	_	_	_	_
155	virus	_	_	_	_	_	_	_	_
156	have	_	_	_	_	_	_	_	_
157	focused	_	_	_	_	_	_	_	_
158	on	_	_	_	_	_	_	_	_
159	the	_	_	_	_	_	_	_	_
160	basic	_	_	_	_	_	_	_	_
161	reproduction	_	_	_	_	_	_	_	_
162	number	_	_	_	_	_	_	_	_
163	,	_	_	_	_	_	_	_	_
164	R	_	_	_	_	_	_	_	_
165	,	_	_	_	_	_	_	_	_
166	which	_	_	_	_	_	_	_	BeginSeg=Yes
167	reflects	_	_	_	_	_	_	_	_
168	the	_	_	_	_	_	_	_	_
169	average	_	_	_	_	_	_	_	_
170	number	_	_	_	_	_	_	_	_
171	of	_	_	_	_	_	_	_	_
172	infections	_	_	_	_	_	_	_	_
173	that	_	_	_	_	_	_	_	BeginSeg=Yes
174	each	_	_	_	_	_	_	_	_
175	new	_	_	_	_	_	_	_	_
176	infection	_	_	_	_	_	_	_	_
177	causes	_	_	_	_	_	_	_	_
178	in	_	_	_	_	_	_	_	_
179	a	_	_	_	_	_	_	_	_
180	susceptible	_	_	_	_	_	_	_	_
181	population	_	_	_	_	_	_	_	_
182	.	_	_	_	_	_	_	_	_
183	Whenever	_	_	_	_	_	_	_	BeginSeg=Yes
184	R	_	_	_	_	_	_	_	_
185	is	_	_	_	_	_	_	_	_
186	greater	_	_	_	_	_	_	_	_
187	than	_	_	_	_	_	_	_	_
188	one	_	_	_	_	_	_	_	_
189	,	_	_	_	_	_	_	_	_
190	epidemic	_	_	_	_	_	_	_	BeginSeg=Yes
191	transition	_	_	_	_	_	_	_	_
192	becomes	_	_	_	_	_	_	_	_
193	possible	_	_	_	_	_	_	_	_
194	and	_	_	_	_	_	_	_	BeginSeg=Yes
195	within	_	_	_	_	_	_	_	_
196	the	_	_	_	_	_	_	_	_
197	Wuhan	_	_	_	_	_	_	_	_
198	province	_	_	_	_	_	_	_	_
199	,	_	_	_	_	_	_	_	_
200	R	_	_	_	_	_	_	_	_
201	has	_	_	_	_	_	_	_	_
202	been	_	_	_	_	_	_	_	_
203	estimated	_	_	_	_	_	_	_	_
204	as	_	_	_	_	_	_	_	_
205	high	_	_	_	_	_	_	_	_
206	as	_	_	_	_	_	_	_	_
207	4.1	_	_	_	_	_	_	_	_
208	1	_	_	_	_	_	_	_	_
209	-	_	_	_	_	_	_	_	_
210	3	_	_	_	_	_	_	_	_
211	.	_	_	_	_	_	_	_	_

# newdoc_id = 5e2c1be088e0e4406e9446e7efc610a6a53d2315
1	Feline	_	_	_	_	_	_	_	BeginSeg=Yes
2	calicivirus	_	_	_	_	_	_	_	_
3	(	_	_	_	_	_	_	_	_
4	FCV	_	_	_	_	_	_	_	_
5	)	_	_	_	_	_	_	_	_
6	is	_	_	_	_	_	_	_	_
7	a	_	_	_	_	_	_	_	_
8	small	_	_	_	_	_	_	_	_
9	non	_	_	_	_	_	_	_	_
10	-	_	_	_	_	_	_	_	_
11	enveloped	_	_	_	_	_	_	_	_
12	virus	_	_	_	_	_	_	_	_
13	containing	_	_	_	_	_	_	_	BeginSeg=Yes
14	a	_	_	_	_	_	_	_	_
15	single	_	_	_	_	_	_	_	_
16	-	_	_	_	_	_	_	_	_
17	stranded	_	_	_	_	_	_	_	_
18	,	_	_	_	_	_	_	_	_
19	positive	_	_	_	_	_	_	_	_
20	-	_	_	_	_	_	_	_	_
21	sense	_	_	_	_	_	_	_	_
22	RNA	_	_	_	_	_	_	_	_
23	genome	_	_	_	_	_	_	_	_
24	of	_	_	_	_	_	_	_	_
25	approximately	_	_	_	_	_	_	_	_
26	7.7	_	_	_	_	_	_	_	_
27	kb	_	_	_	_	_	_	_	_
28	.	_	_	_	_	_	_	_	_
29	FCV	_	_	_	_	_	_	_	BeginSeg=Yes
30	is	_	_	_	_	_	_	_	_
31	a	_	_	_	_	_	_	_	_
32	highly	_	_	_	_	_	_	_	_
33	infectious	_	_	_	_	_	_	_	_
34	pathogen	_	_	_	_	_	_	_	_
35	of	_	_	_	_	_	_	_	_
36	cats	_	_	_	_	_	_	_	_
37	and	_	_	_	_	_	_	_	BeginSeg=Yes
38	typically	_	_	_	_	_	_	_	_
39	causes	_	_	_	_	_	_	_	_
40	moderate	_	_	_	_	_	_	_	_
41	,	_	_	_	_	_	_	_	_
42	self	_	_	_	_	_	_	_	_
43	-	_	_	_	_	_	_	_	_
44	limiting	_	_	_	_	_	_	_	_
45	acute	_	_	_	_	_	_	_	_
46	oral	_	_	_	_	_	_	_	_
47	and	_	_	_	_	_	_	_	_
48	upper	_	_	_	_	_	_	_	_
49	respiratory	_	_	_	_	_	_	_	_
50	tract	_	_	_	_	_	_	_	_
51	diseases	_	_	_	_	_	_	_	_
52	or	_	_	_	_	_	_	_	_
53	chronic	_	_	_	_	_	_	_	_
54	oral	_	_	_	_	_	_	_	_
55	diseases	_	_	_	_	_	_	_	_
56	.	_	_	_	_	_	_	_	_
57	In	_	_	_	_	_	_	_	BeginSeg=Yes
58	addition	_	_	_	_	_	_	_	_
59	,	_	_	_	_	_	_	_	_
60	in	_	_	_	_	_	_	_	_
61	recent	_	_	_	_	_	_	_	_
62	years	_	_	_	_	_	_	_	_
63	,	_	_	_	_	_	_	_	_
64	virulent	_	_	_	_	_	_	_	_
65	,	_	_	_	_	_	_	_	_
66	systemic	_	_	_	_	_	_	_	_
67	FCV	_	_	_	_	_	_	_	_
68	(	_	_	_	_	_	_	_	_
69	vs	_	_	_	_	_	_	_	_
70	-	_	_	_	_	_	_	_	_
71	FCV	_	_	_	_	_	_	_	_
72	)	_	_	_	_	_	_	_	_
73	strains	_	_	_	_	_	_	_	_
74	causing	_	_	_	_	_	_	_	BeginSeg=Yes
75	severe	_	_	_	_	_	_	_	_
76	systemic	_	_	_	_	_	_	_	_
77	diseases	_	_	_	_	_	_	_	_
78	with	_	_	_	_	_	_	_	_
79	a	_	_	_	_	_	_	_	_
80	high	_	_	_	_	_	_	_	_
81	mortality	_	_	_	_	_	_	_	_
82	rate	_	_	_	_	_	_	_	_
83	of	_	_	_	_	_	_	_	_
84	up	_	_	_	_	_	_	_	_
85	to	_	_	_	_	_	_	_	_
86	67	_	_	_	_	_	_	_	_
87	%	_	_	_	_	_	_	_	_
88	have	_	_	_	_	_	_	_	BeginSeg=Yes
89	been	_	_	_	_	_	_	_	_
90	reported	_	_	_	_	_	_	_	_
91	in	_	_	_	_	_	_	_	_
92	cats	_	_	_	_	_	_	_	_
93	.	_	_	_	_	_	_	_	_
94	Although	_	_	_	_	_	_	_	BeginSeg=Yes
95	FCV	_	_	_	_	_	_	_	_
96	vaccines	_	_	_	_	_	_	_	_
97	are	_	_	_	_	_	_	_	_
98	commercially	_	_	_	_	_	_	_	_
99	available	_	_	_	_	_	_	_	_
100	,	_	_	_	_	_	_	_	_
101	their	_	_	_	_	_	_	_	BeginSeg=Yes
102	efficacy	_	_	_	_	_	_	_	_
103	is	_	_	_	_	_	_	_	_
104	limited	_	_	_	_	_	_	_	_
105	due	_	_	_	_	_	_	_	BeginSeg=Yes
106	to	_	_	_	_	_	_	_	_
107	antigenic	_	_	_	_	_	_	_	_
108	diversity	_	_	_	_	_	_	_	_
109	of	_	_	_	_	_	_	_	_
110	FCV	_	_	_	_	_	_	_	_
111	strains	_	_	_	_	_	_	_	_
112	and	_	_	_	_	_	_	_	_
113	short	_	_	_	_	_	_	_	_
114	duration	_	_	_	_	_	_	_	_
115	of	_	_	_	_	_	_	_	_
116	immunity	_	_	_	_	_	_	_	_
117	.	_	_	_	_	_	_	_	_
118	In	_	_	_	_	_	_	_	BeginSeg=Yes
119	this	_	_	_	_	_	_	_	_
120	study	_	_	_	_	_	_	_	_
121	,	_	_	_	_	_	_	_	_
122	we	_	_	_	_	_	_	_	_
123	identified	_	_	_	_	_	_	_	_
124	fexaramine	_	_	_	_	_	_	_	_
125	as	_	_	_	_	_	_	_	_
126	a	_	_	_	_	_	_	_	_
127	potent	_	_	_	_	_	_	_	_
128	inhibitor	_	_	_	_	_	_	_	_
129	of	_	_	_	_	_	_	_	_
130	FCV	_	_	_	_	_	_	_	_
131	including	_	_	_	_	_	_	_	BeginSeg=Yes
132	vs	_	_	_	_	_	_	_	_
133	-	_	_	_	_	_	_	_	_
134	FCV	_	_	_	_	_	_	_	_
135	strains	_	_	_	_	_	_	_	_
136	in	_	_	_	_	_	_	_	_
137	cell	_	_	_	_	_	_	_	_
138	culture	_	_	_	_	_	_	_	_
139	and	_	_	_	_	_	_	_	BeginSeg=Yes
140	demonstrated	_	_	_	_	_	_	_	_
141	that	_	_	_	_	_	_	_	BeginSeg=Yes
142	fexaramine	_	_	_	_	_	_	_	_
143	is	_	_	_	_	_	_	_	_
144	a	_	_	_	_	_	_	_	_
145	entry	_	_	_	_	_	_	_	_
146	blocker	_	_	_	_	_	_	_	_
147	for	_	_	_	_	_	_	_	_
148	FCV	_	_	_	_	_	_	_	_
149	by	_	_	_	_	_	_	_	BeginSeg=Yes
150	using	_	_	_	_	_	_	_	_
151	various	_	_	_	_	_	_	_	_
152	experiments	_	_	_	_	_	_	_	_
153	including	_	_	_	_	_	_	_	BeginSeg=Yes
154	time	_	_	_	_	_	_	_	_
155	-	_	_	_	_	_	_	_	_
156	of	_	_	_	_	_	_	_	_
157	-	_	_	_	_	_	_	_	_
158	addition	_	_	_	_	_	_	_	_
159	studies	_	_	_	_	_	_	_	_
160	,	_	_	_	_	_	_	_	_
161	generation	_	_	_	_	_	_	_	_
162	of	_	_	_	_	_	_	_	_
163	resistant	_	_	_	_	_	_	_	_
164	viruses	_	_	_	_	_	_	_	_
165	in	_	_	_	_	_	_	_	_
166	cell	_	_	_	_	_	_	_	_
167	culture	_	_	_	_	_	_	_	_
168	and	_	_	_	_	_	_	_	_
169	the	_	_	_	_	_	_	_	_
170	reverse	_	_	_	_	_	_	_	_
171	genetics	_	_	_	_	_	_	_	_
172	system	_	_	_	_	_	_	_	_
173	.	_	_	_	_	_	_	_	_
174	A	_	_	_	_	_	_	_	BeginSeg=Yes
175	fexaramine	_	_	_	_	_	_	_	_
176	resistant	_	_	_	_	_	_	_	_
177	FCV	_	_	_	_	_	_	_	_
178	mutant	_	_	_	_	_	_	_	_
179	has	_	_	_	_	_	_	_	_
180	a	_	_	_	_	_	_	_	_
181	single	_	_	_	_	_	_	_	_
182	amino	_	_	_	_	_	_	_	_
183	acid	_	_	_	_	_	_	_	_
184	change	_	_	_	_	_	_	_	_
185	in	_	_	_	_	_	_	_	_
186	the	_	_	_	_	_	_	_	_
187	P2	_	_	_	_	_	_	_	_
188	domain	_	_	_	_	_	_	_	_
189	of	_	_	_	_	_	_	_	_
190	VP1	_	_	_	_	_	_	_	_
191	(	_	_	_	_	_	_	_	_
192	the	_	_	_	_	_	_	_	_
193	major	_	_	_	_	_	_	_	_
194	capsid	_	_	_	_	_	_	_	_
195	)	_	_	_	_	_	_	_	_
196	,	_	_	_	_	_	_	_	_
197	and	_	_	_	_	_	_	_	BeginSeg=Yes
198	the	_	_	_	_	_	_	_	_
199	importance	_	_	_	_	_	_	_	_
200	of	_	_	_	_	_	_	_	_
201	this	_	_	_	_	_	_	_	_
202	mutation	_	_	_	_	_	_	_	_
203	for	_	_	_	_	_	_	_	_
204	conferring	_	_	_	_	_	_	_	_
205	resistance	_	_	_	_	_	_	_	_
206	was	_	_	_	_	_	_	_	_
207	confirmed	_	_	_	_	_	_	_	_
208	using	_	_	_	_	_	_	_	BeginSeg=Yes
209	the	_	_	_	_	_	_	_	_
210	reverse	_	_	_	_	_	_	_	_
211	genetics	_	_	_	_	_	_	_	_
212	system	_	_	_	_	_	_	_	_
213	.	_	_	_	_	_	_	_	_
214	A	_	_	_	_	_	_	_	BeginSeg=Yes
215	comparative	_	_	_	_	_	_	_	_
216	analysis	_	_	_	_	_	_	_	_
217	of	_	_	_	_	_	_	_	_
218	viral	_	_	_	_	_	_	_	_
219	resistance	_	_	_	_	_	_	_	_
220	was	_	_	_	_	_	_	_	_
221	also	_	_	_	_	_	_	_	_
222	performed	_	_	_	_	_	_	_	_
223	using	_	_	_	_	_	_	_	BeginSeg=Yes
224	a	_	_	_	_	_	_	_	_
225	peptidyl	_	_	_	_	_	_	_	_
226	inhibitor	_	_	_	_	_	_	_	_
227	(	_	_	_	_	_	_	_	_
228	NPI52	_	_	_	_	_	_	_	_
229	)	_	_	_	_	_	_	_	_
230	targeting	_	_	_	_	_	_	_	BeginSeg=Yes
231	FCV	_	_	_	_	_	_	_	_
232	3C	_	_	_	_	_	_	_	_
233	-	_	_	_	_	_	_	_	_
234	like	_	_	_	_	_	_	_	_
235	protease	_	_	_	_	_	_	_	_
236	.	_	_	_	_	_	_	_	_
237	Finally	_	_	_	_	_	_	_	BeginSeg=Yes
238	,	_	_	_	_	_	_	_	_
239	the	_	_	_	_	_	_	_	_
240	effects	_	_	_	_	_	_	_	_
241	of	_	_	_	_	_	_	_	_
242	combination	_	_	_	_	_	_	_	_
243	treatment	_	_	_	_	_	_	_	_
244	of	_	_	_	_	_	_	_	_
245	fexaramine	_	_	_	_	_	_	_	_
246	and	_	_	_	_	_	_	_	_
247	NPI52	_	_	_	_	_	_	_	_
248	against	_	_	_	_	_	_	_	_
249	FCV	_	_	_	_	_	_	_	_
250	replication	_	_	_	_	_	_	_	_
251	and	_	_	_	_	_	_	_	_
252	emergence	_	_	_	_	_	_	_	_
253	of	_	_	_	_	_	_	_	_
254	resistant	_	_	_	_	_	_	_	_
255	viruses	_	_	_	_	_	_	_	_
256	were	_	_	_	_	_	_	_	_
257	investigated	_	_	_	_	_	_	_	_
258	in	_	_	_	_	_	_	_	_
259	cell	_	_	_	_	_	_	_	_
260	culture	_	_	_	_	_	_	_	_
261	.	_	_	_	_	_	_	_	_

# newdoc_id = 6197b0f53a6a883f99c2602a89309b8b2f27da92
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	early	_	_	_	_	_	_	_	_
3	detection	_	_	_	_	_	_	_	_
4	of	_	_	_	_	_	_	_	_
5	SARS	_	_	_	_	_	_	_	_
6	-	_	_	_	_	_	_	_	_
7	CoV-2	_	_	_	_	_	_	_	_
8	,	_	_	_	_	_	_	_	_
9	the	_	_	_	_	_	_	_	_
10	causative	_	_	_	_	_	_	_	_
11	agent	_	_	_	_	_	_	_	_
12	of	_	_	_	_	_	_	_	_
13	(	_	_	_	_	_	_	_	_
14	COVID-19	_	_	_	_	_	_	_	_
15	)	_	_	_	_	_	_	_	_
16	is	_	_	_	_	_	_	_	_
17	now	_	_	_	_	_	_	_	_
18	a	_	_	_	_	_	_	_	_
19	critical	_	_	_	_	_	_	_	_
20	task	_	_	_	_	_	_	_	_
21	for	_	_	_	_	_	_	_	_
22	the	_	_	_	_	_	_	_	_
23	clinical	_	_	_	_	_	_	_	_
24	practitioners	_	_	_	_	_	_	_	_
25	.	_	_	_	_	_	_	_	_
26	The	_	_	_	_	_	_	_	BeginSeg=Yes
27	COVID-19	_	_	_	_	_	_	_	_
28	spread	_	_	_	_	_	_	_	_
29	is	_	_	_	_	_	_	_	_
30	announced	_	_	_	_	_	_	_	_
31	as	_	_	_	_	_	_	_	_
32	pandemic	_	_	_	_	_	_	_	_
33	outbreak	_	_	_	_	_	_	_	_
34	between	_	_	_	_	_	_	_	_
35	people	_	_	_	_	_	_	_	_
36	worldwide	_	_	_	_	_	_	_	_
37	by	_	_	_	_	_	_	_	_
38	WHO	_	_	_	_	_	_	_	_
39	since	_	_	_	_	_	_	_	_
40	11/	_	_	_	_	_	_	_	_
41	March/	_	_	_	_	_	_	_	_
42	2020	_	_	_	_	_	_	_	_
43	.	_	_	_	_	_	_	_	_
44	In	_	_	_	_	_	_	_	BeginSeg=Yes
45	this	_	_	_	_	_	_	_	_
46	consequence	_	_	_	_	_	_	_	_
47	,	_	_	_	_	_	_	_	_
48	it	_	_	_	_	_	_	_	_
49	is	_	_	_	_	_	_	_	_
50	top	_	_	_	_	_	_	_	_
51	critical	_	_	_	_	_	_	_	_
52	priority	_	_	_	_	_	_	_	_
53	to	_	_	_	_	_	_	_	_
54	become	_	_	_	_	_	_	_	_
55	aware	_	_	_	_	_	_	_	_
56	of	_	_	_	_	_	_	_	_
57	the	_	_	_	_	_	_	_	_
58	infected	_	_	_	_	_	_	_	_
59	people	_	_	_	_	_	_	_	_
60	so	_	_	_	_	_	_	_	BeginSeg=Yes
61	that	_	_	_	_	_	_	_	_
62	prevention	_	_	_	_	_	_	_	_
63	procedures	_	_	_	_	_	_	_	_
64	can	_	_	_	_	_	_	_	_
65	be	_	_	_	_	_	_	_	_
66	processed	_	_	_	_	_	_	_	_
67	to	_	_	_	_	_	_	_	BeginSeg=Yes
68	minimize	_	_	_	_	_	_	_	_
69	the	_	_	_	_	_	_	_	_
70	COVID-19	_	_	_	_	_	_	_	_
71	spread	_	_	_	_	_	_	_	_
72	and	_	_	_	_	_	_	_	BeginSeg=Yes
73	to	_	_	_	_	_	_	_	_
74	begin	_	_	_	_	_	_	_	_
75	early	_	_	_	_	_	_	_	_
76	medical	_	_	_	_	_	_	_	_
77	health	_	_	_	_	_	_	_	_
78	care	_	_	_	_	_	_	_	_
79	of	_	_	_	_	_	_	_	_
80	those	_	_	_	_	_	_	_	_
81	infected	_	_	_	_	_	_	_	_
82	persons	_	_	_	_	_	_	_	_
83	.	_	_	_	_	_	_	_	_
84	In	_	_	_	_	_	_	_	BeginSeg=Yes
85	this	_	_	_	_	_	_	_	_
86	paper	_	_	_	_	_	_	_	_
87	,	_	_	_	_	_	_	_	_
88	the	_	_	_	_	_	_	_	_
89	deep	_	_	_	_	_	_	_	_
90	studying	_	_	_	_	_	_	_	_
91	based	_	_	_	_	_	_	_	_
92	totally	_	_	_	_	_	_	_	_
93	methodology	_	_	_	_	_	_	_	_
94	is	_	_	_	_	_	_	_	_
95	usually	_	_	_	_	_	_	_	_
96	recommended	_	_	_	_	_	_	_	_
97	for	_	_	_	_	_	_	_	_
98	the	_	_	_	_	_	_	_	_
99	detection	_	_	_	_	_	_	_	_
100	of	_	_	_	_	_	_	_	_
101	COVID-19	_	_	_	_	_	_	_	_
102	infected	_	_	_	_	_	_	_	_
103	patients	_	_	_	_	_	_	_	_
104	using	_	_	_	_	_	_	_	BeginSeg=Yes
105	X	_	_	_	_	_	_	_	_
106	-	_	_	_	_	_	_	_	_
107	ray	_	_	_	_	_	_	_	_
108	images	_	_	_	_	_	_	_	_
109	.	_	_	_	_	_	_	_	_
110	The	_	_	_	_	_	_	_	BeginSeg=Yes
111	help	_	_	_	_	_	_	_	_
112	vector	_	_	_	_	_	_	_	_
113	gadget	_	_	_	_	_	_	_	_
114	classifies	_	_	_	_	_	_	_	_
115	the	_	_	_	_	_	_	_	_
116	corona	_	_	_	_	_	_	_	_
117	affected	_	_	_	_	_	_	_	_
118	X	_	_	_	_	_	_	_	_
119	-	_	_	_	_	_	_	_	_
120	ray	_	_	_	_	_	_	_	_
121	images	_	_	_	_	_	_	_	_
122	from	_	_	_	_	_	_	_	_
123	others	_	_	_	_	_	_	_	_
124	through	_	_	_	_	_	_	_	_
125	usage	_	_	_	_	_	_	_	_
126	of	_	_	_	_	_	_	_	_
127	the	_	_	_	_	_	_	_	_
128	deep	_	_	_	_	_	_	_	_
129	features	_	_	_	_	_	_	_	_
130	.	_	_	_	_	_	_	_	_
131	The	_	_	_	_	_	_	_	BeginSeg=Yes
132	technique	_	_	_	_	_	_	_	_
133	is	_	_	_	_	_	_	_	_
134	useful	_	_	_	_	_	_	_	_
135	for	_	_	_	_	_	_	_	_
136	the	_	_	_	_	_	_	_	_
137	clinical	_	_	_	_	_	_	_	_
138	practitioners	_	_	_	_	_	_	_	_
139	for	_	_	_	_	_	_	_	_
140	early	_	_	_	_	_	_	_	_
141	detection	_	_	_	_	_	_	_	_
142	of	_	_	_	_	_	_	_	_
143	COVID-19	_	_	_	_	_	_	_	_
144	infected	_	_	_	_	_	_	_	_
145	patients	_	_	_	_	_	_	_	_
146	.	_	_	_	_	_	_	_	_
147	The	_	_	_	_	_	_	_	BeginSeg=Yes
148	suggested	_	_	_	_	_	_	_	_
149	system	_	_	_	_	_	_	_	_
150	of	_	_	_	_	_	_	_	_
151	multi	_	_	_	_	_	_	_	_
152	-	_	_	_	_	_	_	_	_
153	level	_	_	_	_	_	_	_	_
154	thresholding	_	_	_	_	_	_	_	_
155	plus	_	_	_	_	_	_	_	_
156	SVM	_	_	_	_	_	_	_	_
157	presented	_	_	_	_	_	_	_	_
158	high	_	_	_	_	_	_	_	_
159	accuracy	_	_	_	_	_	_	_	_
160	in	_	_	_	_	_	_	_	_
161	classification	_	_	_	_	_	_	_	_
162	of	_	_	_	_	_	_	_	_
163	the	_	_	_	_	_	_	_	_
164	infected	_	_	_	_	_	_	_	_
165	lung	_	_	_	_	_	_	_	_
166	with	_	_	_	_	_	_	_	_
167	Covid-19	_	_	_	_	_	_	_	_
168	.	_	_	_	_	_	_	_	_
169	All	_	_	_	_	_	_	_	BeginSeg=Yes
170	images	_	_	_	_	_	_	_	_
171	were	_	_	_	_	_	_	_	_
172	of	_	_	_	_	_	_	_	_
173	the	_	_	_	_	_	_	_	_
174	same	_	_	_	_	_	_	_	_
175	size	_	_	_	_	_	_	_	_
176	and	_	_	_	_	_	_	_	BeginSeg=Yes
177	stored	_	_	_	_	_	_	_	_
178	in	_	_	_	_	_	_	_	_
179	JPEG	_	_	_	_	_	_	_	_
180	format	_	_	_	_	_	_	_	_
181	with	_	_	_	_	_	_	_	_
182	512	_	_	_	_	_	_	_	_
183	*	_	_	_	_	_	_	_	_
184	512	_	_	_	_	_	_	_	_
185	pixels	_	_	_	_	_	_	_	_
186	.	_	_	_	_	_	_	_	_
187	The	_	_	_	_	_	_	_	BeginSeg=Yes
188	average	_	_	_	_	_	_	_	_
189	sensitivity	_	_	_	_	_	_	_	_
190	,	_	_	_	_	_	_	_	_
191	specificity	_	_	_	_	_	_	_	_
192	,	_	_	_	_	_	_	_	_
193	and	_	_	_	_	_	_	_	_
194	accuracy	_	_	_	_	_	_	_	_
195	of	_	_	_	_	_	_	_	_
196	the	_	_	_	_	_	_	_	_
197	lung	_	_	_	_	_	_	_	_
198	classification	_	_	_	_	_	_	_	_
199	using	_	_	_	_	_	_	_	BeginSeg=Yes
200	the	_	_	_	_	_	_	_	_
201	proposed	_	_	_	_	_	_	_	_
202	model	_	_	_	_	_	_	_	_
203	results	_	_	_	_	_	_	_	_
204	were	_	_	_	_	_	_	_	BeginSeg=Yes
205	95.76	_	_	_	_	_	_	_	_
206	%	_	_	_	_	_	_	_	_
207	,	_	_	_	_	_	_	_	_
208	99.7	_	_	_	_	_	_	_	_
209	%	_	_	_	_	_	_	_	_
210	,	_	_	_	_	_	_	_	_
211	and	_	_	_	_	_	_	_	_
212	97.48	_	_	_	_	_	_	_	_
213	%	_	_	_	_	_	_	_	_
214	,	_	_	_	_	_	_	_	_
215	respectively	_	_	_	_	_	_	_	_
216	.	_	_	_	_	_	_	_	_

# newdoc_id = 628c524b306aaaa50ae9b6a7017423445fd97c44
1	Background	_	_	_	_	_	_	_	BeginSeg=Yes
2	:	_	_	_	_	_	_	_	_
3	Anecdotal	_	_	_	_	_	_	_	BeginSeg=Yes
4	reports	_	_	_	_	_	_	_	_
5	of	_	_	_	_	_	_	_	_
6	mood	_	_	_	_	_	_	_	_
7	disorder	_	_	_	_	_	_	_	_
8	following	_	_	_	_	_	_	_	BeginSeg=Yes
9	infection	_	_	_	_	_	_	_	_
10	with	_	_	_	_	_	_	_	_
11	common	_	_	_	_	_	_	_	_
12	respiratory	_	_	_	_	_	_	_	_
13	viruses	_	_	_	_	_	_	_	_
14	with	_	_	_	_	_	_	_	_
15	neurotropic	_	_	_	_	_	_	_	_
16	potential	_	_	_	_	_	_	_	_
17	have	_	_	_	_	_	_	_	BeginSeg=Yes
18	been	_	_	_	_	_	_	_	_
19	in	_	_	_	_	_	_	_	_
20	existence	_	_	_	_	_	_	_	_
21	since	_	_	_	_	_	_	_	_
22	the	_	_	_	_	_	_	_	_
23	last	_	_	_	_	_	_	_	_
24	century	_	_	_	_	_	_	_	_
25	.	_	_	_	_	_	_	_	_
26	Nevertheless	_	_	_	_	_	_	_	BeginSeg=Yes
27	,	_	_	_	_	_	_	_	_
28	systematic	_	_	_	_	_	_	_	_
29	studies	_	_	_	_	_	_	_	_
30	on	_	_	_	_	_	_	_	_
31	the	_	_	_	_	_	_	_	_
32	association	_	_	_	_	_	_	_	_
33	between	_	_	_	_	_	_	_	_
34	these	_	_	_	_	_	_	_	_
35	viruses	_	_	_	_	_	_	_	_
36	and	_	_	_	_	_	_	_	_
37	mood	_	_	_	_	_	_	_	_
38	disorders	_	_	_	_	_	_	_	_
39	are	_	_	_	_	_	_	_	_
40	lacking	_	_	_	_	_	_	_	_
41	.	_	_	_	_	_	_	_	_
42	Methods	_	_	_	_	_	_	_	BeginSeg=Yes
43	:	_	_	_	_	_	_	_	_
44	Influenza	_	_	_	_	_	_	_	BeginSeg=Yes
45	A	_	_	_	_	_	_	_	_
46	,	_	_	_	_	_	_	_	_
47	B	_	_	_	_	_	_	_	_
48	and	_	_	_	_	_	_	_	_
49	coronavirus	_	_	_	_	_	_	_	_
50	antibody	_	_	_	_	_	_	_	_
51	titers	_	_	_	_	_	_	_	_
52	were	_	_	_	_	_	_	_	_
53	measured	_	_	_	_	_	_	_	_
54	in	_	_	_	_	_	_	_	_
55	257	_	_	_	_	_	_	_	_
56	subjects	_	_	_	_	_	_	_	_
57	with	_	_	_	_	_	_	_	_
58	recurrent	_	_	_	_	_	_	_	_
59	unipolar	_	_	_	_	_	_	_	_
60	and	_	_	_	_	_	_	_	_
61	bipolar	_	_	_	_	_	_	_	_
62	disorder	_	_	_	_	_	_	_	_
63	and	_	_	_	_	_	_	_	_
64	healthy	_	_	_	_	_	_	_	_
65	controls	_	_	_	_	_	_	_	_
66	,	_	_	_	_	_	_	_	_
67	by	_	_	_	_	_	_	_	_
68	SCID	_	_	_	_	_	_	_	_
69	.	_	_	_	_	_	_	_	_
70-71	Pearson's	_	_	_	_	_	_	_	_
70	Pearson	_	_	_	_	_	_	_	BeginSeg=Yes
71	's	_	_	_	_	_	_	_	_
72	χ²	_	_	_	_	_	_	_	_
73	tests	_	_	_	_	_	_	_	_
74	and	_	_	_	_	_	_	_	_
75	logistic	_	_	_	_	_	_	_	_
76	regression	_	_	_	_	_	_	_	_
77	models	_	_	_	_	_	_	_	_
78	were	_	_	_	_	_	_	_	_
79	used	_	_	_	_	_	_	_	_
80	to	_	_	_	_	_	_	_	BeginSeg=Yes
81	analyze	_	_	_	_	_	_	_	_
82	associations	_	_	_	_	_	_	_	_
83	between	_	_	_	_	_	_	_	_
84	seropositivity	_	_	_	_	_	_	_	_
85	for	_	_	_	_	_	_	_	_
86	coronaviruses	_	_	_	_	_	_	_	_
87	,	_	_	_	_	_	_	_	_
88	influenza	_	_	_	_	_	_	_	_
89	A	_	_	_	_	_	_	_	_
90	and	_	_	_	_	_	_	_	_
91	B	_	_	_	_	_	_	_	_
92	viruses	_	_	_	_	_	_	_	_
93	and	_	_	_	_	_	_	_	_
94	the	_	_	_	_	_	_	_	_
95	following	_	_	_	_	_	_	_	_
96	:	_	_	_	_	_	_	_	_
97	a	_	_	_	_	_	_	_	BeginSeg=Yes
98	)	_	_	_	_	_	_	_	_
99	history	_	_	_	_	_	_	_	_
100	of	_	_	_	_	_	_	_	_
101	recurrent	_	_	_	_	_	_	_	_
102	mood	_	_	_	_	_	_	_	_
103	disorders	_	_	_	_	_	_	_	_
104	b	_	_	_	_	_	_	_	_
105	)	_	_	_	_	_	_	_	_
106	having	_	_	_	_	_	_	_	_
107	attempted	_	_	_	_	_	_	_	_
108	suicide	_	_	_	_	_	_	_	_
109	in	_	_	_	_	_	_	_	_
110	the	_	_	_	_	_	_	_	_
111	past	_	_	_	_	_	_	_	_
112	c	_	_	_	_	_	_	_	_
113	)	_	_	_	_	_	_	_	_
114	uni	_	_	_	_	_	_	_	_
115	-	_	_	_	_	_	_	_	_
116	vs	_	_	_	_	_	_	_	_
117	.	_	_	_	_	_	_	_	_
118	bi	_	_	_	_	_	_	_	_
119	-	_	_	_	_	_	_	_	_
120	polarity	_	_	_	_	_	_	_	_
121	and	_	_	_	_	_	_	_	_
122	d	_	_	_	_	_	_	_	_
123	)	_	_	_	_	_	_	_	_
124	presence	_	_	_	_	_	_	_	_
125	of	_	_	_	_	_	_	_	_
126	psychotic	_	_	_	_	_	_	_	_
127	symptoms	_	_	_	_	_	_	_	_
128	during	_	_	_	_	_	_	_	_
129	mood	_	_	_	_	_	_	_	_
130	episodes	_	_	_	_	_	_	_	_
131	.	_	_	_	_	_	_	_	_
132	Results	_	_	_	_	_	_	_	BeginSeg=Yes
133	:	_	_	_	_	_	_	_	_
134	Seropositivity	_	_	_	_	_	_	_	BeginSeg=Yes
135	for	_	_	_	_	_	_	_	_
136	influenza	_	_	_	_	_	_	_	_
137	A	_	_	_	_	_	_	_	_
138	(	_	_	_	_	_	_	_	BeginSeg=Yes
139	p	_	_	_	_	_	_	_	_
140	=	_	_	_	_	_	_	_	_
141	0.004	_	_	_	_	_	_	_	_
142	)	_	_	_	_	_	_	_	_
143	,	_	_	_	_	_	_	_	_
144	B	_	_	_	_	_	_	_	BeginSeg=Yes
145	(	_	_	_	_	_	_	_	BeginSeg=Yes
146	p	_	_	_	_	_	_	_	_
147	b	_	_	_	_	_	_	_	_
148	0.0001	_	_	_	_	_	_	_	_
149	)	_	_	_	_	_	_	_	_
150	and	_	_	_	_	_	_	_	BeginSeg=Yes
151	coronaviruses	_	_	_	_	_	_	_	_
152	(	_	_	_	_	_	_	_	BeginSeg=Yes
153	p	_	_	_	_	_	_	_	_
154	b	_	_	_	_	_	_	_	_
155	0.0001	_	_	_	_	_	_	_	_
156	)	_	_	_	_	_	_	_	_
157	were	_	_	_	_	_	_	_	BeginSeg=Yes
158	associated	_	_	_	_	_	_	_	_
159	with	_	_	_	_	_	_	_	_
160	history	_	_	_	_	_	_	_	_
161	of	_	_	_	_	_	_	_	_
162	mood	_	_	_	_	_	_	_	_
163	disorders	_	_	_	_	_	_	_	_
164	but	_	_	_	_	_	_	_	_
165	not	_	_	_	_	_	_	_	_
166	with	_	_	_	_	_	_	_	_
167	the	_	_	_	_	_	_	_	_
168	specific	_	_	_	_	_	_	_	_
169	diagnosis	_	_	_	_	_	_	_	_
170	of	_	_	_	_	_	_	_	_
171	unipolar	_	_	_	_	_	_	_	_
172	or	_	_	_	_	_	_	_	_
173	bipolar	_	_	_	_	_	_	_	_
174	depression	_	_	_	_	_	_	_	_
175	.	_	_	_	_	_	_	_	_
176	Seropositivity	_	_	_	_	_	_	_	BeginSeg=Yes
177	for	_	_	_	_	_	_	_	_
178	influenza	_	_	_	_	_	_	_	_
179	B	_	_	_	_	_	_	_	_
180	was	_	_	_	_	_	_	_	_
181	significantly	_	_	_	_	_	_	_	_
182	associated	_	_	_	_	_	_	_	_
183	with	_	_	_	_	_	_	_	_
184	a	_	_	_	_	_	_	_	_
185	history	_	_	_	_	_	_	_	_
186	of	_	_	_	_	_	_	_	_
187	suicide	_	_	_	_	_	_	_	_
188	attempt	_	_	_	_	_	_	_	_
189	(	_	_	_	_	_	_	_	BeginSeg=Yes
190	p	_	_	_	_	_	_	_	_
191	=	_	_	_	_	_	_	_	_
192	0.001	_	_	_	_	_	_	_	_
193	)	_	_	_	_	_	_	_	_
194	and	_	_	_	_	_	_	_	BeginSeg=Yes
195	history	_	_	_	_	_	_	_	_
196	of	_	_	_	_	_	_	_	_
197	psychotic	_	_	_	_	_	_	_	_
198	symptoms	_	_	_	_	_	_	_	_
199	(	_	_	_	_	_	_	_	BeginSeg=Yes
200	p	_	_	_	_	_	_	_	_
201	=	_	_	_	_	_	_	_	_
202	0.005	_	_	_	_	_	_	_	_
203	)	_	_	_	_	_	_	_	_
204	.	_	_	_	_	_	_	_	_
205	Limitations	_	_	_	_	_	_	_	BeginSeg=Yes
206	:	_	_	_	_	_	_	_	_
207	The	_	_	_	_	_	_	_	BeginSeg=Yes
208	design	_	_	_	_	_	_	_	_
209	was	_	_	_	_	_	_	_	_
210	cross	_	_	_	_	_	_	_	_
211	-	_	_	_	_	_	_	_	_
212	sectional	_	_	_	_	_	_	_	_
213	.	_	_	_	_	_	_	_	_
214	Socioeconomic	_	_	_	_	_	_	_	BeginSeg=Yes
215	factors	_	_	_	_	_	_	_	_
216	,	_	_	_	_	_	_	_	_
217	inflammatory	_	_	_	_	_	_	_	_
218	markers	_	_	_	_	_	_	_	_
219	,	_	_	_	_	_	_	_	_
220	and	_	_	_	_	_	_	_	_
221	axis	_	_	_	_	_	_	_	_
222	II	_	_	_	_	_	_	_	_
223	psychopathology	_	_	_	_	_	_	_	_
224	were	_	_	_	_	_	_	_	_
225	not	_	_	_	_	_	_	_	_
226	assessed	_	_	_	_	_	_	_	_
227	.	_	_	_	_	_	_	_	_
228	Conclusions	_	_	_	_	_	_	_	BeginSeg=Yes
229	:	_	_	_	_	_	_	_	_
230	The	_	_	_	_	_	_	_	BeginSeg=Yes
231	association	_	_	_	_	_	_	_	_
232	of	_	_	_	_	_	_	_	_
233	seropositivity	_	_	_	_	_	_	_	_
234	for	_	_	_	_	_	_	_	_
235	influenza	_	_	_	_	_	_	_	_
236	and	_	_	_	_	_	_	_	_
237	coronaviruses	_	_	_	_	_	_	_	_
238	with	_	_	_	_	_	_	_	_
239	a	_	_	_	_	_	_	_	_
240	history	_	_	_	_	_	_	_	_
241	of	_	_	_	_	_	_	_	_
242	mood	_	_	_	_	_	_	_	_
243	disorders	_	_	_	_	_	_	_	_
244	,	_	_	_	_	_	_	_	_
245	and	_	_	_	_	_	_	_	_
246	influenza	_	_	_	_	_	_	_	_
247	B	_	_	_	_	_	_	_	_
248	with	_	_	_	_	_	_	_	_
249	suicidal	_	_	_	_	_	_	_	_
250	behavior	_	_	_	_	_	_	_	_
251	require	_	_	_	_	_	_	_	_
252	replication	_	_	_	_	_	_	_	_
253	in	_	_	_	_	_	_	_	_
254	larger	_	_	_	_	_	_	_	_
255	longitudinal	_	_	_	_	_	_	_	_
256	samples	_	_	_	_	_	_	_	_
257	.	_	_	_	_	_	_	_	_
258	The	_	_	_	_	_	_	_	BeginSeg=Yes
259	need	_	_	_	_	_	_	_	_
260	for	_	_	_	_	_	_	_	_
261	these	_	_	_	_	_	_	_	_
262	studies	_	_	_	_	_	_	_	_
263	is	_	_	_	_	_	_	_	_
264	additionally	_	_	_	_	_	_	_	_
265	supported	_	_	_	_	_	_	_	_
266	by	_	_	_	_	_	_	_	_
267	the	_	_	_	_	_	_	_	_
268	high	_	_	_	_	_	_	_	_
269	incidence	_	_	_	_	_	_	_	_
270	of	_	_	_	_	_	_	_	_
271	these	_	_	_	_	_	_	_	_
272	viral	_	_	_	_	_	_	_	_
273	infections	_	_	_	_	_	_	_	_
274	,	_	_	_	_	_	_	_	_
275	the	_	_	_	_	_	_	_	_
276	high	_	_	_	_	_	_	_	_
277	prevalence	_	_	_	_	_	_	_	_
278	of	_	_	_	_	_	_	_	_
279	mood	_	_	_	_	_	_	_	_
280	disorders	_	_	_	_	_	_	_	_
281	,	_	_	_	_	_	_	_	_
282	and	_	_	_	_	_	_	_	_
283	resilience	_	_	_	_	_	_	_	_
284	of	_	_	_	_	_	_	_	_
285	suicide	_	_	_	_	_	_	_	_
286	epidemics	_	_	_	_	_	_	_	_
287	.	_	_	_	_	_	_	_	_

# newdoc_id = 64a850b409d63712791c985be7166bfc378315a3
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	novel	_	_	_	_	_	_	_	_
3-4	coronavirus'	_	_	_	_	_	_	_	_
3	coronavirus	_	_	_	_	_	_	_	_
4	'	_	_	_	_	_	_	_	_
5	high	_	_	_	_	_	_	_	_
6	rate	_	_	_	_	_	_	_	_
7	of	_	_	_	_	_	_	_	_
8	asymptomatic	_	_	_	_	_	_	_	_
9	transmission	_	_	_	_	_	_	_	_
10	combined	_	_	_	_	_	_	_	BeginSeg=Yes
11	with	_	_	_	_	_	_	_	_
12	a	_	_	_	_	_	_	_	_
13	lack	_	_	_	_	_	_	_	_
14	of	_	_	_	_	_	_	_	_
15	testing	_	_	_	_	_	_	_	_
16	kits	_	_	_	_	_	_	_	_
17	call	_	_	_	_	_	_	_	BeginSeg=Yes
18	for	_	_	_	_	_	_	_	_
19	a	_	_	_	_	_	_	_	_
20	different	_	_	_	_	_	_	_	_
21	approach	_	_	_	_	_	_	_	_
22	to	_	_	_	_	_	_	_	BeginSeg=Yes
23	monitor	_	_	_	_	_	_	_	_
24	its	_	_	_	_	_	_	_	_
25	spread	_	_	_	_	_	_	_	_
26	and	_	_	_	_	_	_	_	_
27	severity	_	_	_	_	_	_	_	_
28	.	_	_	_	_	_	_	_	_
29	We	_	_	_	_	_	_	_	BeginSeg=Yes
30	proposed	_	_	_	_	_	_	_	_
31	the	_	_	_	_	_	_	_	_
32	use	_	_	_	_	_	_	_	_
33	of	_	_	_	_	_	_	_	_
34	hospitalizations	_	_	_	_	_	_	_	_
35	and	_	_	_	_	_	_	_	_
36	hospital	_	_	_	_	_	_	_	_
37	utilization	_	_	_	_	_	_	_	_
38	data	_	_	_	_	_	_	_	_
39	to	_	_	_	_	_	_	_	BeginSeg=Yes
40	monitor	_	_	_	_	_	_	_	_
41	the	_	_	_	_	_	_	_	_
42	spread	_	_	_	_	_	_	_	_
43	and	_	_	_	_	_	_	_	_
44	severity	_	_	_	_	_	_	_	_
45	.	_	_	_	_	_	_	_	_
46	A	_	_	_	_	_	_	_	BeginSeg=Yes
47	proposed	_	_	_	_	_	_	_	_
48	threshold	_	_	_	_	_	_	_	_
49	of	_	_	_	_	_	_	_	_
50	a	_	_	_	_	_	_	_	_
51	declining	_	_	_	_	_	_	_	_
52	7-day	_	_	_	_	_	_	_	_
53	moving	_	_	_	_	_	_	_	_
54	average	_	_	_	_	_	_	_	_
55	over	_	_	_	_	_	_	_	_
56	a	_	_	_	_	_	_	_	_
57	14-day	_	_	_	_	_	_	_	_
58	period	_	_	_	_	_	_	_	_
59	,	_	_	_	_	_	_	_	_
60	"	_	_	_	_	_	_	_	_
61	7&14	_	_	_	_	_	_	_	_
62	"	_	_	_	_	_	_	_	_
63	was	_	_	_	_	_	_	_	_
64	set	_	_	_	_	_	_	_	_
65	to	_	_	_	_	_	_	_	BeginSeg=Yes
66	communicate	_	_	_	_	_	_	_	_
67	when	_	_	_	_	_	_	_	_
68	a	_	_	_	_	_	_	_	_
69	wave	_	_	_	_	_	_	_	_
70	of	_	_	_	_	_	_	_	_
71	the	_	_	_	_	_	_	_	_
72	novel	_	_	_	_	_	_	_	_
73	coronavirus	_	_	_	_	_	_	_	_
74	may	_	_	_	_	_	_	_	_
75	have	_	_	_	_	_	_	_	_
76	passed	_	_	_	_	_	_	_	_
77	.	_	_	_	_	_	_	_	_
78	The	_	_	_	_	_	_	_	BeginSeg=Yes
79	state	_	_	_	_	_	_	_	_
80	of	_	_	_	_	_	_	_	_
81	Ohio	_	_	_	_	_	_	_	_
82	was	_	_	_	_	_	_	_	_
83	chosen	_	_	_	_	_	_	_	_
84	to	_	_	_	_	_	_	_	BeginSeg=Yes
85	illustrate	_	_	_	_	_	_	_	_
86	this	_	_	_	_	_	_	_	_
87	threshold	_	_	_	_	_	_	_	_
88	.	_	_	_	_	_	_	_	_
89	While	_	_	_	_	_	_	_	BeginSeg=Yes
90	not	_	_	_	_	_	_	_	_
91	the	_	_	_	_	_	_	_	_
92	ideal	_	_	_	_	_	_	_	_
93	solution	_	_	_	_	_	_	_	_
94	for	_	_	_	_	_	_	_	BeginSeg=Yes
95	monitoring	_	_	_	_	_	_	_	_
96	the	_	_	_	_	_	_	_	_
97	spread	_	_	_	_	_	_	_	_
98	of	_	_	_	_	_	_	_	_
99	the	_	_	_	_	_	_	_	_
100	epidemic	_	_	_	_	_	_	_	_
101	,	_	_	_	_	_	_	_	_
102	the	_	_	_	_	_	_	_	BeginSeg=Yes
103	proposed	_	_	_	_	_	_	_	_
104	approach	_	_	_	_	_	_	_	_
105	is	_	_	_	_	_	_	_	_
106	an	_	_	_	_	_	_	_	_
107	easy	_	_	_	_	_	_	_	_
108	to	_	_	_	_	_	_	_	_
109	implement	_	_	_	_	_	_	_	_
110	framework	_	_	_	_	_	_	_	_
111	accounting	_	_	_	_	_	_	_	BeginSeg=Yes
112	for	_	_	_	_	_	_	_	_
113	limitations	_	_	_	_	_	_	_	_
114	of	_	_	_	_	_	_	_	_
115	the	_	_	_	_	_	_	_	_
116	data	_	_	_	_	_	_	_	_
117	inherent	_	_	_	_	_	_	_	BeginSeg=Yes
118	in	_	_	_	_	_	_	_	_
119	the	_	_	_	_	_	_	_	_
120	current	_	_	_	_	_	_	_	_
121	epidemic	_	_	_	_	_	_	_	_
122	.	_	_	_	_	_	_	_	_
123	Hospital	_	_	_	_	_	_	_	BeginSeg=Yes
124	administrators	_	_	_	_	_	_	_	_
125	and	_	_	_	_	_	_	_	_
126	policy	_	_	_	_	_	_	_	_
127	makers	_	_	_	_	_	_	_	_
128	may	_	_	_	_	_	_	_	_
129	benefit	_	_	_	_	_	_	_	_
130	from	_	_	_	_	_	_	_	_
131	incorporating	_	_	_	_	_	_	_	_
132	this	_	_	_	_	_	_	_	_
133	approach	_	_	_	_	_	_	_	_
134	into	_	_	_	_	_	_	_	_
135	their	_	_	_	_	_	_	_	_
136	decision	_	_	_	_	_	_	_	_
137	making	_	_	_	_	_	_	_	_
138	.	_	_	_	_	_	_	_	_

# newdoc_id = 6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c
1	Severe	_	_	_	_	_	_	_	BeginSeg=Yes
2	acute	_	_	_	_	_	_	_	_
3	respiratory	_	_	_	_	_	_	_	_
4	syndrome	_	_	_	_	_	_	_	_
5	coronavirus	_	_	_	_	_	_	_	_
6	2	_	_	_	_	_	_	_	_
7	(	_	_	_	_	_	_	_	_
8	SARS	_	_	_	_	_	_	_	_
9	-	_	_	_	_	_	_	_	_
10	CoV-2	_	_	_	_	_	_	_	_
11	)	_	_	_	_	_	_	_	_
12	caused	_	_	_	_	_	_	_	_
13	the	_	_	_	_	_	_	_	_
14	COVID-19	_	_	_	_	_	_	_	_
15	pandemic	_	_	_	_	_	_	_	_
16	that	_	_	_	_	_	_	_	BeginSeg=Yes
17	has	_	_	_	_	_	_	_	_
18	been	_	_	_	_	_	_	_	_
19	spreading	_	_	_	_	_	_	_	_
20	around	_	_	_	_	_	_	_	_
21	the	_	_	_	_	_	_	_	_
22	world	_	_	_	_	_	_	_	_
23	since	_	_	_	_	_	_	_	_
24	December	_	_	_	_	_	_	_	_
25	2019	_	_	_	_	_	_	_	_
26	.	_	_	_	_	_	_	_	_
27	More	_	_	_	_	_	_	_	BeginSeg=Yes
28	than	_	_	_	_	_	_	_	_
29	10	_	_	_	_	_	_	_	_
30	million	_	_	_	_	_	_	_	_
31	affected	_	_	_	_	_	_	_	_
32	cases	_	_	_	_	_	_	_	_
33	and	_	_	_	_	_	_	_	_
34	more	_	_	_	_	_	_	_	_
35	than	_	_	_	_	_	_	_	_
36	half	_	_	_	_	_	_	_	_
37	a	_	_	_	_	_	_	_	_
38	million	_	_	_	_	_	_	_	_
39	deaths	_	_	_	_	_	_	_	_
40	have	_	_	_	_	_	_	_	_
41	been	_	_	_	_	_	_	_	_
42	reported	_	_	_	_	_	_	_	_
43	so	_	_	_	_	_	_	_	_
44	far	_	_	_	_	_	_	_	_
45	,	_	_	_	_	_	_	_	_
46	while	_	_	_	_	_	_	_	BeginSeg=Yes
47	no	_	_	_	_	_	_	_	_
48	vaccine	_	_	_	_	_	_	_	_
49	is	_	_	_	_	_	_	_	_
50	yet	_	_	_	_	_	_	_	_
51	available	_	_	_	_	_	_	_	_
52	as	_	_	_	_	_	_	_	_
53	a	_	_	_	_	_	_	_	_
54	treatment	_	_	_	_	_	_	_	_
55	.	_	_	_	_	_	_	_	_
56	Considering	_	_	_	_	_	_	_	BeginSeg=Yes
57	the	_	_	_	_	_	_	_	_
58	global	_	_	_	_	_	_	_	_
59	healthcare	_	_	_	_	_	_	_	_
60	urgency	_	_	_	_	_	_	_	_
61	,	_	_	_	_	_	_	_	_
62	several	_	_	_	_	_	_	_	BeginSeg=Yes
63	techniques	_	_	_	_	_	_	_	_
64	,	_	_	_	_	_	_	_	_
65	including	_	_	_	_	_	_	_	BeginSeg=Yes
66	whole	_	_	_	_	_	_	_	_
67	genome	_	_	_	_	_	_	_	_
68	sequencing	_	_	_	_	_	_	_	_
69	and	_	_	_	_	_	_	_	_
70	computed	_	_	_	_	_	_	_	_
71	tomography	_	_	_	_	_	_	_	_
72	imaging	_	_	_	_	_	_	_	_
73	have	_	_	_	_	_	_	_	BeginSeg=Yes
74	been	_	_	_	_	_	_	_	_
75	employed	_	_	_	_	_	_	_	_
76	for	_	_	_	_	_	_	_	BeginSeg=Yes
77	diagnosing	_	_	_	_	_	_	_	_
78	infected	_	_	_	_	_	_	_	_
79	people	_	_	_	_	_	_	_	_
80	.	_	_	_	_	_	_	_	_
81	Considerable	_	_	_	_	_	_	_	BeginSeg=Yes
82	efforts	_	_	_	_	_	_	_	_
83	are	_	_	_	_	_	_	_	_
84	also	_	_	_	_	_	_	_	_
85	directed	_	_	_	_	_	_	_	_
86	at	_	_	_	_	_	_	_	_
87	detecting	_	_	_	_	_	_	_	_
88	and	_	_	_	_	_	_	_	_
89	preventing	_	_	_	_	_	_	_	_
90	different	_	_	_	_	_	_	_	_
91	modes	_	_	_	_	_	_	_	_
92	of	_	_	_	_	_	_	_	_
93	community	_	_	_	_	_	_	_	_
94	transmission	_	_	_	_	_	_	_	_
95	.	_	_	_	_	_	_	_	_
96	Among	_	_	_	_	_	_	_	BeginSeg=Yes
97	them	_	_	_	_	_	_	_	_
98	is	_	_	_	_	_	_	_	_
99	the	_	_	_	_	_	_	_	_
100	rapid	_	_	_	_	_	_	_	_
101	detection	_	_	_	_	_	_	_	_
102	of	_	_	_	_	_	_	_	_
103	virus	_	_	_	_	_	_	_	_
104	presence	_	_	_	_	_	_	_	_
105	on	_	_	_	_	_	_	_	_
106	different	_	_	_	_	_	_	_	_
107	surfaces	_	_	_	_	_	_	_	_
108	with	_	_	_	_	_	_	_	BeginSeg=Yes
109	which	_	_	_	_	_	_	_	_
110	people	_	_	_	_	_	_	_	_
111	may	_	_	_	_	_	_	_	_
112	come	_	_	_	_	_	_	_	_
113	in	_	_	_	_	_	_	_	_
114	contact	_	_	_	_	_	_	_	_
115	.	_	_	_	_	_	_	_	_
116	Detection	_	_	_	_	_	_	_	BeginSeg=Yes
117	based	_	_	_	_	_	_	_	BeginSeg=Yes
118	on	_	_	_	_	_	_	_	_
119	non	_	_	_	_	_	_	_	_
120	-	_	_	_	_	_	_	_	_
121	contact	_	_	_	_	_	_	_	_
122	optical	_	_	_	_	_	_	_	_
123	techniques	_	_	_	_	_	_	_	_
124	is	_	_	_	_	_	_	_	BeginSeg=Yes
125	very	_	_	_	_	_	_	_	_
126	helpful	_	_	_	_	_	_	_	_
127	in	_	_	_	_	_	_	_	_
128	managing	_	_	_	_	_	_	_	_
129	the	_	_	_	_	_	_	_	_
130	spread	_	_	_	_	_	_	_	_
131	of	_	_	_	_	_	_	_	_
132	the	_	_	_	_	_	_	_	_
133	virus	_	_	_	_	_	_	_	_
134	,	_	_	_	_	_	_	_	_
135	and	_	_	_	_	_	_	_	_
136	to	_	_	_	_	_	_	_	_
137	aid	_	_	_	_	_	_	_	_
138	in	_	_	_	_	_	_	_	_
139	the	_	_	_	_	_	_	_	_
140	disinfection	_	_	_	_	_	_	_	_
141	of	_	_	_	_	_	_	_	_
142	surfaces	_	_	_	_	_	_	_	_
143	.	_	_	_	_	_	_	_	_
144	Nanomaterial	_	_	_	_	_	_	_	BeginSeg=Yes
145	-	_	_	_	_	_	_	_	_
146	based	_	_	_	_	_	_	_	_
147	methods	_	_	_	_	_	_	_	_
148	are	_	_	_	_	_	_	_	_
149	proven	_	_	_	_	_	_	_	_
150	suitable	_	_	_	_	_	_	_	_
151	for	_	_	_	_	_	_	_	_
152	rapid	_	_	_	_	_	_	_	_
153	detection	_	_	_	_	_	_	_	_
154	.	_	_	_	_	_	_	_	_
155	Given	_	_	_	_	_	_	_	BeginSeg=Yes
156	the	_	_	_	_	_	_	_	_
157	immense	_	_	_	_	_	_	_	_
158	need	_	_	_	_	_	_	_	_
159	for	_	_	_	_	_	_	_	_
160	science	_	_	_	_	_	_	_	_
161	led	_	_	_	_	_	_	_	_
162	innovative	_	_	_	_	_	_	_	_
163	solutions	_	_	_	_	_	_	_	_
164	,	_	_	_	_	_	_	_	_
165	this	_	_	_	_	_	_	_	BeginSeg=Yes
166	manuscript	_	_	_	_	_	_	_	_
167	critically	_	_	_	_	_	_	_	_
168	reviews	_	_	_	_	_	_	_	_
169	recent	_	_	_	_	_	_	_	_
170	literature	_	_	_	_	_	_	_	_
171	to	_	_	_	_	_	_	_	BeginSeg=Yes
172	specifically	_	_	_	_	_	_	_	_
173	illustrate	_	_	_	_	_	_	_	_
174	nano	_	_	_	_	_	_	_	_
175	-	_	_	_	_	_	_	_	_
176	engineered	_	_	_	_	_	_	_	_
177	effective	_	_	_	_	_	_	_	_
178	and	_	_	_	_	_	_	_	_
179	rapid	_	_	_	_	_	_	_	_
180	solutions	_	_	_	_	_	_	_	_
181	.	_	_	_	_	_	_	_	_
182	In	_	_	_	_	_	_	_	BeginSeg=Yes
183	addition	_	_	_	_	_	_	_	_
184	,	_	_	_	_	_	_	_	_
185	all	_	_	_	_	_	_	_	_
186	the	_	_	_	_	_	_	_	_
187	different	_	_	_	_	_	_	_	_
188	techniques	_	_	_	_	_	_	_	_
189	are	_	_	_	_	_	_	_	_
190	critically	_	_	_	_	_	_	_	_
191	analyzed	_	_	_	_	_	_	_	_
192	,	_	_	_	_	_	_	_	_
193	compared	_	_	_	_	_	_	_	BeginSeg=Yes
194	,	_	_	_	_	_	_	_	_
195	and	_	_	_	_	_	_	_	BeginSeg=Yes
196	contrasted	_	_	_	_	_	_	_	_
197	to	_	_	_	_	_	_	_	BeginSeg=Yes
198	identify	_	_	_	_	_	_	_	_
199	the	_	_	_	_	_	_	_	_
200	most	_	_	_	_	_	_	_	_
201	promising	_	_	_	_	_	_	_	_
202	methods	_	_	_	_	_	_	_	_
203	.	_	_	_	_	_	_	_	_
204	Moreover	_	_	_	_	_	_	_	BeginSeg=Yes
205	,	_	_	_	_	_	_	_	_
206	promising	_	_	_	_	_	_	_	_
207	research	_	_	_	_	_	_	_	_
208	ideas	_	_	_	_	_	_	_	_
209	for	_	_	_	_	_	_	_	_
210	high	_	_	_	_	_	_	_	_
211	accuracy	_	_	_	_	_	_	_	_
212	of	_	_	_	_	_	_	_	_
213	detection	_	_	_	_	_	_	_	_
214	in	_	_	_	_	_	_	_	_
215	trace	_	_	_	_	_	_	_	_
216	concentrations	_	_	_	_	_	_	_	_
217	,	_	_	_	_	_	_	_	_
218	via	_	_	_	_	_	_	_	_
219	color	_	_	_	_	_	_	_	_
220	change	_	_	_	_	_	_	_	_
221	and	_	_	_	_	_	_	_	_
222	light	_	_	_	_	_	_	_	_
223	-	_	_	_	_	_	_	_	_
224	sensitive	_	_	_	_	_	_	_	_
225	nanostructures	_	_	_	_	_	_	_	_
226	,	_	_	_	_	_	_	_	_
227	to	_	_	_	_	_	_	_	BeginSeg=Yes
228	assist	_	_	_	_	_	_	_	_
229	fingerprint	_	_	_	_	_	_	_	_
230	techniques	_	_	_	_	_	_	_	_
231	(	_	_	_	_	_	_	_	BeginSeg=Yes
232	to	_	_	_	_	_	_	_	_
233	identify	_	_	_	_	_	_	_	_
234	the	_	_	_	_	_	_	_	_
235	virus	_	_	_	_	_	_	_	_
236	at	_	_	_	_	_	_	_	_
237	the	_	_	_	_	_	_	_	_
238	contact	_	_	_	_	_	_	_	_
239	surface	_	_	_	_	_	_	_	_
240	of	_	_	_	_	_	_	_	_
241	the	_	_	_	_	_	_	_	_
242	gas	_	_	_	_	_	_	_	_
243	and	_	_	_	_	_	_	_	_
244	solid	_	_	_	_	_	_	_	_
245	phase	_	_	_	_	_	_	_	_
246	)	_	_	_	_	_	_	_	_
247	are	_	_	_	_	_	_	_	BeginSeg=Yes
248	also	_	_	_	_	_	_	_	_
249	presented	_	_	_	_	_	_	_	_
250	.	_	_	_	_	_	_	_	_

# newdoc_id = 6e704c9d3e78ca76678b668e56990e6a02c0e966
1	We	_	_	_	_	_	_	_	BeginSeg=Yes
2	argue	_	_	_	_	_	_	_	_
3	that	_	_	_	_	_	_	_	BeginSeg=Yes
4	the	_	_	_	_	_	_	_	_
5	incentive	_	_	_	_	_	_	_	_
6	structure	_	_	_	_	_	_	_	_
7	of	_	_	_	_	_	_	_	_
8	all	_	_	_	_	_	_	_	_
9	individual	_	_	_	_	_	_	_	_
10	and	_	_	_	_	_	_	_	_
11	coordinated	_	_	_	_	_	_	_	_
12	measures	_	_	_	_	_	_	_	_
13	across	_	_	_	_	_	_	_	_
14	countries	_	_	_	_	_	_	_	_
15	to	_	_	_	_	_	_	_	BeginSeg=Yes
16	contain	_	_	_	_	_	_	_	_
17	the	_	_	_	_	_	_	_	_
18	corona	_	_	_	_	_	_	_	_
19	-	_	_	_	_	_	_	_	_
20	pandemic	_	_	_	_	_	_	_	_
21	is	_	_	_	_	_	_	_	BeginSeg=Yes
22	that	_	_	_	_	_	_	_	_
23	of	_	_	_	_	_	_	_	_
24	a	_	_	_	_	_	_	_	_
25	weakest	_	_	_	_	_	_	_	_
26	-	_	_	_	_	_	_	_	_
27	link	_	_	_	_	_	_	_	_
28	public	_	_	_	_	_	_	_	_
29	good	_	_	_	_	_	_	_	_
30	game	_	_	_	_	_	_	_	_
31	.	_	_	_	_	_	_	_	_
32	We	_	_	_	_	_	_	_	BeginSeg=Yes
33	discuss	_	_	_	_	_	_	_	_
34	a	_	_	_	_	_	_	_	_
35	selection	_	_	_	_	_	_	_	_
36	of	_	_	_	_	_	_	_	_
37	theoretical	_	_	_	_	_	_	_	_
38	and	_	_	_	_	_	_	_	_
39	experimental	_	_	_	_	_	_	_	_
40	key	_	_	_	_	_	_	_	_
41	results	_	_	_	_	_	_	_	_
42	of	_	_	_	_	_	_	_	_
43	weakest	_	_	_	_	_	_	_	_
44	-	_	_	_	_	_	_	_	_
45	link	_	_	_	_	_	_	_	_
46	games	_	_	_	_	_	_	_	_
47	and	_	_	_	_	_	_	_	BeginSeg=Yes
48	interpret	_	_	_	_	_	_	_	_
49	them	_	_	_	_	_	_	_	_
50	in	_	_	_	_	_	_	_	_
51	the	_	_	_	_	_	_	_	_
52	light	_	_	_	_	_	_	_	_
53	of	_	_	_	_	_	_	_	_
54	the	_	_	_	_	_	_	_	_
55	corona	_	_	_	_	_	_	_	_
56	-	_	_	_	_	_	_	_	_
57	pandemic	_	_	_	_	_	_	_	_
58	.	_	_	_	_	_	_	_	_
59	First	_	_	_	_	_	_	_	BeginSeg=Yes
60	,	_	_	_	_	_	_	_	_
61	we	_	_	_	_	_	_	_	_
62	highlight	_	_	_	_	_	_	_	_
63	that	_	_	_	_	_	_	_	BeginSeg=Yes
64	experimental	_	_	_	_	_	_	_	_
65	evidence	_	_	_	_	_	_	_	_
66	does	_	_	_	_	_	_	_	_
67	not	_	_	_	_	_	_	_	_
68	support	_	_	_	_	_	_	_	_
69	the	_	_	_	_	_	_	_	_
70	assumption	_	_	_	_	_	_	_	_
71	that	_	_	_	_	_	_	_	BeginSeg=Yes
72	coordination	_	_	_	_	_	_	_	_
73	can	_	_	_	_	_	_	_	_
74	be	_	_	_	_	_	_	_	_
75	trivially	_	_	_	_	_	_	_	_
76	solved	_	_	_	_	_	_	_	_
77	,	_	_	_	_	_	_	_	_
78	even	_	_	_	_	_	_	_	_
79	among	_	_	_	_	_	_	_	_
80	symmetric	_	_	_	_	_	_	_	_
81	players	_	_	_	_	_	_	_	_
82	.	_	_	_	_	_	_	_	_
83	Second	_	_	_	_	_	_	_	BeginSeg=Yes
84	,	_	_	_	_	_	_	_	_
85	we	_	_	_	_	_	_	_	_
86	argue	_	_	_	_	_	_	_	_
87	that	_	_	_	_	_	_	_	BeginSeg=Yes
88	for	_	_	_	_	_	_	_	_
89	asymmetric	_	_	_	_	_	_	_	_
90	countries	_	_	_	_	_	_	_	_
91	the	_	_	_	_	_	_	_	_
92	weakest	_	_	_	_	_	_	_	_
93	-	_	_	_	_	_	_	_	_
94	link	_	_	_	_	_	_	_	_
95	game	_	_	_	_	_	_	_	_
96	does	_	_	_	_	_	_	_	_
97	not	_	_	_	_	_	_	_	_
98	only	_	_	_	_	_	_	_	_
99	pose	_	_	_	_	_	_	_	_
100	a	_	_	_	_	_	_	_	_
101	problem	_	_	_	_	_	_	_	_
102	of	_	_	_	_	_	_	_	_
103	coordination	_	_	_	_	_	_	_	_
104	,	_	_	_	_	_	_	_	_
105	but	_	_	_	_	_	_	_	BeginSeg=Yes
106	also	_	_	_	_	_	_	_	_
107	a	_	_	_	_	_	_	_	_
108	problem	_	_	_	_	_	_	_	_
109	of	_	_	_	_	_	_	_	_
110	cooperation	_	_	_	_	_	_	_	_
111	.	_	_	_	_	_	_	_	_
112	Third	_	_	_	_	_	_	_	BeginSeg=Yes
113	,	_	_	_	_	_	_	_	_
114	we	_	_	_	_	_	_	_	_
115	show	_	_	_	_	_	_	_	_
116	how	_	_	_	_	_	_	_	BeginSeg=Yes
117	and	_	_	_	_	_	_	_	_
118	under	_	_	_	_	_	_	_	_
119	which	_	_	_	_	_	_	_	_
120	conditions	_	_	_	_	_	_	_	_
121	self	_	_	_	_	_	_	_	_
122	-	_	_	_	_	_	_	_	_
123	enforcing	_	_	_	_	_	_	_	_
124	treaties	_	_	_	_	_	_	_	_
125	can	_	_	_	_	_	_	_	_
126	foster	_	_	_	_	_	_	_	_
127	coordination	_	_	_	_	_	_	_	_
128	and	_	_	_	_	_	_	_	_
129	cooperation	_	_	_	_	_	_	_	_
130	.	_	_	_	_	_	_	_	_
131	We	_	_	_	_	_	_	_	BeginSeg=Yes
132	account	_	_	_	_	_	_	_	_
133	for	_	_	_	_	_	_	_	_
134	the	_	_	_	_	_	_	_	_
135	possibility	_	_	_	_	_	_	_	_
136	that	_	_	_	_	_	_	_	BeginSeg=Yes
137	countries	_	_	_	_	_	_	_	_
138	make	_	_	_	_	_	_	_	_
139	mistakes	_	_	_	_	_	_	_	_
140	when	_	_	_	_	_	_	_	BeginSeg=Yes
141	choosing	_	_	_	_	_	_	_	_
142	their	_	_	_	_	_	_	_	_
143	actions	_	_	_	_	_	_	_	_
144	.	_	_	_	_	_	_	_	_
145	Our	_	_	_	_	_	_	_	BeginSeg=Yes
146	discussion	_	_	_	_	_	_	_	_
147	shows	_	_	_	_	_	_	_	_
148	that	_	_	_	_	_	_	_	BeginSeg=Yes
149	North	_	_	_	_	_	_	_	_
150	-	_	_	_	_	_	_	_	_
151	South	_	_	_	_	_	_	_	_
152	cooperation	_	_	_	_	_	_	_	_
153	is	_	_	_	_	_	_	_	_
154	relevant	_	_	_	_	_	_	_	_
155	and	_	_	_	_	_	_	_	BeginSeg=Yes
156	likely	_	_	_	_	_	_	_	_
157	to	_	_	_	_	_	_	_	_
158	be	_	_	_	_	_	_	_	_
159	self	_	_	_	_	_	_	_	_
160	-	_	_	_	_	_	_	_	_
161	enforcing	_	_	_	_	_	_	_	_
162	and	_	_	_	_	_	_	_	BeginSeg=Yes
163	that	_	_	_	_	_	_	_	_
164	regional	_	_	_	_	_	_	_	_
165	cooperation	_	_	_	_	_	_	_	_
166	,	_	_	_	_	_	_	_	_
167	e.g.	_	_	_	_	_	_	_	BeginSeg=Yes
168	,	_	_	_	_	_	_	_	_
169	within	_	_	_	_	_	_	_	_
170	the	_	_	_	_	_	_	_	_
171	EU	_	_	_	_	_	_	_	_
172	,	_	_	_	_	_	_	_	_
173	will	_	_	_	_	_	_	_	BeginSeg=Yes
174	also	_	_	_	_	_	_	_	_
175	be	_	_	_	_	_	_	_	_
176	important	_	_	_	_	_	_	_	_
177	.	_	_	_	_	_	_	_	_

# newdoc_id = 714d9af12264fb74a536d77b974cbd6ad65f44e2
1	Severe	_	_	_	_	_	_	_	BeginSeg=Yes
2	Acute	_	_	_	_	_	_	_	_
3	Respiratory	_	_	_	_	_	_	_	_
4	Syndrome	_	_	_	_	_	_	_	_
5	Coronavirus-2	_	_	_	_	_	_	_	_
6	(	_	_	_	_	_	_	_	_
7	SARS	_	_	_	_	_	_	_	_
8	-	_	_	_	_	_	_	_	_
9	CoV-2	_	_	_	_	_	_	_	_
10	)	_	_	_	_	_	_	_	_
11	has	_	_	_	_	_	_	_	_
12	recently	_	_	_	_	_	_	_	_
13	caused	_	_	_	_	_	_	_	_
14	a	_	_	_	_	_	_	_	_
15	pandemic	_	_	_	_	_	_	_	_
16	that	_	_	_	_	_	_	_	BeginSeg=Yes
17	has	_	_	_	_	_	_	_	_
18	involved	_	_	_	_	_	_	_	_
19	Italy	_	_	_	_	_	_	_	_
20	as	_	_	_	_	_	_	_	_
21	the	_	_	_	_	_	_	_	_
22	second	_	_	_	_	_	_	_	_
23	worldwide	_	_	_	_	_	_	_	_
24	nation	_	_	_	_	_	_	_	_
25	in	_	_	_	_	_	_	_	_
26	terms	_	_	_	_	_	_	_	_
27	of	_	_	_	_	_	_	_	_
28	infected	_	_	_	_	_	_	_	_
29	patients	_	_	_	_	_	_	_	_
30	and	_	_	_	_	_	_	_	_
31	deaths	_	_	_	_	_	_	_	_
32	.	_	_	_	_	_	_	_	_
33	The	_	_	_	_	_	_	_	BeginSeg=Yes
34	clinical	_	_	_	_	_	_	_	_
35	manifestation	_	_	_	_	_	_	_	_
36	of	_	_	_	_	_	_	_	_
37	Covid-19	_	_	_	_	_	_	_	_
38	ranges	_	_	_	_	_	_	_	_
39	from	_	_	_	_	_	_	_	_
40	asymptomatic	_	_	_	_	_	_	_	_
41	carrier	_	_	_	_	_	_	_	_
42	status	_	_	_	_	_	_	_	_
43	to	_	_	_	_	_	_	_	_
44	severe	_	_	_	_	_	_	_	_
45	pneumonia	_	_	_	_	_	_	_	_
46	.	_	_	_	_	_	_	_	_
47	Asymptomatic	_	_	_	_	_	_	_	BeginSeg=Yes
48	individuals	_	_	_	_	_	_	_	_
49	in	_	_	_	_	_	_	_	_
50	Covid-19	_	_	_	_	_	_	_	_
51	are	_	_	_	_	_	_	_	_
52	those	_	_	_	_	_	_	_	_
53	who	_	_	_	_	_	_	_	BeginSeg=Yes
54	are	_	_	_	_	_	_	_	_
55	carriers	_	_	_	_	_	_	_	_
56	of	_	_	_	_	_	_	_	_
57	the	_	_	_	_	_	_	_	_
58	virus	_	_	_	_	_	_	_	_
59	but	_	_	_	_	_	_	_	BeginSeg=Yes
60	do	_	_	_	_	_	_	_	_
61	not	_	_	_	_	_	_	_	_
62	show	_	_	_	_	_	_	_	_
63	clinical	_	_	_	_	_	_	_	_
64	symptoms	_	_	_	_	_	_	_	_
65	and	_	_	_	_	_	_	_	BeginSeg=Yes
66	are	_	_	_	_	_	_	_	_
67	able	_	_	_	_	_	_	_	_
68	to	_	_	_	_	_	_	_	_
69	transmit	_	_	_	_	_	_	_	_
70	the	_	_	_	_	_	_	_	_
71	disease	_	_	_	_	_	_	_	_
72	in	_	_	_	_	_	_	_	_
73	the	_	_	_	_	_	_	_	_
74	same	_	_	_	_	_	_	_	_
75	degree	_	_	_	_	_	_	_	_
76	as	_	_	_	_	_	_	_	_
77	symptomatic	_	_	_	_	_	_	_	_
78	carriers	_	_	_	_	_	_	_	_
79	.	_	_	_	_	_	_	_	_
80	In	_	_	_	_	_	_	_	BeginSeg=Yes
81	order	_	_	_	_	_	_	_	_
82	to	_	_	_	_	_	_	_	_
83	contain	_	_	_	_	_	_	_	_
84	contagions	_	_	_	_	_	_	_	_
85	is	_	_	_	_	_	_	_	BeginSeg=Yes
86	of	_	_	_	_	_	_	_	_
87	supreme	_	_	_	_	_	_	_	_
88	importance	_	_	_	_	_	_	_	_
89	to	_	_	_	_	_	_	_	_
90	identify	_	_	_	_	_	_	_	_
91	asymptomatic	_	_	_	_	_	_	_	_
92	patients	_	_	_	_	_	_	_	_
93	because	_	_	_	_	_	_	_	BeginSeg=Yes
94	this	_	_	_	_	_	_	_	_
95	subpopulation	_	_	_	_	_	_	_	_
96	is	_	_	_	_	_	_	_	_
97	one	_	_	_	_	_	_	_	_
98	of	_	_	_	_	_	_	_	_
99	the	_	_	_	_	_	_	_	_
100	main	_	_	_	_	_	_	_	_
101	factors	_	_	_	_	_	_	_	_
102	contributing	_	_	_	_	_	_	_	BeginSeg=Yes
103	to	_	_	_	_	_	_	_	_
104	the	_	_	_	_	_	_	_	_
105	spread	_	_	_	_	_	_	_	_
106	of	_	_	_	_	_	_	_	_
107	this	_	_	_	_	_	_	_	_
108	disease	_	_	_	_	_	_	_	_
109	.	_	_	_	_	_	_	_	_
110	We	_	_	_	_	_	_	_	BeginSeg=Yes
111	report	_	_	_	_	_	_	_	_
112	on	_	_	_	_	_	_	_	_
113	six	_	_	_	_	_	_	_	_
114	Italian	_	_	_	_	_	_	_	_
115	patients	_	_	_	_	_	_	_	_
116	with	_	_	_	_	_	_	_	_
117	COVID-19	_	_	_	_	_	_	_	_
118	who	_	_	_	_	_	_	_	BeginSeg=Yes
119	presented	_	_	_	_	_	_	_	_
120	sudden	_	_	_	_	_	_	_	_
121	hyposmia	_	_	_	_	_	_	_	_
122	as	_	_	_	_	_	_	_	_
123	the	_	_	_	_	_	_	_	_
124	only	_	_	_	_	_	_	_	_
125	or	_	_	_	_	_	_	_	_
126	most	_	_	_	_	_	_	_	_
127	prominent	_	_	_	_	_	_	_	_
128	disease	_	_	_	_	_	_	_	_
129	manifestation	_	_	_	_	_	_	_	_
130	,	_	_	_	_	_	_	_	_
131	without	_	_	_	_	_	_	_	_
132	upper	_	_	_	_	_	_	_	_
133	or	_	_	_	_	_	_	_	_
134	lower	_	_	_	_	_	_	_	_
135	respiratory	_	_	_	_	_	_	_	_
136	tract	_	_	_	_	_	_	_	_
137	involvement	_	_	_	_	_	_	_	_
138	or	_	_	_	_	_	_	_	_
139	other	_	_	_	_	_	_	_	_
140	major	_	_	_	_	_	_	_	_
141	features	_	_	_	_	_	_	_	_
142	of	_	_	_	_	_	_	_	_
143	the	_	_	_	_	_	_	_	_
144	disease	_	_	_	_	_	_	_	_
145	.	_	_	_	_	_	_	_	_
146	A	_	_	_	_	_	_	_	BeginSeg=Yes
147	supra	_	_	_	_	_	_	_	_
148	-	_	_	_	_	_	_	_	_
149	threshold	_	_	_	_	_	_	_	_
150	olfaction	_	_	_	_	_	_	_	_
151	test	_	_	_	_	_	_	_	_
152	confirmed	_	_	_	_	_	_	_	_
153	the	_	_	_	_	_	_	_	_
154	hyposmia	_	_	_	_	_	_	_	_
155	in	_	_	_	_	_	_	_	_
156	all	_	_	_	_	_	_	_	_
157	patients	_	_	_	_	_	_	_	_
158	.	_	_	_	_	_	_	_	_

# newdoc_id = 74c27dd895ee9f14d0b9584b8a3551a0600f05e2
1	Plant	_	_	_	_	_	_	_	BeginSeg=Yes
2	artificial	_	_	_	_	_	_	_	_
3	micro	_	_	_	_	_	_	_	_
4	-	_	_	_	_	_	_	_	_
5	RNAs	_	_	_	_	_	_	_	_
6	(	_	_	_	_	_	_	_	_
7	amiRs	_	_	_	_	_	_	_	_
8	)	_	_	_	_	_	_	_	_
9	have	_	_	_	_	_	_	_	_
10	been	_	_	_	_	_	_	_	_
11	engineered	_	_	_	_	_	_	_	_
12	to	_	_	_	_	_	_	_	BeginSeg=Yes
13	target	_	_	_	_	_	_	_	_
14	viral	_	_	_	_	_	_	_	_
15	genomes	_	_	_	_	_	_	_	_
16	and	_	_	_	_	_	_	_	BeginSeg=Yes
17	induce	_	_	_	_	_	_	_	_
18	their	_	_	_	_	_	_	_	_
19	degradation	_	_	_	_	_	_	_	_
20	.	_	_	_	_	_	_	_	_
21	However	_	_	_	_	_	_	_	BeginSeg=Yes
22	,	_	_	_	_	_	_	_	_
23	the	_	_	_	_	_	_	_	_
24	exceptional	_	_	_	_	_	_	_	_
25	evolutionary	_	_	_	_	_	_	_	_
26	plasticity	_	_	_	_	_	_	_	_
27	of	_	_	_	_	_	_	_	_
28	RNA	_	_	_	_	_	_	_	_
29	viruses	_	_	_	_	_	_	_	_
30	threatens	_	_	_	_	_	_	_	_
31	the	_	_	_	_	_	_	_	_
32	durability	_	_	_	_	_	_	_	_
33	of	_	_	_	_	_	_	_	_
34	the	_	_	_	_	_	_	_	_
35	resistance	_	_	_	_	_	_	_	_
36	conferred	_	_	_	_	_	_	_	BeginSeg=Yes
37	by	_	_	_	_	_	_	_	_
38	these	_	_	_	_	_	_	_	_
39	amiRs	_	_	_	_	_	_	_	_
40	.	_	_	_	_	_	_	_	_
41	It	_	_	_	_	_	_	_	BeginSeg=Yes
42	has	_	_	_	_	_	_	_	_
43	recently	_	_	_	_	_	_	_	_
44	been	_	_	_	_	_	_	_	_
45	shown	_	_	_	_	_	_	_	_
46	that	_	_	_	_	_	_	_	_
47	viral	_	_	_	_	_	_	_	_
48	populations	_	_	_	_	_	_	_	_
49	not	_	_	_	_	_	_	_	BeginSeg=Yes
50	experiencing	_	_	_	_	_	_	_	_
51	strong	_	_	_	_	_	_	_	_
52	selective	_	_	_	_	_	_	_	_
53	pressure	_	_	_	_	_	_	_	_
54	from	_	_	_	_	_	_	_	_
55	an	_	_	_	_	_	_	_	_
56	antiviral	_	_	_	_	_	_	_	_
57	amiR	_	_	_	_	_	_	_	_
58	may	_	_	_	_	_	_	_	BeginSeg=Yes
59	already	_	_	_	_	_	_	_	_
60	contain	_	_	_	_	_	_	_	_
61	enough	_	_	_	_	_	_	_	_
62	genetic	_	_	_	_	_	_	_	_
63	variability	_	_	_	_	_	_	_	_
64	in	_	_	_	_	_	_	_	_
65	the	_	_	_	_	_	_	_	_
66	target	_	_	_	_	_	_	_	_
67	sequence	_	_	_	_	_	_	_	_
68	to	_	_	_	_	_	_	_	BeginSeg=Yes
69	escape	_	_	_	_	_	_	_	_
70	plant	_	_	_	_	_	_	_	_
71	resistance	_	_	_	_	_	_	_	_
72	in	_	_	_	_	_	_	_	_
73	an	_	_	_	_	_	_	_	_
74	almost	_	_	_	_	_	_	_	_
75	deterministic	_	_	_	_	_	_	_	_
76	manner	_	_	_	_	_	_	_	_
77	.	_	_	_	_	_	_	_	_
78	Furthermore	_	_	_	_	_	_	_	BeginSeg=Yes
79	,	_	_	_	_	_	_	_	_
80	it	_	_	_	_	_	_	_	_
81	has	_	_	_	_	_	_	_	_
82	also	_	_	_	_	_	_	_	_
83	been	_	_	_	_	_	_	_	_
84	shown	_	_	_	_	_	_	_	_
85	that	_	_	_	_	_	_	_	_
86	viral	_	_	_	_	_	_	_	_
87	populations	_	_	_	_	_	_	_	_
88	exposed	_	_	_	_	_	_	_	BeginSeg=Yes
89	to	_	_	_	_	_	_	_	_
90	subinhibitory	_	_	_	_	_	_	_	_
91	concentrations	_	_	_	_	_	_	_	_
92	of	_	_	_	_	_	_	_	_
93	the	_	_	_	_	_	_	_	_
94	antiviral	_	_	_	_	_	_	_	_
95	amiR	_	_	_	_	_	_	_	_
96	speed	_	_	_	_	_	_	_	BeginSeg=Yes
97	up	_	_	_	_	_	_	_	_
98	this	_	_	_	_	_	_	_	_
99	process	_	_	_	_	_	_	_	_
100	.	_	_	_	_	_	_	_	_
101	In	_	_	_	_	_	_	_	BeginSeg=Yes
102	this	_	_	_	_	_	_	_	_
103	article	_	_	_	_	_	_	_	_
104	,	_	_	_	_	_	_	_	_
105	we	_	_	_	_	_	_	_	_
106	have	_	_	_	_	_	_	_	_
107	characterized	_	_	_	_	_	_	_	_
108	the	_	_	_	_	_	_	_	_
109	molecular	_	_	_	_	_	_	_	_
110	evolutionary	_	_	_	_	_	_	_	_
111	dynamics	_	_	_	_	_	_	_	_
112	of	_	_	_	_	_	_	_	_
113	an	_	_	_	_	_	_	_	_
114	amiR	_	_	_	_	_	_	_	_
115	target	_	_	_	_	_	_	_	_
116	sequence	_	_	_	_	_	_	_	_
117	in	_	_	_	_	_	_	_	_
118	a	_	_	_	_	_	_	_	_
119	viral	_	_	_	_	_	_	_	_
120	genome	_	_	_	_	_	_	_	_
121	under	_	_	_	_	_	_	_	_
122	both	_	_	_	_	_	_	_	_
123	conditions	_	_	_	_	_	_	_	_
124	.	_	_	_	_	_	_	_	_
125	The	_	_	_	_	_	_	_	BeginSeg=Yes
126	use	_	_	_	_	_	_	_	_
127	of	_	_	_	_	_	_	_	_
128	Illumina	_	_	_	_	_	_	_	_
129	ultradeep	_	_	_	_	_	_	_	_
130	sequencing	_	_	_	_	_	_	_	_
131	has	_	_	_	_	_	_	_	_
132	allowed	_	_	_	_	_	_	_	_
133	us	_	_	_	_	_	_	_	_
134	to	_	_	_	_	_	_	_	_
135	identify	_	_	_	_	_	_	_	_
136	virus	_	_	_	_	_	_	_	_
137	sequence	_	_	_	_	_	_	_	_
138	variants	_	_	_	_	_	_	_	_
139	at	_	_	_	_	_	_	_	_
140	frequencies	_	_	_	_	_	_	_	_
141	as	_	_	_	_	_	_	_	_
142	low	_	_	_	_	_	_	_	_
143	as	_	_	_	_	_	_	_	_
144	2	_	_	_	_	_	_	_	_
145	Â	_	_	_	_	_	_	_	_
146	10	_	_	_	_	_	_	_	_
147	À6	_	_	_	_	_	_	_	_
148	and	_	_	_	_	_	_	_	_
149	to	_	_	_	_	_	_	_	_
150	track	_	_	_	_	_	_	_	_
151	their	_	_	_	_	_	_	_	_
152	variation	_	_	_	_	_	_	_	_
153	in	_	_	_	_	_	_	_	_
154	time	_	_	_	_	_	_	_	_
155	before	_	_	_	_	_	_	_	BeginSeg=Yes
156	and	_	_	_	_	_	_	_	_
157	after	_	_	_	_	_	_	_	_
158	the	_	_	_	_	_	_	_	_
159	viral	_	_	_	_	_	_	_	_
160	population	_	_	_	_	_	_	_	_
161	was	_	_	_	_	_	_	_	_
162	able	_	_	_	_	_	_	_	_
163	of	_	_	_	_	_	_	_	_
164	successfully	_	_	_	_	_	_	_	_
165	infecting	_	_	_	_	_	_	_	_
166	plants	_	_	_	_	_	_	_	_
167	fully	_	_	_	_	_	_	_	_
168	resistant	_	_	_	_	_	_	_	_
169	to	_	_	_	_	_	_	_	_
170	the	_	_	_	_	_	_	_	_
171	ancestral	_	_	_	_	_	_	_	_
172	virus	_	_	_	_	_	_	_	_
173	.	_	_	_	_	_	_	_	_
174	We	_	_	_	_	_	_	_	BeginSeg=Yes
175	found	_	_	_	_	_	_	_	_
176	that	_	_	_	_	_	_	_	BeginSeg=Yes
177	every	_	_	_	_	_	_	_	_
178	site	_	_	_	_	_	_	_	_
179	in	_	_	_	_	_	_	_	_
180	the	_	_	_	_	_	_	_	_
181	amiR	_	_	_	_	_	_	_	_
182	-	_	_	_	_	_	_	_	_
183	target	_	_	_	_	_	_	_	_
184	sequence	_	_	_	_	_	_	_	_
185	of	_	_	_	_	_	_	_	_
186	the	_	_	_	_	_	_	_	_
187	viral	_	_	_	_	_	_	_	_
188	genome	_	_	_	_	_	_	_	_
189	presented	_	_	_	_	_	_	_	_
190	variation	_	_	_	_	_	_	_	_
191	and	_	_	_	_	_	_	_	BeginSeg=Yes
192	that	_	_	_	_	_	_	_	_
193	the	_	_	_	_	_	_	_	_
194	variant	_	_	_	_	_	_	_	_
195	that	_	_	_	_	_	_	_	BeginSeg=Yes
196	eventually	_	_	_	_	_	_	_	_
197	broke	_	_	_	_	_	_	_	_
198	resistance	_	_	_	_	_	_	_	_
199	was	_	_	_	_	_	_	_	BeginSeg=Yes
200	sampled	_	_	_	_	_	_	_	_
201	among	_	_	_	_	_	_	_	_
202	the	_	_	_	_	_	_	_	_
203	many	_	_	_	_	_	_	_	_
204	coexisting	_	_	_	_	_	_	_	_
205	ones	_	_	_	_	_	_	_	_
206	.	_	_	_	_	_	_	_	_
207	In	_	_	_	_	_	_	_	BeginSeg=Yes
208	this	_	_	_	_	_	_	_	_
209	system	_	_	_	_	_	_	_	_
210	,	_	_	_	_	_	_	_	_
211	viral	_	_	_	_	_	_	_	_
212	evolution	_	_	_	_	_	_	_	_
213	in	_	_	_	_	_	_	_	_
214	fully	_	_	_	_	_	_	_	_
215	susceptible	_	_	_	_	_	_	_	_
216	plants	_	_	_	_	_	_	_	_
217	results	_	_	_	_	_	_	_	_
218	from	_	_	_	_	_	_	_	_
219	an	_	_	_	_	_	_	_	_
220	equilibrium	_	_	_	_	_	_	_	_
221	between	_	_	_	_	_	_	_	_
222	mutation	_	_	_	_	_	_	_	_
223	and	_	_	_	_	_	_	_	_
224	genetic	_	_	_	_	_	_	_	_
225	drift	_	_	_	_	_	_	_	_
226	,	_	_	_	_	_	_	_	_
227	whereas	_	_	_	_	_	_	_	BeginSeg=Yes
228	evolution	_	_	_	_	_	_	_	_
229	in	_	_	_	_	_	_	_	_
230	partially	_	_	_	_	_	_	_	_
231	resistant	_	_	_	_	_	_	_	_
232	plants	_	_	_	_	_	_	_	_
233	originates	_	_	_	_	_	_	_	_
234	from	_	_	_	_	_	_	_	_
235	more	_	_	_	_	_	_	_	_
236	complex	_	_	_	_	_	_	_	_
237	dynamics	_	_	_	_	_	_	_	_
238	involving	_	_	_	_	_	_	_	BeginSeg=Yes
239	mutation	_	_	_	_	_	_	_	_
240	,	_	_	_	_	_	_	_	_
241	selection	_	_	_	_	_	_	_	_
242	,	_	_	_	_	_	_	_	_
243	and	_	_	_	_	_	_	_	_
244	drift	_	_	_	_	_	_	_	_
245	.	_	_	_	_	_	_	_	_

# newdoc_id = 762f9b6467251b8e21ad0a838c12a2c6c5ab9a10
1	Avian	_	_	_	_	_	_	_	BeginSeg=Yes
2	infectious	_	_	_	_	_	_	_	_
3	bronchitis	_	_	_	_	_	_	_	_
4	virus	_	_	_	_	_	_	_	_
5	(	_	_	_	_	_	_	_	_
6	IBV	_	_	_	_	_	_	_	_
7	)	_	_	_	_	_	_	_	_
8	is	_	_	_	_	_	_	_	_
9	a	_	_	_	_	_	_	_	_
10	member	_	_	_	_	_	_	_	_
11	of	_	_	_	_	_	_	_	_
12	the	_	_	_	_	_	_	_	_
13	group	_	_	_	_	_	_	_	_
14	III	_	_	_	_	_	_	_	_
15	coronaviruses	_	_	_	_	_	_	_	_
16	,	_	_	_	_	_	_	_	_
17	which	_	_	_	_	_	_	_	BeginSeg=Yes
18	differ	_	_	_	_	_	_	_	_
19	from	_	_	_	_	_	_	_	_
20	the	_	_	_	_	_	_	_	_
21	other	_	_	_	_	_	_	_	_
22	groups	_	_	_	_	_	_	_	_
23	of	_	_	_	_	_	_	_	_
24	coronaviruses	_	_	_	_	_	_	_	_
25	in	_	_	_	_	_	_	_	BeginSeg=Yes
26	that	_	_	_	_	_	_	_	_
27	they	_	_	_	_	_	_	_	_
28	do	_	_	_	_	_	_	_	_
29	not	_	_	_	_	_	_	_	_
30	encode	_	_	_	_	_	_	_	_
31	the	_	_	_	_	_	_	_	_
32	essential	_	_	_	_	_	_	_	_
33	pathogenic	_	_	_	_	_	_	_	_
34	factor	_	_	_	_	_	_	_	_
35	nonstructural	_	_	_	_	_	_	_	_
36	protein	_	_	_	_	_	_	_	_
37	1	_	_	_	_	_	_	_	_
38	(	_	_	_	_	_	_	_	_
39	nsp1	_	_	_	_	_	_	_	_
40	)	_	_	_	_	_	_	_	_
41	and	_	_	_	_	_	_	_	BeginSeg=Yes
42	instead	_	_	_	_	_	_	_	_
43	start	_	_	_	_	_	_	_	_
44	with	_	_	_	_	_	_	_	_
45	nsp2	_	_	_	_	_	_	_	_
46	.	_	_	_	_	_	_	_	_
47	IBV	_	_	_	_	_	_	_	BeginSeg=Yes
48	nsp2	_	_	_	_	_	_	_	_
49	is	_	_	_	_	_	_	_	_
50	one	_	_	_	_	_	_	_	_
51	of	_	_	_	_	_	_	_	_
52	the	_	_	_	_	_	_	_	_
53	first	_	_	_	_	_	_	_	_
54	replicase	_	_	_	_	_	_	_	_
55	proteins	_	_	_	_	_	_	_	_
56	to	_	_	_	_	_	_	_	BeginSeg=Yes
57	be	_	_	_	_	_	_	_	_
58	translated	_	_	_	_	_	_	_	_
59	and	_	_	_	_	_	_	_	_
60	processed	_	_	_	_	_	_	_	_
61	in	_	_	_	_	_	_	_	_
62	the	_	_	_	_	_	_	_	_
63	viral	_	_	_	_	_	_	_	_
64	life	_	_	_	_	_	_	_	_
65	cycle	_	_	_	_	_	_	_	_
66	;	_	_	_	_	_	_	_	_
67	however	_	_	_	_	_	_	_	BeginSeg=Yes
68	,	_	_	_	_	_	_	_	_
69	it	_	_	_	_	_	_	_	_
70	has	_	_	_	_	_	_	_	_
71	an	_	_	_	_	_	_	_	_
72	entirely	_	_	_	_	_	_	_	_
73	unknown	_	_	_	_	_	_	_	_
74	function	_	_	_	_	_	_	_	_
75	.	_	_	_	_	_	_	_	_
76	In	_	_	_	_	_	_	_	BeginSeg=Yes
77	order	_	_	_	_	_	_	_	_
78	to	_	_	_	_	_	_	_	_
79	better	_	_	_	_	_	_	_	_
80	understand	_	_	_	_	_	_	_	_
81	the	_	_	_	_	_	_	_	_
82	structural	_	_	_	_	_	_	_	_
83	details	_	_	_	_	_	_	_	_
84	and	_	_	_	_	_	_	_	_
85	functional	_	_	_	_	_	_	_	_
86	mechanism	_	_	_	_	_	_	_	_
87	of	_	_	_	_	_	_	_	_
88	IBV	_	_	_	_	_	_	_	_
89	nsp2	_	_	_	_	_	_	_	_
90	,	_	_	_	_	_	_	_	_
91	the	_	_	_	_	_	_	_	BeginSeg=Yes
92	recombinant	_	_	_	_	_	_	_	_
93	protein	_	_	_	_	_	_	_	_
94	was	_	_	_	_	_	_	_	_
95	cloned	_	_	_	_	_	_	_	_
96	,	_	_	_	_	_	_	_	_
97	overexpressed	_	_	_	_	_	_	_	BeginSeg=Yes
98	in	_	_	_	_	_	_	_	_
99	Escherichia	_	_	_	_	_	_	_	_
100	coli	_	_	_	_	_	_	_	_
101	,	_	_	_	_	_	_	_	_
102	purified	_	_	_	_	_	_	_	BeginSeg=Yes
103	and	_	_	_	_	_	_	_	BeginSeg=Yes
104	crystallized	_	_	_	_	_	_	_	_
105	.	_	_	_	_	_	_	_	_
106	The	_	_	_	_	_	_	_	BeginSeg=Yes
107	crystals	_	_	_	_	_	_	_	_
108	diffracted	_	_	_	_	_	_	_	_
109	to	_	_	_	_	_	_	_	_
110	2.8	_	_	_	_	_	_	_	_
111	Å	_	_	_	_	_	_	_	_
112	resolution	_	_	_	_	_	_	_	_
113	and	_	_	_	_	_	_	_	BeginSeg=Yes
114	belonged	_	_	_	_	_	_	_	_
115	to	_	_	_	_	_	_	_	_
116	space	_	_	_	_	_	_	_	_
117	group	_	_	_	_	_	_	_	_
118	P2	_	_	_	_	_	_	_	_
119	1	_	_	_	_	_	_	_	_
120	,	_	_	_	_	_	_	_	_
121	with	_	_	_	_	_	_	_	_
122	unit	_	_	_	_	_	_	_	_
123	-	_	_	_	_	_	_	_	_
124	cell	_	_	_	_	_	_	_	_
125	parameters	_	_	_	_	_	_	_	_
126	a	_	_	_	_	_	_	_	_
127	=	_	_	_	_	_	_	_	_
128	57.0	_	_	_	_	_	_	_	_
129	,	_	_	_	_	_	_	_	_
130	b	_	_	_	_	_	_	_	_
131	=	_	_	_	_	_	_	_	_
132	192.3	_	_	_	_	_	_	_	_
133	,	_	_	_	_	_	_	_	_
134	c	_	_	_	_	_	_	_	_
135	=	_	_	_	_	_	_	_	_
136	105.7	_	_	_	_	_	_	_	_
137	Å	_	_	_	_	_	_	_	_
138	,	_	_	_	_	_	_	_	_
139	=	_	_	_	_	_	_	_	_
140	90.8	_	_	_	_	_	_	_	_
141	.	_	_	_	_	_	_	_	_
142	Two	_	_	_	_	_	_	_	BeginSeg=Yes
143	molecules	_	_	_	_	_	_	_	_
144	were	_	_	_	_	_	_	_	_
145	found	_	_	_	_	_	_	_	_
146	in	_	_	_	_	_	_	_	_
147	the	_	_	_	_	_	_	_	_
148	asymmetric	_	_	_	_	_	_	_	_
149	unit	_	_	_	_	_	_	_	_
150	;	_	_	_	_	_	_	_	_
151	the	_	_	_	_	_	_	_	BeginSeg=Yes
152	Matthews	_	_	_	_	_	_	_	_
153	coefficient	_	_	_	_	_	_	_	_
154	was	_	_	_	_	_	_	_	_
155	3.9	_	_	_	_	_	_	_	_
156	Å	_	_	_	_	_	_	_	_
157	3	_	_	_	_	_	_	_	_
158	Da	_	_	_	_	_	_	_	_
159	À1	_	_	_	_	_	_	_	_
160	,	_	_	_	_	_	_	_	_
161	corresponding	_	_	_	_	_	_	_	BeginSeg=Yes
162	to	_	_	_	_	_	_	_	_
163	a	_	_	_	_	_	_	_	_
164	solvent	_	_	_	_	_	_	_	_
165	content	_	_	_	_	_	_	_	_
166	of	_	_	_	_	_	_	_	_
167	68.2	_	_	_	_	_	_	_	_
168	%	_	_	_	_	_	_	_	_
169	.	_	_	_	_	_	_	_	_

# newdoc_id = 79fa8fdc827ebf13a568461671621f811d9af7f5
1	Canine	_	_	_	_	_	_	_	BeginSeg=Yes
2	parvovirus	_	_	_	_	_	_	_	_
3	(	_	_	_	_	_	_	_	_
4	CPV	_	_	_	_	_	_	_	_
5	)	_	_	_	_	_	_	_	_
6	is	_	_	_	_	_	_	_	_
7	the	_	_	_	_	_	_	_	_
8	number	_	_	_	_	_	_	_	_
9	one	_	_	_	_	_	_	_	_
10	viral	_	_	_	_	_	_	_	_
11	cause	_	_	_	_	_	_	_	_
12	of	_	_	_	_	_	_	_	_
13	enteritis	_	_	_	_	_	_	_	_
14	,	_	_	_	_	_	_	_	_
15	morbidity	_	_	_	_	_	_	_	_
16	,	_	_	_	_	_	_	_	_
17	and	_	_	_	_	_	_	_	_
18	mortality	_	_	_	_	_	_	_	_
19	in	_	_	_	_	_	_	_	_
20	8-week	_	_	_	_	_	_	_	_
21	-	_	_	_	_	_	_	_	_
22	old	_	_	_	_	_	_	_	_
23	young	_	_	_	_	_	_	_	_
24	puppies	_	_	_	_	_	_	_	_
25	.	_	_	_	_	_	_	_	_
26	We	_	_	_	_	_	_	_	BeginSeg=Yes
27	have	_	_	_	_	_	_	_	_
28	developed	_	_	_	_	_	_	_	_
29	twin	_	_	_	_	_	_	_	_
30	assays	_	_	_	_	_	_	_	_
31	(	_	_	_	_	_	_	_	BeginSeg=Yes
32	slide	_	_	_	_	_	_	_	_
33	agglutination	_	_	_	_	_	_	_	_
34	test	_	_	_	_	_	_	_	_
35	[	_	_	_	_	_	_	_	_
36	SAT	_	_	_	_	_	_	_	_
37	]	_	_	_	_	_	_	_	_
38	for	_	_	_	_	_	_	_	_
39	CPV	_	_	_	_	_	_	_	_
40	antigen	_	_	_	_	_	_	_	_
41	and	_	_	_	_	_	_	_	_
42	slide	_	_	_	_	_	_	_	_
43	inhibition	_	_	_	_	_	_	_	_
44	test	_	_	_	_	_	_	_	_
45	[	_	_	_	_	_	_	_	_
46	SIT	_	_	_	_	_	_	_	_
47	]	_	_	_	_	_	_	_	_
48	for	_	_	_	_	_	_	_	_
49	CPV	_	_	_	_	_	_	_	_
50	antibody	_	_	_	_	_	_	_	_
51	)	_	_	_	_	_	_	_	_
52	that	_	_	_	_	_	_	_	BeginSeg=Yes
53	are	_	_	_	_	_	_	_	_
54	sensitive	_	_	_	_	_	_	_	_
55	,	_	_	_	_	_	_	_	_
56	specific	_	_	_	_	_	_	_	_
57	,	_	_	_	_	_	_	_	_
58	cost	_	_	_	_	_	_	_	_
59	-	_	_	_	_	_	_	_	_
60	effective	_	_	_	_	_	_	_	_
61	,	_	_	_	_	_	_	_	_
62	generic	_	_	_	_	_	_	_	_
63	for	_	_	_	_	_	_	_	_
64	all	_	_	_	_	_	_	_	_
65	genotypes	_	_	_	_	_	_	_	_
66	of	_	_	_	_	_	_	_	_
67	CPV	_	_	_	_	_	_	_	_
68	,	_	_	_	_	_	_	_	_
69	and	_	_	_	_	_	_	_	BeginSeg=Yes
70	provide	_	_	_	_	_	_	_	_
71	instant	_	_	_	_	_	_	_	_
72	results	_	_	_	_	_	_	_	_
73	for	_	_	_	_	_	_	_	_
74	CPV	_	_	_	_	_	_	_	_
75	antigen	_	_	_	_	_	_	_	_
76	detection	_	_	_	_	_	_	_	_
77	in	_	_	_	_	_	_	_	_
78	feces	_	_	_	_	_	_	_	_
79	and	_	_	_	_	_	_	_	_
80	antibody	_	_	_	_	_	_	_	_
81	quantification	_	_	_	_	_	_	_	_
82	in	_	_	_	_	_	_	_	_
83	serum	_	_	_	_	_	_	_	_
84	.	_	_	_	_	_	_	_	_
85	We	_	_	_	_	_	_	_	BeginSeg=Yes
86	found	_	_	_	_	_	_	_	_
87	these	_	_	_	_	_	_	_	_
88	assays	_	_	_	_	_	_	_	_
89	to	_	_	_	_	_	_	_	_
90	be	_	_	_	_	_	_	_	_
91	useful	_	_	_	_	_	_	_	_
92	for	_	_	_	_	_	_	_	_
93	routine	_	_	_	_	_	_	_	_
94	applications	_	_	_	_	_	_	_	_
95	in	_	_	_	_	_	_	_	_
96	kennels	_	_	_	_	_	_	_	_
97	with	_	_	_	_	_	_	_	_
98	large	_	_	_	_	_	_	_	_
99	numbers	_	_	_	_	_	_	_	_
100	of	_	_	_	_	_	_	_	_
101	puppies	_	_	_	_	_	_	_	_
102	at	_	_	_	_	_	_	_	_
103	risk	_	_	_	_	_	_	_	_
104	.	_	_	_	_	_	_	_	_
105	The	_	_	_	_	_	_	_	BeginSeg=Yes
106	results	_	_	_	_	_	_	_	_
107	of	_	_	_	_	_	_	_	_
108	these	_	_	_	_	_	_	_	_
109	assays	_	_	_	_	_	_	_	_
110	are	_	_	_	_	_	_	_	_
111	available	_	_	_	_	_	_	_	_
112	in	_	_	_	_	_	_	_	_
113	1	_	_	_	_	_	_	_	_
114	min	_	_	_	_	_	_	_	_
115	and	_	_	_	_	_	_	_	BeginSeg=Yes
116	do	_	_	_	_	_	_	_	_
117	not	_	_	_	_	_	_	_	_
118	require	_	_	_	_	_	_	_	_
119	any	_	_	_	_	_	_	_	_
120	special	_	_	_	_	_	_	_	_
121	instrumentation	_	_	_	_	_	_	_	_
122	.	_	_	_	_	_	_	_	_
123	SAT	_	_	_	_	_	_	_	BeginSeg=Yes
124	-	_	_	_	_	_	_	_	_
125	SIT	_	_	_	_	_	_	_	_
126	technology	_	_	_	_	_	_	_	_
127	will	_	_	_	_	_	_	_	_
128	find	_	_	_	_	_	_	_	_
129	applications	_	_	_	_	_	_	_	_
130	in	_	_	_	_	_	_	_	_
131	rapid	_	_	_	_	_	_	_	_
132	screening	_	_	_	_	_	_	_	_
133	of	_	_	_	_	_	_	_	_
134	samples	_	_	_	_	_	_	_	_
135	for	_	_	_	_	_	_	_	_
136	other	_	_	_	_	_	_	_	_
137	hemagglutinating	_	_	_	_	_	_	_	_
138	emerging	_	_	_	_	_	_	_	_
139	viruses	_	_	_	_	_	_	_	_
140	of	_	_	_	_	_	_	_	_
141	animals	_	_	_	_	_	_	_	_
142	and	_	_	_	_	_	_	_	_
143	humans	_	_	_	_	_	_	_	_
144	(	_	_	_	_	_	_	_	BeginSeg=Yes
145	influenza	_	_	_	_	_	_	_	_
146	virus	_	_	_	_	_	_	_	_
147	and	_	_	_	_	_	_	_	_
148	severe	_	_	_	_	_	_	_	_
149	acute	_	_	_	_	_	_	_	_
150	respiratory	_	_	_	_	_	_	_	_
151	syndrome	_	_	_	_	_	_	_	_
152	coronavirus	_	_	_	_	_	_	_	_
153	)	_	_	_	_	_	_	_	_
154	.	_	_	_	_	_	_	_	_

# newdoc_id = 7a2057b8b17dac8f41d6e811296470fbca62165e
1	Introduction	_	_	_	_	_	_	_	BeginSeg=Yes
2	:	_	_	_	_	_	_	_	_
3	Myocarditis	_	_	_	_	_	_	_	BeginSeg=Yes
4	is	_	_	_	_	_	_	_	_
5	rarely	_	_	_	_	_	_	_	_
6	reported	_	_	_	_	_	_	_	_
7	as	_	_	_	_	_	_	_	_
8	an	_	_	_	_	_	_	_	_
9	extra	_	_	_	_	_	_	_	_
10	-	_	_	_	_	_	_	_	_
11	pulmonary	_	_	_	_	_	_	_	_
12	manifestation	_	_	_	_	_	_	_	_
13	of	_	_	_	_	_	_	_	_
14	influenza	_	_	_	_	_	_	_	_
15	while	_	_	_	_	_	_	_	BeginSeg=Yes
16	pregnancy	_	_	_	_	_	_	_	_
17	is	_	_	_	_	_	_	_	_
18	a	_	_	_	_	_	_	_	_
19	rare	_	_	_	_	_	_	_	_
20	cause	_	_	_	_	_	_	_	_
21	of	_	_	_	_	_	_	_	_
22	cardiomyopathy	_	_	_	_	_	_	_	_
23	.	_	_	_	_	_	_	_	_
24	Pregnancy	_	_	_	_	_	_	_	BeginSeg=Yes
25	was	_	_	_	_	_	_	_	_
26	identified	_	_	_	_	_	_	_	_
27	as	_	_	_	_	_	_	_	_
28	a	_	_	_	_	_	_	_	_
29	major	_	_	_	_	_	_	_	_
30	risk	_	_	_	_	_	_	_	_
31	factor	_	_	_	_	_	_	_	_
32	for	_	_	_	_	_	_	_	_
33	increased	_	_	_	_	_	_	_	_
34	mortality	_	_	_	_	_	_	_	_
35	and	_	_	_	_	_	_	_	_
36	morbidity	_	_	_	_	_	_	_	_
37	due	_	_	_	_	_	_	_	BeginSeg=Yes
38	to	_	_	_	_	_	_	_	_
39	H	_	_	_	_	_	_	_	_
40	1	_	_	_	_	_	_	_	_
41	N	_	_	_	_	_	_	_	_
42	1	_	_	_	_	_	_	_	_
43	influenza	_	_	_	_	_	_	_	_
44	in	_	_	_	_	_	_	_	_
45	the	_	_	_	_	_	_	_	_
46	pandemic	_	_	_	_	_	_	_	_
47	of	_	_	_	_	_	_	_	_
48	2009	_	_	_	_	_	_	_	_
49	to	_	_	_	_	_	_	_	_
50	2010	_	_	_	_	_	_	_	_
51	.	_	_	_	_	_	_	_	_
52	However	_	_	_	_	_	_	_	BeginSeg=Yes
53	,	_	_	_	_	_	_	_	_
54	to	_	_	_	_	_	_	_	_
55	the	_	_	_	_	_	_	_	_
56	best	_	_	_	_	_	_	_	_
57	of	_	_	_	_	_	_	_	_
58	our	_	_	_	_	_	_	_	_
59	knowledge	_	_	_	_	_	_	_	_
60	there	_	_	_	_	_	_	_	_
61	are	_	_	_	_	_	_	_	_
62	no	_	_	_	_	_	_	_	_
63	previous	_	_	_	_	_	_	_	_
64	reports	_	_	_	_	_	_	_	_
65	in	_	_	_	_	_	_	_	_
66	the	_	_	_	_	_	_	_	_
67	literature	_	_	_	_	_	_	_	_
68	linking	_	_	_	_	_	_	_	BeginSeg=Yes
69	H	_	_	_	_	_	_	_	_
70	1	_	_	_	_	_	_	_	_
71	N	_	_	_	_	_	_	_	_
72	1	_	_	_	_	_	_	_	_
73	with	_	_	_	_	_	_	_	_
74	myocarditis	_	_	_	_	_	_	_	_
75	in	_	_	_	_	_	_	_	_
76	pregnancy	_	_	_	_	_	_	_	_
77	.	_	_	_	_	_	_	_	_
78	Case	_	_	_	_	_	_	_	BeginSeg=Yes
79	presentation	_	_	_	_	_	_	_	_
80	:	_	_	_	_	_	_	_	_
81	We	_	_	_	_	_	_	_	BeginSeg=Yes
82	report	_	_	_	_	_	_	_	_
83	the	_	_	_	_	_	_	_	_
84	cases	_	_	_	_	_	_	_	_
85	of	_	_	_	_	_	_	_	_
86	two	_	_	_	_	_	_	_	_
87	pregnant	_	_	_	_	_	_	_	_
88	Caucasian	_	_	_	_	_	_	_	_
89	women	_	_	_	_	_	_	_	_
90	(	_	_	_	_	_	_	_	BeginSeg=Yes
91	aged	_	_	_	_	_	_	_	_
92	29	_	_	_	_	_	_	_	_
93	and	_	_	_	_	_	_	_	_
94	30	_	_	_	_	_	_	_	_
95	)	_	_	_	_	_	_	_	_
96	,	_	_	_	_	_	_	_	_
97	with	_	_	_	_	_	_	_	BeginSeg=Yes
98	no	_	_	_	_	_	_	_	_
99	preexisting	_	_	_	_	_	_	_	_
100	illness	_	_	_	_	_	_	_	_
101	,	_	_	_	_	_	_	_	_
102	presenting	_	_	_	_	_	_	_	BeginSeg=Yes
103	with	_	_	_	_	_	_	_	_
104	respiratory	_	_	_	_	_	_	_	_
105	manifestations	_	_	_	_	_	_	_	_
106	of	_	_	_	_	_	_	_	_
107	H	_	_	_	_	_	_	_	_
108	1	_	_	_	_	_	_	_	_
109	N	_	_	_	_	_	_	_	_
110	1	_	_	_	_	_	_	_	_
111	influenza	_	_	_	_	_	_	_	_
112	virus	_	_	_	_	_	_	_	_
113	infection	_	_	_	_	_	_	_	_
114	in	_	_	_	_	_	_	_	_
115	their	_	_	_	_	_	_	_	_
116	third	_	_	_	_	_	_	_	_
117	trimester	_	_	_	_	_	_	_	_
118	.	_	_	_	_	_	_	_	_
119	Both	_	_	_	_	_	_	_	BeginSeg=Yes
120	women	_	_	_	_	_	_	_	_
121	developed	_	_	_	_	_	_	_	_
122	evidence	_	_	_	_	_	_	_	_
123	of	_	_	_	_	_	_	_	_
124	myocarditis	_	_	_	_	_	_	_	_
125	.	_	_	_	_	_	_	_	_
126	One	_	_	_	_	_	_	_	BeginSeg=Yes
127	woman	_	_	_	_	_	_	_	_
128	developed	_	_	_	_	_	_	_	_
129	acute	_	_	_	_	_	_	_	_
130	respiratory	_	_	_	_	_	_	_	_
131	distress	_	_	_	_	_	_	_	_
132	syndrome	_	_	_	_	_	_	_	_
133	,	_	_	_	_	_	_	_	_
134	almost	_	_	_	_	_	_	_	BeginSeg=Yes
135	reaching	_	_	_	_	_	_	_	_
136	the	_	_	_	_	_	_	_	_
137	point	_	_	_	_	_	_	_	_
138	of	_	_	_	_	_	_	_	_
139	requiring	_	_	_	_	_	_	_	_
140	extra	_	_	_	_	_	_	_	_
141	-	_	_	_	_	_	_	_	_
142	corporeal	_	_	_	_	_	_	_	_
143	membrane	_	_	_	_	_	_	_	_
144	oxygenation	_	_	_	_	_	_	_	_
145	,	_	_	_	_	_	_	_	_
146	and	_	_	_	_	_	_	_	BeginSeg=Yes
147	subsequently	_	_	_	_	_	_	_	_
148	developed	_	_	_	_	_	_	_	_
149	persistent	_	_	_	_	_	_	_	_
150	cardiomyopathy	_	_	_	_	_	_	_	_
151	;	_	_	_	_	_	_	_	_
152	the	_	_	_	_	_	_	_	BeginSeg=Yes
153	other	_	_	_	_	_	_	_	_
154	recovered	_	_	_	_	_	_	_	_
155	without	_	_	_	_	_	_	_	_
156	any	_	_	_	_	_	_	_	_
157	long	_	_	_	_	_	_	_	_
158	-	_	_	_	_	_	_	_	_
159	term	_	_	_	_	_	_	_	_
160	consequence	_	_	_	_	_	_	_	_
161	.	_	_	_	_	_	_	_	_
162	Conclusions	_	_	_	_	_	_	_	BeginSeg=Yes
163	:	_	_	_	_	_	_	_	_
164	While	_	_	_	_	_	_	_	BeginSeg=Yes
165	it	_	_	_	_	_	_	_	_
166	is	_	_	_	_	_	_	_	_
167	not	_	_	_	_	_	_	_	_
168	possible	_	_	_	_	_	_	_	_
169	to	_	_	_	_	_	_	_	_
170	ascertain	_	_	_	_	_	_	_	_
171	retrospectively	_	_	_	_	_	_	_	_
172	if	_	_	_	_	_	_	_	_
173	myocarditis	_	_	_	_	_	_	_	_
174	was	_	_	_	_	_	_	_	_
175	caused	_	_	_	_	_	_	_	_
176	by	_	_	_	_	_	_	_	_
177	either	_	_	_	_	_	_	_	_
178	infection	_	_	_	_	_	_	_	_
179	with	_	_	_	_	_	_	_	_
180	H	_	_	_	_	_	_	_	_
181	1	_	_	_	_	_	_	_	_
182	N	_	_	_	_	_	_	_	_
183	1	_	_	_	_	_	_	_	_
184	virus	_	_	_	_	_	_	_	_
185	or	_	_	_	_	_	_	_	_
186	as	_	_	_	_	_	_	_	_
187	a	_	_	_	_	_	_	_	_
188	result	_	_	_	_	_	_	_	_
189	of	_	_	_	_	_	_	_	_
190	pregnancy	_	_	_	_	_	_	_	_
191	(	_	_	_	_	_	_	_	_
192	in	_	_	_	_	_	_	_	_
193	the	_	_	_	_	_	_	_	_
194	absence	_	_	_	_	_	_	_	_
195	of	_	_	_	_	_	_	_	_
196	endomyocardial	_	_	_	_	_	_	_	_
197	biopsies	_	_	_	_	_	_	_	_
198	)	_	_	_	_	_	_	_	_
199	,	_	_	_	_	_	_	_	_
200	the	_	_	_	_	_	_	_	BeginSeg=Yes
201	significant	_	_	_	_	_	_	_	_
202	association	_	_	_	_	_	_	_	_
203	with	_	_	_	_	_	_	_	_
204	myocardial	_	_	_	_	_	_	_	_
205	involvement	_	_	_	_	_	_	_	_
206	in	_	_	_	_	_	_	_	_
207	both	_	_	_	_	_	_	_	_
208	women	_	_	_	_	_	_	_	_
209	demonstrates	_	_	_	_	_	_	_	_
210	the	_	_	_	_	_	_	_	_
211	increased	_	_	_	_	_	_	_	_
212	risk	_	_	_	_	_	_	_	_
213	of	_	_	_	_	_	_	_	_
214	exposure	_	_	_	_	_	_	_	_
215	to	_	_	_	_	_	_	_	_
216	H	_	_	_	_	_	_	_	_
217	1	_	_	_	_	_	_	_	_
218	N	_	_	_	_	_	_	_	_
219	1	_	_	_	_	_	_	_	_
220	influenza	_	_	_	_	_	_	_	_
221	virus	_	_	_	_	_	_	_	_
222	in	_	_	_	_	_	_	_	_
223	pregnant	_	_	_	_	_	_	_	_
224	women	_	_	_	_	_	_	_	_
225	.	_	_	_	_	_	_	_	_
226	This	_	_	_	_	_	_	_	BeginSeg=Yes
227	highlights	_	_	_	_	_	_	_	_
228	the	_	_	_	_	_	_	_	_
229	need	_	_	_	_	_	_	_	_
230	for	_	_	_	_	_	_	_	_
231	health	_	_	_	_	_	_	_	_
232	care	_	_	_	_	_	_	_	_
233	providers	_	_	_	_	_	_	_	_
234	to	_	_	_	_	_	_	_	_
235	increase	_	_	_	_	_	_	_	_
236	awareness	_	_	_	_	_	_	_	_
237	amongst	_	_	_	_	_	_	_	_
238	caregivers	_	_	_	_	_	_	_	_
239	to	_	_	_	_	_	_	_	BeginSeg=Yes
240	target	_	_	_	_	_	_	_	_
241	this	_	_	_	_	_	_	_	_
242	'	_	_	_	_	_	_	_	_
243	at	_	_	_	_	_	_	_	_
244	risk	_	_	_	_	_	_	_	_
245	'	_	_	_	_	_	_	_	_
246	group	_	_	_	_	_	_	_	_
247	aggressively	_	_	_	_	_	_	_	_
248	with	_	_	_	_	_	_	_	_
249	vaccination	_	_	_	_	_	_	_	_
250	and	_	_	_	_	_	_	_	_
251	prompt	_	_	_	_	_	_	_	_
252	treatment	_	_	_	_	_	_	_	_
253	.	_	_	_	_	_	_	_	_

# newdoc_id = 7f4558c4cb1d6fb9bbe9a522ca25924740e76b0a
1	SARS	_	_	_	_	_	_	_	BeginSeg=Yes
2	-	_	_	_	_	_	_	_	_
3	CoV-2	_	_	_	_	_	_	_	_
4	is	_	_	_	_	_	_	_	_
5	a	_	_	_	_	_	_	_	_
6	new	_	_	_	_	_	_	_	_
7	RNA	_	_	_	_	_	_	_	_
8	virus	_	_	_	_	_	_	_	_
9	affecting	_	_	_	_	_	_	_	BeginSeg=Yes
10	humans	_	_	_	_	_	_	_	_
11	and	_	_	_	_	_	_	_	BeginSeg=Yes
12	spreads	_	_	_	_	_	_	_	_
13	extensively	_	_	_	_	_	_	_	_
14	through	_	_	_	_	_	_	_	_
15	world	_	_	_	_	_	_	_	_
16	populations	_	_	_	_	_	_	_	_
17	since	_	_	_	_	_	_	_	_
18	its	_	_	_	_	_	_	_	_
19	first	_	_	_	_	_	_	_	_
20	outbreak	_	_	_	_	_	_	_	_
21	in	_	_	_	_	_	_	_	_
22	late	_	_	_	_	_	_	_	_
23	December	_	_	_	_	_	_	_	_
24	,	_	_	_	_	_	_	_	_
25	2019	_	_	_	_	_	_	_	_
26	.	_	_	_	_	_	_	_	_
27	Whether	_	_	_	_	_	_	_	BeginSeg=Yes
28	the	_	_	_	_	_	_	_	_
29	transmissibility	_	_	_	_	_	_	_	_
30	and	_	_	_	_	_	_	_	_
31	pathogenicity	_	_	_	_	_	_	_	_
32	of	_	_	_	_	_	_	_	_
33	SARS	_	_	_	_	_	_	_	_
34	-	_	_	_	_	_	_	_	_
35	CoV-2	_	_	_	_	_	_	_	_
36	is	_	_	_	_	_	_	_	_
37	actively	_	_	_	_	_	_	_	_
38	evolving	_	_	_	_	_	_	_	_
39	,	_	_	_	_	_	_	_	_
40	and	_	_	_	_	_	_	_	_
41	driven	_	_	_	_	_	_	_	_
42	by	_	_	_	_	_	_	_	_
43	adaptation	_	_	_	_	_	_	_	_
44	to	_	_	_	_	_	_	_	_
45	the	_	_	_	_	_	_	_	_
46	new	_	_	_	_	_	_	_	_
47	host	_	_	_	_	_	_	_	_
48	and	_	_	_	_	_	_	_	_
49	environments	_	_	_	_	_	_	_	_
50	is	_	_	_	_	_	_	_	_
51	still	_	_	_	_	_	_	_	_
52	unknown	_	_	_	_	_	_	_	_
53	.	_	_	_	_	_	_	_	_
54	Understanding	_	_	_	_	_	_	_	BeginSeg=Yes
55	the	_	_	_	_	_	_	_	_
56	evolutionary	_	_	_	_	_	_	_	_
57	mechanism	_	_	_	_	_	_	_	_
58	underlying	_	_	_	_	_	_	_	BeginSeg=Yes
59	epidemiological	_	_	_	_	_	_	_	_
60	and	_	_	_	_	_	_	_	_
61	pathological	_	_	_	_	_	_	_	_
62	characteristics	_	_	_	_	_	_	_	_
63	of	_	_	_	_	_	_	_	_
64	COVID-19	_	_	_	_	_	_	_	_
65	is	_	_	_	_	_	_	_	BeginSeg=Yes
66	essential	_	_	_	_	_	_	_	_
67	for	_	_	_	_	_	_	_	_
68	predicting	_	_	_	_	_	_	_	_
69	the	_	_	_	_	_	_	_	_
70	epidemic	_	_	_	_	_	_	_	_
71	trend	_	_	_	_	_	_	_	_
72	,	_	_	_	_	_	_	_	_
73	and	_	_	_	_	_	_	_	BeginSeg=Yes
74	providing	_	_	_	_	_	_	_	_
75	guidance	_	_	_	_	_	_	_	_
76	for	_	_	_	_	_	_	_	_
77	disease	_	_	_	_	_	_	_	_
78	control	_	_	_	_	_	_	_	_
79	and	_	_	_	_	_	_	_	_
80	treatments	_	_	_	_	_	_	_	_
81	.	_	_	_	_	_	_	_	_
82	Interrogating	_	_	_	_	_	_	_	BeginSeg=Yes
83	22,078	_	_	_	_	_	_	_	_
84	SARS	_	_	_	_	_	_	_	_
85	-	_	_	_	_	_	_	_	_
86	CoV-2	_	_	_	_	_	_	_	_
87	genome	_	_	_	_	_	_	_	_
88	sequences	_	_	_	_	_	_	_	_
89	of	_	_	_	_	_	_	_	_
90	84	_	_	_	_	_	_	_	_
91	countries	_	_	_	_	_	_	_	_
92	,	_	_	_	_	_	_	_	_
93	we	_	_	_	_	_	_	_	BeginSeg=Yes
94	demonstrate	_	_	_	_	_	_	_	_
95	with	_	_	_	_	_	_	_	_
96	convincing	_	_	_	_	_	_	_	_
97	evidence	_	_	_	_	_	_	_	_
98	that	_	_	_	_	_	_	_	BeginSeg=Yes
99	(	_	_	_	_	_	_	_	_
100	i	_	_	_	_	_	_	_	_
101	)	_	_	_	_	_	_	_	_
102	SARS	_	_	_	_	_	_	_	_
103	-	_	_	_	_	_	_	_	_
104	CoV-2	_	_	_	_	_	_	_	_
105	genomes	_	_	_	_	_	_	_	_
106	are	_	_	_	_	_	_	_	_
107	overall	_	_	_	_	_	_	_	_
108	conserved	_	_	_	_	_	_	_	_
109	under	_	_	_	_	_	_	_	_
110	purifying	_	_	_	_	_	_	_	_
111	selection	_	_	_	_	_	_	_	_
112	.	_	_	_	_	_	_	_	_
113	(	_	_	_	_	_	_	_	BeginSeg=Yes
114	ii	_	_	_	_	_	_	_	_
115	)	_	_	_	_	_	_	_	_
116	Ongoing	_	_	_	_	_	_	_	_
117	positive	_	_	_	_	_	_	_	_
118	selection	_	_	_	_	_	_	_	_
119	is	_	_	_	_	_	_	_	_
120	actively	_	_	_	_	_	_	_	_
121	driving	_	_	_	_	_	_	_	_
122	the	_	_	_	_	_	_	_	_
123	evolution	_	_	_	_	_	_	_	_
124	of	_	_	_	_	_	_	_	_
125	specific	_	_	_	_	_	_	_	_
126	genes	_	_	_	_	_	_	_	_
127	.	_	_	_	_	_	_	_	_
128	Notably	_	_	_	_	_	_	_	BeginSeg=Yes
129	,	_	_	_	_	_	_	_	_
130	genes	_	_	_	_	_	_	_	_
131	related	_	_	_	_	_	_	_	BeginSeg=Yes
132	to	_	_	_	_	_	_	_	_
133	coronavirus	_	_	_	_	_	_	_	_
134	infection	_	_	_	_	_	_	_	_
135	and	_	_	_	_	_	_	_	_
136	host	_	_	_	_	_	_	_	_
137	immune	_	_	_	_	_	_	_	_
138	system	_	_	_	_	_	_	_	_
139	defense	_	_	_	_	_	_	_	_
140	are	_	_	_	_	_	_	_	BeginSeg=Yes
141	under	_	_	_	_	_	_	_	_
142	adaptive	_	_	_	_	_	_	_	_
143	evolution	_	_	_	_	_	_	_	_
144	while	_	_	_	_	_	_	_	BeginSeg=Yes
145	genes	_	_	_	_	_	_	_	_
146	related	_	_	_	_	_	_	_	BeginSeg=Yes
147	to	_	_	_	_	_	_	_	_
148	viral	_	_	_	_	_	_	_	_
149	RNA	_	_	_	_	_	_	_	_
150	replication	_	_	_	_	_	_	_	_
151	,	_	_	_	_	_	_	_	_
152	transcription	_	_	_	_	_	_	_	_
153	and	_	_	_	_	_	_	_	_
154	translation	_	_	_	_	_	_	_	_
155	are	_	_	_	_	_	_	_	BeginSeg=Yes
156	under	_	_	_	_	_	_	_	_
157	purifying	_	_	_	_	_	_	_	_
158	selection	_	_	_	_	_	_	_	_
159	.	_	_	_	_	_	_	_	_
160	A	_	_	_	_	_	_	_	BeginSeg=Yes
161	spatial	_	_	_	_	_	_	_	_
162	and	_	_	_	_	_	_	_	_
163	temporal	_	_	_	_	_	_	_	_
164	landscape	_	_	_	_	_	_	_	_
165	of	_	_	_	_	_	_	_	_
166	54	_	_	_	_	_	_	_	_
167	critical	_	_	_	_	_	_	_	_
168	mutants	_	_	_	_	_	_	_	_
169	is	_	_	_	_	_	_	_	_
170	constructed	_	_	_	_	_	_	_	_
171	based	_	_	_	_	_	_	_	BeginSeg=Yes
172	on	_	_	_	_	_	_	_	_
173	their	_	_	_	_	_	_	_	_
174	divergence	_	_	_	_	_	_	_	_
175	among	_	_	_	_	_	_	_	_
176	viral	_	_	_	_	_	_	_	_
177	haplotype	_	_	_	_	_	_	_	_
178	clusters	_	_	_	_	_	_	_	_
179	,	_	_	_	_	_	_	_	_
180	of	_	_	_	_	_	_	_	BeginSeg=Yes
181	which	_	_	_	_	_	_	_	_
182	multiple	_	_	_	_	_	_	_	_
183	mutants	_	_	_	_	_	_	_	_
184	potentially	_	_	_	_	_	_	_	_
185	conferring	_	_	_	_	_	_	_	_
186	viral	_	_	_	_	_	_	_	_
187	transmissibility	_	_	_	_	_	_	_	_
188	,	_	_	_	_	_	_	_	_
189	infectivity	_	_	_	_	_	_	_	_
190	and	_	_	_	_	_	_	_	_
191	virulence	_	_	_	_	_	_	_	_
192	of	_	_	_	_	_	_	_	_
193	SARS	_	_	_	_	_	_	_	_
194	-	_	_	_	_	_	_	_	_
195	CoV-2	_	_	_	_	_	_	_	_
196	are	_	_	_	_	_	_	_	_
197	highlighted	_	_	_	_	_	_	_	_
198	.	_	_	_	_	_	_	_	_

# newdoc_id = 804c9ade797c3eae734ac34ddbaa256b02672668
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	current	_	_	_	_	_	_	_	_
3	health	_	_	_	_	_	_	_	_
4	,	_	_	_	_	_	_	_	_
5	political	_	_	_	_	_	_	_	_
6	,	_	_	_	_	_	_	_	_
7	and	_	_	_	_	_	_	_	_
8	environmental	_	_	_	_	_	_	_	_
9	crisis	_	_	_	_	_	_	_	_
10	ongoing	_	_	_	_	_	_	_	BeginSeg=Yes
11	in	_	_	_	_	_	_	_	_
12	Brazil	_	_	_	_	_	_	_	_
13	and	_	_	_	_	_	_	_	BeginSeg=Yes
14	the	_	_	_	_	_	_	_	_
15	advances	_	_	_	_	_	_	_	_
16	of	_	_	_	_	_	_	_	_
17	the	_	_	_	_	_	_	_	_
18	impacts	_	_	_	_	_	_	_	_
19	of	_	_	_	_	_	_	_	_
20	COVID-19	_	_	_	_	_	_	_	_
21	in	_	_	_	_	_	_	_	_
22	traditional	_	_	_	_	_	_	_	_
23	populations	_	_	_	_	_	_	_	_
24	(	_	_	_	_	_	_	_	_
25	as	_	_	_	_	_	_	_	_
26	indigenous	_	_	_	_	_	_	_	_
27	and	_	_	_	_	_	_	_	_
28	quilombolas	_	_	_	_	_	_	_	_
29	)	_	_	_	_	_	_	_	_
30	are	_	_	_	_	_	_	_	_
31	not	_	_	_	_	_	_	_	_
32	yet	_	_	_	_	_	_	_	_
33	prioritized	_	_	_	_	_	_	_	_
34	in	_	_	_	_	_	_	_	_
35	the	_	_	_	_	_	_	_	_
36	scientific	_	_	_	_	_	_	_	_
37	production	_	_	_	_	_	_	_	_
38	about	_	_	_	_	_	_	_	_
39	the	_	_	_	_	_	_	_	_
40	novel	_	_	_	_	_	_	_	_
41	coronavirus	_	_	_	_	_	_	_	_
42	.	_	_	_	_	_	_	_	_
43	We	_	_	_	_	_	_	_	BeginSeg=Yes
44	performed	_	_	_	_	_	_	_	_
45	spatial	_	_	_	_	_	_	_	_
46	correlation	_	_	_	_	_	_	_	_
47	analysis	_	_	_	_	_	_	_	_
48	to	_	_	_	_	_	_	_	BeginSeg=Yes
49	map	_	_	_	_	_	_	_	_
50	the	_	_	_	_	_	_	_	_
51	clusters	_	_	_	_	_	_	_	_
52	and	_	_	_	_	_	_	_	_
53	outliers	_	_	_	_	_	_	_	_
54	of	_	_	_	_	_	_	_	_
55	COVID-19	_	_	_	_	_	_	_	_
56	in	_	_	_	_	_	_	_	_
57	South	_	_	_	_	_	_	_	_
58	of	_	_	_	_	_	_	_	_
59	Brazil	_	_	_	_	_	_	_	_
60	to	_	_	_	_	_	_	_	BeginSeg=Yes
61	identify	_	_	_	_	_	_	_	_
62	indigenous	_	_	_	_	_	_	_	_
63	and	_	_	_	_	_	_	_	_
64	quilombolas	_	_	_	_	_	_	_	_
65	communities	_	_	_	_	_	_	_	_
66	impacted	_	_	_	_	_	_	_	BeginSeg=Yes
67	right	_	_	_	_	_	_	_	_
68	now	_	_	_	_	_	_	_	_
69	in	_	_	_	_	_	_	_	_
70	the	_	_	_	_	_	_	_	_
71	pandemic	_	_	_	_	_	_	_	_
72	.	_	_	_	_	_	_	_	_
73	We	_	_	_	_	_	_	_	BeginSeg=Yes
74	show	_	_	_	_	_	_	_	_
75	that	_	_	_	_	_	_	_	BeginSeg=Yes
76	communities	_	_	_	_	_	_	_	_
77	located	_	_	_	_	_	_	_	BeginSeg=Yes
78	nearby	_	_	_	_	_	_	_	_
79	metropolitan	_	_	_	_	_	_	_	_
80	areas	_	_	_	_	_	_	_	_
81	and	_	_	_	_	_	_	_	_
82	mid	_	_	_	_	_	_	_	_
83	-	_	_	_	_	_	_	_	_
84	sized	_	_	_	_	_	_	_	_
85	cities	_	_	_	_	_	_	_	_
86	are	_	_	_	_	_	_	_	BeginSeg=Yes
87	the	_	_	_	_	_	_	_	_
88	most	_	_	_	_	_	_	_	_
89	impacted	_	_	_	_	_	_	_	_
90	by	_	_	_	_	_	_	_	_
91	the	_	_	_	_	_	_	_	_
92	COVID-19	_	_	_	_	_	_	_	_
93	and	_	_	_	_	_	_	_	BeginSeg=Yes
94	the	_	_	_	_	_	_	_	_
95	advance	_	_	_	_	_	_	_	_
96	of	_	_	_	_	_	_	_	_
97	the	_	_	_	_	_	_	_	_
98	transmission	_	_	_	_	_	_	_	_
99	to	_	_	_	_	_	_	_	_
100	inner	_	_	_	_	_	_	_	_
101	states	_	_	_	_	_	_	_	_
102	may	_	_	_	_	_	_	_	_
103	intensify	_	_	_	_	_	_	_	_
104	the	_	_	_	_	_	_	_	_
105	ongoing	_	_	_	_	_	_	_	_
106	historical	_	_	_	_	_	_	_	_
107	process	_	_	_	_	_	_	_	_
108	of	_	_	_	_	_	_	_	_
109	elimination	_	_	_	_	_	_	_	_
110	of	_	_	_	_	_	_	_	_
111	indigenous	_	_	_	_	_	_	_	_
112	and	_	_	_	_	_	_	_	_
113	quilombolas	_	_	_	_	_	_	_	_
114	people	_	_	_	_	_	_	_	_
115	.	_	_	_	_	_	_	_	_
116	We	_	_	_	_	_	_	_	BeginSeg=Yes
117	call	_	_	_	_	_	_	_	_
118	for	_	_	_	_	_	_	_	_
119	a	_	_	_	_	_	_	_	_
120	global	_	_	_	_	_	_	_	_
121	response	_	_	_	_	_	_	_	_
122	to	_	_	_	_	_	_	_	_
123	the	_	_	_	_	_	_	_	_
124	indigenous	_	_	_	_	_	_	_	_
125	and	_	_	_	_	_	_	_	_
126	quilombolas	_	_	_	_	_	_	_	_
127	situation	_	_	_	_	_	_	_	_
128	in	_	_	_	_	_	_	_	_
129	Brazil	_	_	_	_	_	_	_	_
130	,	_	_	_	_	_	_	_	_
131	pointing	_	_	_	_	_	_	_	BeginSeg=Yes
132	to	_	_	_	_	_	_	_	_
133	the	_	_	_	_	_	_	_	_
134	need	_	_	_	_	_	_	_	_
135	of	_	_	_	_	_	_	_	_
136	more	_	_	_	_	_	_	_	_
137	analysis	_	_	_	_	_	_	_	_
138	in	_	_	_	_	_	_	_	_
139	the	_	_	_	_	_	_	_	_
140	country	_	_	_	_	_	_	_	_
141	;	_	_	_	_	_	_	_	_

# newdoc_id = 80bd28c8ba829f2173211a2fad8f98657676e0a6
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	COVID-19	_	_	_	_	_	_	_	_
3	pandemic	_	_	_	_	_	_	_	_
4	is	_	_	_	_	_	_	_	_
5	the	_	_	_	_	_	_	_	_
6	most	_	_	_	_	_	_	_	_
7	devastating	_	_	_	_	_	_	_	_
8	health	_	_	_	_	_	_	_	_
9	emergency	_	_	_	_	_	_	_	_
10	that	_	_	_	_	_	_	_	BeginSeg=Yes
11	humans	_	_	_	_	_	_	_	_
12	have	_	_	_	_	_	_	_	_
13	seen	_	_	_	_	_	_	_	_
14	over	_	_	_	_	_	_	_	_
15	the	_	_	_	_	_	_	_	_
16	past	_	_	_	_	_	_	_	_
17	century	_	_	_	_	_	_	_	_
18	.	_	_	_	_	_	_	_	_
19	The	_	_	_	_	_	_	_	BeginSeg=Yes
20	war	_	_	_	_	_	_	_	_
21	against	_	_	_	_	_	_	_	_
22	the	_	_	_	_	_	_	_	_
23	disease	_	_	_	_	_	_	_	_
24	has	_	_	_	_	_	_	_	_
25	been	_	_	_	_	_	_	_	_
26	handicapped	_	_	_	_	_	_	_	_
27	by	_	_	_	_	_	_	_	_
28	unavailability	_	_	_	_	_	_	_	_
29	of	_	_	_	_	_	_	_	_
30	effective	_	_	_	_	_	_	_	_
31	therapeutic	_	_	_	_	_	_	_	_
32	options	_	_	_	_	_	_	_	_
33	.	_	_	_	_	_	_	_	_
34	Till	_	_	_	_	_	_	_	BeginSeg=Yes
35	date	_	_	_	_	_	_	_	_
36	,	_	_	_	_	_	_	_	_
37	there	_	_	_	_	_	_	_	_
38	is	_	_	_	_	_	_	_	_
39	no	_	_	_	_	_	_	_	_
40	clinically	_	_	_	_	_	_	_	_
41	approved	_	_	_	_	_	_	_	_
42	vaccine	_	_	_	_	_	_	_	_
43	or	_	_	_	_	_	_	_	_
44	drug	_	_	_	_	_	_	_	_
45	for	_	_	_	_	_	_	_	_
46	the	_	_	_	_	_	_	_	_
47	treatment	_	_	_	_	_	_	_	_
48	of	_	_	_	_	_	_	_	_
49	COVID-19	_	_	_	_	_	_	_	_
50	,	_	_	_	_	_	_	_	_
51	and	_	_	_	_	_	_	_	BeginSeg=Yes
52	the	_	_	_	_	_	_	_	_
53	ongoing	_	_	_	_	_	_	_	_
54	search	_	_	_	_	_	_	_	_
55	to	_	_	_	_	_	_	_	BeginSeg=Yes
56	find	_	_	_	_	_	_	_	_
57	a	_	_	_	_	_	_	_	_
58	novel	_	_	_	_	_	_	_	_
59	therapy	_	_	_	_	_	_	_	_
60	is	_	_	_	_	_	_	_	BeginSeg=Yes
61	progressing	_	_	_	_	_	_	_	_
62	at	_	_	_	_	_	_	_	_
63	pandemic	_	_	_	_	_	_	_	_
64	pace	_	_	_	_	_	_	_	_
65	.	_	_	_	_	_	_	_	_
66	Herein	_	_	_	_	_	_	_	BeginSeg=Yes
67	,	_	_	_	_	_	_	_	_
68	we	_	_	_	_	_	_	_	_
69	propose	_	_	_	_	_	_	_	_
70	a	_	_	_	_	_	_	_	_
71	novel	_	_	_	_	_	_	_	_
72	hypothesis	_	_	_	_	_	_	_	_
73	based	_	_	_	_	_	_	_	BeginSeg=Yes
74	on	_	_	_	_	_	_	_	_
75	sound	_	_	_	_	_	_	_	_
76	research	_	_	_	_	_	_	_	_
77	evidence	_	_	_	_	_	_	_	_
78	that	_	_	_	_	_	_	_	BeginSeg=Yes
79	electric	_	_	_	_	_	_	_	_
80	stimulation	_	_	_	_	_	_	_	_
81	can	_	_	_	_	_	_	_	_
82	be	_	_	_	_	_	_	_	_
83	a	_	_	_	_	_	_	_	_
84	potential	_	_	_	_	_	_	_	_
85	adjuvant	_	_	_	_	_	_	_	_
86	to	_	_	_	_	_	_	_	_
87	the	_	_	_	_	_	_	_	_
88	currently	_	_	_	_	_	_	_	_
89	used	_	_	_	_	_	_	_	_
90	symptomatic	_	_	_	_	_	_	_	_
91	therapies	_	_	_	_	_	_	_	_
92	and	_	_	_	_	_	_	_	_
93	antiviral	_	_	_	_	_	_	_	_
94	drugs	_	_	_	_	_	_	_	_
95	.	_	_	_	_	_	_	_	_
96	Based	_	_	_	_	_	_	_	BeginSeg=Yes
97	on	_	_	_	_	_	_	_	_
98	preclinical	_	_	_	_	_	_	_	_
99	evidence	_	_	_	_	_	_	_	_
100	,	_	_	_	_	_	_	_	_
101	we	_	_	_	_	_	_	_	BeginSeg=Yes
102	propose	_	_	_	_	_	_	_	_
103	that	_	_	_	_	_	_	_	BeginSeg=Yes
104	electric	_	_	_	_	_	_	_	_
105	stimulation	_	_	_	_	_	_	_	_
106	can	_	_	_	_	_	_	_	_
107	improve	_	_	_	_	_	_	_	_
108	respiratory	_	_	_	_	_	_	_	_
109	functions	_	_	_	_	_	_	_	_
110	,	_	_	_	_	_	_	_	_
111	inhibit	_	_	_	_	_	_	_	BeginSeg=Yes
112	SARS	_	_	_	_	_	_	_	_
113	-	_	_	_	_	_	_	_	_
114	CoV-2	_	_	_	_	_	_	_	_
115	growth	_	_	_	_	_	_	_	_
116	,	_	_	_	_	_	_	_	_
117	reduce	_	_	_	_	_	_	_	BeginSeg=Yes
118	pain	_	_	_	_	_	_	_	_
119	,	_	_	_	_	_	_	_	_
120	boost	_	_	_	_	_	_	_	BeginSeg=Yes
121	immunity	_	_	_	_	_	_	_	_
122	and	_	_	_	_	_	_	_	BeginSeg=Yes
123	improve	_	_	_	_	_	_	_	_
124	the	_	_	_	_	_	_	_	_
125	penetration	_	_	_	_	_	_	_	_
126	of	_	_	_	_	_	_	_	_
127	antiviral	_	_	_	_	_	_	_	_
128	drugs	_	_	_	_	_	_	_	_
129	.	_	_	_	_	_	_	_	_
130	We	_	_	_	_	_	_	_	BeginSeg=Yes
131	envisage	_	_	_	_	_	_	_	_
132	that	_	_	_	_	_	_	_	BeginSeg=Yes
133	our	_	_	_	_	_	_	_	_
134	hypothesis	_	_	_	_	_	_	_	_
135	,	_	_	_	_	_	_	_	_
136	if	_	_	_	_	_	_	_	BeginSeg=Yes
137	used	_	_	_	_	_	_	_	_
138	clinically	_	_	_	_	_	_	_	_
139	as	_	_	_	_	_	_	_	_
140	an	_	_	_	_	_	_	_	_
141	adjuvant	_	_	_	_	_	_	_	_
142	,	_	_	_	_	_	_	_	_
143	may	_	_	_	_	_	_	_	BeginSeg=Yes
144	significantly	_	_	_	_	_	_	_	_
145	improve	_	_	_	_	_	_	_	_
146	the	_	_	_	_	_	_	_	_
147	therapeutic	_	_	_	_	_	_	_	_
148	outcomes	_	_	_	_	_	_	_	_
149	of	_	_	_	_	_	_	_	_
150	the	_	_	_	_	_	_	_	_
151	current	_	_	_	_	_	_	_	_
152	treatment	_	_	_	_	_	_	_	_
153	regimen	_	_	_	_	_	_	_	_
154	being	_	_	_	_	_	_	_	BeginSeg=Yes
155	used	_	_	_	_	_	_	_	_
156	around	_	_	_	_	_	_	_	_
157	the	_	_	_	_	_	_	_	_
158	globe	_	_	_	_	_	_	_	_
159	for	_	_	_	_	_	_	_	_
160	the	_	_	_	_	_	_	_	_
161	management	_	_	_	_	_	_	_	_
162	of	_	_	_	_	_	_	_	_
163	COVID-19	_	_	_	_	_	_	_	_
164	.	_	_	_	_	_	_	_	_

# newdoc_id = 8872c8e69ad8ba0f3df7454eb8121c712e60011b
1	A	_	_	_	_	_	_	_	BeginSeg=Yes
2	central	_	_	_	_	_	_	_	_
3	nervous	_	_	_	_	_	_	_	_
4	system	_	_	_	_	_	_	_	_
5	(	_	_	_	_	_	_	_	_
6	CNS	_	_	_	_	_	_	_	_
7	)	_	_	_	_	_	_	_	_
8	disorder	_	_	_	_	_	_	_	_
9	characterized	_	_	_	_	_	_	_	BeginSeg=Yes
10	by	_	_	_	_	_	_	_	_
11	non	_	_	_	_	_	_	_	_
12	-	_	_	_	_	_	_	_	_
13	suppurative	_	_	_	_	_	_	_	_
14	encephalomyelitis	_	_	_	_	_	_	_	_
15	with	_	_	_	_	_	_	_	_
16	neurological	_	_	_	_	_	_	_	_
17	signs	_	_	_	_	_	_	_	_
18	was	_	_	_	_	_	_	_	BeginSeg=Yes
19	induced	_	_	_	_	_	_	_	_
20	experimentally	_	_	_	_	_	_	_	_
21	in	_	_	_	_	_	_	_	_
22	gnotobiotic	_	_	_	_	_	_	_	_
23	pigs	_	_	_	_	_	_	_	_
24	by	_	_	_	_	_	_	_	_
25	intravenous	_	_	_	_	_	_	_	_
26	and	_	_	_	_	_	_	_	_
27	oral	_	_	_	_	_	_	_	_
28	or	_	_	_	_	_	_	_	_
29	intranasal	_	_	_	_	_	_	_	_
30	inoculation	_	_	_	_	_	_	_	_
31	of	_	_	_	_	_	_	_	_
32	the	_	_	_	_	_	_	_	_
33	porcine	_	_	_	_	_	_	_	_
34	teschovirus	_	_	_	_	_	_	_	_
35	(	_	_	_	_	_	_	_	_
36	PTV	_	_	_	_	_	_	_	_
37	)	_	_	_	_	_	_	_	_
38	Toyama	_	_	_	_	_	_	_	_
39	2002	_	_	_	_	_	_	_	_
40	strain	_	_	_	_	_	_	_	_
41	isolated	_	_	_	_	_	_	_	BeginSeg=Yes
42	from	_	_	_	_	_	_	_	_
43	breeding	_	_	_	_	_	_	_	_
44	pigs	_	_	_	_	_	_	_	_
45	in	_	_	_	_	_	_	_	_
46	Japan	_	_	_	_	_	_	_	_
47	.	_	_	_	_	_	_	_	_
48	Lesions	_	_	_	_	_	_	_	BeginSeg=Yes
49	consisting	_	_	_	_	_	_	_	BeginSeg=Yes
50	of	_	_	_	_	_	_	_	_
51	perivascular	_	_	_	_	_	_	_	_
52	cuffing	_	_	_	_	_	_	_	_
53	of	_	_	_	_	_	_	_	_
54	mononuclear	_	_	_	_	_	_	_	_
55	cells	_	_	_	_	_	_	_	_
56	,	_	_	_	_	_	_	_	_
57	focal	_	_	_	_	_	_	_	_
58	gliosis	_	_	_	_	_	_	_	_
59	,	_	_	_	_	_	_	_	_
60	neuronal	_	_	_	_	_	_	_	_
61	necrosis	_	_	_	_	_	_	_	_
62	and	_	_	_	_	_	_	_	_
63	neuronophagia	_	_	_	_	_	_	_	_
64	were	_	_	_	_	_	_	_	BeginSeg=Yes
65	observed	_	_	_	_	_	_	_	_
66	in	_	_	_	_	_	_	_	_
67	the	_	_	_	_	_	_	_	_
68	brainstem	_	_	_	_	_	_	_	_
69	,	_	_	_	_	_	_	_	_
70	cerebellum	_	_	_	_	_	_	_	_
71	and	_	_	_	_	_	_	_	_
72	spinal	_	_	_	_	_	_	_	_
73	cord	_	_	_	_	_	_	_	_
74	.	_	_	_	_	_	_	_	_
75	Non	_	_	_	_	_	_	_	BeginSeg=Yes
76	-	_	_	_	_	_	_	_	_
77	suppurative	_	_	_	_	_	_	_	_
78	ganglionitis	_	_	_	_	_	_	_	_
79	in	_	_	_	_	_	_	_	_
80	the	_	_	_	_	_	_	_	_
81	spinal	_	_	_	_	_	_	_	_
82	ganglion	_	_	_	_	_	_	_	_
83	and	_	_	_	_	_	_	_	_
84	neuritis	_	_	_	_	_	_	_	_
85	in	_	_	_	_	_	_	_	_
86	the	_	_	_	_	_	_	_	_
87	spinal	_	_	_	_	_	_	_	_
88	root	_	_	_	_	_	_	_	_
89	were	_	_	_	_	_	_	_	_
90	also	_	_	_	_	_	_	_	_
91	observed	_	_	_	_	_	_	_	_
92	.	_	_	_	_	_	_	_	_
93	Regardless	_	_	_	_	_	_	_	BeginSeg=Yes
94	of	_	_	_	_	_	_	_	_
95	the	_	_	_	_	_	_	_	_
96	route	_	_	_	_	_	_	_	_
97	of	_	_	_	_	_	_	_	_
98	inoculation	_	_	_	_	_	_	_	_
99	,	_	_	_	_	_	_	_	_
100	all	_	_	_	_	_	_	_	BeginSeg=Yes
101	pigs	_	_	_	_	_	_	_	_
102	infected	_	_	_	_	_	_	_	BeginSeg=Yes
103	experimentally	_	_	_	_	_	_	_	_
104	with	_	_	_	_	_	_	_	_
105	PTV	_	_	_	_	_	_	_	_
106	showed	_	_	_	_	_	_	_	BeginSeg=Yes
107	a	_	_	_	_	_	_	_	_
108	similar	_	_	_	_	_	_	_	_
109	distribution	_	_	_	_	_	_	_	_
110	of	_	_	_	_	_	_	_	_
111	CNS	_	_	_	_	_	_	_	_
112	lesions	_	_	_	_	_	_	_	_
113	.	_	_	_	_	_	_	_	_
114	Histological	_	_	_	_	_	_	_	BeginSeg=Yes
115	lesions	_	_	_	_	_	_	_	_
116	in	_	_	_	_	_	_	_	_
117	the	_	_	_	_	_	_	_	_
118	CNS	_	_	_	_	_	_	_	_
119	caused	_	_	_	_	_	_	_	BeginSeg=Yes
120	by	_	_	_	_	_	_	_	_
121	oral	_	_	_	_	_	_	_	_
122	or	_	_	_	_	_	_	_	_
123	intranasal	_	_	_	_	_	_	_	_
124	inoculation	_	_	_	_	_	_	_	_
125	of	_	_	_	_	_	_	_	_
126	the	_	_	_	_	_	_	_	_
127	virus	_	_	_	_	_	_	_	_
128	were	_	_	_	_	_	_	_	BeginSeg=Yes
129	mild	_	_	_	_	_	_	_	_
130	compared	_	_	_	_	_	_	_	BeginSeg=Yes
131	with	_	_	_	_	_	_	_	_
132	those	_	_	_	_	_	_	_	_
133	induced	_	_	_	_	_	_	_	BeginSeg=Yes
134	by	_	_	_	_	_	_	_	_
135	intravenous	_	_	_	_	_	_	_	_
136	infection	_	_	_	_	_	_	_	_
137	.	_	_	_	_	_	_	_	_
138	Immunohistochemically	_	_	_	_	_	_	_	BeginSeg=Yes
139	,	_	_	_	_	_	_	_	_
140	the	_	_	_	_	_	_	_	_
141	distribution	_	_	_	_	_	_	_	_
142	of	_	_	_	_	_	_	_	_
143	PTV	_	_	_	_	_	_	_	_
144	antigens	_	_	_	_	_	_	_	_
145	corresponded	_	_	_	_	_	_	_	_
146	closely	_	_	_	_	_	_	_	_
147	with	_	_	_	_	_	_	_	_
148	the	_	_	_	_	_	_	_	_
149	distribution	_	_	_	_	_	_	_	_
150	of	_	_	_	_	_	_	_	_
151	brain	_	_	_	_	_	_	_	_
152	lesions	_	_	_	_	_	_	_	_
153	.	_	_	_	_	_	_	_	_
154	PTV	_	_	_	_	_	_	_	BeginSeg=Yes
155	particles	_	_	_	_	_	_	_	_
156	were	_	_	_	_	_	_	_	_
157	detected	_	_	_	_	_	_	_	_
158	via	_	_	_	_	_	_	_	_
159	electron	_	_	_	_	_	_	_	_
160	microscopy	_	_	_	_	_	_	_	_
161	in	_	_	_	_	_	_	_	_
162	the	_	_	_	_	_	_	_	_
163	cytoplasm	_	_	_	_	_	_	_	_
164	of	_	_	_	_	_	_	_	_
165	nerve	_	_	_	_	_	_	_	_
166	cells	_	_	_	_	_	_	_	_
167	and	_	_	_	_	_	_	_	_
168	the	_	_	_	_	_	_	_	_
169	endothelial	_	_	_	_	_	_	_	_
170	cells	_	_	_	_	_	_	_	_
171	of	_	_	_	_	_	_	_	_
172	blood	_	_	_	_	_	_	_	_
173	vessels	_	_	_	_	_	_	_	_
174	in	_	_	_	_	_	_	_	_
175	the	_	_	_	_	_	_	_	_
176	spinal	_	_	_	_	_	_	_	_
177	cord	_	_	_	_	_	_	_	_
178	of	_	_	_	_	_	_	_	_
179	inoculated	_	_	_	_	_	_	_	_
180	pigs	_	_	_	_	_	_	_	_
181	.	_	_	_	_	_	_	_	_
182	Polymerase	_	_	_	_	_	_	_	BeginSeg=Yes
183	chain	_	_	_	_	_	_	_	_
184	reaction	_	_	_	_	_	_	_	_
185	analysis	_	_	_	_	_	_	_	_
186	demonstrated	_	_	_	_	_	_	_	_
187	the	_	_	_	_	_	_	_	_
188	presence	_	_	_	_	_	_	_	_
189	of	_	_	_	_	_	_	_	_
190	PTV	_	_	_	_	_	_	_	_
191	RNA	_	_	_	_	_	_	_	_
192	in	_	_	_	_	_	_	_	_
193	the	_	_	_	_	_	_	_	_
194	CNS	_	_	_	_	_	_	_	_
195	,	_	_	_	_	_	_	_	_
196	tonsils	_	_	_	_	_	_	_	_
197	and	_	_	_	_	_	_	_	_
198	large	_	_	_	_	_	_	_	_
199	intestines	_	_	_	_	_	_	_	_
200	of	_	_	_	_	_	_	_	_
201	21	_	_	_	_	_	_	_	_
202	of	_	_	_	_	_	_	_	_
203	the	_	_	_	_	_	_	_	_
204	22	_	_	_	_	_	_	_	_
205	pigs	_	_	_	_	_	_	_	_
206	inoculated	_	_	_	_	_	_	_	_
207	.	_	_	_	_	_	_	_	_
208	Direct	_	_	_	_	_	_	_	BeginSeg=Yes
209	CNS	_	_	_	_	_	_	_	_
210	invasion	_	_	_	_	_	_	_	_
211	via	_	_	_	_	_	_	_	_
212	the	_	_	_	_	_	_	_	_
213	blood	_	_	_	_	_	_	_	_
214	vessels	_	_	_	_	_	_	_	_
215	appears	_	_	_	_	_	_	_	_
216	to	_	_	_	_	_	_	_	_
217	be	_	_	_	_	_	_	_	_
218	a	_	_	_	_	_	_	_	_
219	major	_	_	_	_	_	_	_	_
220	route	_	_	_	_	_	_	_	_
221	of	_	_	_	_	_	_	_	_
222	infection	_	_	_	_	_	_	_	_
223	for	_	_	_	_	_	_	_	_
224	PTV	_	_	_	_	_	_	_	_
225	.	_	_	_	_	_	_	_	_
226	The	_	_	_	_	_	_	_	BeginSeg=Yes
227	gnotobiotic	_	_	_	_	_	_	_	_
228	pig	_	_	_	_	_	_	_	_
229	provides	_	_	_	_	_	_	_	_
230	a	_	_	_	_	_	_	_	_
231	useful	_	_	_	_	_	_	_	_
232	model	_	_	_	_	_	_	_	_
233	for	_	_	_	_	_	_	_	_
234	further	_	_	_	_	_	_	_	_
235	study	_	_	_	_	_	_	_	_
236	of	_	_	_	_	_	_	_	_
237	PTV	_	_	_	_	_	_	_	_
238	pathogenesis	_	_	_	_	_	_	_	_
239	.	_	_	_	_	_	_	_	_

# newdoc_id = 8d0569b9fe93d0997ca38060117ffc6381122957
1	RNA	_	_	_	_	_	_	_	BeginSeg=Yes
2	interference	_	_	_	_	_	_	_	_
3	(	_	_	_	_	_	_	_	_
4	RNAi	_	_	_	_	_	_	_	_
5	)	_	_	_	_	_	_	_	_
6	is	_	_	_	_	_	_	_	_
7	a	_	_	_	_	_	_	_	_
8	process	_	_	_	_	_	_	_	_
9	in	_	_	_	_	_	_	_	BeginSeg=Yes
10	which	_	_	_	_	_	_	_	_
11	double	_	_	_	_	_	_	_	_
12	-	_	_	_	_	_	_	_	_
13	stranded	_	_	_	_	_	_	_	_
14	RNA	_	_	_	_	_	_	_	_
15	induces	_	_	_	_	_	_	_	_
16	the	_	_	_	_	_	_	_	_
17	post	_	_	_	_	_	_	_	_
18	-	_	_	_	_	_	_	_	_
19	transcriptional	_	_	_	_	_	_	_	_
20	sequence	_	_	_	_	_	_	_	_
21	-	_	_	_	_	_	_	_	_
22	specific	_	_	_	_	_	_	_	_
23	degradation	_	_	_	_	_	_	_	_
24	of	_	_	_	_	_	_	_	_
25	homologous	_	_	_	_	_	_	_	_
26	messenger	_	_	_	_	_	_	_	_
27	RNA	_	_	_	_	_	_	_	_
28	.	_	_	_	_	_	_	_	_
29	The	_	_	_	_	_	_	_	BeginSeg=Yes
30	present	_	_	_	_	_	_	_	_
31	study	_	_	_	_	_	_	_	_
32	was	_	_	_	_	_	_	_	_
33	carried	_	_	_	_	_	_	_	_
34	out	_	_	_	_	_	_	_	_
35	to	_	_	_	_	_	_	_	BeginSeg=Yes
36	apply	_	_	_	_	_	_	_	_
37	the	_	_	_	_	_	_	_	_
38	RNAi	_	_	_	_	_	_	_	_
39	technology	_	_	_	_	_	_	_	_
40	to	_	_	_	_	_	_	_	BeginSeg=Yes
41	inhibit	_	_	_	_	_	_	_	_
42	the	_	_	_	_	_	_	_	_
43	replication	_	_	_	_	_	_	_	_
44	of	_	_	_	_	_	_	_	_
45	feline	_	_	_	_	_	_	_	_
46	immunodeficiency	_	_	_	_	_	_	_	_
47	virus	_	_	_	_	_	_	_	_
48	(	_	_	_	_	_	_	_	_
49	FIV	_	_	_	_	_	_	_	_
50	)	_	_	_	_	_	_	_	_
51	.	_	_	_	_	_	_	_	_
52	Four	_	_	_	_	_	_	_	BeginSeg=Yes
53	small	_	_	_	_	_	_	_	_
54	interfering	_	_	_	_	_	_	_	_
55	RNAs	_	_	_	_	_	_	_	_
56	(	_	_	_	_	_	_	_	_
57	siRNAs	_	_	_	_	_	_	_	_
58	)	_	_	_	_	_	_	_	_
59	homologous	_	_	_	_	_	_	_	_
60	to	_	_	_	_	_	_	_	_
61	the	_	_	_	_	_	_	_	_
62	FIV	_	_	_	_	_	_	_	_
63	gag	_	_	_	_	_	_	_	_
64	gene	_	_	_	_	_	_	_	_
65	were	_	_	_	_	_	_	_	_
66	synthesized	_	_	_	_	_	_	_	_
67	and	_	_	_	_	_	_	_	BeginSeg=Yes
68	transfected	_	_	_	_	_	_	_	_
69	into	_	_	_	_	_	_	_	_
70	a	_	_	_	_	_	_	_	_
71	feline	_	_	_	_	_	_	_	_
72	fibroblastic	_	_	_	_	_	_	_	_
73	cell	_	_	_	_	_	_	_	_
74	line	_	_	_	_	_	_	_	_
75	chronically	_	_	_	_	_	_	_	BeginSeg=Yes
76	infected	_	_	_	_	_	_	_	_
77	with	_	_	_	_	_	_	_	_
78	FIV	_	_	_	_	_	_	_	_
79	(	_	_	_	_	_	_	_	_
80	CRFK	_	_	_	_	_	_	_	_
81	/	_	_	_	_	_	_	_	_
82	FIV	_	_	_	_	_	_	_	_
83	)	_	_	_	_	_	_	_	_
84	.	_	_	_	_	_	_	_	_
85	These	_	_	_	_	_	_	_	BeginSeg=Yes
86	synthetic	_	_	_	_	_	_	_	_
87	siRNAs	_	_	_	_	_	_	_	_
88	efficiently	_	_	_	_	_	_	_	_
89	inhibited	_	_	_	_	_	_	_	_
90	the	_	_	_	_	_	_	_	_
91	replication	_	_	_	_	_	_	_	_
92	of	_	_	_	_	_	_	_	_
93	FIV	_	_	_	_	_	_	_	_
94	.	_	_	_	_	_	_	_	_
95	Next	_	_	_	_	_	_	_	BeginSeg=Yes
96	,	_	_	_	_	_	_	_	_
97	we	_	_	_	_	_	_	_	_
98	examined	_	_	_	_	_	_	_	_
99	the	_	_	_	_	_	_	_	_
100	effect	_	_	_	_	_	_	_	_
101	of	_	_	_	_	_	_	_	_
102	retroviral	_	_	_	_	_	_	_	_
103	vector	_	_	_	_	_	_	_	_
104	-	_	_	_	_	_	_	_	_
105	mediated	_	_	_	_	_	_	_	_
106	transfer	_	_	_	_	_	_	_	_
107	of	_	_	_	_	_	_	_	_
108	FIVspecific	_	_	_	_	_	_	_	_
109	short	_	_	_	_	_	_	_	_
110	hairpin	_	_	_	_	_	_	_	_
111	RNA	_	_	_	_	_	_	_	_
112	(	_	_	_	_	_	_	_	_
113	shRNA	_	_	_	_	_	_	_	_
114	)	_	_	_	_	_	_	_	_
115	on	_	_	_	_	_	_	_	_
116	the	_	_	_	_	_	_	_	_
117	replication	_	_	_	_	_	_	_	_
118	of	_	_	_	_	_	_	_	_
119	FIV	_	_	_	_	_	_	_	_
120	in	_	_	_	_	_	_	_	_
121	a	_	_	_	_	_	_	_	_
122	feline	_	_	_	_	_	_	_	_
123	T	_	_	_	_	_	_	_	_
124	-	_	_	_	_	_	_	_	_
125	cell	_	_	_	_	_	_	_	_
126	line	_	_	_	_	_	_	_	_
127	chronically	_	_	_	_	_	_	_	BeginSeg=Yes
128	infected	_	_	_	_	_	_	_	_
129	with	_	_	_	_	_	_	_	_
130	FIV	_	_	_	_	_	_	_	_
131	(	_	_	_	_	_	_	_	_
132	FL4	_	_	_	_	_	_	_	_
133	)	_	_	_	_	_	_	_	_
134	.	_	_	_	_	_	_	_	_
135	The	_	_	_	_	_	_	_	BeginSeg=Yes
136	retroviral	_	_	_	_	_	_	_	_
137	vector	_	_	_	_	_	_	_	_
138	-	_	_	_	_	_	_	_	_
139	mediated	_	_	_	_	_	_	_	_
140	transfer	_	_	_	_	_	_	_	_
141	of	_	_	_	_	_	_	_	_
142	FIV	_	_	_	_	_	_	_	_
143	-	_	_	_	_	_	_	_	_
144	specific	_	_	_	_	_	_	_	_
145	shRNA	_	_	_	_	_	_	_	_
146	was	_	_	_	_	_	_	_	_
147	shown	_	_	_	_	_	_	_	_
148	to	_	_	_	_	_	_	_	_
149	markedly	_	_	_	_	_	_	_	_
150	inhibit	_	_	_	_	_	_	_	_
151	the	_	_	_	_	_	_	_	_
152	replication	_	_	_	_	_	_	_	_
153	of	_	_	_	_	_	_	_	_
154	FIV	_	_	_	_	_	_	_	_
155	in	_	_	_	_	_	_	_	_
156	the	_	_	_	_	_	_	_	_
157	FL4	_	_	_	_	_	_	_	_
158	cells	_	_	_	_	_	_	_	_
159	.	_	_	_	_	_	_	_	_
160	These	_	_	_	_	_	_	_	BeginSeg=Yes
161	results	_	_	_	_	_	_	_	_
162	provide	_	_	_	_	_	_	_	_
163	useful	_	_	_	_	_	_	_	_
164	information	_	_	_	_	_	_	_	_
165	for	_	_	_	_	_	_	_	_
166	the	_	_	_	_	_	_	_	_
167	development	_	_	_	_	_	_	_	_
168	of	_	_	_	_	_	_	_	_
169	RNAi	_	_	_	_	_	_	_	_
170	-	_	_	_	_	_	_	_	_
171	based	_	_	_	_	_	_	_	_
172	gene	_	_	_	_	_	_	_	_
173	therapy	_	_	_	_	_	_	_	_
174	strategy	_	_	_	_	_	_	_	_
175	to	_	_	_	_	_	_	_	BeginSeg=Yes
176	control	_	_	_	_	_	_	_	_
177	FIV	_	_	_	_	_	_	_	_
178	infection	_	_	_	_	_	_	_	_
179	.	_	_	_	_	_	_	_	_

# newdoc_id = 8e0331893b4854ecd4c22be2f4661f1c6e444405
1	Multilayer	_	_	_	_	_	_	_	BeginSeg=Yes
2	networks	_	_	_	_	_	_	_	_
3	proved	_	_	_	_	_	_	_	_
4	to	_	_	_	_	_	_	_	_
5	be	_	_	_	_	_	_	_	_
6	suitable	_	_	_	_	_	_	_	_
7	in	_	_	_	_	_	_	_	_
8	extracting	_	_	_	_	_	_	_	_
9	and	_	_	_	_	_	_	_	_
10	providing	_	_	_	_	_	_	_	_
11	dependency	_	_	_	_	_	_	_	_
12	information	_	_	_	_	_	_	_	_
13	of	_	_	_	_	_	_	_	_
14	different	_	_	_	_	_	_	_	_
15	complex	_	_	_	_	_	_	_	_
16	systems	_	_	_	_	_	_	_	_
17	.	_	_	_	_	_	_	_	_
18	The	_	_	_	_	_	_	_	BeginSeg=Yes
19	construction	_	_	_	_	_	_	_	_
20	of	_	_	_	_	_	_	_	_
21	these	_	_	_	_	_	_	_	_
22	networks	_	_	_	_	_	_	_	_
23	is	_	_	_	_	_	_	_	_
24	difficult	_	_	_	_	_	_	_	_
25	and	_	_	_	_	_	_	_	BeginSeg=Yes
26	is	_	_	_	_	_	_	_	_
27	mostly	_	_	_	_	_	_	_	_
28	done	_	_	_	_	_	_	_	_
29	with	_	_	_	_	_	_	_	_
30	a	_	_	_	_	_	_	_	_
31	static	_	_	_	_	_	_	_	_
32	approach	_	_	_	_	_	_	_	_
33	,	_	_	_	_	_	_	_	_
34	neglecting	_	_	_	_	_	_	_	BeginSeg=Yes
35	time	_	_	_	_	_	_	_	_
36	delayed	_	_	_	_	_	_	_	_
37	interdependences	_	_	_	_	_	_	_	_
38	.	_	_	_	_	_	_	_	_
39	Tensors	_	_	_	_	_	_	_	BeginSeg=Yes
40	are	_	_	_	_	_	_	_	_
41	objects	_	_	_	_	_	_	_	_
42	that	_	_	_	_	_	_	_	BeginSeg=Yes
43	naturally	_	_	_	_	_	_	_	_
44	represent	_	_	_	_	_	_	_	_
45	multilayer	_	_	_	_	_	_	_	_
46	networks	_	_	_	_	_	_	_	_
47	and	_	_	_	_	_	_	_	BeginSeg=Yes
48	in	_	_	_	_	_	_	_	_
49	this	_	_	_	_	_	_	_	_
50	paper	_	_	_	_	_	_	_	_
51	,	_	_	_	_	_	_	_	_
52	we	_	_	_	_	_	_	_	_
53	propose	_	_	_	_	_	_	_	_
54	a	_	_	_	_	_	_	_	_
55	new	_	_	_	_	_	_	_	_
56	methodology	_	_	_	_	_	_	_	_
57	based	_	_	_	_	_	_	_	BeginSeg=Yes
58	on	_	_	_	_	_	_	_	_
59	Tucker	_	_	_	_	_	_	_	_
60	tensor	_	_	_	_	_	_	_	_
61	autoregression	_	_	_	_	_	_	_	_
62	in	_	_	_	_	_	_	_	BeginSeg=Yes
63	order	_	_	_	_	_	_	_	_
64	to	_	_	_	_	_	_	_	_
65	build	_	_	_	_	_	_	_	_
66	a	_	_	_	_	_	_	_	_
67	multilayer	_	_	_	_	_	_	_	_
68	network	_	_	_	_	_	_	_	_
69	directly	_	_	_	_	_	_	_	_
70	from	_	_	_	_	_	_	_	_
71	data	_	_	_	_	_	_	_	_
72	.	_	_	_	_	_	_	_	_
73	This	_	_	_	_	_	_	_	BeginSeg=Yes
74	methodology	_	_	_	_	_	_	_	_
75	captures	_	_	_	_	_	_	_	_
76	within	_	_	_	_	_	_	_	_
77	and	_	_	_	_	_	_	_	_
78	between	_	_	_	_	_	_	_	_
79	connections	_	_	_	_	_	_	_	_
80	across	_	_	_	_	_	_	_	_
81	layers	_	_	_	_	_	_	_	_
82	and	_	_	_	_	_	_	_	BeginSeg=Yes
83	makes	_	_	_	_	_	_	_	_
84	use	_	_	_	_	_	_	_	_
85	of	_	_	_	_	_	_	_	_
86	a	_	_	_	_	_	_	_	_
87	filtering	_	_	_	_	_	_	_	_
88	procedure	_	_	_	_	_	_	_	_
89	to	_	_	_	_	_	_	_	BeginSeg=Yes
90	extract	_	_	_	_	_	_	_	_
91	relevant	_	_	_	_	_	_	_	_
92	information	_	_	_	_	_	_	_	_
93	and	_	_	_	_	_	_	_	BeginSeg=Yes
94	improve	_	_	_	_	_	_	_	_
95	visualization	_	_	_	_	_	_	_	_
96	.	_	_	_	_	_	_	_	_
97	We	_	_	_	_	_	_	_	BeginSeg=Yes
98	show	_	_	_	_	_	_	_	_
99	the	_	_	_	_	_	_	_	_
100	application	_	_	_	_	_	_	_	_
101	of	_	_	_	_	_	_	_	_
102	this	_	_	_	_	_	_	_	_
103	methodology	_	_	_	_	_	_	_	_
104	to	_	_	_	_	_	_	_	_
105	different	_	_	_	_	_	_	_	_
106	stationary	_	_	_	_	_	_	_	_
107	fractionally	_	_	_	_	_	_	_	_
108	differenced	_	_	_	_	_	_	_	_
109	financial	_	_	_	_	_	_	_	_
110	data	_	_	_	_	_	_	_	_
111	.	_	_	_	_	_	_	_	_
112	We	_	_	_	_	_	_	_	BeginSeg=Yes
113	argue	_	_	_	_	_	_	_	_
114	that	_	_	_	_	_	_	_	BeginSeg=Yes
115	our	_	_	_	_	_	_	_	_
116	result	_	_	_	_	_	_	_	_
117	is	_	_	_	_	_	_	_	_
118	useful	_	_	_	_	_	_	_	_
119	to	_	_	_	_	_	_	_	_
120	understand	_	_	_	_	_	_	_	_
121	the	_	_	_	_	_	_	_	_
122	dependencies	_	_	_	_	_	_	_	_
123	across	_	_	_	_	_	_	_	_
124	three	_	_	_	_	_	_	_	_
125	different	_	_	_	_	_	_	_	_
126	aspects	_	_	_	_	_	_	_	_
127	of	_	_	_	_	_	_	_	_
128	financial	_	_	_	_	_	_	_	_
129	risk	_	_	_	_	_	_	_	_
130	,	_	_	_	_	_	_	_	_
131	namely	_	_	_	_	_	_	_	BeginSeg=Yes
132	market	_	_	_	_	_	_	_	_
133	risk	_	_	_	_	_	_	_	_
134	,	_	_	_	_	_	_	_	_
135	liquidity	_	_	_	_	_	_	_	_
136	risk	_	_	_	_	_	_	_	_
137	,	_	_	_	_	_	_	_	_
138	and	_	_	_	_	_	_	_	_
139	volatility	_	_	_	_	_	_	_	_
140	risk	_	_	_	_	_	_	_	_
141	.	_	_	_	_	_	_	_	_
142	Indeed	_	_	_	_	_	_	_	BeginSeg=Yes
143	,	_	_	_	_	_	_	_	_
144	we	_	_	_	_	_	_	_	_
145	show	_	_	_	_	_	_	_	_
146	how	_	_	_	_	_	_	_	BeginSeg=Yes
147	the	_	_	_	_	_	_	_	_
148	resulting	_	_	_	_	_	_	_	_
149	visualization	_	_	_	_	_	_	_	_
150	is	_	_	_	_	_	_	_	_
151	a	_	_	_	_	_	_	_	_
152	useful	_	_	_	_	_	_	_	_
153	tool	_	_	_	_	_	_	_	_
154	for	_	_	_	_	_	_	_	_
155	risk	_	_	_	_	_	_	_	_
156	managers	_	_	_	_	_	_	_	_
157	depicting	_	_	_	_	_	_	_	BeginSeg=Yes
158	dependency	_	_	_	_	_	_	_	_
159	asymmetries	_	_	_	_	_	_	_	_
160	between	_	_	_	_	_	_	_	_
161	different	_	_	_	_	_	_	_	_
162	risk	_	_	_	_	_	_	_	_
163	factors	_	_	_	_	_	_	_	_
164	and	_	_	_	_	_	_	_	BeginSeg=Yes
165	accounting	_	_	_	_	_	_	_	_
166	for	_	_	_	_	_	_	_	_
167	delayed	_	_	_	_	_	_	_	_
168	cross	_	_	_	_	_	_	_	_
169	dependencies	_	_	_	_	_	_	_	_
170	.	_	_	_	_	_	_	_	_
171	The	_	_	_	_	_	_	_	BeginSeg=Yes
172	constructed	_	_	_	_	_	_	_	_
173	multilayer	_	_	_	_	_	_	_	_
174	network	_	_	_	_	_	_	_	_
175	shows	_	_	_	_	_	_	_	_
176	a	_	_	_	_	_	_	_	_
177	strong	_	_	_	_	_	_	_	_
178	interconnection	_	_	_	_	_	_	_	_
179	between	_	_	_	_	_	_	_	_
180	the	_	_	_	_	_	_	_	_
181	volumes	_	_	_	_	_	_	_	_
182	and	_	_	_	_	_	_	_	_
183	prices	_	_	_	_	_	_	_	_
184	layers	_	_	_	_	_	_	_	_
185	across	_	_	_	_	_	_	_	_
186	all	_	_	_	_	_	_	_	_
187	the	_	_	_	_	_	_	_	_
188	stocks	_	_	_	_	_	_	_	_
189	considered	_	_	_	_	_	_	_	_
190	while	_	_	_	_	_	_	_	BeginSeg=Yes
191	a	_	_	_	_	_	_	_	_
192	lower	_	_	_	_	_	_	_	_
193	number	_	_	_	_	_	_	_	_
194	of	_	_	_	_	_	_	_	_
195	interconnections	_	_	_	_	_	_	_	_
196	between	_	_	_	_	_	_	_	_
197	the	_	_	_	_	_	_	_	_
198	uncertainty	_	_	_	_	_	_	_	_
199	measures	_	_	_	_	_	_	_	_
200	is	_	_	_	_	_	_	_	_
201	identified	_	_	_	_	_	_	_	_
202	.	_	_	_	_	_	_	_	_

# newdoc_id = 8ed17fe60158dbfa61e3d0f39f2838d687bd6dd8
1	A	_	_	_	_	_	_	_	BeginSeg=Yes
2	novel	_	_	_	_	_	_	_	_
3	coronavirus	_	_	_	_	_	_	_	_
4	(	_	_	_	_	_	_	_	_
5	CoV	_	_	_	_	_	_	_	_
6	)	_	_	_	_	_	_	_	_
7	that	_	_	_	_	_	_	_	BeginSeg=Yes
8	causes	_	_	_	_	_	_	_	_
9	a	_	_	_	_	_	_	_	_
10	severe	_	_	_	_	_	_	_	_
11	lower	_	_	_	_	_	_	_	_
12	respiratory	_	_	_	_	_	_	_	_
13	tract	_	_	_	_	_	_	_	_
14	infection	_	_	_	_	_	_	_	_
15	in	_	_	_	_	_	_	_	_
16	humans	_	_	_	_	_	_	_	_
17	,	_	_	_	_	_	_	_	_
18	emerged	_	_	_	_	_	_	_	BeginSeg=Yes
19	in	_	_	_	_	_	_	_	_
20	the	_	_	_	_	_	_	_	_
21	Middle	_	_	_	_	_	_	_	_
22	East	_	_	_	_	_	_	_	_
23	region	_	_	_	_	_	_	_	_
24	in	_	_	_	_	_	_	_	_
25	2012	_	_	_	_	_	_	_	_
26	.	_	_	_	_	_	_	_	_
27	This	_	_	_	_	_	_	_	BeginSeg=Yes
28	virus	_	_	_	_	_	_	_	_
29	,	_	_	_	_	_	_	_	_
30	named	_	_	_	_	_	_	_	BeginSeg=Yes
31	Middle	_	_	_	_	_	_	_	_
32	East	_	_	_	_	_	_	_	_
33	respiratory	_	_	_	_	_	_	_	_
34	syndrome	_	_	_	_	_	_	_	_
35	(	_	_	_	_	_	_	_	_
36	MERS)-CoV	_	_	_	_	_	_	_	_
37	,	_	_	_	_	_	_	_	_
38	is	_	_	_	_	_	_	_	BeginSeg=Yes
39	phylogenetically	_	_	_	_	_	_	_	_
40	related	_	_	_	_	_	_	_	_
41	to	_	_	_	_	_	_	_	_
42	bat	_	_	_	_	_	_	_	_
43	CoVs	_	_	_	_	_	_	_	_
44	,	_	_	_	_	_	_	_	_
45	but	_	_	_	_	_	_	_	BeginSeg=Yes
46	other	_	_	_	_	_	_	_	_
47	animal	_	_	_	_	_	_	_	_
48	species	_	_	_	_	_	_	_	_
49	like	_	_	_	_	_	_	_	_
50	dromedary	_	_	_	_	_	_	_	_
51	camels	_	_	_	_	_	_	_	_
52	may	_	_	_	_	_	_	_	_
53	potentially	_	_	_	_	_	_	_	_
54	act	_	_	_	_	_	_	_	_
55	as	_	_	_	_	_	_	_	_
56	intermediate	_	_	_	_	_	_	_	_
57	hosts	_	_	_	_	_	_	_	_
58	by	_	_	_	_	_	_	_	BeginSeg=Yes
59	spreading	_	_	_	_	_	_	_	_
60	the	_	_	_	_	_	_	_	_
61	virus	_	_	_	_	_	_	_	_
62	to	_	_	_	_	_	_	_	_
63	humans	_	_	_	_	_	_	_	_
64	.	_	_	_	_	_	_	_	_
65	Although	_	_	_	_	_	_	_	BeginSeg=Yes
66	human	_	_	_	_	_	_	_	_
67	to	_	_	_	_	_	_	_	_
68	human	_	_	_	_	_	_	_	_
69	transmission	_	_	_	_	_	_	_	_
70	has	_	_	_	_	_	_	_	_
71	been	_	_	_	_	_	_	_	_
72	demonstrated	_	_	_	_	_	_	_	_
73	,	_	_	_	_	_	_	_	_
74	analysis	_	_	_	_	_	_	_	BeginSeg=Yes
75	of	_	_	_	_	_	_	_	_
76	human	_	_	_	_	_	_	_	_
77	MERS	_	_	_	_	_	_	_	_
78	clusters	_	_	_	_	_	_	_	_
79	indicated	_	_	_	_	_	_	_	_
80	that	_	_	_	_	_	_	_	BeginSeg=Yes
81	chains	_	_	_	_	_	_	_	_
82	of	_	_	_	_	_	_	_	_
83	transmission	_	_	_	_	_	_	_	_
84	were	_	_	_	_	_	_	_	_
85	not	_	_	_	_	_	_	_	_
86	self	_	_	_	_	_	_	_	_
87	-	_	_	_	_	_	_	_	_
88	sustaining	_	_	_	_	_	_	_	_
89	,	_	_	_	_	_	_	_	_
90	especially	_	_	_	_	_	_	_	BeginSeg=Yes
91	when	_	_	_	_	_	_	_	_
92	infection	_	_	_	_	_	_	_	_
93	control	_	_	_	_	_	_	_	_
94	was	_	_	_	_	_	_	_	_
95	implemented	_	_	_	_	_	_	_	_
96	.	_	_	_	_	_	_	_	_
97	Thus	_	_	_	_	_	_	_	BeginSeg=Yes
98	,	_	_	_	_	_	_	_	_
99	timely	_	_	_	_	_	_	_	_
100	identification	_	_	_	_	_	_	_	_
101	of	_	_	_	_	_	_	_	_
102	new	_	_	_	_	_	_	_	_
103	MERS	_	_	_	_	_	_	_	_
104	cases	_	_	_	_	_	_	_	_
105	followed	_	_	_	_	_	_	_	BeginSeg=Yes
106	by	_	_	_	_	_	_	_	_
107	their	_	_	_	_	_	_	_	_
108	quarantine	_	_	_	_	_	_	_	_
109	,	_	_	_	_	_	_	_	_
110	combined	_	_	_	_	_	_	_	BeginSeg=Yes
111	with	_	_	_	_	_	_	_	_
112	measures	_	_	_	_	_	_	_	_
113	to	_	_	_	_	_	_	_	BeginSeg=Yes
114	limit	_	_	_	_	_	_	_	_
115	spread	_	_	_	_	_	_	_	_
116	of	_	_	_	_	_	_	_	_
117	the	_	_	_	_	_	_	_	_
118	virus	_	_	_	_	_	_	_	_
119	from	_	_	_	_	_	_	_	_
120	the	_	_	_	_	_	_	_	_
121	(	_	_	_	_	_	_	_	_
122	intermediate	_	_	_	_	_	_	_	_
123	)	_	_	_	_	_	_	_	_
124	host	_	_	_	_	_	_	_	_
125	to	_	_	_	_	_	_	_	_
126	humans	_	_	_	_	_	_	_	_
127	,	_	_	_	_	_	_	_	_
128	may	_	_	_	_	_	_	_	BeginSeg=Yes
129	be	_	_	_	_	_	_	_	_
130	crucial	_	_	_	_	_	_	_	_
131	in	_	_	_	_	_	_	_	_
132	controlling	_	_	_	_	_	_	_	_
133	the	_	_	_	_	_	_	_	_
134	outbreak	_	_	_	_	_	_	_	_
135	of	_	_	_	_	_	_	_	_
136	this	_	_	_	_	_	_	_	_
137	emerging	_	_	_	_	_	_	_	_
138	CoV.	_	_	_	_	_	_	_	_

# newdoc_id = 90662d7dc7b09e018829ae2bc13e167b218931d8
1	Background	_	_	_	_	_	_	_	BeginSeg=Yes
2	:	_	_	_	_	_	_	_	_
3	Human	_	_	_	_	_	_	_	BeginSeg=Yes
4	monoclonal	_	_	_	_	_	_	_	_
5	antibodies	_	_	_	_	_	_	_	_
6	(	_	_	_	_	_	_	_	_
7	mAbs	_	_	_	_	_	_	_	_
8	)	_	_	_	_	_	_	_	_
9	generated	_	_	_	_	_	_	_	BeginSeg=Yes
10	as	_	_	_	_	_	_	_	_
11	a	_	_	_	_	_	_	_	_
12	result	_	_	_	_	_	_	_	_
13	of	_	_	_	_	_	_	_	_
14	the	_	_	_	_	_	_	_	_
15	immune	_	_	_	_	_	_	_	_
16	response	_	_	_	_	_	_	_	_
17	are	_	_	_	_	_	_	_	BeginSeg=Yes
18	likely	_	_	_	_	_	_	_	_
19	to	_	_	_	_	_	_	_	_
20	be	_	_	_	_	_	_	_	_
21	the	_	_	_	_	_	_	_	_
22	most	_	_	_	_	_	_	_	_
23	effective	_	_	_	_	_	_	_	_
24	therapeutic	_	_	_	_	_	_	_	_
25	antibodies	_	_	_	_	_	_	_	_
26	,	_	_	_	_	_	_	_	_
27	particularly	_	_	_	_	_	_	_	_
28	in	_	_	_	_	_	_	_	_
29	the	_	_	_	_	_	_	_	_
30	case	_	_	_	_	_	_	_	_
31	of	_	_	_	_	_	_	_	_
32	infectious	_	_	_	_	_	_	_	_
33	diseases	_	_	_	_	_	_	_	_
34	against	_	_	_	_	_	_	_	BeginSeg=Yes
35	which	_	_	_	_	_	_	_	_
36	the	_	_	_	_	_	_	_	_
37	immune	_	_	_	_	_	_	_	_
38	response	_	_	_	_	_	_	_	_
39	is	_	_	_	_	_	_	_	_
40	protective	_	_	_	_	_	_	_	_
41	.	_	_	_	_	_	_	_	_
42	Human	_	_	_	_	_	_	_	BeginSeg=Yes
43	cytomegalovirus	_	_	_	_	_	_	_	_
44	(	_	_	_	_	_	_	_	_
45	HCMV	_	_	_	_	_	_	_	_
46	)	_	_	_	_	_	_	_	_
47	is	_	_	_	_	_	_	_	_
48	an	_	_	_	_	_	_	_	_
49	ubiquitous	_	_	_	_	_	_	_	_
50	opportunistic	_	_	_	_	_	_	_	_
51	virus	_	_	_	_	_	_	_	_
52	that	_	_	_	_	_	_	_	BeginSeg=Yes
53	is	_	_	_	_	_	_	_	_
54	the	_	_	_	_	_	_	_	_
55	most	_	_	_	_	_	_	_	_
56	serious	_	_	_	_	_	_	_	_
57	pathogenic	_	_	_	_	_	_	_	_
58	agent	_	_	_	_	_	_	_	_
59	in	_	_	_	_	_	_	_	_
60	transplant	_	_	_	_	_	_	_	_
61	patients	_	_	_	_	_	_	_	_
62	.	_	_	_	_	_	_	_	_
63	The	_	_	_	_	_	_	_	BeginSeg=Yes
64	available	_	_	_	_	_	_	_	_
65	therapeutic	_	_	_	_	_	_	_	_
66	armamentarium	_	_	_	_	_	_	_	_
67	(	_	_	_	_	_	_	_	BeginSeg=Yes
68	e.g.	_	_	_	_	_	_	_	_
69	HCMV	_	_	_	_	_	_	_	_
70	hyperimmune	_	_	_	_	_	_	_	_
71	globulins	_	_	_	_	_	_	_	_
72	or	_	_	_	_	_	_	_	_
73	antivirals	_	_	_	_	_	_	_	_
74	)	_	_	_	_	_	_	_	_
75	is	_	_	_	_	_	_	_	BeginSeg=Yes
76	associated	_	_	_	_	_	_	_	_
77	with	_	_	_	_	_	_	_	_
78	severe	_	_	_	_	_	_	_	_
79	side	_	_	_	_	_	_	_	_
80	effects	_	_	_	_	_	_	_	_
81	and	_	_	_	_	_	_	_	_
82	the	_	_	_	_	_	_	_	_
83	emergence	_	_	_	_	_	_	_	_
84	of	_	_	_	_	_	_	_	_
85	drug	_	_	_	_	_	_	_	_
86	-	_	_	_	_	_	_	_	_
87	resistant	_	_	_	_	_	_	_	_
88	strains	_	_	_	_	_	_	_	_
89	;	_	_	_	_	_	_	_	_
90	therefore	_	_	_	_	_	_	_	BeginSeg=Yes
91	,	_	_	_	_	_	_	_	_
92	neutralizing	_	_	_	_	_	_	_	_
93	human	_	_	_	_	_	_	_	_
94	mAb	_	_	_	_	_	_	_	_
95	may	_	_	_	_	_	_	_	_
96	be	_	_	_	_	_	_	_	_
97	a	_	_	_	_	_	_	_	_
98	decisive	_	_	_	_	_	_	_	_
99	alternative	_	_	_	_	_	_	_	_
100	in	_	_	_	_	_	_	_	_
101	the	_	_	_	_	_	_	_	_
102	prevention	_	_	_	_	_	_	_	_
103	of	_	_	_	_	_	_	_	_
104	primary	_	_	_	_	_	_	_	_
105	and	_	_	_	_	_	_	_	_
106	re	_	_	_	_	_	_	_	_
107	-	_	_	_	_	_	_	_	_
108	activated	_	_	_	_	_	_	_	_
109	HCMV	_	_	_	_	_	_	_	_
110	infections	_	_	_	_	_	_	_	_
111	in	_	_	_	_	_	_	_	_
112	these	_	_	_	_	_	_	_	_
113	patients	_	_	_	_	_	_	_	_
114	.	_	_	_	_	_	_	_	_
115	The	_	_	_	_	_	_	_	BeginSeg=Yes
116	purpose	_	_	_	_	_	_	_	_
117	of	_	_	_	_	_	_	_	_
118	this	_	_	_	_	_	_	_	_
119	study	_	_	_	_	_	_	_	_
120	was	_	_	_	_	_	_	_	_
121	to	_	_	_	_	_	_	_	_
122	generate	_	_	_	_	_	_	_	_
123	neutralizing	_	_	_	_	_	_	_	_
124	mAb	_	_	_	_	_	_	_	_
125	against	_	_	_	_	_	_	_	_
126	HCMV	_	_	_	_	_	_	_	_
127	from	_	_	_	_	_	_	_	_
128	the	_	_	_	_	_	_	_	_
129	immunological	_	_	_	_	_	_	_	_
130	repertoire	_	_	_	_	_	_	_	_
131	of	_	_	_	_	_	_	_	_
132	immune	_	_	_	_	_	_	_	_
133	donors	_	_	_	_	_	_	_	_
134	.	_	_	_	_	_	_	_	_
135	To	_	_	_	_	_	_	_	BeginSeg=Yes
136	this	_	_	_	_	_	_	_	_
137	aim	_	_	_	_	_	_	_	_
138	,	_	_	_	_	_	_	_	_
139	we	_	_	_	_	_	_	_	_
140	designed	_	_	_	_	_	_	_	_
141	an	_	_	_	_	_	_	_	_
142	efficient	_	_	_	_	_	_	_	_
143	technology	_	_	_	_	_	_	_	_
144	relying	_	_	_	_	_	_	_	BeginSeg=Yes
145	on	_	_	_	_	_	_	_	_
146	two	_	_	_	_	_	_	_	_
147	discrete	_	_	_	_	_	_	_	_
148	and	_	_	_	_	_	_	_	_
149	sequential	_	_	_	_	_	_	_	_
150	steps	_	_	_	_	_	_	_	_
151	:	_	_	_	_	_	_	_	_
152	first	_	_	_	_	_	_	_	BeginSeg=Yes
153	,	_	_	_	_	_	_	_	_
154	human	_	_	_	_	_	_	_	_
155	B	_	_	_	_	_	_	_	_
156	-	_	_	_	_	_	_	_	_
157	lymphocytes	_	_	_	_	_	_	_	_
158	are	_	_	_	_	_	_	_	_
159	stimulated	_	_	_	_	_	_	_	_
160	with	_	_	_	_	_	_	_	_
161	TLR9-agonists	_	_	_	_	_	_	_	_
162	and	_	_	_	_	_	_	_	_
163	IL-2	_	_	_	_	_	_	_	_
164	;	_	_	_	_	_	_	_	_
165	second	_	_	_	_	_	_	_	BeginSeg=Yes
166	,	_	_	_	_	_	_	_	_
167	after	_	_	_	_	_	_	_	BeginSeg=Yes
168	both	_	_	_	_	_	_	_	_
169	additives	_	_	_	_	_	_	_	_
170	are	_	_	_	_	_	_	_	_
171	removed	_	_	_	_	_	_	_	_
172	,	_	_	_	_	_	_	_	_
173	the	_	_	_	_	_	_	_	BeginSeg=Yes
174	cells	_	_	_	_	_	_	_	_
175	are	_	_	_	_	_	_	_	_
176	infected	_	_	_	_	_	_	_	_
177	with	_	_	_	_	_	_	_	_
178	EBV	_	_	_	_	_	_	_	_
179	.	_	_	_	_	_	_	_	_
180	Using	_	_	_	_	_	_	_	BeginSeg=Yes
181	this	_	_	_	_	_	_	_	_
182	strategy	_	_	_	_	_	_	_	_
183	we	_	_	_	_	_	_	_	BeginSeg=Yes
184	obtained	_	_	_	_	_	_	_	_
185	29	_	_	_	_	_	_	_	_
186	clones	_	_	_	_	_	_	_	_
187	secreting	_	_	_	_	_	_	_	BeginSeg=Yes
188	IgG	_	_	_	_	_	_	_	_
189	neutralizing	_	_	_	_	_	_	_	BeginSeg=Yes
190	the	_	_	_	_	_	_	_	_
191	HCMV	_	_	_	_	_	_	_	_
192	infectivity	_	_	_	_	_	_	_	_
193	;	_	_	_	_	_	_	_	_
194	four	_	_	_	_	_	_	_	BeginSeg=Yes
195	among	_	_	_	_	_	_	_	_
196	these	_	_	_	_	_	_	_	_
197	were	_	_	_	_	_	_	_	_
198	further	_	_	_	_	_	_	_	_
199	characterized	_	_	_	_	_	_	_	_
200	.	_	_	_	_	_	_	_	_
201	All	_	_	_	_	_	_	_	BeginSeg=Yes
202	of	_	_	_	_	_	_	_	_
203	the	_	_	_	_	_	_	_	_
204	mAbs	_	_	_	_	_	_	_	_
205	neutralize	_	_	_	_	_	_	_	_
206	the	_	_	_	_	_	_	_	_
207	infection	_	_	_	_	_	_	_	_
208	in	_	_	_	_	_	_	_	_
209	different	_	_	_	_	_	_	_	_
210	combinations	_	_	_	_	_	_	_	_
211	of	_	_	_	_	_	_	_	_
212	HCMV	_	_	_	_	_	_	_	_
213	strains	_	_	_	_	_	_	_	_
214	and	_	_	_	_	_	_	_	_
215	target	_	_	_	_	_	_	_	_
216	cells	_	_	_	_	_	_	_	_
217	,	_	_	_	_	_	_	_	_
218	with	_	_	_	_	_	_	_	_
219	a	_	_	_	_	_	_	_	_
220	potency	_	_	_	_	_	_	_	_
221	~20	_	_	_	_	_	_	_	_
222	fold	_	_	_	_	_	_	_	_
223	higher	_	_	_	_	_	_	_	_
224	than	_	_	_	_	_	_	_	_
225	that	_	_	_	_	_	_	_	_
226	of	_	_	_	_	_	_	_	_
227	the	_	_	_	_	_	_	_	_
228	HCMV	_	_	_	_	_	_	_	_
229	hyperimmune	_	_	_	_	_	_	_	_
230	globulins	_	_	_	_	_	_	_	_
231	,	_	_	_	_	_	_	_	_
232	currently	_	_	_	_	_	_	_	BeginSeg=Yes
233	used	_	_	_	_	_	_	_	_
234	in	_	_	_	_	_	_	_	_
235	transplant	_	_	_	_	_	_	_	_
236	recipients	_	_	_	_	_	_	_	_
237	.	_	_	_	_	_	_	_	_
238	Recombinant	_	_	_	_	_	_	_	BeginSeg=Yes
239	human	_	_	_	_	_	_	_	_
240	monoclonal	_	_	_	_	_	_	_	_
241	IgG1	_	_	_	_	_	_	_	_
242	suitable	_	_	_	_	_	_	_	_
243	as	_	_	_	_	_	_	_	_
244	a	_	_	_	_	_	_	_	_
245	prophylactic	_	_	_	_	_	_	_	_
246	or	_	_	_	_	_	_	_	_
247	therapeutic	_	_	_	_	_	_	_	_
248	tool	_	_	_	_	_	_	_	_
249	in	_	_	_	_	_	_	_	_
250	clinical	_	_	_	_	_	_	_	_
251	applications	_	_	_	_	_	_	_	_
252	has	_	_	_	_	_	_	_	_
253	been	_	_	_	_	_	_	_	_
254	generated	_	_	_	_	_	_	_	_
255	.	_	_	_	_	_	_	_	_
256	The	_	_	_	_	_	_	_	BeginSeg=Yes
257	technology	_	_	_	_	_	_	_	_
258	described	_	_	_	_	_	_	_	_
259	has	_	_	_	_	_	_	_	_
260	proven	_	_	_	_	_	_	_	_
261	to	_	_	_	_	_	_	_	_
262	be	_	_	_	_	_	_	_	_
263	more	_	_	_	_	_	_	_	_
264	reproducible	_	_	_	_	_	_	_	_
265	,	_	_	_	_	_	_	_	_
266	efficient	_	_	_	_	_	_	_	_
267	and	_	_	_	_	_	_	_	_
268	rapid	_	_	_	_	_	_	_	_
269	than	_	_	_	_	_	_	_	_
270	previously	_	_	_	_	_	_	_	_
271	reported	_	_	_	_	_	_	_	_
272	techniques	_	_	_	_	_	_	_	_
273	,	_	_	_	_	_	_	_	_
274	and	_	_	_	_	_	_	_	BeginSeg=Yes
275	can	_	_	_	_	_	_	_	_
276	be	_	_	_	_	_	_	_	_
277	adopted	_	_	_	_	_	_	_	_
278	at	_	_	_	_	_	_	_	_
279	low	_	_	_	_	_	_	_	_
280	overall	_	_	_	_	_	_	_	_
281	costs	_	_	_	_	_	_	_	_
282	by	_	_	_	_	_	_	_	_
283	any	_	_	_	_	_	_	_	_
284	cell	_	_	_	_	_	_	_	_
285	biology	_	_	_	_	_	_	_	_
286	laboratory	_	_	_	_	_	_	_	_
287	for	_	_	_	_	_	_	_	_
288	the	_	_	_	_	_	_	_	_
289	development	_	_	_	_	_	_	_	_
290	of	_	_	_	_	_	_	_	_
291	fully	_	_	_	_	_	_	_	_
292	human	_	_	_	_	_	_	_	_
293	mAbs	_	_	_	_	_	_	_	_
294	for	_	_	_	_	_	_	_	_
295	immunotherapeutic	_	_	_	_	_	_	_	_
296	uses	_	_	_	_	_	_	_	_
297	.	_	_	_	_	_	_	_	_

# newdoc_id = 909b7a89053c834c12a9d4348e977e66c6116d42
1	Among	_	_	_	_	_	_	_	BeginSeg=Yes
2	coronaviruses	_	_	_	_	_	_	_	_
3	,	_	_	_	_	_	_	_	_
4	several	_	_	_	_	_	_	_	_
5	members	_	_	_	_	_	_	_	_
6	are	_	_	_	_	_	_	_	_
7	able	_	_	_	_	_	_	_	_
8	to	_	_	_	_	_	_	_	_
9	interact	_	_	_	_	_	_	_	_
10	with	_	_	_	_	_	_	_	_
11	sialic	_	_	_	_	_	_	_	_
12	acids	_	_	_	_	_	_	_	_
13	.	_	_	_	_	_	_	_	_
14	For	_	_	_	_	_	_	_	BeginSeg=Yes
15	bovine	_	_	_	_	_	_	_	_
16	coronavirus	_	_	_	_	_	_	_	_
17	(	_	_	_	_	_	_	_	_
18	BCoV	_	_	_	_	_	_	_	_
19	)	_	_	_	_	_	_	_	_
20	and	_	_	_	_	_	_	_	_
21	related	_	_	_	_	_	_	_	_
22	viruses	_	_	_	_	_	_	_	_
23	,	_	_	_	_	_	_	_	_
24	binding	_	_	_	_	_	_	_	_
25	to	_	_	_	_	_	_	_	_
26	cell	_	_	_	_	_	_	_	_
27	surface	_	_	_	_	_	_	_	_
28	components	_	_	_	_	_	_	_	_
29	containing	_	_	_	_	_	_	_	BeginSeg=Yes
30	N	_	_	_	_	_	_	_	_
31	-acetyl-9-O	_	_	_	_	_	_	_	_
32	-	_	_	_	_	_	_	_	_
33	acetylneuraminic	_	_	_	_	_	_	_	_
34	acid	_	_	_	_	_	_	_	_
35	is	_	_	_	_	_	_	_	BeginSeg=Yes
36	essential	_	_	_	_	_	_	_	_
37	for	_	_	_	_	_	_	_	_
38	initiation	_	_	_	_	_	_	_	_
39	of	_	_	_	_	_	_	_	_
40	an	_	_	_	_	_	_	_	_
41	infection	_	_	_	_	_	_	_	_
42	.	_	_	_	_	_	_	_	_
43	These	_	_	_	_	_	_	_	BeginSeg=Yes
44	viruses	_	_	_	_	_	_	_	_
45	resemble	_	_	_	_	_	_	_	_
46	influenza	_	_	_	_	_	_	_	_
47	C	_	_	_	_	_	_	_	_
48	viruses	_	_	_	_	_	_	_	_
49	because	_	_	_	_	_	_	_	BeginSeg=Yes
50	they	_	_	_	_	_	_	_	_
51	share	_	_	_	_	_	_	_	_
52	not	_	_	_	_	_	_	_	_
53	only	_	_	_	_	_	_	_	_
54	the	_	_	_	_	_	_	_	_
55	receptor	_	_	_	_	_	_	_	_
56	determinant	_	_	_	_	_	_	_	_
57	,	_	_	_	_	_	_	_	_
58	but	_	_	_	_	_	_	_	BeginSeg=Yes
59	also	_	_	_	_	_	_	_	_
60	the	_	_	_	_	_	_	_	_
61	presence	_	_	_	_	_	_	_	_
62	of	_	_	_	_	_	_	_	_
63	an	_	_	_	_	_	_	_	_
64	acetylesterase	_	_	_	_	_	_	_	_
65	that	_	_	_	_	_	_	_	BeginSeg=Yes
66	releases	_	_	_	_	_	_	_	_
67	the	_	_	_	_	_	_	_	_
68	9-O	_	_	_	_	_	_	_	_
69	-	_	_	_	_	_	_	_	_
70	acetyl	_	_	_	_	_	_	_	_
71	group	_	_	_	_	_	_	_	_
72	from	_	_	_	_	_	_	_	_
73	sialic	_	_	_	_	_	_	_	_
74	acid	_	_	_	_	_	_	_	_
75	and	_	_	_	_	_	_	_	BeginSeg=Yes
76	thus	_	_	_	_	_	_	_	_
77	abolishes	_	_	_	_	_	_	_	_
78	the	_	_	_	_	_	_	_	_
79	ability	_	_	_	_	_	_	_	_
80	of	_	_	_	_	_	_	_	_
81	the	_	_	_	_	_	_	_	_
82	respective	_	_	_	_	_	_	_	_
83	sialoglycoconjugate	_	_	_	_	_	_	_	_
84	to	_	_	_	_	_	_	_	_
85	function	_	_	_	_	_	_	_	_
86	as	_	_	_	_	_	_	_	_
87	a	_	_	_	_	_	_	_	_
88	receptor	_	_	_	_	_	_	_	_
89	for	_	_	_	_	_	_	_	_
90	BCoV.	_	_	_	_	_	_	_	_
91	As	_	_	_	_	_	_	_	BeginSeg=Yes
92	in	_	_	_	_	_	_	_	_
93	the	_	_	_	_	_	_	_	_
94	case	_	_	_	_	_	_	_	_
95	of	_	_	_	_	_	_	_	_
96	influenza	_	_	_	_	_	_	_	_
97	viruses	_	_	_	_	_	_	_	_
98	,	_	_	_	_	_	_	_	_
99	the	_	_	_	_	_	_	_	_
100	receptor	_	_	_	_	_	_	_	_
101	-	_	_	_	_	_	_	_	_
102	destroying	_	_	_	_	_	_	_	_
103	enzyme	_	_	_	_	_	_	_	_
104	of	_	_	_	_	_	_	_	_
105	BCoV	_	_	_	_	_	_	_	_
106	is	_	_	_	_	_	_	_	_
107	believed	_	_	_	_	_	_	_	_
108	to	_	_	_	_	_	_	_	_
109	facilitate	_	_	_	_	_	_	_	_
110	the	_	_	_	_	_	_	_	_
111	spread	_	_	_	_	_	_	_	_
112	of	_	_	_	_	_	_	_	_
113	virus	_	_	_	_	_	_	_	_
114	infection	_	_	_	_	_	_	_	_
115	by	_	_	_	_	_	_	_	BeginSeg=Yes
116	removing	_	_	_	_	_	_	_	_
117	receptor	_	_	_	_	_	_	_	_
118	determinants	_	_	_	_	_	_	_	_
119	from	_	_	_	_	_	_	_	_
120	the	_	_	_	_	_	_	_	_
121	surface	_	_	_	_	_	_	_	_
122	of	_	_	_	_	_	_	_	_
123	infected	_	_	_	_	_	_	_	_
124	cells	_	_	_	_	_	_	_	_
125	and	_	_	_	_	_	_	_	BeginSeg=Yes
126	by	_	_	_	_	_	_	_	_
127	preventing	_	_	_	_	_	_	_	_
128	the	_	_	_	_	_	_	_	_
129	formation	_	_	_	_	_	_	_	_
130	of	_	_	_	_	_	_	_	_
131	virus	_	_	_	_	_	_	_	_
132	aggregates	_	_	_	_	_	_	_	_
133	.	_	_	_	_	_	_	_	_
134	Another	_	_	_	_	_	_	_	BeginSeg=Yes
135	coronavirus	_	_	_	_	_	_	_	_
136	,	_	_	_	_	_	_	_	_
137	porcine	_	_	_	_	_	_	_	_
138	transmissible	_	_	_	_	_	_	_	_
139	gastroenteritis	_	_	_	_	_	_	_	_
140	virus	_	_	_	_	_	_	_	_
141	(	_	_	_	_	_	_	_	_
142	TGEV	_	_	_	_	_	_	_	_
143	)	_	_	_	_	_	_	_	_
144	preferentially	_	_	_	_	_	_	_	_
145	recognizes	_	_	_	_	_	_	_	_
146	N	_	_	_	_	_	_	_	_
147	-glycolylneuraminic	_	_	_	_	_	_	_	_
148	acid	_	_	_	_	_	_	_	_
149	.	_	_	_	_	_	_	_	_
150	TGEV	_	_	_	_	_	_	_	BeginSeg=Yes
151	does	_	_	_	_	_	_	_	_
152	not	_	_	_	_	_	_	_	_
153	contain	_	_	_	_	_	_	_	_
154	a	_	_	_	_	_	_	_	_
155	receptor	_	_	_	_	_	_	_	_
156	-	_	_	_	_	_	_	_	_
157	destroying	_	_	_	_	_	_	_	_
158	enzyme	_	_	_	_	_	_	_	_
159	and	_	_	_	_	_	_	_	BeginSeg=Yes
160	does	_	_	_	_	_	_	_	_
161	not	_	_	_	_	_	_	_	_
162	depend	_	_	_	_	_	_	_	_
163	on	_	_	_	_	_	_	_	_
164	the	_	_	_	_	_	_	_	_
165	sialic	_	_	_	_	_	_	_	_
166	acid	_	_	_	_	_	_	_	_
167	binding	_	_	_	_	_	_	_	_
168	activity	_	_	_	_	_	_	_	_
169	for	_	_	_	_	_	_	_	_
170	infection	_	_	_	_	_	_	_	_
171	of	_	_	_	_	_	_	_	_
172	cultured	_	_	_	_	_	_	_	_
173	cells	_	_	_	_	_	_	_	_
174	.	_	_	_	_	_	_	_	_
175	However	_	_	_	_	_	_	_	BeginSeg=Yes
176	,	_	_	_	_	_	_	_	_
177	binding	_	_	_	_	_	_	_	_
178	to	_	_	_	_	_	_	_	_
179	sialic	_	_	_	_	_	_	_	_
180	acids	_	_	_	_	_	_	_	_
181	is	_	_	_	_	_	_	_	_
182	required	_	_	_	_	_	_	_	_
183	for	_	_	_	_	_	_	_	_
184	the	_	_	_	_	_	_	_	_
185	enteropathogenicity	_	_	_	_	_	_	_	_
186	of	_	_	_	_	_	_	_	_
187	TGEV	_	_	_	_	_	_	_	_
188	.	_	_	_	_	_	_	_	_
189	Interaction	_	_	_	_	_	_	_	BeginSeg=Yes
190	with	_	_	_	_	_	_	_	_
191	sialoglycoconjugates	_	_	_	_	_	_	_	_
192	may	_	_	_	_	_	_	_	_
193	help	_	_	_	_	_	_	_	_
194	the	_	_	_	_	_	_	_	_
195	virus	_	_	_	_	_	_	_	_
196	to	_	_	_	_	_	_	_	_
197	pass	_	_	_	_	_	_	_	_
198	through	_	_	_	_	_	_	_	_
199	the	_	_	_	_	_	_	_	_
200	sialic	_	_	_	_	_	_	_	_
201	acid	_	_	_	_	_	_	_	_
202	-	_	_	_	_	_	_	_	_
203	rich	_	_	_	_	_	_	_	_
204	mucus	_	_	_	_	_	_	_	_
205	layer	_	_	_	_	_	_	_	_
206	that	_	_	_	_	_	_	_	BeginSeg=Yes
207	covers	_	_	_	_	_	_	_	_
208	the	_	_	_	_	_	_	_	_
209	viral	_	_	_	_	_	_	_	_
210	target	_	_	_	_	_	_	_	_
211	cells	_	_	_	_	_	_	_	_
212	in	_	_	_	_	_	_	_	_
213	the	_	_	_	_	_	_	_	_
214	epithelium	_	_	_	_	_	_	_	_
215	of	_	_	_	_	_	_	_	_
216	the	_	_	_	_	_	_	_	_
217	small	_	_	_	_	_	_	_	_
218	intestine	_	_	_	_	_	_	_	_
219	.	_	_	_	_	_	_	_	_
220	We	_	_	_	_	_	_	_	BeginSeg=Yes
221	discuss	_	_	_	_	_	_	_	_
222	that	_	_	_	_	_	_	_	BeginSeg=Yes
223	the	_	_	_	_	_	_	_	_
224	BCoV	_	_	_	_	_	_	_	_
225	group	_	_	_	_	_	_	_	_
226	of	_	_	_	_	_	_	_	_
227	viruses	_	_	_	_	_	_	_	_
228	may	_	_	_	_	_	_	_	_
229	have	_	_	_	_	_	_	_	_
230	evolved	_	_	_	_	_	_	_	_
231	from	_	_	_	_	_	_	_	_
232	a	_	_	_	_	_	_	_	_
233	TGEV	_	_	_	_	_	_	_	_
234	-	_	_	_	_	_	_	_	_
235	like	_	_	_	_	_	_	_	_
236	ancestor	_	_	_	_	_	_	_	_
237	by	_	_	_	_	_	_	_	BeginSeg=Yes
238	acquiring	_	_	_	_	_	_	_	_
239	an	_	_	_	_	_	_	_	_
240	acetylesterase	_	_	_	_	_	_	_	_
241	gene	_	_	_	_	_	_	_	_
242	through	_	_	_	_	_	_	_	_
243	heterologous	_	_	_	_	_	_	_	_
244	recombination	_	_	_	_	_	_	_	_
245	.	_	_	_	_	_	_	_	_

# newdoc_id = 91595c90cb3ae1139a1090369bab9b25abbf6f1d
1	Two	_	_	_	_	_	_	_	BeginSeg=Yes
2	recently	_	_	_	_	_	_	_	_
3	detected	_	_	_	_	_	_	_	_
4	viruses	_	_	_	_	_	_	_	_
5	,	_	_	_	_	_	_	_	_
6	human	_	_	_	_	_	_	_	_
7	metapneumovirus	_	_	_	_	_	_	_	_
8	(	_	_	_	_	_	_	_	_
9	hMPV	_	_	_	_	_	_	_	_
10	)	_	_	_	_	_	_	_	_
11	and	_	_	_	_	_	_	_	_
12	coronavirus	_	_	_	_	_	_	_	_
13	NL63	_	_	_	_	_	_	_	_
14	(	_	_	_	_	_	_	_	_
15	HCoV	_	_	_	_	_	_	_	_
16	-	_	_	_	_	_	_	_	_
17	NL63	_	_	_	_	_	_	_	_
18	)	_	_	_	_	_	_	_	_
19	,	_	_	_	_	_	_	_	_
20	have	_	_	_	_	_	_	_	_
21	been	_	_	_	_	_	_	_	_
22	associated	_	_	_	_	_	_	_	_
23	with	_	_	_	_	_	_	_	_
24	acute	_	_	_	_	_	_	_	_
25	respiratory	_	_	_	_	_	_	_	_
26	tract	_	_	_	_	_	_	_	_
27	infections	_	_	_	_	_	_	_	_
28	,	_	_	_	_	_	_	_	_
29	particularly	_	_	_	_	_	_	_	_
30	in	_	_	_	_	_	_	_	_
31	young	_	_	_	_	_	_	_	_
32	children	_	_	_	_	_	_	_	_
33	.	_	_	_	_	_	_	_	_
34	This	_	_	_	_	_	_	_	BeginSeg=Yes
35	study	_	_	_	_	_	_	_	_
36	investigated	_	_	_	_	_	_	_	_
37	the	_	_	_	_	_	_	_	_
38	frequency	_	_	_	_	_	_	_	_
39	of	_	_	_	_	_	_	_	_
40	hMPV	_	_	_	_	_	_	_	_
41	and	_	_	_	_	_	_	_	_
42	HCoV	_	_	_	_	_	_	_	_
43	-	_	_	_	_	_	_	_	_
44	NL63	_	_	_	_	_	_	_	_
45	infections	_	_	_	_	_	_	_	_
46	in	_	_	_	_	_	_	_	_
47	Swedish	_	_	_	_	_	_	_	_
48	children	_	_	_	_	_	_	_	_
49	by	_	_	_	_	_	_	_	BeginSeg=Yes
50	screening	_	_	_	_	_	_	_	_
51	221	_	_	_	_	_	_	_	_
52	nasopharyngeal	_	_	_	_	_	_	_	_
53	aspirates	_	_	_	_	_	_	_	_
54	,	_	_	_	_	_	_	_	_
55	collected	_	_	_	_	_	_	_	BeginSeg=Yes
56	between	_	_	_	_	_	_	_	_
57	November	_	_	_	_	_	_	_	_
58	2003	_	_	_	_	_	_	_	_
59	and	_	_	_	_	_	_	_	_
60	May	_	_	_	_	_	_	_	_
61	2005	_	_	_	_	_	_	_	_
62	,	_	_	_	_	_	_	_	_
63	from	_	_	_	_	_	_	_	BeginSeg=Yes
64	212	_	_	_	_	_	_	_	_
65	children	_	_	_	_	_	_	_	_
66	attending	_	_	_	_	_	_	_	BeginSeg=Yes
67	the	_	_	_	_	_	_	_	_
68	paediatric	_	_	_	_	_	_	_	_
69	department	_	_	_	_	_	_	_	_
70	of	_	_	_	_	_	_	_	_
71	a	_	_	_	_	_	_	_	_
72	county	_	_	_	_	_	_	_	_
73	hospital	_	_	_	_	_	_	_	_
74	in	_	_	_	_	_	_	_	_
75	Sweden	_	_	_	_	_	_	_	_
76	or	_	_	_	_	_	_	_	BeginSeg=Yes
77	submitted	_	_	_	_	_	_	_	_
78	from	_	_	_	_	_	_	_	_
79	local	_	_	_	_	_	_	_	_
80	general	_	_	_	_	_	_	_	_
81	practitioners	_	_	_	_	_	_	_	_
82	.	_	_	_	_	_	_	_	_
83	The	_	_	_	_	_	_	_	BeginSeg=Yes
84	samples	_	_	_	_	_	_	_	_
85	were	_	_	_	_	_	_	_	_
86	originally	_	_	_	_	_	_	_	_
87	submitted	_	_	_	_	_	_	_	_
88	to	_	_	_	_	_	_	_	BeginSeg=Yes
89	be	_	_	_	_	_	_	_	_
90	tested	_	_	_	_	_	_	_	_
91	for	_	_	_	_	_	_	_	_
92	respiratory	_	_	_	_	_	_	_	_
93	syncytial	_	_	_	_	_	_	_	_
94	virus	_	_	_	_	_	_	_	_
95	(	_	_	_	_	_	_	_	_
96	RSV	_	_	_	_	_	_	_	_
97	)	_	_	_	_	_	_	_	_
98	,	_	_	_	_	_	_	_	_
99	and	_	_	_	_	_	_	_	BeginSeg=Yes
100	were	_	_	_	_	_	_	_	_
101	examined	_	_	_	_	_	_	_	_
102	retrospectively	_	_	_	_	_	_	_	_
103	for	_	_	_	_	_	_	_	_
104	hMPV	_	_	_	_	_	_	_	_
105	and	_	_	_	_	_	_	_	_
106	HCoV	_	_	_	_	_	_	_	_
107	-	_	_	_	_	_	_	_	_
108	NL63	_	_	_	_	_	_	_	_
109	by	_	_	_	_	_	_	_	_
110	RT	_	_	_	_	_	_	_	_
111	-	_	_	_	_	_	_	_	_
112	PCR	_	_	_	_	_	_	_	_
113	.	_	_	_	_	_	_	_	_
114	Of	_	_	_	_	_	_	_	BeginSeg=Yes
115	the	_	_	_	_	_	_	_	_
116	212	_	_	_	_	_	_	_	_
117	patients	_	_	_	_	_	_	_	_
118	,	_	_	_	_	_	_	_	_
119	101	_	_	_	_	_	_	_	_
120	were	_	_	_	_	_	_	_	_
121	positive	_	_	_	_	_	_	_	_
122	for	_	_	_	_	_	_	_	_
123	RSV	_	_	_	_	_	_	_	_
124	(	_	_	_	_	_	_	_	BeginSeg=Yes
125	48	_	_	_	_	_	_	_	_
126	%	_	_	_	_	_	_	_	_
127	)	_	_	_	_	_	_	_	_
128	,	_	_	_	_	_	_	_	_
129	22	_	_	_	_	_	_	_	BeginSeg=Yes
130	(	_	_	_	_	_	_	_	BeginSeg=Yes
131	10	_	_	_	_	_	_	_	_
132	%	_	_	_	_	_	_	_	_
133	)	_	_	_	_	_	_	_	_
134	were	_	_	_	_	_	_	_	BeginSeg=Yes
135	positive	_	_	_	_	_	_	_	_
136	for	_	_	_	_	_	_	_	_
137	hMPV	_	_	_	_	_	_	_	_
138	,	_	_	_	_	_	_	_	_
139	and	_	_	_	_	_	_	_	BeginSeg=Yes
140	12	_	_	_	_	_	_	_	_
141	(	_	_	_	_	_	_	_	BeginSeg=Yes
142	6	_	_	_	_	_	_	_	_
143	%	_	_	_	_	_	_	_	_
144	)	_	_	_	_	_	_	_	_
145	were	_	_	_	_	_	_	_	BeginSeg=Yes
146	positive	_	_	_	_	_	_	_	_
147	for	_	_	_	_	_	_	_	_
148	HCoV	_	_	_	_	_	_	_	_
149	-	_	_	_	_	_	_	_	_
150	NL63	_	_	_	_	_	_	_	_
151	.	_	_	_	_	_	_	_	_
152	The	_	_	_	_	_	_	_	BeginSeg=Yes
153	frequency	_	_	_	_	_	_	_	_
154	of	_	_	_	_	_	_	_	_
155	HCoV	_	_	_	_	_	_	_	_
156	-	_	_	_	_	_	_	_	_
157	NL63	_	_	_	_	_	_	_	_
158	infection	_	_	_	_	_	_	_	_
159	increased	_	_	_	_	_	_	_	_
160	from	_	_	_	_	_	_	_	_
161	1	_	_	_	_	_	_	_	_
162	%	_	_	_	_	_	_	_	_
163	in	_	_	_	_	_	_	_	_
164	2003	_	_	_	_	_	_	_	_
165	-	_	_	_	_	_	_	_	_
166	2004	_	_	_	_	_	_	_	_
167	to	_	_	_	_	_	_	_	_
168	10	_	_	_	_	_	_	_	_
169	%	_	_	_	_	_	_	_	_
170	in	_	_	_	_	_	_	_	_
171	2004	_	_	_	_	_	_	_	_
172	-	_	_	_	_	_	_	_	_
173	2005	_	_	_	_	_	_	_	_
174	.	_	_	_	_	_	_	_	_
175	Sequence	_	_	_	_	_	_	_	BeginSeg=Yes
176	analysis	_	_	_	_	_	_	_	_
177	of	_	_	_	_	_	_	_	_
178	parts	_	_	_	_	_	_	_	_
179	of	_	_	_	_	_	_	_	_
180	the	_	_	_	_	_	_	_	_
181	coronavirus	_	_	_	_	_	_	_	_
182	genomes	_	_	_	_	_	_	_	_
183	showed	_	_	_	_	_	_	_	_
184	considerable	_	_	_	_	_	_	_	_
185	similarity	_	_	_	_	_	_	_	_
186	to	_	_	_	_	_	_	_	_
187	the	_	_	_	_	_	_	_	_
188	HCoV	_	_	_	_	_	_	_	_
189	-	_	_	_	_	_	_	_	_
190	NL63	_	_	_	_	_	_	_	_
191	prototype	_	_	_	_	_	_	_	_
192	sequence	_	_	_	_	_	_	_	_
193	.	_	_	_	_	_	_	_	_
194	The	_	_	_	_	_	_	_	BeginSeg=Yes
195	study	_	_	_	_	_	_	_	_
196	demonstrated	_	_	_	_	_	_	_	_
197	that	_	_	_	_	_	_	_	BeginSeg=Yes
198	HCoV	_	_	_	_	_	_	_	_
199	-	_	_	_	_	_	_	_	_
200	NL63	_	_	_	_	_	_	_	_
201	and	_	_	_	_	_	_	_	_
202	hMPV	_	_	_	_	_	_	_	_
203	occur	_	_	_	_	_	_	_	_
204	in	_	_	_	_	_	_	_	_
205	south	_	_	_	_	_	_	_	_
206	-	_	_	_	_	_	_	_	_
207	west	_	_	_	_	_	_	_	_
208	Sweden	_	_	_	_	_	_	_	_
209	with	_	_	_	_	_	_	_	_
210	essentially	_	_	_	_	_	_	_	_
211	the	_	_	_	_	_	_	_	_
212	same	_	_	_	_	_	_	_	_
213	frequency	_	_	_	_	_	_	_	_
214	,	_	_	_	_	_	_	_	_
215	seasonal	_	_	_	_	_	_	_	_
216	distribution	_	_	_	_	_	_	_	_
217	and	_	_	_	_	_	_	_	_
218	clinical	_	_	_	_	_	_	_	_
219	characteristics	_	_	_	_	_	_	_	_
220	as	_	_	_	_	_	_	_	BeginSeg=Yes
221	have	_	_	_	_	_	_	_	_
222	been	_	_	_	_	_	_	_	_
223	reported	_	_	_	_	_	_	_	_
224	in	_	_	_	_	_	_	_	_
225	other	_	_	_	_	_	_	_	_
226	countries	_	_	_	_	_	_	_	_
227	.	_	_	_	_	_	_	_	_

# newdoc_id = 94156e6941fe78191b5997cdeb10cb3fd06e1221
1	Background	_	_	_	_	_	_	_	BeginSeg=Yes
2	:	_	_	_	_	_	_	_	_
3	Acute	_	_	_	_	_	_	_	BeginSeg=Yes
4	viral	_	_	_	_	_	_	_	_
5	necrosis	_	_	_	_	_	_	_	_
6	virus	_	_	_	_	_	_	_	_
7	(	_	_	_	_	_	_	_	_
8	AVNV	_	_	_	_	_	_	_	_
9	)	_	_	_	_	_	_	_	_
10	is	_	_	_	_	_	_	_	_
11	the	_	_	_	_	_	_	_	_
12	causative	_	_	_	_	_	_	_	_
13	agent	_	_	_	_	_	_	_	_
14	of	_	_	_	_	_	_	_	_
15	a	_	_	_	_	_	_	_	_
16	serious	_	_	_	_	_	_	_	_
17	disease	_	_	_	_	_	_	_	_
18	resulting	_	_	_	_	_	_	_	BeginSeg=Yes
19	in	_	_	_	_	_	_	_	_
20	high	_	_	_	_	_	_	_	_
21	mortality	_	_	_	_	_	_	_	_
22	in	_	_	_	_	_	_	_	_
23	cultured	_	_	_	_	_	_	_	_
24	Chinese	_	_	_	_	_	_	_	_
25	scallops	_	_	_	_	_	_	_	_
26	,	_	_	_	_	_	_	_	_
27	Chlamys	_	_	_	_	_	_	_	_
28	farreri	_	_	_	_	_	_	_	_
29	.	_	_	_	_	_	_	_	_
30	We	_	_	_	_	_	_	_	BeginSeg=Yes
31	have	_	_	_	_	_	_	_	_
32	sequenced	_	_	_	_	_	_	_	_
33	and	_	_	_	_	_	_	_	_
34	analyzed	_	_	_	_	_	_	_	_
35	the	_	_	_	_	_	_	_	_
36	complete	_	_	_	_	_	_	_	_
37	genome	_	_	_	_	_	_	_	_
38	of	_	_	_	_	_	_	_	_
39	AVNV	_	_	_	_	_	_	_	_
40	.	_	_	_	_	_	_	_	_
41	Results	_	_	_	_	_	_	_	BeginSeg=Yes
42	:	_	_	_	_	_	_	_	_
43	The	_	_	_	_	_	_	_	BeginSeg=Yes
44	AVNV	_	_	_	_	_	_	_	_
45	genome	_	_	_	_	_	_	_	_
46	is	_	_	_	_	_	_	_	_
47	a	_	_	_	_	_	_	_	_
48	linear	_	_	_	_	_	_	_	_
49	,	_	_	_	_	_	_	_	_
50	double	_	_	_	_	_	_	_	_
51	-	_	_	_	_	_	_	_	_
52	stranded	_	_	_	_	_	_	_	_
53	DNA	_	_	_	_	_	_	_	_
54	molecule	_	_	_	_	_	_	_	_
55	of	_	_	_	_	_	_	_	_
56	210,993	_	_	_	_	_	_	_	_
57	bp	_	_	_	_	_	_	_	_
58	with	_	_	_	_	_	_	_	_
59	a	_	_	_	_	_	_	_	_
60	nucleotide	_	_	_	_	_	_	_	_
61	composition	_	_	_	_	_	_	_	_
62	of	_	_	_	_	_	_	_	_
63	38.5	_	_	_	_	_	_	_	_
64	%	_	_	_	_	_	_	_	_
65	G	_	_	_	_	_	_	_	_
66	+	_	_	_	_	_	_	_	_
67	C.	_	_	_	_	_	_	_	_
68	A	_	_	_	_	_	_	_	BeginSeg=Yes
69	total	_	_	_	_	_	_	_	_
70	of	_	_	_	_	_	_	_	_
71	123	_	_	_	_	_	_	_	_
72	open	_	_	_	_	_	_	_	_
73	reading	_	_	_	_	_	_	_	_
74	frames	_	_	_	_	_	_	_	_
75	were	_	_	_	_	_	_	_	_
76	predicted	_	_	_	_	_	_	_	_
77	to	_	_	_	_	_	_	_	BeginSeg=Yes
78	encode	_	_	_	_	_	_	_	_
79	functional	_	_	_	_	_	_	_	_
80	proteins	_	_	_	_	_	_	_	_
81	,	_	_	_	_	_	_	_	_
82	ranging	_	_	_	_	_	_	_	BeginSeg=Yes
83	from	_	_	_	_	_	_	_	_
84	41	_	_	_	_	_	_	_	_
85	to	_	_	_	_	_	_	_	_
86	1,878	_	_	_	_	_	_	_	_
87	amino	_	_	_	_	_	_	_	_
88	acid	_	_	_	_	_	_	_	_
89	residues	_	_	_	_	_	_	_	_
90	.	_	_	_	_	_	_	_	_
91	The	_	_	_	_	_	_	_	BeginSeg=Yes
92	DNA	_	_	_	_	_	_	_	_
93	sequence	_	_	_	_	_	_	_	_
94	of	_	_	_	_	_	_	_	_
95	AVNV	_	_	_	_	_	_	_	_
96	is	_	_	_	_	_	_	_	_
97	97	_	_	_	_	_	_	_	_
98	%	_	_	_	_	_	_	_	_
99	identical	_	_	_	_	_	_	_	_
100	to	_	_	_	_	_	_	_	_
101	that	_	_	_	_	_	_	_	_
102	of	_	_	_	_	_	_	_	_
103	ostreid	_	_	_	_	_	_	_	_
104	herpesvirus	_	_	_	_	_	_	_	_
105	1	_	_	_	_	_	_	_	_
106	(	_	_	_	_	_	_	_	_
107	OsHV-1	_	_	_	_	_	_	_	_
108	)	_	_	_	_	_	_	_	_
109	,	_	_	_	_	_	_	_	_
110	and	_	_	_	_	_	_	_	BeginSeg=Yes
111	the	_	_	_	_	_	_	_	_
112	amino	_	_	_	_	_	_	_	_
113	acid	_	_	_	_	_	_	_	_
114	sequences	_	_	_	_	_	_	_	_
115	of	_	_	_	_	_	_	_	_
116	the	_	_	_	_	_	_	_	_
117	encoded	_	_	_	_	_	_	_	_
118	proteins	_	_	_	_	_	_	_	_
119	of	_	_	_	_	_	_	_	_
120	these	_	_	_	_	_	_	_	_
121	two	_	_	_	_	_	_	_	_
122	viruses	_	_	_	_	_	_	_	_
123	are	_	_	_	_	_	_	_	_
124	94	_	_	_	_	_	_	_	_
125	-	_	_	_	_	_	_	_	_
126	100	_	_	_	_	_	_	_	_
127	%	_	_	_	_	_	_	_	_
128	identical	_	_	_	_	_	_	_	_
129	.	_	_	_	_	_	_	_	_
130	The	_	_	_	_	_	_	_	BeginSeg=Yes
131	genomic	_	_	_	_	_	_	_	_
132	organization	_	_	_	_	_	_	_	_
133	of	_	_	_	_	_	_	_	_
134	AVNV	_	_	_	_	_	_	_	_
135	is	_	_	_	_	_	_	_	_
136	similar	_	_	_	_	_	_	_	_
137	to	_	_	_	_	_	_	_	_
138	that	_	_	_	_	_	_	_	_
139	of	_	_	_	_	_	_	_	_
140	OsHV-1	_	_	_	_	_	_	_	_
141	,	_	_	_	_	_	_	_	_
142	and	_	_	_	_	_	_	_	BeginSeg=Yes
143	consists	_	_	_	_	_	_	_	_
144	of	_	_	_	_	_	_	_	_
145	two	_	_	_	_	_	_	_	_
146	unique	_	_	_	_	_	_	_	_
147	regions	_	_	_	_	_	_	_	_
148	(	_	_	_	_	_	_	_	BeginSeg=Yes
149	170.4	_	_	_	_	_	_	_	_
150	kb	_	_	_	_	_	_	_	_
151	and	_	_	_	_	_	_	_	_
152	3.4	_	_	_	_	_	_	_	_
153	kb	_	_	_	_	_	_	_	_
154	,	_	_	_	_	_	_	_	_
155	respectively	_	_	_	_	_	_	_	_
156	)	_	_	_	_	_	_	_	_
157	,	_	_	_	_	_	_	_	_
158	each	_	_	_	_	_	_	_	BeginSeg=Yes
159	flanked	_	_	_	_	_	_	_	_
160	by	_	_	_	_	_	_	_	_
161	two	_	_	_	_	_	_	_	_
162	inverted	_	_	_	_	_	_	_	_
163	repeats	_	_	_	_	_	_	_	_
164	(	_	_	_	_	_	_	_	BeginSeg=Yes
165	7.6	_	_	_	_	_	_	_	_
166	kb	_	_	_	_	_	_	_	_
167	and	_	_	_	_	_	_	_	_
168	10.2	_	_	_	_	_	_	_	_
169	kb	_	_	_	_	_	_	_	_
170	,	_	_	_	_	_	_	_	_
171	respectively	_	_	_	_	_	_	_	_
172	)	_	_	_	_	_	_	_	_
173	,	_	_	_	_	_	_	_	_
174	with	_	_	_	_	_	_	_	BeginSeg=Yes
175	a	_	_	_	_	_	_	_	_
176	third	_	_	_	_	_	_	_	_
177	unique	_	_	_	_	_	_	_	_
178	region	_	_	_	_	_	_	_	_
179	(	_	_	_	_	_	_	_	BeginSeg=Yes
180	1.5	_	_	_	_	_	_	_	_
181	kb	_	_	_	_	_	_	_	_
182	)	_	_	_	_	_	_	_	_
183	situated	_	_	_	_	_	_	_	BeginSeg=Yes
184	between	_	_	_	_	_	_	_	_
185	the	_	_	_	_	_	_	_	_
186	two	_	_	_	_	_	_	_	_
187	internal	_	_	_	_	_	_	_	_
188	repeats	_	_	_	_	_	_	_	_
189	.	_	_	_	_	_	_	_	_
190	Conclusions	_	_	_	_	_	_	_	BeginSeg=Yes
191	:	_	_	_	_	_	_	_	_
192	Our	_	_	_	_	_	_	_	BeginSeg=Yes
193	results	_	_	_	_	_	_	_	_
194	indicate	_	_	_	_	_	_	_	_
195	that	_	_	_	_	_	_	_	BeginSeg=Yes
196	AVNV	_	_	_	_	_	_	_	_
197	is	_	_	_	_	_	_	_	_
198	a	_	_	_	_	_	_	_	_
199	variant	_	_	_	_	_	_	_	_
200	of	_	_	_	_	_	_	_	_
201	OsHV-1	_	_	_	_	_	_	_	_
202	.	_	_	_	_	_	_	_	_
203	The	_	_	_	_	_	_	_	BeginSeg=Yes
204	AVNV	_	_	_	_	_	_	_	_
205	genome	_	_	_	_	_	_	_	_
206	sequence	_	_	_	_	_	_	_	_
207	provides	_	_	_	_	_	_	_	_
208	information	_	_	_	_	_	_	_	_
209	useful	_	_	_	_	_	_	_	BeginSeg=Yes
210	for	_	_	_	_	_	_	_	_
211	understanding	_	_	_	_	_	_	_	_
212	the	_	_	_	_	_	_	_	_
213	evolution	_	_	_	_	_	_	_	_
214	and	_	_	_	_	_	_	_	_
215	divergence	_	_	_	_	_	_	_	_
216	of	_	_	_	_	_	_	_	_
217	OsHV-1	_	_	_	_	_	_	_	_
218	in	_	_	_	_	_	_	_	_
219	marine	_	_	_	_	_	_	_	_
220	molluscs	_	_	_	_	_	_	_	_
221	.	_	_	_	_	_	_	_	_

# newdoc_id = 97adff711db916914190dd5fde9ec4923a13f46d
1	Rheum	_	_	_	_	_	_	_	BeginSeg=Yes
2	palmatum	_	_	_	_	_	_	_	_
3	,	_	_	_	_	_	_	_	_
4	Chinese	_	_	_	_	_	_	_	_
5	traditional	_	_	_	_	_	_	_	_
6	herb	_	_	_	_	_	_	_	_
7	,	_	_	_	_	_	_	_	_
8	exhibits	_	_	_	_	_	_	_	_
9	a	_	_	_	_	_	_	_	_
10	great	_	_	_	_	_	_	_	_
11	variety	_	_	_	_	_	_	_	_
12	of	_	_	_	_	_	_	_	_
13	anti	_	_	_	_	_	_	_	_
14	-	_	_	_	_	_	_	_	_
15	cancer	_	_	_	_	_	_	_	_
16	and	_	_	_	_	_	_	_	_
17	anti	_	_	_	_	_	_	_	_
18	-	_	_	_	_	_	_	_	_
19	viruses	_	_	_	_	_	_	_	_
20	properties	_	_	_	_	_	_	_	_
21	.	_	_	_	_	_	_	_	_
22	This	_	_	_	_	_	_	_	BeginSeg=Yes
23	study	_	_	_	_	_	_	_	_
24	rates	_	_	_	_	_	_	_	_
25	antiviral	_	_	_	_	_	_	_	_
26	activity	_	_	_	_	_	_	_	_
27	of	_	_	_	_	_	_	_	_
28	R.	_	_	_	_	_	_	_	_
29	palmatum	_	_	_	_	_	_	_	_
30	extracts	_	_	_	_	_	_	_	_
31	and	_	_	_	_	_	_	_	_
32	its	_	_	_	_	_	_	_	_
33	components	_	_	_	_	_	_	_	_
34	against	_	_	_	_	_	_	_	_
35	Japanese	_	_	_	_	_	_	_	_
36	encephalitis	_	_	_	_	_	_	_	_
37	virus	_	_	_	_	_	_	_	_
38	(	_	_	_	_	_	_	_	_
39	JEV	_	_	_	_	_	_	_	_
40	)	_	_	_	_	_	_	_	_
41	in	_	_	_	_	_	_	_	_
42	vitro	_	_	_	_	_	_	_	_
43	.	_	_	_	_	_	_	_	_
44	Methanol	_	_	_	_	_	_	_	BeginSeg=Yes
45	extract	_	_	_	_	_	_	_	_
46	of	_	_	_	_	_	_	_	_
47	R.	_	_	_	_	_	_	_	_
48	palmatum	_	_	_	_	_	_	_	_
49	contained	_	_	_	_	_	_	_	_
50	higher	_	_	_	_	_	_	_	_
51	levels	_	_	_	_	_	_	_	_
52	of	_	_	_	_	_	_	_	_
53	aloe	_	_	_	_	_	_	_	_
54	emodin	_	_	_	_	_	_	_	_
55	,	_	_	_	_	_	_	_	_
56	chrysophanol	_	_	_	_	_	_	_	_
57	,	_	_	_	_	_	_	_	_
58	rhein	_	_	_	_	_	_	_	_
59	,	_	_	_	_	_	_	_	_
60	emodin	_	_	_	_	_	_	_	_
61	and	_	_	_	_	_	_	_	_
62	physcion	_	_	_	_	_	_	_	_
63	than	_	_	_	_	_	_	_	_
64	water	_	_	_	_	_	_	_	_
65	extract	_	_	_	_	_	_	_	_
66	.	_	_	_	_	_	_	_	_
67	Methanol	_	_	_	_	_	_	_	BeginSeg=Yes
68	extract	_	_	_	_	_	_	_	_
69	(	_	_	_	_	_	_	_	BeginSeg=Yes
70	IC	_	_	_	_	_	_	_	_
71	50	_	_	_	_	_	_	_	_
72	=	_	_	_	_	_	_	_	_
73	15.04	_	_	_	_	_	_	_	_
74	lg	_	_	_	_	_	_	_	_
75	/	_	_	_	_	_	_	_	_
76	ml	_	_	_	_	_	_	_	_
77	)	_	_	_	_	_	_	_	_
78	exhibited	_	_	_	_	_	_	_	BeginSeg=Yes
79	more	_	_	_	_	_	_	_	_
80	potent	_	_	_	_	_	_	_	_
81	inhibitory	_	_	_	_	_	_	_	_
82	effects	_	_	_	_	_	_	_	_
83	on	_	_	_	_	_	_	_	_
84	JEV	_	_	_	_	_	_	_	_
85	plaque	_	_	_	_	_	_	_	_
86	reduction	_	_	_	_	_	_	_	_
87	than	_	_	_	_	_	_	_	_
88	water	_	_	_	_	_	_	_	_
89	extract	_	_	_	_	_	_	_	_
90	(	_	_	_	_	_	_	_	BeginSeg=Yes
91	IC	_	_	_	_	_	_	_	_
92	50	_	_	_	_	_	_	_	_
93	=	_	_	_	_	_	_	_	_
94	51.41	_	_	_	_	_	_	_	_
95	lg	_	_	_	_	_	_	_	_
96	/	_	_	_	_	_	_	_	_
97	ml	_	_	_	_	_	_	_	_
98	)	_	_	_	_	_	_	_	_
99	.	_	_	_	_	_	_	_	_
100	Meanwhile	_	_	_	_	_	_	_	BeginSeg=Yes
101	,	_	_	_	_	_	_	_	_
102	IC	_	_	_	_	_	_	_	_
103	50	_	_	_	_	_	_	_	_
104	values	_	_	_	_	_	_	_	_
105	determined	_	_	_	_	_	_	_	BeginSeg=Yes
106	by	_	_	_	_	_	_	_	_
107	plaque	_	_	_	_	_	_	_	_
108	reduction	_	_	_	_	_	_	_	_
109	assay	_	_	_	_	_	_	_	_
110	were	_	_	_	_	_	_	_	BeginSeg=Yes
111	15.82	_	_	_	_	_	_	_	_
112	lg	_	_	_	_	_	_	_	_
113	/	_	_	_	_	_	_	_	_
114	ml	_	_	_	_	_	_	_	_
115	for	_	_	_	_	_	_	_	_
116	chrysophanol	_	_	_	_	_	_	_	_
117	and	_	_	_	_	_	_	_	_
118	17.39	_	_	_	_	_	_	_	_
119	lg	_	_	_	_	_	_	_	_
120	/	_	_	_	_	_	_	_	_
121	ml	_	_	_	_	_	_	_	_
122	for	_	_	_	_	_	_	_	_
123	aloe	_	_	_	_	_	_	_	_
124	-	_	_	_	_	_	_	_	_
125	emodin	_	_	_	_	_	_	_	_
126	,	_	_	_	_	_	_	_	_
127	respectively	_	_	_	_	_	_	_	_
128	.	_	_	_	_	_	_	_	_
129	Virucidal	_	_	_	_	_	_	_	BeginSeg=Yes
130	activity	_	_	_	_	_	_	_	_
131	of	_	_	_	_	_	_	_	_
132	agents	_	_	_	_	_	_	_	_
133	correlated	_	_	_	_	_	_	_	_
134	with	_	_	_	_	_	_	_	_
135	anti	_	_	_	_	_	_	_	_
136	-	_	_	_	_	_	_	_	_
137	JEV	_	_	_	_	_	_	_	_
138	activity	_	_	_	_	_	_	_	_
139	,	_	_	_	_	_	_	_	_
140	while	_	_	_	_	_	_	_	BeginSeg=Yes
141	virucidal	_	_	_	_	_	_	_	_
142	IC	_	_	_	_	_	_	_	_
143	50	_	_	_	_	_	_	_	_
144	values	_	_	_	_	_	_	_	_
145	were	_	_	_	_	_	_	_	_
146	7.58	_	_	_	_	_	_	_	_
147	lg	_	_	_	_	_	_	_	_
148	/	_	_	_	_	_	_	_	_
149	ml	_	_	_	_	_	_	_	_
150	for	_	_	_	_	_	_	_	_
151	methanol	_	_	_	_	_	_	_	_
152	extract	_	_	_	_	_	_	_	_
153	,	_	_	_	_	_	_	_	_
154	17.36	_	_	_	_	_	_	_	_
155	lg	_	_	_	_	_	_	_	_
156	/	_	_	_	_	_	_	_	_
157	ml	_	_	_	_	_	_	_	_
158	for	_	_	_	_	_	_	_	_
159	water	_	_	_	_	_	_	_	_
160	extract	_	_	_	_	_	_	_	_
161	,	_	_	_	_	_	_	_	_
162	0.75	_	_	_	_	_	_	_	_
163	lg	_	_	_	_	_	_	_	_
164	/	_	_	_	_	_	_	_	_
165	ml	_	_	_	_	_	_	_	_
166	for	_	_	_	_	_	_	_	_
167	chrysophanol	_	_	_	_	_	_	_	_
168	and	_	_	_	_	_	_	_	_
169	0.46	_	_	_	_	_	_	_	_
170	lg	_	_	_	_	_	_	_	_
171	/	_	_	_	_	_	_	_	_
172	ml	_	_	_	_	_	_	_	_
173	for	_	_	_	_	_	_	_	_
174	aloe	_	_	_	_	_	_	_	_
175	-	_	_	_	_	_	_	_	_
176	emodin	_	_	_	_	_	_	_	_
177	,	_	_	_	_	_	_	_	_
178	respectively	_	_	_	_	_	_	_	_
179	.	_	_	_	_	_	_	_	_
180	In	_	_	_	_	_	_	_	BeginSeg=Yes
181	addition	_	_	_	_	_	_	_	_
182	,	_	_	_	_	_	_	_	_
183	10	_	_	_	_	_	_	_	_
184	lg	_	_	_	_	_	_	_	_
185	/	_	_	_	_	_	_	_	_
186	ml	_	_	_	_	_	_	_	_
187	of	_	_	_	_	_	_	_	_
188	extract	_	_	_	_	_	_	_	_
189	,	_	_	_	_	_	_	_	_
190	chrysophanol	_	_	_	_	_	_	_	_
191	or	_	_	_	_	_	_	_	_
192	aloe	_	_	_	_	_	_	_	_
193	emodin	_	_	_	_	_	_	_	_
194	caused	_	_	_	_	_	_	_	_
195	90	_	_	_	_	_	_	_	_
196	%	_	_	_	_	_	_	_	_
197	inhibition	_	_	_	_	_	_	_	_
198	of	_	_	_	_	_	_	_	_
199	JEV	_	_	_	_	_	_	_	_
200	yields	_	_	_	_	_	_	_	_
201	in	_	_	_	_	_	_	_	_
202	cells	_	_	_	_	_	_	_	_
203	and	_	_	_	_	_	_	_	BeginSeg=Yes
204	significantly	_	_	_	_	_	_	_	_
205	activated	_	_	_	_	_	_	_	_
206	gamma	_	_	_	_	_	_	_	_
207	activated	_	_	_	_	_	_	_	_
208	sequence	_	_	_	_	_	_	_	_
209	-	_	_	_	_	_	_	_	_
210	driven	_	_	_	_	_	_	_	_
211	promoters	_	_	_	_	_	_	_	_
212	.	_	_	_	_	_	_	_	_
213	Hence	_	_	_	_	_	_	_	BeginSeg=Yes
214	,	_	_	_	_	_	_	_	_
215	methanol	_	_	_	_	_	_	_	_
216	extract	_	_	_	_	_	_	_	_
217	of	_	_	_	_	_	_	_	_
218	R.	_	_	_	_	_	_	_	_
219	palmatum	_	_	_	_	_	_	_	_
220	and	_	_	_	_	_	_	_	_
221	chrysophanol	_	_	_	_	_	_	_	_
222	with	_	_	_	_	_	_	_	_
223	high	_	_	_	_	_	_	_	_
224	therapeutic	_	_	_	_	_	_	_	_
225	index	_	_	_	_	_	_	_	_
226	might	_	_	_	_	_	_	_	_
227	be	_	_	_	_	_	_	_	_
228	useful	_	_	_	_	_	_	_	_
229	for	_	_	_	_	_	_	_	_
230	development	_	_	_	_	_	_	_	_
231	of	_	_	_	_	_	_	_	_
232	antiviral	_	_	_	_	_	_	_	_
233	agents	_	_	_	_	_	_	_	_
234	against	_	_	_	_	_	_	_	_
235	JEV	_	_	_	_	_	_	_	_
236	.	_	_	_	_	_	_	_	_

# newdoc_id = 980c48327d3bfbfcb0373fdbef063cd1a3d1d339
1	Pathology	_	_	_	_	_	_	_	BeginSeg=Yes
2	practice	_	_	_	_	_	_	_	_
3	is	_	_	_	_	_	_	_	_
4	increasingly	_	_	_	_	_	_	_	_
5	augmented	_	_	_	_	_	_	_	_
6	with	_	_	_	_	_	_	_	_
7	molecular	_	_	_	_	_	_	_	_
8	tests	_	_	_	_	_	_	_	_
9	for	_	_	_	_	_	_	_	_
10	improved	_	_	_	_	_	_	_	_
11	diagnostics	_	_	_	_	_	_	_	_
12	and	_	_	_	_	_	_	_	_
13	patient	_	_	_	_	_	_	_	_
14	management	_	_	_	_	_	_	_	_
15	.	_	_	_	_	_	_	_	_
16	The	_	_	_	_	_	_	_	BeginSeg=Yes
17	polymerase	_	_	_	_	_	_	_	_
18	chain	_	_	_	_	_	_	_	_
19	reaction	_	_	_	_	_	_	_	_
20	(	_	_	_	_	_	_	_	_
21	PCR	_	_	_	_	_	_	_	_
22	)	_	_	_	_	_	_	_	_
23	is	_	_	_	_	_	_	_	_
24	foremost	_	_	_	_	_	_	_	_
25	amongst	_	_	_	_	_	_	_	_
26	these	_	_	_	_	_	_	_	_
27	techniques	_	_	_	_	_	_	_	_
28	.	_	_	_	_	_	_	_	_
29	This	_	_	_	_	_	_	_	BeginSeg=Yes
30	review	_	_	_	_	_	_	_	_
31	explains	_	_	_	_	_	_	_	_
32	the	_	_	_	_	_	_	_	_
33	principles	_	_	_	_	_	_	_	_
34	of	_	_	_	_	_	_	_	_
35	PCR	_	_	_	_	_	_	_	_
36	and	_	_	_	_	_	_	_	_
37	the	_	_	_	_	_	_	_	_
38	methodological	_	_	_	_	_	_	_	_
39	factors	_	_	_	_	_	_	_	_
40	that	_	_	_	_	_	_	_	BeginSeg=Yes
41	contribute	_	_	_	_	_	_	_	_
42	to	_	_	_	_	_	_	_	_
43	a	_	_	_	_	_	_	_	_
44	successful	_	_	_	_	_	_	_	_
45	assay	_	_	_	_	_	_	_	_
46	.	_	_	_	_	_	_	_	_
47	Key	_	_	_	_	_	_	_	BeginSeg=Yes
48	PCR	_	_	_	_	_	_	_	_
49	technique	_	_	_	_	_	_	_	_
50	variations	_	_	_	_	_	_	_	_
51	,	_	_	_	_	_	_	_	_
52	such	_	_	_	_	_	_	_	BeginSeg=Yes
53	as	_	_	_	_	_	_	_	_
54	reverse	_	_	_	_	_	_	_	_
55	transcription	_	_	_	_	_	_	_	_
56	(	_	_	_	_	_	_	_	_
57	RT)-PCR	_	_	_	_	_	_	_	_
58	and	_	_	_	_	_	_	_	_
59	quantitative	_	_	_	_	_	_	_	_
60	real	_	_	_	_	_	_	_	_
61	-	_	_	_	_	_	_	_	_
62	time	_	_	_	_	_	_	_	_
63	(	_	_	_	_	_	_	_	_
64	q	_	_	_	_	_	_	_	_
65	)	_	_	_	_	_	_	_	_
66	PCR	_	_	_	_	_	_	_	_
67	,	_	_	_	_	_	_	_	_
68	are	_	_	_	_	_	_	_	BeginSeg=Yes
69	described	_	_	_	_	_	_	_	_
70	and	_	_	_	_	_	_	_	BeginSeg=Yes
71	an	_	_	_	_	_	_	_	_
72	overview	_	_	_	_	_	_	_	_
73	is	_	_	_	_	_	_	_	_
74	provided	_	_	_	_	_	_	_	_
75	of	_	_	_	_	_	_	_	BeginSeg=Yes
76	how	_	_	_	_	_	_	_	_
77	PCR	_	_	_	_	_	_	_	_
78	products	_	_	_	_	_	_	_	_
79	are	_	_	_	_	_	_	_	_
80	analysed	_	_	_	_	_	_	_	_
81	.	_	_	_	_	_	_	_	_
82	The	_	_	_	_	_	_	_	BeginSeg=Yes
83	review	_	_	_	_	_	_	_	_
84	includes	_	_	_	_	_	_	_	_
85	examples	_	_	_	_	_	_	_	_
86	of	_	_	_	_	_	_	_	_
87	PCR	_	_	_	_	_	_	_	_
88	usage	_	_	_	_	_	_	_	_
89	in	_	_	_	_	_	_	_	_
90	clinical	_	_	_	_	_	_	_	_
91	practice	_	_	_	_	_	_	_	_
92	for	_	_	_	_	_	_	_	_
93	the	_	_	_	_	_	_	_	_
94	detection	_	_	_	_	_	_	_	_
95	of	_	_	_	_	_	_	_	_
96	infectious	_	_	_	_	_	_	_	_
97	and	_	_	_	_	_	_	_	_
98	genetic	_	_	_	_	_	_	_	_
99	diseases	_	_	_	_	_	_	_	_
100	,	_	_	_	_	_	_	_	_
101	for	_	_	_	_	_	_	_	_
102	tumour	_	_	_	_	_	_	_	_
103	diagnostics	_	_	_	_	_	_	_	_
104	and	_	_	_	_	_	_	_	_
105	in	_	_	_	_	_	_	_	_
106	molecular	_	_	_	_	_	_	_	_
107	forensic	_	_	_	_	_	_	_	_
108	applications	_	_	_	_	_	_	_	_
109	such	_	_	_	_	_	_	_	BeginSeg=Yes
110	as	_	_	_	_	_	_	_	_
111	specimen	_	_	_	_	_	_	_	_
112	identity	_	_	_	_	_	_	_	_
113	confirmation	_	_	_	_	_	_	_	_
114	.	_	_	_	_	_	_	_	_
115	The	_	_	_	_	_	_	_	BeginSeg=Yes
116	polymerase	_	_	_	_	_	_	_	_
117	chain	_	_	_	_	_	_	_	_
118	reaction	_	_	_	_	_	_	_	_
119	(	_	_	_	_	_	_	_	_
120	PCR	_	_	_	_	_	_	_	_
121	)	_	_	_	_	_	_	_	_
122	is	_	_	_	_	_	_	_	_
123	a	_	_	_	_	_	_	_	_
124	method	_	_	_	_	_	_	_	_
125	for	_	_	_	_	_	_	_	_
126	the	_	_	_	_	_	_	_	_
127	in	_	_	_	_	_	_	_	_
128	vitro	_	_	_	_	_	_	_	_
129	amplification	_	_	_	_	_	_	_	_
130	of	_	_	_	_	_	_	_	_
131	DNA	_	_	_	_	_	_	_	_
132	sequences	_	_	_	_	_	_	_	_
133	and	_	_	_	_	_	_	_	BeginSeg=Yes
134	involves	_	_	_	_	_	_	_	_
135	automated	_	_	_	_	_	_	_	_
136	cycles	_	_	_	_	_	_	_	_
137	of	_	_	_	_	_	_	_	_
138	denaturation	_	_	_	_	_	_	_	_
139	,	_	_	_	_	_	_	_	_
140	annealing	_	_	_	_	_	_	_	_
141	and	_	_	_	_	_	_	_	_
142	extension	_	_	_	_	_	_	_	_
143	or	_	_	_	_	_	_	_	_
144	synthesis	_	_	_	_	_	_	_	_
145	using	_	_	_	_	_	_	_	BeginSeg=Yes
146	a	_	_	_	_	_	_	_	_
147	thermocycler	_	_	_	_	_	_	_	_
148	.	_	_	_	_	_	_	_	_
149	PCR	_	_	_	_	_	_	_	BeginSeg=Yes
150	was	_	_	_	_	_	_	_	_
151	conceived	_	_	_	_	_	_	_	_
152	and	_	_	_	_	_	_	_	_
153	developed	_	_	_	_	_	_	_	_
154	in	_	_	_	_	_	_	_	_
155	the	_	_	_	_	_	_	_	_
156	early	_	_	_	_	_	_	_	_
157	1980s	_	_	_	_	_	_	_	_
158	by	_	_	_	_	_	_	_	_
159	Kary	_	_	_	_	_	_	_	_
160	Mullis	_	_	_	_	_	_	_	_
161	,	_	_	_	_	_	_	_	_
162	who	_	_	_	_	_	_	_	BeginSeg=Yes
163	was	_	_	_	_	_	_	_	_
164	awarded	_	_	_	_	_	_	_	_
165	the	_	_	_	_	_	_	_	_
166	Nobel	_	_	_	_	_	_	_	_
167	Prize	_	_	_	_	_	_	_	_
168	for	_	_	_	_	_	_	_	_
169	Chemistry	_	_	_	_	_	_	_	_
170	for	_	_	_	_	_	_	_	_
171	the	_	_	_	_	_	_	_	_
172	invention	_	_	_	_	_	_	_	_
173	in	_	_	_	_	_	_	_	_
174	1993	_	_	_	_	_	_	_	_
175	.	_	_	_	_	_	_	_	_
176	1	_	_	_	_	_	_	_	_
177	The	_	_	_	_	_	_	_	BeginSeg=Yes
178	technique	_	_	_	_	_	_	_	_
179	allows	_	_	_	_	_	_	_	_
180	the	_	_	_	_	_	_	_	_
181	sensitive	_	_	_	_	_	_	_	_
182	detection	_	_	_	_	_	_	_	_
183	and	_	_	_	_	_	_	_	_
184	analysis	_	_	_	_	_	_	_	_
185	of	_	_	_	_	_	_	_	_
186	miniscule	_	_	_	_	_	_	_	_
187	quantities	_	_	_	_	_	_	_	_
188	of	_	_	_	_	_	_	_	_
189	nucleic	_	_	_	_	_	_	_	_
190	acids	_	_	_	_	_	_	_	_
191	.	_	_	_	_	_	_	_	_
192	PCR	_	_	_	_	_	_	_	BeginSeg=Yes
193	has	_	_	_	_	_	_	_	_
194	become	_	_	_	_	_	_	_	_
195	established	_	_	_	_	_	_	_	_
196	as	_	_	_	_	_	_	_	_
197	a	_	_	_	_	_	_	_	_
198	routine	_	_	_	_	_	_	_	_
199	method	_	_	_	_	_	_	_	_
200	in	_	_	_	_	_	_	_	_
201	pathology	_	_	_	_	_	_	_	_
202	diagnostics	_	_	_	_	_	_	_	_
203	and	_	_	_	_	_	_	_	BeginSeg=Yes
204	has	_	_	_	_	_	_	_	_
205	been	_	_	_	_	_	_	_	_
206	adapted	_	_	_	_	_	_	_	_
207	for	_	_	_	_	_	_	_	_
208	the	_	_	_	_	_	_	_	_
209	detection	_	_	_	_	_	_	_	_
210	of	_	_	_	_	_	_	_	_
211	infectious	_	_	_	_	_	_	_	_
212	agents	_	_	_	_	_	_	_	_
213	,	_	_	_	_	_	_	_	_
214	mutations	_	_	_	_	_	_	_	_
215	,	_	_	_	_	_	_	_	_
216	translocations	_	_	_	_	_	_	_	_
217	and	_	_	_	_	_	_	_	_
218	gene	_	_	_	_	_	_	_	_
219	amplifications	_	_	_	_	_	_	_	_
220	,	_	_	_	_	_	_	_	_
221	and	_	_	_	_	_	_	_	_
222	for	_	_	_	_	_	_	_	_
223	molecular	_	_	_	_	_	_	_	_
224	forensic	_	_	_	_	_	_	_	_
225	applications	_	_	_	_	_	_	_	_
226	including	_	_	_	_	_	_	_	BeginSeg=Yes
227	identity	_	_	_	_	_	_	_	_
228	testing	_	_	_	_	_	_	_	_
229	.	_	_	_	_	_	_	_	_
230	This	_	_	_	_	_	_	_	BeginSeg=Yes
231	review	_	_	_	_	_	_	_	_
232	covers	_	_	_	_	_	_	_	_
233	the	_	_	_	_	_	_	_	_
234	basics	_	_	_	_	_	_	_	_
235	of	_	_	_	_	_	_	_	_
236	the	_	_	_	_	_	_	_	_
237	PCR	_	_	_	_	_	_	_	_
238	assay	_	_	_	_	_	_	_	_
239	,	_	_	_	_	_	_	_	_
240	describes	_	_	_	_	_	_	_	BeginSeg=Yes
241	PCR	_	_	_	_	_	_	_	_
242	method	_	_	_	_	_	_	_	_
243	variations	_	_	_	_	_	_	_	_
244	and	_	_	_	_	_	_	_	BeginSeg=Yes
245	details	_	_	_	_	_	_	_	_
246	current	_	_	_	_	_	_	_	_
247	pathology	_	_	_	_	_	_	_	_
248	applications	_	_	_	_	_	_	_	_
249	.	_	_	_	_	_	_	_	_

# newdoc_id = 998006100007fee546077ce3c05ded0d35d08ff8
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	goal	_	_	_	_	_	_	_	_
3	of	_	_	_	_	_	_	_	_
4	this	_	_	_	_	_	_	_	_
5	article	_	_	_	_	_	_	_	_
6	is	_	_	_	_	_	_	_	_
7	to	_	_	_	_	_	_	_	_
8	analyze	_	_	_	_	_	_	_	_
9	some	_	_	_	_	_	_	_	_
10	compartmental	_	_	_	_	_	_	_	_
11	models	_	_	_	_	_	_	_	_
12	specially	_	_	_	_	_	_	_	BeginSeg=Yes
13	designed	_	_	_	_	_	_	_	_
14	to	_	_	_	_	_	_	_	BeginSeg=Yes
15	model	_	_	_	_	_	_	_	_
16	the	_	_	_	_	_	_	_	_
17	spread	_	_	_	_	_	_	_	_
18	of	_	_	_	_	_	_	_	_
19	a	_	_	_	_	_	_	_	_
20	disease	_	_	_	_	_	_	_	_
21	whose	_	_	_	_	_	_	_	BeginSeg=Yes
22	transmission	_	_	_	_	_	_	_	_
23	has	_	_	_	_	_	_	_	_
24	the	_	_	_	_	_	_	_	_
25	same	_	_	_	_	_	_	_	_
26	features	_	_	_	_	_	_	_	_
27	as	_	_	_	_	_	_	_	_
28	COVID-19	_	_	_	_	_	_	_	_
29	.	_	_	_	_	_	_	_	_
30	The	_	_	_	_	_	_	_	BeginSeg=Yes
31	major	_	_	_	_	_	_	_	_
32	contributions	_	_	_	_	_	_	_	_
33	of	_	_	_	_	_	_	_	_
34	this	_	_	_	_	_	_	_	_
35	article	_	_	_	_	_	_	_	_
36	are	_	_	_	_	_	_	_	_
37	:	_	_	_	_	_	_	_	_
38	(	_	_	_	_	_	_	_	BeginSeg=Yes
39	1	_	_	_	_	_	_	_	_
40	)	_	_	_	_	_	_	_	_
41	Rigorously	_	_	_	_	_	_	_	_
42	find	_	_	_	_	_	_	_	_
43	sufficient	_	_	_	_	_	_	_	_
44	conditions	_	_	_	_	_	_	_	_
45	for	_	_	_	_	_	_	_	_
46	the	_	_	_	_	_	_	_	_
47	outbreak	_	_	_	_	_	_	_	_
48	to	_	_	_	_	_	_	_	_
49	only	_	_	_	_	_	_	_	_
50	have	_	_	_	_	_	_	_	_
51	one	_	_	_	_	_	_	_	_
52	peak	_	_	_	_	_	_	_	_
53	,	_	_	_	_	_	_	_	_
54	i.e.	_	_	_	_	_	_	_	BeginSeg=Yes
55	for	_	_	_	_	_	_	_	_
56	no	_	_	_	_	_	_	_	_
57	second	_	_	_	_	_	_	_	_
58	wave	_	_	_	_	_	_	_	_
59	of	_	_	_	_	_	_	_	_
60	infection	_	_	_	_	_	_	_	_
61	to	_	_	_	_	_	_	_	_
62	form	_	_	_	_	_	_	_	_
63	;	_	_	_	_	_	_	_	_
64	(	_	_	_	_	_	_	_	BeginSeg=Yes
65	2	_	_	_	_	_	_	_	_
66	)	_	_	_	_	_	_	_	_
67	Investigate	_	_	_	_	_	_	_	_
68	the	_	_	_	_	_	_	_	_
69	formation	_	_	_	_	_	_	_	_
70	of	_	_	_	_	_	_	_	_
71	other	_	_	_	_	_	_	_	_
72	waves	_	_	_	_	_	_	_	_
73	of	_	_	_	_	_	_	_	_
74	infection	_	_	_	_	_	_	_	_
75	when	_	_	_	_	_	_	_	BeginSeg=Yes
76	such	_	_	_	_	_	_	_	_
77	conditions	_	_	_	_	_	_	_	_
78	are	_	_	_	_	_	_	_	_
79	not	_	_	_	_	_	_	_	_
80	met	_	_	_	_	_	_	_	_
81	;	_	_	_	_	_	_	_	_
82	(	_	_	_	_	_	_	_	BeginSeg=Yes
83	3	_	_	_	_	_	_	_	_
84	)	_	_	_	_	_	_	_	_
85	Use	_	_	_	_	_	_	_	_
86	numerical	_	_	_	_	_	_	_	_
87	simulations	_	_	_	_	_	_	_	_
88	to	_	_	_	_	_	_	_	BeginSeg=Yes
89	analyze	_	_	_	_	_	_	_	_
90	the	_	_	_	_	_	_	_	_
91	different	_	_	_	_	_	_	_	_
92	roles	_	_	_	_	_	_	_	_
93	asymptomatic	_	_	_	_	_	_	_	BeginSeg=Yes
94	carriers	_	_	_	_	_	_	_	_
95	can	_	_	_	_	_	_	_	_
96	have	_	_	_	_	_	_	_	_
97	.	_	_	_	_	_	_	_	_
98	We	_	_	_	_	_	_	_	BeginSeg=Yes
99	also	_	_	_	_	_	_	_	_
100	argue	_	_	_	_	_	_	_	_
101	that	_	_	_	_	_	_	_	BeginSeg=Yes
102	dividing	_	_	_	_	_	_	_	_
103	the	_	_	_	_	_	_	_	_
104	population	_	_	_	_	_	_	_	_
105	into	_	_	_	_	_	_	_	_
106	non	_	_	_	_	_	_	_	_
107	-	_	_	_	_	_	_	_	_
108	interacting	_	_	_	_	_	_	_	_
109	groups	_	_	_	_	_	_	_	_
110	leads	_	_	_	_	_	_	_	_
111	to	_	_	_	_	_	_	_	_
112	an	_	_	_	_	_	_	_	_
113	effective	_	_	_	_	_	_	_	_
114	reduction	_	_	_	_	_	_	_	_
115	of	_	_	_	_	_	_	_	_
116	the	_	_	_	_	_	_	_	_
117	transmission	_	_	_	_	_	_	_	_
118	rates	_	_	_	_	_	_	_	_
119	.	_	_	_	_	_	_	_	_
120	As	_	_	_	_	_	_	_	BeginSeg=Yes
121	in	_	_	_	_	_	_	_	_
122	any	_	_	_	_	_	_	_	_
123	compartmental	_	_	_	_	_	_	_	_
124	model	_	_	_	_	_	_	_	_
125	,	_	_	_	_	_	_	_	_
126	the	_	_	_	_	_	_	_	_
127	goal	_	_	_	_	_	_	_	_
128	of	_	_	_	_	_	_	_	_
129	this	_	_	_	_	_	_	_	_
130	article	_	_	_	_	_	_	_	_
131	is	_	_	_	_	_	_	_	_
132	to	_	_	_	_	_	_	_	_
133	provide	_	_	_	_	_	_	_	_
134	qualitative	_	_	_	_	_	_	_	_
135	understanding	_	_	_	_	_	_	_	_
136	rather	_	_	_	_	_	_	_	_
137	than	_	_	_	_	_	_	_	_
138	exact	_	_	_	_	_	_	_	_
139	quantitative	_	_	_	_	_	_	_	_
140	predictions	_	_	_	_	_	_	_	_
141	.	_	_	_	_	_	_	_	_

# newdoc_id = 9ddc68cec5cd84cb4e0ffebe2950149cca597811
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	first	_	_	_	_	_	_	_	_
3	person	_	_	_	_	_	_	_	_
4	-	_	_	_	_	_	_	_	_
5	to	_	_	_	_	_	_	_	_
6	-	_	_	_	_	_	_	_	_
7	person	_	_	_	_	_	_	_	_
8	transmission	_	_	_	_	_	_	_	_
9	of	_	_	_	_	_	_	_	_
10	the	_	_	_	_	_	_	_	_
11	2019-novel	_	_	_	_	_	_	_	_
12	coronavirus	_	_	_	_	_	_	_	_
13	in	_	_	_	_	_	_	_	_
14	Italy	_	_	_	_	_	_	_	_
15	on	_	_	_	_	_	_	_	_
16	21	_	_	_	_	_	_	_	_
17	February	_	_	_	_	_	_	_	_
18	2020	_	_	_	_	_	_	_	_
19	led	_	_	_	_	_	_	_	_
20	to	_	_	_	_	_	_	_	_
21	an	_	_	_	_	_	_	_	_
22	infection	_	_	_	_	_	_	_	_
23	chain	_	_	_	_	_	_	_	_
24	that	_	_	_	_	_	_	_	BeginSeg=Yes
25	represents	_	_	_	_	_	_	_	_
26	one	_	_	_	_	_	_	_	_
27	of	_	_	_	_	_	_	_	_
28	the	_	_	_	_	_	_	_	_
29	largest	_	_	_	_	_	_	_	_
30	known	_	_	_	_	_	_	_	_
31	COVID-19	_	_	_	_	_	_	_	_
32	outbreaks	_	_	_	_	_	_	_	_
33	outside	_	_	_	_	_	_	_	_
34	Asia	_	_	_	_	_	_	_	_
35	.	_	_	_	_	_	_	_	_
36	Hospitals	_	_	_	_	_	_	_	BeginSeg=Yes
37	have	_	_	_	_	_	_	_	_
38	been	_	_	_	_	_	_	_	_
39	forced	_	_	_	_	_	_	_	_
40	to	_	_	_	_	_	_	_	_
41	reorganized	_	_	_	_	_	_	_	_
42	their	_	_	_	_	_	_	_	_
43	units	_	_	_	_	_	_	_	_
44	in	_	_	_	_	_	_	_	_
45	response	_	_	_	_	_	_	_	_
46	to	_	_	_	_	_	_	_	BeginSeg=Yes
47	prepare	_	_	_	_	_	_	_	_
48	for	_	_	_	_	_	_	_	_
49	an	_	_	_	_	_	_	_	_
50	unforeseen	_	_	_	_	_	_	_	_
51	healthcare	_	_	_	_	_	_	_	_
52	emergency	_	_	_	_	_	_	_	_
53	.	_	_	_	_	_	_	_	_
54	In	_	_	_	_	_	_	_	BeginSeg=Yes
55	this	_	_	_	_	_	_	_	_
56	context	_	_	_	_	_	_	_	_
57	,	_	_	_	_	_	_	_	_
58	our	_	_	_	_	_	_	_	_
59	laboratory	_	_	_	_	_	_	_	_
60	(	_	_	_	_	_	_	_	BeginSeg=Yes
61	Molecular	_	_	_	_	_	_	_	_
62	and	_	_	_	_	_	_	_	_
63	Genomic	_	_	_	_	_	_	_	_
64	Diagnostics	_	_	_	_	_	_	_	_
65	Unit	_	_	_	_	_	_	_	_
66	,	_	_	_	_	_	_	_	_
67	Fondazione	_	_	_	_	_	_	_	_
68	Policlinico	_	_	_	_	_	_	_	_
69	Universitario	_	_	_	_	_	_	_	_
70	Agostino	_	_	_	_	_	_	_	_
71	Gemelli	_	_	_	_	_	_	_	_
72	IRCCS	_	_	_	_	_	_	_	_
73	)	_	_	_	_	_	_	_	_
74	re	_	_	_	_	_	_	_	BeginSeg=Yes
75	-	_	_	_	_	_	_	_	_
76	modulated	_	_	_	_	_	_	_	_
77	its	_	_	_	_	_	_	_	_
78	priorities	_	_	_	_	_	_	_	_
79	by	_	_	_	_	_	_	_	BeginSeg=Yes
80	temporarily	_	_	_	_	_	_	_	_
81	interrupting	_	_	_	_	_	_	_	_
82	most	_	_	_	_	_	_	_	_
83	of	_	_	_	_	_	_	_	_
84	the	_	_	_	_	_	_	_	_
85	molecular	_	_	_	_	_	_	_	_
86	tests	_	_	_	_	_	_	_	_
87	guaranteeing	_	_	_	_	_	_	_	BeginSeg=Yes
88	only	_	_	_	_	_	_	_	_
89	those	_	_	_	_	_	_	_	_
90	considered	_	_	_	_	_	_	_	BeginSeg=Yes
91	"	_	_	_	_	_	_	_	_
92	urgent	_	_	_	_	_	_	_	_
93	"	_	_	_	_	_	_	_	_
94	and	_	_	_	_	_	_	_	_
95	not	_	_	_	_	_	_	_	_
96	postponable	_	_	_	_	_	_	_	_
97	.	_	_	_	_	_	_	_	_
98	In	_	_	_	_	_	_	_	BeginSeg=Yes
99	particular	_	_	_	_	_	_	_	_
100	,	_	_	_	_	_	_	_	_
101	this	_	_	_	_	_	_	_	_
102	paper	_	_	_	_	_	_	_	_
103	details	_	_	_	_	_	_	_	_
104	changes	_	_	_	_	_	_	_	_
105	regarding	_	_	_	_	_	_	_	BeginSeg=Yes
106	the	_	_	_	_	_	_	_	_
107	execution	_	_	_	_	_	_	_	_
108	of	_	_	_	_	_	_	_	_
109	germline	_	_	_	_	_	_	_	_
110	BRCA	_	_	_	_	_	_	_	_
111	(	_	_	_	_	_	_	_	_
112	gBRCA	_	_	_	_	_	_	_	_
113	)	_	_	_	_	_	_	_	_
114	testing	_	_	_	_	_	_	_	_
115	in	_	_	_	_	_	_	_	_
116	our	_	_	_	_	_	_	_	_
117	laboratory	_	_	_	_	_	_	_	_
118	.	_	_	_	_	_	_	_	_
119	A	_	_	_	_	_	_	_	BeginSeg=Yes
120	substantial	_	_	_	_	_	_	_	_
121	reduction	_	_	_	_	_	_	_	_
122	in	_	_	_	_	_	_	_	_
123	gBRCA	_	_	_	_	_	_	_	_
124	testing	_	_	_	_	_	_	_	_
125	(	_	_	_	_	_	_	_	BeginSeg=Yes
126	about	_	_	_	_	_	_	_	_
127	60	_	_	_	_	_	_	_	_
128	%	_	_	_	_	_	_	_	_
129	)	_	_	_	_	_	_	_	_
130	compared	_	_	_	_	_	_	_	BeginSeg=Yes
131	to	_	_	_	_	_	_	_	_
132	the	_	_	_	_	_	_	_	_
133	first	_	_	_	_	_	_	_	_
134	2	_	_	_	_	_	_	_	_
135	months	_	_	_	_	_	_	_	_
136	of	_	_	_	_	_	_	_	_
137	the	_	_	_	_	_	_	_	_
138	current	_	_	_	_	_	_	_	_
139	year	_	_	_	_	_	_	_	_
140	was	_	_	_	_	_	_	_	BeginSeg=Yes
141	registered	_	_	_	_	_	_	_	_
142	,	_	_	_	_	_	_	_	_
143	but	_	_	_	_	_	_	_	BeginSeg=Yes
144	the	_	_	_	_	_	_	_	_
145	requests	_	_	_	_	_	_	_	_
146	have	_	_	_	_	_	_	_	_
147	not	_	_	_	_	_	_	_	_
148	been	_	_	_	_	_	_	_	_
149	reset	_	_	_	_	_	_	_	_
150	.	_	_	_	_	_	_	_	_
151	The	_	_	_	_	_	_	_	BeginSeg=Yes
152	requesting	_	_	_	_	_	_	_	_
153	physicians	_	_	_	_	_	_	_	_
154	were	_	_	_	_	_	_	_	_
155	mainly	_	_	_	_	_	_	_	_
156	gynaecologists	_	_	_	_	_	_	_	_
157	and	_	_	_	_	_	_	_	_
158	oncologists	_	_	_	_	_	_	_	_
159	.	_	_	_	_	_	_	_	_
160	These	_	_	_	_	_	_	_	BeginSeg=Yes
161	evidences	_	_	_	_	_	_	_	_
162	further	_	_	_	_	_	_	_	_
163	emphasize	_	_	_	_	_	_	_	_
164	the	_	_	_	_	_	_	_	_
165	new	_	_	_	_	_	_	_	_
166	era	_	_	_	_	_	_	_	_
167	of	_	_	_	_	_	_	_	_
168	gBRCA	_	_	_	_	_	_	_	_
169	testing	_	_	_	_	_	_	_	_
170	in	_	_	_	_	_	_	_	_
171	the	_	_	_	_	_	_	_	_
172	management	_	_	_	_	_	_	_	_
173	of	_	_	_	_	_	_	_	_
174	cancer	_	_	_	_	_	_	_	_
175	patients	_	_	_	_	_	_	_	_
176	and	_	_	_	_	_	_	_	BeginSeg=Yes
177	confirms	_	_	_	_	_	_	_	_
178	definitively	_	_	_	_	_	_	_	_
179	the	_	_	_	_	_	_	_	_
180	integration	_	_	_	_	_	_	_	_
181	of	_	_	_	_	_	_	_	_
182	gBRCA	_	_	_	_	_	_	_	_
183	testing	_	_	_	_	_	_	_	_
184	/	_	_	_	_	_	_	_	_
185	Next	_	_	_	_	_	_	_	_
186	Generation	_	_	_	_	_	_	_	_
187	Sequencing	_	_	_	_	_	_	_	_
188	(	_	_	_	_	_	_	_	_
189	NGS	_	_	_	_	_	_	_	_
190	)	_	_	_	_	_	_	_	_
191	into	_	_	_	_	_	_	_	_
192	clinical	_	_	_	_	_	_	_	_
193	oncology	_	_	_	_	_	_	_	_
194	.	_	_	_	_	_	_	_	_
195	Finally	_	_	_	_	_	_	_	BeginSeg=Yes
196	,	_	_	_	_	_	_	_	_
197	a	_	_	_	_	_	_	_	_
198	re	_	_	_	_	_	_	_	_
199	-	_	_	_	_	_	_	_	_
200	organization	_	_	_	_	_	_	_	_
201	of	_	_	_	_	_	_	_	_
202	gBRCA	_	_	_	_	_	_	_	_
203	testing	_	_	_	_	_	_	_	_
204	in	_	_	_	_	_	_	_	_
205	our	_	_	_	_	_	_	_	_
206	Unit	_	_	_	_	_	_	_	_
207	,	_	_	_	_	_	_	_	_
208	mainly	_	_	_	_	_	_	_	BeginSeg=Yes
209	related	_	_	_	_	_	_	_	_
210	to	_	_	_	_	_	_	_	_
211	delayed	_	_	_	_	_	_	_	_
212	and	_	_	_	_	_	_	_	_
213	reduced	_	_	_	_	_	_	_	_
214	arrival	_	_	_	_	_	_	_	_
215	of	_	_	_	_	_	_	_	_
216	tests	_	_	_	_	_	_	_	_
217	was	_	_	_	_	_	_	_	BeginSeg=Yes
218	necessary	_	_	_	_	_	_	_	_
219	,	_	_	_	_	_	_	_	_
220	ensuring	_	_	_	_	_	_	_	BeginSeg=Yes
221	,	_	_	_	_	_	_	_	_
222	however	_	_	_	_	_	_	_	_
223	,	_	_	_	_	_	_	_	_
224	a	_	_	_	_	_	_	_	_
225	high	_	_	_	_	_	_	_	_
226	-	_	_	_	_	_	_	_	_
227	quality	_	_	_	_	_	_	_	_
228	standard	_	_	_	_	_	_	_	_
229	and	_	_	_	_	_	_	_	_
230	reliability	_	_	_	_	_	_	_	_
231	,	_	_	_	_	_	_	_	_
232	mandatory	_	_	_	_	_	_	_	_
233	for	_	_	_	_	_	_	_	_
234	gBRCA	_	_	_	_	_	_	_	_
235	testing	_	_	_	_	_	_	_	_
236	in	_	_	_	_	_	_	_	_
237	a	_	_	_	_	_	_	_	_
238	clinical	_	_	_	_	_	_	_	_
239	setting	_	_	_	_	_	_	_	_
240	.	_	_	_	_	_	_	_	_

# newdoc_id = 9f75a36d8f57e382a717ee506b636cbdb355802a
1	Cases	_	_	_	_	_	_	_	BeginSeg=Yes
2	of	_	_	_	_	_	_	_	_
3	COVID-19	_	_	_	_	_	_	_	_
4	are	_	_	_	_	_	_	_	_
5	escalating	_	_	_	_	_	_	_	_
6	rapidly	_	_	_	_	_	_	_	_
7	across	_	_	_	_	_	_	_	_
8	the	_	_	_	_	_	_	_	_
9	globe	_	_	_	_	_	_	_	_
10	,	_	_	_	_	_	_	_	_
11	with	_	_	_	_	_	_	_	BeginSeg=Yes
12	the	_	_	_	_	_	_	_	_
13	mortality	_	_	_	_	_	_	_	_
14	risk	_	_	_	_	_	_	_	_
15	being	_	_	_	_	_	_	_	_
16	especially	_	_	_	_	_	_	_	_
17	high	_	_	_	_	_	_	_	_
18	among	_	_	_	_	_	_	_	_
19	those	_	_	_	_	_	_	_	_
20	with	_	_	_	_	_	_	_	_
21	existing	_	_	_	_	_	_	_	_
22	illness	_	_	_	_	_	_	_	_
23	and	_	_	_	_	_	_	_	_
24	multimorbidity	_	_	_	_	_	_	_	_
25	.	_	_	_	_	_	_	_	_
26	This	_	_	_	_	_	_	_	BeginSeg=Yes
27	study	_	_	_	_	_	_	_	_
28	aimed	_	_	_	_	_	_	_	_
29	to	_	_	_	_	_	_	_	_
30	synthesise	_	_	_	_	_	_	_	_
31	evidence	_	_	_	_	_	_	_	_
32	for	_	_	_	_	_	_	_	_
33	the	_	_	_	_	_	_	_	_
34	role	_	_	_	_	_	_	_	_
35	and	_	_	_	_	_	_	_	_
36	response	_	_	_	_	_	_	_	_
37	of	_	_	_	_	_	_	_	_
38	palliative	_	_	_	_	_	_	_	_
39	care	_	_	_	_	_	_	_	_
40	and	_	_	_	_	_	_	_	_
41	hospice	_	_	_	_	_	_	_	_
42	teams	_	_	_	_	_	_	_	_
43	to	_	_	_	_	_	_	_	_
44	viral	_	_	_	_	_	_	_	_
45	epi	_	_	_	_	_	_	_	_
46	/	_	_	_	_	_	_	_	_
47	pandemics	_	_	_	_	_	_	_	_
48	,	_	_	_	_	_	_	_	_
49	to	_	_	_	_	_	_	_	BeginSeg=Yes
50	inform	_	_	_	_	_	_	_	_
51	the	_	_	_	_	_	_	_	_
52	COVID-19	_	_	_	_	_	_	_	_
53	pandemic	_	_	_	_	_	_	_	_
54	response	_	_	_	_	_	_	_	_
55	.	_	_	_	_	_	_	_	_
56	We	_	_	_	_	_	_	_	BeginSeg=Yes
57	conducted	_	_	_	_	_	_	_	_
58	a	_	_	_	_	_	_	_	_
59	rapid	_	_	_	_	_	_	_	_
60	systematic	_	_	_	_	_	_	_	_
61	review	_	_	_	_	_	_	_	_
62	according	_	_	_	_	_	_	_	_
63	to	_	_	_	_	_	_	_	_
64	PRISMA	_	_	_	_	_	_	_	_
65	guidelines	_	_	_	_	_	_	_	_
66	in	_	_	_	_	_	_	_	_
67	five	_	_	_	_	_	_	_	_
68	databases	_	_	_	_	_	_	_	_
69	.	_	_	_	_	_	_	_	_
70	Of	_	_	_	_	_	_	_	BeginSeg=Yes
71	3094	_	_	_	_	_	_	_	_
72	papers	_	_	_	_	_	_	_	_
73	identified	_	_	_	_	_	_	_	_
74	,	_	_	_	_	_	_	_	_
75	ten	_	_	_	_	_	_	_	_
76	were	_	_	_	_	_	_	_	_
77	included	_	_	_	_	_	_	_	_
78	in	_	_	_	_	_	_	_	_
79	this	_	_	_	_	_	_	_	_
80	narrative	_	_	_	_	_	_	_	_
81	synthesis	_	_	_	_	_	_	_	_
82	.	_	_	_	_	_	_	_	_
83	Included	_	_	_	_	_	_	_	BeginSeg=Yes
84	studies	_	_	_	_	_	_	_	_
85	were	_	_	_	_	_	_	_	_
86	from	_	_	_	_	_	_	_	_
87	West	_	_	_	_	_	_	_	_
88	Africa	_	_	_	_	_	_	_	_
89	,	_	_	_	_	_	_	_	_
90	Taiwan	_	_	_	_	_	_	_	_
91	,	_	_	_	_	_	_	_	_
92	Hong	_	_	_	_	_	_	_	_
93	Kong	_	_	_	_	_	_	_	_
94	,	_	_	_	_	_	_	_	_
95	Singapore	_	_	_	_	_	_	_	_
96	,	_	_	_	_	_	_	_	_
97	the	_	_	_	_	_	_	_	_
98	United	_	_	_	_	_	_	_	_
99	States	_	_	_	_	_	_	_	_
100	and	_	_	_	_	_	_	_	_
101	Italy	_	_	_	_	_	_	_	_
102	.	_	_	_	_	_	_	_	_
103	All	_	_	_	_	_	_	_	BeginSeg=Yes
104	had	_	_	_	_	_	_	_	_
105	an	_	_	_	_	_	_	_	_
106	observational	_	_	_	_	_	_	_	_
107	design	_	_	_	_	_	_	_	_
108	.	_	_	_	_	_	_	_	_
109	Findings	_	_	_	_	_	_	_	BeginSeg=Yes
110	were	_	_	_	_	_	_	_	_
111	synthesised	_	_	_	_	_	_	_	_
112	using	_	_	_	_	_	_	_	BeginSeg=Yes
113	a	_	_	_	_	_	_	_	_
114	previously	_	_	_	_	_	_	_	_
115	proposed	_	_	_	_	_	_	_	_
116	framework	_	_	_	_	_	_	_	_
117	according	_	_	_	_	_	_	_	BeginSeg=Yes
118	to	_	_	_	_	_	_	_	_
119	'	_	_	_	_	_	_	_	_
120	systems	_	_	_	_	_	_	_	_
121	'	_	_	_	_	_	_	_	_
122	(	_	_	_	_	_	_	_	BeginSeg=Yes
123	policies	_	_	_	_	_	_	_	_
124	,	_	_	_	_	_	_	_	_
125	training	_	_	_	_	_	_	_	_
126	and	_	_	_	_	_	_	_	_
127	protocols	_	_	_	_	_	_	_	_
128	,	_	_	_	_	_	_	_	_
129	communication	_	_	_	_	_	_	_	_
130	and	_	_	_	_	_	_	_	_
131	coordination	_	_	_	_	_	_	_	_
132	,	_	_	_	_	_	_	_	_
133	data	_	_	_	_	_	_	_	_
134	)	_	_	_	_	_	_	_	_
135	,	_	_	_	_	_	_	_	_
136	'	_	_	_	_	_	_	_	BeginSeg=Yes
137	staff	_	_	_	_	_	_	_	_
138	'	_	_	_	_	_	_	_	_
139	(	_	_	_	_	_	_	_	BeginSeg=Yes
140	deployment	_	_	_	_	_	_	_	_
141	,	_	_	_	_	_	_	_	_
142	skill	_	_	_	_	_	_	_	_
143	mix	_	_	_	_	_	_	_	_
144	,	_	_	_	_	_	_	_	_
145	resilience	_	_	_	_	_	_	_	_
146	)	_	_	_	_	_	_	_	_
147	,	_	_	_	_	_	_	_	_
148	'	_	_	_	_	_	_	_	BeginSeg=Yes
149	space	_	_	_	_	_	_	_	_
150	'	_	_	_	_	_	_	_	_
151	(	_	_	_	_	_	_	_	BeginSeg=Yes
152	community	_	_	_	_	_	_	_	_
153	provision	_	_	_	_	_	_	_	_
154	,	_	_	_	_	_	_	_	_
155	use	_	_	_	_	_	_	_	_
156	of	_	_	_	_	_	_	_	_
157	technology	_	_	_	_	_	_	_	_
158	)	_	_	_	_	_	_	_	_
159	and	_	_	_	_	_	_	_	BeginSeg=Yes
160	'	_	_	_	_	_	_	_	_
161	stuff	_	_	_	_	_	_	_	_
162	'	_	_	_	_	_	_	_	_
163	(	_	_	_	_	_	_	_	BeginSeg=Yes
164	medicines	_	_	_	_	_	_	_	_
165	and	_	_	_	_	_	_	_	_
166	equipment	_	_	_	_	_	_	_	_
167	,	_	_	_	_	_	_	_	_
168	personal	_	_	_	_	_	_	_	_
169	protective	_	_	_	_	_	_	_	_
170	equipment	_	_	_	_	_	_	_	_
171	)	_	_	_	_	_	_	_	_
172	.	_	_	_	_	_	_	_	_
173	We	_	_	_	_	_	_	_	BeginSeg=Yes
174	conclude	_	_	_	_	_	_	_	_
175	that	_	_	_	_	_	_	_	BeginSeg=Yes
176	hospice	_	_	_	_	_	_	_	_
177	and	_	_	_	_	_	_	_	_
178	palliative	_	_	_	_	_	_	_	_
179	services	_	_	_	_	_	_	_	_
180	have	_	_	_	_	_	_	_	_
181	an	_	_	_	_	_	_	_	_
182	essential	_	_	_	_	_	_	_	_
183	role	_	_	_	_	_	_	_	_
184	in	_	_	_	_	_	_	_	_
185	the	_	_	_	_	_	_	_	_
186	response	_	_	_	_	_	_	_	_
187	to	_	_	_	_	_	_	_	_
188	COVID-19	_	_	_	_	_	_	_	_
189	by	_	_	_	_	_	_	_	_
190	:	_	_	_	_	_	_	_	_
191	1	_	_	_	_	_	_	_	BeginSeg=Yes
192	)	_	_	_	_	_	_	_	_
193	responding	_	_	_	_	_	_	_	_
194	rapidly	_	_	_	_	_	_	_	_
195	and	_	_	_	_	_	_	_	_
196	flexibly	_	_	_	_	_	_	_	_
197	;	_	_	_	_	_	_	_	_
198	2	_	_	_	_	_	_	_	BeginSeg=Yes
199	)	_	_	_	_	_	_	_	_
200	ensuring	_	_	_	_	_	_	_	_
201	protocols	_	_	_	_	_	_	_	_
202	for	_	_	_	_	_	_	_	_
203	symptom	_	_	_	_	_	_	_	_
204	management	_	_	_	_	_	_	_	_
205	are	_	_	_	_	_	_	_	_
206	available	_	_	_	_	_	_	_	_
207	,	_	_	_	_	_	_	_	_
208	and	_	_	_	_	_	_	_	BeginSeg=Yes
209	training	_	_	_	_	_	_	_	_
210	non	_	_	_	_	_	_	_	_
211	-	_	_	_	_	_	_	_	_
212	specialists	_	_	_	_	_	_	_	_
213	in	_	_	_	_	_	_	_	_
214	their	_	_	_	_	_	_	_	_
215	use	_	_	_	_	_	_	_	_
216	;	_	_	_	_	_	_	_	_
217	3	_	_	_	_	_	_	_	BeginSeg=Yes
218	)	_	_	_	_	_	_	_	_
219	being	_	_	_	_	_	_	_	_
220	involved	_	_	_	_	_	_	_	_
221	in	_	_	_	_	_	_	_	_
222	triage	_	_	_	_	_	_	_	_
223	;	_	_	_	_	_	_	_	_
224	4	_	_	_	_	_	_	_	BeginSeg=Yes
225	)	_	_	_	_	_	_	_	_
226	considering	_	_	_	_	_	_	_	_
227	shifting	_	_	_	_	_	_	_	_
228	resources	_	_	_	_	_	_	_	_
229	into	_	_	_	_	_	_	_	_
230	the	_	_	_	_	_	_	_	_
231	community	_	_	_	_	_	_	_	_
232	;	_	_	_	_	_	_	_	_
233	5	_	_	_	_	_	_	_	BeginSeg=Yes
234	)	_	_	_	_	_	_	_	_
235	considering	_	_	_	_	_	_	_	_
236	redeploying	_	_	_	_	_	_	_	_
237	volunteers	_	_	_	_	_	_	_	_
238	to	_	_	_	_	_	_	_	BeginSeg=Yes
239	provide	_	_	_	_	_	_	_	_
240	psychosocial	_	_	_	_	_	_	_	_
241	and	_	_	_	_	_	_	_	_
242	bereavement	_	_	_	_	_	_	_	_
243	care	_	_	_	_	_	_	_	_
244	;	_	_	_	_	_	_	_	_
245	6	_	_	_	_	_	_	_	BeginSeg=Yes
246	)	_	_	_	_	_	_	_	_
247	facilitating	_	_	_	_	_	_	_	_
248	camaraderie	_	_	_	_	_	_	_	_
249	among	_	_	_	_	_	_	_	_
250	staff	_	_	_	_	_	_	_	_
251	and	_	_	_	_	_	_	_	BeginSeg=Yes
252	adopt	_	_	_	_	_	_	_	_
253	measures	_	_	_	_	_	_	_	_
254	to	_	_	_	_	_	_	_	BeginSeg=Yes
255	deal	_	_	_	_	_	_	_	_
256	with	_	_	_	_	_	_	_	_
257	stress	_	_	_	_	_	_	_	_
258	;	_	_	_	_	_	_	_	_
259	7	_	_	_	_	_	_	_	BeginSeg=Yes
260	)	_	_	_	_	_	_	_	_
261	using	_	_	_	_	_	_	_	_
262	technology	_	_	_	_	_	_	_	_
263	to	_	_	_	_	_	_	_	BeginSeg=Yes
264	communicate	_	_	_	_	_	_	_	_
265	with	_	_	_	_	_	_	_	_
266	patients	_	_	_	_	_	_	_	_
267	and	_	_	_	_	_	_	_	_
268	carers	_	_	_	_	_	_	_	_
269	;	_	_	_	_	_	_	_	_
270	8)	_	_	_	_	_	_	_	BeginSeg=Yes
271	adopting	_	_	_	_	_	_	_	_
272	standardised	_	_	_	_	_	_	_	_
273	data	_	_	_	_	_	_	_	_
274	collection	_	_	_	_	_	_	_	_
275	systems	_	_	_	_	_	_	_	_
276	to	_	_	_	_	_	_	_	BeginSeg=Yes
277	inform	_	_	_	_	_	_	_	_
278	operational	_	_	_	_	_	_	_	_
279	changes	_	_	_	_	_	_	_	_
280	and	_	_	_	_	_	_	_	BeginSeg=Yes
281	improve	_	_	_	_	_	_	_	_
282	care	_	_	_	_	_	_	_	_
283	.	_	_	_	_	_	_	_	_
284	An	_	_	_	_	_	_	_	BeginSeg=Yes
285	evidence	_	_	_	_	_	_	_	_
286	synthesis	_	_	_	_	_	_	_	_
287	on	_	_	_	_	_	_	_	_
288	the	_	_	_	_	_	_	_	_
289	role	_	_	_	_	_	_	_	_
290	and	_	_	_	_	_	_	_	_
291	response	_	_	_	_	_	_	_	_
292	of	_	_	_	_	_	_	_	_
293	hospice	_	_	_	_	_	_	_	_
294	and	_	_	_	_	_	_	_	_
295	palliative	_	_	_	_	_	_	_	_
296	care	_	_	_	_	_	_	_	_
297	in	_	_	_	_	_	_	_	_
298	epi	_	_	_	_	_	_	_	_
299	/	_	_	_	_	_	_	_	_
300	pandemics	_	_	_	_	_	_	_	_
301	,	_	_	_	_	_	_	_	_
302	to	_	_	_	_	_	_	_	BeginSeg=Yes
303	inform	_	_	_	_	_	_	_	_
304	response	_	_	_	_	_	_	_	_
305	to	_	_	_	_	_	_	_	_
306	COVID-19	_	_	_	_	_	_	_	_
307	.	_	_	_	_	_	_	_	_
308	Hospice	_	_	_	_	_	_	_	BeginSeg=Yes
309	and	_	_	_	_	_	_	_	_
310	palliative	_	_	_	_	_	_	_	_
311	care	_	_	_	_	_	_	_	_
312	services	_	_	_	_	_	_	_	_
313	should	_	_	_	_	_	_	_	_
314	:	_	_	_	_	_	_	_	_
315	respond	_	_	_	_	_	_	_	BeginSeg=Yes
316	rapidly	_	_	_	_	_	_	_	_
317	and	_	_	_	_	_	_	_	_
318	flexibly	_	_	_	_	_	_	_	_
319	;	_	_	_	_	_	_	_	_
320	produce	_	_	_	_	_	_	_	BeginSeg=Yes
321	protocols	_	_	_	_	_	_	_	_
322	;	_	_	_	_	_	_	_	_
323	shift	_	_	_	_	_	_	_	BeginSeg=Yes
324	resources	_	_	_	_	_	_	_	_
325	to	_	_	_	_	_	_	_	_
326	the	_	_	_	_	_	_	_	_
327	community	_	_	_	_	_	_	_	_
328	;	_	_	_	_	_	_	_	_
329	redeploy	_	_	_	_	_	_	_	BeginSeg=Yes
330	volunteers	_	_	_	_	_	_	_	_
331	;	_	_	_	_	_	_	_	_
332	facilitate	_	_	_	_	_	_	_	BeginSeg=Yes
333	staff	_	_	_	_	_	_	_	_
334	camaraderie	_	_	_	_	_	_	_	_
335	;	_	_	_	_	_	_	_	_
336	communicate	_	_	_	_	_	_	_	BeginSeg=Yes
337	with	_	_	_	_	_	_	_	_
338	patients	_	_	_	_	_	_	_	_
339	/	_	_	_	_	_	_	_	_
340	carers	_	_	_	_	_	_	_	_
341	via	_	_	_	_	_	_	_	_
342	technology	_	_	_	_	_	_	_	_
343	;	_	_	_	_	_	_	_	_
344	standardise	_	_	_	_	_	_	_	BeginSeg=Yes
345	data	_	_	_	_	_	_	_	_
346	collection	_	_	_	_	_	_	_	_
347	.	_	_	_	_	_	_	_	_

# newdoc_id = a5ff05575328a71f49ebc06441902568fc955c72
1	RNA	_	_	_	_	_	_	_	BeginSeg=Yes
2	viruses	_	_	_	_	_	_	_	_
3	show	_	_	_	_	_	_	_	_
4	enormous	_	_	_	_	_	_	_	_
5	capacity	_	_	_	_	_	_	_	_
6	to	_	_	_	_	_	_	_	BeginSeg=Yes
7	evolve	_	_	_	_	_	_	_	_
8	and	_	_	_	_	_	_	_	BeginSeg=Yes
9	adapt	_	_	_	_	_	_	_	_
10	to	_	_	_	_	_	_	_	_
11	new	_	_	_	_	_	_	_	_
12	cellular	_	_	_	_	_	_	_	_
13	and	_	_	_	_	_	_	_	_
14	molecular	_	_	_	_	_	_	_	_
15	contexts	_	_	_	_	_	_	_	_
16	,	_	_	_	_	_	_	_	_
17	a	_	_	_	_	_	_	_	BeginSeg=Yes
18	consequence	_	_	_	_	_	_	_	_
19	of	_	_	_	_	_	_	_	_
20	mutations	_	_	_	_	_	_	_	_
21	arising	_	_	_	_	_	_	_	BeginSeg=Yes
22	from	_	_	_	_	_	_	_	_
23	errors	_	_	_	_	_	_	_	_
24	made	_	_	_	_	_	_	_	BeginSeg=Yes
25	by	_	_	_	_	_	_	_	_
26	viral	_	_	_	_	_	_	_	_
27	RNA	_	_	_	_	_	_	_	_
28	-	_	_	_	_	_	_	_	_
29	dependent	_	_	_	_	_	_	_	_
30	RNA	_	_	_	_	_	_	_	_
31	polymerase	_	_	_	_	_	_	_	_
32	during	_	_	_	_	_	_	_	_
33	replication	_	_	_	_	_	_	_	_
34	.	_	_	_	_	_	_	_	_
35	Sequence	_	_	_	_	_	_	_	BeginSeg=Yes
36	variation	_	_	_	_	_	_	_	_
37	must	_	_	_	_	_	_	_	_
38	occur	_	_	_	_	_	_	_	_
39	,	_	_	_	_	_	_	_	_
40	however	_	_	_	_	_	_	_	_
41	,	_	_	_	_	_	_	_	_
42	without	_	_	_	_	_	_	_	BeginSeg=Yes
43	compromising	_	_	_	_	_	_	_	_
44	functions	_	_	_	_	_	_	_	_
45	essential	_	_	_	_	_	_	_	BeginSeg=Yes
46	for	_	_	_	_	_	_	_	_
47	the	_	_	_	_	_	_	_	_
48	completion	_	_	_	_	_	_	_	_
49	of	_	_	_	_	_	_	_	_
50	the	_	_	_	_	_	_	_	_
51	viral	_	_	_	_	_	_	_	_
52	cycle	_	_	_	_	_	_	_	_
53	.	_	_	_	_	_	_	_	_
54	RNA	_	_	_	_	_	_	_	BeginSeg=Yes
55	viruses	_	_	_	_	_	_	_	_
56	are	_	_	_	_	_	_	_	_
57	safeguarded	_	_	_	_	_	_	_	_
58	in	_	_	_	_	_	_	_	_
59	this	_	_	_	_	_	_	_	_
60	respect	_	_	_	_	_	_	_	_
61	by	_	_	_	_	_	_	_	_
62	their	_	_	_	_	_	_	_	_
63	genome	_	_	_	_	_	_	_	_
64	carrying	_	_	_	_	_	_	_	BeginSeg=Yes
65	conserved	_	_	_	_	_	_	_	_
66	information	_	_	_	_	_	_	_	_
67	that	_	_	_	_	_	_	_	BeginSeg=Yes
68	does	_	_	_	_	_	_	_	_
69	not	_	_	_	_	_	_	_	_
70	code	_	_	_	_	_	_	_	_
71	only	_	_	_	_	_	_	_	_
72	for	_	_	_	_	_	_	_	_
73	proteins	_	_	_	_	_	_	_	_
74	but	_	_	_	_	_	_	_	BeginSeg=Yes
75	also	_	_	_	_	_	_	_	_
76	for	_	_	_	_	_	_	_	_
77	the	_	_	_	_	_	_	_	_
78	formation	_	_	_	_	_	_	_	_
79	of	_	_	_	_	_	_	_	_
80	structurally	_	_	_	_	_	_	_	_
81	conserved	_	_	_	_	_	_	_	_
82	RNA	_	_	_	_	_	_	_	_
83	domains	_	_	_	_	_	_	_	_
84	that	_	_	_	_	_	_	_	BeginSeg=Yes
85	directly	_	_	_	_	_	_	_	_
86	perform	_	_	_	_	_	_	_	_
87	these	_	_	_	_	_	_	_	_
88	critical	_	_	_	_	_	_	_	_
89	functions	_	_	_	_	_	_	_	_
90	.	_	_	_	_	_	_	_	_
91	Functional	_	_	_	_	_	_	_	BeginSeg=Yes
92	RNA	_	_	_	_	_	_	_	_
93	domains	_	_	_	_	_	_	_	_
94	can	_	_	_	_	_	_	_	_
95	interact	_	_	_	_	_	_	_	_
96	with	_	_	_	_	_	_	_	_
97	other	_	_	_	_	_	_	_	_
98	regions	_	_	_	_	_	_	_	_
99	of	_	_	_	_	_	_	_	_
100	the	_	_	_	_	_	_	_	_
101	viral	_	_	_	_	_	_	_	_
102	genome	_	_	_	_	_	_	_	_
103	and/or	_	_	_	_	_	_	_	_
104	proteins	_	_	_	_	_	_	_	_
105	to	_	_	_	_	_	_	_	BeginSeg=Yes
106	direct	_	_	_	_	_	_	_	_
107	viral	_	_	_	_	_	_	_	_
108	translation	_	_	_	_	_	_	_	_
109	,	_	_	_	_	_	_	_	_
110	replication	_	_	_	_	_	_	_	_
111	and	_	_	_	_	_	_	_	_
112	encapsidation	_	_	_	_	_	_	_	_
113	.	_	_	_	_	_	_	_	_
114	They	_	_	_	_	_	_	_	BeginSeg=Yes
115	are	_	_	_	_	_	_	_	_
116	therefore	_	_	_	_	_	_	_	_
117	potential	_	_	_	_	_	_	_	_
118	targets	_	_	_	_	_	_	_	_
119	for	_	_	_	_	_	_	_	_
120	novel	_	_	_	_	_	_	_	_
121	therapeutic	_	_	_	_	_	_	_	_
122	strategies	_	_	_	_	_	_	_	_
123	.	_	_	_	_	_	_	_	_
124	This	_	_	_	_	_	_	_	BeginSeg=Yes
125	review	_	_	_	_	_	_	_	_
126	summarises	_	_	_	_	_	_	_	_
127	our	_	_	_	_	_	_	_	_
128	knowledge	_	_	_	_	_	_	_	_
129	of	_	_	_	_	_	_	_	_
130	the	_	_	_	_	_	_	_	_
131	functional	_	_	_	_	_	_	_	_
132	RNA	_	_	_	_	_	_	_	_
133	domains	_	_	_	_	_	_	_	_
134	of	_	_	_	_	_	_	_	_
135	human	_	_	_	_	_	_	_	_
136	RNA	_	_	_	_	_	_	_	_
137	viruses	_	_	_	_	_	_	_	_
138	and	_	_	_	_	_	_	_	BeginSeg=Yes
139	examines	_	_	_	_	_	_	_	_
140	the	_	_	_	_	_	_	_	_
141	achievements	_	_	_	_	_	_	_	_
142	made	_	_	_	_	_	_	_	BeginSeg=Yes
143	in	_	_	_	_	_	_	_	_
144	the	_	_	_	_	_	_	_	_
145	design	_	_	_	_	_	_	_	_
146	of	_	_	_	_	_	_	_	_
147	antiviral	_	_	_	_	_	_	_	_
148	compounds	_	_	_	_	_	_	_	_
149	that	_	_	_	_	_	_	_	BeginSeg=Yes
150	interfere	_	_	_	_	_	_	_	_
151	with	_	_	_	_	_	_	_	_
152	their	_	_	_	_	_	_	_	_
153	folding	_	_	_	_	_	_	_	_
154	and	_	_	_	_	_	_	_	_
155	therefore	_	_	_	_	_	_	_	_
156	their	_	_	_	_	_	_	_	_
157	function	_	_	_	_	_	_	_	_
158	.	_	_	_	_	_	_	_	_

# newdoc_id = a64f73ac0e74f9eca66d9c4876006757c8399e49
1	There	_	_	_	_	_	_	_	BeginSeg=Yes
2	is	_	_	_	_	_	_	_	_
3	limited	_	_	_	_	_	_	_	_
4	evidence	_	_	_	_	_	_	_	_
5	as	_	_	_	_	_	_	_	BeginSeg=Yes
6	to	_	_	_	_	_	_	_	_
7	how	_	_	_	_	_	_	_	_
8	COVID-19	_	_	_	_	_	_	_	_
9	infection	_	_	_	_	_	_	_	_
10	fatality	_	_	_	_	_	_	_	_
11	rates	_	_	_	_	_	_	_	_
12	(	_	_	_	_	_	_	_	_
13	IFR	_	_	_	_	_	_	_	_
14	)	_	_	_	_	_	_	_	_
15	may	_	_	_	_	_	_	_	_
16	vary	_	_	_	_	_	_	_	_
17	by	_	_	_	_	_	_	_	_
18	ethnicity	_	_	_	_	_	_	_	_
19	.	_	_	_	_	_	_	_	_
20	We	_	_	_	_	_	_	_	BeginSeg=Yes
21	combine	_	_	_	_	_	_	_	_
22	demographic	_	_	_	_	_	_	_	_
23	and	_	_	_	_	_	_	_	_
24	health	_	_	_	_	_	_	_	_
25	data	_	_	_	_	_	_	_	_
26	for	_	_	_	_	_	_	_	_
27	ethnic	_	_	_	_	_	_	_	_
28	groupings	_	_	_	_	_	_	_	_
29	in	_	_	_	_	_	_	_	_
30	Aotearoa	_	_	_	_	_	_	_	_
31	New	_	_	_	_	_	_	_	_
32	Zealand	_	_	_	_	_	_	_	_
33	with	_	_	_	_	_	_	_	_
34	international	_	_	_	_	_	_	_	_
35	data	_	_	_	_	_	_	_	_
36	on	_	_	_	_	_	_	_	_
37	IFR	_	_	_	_	_	_	_	_
38	for	_	_	_	_	_	_	_	_
39	different	_	_	_	_	_	_	_	_
40	age	_	_	_	_	_	_	_	_
41	groups	_	_	_	_	_	_	_	_
42	to	_	_	_	_	_	_	_	BeginSeg=Yes
43	estimate	_	_	_	_	_	_	_	_
44	inequities	_	_	_	_	_	_	_	_
45	in	_	_	_	_	_	_	_	_
46	IFR	_	_	_	_	_	_	_	_
47	by	_	_	_	_	_	_	_	_
48	ethnicity	_	_	_	_	_	_	_	_
49	.	_	_	_	_	_	_	_	_
50	We	_	_	_	_	_	_	_	BeginSeg=Yes
51	find	_	_	_	_	_	_	_	_
52	that	_	_	_	_	_	_	_	BeginSeg=Yes
53	,	_	_	_	_	_	_	_	_
54	if	_	_	_	_	_	_	_	BeginSeg=Yes
55	age	_	_	_	_	_	_	_	_
56	is	_	_	_	_	_	_	_	_
57	the	_	_	_	_	_	_	_	_
58	dominant	_	_	_	_	_	_	_	_
59	factor	_	_	_	_	_	_	_	_
60	determining	_	_	_	_	_	_	_	_
61	IFR	_	_	_	_	_	_	_	_
62	,	_	_	_	_	_	_	_	_
63	estimated	_	_	_	_	_	_	_	BeginSeg=Yes
64	IFR	_	_	_	_	_	_	_	_
65	for	_	_	_	_	_	_	_	_
66	Māori	_	_	_	_	_	_	_	_
67	is	_	_	_	_	_	_	_	_
68	around	_	_	_	_	_	_	_	_
69	50	_	_	_	_	_	_	_	_
70	%	_	_	_	_	_	_	_	_
71	higher	_	_	_	_	_	_	_	_
72	than	_	_	_	_	_	_	_	_
73	non	_	_	_	_	_	_	_	_
74	-	_	_	_	_	_	_	_	_
75	Māori	_	_	_	_	_	_	_	_
76	.	_	_	_	_	_	_	_	_
77	If	_	_	_	_	_	_	_	BeginSeg=Yes
78	underlying	_	_	_	_	_	_	_	_
79	health	_	_	_	_	_	_	_	_
80	conditions	_	_	_	_	_	_	_	_
81	are	_	_	_	_	_	_	_	_
82	more	_	_	_	_	_	_	_	_
83	important	_	_	_	_	_	_	_	_
84	than	_	_	_	_	_	_	_	_
85	age	_	_	_	_	_	_	_	_
86	per	_	_	_	_	_	_	_	_
87	se	_	_	_	_	_	_	_	_
88	,	_	_	_	_	_	_	_	_
89	then	_	_	_	_	_	_	_	BeginSeg=Yes
90	estimated	_	_	_	_	_	_	_	_
91	IFR	_	_	_	_	_	_	_	_
92	for	_	_	_	_	_	_	_	_
93	Māori	_	_	_	_	_	_	_	_
94	is	_	_	_	_	_	_	_	_
95	more	_	_	_	_	_	_	_	_
96	than	_	_	_	_	_	_	_	_
97	2.5	_	_	_	_	_	_	_	_
98	times	_	_	_	_	_	_	_	_
99	that	_	_	_	_	_	_	_	_
100	of	_	_	_	_	_	_	_	_
101	New	_	_	_	_	_	_	_	_
102	Zealand	_	_	_	_	_	_	_	_
103	European	_	_	_	_	_	_	_	_
104	,	_	_	_	_	_	_	_	_
105	and	_	_	_	_	_	_	_	BeginSeg=Yes
106	estimated	_	_	_	_	_	_	_	_
107	IFR	_	_	_	_	_	_	_	_
108	for	_	_	_	_	_	_	_	_
109	Pasifika	_	_	_	_	_	_	_	_
110	is	_	_	_	_	_	_	_	_
111	almost	_	_	_	_	_	_	_	_
112	double	_	_	_	_	_	_	_	_
113	that	_	_	_	_	_	_	_	_
114	of	_	_	_	_	_	_	_	_
115	New	_	_	_	_	_	_	_	_
116	Zealand	_	_	_	_	_	_	_	_
117	European	_	_	_	_	_	_	_	_
118	.	_	_	_	_	_	_	_	_
119	IFRs	_	_	_	_	_	_	_	BeginSeg=Yes
120	for	_	_	_	_	_	_	_	_
121	Māori	_	_	_	_	_	_	_	_
122	and	_	_	_	_	_	_	_	_
123	Pasifika	_	_	_	_	_	_	_	_
124	are	_	_	_	_	_	_	_	_
125	likely	_	_	_	_	_	_	_	_
126	to	_	_	_	_	_	_	_	_
127	be	_	_	_	_	_	_	_	_
128	increased	_	_	_	_	_	_	_	_
129	above	_	_	_	_	_	_	_	_
130	these	_	_	_	_	_	_	_	_
131	estimates	_	_	_	_	_	_	_	_
132	by	_	_	_	_	_	_	_	_
133	racism	_	_	_	_	_	_	_	_
134	within	_	_	_	_	_	_	_	_
135	the	_	_	_	_	_	_	_	_
136	healthcare	_	_	_	_	_	_	_	_
137	system	_	_	_	_	_	_	_	_
138	and	_	_	_	_	_	_	_	_
139	other	_	_	_	_	_	_	_	_
140	inequities	_	_	_	_	_	_	_	_
141	not	_	_	_	_	_	_	_	BeginSeg=Yes
142	reflected	_	_	_	_	_	_	_	_
143	in	_	_	_	_	_	_	_	_
144	official	_	_	_	_	_	_	_	_
145	data	_	_	_	_	_	_	_	_
146	.	_	_	_	_	_	_	_	_
147	IFR	_	_	_	_	_	_	_	BeginSeg=Yes
148	does	_	_	_	_	_	_	_	_
149	not	_	_	_	_	_	_	_	_
150	account	_	_	_	_	_	_	_	_
151	for	_	_	_	_	_	_	_	_
152	differences	_	_	_	_	_	_	_	_
153	among	_	_	_	_	_	_	_	_
154	ethnicities	_	_	_	_	_	_	_	_
155	in	_	_	_	_	_	_	_	_
156	COVID-19	_	_	_	_	_	_	_	_
157	incidence	_	_	_	_	_	_	_	_
158	,	_	_	_	_	_	_	_	_
159	which	_	_	_	_	_	_	_	BeginSeg=Yes
160	could	_	_	_	_	_	_	_	_
161	be	_	_	_	_	_	_	_	_
162	higher	_	_	_	_	_	_	_	_
163	in	_	_	_	_	_	_	_	_
164	Māori	_	_	_	_	_	_	_	_
165	and	_	_	_	_	_	_	_	_
166	Pasifik	_	_	_	_	_	_	_	_
167	as	_	_	_	_	_	_	_	BeginSeg=Yes
168	a	_	_	_	_	_	_	_	_
169	result	_	_	_	_	_	_	_	_
170	of	_	_	_	_	_	_	_	_
171	crowded	_	_	_	_	_	_	_	_
172	housing	_	_	_	_	_	_	_	_
173	and	_	_	_	_	_	_	_	_
174	higher	_	_	_	_	_	_	_	_
175	intergenerational	_	_	_	_	_	_	_	_
176	contact	_	_	_	_	_	_	_	_
177	rates	_	_	_	_	_	_	_	_
178	.	_	_	_	_	_	_	_	_
179	These	_	_	_	_	_	_	_	BeginSeg=Yes
180	factors	_	_	_	_	_	_	_	_
181	should	_	_	_	_	_	_	_	_
182	be	_	_	_	_	_	_	_	_
183	included	_	_	_	_	_	_	_	_
184	in	_	_	_	_	_	_	_	_
185	future	_	_	_	_	_	_	_	_
186	disease	_	_	_	_	_	_	_	_
187	incidence	_	_	_	_	_	_	_	_
188	modelling	_	_	_	_	_	_	_	_
189	.	_	_	_	_	_	_	_	_
190	The	_	_	_	_	_	_	_	BeginSeg=Yes
191	communities	_	_	_	_	_	_	_	_
192	at	_	_	_	_	_	_	_	_
193	the	_	_	_	_	_	_	_	_
194	highest	_	_	_	_	_	_	_	_
195	risk	_	_	_	_	_	_	_	_
196	will	_	_	_	_	_	_	_	_
197	be	_	_	_	_	_	_	_	_
198	those	_	_	_	_	_	_	_	_
199	with	_	_	_	_	_	_	_	_
200	elderly	_	_	_	_	_	_	_	_
201	populations	_	_	_	_	_	_	_	_
202	,	_	_	_	_	_	_	_	_
203	and	_	_	_	_	_	_	_	_
204	Māori	_	_	_	_	_	_	_	_
205	and	_	_	_	_	_	_	_	_
206	Pasifika	_	_	_	_	_	_	_	_
207	communities	_	_	_	_	_	_	_	_
208	,	_	_	_	_	_	_	_	_
209	where	_	_	_	_	_	_	_	BeginSeg=Yes
210	the	_	_	_	_	_	_	_	_
211	compounded	_	_	_	_	_	_	_	_
212	effects	_	_	_	_	_	_	_	_
213	of	_	_	_	_	_	_	_	_
214	underlying	_	_	_	_	_	_	_	_
215	health	_	_	_	_	_	_	_	_
216	conditions	_	_	_	_	_	_	_	_
217	,	_	_	_	_	_	_	_	_
218	socioeconomic	_	_	_	_	_	_	_	_
219	disadvantage	_	_	_	_	_	_	_	_
220	,	_	_	_	_	_	_	_	_
221	and	_	_	_	_	_	_	_	_
222	structural	_	_	_	_	_	_	_	_
223	racism	_	_	_	_	_	_	_	_
224	result	_	_	_	_	_	_	_	_
225	in	_	_	_	_	_	_	_	_
226	imbricated	_	_	_	_	_	_	_	_
227	risk	_	_	_	_	_	_	_	_
228	of	_	_	_	_	_	_	_	BeginSeg=Yes
229	contracting	_	_	_	_	_	_	_	_
230	COVID-19	_	_	_	_	_	_	_	_
231	,	_	_	_	_	_	_	_	_
232	becoming	_	_	_	_	_	_	_	BeginSeg=Yes
233	unwell	_	_	_	_	_	_	_	_
234	,	_	_	_	_	_	_	_	_
235	and	_	_	_	_	_	_	_	_
236	death	_	_	_	_	_	_	_	_
237	.	_	_	_	_	_	_	_	_

# newdoc_id = a6ae0b0a1b76a367c6a95d58052c65b2c5feb850
1	Multiple	_	_	_	_	_	_	_	BeginSeg=Yes
2	sclerosis	_	_	_	_	_	_	_	_
3	(	_	_	_	_	_	_	_	_
4	MS	_	_	_	_	_	_	_	_
5	)	_	_	_	_	_	_	_	_
6	is	_	_	_	_	_	_	_	_
7	an	_	_	_	_	_	_	_	_
8	autoimmune	_	_	_	_	_	_	_	_
9	disease	_	_	_	_	_	_	_	_
10	of	_	_	_	_	_	_	_	_
11	the	_	_	_	_	_	_	_	_
12	central	_	_	_	_	_	_	_	_
13	nervous	_	_	_	_	_	_	_	_
14	system	_	_	_	_	_	_	_	_
15	(	_	_	_	_	_	_	_	_
16	CNS	_	_	_	_	_	_	_	_
17	)	_	_	_	_	_	_	_	_
18	that	_	_	_	_	_	_	_	BeginSeg=Yes
19	affects	_	_	_	_	_	_	_	_
20	about	_	_	_	_	_	_	_	_
21	0.1	_	_	_	_	_	_	_	_
22	%	_	_	_	_	_	_	_	_
23	of	_	_	_	_	_	_	_	_
24	the	_	_	_	_	_	_	_	_
25	worldwide	_	_	_	_	_	_	_	_
26	population	_	_	_	_	_	_	_	_
27	.	_	_	_	_	_	_	_	_
28	This	_	_	_	_	_	_	_	BeginSeg=Yes
29	deleterious	_	_	_	_	_	_	_	_
30	disease	_	_	_	_	_	_	_	_
31	is	_	_	_	_	_	_	_	_
32	marked	_	_	_	_	_	_	_	_
33	by	_	_	_	_	_	_	_	_
34	infiltration	_	_	_	_	_	_	_	_
35	of	_	_	_	_	_	_	_	_
36	myelinspecific	_	_	_	_	_	_	_	_
37	T	_	_	_	_	_	_	_	_
38	cells	_	_	_	_	_	_	_	_
39	that	_	_	_	_	_	_	_	BeginSeg=Yes
40	attack	_	_	_	_	_	_	_	_
41	the	_	_	_	_	_	_	_	_
42	protective	_	_	_	_	_	_	_	_
43	myelin	_	_	_	_	_	_	_	_
44	sheath	_	_	_	_	_	_	_	_
45	that	_	_	_	_	_	_	_	BeginSeg=Yes
46	surrounds	_	_	_	_	_	_	_	_
47	CNS	_	_	_	_	_	_	_	_
48	nerve	_	_	_	_	_	_	_	_
49	axons	_	_	_	_	_	_	_	_
50	.	_	_	_	_	_	_	_	_
51	Upon	_	_	_	_	_	_	_	BeginSeg=Yes
52	demyelination	_	_	_	_	_	_	_	_
53	,	_	_	_	_	_	_	_	_
54	saltatory	_	_	_	_	_	_	_	_
55	nerve	_	_	_	_	_	_	_	_
56	conduction	_	_	_	_	_	_	_	_
57	is	_	_	_	_	_	_	_	_
58	disrupted	_	_	_	_	_	_	_	_
59	,	_	_	_	_	_	_	_	_
60	and	_	_	_	_	_	_	_	BeginSeg=Yes
61	patients	_	_	_	_	_	_	_	_
62	experience	_	_	_	_	_	_	_	_
63	neurologic	_	_	_	_	_	_	_	_
64	deficiencies	_	_	_	_	_	_	_	_
65	.	_	_	_	_	_	_	_	_
66	The	_	_	_	_	_	_	_	BeginSeg=Yes
67	exact	_	_	_	_	_	_	_	_
68	cause	_	_	_	_	_	_	_	_
69	for	_	_	_	_	_	_	_	_
70	MS	_	_	_	_	_	_	_	_
71	remains	_	_	_	_	_	_	_	_
72	unknown	_	_	_	_	_	_	_	_
73	,	_	_	_	_	_	_	_	_
74	although	_	_	_	_	_	_	_	BeginSeg=Yes
75	most	_	_	_	_	_	_	_	_
76	evidence	_	_	_	_	_	_	_	_
77	supports	_	_	_	_	_	_	_	_
78	the	_	_	_	_	_	_	_	_
79	hypothesis	_	_	_	_	_	_	_	_
80	that	_	_	_	_	_	_	_	BeginSeg=Yes
81	both	_	_	_	_	_	_	_	_
82	genetic	_	_	_	_	_	_	_	_
83	and	_	_	_	_	_	_	_	_
84	environmental	_	_	_	_	_	_	_	_
85	factors	_	_	_	_	_	_	_	_
86	contribute	_	_	_	_	_	_	_	_
87	to	_	_	_	_	_	_	_	_
88	disease	_	_	_	_	_	_	_	_
89	development	_	_	_	_	_	_	_	_
90	.	_	_	_	_	_	_	_	_
91	Epidemiologic	_	_	_	_	_	_	_	BeginSeg=Yes
92	evidence	_	_	_	_	_	_	_	_
93	supports	_	_	_	_	_	_	_	_
94	a	_	_	_	_	_	_	_	_
95	role	_	_	_	_	_	_	_	_
96	for	_	_	_	_	_	_	_	_
97	environmental	_	_	_	_	_	_	_	_
98	pathogens	_	_	_	_	_	_	_	_
99	,	_	_	_	_	_	_	_	_
100	such	_	_	_	_	_	_	_	BeginSeg=Yes
101	as	_	_	_	_	_	_	_	_
102	viruses	_	_	_	_	_	_	_	_
103	,	_	_	_	_	_	_	_	_
104	as	_	_	_	_	_	_	_	BeginSeg=Yes
105	potentially	_	_	_	_	_	_	_	_
106	key	_	_	_	_	_	_	_	_
107	contributors	_	_	_	_	_	_	_	_
108	to	_	_	_	_	_	_	_	_
109	MS	_	_	_	_	_	_	_	_
110	induction	_	_	_	_	_	_	_	_
111	.	_	_	_	_	_	_	_	_
112	Pathogens	_	_	_	_	_	_	_	BeginSeg=Yes
113	can	_	_	_	_	_	_	_	_
114	induce	_	_	_	_	_	_	_	_
115	autoimmunity	_	_	_	_	_	_	_	_
116	via	_	_	_	_	_	_	_	_
117	several	_	_	_	_	_	_	_	_
118	well	_	_	_	_	_	_	_	_
119	-	_	_	_	_	_	_	_	_
120	studied	_	_	_	_	_	_	_	_
121	mechanisms	_	_	_	_	_	_	_	_
122	with	_	_	_	_	_	_	_	_
123	the	_	_	_	_	_	_	_	_
124	most	_	_	_	_	_	_	_	_
125	postulated	_	_	_	_	_	_	_	_
126	being	_	_	_	_	_	_	_	_
127	molecular	_	_	_	_	_	_	_	_
128	mimicry	_	_	_	_	_	_	_	_
129	.	_	_	_	_	_	_	_	_
130	Molecular	_	_	_	_	_	_	_	BeginSeg=Yes
131	mimicry	_	_	_	_	_	_	_	_
132	occurs	_	_	_	_	_	_	_	_
133	when	_	_	_	_	_	_	_	BeginSeg=Yes
134	T	_	_	_	_	_	_	_	_
135	cells	_	_	_	_	_	_	_	_
136	specific	_	_	_	_	_	_	_	_
137	for	_	_	_	_	_	_	_	_
138	peptide	_	_	_	_	_	_	_	_
139	epitopes	_	_	_	_	_	_	_	_
140	derived	_	_	_	_	_	_	_	_
141	from	_	_	_	_	_	_	_	_
142	pathogens	_	_	_	_	_	_	_	_
143	cross	_	_	_	_	_	_	_	_
144	-	_	_	_	_	_	_	_	_
145	react	_	_	_	_	_	_	_	_
146	with	_	_	_	_	_	_	_	_
147	selfepitopes	_	_	_	_	_	_	_	_
148	,	_	_	_	_	_	_	_	_
149	leading	_	_	_	_	_	_	_	BeginSeg=Yes
150	to	_	_	_	_	_	_	_	_
151	autoimmune	_	_	_	_	_	_	_	_
152	tissue	_	_	_	_	_	_	_	_
153	destruction	_	_	_	_	_	_	_	_
154	.	_	_	_	_	_	_	_	_
155	In	_	_	_	_	_	_	_	BeginSeg=Yes
156	this	_	_	_	_	_	_	_	_
157	review	_	_	_	_	_	_	_	_
158	,	_	_	_	_	_	_	_	_
159	we	_	_	_	_	_	_	_	_
160	discuss	_	_	_	_	_	_	_	_
161	an	_	_	_	_	_	_	_	_
162	in	_	_	_	_	_	_	_	_
163	vivo	_	_	_	_	_	_	_	_
164	virusinduced	_	_	_	_	_	_	_	_
165	mouse	_	_	_	_	_	_	_	_
166	model	_	_	_	_	_	_	_	_
167	of	_	_	_	_	_	_	_	_
168	MS	_	_	_	_	_	_	_	_
169	developed	_	_	_	_	_	_	_	BeginSeg=Yes
170	in	_	_	_	_	_	_	_	_
171	our	_	_	_	_	_	_	_	_
172	laboratory	_	_	_	_	_	_	_	_
173	,	_	_	_	_	_	_	_	_
174	which	_	_	_	_	_	_	_	BeginSeg=Yes
175	has	_	_	_	_	_	_	_	_
176	contributed	_	_	_	_	_	_	_	_
177	greatly	_	_	_	_	_	_	_	_
178	to	_	_	_	_	_	_	_	_
179	our	_	_	_	_	_	_	_	_
180	understanding	_	_	_	_	_	_	_	_
181	of	_	_	_	_	_	_	_	_
182	the	_	_	_	_	_	_	_	_
183	mechanisms	_	_	_	_	_	_	_	_
184	underlying	_	_	_	_	_	_	_	BeginSeg=Yes
185	molecular	_	_	_	_	_	_	_	_
186	mimicry	_	_	_	_	_	_	_	_
187	-	_	_	_	_	_	_	_	_
188	induced	_	_	_	_	_	_	_	_
189	CNS	_	_	_	_	_	_	_	_
190	autoimmunity	_	_	_	_	_	_	_	_
191	.	_	_	_	_	_	_	_	_

# newdoc_id = a6f51bc35967b5ec3948012d00a543a9f51b450f
1	In	_	_	_	_	_	_	_	BeginSeg=Yes
2	mammalian	_	_	_	_	_	_	_	_
3	cells	_	_	_	_	_	_	_	_
4	,	_	_	_	_	_	_	_	_
5	the	_	_	_	_	_	_	_	_
6	Golgi	_	_	_	_	_	_	_	_
7	complex	_	_	_	_	_	_	_	_
8	has	_	_	_	_	_	_	_	_
9	an	_	_	_	_	_	_	_	_
10	elaborate	_	_	_	_	_	_	_	_
11	structure	_	_	_	_	_	_	_	_
12	consisting	_	_	_	_	_	_	_	BeginSeg=Yes
13	of	_	_	_	_	_	_	_	_
14	stacked	_	_	_	_	_	_	_	_
15	,	_	_	_	_	_	_	_	_
16	flattened	_	_	_	_	_	_	_	_
17	cisternal	_	_	_	_	_	_	_	_
18	membranes	_	_	_	_	_	_	_	_
19	collected	_	_	_	_	_	_	_	BeginSeg=Yes
20	into	_	_	_	_	_	_	_	_
21	a	_	_	_	_	_	_	_	_
22	ribbon	_	_	_	_	_	_	_	_
23	in	_	_	_	_	_	_	_	_
24	the	_	_	_	_	_	_	_	_
25	center	_	_	_	_	_	_	_	_
26	of	_	_	_	_	_	_	_	_
27	the	_	_	_	_	_	_	_	_
28	cell	_	_	_	_	_	_	_	_
29	.	_	_	_	_	_	_	_	_
30	Amazingly	_	_	_	_	_	_	_	BeginSeg=Yes
31	,	_	_	_	_	_	_	_	_
32	the	_	_	_	_	_	_	_	_
33	flattened	_	_	_	_	_	_	_	_
34	cisternae	_	_	_	_	_	_	_	_
35	can	_	_	_	_	_	_	_	_
36	rapidly	_	_	_	_	_	_	_	_
37	dilate	_	_	_	_	_	_	_	_
38	to	_	_	_	_	_	_	_	BeginSeg=Yes
39	accommodate	_	_	_	_	_	_	_	_
40	large	_	_	_	_	_	_	_	_
41	cargo	_	_	_	_	_	_	_	_
42	as	_	_	_	_	_	_	_	BeginSeg=Yes
43	it	_	_	_	_	_	_	_	_
44	traffics	_	_	_	_	_	_	_	_
45	through	_	_	_	_	_	_	_	_
46	the	_	_	_	_	_	_	_	_
47	organelle	_	_	_	_	_	_	_	_
48	.	_	_	_	_	_	_	_	_
49	The	_	_	_	_	_	_	_	BeginSeg=Yes
50	mechanism	_	_	_	_	_	_	_	_
51	by	_	_	_	_	_	_	_	BeginSeg=Yes
52	which	_	_	_	_	_	_	_	_
53	this	_	_	_	_	_	_	_	_
54	occurs	_	_	_	_	_	_	_	_
55	is	_	_	_	_	_	_	_	BeginSeg=Yes
56	unknown	_	_	_	_	_	_	_	_
57	.	_	_	_	_	_	_	_	_
58	Exocytosis	_	_	_	_	_	_	_	BeginSeg=Yes
59	of	_	_	_	_	_	_	_	_
60	large	_	_	_	_	_	_	_	_
61	cargo	_	_	_	_	_	_	_	_
62	is	_	_	_	_	_	_	_	_
63	essential	_	_	_	_	_	_	_	_
64	for	_	_	_	_	_	_	_	_
65	many	_	_	_	_	_	_	_	_
66	physiological	_	_	_	_	_	_	_	_
67	processes	_	_	_	_	_	_	_	_
68	,	_	_	_	_	_	_	_	_
69	including	_	_	_	_	_	_	_	BeginSeg=Yes
70	collagen	_	_	_	_	_	_	_	_
71	and	_	_	_	_	_	_	_	_
72	lipoprotein	_	_	_	_	_	_	_	_
73	secretion	_	_	_	_	_	_	_	_
74	,	_	_	_	_	_	_	_	_
75	and	_	_	_	_	_	_	_	BeginSeg=Yes
76	defects	_	_	_	_	_	_	_	_
77	in	_	_	_	_	_	_	_	_
78	the	_	_	_	_	_	_	_	_
79	process	_	_	_	_	_	_	_	_
80	lead	_	_	_	_	_	_	_	_
81	to	_	_	_	_	_	_	_	_
82	disease	_	_	_	_	_	_	_	_
83	.	_	_	_	_	_	_	_	_
84	In	_	_	_	_	_	_	_	BeginSeg=Yes
85	addition	_	_	_	_	_	_	_	_
86	,	_	_	_	_	_	_	_	_
87	enveloped	_	_	_	_	_	_	_	_
88	viruses	_	_	_	_	_	_	_	_
89	that	_	_	_	_	_	_	_	BeginSeg=Yes
90	bud	_	_	_	_	_	_	_	_
91	into	_	_	_	_	_	_	_	_
92	the	_	_	_	_	_	_	_	_
93	endoplasmic	_	_	_	_	_	_	_	_
94	reticulum	_	_	_	_	_	_	_	_
95	or	_	_	_	_	_	_	_	_
96	Golgi	_	_	_	_	_	_	_	_
97	complex	_	_	_	_	_	_	_	_
98	must	_	_	_	_	_	_	_	BeginSeg=Yes
99	also	_	_	_	_	_	_	_	_
100	be	_	_	_	_	_	_	_	_
101	transported	_	_	_	_	_	_	_	_
102	through	_	_	_	_	_	_	_	_
103	Golgi	_	_	_	_	_	_	_	_
104	cisternae	_	_	_	_	_	_	_	_
105	for	_	_	_	_	_	_	_	_
106	secretion	_	_	_	_	_	_	_	_
107	from	_	_	_	_	_	_	_	_
108	the	_	_	_	_	_	_	_	_
109	infected	_	_	_	_	_	_	_	_
110	cell	_	_	_	_	_	_	_	_
111	.	_	_	_	_	_	_	_	_
112	This	_	_	_	_	_	_	_	BeginSeg=Yes
113	review	_	_	_	_	_	_	_	_
114	summarizes	_	_	_	_	_	_	_	_
115	our	_	_	_	_	_	_	_	_
116	understanding	_	_	_	_	_	_	_	_
117	of	_	_	_	_	_	_	_	_
118	intra	_	_	_	_	_	_	_	_
119	-	_	_	_	_	_	_	_	_
120	Golgi	_	_	_	_	_	_	_	_
121	transport	_	_	_	_	_	_	_	_
122	of	_	_	_	_	_	_	_	_
123	large	_	_	_	_	_	_	_	_
124	cargo	_	_	_	_	_	_	_	_
125	,	_	_	_	_	_	_	_	_
126	and	_	_	_	_	_	_	_	BeginSeg=Yes
127	outlines	_	_	_	_	_	_	_	_
128	current	_	_	_	_	_	_	_	_
129	questions	_	_	_	_	_	_	_	_
130	open	_	_	_	_	_	_	_	BeginSeg=Yes
131	for	_	_	_	_	_	_	_	_
132	experimentation	_	_	_	_	_	_	_	_
133	.	_	_	_	_	_	_	_	_

# newdoc_id = a7ba852208db4acf89b85705dd9a04d667da521c
1	Norovirus	_	_	_	_	_	_	_	BeginSeg=Yes
2	is	_	_	_	_	_	_	_	_
3	a	_	_	_	_	_	_	_	_
4	major	_	_	_	_	_	_	_	_
5	etiologic	_	_	_	_	_	_	_	_
6	agent	_	_	_	_	_	_	_	_
7	in	_	_	_	_	_	_	_	_
8	worldwide	_	_	_	_	_	_	_	_
9	outbreaks	_	_	_	_	_	_	_	_
10	of	_	_	_	_	_	_	_	_
11	gastroenteritis	_	_	_	_	_	_	_	_
12	associated	_	_	_	_	_	_	_	BeginSeg=Yes
13	with	_	_	_	_	_	_	_	_
14	food	_	_	_	_	_	_	_	_
15	as	_	_	_	_	_	_	_	_
16	well	_	_	_	_	_	_	_	_
17	as	_	_	_	_	_	_	_	_
18	person	_	_	_	_	_	_	_	_
19	-	_	_	_	_	_	_	_	_
20	to	_	_	_	_	_	_	_	_
21	-	_	_	_	_	_	_	_	_
22	person	_	_	_	_	_	_	_	_
23	transmission	_	_	_	_	_	_	_	_
24	.	_	_	_	_	_	_	_	_
25	The	_	_	_	_	_	_	_	BeginSeg=Yes
26	ubiquitous	_	_	_	_	_	_	_	_
27	nature	_	_	_	_	_	_	_	_
28	of	_	_	_	_	_	_	_	_
29	Norovirus	_	_	_	_	_	_	_	_
30	necessitates	_	_	_	_	_	_	_	_
31	simple	_	_	_	_	_	_	_	_
32	and	_	_	_	_	_	_	_	_
33	rapid	_	_	_	_	_	_	_	_
34	detection	_	_	_	_	_	_	_	_
35	methods	_	_	_	_	_	_	_	_
36	with	_	_	_	_	_	_	_	_
37	high	_	_	_	_	_	_	_	_
38	accuracy	_	_	_	_	_	_	_	_
39	and	_	_	_	_	_	_	_	_
40	sensitivity	_	_	_	_	_	_	_	_
41	.	_	_	_	_	_	_	_	_
42	To	_	_	_	_	_	_	_	BeginSeg=Yes
43	this	_	_	_	_	_	_	_	_
44	end	_	_	_	_	_	_	_	_
45	,	_	_	_	_	_	_	_	_
46	several	_	_	_	_	_	_	_	_
47	investigators	_	_	_	_	_	_	_	_
48	have	_	_	_	_	_	_	_	_
49	evaluated	_	_	_	_	_	_	_	_
50	the	_	_	_	_	_	_	_	_
51	usefulness	_	_	_	_	_	_	_	_
52	of	_	_	_	_	_	_	_	_
53	commercial	_	_	_	_	_	_	_	_
54	reverse	_	_	_	_	_	_	_	_
55	-	_	_	_	_	_	_	_	_
56	transcription	_	_	_	_	_	_	_	_
57	loop	_	_	_	_	_	_	_	_
58	-	_	_	_	_	_	_	_	_
59	mediated	_	_	_	_	_	_	_	_
60	isothermal	_	_	_	_	_	_	_	_
61	amplification	_	_	_	_	_	_	_	_
62	(	_	_	_	_	_	_	_	_
63	RT	_	_	_	_	_	_	_	_
64	-	_	_	_	_	_	_	_	_
65	LAMP	_	_	_	_	_	_	_	_
66	)	_	_	_	_	_	_	_	_
67	kits	_	_	_	_	_	_	_	_
68	for	_	_	_	_	_	_	_	BeginSeg=Yes
69	detecting	_	_	_	_	_	_	_	_
70	Norovirus	_	_	_	_	_	_	_	_
71	genogroups	_	_	_	_	_	_	_	_
72	I	_	_	_	_	_	_	_	_
73	(	_	_	_	_	_	_	_	_
74	GI	_	_	_	_	_	_	_	_
75	)	_	_	_	_	_	_	_	_
76	and	_	_	_	_	_	_	_	_
77	II	_	_	_	_	_	_	_	_
78	(	_	_	_	_	_	_	_	_
79	GII	_	_	_	_	_	_	_	_
80	)	_	_	_	_	_	_	_	_
81	.	_	_	_	_	_	_	_	_
82	In	_	_	_	_	_	_	_	BeginSeg=Yes
83	previous	_	_	_	_	_	_	_	_
84	studies	_	_	_	_	_	_	_	_
85	,	_	_	_	_	_	_	_	_
86	the	_	_	_	_	_	_	_	_
87	conventional	_	_	_	_	_	_	_	_
88	Loopamp	_	_	_	_	_	_	_	_
89	kit	_	_	_	_	_	_	_	_
90	for	_	_	_	_	_	_	_	_
91	Norovirus	_	_	_	_	_	_	_	_
92	GII	_	_	_	_	_	_	_	_
93	showed	_	_	_	_	_	_	_	_
94	a	_	_	_	_	_	_	_	_
95	relatively	_	_	_	_	_	_	_	_
96	high	_	_	_	_	_	_	_	_
97	detection	_	_	_	_	_	_	_	_
98	rate	_	_	_	_	_	_	_	_
99	,	_	_	_	_	_	_	_	_
100	while	_	_	_	_	_	_	_	BeginSeg=Yes
101	that	_	_	_	_	_	_	_	_
102	for	_	_	_	_	_	_	_	_
103	Norovirus	_	_	_	_	_	_	_	_
104	GI	_	_	_	_	_	_	_	_
105	showed	_	_	_	_	_	_	_	_
106	a	_	_	_	_	_	_	_	_
107	relatively	_	_	_	_	_	_	_	_
108	low	_	_	_	_	_	_	_	_
109	detection	_	_	_	_	_	_	_	_
110	rate	_	_	_	_	_	_	_	_
111	.	_	_	_	_	_	_	_	_
112	In	_	_	_	_	_	_	_	BeginSeg=Yes
113	the	_	_	_	_	_	_	_	_
114	present	_	_	_	_	_	_	_	_
115	study	_	_	_	_	_	_	_	_
116	,	_	_	_	_	_	_	_	_
117	clinical	_	_	_	_	_	_	_	_
118	Norovirus	_	_	_	_	_	_	_	_
119	specimens	_	_	_	_	_	_	_	_
120	were	_	_	_	_	_	_	_	_
121	used	_	_	_	_	_	_	_	_
122	to	_	_	_	_	_	_	_	BeginSeg=Yes
123	compare	_	_	_	_	_	_	_	_
124	the	_	_	_	_	_	_	_	_
125	detection	_	_	_	_	_	_	_	_
126	rate	_	_	_	_	_	_	_	_
127	of	_	_	_	_	_	_	_	_
128	a	_	_	_	_	_	_	_	_
129	modified	_	_	_	_	_	_	_	_
130	Loopamp	_	_	_	_	_	_	_	_
131	kit	_	_	_	_	_	_	_	_
132	for	_	_	_	_	_	_	_	_
133	Norovirus	_	_	_	_	_	_	_	_
134	GI	_	_	_	_	_	_	_	_
135	with	_	_	_	_	_	_	_	_
136	the	_	_	_	_	_	_	_	_
137	rates	_	_	_	_	_	_	_	_
138	of	_	_	_	_	_	_	_	_
139	the	_	_	_	_	_	_	_	_
140	conventional	_	_	_	_	_	_	_	_
141	Loopamp	_	_	_	_	_	_	_	_
142	kit	_	_	_	_	_	_	_	_
143	for	_	_	_	_	_	_	_	_
144	Norovirus	_	_	_	_	_	_	_	_
145	GI	_	_	_	_	_	_	_	_
146	and	_	_	_	_	_	_	_	_
147	an	_	_	_	_	_	_	_	_
148	'	_	_	_	_	_	_	_	_
149	'	_	_	_	_	_	_	_	_
150	in	_	_	_	_	_	_	_	_
151	-	_	_	_	_	_	_	_	_
152	house	_	_	_	_	_	_	_	_
153	'	_	_	_	_	_	_	_	_
154	'	_	_	_	_	_	_	_	_
155	RT	_	_	_	_	_	_	_	_
156	-	_	_	_	_	_	_	_	_
157	LAMP	_	_	_	_	_	_	_	_
158	GI	_	_	_	_	_	_	_	_
159	primer	_	_	_	_	_	_	_	_
160	set	_	_	_	_	_	_	_	_
161	,	_	_	_	_	_	_	_	_
162	methods	_	_	_	_	_	_	_	_
163	which	_	_	_	_	_	_	_	BeginSeg=Yes
164	had	_	_	_	_	_	_	_	_
165	a	_	_	_	_	_	_	_	_
166	high	_	_	_	_	_	_	_	_
167	detection	_	_	_	_	_	_	_	_
168	rate	_	_	_	_	_	_	_	_
169	.	_	_	_	_	_	_	_	_
170	Results	_	_	_	_	_	_	_	BeginSeg=Yes
171	from	_	_	_	_	_	_	_	_
172	the	_	_	_	_	_	_	_	_
173	present	_	_	_	_	_	_	_	_
174	study	_	_	_	_	_	_	_	_
175	showed	_	_	_	_	_	_	_	_
176	that	_	_	_	_	_	_	_	BeginSeg=Yes
177	the	_	_	_	_	_	_	_	_
178	modified	_	_	_	_	_	_	_	_
179	Loopamp	_	_	_	_	_	_	_	_
180	kit	_	_	_	_	_	_	_	_
181	for	_	_	_	_	_	_	_	_
182	Norovirus	_	_	_	_	_	_	_	_
183	GI	_	_	_	_	_	_	_	_
184	had	_	_	_	_	_	_	_	_
185	a	_	_	_	_	_	_	_	_
186	higher	_	_	_	_	_	_	_	_
187	detection	_	_	_	_	_	_	_	_
188	rate	_	_	_	_	_	_	_	_
189	for	_	_	_	_	_	_	_	_
190	two	_	_	_	_	_	_	_	_
191	viral	_	_	_	_	_	_	_	_
192	genotypes	_	_	_	_	_	_	_	_
193	(	_	_	_	_	_	_	_	BeginSeg=Yes
194	GI.3	_	_	_	_	_	_	_	_
195	,	_	_	_	_	_	_	_	_
196	GI.11	_	_	_	_	_	_	_	_
197	)	_	_	_	_	_	_	_	_
198	.	_	_	_	_	_	_	_	_
199	On	_	_	_	_	_	_	_	BeginSeg=Yes
200	comparison	_	_	_	_	_	_	_	_
201	with	_	_	_	_	_	_	_	_
202	an	_	_	_	_	_	_	_	_
203	'	_	_	_	_	_	_	_	_
204	'	_	_	_	_	_	_	_	_
205	in	_	_	_	_	_	_	_	_
206	-	_	_	_	_	_	_	_	_
207	house	_	_	_	_	_	_	_	_
208	'	_	_	_	_	_	_	_	_
209	'	_	_	_	_	_	_	_	_
210	GII	_	_	_	_	_	_	_	_
211	primer	_	_	_	_	_	_	_	_
212	set	_	_	_	_	_	_	_	_
213	using	_	_	_	_	_	_	_	BeginSeg=Yes
214	genotype	_	_	_	_	_	_	_	_
215	GII.4	_	_	_	_	_	_	_	_
216	viruses	_	_	_	_	_	_	_	_
217	circulating	_	_	_	_	_	_	_	BeginSeg=Yes
218	recently	_	_	_	_	_	_	_	_
219	,	_	_	_	_	_	_	_	_
220	the	_	_	_	_	_	_	_	BeginSeg=Yes
221	detection	_	_	_	_	_	_	_	_
222	rate	_	_	_	_	_	_	_	_
223	by	_	_	_	_	_	_	_	_
224	the	_	_	_	_	_	_	_	_
225	Loopamp	_	_	_	_	_	_	_	_
226	kit	_	_	_	_	_	_	_	_
227	for	_	_	_	_	_	_	_	_
228	Norovirus	_	_	_	_	_	_	_	_
229	GII	_	_	_	_	_	_	_	_
230	was	_	_	_	_	_	_	_	_
231	found	_	_	_	_	_	_	_	_
232	to	_	_	_	_	_	_	_	_
233	be	_	_	_	_	_	_	_	_
234	higher	_	_	_	_	_	_	_	_
235	,	_	_	_	_	_	_	_	_
236	with	_	_	_	_	_	_	_	_
237	a	_	_	_	_	_	_	_	_
238	98	_	_	_	_	_	_	_	_
239	%	_	_	_	_	_	_	_	_
240	detection	_	_	_	_	_	_	_	_
241	rate	_	_	_	_	_	_	_	_
242	.	_	_	_	_	_	_	_	_
243	These	_	_	_	_	_	_	_	BeginSeg=Yes
244	results	_	_	_	_	_	_	_	_
245	indicate	_	_	_	_	_	_	_	_
246	the	_	_	_	_	_	_	_	_
247	applicability	_	_	_	_	_	_	_	_
248	of	_	_	_	_	_	_	_	_
249	the	_	_	_	_	_	_	_	_
250	modified	_	_	_	_	_	_	_	_
251	LAMP	_	_	_	_	_	_	_	_
252	kit	_	_	_	_	_	_	_	_
253	for	_	_	_	_	_	_	_	_
254	GI	_	_	_	_	_	_	_	_
255	and	_	_	_	_	_	_	_	_
256	the	_	_	_	_	_	_	_	_
257	conventional	_	_	_	_	_	_	_	_
258	LAMP	_	_	_	_	_	_	_	_
259	kit	_	_	_	_	_	_	_	_
260	for	_	_	_	_	_	_	_	_
261	GII	_	_	_	_	_	_	_	_
262	for	_	_	_	_	_	_	_	_
263	detection	_	_	_	_	_	_	_	_
264	of	_	_	_	_	_	_	_	_
265	Noroviruses	_	_	_	_	_	_	_	_
266	in	_	_	_	_	_	_	_	_
267	clinical	_	_	_	_	_	_	_	_
268	samples	_	_	_	_	_	_	_	_
269	.	_	_	_	_	_	_	_	_

# newdoc_id = a924e53c9e50e932f6d0b3938b5bdf284e1736a7
1	Apoptosis	_	_	_	_	_	_	_	BeginSeg=Yes
2	plays	_	_	_	_	_	_	_	_
3	an	_	_	_	_	_	_	_	_
4	important	_	_	_	_	_	_	_	_
5	role	_	_	_	_	_	_	_	_
6	in	_	_	_	_	_	_	_	_
7	the	_	_	_	_	_	_	_	_
8	pathogenesis	_	_	_	_	_	_	_	_
9	of	_	_	_	_	_	_	_	_
10	viral	_	_	_	_	_	_	_	_
11	infections	_	_	_	_	_	_	_	_
12	.	_	_	_	_	_	_	_	_
13	In	_	_	_	_	_	_	_	BeginSeg=Yes
14	this	_	_	_	_	_	_	_	_
15	study	_	_	_	_	_	_	_	_
16	,	_	_	_	_	_	_	_	_
17	we	_	_	_	_	_	_	_	_
18	investigated	_	_	_	_	_	_	_	_
19	the	_	_	_	_	_	_	_	_
20	cell	_	_	_	_	_	_	_	_
21	death	_	_	_	_	_	_	_	_
22	processes	_	_	_	_	_	_	_	_
23	during	_	_	_	_	_	_	_	_
24	productive	_	_	_	_	_	_	_	_
25	HHV-6A	_	_	_	_	_	_	_	_
26	infection	_	_	_	_	_	_	_	_
27	and	_	_	_	_	_	_	_	_
28	the	_	_	_	_	_	_	_	_
29	underlying	_	_	_	_	_	_	_	_
30	mechanisms	_	_	_	_	_	_	_	_
31	.	_	_	_	_	_	_	_	_
32	Annexin	_	_	_	_	_	_	_	BeginSeg=Yes
33	V	_	_	_	_	_	_	_	_
34	-	_	_	_	_	_	_	_	_
35	PI	_	_	_	_	_	_	_	_
36	staining	_	_	_	_	_	_	_	_
37	and	_	_	_	_	_	_	_	_
38	electron	_	_	_	_	_	_	_	_
39	microscopy	_	_	_	_	_	_	_	_
40	indicated	_	_	_	_	_	_	_	_
41	that	_	_	_	_	_	_	_	BeginSeg=Yes
42	HHV-6A	_	_	_	_	_	_	_	_
43	is	_	_	_	_	_	_	_	_
44	a	_	_	_	_	_	_	_	_
45	strong	_	_	_	_	_	_	_	_
46	inducer	_	_	_	_	_	_	_	_
47	of	_	_	_	_	_	_	_	_
48	apoptosis	_	_	_	_	_	_	_	_
49	.	_	_	_	_	_	_	_	_
50	HHV-6A	_	_	_	_	_	_	_	BeginSeg=Yes
51	infection	_	_	_	_	_	_	_	_
52	decreased	_	_	_	_	_	_	_	_
53	mitochondrial	_	_	_	_	_	_	_	_
54	transmembrane	_	_	_	_	_	_	_	_
55	potential	_	_	_	_	_	_	_	_
56	and	_	_	_	_	_	_	_	BeginSeg=Yes
57	led	_	_	_	_	_	_	_	_
58	to	_	_	_	_	_	_	_	_
59	morphological	_	_	_	_	_	_	_	_
60	changes	_	_	_	_	_	_	_	_
61	of	_	_	_	_	_	_	_	_
62	mitochondria	_	_	_	_	_	_	_	_
63	.	_	_	_	_	_	_	_	_
64	The	_	_	_	_	_	_	_	BeginSeg=Yes
65	cell	_	_	_	_	_	_	_	_
66	death	_	_	_	_	_	_	_	_
67	was	_	_	_	_	_	_	_	_
68	associated	_	_	_	_	_	_	_	_
69	with	_	_	_	_	_	_	_	_
70	activation	_	_	_	_	_	_	_	_
71	of	_	_	_	_	_	_	_	_
72	caspase-3	_	_	_	_	_	_	_	_
73	and	_	_	_	_	_	_	_	_
74	cleavage	_	_	_	_	_	_	_	_
75	of	_	_	_	_	_	_	_	_
76	DNA	_	_	_	_	_	_	_	_
77	repair	_	_	_	_	_	_	_	_
78	enzyme	_	_	_	_	_	_	_	_
79	poly	_	_	_	_	_	_	_	_
80	(	_	_	_	_	_	_	_	_
81	ADP	_	_	_	_	_	_	_	_
82	-	_	_	_	_	_	_	_	_
83	ribose	_	_	_	_	_	_	_	_
84	)	_	_	_	_	_	_	_	_
85	polymerase	_	_	_	_	_	_	_	_
86	,	_	_	_	_	_	_	_	_
87	which	_	_	_	_	_	_	_	BeginSeg=Yes
88	is	_	_	_	_	_	_	_	_
89	known	_	_	_	_	_	_	_	_
90	to	_	_	_	_	_	_	_	_
91	be	_	_	_	_	_	_	_	_
92	an	_	_	_	_	_	_	_	_
93	important	_	_	_	_	_	_	_	_
94	substrate	_	_	_	_	_	_	_	_
95	for	_	_	_	_	_	_	_	_
96	activated	_	_	_	_	_	_	_	_
97	caspase-3	_	_	_	_	_	_	_	_
98	.	_	_	_	_	_	_	_	_
99	Caspase-9	_	_	_	_	_	_	_	BeginSeg=Yes
100	was	_	_	_	_	_	_	_	_
101	activated	_	_	_	_	_	_	_	_
102	significantly	_	_	_	_	_	_	_	_
103	in	_	_	_	_	_	_	_	_
104	HHV-6Ainfected	_	_	_	_	_	_	_	_
105	cells	_	_	_	_	_	_	_	_
106	,	_	_	_	_	_	_	_	_
107	whereas	_	_	_	_	_	_	_	BeginSeg=Yes
108	caspase-8	_	_	_	_	_	_	_	_
109	was	_	_	_	_	_	_	_	_
110	not	_	_	_	_	_	_	_	_
111	activated	_	_	_	_	_	_	_	_
112	obviously	_	_	_	_	_	_	_	_
113	.	_	_	_	_	_	_	_	_
114	Moreover	_	_	_	_	_	_	_	BeginSeg=Yes
115	,	_	_	_	_	_	_	_	_
116	HHV-6A	_	_	_	_	_	_	_	_
117	infection	_	_	_	_	_	_	_	_
118	upregulated	_	_	_	_	_	_	_	_
119	Bax	_	_	_	_	_	_	_	_
120	and	_	_	_	_	_	_	_	_
121	downregulated	_	_	_	_	_	_	_	_
122	Bcl-2	_	_	_	_	_	_	_	_
123	.	_	_	_	_	_	_	_	_
124	This	_	_	_	_	_	_	_	BeginSeg=Yes
125	is	_	_	_	_	_	_	_	_
126	the	_	_	_	_	_	_	_	_
127	first	_	_	_	_	_	_	_	_
128	demonstration	_	_	_	_	_	_	_	_
129	of	_	_	_	_	_	_	_	_
130	mitochondrion	_	_	_	_	_	_	_	_
131	-	_	_	_	_	_	_	_	_
132	mediated	_	_	_	_	_	_	_	_
133	,	_	_	_	_	_	_	_	_
134	caspase	_	_	_	_	_	_	_	_
135	-	_	_	_	_	_	_	_	_
136	dependent	_	_	_	_	_	_	_	_
137	apoptosis	_	_	_	_	_	_	_	_
138	in	_	_	_	_	_	_	_	_
139	HHV-6A	_	_	_	_	_	_	_	_
140	-	_	_	_	_	_	_	_	_
141	infected	_	_	_	_	_	_	_	_
142	cells	_	_	_	_	_	_	_	_
143	.	_	_	_	_	_	_	_	_

# newdoc_id = a987e584291a44e8bbab14f9909629b8bba57853
1	SARS	_	_	_	_	_	_	_	BeginSeg=Yes
2	-	_	_	_	_	_	_	_	_
3	CoV-2	_	_	_	_	_	_	_	_
4	genetic	_	_	_	_	_	_	_	_
5	identification	_	_	_	_	_	_	_	_
6	is	_	_	_	_	_	_	_	_
7	based	_	_	_	_	_	_	_	_
8	on	_	_	_	_	_	_	_	_
9	viral	_	_	_	_	_	_	_	_
10	RNA	_	_	_	_	_	_	_	_
11	extraction	_	_	_	_	_	_	_	_
12	prior	_	_	_	_	_	_	_	_
13	to	_	_	_	_	_	_	_	_
14	RT	_	_	_	_	_	_	_	_
15	-	_	_	_	_	_	_	_	_
16	qPCR	_	_	_	_	_	_	_	_
17	assay	_	_	_	_	_	_	_	_
18	,	_	_	_	_	_	_	_	_
19	however	_	_	_	_	_	_	_	BeginSeg=Yes
20	recent	_	_	_	_	_	_	_	_
21	studies	_	_	_	_	_	_	_	_
22	support	_	_	_	_	_	_	_	_
23	the	_	_	_	_	_	_	_	_
24	elimination	_	_	_	_	_	_	_	_
25	of	_	_	_	_	_	_	_	_
26	the	_	_	_	_	_	_	_	_
27	extraction	_	_	_	_	_	_	_	_
28	step	_	_	_	_	_	_	_	_
29	.	_	_	_	_	_	_	_	_
30	Herein	_	_	_	_	_	_	_	BeginSeg=Yes
31	,	_	_	_	_	_	_	_	_
32	we	_	_	_	_	_	_	_	_
33	assessed	_	_	_	_	_	_	_	_
34	the	_	_	_	_	_	_	_	_
35	RNA	_	_	_	_	_	_	_	_
36	extraction	_	_	_	_	_	_	_	_
37	necessity	_	_	_	_	_	_	_	_
38	,	_	_	_	_	_	_	_	_
39	by	_	_	_	_	_	_	_	BeginSeg=Yes
40	comparing	_	_	_	_	_	_	_	_
41	RT	_	_	_	_	_	_	_	_
42	-	_	_	_	_	_	_	_	_
43	qPCR	_	_	_	_	_	_	_	_
44	efficacy	_	_	_	_	_	_	_	_
45	in	_	_	_	_	_	_	_	_
46	several	_	_	_	_	_	_	_	_
47	direct	_	_	_	_	_	_	_	_
48	approaches	_	_	_	_	_	_	_	_
49	vs.	_	_	_	_	_	_	_	_
50	the	_	_	_	_	_	_	_	_
51	gold	_	_	_	_	_	_	_	_
52	standard	_	_	_	_	_	_	_	_
53	RNA	_	_	_	_	_	_	_	_
54	extraction	_	_	_	_	_	_	_	_
55	,	_	_	_	_	_	_	_	_
56	in	_	_	_	_	_	_	_	BeginSeg=Yes
57	detection	_	_	_	_	_	_	_	_
58	of	_	_	_	_	_	_	_	_
59	SARS	_	_	_	_	_	_	_	_
60	-	_	_	_	_	_	_	_	_
61	CoV-2	_	_	_	_	_	_	_	_
62	from	_	_	_	_	_	_	_	_
63	laboratory	_	_	_	_	_	_	_	_
64	samples	_	_	_	_	_	_	_	_
65	as	_	_	_	_	_	_	_	_
66	well	_	_	_	_	_	_	_	_
67	as	_	_	_	_	_	_	_	_
68	clinical	_	_	_	_	_	_	_	_
69	Oro	_	_	_	_	_	_	_	_
70	-	_	_	_	_	_	_	_	_
71	nasopharyngeal	_	_	_	_	_	_	_	_
72	SARS	_	_	_	_	_	_	_	_
73	-	_	_	_	_	_	_	_	_
74	CoV-2	_	_	_	_	_	_	_	_
75	swabs	_	_	_	_	_	_	_	_
76	.	_	_	_	_	_	_	_	_
77	Our	_	_	_	_	_	_	_	BeginSeg=Yes
78	findings	_	_	_	_	_	_	_	_
79	show	_	_	_	_	_	_	_	_
80	advantage	_	_	_	_	_	_	_	_
81	for	_	_	_	_	_	_	_	_
82	the	_	_	_	_	_	_	_	_
83	extraction	_	_	_	_	_	_	_	_
84	procedure	_	_	_	_	_	_	_	_
85	,	_	_	_	_	_	_	_	_
86	however	_	_	_	_	_	_	_	BeginSeg=Yes
87	a	_	_	_	_	_	_	_	_
88	direct	_	_	_	_	_	_	_	_
89	no	_	_	_	_	_	_	_	_
90	-	_	_	_	_	_	_	_	_
91	buffer	_	_	_	_	_	_	_	_
92	approach	_	_	_	_	_	_	_	_
93	might	_	_	_	_	_	_	_	_
94	be	_	_	_	_	_	_	_	_
95	an	_	_	_	_	_	_	_	_
96	alternative	_	_	_	_	_	_	_	_
97	,	_	_	_	_	_	_	_	_
98	since	_	_	_	_	_	_	_	BeginSeg=Yes
99	it	_	_	_	_	_	_	_	_
100	identified	_	_	_	_	_	_	_	_
101	up	_	_	_	_	_	_	_	_
102	to	_	_	_	_	_	_	_	_
103	70	_	_	_	_	_	_	_	_
104	%	_	_	_	_	_	_	_	_
105	of	_	_	_	_	_	_	_	_
106	positive	_	_	_	_	_	_	_	_
107	clinical	_	_	_	_	_	_	_	_
108	specimens	_	_	_	_	_	_	_	_
109	.	_	_	_	_	_	_	_	_

# newdoc_id = aa339dc08635486396623300d7ab64d1c8d632f6
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	attention	_	_	_	_	_	_	_	_
3	mechanism	_	_	_	_	_	_	_	_
4	has	_	_	_	_	_	_	_	_
5	demonstrated	_	_	_	_	_	_	_	_
6	superior	_	_	_	_	_	_	_	_
7	performance	_	_	_	_	_	_	_	_
8	for	_	_	_	_	_	_	_	_
9	inference	_	_	_	_	_	_	_	_
10	over	_	_	_	_	_	_	_	_
11	nodes	_	_	_	_	_	_	_	_
12	in	_	_	_	_	_	_	_	_
13	graph	_	_	_	_	_	_	_	_
14	neural	_	_	_	_	_	_	_	_
15	networks	_	_	_	_	_	_	_	_
16	(	_	_	_	_	_	_	_	_
17	GNNs	_	_	_	_	_	_	_	_
18	)	_	_	_	_	_	_	_	_
19	,	_	_	_	_	_	_	_	_
20	however	_	_	_	_	_	_	_	BeginSeg=Yes
21	,	_	_	_	_	_	_	_	_
22	they	_	_	_	_	_	_	_	_
23	result	_	_	_	_	_	_	_	_
24	in	_	_	_	_	_	_	_	_
25	a	_	_	_	_	_	_	_	_
26	high	_	_	_	_	_	_	_	_
27	computational	_	_	_	_	_	_	_	_
28	burden	_	_	_	_	_	_	_	_
29	during	_	_	_	_	_	_	_	_
30	both	_	_	_	_	_	_	_	_
31	training	_	_	_	_	_	_	_	_
32	and	_	_	_	_	_	_	_	_
33	inference	_	_	_	_	_	_	_	_
34	.	_	_	_	_	_	_	_	_
35	We	_	_	_	_	_	_	_	BeginSeg=Yes
36	propose	_	_	_	_	_	_	_	_
37	FastGAT	_	_	_	_	_	_	_	_
38	,	_	_	_	_	_	_	_	_
39	a	_	_	_	_	_	_	_	_
40	method	_	_	_	_	_	_	_	_
41	to	_	_	_	_	_	_	_	BeginSeg=Yes
42	make	_	_	_	_	_	_	_	_
43	attention	_	_	_	_	_	_	_	_
44	based	_	_	_	_	_	_	_	_
45	GNNs	_	_	_	_	_	_	_	_
46	lightweight	_	_	_	_	_	_	_	_
47	by	_	_	_	_	_	_	_	BeginSeg=Yes
48	using	_	_	_	_	_	_	_	_
49	spectral	_	_	_	_	_	_	_	_
50	sparsification	_	_	_	_	_	_	_	_
51	to	_	_	_	_	_	_	_	BeginSeg=Yes
52	generate	_	_	_	_	_	_	_	_
53	an	_	_	_	_	_	_	_	_
54	optimal	_	_	_	_	_	_	_	_
55	pruning	_	_	_	_	_	_	_	_
56	of	_	_	_	_	_	_	_	_
57	the	_	_	_	_	_	_	_	_
58	input	_	_	_	_	_	_	_	_
59	graph	_	_	_	_	_	_	_	_
60	.	_	_	_	_	_	_	_	_
61	This	_	_	_	_	_	_	_	BeginSeg=Yes
62	results	_	_	_	_	_	_	_	_
63	in	_	_	_	_	_	_	_	_
64	a	_	_	_	_	_	_	_	_
65	per	_	_	_	_	_	_	_	_
66	-	_	_	_	_	_	_	_	_
67	epoch	_	_	_	_	_	_	_	_
68	time	_	_	_	_	_	_	_	_
69	that	_	_	_	_	_	_	_	BeginSeg=Yes
70	is	_	_	_	_	_	_	_	_
71	almost	_	_	_	_	_	_	_	_
72	linear	_	_	_	_	_	_	_	_
73	in	_	_	_	_	_	_	_	_
74	the	_	_	_	_	_	_	_	_
75	number	_	_	_	_	_	_	_	_
76	of	_	_	_	_	_	_	_	_
77	graph	_	_	_	_	_	_	_	_
78	nodes	_	_	_	_	_	_	_	_
79	as	_	_	_	_	_	_	_	BeginSeg=Yes
80	opposed	_	_	_	_	_	_	_	_
81	to	_	_	_	_	_	_	_	_
82	quadratic	_	_	_	_	_	_	_	_
83	.	_	_	_	_	_	_	_	_
84	Further	_	_	_	_	_	_	_	BeginSeg=Yes
85	,	_	_	_	_	_	_	_	_
86	we	_	_	_	_	_	_	_	_
87	provide	_	_	_	_	_	_	_	_
88	a	_	_	_	_	_	_	_	_
89	re	_	_	_	_	_	_	_	_
90	-	_	_	_	_	_	_	_	_
91	formulation	_	_	_	_	_	_	_	_
92	of	_	_	_	_	_	_	_	_
93	a	_	_	_	_	_	_	_	_
94	specific	_	_	_	_	_	_	_	_
95	attention	_	_	_	_	_	_	_	_
96	based	_	_	_	_	_	_	_	_
97	GNN	_	_	_	_	_	_	_	_
98	,	_	_	_	_	_	_	_	_
99	Graph	_	_	_	_	_	_	_	_
100	Attention	_	_	_	_	_	_	_	_
101	Network	_	_	_	_	_	_	_	_
102	(	_	_	_	_	_	_	_	_
103	GAT	_	_	_	_	_	_	_	_
104	)	_	_	_	_	_	_	_	_
105	that	_	_	_	_	_	_	_	BeginSeg=Yes
106	interprets	_	_	_	_	_	_	_	_
107	it	_	_	_	_	_	_	_	_
108	as	_	_	_	_	_	_	_	_
109	a	_	_	_	_	_	_	_	_
110	graph	_	_	_	_	_	_	_	_
111	convolution	_	_	_	_	_	_	_	_
112	method	_	_	_	_	_	_	_	_
113	using	_	_	_	_	_	_	_	BeginSeg=Yes
114	the	_	_	_	_	_	_	_	_
115	random	_	_	_	_	_	_	_	_
116	walk	_	_	_	_	_	_	_	_
117	normalized	_	_	_	_	_	_	_	_
118	graph	_	_	_	_	_	_	_	_
119	Laplacian	_	_	_	_	_	_	_	_
120	.	_	_	_	_	_	_	_	_
121	Using	_	_	_	_	_	_	_	BeginSeg=Yes
122	this	_	_	_	_	_	_	_	_
123	framework	_	_	_	_	_	_	_	_
124	,	_	_	_	_	_	_	_	_
125	we	_	_	_	_	_	_	_	BeginSeg=Yes
126	theoretically	_	_	_	_	_	_	_	_
127	prove	_	_	_	_	_	_	_	_
128	that	_	_	_	_	_	_	_	BeginSeg=Yes
129	spectral	_	_	_	_	_	_	_	_
130	sparsification	_	_	_	_	_	_	_	_
131	preserves	_	_	_	_	_	_	_	_
132	the	_	_	_	_	_	_	_	_
133	features	_	_	_	_	_	_	_	_
134	computed	_	_	_	_	_	_	_	BeginSeg=Yes
135	by	_	_	_	_	_	_	_	_
136	the	_	_	_	_	_	_	_	_
137	GAT	_	_	_	_	_	_	_	_
138	model	_	_	_	_	_	_	_	_
139	,	_	_	_	_	_	_	_	_
140	thereby	_	_	_	_	_	_	_	BeginSeg=Yes
141	justifying	_	_	_	_	_	_	_	_
142	our	_	_	_	_	_	_	_	_
143	FastGAT	_	_	_	_	_	_	_	_
144	algorithm	_	_	_	_	_	_	_	_
145	.	_	_	_	_	_	_	_	_
146	We	_	_	_	_	_	_	_	BeginSeg=Yes
147	experimentally	_	_	_	_	_	_	_	_
148	evaluate	_	_	_	_	_	_	_	_
149	FastGAT	_	_	_	_	_	_	_	_
150	on	_	_	_	_	_	_	_	_
151	several	_	_	_	_	_	_	_	_
152	large	_	_	_	_	_	_	_	_
153	real	_	_	_	_	_	_	_	_
154	world	_	_	_	_	_	_	_	_
155	graph	_	_	_	_	_	_	_	_
156	datasets	_	_	_	_	_	_	_	_
157	for	_	_	_	_	_	_	_	_
158	node	_	_	_	_	_	_	_	_
159	classification	_	_	_	_	_	_	_	_
160	tasks	_	_	_	_	_	_	_	_
161	,	_	_	_	_	_	_	_	_
162	FastGAT	_	_	_	_	_	_	_	BeginSeg=Yes
163	can	_	_	_	_	_	_	_	_
164	dramatically	_	_	_	_	_	_	_	_
165	reduce	_	_	_	_	_	_	_	_
166	(	_	_	_	_	_	_	_	BeginSeg=Yes
167	up	_	_	_	_	_	_	_	_
168	to	_	_	_	_	_	_	_	_
169	10x	_	_	_	_	_	_	_	_
170	)	_	_	_	_	_	_	_	_
171	the	_	_	_	_	_	_	_	BeginSeg=Yes
172	computational	_	_	_	_	_	_	_	_
173	time	_	_	_	_	_	_	_	_
174	and	_	_	_	_	_	_	_	_
175	memory	_	_	_	_	_	_	_	_
176	requirements	_	_	_	_	_	_	_	_
177	,	_	_	_	_	_	_	_	_
178	allowing	_	_	_	_	_	_	_	BeginSeg=Yes
179	the	_	_	_	_	_	_	_	_
180	usage	_	_	_	_	_	_	_	_
181	of	_	_	_	_	_	_	_	_
182	attention	_	_	_	_	_	_	_	_
183	based	_	_	_	_	_	_	_	_
184	GNNs	_	_	_	_	_	_	_	_
185	on	_	_	_	_	_	_	_	_
186	large	_	_	_	_	_	_	_	_
187	graphs	_	_	_	_	_	_	_	_
188	.	_	_	_	_	_	_	_	_

# newdoc_id = ab47b7fee600cd540e17d363002a05a3bdfdd306
1	Current	_	_	_	_	_	_	_	BeginSeg=Yes
2	research	_	_	_	_	_	_	_	_
3	is	_	_	_	_	_	_	_	_
4	an	_	_	_	_	_	_	_	_
5	attempt	_	_	_	_	_	_	_	_
6	to	_	_	_	_	_	_	_	BeginSeg=Yes
7	understand	_	_	_	_	_	_	_	_
8	the	_	_	_	_	_	_	_	_
9	CoVID-19	_	_	_	_	_	_	_	_
10	pandemic	_	_	_	_	_	_	_	_
11	curve	_	_	_	_	_	_	_	_
12	through	_	_	_	_	_	_	_	_
13	statistical	_	_	_	_	_	_	_	_
14	approach	_	_	_	_	_	_	_	_
15	of	_	_	_	_	_	_	_	_
16	probability	_	_	_	_	_	_	_	_
17	density	_	_	_	_	_	_	_	_
18	function	_	_	_	_	_	_	_	_
19	with	_	_	_	_	_	_	_	_
20	associated	_	_	_	_	_	_	_	_
21	skewness	_	_	_	_	_	_	_	_
22	and	_	_	_	_	_	_	_	_
23	kurtosis	_	_	_	_	_	_	_	_
24	measures	_	_	_	_	_	_	_	_
25	,	_	_	_	_	_	_	_	_
26	change	_	_	_	_	_	_	_	_
27	point	_	_	_	_	_	_	_	_
28	detection	_	_	_	_	_	_	_	_
29	and	_	_	_	_	_	_	_	_
30	polynomial	_	_	_	_	_	_	_	_
31	fitting	_	_	_	_	_	_	_	_
32	to	_	_	_	_	_	_	_	BeginSeg=Yes
33	estimate	_	_	_	_	_	_	_	_
34	infected	_	_	_	_	_	_	_	_
35	population	_	_	_	_	_	_	_	_
36	along	_	_	_	_	_	_	_	_
37	with	_	_	_	_	_	_	_	_
38	30	_	_	_	_	_	_	_	_
39	days	_	_	_	_	_	_	_	_
40	projection	_	_	_	_	_	_	_	_
41	.	_	_	_	_	_	_	_	_
42	The	_	_	_	_	_	_	_	BeginSeg=Yes
43	pandemic	_	_	_	_	_	_	_	_
44	curve	_	_	_	_	_	_	_	_
45	has	_	_	_	_	_	_	_	_
46	been	_	_	_	_	_	_	_	_
47	explored	_	_	_	_	_	_	_	_
48	for	_	_	_	_	_	_	_	_
49	above	_	_	_	_	_	_	_	_
50	average	_	_	_	_	_	_	_	_
51	affected	_	_	_	_	_	_	_	_
52	countries	_	_	_	_	_	_	_	_
53	,	_	_	_	_	_	_	_	_
54	six	_	_	_	_	_	_	_	_
55	regions	_	_	_	_	_	_	_	_
56	and	_	_	_	_	_	_	_	_
57	global	_	_	_	_	_	_	_	_
58	scale	_	_	_	_	_	_	_	_
59	during	_	_	_	_	_	_	_	_
60	64	_	_	_	_	_	_	_	_
61	days	_	_	_	_	_	_	_	_
62	of	_	_	_	_	_	_	_	_
63	22nd	_	_	_	_	_	_	_	_
64	January	_	_	_	_	_	_	_	_
65	to	_	_	_	_	_	_	_	_
66	24th	_	_	_	_	_	_	_	_
67	March	_	_	_	_	_	_	_	_
68	,	_	_	_	_	_	_	_	_
69	2020	_	_	_	_	_	_	_	_
70	.	_	_	_	_	_	_	_	_
71	The	_	_	_	_	_	_	_	BeginSeg=Yes
72	global	_	_	_	_	_	_	_	_
73	cases	_	_	_	_	_	_	_	_
74	infection	_	_	_	_	_	_	_	_
75	as	_	_	_	_	_	_	_	_
76	well	_	_	_	_	_	_	_	_
77	as	_	_	_	_	_	_	_	_
78	recovery	_	_	_	_	_	_	_	_
79	rate	_	_	_	_	_	_	_	_
80	curves	_	_	_	_	_	_	_	_
81	remained	_	_	_	_	_	_	_	_
82	in	_	_	_	_	_	_	_	_
83	the	_	_	_	_	_	_	_	_
84	ranged	_	_	_	_	_	_	_	_
85	of	_	_	_	_	_	_	_	_
86	0	_	_	_	_	_	_	_	_
87	-9.89	_	_	_	_	_	_	_	_
88	and	_	_	_	_	_	_	_	_
89	0	_	_	_	_	_	_	_	_
90	-8.89	_	_	_	_	_	_	_	_
91	%	_	_	_	_	_	_	_	_
92	,	_	_	_	_	_	_	_	_
93	respectively	_	_	_	_	_	_	_	_
94	.	_	_	_	_	_	_	_	_
95	The	_	_	_	_	_	_	_	BeginSeg=Yes
96	confirmed	_	_	_	_	_	_	_	_
97	cases	_	_	_	_	_	_	_	_
98	probability	_	_	_	_	_	_	_	_
99	density	_	_	_	_	_	_	_	_
100	curve	_	_	_	_	_	_	_	_
101	is	_	_	_	_	_	_	_	_
102	high	_	_	_	_	_	_	_	_
103	positive	_	_	_	_	_	_	_	_
104	skewed	_	_	_	_	_	_	_	_
105	and	_	_	_	_	_	_	_	_
106	leptokurtic	_	_	_	_	_	_	_	_
107	with	_	_	_	_	_	_	_	_
108	mean	_	_	_	_	_	_	_	_
109	global	_	_	_	_	_	_	_	_
110	infected	_	_	_	_	_	_	_	_
111	daily	_	_	_	_	_	_	_	_
112	population	_	_	_	_	_	_	_	_
113	of	_	_	_	_	_	_	_	_
114	6620	_	_	_	_	_	_	_	_
115	.	_	_	_	_	_	_	_	_
116	The	_	_	_	_	_	_	_	BeginSeg=Yes
117	recovered	_	_	_	_	_	_	_	_
118	cases	_	_	_	_	_	_	_	_
119	showed	_	_	_	_	_	_	_	_
120	bimodal	_	_	_	_	_	_	_	_
121	positive	_	_	_	_	_	_	_	_
122	skewed	_	_	_	_	_	_	_	_
123	curve	_	_	_	_	_	_	_	_
124	of	_	_	_	_	_	_	_	_
125	leptokurtic	_	_	_	_	_	_	_	_
126	type	_	_	_	_	_	_	_	_
127	with	_	_	_	_	_	_	_	_
128	daily	_	_	_	_	_	_	_	_
129	recovery	_	_	_	_	_	_	_	_
130	of	_	_	_	_	_	_	_	_
131	1708	_	_	_	_	_	_	_	_
132	.	_	_	_	_	_	_	_	_
133	The	_	_	_	_	_	_	_	BeginSeg=Yes
134	change	_	_	_	_	_	_	_	_
135	point	_	_	_	_	_	_	_	_
136	detection	_	_	_	_	_	_	_	_
137	helped	_	_	_	_	_	_	_	_
138	to	_	_	_	_	_	_	_	_
139	understand	_	_	_	_	_	_	_	_
140	the	_	_	_	_	_	_	_	_
141	CoVID-19	_	_	_	_	_	_	_	_
142	curve	_	_	_	_	_	_	_	_
143	in	_	_	_	_	_	_	_	_
144	term	_	_	_	_	_	_	_	_
145	of	_	_	_	_	_	_	_	_
146	sudden	_	_	_	_	_	_	_	_
147	change	_	_	_	_	_	_	_	_
148	in	_	_	_	_	_	_	_	_
149	term	_	_	_	_	_	_	_	_
150	of	_	_	_	_	_	_	_	_
151	mean	_	_	_	_	_	_	_	_
152	or	_	_	_	_	_	_	_	_
153	mean	_	_	_	_	_	_	_	_
154	with	_	_	_	_	_	_	_	_
155	variance	_	_	_	_	_	_	_	_
156	.	_	_	_	_	_	_	_	_
157	This	_	_	_	_	_	_	_	BeginSeg=Yes
158	pointed	_	_	_	_	_	_	_	_
159	out	_	_	_	_	_	_	_	_
160	disease	_	_	_	_	_	_	_	BeginSeg=Yes
161	curve	_	_	_	_	_	_	_	_
162	is	_	_	_	_	_	_	_	_
163	consist	_	_	_	_	_	_	_	_
164	of	_	_	_	_	_	_	_	_
165	three	_	_	_	_	_	_	_	_
166	phases	_	_	_	_	_	_	_	_
167	and	_	_	_	_	_	_	_	_
168	last	_	_	_	_	_	_	_	_
169	segment	_	_	_	_	_	_	_	_
170	that	_	_	_	_	_	_	_	BeginSeg=Yes
171	varies	_	_	_	_	_	_	_	_
172	in	_	_	_	_	_	_	_	_
173	term	_	_	_	_	_	_	_	_
174	of	_	_	_	_	_	_	_	_
175	day	_	_	_	_	_	_	_	_
176	lengths	_	_	_	_	_	_	_	_
177	.	_	_	_	_	_	_	_	_
178	The	_	_	_	_	_	_	_	BeginSeg=Yes
179	mean	_	_	_	_	_	_	_	_
180	with	_	_	_	_	_	_	_	_
181	variance	_	_	_	_	_	_	_	_
182	based	_	_	_	_	_	_	_	_
183	change	_	_	_	_	_	_	_	_
184	detection	_	_	_	_	_	_	_	_
185	is	_	_	_	_	_	_	_	_
186	better	_	_	_	_	_	_	_	_
187	in	_	_	_	_	_	_	_	_
188	differentiating	_	_	_	_	_	_	_	_
189	phases	_	_	_	_	_	_	_	_
190	and	_	_	_	_	_	_	_	_
191	associated	_	_	_	_	_	_	_	_
192	segment	_	_	_	_	_	_	_	_
193	length	_	_	_	_	_	_	_	_
194	as	_	_	_	_	_	_	_	BeginSeg=Yes
195	compared	_	_	_	_	_	_	_	_
196	to	_	_	_	_	_	_	_	_
197	mean	_	_	_	_	_	_	_	_
198	.	_	_	_	_	_	_	_	_
199	Global	_	_	_	_	_	_	_	BeginSeg=Yes
200	infected	_	_	_	_	_	_	_	_
201	population	_	_	_	_	_	_	_	_
202	might	_	_	_	_	_	_	_	_
203	rise	_	_	_	_	_	_	_	_
204	in	_	_	_	_	_	_	_	_
205	the	_	_	_	_	_	_	_	_
206	range	_	_	_	_	_	_	_	_
207	of	_	_	_	_	_	_	_	_
208	0.750	_	_	_	_	_	_	_	_
209	to	_	_	_	_	_	_	_	_
210	4.680	_	_	_	_	_	_	_	_
211	million	_	_	_	_	_	_	_	_
212	by	_	_	_	_	_	_	_	_
213	24	_	_	_	_	_	_	_	_
214	th	_	_	_	_	_	_	_	_
215	April	_	_	_	_	_	_	_	_
216	2020	_	_	_	_	_	_	_	_
217	,	_	_	_	_	_	_	_	_
218	depending	_	_	_	_	_	_	_	BeginSeg=Yes
219	upon	_	_	_	_	_	_	_	_
220	the	_	_	_	_	_	_	_	_
221	pandemic	_	_	_	_	_	_	_	_
222	curve	_	_	_	_	_	_	_	_
223	progress	_	_	_	_	_	_	_	_
224	beyond	_	_	_	_	_	_	_	_
225	24th	_	_	_	_	_	_	_	_
226	March	_	_	_	_	_	_	_	_
227	,	_	_	_	_	_	_	_	_
228	2020	_	_	_	_	_	_	_	_
229	.	_	_	_	_	_	_	_	_
230	Expected	_	_	_	_	_	_	_	BeginSeg=Yes
231	most	_	_	_	_	_	_	_	_
232	affected	_	_	_	_	_	_	_	_
233	countries	_	_	_	_	_	_	_	_
234	will	_	_	_	_	_	_	_	_
235	be	_	_	_	_	_	_	_	_
236	USA	_	_	_	_	_	_	_	_
237	,	_	_	_	_	_	_	_	_
238	and	_	_	_	_	_	_	_	_
239	UK	_	_	_	_	_	_	_	_
240	with	_	_	_	_	_	_	_	_
241	at	_	_	_	_	_	_	_	_
242	least	_	_	_	_	_	_	_	_
243	infected	_	_	_	_	_	_	_	_
244	population	_	_	_	_	_	_	_	_
245	of	_	_	_	_	_	_	_	_
246	over	_	_	_	_	_	_	_	_
247	0.100	_	_	_	_	_	_	_	_
248	million	_	_	_	_	_	_	_	_
249	.	_	_	_	_	_	_	_	_
250	Infected	_	_	_	_	_	_	_	BeginSeg=Yes
251	population	_	_	_	_	_	_	_	_
252	polynomial	_	_	_	_	_	_	_	_
253	projection	_	_	_	_	_	_	_	_
254	errors	_	_	_	_	_	_	_	_
255	remained	_	_	_	_	_	_	_	_
256	in	_	_	_	_	_	_	_	_
257	the	_	_	_	_	_	_	_	_
258	range	_	_	_	_	_	_	_	_
259	of	_	_	_	_	_	_	_	_
260	-78.8	_	_	_	_	_	_	_	_
261	to	_	_	_	_	_	_	_	_
262	49.0	_	_	_	_	_	_	_	_
263	%	_	_	_	_	_	_	_	_
264	.	_	_	_	_	_	_	_	_

# newdoc_id = ac51af9995edb441f0ce4fdc384908daa6e83675
1	TREM2	_	_	_	_	_	_	_	BeginSeg=Yes
2	variants	_	_	_	_	_	_	_	_
3	have	_	_	_	_	_	_	_	_
4	been	_	_	_	_	_	_	_	_
5	identified	_	_	_	_	_	_	_	_
6	as	_	_	_	_	_	_	_	_
7	risk	_	_	_	_	_	_	_	_
8	factors	_	_	_	_	_	_	_	_
9	for	_	_	_	_	_	_	_	_
10-11	Alzheimer's	_	_	_	_	_	_	_	_
10	Alzheimer	_	_	_	_	_	_	_	_
11	's	_	_	_	_	_	_	_	_
12	disease	_	_	_	_	_	_	_	_
13	(	_	_	_	_	_	_	_	_
14	AD	_	_	_	_	_	_	_	_
15	)	_	_	_	_	_	_	_	_
16	and	_	_	_	_	_	_	_	_
17	other	_	_	_	_	_	_	_	_
18	neurodegenerative	_	_	_	_	_	_	_	_
19	diseases	_	_	_	_	_	_	_	_
20	(	_	_	_	_	_	_	_	_
21	NDDs	_	_	_	_	_	_	_	_
22	)	_	_	_	_	_	_	_	_
23	.	_	_	_	_	_	_	_	_
24	Because	_	_	_	_	_	_	_	BeginSeg=Yes
25	TREM2	_	_	_	_	_	_	_	_
26	encodes	_	_	_	_	_	_	_	_
27	a	_	_	_	_	_	_	_	_
28	receptor	_	_	_	_	_	_	_	_
29	exclusively	_	_	_	_	_	_	_	BeginSeg=Yes
30	expressed	_	_	_	_	_	_	_	_
31	on	_	_	_	_	_	_	_	_
32	immune	_	_	_	_	_	_	_	_
33	cells	_	_	_	_	_	_	_	_
34	,	_	_	_	_	_	_	_	_
35	identification	_	_	_	_	_	_	_	BeginSeg=Yes
36	of	_	_	_	_	_	_	_	_
37	these	_	_	_	_	_	_	_	_
38	variants	_	_	_	_	_	_	_	_
39	conclusively	_	_	_	_	_	_	_	_
40	demonstrates	_	_	_	_	_	_	_	_
41	that	_	_	_	_	_	_	_	BeginSeg=Yes
42	the	_	_	_	_	_	_	_	_
43	immune	_	_	_	_	_	_	_	_
44	response	_	_	_	_	_	_	_	_
45	can	_	_	_	_	_	_	_	_
46	play	_	_	_	_	_	_	_	_
47	an	_	_	_	_	_	_	_	_
48	active	_	_	_	_	_	_	_	_
49	role	_	_	_	_	_	_	_	_
50	in	_	_	_	_	_	_	_	_
51	the	_	_	_	_	_	_	_	_
52	pathogenesis	_	_	_	_	_	_	_	_
53	of	_	_	_	_	_	_	_	_
54	NDDs	_	_	_	_	_	_	_	_
55	.	_	_	_	_	_	_	_	_
56	These	_	_	_	_	_	_	_	BeginSeg=Yes
57	TREM2	_	_	_	_	_	_	_	_
58	variants	_	_	_	_	_	_	_	_
59	also	_	_	_	_	_	_	_	_
60	confer	_	_	_	_	_	_	_	_
61	the	_	_	_	_	_	_	_	_
62	highest	_	_	_	_	_	_	_	_
63	risk	_	_	_	_	_	_	_	_
64	for	_	_	_	_	_	_	_	BeginSeg=Yes
65	developing	_	_	_	_	_	_	_	_
66-67	Alzheimer's	_	_	_	_	_	_	_	_
66	Alzheimer	_	_	_	_	_	_	_	_
67	's	_	_	_	_	_	_	_	_
68	disease	_	_	_	_	_	_	_	_
69	of	_	_	_	_	_	_	_	_
70	any	_	_	_	_	_	_	_	_
71	risk	_	_	_	_	_	_	_	_
72	factor	_	_	_	_	_	_	_	_
73	identified	_	_	_	_	_	_	_	BeginSeg=Yes
74	in	_	_	_	_	_	_	_	_
75	nearly	_	_	_	_	_	_	_	_
76	two	_	_	_	_	_	_	_	_
77	decades	_	_	_	_	_	_	_	_
78	,	_	_	_	_	_	_	_	_
79	suggesting	_	_	_	_	_	_	_	BeginSeg=Yes
80	that	_	_	_	_	_	_	_	BeginSeg=Yes
81	understanding	_	_	_	_	_	_	_	_
82	more	_	_	_	_	_	_	_	_
83	about	_	_	_	_	_	_	_	_
84	TREM2	_	_	_	_	_	_	_	_
85	function	_	_	_	_	_	_	_	_
86	could	_	_	_	_	_	_	_	_
87	provide	_	_	_	_	_	_	_	_
88	key	_	_	_	_	_	_	_	_
89	insights	_	_	_	_	_	_	_	_
90	into	_	_	_	_	_	_	_	_
91	NDD	_	_	_	_	_	_	_	_
92	pathology	_	_	_	_	_	_	_	_
93	and	_	_	_	_	_	_	_	BeginSeg=Yes
94	provide	_	_	_	_	_	_	_	_
95	avenues	_	_	_	_	_	_	_	_
96	for	_	_	_	_	_	_	_	_
97	novel	_	_	_	_	_	_	_	_
98	immune	_	_	_	_	_	_	_	_
99	-	_	_	_	_	_	_	_	_
100	related	_	_	_	_	_	_	_	_
101	NDD	_	_	_	_	_	_	_	_
102	biomarkers	_	_	_	_	_	_	_	_
103	and	_	_	_	_	_	_	_	_
104	therapeutics	_	_	_	_	_	_	_	_
105	.	_	_	_	_	_	_	_	_
106	The	_	_	_	_	_	_	_	BeginSeg=Yes
107	expression	_	_	_	_	_	_	_	_
108	,	_	_	_	_	_	_	_	_
109	signaling	_	_	_	_	_	_	_	_
110	and	_	_	_	_	_	_	_	_
111	function	_	_	_	_	_	_	_	_
112	of	_	_	_	_	_	_	_	_
113	TREM2	_	_	_	_	_	_	_	_
114	in	_	_	_	_	_	_	_	_
115	NDDs	_	_	_	_	_	_	_	_
116	have	_	_	_	_	_	_	_	_
117	been	_	_	_	_	_	_	_	_
118	extensively	_	_	_	_	_	_	_	_
119	investigated	_	_	_	_	_	_	_	_
120	in	_	_	_	_	_	_	_	_
121	an	_	_	_	_	_	_	_	_
122	effort	_	_	_	_	_	_	_	_
123	to	_	_	_	_	_	_	_	BeginSeg=Yes
124	understand	_	_	_	_	_	_	_	_
125	the	_	_	_	_	_	_	_	_
126	role	_	_	_	_	_	_	_	_
127	of	_	_	_	_	_	_	_	_
128	immune	_	_	_	_	_	_	_	_
129	function	_	_	_	_	_	_	_	_
130	in	_	_	_	_	_	_	_	_
131	disease	_	_	_	_	_	_	_	_
132	pathogenesis	_	_	_	_	_	_	_	_
133	and	_	_	_	_	_	_	_	_
134	progression	_	_	_	_	_	_	_	_
135	.	_	_	_	_	_	_	_	_
136	We	_	_	_	_	_	_	_	BeginSeg=Yes
137	provide	_	_	_	_	_	_	_	_
138	a	_	_	_	_	_	_	_	_
139	comprehensive	_	_	_	_	_	_	_	_
140	review	_	_	_	_	_	_	_	_
141	of	_	_	_	_	_	_	_	_
142	our	_	_	_	_	_	_	_	_
143	current	_	_	_	_	_	_	_	_
144	understanding	_	_	_	_	_	_	_	_
145	of	_	_	_	_	_	_	_	_
146	TREM2	_	_	_	_	_	_	_	_
147	biology	_	_	_	_	_	_	_	_
148	,	_	_	_	_	_	_	_	_
149	including	_	_	_	_	_	_	_	BeginSeg=Yes
150	new	_	_	_	_	_	_	_	_
151	insights	_	_	_	_	_	_	_	_
152	into	_	_	_	_	_	_	_	_
153	the	_	_	_	_	_	_	_	_
154	regulation	_	_	_	_	_	_	_	_
155	of	_	_	_	_	_	_	_	_
156	TREM2	_	_	_	_	_	_	_	_
157	expression	_	_	_	_	_	_	_	_
158	,	_	_	_	_	_	_	_	_
159	and	_	_	_	_	_	_	_	_
160	TREM2	_	_	_	_	_	_	_	_
161	signaling	_	_	_	_	_	_	_	_
162	and	_	_	_	_	_	_	_	_
163	function	_	_	_	_	_	_	_	_
164	across	_	_	_	_	_	_	_	_
165	NDDs	_	_	_	_	_	_	_	_
166	.	_	_	_	_	_	_	_	_
167	While	_	_	_	_	_	_	_	BeginSeg=Yes
168	many	_	_	_	_	_	_	_	_
169	open	_	_	_	_	_	_	_	_
170	questions	_	_	_	_	_	_	_	_
171	remain	_	_	_	_	_	_	_	_
172	,	_	_	_	_	_	_	_	_
173	the	_	_	_	_	_	_	_	BeginSeg=Yes
174	current	_	_	_	_	_	_	_	_
175	body	_	_	_	_	_	_	_	_
176	of	_	_	_	_	_	_	_	_
177	literature	_	_	_	_	_	_	_	_
178	provides	_	_	_	_	_	_	_	_
179	clarity	_	_	_	_	_	_	_	_
180	on	_	_	_	_	_	_	_	_
181	several	_	_	_	_	_	_	_	_
182	issues	_	_	_	_	_	_	_	_
183	.	_	_	_	_	_	_	_	_
184	While	_	_	_	_	_	_	_	BeginSeg=Yes
185	it	_	_	_	_	_	_	_	_
186	is	_	_	_	_	_	_	_	_
187	still	_	_	_	_	_	_	_	_
188	often	_	_	_	_	_	_	_	_
189	cited	_	_	_	_	_	_	_	_
190	that	_	_	_	_	_	_	_	_
191	TREM2	_	_	_	_	_	_	_	_
192	expression	_	_	_	_	_	_	_	_
193	is	_	_	_	_	_	_	_	_
194	decreased	_	_	_	_	_	_	_	_
195	by	_	_	_	_	_	_	_	_
196	pro	_	_	_	_	_	_	_	_
197	-	_	_	_	_	_	_	_	_
198	inflammatory	_	_	_	_	_	_	_	_
199	stimuli	_	_	_	_	_	_	_	_
200	,	_	_	_	_	_	_	_	_
201	it	_	_	_	_	_	_	_	BeginSeg=Yes
202	is	_	_	_	_	_	_	_	_
203	now	_	_	_	_	_	_	_	_
204	clear	_	_	_	_	_	_	_	_
205	that	_	_	_	_	_	_	_	_
206	this	_	_	_	_	_	_	_	_
207	is	_	_	_	_	_	_	_	_
208	true	_	_	_	_	_	_	_	_
209	in	_	_	_	_	_	_	_	_
210	vitro	_	_	_	_	_	_	_	_
211	,	_	_	_	_	_	_	_	_
212	but	_	_	_	_	_	_	_	BeginSeg=Yes
213	inflammatory	_	_	_	_	_	_	_	_
214	stimuli	_	_	_	_	_	_	_	_
215	in	_	_	_	_	_	_	_	_
216	vivo	_	_	_	_	_	_	_	_
217	almost	_	_	_	_	_	_	_	_
218	universally	_	_	_	_	_	_	_	_
219	increase	_	_	_	_	_	_	_	_
220	TREM2	_	_	_	_	_	_	_	_
221	expression	_	_	_	_	_	_	_	_
222	.	_	_	_	_	_	_	_	_
223	Likewise	_	_	_	_	_	_	_	BeginSeg=Yes
224	,	_	_	_	_	_	_	_	_
225	while	_	_	_	_	_	_	_	BeginSeg=Yes
226	TREM2	_	_	_	_	_	_	_	_
227	function	_	_	_	_	_	_	_	_
228	is	_	_	_	_	_	_	_	_
229	classically	_	_	_	_	_	_	_	_
230	described	_	_	_	_	_	_	_	_
231	as	_	_	_	_	_	_	_	_
232	promoting	_	_	_	_	_	_	_	_
233	an	_	_	_	_	_	_	_	_
234	anti	_	_	_	_	_	_	_	_
235	-	_	_	_	_	_	_	_	_
236	inflammatory	_	_	_	_	_	_	_	_
237	phenotype	_	_	_	_	_	_	_	_
238	,	_	_	_	_	_	_	_	_
239	more	_	_	_	_	_	_	_	BeginSeg=Yes
240	than	_	_	_	_	_	_	_	_
241	half	_	_	_	_	_	_	_	_
242	of	_	_	_	_	_	_	_	_
243	published	_	_	_	_	_	_	_	_
244	studies	_	_	_	_	_	_	_	_
245	demonstrate	_	_	_	_	_	_	_	_
246	a	_	_	_	_	_	_	_	_
247	pro	_	_	_	_	_	_	_	_
248	-	_	_	_	_	_	_	_	_
249	inflammatory	_	_	_	_	_	_	_	_
250	role	_	_	_	_	_	_	_	_
251	for	_	_	_	_	_	_	_	_
252	TREM2	_	_	_	_	_	_	_	_
253	,	_	_	_	_	_	_	_	_
254	suggesting	_	_	_	_	_	_	_	BeginSeg=Yes
255	that	_	_	_	_	_	_	_	BeginSeg=Yes
256	its	_	_	_	_	_	_	_	_
257	role	_	_	_	_	_	_	_	_
258	in	_	_	_	_	_	_	_	_
259	inflammation	_	_	_	_	_	_	_	_
260	is	_	_	_	_	_	_	_	_
261	much	_	_	_	_	_	_	_	_
262	more	_	_	_	_	_	_	_	_
263	complex	_	_	_	_	_	_	_	_
264	.	_	_	_	_	_	_	_	_
265	Finally	_	_	_	_	_	_	_	BeginSeg=Yes
266	,	_	_	_	_	_	_	_	_
267	these	_	_	_	_	_	_	_	_
268	components	_	_	_	_	_	_	_	_
269	of	_	_	_	_	_	_	_	_
270	TREM2	_	_	_	_	_	_	_	_
271	biology	_	_	_	_	_	_	_	_
272	are	_	_	_	_	_	_	_	_
273	applied	_	_	_	_	_	_	_	_
274	to	_	_	_	_	_	_	_	_
275	a	_	_	_	_	_	_	_	_
276	discussion	_	_	_	_	_	_	_	_
277	of	_	_	_	_	_	_	_	BeginSeg=Yes
278	how	_	_	_	_	_	_	_	_
279	TREM2	_	_	_	_	_	_	_	_
280	impacts	_	_	_	_	_	_	_	_
281	NDD	_	_	_	_	_	_	_	_
282	pathologies	_	_	_	_	_	_	_	_
283	and	_	_	_	_	_	_	_	BeginSeg=Yes
284	the	_	_	_	_	_	_	_	_
285	latest	_	_	_	_	_	_	_	_
286	assessment	_	_	_	_	_	_	_	_
287	of	_	_	_	_	_	_	_	BeginSeg=Yes
288	how	_	_	_	_	_	_	_	_
289	these	_	_	_	_	_	_	_	_
290	findings	_	_	_	_	_	_	_	_
291	might	_	_	_	_	_	_	_	_
292	be	_	_	_	_	_	_	_	_
293	applied	_	_	_	_	_	_	_	_
294	to	_	_	_	_	_	_	_	_
295	immune	_	_	_	_	_	_	_	_
296	-	_	_	_	_	_	_	_	_
297	directed	_	_	_	_	_	_	_	_
298	clinical	_	_	_	_	_	_	_	_
299	biomarkers	_	_	_	_	_	_	_	_
300	and	_	_	_	_	_	_	_	_
301	therapeutics	_	_	_	_	_	_	_	_
302	.	_	_	_	_	_	_	_	_

# newdoc_id = ad147a4279222c5e480a5636fb879540eded760e
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	epidemic	_	_	_	_	_	_	_	_
3	threshold	_	_	_	_	_	_	_	_
4	of	_	_	_	_	_	_	_	_
5	the	_	_	_	_	_	_	_	_
6	susceptible	_	_	_	_	_	_	_	_
7	-	_	_	_	_	_	_	_	_
8	infected	_	_	_	_	_	_	_	_
9	-	_	_	_	_	_	_	_	_
10	recovered	_	_	_	_	_	_	_	_
11	model	_	_	_	_	_	_	_	_
12	is	_	_	_	_	_	_	_	_
13	a	_	_	_	_	_	_	_	_
14	boundary	_	_	_	_	_	_	_	_
15	separating	_	_	_	_	_	_	_	_
16	parameters	_	_	_	_	_	_	_	_
17	that	_	_	_	_	_	_	_	BeginSeg=Yes
18	permit	_	_	_	_	_	_	_	_
19	epidemics	_	_	_	_	_	_	_	_
20	from	_	_	_	_	_	_	_	_
21	those	_	_	_	_	_	_	_	_
22	that	_	_	_	_	_	_	_	BeginSeg=Yes
23	do	_	_	_	_	_	_	_	_
24	not	_	_	_	_	_	_	_	_
25	.	_	_	_	_	_	_	_	_
26	This	_	_	_	_	_	_	_	BeginSeg=Yes
27	threshold	_	_	_	_	_	_	_	_
28	corresponds	_	_	_	_	_	_	_	_
29	to	_	_	_	_	_	_	_	_
30	parameters	_	_	_	_	_	_	_	_
31	where	_	_	_	_	_	_	_	BeginSeg=Yes
32	the	_	_	_	_	_	_	_	_
33-34	system's	_	_	_	_	_	_	_	_
33	system	_	_	_	_	_	_	_	_
34	's	_	_	_	_	_	_	_	_
35	equilibrium	_	_	_	_	_	_	_	_
36	becomes	_	_	_	_	_	_	_	_
37	unstable	_	_	_	_	_	_	_	_
38	.	_	_	_	_	_	_	_	_
39	Consequently	_	_	_	_	_	_	_	BeginSeg=Yes
40	,	_	_	_	_	_	_	_	_
41	we	_	_	_	_	_	_	_	_
42	use	_	_	_	_	_	_	_	_
43	the	_	_	_	_	_	_	_	_
44	average	_	_	_	_	_	_	_	_
45	rate	_	_	_	_	_	_	_	_
46	at	_	_	_	_	_	_	_	BeginSeg=Yes
47	which	_	_	_	_	_	_	_	_
48	deviations	_	_	_	_	_	_	_	_
49	from	_	_	_	_	_	_	_	_
50	the	_	_	_	_	_	_	_	_
51	equilibrium	_	_	_	_	_	_	_	_
52	shrink	_	_	_	_	_	_	_	_
53	to	_	_	_	_	_	_	_	BeginSeg=Yes
54	define	_	_	_	_	_	_	_	_
55	a	_	_	_	_	_	_	_	_
56	distance	_	_	_	_	_	_	_	_
57	to	_	_	_	_	_	_	_	_
58	this	_	_	_	_	_	_	_	_
59	threshold	_	_	_	_	_	_	_	_
60	.	_	_	_	_	_	_	_	_
61	However	_	_	_	_	_	_	_	BeginSeg=Yes
62	,	_	_	_	_	_	_	_	_
63	the	_	_	_	_	_	_	_	_
64	vital	_	_	_	_	_	_	_	_
65	dynamics	_	_	_	_	_	_	_	_
66	of	_	_	_	_	_	_	_	_
67	the	_	_	_	_	_	_	_	_
68	host	_	_	_	_	_	_	_	_
69	population	_	_	_	_	_	_	_	_
70	may	_	_	_	_	_	_	_	_
71	occur	_	_	_	_	_	_	_	_
72	slowly	_	_	_	_	_	_	_	_
73	even	_	_	_	_	_	_	_	BeginSeg=Yes
74	when	_	_	_	_	_	_	_	_
75	transmission	_	_	_	_	_	_	_	_
76	is	_	_	_	_	_	_	_	_
77	far	_	_	_	_	_	_	_	_
78	from	_	_	_	_	_	_	_	_
79	threshold	_	_	_	_	_	_	_	_
80	levels	_	_	_	_	_	_	_	_
81	.	_	_	_	_	_	_	_	_
82	Here	_	_	_	_	_	_	_	BeginSeg=Yes
83	,	_	_	_	_	_	_	_	_
84	we	_	_	_	_	_	_	_	_
85	show	_	_	_	_	_	_	_	_
86	analytically	_	_	_	_	_	_	_	_
87	how	_	_	_	_	_	_	_	BeginSeg=Yes
88	such	_	_	_	_	_	_	_	_
89	slow	_	_	_	_	_	_	_	_
90	dynamics	_	_	_	_	_	_	_	_
91	can	_	_	_	_	_	_	_	_
92	prevent	_	_	_	_	_	_	_	_
93	estimation	_	_	_	_	_	_	_	_
94	of	_	_	_	_	_	_	_	_
95	the	_	_	_	_	_	_	_	_
96	distance	_	_	_	_	_	_	_	_
97	to	_	_	_	_	_	_	_	_
98	the	_	_	_	_	_	_	_	_
99	threshold	_	_	_	_	_	_	_	_
100	from	_	_	_	_	_	_	_	_
101	fluctuations	_	_	_	_	_	_	_	_
102	in	_	_	_	_	_	_	_	_
103	the	_	_	_	_	_	_	_	_
104	susceptible	_	_	_	_	_	_	_	_
105	population	_	_	_	_	_	_	_	_
106	.	_	_	_	_	_	_	_	_
107	Although	_	_	_	_	_	_	_	BeginSeg=Yes
108	these	_	_	_	_	_	_	_	_
109	results	_	_	_	_	_	_	_	_
110	are	_	_	_	_	_	_	_	_
111	exact	_	_	_	_	_	_	_	_
112	only	_	_	_	_	_	_	_	_
113	in	_	_	_	_	_	_	_	_
114	the	_	_	_	_	_	_	_	_
115	limit	_	_	_	_	_	_	_	_
116	of	_	_	_	_	_	_	_	_
117	long	_	_	_	_	_	_	_	_
118	-	_	_	_	_	_	_	_	_
119	term	_	_	_	_	_	_	_	_
120	observation	_	_	_	_	_	_	_	_
121	of	_	_	_	_	_	_	_	_
122	a	_	_	_	_	_	_	_	_
123	large	_	_	_	_	_	_	_	_
124	system	_	_	_	_	_	_	_	_
125	,	_	_	_	_	_	_	_	_
126	simulations	_	_	_	_	_	_	_	BeginSeg=Yes
127	show	_	_	_	_	_	_	_	_
128	that	_	_	_	_	_	_	_	BeginSeg=Yes
129	they	_	_	_	_	_	_	_	_
130	still	_	_	_	_	_	_	_	_
131	provide	_	_	_	_	_	_	_	_
132	useful	_	_	_	_	_	_	_	_
133	insight	_	_	_	_	_	_	_	_
134	into	_	_	_	_	_	_	_	_
135	systems	_	_	_	_	_	_	_	_
136	with	_	_	_	_	_	_	_	_
137	a	_	_	_	_	_	_	_	_
138	range	_	_	_	_	_	_	_	_
139	of	_	_	_	_	_	_	_	_
140	population	_	_	_	_	_	_	_	_
141	sizes	_	_	_	_	_	_	_	_
142	,	_	_	_	_	_	_	_	_
143	environmental	_	_	_	_	_	_	_	_
144	noise	_	_	_	_	_	_	_	_
145	and	_	_	_	_	_	_	_	_
146	observation	_	_	_	_	_	_	_	_
147	schemes	_	_	_	_	_	_	_	_
148	.	_	_	_	_	_	_	_	_
149	Having	_	_	_	_	_	_	_	BeginSeg=Yes
150	established	_	_	_	_	_	_	_	_
151	some	_	_	_	_	_	_	_	_
152	guidelines	_	_	_	_	_	_	_	_
153	about	_	_	_	_	_	_	_	BeginSeg=Yes
154	when	_	_	_	_	_	_	_	_
155	estimates	_	_	_	_	_	_	_	_
156	are	_	_	_	_	_	_	_	_
157	accurate	_	_	_	_	_	_	_	_
158	,	_	_	_	_	_	_	_	_
159	we	_	_	_	_	_	_	_	BeginSeg=Yes
160	then	_	_	_	_	_	_	_	_
161	illustrate	_	_	_	_	_	_	_	_
162	how	_	_	_	_	_	_	_	BeginSeg=Yes
163	multiple	_	_	_	_	_	_	_	_
164	distance	_	_	_	_	_	_	_	_
165	estimates	_	_	_	_	_	_	_	_
166	can	_	_	_	_	_	_	_	_
167	be	_	_	_	_	_	_	_	_
168	used	_	_	_	_	_	_	_	_
169	to	_	_	_	_	_	_	_	BeginSeg=Yes
170	estimate	_	_	_	_	_	_	_	_
171	the	_	_	_	_	_	_	_	_
172	rate	_	_	_	_	_	_	_	_
173	of	_	_	_	_	_	_	_	_
174	approach	_	_	_	_	_	_	_	_
175	to	_	_	_	_	_	_	_	_
176	the	_	_	_	_	_	_	_	_
177	threshold	_	_	_	_	_	_	_	_
178	.	_	_	_	_	_	_	_	_
179	The	_	_	_	_	_	_	_	BeginSeg=Yes
180	estimation	_	_	_	_	_	_	_	_
181	approach	_	_	_	_	_	_	_	_
182	is	_	_	_	_	_	_	_	_
183	general	_	_	_	_	_	_	_	_
184	and	_	_	_	_	_	_	_	BeginSeg=Yes
185	may	_	_	_	_	_	_	_	_
186	be	_	_	_	_	_	_	_	_
187	applicable	_	_	_	_	_	_	_	_
188	to	_	_	_	_	_	_	_	_
189	zoonotic	_	_	_	_	_	_	_	_
190	pathogens	_	_	_	_	_	_	_	_
191	such	_	_	_	_	_	_	_	BeginSeg=Yes
192	as	_	_	_	_	_	_	_	_
193	Middle	_	_	_	_	_	_	_	_
194	East	_	_	_	_	_	_	_	_
195	respiratory	_	_	_	_	_	_	_	_
196	syndrome	_	_	_	_	_	_	_	_
197	-	_	_	_	_	_	_	_	_
198	related	_	_	_	_	_	_	_	_
199	coronavirus	_	_	_	_	_	_	_	_
200	(	_	_	_	_	_	_	_	_
201	MERS	_	_	_	_	_	_	_	_
202	-	_	_	_	_	_	_	_	_
203	CoV	_	_	_	_	_	_	_	_
204	)	_	_	_	_	_	_	_	_
205	as	_	_	_	_	_	_	_	_
206	well	_	_	_	_	_	_	_	_
207	as	_	_	_	_	_	_	_	_
208	vaccine	_	_	_	_	_	_	_	_
209	-	_	_	_	_	_	_	_	_
210	preventable	_	_	_	_	_	_	_	_
211	diseases	_	_	_	_	_	_	_	_
212	like	_	_	_	_	_	_	_	_
213	measles	_	_	_	_	_	_	_	_
214	.	_	_	_	_	_	_	_	_

# newdoc_id = aedcbf29dcf8ecc0cf24cccd05124571f06fe258
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	entry	_	_	_	_	_	_	_	_
3	of	_	_	_	_	_	_	_	_
4	two	_	_	_	_	_	_	_	_
5	dengue	_	_	_	_	_	_	_	_
6	virus	_	_	_	_	_	_	_	_
7	(	_	_	_	_	_	_	_	_
8	DENV	_	_	_	_	_	_	_	_
9	)	_	_	_	_	_	_	_	_
10	serotypes	_	_	_	_	_	_	_	_
11	into	_	_	_	_	_	_	_	_
12	Vero	_	_	_	_	_	_	_	_
13	cells	_	_	_	_	_	_	_	_
14	was	_	_	_	_	_	_	_	_
15	analysed	_	_	_	_	_	_	_	_
16	using	_	_	_	_	_	_	_	BeginSeg=Yes
17	biochemical	_	_	_	_	_	_	_	_
18	inhibitors	_	_	_	_	_	_	_	_
19	,	_	_	_	_	_	_	_	_
20	dominant	_	_	_	_	_	_	_	_
21	negative	_	_	_	_	_	_	_	_
22	mutants	_	_	_	_	_	_	_	_
23	of	_	_	_	_	_	_	_	_
24	cellular	_	_	_	_	_	_	_	_
25	proteins	_	_	_	_	_	_	_	_
26	involved	_	_	_	_	_	_	_	BeginSeg=Yes
27	in	_	_	_	_	_	_	_	_
28	endocytic	_	_	_	_	_	_	_	_
29	pathways	_	_	_	_	_	_	_	_
30	,	_	_	_	_	_	_	_	_
31	fluorescence	_	_	_	_	_	_	_	BeginSeg=Yes
32	microscopy	_	_	_	_	_	_	_	_
33	and	_	_	_	_	_	_	_	_
34	infectivity	_	_	_	_	_	_	_	_
35	determinations	_	_	_	_	_	_	_	_
36	.	_	_	_	_	_	_	_	_
37	By	_	_	_	_	_	_	_	BeginSeg=Yes
38	treatment	_	_	_	_	_	_	_	_
39	with	_	_	_	_	_	_	_	_
40	dansylcadaverine	_	_	_	_	_	_	_	_
41	and	_	_	_	_	_	_	_	_
42	chlorpromazine	_	_	_	_	_	_	_	_
43	and	_	_	_	_	_	_	_	_
44	overexpression	_	_	_	_	_	_	_	_
45	of	_	_	_	_	_	_	_	_
46	a	_	_	_	_	_	_	_	_
47	dominant	_	_	_	_	_	_	_	_
48	negative	_	_	_	_	_	_	_	_
49	form	_	_	_	_	_	_	_	_
50	of	_	_	_	_	_	_	_	_
51	the	_	_	_	_	_	_	_	_
52	Eps15	_	_	_	_	_	_	_	_
53	protein	_	_	_	_	_	_	_	_
54	,	_	_	_	_	_	_	_	_
55	a	_	_	_	_	_	_	_	_
56	clathrin	_	_	_	_	_	_	_	_
57	-	_	_	_	_	_	_	_	_
58	mediated	_	_	_	_	_	_	_	_
59	endocytosis	_	_	_	_	_	_	_	_
60	for	_	_	_	_	_	_	_	_
61	productive	_	_	_	_	_	_	_	_
62	DENV-1	_	_	_	_	_	_	_	_
63	internalization	_	_	_	_	_	_	_	_
64	into	_	_	_	_	_	_	_	_
65	Vero	_	_	_	_	_	_	_	_
66	cells	_	_	_	_	_	_	_	_
67	was	_	_	_	_	_	_	_	_
68	demonstrated	_	_	_	_	_	_	_	_
69	whereas	_	_	_	_	_	_	_	BeginSeg=Yes
70	the	_	_	_	_	_	_	_	_
71	infectious	_	_	_	_	_	_	_	_
72	entry	_	_	_	_	_	_	_	_
73	of	_	_	_	_	_	_	_	_
74	DENV-2	_	_	_	_	_	_	_	_
75	in	_	_	_	_	_	_	_	_
76	the	_	_	_	_	_	_	_	_
77	same	_	_	_	_	_	_	_	_
78	cell	_	_	_	_	_	_	_	_
79	system	_	_	_	_	_	_	_	_
80	was	_	_	_	_	_	_	_	_
81	independent	_	_	_	_	_	_	_	_
82	of	_	_	_	_	_	_	_	_
83	clathrin	_	_	_	_	_	_	_	_
84	.	_	_	_	_	_	_	_	_
85	Treatment	_	_	_	_	_	_	_	BeginSeg=Yes
86	with	_	_	_	_	_	_	_	_
87	the	_	_	_	_	_	_	_	_
88	inhibitors	_	_	_	_	_	_	_	_
89	nystatin	_	_	_	_	_	_	_	_
90	and	_	_	_	_	_	_	_	_
91	methyl	_	_	_	_	_	_	_	_
92	-	_	_	_	_	_	_	_	_
93	b	_	_	_	_	_	_	_	_
94	-	_	_	_	_	_	_	_	_
95	cyclodextrin	_	_	_	_	_	_	_	_
96	,	_	_	_	_	_	_	_	_
97	as	_	_	_	_	_	_	_	_
98	well	_	_	_	_	_	_	_	_
99	as	_	_	_	_	_	_	_	_
100	transfection	_	_	_	_	_	_	_	_
101	of	_	_	_	_	_	_	_	_
102	Vero	_	_	_	_	_	_	_	_
103	cells	_	_	_	_	_	_	_	_
104	with	_	_	_	_	_	_	_	_
105	dominant	_	_	_	_	_	_	_	_
106	negative	_	_	_	_	_	_	_	_
107	caveolin-1	_	_	_	_	_	_	_	_
108	,	_	_	_	_	_	_	_	_
109	had	_	_	_	_	_	_	_	_
110	no	_	_	_	_	_	_	_	_
111	effect	_	_	_	_	_	_	_	_
112	on	_	_	_	_	_	_	_	_
113	DENV-2	_	_	_	_	_	_	_	_
114	virus	_	_	_	_	_	_	_	_
115	infection	_	_	_	_	_	_	_	_
116	.	_	_	_	_	_	_	_	_
117	It	_	_	_	_	_	_	_	BeginSeg=Yes
118	was	_	_	_	_	_	_	_	_
119	also	_	_	_	_	_	_	_	_
120	shown	_	_	_	_	_	_	_	_
121	,	_	_	_	_	_	_	_	_
122	by	_	_	_	_	_	_	_	BeginSeg=Yes
123	using	_	_	_	_	_	_	_	_
124	the	_	_	_	_	_	_	_	_
125	K44A	_	_	_	_	_	_	_	_
126	mutant	_	_	_	_	_	_	_	_
127	and	_	_	_	_	_	_	_	_
128	the	_	_	_	_	_	_	_	_
129	inhibitor	_	_	_	_	_	_	_	_
130	dynasore	_	_	_	_	_	_	_	_
131	,	_	_	_	_	_	_	_	_
132	that	_	_	_	_	_	_	_	BeginSeg=Yes
133	dynamin	_	_	_	_	_	_	_	_
134	was	_	_	_	_	_	_	_	_
135	required	_	_	_	_	_	_	_	_
136	for	_	_	_	_	_	_	_	_
137	DENV-2	_	_	_	_	_	_	_	_
138	entry	_	_	_	_	_	_	_	_
139	.	_	_	_	_	_	_	_	_
140	Consequently	_	_	_	_	_	_	_	BeginSeg=Yes
141	,	_	_	_	_	_	_	_	_
142	the	_	_	_	_	_	_	_	_
143	infectious	_	_	_	_	_	_	_	_
144	entry	_	_	_	_	_	_	_	_
145	of	_	_	_	_	_	_	_	_
146	DENV-2	_	_	_	_	_	_	_	_
147	into	_	_	_	_	_	_	_	_
148	Vero	_	_	_	_	_	_	_	_
149	cells	_	_	_	_	_	_	_	_
150	occurs	_	_	_	_	_	_	_	_
151	by	_	_	_	_	_	_	_	_
152	a	_	_	_	_	_	_	_	_
153	non	_	_	_	_	_	_	_	_
154	-	_	_	_	_	_	_	_	_
155	classical	_	_	_	_	_	_	_	_
156	endocytic	_	_	_	_	_	_	_	_
157	pathway	_	_	_	_	_	_	_	_
158	independent	_	_	_	_	_	_	_	_
159	of	_	_	_	_	_	_	_	_
160	clathrin	_	_	_	_	_	_	_	_
161	,	_	_	_	_	_	_	_	_
162	caveolae	_	_	_	_	_	_	_	_
163	and	_	_	_	_	_	_	_	_
164	lipid	_	_	_	_	_	_	_	_
165	rafts	_	_	_	_	_	_	_	_
166	,	_	_	_	_	_	_	_	_
167	but	_	_	_	_	_	_	_	_
168	dependent	_	_	_	_	_	_	_	_
169	on	_	_	_	_	_	_	_	_
170	dynamin	_	_	_	_	_	_	_	_
171	.	_	_	_	_	_	_	_	_
172	By	_	_	_	_	_	_	_	BeginSeg=Yes
173	contrast	_	_	_	_	_	_	_	_
174	,	_	_	_	_	_	_	_	_
175	DENV-2	_	_	_	_	_	_	_	_
176	entry	_	_	_	_	_	_	_	_
177	into	_	_	_	_	_	_	_	_
178	A549	_	_	_	_	_	_	_	_
179	cells	_	_	_	_	_	_	_	_
180	was	_	_	_	_	_	_	_	_
181	clathrin	_	_	_	_	_	_	_	_
182	-	_	_	_	_	_	_	_	_
183	dependent	_	_	_	_	_	_	_	_
184	,	_	_	_	_	_	_	_	_
185	as	_	_	_	_	_	_	_	BeginSeg=Yes
186	previously	_	_	_	_	_	_	_	_
187	reported	_	_	_	_	_	_	_	_
188	in	_	_	_	_	_	_	_	_
189	HeLa	_	_	_	_	_	_	_	_
190	,	_	_	_	_	_	_	_	_
191	C6/36	_	_	_	_	_	_	_	_
192	and	_	_	_	_	_	_	_	_
193	BS	_	_	_	_	_	_	_	_
194	-	_	_	_	_	_	_	_	_
195	C-1	_	_	_	_	_	_	_	_
196	cells	_	_	_	_	_	_	_	_
197	.	_	_	_	_	_	_	_	_
198	Our	_	_	_	_	_	_	_	BeginSeg=Yes
199	results	_	_	_	_	_	_	_	_
200	conclusively	_	_	_	_	_	_	_	_
201	show	_	_	_	_	_	_	_	_
202	,	_	_	_	_	_	_	_	_
203	for	_	_	_	_	_	_	_	_
204	the	_	_	_	_	_	_	_	_
205	first	_	_	_	_	_	_	_	_
206	time	_	_	_	_	_	_	_	_
207	,	_	_	_	_	_	_	_	_
208	a	_	_	_	_	_	_	_	_
209	differential	_	_	_	_	_	_	_	_
210	mode	_	_	_	_	_	_	_	_
211	of	_	_	_	_	_	_	_	_
212	infective	_	_	_	_	_	_	_	_
213	entry	_	_	_	_	_	_	_	_
214	for	_	_	_	_	_	_	_	_
215	DENV-1	_	_	_	_	_	_	_	_
216	and	_	_	_	_	_	_	_	_
217	DENV-2	_	_	_	_	_	_	_	_
218	into	_	_	_	_	_	_	_	_
219	a	_	_	_	_	_	_	_	_
220	common	_	_	_	_	_	_	_	_
221	host	_	_	_	_	_	_	_	_
222	cell	_	_	_	_	_	_	_	_
223	,	_	_	_	_	_	_	_	_
224	Vero	_	_	_	_	_	_	_	_
225	cells	_	_	_	_	_	_	_	_
226	,	_	_	_	_	_	_	_	_
227	as	_	_	_	_	_	_	_	_
228	well	_	_	_	_	_	_	_	_
229	as	_	_	_	_	_	_	_	_
230	alternative	_	_	_	_	_	_	_	_
231	entry	_	_	_	_	_	_	_	_
232	pathways	_	_	_	_	_	_	_	_
233	for	_	_	_	_	_	_	_	_
234	a	_	_	_	_	_	_	_	_
235	given	_	_	_	_	_	_	_	_
236	serotype	_	_	_	_	_	_	_	_
237	,	_	_	_	_	_	_	_	_
238	DENV-2	_	_	_	_	_	_	_	_
239	,	_	_	_	_	_	_	_	_
240	into	_	_	_	_	_	_	_	_
241	different	_	_	_	_	_	_	_	_
242	types	_	_	_	_	_	_	_	_
243	of	_	_	_	_	_	_	_	_
244	cells	_	_	_	_	_	_	_	_
245	.	_	_	_	_	_	_	_	_

# newdoc_id = b25406fedda8c98e076135cef12df228ca6fd4f1
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	coronavirus	_	_	_	_	_	_	_	_
3	disease	_	_	_	_	_	_	_	_
4	2019	_	_	_	_	_	_	_	_
5	pandemic	_	_	_	_	_	_	_	_
6	has	_	_	_	_	_	_	_	_
7	led	_	_	_	_	_	_	_	_
8	to	_	_	_	_	_	_	_	_
9	the	_	_	_	_	_	_	_	_
10	manufacturing	_	_	_	_	_	_	_	_
11	of	_	_	_	_	_	_	_	_
12	novel	_	_	_	_	_	_	_	_
13	devices	_	_	_	_	_	_	_	_
14	to	_	_	_	_	_	_	_	BeginSeg=Yes
15	protect	_	_	_	_	_	_	_	_
16	clinicians	_	_	_	_	_	_	_	_
17	from	_	_	_	_	_	_	_	_
18	the	_	_	_	_	_	_	_	_
19	risk	_	_	_	_	_	_	_	_
20	of	_	_	_	_	_	_	_	_
21	transmission	_	_	_	_	_	_	_	_
22	,	_	_	_	_	_	_	_	_
23	including	_	_	_	_	_	_	_	BeginSeg=Yes
24	the	_	_	_	_	_	_	_	_
25	aerosol	_	_	_	_	_	_	_	_
26	box	_	_	_	_	_	_	_	_
27	for	_	_	_	_	_	_	_	_
28	use	_	_	_	_	_	_	_	_
29	during	_	_	_	_	_	_	_	_
30	tracheal	_	_	_	_	_	_	_	_
31	intubation	_	_	_	_	_	_	_	_
32	.	_	_	_	_	_	_	_	_
33	We	_	_	_	_	_	_	_	BeginSeg=Yes
34	evaluated	_	_	_	_	_	_	_	_
35	the	_	_	_	_	_	_	_	_
36	impact	_	_	_	_	_	_	_	_
37	of	_	_	_	_	_	_	_	_
38	two	_	_	_	_	_	_	_	_
39	aerosol	_	_	_	_	_	_	_	_
40	boxes	_	_	_	_	_	_	_	_
41	(	_	_	_	_	_	_	_	BeginSeg=Yes
42	an	_	_	_	_	_	_	_	_
43	early	_	_	_	_	_	_	_	_
44	-	_	_	_	_	_	_	_	_
45	generation	_	_	_	_	_	_	_	_
46	box	_	_	_	_	_	_	_	_
47	and	_	_	_	_	_	_	_	_
48	a	_	_	_	_	_	_	_	_
49	latest	_	_	_	_	_	_	_	_
50	-	_	_	_	_	_	_	_	_
51	generation	_	_	_	_	_	_	_	_
52	box	_	_	_	_	_	_	_	_
53	)	_	_	_	_	_	_	_	_
54	on	_	_	_	_	_	_	_	BeginSeg=Yes
55	intubations	_	_	_	_	_	_	_	_
56	in	_	_	_	_	_	_	_	_
57	patients	_	_	_	_	_	_	_	_
58	with	_	_	_	_	_	_	_	_
59	severe	_	_	_	_	_	_	_	_
60	coronavirus	_	_	_	_	_	_	_	_
61	disease	_	_	_	_	_	_	_	_
62	2019	_	_	_	_	_	_	_	_
63	with	_	_	_	_	_	_	_	_
64	an	_	_	_	_	_	_	_	_
65	in	_	_	_	_	_	_	_	_
66	-	_	_	_	_	_	_	_	_
67	situ	_	_	_	_	_	_	_	_
68	simulation	_	_	_	_	_	_	_	_
69	crossover	_	_	_	_	_	_	_	_
70	study	_	_	_	_	_	_	_	_
71	.	_	_	_	_	_	_	_	_
72	The	_	_	_	_	_	_	_	BeginSeg=Yes
73	simulated	_	_	_	_	_	_	_	_
74	process	_	_	_	_	_	_	_	_
75	complied	_	_	_	_	_	_	_	_
76	with	_	_	_	_	_	_	_	_
77	the	_	_	_	_	_	_	_	_
78	Safe	_	_	_	_	_	_	_	_
79	Airway	_	_	_	_	_	_	_	_
80	Society	_	_	_	_	_	_	_	_
81	coronavirus	_	_	_	_	_	_	_	_
82	disease	_	_	_	_	_	_	_	_
83	2019	_	_	_	_	_	_	_	_
84	airway	_	_	_	_	_	_	_	_
85	management	_	_	_	_	_	_	_	_
86	guidelines	_	_	_	_	_	_	_	_
87	.	_	_	_	_	_	_	_	_
88	The	_	_	_	_	_	_	_	BeginSeg=Yes
89	primary	_	_	_	_	_	_	_	_
90	outcome	_	_	_	_	_	_	_	_
91	was	_	_	_	_	_	_	_	_
92	intubation	_	_	_	_	_	_	_	_
93	time	_	_	_	_	_	_	_	_
94	;	_	_	_	_	_	_	_	_
95	secondary	_	_	_	_	_	_	_	BeginSeg=Yes
96	outcomes	_	_	_	_	_	_	_	_
97	included	_	_	_	_	_	_	_	_
98	first	_	_	_	_	_	_	_	_
99	-	_	_	_	_	_	_	_	_
100	pass	_	_	_	_	_	_	_	_
101	success	_	_	_	_	_	_	_	_
102	and	_	_	_	_	_	_	_	_
103	breaches	_	_	_	_	_	_	_	_
104	to	_	_	_	_	_	_	_	_
105	personal	_	_	_	_	_	_	_	_
106	protective	_	_	_	_	_	_	_	_
107	equipment	_	_	_	_	_	_	_	_
108	.	_	_	_	_	_	_	_	_
109	All	_	_	_	_	_	_	_	BeginSeg=Yes
110	intubations	_	_	_	_	_	_	_	_
111	were	_	_	_	_	_	_	_	_
112	performed	_	_	_	_	_	_	_	_
113	by	_	_	_	_	_	_	_	_
114	specialist	_	_	_	_	_	_	_	_
115	(	_	_	_	_	_	_	_	_
116	consultant	_	_	_	_	_	_	_	_
117	)	_	_	_	_	_	_	_	_
118	anaesthetists	_	_	_	_	_	_	_	_
119	and	_	_	_	_	_	_	_	_
120	video	_	_	_	_	_	_	_	_
121	recorded	_	_	_	_	_	_	_	_
122	.	_	_	_	_	_	_	_	_
123	Twelve	_	_	_	_	_	_	_	BeginSeg=Yes
124	anaesthetists	_	_	_	_	_	_	_	_
125	performed	_	_	_	_	_	_	_	_
126	36	_	_	_	_	_	_	_	_
127	intubations	_	_	_	_	_	_	_	_
128	.	_	_	_	_	_	_	_	_
129	Intubation	_	_	_	_	_	_	_	BeginSeg=Yes
130	time	_	_	_	_	_	_	_	_
131	with	_	_	_	_	_	_	_	_
132	no	_	_	_	_	_	_	_	_
133	aerosol	_	_	_	_	_	_	_	_
134	box	_	_	_	_	_	_	_	_
135	was	_	_	_	_	_	_	_	_
136	significantly	_	_	_	_	_	_	_	_
137	shorter	_	_	_	_	_	_	_	_
138	than	_	_	_	_	_	_	_	_
139	with	_	_	_	_	_	_	_	_
140	the	_	_	_	_	_	_	_	_
141	early	_	_	_	_	_	_	_	_
142	-	_	_	_	_	_	_	_	_
143	generation	_	_	_	_	_	_	_	_
144	box	_	_	_	_	_	_	_	_
145	(	_	_	_	_	_	_	_	BeginSeg=Yes
146	median	_	_	_	_	_	_	_	_
147	(	_	_	_	_	_	_	_	_
148	IQR	_	_	_	_	_	_	_	_
149	[	_	_	_	_	_	_	_	_
150	range	_	_	_	_	_	_	_	_
151	]	_	_	_	_	_	_	_	_
152	)	_	_	_	_	_	_	_	_
153	42.9	_	_	_	_	_	_	_	_
154	(	_	_	_	_	_	_	_	_
155	32.9	_	_	_	_	_	_	_	_
156	-	_	_	_	_	_	_	_	_
157	46.9	_	_	_	_	_	_	_	_
158	[	_	_	_	_	_	_	_	_
159	30.9	_	_	_	_	_	_	_	_
160	-	_	_	_	_	_	_	_	_
161	57.6])s	_	_	_	_	_	_	_	_
162	vs.	_	_	_	_	_	_	_	_
163	82.1	_	_	_	_	_	_	_	_
164	(	_	_	_	_	_	_	_	_
165	45.1	_	_	_	_	_	_	_	_
166	-	_	_	_	_	_	_	_	_
167	98.3	_	_	_	_	_	_	_	_
168	[	_	_	_	_	_	_	_	_
169	30.8	_	_	_	_	_	_	_	_
170	-	_	_	_	_	_	_	_	_
171	180.0])s	_	_	_	_	_	_	_	_
172	p	_	_	_	_	_	_	_	_
173	=	_	_	_	_	_	_	_	_
174	0.002	_	_	_	_	_	_	_	_
175	)	_	_	_	_	_	_	_	_
176	and	_	_	_	_	_	_	_	BeginSeg=Yes
177	the	_	_	_	_	_	_	_	_
178	latest	_	_	_	_	_	_	_	_
179	-	_	_	_	_	_	_	_	_
180	generation	_	_	_	_	_	_	_	_
181	box	_	_	_	_	_	_	_	_
182	(	_	_	_	_	_	_	_	BeginSeg=Yes
183	52.4	_	_	_	_	_	_	_	_
184	(	_	_	_	_	_	_	_	_
185	43.1	_	_	_	_	_	_	_	_
186	-	_	_	_	_	_	_	_	_
187	70.3	_	_	_	_	_	_	_	_
188	[	_	_	_	_	_	_	_	_
189	35.7	_	_	_	_	_	_	_	_
190	-	_	_	_	_	_	_	_	_
191	169.2])s	_	_	_	_	_	_	_	_
192	,	_	_	_	_	_	_	_	_
193	p	_	_	_	_	_	_	_	_
194	=	_	_	_	_	_	_	_	_
195	0.008	_	_	_	_	_	_	_	_
196	)	_	_	_	_	_	_	_	_
197	.	_	_	_	_	_	_	_	_
198	No	_	_	_	_	_	_	_	BeginSeg=Yes
199	intubations	_	_	_	_	_	_	_	_
200	without	_	_	_	_	_	_	_	_
201	a	_	_	_	_	_	_	_	_
202	box	_	_	_	_	_	_	_	_
203	took	_	_	_	_	_	_	_	_
204	more	_	_	_	_	_	_	_	_
205	than	_	_	_	_	_	_	_	_
206	1	_	_	_	_	_	_	_	_
207	min	_	_	_	_	_	_	_	_
208	,	_	_	_	_	_	_	_	_
209	whereas	_	_	_	_	_	_	_	BeginSeg=Yes
210	14	_	_	_	_	_	_	_	_
211	(	_	_	_	_	_	_	_	BeginSeg=Yes
212	58	_	_	_	_	_	_	_	_
213	%	_	_	_	_	_	_	_	_
214	)	_	_	_	_	_	_	_	_
215	intubations	_	_	_	_	_	_	_	BeginSeg=Yes
216	with	_	_	_	_	_	_	_	_
217	a	_	_	_	_	_	_	_	_
218	box	_	_	_	_	_	_	_	_
219	took	_	_	_	_	_	_	_	_
220	over	_	_	_	_	_	_	_	_
221	1	_	_	_	_	_	_	_	_
222	min	_	_	_	_	_	_	_	_
223	and	_	_	_	_	_	_	_	BeginSeg=Yes
224	4	_	_	_	_	_	_	_	_
225	(	_	_	_	_	_	_	_	BeginSeg=Yes
226	17	_	_	_	_	_	_	_	_
227	%	_	_	_	_	_	_	_	_
228	)	_	_	_	_	_	_	_	_
229	took	_	_	_	_	_	_	_	BeginSeg=Yes
230	over	_	_	_	_	_	_	_	_
231	2	_	_	_	_	_	_	_	_
232	min	_	_	_	_	_	_	_	_
233	(	_	_	_	_	_	_	_	BeginSeg=Yes
234	including	_	_	_	_	_	_	_	_
235	one	_	_	_	_	_	_	_	_
236	failure	_	_	_	_	_	_	_	_
237	)	_	_	_	_	_	_	_	_
238	.	_	_	_	_	_	_	_	_
239	Without	_	_	_	_	_	_	_	BeginSeg=Yes
240	an	_	_	_	_	_	_	_	_
241	aerosol	_	_	_	_	_	_	_	_
242	box	_	_	_	_	_	_	_	_
243	,	_	_	_	_	_	_	_	_
244	all	_	_	_	_	_	_	_	_
245	anaesthetists	_	_	_	_	_	_	_	_
246	obtained	_	_	_	_	_	_	_	_
247	first	_	_	_	_	_	_	_	_
248	-	_	_	_	_	_	_	_	_
249	pass	_	_	_	_	_	_	_	_
250	success	_	_	_	_	_	_	_	_
251	.	_	_	_	_	_	_	_	_
252	With	_	_	_	_	_	_	_	BeginSeg=Yes
253	the	_	_	_	_	_	_	_	_
254	early	_	_	_	_	_	_	_	_
255	-	_	_	_	_	_	_	_	_
256	generation	_	_	_	_	_	_	_	_
257	and	_	_	_	_	_	_	_	_
258	latest	_	_	_	_	_	_	_	_
259	-	_	_	_	_	_	_	_	_
260	generation	_	_	_	_	_	_	_	_
261	boxes	_	_	_	_	_	_	_	_
262	,	_	_	_	_	_	_	_	_
263	9	_	_	_	_	_	_	_	_
264	(	_	_	_	_	_	_	_	BeginSeg=Yes
265	75	_	_	_	_	_	_	_	_
266	%	_	_	_	_	_	_	_	_
267	)	_	_	_	_	_	_	_	_
268	and	_	_	_	_	_	_	_	BeginSeg=Yes
269	10	_	_	_	_	_	_	_	_
270	(	_	_	_	_	_	_	_	BeginSeg=Yes
271	83	_	_	_	_	_	_	_	_
272	%	_	_	_	_	_	_	_	_
273	)	_	_	_	_	_	_	_	_
274	participants	_	_	_	_	_	_	_	BeginSeg=Yes
275	obtained	_	_	_	_	_	_	_	_
276	first	_	_	_	_	_	_	_	_
277	-	_	_	_	_	_	_	_	_
278	pass	_	_	_	_	_	_	_	_
279	success	_	_	_	_	_	_	_	_
280	,	_	_	_	_	_	_	_	_
281	respectively	_	_	_	_	_	_	_	_
282	.	_	_	_	_	_	_	_	_

# newdoc_id = b61d4d87ea3b4fa2ff058ee867bdac4f15c0cf11
1	As	_	_	_	_	_	_	_	BeginSeg=Yes
2	intracellular	_	_	_	_	_	_	_	_
3	parasites	_	_	_	_	_	_	_	_
4	,	_	_	_	_	_	_	_	_
5	viruses	_	_	_	_	_	_	_	_
6	require	_	_	_	_	_	_	_	_
7	a	_	_	_	_	_	_	_	_
8	host	_	_	_	_	_	_	_	_
9	cell	_	_	_	_	_	_	_	_
10	in	_	_	_	_	_	_	_	BeginSeg=Yes
11	order	_	_	_	_	_	_	_	_
12	to	_	_	_	_	_	_	_	_
13	replicate	_	_	_	_	_	_	_	_
14	.	_	_	_	_	_	_	_	_
15	However	_	_	_	_	_	_	_	BeginSeg=Yes
16	,	_	_	_	_	_	_	_	_
17	they	_	_	_	_	_	_	_	_
18	face	_	_	_	_	_	_	_	_
19	a	_	_	_	_	_	_	_	_
20	series	_	_	_	_	_	_	_	_
21	of	_	_	_	_	_	_	_	_
22	cellular	_	_	_	_	_	_	_	_
23	responses	_	_	_	_	_	_	_	_
24	against	_	_	_	_	_	_	_	_
25	infection	_	_	_	_	_	_	_	_
26	.	_	_	_	_	_	_	_	_
27	One	_	_	_	_	_	_	_	BeginSeg=Yes
28	of	_	_	_	_	_	_	_	_
29	these	_	_	_	_	_	_	_	_
30	responses	_	_	_	_	_	_	_	_
31	is	_	_	_	_	_	_	_	_
32	the	_	_	_	_	_	_	_	_
33	activation	_	_	_	_	_	_	_	_
34	of	_	_	_	_	_	_	_	_
35	the	_	_	_	_	_	_	_	_
36	double	_	_	_	_	_	_	_	_
37	-	_	_	_	_	_	_	_	_
38	stranded	_	_	_	_	_	_	_	_
39	RNA	_	_	_	_	_	_	_	_
40	(	_	_	_	_	_	_	_	_
41	dsRNA)-activated	_	_	_	_	_	_	_	_
42	protein	_	_	_	_	_	_	_	_
43	kinase	_	_	_	_	_	_	_	_
44	R	_	_	_	_	_	_	_	_
45	(	_	_	_	_	_	_	_	_
46	PKR	_	_	_	_	_	_	_	_
47	)	_	_	_	_	_	_	_	_
48	.	_	_	_	_	_	_	_	_
49	PKR	_	_	_	_	_	_	_	BeginSeg=Yes
50	phosphorylates	_	_	_	_	_	_	_	_
51	the	_	_	_	_	_	_	_	_
52	α	_	_	_	_	_	_	_	_
53	subunit	_	_	_	_	_	_	_	_
54	of	_	_	_	_	_	_	_	_
55	eukaryotic	_	_	_	_	_	_	_	_
56	translation	_	_	_	_	_	_	_	_
57	initiation	_	_	_	_	_	_	_	_
58	factor	_	_	_	_	_	_	_	_
59	2	_	_	_	_	_	_	_	_
60	(	_	_	_	_	_	_	_	_
61	eIF2α	_	_	_	_	_	_	_	_
62	)	_	_	_	_	_	_	_	_
63	,	_	_	_	_	_	_	_	_
64	which	_	_	_	_	_	_	_	BeginSeg=Yes
65	in	_	_	_	_	_	_	_	_
66	turn	_	_	_	_	_	_	_	_
67	results	_	_	_	_	_	_	_	_
68	in	_	_	_	_	_	_	_	_
69	global	_	_	_	_	_	_	_	_
70	protein	_	_	_	_	_	_	_	_
71	synthesis	_	_	_	_	_	_	_	_
72	inhibition	_	_	_	_	_	_	_	_
73	and	_	_	_	_	_	_	_	_
74	formation	_	_	_	_	_	_	_	_
75	of	_	_	_	_	_	_	_	_
76	stress	_	_	_	_	_	_	_	_
77	granules	_	_	_	_	_	_	_	_
78	(	_	_	_	_	_	_	_	_
79	SGs	_	_	_	_	_	_	_	_
80	)	_	_	_	_	_	_	_	_
81	.	_	_	_	_	_	_	_	_
82	Recent	_	_	_	_	_	_	_	BeginSeg=Yes
83	studies	_	_	_	_	_	_	_	_
84	have	_	_	_	_	_	_	_	_
85	shown	_	_	_	_	_	_	_	_
86	that	_	_	_	_	_	_	_	BeginSeg=Yes
87	SGs	_	_	_	_	_	_	_	_
88	can	_	_	_	_	_	_	_	_
89	interfere	_	_	_	_	_	_	_	_
90	with	_	_	_	_	_	_	_	_
91	the	_	_	_	_	_	_	_	_
92	replicative	_	_	_	_	_	_	_	_
93	cycle	_	_	_	_	_	_	_	_
94	of	_	_	_	_	_	_	_	_
95	certain	_	_	_	_	_	_	_	_
96	viruses	_	_	_	_	_	_	_	_
97	.	_	_	_	_	_	_	_	_
98	This	_	_	_	_	_	_	_	BeginSeg=Yes
99	review	_	_	_	_	_	_	_	_
100	addresses	_	_	_	_	_	_	_	_
101	how	_	_	_	_	_	_	_	BeginSeg=Yes
102	viruses	_	_	_	_	_	_	_	_
103	have	_	_	_	_	_	_	_	_
104	evolved	_	_	_	_	_	_	_	_
105	different	_	_	_	_	_	_	_	_
106	control	_	_	_	_	_	_	_	_
107	strategies	_	_	_	_	_	_	_	_
108	at	_	_	_	_	_	_	_	_
109	the	_	_	_	_	_	_	_	_
110	SG	_	_	_	_	_	_	_	_
111	level	_	_	_	_	_	_	_	_
112	to	_	_	_	_	_	_	_	BeginSeg=Yes
113	ensure	_	_	_	_	_	_	_	_
114	an	_	_	_	_	_	_	_	_
115	efficient	_	_	_	_	_	_	_	_
116	replication	_	_	_	_	_	_	_	_
117	cycle	_	_	_	_	_	_	_	_
118	during	_	_	_	_	_	_	_	_
119	the	_	_	_	_	_	_	_	_
120	cellular	_	_	_	_	_	_	_	_
121	stress	_	_	_	_	_	_	_	_
122	response	_	_	_	_	_	_	_	_
123	triggered	_	_	_	_	_	_	_	BeginSeg=Yes
124	by	_	_	_	_	_	_	_	_
125	the	_	_	_	_	_	_	_	_
126	viral	_	_	_	_	_	_	_	_
127	infection	_	_	_	_	_	_	_	_
128	.	_	_	_	_	_	_	_	_

# newdoc_id = b663a1cc707cf69d2f90bda78f077b45b4f4daa5
1	Monadic	_	_	_	_	_	_	_	BeginSeg=Yes
2	decomposability	_	_	_	_	_	_	_	_
3	is	_	_	_	_	_	_	_	_
4	a	_	_	_	_	_	_	_	_
5	notion	_	_	_	_	_	_	_	_
6	of	_	_	_	_	_	_	_	_
7	variable	_	_	_	_	_	_	_	_
8	independence	_	_	_	_	_	_	_	_
9	,	_	_	_	_	_	_	_	_
10	which	_	_	_	_	_	_	_	BeginSeg=Yes
11	asks	_	_	_	_	_	_	_	_
12	whether	_	_	_	_	_	_	_	_
13	a	_	_	_	_	_	_	_	_
14	given	_	_	_	_	_	_	_	_
15	formula	_	_	_	_	_	_	_	_
16	in	_	_	_	_	_	_	_	_
17	a	_	_	_	_	_	_	_	_
18	first	_	_	_	_	_	_	_	_
19	-	_	_	_	_	_	_	_	_
20	order	_	_	_	_	_	_	_	_
21	theory	_	_	_	_	_	_	_	_
22	is	_	_	_	_	_	_	_	_
23	expressible	_	_	_	_	_	_	_	_
24	as	_	_	_	_	_	_	_	_
25	a	_	_	_	_	_	_	_	_
26	Boolean	_	_	_	_	_	_	_	_
27	combination	_	_	_	_	_	_	_	_
28	of	_	_	_	_	_	_	_	_
29	monadic	_	_	_	_	_	_	_	_
30	predicates	_	_	_	_	_	_	_	_
31	in	_	_	_	_	_	_	_	_
32	the	_	_	_	_	_	_	_	_
33	theory	_	_	_	_	_	_	_	_
34	.	_	_	_	_	_	_	_	_
35	Recently	_	_	_	_	_	_	_	BeginSeg=Yes
36	,	_	_	_	_	_	_	_	_
37	Veanes	_	_	_	_	_	_	_	_
38	et	_	_	_	_	_	_	_	_
39	al	_	_	_	_	_	_	_	_
40	.	_	_	_	_	_	_	_	_
41	showed	_	_	_	_	_	_	_	_
42	the	_	_	_	_	_	_	_	_
43	usefulness	_	_	_	_	_	_	_	_
44	of	_	_	_	_	_	_	_	_
45	monadic	_	_	_	_	_	_	_	_
46	decomposability	_	_	_	_	_	_	_	_
47	in	_	_	_	_	_	_	_	_
48	the	_	_	_	_	_	_	_	_
49	context	_	_	_	_	_	_	_	_
50	of	_	_	_	_	_	_	_	_
51	SMT	_	_	_	_	_	_	_	_
52	(	_	_	_	_	_	_	_	BeginSeg=Yes
53	i.e.	_	_	_	_	_	_	_	_
54	the	_	_	_	_	_	_	_	_
55	input	_	_	_	_	_	_	_	_
56	formula	_	_	_	_	_	_	_	_
57	is	_	_	_	_	_	_	_	_
58	quantifier	_	_	_	_	_	_	_	_
59	-	_	_	_	_	_	_	_	_
60	free	_	_	_	_	_	_	_	_
61	)	_	_	_	_	_	_	_	_
62	,	_	_	_	_	_	_	_	_
63	and	_	_	_	_	_	_	_	BeginSeg=Yes
64	found	_	_	_	_	_	_	_	_
65	various	_	_	_	_	_	_	_	_
66	interesting	_	_	_	_	_	_	_	_
67	applications	_	_	_	_	_	_	_	_
68	including	_	_	_	_	_	_	_	BeginSeg=Yes
69	string	_	_	_	_	_	_	_	_
70	analysis	_	_	_	_	_	_	_	_
71	.	_	_	_	_	_	_	_	_
72	However	_	_	_	_	_	_	_	BeginSeg=Yes
73	,	_	_	_	_	_	_	_	_
74	checking	_	_	_	_	_	_	_	_
75	monadic	_	_	_	_	_	_	_	_
76	decomposability	_	_	_	_	_	_	_	_
77	is	_	_	_	_	_	_	_	_
78	undecidable	_	_	_	_	_	_	_	_
79	in	_	_	_	_	_	_	_	_
80	general	_	_	_	_	_	_	_	_
81	.	_	_	_	_	_	_	_	_
82	Decidability	_	_	_	_	_	_	_	BeginSeg=Yes
83	for	_	_	_	_	_	_	_	_
84	certain	_	_	_	_	_	_	_	_
85	theories	_	_	_	_	_	_	_	_
86	is	_	_	_	_	_	_	_	_
87	known	_	_	_	_	_	_	_	_
88	(	_	_	_	_	_	_	_	BeginSeg=Yes
89	e.g.	_	_	_	_	_	_	_	_
90	Presburger	_	_	_	_	_	_	_	_
91	Arithmetic	_	_	_	_	_	_	_	_
92	,	_	_	_	_	_	_	_	_
93-94	Tarski's	_	_	_	_	_	_	_	_
93	Tarski	_	_	_	_	_	_	_	_
94	's	_	_	_	_	_	_	_	_
95	Real	_	_	_	_	_	_	_	_
96	-	_	_	_	_	_	_	_	_
97	Closed	_	_	_	_	_	_	_	_
98	Field	_	_	_	_	_	_	_	_
99	)	_	_	_	_	_	_	_	_
100	,	_	_	_	_	_	_	_	_
101	but	_	_	_	_	_	_	_	BeginSeg=Yes
102	there	_	_	_	_	_	_	_	_
103	are	_	_	_	_	_	_	_	_
104	very	_	_	_	_	_	_	_	_
105	few	_	_	_	_	_	_	_	_
106	results	_	_	_	_	_	_	_	_
107	regarding	_	_	_	_	_	_	_	BeginSeg=Yes
108	their	_	_	_	_	_	_	_	_
109	computational	_	_	_	_	_	_	_	_
110	complexity	_	_	_	_	_	_	_	_
111	.	_	_	_	_	_	_	_	_
112	In	_	_	_	_	_	_	_	BeginSeg=Yes
113	this	_	_	_	_	_	_	_	_
114	paper	_	_	_	_	_	_	_	_
115	,	_	_	_	_	_	_	_	_
116	we	_	_	_	_	_	_	_	_
117	study	_	_	_	_	_	_	_	_
118	monadic	_	_	_	_	_	_	_	_
119	decomposability	_	_	_	_	_	_	_	_
120	of	_	_	_	_	_	_	_	_
121	integer	_	_	_	_	_	_	_	_
122	linear	_	_	_	_	_	_	_	_
123	arithmetic	_	_	_	_	_	_	_	_
124	in	_	_	_	_	_	_	_	_
125	the	_	_	_	_	_	_	_	_
126	setting	_	_	_	_	_	_	_	_
127	of	_	_	_	_	_	_	_	_
128	SMT	_	_	_	_	_	_	_	_
129	.	_	_	_	_	_	_	_	_
130	We	_	_	_	_	_	_	_	BeginSeg=Yes
131	show	_	_	_	_	_	_	_	_
132	that	_	_	_	_	_	_	_	_
133	this	_	_	_	_	_	_	_	_
134	decision	_	_	_	_	_	_	_	_
135	problem	_	_	_	_	_	_	_	_
136	is	_	_	_	_	_	_	_	_
137	coNP	_	_	_	_	_	_	_	_
138	-	_	_	_	_	_	_	_	_
139	complete	_	_	_	_	_	_	_	_
140	and	_	_	_	_	_	_	_	BeginSeg=Yes
141	,	_	_	_	_	_	_	_	_
142	when	_	_	_	_	_	_	_	BeginSeg=Yes
143	monadically	_	_	_	_	_	_	_	_
144	decomposable	_	_	_	_	_	_	_	_
145	,	_	_	_	_	_	_	_	_
146	a	_	_	_	_	_	_	_	BeginSeg=Yes
147	formula	_	_	_	_	_	_	_	_
148	admits	_	_	_	_	_	_	_	_
149	a	_	_	_	_	_	_	_	_
150	decomposition	_	_	_	_	_	_	_	_
151	of	_	_	_	_	_	_	_	_
152	exponential	_	_	_	_	_	_	_	_
153	size	_	_	_	_	_	_	_	_
154	in	_	_	_	_	_	_	_	_
155	the	_	_	_	_	_	_	_	_
156	worst	_	_	_	_	_	_	_	_
157	case	_	_	_	_	_	_	_	_
158	.	_	_	_	_	_	_	_	_
159	We	_	_	_	_	_	_	_	BeginSeg=Yes
160	provide	_	_	_	_	_	_	_	_
161	a	_	_	_	_	_	_	_	_
162	new	_	_	_	_	_	_	_	_
163	application	_	_	_	_	_	_	_	_
164	of	_	_	_	_	_	_	_	_
165	our	_	_	_	_	_	_	_	_
166	results	_	_	_	_	_	_	_	_
167	to	_	_	_	_	_	_	_	_
168	string	_	_	_	_	_	_	_	_
169	constraint	_	_	_	_	_	_	_	_
170	solving	_	_	_	_	_	_	_	_
171	with	_	_	_	_	_	_	_	_
172	length	_	_	_	_	_	_	_	_
173	constraints	_	_	_	_	_	_	_	_
174	.	_	_	_	_	_	_	_	_
175	We	_	_	_	_	_	_	_	BeginSeg=Yes
176	then	_	_	_	_	_	_	_	_
177	extend	_	_	_	_	_	_	_	_
178	our	_	_	_	_	_	_	_	_
179	results	_	_	_	_	_	_	_	_
180	to	_	_	_	_	_	_	_	_
181	variadic	_	_	_	_	_	_	_	_
182	decomposability	_	_	_	_	_	_	_	_
183	,	_	_	_	_	_	_	_	_
184	where	_	_	_	_	_	_	_	BeginSeg=Yes
185	predicates	_	_	_	_	_	_	_	_
186	could	_	_	_	_	_	_	_	_
187	admit	_	_	_	_	_	_	_	_
188	multiple	_	_	_	_	_	_	_	_
189	free	_	_	_	_	_	_	_	_
190	variables	_	_	_	_	_	_	_	_
191	(	_	_	_	_	_	_	_	BeginSeg=Yes
192	in	_	_	_	_	_	_	_	_
193	contrast	_	_	_	_	_	_	_	_
194	to	_	_	_	_	_	_	_	_
195	monadic	_	_	_	_	_	_	_	_
196	decomposability	_	_	_	_	_	_	_	_
197	)	_	_	_	_	_	_	_	_
198	.	_	_	_	_	_	_	_	_
199	Finally	_	_	_	_	_	_	_	BeginSeg=Yes
200	,	_	_	_	_	_	_	_	_
201	we	_	_	_	_	_	_	_	_
202	give	_	_	_	_	_	_	_	_
203	an	_	_	_	_	_	_	_	_
204	application	_	_	_	_	_	_	_	_
205	to	_	_	_	_	_	_	_	_
206	quantifier	_	_	_	_	_	_	_	_
207	elimination	_	_	_	_	_	_	_	_
208	in	_	_	_	_	_	_	_	_
209	integer	_	_	_	_	_	_	_	_
210	linear	_	_	_	_	_	_	_	_
211	arithmetic	_	_	_	_	_	_	_	_
212	where	_	_	_	_	_	_	_	BeginSeg=Yes
213	the	_	_	_	_	_	_	_	_
214	variables	_	_	_	_	_	_	_	_
215	in	_	_	_	_	_	_	_	_
216	a	_	_	_	_	_	_	_	_
217	block	_	_	_	_	_	_	_	_
218	of	_	_	_	_	_	_	_	_
219	quantifiers	_	_	_	_	_	_	_	_
220	,	_	_	_	_	_	_	_	_
221	if	_	_	_	_	_	_	_	BeginSeg=Yes
222	independent	_	_	_	_	_	_	_	_
223	,	_	_	_	_	_	_	_	_
224	could	_	_	_	_	_	_	_	BeginSeg=Yes
225	be	_	_	_	_	_	_	_	_
226	eliminated	_	_	_	_	_	_	_	_
227	with	_	_	_	_	_	_	_	_
228	an	_	_	_	_	_	_	_	_
229	exponential	_	_	_	_	_	_	_	_
230	(	_	_	_	_	_	_	_	BeginSeg=Yes
231	instead	_	_	_	_	_	_	_	_
232	of	_	_	_	_	_	_	_	_
233	the	_	_	_	_	_	_	_	_
234	standard	_	_	_	_	_	_	_	_
235	doubly	_	_	_	_	_	_	_	_
236	exponential	_	_	_	_	_	_	_	_
237	)	_	_	_	_	_	_	_	_
238	blow	_	_	_	_	_	_	_	BeginSeg=Yes
239	-	_	_	_	_	_	_	_	_
240	up	_	_	_	_	_	_	_	_
241	.	_	_	_	_	_	_	_	_

# newdoc_id = ba3522d00ecebd159c5b5dc90119df8642993c49
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	type	_	_	_	_	_	_	_	_
3	II	_	_	_	_	_	_	_	_
4	transmembrane	_	_	_	_	_	_	_	_
5	serine	_	_	_	_	_	_	_	_
6	proteases	_	_	_	_	_	_	_	_
7	TMPRSS2	_	_	_	_	_	_	_	_
8	and	_	_	_	_	_	_	_	_
9	HAT	_	_	_	_	_	_	_	_
10	activate	_	_	_	_	_	_	_	_
11	influenza	_	_	_	_	_	_	_	_
12	viruses	_	_	_	_	_	_	_	_
13	and	_	_	_	_	_	_	_	_
14	the	_	_	_	_	_	_	_	_
15	SARS	_	_	_	_	_	_	_	_
16	-	_	_	_	_	_	_	_	_
17	coronavirus	_	_	_	_	_	_	_	_
18	(	_	_	_	_	_	_	_	_
19	TMPRSS2	_	_	_	_	_	_	_	_
20	)	_	_	_	_	_	_	_	_
21	in	_	_	_	_	_	_	_	_
22	cell	_	_	_	_	_	_	_	_
23	culture	_	_	_	_	_	_	_	_
24	and	_	_	_	_	_	_	_	BeginSeg=Yes
25	may	_	_	_	_	_	_	_	_
26	play	_	_	_	_	_	_	_	_
27	an	_	_	_	_	_	_	_	_
28	important	_	_	_	_	_	_	_	_
29	role	_	_	_	_	_	_	_	_
30	in	_	_	_	_	_	_	_	_
31	viral	_	_	_	_	_	_	_	_
32	spread	_	_	_	_	_	_	_	_
33	and	_	_	_	_	_	_	_	_
34	pathogenesis	_	_	_	_	_	_	_	_
35	in	_	_	_	_	_	_	_	_
36	the	_	_	_	_	_	_	_	_
37	infected	_	_	_	_	_	_	_	_
38	host	_	_	_	_	_	_	_	_
39	.	_	_	_	_	_	_	_	_
40	However	_	_	_	_	_	_	_	BeginSeg=Yes
41	,	_	_	_	_	_	_	_	_
42	it	_	_	_	_	_	_	_	_
43	is	_	_	_	_	_	_	_	_
44	at	_	_	_	_	_	_	_	_
45	present	_	_	_	_	_	_	_	_
46	largely	_	_	_	_	_	_	_	_
47	unclear	_	_	_	_	_	_	_	_
48	to	_	_	_	_	_	_	_	_
49	what	_	_	_	_	_	_	_	_
50	extent	_	_	_	_	_	_	_	_
51	these	_	_	_	_	_	_	_	_
52	proteases	_	_	_	_	_	_	_	_
53	are	_	_	_	_	_	_	_	_
54	expressed	_	_	_	_	_	_	_	_
55	in	_	_	_	_	_	_	_	_
56	viral	_	_	_	_	_	_	_	_
57	target	_	_	_	_	_	_	_	_
58	cells	_	_	_	_	_	_	_	_
59	in	_	_	_	_	_	_	_	_
60	human	_	_	_	_	_	_	_	_
61	tissues	_	_	_	_	_	_	_	_
62	.	_	_	_	_	_	_	_	_
63	Here	_	_	_	_	_	_	_	BeginSeg=Yes
64	,	_	_	_	_	_	_	_	_
65	we	_	_	_	_	_	_	_	_
66	show	_	_	_	_	_	_	_	_
67	that	_	_	_	_	_	_	_	BeginSeg=Yes
68	both	_	_	_	_	_	_	_	_
69	HAT	_	_	_	_	_	_	_	_
70	and	_	_	_	_	_	_	_	_
71	TMPRSS2	_	_	_	_	_	_	_	_
72	are	_	_	_	_	_	_	_	_
73	coexpressed	_	_	_	_	_	_	_	_
74	with	_	_	_	_	_	_	_	_
75	2,6-linked	_	_	_	_	_	_	_	_
76	sialic	_	_	_	_	_	_	_	_
77	acids	_	_	_	_	_	_	_	_
78	,	_	_	_	_	_	_	_	_
79	the	_	_	_	_	_	_	_	_
80	major	_	_	_	_	_	_	_	_
81	receptor	_	_	_	_	_	_	_	_
82	determinant	_	_	_	_	_	_	_	_
83	of	_	_	_	_	_	_	_	_
84	human	_	_	_	_	_	_	_	_
85	influenza	_	_	_	_	_	_	_	_
86	viruses	_	_	_	_	_	_	_	_
87	,	_	_	_	_	_	_	_	_
88	throughout	_	_	_	_	_	_	_	_
89	the	_	_	_	_	_	_	_	_
90	human	_	_	_	_	_	_	_	_
91	respiratory	_	_	_	_	_	_	_	_
92	tract	_	_	_	_	_	_	_	_
93	.	_	_	_	_	_	_	_	_
94	Similarly	_	_	_	_	_	_	_	BeginSeg=Yes
95	,	_	_	_	_	_	_	_	_
96	coexpression	_	_	_	_	_	_	_	_
97	of	_	_	_	_	_	_	_	_
98	ACE2	_	_	_	_	_	_	_	_
99	,	_	_	_	_	_	_	_	_
100	the	_	_	_	_	_	_	_	_
101	SARS	_	_	_	_	_	_	_	_
102	-	_	_	_	_	_	_	_	_
103	coronavirus	_	_	_	_	_	_	_	_
104	receptor	_	_	_	_	_	_	_	_
105	,	_	_	_	_	_	_	_	_
106	and	_	_	_	_	_	_	_	_
107	TMPRSS2	_	_	_	_	_	_	_	_
108	was	_	_	_	_	_	_	_	_
109	frequently	_	_	_	_	_	_	_	_
110	found	_	_	_	_	_	_	_	_
111	in	_	_	_	_	_	_	_	_
112	the	_	_	_	_	_	_	_	_
113	upper	_	_	_	_	_	_	_	_
114	and	_	_	_	_	_	_	_	_
115	lower	_	_	_	_	_	_	_	_
116	aerodigestive	_	_	_	_	_	_	_	_
117	tract	_	_	_	_	_	_	_	_
118	,	_	_	_	_	_	_	_	_
119	with	_	_	_	_	_	_	_	_
120	the	_	_	_	_	_	_	_	_
121	exception	_	_	_	_	_	_	_	_
122	of	_	_	_	_	_	_	_	_
123	the	_	_	_	_	_	_	_	_
124	vocal	_	_	_	_	_	_	_	_
125	folds	_	_	_	_	_	_	_	_
126	,	_	_	_	_	_	_	_	_
127	epiglottis	_	_	_	_	_	_	_	_
128	and	_	_	_	_	_	_	_	_
129	trachea	_	_	_	_	_	_	_	_
130	.	_	_	_	_	_	_	_	_
131	Finally	_	_	_	_	_	_	_	BeginSeg=Yes
132	,	_	_	_	_	_	_	_	_
133	activation	_	_	_	_	_	_	_	_
134	of	_	_	_	_	_	_	_	_
135	influenza	_	_	_	_	_	_	_	_
136	virus	_	_	_	_	_	_	_	_
137	was	_	_	_	_	_	_	_	_
138	conserved	_	_	_	_	_	_	_	_
139	between	_	_	_	_	_	_	_	_
140	human	_	_	_	_	_	_	_	_
141	,	_	_	_	_	_	_	_	_
142	avian	_	_	_	_	_	_	_	_
143	and	_	_	_	_	_	_	_	_
144	porcine	_	_	_	_	_	_	_	_
145	TMPRSS2	_	_	_	_	_	_	_	_
146	,	_	_	_	_	_	_	_	_
147	suggesting	_	_	_	_	_	_	_	BeginSeg=Yes
148	that	_	_	_	_	_	_	_	BeginSeg=Yes
149	this	_	_	_	_	_	_	_	_
150	protease	_	_	_	_	_	_	_	_
151	might	_	_	_	_	_	_	_	_
152	activate	_	_	_	_	_	_	_	_
153	influenza	_	_	_	_	_	_	_	_
154	virus	_	_	_	_	_	_	_	_
155	in	_	_	_	_	_	_	_	_
156	reservoir-	_	_	_	_	_	_	_	_
157	,	_	_	_	_	_	_	_	_
158	intermediate	_	_	_	_	_	_	_	_
159	-	_	_	_	_	_	_	_	_
160	and	_	_	_	_	_	_	_	_
161	human	_	_	_	_	_	_	_	_
162	hosts	_	_	_	_	_	_	_	_
163	.	_	_	_	_	_	_	_	_
164	In	_	_	_	_	_	_	_	BeginSeg=Yes
165	sum	_	_	_	_	_	_	_	_
166	,	_	_	_	_	_	_	_	_
167	our	_	_	_	_	_	_	_	_
168	results	_	_	_	_	_	_	_	_
169	show	_	_	_	_	_	_	_	_
170	that	_	_	_	_	_	_	_	BeginSeg=Yes
171	TMPRSS2	_	_	_	_	_	_	_	_
172	and	_	_	_	_	_	_	_	_
173	HAT	_	_	_	_	_	_	_	_
174	are	_	_	_	_	_	_	_	_
175	expressed	_	_	_	_	_	_	_	_
176	by	_	_	_	_	_	_	_	_
177	important	_	_	_	_	_	_	_	_
178	influenza	_	_	_	_	_	_	_	_
179	and	_	_	_	_	_	_	_	_
180	SARS	_	_	_	_	_	_	_	_
181	-	_	_	_	_	_	_	_	_
182	coronavirus	_	_	_	_	_	_	_	_
183	target	_	_	_	_	_	_	_	_
184	cells	_	_	_	_	_	_	_	_
185	and	_	_	_	_	_	_	_	BeginSeg=Yes
186	could	_	_	_	_	_	_	_	_
187	thus	_	_	_	_	_	_	_	_
188	support	_	_	_	_	_	_	_	_
189	viral	_	_	_	_	_	_	_	_
190	spread	_	_	_	_	_	_	_	_
191	in	_	_	_	_	_	_	_	_
192	the	_	_	_	_	_	_	_	_
193	human	_	_	_	_	_	_	_	_
194	host	_	_	_	_	_	_	_	_
195	.	_	_	_	_	_	_	_	_

# newdoc_id = ba755009e5f7330a8344f1b2dd8e65d54b8488e8
1	Background	_	_	_	_	_	_	_	BeginSeg=Yes
2	:	_	_	_	_	_	_	_	_
3	In	_	_	_	_	_	_	_	BeginSeg=Yes
4	China	_	_	_	_	_	_	_	_
5	,	_	_	_	_	_	_	_	_
6	large	_	_	_	_	_	_	_	_
7	-	_	_	_	_	_	_	_	_
8	scale	_	_	_	_	_	_	_	_
9	outbreaks	_	_	_	_	_	_	_	_
10	of	_	_	_	_	_	_	_	_
11	severe	_	_	_	_	_	_	_	_
12	diarrhea	_	_	_	_	_	_	_	_
13	caused	_	_	_	_	_	_	_	BeginSeg=Yes
14	by	_	_	_	_	_	_	_	_
15	viruses	_	_	_	_	_	_	_	_
16	have	_	_	_	_	_	_	_	BeginSeg=Yes
17	occurred	_	_	_	_	_	_	_	_
18	in	_	_	_	_	_	_	_	_
19	pigs	_	_	_	_	_	_	_	_
20	since	_	_	_	_	_	_	_	_
21	late	_	_	_	_	_	_	_	_
22	2010	_	_	_	_	_	_	_	_
23	.	_	_	_	_	_	_	_	_
24	To	_	_	_	_	_	_	_	BeginSeg=Yes
25	investigate	_	_	_	_	_	_	_	_
26	the	_	_	_	_	_	_	_	_
27	prevalence	_	_	_	_	_	_	_	_
28	and	_	_	_	_	_	_	_	_
29	genetic	_	_	_	_	_	_	_	_
30	evolution	_	_	_	_	_	_	_	_
31	of	_	_	_	_	_	_	_	_
32	diarrhea	_	_	_	_	_	_	_	_
33	-	_	_	_	_	_	_	_	_
34	associated	_	_	_	_	_	_	_	_
35	viruses	_	_	_	_	_	_	_	_
36	responsible	_	_	_	_	_	_	_	BeginSeg=Yes
37	for	_	_	_	_	_	_	_	_
38	the	_	_	_	_	_	_	_	_
39	outbreaks	_	_	_	_	_	_	_	_
40	,	_	_	_	_	_	_	_	_
41	a	_	_	_	_	_	_	_	BeginSeg=Yes
42	total	_	_	_	_	_	_	_	_
43	of	_	_	_	_	_	_	_	_
44	2987	_	_	_	_	_	_	_	_
45	field	_	_	_	_	_	_	_	_
46	diarrheal	_	_	_	_	_	_	_	_
47	samples	_	_	_	_	_	_	_	_
48	collected	_	_	_	_	_	_	_	BeginSeg=Yes
49	from	_	_	_	_	_	_	_	_
50	168	_	_	_	_	_	_	_	_
51	pig	_	_	_	_	_	_	_	_
52	farms	_	_	_	_	_	_	_	_
53	in	_	_	_	_	_	_	_	_
54	five	_	_	_	_	_	_	_	_
55	provinces	_	_	_	_	_	_	_	_
56	in	_	_	_	_	_	_	_	_
57	Southern	_	_	_	_	_	_	_	_
58	China	_	_	_	_	_	_	_	_
59	during	_	_	_	_	_	_	_	_
60	2012	_	_	_	_	_	_	_	_
61	-	_	_	_	_	_	_	_	_
62	2018	_	_	_	_	_	_	_	_
63	were	_	_	_	_	_	_	_	BeginSeg=Yes
64	tested	_	_	_	_	_	_	_	_
65	.	_	_	_	_	_	_	_	_
66	Results	_	_	_	_	_	_	_	BeginSeg=Yes
67	:	_	_	_	_	_	_	_	_
68	Porcine	_	_	_	_	_	_	_	BeginSeg=Yes
69	epidemic	_	_	_	_	_	_	_	_
70	diarrhea	_	_	_	_	_	_	_	_
71	virus	_	_	_	_	_	_	_	_
72	(	_	_	_	_	_	_	_	_
73	PEDV	_	_	_	_	_	_	_	_
74	)	_	_	_	_	_	_	_	_
75	was	_	_	_	_	_	_	_	_
76	most	_	_	_	_	_	_	_	_
77	frequently	_	_	_	_	_	_	_	_
78	detected	_	_	_	_	_	_	_	_
79	virus	_	_	_	_	_	_	_	_
80	with	_	_	_	_	_	_	_	_
81	prevalence	_	_	_	_	_	_	_	_
82	rates	_	_	_	_	_	_	_	_
83	between	_	_	_	_	_	_	_	_
84	50.21	_	_	_	_	_	_	_	_
85	and	_	_	_	_	_	_	_	_
86	62.10	_	_	_	_	_	_	_	_
87	%	_	_	_	_	_	_	_	_
88	in	_	_	_	_	_	_	_	_
89	samples	_	_	_	_	_	_	_	_
90	,	_	_	_	_	_	_	_	_
91	and	_	_	_	_	_	_	_	_
92	96.43	_	_	_	_	_	_	_	_
93	%	_	_	_	_	_	_	_	_
94	(	_	_	_	_	_	_	_	_
95	162/168	_	_	_	_	_	_	_	_
96	)	_	_	_	_	_	_	_	_
97	in	_	_	_	_	_	_	_	_
98	premises	_	_	_	_	_	_	_	_
99	,	_	_	_	_	_	_	_	_
100	respectively	_	_	_	_	_	_	_	_
101	.	_	_	_	_	_	_	_	_
102	Porcine	_	_	_	_	_	_	_	BeginSeg=Yes
103	deltacoronavirus	_	_	_	_	_	_	_	_
104	(	_	_	_	_	_	_	_	_
105	PDCoV	_	_	_	_	_	_	_	_
106	)	_	_	_	_	_	_	_	_
107	was	_	_	_	_	_	_	_	_
108	the	_	_	_	_	_	_	_	_
109	second	_	_	_	_	_	_	_	_
110	prevalent	_	_	_	_	_	_	_	_
111	virus	_	_	_	_	_	_	_	_
112	with	_	_	_	_	_	_	_	_
113	prevalence	_	_	_	_	_	_	_	_
114	rates	_	_	_	_	_	_	_	_
115	ranging	_	_	_	_	_	_	_	BeginSeg=Yes
116	from	_	_	_	_	_	_	_	_
117	19.62	_	_	_	_	_	_	_	_
118	to	_	_	_	_	_	_	_	_
119	29.19	_	_	_	_	_	_	_	_
120	%	_	_	_	_	_	_	_	_
121	in	_	_	_	_	_	_	_	_
122	samples	_	_	_	_	_	_	_	_
123	,	_	_	_	_	_	_	_	_
124	and	_	_	_	_	_	_	_	_
125	70.24	_	_	_	_	_	_	_	_
126	%	_	_	_	_	_	_	_	_
127	(	_	_	_	_	_	_	_	BeginSeg=Yes
128	118/168	_	_	_	_	_	_	_	_
129	)	_	_	_	_	_	_	_	_
130	in	_	_	_	_	_	_	_	BeginSeg=Yes
131	premises	_	_	_	_	_	_	_	_
132	,	_	_	_	_	_	_	_	_
133	respectively	_	_	_	_	_	_	_	_
134	.	_	_	_	_	_	_	_	_
135	Both	_	_	_	_	_	_	_	BeginSeg=Yes
136	transmissible	_	_	_	_	_	_	_	_
137	gastroenteritis	_	_	_	_	_	_	_	_
138	virus	_	_	_	_	_	_	_	_
139	(	_	_	_	_	_	_	_	_
140	TGEV	_	_	_	_	_	_	_	_
141	)	_	_	_	_	_	_	_	_
142	and	_	_	_	_	_	_	_	_
143	porcine	_	_	_	_	_	_	_	_
144	rotavirus	_	_	_	_	_	_	_	_
145	(	_	_	_	_	_	_	_	_
146	PoRV	_	_	_	_	_	_	_	_
147	)	_	_	_	_	_	_	_	_
148	were	_	_	_	_	_	_	_	_
149	detected	_	_	_	_	_	_	_	_
150	at	_	_	_	_	_	_	_	_
151	low	_	_	_	_	_	_	_	_
152	prevalence	_	_	_	_	_	_	_	_
153	rates	_	_	_	_	_	_	_	_
154	of	_	_	_	_	_	_	_	_
155	<	_	_	_	_	_	_	_	_
156	3	_	_	_	_	_	_	_	_
157	%	_	_	_	_	_	_	_	_
158	in	_	_	_	_	_	_	_	_
159	samples	_	_	_	_	_	_	_	_
160	and	_	_	_	_	_	_	_	_
161	10.12	_	_	_	_	_	_	_	_
162	%	_	_	_	_	_	_	_	_
163	in	_	_	_	_	_	_	_	_
164	premises	_	_	_	_	_	_	_	_
165	.	_	_	_	_	_	_	_	_
166	In	_	_	_	_	_	_	_	BeginSeg=Yes
167	this	_	_	_	_	_	_	_	_
168	study	_	_	_	_	_	_	_	_
169	,	_	_	_	_	_	_	_	_
170	we	_	_	_	_	_	_	_	_
171	identified	_	_	_	_	_	_	_	_
172	a	_	_	_	_	_	_	_	_
173	newly	_	_	_	_	_	_	_	_
174	emerged	_	_	_	_	_	_	_	_
175	swine	_	_	_	_	_	_	_	_
176	acute	_	_	_	_	_	_	_	_
177	diarrhea	_	_	_	_	_	_	_	_
178	syndrome	_	_	_	_	_	_	_	_
179	coronavirus	_	_	_	_	_	_	_	_
180	(	_	_	_	_	_	_	_	_
181	SADS	_	_	_	_	_	_	_	_
182	-	_	_	_	_	_	_	_	_
183	CoV	_	_	_	_	_	_	_	_
184	)	_	_	_	_	_	_	_	_
185	in	_	_	_	_	_	_	_	_
186	diarrheal	_	_	_	_	_	_	_	_
187	samples	_	_	_	_	_	_	_	_
188	of	_	_	_	_	_	_	_	_
189	piglets	_	_	_	_	_	_	_	_
190	from	_	_	_	_	_	_	_	_
191	Fujian	_	_	_	_	_	_	_	_
192	province	_	_	_	_	_	_	_	_
193	in	_	_	_	_	_	_	_	_
194	Southern	_	_	_	_	_	_	_	_
195	China	_	_	_	_	_	_	_	_
196	,	_	_	_	_	_	_	_	_
197	and	_	_	_	_	_	_	_	BeginSeg=Yes
198	the	_	_	_	_	_	_	_	_
199	prevalence	_	_	_	_	_	_	_	_
200	rate	_	_	_	_	_	_	_	_
201	of	_	_	_	_	_	_	_	_
202	SADS	_	_	_	_	_	_	_	_
203	-	_	_	_	_	_	_	_	_
204	CoV	_	_	_	_	_	_	_	_
205	was	_	_	_	_	_	_	_	_
206	10.29	_	_	_	_	_	_	_	_
207	%	_	_	_	_	_	_	_	_
208	(	_	_	_	_	_	_	_	BeginSeg=Yes
209	7/68	_	_	_	_	_	_	_	_
210	)	_	_	_	_	_	_	_	_
211	.	_	_	_	_	_	_	_	_
212	Co	_	_	_	_	_	_	_	BeginSeg=Yes
213	-	_	_	_	_	_	_	_	_
214	infections	_	_	_	_	_	_	_	_
215	of	_	_	_	_	_	_	_	_
216	these	_	_	_	_	_	_	_	_
217	diarrhea	_	_	_	_	_	_	_	_
218	-	_	_	_	_	_	_	_	_
219	associated	_	_	_	_	_	_	_	_
220	viruses	_	_	_	_	_	_	_	_
221	were	_	_	_	_	_	_	_	_
222	common	_	_	_	_	_	_	_	_
223	.	_	_	_	_	_	_	_	_
224	The	_	_	_	_	_	_	_	BeginSeg=Yes
225	most	_	_	_	_	_	_	_	_
226	frequent	_	_	_	_	_	_	_	_
227	co	_	_	_	_	_	_	_	_
228	-	_	_	_	_	_	_	_	_
229	infection	_	_	_	_	_	_	_	_
230	was	_	_	_	_	_	_	_	_
231	PEDV	_	_	_	_	_	_	_	_
232	with	_	_	_	_	_	_	_	_
233	PDCoV	_	_	_	_	_	_	_	_
234	,	_	_	_	_	_	_	_	_
235	with	_	_	_	_	_	_	_	_
236	an	_	_	_	_	_	_	_	_
237	average	_	_	_	_	_	_	_	_
238	detection	_	_	_	_	_	_	_	_
239	rate	_	_	_	_	_	_	_	_
240	of	_	_	_	_	_	_	_	_
241	12.72	_	_	_	_	_	_	_	_
242	%	_	_	_	_	_	_	_	_
243	(	_	_	_	_	_	_	_	BeginSeg=Yes
244	380/2987	_	_	_	_	_	_	_	_
245	,	_	_	_	_	_	_	_	_
246	ranging	_	_	_	_	_	_	_	_
247	from	_	_	_	_	_	_	_	_
248	8.26	_	_	_	_	_	_	_	_
249	-	_	_	_	_	_	_	_	_
250	17.33	_	_	_	_	_	_	_	_
251	%	_	_	_	_	_	_	_	_
252	)	_	_	_	_	_	_	_	_
253	.	_	_	_	_	_	_	_	_
254	Phylogenetic	_	_	_	_	_	_	_	BeginSeg=Yes
255	analysis	_	_	_	_	_	_	_	_
256	revealed	_	_	_	_	_	_	_	_
257	that	_	_	_	_	_	_	_	BeginSeg=Yes
258	PEDVs	_	_	_	_	_	_	_	_
259	circulating	_	_	_	_	_	_	_	BeginSeg=Yes
260	in	_	_	_	_	_	_	_	_
261	Southern	_	_	_	_	_	_	_	_
262	China	_	_	_	_	_	_	_	_
263	during	_	_	_	_	_	_	_	_
264	the	_	_	_	_	_	_	_	_
265	last	_	_	_	_	_	_	_	_
266	7	_	_	_	_	_	_	_	_
267	years	_	_	_	_	_	_	_	_
268	were	_	_	_	_	_	_	_	BeginSeg=Yes
269	clustered	_	_	_	_	_	_	_	_
270	with	_	_	_	_	_	_	_	_
271	the	_	_	_	_	_	_	_	_
272	variant	_	_	_	_	_	_	_	_
273	strains	_	_	_	_	_	_	_	_
274	of	_	_	_	_	_	_	_	_
275	PEDV	_	_	_	_	_	_	_	_
276	in	_	_	_	_	_	_	_	_
277	genotype	_	_	_	_	_	_	_	_
278	IIa	_	_	_	_	_	_	_	_
279	.	_	_	_	_	_	_	_	_
280	The	_	_	_	_	_	_	_	BeginSeg=Yes
281	most	_	_	_	_	_	_	_	_
282	frequent	_	_	_	_	_	_	_	_
283	mutations	_	_	_	_	_	_	_	_
284	were	_	_	_	_	_	_	_	_
285	present	_	_	_	_	_	_	_	_
286	in	_	_	_	_	_	_	_	_
287	the	_	_	_	_	_	_	_	_
288	collagenase	_	_	_	_	_	_	_	_
289	equivalent	_	_	_	_	_	_	_	_
290	(	_	_	_	_	_	_	_	_
291	COE	_	_	_	_	_	_	_	_
292	)	_	_	_	_	_	_	_	_
293	and	_	_	_	_	_	_	_	_
294	epitope	_	_	_	_	_	_	_	_
295	regions	_	_	_	_	_	_	_	_
296	of	_	_	_	_	_	_	_	_
297	the	_	_	_	_	_	_	_	_
298	spike	_	_	_	_	_	_	_	_
299	gene	_	_	_	_	_	_	_	_
300	of	_	_	_	_	_	_	_	_
301	the	_	_	_	_	_	_	_	_
302	PEDVs	_	_	_	_	_	_	_	_
303	currently	_	_	_	_	_	_	_	BeginSeg=Yes
304	circulating	_	_	_	_	_	_	_	_
305	in	_	_	_	_	_	_	_	_
306	the	_	_	_	_	_	_	_	_
307	field	_	_	_	_	_	_	_	_
308	.	_	_	_	_	_	_	_	_
309	Genetic	_	_	_	_	_	_	_	BeginSeg=Yes
310	relationships	_	_	_	_	_	_	_	_
311	of	_	_	_	_	_	_	_	_
312	PDCoVs	_	_	_	_	_	_	_	_
313	were	_	_	_	_	_	_	_	_
314	closely	_	_	_	_	_	_	_	_
315	related	_	_	_	_	_	_	_	_
316	with	_	_	_	_	_	_	_	_
317	Chinese	_	_	_	_	_	_	_	_
318	strains	_	_	_	_	_	_	_	_
319	,	_	_	_	_	_	_	_	_
320	other	_	_	_	_	_	_	_	_
321	than	_	_	_	_	_	_	_	_
322	those	_	_	_	_	_	_	_	_
323	present	_	_	_	_	_	_	_	_
324	in	_	_	_	_	_	_	_	_
325	the	_	_	_	_	_	_	_	_
326	USA	_	_	_	_	_	_	_	_
327	,	_	_	_	_	_	_	_	_
328	South	_	_	_	_	_	_	_	_
329	Korea	_	_	_	_	_	_	_	_
330	,	_	_	_	_	_	_	_	_
331	Thailand	_	_	_	_	_	_	_	_
332	and	_	_	_	_	_	_	_	_
333-334	Lao's	_	_	_	_	_	_	_	_
333	Lao	_	_	_	_	_	_	_	_
334	's	_	_	_	_	_	_	_	_
335	public	_	_	_	_	_	_	_	_
336	.	_	_	_	_	_	_	_	_
337	Conclusions	_	_	_	_	_	_	_	BeginSeg=Yes
338	:	_	_	_	_	_	_	_	_
339	The	_	_	_	_	_	_	_	BeginSeg=Yes
340	findings	_	_	_	_	_	_	_	_
341	of	_	_	_	_	_	_	_	_
342	this	_	_	_	_	_	_	_	_
343	study	_	_	_	_	_	_	_	_
344	indicated	_	_	_	_	_	_	_	_
345	that	_	_	_	_	_	_	_	BeginSeg=Yes
346	variant	_	_	_	_	_	_	_	_
347	PEDV	_	_	_	_	_	_	_	_
348	,	_	_	_	_	_	_	_	_
349	PDCoV	_	_	_	_	_	_	_	_
350	,	_	_	_	_	_	_	_	_
351	and	_	_	_	_	_	_	_	_
352	SADS	_	_	_	_	_	_	_	_
353	-	_	_	_	_	_	_	_	_
354	CoV	_	_	_	_	_	_	_	_
355	were	_	_	_	_	_	_	_	_
356	leading	_	_	_	_	_	_	_	_
357	etiologic	_	_	_	_	_	_	_	_
358	agents	_	_	_	_	_	_	_	_
359	of	_	_	_	_	_	_	_	_
360	porcine	_	_	_	_	_	_	_	_
361	diarrhea	_	_	_	_	_	_	_	_
362	,	_	_	_	_	_	_	_	_
363	and	_	_	_	_	_	_	_	BeginSeg=Yes
364	either	_	_	_	_	_	_	_	_
365	mono	_	_	_	_	_	_	_	_
366	-	_	_	_	_	_	_	_	_
367	infections	_	_	_	_	_	_	_	_
368	or	_	_	_	_	_	_	_	_
369	co	_	_	_	_	_	_	_	_
370	-	_	_	_	_	_	_	_	_
371	infections	_	_	_	_	_	_	_	_
372	of	_	_	_	_	_	_	_	_
373	pathogenic	_	_	_	_	_	_	_	_
374	enteric	_	_	_	_	_	_	_	_
375	CoVs	_	_	_	_	_	_	_	_
376	were	_	_	_	_	_	_	_	_
377	common	_	_	_	_	_	_	_	_
378	in	_	_	_	_	_	_	_	_
379	pigs	_	_	_	_	_	_	_	_
380	in	_	_	_	_	_	_	_	_
381	Southern	_	_	_	_	_	_	_	_
382	China	_	_	_	_	_	_	_	_
383	during	_	_	_	_	_	_	_	_
384	2012	_	_	_	_	_	_	_	_
385	-	_	_	_	_	_	_	_	_
386	2018	_	_	_	_	_	_	_	_
387	.	_	_	_	_	_	_	_	_
388	Thus	_	_	_	_	_	_	_	BeginSeg=Yes
389	,	_	_	_	_	_	_	_	_
390	significant	_	_	_	_	_	_	_	_
391	attention	_	_	_	_	_	_	_	_
392	should	_	_	_	_	_	_	_	_
393	be	_	_	_	_	_	_	_	_
394	paid	_	_	_	_	_	_	_	_
395	in	_	_	_	_	_	_	_	BeginSeg=Yes
396	order	_	_	_	_	_	_	_	_
397	to	_	_	_	_	_	_	_	_
398	effectively	_	_	_	_	_	_	_	_
399	prevent	_	_	_	_	_	_	_	_
400	and	_	_	_	_	_	_	_	_
401	control	_	_	_	_	_	_	_	_
402	porcine	_	_	_	_	_	_	_	_
403	viral	_	_	_	_	_	_	_	_
404	diarrhea	_	_	_	_	_	_	_	_
405	.	_	_	_	_	_	_	_	_

# newdoc_id = bab3d2a212eaf7740a45ee8efeec3db99bf94589
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	classical	_	_	_	_	_	_	_	_
3	symptoms	_	_	_	_	_	_	_	_
4	of	_	_	_	_	_	_	_	_
5	porcine	_	_	_	_	_	_	_	_
6	epidemic	_	_	_	_	_	_	_	_
7	diarrhea	_	_	_	_	_	_	_	_
8	(	_	_	_	_	_	_	_	_
9	PED	_	_	_	_	_	_	_	_
10	)	_	_	_	_	_	_	_	_
11	are	_	_	_	_	_	_	_	_
12	acute	_	_	_	_	_	_	_	_
13	diarrhea	_	_	_	_	_	_	_	_
14	and	_	_	_	_	_	_	_	_
15	dehydration	_	_	_	_	_	_	_	_
16	.	_	_	_	_	_	_	_	_
17	The	_	_	_	_	_	_	_	BeginSeg=Yes
18	isolated	_	_	_	_	_	_	_	_
19	porcine	_	_	_	_	_	_	_	_
20	epidemic	_	_	_	_	_	_	_	_
21	diarrhea	_	_	_	_	_	_	_	_
22	virus	_	_	_	_	_	_	_	_
23	(	_	_	_	_	_	_	_	_
24	PEDV	_	_	_	_	_	_	_	_
25	)	_	_	_	_	_	_	_	_
26	CH	_	_	_	_	_	_	_	_
27	/	_	_	_	_	_	_	_	_
28	GDGZ/2012	_	_	_	_	_	_	_	_
29	strain	_	_	_	_	_	_	_	_
30	was	_	_	_	_	_	_	_	_
31	obtained	_	_	_	_	_	_	_	_
32	from	_	_	_	_	_	_	_	_
33	the	_	_	_	_	_	_	_	_
34	feces	_	_	_	_	_	_	_	_
35	of	_	_	_	_	_	_	_	_
36	diseased	_	_	_	_	_	_	_	_
37	pigs	_	_	_	_	_	_	_	_
38	in	_	_	_	_	_	_	_	_
39	2012	_	_	_	_	_	_	_	_
40	in	_	_	_	_	_	_	_	_
41	southern	_	_	_	_	_	_	_	_
42	China	_	_	_	_	_	_	_	_
43	.	_	_	_	_	_	_	_	_
44	We	_	_	_	_	_	_	_	BeginSeg=Yes
45	report	_	_	_	_	_	_	_	_
46	the	_	_	_	_	_	_	_	_
47	complete	_	_	_	_	_	_	_	_
48	genome	_	_	_	_	_	_	_	_
49	sequence	_	_	_	_	_	_	_	_
50	of	_	_	_	_	_	_	_	_
51	strain	_	_	_	_	_	_	_	_
52	CH	_	_	_	_	_	_	_	_
53	/	_	_	_	_	_	_	_	_
54	GDGZ/2012	_	_	_	_	_	_	_	_
55	,	_	_	_	_	_	_	_	_
56	which	_	_	_	_	_	_	_	BeginSeg=Yes
57	might	_	_	_	_	_	_	_	_
58	be	_	_	_	_	_	_	_	_
59	useful	_	_	_	_	_	_	_	_
60	for	_	_	_	_	_	_	_	_
61	better	_	_	_	_	_	_	_	_
62	understanding	_	_	_	_	_	_	_	_
63	the	_	_	_	_	_	_	_	_
64	molecular	_	_	_	_	_	_	_	_
65	characteristics	_	_	_	_	_	_	_	_
66	of	_	_	_	_	_	_	_	_
67	this	_	_	_	_	_	_	_	_
68	virus	_	_	_	_	_	_	_	_
69	.	_	_	_	_	_	_	_	_

# newdoc_id = bcbee2c092b43738b2504034db8246acb059d4c5
1	In	_	_	_	_	_	_	_	BeginSeg=Yes
2	Tanzania	_	_	_	_	_	_	_	_
3	,	_	_	_	_	_	_	_	_
4	Unprecedented	_	_	_	_	_	_	_	_
5	measures	_	_	_	_	_	_	_	_
6	have	_	_	_	_	_	_	_	_
7	been	_	_	_	_	_	_	_	_
8	adopted	_	_	_	_	_	_	_	_
9	to	_	_	_	_	_	_	_	BeginSeg=Yes
10	control	_	_	_	_	_	_	_	_
11	the	_	_	_	_	_	_	_	_
12	rapid	_	_	_	_	_	_	_	_
13	spread	_	_	_	_	_	_	_	_
14	of	_	_	_	_	_	_	_	_
15	the	_	_	_	_	_	_	_	_
16	ongoing	_	_	_	_	_	_	_	_
17	COVID-19	_	_	_	_	_	_	_	_
18	epidemic	_	_	_	_	_	_	_	_
19	.	_	_	_	_	_	_	_	_
20	Residents	_	_	_	_	_	_	_	BeginSeg=Yes
21	adherence	_	_	_	_	_	_	_	_
22	to	_	_	_	_	_	_	_	_
23	control	_	_	_	_	_	_	_	_
24	measures	_	_	_	_	_	_	_	_
25	is	_	_	_	_	_	_	_	_
26	affected	_	_	_	_	_	_	_	_
27	by	_	_	_	_	_	_	_	_
28	their	_	_	_	_	_	_	_	_
29	knowledge	_	_	_	_	_	_	_	_
30	,	_	_	_	_	_	_	_	_
31	attitudes	_	_	_	_	_	_	_	_
32	,	_	_	_	_	_	_	_	_
33	and	_	_	_	_	_	_	_	_
34	practices	_	_	_	_	_	_	_	_
35	(	_	_	_	_	_	_	_	_
36	KAP	_	_	_	_	_	_	_	_
37	)	_	_	_	_	_	_	_	_
38	towards	_	_	_	_	_	_	_	_
39	COVID-19	_	_	_	_	_	_	_	_
40	.	_	_	_	_	_	_	_	_
41	In	_	_	_	_	_	_	_	BeginSeg=Yes
42	this	_	_	_	_	_	_	_	_
43	study	_	_	_	_	_	_	_	_
44	,	_	_	_	_	_	_	_	_
45	we	_	_	_	_	_	_	_	_
46	investigated	_	_	_	_	_	_	_	_
47	Tanzanian	_	_	_	_	_	_	_	_
48-49	residents'	_	_	_	_	_	_	_	_
48	residents	_	_	_	_	_	_	_	_
49	'	_	_	_	_	_	_	_	_
50	KAP	_	_	_	_	_	_	_	_
51	towards	_	_	_	_	_	_	_	_
52	COVID-19	_	_	_	_	_	_	_	_
53	during	_	_	_	_	_	_	_	_
54	the	_	_	_	_	_	_	_	_
55	rapid	_	_	_	_	_	_	_	_
56	rise	_	_	_	_	_	_	_	_
57	period	_	_	_	_	_	_	_	_
58	of	_	_	_	_	_	_	_	_
59	the	_	_	_	_	_	_	_	_
60	outbreak	_	_	_	_	_	_	_	_
61	.	_	_	_	_	_	_	_	_
62	This	_	_	_	_	_	_	_	BeginSeg=Yes
63	was	_	_	_	_	_	_	_	_
64	a	_	_	_	_	_	_	_	_
65	cross	_	_	_	_	_	_	_	_
66	sectional	_	_	_	_	_	_	_	_
67	study	_	_	_	_	_	_	_	_
68	that	_	_	_	_	_	_	_	BeginSeg=Yes
69	involved	_	_	_	_	_	_	_	_
70	sample	_	_	_	_	_	_	_	_
71	of	_	_	_	_	_	_	_	_
72	online	_	_	_	_	_	_	_	_
73	Tanzanian	_	_	_	_	_	_	_	_
74	residents	_	_	_	_	_	_	_	_
75	who	_	_	_	_	_	_	_	BeginSeg=Yes
76	was	_	_	_	_	_	_	_	_
77	recruited	_	_	_	_	_	_	_	_
78	via	_	_	_	_	_	_	_	_
79	authors	_	_	_	_	_	_	_	_
80	networks	_	_	_	_	_	_	_	_
81	with	_	_	_	_	_	_	_	_
82	residents	_	_	_	_	_	_	_	_
83	and	_	_	_	_	_	_	_	_
84	social	_	_	_	_	_	_	_	_
85	media	_	_	_	_	_	_	_	_
86	.	_	_	_	_	_	_	_	_
87	A	_	_	_	_	_	_	_	BeginSeg=Yes
88	self	_	_	_	_	_	_	_	_
89	-	_	_	_	_	_	_	_	_
90	developed	_	_	_	_	_	_	_	_
91	online	_	_	_	_	_	_	_	_
92	KAP	_	_	_	_	_	_	_	_
93	questionnaire	_	_	_	_	_	_	_	_
94	using	_	_	_	_	_	_	_	BeginSeg=Yes
95	Survey	_	_	_	_	_	_	_	_
96	Monkey	_	_	_	_	_	_	_	_
97	tool	_	_	_	_	_	_	_	_
98	was	_	_	_	_	_	_	_	BeginSeg=Yes
99	used	_	_	_	_	_	_	_	_
100	to	_	_	_	_	_	_	_	BeginSeg=Yes
101	collect	_	_	_	_	_	_	_	_
102	data	_	_	_	_	_	_	_	_
103	from	_	_	_	_	_	_	_	_
104	participants	_	_	_	_	_	_	_	_
105	.	_	_	_	_	_	_	_	_
106	The	_	_	_	_	_	_	_	BeginSeg=Yes
107	questionnaire	_	_	_	_	_	_	_	_
108	assessed	_	_	_	_	_	_	_	_
109	demographic	_	_	_	_	_	_	_	_
110	and	_	_	_	_	_	_	_	BeginSeg=Yes
111	had	_	_	_	_	_	_	_	_
112	12	_	_	_	_	_	_	_	_
113	questions	_	_	_	_	_	_	_	_
114	on	_	_	_	_	_	_	_	_
115	COVID	_	_	_	_	_	_	_	_
116	Knowledge	_	_	_	_	_	_	_	_
117	and	_	_	_	_	_	_	_	_
118	5	_	_	_	_	_	_	_	_
119	questions	_	_	_	_	_	_	_	_
120	on	_	_	_	_	_	_	_	_
121	attitude	_	_	_	_	_	_	_	_
122	and	_	_	_	_	_	_	_	_
123	practice	_	_	_	_	_	_	_	_
124	.	_	_	_	_	_	_	_	_
125	Descriptive	_	_	_	_	_	_	_	BeginSeg=Yes
126	and	_	_	_	_	_	_	_	_
127	inferential	_	_	_	_	_	_	_	_
128	analysis	_	_	_	_	_	_	_	_
129	was	_	_	_	_	_	_	_	_
130	carried	_	_	_	_	_	_	_	_
131	out	_	_	_	_	_	_	_	_
132	using	_	_	_	_	_	_	_	BeginSeg=Yes
133	SPSS	_	_	_	_	_	_	_	_
134	17	_	_	_	_	_	_	_	_
135	.	_	_	_	_	_	_	_	_
136	Four	_	_	_	_	_	_	_	BeginSeg=Yes
137	hundred	_	_	_	_	_	_	_	_
138	residents	_	_	_	_	_	_	_	_
139	completed	_	_	_	_	_	_	_	_
140	a	_	_	_	_	_	_	_	_
141	survey	_	_	_	_	_	_	_	_
142	.	_	_	_	_	_	_	_	_
143	The	_	_	_	_	_	_	_	BeginSeg=Yes
144	mean	_	_	_	_	_	_	_	_
145	age	_	_	_	_	_	_	_	_
146	of	_	_	_	_	_	_	_	_
147	study	_	_	_	_	_	_	_	_
148	participants	_	_	_	_	_	_	_	_
149	was	_	_	_	_	_	_	_	_
150	28	_	_	_	_	_	_	_	_
151	years	_	_	_	_	_	_	_	_
152	,	_	_	_	_	_	_	_	_
153	and	_	_	_	_	_	_	_	BeginSeg=Yes
154	majorities	_	_	_	_	_	_	_	_
155	were	_	_	_	_	_	_	_	_
156	females	_	_	_	_	_	_	_	_
157	216	_	_	_	_	_	_	_	_
158	(	_	_	_	_	_	_	_	BeginSeg=Yes
159	54.0	_	_	_	_	_	_	_	_
160	%	_	_	_	_	_	_	_	_
161	)	_	_	_	_	_	_	_	_
162	.	_	_	_	_	_	_	_	_
163	There	_	_	_	_	_	_	_	BeginSeg=Yes
164	were	_	_	_	_	_	_	_	_
165	no	_	_	_	_	_	_	_	_
166	significant	_	_	_	_	_	_	_	_
167	different	_	_	_	_	_	_	_	_
168	in	_	_	_	_	_	_	_	_
169	relation	_	_	_	_	_	_	_	_
170	to	_	_	_	_	_	_	_	_
171	demographic	_	_	_	_	_	_	_	_
172	variables	_	_	_	_	_	_	_	_
173	(	_	_	_	_	_	_	_	BeginSeg=Yes
174	p>0.3	_	_	_	_	_	_	_	_
175	)	_	_	_	_	_	_	_	_
176	.	_	_	_	_	_	_	_	_
177	Those	_	_	_	_	_	_	_	BeginSeg=Yes
178	who	_	_	_	_	_	_	_	_
179	held	_	_	_	_	_	_	_	_
180	a	_	_	_	_	_	_	_	_
181	bachelor	_	_	_	_	_	_	_	_
182	degree	_	_	_	_	_	_	_	_
183	or	_	_	_	_	_	_	_	_
184	above	_	_	_	_	_	_	_	_
185	(	_	_	_	_	_	_	_	BeginSeg=Yes
186	60.3	_	_	_	_	_	_	_	_
187	%	_	_	_	_	_	_	_	_
188	)	_	_	_	_	_	_	_	_
189	had	_	_	_	_	_	_	_	BeginSeg=Yes
190	more	_	_	_	_	_	_	_	_
191	correct	_	_	_	_	_	_	_	_
192	score	_	_	_	_	_	_	_	_
193	.	_	_	_	_	_	_	_	_
194	The	_	_	_	_	_	_	_	BeginSeg=Yes
195	overall	_	_	_	_	_	_	_	_
196	,	_	_	_	_	_	_	_	_
197	(	_	_	_	_	_	_	_	_
198	84.4	_	_	_	_	_	_	_	_
199	%	_	_	_	_	_	_	_	_
200	)	_	_	_	_	_	_	_	_
201	of	_	_	_	_	_	_	_	_
202	participants	_	_	_	_	_	_	_	_
203	had	_	_	_	_	_	_	_	_
204	good	_	_	_	_	_	_	_	_
205	knowledge	_	_	_	_	_	_	_	_
206	level	_	_	_	_	_	_	_	_
207	and	_	_	_	_	_	_	_	BeginSeg=Yes
208	the	_	_	_	_	_	_	_	_
209	good	_	_	_	_	_	_	_	_
210	knowledge	_	_	_	_	_	_	_	_
211	was	_	_	_	_	_	_	_	_
212	associated	_	_	_	_	_	_	_	_
213	with	_	_	_	_	_	_	_	_
214	education	_	_	_	_	_	_	_	_
215	level	_	_	_	_	_	_	_	_
216	(	_	_	_	_	_	_	_	BeginSeg=Yes
217	p=0.001	_	_	_	_	_	_	_	_
218	)	_	_	_	_	_	_	_	_
219	.	_	_	_	_	_	_	_	_
220	Nearly	_	_	_	_	_	_	_	BeginSeg=Yes
221	all	_	_	_	_	_	_	_	_
222	of	_	_	_	_	_	_	_	_
223	the	_	_	_	_	_	_	_	_
224	participants	_	_	_	_	_	_	_	_
225	(	_	_	_	_	_	_	_	BeginSeg=Yes
226	96.0	_	_	_	_	_	_	_	_
227	%	_	_	_	_	_	_	_	_
228	)	_	_	_	_	_	_	_	_
229	had	_	_	_	_	_	_	_	BeginSeg=Yes
230	confidence	_	_	_	_	_	_	_	_
231	that	_	_	_	_	_	_	_	BeginSeg=Yes
232	Tanzania	_	_	_	_	_	_	_	_
233	can	_	_	_	_	_	_	_	_
234	win	_	_	_	_	_	_	_	_
235	the	_	_	_	_	_	_	_	_
236	battle	_	_	_	_	_	_	_	_
237	against	_	_	_	_	_	_	_	_
238	COVID-19	_	_	_	_	_	_	_	_
239	.	_	_	_	_	_	_	_	_
240	:	_	_	_	_	_	_	_	BeginSeg=Yes
241	medRxiv	_	_	_	_	_	_	_	_
242	preprint	_	_	_	_	_	_	_	_
243	2	_	_	_	_	_	_	_	_
244	The	_	_	_	_	_	_	_	BeginSeg=Yes
245	majority	_	_	_	_	_	_	_	_
246	of	_	_	_	_	_	_	_	_
247	the	_	_	_	_	_	_	_	_
248	respondents	_	_	_	_	_	_	_	_
249	(	_	_	_	_	_	_	_	BeginSeg=Yes
250	77	_	_	_	_	_	_	_	_
251	%	_	_	_	_	_	_	_	_
252	)	_	_	_	_	_	_	_	_
253	did	_	_	_	_	_	_	_	BeginSeg=Yes
254	not	_	_	_	_	_	_	_	_
255	do	_	_	_	_	_	_	_	_
256	to	_	_	_	_	_	_	_	_
257	the	_	_	_	_	_	_	_	_
258	crowded	_	_	_	_	_	_	_	_
259	place	_	_	_	_	_	_	_	_
260	in	_	_	_	_	_	_	_	_
261	recent	_	_	_	_	_	_	_	_
262	says	_	_	_	_	_	_	_	_
263	.	_	_	_	_	_	_	_	_
264	Multiple	_	_	_	_	_	_	_	BeginSeg=Yes
265	linear	_	_	_	_	_	_	_	_
266	regression	_	_	_	_	_	_	_	_
267	analysis	_	_	_	_	_	_	_	_
268	showed	_	_	_	_	_	_	_	_
269	that	_	_	_	_	_	_	_	BeginSeg=Yes
270	male	_	_	_	_	_	_	_	_
271	gender	_	_	_	_	_	_	_	_
272	,	_	_	_	_	_	_	_	_
273	age	_	_	_	_	_	_	_	_
274	-	_	_	_	_	_	_	_	_
275	group	_	_	_	_	_	_	_	_
276	of	_	_	_	_	_	_	_	_
277	16	_	_	_	_	_	_	_	_
278	-	_	_	_	_	_	_	_	_
279	29	_	_	_	_	_	_	_	_
280	years	_	_	_	_	_	_	_	_
281	and	_	_	_	_	_	_	_	_
282	education	_	_	_	_	_	_	_	_
283	of	_	_	_	_	_	_	_	_
284	secondary	_	_	_	_	_	_	_	_
285	or	_	_	_	_	_	_	_	_
286	lower	_	_	_	_	_	_	_	_
287	were	_	_	_	_	_	_	_	_
288	significantly	_	_	_	_	_	_	_	_
289	associated	_	_	_	_	_	_	_	_
290	with	_	_	_	_	_	_	_	_
291	lower	_	_	_	_	_	_	_	_
292	knowledge	_	_	_	_	_	_	_	_
293	score	_	_	_	_	_	_	_	_
294	.	_	_	_	_	_	_	_	_
295	Our	_	_	_	_	_	_	_	BeginSeg=Yes
296	findings	_	_	_	_	_	_	_	_
297	suggest	_	_	_	_	_	_	_	_
298	that	_	_	_	_	_	_	_	BeginSeg=Yes
299	residents	_	_	_	_	_	_	_	_
300	of	_	_	_	_	_	_	_	_
301	a	_	_	_	_	_	_	_	_
302	relatively	_	_	_	_	_	_	_	_
303	high	_	_	_	_	_	_	_	_
304	level	_	_	_	_	_	_	_	_
305	of	_	_	_	_	_	_	_	_
306	socioeconomic	_	_	_	_	_	_	_	_
307	status	_	_	_	_	_	_	_	_
308	,	_	_	_	_	_	_	_	_
309	have	_	_	_	_	_	_	_	_
310	had	_	_	_	_	_	_	_	_
311	good	_	_	_	_	_	_	_	_
312	knowledge	_	_	_	_	_	_	_	_
313	,	_	_	_	_	_	_	_	_
314	optimistic	_	_	_	_	_	_	_	_
315	attitudes	_	_	_	_	_	_	_	_
316	,	_	_	_	_	_	_	_	_
317	and	_	_	_	_	_	_	_	_
318	appropriate	_	_	_	_	_	_	_	_
319	practices	_	_	_	_	_	_	_	_
320	towards	_	_	_	_	_	_	_	_
321	COVID-19	_	_	_	_	_	_	_	_
322	during	_	_	_	_	_	_	_	_
323	the	_	_	_	_	_	_	_	_
324	rapid	_	_	_	_	_	_	_	_
325	rise	_	_	_	_	_	_	_	_
326	period	_	_	_	_	_	_	_	_
327	of	_	_	_	_	_	_	_	_
328	the	_	_	_	_	_	_	_	_
329	COVID-19	_	_	_	_	_	_	_	_
330	outbreak	_	_	_	_	_	_	_	_
331	.	_	_	_	_	_	_	_	_
332	Suggesting	_	_	_	_	_	_	_	BeginSeg=Yes
333	that	_	_	_	_	_	_	_	BeginSeg=Yes
334	health	_	_	_	_	_	_	_	_
335	education	_	_	_	_	_	_	_	_
336	programs	_	_	_	_	_	_	_	_
337	aimed	_	_	_	_	_	_	_	BeginSeg=Yes
338	at	_	_	_	_	_	_	_	_
339	improving	_	_	_	_	_	_	_	_
340	COVID-19	_	_	_	_	_	_	_	_
341	knowledge	_	_	_	_	_	_	_	_
342	are	_	_	_	_	_	_	_	BeginSeg=Yes
343	helpful	_	_	_	_	_	_	_	_
344	for	_	_	_	_	_	_	_	_
345	encouraging	_	_	_	_	_	_	_	_
346	an	_	_	_	_	_	_	_	_
347	optimistic	_	_	_	_	_	_	_	_
348	attitudes	_	_	_	_	_	_	_	_
349	and	_	_	_	_	_	_	_	_
350	maintaining	_	_	_	_	_	_	_	_
351	safe	_	_	_	_	_	_	_	_
352	practices	_	_	_	_	_	_	_	_
353	.	_	_	_	_	_	_	_	_
354	Due	_	_	_	_	_	_	_	BeginSeg=Yes
355	to	_	_	_	_	_	_	_	_
356	the	_	_	_	_	_	_	_	_
357	limitation	_	_	_	_	_	_	_	_
358	in	_	_	_	_	_	_	_	_
359	representativeness	_	_	_	_	_	_	_	_
360	of	_	_	_	_	_	_	_	_
361	the	_	_	_	_	_	_	_	_
362	sample	_	_	_	_	_	_	_	_
363	,	_	_	_	_	_	_	_	_
364	more	_	_	_	_	_	_	_	BeginSeg=Yes
365	studies	_	_	_	_	_	_	_	_
366	are	_	_	_	_	_	_	_	_
367	warranted	_	_	_	_	_	_	_	_
368	to	_	_	_	_	_	_	_	BeginSeg=Yes
369	investigate	_	_	_	_	_	_	_	_
370	the	_	_	_	_	_	_	_	_
371	KAP	_	_	_	_	_	_	_	_
372	towards	_	_	_	_	_	_	_	_
373	COVID-19	_	_	_	_	_	_	_	_
374	among	_	_	_	_	_	_	_	_
375	Tanzania	_	_	_	_	_	_	_	_
376	residents	_	_	_	_	_	_	_	_
377	of	_	_	_	_	_	_	_	_
378	a	_	_	_	_	_	_	_	_
379	low	_	_	_	_	_	_	_	_
380	socioeconomic	_	_	_	_	_	_	_	_
381	status	_	_	_	_	_	_	_	_
382	.	_	_	_	_	_	_	_	_

# newdoc_id = be7c8e5eb861bc4ef5334a348c6741638ffef108
1	Coronavirus	_	_	_	_	_	_	_	BeginSeg=Yes
2	Disease	_	_	_	_	_	_	_	_
3	2019	_	_	_	_	_	_	_	_
4	(	_	_	_	_	_	_	_	_
5	COVID-19	_	_	_	_	_	_	_	_
6	)	_	_	_	_	_	_	_	_
7	spread	_	_	_	_	_	_	_	_
8	globally	_	_	_	_	_	_	_	_
9	in	_	_	_	_	_	_	_	_
10	early	_	_	_	_	_	_	_	_
11	2020	_	_	_	_	_	_	_	_
12	,	_	_	_	_	_	_	_	_
13	causing	_	_	_	_	_	_	_	BeginSeg=Yes
14	the	_	_	_	_	_	_	_	_
15	world	_	_	_	_	_	_	_	_
16	to	_	_	_	_	_	_	_	_
17	face	_	_	_	_	_	_	_	_
18	an	_	_	_	_	_	_	_	_
19	existential	_	_	_	_	_	_	_	_
20	health	_	_	_	_	_	_	_	_
21	crisis	_	_	_	_	_	_	_	_
22	.	_	_	_	_	_	_	_	_
23	Automated	_	_	_	_	_	_	_	BeginSeg=Yes
24	detection	_	_	_	_	_	_	_	_
25	of	_	_	_	_	_	_	_	_
26	lung	_	_	_	_	_	_	_	_
27	infections	_	_	_	_	_	_	_	_
28	from	_	_	_	_	_	_	_	_
29	computed	_	_	_	_	_	_	_	_
30	tomography	_	_	_	_	_	_	_	_
31	(	_	_	_	_	_	_	_	_
32	CT	_	_	_	_	_	_	_	_
33	)	_	_	_	_	_	_	_	_
34	images	_	_	_	_	_	_	_	_
35	offers	_	_	_	_	_	_	_	_
36	a	_	_	_	_	_	_	_	_
37	great	_	_	_	_	_	_	_	_
38	potential	_	_	_	_	_	_	_	_
39	to	_	_	_	_	_	_	_	BeginSeg=Yes
40	augment	_	_	_	_	_	_	_	_
41	the	_	_	_	_	_	_	_	_
42	traditional	_	_	_	_	_	_	_	_
43	healthcare	_	_	_	_	_	_	_	_
44	strategy	_	_	_	_	_	_	_	_
45	for	_	_	_	_	_	_	_	BeginSeg=Yes
46	tackling	_	_	_	_	_	_	_	_
47	COVID-19	_	_	_	_	_	_	_	_
48	.	_	_	_	_	_	_	_	_
49	However	_	_	_	_	_	_	_	BeginSeg=Yes
50	,	_	_	_	_	_	_	_	_
51	segmenting	_	_	_	_	_	_	_	_
52	infected	_	_	_	_	_	_	_	_
53	regions	_	_	_	_	_	_	_	_
54	from	_	_	_	_	_	_	_	_
55	CT	_	_	_	_	_	_	_	_
56	scans	_	_	_	_	_	_	_	_
57	faces	_	_	_	_	_	_	_	_
58	several	_	_	_	_	_	_	_	_
59	challenges	_	_	_	_	_	_	_	_
60	,	_	_	_	_	_	_	_	_
61	including	_	_	_	_	_	_	_	BeginSeg=Yes
62	high	_	_	_	_	_	_	_	_
63	variation	_	_	_	_	_	_	_	_
64	in	_	_	_	_	_	_	_	_
65	infection	_	_	_	_	_	_	_	_
66	characteristics	_	_	_	_	_	_	_	_
67	,	_	_	_	_	_	_	_	_
68	and	_	_	_	_	_	_	_	_
69	low	_	_	_	_	_	_	_	_
70	intensity	_	_	_	_	_	_	_	_
71	contrast	_	_	_	_	_	_	_	_
72	between	_	_	_	_	_	_	_	_
73	infections	_	_	_	_	_	_	_	_
74	and	_	_	_	_	_	_	_	_
75	normal	_	_	_	_	_	_	_	_
76	tissues	_	_	_	_	_	_	_	_
77	.	_	_	_	_	_	_	_	_
78	Further	_	_	_	_	_	_	_	BeginSeg=Yes
79	,	_	_	_	_	_	_	_	_
80	collecting	_	_	_	_	_	_	_	_
81	a	_	_	_	_	_	_	_	_
82	large	_	_	_	_	_	_	_	_
83	amount	_	_	_	_	_	_	_	_
84	of	_	_	_	_	_	_	_	_
85	data	_	_	_	_	_	_	_	_
86	is	_	_	_	_	_	_	_	_
87	impractical	_	_	_	_	_	_	_	_
88	within	_	_	_	_	_	_	_	_
89	a	_	_	_	_	_	_	_	_
90	short	_	_	_	_	_	_	_	_
91	time	_	_	_	_	_	_	_	_
92	period	_	_	_	_	_	_	_	_
93	,	_	_	_	_	_	_	_	_
94	inhibiting	_	_	_	_	_	_	_	BeginSeg=Yes
95	the	_	_	_	_	_	_	_	_
96	training	_	_	_	_	_	_	_	_
97	of	_	_	_	_	_	_	_	_
98	a	_	_	_	_	_	_	_	_
99	deep	_	_	_	_	_	_	_	_
100	model	_	_	_	_	_	_	_	_
101	.	_	_	_	_	_	_	_	_
102	To	_	_	_	_	_	_	_	BeginSeg=Yes
103	address	_	_	_	_	_	_	_	_
104	these	_	_	_	_	_	_	_	_
105	challenges	_	_	_	_	_	_	_	_
106	,	_	_	_	_	_	_	_	_
107	a	_	_	_	_	_	_	_	BeginSeg=Yes
108	novel	_	_	_	_	_	_	_	_
109	COVID-19	_	_	_	_	_	_	_	_
110	Lung	_	_	_	_	_	_	_	_
111	Infection	_	_	_	_	_	_	_	_
112	Segmentation	_	_	_	_	_	_	_	_
113	Deep	_	_	_	_	_	_	_	_
114	Network	_	_	_	_	_	_	_	_
115	(	_	_	_	_	_	_	_	_
116	Inf	_	_	_	_	_	_	_	_
117	-	_	_	_	_	_	_	_	_
118	Net	_	_	_	_	_	_	_	_
119	)	_	_	_	_	_	_	_	_
120	is	_	_	_	_	_	_	_	_
121	proposed	_	_	_	_	_	_	_	_
122	to	_	_	_	_	_	_	_	BeginSeg=Yes
123	automatically	_	_	_	_	_	_	_	_
124	identify	_	_	_	_	_	_	_	_
125	infected	_	_	_	_	_	_	_	_
126	regions	_	_	_	_	_	_	_	_
127	from	_	_	_	_	_	_	_	_
128	chest	_	_	_	_	_	_	_	_
129	CT	_	_	_	_	_	_	_	_
130	scans	_	_	_	_	_	_	_	_
131	.	_	_	_	_	_	_	_	_
132	In	_	_	_	_	_	_	_	BeginSeg=Yes
133	our	_	_	_	_	_	_	_	_
134	Inf	_	_	_	_	_	_	_	_
135	-	_	_	_	_	_	_	_	_
136	Net	_	_	_	_	_	_	_	_
137	,	_	_	_	_	_	_	_	_
138	a	_	_	_	_	_	_	_	_
139	parallel	_	_	_	_	_	_	_	_
140	partial	_	_	_	_	_	_	_	_
141	decoder	_	_	_	_	_	_	_	_
142	is	_	_	_	_	_	_	_	_
143	used	_	_	_	_	_	_	_	_
144	to	_	_	_	_	_	_	_	BeginSeg=Yes
145	aggregate	_	_	_	_	_	_	_	_
146	the	_	_	_	_	_	_	_	_
147	high	_	_	_	_	_	_	_	_
148	-	_	_	_	_	_	_	_	_
149	level	_	_	_	_	_	_	_	_
150	features	_	_	_	_	_	_	_	_
151	and	_	_	_	_	_	_	_	BeginSeg=Yes
152	generate	_	_	_	_	_	_	_	_
153	a	_	_	_	_	_	_	_	_
154	global	_	_	_	_	_	_	_	_
155	map	_	_	_	_	_	_	_	_
156	.	_	_	_	_	_	_	_	_
157	Then	_	_	_	_	_	_	_	BeginSeg=Yes
158	,	_	_	_	_	_	_	_	_
159	the	_	_	_	_	_	_	_	_
160	implicit	_	_	_	_	_	_	_	_
161	reverse	_	_	_	_	_	_	_	_
162	attention	_	_	_	_	_	_	_	_
163	and	_	_	_	_	_	_	_	_
164	explicit	_	_	_	_	_	_	_	_
165	edge	_	_	_	_	_	_	_	_
166	-	_	_	_	_	_	_	_	_
167	attention	_	_	_	_	_	_	_	_
168	are	_	_	_	_	_	_	_	_
169	utilized	_	_	_	_	_	_	_	_
170	to	_	_	_	_	_	_	_	BeginSeg=Yes
171	model	_	_	_	_	_	_	_	_
172	the	_	_	_	_	_	_	_	_
173	boundaries	_	_	_	_	_	_	_	_
174	and	_	_	_	_	_	_	_	BeginSeg=Yes
175	enhance	_	_	_	_	_	_	_	_
176	the	_	_	_	_	_	_	_	_
177	representations	_	_	_	_	_	_	_	_
178	.	_	_	_	_	_	_	_	_
179	Moreover	_	_	_	_	_	_	_	BeginSeg=Yes
180	,	_	_	_	_	_	_	_	_
181	to	_	_	_	_	_	_	_	BeginSeg=Yes
182	alleviate	_	_	_	_	_	_	_	_
183	the	_	_	_	_	_	_	_	_
184	shortage	_	_	_	_	_	_	_	_
185	of	_	_	_	_	_	_	_	_
186	labeled	_	_	_	_	_	_	_	_
187	data	_	_	_	_	_	_	_	_
188	,	_	_	_	_	_	_	_	_
189	we	_	_	_	_	_	_	_	BeginSeg=Yes
190	present	_	_	_	_	_	_	_	_
191	a	_	_	_	_	_	_	_	_
192	semi	_	_	_	_	_	_	_	_
193	-	_	_	_	_	_	_	_	_
194	supervised	_	_	_	_	_	_	_	_
195	segmentation	_	_	_	_	_	_	_	_
196	framework	_	_	_	_	_	_	_	_
197	based	_	_	_	_	_	_	_	BeginSeg=Yes
198	on	_	_	_	_	_	_	_	_
199	a	_	_	_	_	_	_	_	_
200	randomly	_	_	_	_	_	_	_	_
201	selected	_	_	_	_	_	_	_	_
202	propagation	_	_	_	_	_	_	_	_
203	strategy	_	_	_	_	_	_	_	_
204	,	_	_	_	_	_	_	_	_
205	which	_	_	_	_	_	_	_	BeginSeg=Yes
206	only	_	_	_	_	_	_	_	_
207	requires	_	_	_	_	_	_	_	_
208	a	_	_	_	_	_	_	_	_
209	few	_	_	_	_	_	_	_	_
210	labeled	_	_	_	_	_	_	_	_
211	images	_	_	_	_	_	_	_	_
212	and	_	_	_	_	_	_	_	BeginSeg=Yes
213	leverages	_	_	_	_	_	_	_	_
214	primarily	_	_	_	_	_	_	_	_
215	unlabeled	_	_	_	_	_	_	_	_
216	data	_	_	_	_	_	_	_	_
217	.	_	_	_	_	_	_	_	_
218	Our	_	_	_	_	_	_	_	BeginSeg=Yes
219	semi	_	_	_	_	_	_	_	_
220	-	_	_	_	_	_	_	_	_
221	supervised	_	_	_	_	_	_	_	_
222	framework	_	_	_	_	_	_	_	_
223	can	_	_	_	_	_	_	_	_
224	improve	_	_	_	_	_	_	_	_
225	the	_	_	_	_	_	_	_	_
226	learning	_	_	_	_	_	_	_	_
227	ability	_	_	_	_	_	_	_	_
228	and	_	_	_	_	_	_	_	BeginSeg=Yes
229	achieve	_	_	_	_	_	_	_	_
230	a	_	_	_	_	_	_	_	_
231	higher	_	_	_	_	_	_	_	_
232	performance	_	_	_	_	_	_	_	_
233	.	_	_	_	_	_	_	_	_
234	Extensive	_	_	_	_	_	_	_	BeginSeg=Yes
235	experiments	_	_	_	_	_	_	_	_
236	on	_	_	_	_	_	_	_	_
237	our	_	_	_	_	_	_	_	_
238	COVID	_	_	_	_	_	_	_	_
239	-	_	_	_	_	_	_	_	_
240	SemiSeg	_	_	_	_	_	_	_	_
241	and	_	_	_	_	_	_	_	_
242	and	_	_	_	_	_	_	_	_
243	real	_	_	_	_	_	_	_	_
244	CT	_	_	_	_	_	_	_	_
245	volumes	_	_	_	_	_	_	_	_
246	demonstrate	_	_	_	_	_	_	_	_
247	that	_	_	_	_	_	_	_	BeginSeg=Yes
248	the	_	_	_	_	_	_	_	_
249	proposed	_	_	_	_	_	_	_	_
250	Inf	_	_	_	_	_	_	_	_
251	-	_	_	_	_	_	_	_	_
252	Net	_	_	_	_	_	_	_	_
253	outperforms	_	_	_	_	_	_	_	_
254	most	_	_	_	_	_	_	_	_
255	cutting	_	_	_	_	_	_	_	_
256	-	_	_	_	_	_	_	_	_
257	edge	_	_	_	_	_	_	_	_
258	segmentation	_	_	_	_	_	_	_	_
259	models	_	_	_	_	_	_	_	_
260	and	_	_	_	_	_	_	_	BeginSeg=Yes
261	advances	_	_	_	_	_	_	_	_
262	the	_	_	_	_	_	_	_	_
263	state	_	_	_	_	_	_	_	_
264	-	_	_	_	_	_	_	_	_
265	of	_	_	_	_	_	_	_	_
266	-	_	_	_	_	_	_	_	_
267	theart	_	_	_	_	_	_	_	_
268	performance	_	_	_	_	_	_	_	_
269	.	_	_	_	_	_	_	_	_

# newdoc_id = bfab901132bb4f31381dd086e6c45472fa9b4e44
1	A	_	_	_	_	_	_	_	BeginSeg=Yes
2	simulation	_	_	_	_	_	_	_	_
3	tool	_	_	_	_	_	_	_	_
4	that	_	_	_	_	_	_	_	BeginSeg=Yes
5	supports	_	_	_	_	_	_	_	_
6	developers	_	_	_	_	_	_	_	_
7	to	_	_	_	_	_	_	_	_
8	build	_	_	_	_	_	_	_	_
9	scenarios	_	_	_	_	_	_	_	_
10	automatically	_	_	_	_	_	_	_	_
11	in	_	_	_	_	_	_	_	_
12	multiple	_	_	_	_	_	_	_	_
13	simulation	_	_	_	_	_	_	_	_
14	platforms	_	_	_	_	_	_	_	_
15	is	_	_	_	_	_	_	_	BeginSeg=Yes
16	proposed	_	_	_	_	_	_	_	_
17	.	_	_	_	_	_	_	_	_
18	As	_	_	_	_	_	_	_	BeginSeg=Yes
19	an	_	_	_	_	_	_	_	_
20	essential	_	_	_	_	_	_	_	_
21	part	_	_	_	_	_	_	_	_
22	of	_	_	_	_	_	_	_	_
23	this	_	_	_	_	_	_	_	_
24	simulator	_	_	_	_	_	_	_	_
25	,	_	_	_	_	_	_	_	_
26	this	_	_	_	_	_	_	_	_
27	study	_	_	_	_	_	_	_	_
28	proposed	_	_	_	_	_	_	_	_
29	an	_	_	_	_	_	_	_	_
30	activity	_	_	_	_	_	_	_	_
31	schedule	_	_	_	_	_	_	_	_
32	generator	_	_	_	_	_	_	_	_
33	to	_	_	_	_	_	_	_	BeginSeg=Yes
34	mimic	_	_	_	_	_	_	_	_
35	the	_	_	_	_	_	_	_	_
36	daily	_	_	_	_	_	_	_	_
37	life	_	_	_	_	_	_	_	_
38	of	_	_	_	_	_	_	_	_
39	elderly	_	_	_	_	_	_	_	_
40	people	_	_	_	_	_	_	_	_
41	living	_	_	_	_	_	_	_	BeginSeg=Yes
42	alone	_	_	_	_	_	_	_	_
43	.	_	_	_	_	_	_	_	_
44	This	_	_	_	_	_	_	_	BeginSeg=Yes
45	generator	_	_	_	_	_	_	_	_
46	outperforms	_	_	_	_	_	_	_	_
47	existing	_	_	_	_	_	_	_	_
48	methods	_	_	_	_	_	_	_	_
49	of	_	_	_	_	_	_	_	_
50	activity	_	_	_	_	_	_	_	_
51	schedule	_	_	_	_	_	_	_	_
52	planning	_	_	_	_	_	_	_	_
53	in	_	_	_	_	_	_	_	_
54	three	_	_	_	_	_	_	_	_
55	aspects	_	_	_	_	_	_	_	_
56	:	_	_	_	_	_	_	_	_
57	1	_	_	_	_	_	_	_	BeginSeg=Yes
58	)	_	_	_	_	_	_	_	_
59	it	_	_	_	_	_	_	_	_
60	is	_	_	_	_	_	_	_	_
61	adaptive	_	_	_	_	_	_	_	_
62	to	_	_	_	_	_	_	_	_
63	the	_	_	_	_	_	_	_	_
64	layout	_	_	_	_	_	_	_	_
65	of	_	_	_	_	_	_	_	_
66	a	_	_	_	_	_	_	_	_
67	simulated	_	_	_	_	_	_	_	_
68	smart	_	_	_	_	_	_	_	_
69	house	_	_	_	_	_	_	_	_
70	;	_	_	_	_	_	_	_	_
71	2	_	_	_	_	_	_	_	BeginSeg=Yes
72	)	_	_	_	_	_	_	_	_
73	there	_	_	_	_	_	_	_	_
74	is	_	_	_	_	_	_	_	_
75	no	_	_	_	_	_	_	_	_
76	unspecified	_	_	_	_	_	_	_	_
77	time	_	_	_	_	_	_	_	_
78	in	_	_	_	_	_	_	_	_
79	the	_	_	_	_	_	_	_	_
80	timeline	_	_	_	_	_	_	_	_
81	of	_	_	_	_	_	_	_	_
82	generated	_	_	_	_	_	_	_	_
83	schedules	_	_	_	_	_	_	_	_
84	;	_	_	_	_	_	_	_	_
85	and	_	_	_	_	_	_	_	BeginSeg=Yes
86	3	_	_	_	_	_	_	_	_
87	)	_	_	_	_	_	_	_	_
88	it	_	_	_	_	_	_	_	_
89	generates	_	_	_	_	_	_	_	_
90	stable	_	_	_	_	_	_	_	_
91	,	_	_	_	_	_	_	_	_
92	but	_	_	_	_	_	_	_	_
93	not	_	_	_	_	_	_	_	_
94	tedious	_	_	_	_	_	_	_	_
95	schedules	_	_	_	_	_	_	_	_
96	for	_	_	_	_	_	_	_	_
97	a	_	_	_	_	_	_	_	_
98	number	_	_	_	_	_	_	_	_
99	of	_	_	_	_	_	_	_	_
100	days	_	_	_	_	_	_	_	_
101	.	_	_	_	_	_	_	_	_
102	A	_	_	_	_	_	_	_	BeginSeg=Yes
103	real	_	_	_	_	_	_	_	_
104	-	_	_	_	_	_	_	_	_
105	time	_	_	_	_	_	_	_	_
106	location	_	_	_	_	_	_	_	_
107	data	_	_	_	_	_	_	_	_
108	generator	_	_	_	_	_	_	_	_
109	is	_	_	_	_	_	_	_	_
110	proposed	_	_	_	_	_	_	_	_
111	to	_	_	_	_	_	_	_	BeginSeg=Yes
112	convert	_	_	_	_	_	_	_	_
113	generated	_	_	_	_	_	_	_	_
114	schedules	_	_	_	_	_	_	_	_
115	to	_	_	_	_	_	_	_	_
116	simulated	_	_	_	_	_	_	_	_
117	real	_	_	_	_	_	_	_	_
118	-	_	_	_	_	_	_	_	_
119	time	_	_	_	_	_	_	_	_
120	location	_	_	_	_	_	_	_	_
121	data	_	_	_	_	_	_	_	_
122	of	_	_	_	_	_	_	_	_
123	the	_	_	_	_	_	_	_	_
124	resident	_	_	_	_	_	_	_	_
125	,	_	_	_	_	_	_	_	_
126	and	_	_	_	_	_	_	_	BeginSeg=Yes
127	a	_	_	_	_	_	_	_	_
128	proposed	_	_	_	_	_	_	_	_
129	interface	_	_	_	_	_	_	_	_
130	converts	_	_	_	_	_	_	_	_
131	these	_	_	_	_	_	_	_	_
132	simulated	_	_	_	_	_	_	_	_
133	location	_	_	_	_	_	_	_	_
134	data	_	_	_	_	_	_	_	_
135	to	_	_	_	_	_	_	_	_
136	simulated	_	_	_	_	_	_	_	_
137	records	_	_	_	_	_	_	_	_
138	of	_	_	_	_	_	_	_	_
139	virtual	_	_	_	_	_	_	_	_
140	passive	_	_	_	_	_	_	_	_
141	infrared	_	_	_	_	_	_	_	_
142	(	_	_	_	_	_	_	_	_
143	PIR	_	_	_	_	_	_	_	_
144	)	_	_	_	_	_	_	_	_
145	sensors	_	_	_	_	_	_	_	_
146	,	_	_	_	_	_	_	_	_
147	which	_	_	_	_	_	_	_	BeginSeg=Yes
148	can	_	_	_	_	_	_	_	_
149	be	_	_	_	_	_	_	_	_
150	used	_	_	_	_	_	_	_	_
151	to	_	_	_	_	_	_	_	BeginSeg=Yes
152	optimize	_	_	_	_	_	_	_	_
153	placement	_	_	_	_	_	_	_	_
154	of	_	_	_	_	_	_	_	_
155	PIR	_	_	_	_	_	_	_	_
156	sensors	_	_	_	_	_	_	_	_
157	in	_	_	_	_	_	_	_	_
158	a	_	_	_	_	_	_	_	_
159	smart	_	_	_	_	_	_	_	_
160	house	_	_	_	_	_	_	_	_
161	.	_	_	_	_	_	_	_	_

# newdoc_id = c0e6a4d852babb843d63198cc1e16146efc108b1
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	Severe	_	_	_	_	_	_	_	_
3	Acute	_	_	_	_	_	_	_	_
4	Respiratory	_	_	_	_	_	_	_	_
5	Syndrome	_	_	_	_	_	_	_	_
6	-	_	_	_	_	_	_	_	_
7	Coronavirus	_	_	_	_	_	_	_	_
8	(	_	_	_	_	_	_	_	_
9	SARS	_	_	_	_	_	_	_	_
10	-	_	_	_	_	_	_	_	_
11	CoV	_	_	_	_	_	_	_	_
12	)	_	_	_	_	_	_	_	_
13	3a	_	_	_	_	_	_	_	_
14	locus	_	_	_	_	_	_	_	_
15	encodes	_	_	_	_	_	_	_	_
16	a	_	_	_	_	_	_	_	_
17	274	_	_	_	_	_	_	_	_
18	a.a	_	_	_	_	_	_	_	_
19	.	_	_	_	_	_	_	_	_
20	novel	_	_	_	_	_	_	_	_
21	protein	_	_	_	_	_	_	_	_
22	,	_	_	_	_	_	_	_	_
23	and	_	_	_	_	_	_	_	BeginSeg=Yes
24	its	_	_	_	_	_	_	_	_
25	expression	_	_	_	_	_	_	_	_
26	has	_	_	_	_	_	_	_	_
27	been	_	_	_	_	_	_	_	_
28	confirmed	_	_	_	_	_	_	_	_
29	in	_	_	_	_	_	_	_	_
30	SARS	_	_	_	_	_	_	_	_
31	patients	_	_	_	_	_	_	_	_
32	.	_	_	_	_	_	_	_	_
33	To	_	_	_	_	_	_	_	BeginSeg=Yes
34	study	_	_	_	_	_	_	_	_
35	functional	_	_	_	_	_	_	_	_
36	roles	_	_	_	_	_	_	_	_
37	of	_	_	_	_	_	_	_	_
38	3a	_	_	_	_	_	_	_	_
39	,	_	_	_	_	_	_	_	_
40	we	_	_	_	_	_	_	_	BeginSeg=Yes
41	established	_	_	_	_	_	_	_	_
42	a	_	_	_	_	_	_	_	_
43	transgenic	_	_	_	_	_	_	_	_
44	fly	_	_	_	_	_	_	_	_
45	model	_	_	_	_	_	_	_	_
46	for	_	_	_	_	_	_	_	_
47	the	_	_	_	_	_	_	_	_
48	SARS	_	_	_	_	_	_	_	_
49	-	_	_	_	_	_	_	_	_
50	CoV	_	_	_	_	_	_	_	_
51	3a	_	_	_	_	_	_	_	_
52	gene	_	_	_	_	_	_	_	_
53	.	_	_	_	_	_	_	_	_
54	Misexpression	_	_	_	_	_	_	_	BeginSeg=Yes
55	of	_	_	_	_	_	_	_	_
56	3a	_	_	_	_	_	_	_	_
57	in	_	_	_	_	_	_	_	_
58	Drosophila	_	_	_	_	_	_	_	_
59	caused	_	_	_	_	_	_	_	_
60	a	_	_	_	_	_	_	_	_
61	dominant	_	_	_	_	_	_	_	_
62	rough	_	_	_	_	_	_	_	_
63	eye	_	_	_	_	_	_	_	_
64	phenotype	_	_	_	_	_	_	_	_
65	.	_	_	_	_	_	_	_	_
66	Using	_	_	_	_	_	_	_	BeginSeg=Yes
67	a	_	_	_	_	_	_	_	_
68	specific	_	_	_	_	_	_	_	_
69	monoclonal	_	_	_	_	_	_	_	_
70	antibody	_	_	_	_	_	_	_	_
71	,	_	_	_	_	_	_	_	_
72	we	_	_	_	_	_	_	_	BeginSeg=Yes
73	demonstrated	_	_	_	_	_	_	_	_
74	that	_	_	_	_	_	_	_	BeginSeg=Yes
75	the	_	_	_	_	_	_	_	_
76	3a	_	_	_	_	_	_	_	_
77	protein	_	_	_	_	_	_	_	_
78	displayed	_	_	_	_	_	_	_	_
79	a	_	_	_	_	_	_	_	_
80	punctate	_	_	_	_	_	_	_	_
81	cytoplasmic	_	_	_	_	_	_	_	_
82	localization	_	_	_	_	_	_	_	_
83	in	_	_	_	_	_	_	_	_
84	Drosophila	_	_	_	_	_	_	_	_
85	as	_	_	_	_	_	_	_	_
86	in	_	_	_	_	_	_	_	_
87	SARS	_	_	_	_	_	_	_	_
88	-	_	_	_	_	_	_	_	_
89	CoV	_	_	_	_	_	_	_	_
90	-	_	_	_	_	_	_	_	_
91	infected	_	_	_	_	_	_	_	_
92	cells	_	_	_	_	_	_	_	_
93	.	_	_	_	_	_	_	_	_
94	We	_	_	_	_	_	_	_	BeginSeg=Yes
95	provide	_	_	_	_	_	_	_	_
96	genetic	_	_	_	_	_	_	_	_
97	evidence	_	_	_	_	_	_	_	_
98	to	_	_	_	_	_	_	_	BeginSeg=Yes
99	support	_	_	_	_	_	_	_	_
100	that	_	_	_	_	_	_	_	BeginSeg=Yes
101	3a	_	_	_	_	_	_	_	_
102	is	_	_	_	_	_	_	_	_
103	functionally	_	_	_	_	_	_	_	_
104	related	_	_	_	_	_	_	_	_
105	to	_	_	_	_	_	_	_	_
106	clathrin	_	_	_	_	_	_	_	_
107	-	_	_	_	_	_	_	_	_
108	mediated	_	_	_	_	_	_	_	_
109	endocytosis	_	_	_	_	_	_	_	_
110	.	_	_	_	_	_	_	_	_
111	We	_	_	_	_	_	_	_	BeginSeg=Yes
112	further	_	_	_	_	_	_	_	_
113	found	_	_	_	_	_	_	_	_
114	that	_	_	_	_	_	_	_	BeginSeg=Yes
115	3a	_	_	_	_	_	_	_	_
116	misexpression	_	_	_	_	_	_	_	_
117	induces	_	_	_	_	_	_	_	_
118	apoptosis	_	_	_	_	_	_	_	_
119	,	_	_	_	_	_	_	_	_
120	which	_	_	_	_	_	_	_	BeginSeg=Yes
121	could	_	_	_	_	_	_	_	_
122	be	_	_	_	_	_	_	_	_
123	modulated	_	_	_	_	_	_	_	_
124	by	_	_	_	_	_	_	_	_
125	cellular	_	_	_	_	_	_	_	_
126	cytochrome	_	_	_	_	_	_	_	_
127	c	_	_	_	_	_	_	_	_
128	levels	_	_	_	_	_	_	_	_
129	and	_	_	_	_	_	_	_	_
130	caspase	_	_	_	_	_	_	_	_
131	activity	_	_	_	_	_	_	_	_
132	.	_	_	_	_	_	_	_	_
133	From	_	_	_	_	_	_	_	BeginSeg=Yes
134	a	_	_	_	_	_	_	_	_
135	forward	_	_	_	_	_	_	_	_
136	genetic	_	_	_	_	_	_	_	_
137	screen	_	_	_	_	_	_	_	_
138	,	_	_	_	_	_	_	_	_
139	78	_	_	_	_	_	_	_	_
140	dominant	_	_	_	_	_	_	_	_
141	3a	_	_	_	_	_	_	_	_
142	modifying	_	_	_	_	_	_	_	_
143	loci	_	_	_	_	_	_	_	_
144	were	_	_	_	_	_	_	_	_
145	recovered	_	_	_	_	_	_	_	_
146	and	_	_	_	_	_	_	_	BeginSeg=Yes
147	the	_	_	_	_	_	_	_	_
148	identity	_	_	_	_	_	_	_	_
149	of	_	_	_	_	_	_	_	_
150	these	_	_	_	_	_	_	_	_
151	modifiers	_	_	_	_	_	_	_	_
152	revealed	_	_	_	_	_	_	_	_
153	that	_	_	_	_	_	_	_	BeginSeg=Yes
154	the	_	_	_	_	_	_	_	_
155	severity	_	_	_	_	_	_	_	_
156	of	_	_	_	_	_	_	_	_
157	the	_	_	_	_	_	_	_	_
158	3a	_	_	_	_	_	_	_	_
159	-	_	_	_	_	_	_	_	_
160	induced	_	_	_	_	_	_	_	_
161	rough	_	_	_	_	_	_	_	_
162	eye	_	_	_	_	_	_	_	_
163	phenotype	_	_	_	_	_	_	_	_
164	depends	_	_	_	_	_	_	_	_
165	on	_	_	_	_	_	_	_	_
166	multiple	_	_	_	_	_	_	_	_
167	cellular	_	_	_	_	_	_	_	_
168	processes	_	_	_	_	_	_	_	_
169	including	_	_	_	_	_	_	_	BeginSeg=Yes
170	gene	_	_	_	_	_	_	_	_
171	transcriptional	_	_	_	_	_	_	_	_
172	regulation	_	_	_	_	_	_	_	_
173	.	_	_	_	_	_	_	_	_

# newdoc_id = c280d46d6fa7e2c2938a5c09bd6b092e1058a9b0
1	Mucosal	_	_	_	_	_	_	_	BeginSeg=Yes
2	vaccination	_	_	_	_	_	_	_	_
3	is	_	_	_	_	_	_	_	_
4	an	_	_	_	_	_	_	_	_
5	effective	_	_	_	_	_	_	_	_
6	strategy	_	_	_	_	_	_	_	_
7	for	_	_	_	_	_	_	_	BeginSeg=Yes
8	generating	_	_	_	_	_	_	_	_
9	antigen	_	_	_	_	_	_	_	_
10	-	_	_	_	_	_	_	_	_
11	specific	_	_	_	_	_	_	_	_
12	immune	_	_	_	_	_	_	_	_
13	responses	_	_	_	_	_	_	_	_
14	against	_	_	_	_	_	_	_	_
15	mucosal	_	_	_	_	_	_	_	_
16	infections	_	_	_	_	_	_	_	_
17	of	_	_	_	_	_	_	_	_
18	foot	_	_	_	_	_	_	_	_
19	-	_	_	_	_	_	_	_	_
20	and	_	_	_	_	_	_	_	_
21	-	_	_	_	_	_	_	_	_
22	mouth	_	_	_	_	_	_	_	_
23	disease	_	_	_	_	_	_	_	_
24	virus	_	_	_	_	_	_	_	_
25	(	_	_	_	_	_	_	_	_
26	FMDV	_	_	_	_	_	_	_	_
27	)	_	_	_	_	_	_	_	_
28	.	_	_	_	_	_	_	_	_
29	In	_	_	_	_	_	_	_	BeginSeg=Yes
30	this	_	_	_	_	_	_	_	_
31	study	_	_	_	_	_	_	_	_
32	,	_	_	_	_	_	_	_	_
33	Lactobacillus	_	_	_	_	_	_	_	_
34	plantarum	_	_	_	_	_	_	_	_
35	strains	_	_	_	_	_	_	_	_
36	NC8	_	_	_	_	_	_	_	_
37	and	_	_	_	_	_	_	_	_
38	WCFS1	_	_	_	_	_	_	_	_
39	were	_	_	_	_	_	_	_	_
40	used	_	_	_	_	_	_	_	_
41	as	_	_	_	_	_	_	_	_
42	oral	_	_	_	_	_	_	_	_
43	delivery	_	_	_	_	_	_	_	_
44	vehicles	_	_	_	_	_	_	_	_
45	containing	_	_	_	_	_	_	_	BeginSeg=Yes
46	a	_	_	_	_	_	_	_	_
47	pSIP411-VP1	_	_	_	_	_	_	_	_
48	recombinant	_	_	_	_	_	_	_	_
49	plasmid	_	_	_	_	_	_	_	_
50	to	_	_	_	_	_	_	_	BeginSeg=Yes
51	initiate	_	_	_	_	_	_	_	_
52	mucosal	_	_	_	_	_	_	_	_
53	and	_	_	_	_	_	_	_	_
54	systemic	_	_	_	_	_	_	_	_
55	immune	_	_	_	_	_	_	_	_
56	responses	_	_	_	_	_	_	_	_
57	in	_	_	_	_	_	_	_	_
58	guinea	_	_	_	_	_	_	_	_
59	pigs	_	_	_	_	_	_	_	_
60	.	_	_	_	_	_	_	_	_
61	Guinea	_	_	_	_	_	_	_	BeginSeg=Yes
62	pigs	_	_	_	_	_	_	_	_
63	were	_	_	_	_	_	_	_	_
64	orally	_	_	_	_	_	_	_	_
65	vaccinated	_	_	_	_	_	_	_	_
66	(	_	_	_	_	_	_	_	BeginSeg=Yes
67	three	_	_	_	_	_	_	_	_
68	doses	_	_	_	_	_	_	_	_
69	)	_	_	_	_	_	_	_	_
70	with	_	_	_	_	_	_	_	BeginSeg=Yes
71	NC8-pSIP411	_	_	_	_	_	_	_	_
72	,	_	_	_	_	_	_	_	_
73	NC8-pSIP411-VP1	_	_	_	_	_	_	_	_
74	,	_	_	_	_	_	_	_	_
75	WCFS1-pSIP411	_	_	_	_	_	_	_	_
76	,	_	_	_	_	_	_	_	_
77	WCFS1-pSIP411-VP1	_	_	_	_	_	_	_	_
78	or	_	_	_	_	_	_	_	_
79	milk	_	_	_	_	_	_	_	_
80	.	_	_	_	_	_	_	_	_
81	Animals	_	_	_	_	_	_	_	BeginSeg=Yes
82	immunized	_	_	_	_	_	_	_	BeginSeg=Yes
83	with	_	_	_	_	_	_	_	_
84	NC8-pSIP411-VP1	_	_	_	_	_	_	_	_
85	and	_	_	_	_	_	_	_	_
86	WCFS1-pSIP411-VP1	_	_	_	_	_	_	_	_
87	developed	_	_	_	_	_	_	_	BeginSeg=Yes
88	high	_	_	_	_	_	_	_	_
89	levels	_	_	_	_	_	_	_	_
90	of	_	_	_	_	_	_	_	_
91	antigen	_	_	_	_	_	_	_	_
92	-	_	_	_	_	_	_	_	_
93	specific	_	_	_	_	_	_	_	_
94	serum	_	_	_	_	_	_	_	_
95	IgG	_	_	_	_	_	_	_	_
96	,	_	_	_	_	_	_	_	_
97	IgA	_	_	_	_	_	_	_	_
98	,	_	_	_	_	_	_	_	_
99	IgM	_	_	_	_	_	_	_	_
100	,	_	_	_	_	_	_	_	_
101	mucosal	_	_	_	_	_	_	_	_
102	secretory	_	_	_	_	_	_	_	_
103	IgA	_	_	_	_	_	_	_	_
104	(	_	_	_	_	_	_	_	_
105	sIgA	_	_	_	_	_	_	_	_
106	)	_	_	_	_	_	_	_	_
107	and	_	_	_	_	_	_	_	_
108	neutralizing	_	_	_	_	_	_	_	_
109	antibodies	_	_	_	_	_	_	_	_
110	,	_	_	_	_	_	_	_	_
111	and	_	_	_	_	_	_	_	BeginSeg=Yes
112	revealed	_	_	_	_	_	_	_	_
113	stronger	_	_	_	_	_	_	_	_
114	cell	_	_	_	_	_	_	_	_
115	-	_	_	_	_	_	_	_	_
116	mediated	_	_	_	_	_	_	_	_
117	immune	_	_	_	_	_	_	_	_
118	responses	_	_	_	_	_	_	_	_
119	and	_	_	_	_	_	_	_	BeginSeg=Yes
120	enhanced	_	_	_	_	_	_	_	_
121	protection	_	_	_	_	_	_	_	_
122	against	_	_	_	_	_	_	_	_
123	FMDV	_	_	_	_	_	_	_	_
124	challenge	_	_	_	_	_	_	_	_
125	compared	_	_	_	_	_	_	_	BeginSeg=Yes
126	with	_	_	_	_	_	_	_	_
127	control	_	_	_	_	_	_	_	_
128	groups	_	_	_	_	_	_	_	_
129	.	_	_	_	_	_	_	_	_
130	The	_	_	_	_	_	_	_	BeginSeg=Yes
131	recombinant	_	_	_	_	_	_	_	_
132	pSIP411-VP1	_	_	_	_	_	_	_	_
133	effectively	_	_	_	_	_	_	_	_
134	improved	_	_	_	_	_	_	_	_
135	immunoprotection	_	_	_	_	_	_	_	_
136	against	_	_	_	_	_	_	_	_
137	FMDV	_	_	_	_	_	_	_	_
138	in	_	_	_	_	_	_	_	_
139	guinea	_	_	_	_	_	_	_	_
140	pigs	_	_	_	_	_	_	_	_
141	.	_	_	_	_	_	_	_	_

# newdoc_id = c4aa9bb066a64db00b8bdd44d5c021c5603a09a2
1	Background	_	_	_	_	_	_	_	BeginSeg=Yes
2	.	_	_	_	_	_	_	_	_
3	Influenza	_	_	_	_	_	_	_	BeginSeg=Yes
4	A(H7N9	_	_	_	_	_	_	_	_
5	)	_	_	_	_	_	_	_	_
6	viruses	_	_	_	_	_	_	_	_
7	isolated	_	_	_	_	_	_	_	BeginSeg=Yes
8	from	_	_	_	_	_	_	_	_
9	humans	_	_	_	_	_	_	_	_
10	show	_	_	_	_	_	_	_	BeginSeg=Yes
11	features	_	_	_	_	_	_	_	_
12	suggesting	_	_	_	_	_	_	_	BeginSeg=Yes
13	partial	_	_	_	_	_	_	_	_
14	adaptation	_	_	_	_	_	_	_	_
15	to	_	_	_	_	_	_	_	_
16	mammals	_	_	_	_	_	_	_	_
17	.	_	_	_	_	_	_	_	_
18	To	_	_	_	_	_	_	_	BeginSeg=Yes
19	provide	_	_	_	_	_	_	_	_
20	insights	_	_	_	_	_	_	_	_
21	into	_	_	_	_	_	_	_	_
22	the	_	_	_	_	_	_	_	_
23	pathogenesis	_	_	_	_	_	_	_	_
24	of	_	_	_	_	_	_	_	_
25	H7N9	_	_	_	_	_	_	_	_
26	virus	_	_	_	_	_	_	_	_
27	infection	_	_	_	_	_	_	_	_
28	,	_	_	_	_	_	_	_	_
29	we	_	_	_	_	_	_	_	BeginSeg=Yes
30	compared	_	_	_	_	_	_	_	_
31	risk	_	_	_	_	_	_	_	_
32	factors	_	_	_	_	_	_	_	_
33	,	_	_	_	_	_	_	_	_
34	clinical	_	_	_	_	_	_	_	_
35	presentation	_	_	_	_	_	_	_	_
36	,	_	_	_	_	_	_	_	_
37	and	_	_	_	_	_	_	_	_
38	progression	_	_	_	_	_	_	_	_
39	of	_	_	_	_	_	_	_	_
40	patients	_	_	_	_	_	_	_	_
41	hospitalized	_	_	_	_	_	_	_	BeginSeg=Yes
42	with	_	_	_	_	_	_	_	_
43	H7N9	_	_	_	_	_	_	_	_
44	,	_	_	_	_	_	_	_	_
45	H5N1	_	_	_	_	_	_	_	_
46	,	_	_	_	_	_	_	_	_
47	and	_	_	_	_	_	_	_	_
48	2009	_	_	_	_	_	_	_	_
49	pandemic	_	_	_	_	_	_	_	_
50	H1N1	_	_	_	_	_	_	_	_
51	(	_	_	_	_	_	_	_	_
52	pH1N1	_	_	_	_	_	_	_	_
53	)	_	_	_	_	_	_	_	_
54	virus	_	_	_	_	_	_	_	_
55	infections	_	_	_	_	_	_	_	_
56	.	_	_	_	_	_	_	_	_
57	Methods	_	_	_	_	_	_	_	BeginSeg=Yes
58	.	_	_	_	_	_	_	_	_
59	We	_	_	_	_	_	_	_	BeginSeg=Yes
60	compared	_	_	_	_	_	_	_	_
61	individual	_	_	_	_	_	_	_	_
62	-	_	_	_	_	_	_	_	_
63	level	_	_	_	_	_	_	_	_
64	data	_	_	_	_	_	_	_	_
65	from	_	_	_	_	_	_	_	_
66	patients	_	_	_	_	_	_	_	_
67	hospitalized	_	_	_	_	_	_	_	BeginSeg=Yes
68	with	_	_	_	_	_	_	_	_
69	infection	_	_	_	_	_	_	_	_
70	by	_	_	_	_	_	_	_	_
71	H7N9	_	_	_	_	_	_	_	_
72	(	_	_	_	_	_	_	_	BeginSeg=Yes
73	n	_	_	_	_	_	_	_	_
74	=	_	_	_	_	_	_	_	_
75	123	_	_	_	_	_	_	_	_
76	)	_	_	_	_	_	_	_	_
77	,	_	_	_	_	_	_	_	_
78	H5N1	_	_	_	_	_	_	_	BeginSeg=Yes
79	(	_	_	_	_	_	_	_	BeginSeg=Yes
80	n	_	_	_	_	_	_	_	_
81	=	_	_	_	_	_	_	_	_
82	119	_	_	_	_	_	_	_	_
83	;	_	_	_	_	_	_	_	_
84	43	_	_	_	_	_	_	_	_
85	China	_	_	_	_	_	_	_	_
86	,	_	_	_	_	_	_	_	_
87	76	_	_	_	_	_	_	_	_
88	Vietnam	_	_	_	_	_	_	_	_
89	)	_	_	_	_	_	_	_	_
90	,	_	_	_	_	_	_	_	BeginSeg=Yes
91	and	_	_	_	_	_	_	_	_
92	pH1N1	_	_	_	_	_	_	_	_
93	(	_	_	_	_	_	_	_	BeginSeg=Yes
94	n	_	_	_	_	_	_	_	_
95	=	_	_	_	_	_	_	_	_
96	3486	_	_	_	_	_	_	_	_
97	)	_	_	_	_	_	_	_	_
98	viruses	_	_	_	_	_	_	_	BeginSeg=Yes
99	.	_	_	_	_	_	_	_	_
100	We	_	_	_	_	_	_	_	BeginSeg=Yes
101	assessed	_	_	_	_	_	_	_	_
102	risk	_	_	_	_	_	_	_	_
103	factors	_	_	_	_	_	_	_	_
104	for	_	_	_	_	_	_	_	_
105	hospitalization	_	_	_	_	_	_	_	_
106	after	_	_	_	_	_	_	_	_
107	adjustment	_	_	_	_	_	_	_	_
108	for	_	_	_	_	_	_	_	_
109	age	_	_	_	_	_	_	_	_
110	-	_	_	_	_	_	_	_	_
111	and	_	_	_	_	_	_	_	_
112	sex	_	_	_	_	_	_	_	_
113	-	_	_	_	_	_	_	_	_
114	specific	_	_	_	_	_	_	_	_
115	prevalence	_	_	_	_	_	_	_	_
116	of	_	_	_	_	_	_	_	_
117	risk	_	_	_	_	_	_	_	_
118	factors	_	_	_	_	_	_	_	_
119	in	_	_	_	_	_	_	_	_
120	the	_	_	_	_	_	_	_	_
121	general	_	_	_	_	_	_	_	_
122	Chinese	_	_	_	_	_	_	_	_
123	population	_	_	_	_	_	_	_	_
124	.	_	_	_	_	_	_	_	_
125	Results	_	_	_	_	_	_	_	BeginSeg=Yes
126	.	_	_	_	_	_	_	_	_
127	The	_	_	_	_	_	_	_	BeginSeg=Yes
128	median	_	_	_	_	_	_	_	_
129	age	_	_	_	_	_	_	_	_
130	of	_	_	_	_	_	_	_	_
131	patients	_	_	_	_	_	_	_	_
132	with	_	_	_	_	_	_	_	_
133	H7N9	_	_	_	_	_	_	_	_
134	virus	_	_	_	_	_	_	_	_
135	infection	_	_	_	_	_	_	_	_
136	was	_	_	_	_	_	_	_	_
137	older	_	_	_	_	_	_	_	_
138	than	_	_	_	_	_	_	_	_
139	other	_	_	_	_	_	_	_	_
140	patient	_	_	_	_	_	_	_	_
141	groups	_	_	_	_	_	_	_	_
142	(	_	_	_	_	_	_	_	BeginSeg=Yes
143	63	_	_	_	_	_	_	_	_
144	years	_	_	_	_	_	_	_	_
145	;	_	_	_	_	_	_	_	_
146	P	_	_	_	_	_	_	_	_
147	<	_	_	_	_	_	_	_	_
148	.001	_	_	_	_	_	_	_	_
149	)	_	_	_	_	_	_	_	_
150	and	_	_	_	_	_	_	_	BeginSeg=Yes
151	a	_	_	_	_	_	_	_	_
152	higher	_	_	_	_	_	_	_	_
153	proportion	_	_	_	_	_	_	_	_
154	was	_	_	_	_	_	_	_	_
155	male	_	_	_	_	_	_	_	_
156	(	_	_	_	_	_	_	_	BeginSeg=Yes
157	71	_	_	_	_	_	_	_	_
158	%	_	_	_	_	_	_	_	_
159	;	_	_	_	_	_	_	_	_
160	P	_	_	_	_	_	_	_	_
161	<	_	_	_	_	_	_	_	_
162	.02	_	_	_	_	_	_	_	_
163	)	_	_	_	_	_	_	_	_
164	.	_	_	_	_	_	_	_	_
165	After	_	_	_	_	_	_	_	BeginSeg=Yes
166	adjustment	_	_	_	_	_	_	_	_
167	for	_	_	_	_	_	_	_	_
168	age	_	_	_	_	_	_	_	_
169	and	_	_	_	_	_	_	_	_
170	sex	_	_	_	_	_	_	_	_
171	,	_	_	_	_	_	_	_	_
172	chronic	_	_	_	_	_	_	_	_
173	heart	_	_	_	_	_	_	_	_
174	disease	_	_	_	_	_	_	_	_
175	was	_	_	_	_	_	_	_	_
176	associated	_	_	_	_	_	_	_	_
177	with	_	_	_	_	_	_	_	_
178	an	_	_	_	_	_	_	_	_
179	increased	_	_	_	_	_	_	_	_
180	risk	_	_	_	_	_	_	_	_
181	of	_	_	_	_	_	_	_	_
182	hospitalization	_	_	_	_	_	_	_	_
183	with	_	_	_	_	_	_	_	_
184	H7N9	_	_	_	_	_	_	_	_
185	(	_	_	_	_	_	_	_	BeginSeg=Yes
186	relative	_	_	_	_	_	_	_	_
187	risk	_	_	_	_	_	_	_	_
188	,	_	_	_	_	_	_	_	_
189	9.68	_	_	_	_	_	_	_	_
190	;	_	_	_	_	_	_	_	_
191	95	_	_	_	_	_	_	_	_
192	%	_	_	_	_	_	_	_	_
193	confidence	_	_	_	_	_	_	_	_
194	interval	_	_	_	_	_	_	_	_
195	,	_	_	_	_	_	_	_	_
196	5.24	_	_	_	_	_	_	_	_
197	-	_	_	_	_	_	_	_	_
198	17.9	_	_	_	_	_	_	_	_
199	)	_	_	_	_	_	_	_	_
200	.	_	_	_	_	_	_	_	_
201	H7N9	_	_	_	_	_	_	_	BeginSeg=Yes
202	patients	_	_	_	_	_	_	_	_
203	had	_	_	_	_	_	_	_	_
204	similar	_	_	_	_	_	_	_	_
205	patterns	_	_	_	_	_	_	_	_
206	of	_	_	_	_	_	_	_	_
207	leukopenia	_	_	_	_	_	_	_	_
208	,	_	_	_	_	_	_	_	_
209	thrombocytopenia	_	_	_	_	_	_	_	_
210	,	_	_	_	_	_	_	_	_
211	and	_	_	_	_	_	_	_	_
212	elevated	_	_	_	_	_	_	_	_
213	alanine	_	_	_	_	_	_	_	_
214	aminotransferase	_	_	_	_	_	_	_	_
215	,	_	_	_	_	_	_	_	_
216	creatinine	_	_	_	_	_	_	_	_
217	kinase	_	_	_	_	_	_	_	_
218	,	_	_	_	_	_	_	_	_
219	C	_	_	_	_	_	_	_	_
220	-	_	_	_	_	_	_	_	_
221	reactive	_	_	_	_	_	_	_	_
222	protein	_	_	_	_	_	_	_	_
223	,	_	_	_	_	_	_	_	_
224	and	_	_	_	_	_	_	_	_
225	lactate	_	_	_	_	_	_	_	_
226	dehydrogenase	_	_	_	_	_	_	_	_
227	to	_	_	_	_	_	_	_	_
228	those	_	_	_	_	_	_	_	_
229	seen	_	_	_	_	_	_	_	BeginSeg=Yes
230	in	_	_	_	_	_	_	_	_
231	H5N1	_	_	_	_	_	_	_	_
232	patients	_	_	_	_	_	_	_	_
233	,	_	_	_	_	_	_	_	_
234	which	_	_	_	_	_	_	_	BeginSeg=Yes
235	were	_	_	_	_	_	_	_	_
236	all	_	_	_	_	_	_	_	_
237	significantly	_	_	_	_	_	_	_	_
238	different	_	_	_	_	_	_	_	_
239	from	_	_	_	_	_	_	_	_
240	pH1N1	_	_	_	_	_	_	_	_
241	patients	_	_	_	_	_	_	_	_
242	(	_	_	_	_	_	_	_	BeginSeg=Yes
243	P	_	_	_	_	_	_	_	_
244	<	_	_	_	_	_	_	_	_
245	.005	_	_	_	_	_	_	_	_
246	)	_	_	_	_	_	_	_	_
247	.	_	_	_	_	_	_	_	_
248	H7N9	_	_	_	_	_	_	_	BeginSeg=Yes
249	patients	_	_	_	_	_	_	_	_
250	had	_	_	_	_	_	_	_	_
251	a	_	_	_	_	_	_	_	_
252	longer	_	_	_	_	_	_	_	_
253	duration	_	_	_	_	_	_	_	_
254	of	_	_	_	_	_	_	_	_
255	hospitalization	_	_	_	_	_	_	_	_
256	than	_	_	_	_	_	_	_	_
257	either	_	_	_	_	_	_	_	_
258	H5N1	_	_	_	_	_	_	_	_
259	or	_	_	_	_	_	_	_	_
260	pH1N1	_	_	_	_	_	_	_	_
261	patients	_	_	_	_	_	_	_	_
262	(	_	_	_	_	_	_	_	BeginSeg=Yes
263	P	_	_	_	_	_	_	_	_
264	<	_	_	_	_	_	_	_	_
265	.001	_	_	_	_	_	_	_	_
266	)	_	_	_	_	_	_	_	_
267	,	_	_	_	_	_	_	_	_
268	and	_	_	_	_	_	_	_	BeginSeg=Yes
269	the	_	_	_	_	_	_	_	_
270	median	_	_	_	_	_	_	_	_
271	time	_	_	_	_	_	_	_	_
272	from	_	_	_	_	_	_	_	_
273	onset	_	_	_	_	_	_	_	_
274	to	_	_	_	_	_	_	_	_
275	death	_	_	_	_	_	_	_	_
276	was	_	_	_	_	_	_	_	_
277	18	_	_	_	_	_	_	_	_
278	days	_	_	_	_	_	_	_	_
279	for	_	_	_	_	_	_	_	_
280	H7N9	_	_	_	_	_	_	_	_
281	(	_	_	_	_	_	_	_	BeginSeg=Yes
282	P	_	_	_	_	_	_	_	_
283	=	_	_	_	_	_	_	_	_
284	.002	_	_	_	_	_	_	_	_
285	)	_	_	_	_	_	_	_	_
286	vs	_	_	_	_	_	_	_	BeginSeg=Yes
287	11	_	_	_	_	_	_	_	_
288	days	_	_	_	_	_	_	_	_
289	for	_	_	_	_	_	_	_	_
290	H5N1	_	_	_	_	_	_	_	_
291	and	_	_	_	_	_	_	_	_
292	15	_	_	_	_	_	_	_	_
293	days	_	_	_	_	_	_	_	_
294	for	_	_	_	_	_	_	_	_
295	pH1N1	_	_	_	_	_	_	_	_
296	(	_	_	_	_	_	_	_	BeginSeg=Yes
297	P	_	_	_	_	_	_	_	_
298	=	_	_	_	_	_	_	_	_
299	.154	_	_	_	_	_	_	_	_
300	)	_	_	_	_	_	_	_	_
301	.	_	_	_	_	_	_	_	_
302	Conclusions	_	_	_	_	_	_	_	BeginSeg=Yes
303	.	_	_	_	_	_	_	_	_
304	The	_	_	_	_	_	_	_	BeginSeg=Yes
305	identification	_	_	_	_	_	_	_	_
306	of	_	_	_	_	_	_	_	_
307	known	_	_	_	_	_	_	_	_
308	risk	_	_	_	_	_	_	_	_
309	factors	_	_	_	_	_	_	_	_
310	for	_	_	_	_	_	_	_	_
311	severe	_	_	_	_	_	_	_	_
312	seasonal	_	_	_	_	_	_	_	_
313	influenza	_	_	_	_	_	_	_	_
314	and	_	_	_	_	_	_	_	_
315	the	_	_	_	_	_	_	_	_
316	more	_	_	_	_	_	_	_	_
317	protracted	_	_	_	_	_	_	_	_
318	clinical	_	_	_	_	_	_	_	_
319	course	_	_	_	_	_	_	_	_
320	compared	_	_	_	_	_	_	_	BeginSeg=Yes
321	with	_	_	_	_	_	_	_	_
322	that	_	_	_	_	_	_	_	_
323	of	_	_	_	_	_	_	_	_
324	H5N1	_	_	_	_	_	_	_	_
325	suggests	_	_	_	_	_	_	_	BeginSeg=Yes
326	that	_	_	_	_	_	_	_	BeginSeg=Yes
327	host	_	_	_	_	_	_	_	_
328	factors	_	_	_	_	_	_	_	_
329	are	_	_	_	_	_	_	_	_
330	an	_	_	_	_	_	_	_	_
331	important	_	_	_	_	_	_	_	_
332	contributor	_	_	_	_	_	_	_	_
333	to	_	_	_	_	_	_	_	_
334	H7N9	_	_	_	_	_	_	_	_
335	severity	_	_	_	_	_	_	_	_
336	.	_	_	_	_	_	_	_	_

# newdoc_id = c526fbee33eed355a7c7437950603c4835418b0e
1	In	_	_	_	_	_	_	_	BeginSeg=Yes
2	general	_	_	_	_	_	_	_	_
3	,	_	_	_	_	_	_	_	_
4	a	_	_	_	_	_	_	_	_
5	whole	_	_	_	_	_	_	_	_
6	virion	_	_	_	_	_	_	_	_
7	serves	_	_	_	_	_	_	_	_
8	as	_	_	_	_	_	_	_	_
9	a	_	_	_	_	_	_	_	_
10	simple	_	_	_	_	_	_	_	_
11	vaccine	_	_	_	_	_	_	_	_
12	antigen	_	_	_	_	_	_	_	_
13	and	_	_	_	_	_	_	_	_
14	often	_	_	_	_	_	_	_	_
15	essential	_	_	_	_	_	_	_	_
16	material	_	_	_	_	_	_	_	_
17	for	_	_	_	_	_	_	_	_
18	the	_	_	_	_	_	_	_	_
19	analysis	_	_	_	_	_	_	_	_
20	of	_	_	_	_	_	_	_	_
21	immune	_	_	_	_	_	_	_	_
22	responses	_	_	_	_	_	_	_	_
23	against	_	_	_	_	_	_	_	_
24	virus	_	_	_	_	_	_	_	_
25	infection	_	_	_	_	_	_	_	_
26	.	_	_	_	_	_	_	_	_
27	However	_	_	_	_	_	_	_	BeginSeg=Yes
28	,	_	_	_	_	_	_	_	_
29	to	_	_	_	_	_	_	_	BeginSeg=Yes
30	work	_	_	_	_	_	_	_	_
31	with	_	_	_	_	_	_	_	_
32	highly	_	_	_	_	_	_	_	_
33	contagious	_	_	_	_	_	_	_	_
34	pathogens	_	_	_	_	_	_	_	_
35	,	_	_	_	_	_	_	_	_
36	it	_	_	_	_	_	_	_	BeginSeg=Yes
37	is	_	_	_	_	_	_	_	_
38	necessary	_	_	_	_	_	_	_	_
39	to	_	_	_	_	_	_	_	_
40	take	_	_	_	_	_	_	_	_
41	precautions	_	_	_	_	_	_	_	_
42	against	_	_	_	_	_	_	_	_
43	laboratory	_	_	_	_	_	_	_	_
44	-	_	_	_	_	_	_	_	_
45	acquired	_	_	_	_	_	_	_	_
46	infection	_	_	_	_	_	_	_	_
47	.	_	_	_	_	_	_	_	_
48	We	_	_	_	_	_	_	_	BeginSeg=Yes
49	have	_	_	_	_	_	_	_	_
50	learned	_	_	_	_	_	_	_	_
51	many	_	_	_	_	_	_	_	_
52	lessons	_	_	_	_	_	_	_	_
53	from	_	_	_	_	_	_	_	_
54	the	_	_	_	_	_	_	_	_
55	recent	_	_	_	_	_	_	_	_
56	outbreak	_	_	_	_	_	_	_	_
57	of	_	_	_	_	_	_	_	_
58	severe	_	_	_	_	_	_	_	_
59	acute	_	_	_	_	_	_	_	_
60	respiratory	_	_	_	_	_	_	_	_
61	syndrome	_	_	_	_	_	_	_	_
62	(	_	_	_	_	_	_	_	_
63	SARS	_	_	_	_	_	_	_	_
64	)	_	_	_	_	_	_	_	_
65	.	_	_	_	_	_	_	_	_
66	In	_	_	_	_	_	_	_	BeginSeg=Yes
67	order	_	_	_	_	_	_	_	_
68	to	_	_	_	_	_	_	_	_
69	develop	_	_	_	_	_	_	_	_
70	an	_	_	_	_	_	_	_	_
71	effective	_	_	_	_	_	_	_	_
72	vaccine	_	_	_	_	_	_	_	_
73	and	_	_	_	_	_	_	_	_
74	diagnostic	_	_	_	_	_	_	_	_
75	tools	_	_	_	_	_	_	_	_
76	,	_	_	_	_	_	_	_	_
77	we	_	_	_	_	_	_	_	BeginSeg=Yes
78	prepared	_	_	_	_	_	_	_	_
79	UV	_	_	_	_	_	_	_	_
80	-	_	_	_	_	_	_	_	_
81	inactivated	_	_	_	_	_	_	_	_
82	SARS	_	_	_	_	_	_	_	_
83	coronavirus	_	_	_	_	_	_	_	_
84	on	_	_	_	_	_	_	_	_
85	a	_	_	_	_	_	_	_	_
86	large	_	_	_	_	_	_	_	_
87	scale	_	_	_	_	_	_	_	_
88	under	_	_	_	_	_	_	_	_
89	the	_	_	_	_	_	_	_	_
90	strict	_	_	_	_	_	_	_	_
91	Biosafety	_	_	_	_	_	_	_	_
92	Level	_	_	_	_	_	_	_	_
93	3	_	_	_	_	_	_	_	_
94	(	_	_	_	_	_	_	_	_
95	BSL3	_	_	_	_	_	_	_	_
96	)	_	_	_	_	_	_	_	_
97	regulation	_	_	_	_	_	_	_	_
98	.	_	_	_	_	_	_	_	_
99	Our	_	_	_	_	_	_	_	BeginSeg=Yes
100	protocol	_	_	_	_	_	_	_	_
101	for	_	_	_	_	_	_	_	_
102	large	_	_	_	_	_	_	_	_
103	-	_	_	_	_	_	_	_	_
104	scale	_	_	_	_	_	_	_	_
105	preparation	_	_	_	_	_	_	_	_
106	of	_	_	_	_	_	_	_	_
107	UV	_	_	_	_	_	_	_	_
108	-	_	_	_	_	_	_	_	_
109	inactivated	_	_	_	_	_	_	_	_
110	SARS	_	_	_	_	_	_	_	_
111	-	_	_	_	_	_	_	_	_
112	CoV	_	_	_	_	_	_	_	_
113	including	_	_	_	_	_	_	_	BeginSeg=Yes
114	virus	_	_	_	_	_	_	_	_
115	expansion	_	_	_	_	_	_	_	_
116	,	_	_	_	_	_	_	_	_
117	titration	_	_	_	_	_	_	_	_
118	,	_	_	_	_	_	_	_	_
119	inactivation	_	_	_	_	_	_	_	_
120	,	_	_	_	_	_	_	_	_
121	and	_	_	_	_	_	_	_	_
122	ultracentrifugation	_	_	_	_	_	_	_	_
123	is	_	_	_	_	_	_	_	BeginSeg=Yes
124	applicable	_	_	_	_	_	_	_	_
125	to	_	_	_	_	_	_	_	_
126	any	_	_	_	_	_	_	_	_
127	newly	_	_	_	_	_	_	_	_
128	emerging	_	_	_	_	_	_	_	_
129	virus	_	_	_	_	_	_	_	_
130	we	_	_	_	_	_	_	_	BeginSeg=Yes
131	might	_	_	_	_	_	_	_	_
132	encounter	_	_	_	_	_	_	_	_
133	in	_	_	_	_	_	_	_	_
134	the	_	_	_	_	_	_	_	_
135	future	_	_	_	_	_	_	_	_
136	.	_	_	_	_	_	_	_	_

# newdoc_id = c635d21a8dd780ebae0bfe87fd7ef1d7d717c4ec
1	To	_	_	_	_	_	_	_	BeginSeg=Yes
2	assess	_	_	_	_	_	_	_	_
3	the	_	_	_	_	_	_	_	_
4	economic	_	_	_	_	_	_	_	_
5	impact	_	_	_	_	_	_	_	_
6	of	_	_	_	_	_	_	_	_
7	bovine	_	_	_	_	_	_	_	_
8	coronavirus	_	_	_	_	_	_	_	_
9	(	_	_	_	_	_	_	_	_
10	BCV	_	_	_	_	_	_	_	_
11	)	_	_	_	_	_	_	_	_
12	and	_	_	_	_	_	_	_	_
13	bovine	_	_	_	_	_	_	_	_
14	respiratory	_	_	_	_	_	_	_	_
15	syncytial	_	_	_	_	_	_	_	_
16	virus	_	_	_	_	_	_	_	_
17	(	_	_	_	_	_	_	_	_
18	BRSV	_	_	_	_	_	_	_	_
19	)	_	_	_	_	_	_	_	_
20	infections	_	_	_	_	_	_	_	_
21	,	_	_	_	_	_	_	_	_
22	accurate	_	_	_	_	_	_	_	BeginSeg=Yes
23	estimates	_	_	_	_	_	_	_	_
24	of	_	_	_	_	_	_	_	_
25	their	_	_	_	_	_	_	_	_
26	associated	_	_	_	_	_	_	_	_
27	effects	_	_	_	_	_	_	_	_
28	on	_	_	_	_	_	_	_	_
29	animal	_	_	_	_	_	_	_	_
30	performance	_	_	_	_	_	_	_	_
31	are	_	_	_	_	_	_	_	_
32	needed	_	_	_	_	_	_	_	_
33	.	_	_	_	_	_	_	_	_
34	This	_	_	_	_	_	_	_	BeginSeg=Yes
35	study	_	_	_	_	_	_	_	_
36	aimed	_	_	_	_	_	_	_	_
37	to	_	_	_	_	_	_	_	_
38	quantify	_	_	_	_	_	_	_	_
39	the	_	_	_	_	_	_	_	_
40	variation	_	_	_	_	_	_	_	_
41	in	_	_	_	_	_	_	_	_
42	individual	_	_	_	_	_	_	_	_
43	test	_	_	_	_	_	_	_	_
44	-	_	_	_	_	_	_	_	_
45	day	_	_	_	_	_	_	_	_
46	milk	_	_	_	_	_	_	_	_
47	yield	_	_	_	_	_	_	_	_
48	and	_	_	_	_	_	_	_	_
49	somatic	_	_	_	_	_	_	_	_
50	cell	_	_	_	_	_	_	_	_
51	count	_	_	_	_	_	_	_	_
52	,	_	_	_	_	_	_	_	_
53	risk	_	_	_	_	_	_	_	_
54	of	_	_	_	_	_	_	_	_
55	reproductive	_	_	_	_	_	_	_	_
56	failure	_	_	_	_	_	_	_	_
57	after	_	_	_	_	_	_	_	_
58	first	_	_	_	_	_	_	_	_
59	service	_	_	_	_	_	_	_	_
60	of	_	_	_	_	_	_	_	_
61	dairy	_	_	_	_	_	_	_	_
62	cows	_	_	_	_	_	_	_	_
63	,	_	_	_	_	_	_	_	_
64	and	_	_	_	_	_	_	_	_
65	risk	_	_	_	_	_	_	_	_
66	of	_	_	_	_	_	_	_	_
67	death	_	_	_	_	_	_	_	_
68	of	_	_	_	_	_	_	_	_
69	calves	_	_	_	_	_	_	_	_
70	and	_	_	_	_	_	_	_	_
71	heifers	_	_	_	_	_	_	_	_
72	according	_	_	_	_	_	_	_	_
73	to	_	_	_	_	_	_	_	_
74	the	_	_	_	_	_	_	_	_
75	BCV	_	_	_	_	_	_	_	_
76	and	_	_	_	_	_	_	_	_
77	BRSV	_	_	_	_	_	_	_	_
78	status	_	_	_	_	_	_	_	_
79	of	_	_	_	_	_	_	_	_
80	the	_	_	_	_	_	_	_	_
81	herd	_	_	_	_	_	_	_	_
82	.	_	_	_	_	_	_	_	_
83	Three	_	_	_	_	_	_	_	BeginSeg=Yes
84	types	_	_	_	_	_	_	_	_
85	of	_	_	_	_	_	_	_	_
86	status	_	_	_	_	_	_	_	_
87	were	_	_	_	_	_	_	_	_
88	defined	_	_	_	_	_	_	_	_
89	for	_	_	_	_	_	_	_	_
90	BCV	_	_	_	_	_	_	_	_
91	and	_	_	_	_	_	_	_	_
92	BRSV	_	_	_	_	_	_	_	_
93	infections	_	_	_	_	_	_	_	_
94	,	_	_	_	_	_	_	_	_
95	based	_	_	_	_	_	_	_	BeginSeg=Yes
96	on	_	_	_	_	_	_	_	_
97	1	_	_	_	_	_	_	_	_
98	)	_	_	_	_	_	_	_	_
99	the	_	_	_	_	_	_	_	_
100	dynamics	_	_	_	_	_	_	_	_
101	over	_	_	_	_	_	_	_	_
102	a	_	_	_	_	_	_	_	_
103	7-mo	_	_	_	_	_	_	_	_
104	period	_	_	_	_	_	_	_	_
105	of	_	_	_	_	_	_	_	_
106	BCV	_	_	_	_	_	_	_	_
107	-	_	_	_	_	_	_	_	_
108	and	_	_	_	_	_	_	_	_
109	BRSV	_	_	_	_	_	_	_	_
110	-	_	_	_	_	_	_	_	_
111	specific	_	_	_	_	_	_	_	_
112	antibody	_	_	_	_	_	_	_	_
113	levels	_	_	_	_	_	_	_	_
114	in	_	_	_	_	_	_	_	_
115	pooled	_	_	_	_	_	_	_	_
116	milk	_	_	_	_	_	_	_	_
117	of	_	_	_	_	_	_	_	_
118	primiparous	_	_	_	_	_	_	_	_
119	cows	_	_	_	_	_	_	_	_
120	;	_	_	_	_	_	_	_	_
121	2	_	_	_	_	_	_	_	BeginSeg=Yes
122	)	_	_	_	_	_	_	_	_
123	the	_	_	_	_	_	_	_	_
124	possible	_	_	_	_	_	_	_	_
125	occurrence	_	_	_	_	_	_	_	_
126	of	_	_	_	_	_	_	_	_
127	presumably	_	_	_	_	_	_	_	_
128	BCV	_	_	_	_	_	_	_	_
129	-	_	_	_	_	_	_	_	_
130	and	_	_	_	_	_	_	_	_
131	BRSV	_	_	_	_	_	_	_	_
132	-	_	_	_	_	_	_	_	_
133	related	_	_	_	_	_	_	_	_
134	clinical	_	_	_	_	_	_	_	_
135	outbreaks	_	_	_	_	_	_	_	_
136	;	_	_	_	_	_	_	_	_
137	and	_	_	_	_	_	_	_	BeginSeg=Yes
138	3	_	_	_	_	_	_	_	_
139	)	_	_	_	_	_	_	_	_
140	the	_	_	_	_	_	_	_	_
141	combination	_	_	_	_	_	_	_	_
142	of	_	_	_	_	_	_	_	_
143	both	_	_	_	_	_	_	_	_
144	pieces	_	_	_	_	_	_	_	_
145	of	_	_	_	_	_	_	_	_
146	information	_	_	_	_	_	_	_	_
147	.	_	_	_	_	_	_	_	_
148	A	_	_	_	_	_	_	_	BeginSeg=Yes
149	total	_	_	_	_	_	_	_	_
150	of	_	_	_	_	_	_	_	_
151	36,184	_	_	_	_	_	_	_	_
152	test	_	_	_	_	_	_	_	_
153	days	_	_	_	_	_	_	_	_
154	,	_	_	_	_	_	_	_	_
155	2,716	_	_	_	_	_	_	_	_
156	cows	_	_	_	_	_	_	_	_
157	with	_	_	_	_	_	_	_	_
158	a	_	_	_	_	_	_	_	_
159	first	_	_	_	_	_	_	_	_
160	service	_	_	_	_	_	_	_	_
161	,	_	_	_	_	_	_	_	_
162	and	_	_	_	_	_	_	_	_
163	4,104	_	_	_	_	_	_	_	_
164	calves	_	_	_	_	_	_	_	_
165	and	_	_	_	_	_	_	_	_
166	heifers	_	_	_	_	_	_	_	_
167	in	_	_	_	_	_	_	_	_
168	65	_	_	_	_	_	_	_	_
169	Swedish	_	_	_	_	_	_	_	_
170	herds	_	_	_	_	_	_	_	_
171	were	_	_	_	_	_	_	_	_
172	included	_	_	_	_	_	_	_	_
173	in	_	_	_	_	_	_	_	_
174	the	_	_	_	_	_	_	_	_
175	analyses	_	_	_	_	_	_	_	_
176	.	_	_	_	_	_	_	_	_
177	Animal	_	_	_	_	_	_	_	BeginSeg=Yes
178	performance	_	_	_	_	_	_	_	_
179	associated	_	_	_	_	_	_	_	_
180	with	_	_	_	_	_	_	_	_
181	BCV	_	_	_	_	_	_	_	_
182	and	_	_	_	_	_	_	_	_
183	BRSV	_	_	_	_	_	_	_	_
184	infections	_	_	_	_	_	_	_	_
185	was	_	_	_	_	_	_	_	_
186	quantified	_	_	_	_	_	_	_	_
187	using	_	_	_	_	_	_	_	BeginSeg=Yes
188	hierarchical	_	_	_	_	_	_	_	_
189	mixed	_	_	_	_	_	_	_	_
190	generalized	_	_	_	_	_	_	_	_
191	and	_	_	_	_	_	_	_	_
192	survival	_	_	_	_	_	_	_	_
193	models	_	_	_	_	_	_	_	_
194	,	_	_	_	_	_	_	_	_
195	after	_	_	_	_	_	_	_	_
196	adjustment	_	_	_	_	_	_	_	_
197	for	_	_	_	_	_	_	_	_
198	covariates	_	_	_	_	_	_	_	_
199	known	_	_	_	_	_	_	_	BeginSeg=Yes
200	to	_	_	_	_	_	_	_	_
201	influence	_	_	_	_	_	_	_	_
202	the	_	_	_	_	_	_	_	_
203	performance	_	_	_	_	_	_	_	_
204	under	_	_	_	_	_	_	_	_
205	study	_	_	_	_	_	_	_	_
206	.	_	_	_	_	_	_	_	_
207	A	_	_	_	_	_	_	_	BeginSeg=Yes
208	significant	_	_	_	_	_	_	_	_
209	reduction	_	_	_	_	_	_	_	_
210	in	_	_	_	_	_	_	_	_
211	milk	_	_	_	_	_	_	_	_
212	yield	_	_	_	_	_	_	_	_
213	was	_	_	_	_	_	_	_	_
214	observed	_	_	_	_	_	_	_	_
215	for	_	_	_	_	_	_	_	_
216	cows	_	_	_	_	_	_	_	_
217	in	_	_	_	_	_	_	_	_
218	presumably	_	_	_	_	_	_	_	_
219	BRSV	_	_	_	_	_	_	_	_
220	recently	_	_	_	_	_	_	_	_
221	infected	_	_	_	_	_	_	_	_
222	herds	_	_	_	_	_	_	_	_
223	,	_	_	_	_	_	_	_	_
224	as	_	_	_	_	_	_	_	_
225	well	_	_	_	_	_	_	_	_
226	as	_	_	_	_	_	_	_	_
227	in	_	_	_	_	_	_	_	_
228	herds	_	_	_	_	_	_	_	_
229	having	_	_	_	_	_	_	_	_
230	a	_	_	_	_	_	_	_	_
231	presumably	_	_	_	_	_	_	_	_
232	BRSV	_	_	_	_	_	_	_	_
233	-	_	_	_	_	_	_	_	_
234	related	_	_	_	_	_	_	_	_
235	clinical	_	_	_	_	_	_	_	_
236	outbreak	_	_	_	_	_	_	_	_
237	(	_	_	_	_	_	_	_	BeginSeg=Yes
238	of	_	_	_	_	_	_	_	_
239	0.57	_	_	_	_	_	_	_	_
240	and	_	_	_	_	_	_	_	_
241	0.91	_	_	_	_	_	_	_	_
242	kg	_	_	_	_	_	_	_	_
243	/	_	_	_	_	_	_	_	_
244	d	_	_	_	_	_	_	_	_
245	,	_	_	_	_	_	_	_	_
246	respectively	_	_	_	_	_	_	_	_
247	)	_	_	_	_	_	_	_	_
248	,	_	_	_	_	_	_	_	_
249	compared	_	_	_	_	_	_	_	BeginSeg=Yes
250	with	_	_	_	_	_	_	_	_
251	cows	_	_	_	_	_	_	_	_
252	in	_	_	_	_	_	_	_	_
253	presumably	_	_	_	_	_	_	_	_
254	infection	_	_	_	_	_	_	_	_
255	-	_	_	_	_	_	_	_	_
256	free	_	_	_	_	_	_	_	_
257	herds	_	_	_	_	_	_	_	_
258	.	_	_	_	_	_	_	_	_
259	There	_	_	_	_	_	_	_	BeginSeg=Yes
260	was	_	_	_	_	_	_	_	_
261	also	_	_	_	_	_	_	_	_
262	a	_	_	_	_	_	_	_	_
263	significant	_	_	_	_	_	_	_	_
264	increase	_	_	_	_	_	_	_	_
265	in	_	_	_	_	_	_	_	_
266	somatic	_	_	_	_	_	_	_	_
267	cell	_	_	_	_	_	_	_	_
268	count	_	_	_	_	_	_	_	_
269	(	_	_	_	_	_	_	_	BeginSeg=Yes
270	of	_	_	_	_	_	_	_	_
271	12,000	_	_	_	_	_	_	_	_
272	cells	_	_	_	_	_	_	_	_
273	/	_	_	_	_	_	_	_	_
274	mL	_	_	_	_	_	_	_	_
275	)	_	_	_	_	_	_	_	_
276	for	_	_	_	_	_	_	_	BeginSeg=Yes
277	cows	_	_	_	_	_	_	_	_
278	located	_	_	_	_	_	_	_	_
279	in	_	_	_	_	_	_	_	_
280	herds	_	_	_	_	_	_	_	_
281	with	_	_	_	_	_	_	_	_
282	a	_	_	_	_	_	_	_	_
283	BRSV	_	_	_	_	_	_	_	_
284	outbreak	_	_	_	_	_	_	_	_
285	.	_	_	_	_	_	_	_	_
286	The	_	_	_	_	_	_	_	BeginSeg=Yes
287	risk	_	_	_	_	_	_	_	_
288	of	_	_	_	_	_	_	_	_
289	failure	_	_	_	_	_	_	_	_
290	after	_	_	_	_	_	_	_	_
291	first	_	_	_	_	_	_	_	_
292	service	_	_	_	_	_	_	_	_
293	,	_	_	_	_	_	_	_	_
294	as	_	_	_	_	_	_	_	_
295	well	_	_	_	_	_	_	_	_
296	as	_	_	_	_	_	_	_	_
297	the	_	_	_	_	_	_	_	_
298	risk	_	_	_	_	_	_	_	_
299	of	_	_	_	_	_	_	_	_
300	death	_	_	_	_	_	_	_	_
301	in	_	_	_	_	_	_	_	_
302	calf	_	_	_	_	_	_	_	_
303	and	_	_	_	_	_	_	_	_
304	heifer	_	_	_	_	_	_	_	_
305	,	_	_	_	_	_	_	_	_
306	was	_	_	_	_	_	_	_	_
307	numerically	_	_	_	_	_	_	_	_
308	higher	_	_	_	_	_	_	_	_
309	in	_	_	_	_	_	_	_	_
310	BRSV	_	_	_	_	_	_	_	_
311	-	_	_	_	_	_	_	_	_
312	infected	_	_	_	_	_	_	_	_
313	herds	_	_	_	_	_	_	_	_
314	,	_	_	_	_	_	_	_	_
315	although	_	_	_	_	_	_	_	BeginSeg=Yes
316	this	_	_	_	_	_	_	_	_
317	was	_	_	_	_	_	_	_	_
318	not	_	_	_	_	_	_	_	_
319	statistically	_	_	_	_	_	_	_	_
320	significant	_	_	_	_	_	_	_	_
321	.	_	_	_	_	_	_	_	_
322	In	_	_	_	_	_	_	_	BeginSeg=Yes
323	contrast	_	_	_	_	_	_	_	_
324	,	_	_	_	_	_	_	_	_
325	BCV	_	_	_	_	_	_	_	_
326	infection	_	_	_	_	_	_	_	_
327	herd	_	_	_	_	_	_	_	_
328	status	_	_	_	_	_	_	_	_
329	,	_	_	_	_	_	_	_	_
330	as	_	_	_	_	_	_	_	BeginSeg=Yes
331	defined	_	_	_	_	_	_	_	_
332	in	_	_	_	_	_	_	_	_
333	the	_	_	_	_	_	_	_	_
334	present	_	_	_	_	_	_	_	_
335	study	_	_	_	_	_	_	_	_
336	,	_	_	_	_	_	_	_	_
337	was	_	_	_	_	_	_	_	BeginSeg=Yes
338	not	_	_	_	_	_	_	_	_
339	significantly	_	_	_	_	_	_	_	_
340	associated	_	_	_	_	_	_	_	_
341	with	_	_	_	_	_	_	_	_
342	any	_	_	_	_	_	_	_	_
343	production	_	_	_	_	_	_	_	_
344	losses	_	_	_	_	_	_	_	_
345	in	_	_	_	_	_	_	_	_
346	animals	_	_	_	_	_	_	_	_
347	from	_	_	_	_	_	_	_	_
348	infected	_	_	_	_	_	_	_	_
349	herds	_	_	_	_	_	_	_	_
350	compared	_	_	_	_	_	_	_	BeginSeg=Yes
351	with	_	_	_	_	_	_	_	_
352	those	_	_	_	_	_	_	_	_
353	in	_	_	_	_	_	_	_	_
354	infection	_	_	_	_	_	_	_	_
355	-	_	_	_	_	_	_	_	_
356	free	_	_	_	_	_	_	_	_
357	herds	_	_	_	_	_	_	_	_
358	.	_	_	_	_	_	_	_	_

# newdoc_id = c74427793f554edd3e181603dfdf53f4c89ad129
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	treatment	_	_	_	_	_	_	_	_
3	of	_	_	_	_	_	_	_	_
4	surgical	_	_	_	_	_	_	_	_
5	patients	_	_	_	_	_	_	_	_
6	who	_	_	_	_	_	_	_	BeginSeg=Yes
7	are	_	_	_	_	_	_	_	_
8	confirmed	_	_	_	_	_	_	_	_
9	or	_	_	_	_	_	_	_	_
10	suspected	_	_	_	_	_	_	_	_
11	of	_	_	_	_	_	_	_	_
12	coronavirus	_	_	_	_	_	_	_	_
13	disease	_	_	_	_	_	_	_	_
14	2019	_	_	_	_	_	_	_	_
15	(	_	_	_	_	_	_	_	_
16	COVID-19	_	_	_	_	_	_	_	_
17	)	_	_	_	_	_	_	_	_
18	is	_	_	_	_	_	_	_	BeginSeg=Yes
19	a	_	_	_	_	_	_	_	_
20	challenge	_	_	_	_	_	_	_	_
21	for	_	_	_	_	_	_	_	_
22	all	_	_	_	_	_	_	_	_
23	anesthesiologists	_	_	_	_	_	_	_	_
24	.	_	_	_	_	_	_	_	_
25	The	_	_	_	_	_	_	_	BeginSeg=Yes
26	safety	_	_	_	_	_	_	_	_
27	of	_	_	_	_	_	_	_	_
28	both	_	_	_	_	_	_	_	_
29	patients	_	_	_	_	_	_	_	_
30	and	_	_	_	_	_	_	_	_
31	healthcare	_	_	_	_	_	_	_	_
32	workers	_	_	_	_	_	_	_	_
33	should	_	_	_	_	_	_	_	_
34	be	_	_	_	_	_	_	_	_
35	taken	_	_	_	_	_	_	_	_
36	into	_	_	_	_	_	_	_	_
37	consideration	_	_	_	_	_	_	_	_
38	when	_	_	_	_	_	_	_	BeginSeg=Yes
39	performing	_	_	_	_	_	_	_	_
40	anesthesia	_	_	_	_	_	_	_	_
41	management	_	_	_	_	_	_	_	_
42	for	_	_	_	_	_	_	_	_
43	patients	_	_	_	_	_	_	_	_
44	with	_	_	_	_	_	_	_	_
45	COVID-19	_	_	_	_	_	_	_	_
46	.	_	_	_	_	_	_	_	_
47	General	_	_	_	_	_	_	_	BeginSeg=Yes
48	anesthesia	_	_	_	_	_	_	_	_
49	requiring	_	_	_	_	_	_	_	BeginSeg=Yes
50	airway	_	_	_	_	_	_	_	_
51	intervention	_	_	_	_	_	_	_	_
52	may	_	_	_	_	_	_	_	BeginSeg=Yes
53	exacerbate	_	_	_	_	_	_	_	_
54	COVID-19	_	_	_	_	_	_	_	_
55	pneumonia	_	_	_	_	_	_	_	_
56	,	_	_	_	_	_	_	_	_
57	and	_	_	_	_	_	_	_	BeginSeg=Yes
58	aerosol	_	_	_	_	_	_	_	_
59	generation	_	_	_	_	_	_	_	_
60	during	_	_	_	_	_	_	_	_
61	airway	_	_	_	_	_	_	_	_
62	intervention	_	_	_	_	_	_	_	_
63	risks	_	_	_	_	_	_	_	_
64	COVID-19	_	_	_	_	_	_	_	_
65	transmission	_	_	_	_	_	_	_	_
66	to	_	_	_	_	_	_	_	_
67	medical	_	_	_	_	_	_	_	_
68	staff	_	_	_	_	_	_	_	_
69	.	_	_	_	_	_	_	_	_
70	However	_	_	_	_	_	_	_	BeginSeg=Yes
71	,	_	_	_	_	_	_	_	_
72	regional	_	_	_	_	_	_	_	_
73	anesthesia	_	_	_	_	_	_	_	_
74	is	_	_	_	_	_	_	_	_
75	not	_	_	_	_	_	_	_	_
76	an	_	_	_	_	_	_	_	_
77	aerosol	_	_	_	_	_	_	_	_
78	-	_	_	_	_	_	_	_	_
79	generating	_	_	_	_	_	_	_	_
80	procedure	_	_	_	_	_	_	_	_
81	.	_	_	_	_	_	_	_	_
82	The	_	_	_	_	_	_	_	BeginSeg=Yes
83	neuraxial	_	_	_	_	_	_	_	_
84	anesthesia	_	_	_	_	_	_	_	_
85	may	_	_	_	_	_	_	_	_
86	have	_	_	_	_	_	_	_	_
87	little	_	_	_	_	_	_	_	_
88	adverse	_	_	_	_	_	_	_	_
89	influence	_	_	_	_	_	_	_	_
90	on	_	_	_	_	_	_	_	_
91	clinical	_	_	_	_	_	_	_	_
92	outcomes	_	_	_	_	_	_	_	_
93	in	_	_	_	_	_	_	_	_
94	patients	_	_	_	_	_	_	_	_
95	with	_	_	_	_	_	_	_	_
96	COVID-19	_	_	_	_	_	_	_	_
97	after	_	_	_	_	_	_	_	BeginSeg=Yes
98	reviewing	_	_	_	_	_	_	_	_
99	previous	_	_	_	_	_	_	_	_
100	case	_	_	_	_	_	_	_	_
101	reports	_	_	_	_	_	_	_	_
102	.	_	_	_	_	_	_	_	_
103	Regional	_	_	_	_	_	_	_	BeginSeg=Yes
104	anesthesia	_	_	_	_	_	_	_	_
105	may	_	_	_	_	_	_	_	_
106	have	_	_	_	_	_	_	_	_
107	some	_	_	_	_	_	_	_	_
108	advantages	_	_	_	_	_	_	_	_
109	over	_	_	_	_	_	_	_	_
110	general	_	_	_	_	_	_	_	_
111	anesthesia	_	_	_	_	_	_	_	_
112	for	_	_	_	_	_	_	_	_
113	this	_	_	_	_	_	_	_	_
114	group	_	_	_	_	_	_	_	_
115	of	_	_	_	_	_	_	_	_
116	patients	_	_	_	_	_	_	_	_
117	,	_	_	_	_	_	_	_	_
118	but	_	_	_	_	_	_	_	BeginSeg=Yes
119	unplanned	_	_	_	_	_	_	_	_
120	conversion	_	_	_	_	_	_	_	_
121	to	_	_	_	_	_	_	_	_
122	general	_	_	_	_	_	_	_	_
123	anesthesia	_	_	_	_	_	_	_	_
124	during	_	_	_	_	_	_	_	_
125	surgery	_	_	_	_	_	_	_	_
126	is	_	_	_	_	_	_	_	_
127	not	_	_	_	_	_	_	_	_
128	preferred	_	_	_	_	_	_	_	_
129	.	_	_	_	_	_	_	_	_
130	Thus	_	_	_	_	_	_	_	BeginSeg=Yes
131	,	_	_	_	_	_	_	_	_
132	careful	_	_	_	_	_	_	_	_
133	consideration	_	_	_	_	_	_	_	_
134	should	_	_	_	_	_	_	_	_
135	be	_	_	_	_	_	_	_	_
136	given	_	_	_	_	_	_	_	_
137	to	_	_	_	_	_	_	_	BeginSeg=Yes
138	ensure	_	_	_	_	_	_	_	_
139	that	_	_	_	_	_	_	_	BeginSeg=Yes
140	the	_	_	_	_	_	_	_	_
141	surgery	_	_	_	_	_	_	_	_
142	is	_	_	_	_	_	_	_	_
143	performed	_	_	_	_	_	_	_	_
144	entirely	_	_	_	_	_	_	_	_
145	under	_	_	_	_	_	_	_	_
146	regional	_	_	_	_	_	_	_	_
147	anesthesia	_	_	_	_	_	_	_	_
148	.	_	_	_	_	_	_	_	_
149	The	_	_	_	_	_	_	_	BeginSeg=Yes
150	use	_	_	_	_	_	_	_	_
151	of	_	_	_	_	_	_	_	_
152	ultrasound	_	_	_	_	_	_	_	_
153	guidance	_	_	_	_	_	_	_	_
154	and	_	_	_	_	_	_	_	_
155	the	_	_	_	_	_	_	_	_
156	performance	_	_	_	_	_	_	_	_
157	by	_	_	_	_	_	_	_	_
158	an	_	_	_	_	_	_	_	_
159	experienced	_	_	_	_	_	_	_	_
160	physician	_	_	_	_	_	_	_	_
161	may	_	_	_	_	_	_	_	_
162	reduce	_	_	_	_	_	_	_	_
163	the	_	_	_	_	_	_	_	_
164	incidence	_	_	_	_	_	_	_	_
165	of	_	_	_	_	_	_	_	_
166	failed	_	_	_	_	_	_	_	_
167	block	_	_	_	_	_	_	_	_
168	and	_	_	_	_	_	_	_	_
169	complications	_	_	_	_	_	_	_	_
170	.	_	_	_	_	_	_	_	_
171	The	_	_	_	_	_	_	_	BeginSeg=Yes
172	use	_	_	_	_	_	_	_	_
173	of	_	_	_	_	_	_	_	_
174	long	_	_	_	_	_	_	_	_
175	-	_	_	_	_	_	_	_	_
176	acting	_	_	_	_	_	_	_	_
177	local	_	_	_	_	_	_	_	_
178	anesthetic	_	_	_	_	_	_	_	_
179	prolongs	_	_	_	_	_	_	_	_
180	the	_	_	_	_	_	_	_	_
181	anesthetic	_	_	_	_	_	_	_	_
182	effect	_	_	_	_	_	_	_	_
183	of	_	_	_	_	_	_	_	_
184	regional	_	_	_	_	_	_	_	_
185	anesthesia	_	_	_	_	_	_	_	_
186	.	_	_	_	_	_	_	_	_
187	Besides	_	_	_	_	_	_	_	BeginSeg=Yes
188	,	_	_	_	_	_	_	_	_
189	a	_	_	_	_	_	_	_	_
190	safe	_	_	_	_	_	_	_	_
191	and	_	_	_	_	_	_	_	_
192	sufficient	_	_	_	_	_	_	_	_
193	dose	_	_	_	_	_	_	_	_
194	of	_	_	_	_	_	_	_	_
195	local	_	_	_	_	_	_	_	_
196	anesthetic	_	_	_	_	_	_	_	_
197	should	_	_	_	_	_	_	_	_
198	be	_	_	_	_	_	_	_	_
199	used	_	_	_	_	_	_	_	_
200	.	_	_	_	_	_	_	_	_

# newdoc_id = c90121a3f539b59d4b528f3a1dd172b75533c0cc
1	Bird	_	_	_	_	_	_	_	BeginSeg=Yes
2	to	_	_	_	_	_	_	_	_
3	human	_	_	_	_	_	_	_	_
4	transmission	_	_	_	_	_	_	_	_
5	of	_	_	_	_	_	_	_	_
6	high	_	_	_	_	_	_	_	_
7	pathogenicity	_	_	_	_	_	_	_	_
8	avian	_	_	_	_	_	_	_	_
9	influenza	_	_	_	_	_	_	_	_
10	virus	_	_	_	_	_	_	_	_
11	(	_	_	_	_	_	_	_	_
12	HPAIV	_	_	_	_	_	_	_	_
13	)	_	_	_	_	_	_	_	_
14	poses	_	_	_	_	_	_	_	_
15	a	_	_	_	_	_	_	_	_
16	significant	_	_	_	_	_	_	_	_
17	risk	_	_	_	_	_	_	_	_
18	of	_	_	_	_	_	_	_	BeginSeg=Yes
19	triggering	_	_	_	_	_	_	_	_
20	a	_	_	_	_	_	_	_	_
21	flu	_	_	_	_	_	_	_	_
22	pandemic	_	_	_	_	_	_	_	_
23	in	_	_	_	_	_	_	_	_
24	the	_	_	_	_	_	_	_	_
25	human	_	_	_	_	_	_	_	_
26	population	_	_	_	_	_	_	_	_
27	.	_	_	_	_	_	_	_	_
28	Therefore	_	_	_	_	_	_	_	BeginSeg=Yes
29	,	_	_	_	_	_	_	_	_
30	vaccination	_	_	_	_	_	_	_	_
31	of	_	_	_	_	_	_	_	_
32	susceptible	_	_	_	_	_	_	_	_
33	poultry	_	_	_	_	_	_	_	_
34	during	_	_	_	_	_	_	_	_
35	an	_	_	_	_	_	_	_	_
36	HPAIV	_	_	_	_	_	_	_	_
37	outbreak	_	_	_	_	_	_	_	_
38	might	_	_	_	_	_	_	_	_
39	be	_	_	_	_	_	_	_	_
40	the	_	_	_	_	_	_	_	_
41	best	_	_	_	_	_	_	_	_
42	remedy	_	_	_	_	_	_	_	_
43	to	_	_	_	_	_	_	_	BeginSeg=Yes
44	prevent	_	_	_	_	_	_	_	_
45	such	_	_	_	_	_	_	_	_
46	transmissions	_	_	_	_	_	_	_	_
47	.	_	_	_	_	_	_	_	_
48	To	_	_	_	_	_	_	_	BeginSeg=Yes
49	this	_	_	_	_	_	_	_	_
50	end	_	_	_	_	_	_	_	_
51	,	_	_	_	_	_	_	_	_
52	suitable	_	_	_	_	_	_	_	_
53	formulations	_	_	_	_	_	_	_	_
54	and	_	_	_	_	_	_	_	_
55	an	_	_	_	_	_	_	_	_
56	effective	_	_	_	_	_	_	_	_
57	mass	_	_	_	_	_	_	_	_
58	vaccination	_	_	_	_	_	_	_	_
59	method	_	_	_	_	_	_	_	_
60	that	_	_	_	_	_	_	_	BeginSeg=Yes
61	can	_	_	_	_	_	_	_	_
62	be	_	_	_	_	_	_	_	_
63	translated	_	_	_	_	_	_	_	_
64	to	_	_	_	_	_	_	_	_
65	field	_	_	_	_	_	_	_	_
66	settings	_	_	_	_	_	_	_	_
67	needs	_	_	_	_	_	_	_	BeginSeg=Yes
68	to	_	_	_	_	_	_	_	_
69	be	_	_	_	_	_	_	_	_
70	developed	_	_	_	_	_	_	_	_
71	.	_	_	_	_	_	_	_	_
72	Our	_	_	_	_	_	_	_	BeginSeg=Yes
73	previous	_	_	_	_	_	_	_	_
74	study	_	_	_	_	_	_	_	_
75	in	_	_	_	_	_	_	_	_
76	chickens	_	_	_	_	_	_	_	_
77	has	_	_	_	_	_	_	_	_
78	shown	_	_	_	_	_	_	_	_
79	that	_	_	_	_	_	_	_	BeginSeg=Yes
80	inhalation	_	_	_	_	_	_	_	_
81	of	_	_	_	_	_	_	_	_
82	a	_	_	_	_	_	_	_	_
83	non	_	_	_	_	_	_	_	_
84	-	_	_	_	_	_	_	_	_
85	adjuvanted	_	_	_	_	_	_	_	_
86	dry	_	_	_	_	_	_	_	_
87	powder	_	_	_	_	_	_	_	_
88	influenza	_	_	_	_	_	_	_	_
89	vaccine	_	_	_	_	_	_	_	_
90	formulation	_	_	_	_	_	_	_	_
91	during	_	_	_	_	_	_	_	_
92	normal	_	_	_	_	_	_	_	_
93	breathing	_	_	_	_	_	_	_	_
94	results	_	_	_	_	_	_	_	_
95	in	_	_	_	_	_	_	_	_
96	partial	_	_	_	_	_	_	_	_
97	protection	_	_	_	_	_	_	_	_
98	against	_	_	_	_	_	_	_	_
99	lethal	_	_	_	_	_	_	_	_
100	influenza	_	_	_	_	_	_	_	_
101	challenge	_	_	_	_	_	_	_	_
102	.	_	_	_	_	_	_	_	_
103	The	_	_	_	_	_	_	_	BeginSeg=Yes
104	aim	_	_	_	_	_	_	_	_
105	of	_	_	_	_	_	_	_	_
106	the	_	_	_	_	_	_	_	_
107	present	_	_	_	_	_	_	_	_
108	study	_	_	_	_	_	_	_	_
109	was	_	_	_	_	_	_	_	_
110	to	_	_	_	_	_	_	_	_
111	improve	_	_	_	_	_	_	_	_
112	the	_	_	_	_	_	_	_	_
113	effectiveness	_	_	_	_	_	_	_	_
114	of	_	_	_	_	_	_	_	_
115	pulmonary	_	_	_	_	_	_	_	_
116	vaccination	_	_	_	_	_	_	_	_
117	by	_	_	_	_	_	_	_	BeginSeg=Yes
118	increasing	_	_	_	_	_	_	_	_
119	the	_	_	_	_	_	_	_	_
120	vaccine	_	_	_	_	_	_	_	_
121	dose	_	_	_	_	_	_	_	_
122	deposited	_	_	_	_	_	_	_	BeginSeg=Yes
123	in	_	_	_	_	_	_	_	_
124	the	_	_	_	_	_	_	_	_
125	lungs	_	_	_	_	_	_	_	_
126	and	_	_	_	_	_	_	_	BeginSeg=Yes
127	by	_	_	_	_	_	_	_	_
128	the	_	_	_	_	_	_	_	_
129	use	_	_	_	_	_	_	_	_
130	of	_	_	_	_	_	_	_	_
131	suitable	_	_	_	_	_	_	_	_
132	adjuvants	_	_	_	_	_	_	_	_
133	.	_	_	_	_	_	_	_	_
134	Two	_	_	_	_	_	_	_	BeginSeg=Yes
135	adjuvants	_	_	_	_	_	_	_	_
136	,	_	_	_	_	_	_	_	_
137	namely	_	_	_	_	_	_	_	_
138	,	_	_	_	_	_	_	_	_
139	Bacterium	_	_	_	_	_	_	_	_
140	-	_	_	_	_	_	_	_	_
141	like	_	_	_	_	_	_	_	_
142	Particles	_	_	_	_	_	_	_	_
143	(	_	_	_	_	_	_	_	_
144	BLP	_	_	_	_	_	_	_	_
145	)	_	_	_	_	_	_	_	_
146	and	_	_	_	_	_	_	_	_
147	Advax	_	_	_	_	_	_	_	_
148	,	_	_	_	_	_	_	_	_
149	were	_	_	_	_	_	_	_	_
150	spray	_	_	_	_	_	_	_	_
151	freeze	_	_	_	_	_	_	_	_
152	dried	_	_	_	_	_	_	_	_
153	with	_	_	_	_	_	_	_	_
154	influenza	_	_	_	_	_	_	_	_
155	vaccine	_	_	_	_	_	_	_	_
156	into	_	_	_	_	_	_	_	_
157	dry	_	_	_	_	_	_	_	_
158	powder	_	_	_	_	_	_	_	_
159	formulations	_	_	_	_	_	_	_	_
160	.	_	_	_	_	_	_	_	_
161	Delivery	_	_	_	_	_	_	_	BeginSeg=Yes
162	of	_	_	_	_	_	_	_	_
163	dry	_	_	_	_	_	_	_	_
164	formulations	_	_	_	_	_	_	_	_
165	directly	_	_	_	_	_	_	_	_
166	at	_	_	_	_	_	_	_	_
167	the	_	_	_	_	_	_	_	_
168	syrinx	_	_	_	_	_	_	_	_
169	revealed	_	_	_	_	_	_	_	_
170	that	_	_	_	_	_	_	_	BeginSeg=Yes
171	BLP	_	_	_	_	_	_	_	_
172	and	_	_	_	_	_	_	_	_
173	Advax	_	_	_	_	_	_	_	_
174	had	_	_	_	_	_	_	_	_
175	the	_	_	_	_	_	_	_	_
176	potential	_	_	_	_	_	_	_	_
177	to	_	_	_	_	_	_	_	BeginSeg=Yes
178	boost	_	_	_	_	_	_	_	_
179	either	_	_	_	_	_	_	_	_
180	systemic	_	_	_	_	_	_	_	_
181	or	_	_	_	_	_	_	_	_
182	mucosal	_	_	_	_	_	_	_	_
183	immune	_	_	_	_	_	_	_	_
184	responses	_	_	_	_	_	_	_	_
185	or	_	_	_	_	_	_	_	_
186	both	_	_	_	_	_	_	_	_
187	.	_	_	_	_	_	_	_	_
188	Upon	_	_	_	_	_	_	_	BeginSeg=Yes
189	passive	_	_	_	_	_	_	_	_
190	inhalation	_	_	_	_	_	_	_	_
191	of	_	_	_	_	_	_	_	_
192	dry	_	_	_	_	_	_	_	_
193	influenza	_	_	_	_	_	_	_	_
194	vaccine	_	_	_	_	_	_	_	_
195	formulations	_	_	_	_	_	_	_	_
196	in	_	_	_	_	_	_	_	_
197	an	_	_	_	_	_	_	_	_
198	optimized	_	_	_	_	_	_	_	_
199	set	_	_	_	_	_	_	_	_
200	-	_	_	_	_	_	_	_	_
201	up	_	_	_	_	_	_	_	_
202	,	_	_	_	_	_	_	_	_
203	BLP	_	_	_	_	_	_	_	_
204	and	_	_	_	_	_	_	_	_
205	Advax	_	_	_	_	_	_	_	_
206	/	_	_	_	_	_	_	_	_
207	BLP	_	_	_	_	_	_	_	_
208	adjuvanted	_	_	_	_	_	_	_	_
209	formulations	_	_	_	_	_	_	_	_
210	induced	_	_	_	_	_	_	_	_
211	significantly	_	_	_	_	_	_	_	_
212	higher	_	_	_	_	_	_	_	_
213	systemic	_	_	_	_	_	_	_	_
214	immune	_	_	_	_	_	_	_	_
215	responses	_	_	_	_	_	_	_	_
216	than	_	_	_	_	_	_	_	_
217	the	_	_	_	_	_	_	_	_
218	nonadjuvanted	_	_	_	_	_	_	_	_
219	formulation	_	_	_	_	_	_	_	_
220	.	_	_	_	_	_	_	_	_
221	Remarkably	_	_	_	_	_	_	_	BeginSeg=Yes
222	,	_	_	_	_	_	_	_	_
223	all	_	_	_	_	_	_	_	_
224	vaccinated	_	_	_	_	_	_	_	_
225	animals	_	_	_	_	_	_	_	_
226	not	_	_	_	_	_	_	_	_
227	only	_	_	_	_	_	_	_	_
228	survived	_	_	_	_	_	_	_	_
229	a	_	_	_	_	_	_	_	_
230	lethal	_	_	_	_	_	_	_	_
231	influenza	_	_	_	_	_	_	_	_
232	challenge	_	_	_	_	_	_	_	_
233	,	_	_	_	_	_	_	_	_
234	but	_	_	_	_	_	_	_	BeginSeg=Yes
235	also	_	_	_	_	_	_	_	_
236	did	_	_	_	_	_	_	_	_
237	not	_	_	_	_	_	_	_	_
238	show	_	_	_	_	_	_	_	_
239	any	_	_	_	_	_	_	_	_
240	shedding	_	_	_	_	_	_	_	_
241	of	_	_	_	_	_	_	_	_
242	challenge	_	_	_	_	_	_	_	_
243	virus	_	_	_	_	_	_	_	_
244	except	_	_	_	_	_	_	_	_
245	for	_	_	_	_	_	_	_	_
246	two	_	_	_	_	_	_	_	_
247	out	_	_	_	_	_	_	_	_
248	of	_	_	_	_	_	_	_	_
249	six	_	_	_	_	_	_	_	_
250	animals	_	_	_	_	_	_	_	_
251	in	_	_	_	_	_	_	_	_
252	the	_	_	_	_	_	_	_	_
253	Advax	_	_	_	_	_	_	_	_
254	group	_	_	_	_	_	_	_	_
255	.	_	_	_	_	_	_	_	_
256	Overall	_	_	_	_	_	_	_	BeginSeg=Yes
257	,	_	_	_	_	_	_	_	_
258	our	_	_	_	_	_	_	_	_
259	results	_	_	_	_	_	_	_	_
260	indicate	_	_	_	_	_	_	_	_
261	that	_	_	_	_	_	_	_	BeginSeg=Yes
262	passive	_	_	_	_	_	_	_	_
263	inhalation	_	_	_	_	_	_	_	_
264	is	_	_	_	_	_	_	_	_
265	feasible	_	_	_	_	_	_	_	_
266	,	_	_	_	_	_	_	_	_
267	effective	_	_	_	_	_	_	_	_
268	and	_	_	_	_	_	_	_	_
269	suitable	_	_	_	_	_	_	_	_
270	for	_	_	_	_	_	_	_	_
271	mass	_	_	_	_	_	_	_	_
272	vaccination	_	_	_	_	_	_	_	_
273	of	_	_	_	_	_	_	_	_
274	chickens	_	_	_	_	_	_	_	_
275	if	_	_	_	_	_	_	_	BeginSeg=Yes
276	it	_	_	_	_	_	_	_	_
277	can	_	_	_	_	_	_	_	_
278	be	_	_	_	_	_	_	_	_
279	adapted	_	_	_	_	_	_	_	_
280	to	_	_	_	_	_	_	_	_
281	field	_	_	_	_	_	_	_	_
282	settings	_	_	_	_	_	_	_	_
283	.	_	_	_	_	_	_	_	_

# newdoc_id = ca2a4dbdc3d133ac018b4427e143e1a5ca45d1eb
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	pandemic	_	_	_	_	_	_	_	_
3	spread	_	_	_	_	_	_	_	_
4	of	_	_	_	_	_	_	_	_
5	the	_	_	_	_	_	_	_	_
6	COVID-19	_	_	_	_	_	_	_	_
7	virus	_	_	_	_	_	_	_	_
8	has	_	_	_	_	_	_	_	_
9	,	_	_	_	_	_	_	_	_
10	as	_	_	_	_	_	_	_	_
11	of	_	_	_	_	_	_	_	_
12	20	_	_	_	_	_	_	_	_
13	th	_	_	_	_	_	_	_	_
14	of	_	_	_	_	_	_	_	_
15	April	_	_	_	_	_	_	_	_
16	2020	_	_	_	_	_	_	_	_
17	,	_	_	_	_	_	_	_	_
18	reached	_	_	_	_	_	_	_	_
19	most	_	_	_	_	_	_	_	_
20	countries	_	_	_	_	_	_	_	_
21	of	_	_	_	_	_	_	_	_
22	the	_	_	_	_	_	_	_	_
23	world	_	_	_	_	_	_	_	_
24	.	_	_	_	_	_	_	_	_
25	In	_	_	_	_	_	_	_	BeginSeg=Yes
26	an	_	_	_	_	_	_	_	_
27	effort	_	_	_	_	_	_	_	_
28	to	_	_	_	_	_	_	_	BeginSeg=Yes
29	design	_	_	_	_	_	_	_	_
30	informed	_	_	_	_	_	_	_	_
31	public	_	_	_	_	_	_	_	_
32	health	_	_	_	_	_	_	_	_
33	policies	_	_	_	_	_	_	_	_
34	,	_	_	_	_	_	_	_	_
35	many	_	_	_	_	_	_	_	BeginSeg=Yes
36	modelling	_	_	_	_	_	_	_	_
37	studies	_	_	_	_	_	_	_	_
38	have	_	_	_	_	_	_	_	_
39	been	_	_	_	_	_	_	_	_
40	performed	_	_	_	_	_	_	_	_
41	to	_	_	_	_	_	_	_	BeginSeg=Yes
42	predict	_	_	_	_	_	_	_	_
43	crucial	_	_	_	_	_	_	_	_
44	outcomes	_	_	_	_	_	_	_	_
45	of	_	_	_	_	_	_	_	_
46	interest	_	_	_	_	_	_	_	_
47	,	_	_	_	_	_	_	_	_
48	including	_	_	_	_	_	_	_	BeginSeg=Yes
49	ICU	_	_	_	_	_	_	_	_
50	solicitation	_	_	_	_	_	_	_	_
51	,	_	_	_	_	_	_	_	_
52	cumulated	_	_	_	_	_	_	_	_
53	death	_	_	_	_	_	_	_	_
54	counts	_	_	_	_	_	_	_	_
55	,	_	_	_	_	_	_	_	_
56	etc	_	_	_	_	_	_	_	_
57	…	_	_	_	_	_	_	_	_
58	The	_	_	_	_	_	_	_	BeginSeg=Yes
59	corresponding	_	_	_	_	_	_	_	_
60	data	_	_	_	_	_	_	_	_
61	analyses	_	_	_	_	_	_	_	_
62	however	_	_	_	_	_	_	_	_
63	,	_	_	_	_	_	_	_	_
64	mostly	_	_	_	_	_	_	_	_
65	rely	_	_	_	_	_	_	_	_
66	on	_	_	_	_	_	_	_	_
67	restricted	_	_	_	_	_	_	_	_
68	(	_	_	_	_	_	_	_	_
69	openly	_	_	_	_	_	_	_	_
70	available	_	_	_	_	_	_	_	_
71	)	_	_	_	_	_	_	_	_
72	data	_	_	_	_	_	_	_	_
73	sources	_	_	_	_	_	_	_	_
74	,	_	_	_	_	_	_	_	_
75	which	_	_	_	_	_	_	_	BeginSeg=Yes
76	typically	_	_	_	_	_	_	_	_
77	include	_	_	_	_	_	_	_	_
78	daily	_	_	_	_	_	_	_	_
79	death	_	_	_	_	_	_	_	_
80	rates	_	_	_	_	_	_	_	_
81	and	_	_	_	_	_	_	_	_
82	confirmed	_	_	_	_	_	_	_	_
83	COVID	_	_	_	_	_	_	_	_
84	cases	_	_	_	_	_	_	_	_
85	time	_	_	_	_	_	_	_	_
86	series	_	_	_	_	_	_	_	_
87	.	_	_	_	_	_	_	_	_
88	In	_	_	_	_	_	_	_	BeginSeg=Yes
89	addition	_	_	_	_	_	_	_	_
90	,	_	_	_	_	_	_	_	_
91	many	_	_	_	_	_	_	_	_
92	of	_	_	_	_	_	_	_	_
93	these	_	_	_	_	_	_	_	_
94	predictions	_	_	_	_	_	_	_	_
95	are	_	_	_	_	_	_	_	_
96	derived	_	_	_	_	_	_	_	_
97	before	_	_	_	_	_	_	_	BeginSeg=Yes
98	the	_	_	_	_	_	_	_	_
99	peak	_	_	_	_	_	_	_	_
100	of	_	_	_	_	_	_	_	_
101	the	_	_	_	_	_	_	_	_
102	outbreak	_	_	_	_	_	_	_	_
103	has	_	_	_	_	_	_	_	_
104	been	_	_	_	_	_	_	_	_
105	observed	_	_	_	_	_	_	_	_
106	yet	_	_	_	_	_	_	_	_
107	(	_	_	_	_	_	_	_	BeginSeg=Yes
108	as	_	_	_	_	_	_	_	_
109	is	_	_	_	_	_	_	_	_
110	still	_	_	_	_	_	_	_	_
111	currently	_	_	_	_	_	_	_	_
112	the	_	_	_	_	_	_	_	_
113	case	_	_	_	_	_	_	_	_
114	for	_	_	_	_	_	_	_	_
115	many	_	_	_	_	_	_	_	_
116	countries	_	_	_	_	_	_	_	_
117	)	_	_	_	_	_	_	_	_
118	.	_	_	_	_	_	_	_	_
119	In	_	_	_	_	_	_	_	BeginSeg=Yes
120	this	_	_	_	_	_	_	_	_
121	work	_	_	_	_	_	_	_	_
122	,	_	_	_	_	_	_	_	_
123	we	_	_	_	_	_	_	_	_
124	show	_	_	_	_	_	_	_	_
125	that	_	_	_	_	_	_	_	BeginSeg=Yes
126	peak	_	_	_	_	_	_	_	_
127	phase	_	_	_	_	_	_	_	_
128	and	_	_	_	_	_	_	_	_
129	data	_	_	_	_	_	_	_	_
130	paucity	_	_	_	_	_	_	_	_
131	have	_	_	_	_	_	_	_	_
132	a	_	_	_	_	_	_	_	_
133	substantial	_	_	_	_	_	_	_	_
134	impact	_	_	_	_	_	_	_	_
135	on	_	_	_	_	_	_	_	_
136	the	_	_	_	_	_	_	_	_
137	reliability	_	_	_	_	_	_	_	_
138	of	_	_	_	_	_	_	_	_
139	model	_	_	_	_	_	_	_	_
140	predictions	_	_	_	_	_	_	_	_
141	.	_	_	_	_	_	_	_	_
142	Although	_	_	_	_	_	_	_	BeginSeg=Yes
143	we	_	_	_	_	_	_	_	_
144	focus	_	_	_	_	_	_	_	_
145	on	_	_	_	_	_	_	_	_
146	a	_	_	_	_	_	_	_	_
147	recent	_	_	_	_	_	_	_	_
148	model	_	_	_	_	_	_	_	_
149	of	_	_	_	_	_	_	_	_
150	the	_	_	_	_	_	_	_	_
151	COVID	_	_	_	_	_	_	_	_
152	pandemics	_	_	_	_	_	_	_	_
153	,	_	_	_	_	_	_	_	_
154	our	_	_	_	_	_	_	_	BeginSeg=Yes
155	conclusions	_	_	_	_	_	_	_	_
156	most	_	_	_	_	_	_	_	_
157	likely	_	_	_	_	_	_	_	_
158	apply	_	_	_	_	_	_	_	_
159	to	_	_	_	_	_	_	_	_
160	most	_	_	_	_	_	_	_	_
161	existing	_	_	_	_	_	_	_	_
162	models	_	_	_	_	_	_	_	_
163	,	_	_	_	_	_	_	_	_
164	which	_	_	_	_	_	_	_	BeginSeg=Yes
165	are	_	_	_	_	_	_	_	_
166	variants	_	_	_	_	_	_	_	_
167	of	_	_	_	_	_	_	_	_
168	the	_	_	_	_	_	_	_	_
169	socalled	_	_	_	_	_	_	_	_
170	"	_	_	_	_	_	_	_	_
171	Susceptible	_	_	_	_	_	_	_	_
172	-	_	_	_	_	_	_	_	_
173	Infected	_	_	_	_	_	_	_	_
174	-	_	_	_	_	_	_	_	_
175	Removed	_	_	_	_	_	_	_	_
176	"	_	_	_	_	_	_	_	_
177	or	_	_	_	_	_	_	_	_
178	SIR	_	_	_	_	_	_	_	_
179	framework	_	_	_	_	_	_	_	_
180	.	_	_	_	_	_	_	_	_
181	Our	_	_	_	_	_	_	_	BeginSeg=Yes
182	results	_	_	_	_	_	_	_	_
183	highlight	_	_	_	_	_	_	_	_
184	the	_	_	_	_	_	_	_	_
185	need	_	_	_	_	_	_	_	_
186	for	_	_	_	_	_	_	_	BeginSeg=Yes
187	performing	_	_	_	_	_	_	_	_
188	systematic	_	_	_	_	_	_	_	_
189	reliability	_	_	_	_	_	_	_	_
190	evaluations	_	_	_	_	_	_	_	_
191	for	_	_	_	_	_	_	_	_
192	all	_	_	_	_	_	_	_	_
193	models	_	_	_	_	_	_	_	_
194	that	_	_	_	_	_	_	_	BeginSeg=Yes
195	currently	_	_	_	_	_	_	_	_
196	inform	_	_	_	_	_	_	_	_
197	public	_	_	_	_	_	_	_	_
198	health	_	_	_	_	_	_	_	_
199	policies	_	_	_	_	_	_	_	_
200	.	_	_	_	_	_	_	_	_
201	They	_	_	_	_	_	_	_	BeginSeg=Yes
202	also	_	_	_	_	_	_	_	_
203	motivate	_	_	_	_	_	_	_	_
204	a	_	_	_	_	_	_	_	_
205	plea	_	_	_	_	_	_	_	_
206	for	_	_	_	_	_	_	_	BeginSeg=Yes
207	gathering	_	_	_	_	_	_	_	_
208	and	_	_	_	_	_	_	_	_
209	opening	_	_	_	_	_	_	_	_
210	richer	_	_	_	_	_	_	_	_
211	and	_	_	_	_	_	_	_	_
212	more	_	_	_	_	_	_	_	_
213	reliable	_	_	_	_	_	_	_	_
214	data	_	_	_	_	_	_	_	_
215	time	_	_	_	_	_	_	_	_
216	series	_	_	_	_	_	_	_	_
217	(	_	_	_	_	_	_	_	BeginSeg=Yes
218	e.g.	_	_	_	_	_	_	_	_
219	,	_	_	_	_	_	_	_	_
220	ICU	_	_	_	_	_	_	_	_
221	occupancy	_	_	_	_	_	_	_	_
222	,	_	_	_	_	_	_	_	_
223	negative	_	_	_	_	_	_	_	_
224	test	_	_	_	_	_	_	_	_
225	rates	_	_	_	_	_	_	_	_
226	,	_	_	_	_	_	_	_	_
227	social	_	_	_	_	_	_	_	_
228	distancing	_	_	_	_	_	_	_	_
229	commitment	_	_	_	_	_	_	_	_
230	reports	_	_	_	_	_	_	_	_
231	,	_	_	_	_	_	_	_	_
232	etc	_	_	_	_	_	_	_	_
233	)	_	_	_	_	_	_	_	_
234	.	_	_	_	_	_	_	_	_

# newdoc_id = cb6074cfc9898c507ee6f98f9888fb652b409069
1	On	_	_	_	_	_	_	_	BeginSeg=Yes
2	30	_	_	_	_	_	_	_	_
3	January	_	_	_	_	_	_	_	_
4	2020	_	_	_	_	_	_	_	_
5	,	_	_	_	_	_	_	_	_
6	the	_	_	_	_	_	_	_	_
7	WHO	_	_	_	_	_	_	_	_
8	declared	_	_	_	_	_	_	_	_
9	the	_	_	_	_	_	_	_	_
10	coronavirus	_	_	_	_	_	_	_	_
11	disease	_	_	_	_	_	_	_	_
12	2019	_	_	_	_	_	_	_	_
13	(	_	_	_	_	_	_	_	_
14	COVID-19	_	_	_	_	_	_	_	_
15	)	_	_	_	_	_	_	_	_
16	a	_	_	_	_	_	_	_	_
17	public	_	_	_	_	_	_	_	_
18	health	_	_	_	_	_	_	_	_
19	emergency	_	_	_	_	_	_	_	_
20	of	_	_	_	_	_	_	_	_
21	international	_	_	_	_	_	_	_	_
22	concern	_	_	_	_	_	_	_	_
23	.	_	_	_	_	_	_	_	_
24	By	_	_	_	_	_	_	_	BeginSeg=Yes
25	11	_	_	_	_	_	_	_	_
26	March	_	_	_	_	_	_	_	_
27	2020	_	_	_	_	_	_	_	_
28	,	_	_	_	_	_	_	_	_
29	it	_	_	_	_	_	_	_	_
30	was	_	_	_	_	_	_	_	_
31	designated	_	_	_	_	_	_	_	_
32	a	_	_	_	_	_	_	_	_
33	pandemic	_	_	_	_	_	_	_	_
34	owing	_	_	_	_	_	_	_	BeginSeg=Yes
35	to	_	_	_	_	_	_	_	_
36	its	_	_	_	_	_	_	_	_
37	rapid	_	_	_	_	_	_	_	_
38	worldwide	_	_	_	_	_	_	_	_
39	spread	_	_	_	_	_	_	_	_
40	.	_	_	_	_	_	_	_	_
41	In	_	_	_	_	_	_	_	BeginSeg=Yes
42	this	_	_	_	_	_	_	_	_
43	short	_	_	_	_	_	_	_	_
44	article	_	_	_	_	_	_	_	_
45	we	_	_	_	_	_	_	_	_
46	provide	_	_	_	_	_	_	_	_
47	some	_	_	_	_	_	_	_	_
48	information	_	_	_	_	_	_	_	_
49	that	_	_	_	_	_	_	_	BeginSeg=Yes
50	might	_	_	_	_	_	_	_	_
51	be	_	_	_	_	_	_	_	_
52	useful	_	_	_	_	_	_	_	_
53	and	_	_	_	_	_	_	_	BeginSeg=Yes
54	help	_	_	_	_	_	_	_	_
55	equip	_	_	_	_	_	_	_	_
56	colleagues	_	_	_	_	_	_	_	_
57	to	_	_	_	_	_	_	_	BeginSeg=Yes
58	reduce	_	_	_	_	_	_	_	_
59	medical	_	_	_	_	_	_	_	_
60	error	_	_	_	_	_	_	_	_
61	during	_	_	_	_	_	_	_	_
62	a	_	_	_	_	_	_	_	_
63	pandemic	_	_	_	_	_	_	_	_
64	.	_	_	_	_	_	_	_	_
65	We	_	_	_	_	_	_	_	BeginSeg=Yes
66	advocate	_	_	_	_	_	_	_	_
67	a	_	_	_	_	_	_	_	_
68	systems	_	_	_	_	_	_	_	_
69	-	_	_	_	_	_	_	_	_
70	based	_	_	_	_	_	_	_	_
71	approach	_	_	_	_	_	_	_	_
72	,	_	_	_	_	_	_	_	_
73	rather	_	_	_	_	_	_	_	_
74	than	_	_	_	_	_	_	_	_
75	an	_	_	_	_	_	_	_	_
76-77	individual's	_	_	_	_	_	_	_	_
76	individual	_	_	_	_	_	_	_	_
77	's	_	_	_	_	_	_	_	_
78	sole	_	_	_	_	_	_	_	_
79	responsibility	_	_	_	_	_	_	_	_
80	,	_	_	_	_	_	_	_	_
81	and	_	_	_	_	_	_	_	BeginSeg=Yes
82	,	_	_	_	_	_	_	_	_
83	look	_	_	_	_	_	_	_	_
84	at	_	_	_	_	_	_	_	_
85	ways	_	_	_	_	_	_	_	_
86	to	_	_	_	_	_	_	_	BeginSeg=Yes
87	provide	_	_	_	_	_	_	_	_
88	safer	_	_	_	_	_	_	_	_
89	healthcare	_	_	_	_	_	_	_	_
90	.	_	_	_	_	_	_	_	_

# newdoc_id = ceda3aacfcc249a8bdff8eb316c13638860e560b
1	I	_	_	_	_	_	_	_	BeginSeg=Yes
2	use	_	_	_	_	_	_	_	_
3	the	_	_	_	_	_	_	_	_
4	COVID-19	_	_	_	_	_	_	_	_
5	death	_	_	_	_	_	_	_	_
6	rate	_	_	_	_	_	_	_	_
7	in	_	_	_	_	_	_	_	_
8	South	_	_	_	_	_	_	_	_
9	Korea	_	_	_	_	_	_	_	_
10	and	_	_	_	_	_	_	_	_
11	a	_	_	_	_	_	_	_	_
12	method	_	_	_	_	_	_	_	_
13	relating	_	_	_	_	_	_	_	BeginSeg=Yes
14	the	_	_	_	_	_	_	_	_
15	ratio	_	_	_	_	_	_	_	_
16	of	_	_	_	_	_	_	_	_
17	death	_	_	_	_	_	_	_	_
18	rates	_	_	_	_	_	_	_	_
19	in	_	_	_	_	_	_	_	_
20	a	_	_	_	_	_	_	_	_
21	U.S.	_	_	_	_	_	_	_	_
22	state	_	_	_	_	_	_	_	_
23	to	_	_	_	_	_	_	_	_
24	its	_	_	_	_	_	_	_	_
25	share	_	_	_	_	_	_	_	_
26	of	_	_	_	_	_	_	_	_
27	cumulative	_	_	_	_	_	_	_	_
28	positive	_	_	_	_	_	_	_	_
29	tests	_	_	_	_	_	_	_	_
30	to	_	_	_	_	_	_	_	BeginSeg=Yes
31	estimate	_	_	_	_	_	_	_	_
32	the	_	_	_	_	_	_	_	_
33	total	_	_	_	_	_	_	_	_
34	cases	_	_	_	_	_	_	_	_
35	of	_	_	_	_	_	_	_	_
36	COVID-19	_	_	_	_	_	_	_	_
37	in	_	_	_	_	_	_	_	_
38	the	_	_	_	_	_	_	_	_
39	U.S.	_	_	_	_	_	_	_	_
40	and	_	_	_	_	_	_	_	BeginSeg=Yes
41	to	_	_	_	_	_	_	_	_
42	estimate	_	_	_	_	_	_	_	_
43	the	_	_	_	_	_	_	_	_
44	extent	_	_	_	_	_	_	_	_
45	of	_	_	_	_	_	_	_	_
46	infection	_	_	_	_	_	_	_	_
47	and	_	_	_	_	_	_	_	_
48	the	_	_	_	_	_	_	_	_
49	unidentified	_	_	_	_	_	_	_	_
50	share	_	_	_	_	_	_	_	_
51	of	_	_	_	_	_	_	_	_
52	the	_	_	_	_	_	_	_	_
53	infected	_	_	_	_	_	_	_	_
54	population	_	_	_	_	_	_	_	_
55	in	_	_	_	_	_	_	_	_
56	each	_	_	_	_	_	_	_	_
57	of	_	_	_	_	_	_	_	_
58	the	_	_	_	_	_	_	_	_
59	lower-48	_	_	_	_	_	_	_	_
60	states	_	_	_	_	_	_	_	_
61	and	_	_	_	_	_	_	_	_
62	in	_	_	_	_	_	_	_	_
63	New	_	_	_	_	_	_	_	_
64	York	_	_	_	_	_	_	_	_
65	City	_	_	_	_	_	_	_	_
66	in	_	_	_	_	_	_	_	_
67	mid	_	_	_	_	_	_	_	_
68	-	_	_	_	_	_	_	_	_
69	April	_	_	_	_	_	_	_	_
70	,	_	_	_	_	_	_	_	_
71	2020	_	_	_	_	_	_	_	_
72	.	_	_	_	_	_	_	_	_
73	I	_	_	_	_	_	_	_	BeginSeg=Yes
74	identify	_	_	_	_	_	_	_	_
75	a	_	_	_	_	_	_	_	_
76	logarithmic	_	_	_	_	_	_	_	_
77	relationship	_	_	_	_	_	_	_	_
78	between	_	_	_	_	_	_	_	_
79	the	_	_	_	_	_	_	_	_
80	cumulative	_	_	_	_	_	_	_	_
81	death	_	_	_	_	_	_	_	_
82	rate	_	_	_	_	_	_	_	_
83	in	_	_	_	_	_	_	_	_
84	a	_	_	_	_	_	_	_	_
85	state	_	_	_	_	_	_	_	_
86	and	_	_	_	_	_	_	_	_
87	its	_	_	_	_	_	_	_	_
88	cumulative	_	_	_	_	_	_	_	_
89	positive	_	_	_	_	_	_	_	_
90	share	_	_	_	_	_	_	_	_
91	of	_	_	_	_	_	_	_	_
92	tests	_	_	_	_	_	_	_	_
93	.	_	_	_	_	_	_	_	_
94	Using	_	_	_	_	_	_	_	BeginSeg=Yes
95	this	_	_	_	_	_	_	_	_
96	relationship	_	_	_	_	_	_	_	_
97	,	_	_	_	_	_	_	_	_
98	I	_	_	_	_	_	_	_	BeginSeg=Yes
99	find	_	_	_	_	_	_	_	_
100	that	_	_	_	_	_	_	_	BeginSeg=Yes
101	4.3	_	_	_	_	_	_	_	_
102	-	_	_	_	_	_	_	_	_
103	5.4	_	_	_	_	_	_	_	_
104	million	_	_	_	_	_	_	_	_
105	people	_	_	_	_	_	_	_	_
106	,	_	_	_	_	_	_	_	_
107	1.4	_	_	_	_	_	_	_	_
108	-	_	_	_	_	_	_	_	_
109	1.7	_	_	_	_	_	_	_	_
110	%	_	_	_	_	_	_	_	_
111	of	_	_	_	_	_	_	_	_
112	the	_	_	_	_	_	_	_	_
113	U.S.	_	_	_	_	_	_	_	_
114	population	_	_	_	_	_	_	_	_
115	,	_	_	_	_	_	_	_	_
116	were	_	_	_	_	_	_	_	_
117	infected	_	_	_	_	_	_	_	_
118	,	_	_	_	_	_	_	_	_
119	with	_	_	_	_	_	_	_	_
120	rates	_	_	_	_	_	_	_	_
121	of	_	_	_	_	_	_	_	_
122	infection	_	_	_	_	_	_	_	_
123	that	_	_	_	_	_	_	_	BeginSeg=Yes
124	ranged	_	_	_	_	_	_	_	_
125	from	_	_	_	_	_	_	_	_
126	0.1	_	_	_	_	_	_	_	_
127	%	_	_	_	_	_	_	_	_
128	in	_	_	_	_	_	_	_	_
129	more	_	_	_	_	_	_	_	_
130	rural	_	_	_	_	_	_	_	_
131	states	_	_	_	_	_	_	_	_
132	to	_	_	_	_	_	_	_	_
133	8	_	_	_	_	_	_	_	_
134	-	_	_	_	_	_	_	_	_
135	10	_	_	_	_	_	_	_	_
136	%	_	_	_	_	_	_	_	_
137	in	_	_	_	_	_	_	_	_
138	New	_	_	_	_	_	_	_	_
139	York	_	_	_	_	_	_	_	_
140	state	_	_	_	_	_	_	_	_
141	and	_	_	_	_	_	_	_	_
142	11	_	_	_	_	_	_	_	_
143	-	_	_	_	_	_	_	_	_
144	13	_	_	_	_	_	_	_	_
145	%	_	_	_	_	_	_	_	_
146	in	_	_	_	_	_	_	_	_
147	New	_	_	_	_	_	_	_	_
148	York	_	_	_	_	_	_	_	_
149	City	_	_	_	_	_	_	_	_
150	.	_	_	_	_	_	_	_	_
151	Only	_	_	_	_	_	_	_	BeginSeg=Yes
152	16	_	_	_	_	_	_	_	_
153	-	_	_	_	_	_	_	_	_
154	20	_	_	_	_	_	_	_	_
155	%	_	_	_	_	_	_	_	_
156	of	_	_	_	_	_	_	_	_
157	these	_	_	_	_	_	_	_	_
158	infected	_	_	_	_	_	_	_	_
159	individuals	_	_	_	_	_	_	_	_
160	were	_	_	_	_	_	_	_	_
161	identified	_	_	_	_	_	_	_	_
162	later	_	_	_	_	_	_	_	_
163	through	_	_	_	_	_	_	_	_
164	testing	_	_	_	_	_	_	_	_
165	.	_	_	_	_	_	_	_	_

# newdoc_id = d125abb6f1e1cb460e9dd29bf71df2895151761d
1	Background	_	_	_	_	_	_	_	BeginSeg=Yes
2	:	_	_	_	_	_	_	_	_
3	Intimate	_	_	_	_	_	_	_	BeginSeg=Yes
4	partner	_	_	_	_	_	_	_	_
5	violence	_	_	_	_	_	_	_	_
6	(	_	_	_	_	_	_	_	_
7	IPV	_	_	_	_	_	_	_	_
8	)	_	_	_	_	_	_	_	_
9	is	_	_	_	_	_	_	_	_
10	defined	_	_	_	_	_	_	_	_
11	as	_	_	_	_	_	_	_	_
12	physical	_	_	_	_	_	_	_	_
13	or	_	_	_	_	_	_	_	_
14	sexual	_	_	_	_	_	_	_	_
15	violence	_	_	_	_	_	_	_	_
16	,	_	_	_	_	_	_	_	_
17	emotional	_	_	_	_	_	_	_	_
18	abuse	_	_	_	_	_	_	_	_
19	and	_	_	_	_	_	_	_	_
20	stalking	_	_	_	_	_	_	_	_
21	.	_	_	_	_	_	_	_	_
22	It	_	_	_	_	_	_	_	BeginSeg=Yes
23	is	_	_	_	_	_	_	_	_
24	typically	_	_	_	_	_	_	_	_
25	experienced	_	_	_	_	_	_	_	_
26	by	_	_	_	_	_	_	_	_
27	women	_	_	_	_	_	_	_	_
28	but	_	_	_	_	_	_	_	BeginSeg=Yes
29	can	_	_	_	_	_	_	_	_
30	also	_	_	_	_	_	_	_	_
31	be	_	_	_	_	_	_	_	_
32	experienced	_	_	_	_	_	_	_	_
33	by	_	_	_	_	_	_	_	_
34	men	_	_	_	_	_	_	_	_
35	.	_	_	_	_	_	_	_	_
36	During	_	_	_	_	_	_	_	BeginSeg=Yes
37	quarantine	_	_	_	_	_	_	_	_
38	due	_	_	_	_	_	_	_	_
39	to	_	_	_	_	_	_	_	_
40	the	_	_	_	_	_	_	_	_
41	COVID-19	_	_	_	_	_	_	_	_
42	,	_	_	_	_	_	_	_	_
43	home	_	_	_	_	_	_	_	_
44	risks	_	_	_	_	_	_	_	_
45	to	_	_	_	_	_	_	_	_
46	become	_	_	_	_	_	_	_	_
47	a	_	_	_	_	_	_	_	_
48	very	_	_	_	_	_	_	_	_
49	dangerous	_	_	_	_	_	_	_	_
50	place	_	_	_	_	_	_	_	_
51	for	_	_	_	_	_	_	_	_
52	victims	_	_	_	_	_	_	_	_
53	of	_	_	_	_	_	_	_	_
54	domestic	_	_	_	_	_	_	_	_
55	violence	_	_	_	_	_	_	_	_
56	.	_	_	_	_	_	_	_	_
57	Method	_	_	_	_	_	_	_	BeginSeg=Yes
58	:	_	_	_	_	_	_	_	_
59	Very	_	_	_	_	_	_	_	BeginSeg=Yes
60	recent	_	_	_	_	_	_	_	_
61	studies	_	_	_	_	_	_	_	_
62	focusing	_	_	_	_	_	_	_	BeginSeg=Yes
63	on	_	_	_	_	_	_	_	_
64	abusive	_	_	_	_	_	_	_	_
65	situations	_	_	_	_	_	_	_	_
66	during	_	_	_	_	_	_	_	_
67	COVID	_	_	_	_	_	_	_	_
68	emergence	_	_	_	_	_	_	_	_
69	were	_	_	_	_	_	_	_	BeginSeg=Yes
70	identified	_	_	_	_	_	_	_	_
71	in	_	_	_	_	_	_	_	_
72	PubMed	_	_	_	_	_	_	_	_
73	/	_	_	_	_	_	_	_	_
74	Medline	_	_	_	_	_	_	_	_
75	,	_	_	_	_	_	_	_	_
76	Scopus	_	_	_	_	_	_	_	_
77	,	_	_	_	_	_	_	_	_
78	Embase	_	_	_	_	_	_	_	_
79	.	_	_	_	_	_	_	_	_
80	Conclusions	_	_	_	_	_	_	_	BeginSeg=Yes
81	:	_	_	_	_	_	_	_	_
82	Especially	_	_	_	_	_	_	_	BeginSeg=Yes
83	during	_	_	_	_	_	_	_	_
84	quarantine	_	_	_	_	_	_	_	_
85	and	_	_	_	_	_	_	_	_
86	COVID	_	_	_	_	_	_	_	_
87	emergence	_	_	_	_	_	_	_	_
88	around	_	_	_	_	_	_	_	_
89	the	_	_	_	_	_	_	_	_
90	world	_	_	_	_	_	_	_	_
91	there	_	_	_	_	_	_	_	_
92	is	_	_	_	_	_	_	_	_
93	a	_	_	_	_	_	_	_	_
94	need	_	_	_	_	_	_	_	_
95	of	_	_	_	_	_	_	_	_
96	programs	_	_	_	_	_	_	_	_
97	aimed	_	_	_	_	_	_	_	BeginSeg=Yes
98	to	_	_	_	_	_	_	_	_
99	prevent	_	_	_	_	_	_	_	_
100	acts	_	_	_	_	_	_	_	_
101	of	_	_	_	_	_	_	_	_
102	domestic	_	_	_	_	_	_	_	_
103	violence	_	_	_	_	_	_	_	_
104	and	_	_	_	_	_	_	_	_
105	to	_	_	_	_	_	_	_	_
106	achieve	_	_	_	_	_	_	_	_
107	accurate	_	_	_	_	_	_	_	_
108	assessment	_	_	_	_	_	_	_	_
109	of	_	_	_	_	_	_	_	_
110	multiple	_	_	_	_	_	_	_	_
111	domains	_	_	_	_	_	_	_	_
112	of	_	_	_	_	_	_	_	_
113	abuse	_	_	_	_	_	_	_	_
114	(	_	_	_	_	_	_	_	BeginSeg=Yes
115	psychological	_	_	_	_	_	_	_	_
116	,	_	_	_	_	_	_	_	_
117	physical	_	_	_	_	_	_	_	_
118	,	_	_	_	_	_	_	_	_
119	sexual	_	_	_	_	_	_	_	_
120	)	_	_	_	_	_	_	_	_
121	provided	_	_	_	_	_	_	_	BeginSeg=Yes
122	by	_	_	_	_	_	_	_	_
123	trained	_	_	_	_	_	_	_	_
124	multidisciplinary	_	_	_	_	_	_	_	_
125	staffs	_	_	_	_	_	_	_	_
126	(	_	_	_	_	_	_	_	BeginSeg=Yes
127	including	_	_	_	_	_	_	_	_
128	psychiatrists	_	_	_	_	_	_	_	_
129	,	_	_	_	_	_	_	_	_
130	psychologists	_	_	_	_	_	_	_	_
131	,	_	_	_	_	_	_	_	_
132	social	_	_	_	_	_	_	_	_
133	and	_	_	_	_	_	_	_	_
134	legal	_	_	_	_	_	_	_	_
135	services	_	_	_	_	_	_	_	_
136	)	_	_	_	_	_	_	_	_
137	.	_	_	_	_	_	_	_	_

# newdoc_id = d1bc51c207da125a38e3ab23f94966c37bf6bf8f
1	This	_	_	_	_	_	_	_	BeginSeg=Yes
2	paper	_	_	_	_	_	_	_	_
3	employs	_	_	_	_	_	_	_	_
4	syndemics	_	_	_	_	_	_	_	_
5	theory	_	_	_	_	_	_	_	_
6	to	_	_	_	_	_	_	_	BeginSeg=Yes
7	explain	_	_	_	_	_	_	_	_
8	high	_	_	_	_	_	_	_	_
9	rates	_	_	_	_	_	_	_	_
10	of	_	_	_	_	_	_	_	_
11	sexually	_	_	_	_	_	_	_	_
12	transmitted	_	_	_	_	_	_	_	_
13	disease	_	_	_	_	_	_	_	_
14	among	_	_	_	_	_	_	_	_
15	inner	_	_	_	_	_	_	_	_
16	city	_	_	_	_	_	_	_	_
17	African	_	_	_	_	_	_	_	_
18	American	_	_	_	_	_	_	_	_
19	and	_	_	_	_	_	_	_	_
20	Puerto	_	_	_	_	_	_	_	_
21	Rican	_	_	_	_	_	_	_	_
22	heterosexual	_	_	_	_	_	_	_	_
23	young	_	_	_	_	_	_	_	_
24	adults	_	_	_	_	_	_	_	_
25	in	_	_	_	_	_	_	_	_
26	Hartford	_	_	_	_	_	_	_	_
27	,	_	_	_	_	_	_	_	_
28	CT	_	_	_	_	_	_	_	_
29	,	_	_	_	_	_	_	_	_
30	USA	_	_	_	_	_	_	_	_
31	.	_	_	_	_	_	_	_	_
32	Syndemic	_	_	_	_	_	_	_	BeginSeg=Yes
33	theory	_	_	_	_	_	_	_	_
34	helps	_	_	_	_	_	_	_	_
35	to	_	_	_	_	_	_	_	_
36	elucidate	_	_	_	_	_	_	_	_
37	the	_	_	_	_	_	_	_	_
38	tendency	_	_	_	_	_	_	_	_
39	for	_	_	_	_	_	_	_	_
40	multiple	_	_	_	_	_	_	_	_
41	co	_	_	_	_	_	_	_	_
42	-	_	_	_	_	_	_	_	_
43	terminus	_	_	_	_	_	_	_	_
44	and	_	_	_	_	_	_	_	_
45	interacting	_	_	_	_	_	_	_	_
46	epidemics	_	_	_	_	_	_	_	_
47	to	_	_	_	_	_	_	_	BeginSeg=Yes
48	develop	_	_	_	_	_	_	_	_
49	under	_	_	_	_	_	_	_	_
50	conditions	_	_	_	_	_	_	_	_
51	of	_	_	_	_	_	_	_	_
52	health	_	_	_	_	_	_	_	_
53	and	_	_	_	_	_	_	_	_
54	social	_	_	_	_	_	_	_	_
55	disparity	_	_	_	_	_	_	_	_
56	.	_	_	_	_	_	_	_	_
57	Based	_	_	_	_	_	_	_	BeginSeg=Yes
58	on	_	_	_	_	_	_	_	_
59	enhanced	_	_	_	_	_	_	_	_
60	focus	_	_	_	_	_	_	_	_
61	group	_	_	_	_	_	_	_	_
62	and	_	_	_	_	_	_	_	_
63	in	_	_	_	_	_	_	_	_
64	-	_	_	_	_	_	_	_	_
65	depth	_	_	_	_	_	_	_	_
66	interview	_	_	_	_	_	_	_	_
67	data	_	_	_	_	_	_	_	_
68	,	_	_	_	_	_	_	_	_
69	the	_	_	_	_	_	_	_	BeginSeg=Yes
70	paper	_	_	_	_	_	_	_	_
71	argues	_	_	_	_	_	_	_	_
72	that	_	_	_	_	_	_	_	BeginSeg=Yes
73	respondents	_	_	_	_	_	_	_	_
74	employed	_	_	_	_	_	_	_	_
75	a	_	_	_	_	_	_	_	_
76	cultural	_	_	_	_	_	_	_	_
77	logic	_	_	_	_	_	_	_	_
78	of	_	_	_	_	_	_	_	_
79	risk	_	_	_	_	_	_	_	_
80	assessment	_	_	_	_	_	_	_	_
81	which	_	_	_	_	_	_	_	BeginSeg=Yes
82	put	_	_	_	_	_	_	_	_
83	them	_	_	_	_	_	_	_	_
84	at	_	_	_	_	_	_	_	_
85	high	_	_	_	_	_	_	_	_
86	risk	_	_	_	_	_	_	_	_
87	for	_	_	_	_	_	_	_	_
88	STD	_	_	_	_	_	_	_	_
89	infection	_	_	_	_	_	_	_	_
90	.	_	_	_	_	_	_	_	_
91	This	_	_	_	_	_	_	_	BeginSeg=Yes
92	cultural	_	_	_	_	_	_	_	_
93	logic	_	_	_	_	_	_	_	_
94	was	_	_	_	_	_	_	_	_
95	shaped	_	_	_	_	_	_	_	_
96	by	_	_	_	_	_	_	_	_
97	their	_	_	_	_	_	_	_	_
98	experiences	_	_	_	_	_	_	_	_
99	of	_	_	_	_	_	_	_	BeginSeg=Yes
100	growing	_	_	_	_	_	_	_	_
101	up	_	_	_	_	_	_	_	_
102	in	_	_	_	_	_	_	_	_
103	the	_	_	_	_	_	_	_	_
104	inner	_	_	_	_	_	_	_	_
105	city	_	_	_	_	_	_	_	_
106	which	_	_	_	_	_	_	_	BeginSeg=Yes
107	included	_	_	_	_	_	_	_	_
108	:	_	_	_	_	_	_	_	_
109	coming	_	_	_	_	_	_	_	_
110	of	_	_	_	_	_	_	_	_
111	age	_	_	_	_	_	_	_	_
112	in	_	_	_	_	_	_	_	_
113	an	_	_	_	_	_	_	_	_
114	impoverished	_	_	_	_	_	_	_	_
115	family	_	_	_	_	_	_	_	_
116	,	_	_	_	_	_	_	_	_
117	living	_	_	_	_	_	_	_	_
118	in	_	_	_	_	_	_	_	_
119	a	_	_	_	_	_	_	_	_
120	broken	_	_	_	_	_	_	_	_
121	home	_	_	_	_	_	_	_	_
122	,	_	_	_	_	_	_	_	_
123	experiencing	_	_	_	_	_	_	_	_
124	domestic	_	_	_	_	_	_	_	_
125	violence	_	_	_	_	_	_	_	_
126	,	_	_	_	_	_	_	_	_
127	limited	_	_	_	_	_	_	_	_
128	expectations	_	_	_	_	_	_	_	_
129	of	_	_	_	_	_	_	_	_
130	the	_	_	_	_	_	_	_	_
131	future	_	_	_	_	_	_	_	_
132	,	_	_	_	_	_	_	_	_
133	limited	_	_	_	_	_	_	_	_
134	exposure	_	_	_	_	_	_	_	_
135	to	_	_	_	_	_	_	_	_
136	positive	_	_	_	_	_	_	_	_
137	role	_	_	_	_	_	_	_	_
138	models	_	_	_	_	_	_	_	_
139	,	_	_	_	_	_	_	_	_
140	lack	_	_	_	_	_	_	_	_
141	of	_	_	_	_	_	_	_	_
142	expectation	_	_	_	_	_	_	_	_
143	of	_	_	_	_	_	_	_	_
144	the	_	_	_	_	_	_	_	_
145	dependency	_	_	_	_	_	_	_	_
146	of	_	_	_	_	_	_	_	_
147	others	_	_	_	_	_	_	_	_
148	,	_	_	_	_	_	_	_	_
149	and	_	_	_	_	_	_	_	_
150	fear	_	_	_	_	_	_	_	_
151	of	_	_	_	_	_	_	_	_
152	intimacy	_	_	_	_	_	_	_	_
153	.	_	_	_	_	_	_	_	_

# newdoc_id = d1ce2321a8a67ec9c9823cb9c15543fce565ed85
1	Typical	_	_	_	_	_	_	_	BeginSeg=Yes
2	enteropathogenic	_	_	_	_	_	_	_	_
3	E.	_	_	_	_	_	_	_	_
4	coli	_	_	_	_	_	_	_	_
5	(	_	_	_	_	_	_	_	_
6	tEPEC	_	_	_	_	_	_	_	_
7	)	_	_	_	_	_	_	_	_
8	carries	_	_	_	_	_	_	_	_
9	the	_	_	_	_	_	_	_	_
10	highest	_	_	_	_	_	_	_	_
11	hazard	_	_	_	_	_	_	_	_
12	of	_	_	_	_	_	_	_	_
13	death	_	_	_	_	_	_	_	_
14	in	_	_	_	_	_	_	_	_
15	children	_	_	_	_	_	_	_	_
16	with	_	_	_	_	_	_	_	_
17	diarrhea	_	_	_	_	_	_	_	_
18	and	_	_	_	_	_	_	_	BeginSeg=Yes
19	atypical	_	_	_	_	_	_	_	_
20	EPEC	_	_	_	_	_	_	_	_
21	(	_	_	_	_	_	_	_	_
22	aEPEC	_	_	_	_	_	_	_	_
23	)	_	_	_	_	_	_	_	_
24	was	_	_	_	_	_	_	_	_
25	recently	_	_	_	_	_	_	_	_
26	identified	_	_	_	_	_	_	_	_
27	as	_	_	_	_	_	_	_	_
28	significantly	_	_	_	_	_	_	_	_
29	associated	_	_	_	_	_	_	_	_
30	with	_	_	_	_	_	_	_	_
31	diarrheal	_	_	_	_	_	_	_	_
32	mortality	_	_	_	_	_	_	_	_
33	in	_	_	_	_	_	_	_	_
34	kittens	_	_	_	_	_	_	_	_
35	.	_	_	_	_	_	_	_	_
36	In	_	_	_	_	_	_	_	BeginSeg=Yes
37	both	_	_	_	_	_	_	_	_
38	children	_	_	_	_	_	_	_	_
39	and	_	_	_	_	_	_	_	_
40	kittens	_	_	_	_	_	_	_	_
41	there	_	_	_	_	_	_	_	_
42	is	_	_	_	_	_	_	_	_
43	a	_	_	_	_	_	_	_	_
44	significant	_	_	_	_	_	_	_	_
45	association	_	_	_	_	_	_	_	_
46	between	_	_	_	_	_	_	_	_
47	aEPEC	_	_	_	_	_	_	_	_
48	burden	_	_	_	_	_	_	_	_
49	and	_	_	_	_	_	_	_	_
50	diarrheal	_	_	_	_	_	_	_	_
51	disease	_	_	_	_	_	_	_	_
52	,	_	_	_	_	_	_	_	_
53	however	_	_	_	_	_	_	_	BeginSeg=Yes
54	the	_	_	_	_	_	_	_	_
55	infection	_	_	_	_	_	_	_	_
56	can	_	_	_	_	_	_	_	_
57	be	_	_	_	_	_	_	_	_
58	found	_	_	_	_	_	_	_	_
59	in	_	_	_	_	_	_	_	_
60	individuals	_	_	_	_	_	_	_	_
61	with	_	_	_	_	_	_	_	_
62	and	_	_	_	_	_	_	_	_
63	without	_	_	_	_	_	_	_	_
64	diarrhea	_	_	_	_	_	_	_	_
65	.	_	_	_	_	_	_	_	_
66	It	_	_	_	_	_	_	_	BeginSeg=Yes
67	remains	_	_	_	_	_	_	_	_
68	unclear	_	_	_	_	_	_	_	_
69	to	_	_	_	_	_	_	_	_
70	what	_	_	_	_	_	_	_	_
71	extent	_	_	_	_	_	_	_	_
72	,	_	_	_	_	_	_	_	_
73	under	_	_	_	_	_	_	_	_
74	what	_	_	_	_	_	_	_	_
75	conditions	_	_	_	_	_	_	_	_
76	,	_	_	_	_	_	_	_	_
77	or	_	_	_	_	_	_	_	_
78	by	_	_	_	_	_	_	_	_
79	what	_	_	_	_	_	_	_	_
80	mechanisms	_	_	_	_	_	_	_	_
81	aEPEC	_	_	_	_	_	_	_	_
82	serves	_	_	_	_	_	_	_	_
83	as	_	_	_	_	_	_	_	_
84	a	_	_	_	_	_	_	_	_
85	primary	_	_	_	_	_	_	_	_
86	pathogen	_	_	_	_	_	_	_	_
87	in	_	_	_	_	_	_	_	_
88	individuals	_	_	_	_	_	_	_	_
89	with	_	_	_	_	_	_	_	_
90	diarrhea	_	_	_	_	_	_	_	_
91	.	_	_	_	_	_	_	_	_
92	It	_	_	_	_	_	_	_	BeginSeg=Yes
93	seems	_	_	_	_	_	_	_	_
94	likely	_	_	_	_	_	_	_	_
95	that	_	_	_	_	_	_	_	_
96	a	_	_	_	_	_	_	_	_
97	combination	_	_	_	_	_	_	_	_
98	of	_	_	_	_	_	_	_	_
99	host	_	_	_	_	_	_	_	_
100	and	_	_	_	_	_	_	_	_
101	bacterial	_	_	_	_	_	_	_	_
102	factors	_	_	_	_	_	_	_	_
103	enable	_	_	_	_	_	_	_	_
104	aEPEC	_	_	_	_	_	_	_	_
105	to	_	_	_	_	_	_	_	_
106	cause	_	_	_	_	_	_	_	_
107	disease	_	_	_	_	_	_	_	_
108	in	_	_	_	_	_	_	_	_
109	some	_	_	_	_	_	_	_	_
110	individuals	_	_	_	_	_	_	_	_
111	and	_	_	_	_	_	_	_	_
112	not	_	_	_	_	_	_	_	_
113	in	_	_	_	_	_	_	_	_
114	others	_	_	_	_	_	_	_	_
115	.	_	_	_	_	_	_	_	_
116	The	_	_	_	_	_	_	_	BeginSeg=Yes
117	purpose	_	_	_	_	_	_	_	_
118	of	_	_	_	_	_	_	_	_
119	this	_	_	_	_	_	_	_	_
120	study	_	_	_	_	_	_	_	_
121	was	_	_	_	_	_	_	_	_
122	to	_	_	_	_	_	_	_	_
123	determine	_	_	_	_	_	_	_	_
124	the	_	_	_	_	_	_	_	_
125	impact	_	_	_	_	_	_	_	_
126	of	_	_	_	_	_	_	_	_
127	aEPEC	_	_	_	_	_	_	_	_
128	on	_	_	_	_	_	_	_	_
129	intestinal	_	_	_	_	_	_	_	_
130	function	_	_	_	_	_	_	_	_
131	and	_	_	_	_	_	_	_	_
132	diarrhea	_	_	_	_	_	_	_	_
133	in	_	_	_	_	_	_	_	_
134	kittens	_	_	_	_	_	_	_	_
135	following	_	_	_	_	_	_	_	BeginSeg=Yes
136	experimentally	_	_	_	_	_	_	_	_
137	-	_	_	_	_	_	_	_	_
138	induced	_	_	_	_	_	_	_	_
139	carriage	_	_	_	_	_	_	_	_
140	and	_	_	_	_	_	_	_	BeginSeg=Yes
141	the	_	_	_	_	_	_	_	_
142	influence	_	_	_	_	_	_	_	_
143	of	_	_	_	_	_	_	_	_
144	a	_	_	_	_	_	_	_	_
145	disrupted	_	_	_	_	_	_	_	_
146	intestinal	_	_	_	_	_	_	_	_
147	microbiota	_	_	_	_	_	_	_	_
148	on	_	_	_	_	_	_	_	_
149	disease	_	_	_	_	_	_	_	_
150	susceptibility	_	_	_	_	_	_	_	_
151	.	_	_	_	_	_	_	_	_
152	Results	_	_	_	_	_	_	_	BeginSeg=Yes
153	of	_	_	_	_	_	_	_	_
154	this	_	_	_	_	_	_	_	_
155	study	_	_	_	_	_	_	_	_
156	identify	_	_	_	_	_	_	_	_
157	aEPEC	_	_	_	_	_	_	_	_
158	as	_	_	_	_	_	_	_	_
159	a	_	_	_	_	_	_	_	_
160	potential	_	_	_	_	_	_	_	_
161	pathogen	_	_	_	_	_	_	_	_
162	in	_	_	_	_	_	_	_	_
163	kittens	_	_	_	_	_	_	_	_
164	.	_	_	_	_	_	_	_	_
165	In	_	_	_	_	_	_	_	BeginSeg=Yes
166	the	_	_	_	_	_	_	_	_
167	absence	_	_	_	_	_	_	_	_
168	of	_	_	_	_	_	_	_	_
169	disruption	_	_	_	_	_	_	_	_
170	to	_	_	_	_	_	_	_	_
171	the	_	_	_	_	_	_	_	_
172	intestinal	_	_	_	_	_	_	_	_
173	microbiota	_	_	_	_	_	_	_	_
174	,	_	_	_	_	_	_	_	_
175	kittens	_	_	_	_	_	_	_	BeginSeg=Yes
176	are	_	_	_	_	_	_	_	_
177	resistant	_	_	_	_	_	_	_	_
178	to	_	_	_	_	_	_	_	_
179	clinical	_	_	_	_	_	_	_	_
180	signs	_	_	_	_	_	_	_	_
181	of	_	_	_	_	_	_	_	_
182	aEPEC	_	_	_	_	_	_	_	_
183	carriage	_	_	_	_	_	_	_	_
184	but	_	_	_	_	_	_	_	BeginSeg=Yes
185	demonstrate	_	_	_	_	_	_	_	_
186	significant	_	_	_	_	_	_	_	_
187	occult	_	_	_	_	_	_	_	_
188	changes	_	_	_	_	_	_	_	_
189	in	_	_	_	_	_	_	_	_
190	intestinal	_	_	_	_	_	_	_	_
191	absorption	_	_	_	_	_	_	_	_
192	and	_	_	_	_	_	_	_	_
193	permeability	_	_	_	_	_	_	_	_
194	.	_	_	_	_	_	_	_	_
195	Antibiotic	_	_	_	_	_	_	_	BeginSeg=Yes
196	-	_	_	_	_	_	_	_	_
197	induced	_	_	_	_	_	_	_	_
198	disruption	_	_	_	_	_	_	_	_
199	of	_	_	_	_	_	_	_	_
200	the	_	_	_	_	_	_	_	_
201	intestinal	_	_	_	_	_	_	_	_
202	microbiota	_	_	_	_	_	_	_	_
203	prior	_	_	_	_	_	_	_	_
204	to	_	_	_	_	_	_	_	_
205	infection	_	_	_	_	_	_	_	_
206	increases	_	_	_	_	_	_	_	_
207	subsequent	_	_	_	_	_	_	_	_
208	intestinal	_	_	_	_	_	_	_	_
209	water	_	_	_	_	_	_	_	_
210	loss	_	_	_	_	_	_	_	_
211	as	_	_	_	_	_	_	_	BeginSeg=Yes
212	determined	_	_	_	_	_	_	_	_
213	by	_	_	_	_	_	_	_	_
214	%	_	_	_	_	_	_	_	_
215	fecal	_	_	_	_	_	_	_	_
216	wet	_	_	_	_	_	_	_	_
217	weight	_	_	_	_	_	_	_	_
218	.	_	_	_	_	_	_	_	_
219	Enrichment	_	_	_	_	_	_	_	BeginSeg=Yes
220	of	_	_	_	_	_	_	_	_
221	the	_	_	_	_	_	_	_	_
222	intestinal	_	_	_	_	_	_	_	_
223	microbiota	_	_	_	_	_	_	_	_
224	with	_	_	_	_	_	_	_	_
225	a	_	_	_	_	_	_	_	_
226	commensal	_	_	_	_	_	_	_	_
227	member	_	_	_	_	_	_	_	_
228	of	_	_	_	_	_	_	_	_
229	the	_	_	_	_	_	_	_	_
230	feline	_	_	_	_	_	_	_	_
231	mucosa	_	_	_	_	_	_	_	_
232	-	_	_	_	_	_	_	_	_
233	associated	_	_	_	_	_	_	_	_
234	microbiota	_	_	_	_	_	_	_	_
235	,	_	_	_	_	_	_	_	_
236	Enterococcus	_	_	_	_	_	_	_	_
237	hirae	_	_	_	_	_	_	_	_
238	,	_	_	_	_	_	_	_	_
239	ameliorated	_	_	_	_	_	_	_	_
240	the	_	_	_	_	_	_	_	_
241	effects	_	_	_	_	_	_	_	_
242	of	_	_	_	_	_	_	_	_
243	aEPEC	_	_	_	_	_	_	_	_
244	experimental	_	_	_	_	_	_	_	_
245	infection	_	_	_	_	_	_	_	_
246	on	_	_	_	_	_	_	_	_
247	intestinal	_	_	_	_	_	_	_	_
248	function	_	_	_	_	_	_	_	_
249	and	_	_	_	_	_	_	_	_
250	water	_	_	_	_	_	_	_	_
251	loss	_	_	_	_	_	_	_	_
252	.	_	_	_	_	_	_	_	_
253	These	_	_	_	_	_	_	_	BeginSeg=Yes
254	observations	_	_	_	_	_	_	_	_
255	begin	_	_	_	_	_	_	_	_
256	to	_	_	_	_	_	_	_	_
257	unravel	_	_	_	_	_	_	_	_
258	the	_	_	_	_	_	_	_	_
259	mechanisms	_	_	_	_	_	_	_	_
260	by	_	_	_	_	_	_	_	BeginSeg=Yes
261	which	_	_	_	_	_	_	_	_
262	aEPEC	_	_	_	_	_	_	_	_
263	infection	_	_	_	_	_	_	_	_
264	may	_	_	_	_	_	_	_	_
265	be	_	_	_	_	_	_	_	_
266	able	_	_	_	_	_	_	_	_
267	to	_	_	_	_	_	_	_	_
268	exploit	_	_	_	_	_	_	_	_
269	susceptible	_	_	_	_	_	_	_	_
270	hosts	_	_	_	_	_	_	_	_
271	.	_	_	_	_	_	_	_	_

# newdoc_id = d2bf31d4a63b71e7b5bb16f4375134d4ef881d25
1	Studies	_	_	_	_	_	_	_	BeginSeg=Yes
2	of	_	_	_	_	_	_	_	_
3	SARS	_	_	_	_	_	_	_	_
4	coronavirus	_	_	_	_	_	_	_	_
5	(	_	_	_	_	_	_	_	_
6	SARS	_	_	_	_	_	_	_	_
7	-	_	_	_	_	_	_	_	_
8	CoV)	_	_	_	_	_	_	_	_
9	-	_	_	_	_	_	_	_	BeginSeg=Yes
10	the	_	_	_	_	_	_	_	_
11	causative	_	_	_	_	_	_	_	_
12	agent	_	_	_	_	_	_	_	_
13	of	_	_	_	_	_	_	_	_
14	severe	_	_	_	_	_	_	_	_
15	acute	_	_	_	_	_	_	_	_
16	respiratory	_	_	_	_	_	_	_	_
17	syndrome	_	_	_	_	_	_	_	_
18	(	_	_	_	_	_	_	_	_
19	SARS)	_	_	_	_	_	_	_	_
20	-	_	_	_	_	_	_	_	_
21	have	_	_	_	_	_	_	_	BeginSeg=Yes
22	been	_	_	_	_	_	_	_	_
23	hampered	_	_	_	_	_	_	_	_
24	by	_	_	_	_	_	_	_	_
25	its	_	_	_	_	_	_	_	_
26	high	_	_	_	_	_	_	_	_
27	transmission	_	_	_	_	_	_	_	_
28	rate	_	_	_	_	_	_	_	_
29	and	_	_	_	_	_	_	_	_
30	the	_	_	_	_	_	_	_	_
31	pathogenicity	_	_	_	_	_	_	_	_
32	of	_	_	_	_	_	_	_	_
33	this	_	_	_	_	_	_	_	_
34	virus	_	_	_	_	_	_	_	_
35	.	_	_	_	_	_	_	_	_
36	To	_	_	_	_	_	_	_	BeginSeg=Yes
37	permit	_	_	_	_	_	_	_	_
38	analysis	_	_	_	_	_	_	_	_
39	of	_	_	_	_	_	_	_	_
40	the	_	_	_	_	_	_	_	_
41	host	_	_	_	_	_	_	_	_
42	range	_	_	_	_	_	_	_	_
43	and	_	_	_	_	_	_	_	_
44	entry	_	_	_	_	_	_	_	_
45	mechanism	_	_	_	_	_	_	_	_
46	of	_	_	_	_	_	_	_	_
47	SARS	_	_	_	_	_	_	_	_
48	-	_	_	_	_	_	_	_	_
49	CoV	_	_	_	_	_	_	_	_
50	,	_	_	_	_	_	_	_	_
51	we	_	_	_	_	_	_	_	BeginSeg=Yes
52	incorporated	_	_	_	_	_	_	_	_
53	the	_	_	_	_	_	_	_	_
54	humanized	_	_	_	_	_	_	_	_
55	SARS	_	_	_	_	_	_	_	_
56	-	_	_	_	_	_	_	_	_
57	CoV	_	_	_	_	_	_	_	_
58	spike	_	_	_	_	_	_	_	_
59	(	_	_	_	_	_	_	_	_
60	S	_	_	_	_	_	_	_	_
61	)	_	_	_	_	_	_	_	_
62	glycoprotein	_	_	_	_	_	_	_	_
63	into	_	_	_	_	_	_	_	_
64	HIV	_	_	_	_	_	_	_	_
65	particles	_	_	_	_	_	_	_	_
66	to	_	_	_	_	_	_	_	BeginSeg=Yes
67	generate	_	_	_	_	_	_	_	_
68	a	_	_	_	_	_	_	_	_
69	highly	_	_	_	_	_	_	_	_
70	infectious	_	_	_	_	_	_	_	_
71	SARS	_	_	_	_	_	_	_	_
72	-	_	_	_	_	_	_	_	_
73	CoV	_	_	_	_	_	_	_	_
74	pseudotyped	_	_	_	_	_	_	_	_
75	virus	_	_	_	_	_	_	_	_
76	.	_	_	_	_	_	_	_	_
77	The	_	_	_	_	_	_	_	BeginSeg=Yes
78	infection	_	_	_	_	_	_	_	_
79	on	_	_	_	_	_	_	_	_
80	Vero	_	_	_	_	_	_	_	_
81	E6	_	_	_	_	_	_	_	_
82	-	_	_	_	_	_	_	_	BeginSeg=Yes
83	a	_	_	_	_	_	_	_	_
84	permissive	_	_	_	_	_	_	_	_
85	cell	_	_	_	_	_	_	_	_
86	line	_	_	_	_	_	_	_	_
87	to	_	_	_	_	_	_	_	_
88	SARS	_	_	_	_	_	_	_	_
89	-	_	_	_	_	_	_	_	_
90	CoV	_	_	_	_	_	_	_	_
91	-	_	_	_	_	_	_	_	_
92	could	_	_	_	_	_	_	_	BeginSeg=Yes
93	be	_	_	_	_	_	_	_	_
94	neutralized	_	_	_	_	_	_	_	_
95	by	_	_	_	_	_	_	_	_
96	sera	_	_	_	_	_	_	_	_
97	from	_	_	_	_	_	_	_	_
98	convalescent	_	_	_	_	_	_	_	_
99	SARS	_	_	_	_	_	_	_	_
100	patients	_	_	_	_	_	_	_	_
101	,	_	_	_	_	_	_	_	_
102	and	_	_	_	_	_	_	_	BeginSeg=Yes
103	the	_	_	_	_	_	_	_	_
104	entry	_	_	_	_	_	_	_	_
105	was	_	_	_	_	_	_	_	_
106	a	_	_	_	_	_	_	_	_
107	pH	_	_	_	_	_	_	_	_
108	-	_	_	_	_	_	_	_	_
109	dependent	_	_	_	_	_	_	_	_
110	process	_	_	_	_	_	_	_	_
111	.	_	_	_	_	_	_	_	_
112	With	_	_	_	_	_	_	_	BeginSeg=Yes
113	these	_	_	_	_	_	_	_	_
114	highly	_	_	_	_	_	_	_	_
115	infectious	_	_	_	_	_	_	_	_
116	SARS	_	_	_	_	_	_	_	_
117	-	_	_	_	_	_	_	_	_
118	CoV	_	_	_	_	_	_	_	_
119	pseudotypes	_	_	_	_	_	_	_	_
120	,	_	_	_	_	_	_	_	_
121	several	_	_	_	_	_	_	_	_
122	cell	_	_	_	_	_	_	_	_
123	lines	_	_	_	_	_	_	_	_
124	derived	_	_	_	_	_	_	_	BeginSeg=Yes
125	from	_	_	_	_	_	_	_	_
126	various	_	_	_	_	_	_	_	_
127	tissues	_	_	_	_	_	_	_	_
128	were	_	_	_	_	_	_	_	BeginSeg=Yes
129	revealed	_	_	_	_	_	_	_	_
130	as	_	_	_	_	_	_	_	_
131	susceptible	_	_	_	_	_	_	_	_
132	to	_	_	_	_	_	_	_	_
133	SARS	_	_	_	_	_	_	_	_
134	-	_	_	_	_	_	_	_	_
135	CoV	_	_	_	_	_	_	_	_
136	,	_	_	_	_	_	_	_	_
137	which	_	_	_	_	_	_	_	BeginSeg=Yes
138	were	_	_	_	_	_	_	_	_
139	highly	_	_	_	_	_	_	_	_
140	corresponding	_	_	_	_	_	_	_	_
141	to	_	_	_	_	_	_	_	_
142	the	_	_	_	_	_	_	_	_
143	expression	_	_	_	_	_	_	_	_
144	pattern	_	_	_	_	_	_	_	_
145	of	_	_	_	_	_	_	_	_
146	virusÕs	_	_	_	_	_	_	_	_
147	receptor	_	_	_	_	_	_	_	_
148	angiotensin	_	_	_	_	_	_	_	_
149	-	_	_	_	_	_	_	_	_
150	converting	_	_	_	_	_	_	_	_
151	enzyme	_	_	_	_	_	_	_	_
152	2	_	_	_	_	_	_	_	_
153	(	_	_	_	_	_	_	_	_
154	ACE2	_	_	_	_	_	_	_	_
155	)	_	_	_	_	_	_	_	_
156	.	_	_	_	_	_	_	_	_
157	In	_	_	_	_	_	_	_	BeginSeg=Yes
158	addition	_	_	_	_	_	_	_	_
159	,	_	_	_	_	_	_	_	_
160	we	_	_	_	_	_	_	_	_
161	also	_	_	_	_	_	_	_	_
162	demonstrated	_	_	_	_	_	_	_	_
163	angiotensin	_	_	_	_	_	_	_	BeginSeg=Yes
164	1	_	_	_	_	_	_	_	_
165	converting	_	_	_	_	_	_	_	_
166	enzyme	_	_	_	_	_	_	_	_
167	(	_	_	_	_	_	_	_	_
168	ACE)	_	_	_	_	_	_	_	_
169	-	_	_	_	_	_	_	_	BeginSeg=Yes
170	the	_	_	_	_	_	_	_	_
171	homologue	_	_	_	_	_	_	_	_
172	of	_	_	_	_	_	_	_	_
173	ACE2	_	_	_	_	_	_	_	_
174	could	_	_	_	_	_	_	_	BeginSeg=Yes
175	not	_	_	_	_	_	_	_	_
176	function	_	_	_	_	_	_	_	_
177	as	_	_	_	_	_	_	_	_
178	a	_	_	_	_	_	_	_	_
179	receptor	_	_	_	_	_	_	_	_
180	for	_	_	_	_	_	_	_	_
181	SARS	_	_	_	_	_	_	_	_
182	-	_	_	_	_	_	_	_	_
183	CoV.	_	_	_	_	_	_	_	_

# newdoc_id = d7e5ba009aed400fac0a223f7fe364b16ac84ae6
1	Next	_	_	_	_	_	_	_	BeginSeg=Yes
2	-	_	_	_	_	_	_	_	_
3	Generation	_	_	_	_	_	_	_	_
4	Sequencing	_	_	_	_	_	_	_	_
5	has	_	_	_	_	_	_	_	_
6	been	_	_	_	_	_	_	_	_
7	used	_	_	_	_	_	_	_	_
8	in	_	_	_	_	_	_	_	_
9	numerous	_	_	_	_	_	_	_	_
10	investigations	_	_	_	_	_	_	_	_
11	to	_	_	_	_	_	_	_	BeginSeg=Yes
12	characterize	_	_	_	_	_	_	_	_
13	andquantifythe	_	_	_	_	_	_	_	_
14	genetic	_	_	_	_	_	_	_	_
15	diversity	_	_	_	_	_	_	_	_
16	of	_	_	_	_	_	_	_	_
17	a	_	_	_	_	_	_	_	_
18	virus	_	_	_	_	_	_	_	_
19	sample	_	_	_	_	_	_	_	_
20	through	_	_	_	_	_	_	_	_
21	the	_	_	_	_	_	_	_	_
22	mapping	_	_	_	_	_	_	_	_
23	of	_	_	_	_	_	_	_	_
24	polymorphisms	_	_	_	_	_	_	_	_
25	and	_	_	_	_	_	_	_	_
26	measurement	_	_	_	_	_	_	_	_
27	of	_	_	_	_	_	_	_	_
28	mutation	_	_	_	_	_	_	_	_
29	frequencies	_	_	_	_	_	_	_	_
30	.	_	_	_	_	_	_	_	_
31	Next	_	_	_	_	_	_	_	BeginSeg=Yes
32	-	_	_	_	_	_	_	_	_
33	Generation	_	_	_	_	_	_	_	_
34	Sequencing	_	_	_	_	_	_	_	_
35	has	_	_	_	_	_	_	_	_
36	also	_	_	_	_	_	_	_	_
37	been	_	_	_	_	_	_	_	_
38	employed	_	_	_	_	_	_	_	_
39	to	_	_	_	_	_	_	_	BeginSeg=Yes
40	identify	_	_	_	_	_	_	_	_
41	recombination	_	_	_	_	_	_	_	_
42	events	_	_	_	_	_	_	_	_
43	occurring	_	_	_	_	_	_	_	BeginSeg=Yes
44	within	_	_	_	_	_	_	_	_
45	the	_	_	_	_	_	_	_	_
46	genomes	_	_	_	_	_	_	_	_
47	of	_	_	_	_	_	_	_	_
48	higher	_	_	_	_	_	_	_	_
49	organisms	_	_	_	_	_	_	_	_
50	,	_	_	_	_	_	_	_	_
51	for	_	_	_	_	_	_	_	BeginSeg=Yes
52	example	_	_	_	_	_	_	_	_
53	,	_	_	_	_	_	_	_	_
54	detecting	_	_	_	_	_	_	_	_
55	alternative	_	_	_	_	_	_	_	_
56	RNA	_	_	_	_	_	_	_	_
57	splicing	_	_	_	_	_	_	_	_
58	events	_	_	_	_	_	_	_	_
59	and	_	_	_	_	_	_	_	_
60	oncogenic	_	_	_	_	_	_	_	_
61	chromosomal	_	_	_	_	_	_	_	_
62	rearrangements	_	_	_	_	_	_	_	_
63	.	_	_	_	_	_	_	_	_
64	Here	_	_	_	_	_	_	_	BeginSeg=Yes
65	,	_	_	_	_	_	_	_	_
66	we	_	_	_	_	_	_	_	_
67	combine	_	_	_	_	_	_	_	_
68	these	_	_	_	_	_	_	_	_
69	two	_	_	_	_	_	_	_	_
70	approaches	_	_	_	_	_	_	_	_
71	to	_	_	_	_	_	_	_	BeginSeg=Yes
72	profile	_	_	_	_	_	_	_	_
73	RNA	_	_	_	_	_	_	_	_
74	recombination	_	_	_	_	_	_	_	_
75	within	_	_	_	_	_	_	_	_
76	the	_	_	_	_	_	_	_	_
77	encapsidated	_	_	_	_	_	_	_	_
78	genome	_	_	_	_	_	_	_	_
79	of	_	_	_	_	_	_	_	_
80	a	_	_	_	_	_	_	_	_
81	eukaryotic	_	_	_	_	_	_	_	_
82	RNA	_	_	_	_	_	_	_	_
83	virus	_	_	_	_	_	_	_	_
84	,	_	_	_	_	_	_	_	_
85	Flock	_	_	_	_	_	_	_	_
86	House	_	_	_	_	_	_	_	_
87	Virus	_	_	_	_	_	_	_	_
88	.	_	_	_	_	_	_	_	_
89	We	_	_	_	_	_	_	_	BeginSeg=Yes
90	detect	_	_	_	_	_	_	_	_
91	hundreds	_	_	_	_	_	_	_	_
92	of	_	_	_	_	_	_	_	_
93	thousands	_	_	_	_	_	_	_	_
94	of	_	_	_	_	_	_	_	_
95	recombination	_	_	_	_	_	_	_	_
96	events	_	_	_	_	_	_	_	_
97	,	_	_	_	_	_	_	_	_
98	with	_	_	_	_	_	_	_	_
99	single	_	_	_	_	_	_	_	_
100	-	_	_	_	_	_	_	_	_
101	nucleotide	_	_	_	_	_	_	_	_
102	resolution	_	_	_	_	_	_	_	_
103	,	_	_	_	_	_	_	_	_
104	which	_	_	_	_	_	_	_	BeginSeg=Yes
105	result	_	_	_	_	_	_	_	_
106	in	_	_	_	_	_	_	_	_
107	diversity	_	_	_	_	_	_	_	_
108	in	_	_	_	_	_	_	_	_
109	the	_	_	_	_	_	_	_	_
110	encapsidated	_	_	_	_	_	_	_	_
111	genome	_	_	_	_	_	_	_	_
112	rivaling	_	_	_	_	_	_	_	BeginSeg=Yes
113	that	_	_	_	_	_	_	_	_
114	due	_	_	_	_	_	_	_	_
115	to	_	_	_	_	_	_	_	_
116	mismatch	_	_	_	_	_	_	_	_
117	mutation	_	_	_	_	_	_	_	_
118	.	_	_	_	_	_	_	_	_
119	We	_	_	_	_	_	_	_	BeginSeg=Yes
120	detect	_	_	_	_	_	_	_	_
121	previously	_	_	_	_	_	_	_	_
122	identified	_	_	_	_	_	_	_	_
123	Defective	_	_	_	_	_	_	_	_
124	-	_	_	_	_	_	_	_	_
125	RNAs	_	_	_	_	_	_	_	_
126	as	_	_	_	_	_	_	_	_
127	well	_	_	_	_	_	_	_	_
128	as	_	_	_	_	_	_	_	_
129	many	_	_	_	_	_	_	_	_
130	other	_	_	_	_	_	_	_	_
131	abundant	_	_	_	_	_	_	_	_
132	and	_	_	_	_	_	_	_	_
133	novel	_	_	_	_	_	_	_	_
134	Defective	_	_	_	_	_	_	_	_
135	-	_	_	_	_	_	_	_	_
136	RNAs	_	_	_	_	_	_	_	_
137	.	_	_	_	_	_	_	_	_
138	Our	_	_	_	_	_	_	_	BeginSeg=Yes
139	approach	_	_	_	_	_	_	_	_
140	is	_	_	_	_	_	_	_	_
141	exceptionally	_	_	_	_	_	_	_	_
142	sensitive	_	_	_	_	_	_	_	_
143	,	_	_	_	_	_	_	_	_
144	unbiased	_	_	_	_	_	_	_	_
145	,	_	_	_	_	_	_	_	_
146	and	_	_	_	_	_	_	_	BeginSeg=Yes
147	requires	_	_	_	_	_	_	_	_
148	no	_	_	_	_	_	_	_	_
149	prior	_	_	_	_	_	_	_	_
150	knowledge	_	_	_	_	_	_	_	_
151	beyond	_	_	_	_	_	_	_	_
152	the	_	_	_	_	_	_	_	_
153	virus	_	_	_	_	_	_	_	_
154	genome	_	_	_	_	_	_	_	_
155	sequence	_	_	_	_	_	_	_	_
156	.	_	_	_	_	_	_	_	_
157	RNA	_	_	_	_	_	_	_	BeginSeg=Yes
158	recombination	_	_	_	_	_	_	_	_
159	is	_	_	_	_	_	_	_	_
160	a	_	_	_	_	_	_	_	_
161	powerful	_	_	_	_	_	_	_	_
162	driving	_	_	_	_	_	_	_	_
163	force	_	_	_	_	_	_	_	_
164	behind	_	_	_	_	_	_	_	_
165	the	_	_	_	_	_	_	_	_
166	evolution	_	_	_	_	_	_	_	_
167	and	_	_	_	_	_	_	_	_
168	adaptation	_	_	_	_	_	_	_	_
169	of	_	_	_	_	_	_	_	_
170	RNA	_	_	_	_	_	_	_	_
171	viruses	_	_	_	_	_	_	_	_
172	.	_	_	_	_	_	_	_	_
173	The	_	_	_	_	_	_	_	BeginSeg=Yes
174	strategy	_	_	_	_	_	_	_	_
175	implemented	_	_	_	_	_	_	_	BeginSeg=Yes
176	here	_	_	_	_	_	_	_	_
177	is	_	_	_	_	_	_	_	BeginSeg=Yes
178	widely	_	_	_	_	_	_	_	_
179	applicable	_	_	_	_	_	_	_	_
180	and	_	_	_	_	_	_	_	BeginSeg=Yes
181	provides	_	_	_	_	_	_	_	_
182	a	_	_	_	_	_	_	_	_
183	highly	_	_	_	_	_	_	_	_
184	detailed	_	_	_	_	_	_	_	_
185	description	_	_	_	_	_	_	_	_
186	of	_	_	_	_	_	_	_	_
187	the	_	_	_	_	_	_	_	_
188	complex	_	_	_	_	_	_	_	_
189	mutational	_	_	_	_	_	_	_	_
190	landscape	_	_	_	_	_	_	_	_
191	of	_	_	_	_	_	_	_	_
192	the	_	_	_	_	_	_	_	_
193	transmissible	_	_	_	_	_	_	_	_
194	viral	_	_	_	_	_	_	_	_
195	genome	_	_	_	_	_	_	_	_
196	.	_	_	_	_	_	_	_	_

# newdoc_id = d87f44c7d76e4c51ed8e72103669c275e2db3e71
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	major	_	_	_	_	_	_	_	_
3	physiological	_	_	_	_	_	_	_	_
4	function	_	_	_	_	_	_	_	_
5	of	_	_	_	_	_	_	_	_
6	milk	_	_	_	_	_	_	_	_
7	is	_	_	_	_	_	_	_	_
8	the	_	_	_	_	_	_	_	_
9	transport	_	_	_	_	_	_	_	_
10	of	_	_	_	_	_	_	_	_
11	amino	_	_	_	_	_	_	_	_
12	acids	_	_	_	_	_	_	_	_
13	,	_	_	_	_	_	_	_	_
14	carbohydrates	_	_	_	_	_	_	_	_
15	,	_	_	_	_	_	_	_	_
16	lipids	_	_	_	_	_	_	_	_
17	and	_	_	_	_	_	_	_	_
18	minerals	_	_	_	_	_	_	_	_
19	to	_	_	_	_	_	_	_	_
20	mammalian	_	_	_	_	_	_	_	_
21	offspring	_	_	_	_	_	_	_	_
22	.	_	_	_	_	_	_	_	_
23	Caseins	_	_	_	_	_	_	_	BeginSeg=Yes
24	,	_	_	_	_	_	_	_	_
25	the	_	_	_	_	_	_	_	_
26	major	_	_	_	_	_	_	_	_
27	milk	_	_	_	_	_	_	_	_
28	proteins	_	_	_	_	_	_	_	_
29	,	_	_	_	_	_	_	_	_
30	are	_	_	_	_	_	_	_	_
31	secreted	_	_	_	_	_	_	_	_
32	in	_	_	_	_	_	_	_	_
33	the	_	_	_	_	_	_	_	_
34	form	_	_	_	_	_	_	_	_
35	of	_	_	_	_	_	_	_	_
36	a	_	_	_	_	_	_	_	_
37	micelle	_	_	_	_	_	_	_	_
38	consisting	_	_	_	_	_	_	_	BeginSeg=Yes
39	of	_	_	_	_	_	_	_	_
40	protein	_	_	_	_	_	_	_	_
41	and	_	_	_	_	_	_	_	_
42	calciumphosphate	_	_	_	_	_	_	_	_
43	.	_	_	_	_	_	_	_	_
44	We	_	_	_	_	_	_	_	BeginSeg=Yes
45	have	_	_	_	_	_	_	_	_
46	analysed	_	_	_	_	_	_	_	_
47	the	_	_	_	_	_	_	_	_
48	role	_	_	_	_	_	_	_	_
49	of	_	_	_	_	_	_	_	_
50	the	_	_	_	_	_	_	_	_
51	milk	_	_	_	_	_	_	_	_
52	protein	_	_	_	_	_	_	_	_
53	a	_	_	_	_	_	_	_	_
54	-	_	_	_	_	_	_	_	_
55	casein	_	_	_	_	_	_	_	_
56	by	_	_	_	_	_	_	_	BeginSeg=Yes
57	inactivating	_	_	_	_	_	_	_	_
58	the	_	_	_	_	_	_	_	_
59	corresponding	_	_	_	_	_	_	_	_
60	gene	_	_	_	_	_	_	_	_
61	in	_	_	_	_	_	_	_	_
62	mice	_	_	_	_	_	_	_	_
63	.	_	_	_	_	_	_	_	_
64	Absence	_	_	_	_	_	_	_	BeginSeg=Yes
65	of	_	_	_	_	_	_	_	_
66	a	_	_	_	_	_	_	_	_
67	-	_	_	_	_	_	_	_	_
68	casein	_	_	_	_	_	_	_	_
69	protein	_	_	_	_	_	_	_	_
70	significantly	_	_	_	_	_	_	_	_
71	curtails	_	_	_	_	_	_	_	_
72	secretion	_	_	_	_	_	_	_	_
73	of	_	_	_	_	_	_	_	_
74	other	_	_	_	_	_	_	_	_
75	milk	_	_	_	_	_	_	_	_
76	proteins	_	_	_	_	_	_	_	_
77	and	_	_	_	_	_	_	_	_
78	calcium	_	_	_	_	_	_	_	_
79	-	_	_	_	_	_	_	_	_
80	phosphate	_	_	_	_	_	_	_	_
81	,	_	_	_	_	_	_	_	_
82	suggesting	_	_	_	_	_	_	_	BeginSeg=Yes
83	a	_	_	_	_	_	_	_	_
84	role	_	_	_	_	_	_	_	_
85	for	_	_	_	_	_	_	_	_
86	a	_	_	_	_	_	_	_	_
87	-	_	_	_	_	_	_	_	_
88	casein	_	_	_	_	_	_	_	_
89	in	_	_	_	_	_	_	_	_
90	the	_	_	_	_	_	_	_	_
91	establishment	_	_	_	_	_	_	_	_
92	of	_	_	_	_	_	_	_	_
93	casein	_	_	_	_	_	_	_	_
94	micelles	_	_	_	_	_	_	_	_
95	.	_	_	_	_	_	_	_	_
96	In	_	_	_	_	_	_	_	BeginSeg=Yes
97	contrast	_	_	_	_	_	_	_	_
98	,	_	_	_	_	_	_	_	_
99	secretion	_	_	_	_	_	_	_	_
100	of	_	_	_	_	_	_	_	_
101	albumin	_	_	_	_	_	_	_	_
102	,	_	_	_	_	_	_	_	_
103	which	_	_	_	_	_	_	_	BeginSeg=Yes
104	is	_	_	_	_	_	_	_	_
105	not	_	_	_	_	_	_	_	_
106	synthesized	_	_	_	_	_	_	_	_
107	in	_	_	_	_	_	_	_	_
108	the	_	_	_	_	_	_	_	_
109	mammary	_	_	_	_	_	_	_	_
110	epithelium	_	_	_	_	_	_	_	_
111	,	_	_	_	_	_	_	_	_
112	into	_	_	_	_	_	_	_	BeginSeg=Yes
113	milk	_	_	_	_	_	_	_	_
114	is	_	_	_	_	_	_	_	_
115	not	_	_	_	_	_	_	_	_
116	reduced	_	_	_	_	_	_	_	_
117	.	_	_	_	_	_	_	_	_
118	The	_	_	_	_	_	_	_	BeginSeg=Yes
119	absence	_	_	_	_	_	_	_	_
120	of	_	_	_	_	_	_	_	_
121	a	_	_	_	_	_	_	_	_
122	-	_	_	_	_	_	_	_	_
123	casein	_	_	_	_	_	_	_	_
124	also	_	_	_	_	_	_	_	_
125	significantly	_	_	_	_	_	_	_	_
126	inhibits	_	_	_	_	_	_	_	_
127	transcription	_	_	_	_	_	_	_	_
128	of	_	_	_	_	_	_	_	_
129	the	_	_	_	_	_	_	_	_
130	other	_	_	_	_	_	_	_	_
131	casein	_	_	_	_	_	_	_	_
132	genes	_	_	_	_	_	_	_	_
133	.	_	_	_	_	_	_	_	_
134	a	_	_	_	_	_	_	_	BeginSeg=Yes
135	-	_	_	_	_	_	_	_	_
136	Casein	_	_	_	_	_	_	_	_
137	deficiency	_	_	_	_	_	_	_	_
138	severely	_	_	_	_	_	_	_	_
139	delays	_	_	_	_	_	_	_	_
140	pup	_	_	_	_	_	_	_	_
141	growth	_	_	_	_	_	_	_	_
142	during	_	_	_	_	_	_	_	_
143	lactation	_	_	_	_	_	_	_	_
144	and	_	_	_	_	_	_	_	BeginSeg=Yes
145	results	_	_	_	_	_	_	_	_
146	in	_	_	_	_	_	_	_	_
147	a	_	_	_	_	_	_	_	_
148	life	_	_	_	_	_	_	_	_
149	-	_	_	_	_	_	_	_	_
150	long	_	_	_	_	_	_	_	_
151	body	_	_	_	_	_	_	_	_
152	size	_	_	_	_	_	_	_	_
153	reduction	_	_	_	_	_	_	_	_
154	compared	_	_	_	_	_	_	_	BeginSeg=Yes
155	to	_	_	_	_	_	_	_	_
156	control	_	_	_	_	_	_	_	_
157	animals	_	_	_	_	_	_	_	_
158	,	_	_	_	_	_	_	_	_
159	but	_	_	_	_	_	_	_	BeginSeg=Yes
160	has	_	_	_	_	_	_	_	_
161	only	_	_	_	_	_	_	_	_
162	transient	_	_	_	_	_	_	_	_
163	effects	_	_	_	_	_	_	_	_
164	on	_	_	_	_	_	_	_	_
165	physical	_	_	_	_	_	_	_	_
166	and	_	_	_	_	_	_	_	_
167	behavioural	_	_	_	_	_	_	_	_
168	development	_	_	_	_	_	_	_	_
169	of	_	_	_	_	_	_	_	_
170	the	_	_	_	_	_	_	_	_
171	pups	_	_	_	_	_	_	_	_
172	.	_	_	_	_	_	_	_	_
173	The	_	_	_	_	_	_	_	BeginSeg=Yes
174	data	_	_	_	_	_	_	_	_
175	support	_	_	_	_	_	_	_	_
176	a	_	_	_	_	_	_	_	_
177	critical	_	_	_	_	_	_	_	_
178	role	_	_	_	_	_	_	_	_
179	for	_	_	_	_	_	_	_	_
180	a	_	_	_	_	_	_	_	_
181	-	_	_	_	_	_	_	_	_
182	casein	_	_	_	_	_	_	_	_
183	in	_	_	_	_	_	_	_	_
184	casein	_	_	_	_	_	_	_	_
185	micelle	_	_	_	_	_	_	_	_
186	assembly	_	_	_	_	_	_	_	_
187	.	_	_	_	_	_	_	_	_
188	The	_	_	_	_	_	_	_	BeginSeg=Yes
189	results	_	_	_	_	_	_	_	_
190	also	_	_	_	_	_	_	_	_
191	confirm	_	_	_	_	_	_	_	_
192	lactation	_	_	_	_	_	_	_	_
193	as	_	_	_	_	_	_	_	_
194	a	_	_	_	_	_	_	_	_
195	critical	_	_	_	_	_	_	_	_
196	window	_	_	_	_	_	_	_	_
197	of	_	_	_	_	_	_	_	_
198	metabolic	_	_	_	_	_	_	_	_
199	programming	_	_	_	_	_	_	_	_
200	and	_	_	_	_	_	_	_	BeginSeg=Yes
201	suggest	_	_	_	_	_	_	_	_
202	milk	_	_	_	_	_	_	_	_
203	protein	_	_	_	_	_	_	_	_
204	concentration	_	_	_	_	_	_	_	_
205	as	_	_	_	_	_	_	_	_
206	a	_	_	_	_	_	_	_	_
207	decisive	_	_	_	_	_	_	_	_
208	factor	_	_	_	_	_	_	_	_
209	in	_	_	_	_	_	_	_	BeginSeg=Yes
210	determining	_	_	_	_	_	_	_	_
211	adult	_	_	_	_	_	_	_	_
212	body	_	_	_	_	_	_	_	_
213	weight	_	_	_	_	_	_	_	_
214	.	_	_	_	_	_	_	_	_

# newdoc_id = db9cea6a24f86d7bc1250050693fd459e3de6e2b
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	detection	_	_	_	_	_	_	_	_
3	of	_	_	_	_	_	_	_	_
4	scintillation	_	_	_	_	_	_	_	_
5	light	_	_	_	_	_	_	_	_
6	from	_	_	_	_	_	_	_	_
7	liquid	_	_	_	_	_	_	_	_
8	argon	_	_	_	_	_	_	_	_
9	is	_	_	_	_	_	_	_	_
10	an	_	_	_	_	_	_	_	_
11	experimental	_	_	_	_	_	_	_	_
12	technique	_	_	_	_	_	_	_	_
13	key	_	_	_	_	_	_	_	BeginSeg=Yes
14	to	_	_	_	_	_	_	_	_
15	a	_	_	_	_	_	_	_	_
16	number	_	_	_	_	_	_	_	_
17	of	_	_	_	_	_	_	_	_
18	current	_	_	_	_	_	_	_	_
19	and	_	_	_	_	_	_	_	_
20	future	_	_	_	_	_	_	_	_
21	nuclear	_	_	_	_	_	_	_	_
22	/	_	_	_	_	_	_	_	_
23	particle	_	_	_	_	_	_	_	_
24	physics	_	_	_	_	_	_	_	_
25	experiments	_	_	_	_	_	_	_	_
26	,	_	_	_	_	_	_	_	_
27	such	_	_	_	_	_	_	_	BeginSeg=Yes
28	as	_	_	_	_	_	_	_	_
29	neutrino	_	_	_	_	_	_	_	_
30	physics	_	_	_	_	_	_	_	_
31	,	_	_	_	_	_	_	_	_
32	neutrinoless	_	_	_	_	_	_	_	_
33	double	_	_	_	_	_	_	_	_
34	beta	_	_	_	_	_	_	_	_
35	decay	_	_	_	_	_	_	_	_
36	and	_	_	_	_	_	_	_	_
37	dark	_	_	_	_	_	_	_	_
38	matter	_	_	_	_	_	_	_	_
39	searches	_	_	_	_	_	_	_	_
40	.	_	_	_	_	_	_	_	_
41	Although	_	_	_	_	_	_	_	BeginSeg=Yes
42	the	_	_	_	_	_	_	_	_
43	idea	_	_	_	_	_	_	_	_
44	of	_	_	_	_	_	_	_	BeginSeg=Yes
45	adding	_	_	_	_	_	_	_	_
46	small	_	_	_	_	_	_	_	_
47	quantities	_	_	_	_	_	_	_	_
48	of	_	_	_	_	_	_	_	_
49	xenon	_	_	_	_	_	_	_	_
50	(	_	_	_	_	_	_	_	_
51	doping	_	_	_	_	_	_	_	_
52	)	_	_	_	_	_	_	_	_
53	to	_	_	_	_	_	_	_	BeginSeg=Yes
54	enhance	_	_	_	_	_	_	_	_
55	the	_	_	_	_	_	_	_	_
56	light	_	_	_	_	_	_	_	_
57	yield	_	_	_	_	_	_	_	_
58	has	_	_	_	_	_	_	_	BeginSeg=Yes
59	attracted	_	_	_	_	_	_	_	_
60	considerable	_	_	_	_	_	_	_	_
61	interest	_	_	_	_	_	_	_	_
62	,	_	_	_	_	_	_	_	_
63	this	_	_	_	_	_	_	_	BeginSeg=Yes
64	technique	_	_	_	_	_	_	_	_
65	has	_	_	_	_	_	_	_	_
66	never	_	_	_	_	_	_	_	_
67	been	_	_	_	_	_	_	_	_
68	demonstrated	_	_	_	_	_	_	_	_
69	at	_	_	_	_	_	_	_	_
70	the	_	_	_	_	_	_	_	_
71	necessary	_	_	_	_	_	_	_	_
72	scale	_	_	_	_	_	_	_	_
73	.	_	_	_	_	_	_	_	_
74	Here	_	_	_	_	_	_	_	BeginSeg=Yes
75	we	_	_	_	_	_	_	_	_
76	report	_	_	_	_	_	_	_	_
77	on	_	_	_	_	_	_	_	_
78	xenon	_	_	_	_	_	_	_	_
79	doping	_	_	_	_	_	_	_	_
80	in	_	_	_	_	_	_	_	_
81	a	_	_	_	_	_	_	_	_
82	100	_	_	_	_	_	_	_	_
83	l	_	_	_	_	_	_	_	_
84	crogenic	_	_	_	_	_	_	_	_
85	vessel	_	_	_	_	_	_	_	_
86	.	_	_	_	_	_	_	_	_
87	We	_	_	_	_	_	_	_	BeginSeg=Yes
88	observed	_	_	_	_	_	_	_	_
89	an	_	_	_	_	_	_	_	_
90	increase	_	_	_	_	_	_	_	_
91	in	_	_	_	_	_	_	_	_
92	light	_	_	_	_	_	_	_	_
93	yield	_	_	_	_	_	_	_	_
94	by	_	_	_	_	_	_	_	_
95	a	_	_	_	_	_	_	_	_
96	factor	_	_	_	_	_	_	_	_
97	of	_	_	_	_	_	_	_	_
98	1.81±0.04	_	_	_	_	_	_	_	_
99	at	_	_	_	_	_	_	_	_
100	a	_	_	_	_	_	_	_	_
101	dopant	_	_	_	_	_	_	_	_
102	concentration	_	_	_	_	_	_	_	_
103	of	_	_	_	_	_	_	_	_
104	10	_	_	_	_	_	_	_	_
105	ppm	_	_	_	_	_	_	_	_
106	,	_	_	_	_	_	_	_	_
107	consistent	_	_	_	_	_	_	_	BeginSeg=Yes
108	with	_	_	_	_	_	_	_	_
109	a	_	_	_	_	_	_	_	_
110	Geant4	_	_	_	_	_	_	_	_
111	prediction	_	_	_	_	_	_	_	_
112	of	_	_	_	_	_	_	_	_
113	1.83±0.02	_	_	_	_	_	_	_	_
114	.	_	_	_	_	_	_	_	_
115	We	_	_	_	_	_	_	_	BeginSeg=Yes
116	determine	_	_	_	_	_	_	_	_
117	a	_	_	_	_	_	_	_	_
118	lower	_	_	_	_	_	_	_	_
119	limit	_	_	_	_	_	_	_	_
120	on	_	_	_	_	_	_	_	_
121	the	_	_	_	_	_	_	_	_
122	attenuation	_	_	_	_	_	_	_	_
123	length	_	_	_	_	_	_	_	_
124	of	_	_	_	_	_	_	_	_
125	3	_	_	_	_	_	_	_	_
126	m	_	_	_	_	_	_	_	_
127	at	_	_	_	_	_	_	_	_
128	a	_	_	_	_	_	_	_	_
129	concentration	_	_	_	_	_	_	_	_
130	of	_	_	_	_	_	_	_	_
131	10	_	_	_	_	_	_	_	_
132	ppm	_	_	_	_	_	_	_	_
133	.	_	_	_	_	_	_	_	_

# newdoc_id = e296fa71274bad6cabcf683a2ba47e58b1326877
1	This	_	_	_	_	_	_	_	BeginSeg=Yes
2	paper	_	_	_	_	_	_	_	_
3	offers	_	_	_	_	_	_	_	_
4	a	_	_	_	_	_	_	_	_
5	state	_	_	_	_	_	_	_	_
6	-	_	_	_	_	_	_	_	_
7	of	_	_	_	_	_	_	_	_
8	-	_	_	_	_	_	_	_	_
9	the	_	_	_	_	_	_	_	_
10	-	_	_	_	_	_	_	_	_
11	art	_	_	_	_	_	_	_	_
12	overview	_	_	_	_	_	_	_	_
13	of	_	_	_	_	_	_	_	_
14	the	_	_	_	_	_	_	_	_
15	intertwined	_	_	_	_	_	_	_	_
16	privacy	_	_	_	_	_	_	_	_
17	,	_	_	_	_	_	_	_	_
18	confidentiality	_	_	_	_	_	_	_	_
19	,	_	_	_	_	_	_	_	_
20	and	_	_	_	_	_	_	_	_
21	security	_	_	_	_	_	_	_	_
22	issues	_	_	_	_	_	_	_	_
23	that	_	_	_	_	_	_	_	BeginSeg=Yes
24	are	_	_	_	_	_	_	_	_
25	commonly	_	_	_	_	_	_	_	_
26	encountered	_	_	_	_	_	_	_	_
27	in	_	_	_	_	_	_	_	_
28	health	_	_	_	_	_	_	_	_
29	research	_	_	_	_	_	_	_	_
30	involving	_	_	_	_	_	_	_	BeginSeg=Yes
31	disaggregate	_	_	_	_	_	_	_	_
32	geographic	_	_	_	_	_	_	_	_
33	data	_	_	_	_	_	_	_	_
34	about	_	_	_	_	_	_	_	_
35	individuals	_	_	_	_	_	_	_	_
36	.	_	_	_	_	_	_	_	_
37	Key	_	_	_	_	_	_	_	BeginSeg=Yes
38	definitions	_	_	_	_	_	_	_	_
39	are	_	_	_	_	_	_	_	_
40	provided	_	_	_	_	_	_	_	_
41	,	_	_	_	_	_	_	_	_
42	along	_	_	_	_	_	_	_	_
43	with	_	_	_	_	_	_	_	_
44	some	_	_	_	_	_	_	_	_
45	examples	_	_	_	_	_	_	_	_
46	of	_	_	_	_	_	_	_	_
47	actual	_	_	_	_	_	_	_	_
48	and	_	_	_	_	_	_	_	_
49	potential	_	_	_	_	_	_	_	_
50	security	_	_	_	_	_	_	_	_
51	and	_	_	_	_	_	_	_	_
52	confidentiality	_	_	_	_	_	_	_	_
53	breaches	_	_	_	_	_	_	_	_
54	and	_	_	_	_	_	_	_	_
55	related	_	_	_	_	_	_	_	_
56	incidents	_	_	_	_	_	_	_	_
57	that	_	_	_	_	_	_	_	BeginSeg=Yes
58	captured	_	_	_	_	_	_	_	_
59	mainstream	_	_	_	_	_	_	_	_
60	media	_	_	_	_	_	_	_	_
61	and	_	_	_	_	_	_	_	_
62	public	_	_	_	_	_	_	_	_
63	interest	_	_	_	_	_	_	_	_
64	in	_	_	_	_	_	_	_	_
65	recent	_	_	_	_	_	_	_	_
66	months	_	_	_	_	_	_	_	_
67	and	_	_	_	_	_	_	_	_
68	years	_	_	_	_	_	_	_	_
69	.	_	_	_	_	_	_	_	_
70	The	_	_	_	_	_	_	_	BeginSeg=Yes
71	paper	_	_	_	_	_	_	_	_
72	then	_	_	_	_	_	_	_	_
73	goes	_	_	_	_	_	_	_	_
74	on	_	_	_	_	_	_	_	_
75	to	_	_	_	_	_	_	_	_
76	present	_	_	_	_	_	_	_	_
77	a	_	_	_	_	_	_	_	_
78	brief	_	_	_	_	_	_	_	_
79	survey	_	_	_	_	_	_	_	_
80	of	_	_	_	_	_	_	_	_
81	the	_	_	_	_	_	_	_	_
82	research	_	_	_	_	_	_	_	_
83	literature	_	_	_	_	_	_	_	_
84	on	_	_	_	_	_	_	_	_
85	location	_	_	_	_	_	_	_	_
86	privacy	_	_	_	_	_	_	_	_
87	/	_	_	_	_	_	_	_	_
88	confidentiality	_	_	_	_	_	_	_	_
89	concerns	_	_	_	_	_	_	_	_
90	and	_	_	_	_	_	_	_	_
91	on	_	_	_	_	_	_	_	_
92	privacy	_	_	_	_	_	_	_	_
93	-	_	_	_	_	_	_	_	_
94	preserving	_	_	_	_	_	_	_	_
95	solutions	_	_	_	_	_	_	_	_
96	in	_	_	_	_	_	_	_	_
97	conventional	_	_	_	_	_	_	_	_
98	health	_	_	_	_	_	_	_	_
99	research	_	_	_	_	_	_	_	_
100	and	_	_	_	_	_	_	_	_
101	beyond	_	_	_	_	_	_	_	_
102	,	_	_	_	_	_	_	_	_
103	touching	_	_	_	_	_	_	_	BeginSeg=Yes
104	on	_	_	_	_	_	_	_	_
105	the	_	_	_	_	_	_	_	_
106	emerging	_	_	_	_	_	_	_	_
107	privacy	_	_	_	_	_	_	_	_
108	issues	_	_	_	_	_	_	_	_
109	associated	_	_	_	_	_	_	_	BeginSeg=Yes
110	with	_	_	_	_	_	_	_	_
111	online	_	_	_	_	_	_	_	_
112	consumer	_	_	_	_	_	_	_	_
113	geoinformatics	_	_	_	_	_	_	_	_
114	and	_	_	_	_	_	_	_	_
115	location	_	_	_	_	_	_	_	_
116	-	_	_	_	_	_	_	_	_
117	based	_	_	_	_	_	_	_	_
118	services	_	_	_	_	_	_	_	_
119	.	_	_	_	_	_	_	_	_
120	The	_	_	_	_	_	_	_	BeginSeg=Yes
121	'	_	_	_	_	_	_	_	_
122	missing	_	_	_	_	_	_	_	_
123	ring	_	_	_	_	_	_	_	_
124	'	_	_	_	_	_	_	_	_
125	(	_	_	_	_	_	_	_	_
126	in	_	_	_	_	_	_	_	_
127	many	_	_	_	_	_	_	_	_
128	treatments	_	_	_	_	_	_	_	_
129	of	_	_	_	_	_	_	_	_
130	the	_	_	_	_	_	_	_	_
131	topic	_	_	_	_	_	_	_	_
132	)	_	_	_	_	_	_	_	_
133	of	_	_	_	_	_	_	_	_
134	data	_	_	_	_	_	_	_	_
135	security	_	_	_	_	_	_	_	_
136	is	_	_	_	_	_	_	_	_
137	also	_	_	_	_	_	_	_	_
138	discussed	_	_	_	_	_	_	_	_
139	.	_	_	_	_	_	_	_	_
140	Personal	_	_	_	_	_	_	_	BeginSeg=Yes
141	information	_	_	_	_	_	_	_	_
142	and	_	_	_	_	_	_	_	_
143	privacy	_	_	_	_	_	_	_	_
144	legislations	_	_	_	_	_	_	_	_
145	in	_	_	_	_	_	_	_	_
146	two	_	_	_	_	_	_	_	_
147	countries	_	_	_	_	_	_	_	_
148	,	_	_	_	_	_	_	_	_
149	Canada	_	_	_	_	_	_	_	_
150	and	_	_	_	_	_	_	_	_
151	the	_	_	_	_	_	_	_	_
152	UK	_	_	_	_	_	_	_	_
153	,	_	_	_	_	_	_	_	_
154	are	_	_	_	_	_	_	_	_
155	covered	_	_	_	_	_	_	_	_
156	,	_	_	_	_	_	_	_	_
157	as	_	_	_	_	_	_	_	_
158	well	_	_	_	_	_	_	_	_
159	as	_	_	_	_	_	_	_	_
160	some	_	_	_	_	_	_	_	_
161	examples	_	_	_	_	_	_	_	_
162	of	_	_	_	_	_	_	_	_
163	recent	_	_	_	_	_	_	_	_
164	research	_	_	_	_	_	_	_	_
165	projects	_	_	_	_	_	_	_	_
166	and	_	_	_	_	_	_	_	_
167	events	_	_	_	_	_	_	_	_
168	about	_	_	_	_	_	_	_	_
169	the	_	_	_	_	_	_	_	_
170	subject	_	_	_	_	_	_	_	_
171	.	_	_	_	_	_	_	_	_
172	Select	_	_	_	_	_	_	_	BeginSeg=Yes
173	highlights	_	_	_	_	_	_	_	_
174	from	_	_	_	_	_	_	_	_
175	a	_	_	_	_	_	_	_	_
176	June	_	_	_	_	_	_	_	_
177	2009	_	_	_	_	_	_	_	_
178	URISA	_	_	_	_	_	_	_	_
179	(	_	_	_	_	_	_	_	_
180	Urban	_	_	_	_	_	_	_	_
181	and	_	_	_	_	_	_	_	_
182	Regional	_	_	_	_	_	_	_	_
183	Information	_	_	_	_	_	_	_	_
184	Systems	_	_	_	_	_	_	_	_
185	Association	_	_	_	_	_	_	_	_
186	)	_	_	_	_	_	_	_	_
187	workshop	_	_	_	_	_	_	_	_
188	entitled	_	_	_	_	_	_	_	_
189	'	_	_	_	_	_	_	_	_
190	Protecting	_	_	_	_	_	_	_	_
191	Privacy	_	_	_	_	_	_	_	_
192	and	_	_	_	_	_	_	_	_
193	Confidentiality	_	_	_	_	_	_	_	_
194	of	_	_	_	_	_	_	_	_
195	Geographic	_	_	_	_	_	_	_	_
196	Data	_	_	_	_	_	_	_	_
197	in	_	_	_	_	_	_	_	_
198	Health	_	_	_	_	_	_	_	_
199	Research	_	_	_	_	_	_	_	_
200	'	_	_	_	_	_	_	_	_
201	are	_	_	_	_	_	_	_	_
202	then	_	_	_	_	_	_	_	_
203	presented	_	_	_	_	_	_	_	_
204	.	_	_	_	_	_	_	_	_
205	The	_	_	_	_	_	_	_	BeginSeg=Yes
206	paper	_	_	_	_	_	_	_	_
207	concludes	_	_	_	_	_	_	_	_
208	by	_	_	_	_	_	_	_	BeginSeg=Yes
209	briefly	_	_	_	_	_	_	_	_
210	charting	_	_	_	_	_	_	_	_
211	the	_	_	_	_	_	_	_	_
212	complexity	_	_	_	_	_	_	_	_
213	of	_	_	_	_	_	_	_	_
214	the	_	_	_	_	_	_	_	_
215	domain	_	_	_	_	_	_	_	_
216	and	_	_	_	_	_	_	_	_
217	the	_	_	_	_	_	_	_	_
218	many	_	_	_	_	_	_	_	_
219	challenges	_	_	_	_	_	_	_	_
220	associated	_	_	_	_	_	_	_	BeginSeg=Yes
221	with	_	_	_	_	_	_	_	_
222	it	_	_	_	_	_	_	_	_
223	,	_	_	_	_	_	_	_	_
224	and	_	_	_	_	_	_	_	BeginSeg=Yes
225	proposing	_	_	_	_	_	_	_	_
226	a	_	_	_	_	_	_	_	_
227	novel	_	_	_	_	_	_	_	_
228	,	_	_	_	_	_	_	_	_
229	'	_	_	_	_	_	_	_	_
230	one	_	_	_	_	_	_	_	_
231	stop	_	_	_	_	_	_	_	_
232	shop	_	_	_	_	_	_	_	_
233	'	_	_	_	_	_	_	_	_
234	case	_	_	_	_	_	_	_	_
235	-	_	_	_	_	_	_	_	_
236	based	_	_	_	_	_	_	_	_
237	reasoning	_	_	_	_	_	_	_	_
238	framework	_	_	_	_	_	_	_	_
239	to	_	_	_	_	_	_	_	BeginSeg=Yes
240	streamline	_	_	_	_	_	_	_	_
241	the	_	_	_	_	_	_	_	_
242	provision	_	_	_	_	_	_	_	_
243	of	_	_	_	_	_	_	_	_
244	clear	_	_	_	_	_	_	_	_
245	and	_	_	_	_	_	_	_	_
246	individualised	_	_	_	_	_	_	_	_
247	guidance	_	_	_	_	_	_	_	_
248	for	_	_	_	_	_	_	_	_
249	the	_	_	_	_	_	_	_	_
250	design	_	_	_	_	_	_	_	_
251	and	_	_	_	_	_	_	_	_
252	approval	_	_	_	_	_	_	_	_
253	of	_	_	_	_	_	_	_	_
254	new	_	_	_	_	_	_	_	_
255	research	_	_	_	_	_	_	_	_
256	projects	_	_	_	_	_	_	_	_
257	(	_	_	_	_	_	_	_	BeginSeg=Yes
258	involving	_	_	_	_	_	_	_	_
259	geographical	_	_	_	_	_	_	_	_
260	identifiers	_	_	_	_	_	_	_	_
261	about	_	_	_	_	_	_	_	_
262	individuals	_	_	_	_	_	_	_	_
263	)	_	_	_	_	_	_	_	_
264	,	_	_	_	_	_	_	_	_
265	including	_	_	_	_	_	_	_	BeginSeg=Yes
266	crisp	_	_	_	_	_	_	_	_
267	recommendations	_	_	_	_	_	_	_	_
268	on	_	_	_	_	_	_	_	BeginSeg=Yes
269	which	_	_	_	_	_	_	_	_
270	specific	_	_	_	_	_	_	_	_
271	privacy	_	_	_	_	_	_	_	_
272	-	_	_	_	_	_	_	_	_
273	preserving	_	_	_	_	_	_	_	_
274	solutions	_	_	_	_	_	_	_	_
275	and	_	_	_	_	_	_	_	_
276	approaches	_	_	_	_	_	_	_	_
277	would	_	_	_	_	_	_	_	_
278	be	_	_	_	_	_	_	_	_
279	suitable	_	_	_	_	_	_	_	_
280	in	_	_	_	_	_	_	_	_
281	each	_	_	_	_	_	_	_	_
282	case	_	_	_	_	_	_	_	_
283	.	_	_	_	_	_	_	_	_

# newdoc_id = e29e17f37924d1d14edf56276a5dcca87851e62f
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	HIV-1	_	_	_	_	_	_	_	_
3	frameshift	_	_	_	_	_	_	_	_
4	-	_	_	_	_	_	_	_	_
5	stimulating	_	_	_	_	_	_	_	_
6	(	_	_	_	_	_	_	_	_
7	FSS	_	_	_	_	_	_	_	_
8	)	_	_	_	_	_	_	_	_
9	RNA	_	_	_	_	_	_	_	_
10	,	_	_	_	_	_	_	_	_
11	a	_	_	_	_	_	_	_	_
12	regulatory	_	_	_	_	_	_	_	_
13	RNA	_	_	_	_	_	_	_	_
14	of	_	_	_	_	_	_	_	_
15	critical	_	_	_	_	_	_	_	_
16	importance	_	_	_	_	_	_	_	_
17	in	_	_	_	_	_	_	_	_
18	the	_	_	_	_	_	_	_	_
19-20	virus'	_	_	_	_	_	_	_	_
19	virus	_	_	_	_	_	_	_	_
20	'	_	_	_	_	_	_	_	_
21	life	_	_	_	_	_	_	_	_
22	cycle	_	_	_	_	_	_	_	_
23	,	_	_	_	_	_	_	_	_
24	has	_	_	_	_	_	_	_	_
25	been	_	_	_	_	_	_	_	_
26	posited	_	_	_	_	_	_	_	_
27	as	_	_	_	_	_	_	_	_
28	a	_	_	_	_	_	_	_	_
29	novel	_	_	_	_	_	_	_	_
30	target	_	_	_	_	_	_	_	_
31	for	_	_	_	_	_	_	_	_
32	anti	_	_	_	_	_	_	_	_
33	-	_	_	_	_	_	_	_	_
34	HIV	_	_	_	_	_	_	_	_
35	drug	_	_	_	_	_	_	_	_
36	development	_	_	_	_	_	_	_	_
37	.	_	_	_	_	_	_	_	_
38	We	_	_	_	_	_	_	_	BeginSeg=Yes
39	report	_	_	_	_	_	_	_	_
40	the	_	_	_	_	_	_	_	_
41	synthesis	_	_	_	_	_	_	_	_
42	and	_	_	_	_	_	_	_	_
43	evaluation	_	_	_	_	_	_	_	_
44	of	_	_	_	_	_	_	_	_
45	triazole	_	_	_	_	_	_	_	_
46	-	_	_	_	_	_	_	_	_
47	containing	_	_	_	_	_	_	_	_
48	compounds	_	_	_	_	_	_	_	_
49	able	_	_	_	_	_	_	_	BeginSeg=Yes
50	to	_	_	_	_	_	_	_	_
51	bind	_	_	_	_	_	_	_	_
52	the	_	_	_	_	_	_	_	_
53	FSS	_	_	_	_	_	_	_	_
54	with	_	_	_	_	_	_	_	_
55	high	_	_	_	_	_	_	_	_
56	affinity	_	_	_	_	_	_	_	_
57	and	_	_	_	_	_	_	_	_
58	selectivity	_	_	_	_	_	_	_	_
59	.	_	_	_	_	_	_	_	_
60	Readily	_	_	_	_	_	_	_	BeginSeg=Yes
61	accessible	_	_	_	_	_	_	_	_
62	synthetically	_	_	_	_	_	_	_	_
63	,	_	_	_	_	_	_	_	_
64	these	_	_	_	_	_	_	_	_
65	compounds	_	_	_	_	_	_	_	_
66	are	_	_	_	_	_	_	_	_
67	less	_	_	_	_	_	_	_	_
68	toxic	_	_	_	_	_	_	_	_
69	than	_	_	_	_	_	_	_	_
70	previously	_	_	_	_	_	_	_	_
71	reported	_	_	_	_	_	_	_	_
72	olefin	_	_	_	_	_	_	_	_
73	congeners	_	_	_	_	_	_	_	_
74	.	_	_	_	_	_	_	_	_
75	We	_	_	_	_	_	_	_	BeginSeg=Yes
76	show	_	_	_	_	_	_	_	_
77	for	_	_	_	_	_	_	_	_
78	the	_	_	_	_	_	_	_	_
79	first	_	_	_	_	_	_	_	_
80	time	_	_	_	_	_	_	_	_
81	that	_	_	_	_	_	_	_	BeginSeg=Yes
82	FSS	_	_	_	_	_	_	_	_
83	-	_	_	_	_	_	_	_	_
84	targeting	_	_	_	_	_	_	_	_
85	compounds	_	_	_	_	_	_	_	_
86	have	_	_	_	_	_	_	_	_
87	antiviral	_	_	_	_	_	_	_	_
88	activity	_	_	_	_	_	_	_	_
89	against	_	_	_	_	_	_	_	_
90	replication	_	_	_	_	_	_	_	_
91	-	_	_	_	_	_	_	_	_
92	competent	_	_	_	_	_	_	_	_
93	HIV	_	_	_	_	_	_	_	_
94	in	_	_	_	_	_	_	_	_
95	human	_	_	_	_	_	_	_	_
96	cells	_	_	_	_	_	_	_	_
97	,	_	_	_	_	_	_	_	_
98	including	_	_	_	_	_	_	_	BeginSeg=Yes
99	a	_	_	_	_	_	_	_	_
100	highly	_	_	_	_	_	_	_	_
101	cytopathic	_	_	_	_	_	_	_	_
102	,	_	_	_	_	_	_	_	_
103	multidrug	_	_	_	_	_	_	_	_
104	-	_	_	_	_	_	_	_	_
105	resistant	_	_	_	_	_	_	_	_
106	strain	_	_	_	_	_	_	_	_
107	.	_	_	_	_	_	_	_	_
108	These	_	_	_	_	_	_	_	BeginSeg=Yes
109	results	_	_	_	_	_	_	_	_
110	support	_	_	_	_	_	_	_	_
111	the	_	_	_	_	_	_	_	_
112	viability	_	_	_	_	_	_	_	_
113	of	_	_	_	_	_	_	_	_
114	the	_	_	_	_	_	_	_	_
115	HIV-1	_	_	_	_	_	_	_	_
116	FSS	_	_	_	_	_	_	_	_
117	RNA	_	_	_	_	_	_	_	_
118	as	_	_	_	_	_	_	_	_
119	a	_	_	_	_	_	_	_	_
120	therapeutic	_	_	_	_	_	_	_	_
121	target	_	_	_	_	_	_	_	_
122	and	_	_	_	_	_	_	_	BeginSeg=Yes
123	more	_	_	_	_	_	_	_	_
124	generally	_	_	_	_	_	_	_	_
125	highlight	_	_	_	_	_	_	_	_
126	opportunities	_	_	_	_	_	_	_	_
127	for	_	_	_	_	_	_	_	_
128	synthetic	_	_	_	_	_	_	_	_
129	molecule	_	_	_	_	_	_	_	_
130	-	_	_	_	_	_	_	_	_
131	mediated	_	_	_	_	_	_	_	_
132	interference	_	_	_	_	_	_	_	_
133	with	_	_	_	_	_	_	_	_
134	protein	_	_	_	_	_	_	_	_
135	recoding	_	_	_	_	_	_	_	_
136	in	_	_	_	_	_	_	_	_
137	a	_	_	_	_	_	_	_	_
138	wide	_	_	_	_	_	_	_	_
139	range	_	_	_	_	_	_	_	_
140	of	_	_	_	_	_	_	_	_
141	organisms	_	_	_	_	_	_	_	_
142	.	_	_	_	_	_	_	_	_

# newdoc_id = e2c49130523a4232721c16791431632d09810a38
1	COVID-19	_	_	_	_	_	_	_	BeginSeg=Yes
2	has	_	_	_	_	_	_	_	_
3	massively	_	_	_	_	_	_	_	_
4	changed	_	_	_	_	_	_	_	_
5	the	_	_	_	_	_	_	_	_
6	health	_	_	_	_	_	_	_	_
7	landscape	_	_	_	_	_	_	_	_
8	around	_	_	_	_	_	_	_	_
9	the	_	_	_	_	_	_	_	_
10	world	_	_	_	_	_	_	_	_
11	.	_	_	_	_	_	_	_	_
12	Wide	_	_	_	_	_	_	_	BeginSeg=Yes
13	-	_	_	_	_	_	_	_	_
14	ranging	_	_	_	_	_	_	_	_
15	changes	_	_	_	_	_	_	_	_
16	to	_	_	_	_	_	_	_	_
17	healthcare	_	_	_	_	_	_	_	_
18	delivery	_	_	_	_	_	_	_	_
19	have	_	_	_	_	_	_	_	_
20	occurred	_	_	_	_	_	_	_	_
21	,	_	_	_	_	_	_	_	_
22	especially	_	_	_	_	_	_	_	_
23	in	_	_	_	_	_	_	_	_
24	hospitals	_	_	_	_	_	_	_	_
25	and	_	_	_	_	_	_	_	_
26	EDs	_	_	_	_	_	_	_	_
27	.	_	_	_	_	_	_	_	_
28	Health	_	_	_	_	_	_	_	BeginSeg=Yes
29	services	_	_	_	_	_	_	_	_
30	have	_	_	_	_	_	_	_	_
31	made	_	_	_	_	_	_	_	_
32	local	_	_	_	_	_	_	_	_
33	decisions	_	_	_	_	_	_	_	_
34	about	_	_	_	_	_	_	_	_
35	care	_	_	_	_	_	_	_	_
36	pathways	_	_	_	_	_	_	_	_
37	,	_	_	_	_	_	_	_	_
38	in	_	_	_	_	_	_	_	_
39	some	_	_	_	_	_	_	_	_
40	cases	_	_	_	_	_	_	_	_
41	deviating	_	_	_	_	_	_	_	BeginSeg=Yes
42	from	_	_	_	_	_	_	_	_
43	what	_	_	_	_	_	_	_	_
44	would	_	_	_	_	_	_	_	_
45	,	_	_	_	_	_	_	_	_
46	until	_	_	_	_	_	_	_	_
47	recently	_	_	_	_	_	_	_	_
48	,	_	_	_	_	_	_	_	_
49	have	_	_	_	_	_	_	_	_
50	been	_	_	_	_	_	_	_	_
51	considered	_	_	_	_	_	_	_	_
52	widely	_	_	_	_	_	_	_	_
53	accepted	_	_	_	_	_	_	_	_
54	care	_	_	_	_	_	_	_	_
55	.	_	_	_	_	_	_	_	_
56	These	_	_	_	_	_	_	_	BeginSeg=Yes
57	changes	_	_	_	_	_	_	_	_
58	bring	_	_	_	_	_	_	_	_
59	with	_	_	_	_	_	_	_	_
60	them	_	_	_	_	_	_	_	_
61	new	_	_	_	_	_	_	_	_
62	medicolegal	_	_	_	_	_	_	_	_
63	risk	_	_	_	_	_	_	_	_
64	for	_	_	_	_	_	_	_	_
65	clinicians	_	_	_	_	_	_	_	_
66	.	_	_	_	_	_	_	_	_
67	In	_	_	_	_	_	_	_	BeginSeg=Yes
68	Australia	_	_	_	_	_	_	_	_
69	,	_	_	_	_	_	_	_	_
70	civil	_	_	_	_	_	_	_	_
71	liability	_	_	_	_	_	_	_	_
72	Acts	_	_	_	_	_	_	_	_
73	provide	_	_	_	_	_	_	_	_
74	protection	_	_	_	_	_	_	_	_
75	for	_	_	_	_	_	_	_	_
76	professionals	_	_	_	_	_	_	_	_
77	when	_	_	_	_	_	_	_	BeginSeg=Yes
78	the	_	_	_	_	_	_	_	_
79	criterion	_	_	_	_	_	_	_	_
80	of	_	_	_	_	_	_	_	BeginSeg=Yes
81	having	_	_	_	_	_	_	_	_
82	undertaken	_	_	_	_	_	_	_	_
83	'	_	_	_	_	_	_	_	_
84	competent	_	_	_	_	_	_	_	_
85	'	_	_	_	_	_	_	_	_
86	practice	_	_	_	_	_	_	_	_
87	that	_	_	_	_	_	_	_	BeginSeg=Yes
88	would	_	_	_	_	_	_	_	_
89	be	_	_	_	_	_	_	_	_
90	'	_	_	_	_	_	_	_	_
91	widely	_	_	_	_	_	_	_	_
92	accepted	_	_	_	_	_	_	_	_
93	'	_	_	_	_	_	_	_	_
94	'	_	_	_	_	_	_	_	_
95	in	_	_	_	_	_	_	_	_
96	the	_	_	_	_	_	_	_	_
97	circumstances	_	_	_	_	_	_	_	_
98	'	_	_	_	_	_	_	_	_
99	is	_	_	_	_	_	_	_	BeginSeg=Yes
100	met	_	_	_	_	_	_	_	_
101	.	_	_	_	_	_	_	_	_
102	There	_	_	_	_	_	_	_	BeginSeg=Yes
103	is	_	_	_	_	_	_	_	_
104	doubt	_	_	_	_	_	_	_	_
105	how	_	_	_	_	_	_	_	_
106	courts	_	_	_	_	_	_	_	_
107	,	_	_	_	_	_	_	_	_
108	and	_	_	_	_	_	_	_	_
109	the	_	_	_	_	_	_	_	_
110	medical	_	_	_	_	_	_	_	_
111	experts	_	_	_	_	_	_	_	_
112	who	_	_	_	_	_	_	_	BeginSeg=Yes
113	advise	_	_	_	_	_	_	_	_
114	them	_	_	_	_	_	_	_	_
115	,	_	_	_	_	_	_	_	_
116	will	_	_	_	_	_	_	_	BeginSeg=Yes
117	evaluate	_	_	_	_	_	_	_	_
118	clinical	_	_	_	_	_	_	_	_
119	care	_	_	_	_	_	_	_	_
120	provided	_	_	_	_	_	_	_	BeginSeg=Yes
121	during	_	_	_	_	_	_	_	_
122	the	_	_	_	_	_	_	_	_
123	pandemic	_	_	_	_	_	_	_	_
124	when	_	_	_	_	_	_	_	BeginSeg=Yes
125	health	_	_	_	_	_	_	_	_
126	services	_	_	_	_	_	_	_	_
127	have	_	_	_	_	_	_	_	_
128	developed	_	_	_	_	_	_	_	_
129	local	_	_	_	_	_	_	_	_
130	care	_	_	_	_	_	_	_	_
131	pathways	_	_	_	_	_	_	_	_
132	and	_	_	_	_	_	_	_	BeginSeg=Yes
133	there	_	_	_	_	_	_	_	_
134	is	_	_	_	_	_	_	_	_
135	no	_	_	_	_	_	_	_	_
136	nationally	_	_	_	_	_	_	_	_
137	accepted	_	_	_	_	_	_	_	_
138	standard	_	_	_	_	_	_	_	_
139	.	_	_	_	_	_	_	_	_

# newdoc_id = e6aaada1af8e6361fefb6307231035a4da1c6141
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	Severe	_	_	_	_	_	_	_	_
3	Acute	_	_	_	_	_	_	_	_
4	Respiratory	_	_	_	_	_	_	_	_
5	Syndrome	_	_	_	_	_	_	_	_
6	Coronavirus	_	_	_	_	_	_	_	_
7	2	_	_	_	_	_	_	_	_
8	(	_	_	_	_	_	_	_	_
9	SARS	_	_	_	_	_	_	_	_
10	-	_	_	_	_	_	_	_	_
11	CoV-2	_	_	_	_	_	_	_	_
12	)	_	_	_	_	_	_	_	_
13	is	_	_	_	_	_	_	_	_
14	a	_	_	_	_	_	_	_	_
15	novel	_	_	_	_	_	_	_	_
16	coronavirus	_	_	_	_	_	_	_	_
17	first	_	_	_	_	_	_	_	BeginSeg=Yes
18	identified	_	_	_	_	_	_	_	_
19	in	_	_	_	_	_	_	_	_
20	Wuhan	_	_	_	_	_	_	_	_
21	,	_	_	_	_	_	_	_	_
22	China	_	_	_	_	_	_	_	_
23	,	_	_	_	_	_	_	_	_
24	and	_	_	_	_	_	_	_	BeginSeg=Yes
25	the	_	_	_	_	_	_	_	_
26	etiological	_	_	_	_	_	_	_	_
27	agent	_	_	_	_	_	_	_	_
28	of	_	_	_	_	_	_	_	_
29	Coronavirus	_	_	_	_	_	_	_	_
30	Disease-2019	_	_	_	_	_	_	_	_
31	.	_	_	_	_	_	_	_	_
32	This	_	_	_	_	_	_	_	BeginSeg=Yes
33	infection	_	_	_	_	_	_	_	_
34	spreads	_	_	_	_	_	_	_	_
35	mainly	_	_	_	_	_	_	_	_
36	through	_	_	_	_	_	_	_	_
37	direct	_	_	_	_	_	_	_	_
38	contact	_	_	_	_	_	_	_	_
39	with	_	_	_	_	_	_	_	_
40	Flügge	_	_	_	_	_	_	_	_
41	micro	_	_	_	_	_	_	_	_
42	droplets	_	_	_	_	_	_	_	_
43	or	_	_	_	_	_	_	_	_
44	core	_	_	_	_	_	_	_	_
45	droplets	_	_	_	_	_	_	_	_
46	that	_	_	_	_	_	_	_	BeginSeg=Yes
47	remain	_	_	_	_	_	_	_	_
48	suspended	_	_	_	_	_	_	_	_
49	as	_	_	_	_	_	_	_	_
50	aerosol	_	_	_	_	_	_	_	_
51	.	_	_	_	_	_	_	_	_
52	Moreover	_	_	_	_	_	_	_	BeginSeg=Yes
53	,	_	_	_	_	_	_	_	_
54	it	_	_	_	_	_	_	_	_
55	has	_	_	_	_	_	_	_	_
56	been	_	_	_	_	_	_	_	_
57	reported	_	_	_	_	_	_	_	_
58	that	_	_	_	_	_	_	_	_
59	infected	_	_	_	_	_	_	_	_
60	subjects	_	_	_	_	_	_	_	_
61	,	_	_	_	_	_	_	_	_
62	both	_	_	_	_	_	_	_	_
63	with	_	_	_	_	_	_	_	_
64	and	_	_	_	_	_	_	_	_
65	without	_	_	_	_	_	_	_	_
66	clinical	_	_	_	_	_	_	_	_
67	signs	_	_	_	_	_	_	_	_
68	of	_	_	_	_	_	_	_	_
69	COVID-19	_	_	_	_	_	_	_	_
70	,	_	_	_	_	_	_	_	_
71	can	_	_	_	_	_	_	_	_
72	transmit	_	_	_	_	_	_	_	_
73	the	_	_	_	_	_	_	_	_
74	virus	_	_	_	_	_	_	_	_
75	.	_	_	_	_	_	_	_	_
76	Since	_	_	_	_	_	_	_	BeginSeg=Yes
77	the	_	_	_	_	_	_	_	_
78	infection	_	_	_	_	_	_	_	_
79	typically	_	_	_	_	_	_	_	_
80	enters	_	_	_	_	_	_	_	_
81	through	_	_	_	_	_	_	_	_
82	mouth	_	_	_	_	_	_	_	_
83	,	_	_	_	_	_	_	_	_
84	nose	_	_	_	_	_	_	_	_
85	,	_	_	_	_	_	_	_	_
86	and	_	_	_	_	_	_	_	_
87	eyes	_	_	_	_	_	_	_	_
88	,	_	_	_	_	_	_	_	_
89	dentistry	_	_	_	_	_	_	_	BeginSeg=Yes
90	is	_	_	_	_	_	_	_	_
91	one	_	_	_	_	_	_	_	_
92	of	_	_	_	_	_	_	_	_
93	the	_	_	_	_	_	_	_	_
94	medical	_	_	_	_	_	_	_	_
95	practices	_	_	_	_	_	_	_	_
96	at	_	_	_	_	_	_	_	_
97	highest	_	_	_	_	_	_	_	_
98	risk	_	_	_	_	_	_	_	_
99	of	_	_	_	_	_	_	_	_
100	infection	_	_	_	_	_	_	_	_
101	due	_	_	_	_	_	_	_	BeginSeg=Yes
102	to	_	_	_	_	_	_	_	_
103	the	_	_	_	_	_	_	_	_
104	frequent	_	_	_	_	_	_	_	_
105	production	_	_	_	_	_	_	_	_
106	of	_	_	_	_	_	_	_	_
107	aerosol	_	_	_	_	_	_	_	_
108	and	_	_	_	_	_	_	_	_
109	the	_	_	_	_	_	_	_	_
110	constant	_	_	_	_	_	_	_	_
111	presence	_	_	_	_	_	_	_	_
112	of	_	_	_	_	_	_	_	_
113	saliva	_	_	_	_	_	_	_	_
114	.	_	_	_	_	_	_	_	_
115	The	_	_	_	_	_	_	_	BeginSeg=Yes
116	World	_	_	_	_	_	_	_	_
117	Health	_	_	_	_	_	_	_	_
118	Organization	_	_	_	_	_	_	_	_
119	(	_	_	_	_	_	_	_	_
120	WHO	_	_	_	_	_	_	_	_
121	)	_	_	_	_	_	_	_	_
122	has	_	_	_	_	_	_	_	_
123	suggested	_	_	_	_	_	_	_	_
124	that	_	_	_	_	_	_	_	BeginSeg=Yes
125	only	_	_	_	_	_	_	_	_
126	emergency	_	_	_	_	_	_	_	_
127	/	_	_	_	_	_	_	_	_
128	urgent	_	_	_	_	_	_	_	_
129	procedures	_	_	_	_	_	_	_	_
130	should	_	_	_	_	_	_	_	_
131	be	_	_	_	_	_	_	_	_
132	performed	_	_	_	_	_	_	_	_
133	during	_	_	_	_	_	_	_	_
134	the	_	_	_	_	_	_	_	_
135	coronavirus	_	_	_	_	_	_	_	_
136	outbreak	_	_	_	_	_	_	_	_
137	.	_	_	_	_	_	_	_	_
138	Considering	_	_	_	_	_	_	_	BeginSeg=Yes
139	the	_	_	_	_	_	_	_	_
140-141	virus'	_	_	_	_	_	_	_	_
140	virus	_	_	_	_	_	_	_	_
141	'	_	_	_	_	_	_	_	_
142	route	_	_	_	_	_	_	_	_
143	of	_	_	_	_	_	_	_	_
144	transmission	_	_	_	_	_	_	_	_
145	,	_	_	_	_	_	_	_	_
146	a	_	_	_	_	_	_	_	BeginSeg=Yes
147	specific	_	_	_	_	_	_	_	_
148	protocol	_	_	_	_	_	_	_	_
149	should	_	_	_	_	_	_	_	_
150	be	_	_	_	_	_	_	_	_
151	applied	_	_	_	_	_	_	_	_
152	to	_	_	_	_	_	_	_	BeginSeg=Yes
153	reduce	_	_	_	_	_	_	_	_
154	the	_	_	_	_	_	_	_	_
155	risk	_	_	_	_	_	_	_	_
156	of	_	_	_	_	_	_	_	_
157	infection	_	_	_	_	_	_	_	_
158	in	_	_	_	_	_	_	_	BeginSeg=Yes
159	addition	_	_	_	_	_	_	_	_
160	to	_	_	_	_	_	_	_	_
161	measures	_	_	_	_	_	_	_	_
162	that	_	_	_	_	_	_	_	BeginSeg=Yes
163	prevent	_	_	_	_	_	_	_	_
164	the	_	_	_	_	_	_	_	_
165	spread	_	_	_	_	_	_	_	_
166	of	_	_	_	_	_	_	_	_
167	infection	_	_	_	_	_	_	_	_
168	from	_	_	_	_	_	_	_	_
169	a	_	_	_	_	_	_	_	_
170	patient	_	_	_	_	_	_	_	_
171	to	_	_	_	_	_	_	_	_
172	another	_	_	_	_	_	_	_	_
173	person	_	_	_	_	_	_	_	_
174	or	_	_	_	_	_	_	_	_
175	medical	_	_	_	_	_	_	_	_
176	tools	_	_	_	_	_	_	_	_
177	and	_	_	_	_	_	_	_	_
178	equipment	_	_	_	_	_	_	_	_
179	(	_	_	_	_	_	_	_	_
180	cross	_	_	_	_	_	_	_	_
181	-	_	_	_	_	_	_	_	_
182	infection	_	_	_	_	_	_	_	_
183	)	_	_	_	_	_	_	_	_
184	.	_	_	_	_	_	_	_	_
185	This	_	_	_	_	_	_	_	BeginSeg=Yes
186	protocol	_	_	_	_	_	_	_	_
187	should	_	_	_	_	_	_	_	_
188	be	_	_	_	_	_	_	_	_
189	implemented	_	_	_	_	_	_	_	_
190	by	_	_	_	_	_	_	_	BeginSeg=Yes
191	modifying	_	_	_	_	_	_	_	_
192	both	_	_	_	_	_	_	_	_
193	patient	_	_	_	_	_	_	_	_
194	management	_	_	_	_	_	_	_	_
195	and	_	_	_	_	_	_	_	_
196	clinical	_	_	_	_	_	_	_	_
197	practice	_	_	_	_	_	_	_	_
198	,	_	_	_	_	_	_	_	_
199	introducing	_	_	_	_	_	_	_	BeginSeg=Yes
200	particular	_	_	_	_	_	_	_	_
201	devices	_	_	_	_	_	_	_	_
202	and	_	_	_	_	_	_	_	_
203	organizational	_	_	_	_	_	_	_	_
204	practices	_	_	_	_	_	_	_	_
205	.	_	_	_	_	_	_	_	_
206	This	_	_	_	_	_	_	_	BeginSeg=Yes
207	paper	_	_	_	_	_	_	_	_
208	aims	_	_	_	_	_	_	_	_
209	to	_	_	_	_	_	_	_	_
210	discuss	_	_	_	_	_	_	_	_
211	and	_	_	_	_	_	_	_	_
212	suggest	_	_	_	_	_	_	_	_
213	the	_	_	_	_	_	_	_	_
214	most	_	_	_	_	_	_	_	_
215	appropriate	_	_	_	_	_	_	_	_
216	procedures	_	_	_	_	_	_	_	_
217	in	_	_	_	_	_	_	_	_
218	every	_	_	_	_	_	_	_	_
219	aspect	_	_	_	_	_	_	_	_
220	of	_	_	_	_	_	_	_	_
221	dental	_	_	_	_	_	_	_	_
222	practice	_	_	_	_	_	_	_	_
223	to	_	_	_	_	_	_	_	BeginSeg=Yes
224	reduce	_	_	_	_	_	_	_	_
225	infection	_	_	_	_	_	_	_	_
226	risk	_	_	_	_	_	_	_	_
227	.	_	_	_	_	_	_	_	_

# newdoc_id = e767d7dc7a215fc7e1eed093425089a179eba77a
1	A	_	_	_	_	_	_	_	BeginSeg=Yes
2	combination	_	_	_	_	_	_	_	_
3	of	_	_	_	_	_	_	_	_
4	federal	_	_	_	_	_	_	_	_
5	and	_	_	_	_	_	_	_	_
6	state	_	_	_	_	_	_	_	_
7	-	_	_	_	_	_	_	_	_
8	level	_	_	_	_	_	_	_	_
9	decision	_	_	_	_	_	_	_	_
10	making	_	_	_	_	_	_	_	_
11	has	_	_	_	_	_	_	_	_
12	shaped	_	_	_	_	_	_	_	_
13	the	_	_	_	_	_	_	_	_
14	response	_	_	_	_	_	_	_	_
15	to	_	_	_	_	_	_	_	_
16	COVID-19	_	_	_	_	_	_	_	_
17	in	_	_	_	_	_	_	_	_
18	the	_	_	_	_	_	_	_	_
19	United	_	_	_	_	_	_	_	_
20	States	_	_	_	_	_	_	_	_
21	.	_	_	_	_	_	_	_	_
22	In	_	_	_	_	_	_	_	BeginSeg=Yes
23	this	_	_	_	_	_	_	_	_
24	paper	_	_	_	_	_	_	_	_
25	we	_	_	_	_	_	_	_	_
26	analyze	_	_	_	_	_	_	_	_
27	the	_	_	_	_	_	_	_	_
28	Twitter	_	_	_	_	_	_	_	_
29	narratives	_	_	_	_	_	_	_	_
30	around	_	_	_	_	_	_	_	_
31	this	_	_	_	_	_	_	_	_
32	decision	_	_	_	_	_	_	_	_
33	making	_	_	_	_	_	_	_	_
34	by	_	_	_	_	_	_	_	BeginSeg=Yes
35	applying	_	_	_	_	_	_	_	_
36	a	_	_	_	_	_	_	_	_
37	dynamic	_	_	_	_	_	_	_	_
38	topic	_	_	_	_	_	_	_	_
39	model	_	_	_	_	_	_	_	_
40	to	_	_	_	_	_	_	_	_
41	COVID-19	_	_	_	_	_	_	_	_
42	related	_	_	_	_	_	_	_	_
43	tweets	_	_	_	_	_	_	_	_
44	by	_	_	_	_	_	_	_	_
45	U.S.	_	_	_	_	_	_	_	_
46	Governors	_	_	_	_	_	_	_	_
47	and	_	_	_	_	_	_	_	_
48	Presidential	_	_	_	_	_	_	_	_
49	cabinet	_	_	_	_	_	_	_	_
50	members	_	_	_	_	_	_	_	_
51	.	_	_	_	_	_	_	_	_
52	We	_	_	_	_	_	_	_	BeginSeg=Yes
53	use	_	_	_	_	_	_	_	_
54	a	_	_	_	_	_	_	_	_
55	network	_	_	_	_	_	_	_	_
56	Hawkes	_	_	_	_	_	_	_	_
57	binomial	_	_	_	_	_	_	_	_
58	topic	_	_	_	_	_	_	_	_
59	model	_	_	_	_	_	_	_	_
60	to	_	_	_	_	_	_	_	BeginSeg=Yes
61	track	_	_	_	_	_	_	_	_
62	evolving	_	_	_	_	_	_	_	_
63	sub	_	_	_	_	_	_	_	_
64	-	_	_	_	_	_	_	_	_
65	topics	_	_	_	_	_	_	_	_
66	around	_	_	_	_	_	_	_	_
67	risk	_	_	_	_	_	_	_	_
68	,	_	_	_	_	_	_	_	_
69	testing	_	_	_	_	_	_	_	_
70	and	_	_	_	_	_	_	_	_
71	treatment	_	_	_	_	_	_	_	_
72	.	_	_	_	_	_	_	_	_
73	We	_	_	_	_	_	_	_	BeginSeg=Yes
74	also	_	_	_	_	_	_	_	_
75	construct	_	_	_	_	_	_	_	_
76	influence	_	_	_	_	_	_	_	_
77	networks	_	_	_	_	_	_	_	_
78	amongst	_	_	_	_	_	_	_	_
79	government	_	_	_	_	_	_	_	_
80	officials	_	_	_	_	_	_	_	_
81	using	_	_	_	_	_	_	_	BeginSeg=Yes
82	Granger	_	_	_	_	_	_	_	_
83	causality	_	_	_	_	_	_	_	_
84	inferred	_	_	_	_	_	_	_	BeginSeg=Yes
85	from	_	_	_	_	_	_	_	_
86	the	_	_	_	_	_	_	_	_
87	network	_	_	_	_	_	_	_	_
88	Hawkes	_	_	_	_	_	_	_	_
89	process	_	_	_	_	_	_	_	_
90	.	_	_	_	_	_	_	_	_

# newdoc_id = e8a03d8f27e9d7b3716997e27ae897e802221339
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	hologram	_	_	_	_	_	_	_	_
3	is	_	_	_	_	_	_	_	_
4	an	_	_	_	_	_	_	_	_
5	ideal	_	_	_	_	_	_	_	_
6	method	_	_	_	_	_	_	_	_
7	for	_	_	_	_	_	_	_	BeginSeg=Yes
8	displaying	_	_	_	_	_	_	_	_
9	three	_	_	_	_	_	_	_	_
10	-	_	_	_	_	_	_	_	_
11	dimensional	_	_	_	_	_	_	_	_
12	images	_	_	_	_	_	_	_	_
13	visible	_	_	_	_	_	_	_	_
14	to	_	_	_	_	_	_	_	_
15	the	_	_	_	_	_	_	_	_
16	naked	_	_	_	_	_	_	_	_
17	eye	_	_	_	_	_	_	_	_
18	.	_	_	_	_	_	_	_	_
19	Metasurfaces	_	_	_	_	_	_	_	BeginSeg=Yes
20	consisting	_	_	_	_	_	_	_	BeginSeg=Yes
21	of	_	_	_	_	_	_	_	_
22	subwavelength	_	_	_	_	_	_	_	_
23	structures	_	_	_	_	_	_	_	_
24	show	_	_	_	_	_	_	_	BeginSeg=Yes
25	great	_	_	_	_	_	_	_	_
26	potential	_	_	_	_	_	_	_	_
27	in	_	_	_	_	_	_	_	_
28	light	_	_	_	_	_	_	_	_
29	field	_	_	_	_	_	_	_	_
30	manipulation	_	_	_	_	_	_	_	_
31	,	_	_	_	_	_	_	_	_
32	which	_	_	_	_	_	_	_	BeginSeg=Yes
33	is	_	_	_	_	_	_	_	_
34	useful	_	_	_	_	_	_	_	_
35	for	_	_	_	_	_	_	_	_
36	overcoming	_	_	_	_	_	_	_	_
37	the	_	_	_	_	_	_	_	_
38	drawbacks	_	_	_	_	_	_	_	_
39	of	_	_	_	_	_	_	_	_
40	common	_	_	_	_	_	_	_	_
41	computer	_	_	_	_	_	_	_	_
42	-	_	_	_	_	_	_	_	_
43	generated	_	_	_	_	_	_	_	_
44	holography	_	_	_	_	_	_	_	_
45	.	_	_	_	_	_	_	_	_
46	However	_	_	_	_	_	_	_	BeginSeg=Yes
47	,	_	_	_	_	_	_	_	_
48	there	_	_	_	_	_	_	_	_
49	are	_	_	_	_	_	_	_	_
50	long	_	_	_	_	_	_	_	_
51	-	_	_	_	_	_	_	_	_
52	existing	_	_	_	_	_	_	_	_
53	challenges	_	_	_	_	_	_	_	_
54	to	_	_	_	_	_	_	_	_
55	achieving	_	_	_	_	_	_	_	_
56	dynamic	_	_	_	_	_	_	_	_
57	meta	_	_	_	_	_	_	_	_
58	-	_	_	_	_	_	_	_	_
59	holography	_	_	_	_	_	_	_	_
60	in	_	_	_	_	_	_	_	_
61	the	_	_	_	_	_	_	_	_
62	visible	_	_	_	_	_	_	_	_
63	range	_	_	_	_	_	_	_	_
64	,	_	_	_	_	_	_	_	_
65	such	_	_	_	_	_	_	_	BeginSeg=Yes
66	as	_	_	_	_	_	_	_	_
67	low	_	_	_	_	_	_	_	_
68	frame	_	_	_	_	_	_	_	_
69	rate	_	_	_	_	_	_	_	_
70	and	_	_	_	_	_	_	_	_
71	low	_	_	_	_	_	_	_	_
72	frame	_	_	_	_	_	_	_	_
73	number	_	_	_	_	_	_	_	_
74	.	_	_	_	_	_	_	_	_
75	In	_	_	_	_	_	_	_	BeginSeg=Yes
76	this	_	_	_	_	_	_	_	_
77	work	_	_	_	_	_	_	_	_
78	,	_	_	_	_	_	_	_	_
79	we	_	_	_	_	_	_	_	_
80	demonstrate	_	_	_	_	_	_	_	_
81	a	_	_	_	_	_	_	_	_
82	design	_	_	_	_	_	_	_	_
83	of	_	_	_	_	_	_	_	_
84	meta	_	_	_	_	_	_	_	_
85	-	_	_	_	_	_	_	_	_
86	holography	_	_	_	_	_	_	_	_
87	that	_	_	_	_	_	_	_	BeginSeg=Yes
88	can	_	_	_	_	_	_	_	_
89	achieve	_	_	_	_	_	_	_	_
90	2	_	_	_	_	_	_	_	_
91	28	_	_	_	_	_	_	_	_
92	different	_	_	_	_	_	_	_	_
93	holographic	_	_	_	_	_	_	_	_
94	frames	_	_	_	_	_	_	_	_
95	and	_	_	_	_	_	_	_	_
96	an	_	_	_	_	_	_	_	_
97	extremely	_	_	_	_	_	_	_	_
98	high	_	_	_	_	_	_	_	_
99	frame	_	_	_	_	_	_	_	_
100	rate	_	_	_	_	_	_	_	_
101	(	_	_	_	_	_	_	_	BeginSeg=Yes
102	9523	_	_	_	_	_	_	_	_
103	frames	_	_	_	_	_	_	_	_
104	per	_	_	_	_	_	_	_	_
105	second	_	_	_	_	_	_	_	_
106	)	_	_	_	_	_	_	_	_
107	in	_	_	_	_	_	_	_	BeginSeg=Yes
108	the	_	_	_	_	_	_	_	_
109	visible	_	_	_	_	_	_	_	_
110	range	_	_	_	_	_	_	_	_
111	.	_	_	_	_	_	_	_	_
112	The	_	_	_	_	_	_	_	BeginSeg=Yes
113	design	_	_	_	_	_	_	_	_
114	is	_	_	_	_	_	_	_	_
115	based	_	_	_	_	_	_	_	_
116	on	_	_	_	_	_	_	_	_
117	a	_	_	_	_	_	_	_	_
118	space	_	_	_	_	_	_	_	_
119	channel	_	_	_	_	_	_	_	_
120	metasurface	_	_	_	_	_	_	_	_
121	and	_	_	_	_	_	_	_	_
122	a	_	_	_	_	_	_	_	_
123	high	_	_	_	_	_	_	_	_
124	-	_	_	_	_	_	_	_	_
125	speed	_	_	_	_	_	_	_	_
126	dynamic	_	_	_	_	_	_	_	_
127	structured	_	_	_	_	_	_	_	_
128	laser	_	_	_	_	_	_	_	_
129	beam	_	_	_	_	_	_	_	_
130	modulation	_	_	_	_	_	_	_	_
131	module	_	_	_	_	_	_	_	_
132	.	_	_	_	_	_	_	_	_
133	The	_	_	_	_	_	_	_	BeginSeg=Yes
134	space	_	_	_	_	_	_	_	_
135	channel	_	_	_	_	_	_	_	_
136	consists	_	_	_	_	_	_	_	_
137	of	_	_	_	_	_	_	_	_
138	silicon	_	_	_	_	_	_	_	_
139	nitride	_	_	_	_	_	_	_	_
140	nanopillars	_	_	_	_	_	_	_	_
141	with	_	_	_	_	_	_	_	_
142	a	_	_	_	_	_	_	_	_
143	high	_	_	_	_	_	_	_	_
144	modulation	_	_	_	_	_	_	_	_
145	efficiency	_	_	_	_	_	_	_	_
146	.	_	_	_	_	_	_	_	_
147	This	_	_	_	_	_	_	_	BeginSeg=Yes
148	method	_	_	_	_	_	_	_	_
149	can	_	_	_	_	_	_	_	_
150	satisfy	_	_	_	_	_	_	_	_
151	the	_	_	_	_	_	_	_	_
152	needs	_	_	_	_	_	_	_	_
153	of	_	_	_	_	_	_	_	_
154	a	_	_	_	_	_	_	_	_
155	holographic	_	_	_	_	_	_	_	_
156	display	_	_	_	_	_	_	_	_
157	and	_	_	_	_	_	_	_	BeginSeg=Yes
158	be	_	_	_	_	_	_	_	_
159	useful	_	_	_	_	_	_	_	_
160	in	_	_	_	_	_	_	_	_
161	other	_	_	_	_	_	_	_	_
162	applications	_	_	_	_	_	_	_	_
163	,	_	_	_	_	_	_	_	_
164	such	_	_	_	_	_	_	_	BeginSeg=Yes
165	as	_	_	_	_	_	_	_	_
166	laser	_	_	_	_	_	_	_	_
167	fabrication	_	_	_	_	_	_	_	_
168	,	_	_	_	_	_	_	_	_
169	optical	_	_	_	_	_	_	_	_
170	storage	_	_	_	_	_	_	_	_
171	,	_	_	_	_	_	_	_	_
172	optics	_	_	_	_	_	_	_	_
173	communications	_	_	_	_	_	_	_	_
174	,	_	_	_	_	_	_	_	_
175	and	_	_	_	_	_	_	_	_
176	information	_	_	_	_	_	_	_	_
177	processing	_	_	_	_	_	_	_	_
178	.	_	_	_	_	_	_	_	_
179	Dynamic	_	_	_	_	_	_	_	BeginSeg=Yes
180	3D	_	_	_	_	_	_	_	_
181	meta	_	_	_	_	_	_	_	_
182	-	_	_	_	_	_	_	_	_
183	holography	_	_	_	_	_	_	_	_
184	in	_	_	_	_	_	_	_	_
185	visible	_	_	_	_	_	_	_	_
186	range	_	_	_	_	_	_	_	_
187	with	_	_	_	_	_	_	_	_
188	large	_	_	_	_	_	_	_	_
189	frame	_	_	_	_	_	_	_	_
190	number	_	_	_	_	_	_	_	_
191	and	_	_	_	_	_	_	_	_
192	high	_	_	_	_	_	_	_	_
193	frame	_	_	_	_	_	_	_	_
194	rate	_	_	_	_	_	_	_	_
195	.	_	_	_	_	_	_	_	_
196	Sci	_	_	_	_	_	_	_	BeginSeg=Yes
197	.	_	_	_	_	_	_	_	_
198	Adv	_	_	_	_	_	_	_	_
199	.	_	_	_	_	_	_	_	_
200	6	_	_	_	_	_	_	_	_
201	,	_	_	_	_	_	_	_	_
202	eaba8595	_	_	_	_	_	_	_	_
203	(	_	_	_	_	_	_	_	_
204	2020	_	_	_	_	_	_	_	_
205	)	_	_	_	_	_	_	_	_
206	.	_	_	_	_	_	_	_	_

# newdoc_id = e8c619b901c3fd4c2e830df5c471e7b7d204be6b
1	An	_	_	_	_	_	_	_	BeginSeg=Yes
2	increasing	_	_	_	_	_	_	_	_
3	body	_	_	_	_	_	_	_	_
4	of	_	_	_	_	_	_	_	_
5	evidence	_	_	_	_	_	_	_	_
6	highlights	_	_	_	_	_	_	_	_
7	the	_	_	_	_	_	_	_	_
8	role	_	_	_	_	_	_	_	_
9	of	_	_	_	_	_	_	_	_
10	host	_	_	_	_	_	_	_	_
11	genetic	_	_	_	_	_	_	_	_
12	variation	_	_	_	_	_	_	_	_
13	in	_	_	_	_	_	_	_	BeginSeg=Yes
14	driving	_	_	_	_	_	_	_	_
15	susceptibility	_	_	_	_	_	_	_	_
16	to	_	_	_	_	_	_	_	_
17	severe	_	_	_	_	_	_	_	_
18	disease	_	_	_	_	_	_	_	_
19	following	_	_	_	_	_	_	_	BeginSeg=Yes
20	pathogen	_	_	_	_	_	_	_	_
21	infection	_	_	_	_	_	_	_	_
22	.	_	_	_	_	_	_	_	_
23	In	_	_	_	_	_	_	_	BeginSeg=Yes
24	order	_	_	_	_	_	_	_	_
25	to	_	_	_	_	_	_	_	_
26	fully	_	_	_	_	_	_	_	_
27	appreciate	_	_	_	_	_	_	_	_
28	the	_	_	_	_	_	_	_	_
29	importance	_	_	_	_	_	_	_	_
30	of	_	_	_	_	_	_	_	_
31	host	_	_	_	_	_	_	_	_
32	genetics	_	_	_	_	_	_	_	_
33	on	_	_	_	_	_	_	_	_
34	infection	_	_	_	_	_	_	_	_
35	susceptibility	_	_	_	_	_	_	_	_
36	and	_	_	_	_	_	_	_	_
37	resulting	_	_	_	_	_	_	_	_
38	disease	_	_	_	_	_	_	_	_
39	,	_	_	_	_	_	_	_	_
40	genetically	_	_	_	_	_	_	_	BeginSeg=Yes
41	variable	_	_	_	_	_	_	_	_
42	experimental	_	_	_	_	_	_	_	_
43	model	_	_	_	_	_	_	_	_
44	systems	_	_	_	_	_	_	_	_
45	should	_	_	_	_	_	_	_	_
46	be	_	_	_	_	_	_	_	_
47	employed	_	_	_	_	_	_	_	_
48	.	_	_	_	_	_	_	_	_
49	These	_	_	_	_	_	_	_	BeginSeg=Yes
50	systems	_	_	_	_	_	_	_	_
51	allow	_	_	_	_	_	_	_	_
52	for	_	_	_	_	_	_	_	_
53	the	_	_	_	_	_	_	_	_
54	identification	_	_	_	_	_	_	_	_
55	,	_	_	_	_	_	_	_	_
56	characterization	_	_	_	_	_	_	_	_
57	,	_	_	_	_	_	_	_	_
58	and	_	_	_	_	_	_	_	_
59	mechanistic	_	_	_	_	_	_	_	_
60	dissection	_	_	_	_	_	_	_	_
61	of	_	_	_	_	_	_	_	_
62	genetic	_	_	_	_	_	_	_	_
63	variants	_	_	_	_	_	_	_	_
64	that	_	_	_	_	_	_	_	BeginSeg=Yes
65	cause	_	_	_	_	_	_	_	_
66	differential	_	_	_	_	_	_	_	_
67	disease	_	_	_	_	_	_	_	_
68	responses	_	_	_	_	_	_	_	_
69	.	_	_	_	_	_	_	_	_
70	Herein	_	_	_	_	_	_	_	BeginSeg=Yes
71	we	_	_	_	_	_	_	_	_
72	discuss	_	_	_	_	_	_	_	_
73	application	_	_	_	_	_	_	_	_
74	of	_	_	_	_	_	_	_	_
75	the	_	_	_	_	_	_	_	_
76	Collaborative	_	_	_	_	_	_	_	_
77	Cross	_	_	_	_	_	_	_	_
78	(	_	_	_	_	_	_	_	_
79	CC	_	_	_	_	_	_	_	_
80	)	_	_	_	_	_	_	_	_
81	panel	_	_	_	_	_	_	_	_
82	of	_	_	_	_	_	_	_	_
83	recombinant	_	_	_	_	_	_	_	_
84	inbred	_	_	_	_	_	_	_	_
85	strains	_	_	_	_	_	_	_	_
86	to	_	_	_	_	_	_	_	BeginSeg=Yes
87	study	_	_	_	_	_	_	_	_
88	viral	_	_	_	_	_	_	_	_
89	pathogenesis	_	_	_	_	_	_	_	_
90	,	_	_	_	_	_	_	_	_
91	focusing	_	_	_	_	_	_	_	BeginSeg=Yes
92	on	_	_	_	_	_	_	_	_
93	practical	_	_	_	_	_	_	_	_
94	considerations	_	_	_	_	_	_	_	_
95	for	_	_	_	_	_	_	_	_
96	experimental	_	_	_	_	_	_	_	_
97	design	_	_	_	_	_	_	_	_
98	,	_	_	_	_	_	_	_	_
99	assessment	_	_	_	_	_	_	_	_
100	and	_	_	_	_	_	_	_	_
101	analysis	_	_	_	_	_	_	_	_
102	of	_	_	_	_	_	_	_	_
103	disease	_	_	_	_	_	_	_	_
104	responses	_	_	_	_	_	_	_	_
105	within	_	_	_	_	_	_	_	_
106	the	_	_	_	_	_	_	_	_
107	CC	_	_	_	_	_	_	_	_
108	,	_	_	_	_	_	_	_	_
109	as	_	_	_	_	_	_	_	_
110	well	_	_	_	_	_	_	_	_
111	as	_	_	_	_	_	_	_	_
112	some	_	_	_	_	_	_	_	_
113	of	_	_	_	_	_	_	_	_
114	the	_	_	_	_	_	_	_	_
115	resources	_	_	_	_	_	_	_	_
116	developed	_	_	_	_	_	_	_	BeginSeg=Yes
117	for	_	_	_	_	_	_	_	_
118	the	_	_	_	_	_	_	_	_
119	CC	_	_	_	_	_	_	_	_
120	.	_	_	_	_	_	_	_	_
121	Although	_	_	_	_	_	_	_	BeginSeg=Yes
122	the	_	_	_	_	_	_	_	_
123	focus	_	_	_	_	_	_	_	_
124	of	_	_	_	_	_	_	_	_
125	this	_	_	_	_	_	_	_	_
126	chapter	_	_	_	_	_	_	_	_
127	is	_	_	_	_	_	_	_	_
128	on	_	_	_	_	_	_	_	_
129	viral	_	_	_	_	_	_	_	_
130	pathogenesis	_	_	_	_	_	_	_	_
131	,	_	_	_	_	_	_	_	_
132	many	_	_	_	_	_	_	_	BeginSeg=Yes
133	of	_	_	_	_	_	_	_	_
134	the	_	_	_	_	_	_	_	_
135	methods	_	_	_	_	_	_	_	_
136	presented	_	_	_	_	_	_	_	BeginSeg=Yes
137	within	_	_	_	_	_	_	_	_
138	are	_	_	_	_	_	_	_	BeginSeg=Yes
139	applicable	_	_	_	_	_	_	_	_
140	to	_	_	_	_	_	_	_	_
141	studies	_	_	_	_	_	_	_	_
142	of	_	_	_	_	_	_	_	_
143	other	_	_	_	_	_	_	_	_
144	pathogens	_	_	_	_	_	_	_	_
145	,	_	_	_	_	_	_	_	_
146	as	_	_	_	_	_	_	_	_
147	well	_	_	_	_	_	_	_	_
148	as	_	_	_	_	_	_	_	_
149	to	_	_	_	_	_	_	_	_
150	case	_	_	_	_	_	_	_	_
151	-	_	_	_	_	_	_	_	_
152	control	_	_	_	_	_	_	_	_
153	designs	_	_	_	_	_	_	_	_
154	in	_	_	_	_	_	_	_	_
155	genetically	_	_	_	_	_	_	_	_
156	diverse	_	_	_	_	_	_	_	_
157	populations	_	_	_	_	_	_	_	_
158	.	_	_	_	_	_	_	_	_

# newdoc_id = e8fa052071eb975ce74b51e1927e26803deea863
1	Alanyl	_	_	_	_	_	_	_	BeginSeg=Yes
2	aminopeptidase	_	_	_	_	_	_	_	_
3	(	_	_	_	_	_	_	_	_
4	APN	_	_	_	_	_	_	_	_
5	)	_	_	_	_	_	_	_	_
6	is	_	_	_	_	_	_	_	_
7	a	_	_	_	_	_	_	_	_
8	surface	_	_	_	_	_	_	_	_
9	-	_	_	_	_	_	_	_	_
10	bound	_	_	_	_	_	_	_	_
11	metallopeptidase	_	_	_	_	_	_	_	_
12	that	_	_	_	_	_	_	_	BeginSeg=Yes
13	processes	_	_	_	_	_	_	_	_
14	the	_	_	_	_	_	_	_	_
15	N	_	_	_	_	_	_	_	_
16	-	_	_	_	_	_	_	_	_
17	terminals	_	_	_	_	_	_	_	_
18	of	_	_	_	_	_	_	_	_
19	biologically	_	_	_	_	_	_	_	_
20	active	_	_	_	_	_	_	_	_
21	peptides	_	_	_	_	_	_	_	_
22	such	_	_	_	_	_	_	_	BeginSeg=Yes
23	as	_	_	_	_	_	_	_	_
24	enkephalins	_	_	_	_	_	_	_	_
25	,	_	_	_	_	_	_	_	_
26	angiotensins	_	_	_	_	_	_	_	_
27	,	_	_	_	_	_	_	_	_
28	neurokinins	_	_	_	_	_	_	_	_
29	,	_	_	_	_	_	_	_	_
30	and	_	_	_	_	_	_	_	_
31	cytokines	_	_	_	_	_	_	_	_
32	.	_	_	_	_	_	_	_	_
33	It	_	_	_	_	_	_	_	BeginSeg=Yes
34	exerts	_	_	_	_	_	_	_	_
35	profound	_	_	_	_	_	_	_	_
36	activity	_	_	_	_	_	_	_	_
37	on	_	_	_	_	_	_	_	_
38	vital	_	_	_	_	_	_	_	_
39	processes	_	_	_	_	_	_	_	_
40	such	_	_	_	_	_	_	_	BeginSeg=Yes
41	as	_	_	_	_	_	_	_	_
42	immune	_	_	_	_	_	_	_	_
43	response	_	_	_	_	_	_	_	_
44	,	_	_	_	_	_	_	_	_
45	cellular	_	_	_	_	_	_	_	_
46	growth	_	_	_	_	_	_	_	_
47	,	_	_	_	_	_	_	_	_
48	and	_	_	_	_	_	_	_	_
49	blood	_	_	_	_	_	_	_	_
50	pressure	_	_	_	_	_	_	_	_
51	control	_	_	_	_	_	_	_	_
52	.	_	_	_	_	_	_	_	_
53	Inhibition	_	_	_	_	_	_	_	BeginSeg=Yes
54	of	_	_	_	_	_	_	_	_
55	either	_	_	_	_	_	_	_	_
56	APN	_	_	_	_	_	_	_	_
57	gene	_	_	_	_	_	_	_	_
58	expression	_	_	_	_	_	_	_	_
59	or	_	_	_	_	_	_	_	_
60	its	_	_	_	_	_	_	_	_
61	enzymatic	_	_	_	_	_	_	_	_
62	activity	_	_	_	_	_	_	_	_
63	severely	_	_	_	_	_	_	_	_
64	affects	_	_	_	_	_	_	_	_
65	leukocyte	_	_	_	_	_	_	_	_
66	growth	_	_	_	_	_	_	_	_
67	and	_	_	_	_	_	_	_	_
68	function	_	_	_	_	_	_	_	_
69	.	_	_	_	_	_	_	_	_
70	We	_	_	_	_	_	_	_	BeginSeg=Yes
71	show	_	_	_	_	_	_	_	_
72	here	_	_	_	_	_	_	_	_
73	that	_	_	_	_	_	_	_	BeginSeg=Yes
74	oxidoreductasemediated	_	_	_	_	_	_	_	_
75	modulations	_	_	_	_	_	_	_	_
76	of	_	_	_	_	_	_	_	_
77	the	_	_	_	_	_	_	_	_
78	cell	_	_	_	_	_	_	_	_
79	surface	_	_	_	_	_	_	_	_
80	thiol	_	_	_	_	_	_	_	_
81	status	_	_	_	_	_	_	_	_
82	affect	_	_	_	_	_	_	_	_
83	the	_	_	_	_	_	_	_	_
84	enzymatic	_	_	_	_	_	_	_	_
85	activity	_	_	_	_	_	_	_	_
86	of	_	_	_	_	_	_	_	_
87	APN	_	_	_	_	_	_	_	_
88	.	_	_	_	_	_	_	_	_
89	Additional	_	_	_	_	_	_	_	BeginSeg=Yes
90	evidence	_	_	_	_	_	_	_	_
91	for	_	_	_	_	_	_	_	_
92	the	_	_	_	_	_	_	_	_
93	pivotal	_	_	_	_	_	_	_	_
94	role	_	_	_	_	_	_	_	_
95	of	_	_	_	_	_	_	_	_
96	extracellular	_	_	_	_	_	_	_	_
97	cysteines	_	_	_	_	_	_	_	_
98	in	_	_	_	_	_	_	_	_
99	the	_	_	_	_	_	_	_	_
100	APN	_	_	_	_	_	_	_	_
101	molecule	_	_	_	_	_	_	_	_
102	was	_	_	_	_	_	_	_	_
103	obtained	_	_	_	_	_	_	_	_
104	when	_	_	_	_	_	_	_	BeginSeg=Yes
105	substitution	_	_	_	_	_	_	_	_
106	of	_	_	_	_	_	_	_	_
107	any	_	_	_	_	_	_	_	_
108	of	_	_	_	_	_	_	_	_
109	these	_	_	_	_	_	_	_	_
110	six	_	_	_	_	_	_	_	_
111	cysteines	_	_	_	_	_	_	_	_
112	caused	_	_	_	_	_	_	_	_
113	complete	_	_	_	_	_	_	_	_
114	loss	_	_	_	_	_	_	_	_
115	of	_	_	_	_	_	_	_	_
116	surface	_	_	_	_	_	_	_	_
117	expression	_	_	_	_	_	_	_	_
118	and	_	_	_	_	_	_	_	_
119	enzymatic	_	_	_	_	_	_	_	_
120	activity	_	_	_	_	_	_	_	_
121	.	_	_	_	_	_	_	_	_
122	In	_	_	_	_	_	_	_	BeginSeg=Yes
123	contrast	_	_	_	_	_	_	_	_
124	,	_	_	_	_	_	_	_	_
125	the	_	_	_	_	_	_	_	_
126	transmembrane	_	_	_	_	_	_	_	_
127	Cys24	_	_	_	_	_	_	_	_
128	appears	_	_	_	_	_	_	_	_
129	to	_	_	_	_	_	_	_	_
130	have	_	_	_	_	_	_	_	_
131	no	_	_	_	_	_	_	_	_
132	similar	_	_	_	_	_	_	_	_
133	function	_	_	_	_	_	_	_	_
134	.	_	_	_	_	_	_	_	_
135	Enzymatically	_	_	_	_	_	_	_	BeginSeg=Yes
136	inactive	_	_	_	_	_	_	_	_
137	cysteine	_	_	_	_	_	_	_	_
138	mutants	_	_	_	_	_	_	_	_
139	were	_	_	_	_	_	_	_	_
140	retained	_	_	_	_	_	_	_	_
141	in	_	_	_	_	_	_	_	_
142	the	_	_	_	_	_	_	_	_
143	endoplasmic	_	_	_	_	_	_	_	_
144	reticulum	_	_	_	_	_	_	_	_
145	as	_	_	_	_	_	_	_	BeginSeg=Yes
146	shown	_	_	_	_	_	_	_	_
147	by	_	_	_	_	_	_	_	_
148	high	_	_	_	_	_	_	_	_
149	-	_	_	_	_	_	_	_	_
150	resolution	_	_	_	_	_	_	_	_
151	imaging	_	_	_	_	_	_	_	_
152	and	_	_	_	_	_	_	_	_
153	Endoglycosidase	_	_	_	_	_	_	_	_
154	H	_	_	_	_	_	_	_	_
155	digestion	_	_	_	_	_	_	_	_
156	.	_	_	_	_	_	_	_	_
157	In	_	_	_	_	_	_	_	BeginSeg=Yes
158	the	_	_	_	_	_	_	_	_
159	absence	_	_	_	_	_	_	_	_
160	of	_	_	_	_	_	_	_	_
161	any	_	_	_	_	_	_	_	_
162	crystal	_	_	_	_	_	_	_	_
163	-	_	_	_	_	_	_	_	_
164	structure	_	_	_	_	_	_	_	_
165	data	_	_	_	_	_	_	_	_
166	,	_	_	_	_	_	_	_	_
167	the	_	_	_	_	_	_	_	_
168	demonstration	_	_	_	_	_	_	_	_
169	that	_	_	_	_	_	_	_	BeginSeg=Yes
170	individual	_	_	_	_	_	_	_	_
171	extracellular	_	_	_	_	_	_	_	_
172	cysteines	_	_	_	_	_	_	_	_
173	contribute	_	_	_	_	_	_	_	_
174	to	_	_	_	_	_	_	_	_
175	APN	_	_	_	_	_	_	_	_
176	expression	_	_	_	_	_	_	_	_
177	and	_	_	_	_	_	_	_	_
178	function	_	_	_	_	_	_	_	_
179	appears	_	_	_	_	_	_	_	BeginSeg=Yes
180	to	_	_	_	_	_	_	_	_
181	be	_	_	_	_	_	_	_	_
182	of	_	_	_	_	_	_	_	_
183	particular	_	_	_	_	_	_	_	_
184	importance	_	_	_	_	_	_	_	_
185	.	_	_	_	_	_	_	_	_
186	The	_	_	_	_	_	_	_	BeginSeg=Yes
187	data	_	_	_	_	_	_	_	_
188	are	_	_	_	_	_	_	_	_
189	the	_	_	_	_	_	_	_	_
190	first	_	_	_	_	_	_	_	_
191	to	_	_	_	_	_	_	_	BeginSeg=Yes
192	show	_	_	_	_	_	_	_	_
193	thiol	_	_	_	_	_	_	_	_
194	-	_	_	_	_	_	_	_	_
195	dependent	_	_	_	_	_	_	_	_
196	modulation	_	_	_	_	_	_	_	_
197	of	_	_	_	_	_	_	_	_
198	the	_	_	_	_	_	_	_	_
199	activity	_	_	_	_	_	_	_	_
200	of	_	_	_	_	_	_	_	_
201	a	_	_	_	_	_	_	_	_
202	typical	_	_	_	_	_	_	_	_
203	surfacebound	_	_	_	_	_	_	_	_
204	peptidase	_	_	_	_	_	_	_	_
205	at	_	_	_	_	_	_	_	_
206	the	_	_	_	_	_	_	_	_
207	cell	_	_	_	_	_	_	_	_
208	surface	_	_	_	_	_	_	_	_
209	,	_	_	_	_	_	_	_	_
210	probably	_	_	_	_	_	_	_	BeginSeg=Yes
211	reflecting	_	_	_	_	_	_	_	_
212	a	_	_	_	_	_	_	_	_
213	general	_	_	_	_	_	_	_	_
214	regulating	_	_	_	_	_	_	_	_
215	mechanism	_	_	_	_	_	_	_	_
216	.	_	_	_	_	_	_	_	_
217	This	_	_	_	_	_	_	_	BeginSeg=Yes
218	may	_	_	_	_	_	_	_	_
219	relate	_	_	_	_	_	_	_	_
220	to	_	_	_	_	_	_	_	_
221	various	_	_	_	_	_	_	_	_
222	disease	_	_	_	_	_	_	_	_
223	processes	_	_	_	_	_	_	_	_
224	such	_	_	_	_	_	_	_	BeginSeg=Yes
225	as	_	_	_	_	_	_	_	_
226	inflammation	_	_	_	_	_	_	_	_
227	or	_	_	_	_	_	_	_	_
228	malignant	_	_	_	_	_	_	_	_
229	transformation	_	_	_	_	_	_	_	_
230	.	_	_	_	_	_	_	_	_

# newdoc_id = eafd17ebcaf051ac6cdf146a974e4cd0a8f528ea
1	Although	_	_	_	_	_	_	_	BeginSeg=Yes
2	information	_	_	_	_	_	_	_	_
3	on	_	_	_	_	_	_	_	_
4	efficacy	_	_	_	_	_	_	_	_
5	and	_	_	_	_	_	_	_	_
6	adverse	_	_	_	_	_	_	_	_
7	drug	_	_	_	_	_	_	_	_
8	reactions	_	_	_	_	_	_	_	_
9	is	_	_	_	_	_	_	_	_
10	lacking	_	_	_	_	_	_	_	_
11	,	_	_	_	_	_	_	_	_
12	ribavirin	_	_	_	_	_	_	_	BeginSeg=Yes
13	has	_	_	_	_	_	_	_	_
14	been	_	_	_	_	_	_	_	_
15	used	_	_	_	_	_	_	_	_
16	empirically	_	_	_	_	_	_	_	_
17	for	_	_	_	_	_	_	_	_
18	the	_	_	_	_	_	_	_	_
19	treatment	_	_	_	_	_	_	_	_
20	of	_	_	_	_	_	_	_	_
21	severe	_	_	_	_	_	_	_	_
22	acute	_	_	_	_	_	_	_	_
23	respiratory	_	_	_	_	_	_	_	_
24	syndrome	_	_	_	_	_	_	_	_
25	(	_	_	_	_	_	_	_	_
26	SARS	_	_	_	_	_	_	_	_
27	)	_	_	_	_	_	_	_	_
28	.	_	_	_	_	_	_	_	_
29	We	_	_	_	_	_	_	_	BeginSeg=Yes
30	report	_	_	_	_	_	_	_	_
31	common	_	_	_	_	_	_	_	_
32	adverse	_	_	_	_	_	_	_	_
33	events	_	_	_	_	_	_	_	_
34	in	_	_	_	_	_	_	_	_
35	110	_	_	_	_	_	_	_	_
36	patients	_	_	_	_	_	_	_	_
37	with	_	_	_	_	_	_	_	_
38	suspected	_	_	_	_	_	_	_	_
39	or	_	_	_	_	_	_	_	_
40	probable	_	_	_	_	_	_	_	_
41	SARS	_	_	_	_	_	_	_	_
42	who	_	_	_	_	_	_	_	BeginSeg=Yes
43	were	_	_	_	_	_	_	_	_
44	treated	_	_	_	_	_	_	_	_
45	with	_	_	_	_	_	_	_	_
46	ribavirin	_	_	_	_	_	_	_	_
47	.	_	_	_	_	_	_	_	_
48	Sixty	_	_	_	_	_	_	_	BeginSeg=Yes
49	-	_	_	_	_	_	_	_	_
50	one	_	_	_	_	_	_	_	_
51	percent	_	_	_	_	_	_	_	_
52	of	_	_	_	_	_	_	_	_
53	the	_	_	_	_	_	_	_	_
54	patients	_	_	_	_	_	_	_	_
55	had	_	_	_	_	_	_	_	_
56	evidence	_	_	_	_	_	_	_	_
57	of	_	_	_	_	_	_	_	_
58	hemolytic	_	_	_	_	_	_	_	_
59	anemia	_	_	_	_	_	_	_	_
60	,	_	_	_	_	_	_	_	_
61	and	_	_	_	_	_	_	_	BeginSeg=Yes
62	hypocalcemia	_	_	_	_	_	_	_	_
63	and	_	_	_	_	_	_	_	_
64	hypomagnesmia	_	_	_	_	_	_	_	_
65	were	_	_	_	_	_	_	_	_
66	reported	_	_	_	_	_	_	_	_
67	in	_	_	_	_	_	_	_	_
68	58	_	_	_	_	_	_	_	_
69	%	_	_	_	_	_	_	_	_
70	and	_	_	_	_	_	_	_	_
71	46	_	_	_	_	_	_	_	_
72	%	_	_	_	_	_	_	_	_
73	of	_	_	_	_	_	_	_	_
74	patients	_	_	_	_	_	_	_	_
75	,	_	_	_	_	_	_	_	_
76	respectively	_	_	_	_	_	_	_	_
77	.	_	_	_	_	_	_	_	_

# newdoc_id = eb68173ed9ade0c27573673e9a45ef1be8191edc
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	optimization	_	_	_	_	_	_	_	_
3	problem	_	_	_	_	_	_	_	_
4	of	_	_	_	_	_	_	_	_
5	fishing	_	_	_	_	_	_	_	_
6	for	_	_	_	_	_	_	_	_
7	a	_	_	_	_	_	_	_	_
8	stochastic	_	_	_	_	_	_	_	_
9	logistic	_	_	_	_	_	_	_	_
10	model	_	_	_	_	_	_	_	_
11	is	_	_	_	_	_	_	_	_
12	studied	_	_	_	_	_	_	_	_
13	in	_	_	_	_	_	_	_	_
14	this	_	_	_	_	_	_	_	_
15	paper	_	_	_	_	_	_	_	_
16	.	_	_	_	_	_	_	_	_
17	Besides	_	_	_	_	_	_	_	BeginSeg=Yes
18	a	_	_	_	_	_	_	_	_
19	standard	_	_	_	_	_	_	_	_
20	geometric	_	_	_	_	_	_	_	_
21	Brownian	_	_	_	_	_	_	_	_
22	motion	_	_	_	_	_	_	_	_
23	,	_	_	_	_	_	_	_	_
24	another	_	_	_	_	_	_	_	_
25	two	_	_	_	_	_	_	_	_
26	driving	_	_	_	_	_	_	_	_
27	processes	_	_	_	_	_	_	_	_
28	are	_	_	_	_	_	_	_	_
29	taken	_	_	_	_	_	_	_	_
30	into	_	_	_	_	_	_	_	_
31	account	_	_	_	_	_	_	_	_
32	:	_	_	_	_	_	_	_	_
33	a	_	_	_	_	_	_	_	BeginSeg=Yes
34	stationary	_	_	_	_	_	_	_	_
35	Poisson	_	_	_	_	_	_	_	_
36	point	_	_	_	_	_	_	_	_
37	process	_	_	_	_	_	_	_	_
38	and	_	_	_	_	_	_	_	_
39	a	_	_	_	_	_	_	_	_
40	continuous	_	_	_	_	_	_	_	_
41	-	_	_	_	_	_	_	_	_
42	time	_	_	_	_	_	_	_	_
43	finite	_	_	_	_	_	_	_	_
44	-	_	_	_	_	_	_	_	_
45	state	_	_	_	_	_	_	_	_
46	Markov	_	_	_	_	_	_	_	_
47	chain	_	_	_	_	_	_	_	_
48	.	_	_	_	_	_	_	_	_
49	The	_	_	_	_	_	_	_	BeginSeg=Yes
50	classical	_	_	_	_	_	_	_	_
51	harvesting	_	_	_	_	_	_	_	_
52	problem	_	_	_	_	_	_	_	_
53	for	_	_	_	_	_	_	_	_
54	this	_	_	_	_	_	_	_	_
55	model	_	_	_	_	_	_	_	_
56	is	_	_	_	_	_	_	_	_
57	a	_	_	_	_	_	_	_	_
58	big	_	_	_	_	_	_	_	_
59	difficult	_	_	_	_	_	_	_	_
60	puzzle	_	_	_	_	_	_	_	_
61	since	_	_	_	_	_	_	_	BeginSeg=Yes
62	the	_	_	_	_	_	_	_	_
63	corresponding	_	_	_	_	_	_	_	_
64	Fokker	_	_	_	_	_	_	_	_
65	-	_	_	_	_	_	_	_	_
66	Planck	_	_	_	_	_	_	_	_
67	equations	_	_	_	_	_	_	_	_
68	with	_	_	_	_	_	_	_	_
69	three	_	_	_	_	_	_	_	_
70	types	_	_	_	_	_	_	_	_
71	of	_	_	_	_	_	_	_	_
72	noise	_	_	_	_	_	_	_	_
73	are	_	_	_	_	_	_	_	_
74	very	_	_	_	_	_	_	_	_
75	difficult	_	_	_	_	_	_	_	_
76	to	_	_	_	_	_	_	_	_
77	solve	_	_	_	_	_	_	_	_
78	.	_	_	_	_	_	_	_	_
79	Our	_	_	_	_	_	_	_	BeginSeg=Yes
80	main	_	_	_	_	_	_	_	_
81	goal	_	_	_	_	_	_	_	_
82	of	_	_	_	_	_	_	_	_
83	this	_	_	_	_	_	_	_	_
84	paper	_	_	_	_	_	_	_	_
85	is	_	_	_	_	_	_	_	_
86	to	_	_	_	_	_	_	_	_
87	work	_	_	_	_	_	_	_	_
88	out	_	_	_	_	_	_	_	_
89	the	_	_	_	_	_	_	_	_
90	optimization	_	_	_	_	_	_	_	_
91	problem	_	_	_	_	_	_	_	_
92	with	_	_	_	_	_	_	_	_
93	respect	_	_	_	_	_	_	_	_
94	to	_	_	_	_	_	_	_	_
95	stationary	_	_	_	_	_	_	_	_
96	probability	_	_	_	_	_	_	_	_
97	density	_	_	_	_	_	_	_	_
98	.	_	_	_	_	_	_	_	_
99	One	_	_	_	_	_	_	_	BeginSeg=Yes
100	of	_	_	_	_	_	_	_	_
101	the	_	_	_	_	_	_	_	_
102	main	_	_	_	_	_	_	_	_
103	contributions	_	_	_	_	_	_	_	_
104	is	_	_	_	_	_	_	_	_
105	to	_	_	_	_	_	_	_	_
106	provide	_	_	_	_	_	_	_	_
107	a	_	_	_	_	_	_	_	_
108	new	_	_	_	_	_	_	_	_
109	equivalent	_	_	_	_	_	_	_	_
110	approach	_	_	_	_	_	_	_	_
111	to	_	_	_	_	_	_	_	BeginSeg=Yes
112	overcome	_	_	_	_	_	_	_	_
113	this	_	_	_	_	_	_	_	_
114	problem	_	_	_	_	_	_	_	_
115	.	_	_	_	_	_	_	_	_
116	More	_	_	_	_	_	_	_	BeginSeg=Yes
117	precisely	_	_	_	_	_	_	_	_
118	,	_	_	_	_	_	_	_	_
119	an	_	_	_	_	_	_	_	_
120	ergodic	_	_	_	_	_	_	_	_
121	method	_	_	_	_	_	_	_	_
122	is	_	_	_	_	_	_	_	_
123	used	_	_	_	_	_	_	_	_
124	to	_	_	_	_	_	_	_	BeginSeg=Yes
125	show	_	_	_	_	_	_	_	_
126	the	_	_	_	_	_	_	_	_
127	almost	_	_	_	_	_	_	_	_
128	surely	_	_	_	_	_	_	_	_
129	equivalency	_	_	_	_	_	_	_	_
130	between	_	_	_	_	_	_	_	_
131	the	_	_	_	_	_	_	_	_
132	time	_	_	_	_	_	_	_	_
133	averaging	_	_	_	_	_	_	_	_
134	yield	_	_	_	_	_	_	_	_
135	and	_	_	_	_	_	_	_	_
136	sustainable	_	_	_	_	_	_	_	_
137	yield	_	_	_	_	_	_	_	_
138	.	_	_	_	_	_	_	_	_
139	Results	_	_	_	_	_	_	_	BeginSeg=Yes
140	show	_	_	_	_	_	_	_	_
141	that	_	_	_	_	_	_	_	BeginSeg=Yes
142	the	_	_	_	_	_	_	_	_
143	optimal	_	_	_	_	_	_	_	_
144	strategy	_	_	_	_	_	_	_	_
145	changes	_	_	_	_	_	_	_	_
146	with	_	_	_	_	_	_	_	_
147	environment	_	_	_	_	_	_	_	_
148	.	_	_	_	_	_	_	_	_
149	An	_	_	_	_	_	_	_	BeginSeg=Yes
150	interesting	_	_	_	_	_	_	_	_
151	thing	_	_	_	_	_	_	_	_
152	is	_	_	_	_	_	_	_	_
153	that	_	_	_	_	_	_	_	_
154	the	_	_	_	_	_	_	_	_
155	optimal	_	_	_	_	_	_	_	_
156	strategy	_	_	_	_	_	_	_	_
157	for	_	_	_	_	_	_	_	_
158	each	_	_	_	_	_	_	_	_
159	state	_	_	_	_	_	_	_	_
160	is	_	_	_	_	_	_	_	_
161	equivalent	_	_	_	_	_	_	_	_
162	to	_	_	_	_	_	_	_	_
163	the	_	_	_	_	_	_	_	_
164	global	_	_	_	_	_	_	_	_
165	optimality	_	_	_	_	_	_	_	_
166	.	_	_	_	_	_	_	_	_

# newdoc_id = ed43a39e585d77f1fecd662508f8042ed4ad3396
1	Background	_	_	_	_	_	_	_	BeginSeg=Yes
2	:	_	_	_	_	_	_	_	_
3	As	_	_	_	_	_	_	_	BeginSeg=Yes
4	the	_	_	_	_	_	_	_	_
5	outbreak	_	_	_	_	_	_	_	_
6	of	_	_	_	_	_	_	_	_
7	Coronavirus	_	_	_	_	_	_	_	_
8	disease	_	_	_	_	_	_	_	_
9	2019	_	_	_	_	_	_	_	_
10	(	_	_	_	_	_	_	_	_
11	COVID-19	_	_	_	_	_	_	_	_
12	)	_	_	_	_	_	_	_	_
13	is	_	_	_	_	_	_	_	_
14	a	_	_	_	_	_	_	_	_
15	worldwide	_	_	_	_	_	_	_	_
16	pandemic	_	_	_	_	_	_	_	_
17	,	_	_	_	_	_	_	_	_
18	and	_	_	_	_	_	_	_	BeginSeg=Yes
19	it	_	_	_	_	_	_	_	_
20	is	_	_	_	_	_	_	_	_
21	rapidly	_	_	_	_	_	_	_	_
22	expanding	_	_	_	_	_	_	_	_
23	in	_	_	_	_	_	_	_	_
24	Iran	_	_	_	_	_	_	_	_
25	,	_	_	_	_	_	_	_	_
26	real	_	_	_	_	_	_	_	BeginSeg=Yes
27	-	_	_	_	_	_	_	_	_
28	time	_	_	_	_	_	_	_	_
29	analyses	_	_	_	_	_	_	_	_
30	of	_	_	_	_	_	_	_	_
31	epidemiological	_	_	_	_	_	_	_	_
32	data	_	_	_	_	_	_	_	_
33	are	_	_	_	_	_	_	_	_
34	needed	_	_	_	_	_	_	_	_
35	to	_	_	_	_	_	_	_	_
36	increase	_	_	_	_	_	_	_	_
37	situational	_	_	_	_	_	_	_	_
38	awareness	_	_	_	_	_	_	_	_
39	and	_	_	_	_	_	_	_	_
40	inform	_	_	_	_	_	_	_	_
41	interventions	_	_	_	_	_	_	_	_
42	.	_	_	_	_	_	_	_	_
43	In	_	_	_	_	_	_	_	BeginSeg=Yes
44	this	_	_	_	_	_	_	_	_
45	study	_	_	_	_	_	_	_	_
46	,	_	_	_	_	_	_	_	_
47	we	_	_	_	_	_	_	_	_
48	built	_	_	_	_	_	_	_	_
49	a	_	_	_	_	_	_	_	_
50	predictive	_	_	_	_	_	_	_	_
51	model	_	_	_	_	_	_	_	_
52	based	_	_	_	_	_	_	_	BeginSeg=Yes
53	on	_	_	_	_	_	_	_	_
54	the	_	_	_	_	_	_	_	_
55	cumulative	_	_	_	_	_	_	_	_
56	trend	_	_	_	_	_	_	_	_
57	of	_	_	_	_	_	_	_	_
58	new	_	_	_	_	_	_	_	_
59	cases	_	_	_	_	_	_	_	_
60	and	_	_	_	_	_	_	_	_
61	deaths	_	_	_	_	_	_	_	_
62	for	_	_	_	_	_	_	_	_
63	the	_	_	_	_	_	_	_	_
64	top	_	_	_	_	_	_	_	_
65	five	_	_	_	_	_	_	_	_
66	provinces	_	_	_	_	_	_	_	_
67	.	_	_	_	_	_	_	_	_
68	We	_	_	_	_	_	_	_	BeginSeg=Yes
69	will	_	_	_	_	_	_	_	_
70	also	_	_	_	_	_	_	_	_
71	look	_	_	_	_	_	_	_	_
72	at	_	_	_	_	_	_	_	_
73	modeling	_	_	_	_	_	_	_	_
74	the	_	_	_	_	_	_	_	_
75	trends	_	_	_	_	_	_	_	_
76	for	_	_	_	_	_	_	_	_
77	confirmed	_	_	_	_	_	_	_	_
78	cases	_	_	_	_	_	_	_	_
79	,	_	_	_	_	_	_	_	_
80	deaths	_	_	_	_	_	_	_	_
81	and	_	_	_	_	_	_	_	_
82	recovered	_	_	_	_	_	_	_	_
83	for	_	_	_	_	_	_	_	_
84	the	_	_	_	_	_	_	_	_
85	whole	_	_	_	_	_	_	_	_
86	country	_	_	_	_	_	_	_	_
87	.	_	_	_	_	_	_	_	_
88	Method	_	_	_	_	_	_	_	BeginSeg=Yes
89	:	_	_	_	_	_	_	_	_
90	In	_	_	_	_	_	_	_	BeginSeg=Yes
91	this	_	_	_	_	_	_	_	_
92	study	_	_	_	_	_	_	_	_
93	,	_	_	_	_	_	_	_	_
94	we	_	_	_	_	_	_	_	_
95	have	_	_	_	_	_	_	_	_
96	chosen	_	_	_	_	_	_	_	_
97	to	_	_	_	_	_	_	_	_
98	apply	_	_	_	_	_	_	_	_
99	the	_	_	_	_	_	_	_	_
100	exponential	_	_	_	_	_	_	_	_
101	smoothing	_	_	_	_	_	_	_	_
102	model	_	_	_	_	_	_	_	_
103	to	_	_	_	_	_	_	_	BeginSeg=Yes
104	iteratively	_	_	_	_	_	_	_	_
105	forecast	_	_	_	_	_	_	_	_
106	future	_	_	_	_	_	_	_	_
107	values	_	_	_	_	_	_	_	_
108	of	_	_	_	_	_	_	_	_
109	a	_	_	_	_	_	_	_	_
110	regular	_	_	_	_	_	_	_	_
111	time	_	_	_	_	_	_	_	_
112	series	_	_	_	_	_	_	_	_
113	from	_	_	_	_	_	_	_	_
114	weighted	_	_	_	_	_	_	_	_
115	averages	_	_	_	_	_	_	_	_
116	of	_	_	_	_	_	_	_	_
117	past	_	_	_	_	_	_	_	_
118	daily	_	_	_	_	_	_	_	_
119	values	_	_	_	_	_	_	_	_
120	.	_	_	_	_	_	_	_	_
121	This	_	_	_	_	_	_	_	BeginSeg=Yes
122	method	_	_	_	_	_	_	_	_
123	is	_	_	_	_	_	_	_	_
124	exponential	_	_	_	_	_	_	_	_
125	because	_	_	_	_	_	_	_	BeginSeg=Yes
126	the	_	_	_	_	_	_	_	_
127	value	_	_	_	_	_	_	_	_
128	of	_	_	_	_	_	_	_	_
129	each	_	_	_	_	_	_	_	_
130	level	_	_	_	_	_	_	_	_
131	is	_	_	_	_	_	_	_	_
132	influenced	_	_	_	_	_	_	_	_
133	by	_	_	_	_	_	_	_	_
134	every	_	_	_	_	_	_	_	_
135	preceding	_	_	_	_	_	_	_	_
136	actual	_	_	_	_	_	_	_	_
137	value	_	_	_	_	_	_	_	_
138	to	_	_	_	_	_	_	_	_
139	an	_	_	_	_	_	_	_	_
140	exponentially	_	_	_	_	_	_	_	_
141	decreasing	_	_	_	_	_	_	_	_
142	degree	_	_	_	_	_	_	_	_
143	-	_	_	_	_	_	_	_	BeginSeg=Yes
144	more	_	_	_	_	_	_	_	_
145	recent	_	_	_	_	_	_	_	_
146	values	_	_	_	_	_	_	_	_
147	are	_	_	_	_	_	_	_	_
148	given	_	_	_	_	_	_	_	_
149	greater	_	_	_	_	_	_	_	_
150	weight	_	_	_	_	_	_	_	_
151	.	_	_	_	_	_	_	_	_
152	The	_	_	_	_	_	_	_	BeginSeg=Yes
153	available	_	_	_	_	_	_	_	_
154	data	_	_	_	_	_	_	_	_
155	is	_	_	_	_	_	_	_	_
156	too	_	_	_	_	_	_	_	_
157	small	_	_	_	_	_	_	_	_
158	to	_	_	_	_	_	_	_	BeginSeg=Yes
159	identify	_	_	_	_	_	_	_	_
160	seasonal	_	_	_	_	_	_	_	_
161	patterns	_	_	_	_	_	_	_	_
162	and	_	_	_	_	_	_	_	BeginSeg=Yes
163	make	_	_	_	_	_	_	_	_
164	a	_	_	_	_	_	_	_	_
165	predictable	_	_	_	_	_	_	_	_
166	variation	_	_	_	_	_	_	_	_
167	in	_	_	_	_	_	_	_	_
168	value	_	_	_	_	_	_	_	_
169	,	_	_	_	_	_	_	_	_
170	such	_	_	_	_	_	_	_	BeginSeg=Yes
171	as	_	_	_	_	_	_	_	_
172	annual	_	_	_	_	_	_	_	_
173	fluctuation	_	_	_	_	_	_	_	_
174	in	_	_	_	_	_	_	_	_
175	temperature	_	_	_	_	_	_	_	_
176	related	_	_	_	_	_	_	_	BeginSeg=Yes
177	to	_	_	_	_	_	_	_	_
178	the	_	_	_	_	_	_	_	_
179	season	_	_	_	_	_	_	_	_
180	.	_	_	_	_	_	_	_	_
181	The	_	_	_	_	_	_	_	BeginSeg=Yes
182	trend	_	_	_	_	_	_	_	_
183	is	_	_	_	_	_	_	_	_
184	a	_	_	_	_	_	_	_	_
185	tendency	_	_	_	_	_	_	_	_
186	of	_	_	_	_	_	_	_	_
187	the	_	_	_	_	_	_	_	_
188	data	_	_	_	_	_	_	_	_
189	to	_	_	_	_	_	_	_	BeginSeg=Yes
190	increase	_	_	_	_	_	_	_	_
191	or	_	_	_	_	_	_	_	_
192	decrease	_	_	_	_	_	_	_	_
193	over	_	_	_	_	_	_	_	_
194	time	_	_	_	_	_	_	_	_
195	.	_	_	_	_	_	_	_	_

# newdoc_id = ee370aa6a34ccb5c96e1a213dbed64a2fe4af89f
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	recent	_	_	_	_	_	_	_	_
3	outbreak	_	_	_	_	_	_	_	_
4	of	_	_	_	_	_	_	_	_
5	severe	_	_	_	_	_	_	_	_
6	acute	_	_	_	_	_	_	_	_
7	respiratory	_	_	_	_	_	_	_	_
8	syndrome	_	_	_	_	_	_	_	_
9	(	_	_	_	_	_	_	_	_
10	SARS	_	_	_	_	_	_	_	_
11	)	_	_	_	_	_	_	_	_
12	caused	_	_	_	_	_	_	_	BeginSeg=Yes
13	by	_	_	_	_	_	_	_	_
14	SARS	_	_	_	_	_	_	_	_
15	coronavirus	_	_	_	_	_	_	_	_
16	(	_	_	_	_	_	_	_	_
17	SARS	_	_	_	_	_	_	_	_
18	-	_	_	_	_	_	_	_	_
19	CoV	_	_	_	_	_	_	_	_
20	)	_	_	_	_	_	_	_	_
21	has	_	_	_	_	_	_	_	BeginSeg=Yes
22	necessitated	_	_	_	_	_	_	_	_
23	an	_	_	_	_	_	_	_	_
24	in	_	_	_	_	_	_	_	_
25	-	_	_	_	_	_	_	_	_
26	depth	_	_	_	_	_	_	_	_
27	molecular	_	_	_	_	_	_	_	_
28	understanding	_	_	_	_	_	_	_	_
29	of	_	_	_	_	_	_	_	_
30	the	_	_	_	_	_	_	_	_
31	virus	_	_	_	_	_	_	_	_
32	to	_	_	_	_	_	_	_	BeginSeg=Yes
33	identify	_	_	_	_	_	_	_	_
34	new	_	_	_	_	_	_	_	_
35	drug	_	_	_	_	_	_	_	_
36	targets	_	_	_	_	_	_	_	_
37	.	_	_	_	_	_	_	_	_
38	The	_	_	_	_	_	_	_	BeginSeg=Yes
39	availability	_	_	_	_	_	_	_	_
40	of	_	_	_	_	_	_	_	_
41	complete	_	_	_	_	_	_	_	_
42	genome	_	_	_	_	_	_	_	_
43	sequence	_	_	_	_	_	_	_	_
44	of	_	_	_	_	_	_	_	_
45	several	_	_	_	_	_	_	_	_
46	strains	_	_	_	_	_	_	_	_
47	of	_	_	_	_	_	_	_	_
48	SARS	_	_	_	_	_	_	_	_
49	virus	_	_	_	_	_	_	_	_
50	provides	_	_	_	_	_	_	_	_
51	the	_	_	_	_	_	_	_	_
52	possibility	_	_	_	_	_	_	_	_
53	of	_	_	_	_	_	_	_	_
54	identification	_	_	_	_	_	_	_	_
55	of	_	_	_	_	_	_	_	_
56	protein	_	_	_	_	_	_	_	_
57	-	_	_	_	_	_	_	_	_
58	coding	_	_	_	_	_	_	_	_
59	genes	_	_	_	_	_	_	_	_
60	and	_	_	_	_	_	_	_	_
61	defining	_	_	_	_	_	_	_	_
62	their	_	_	_	_	_	_	_	_
63	functions	_	_	_	_	_	_	_	_
64	.	_	_	_	_	_	_	_	_
65	Computational	_	_	_	_	_	_	_	BeginSeg=Yes
66	approach	_	_	_	_	_	_	_	_
67	to	_	_	_	_	_	_	_	BeginSeg=Yes
68	identify	_	_	_	_	_	_	_	_
69	protein	_	_	_	_	_	_	_	_
70	-	_	_	_	_	_	_	_	_
71	coding	_	_	_	_	_	_	_	_
72	genes	_	_	_	_	_	_	_	_
73	and	_	_	_	_	_	_	_	_
74	their	_	_	_	_	_	_	_	_
75	putative	_	_	_	_	_	_	_	_
76	functions	_	_	_	_	_	_	_	_
77	will	_	_	_	_	_	_	_	BeginSeg=Yes
78	help	_	_	_	_	_	_	_	_
79	in	_	_	_	_	_	_	_	_
80	designing	_	_	_	_	_	_	_	_
81	experimental	_	_	_	_	_	_	_	_
82	protocols	_	_	_	_	_	_	_	_
83	.	_	_	_	_	_	_	_	_
84	Results	_	_	_	_	_	_	_	BeginSeg=Yes
85	:	_	_	_	_	_	_	_	_
86	In	_	_	_	_	_	_	_	BeginSeg=Yes
87	this	_	_	_	_	_	_	_	_
88	paper	_	_	_	_	_	_	_	_
89	,	_	_	_	_	_	_	_	_
90	a	_	_	_	_	_	_	_	_
91	novel	_	_	_	_	_	_	_	_
92	analysis	_	_	_	_	_	_	_	_
93	of	_	_	_	_	_	_	_	_
94	SARS	_	_	_	_	_	_	_	_
95	genome	_	_	_	_	_	_	_	_
96	using	_	_	_	_	_	_	_	BeginSeg=Yes
97	gene	_	_	_	_	_	_	_	_
98	prediction	_	_	_	_	_	_	_	_
99	method	_	_	_	_	_	_	_	_
100	GeneDecipher	_	_	_	_	_	_	_	_
101	developed	_	_	_	_	_	_	_	BeginSeg=Yes
102	in	_	_	_	_	_	_	_	_
103	our	_	_	_	_	_	_	_	_
104	laboratory	_	_	_	_	_	_	_	_
105	has	_	_	_	_	_	_	_	BeginSeg=Yes
106	been	_	_	_	_	_	_	_	_
107	presented	_	_	_	_	_	_	_	_
108	.	_	_	_	_	_	_	_	_
109	Each	_	_	_	_	_	_	_	BeginSeg=Yes
110	of	_	_	_	_	_	_	_	_
111	the	_	_	_	_	_	_	_	_
112	18	_	_	_	_	_	_	_	_
113	newly	_	_	_	_	_	_	_	_
114	sequenced	_	_	_	_	_	_	_	_
115	SARS	_	_	_	_	_	_	_	_
116	-	_	_	_	_	_	_	_	_
117	CoV	_	_	_	_	_	_	_	_
118	genomes	_	_	_	_	_	_	_	_
119	has	_	_	_	_	_	_	_	_
120	been	_	_	_	_	_	_	_	_
121	analyzed	_	_	_	_	_	_	_	_
122	using	_	_	_	_	_	_	_	BeginSeg=Yes
123	GeneDecipher	_	_	_	_	_	_	_	_
124	.	_	_	_	_	_	_	_	_
125	In	_	_	_	_	_	_	_	BeginSeg=Yes
126	addition	_	_	_	_	_	_	_	_
127	to	_	_	_	_	_	_	_	_
128	polyprotein	_	_	_	_	_	_	_	_
129	1ab	_	_	_	_	_	_	_	_
130	1	_	_	_	_	_	_	_	_
131	,	_	_	_	_	_	_	_	_
132	polyprotein	_	_	_	_	_	_	_	_
133	1a	_	_	_	_	_	_	_	_
134	and	_	_	_	_	_	_	_	_
135	the	_	_	_	_	_	_	_	_
136	four	_	_	_	_	_	_	_	_
137	genes	_	_	_	_	_	_	_	_
138	coding	_	_	_	_	_	_	_	_
139	for	_	_	_	_	_	_	_	_
140	major	_	_	_	_	_	_	_	_
141	structural	_	_	_	_	_	_	_	_
142	proteins	_	_	_	_	_	_	_	_
143	spike	_	_	_	_	_	_	_	_
144	(	_	_	_	_	_	_	_	_
145	S	_	_	_	_	_	_	_	_
146	)	_	_	_	_	_	_	_	_
147	,	_	_	_	_	_	_	_	_
148	small	_	_	_	_	_	_	_	_
149	envelope	_	_	_	_	_	_	_	_
150	(	_	_	_	_	_	_	_	_
151	E	_	_	_	_	_	_	_	_
152	)	_	_	_	_	_	_	_	_
153	,	_	_	_	_	_	_	_	_
154	membrane	_	_	_	_	_	_	_	_
155	(	_	_	_	_	_	_	_	_
156	M	_	_	_	_	_	_	_	_
157	)	_	_	_	_	_	_	_	_
158	and	_	_	_	_	_	_	_	_
159	nucleocapsid	_	_	_	_	_	_	_	_
160	(	_	_	_	_	_	_	_	_
161	N	_	_	_	_	_	_	_	_
162	)	_	_	_	_	_	_	_	_
163	,	_	_	_	_	_	_	_	_
164	six	_	_	_	_	_	_	_	_
165	to	_	_	_	_	_	_	_	_
166	eight	_	_	_	_	_	_	_	_
167	additional	_	_	_	_	_	_	_	_
168	proteins	_	_	_	_	_	_	_	_
169	have	_	_	_	_	_	_	_	_
170	been	_	_	_	_	_	_	_	_
171	predicted	_	_	_	_	_	_	_	_
172	depending	_	_	_	_	_	_	_	BeginSeg=Yes
173	upon	_	_	_	_	_	_	_	_
174	the	_	_	_	_	_	_	_	_
175	strain	_	_	_	_	_	_	_	_
176	analyzed	_	_	_	_	_	_	_	BeginSeg=Yes
177	.	_	_	_	_	_	_	_	_
178	Their	_	_	_	_	_	_	_	BeginSeg=Yes
179	lengths	_	_	_	_	_	_	_	_
180	range	_	_	_	_	_	_	_	_
181	between	_	_	_	_	_	_	_	_
182	61	_	_	_	_	_	_	_	_
183	and	_	_	_	_	_	_	_	_
184	274	_	_	_	_	_	_	_	_
185	amino	_	_	_	_	_	_	_	_
186	acids	_	_	_	_	_	_	_	_
187	.	_	_	_	_	_	_	_	_
188	Our	_	_	_	_	_	_	_	BeginSeg=Yes
189	method	_	_	_	_	_	_	_	_
190	also	_	_	_	_	_	_	_	_
191	suggests	_	_	_	_	_	_	_	_
192	that	_	_	_	_	_	_	_	BeginSeg=Yes
193	polyprotein	_	_	_	_	_	_	_	_
194	1ab	_	_	_	_	_	_	_	_
195	,	_	_	_	_	_	_	_	_
196	polyprotein	_	_	_	_	_	_	_	_
197	1a	_	_	_	_	_	_	_	_
198	,	_	_	_	_	_	_	_	_
199	S	_	_	_	_	_	_	_	_
200	,	_	_	_	_	_	_	_	_
201	M	_	_	_	_	_	_	_	_
202	and	_	_	_	_	_	_	_	_
203	N	_	_	_	_	_	_	_	_
204	are	_	_	_	_	_	_	_	_
205	proteins	_	_	_	_	_	_	_	_
206	of	_	_	_	_	_	_	_	_
207	viral	_	_	_	_	_	_	_	_
208	origin	_	_	_	_	_	_	_	_
209	and	_	_	_	_	_	_	_	BeginSeg=Yes
210	others	_	_	_	_	_	_	_	_
211	are	_	_	_	_	_	_	_	_
212	of	_	_	_	_	_	_	_	_
213	prokaryotic	_	_	_	_	_	_	_	_
214	.	_	_	_	_	_	_	_	_
215	Putative	_	_	_	_	_	_	_	BeginSeg=Yes
216	functions	_	_	_	_	_	_	_	_
217	of	_	_	_	_	_	_	_	_
218	all	_	_	_	_	_	_	_	_
219	predicted	_	_	_	_	_	_	_	_
220	protein	_	_	_	_	_	_	_	_
221	-	_	_	_	_	_	_	_	_
222	coding	_	_	_	_	_	_	_	_
223	genes	_	_	_	_	_	_	_	_
224	have	_	_	_	_	_	_	_	_
225	been	_	_	_	_	_	_	_	_
226	suggested	_	_	_	_	_	_	_	_
227	using	_	_	_	_	_	_	_	BeginSeg=Yes
228	conserved	_	_	_	_	_	_	_	_
229	peptides	_	_	_	_	_	_	_	_
230	present	_	_	_	_	_	_	_	_
231	in	_	_	_	_	_	_	_	_
232	their	_	_	_	_	_	_	_	_
233	open	_	_	_	_	_	_	_	_
234	reading	_	_	_	_	_	_	_	_
235	frames	_	_	_	_	_	_	_	_
236	.	_	_	_	_	_	_	_	_
237	Availability	_	_	_	_	_	_	_	BeginSeg=Yes
238	:	_	_	_	_	_	_	_	_
239	Detailed	_	_	_	_	_	_	_	BeginSeg=Yes
240	results	_	_	_	_	_	_	_	_
241	of	_	_	_	_	_	_	_	_
242	GeneDecipher	_	_	_	_	_	_	_	_
243	analysis	_	_	_	_	_	_	_	_
244	of	_	_	_	_	_	_	_	_
245	all	_	_	_	_	_	_	_	_
246	the	_	_	_	_	_	_	_	_
247	18	_	_	_	_	_	_	_	_
248	strains	_	_	_	_	_	_	_	_
249	of	_	_	_	_	_	_	_	_
250	SARS	_	_	_	_	_	_	_	_
251	-	_	_	_	_	_	_	_	_
252	CoV	_	_	_	_	_	_	_	_
253	genomes	_	_	_	_	_	_	_	_
254	are	_	_	_	_	_	_	_	_
255	available	_	_	_	_	_	_	_	_
256	at	_	_	_	_	_	_	_	_

# newdoc_id = eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309
1	A	_	_	_	_	_	_	_	BeginSeg=Yes
2	number	_	_	_	_	_	_	_	_
3	of	_	_	_	_	_	_	_	_
4	methods	_	_	_	_	_	_	_	_
5	based	_	_	_	_	_	_	_	BeginSeg=Yes
6	on	_	_	_	_	_	_	_	_
7	the	_	_	_	_	_	_	_	_
8	deep	_	_	_	_	_	_	_	_
9	learning	_	_	_	_	_	_	_	_
10	have	_	_	_	_	_	_	_	BeginSeg=Yes
11	been	_	_	_	_	_	_	_	_
12	applied	_	_	_	_	_	_	_	_
13	to	_	_	_	_	_	_	_	_
14	medical	_	_	_	_	_	_	_	_
15	image	_	_	_	_	_	_	_	_
16	segmentation	_	_	_	_	_	_	_	_
17	and	_	_	_	_	_	_	_	BeginSeg=Yes
18	have	_	_	_	_	_	_	_	_
19	achieved	_	_	_	_	_	_	_	_
20	state	_	_	_	_	_	_	_	_
21	-	_	_	_	_	_	_	_	_
22	of	_	_	_	_	_	_	_	_
23	-	_	_	_	_	_	_	_	_
24	the	_	_	_	_	_	_	_	_
25	-	_	_	_	_	_	_	_	_
26	art	_	_	_	_	_	_	_	_
27	performance	_	_	_	_	_	_	_	_
28	.	_	_	_	_	_	_	_	_
29	Due	_	_	_	_	_	_	_	BeginSeg=Yes
30	to	_	_	_	_	_	_	_	_
31	the	_	_	_	_	_	_	_	_
32	importance	_	_	_	_	_	_	_	_
33	of	_	_	_	_	_	_	_	_
34	chest	_	_	_	_	_	_	_	_
35	x	_	_	_	_	_	_	_	_
36	-	_	_	_	_	_	_	_	_
37	ray	_	_	_	_	_	_	_	_
38	data	_	_	_	_	_	_	_	_
39	in	_	_	_	_	_	_	_	BeginSeg=Yes
40	studying	_	_	_	_	_	_	_	_
41	COVID-19	_	_	_	_	_	_	_	_
42	,	_	_	_	_	_	_	_	_
43	there	_	_	_	_	_	_	_	BeginSeg=Yes
44	is	_	_	_	_	_	_	_	_
45	a	_	_	_	_	_	_	_	_
46	demand	_	_	_	_	_	_	_	_
47	for	_	_	_	_	_	_	_	_
48	state	_	_	_	_	_	_	_	_
49	-	_	_	_	_	_	_	_	_
50	of	_	_	_	_	_	_	_	_
51	-	_	_	_	_	_	_	_	_
52	art	_	_	_	_	_	_	_	_
53	models	_	_	_	_	_	_	_	_
54	capable	_	_	_	_	_	_	_	_
55	of	_	_	_	_	_	_	_	_
56	precisely	_	_	_	_	_	_	_	_
57	segmenting	_	_	_	_	_	_	_	_
58	chest	_	_	_	_	_	_	_	_
59	x	_	_	_	_	_	_	_	_
60	-	_	_	_	_	_	_	_	_
61	rays	_	_	_	_	_	_	_	_
62	before	_	_	_	_	_	_	_	BeginSeg=Yes
63	obtaining	_	_	_	_	_	_	_	_
64	mask	_	_	_	_	_	_	_	_
65	annotations	_	_	_	_	_	_	_	_
66	about	_	_	_	_	_	_	_	_
67	this	_	_	_	_	_	_	_	_
68	sort	_	_	_	_	_	_	_	_
69	of	_	_	_	_	_	_	_	_
70	dataset	_	_	_	_	_	_	_	_
71	.	_	_	_	_	_	_	_	_
72	The	_	_	_	_	_	_	_	BeginSeg=Yes
73	dataset	_	_	_	_	_	_	_	_
74	for	_	_	_	_	_	_	_	BeginSeg=Yes
75	exploring	_	_	_	_	_	_	_	_
76	best	_	_	_	_	_	_	_	_
77	pre	_	_	_	_	_	_	_	_
78	-	_	_	_	_	_	_	_	_
79	trained	_	_	_	_	_	_	_	_
80	model	_	_	_	_	_	_	_	_
81	is	_	_	_	_	_	_	_	BeginSeg=Yes
82	from	_	_	_	_	_	_	_	_
83	Montgomery	_	_	_	_	_	_	_	_
84	and	_	_	_	_	_	_	_	_
85	Shenzhen	_	_	_	_	_	_	_	_
86	hospital	_	_	_	_	_	_	_	_
87	which	_	_	_	_	_	_	_	BeginSeg=Yes
88	had	_	_	_	_	_	_	_	_
89	opened	_	_	_	_	_	_	_	_
90	in	_	_	_	_	_	_	_	_
91	2014	_	_	_	_	_	_	_	_
92	.	_	_	_	_	_	_	_	_
93	The	_	_	_	_	_	_	_	BeginSeg=Yes
94	most	_	_	_	_	_	_	_	_
95	famous	_	_	_	_	_	_	_	_
96	technique	_	_	_	_	_	_	_	_
97	is	_	_	_	_	_	_	_	_
98	U	_	_	_	_	_	_	_	_
99	-	_	_	_	_	_	_	_	_
100	Net	_	_	_	_	_	_	_	_
101	which	_	_	_	_	_	_	_	BeginSeg=Yes
102	has	_	_	_	_	_	_	_	_
103	been	_	_	_	_	_	_	_	_
104	used	_	_	_	_	_	_	_	_
105	to	_	_	_	_	_	_	_	_
106	many	_	_	_	_	_	_	_	_
107	medical	_	_	_	_	_	_	_	_
108	datasets	_	_	_	_	_	_	_	_
109	including	_	_	_	_	_	_	_	BeginSeg=Yes
110	the	_	_	_	_	_	_	_	_
111	Chest	_	_	_	_	_	_	_	_
112	X	_	_	_	_	_	_	_	_
113	-	_	_	_	_	_	_	_	_
114	ray	_	_	_	_	_	_	_	_
115	.	_	_	_	_	_	_	_	_
116	However	_	_	_	_	_	_	_	BeginSeg=Yes
117	,	_	_	_	_	_	_	_	_
118	most	_	_	_	_	_	_	_	_
119	of	_	_	_	_	_	_	_	_
120	variant	_	_	_	_	_	_	_	_
121	U	_	_	_	_	_	_	_	_
122	-	_	_	_	_	_	_	_	_
123	Net	_	_	_	_	_	_	_	_
124	mainly	_	_	_	_	_	_	_	_
125	focus	_	_	_	_	_	_	_	_
126	on	_	_	_	_	_	_	_	_
127	extraction	_	_	_	_	_	_	_	_
128	of	_	_	_	_	_	_	_	_
129	contextual	_	_	_	_	_	_	_	_
130	information	_	_	_	_	_	_	_	_
131	and	_	_	_	_	_	_	_	_
132	dense	_	_	_	_	_	_	_	_
133	skip	_	_	_	_	_	_	_	_
134	connection	_	_	_	_	_	_	_	_
135	.	_	_	_	_	_	_	_	_
136	There	_	_	_	_	_	_	_	BeginSeg=Yes
137	is	_	_	_	_	_	_	_	_
138	still	_	_	_	_	_	_	_	_
139	a	_	_	_	_	_	_	_	_
140	large	_	_	_	_	_	_	_	_
141	space	_	_	_	_	_	_	_	_
142	for	_	_	_	_	_	_	_	BeginSeg=Yes
143	improving	_	_	_	_	_	_	_	_
144	extraction	_	_	_	_	_	_	_	_
145	of	_	_	_	_	_	_	_	_
146	spatial	_	_	_	_	_	_	_	_
147	feature	_	_	_	_	_	_	_	_
148	.	_	_	_	_	_	_	_	_
149	In	_	_	_	_	_	_	_	BeginSeg=Yes
150	this	_	_	_	_	_	_	_	_
151	paper	_	_	_	_	_	_	_	_
152	,	_	_	_	_	_	_	_	_
153	we	_	_	_	_	_	_	_	_
154	propose	_	_	_	_	_	_	_	_
155	a	_	_	_	_	_	_	_	_
156	dual	_	_	_	_	_	_	_	_
157	encoder	_	_	_	_	_	_	_	_
158	fusion	_	_	_	_	_	_	_	_
159	U	_	_	_	_	_	_	_	_
160	-	_	_	_	_	_	_	_	_
161	Net	_	_	_	_	_	_	_	_
162	framework	_	_	_	_	_	_	_	_
163	for	_	_	_	_	_	_	_	_
164	Chest	_	_	_	_	_	_	_	_
165	X	_	_	_	_	_	_	_	_
166	-	_	_	_	_	_	_	_	_
167	rays	_	_	_	_	_	_	_	_
168	based	_	_	_	_	_	_	_	BeginSeg=Yes
169	on	_	_	_	_	_	_	_	_
170	Inception	_	_	_	_	_	_	_	_
171	Convolutional	_	_	_	_	_	_	_	_
172	Neural	_	_	_	_	_	_	_	_
173	Network	_	_	_	_	_	_	_	_
174	with	_	_	_	_	_	_	_	_
175	dilation	_	_	_	_	_	_	_	_
176	,	_	_	_	_	_	_	_	_
177	Densely	_	_	_	_	_	_	_	_
178	Connected	_	_	_	_	_	_	_	_
179	Recurrent	_	_	_	_	_	_	_	_
180	Convolutional	_	_	_	_	_	_	_	_
181	Neural	_	_	_	_	_	_	_	_
182	Network	_	_	_	_	_	_	_	_
183	,	_	_	_	_	_	_	_	_
184	which	_	_	_	_	_	_	_	BeginSeg=Yes
185	is	_	_	_	_	_	_	_	_
186	named	_	_	_	_	_	_	_	_
187	DEFU	_	_	_	_	_	_	_	_
188	-	_	_	_	_	_	_	_	_
189	Net	_	_	_	_	_	_	_	_
190	.	_	_	_	_	_	_	_	_
191	The	_	_	_	_	_	_	_	BeginSeg=Yes
192	densely	_	_	_	_	_	_	_	_
193	connected	_	_	_	_	_	_	_	_
194	recurrent	_	_	_	_	_	_	_	_
195	path	_	_	_	_	_	_	_	_
196	extends	_	_	_	_	_	_	_	_
197	the	_	_	_	_	_	_	_	_
198	network	_	_	_	_	_	_	_	_
199	deeper	_	_	_	_	_	_	_	_
200	for	_	_	_	_	_	_	_	BeginSeg=Yes
201	facilitating	_	_	_	_	_	_	_	_
202	context	_	_	_	_	_	_	_	_
203	feature	_	_	_	_	_	_	_	_
204	extraction	_	_	_	_	_	_	_	_
205	.	_	_	_	_	_	_	_	_
206	In	_	_	_	_	_	_	_	BeginSeg=Yes
207	order	_	_	_	_	_	_	_	_
208	to	_	_	_	_	_	_	_	_
209	increase	_	_	_	_	_	_	_	_
210	the	_	_	_	_	_	_	_	_
211	width	_	_	_	_	_	_	_	_
212	of	_	_	_	_	_	_	_	_
213	network	_	_	_	_	_	_	_	_
214	and	_	_	_	_	_	_	_	BeginSeg=Yes
215	enrich	_	_	_	_	_	_	_	_
216	representation	_	_	_	_	_	_	_	_
217	of	_	_	_	_	_	_	_	_
218	features	_	_	_	_	_	_	_	_
219	,	_	_	_	_	_	_	_	_
220	the	_	_	_	_	_	_	_	BeginSeg=Yes
221	inception	_	_	_	_	_	_	_	_
222	blocks	_	_	_	_	_	_	_	_
223	with	_	_	_	_	_	_	_	_
224	dilation	_	_	_	_	_	_	_	_
225	have	_	_	_	_	_	_	_	_
226	been	_	_	_	_	_	_	_	_
227	used	_	_	_	_	_	_	_	_
228	.	_	_	_	_	_	_	_	_
229	The	_	_	_	_	_	_	_	BeginSeg=Yes
230	inception	_	_	_	_	_	_	_	_
231	blocks	_	_	_	_	_	_	_	_
232	can	_	_	_	_	_	_	_	_
233	capture	_	_	_	_	_	_	_	_
234	globally	_	_	_	_	_	_	_	_
235	and	_	_	_	_	_	_	_	_
236	locally	_	_	_	_	_	_	_	_
237	spatial	_	_	_	_	_	_	_	_
238	information	_	_	_	_	_	_	_	_
239	by	_	_	_	_	_	_	_	_
240	various	_	_	_	_	_	_	_	_
241	receptive	_	_	_	_	_	_	_	_
242	fields	_	_	_	_	_	_	_	_
243	.	_	_	_	_	_	_	_	_
244	Meanwhile	_	_	_	_	_	_	_	BeginSeg=Yes
245	,	_	_	_	_	_	_	_	_
246	the	_	_	_	_	_	_	_	_
247	features	_	_	_	_	_	_	_	_
248	fusion	_	_	_	_	_	_	_	_
249	of	_	_	_	_	_	_	_	_
250	two	_	_	_	_	_	_	_	_
251	path	_	_	_	_	_	_	_	_
252	by	_	_	_	_	_	_	_	_
253	summation	_	_	_	_	_	_	_	_
254	preserve	_	_	_	_	_	_	_	_
255	the	_	_	_	_	_	_	_	_
256	context	_	_	_	_	_	_	_	_
257	and	_	_	_	_	_	_	_	_
258	the	_	_	_	_	_	_	_	_
259	spatial	_	_	_	_	_	_	_	_
260	information	_	_	_	_	_	_	_	_
261	for	_	_	_	_	_	_	_	_
262	decoding	_	_	_	_	_	_	_	_
263	part	_	_	_	_	_	_	_	_
264	.	_	_	_	_	_	_	_	_
265	This	_	_	_	_	_	_	_	BeginSeg=Yes
266	multi	_	_	_	_	_	_	_	_
267	-	_	_	_	_	_	_	_	_
268	learning	_	_	_	_	_	_	_	_
269	-	_	_	_	_	_	_	_	_
270	scale	_	_	_	_	_	_	_	_
271	model	_	_	_	_	_	_	_	_
272	are	_	_	_	_	_	_	_	_
273	benefiting	_	_	_	_	_	_	_	_
274	in	_	_	_	_	_	_	_	_
275	Chest	_	_	_	_	_	_	_	_
276	X	_	_	_	_	_	_	_	_
277	-	_	_	_	_	_	_	_	_
278	ray	_	_	_	_	_	_	_	_
279	dataset	_	_	_	_	_	_	_	_
280	from	_	_	_	_	_	_	_	_
281	two	_	_	_	_	_	_	_	_
282	different	_	_	_	_	_	_	_	_
283	manufacturers	_	_	_	_	_	_	_	_
284	(	_	_	_	_	_	_	_	BeginSeg=Yes
285	Montgomery	_	_	_	_	_	_	_	_
286	and	_	_	_	_	_	_	_	_
287	Shenzhen	_	_	_	_	_	_	_	_
288	hospital	_	_	_	_	_	_	_	_
289	)	_	_	_	_	_	_	_	_
290	.	_	_	_	_	_	_	_	_
291	The	_	_	_	_	_	_	_	BeginSeg=Yes
292	DEFU	_	_	_	_	_	_	_	_
293	-	_	_	_	_	_	_	_	_
294	Net	_	_	_	_	_	_	_	_
295	achieves	_	_	_	_	_	_	_	_
296	the	_	_	_	_	_	_	_	_
297	better	_	_	_	_	_	_	_	_
298	performance	_	_	_	_	_	_	_	_
299	than	_	_	_	_	_	_	_	_
300	basic	_	_	_	_	_	_	_	_
301	U	_	_	_	_	_	_	_	_
302	-	_	_	_	_	_	_	_	_
303	Net	_	_	_	_	_	_	_	_
304	,	_	_	_	_	_	_	_	_
305	residual	_	_	_	_	_	_	_	_
306	U	_	_	_	_	_	_	_	_
307	-	_	_	_	_	_	_	_	_
308	Net	_	_	_	_	_	_	_	_
309	,	_	_	_	_	_	_	_	_
310	BCDU	_	_	_	_	_	_	_	_
311	-	_	_	_	_	_	_	_	_
312	Net	_	_	_	_	_	_	_	_
313	,	_	_	_	_	_	_	_	_
314	modified	_	_	_	_	_	_	_	_
315	R2U	_	_	_	_	_	_	_	_
316	-	_	_	_	_	_	_	_	_
317	Net	_	_	_	_	_	_	_	_
318	and	_	_	_	_	_	_	_	_
319	modified	_	_	_	_	_	_	_	_
320	attention	_	_	_	_	_	_	_	_
321	R2U	_	_	_	_	_	_	_	_
322	-	_	_	_	_	_	_	_	_
323	Net	_	_	_	_	_	_	_	_
324	.	_	_	_	_	_	_	_	_
325	This	_	_	_	_	_	_	_	BeginSeg=Yes
326	model	_	_	_	_	_	_	_	_
327	is	_	_	_	_	_	_	_	_
328	proved	_	_	_	_	_	_	_	_
329	the	_	_	_	_	_	_	_	_
330	feasibility	_	_	_	_	_	_	_	_
331	for	_	_	_	_	_	_	_	_
332	mixed	_	_	_	_	_	_	_	_
333	dataset	_	_	_	_	_	_	_	_
334	.	_	_	_	_	_	_	_	_
335	The	_	_	_	_	_	_	_	BeginSeg=Yes
336	open	_	_	_	_	_	_	_	_
337	source	_	_	_	_	_	_	_	_
338	code	_	_	_	_	_	_	_	_
339	for	_	_	_	_	_	_	_	_
340	this	_	_	_	_	_	_	_	_
341	proposed	_	_	_	_	_	_	_	_
342	framework	_	_	_	_	_	_	_	_
343	will	_	_	_	_	_	_	_	_
344	be	_	_	_	_	_	_	_	_
345	public	_	_	_	_	_	_	_	_
346	soon	_	_	_	_	_	_	_	_
347	.	_	_	_	_	_	_	_	_

# newdoc_id = f26b4d2b79d661c896a22c4050ae0818effafe8f
1	Porcine	_	_	_	_	_	_	_	BeginSeg=Yes
2	reproductive	_	_	_	_	_	_	_	_
3	and	_	_	_	_	_	_	_	_
4	respiratory	_	_	_	_	_	_	_	_
5	syndrome	_	_	_	_	_	_	_	_
6	virus	_	_	_	_	_	_	_	_
7	(	_	_	_	_	_	_	_	_
8	PRRSV	_	_	_	_	_	_	_	_
9	)	_	_	_	_	_	_	_	_
10	is	_	_	_	_	_	_	_	_
11	an	_	_	_	_	_	_	_	_
12	economically	_	_	_	_	_	_	_	_
13	important	_	_	_	_	_	_	_	_
14	swine	_	_	_	_	_	_	_	_
15	pathogen	_	_	_	_	_	_	_	_
16	.	_	_	_	_	_	_	_	_
17	Since	_	_	_	_	_	_	_	BeginSeg=Yes
18	its	_	_	_	_	_	_	_	_
19	discovery	_	_	_	_	_	_	_	_
20	in	_	_	_	_	_	_	_	_
21	the	_	_	_	_	_	_	_	_
22	early	_	_	_	_	_	_	_	_
23	1990s	_	_	_	_	_	_	_	_
24	,	_	_	_	_	_	_	_	_
25	tremendous	_	_	_	_	_	_	_	_
26	progresses	_	_	_	_	_	_	_	_
27	have	_	_	_	_	_	_	_	_
28	been	_	_	_	_	_	_	_	_
29	made	_	_	_	_	_	_	_	_
30	in	_	_	_	_	_	_	_	_
31	understanding	_	_	_	_	_	_	_	_
32	the	_	_	_	_	_	_	_	_
33	molecular	_	_	_	_	_	_	_	_
34	biology	_	_	_	_	_	_	_	_
35	and	_	_	_	_	_	_	_	_
36	pathogenesis	_	_	_	_	_	_	_	_
37	of	_	_	_	_	_	_	_	_
38	PRRSV	_	_	_	_	_	_	_	_
39	.	_	_	_	_	_	_	_	_
40	Although	_	_	_	_	_	_	_	BeginSeg=Yes
41	modified	_	_	_	_	_	_	_	_
42	live	_	_	_	_	_	_	_	_
43	-	_	_	_	_	_	_	_	_
44	attenuated	_	_	_	_	_	_	_	_
45	vaccines	_	_	_	_	_	_	_	_
46	(	_	_	_	_	_	_	_	_
47	MLVs	_	_	_	_	_	_	_	_
48	)	_	_	_	_	_	_	_	_
49	and	_	_	_	_	_	_	_	_
50	inactivated	_	_	_	_	_	_	_	_
51	vaccines	_	_	_	_	_	_	_	_
52	against	_	_	_	_	_	_	_	_
53	PRRSV	_	_	_	_	_	_	_	_
54	have	_	_	_	_	_	_	_	_
55	been	_	_	_	_	_	_	_	_
56	available	_	_	_	_	_	_	_	_
57	for	_	_	_	_	_	_	_	_
58	more	_	_	_	_	_	_	_	_
59	than	_	_	_	_	_	_	_	_
60	a	_	_	_	_	_	_	_	_
61	decade	_	_	_	_	_	_	_	_
62	,	_	_	_	_	_	_	_	_
63	the	_	_	_	_	_	_	_	BeginSeg=Yes
64	disease	_	_	_	_	_	_	_	_
65	remains	_	_	_	_	_	_	_	_
66	difficult	_	_	_	_	_	_	_	_
67	to	_	_	_	_	_	_	_	_
68	control	_	_	_	_	_	_	_	_
69	.	_	_	_	_	_	_	_	_
70	The	_	_	_	_	_	_	_	BeginSeg=Yes
71	efficacies	_	_	_	_	_	_	_	_
72	of	_	_	_	_	_	_	_	_
73	these	_	_	_	_	_	_	_	_
74	vaccines	_	_	_	_	_	_	_	_
75	especially	_	_	_	_	_	_	_	_
76	against	_	_	_	_	_	_	_	_
77	heterologous	_	_	_	_	_	_	_	_
78	strains	_	_	_	_	_	_	_	_
79	remain	_	_	_	_	_	_	_	_
80	questionable	_	_	_	_	_	_	_	_
81	:	_	_	_	_	_	_	_	_
82	the	_	_	_	_	_	_	_	BeginSeg=Yes
83	MLVs	_	_	_	_	_	_	_	_
84	were	_	_	_	_	_	_	_	_
85	generally	_	_	_	_	_	_	_	_
86	effective	_	_	_	_	_	_	_	_
87	against	_	_	_	_	_	_	_	_
88	homologous	_	_	_	_	_	_	_	_
89	strains	_	_	_	_	_	_	_	_
90	but	_	_	_	_	_	_	_	_
91	variable	_	_	_	_	_	_	_	_
92	in	_	_	_	_	_	_	_	_
93	success	_	_	_	_	_	_	_	_
94	against	_	_	_	_	_	_	_	_
95	heterologous	_	_	_	_	_	_	_	_
96	strains	_	_	_	_	_	_	_	_
97	,	_	_	_	_	_	_	_	_
98	and	_	_	_	_	_	_	_	BeginSeg=Yes
99	the	_	_	_	_	_	_	_	_
100	outcomes	_	_	_	_	_	_	_	_
101	of	_	_	_	_	_	_	_	_
102	inactivated	_	_	_	_	_	_	_	_
103	vaccines	_	_	_	_	_	_	_	_
104	in	_	_	_	_	_	_	_	_
105	the	_	_	_	_	_	_	_	_
106	field	_	_	_	_	_	_	_	_
107	are	_	_	_	_	_	_	_	_
108	not	_	_	_	_	_	_	_	_
109	very	_	_	_	_	_	_	_	_
110	promising	_	_	_	_	_	_	_	_
111	.	_	_	_	_	_	_	_	_
112	With	_	_	_	_	_	_	_	BeginSeg=Yes
113	the	_	_	_	_	_	_	_	_
114	development	_	_	_	_	_	_	_	_
115	of	_	_	_	_	_	_	_	_
116	PRRSV	_	_	_	_	_	_	_	_
117	reverse	_	_	_	_	_	_	_	_
118	genetics	_	_	_	_	_	_	_	_
119	systems	_	_	_	_	_	_	_	_
120	and	_	_	_	_	_	_	_	_
121	the	_	_	_	_	_	_	_	_
122	acquisition	_	_	_	_	_	_	_	_
123	of	_	_	_	_	_	_	_	_
124	new	_	_	_	_	_	_	_	_
125	understanding	_	_	_	_	_	_	_	_
126	on	_	_	_	_	_	_	_	_
127	anti	_	_	_	_	_	_	_	_
128	-	_	_	_	_	_	_	_	_
129	PRRSV	_	_	_	_	_	_	_	_
130	immunity	_	_	_	_	_	_	_	_
131	,	_	_	_	_	_	_	_	_
132	rational	_	_	_	_	_	_	_	_
133	design	_	_	_	_	_	_	_	_
134	of	_	_	_	_	_	_	_	_
135	the	_	_	_	_	_	_	_	_
136	next	_	_	_	_	_	_	_	_
137	generation	_	_	_	_	_	_	_	_
138	of	_	_	_	_	_	_	_	_
139	PRRSV	_	_	_	_	_	_	_	_
140	vaccines	_	_	_	_	_	_	_	_
141	can	_	_	_	_	_	_	_	_
142	now	_	_	_	_	_	_	_	_
143	be	_	_	_	_	_	_	_	_
144	explored	_	_	_	_	_	_	_	_
145	.	_	_	_	_	_	_	_	_
146	In	_	_	_	_	_	_	_	BeginSeg=Yes
147	this	_	_	_	_	_	_	_	_
148	review	_	_	_	_	_	_	_	_
149	,	_	_	_	_	_	_	_	_
150	we	_	_	_	_	_	_	_	_
151	discussed	_	_	_	_	_	_	_	_
152	the	_	_	_	_	_	_	_	_
153	recent	_	_	_	_	_	_	_	_
154	advances	_	_	_	_	_	_	_	_
155	in	_	_	_	_	_	_	_	_
156	anti	_	_	_	_	_	_	_	_
157	-	_	_	_	_	_	_	_	_
158	PRRSV	_	_	_	_	_	_	_	_
159	immunity	_	_	_	_	_	_	_	_
160	and	_	_	_	_	_	_	_	_
161	vaccinology	_	_	_	_	_	_	_	_
162	,	_	_	_	_	_	_	_	_
163	the	_	_	_	_	_	_	_	_
164	recent	_	_	_	_	_	_	_	_
165	progresses	_	_	_	_	_	_	_	_
166	in	_	_	_	_	_	_	_	_
167	PRRSV	_	_	_	_	_	_	_	_
168	vaccine	_	_	_	_	_	_	_	_
169	development	_	_	_	_	_	_	_	_
170	particularly	_	_	_	_	_	_	_	_
171	the	_	_	_	_	_	_	_	_
172	reverse	_	_	_	_	_	_	_	_
173	genetics	_	_	_	_	_	_	_	_
174	system	_	_	_	_	_	_	_	_
175	-	_	_	_	_	_	_	_	_
176	based	_	_	_	_	_	_	_	_
177	vaccine	_	_	_	_	_	_	_	_
178	development	_	_	_	_	_	_	_	_
179	,	_	_	_	_	_	_	_	_
180	and	_	_	_	_	_	_	_	BeginSeg=Yes
181	provided	_	_	_	_	_	_	_	_
182	a	_	_	_	_	_	_	_	_
183	perspective	_	_	_	_	_	_	_	_
184	on	_	_	_	_	_	_	_	_
185	potential	_	_	_	_	_	_	_	_
186	novel	_	_	_	_	_	_	_	_
187	strategies	_	_	_	_	_	_	_	_
188	and	_	_	_	_	_	_	_	_
189	approaches	_	_	_	_	_	_	_	_
190	that	_	_	_	_	_	_	_	BeginSeg=Yes
191	may	_	_	_	_	_	_	_	_
192	be	_	_	_	_	_	_	_	_
193	applicable	_	_	_	_	_	_	_	_
194	to	_	_	_	_	_	_	_	_
195	the	_	_	_	_	_	_	_	_
196	development	_	_	_	_	_	_	_	_
197	of	_	_	_	_	_	_	_	_
198	the	_	_	_	_	_	_	_	_
199	next	_	_	_	_	_	_	_	_
200	generation	_	_	_	_	_	_	_	_
201	of	_	_	_	_	_	_	_	_
202	PRRSV	_	_	_	_	_	_	_	_
203	vaccines	_	_	_	_	_	_	_	_
204	.	_	_	_	_	_	_	_	_

# newdoc_id = f7185938312bfa794681998fe0bff4e2697c053d
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	development	_	_	_	_	_	_	_	_
3	of	_	_	_	_	_	_	_	_
4	synthetic	_	_	_	_	_	_	_	_
5	peptide	_	_	_	_	_	_	_	_
6	-	_	_	_	_	_	_	_	_
7	based	_	_	_	_	_	_	_	_
8	vaccines	_	_	_	_	_	_	_	_
9	has	_	_	_	_	_	_	_	_
10	many	_	_	_	_	_	_	_	_
11	advantages	_	_	_	_	_	_	_	_
12	in	_	_	_	_	_	_	_	BeginSeg=Yes
13	comparison	_	_	_	_	_	_	_	_
14	with	_	_	_	_	_	_	_	_
15	vaccines	_	_	_	_	_	_	_	_
16	based	_	_	_	_	_	_	_	BeginSeg=Yes
17	on	_	_	_	_	_	_	_	_
18	live	_	_	_	_	_	_	_	_
19	attenuated	_	_	_	_	_	_	_	_
20	organisms	_	_	_	_	_	_	_	_
21	,	_	_	_	_	_	_	_	_
22	inactivated	_	_	_	_	_	_	_	_
23	or	_	_	_	_	_	_	_	_
24	killed	_	_	_	_	_	_	_	_
25	organism	_	_	_	_	_	_	_	_
26	,	_	_	_	_	_	_	_	_
27	or	_	_	_	_	_	_	_	_
28	toxins	_	_	_	_	_	_	_	_
29	.	_	_	_	_	_	_	_	_
30	Peptide	_	_	_	_	_	_	_	BeginSeg=Yes
31	-	_	_	_	_	_	_	_	_
32	based	_	_	_	_	_	_	_	_
33	vaccines	_	_	_	_	_	_	_	_
34	can	_	_	_	_	_	_	_	_
35	not	_	_	_	_	_	_	_	_
36	revert	_	_	_	_	_	_	_	_
37	to	_	_	_	_	_	_	_	_
38	a	_	_	_	_	_	_	_	_
39	virulent	_	_	_	_	_	_	_	_
40	form	_	_	_	_	_	_	_	_
41	,	_	_	_	_	_	_	_	_
42	allow	_	_	_	_	_	_	_	BeginSeg=Yes
43	a	_	_	_	_	_	_	_	_
44	better	_	_	_	_	_	_	_	_
45	conservation	_	_	_	_	_	_	_	_
46	,	_	_	_	_	_	_	_	_
47	and	_	_	_	_	_	_	_	BeginSeg=Yes
48	are	_	_	_	_	_	_	_	_
49	produced	_	_	_	_	_	_	_	_
50	more	_	_	_	_	_	_	_	_
51	easily	_	_	_	_	_	_	_	_
52	and	_	_	_	_	_	_	_	_
53	safely	_	_	_	_	_	_	_	_
54	.	_	_	_	_	_	_	_	_
55	However	_	_	_	_	_	_	_	BeginSeg=Yes
56	,	_	_	_	_	_	_	_	_
57	they	_	_	_	_	_	_	_	_
58	generate	_	_	_	_	_	_	_	_
59	a	_	_	_	_	_	_	_	_
60	weaker	_	_	_	_	_	_	_	_
61	immune	_	_	_	_	_	_	_	_
62	response	_	_	_	_	_	_	_	_
63	than	_	_	_	_	_	_	_	_
64	other	_	_	_	_	_	_	_	_
65	vaccines	_	_	_	_	_	_	_	_
66	,	_	_	_	_	_	_	_	_
67	and	_	_	_	_	_	_	_	BeginSeg=Yes
68	the	_	_	_	_	_	_	_	_
69	inclusion	_	_	_	_	_	_	_	_
70	of	_	_	_	_	_	_	_	_
71	adjuvants	_	_	_	_	_	_	_	_
72	and/or	_	_	_	_	_	_	_	_
73	the	_	_	_	_	_	_	_	_
74	use	_	_	_	_	_	_	_	_
75	of	_	_	_	_	_	_	_	_
76	vaccine	_	_	_	_	_	_	_	_
77	delivery	_	_	_	_	_	_	_	_
78	systems	_	_	_	_	_	_	_	_
79	is	_	_	_	_	_	_	_	_
80	almost	_	_	_	_	_	_	_	_
81	always	_	_	_	_	_	_	_	_
82	needed	_	_	_	_	_	_	_	_
83	.	_	_	_	_	_	_	_	_
84	Among	_	_	_	_	_	_	_	BeginSeg=Yes
85	vaccine	_	_	_	_	_	_	_	_
86	delivery	_	_	_	_	_	_	_	_
87	systems	_	_	_	_	_	_	_	_
88	,	_	_	_	_	_	_	_	_
89	micro	_	_	_	_	_	_	_	_
90	-	_	_	_	_	_	_	_	_
91	and	_	_	_	_	_	_	_	_
92	nanoparticulated	_	_	_	_	_	_	_	_
93	ones	_	_	_	_	_	_	_	_
94	are	_	_	_	_	_	_	_	_
95	attractive	_	_	_	_	_	_	_	_
96	,	_	_	_	_	_	_	_	_
97	because	_	_	_	_	_	_	_	BeginSeg=Yes
98	their	_	_	_	_	_	_	_	_
99	particulate	_	_	_	_	_	_	_	_
100	nature	_	_	_	_	_	_	_	_
101	can	_	_	_	_	_	_	_	_
102	increase	_	_	_	_	_	_	_	_
103	cross	_	_	_	_	_	_	_	_
104	-	_	_	_	_	_	_	_	_
105	presentation	_	_	_	_	_	_	_	_
106	of	_	_	_	_	_	_	_	_
107	the	_	_	_	_	_	_	_	_
108	peptide	_	_	_	_	_	_	_	_
109	.	_	_	_	_	_	_	_	_
110	In	_	_	_	_	_	_	_	BeginSeg=Yes
111	addition	_	_	_	_	_	_	_	_
112	,	_	_	_	_	_	_	_	_
113	they	_	_	_	_	_	_	_	_
114	can	_	_	_	_	_	_	_	_
115	be	_	_	_	_	_	_	_	_
116	passively	_	_	_	_	_	_	_	_
117	or	_	_	_	_	_	_	_	_
118	actively	_	_	_	_	_	_	_	_
119	targeted	_	_	_	_	_	_	_	_
120	to	_	_	_	_	_	_	_	_
121	antigen	_	_	_	_	_	_	_	_
122	presenting	_	_	_	_	_	_	_	_
123	cells	_	_	_	_	_	_	_	_
124	.	_	_	_	_	_	_	_	_
125	Furthermore	_	_	_	_	_	_	_	BeginSeg=Yes
126	,	_	_	_	_	_	_	_	_
127	particulate	_	_	_	_	_	_	_	_
128	adjuvants	_	_	_	_	_	_	_	_
129	are	_	_	_	_	_	_	_	_
130	able	_	_	_	_	_	_	_	_
131	to	_	_	_	_	_	_	_	_
132	directly	_	_	_	_	_	_	_	_
133	activate	_	_	_	_	_	_	_	_
134	innate	_	_	_	_	_	_	_	_
135	immune	_	_	_	_	_	_	_	_
136	system	_	_	_	_	_	_	_	_
137	in	_	_	_	_	_	_	_	_
138	vivo	_	_	_	_	_	_	_	_
139	.	_	_	_	_	_	_	_	_
140	Here	_	_	_	_	_	_	_	BeginSeg=Yes
141	,	_	_	_	_	_	_	_	_
142	we	_	_	_	_	_	_	_	_
143	summarize	_	_	_	_	_	_	_	_
144	micro	_	_	_	_	_	_	_	_
145	-	_	_	_	_	_	_	_	_
146	and	_	_	_	_	_	_	_	_
147	nanoparticulated	_	_	_	_	_	_	_	_
148	vaccine	_	_	_	_	_	_	_	_
149	delivery	_	_	_	_	_	_	_	_
150	systems	_	_	_	_	_	_	_	_
151	used	_	_	_	_	_	_	_	BeginSeg=Yes
152	in	_	_	_	_	_	_	_	_
153	the	_	_	_	_	_	_	_	_
154	field	_	_	_	_	_	_	_	_
155	of	_	_	_	_	_	_	_	_
156	synthetic	_	_	_	_	_	_	_	_
157	peptide	_	_	_	_	_	_	_	_
158	-	_	_	_	_	_	_	_	_
159	based	_	_	_	_	_	_	_	_
160	vaccines	_	_	_	_	_	_	_	_
161	as	_	_	_	_	_	_	_	BeginSeg=Yes
162	well	_	_	_	_	_	_	_	_
163	as	_	_	_	_	_	_	_	_
164	strategies	_	_	_	_	_	_	_	_
165	to	_	_	_	_	_	_	_	BeginSeg=Yes
166	increase	_	_	_	_	_	_	_	_
167	their	_	_	_	_	_	_	_	_
168	immunogenicity	_	_	_	_	_	_	_	_
169	.	_	_	_	_	_	_	_	_

# newdoc_id = f729e0e5f3472840a5f1be47d12b29c83d1c4879
1	Infection	_	_	_	_	_	_	_	BeginSeg=Yes
2	with	_	_	_	_	_	_	_	_
3	Mycobacterium	_	_	_	_	_	_	_	_
4	tuberculosis	_	_	_	_	_	_	_	_
5	remains	_	_	_	_	_	_	_	_
6	a	_	_	_	_	_	_	_	_
7	major	_	_	_	_	_	_	_	_
8	cause	_	_	_	_	_	_	_	_
9	of	_	_	_	_	_	_	_	_
10	morbidity	_	_	_	_	_	_	_	_
11	and	_	_	_	_	_	_	_	_
12	mortality	_	_	_	_	_	_	_	_
13	all	_	_	_	_	_	_	_	_
14	over	_	_	_	_	_	_	_	_
15	the	_	_	_	_	_	_	_	_
16	world	_	_	_	_	_	_	_	_
17	.	_	_	_	_	_	_	_	_
18	Since	_	_	_	_	_	_	_	BeginSeg=Yes
19	the	_	_	_	_	_	_	_	_
20	effectiveness	_	_	_	_	_	_	_	_
21	of	_	_	_	_	_	_	_	_
22	the	_	_	_	_	_	_	_	_
23	only	_	_	_	_	_	_	_	_
24	available	_	_	_	_	_	_	_	_
25	tuberculosis	_	_	_	_	_	_	_	_
26	vaccine	_	_	_	_	_	_	_	_
27	,	_	_	_	_	_	_	_	_
28	Mycobacterium	_	_	_	_	_	_	_	_
29	bovis	_	_	_	_	_	_	_	_
30	bacillus	_	_	_	_	_	_	_	_
31	Calmette	_	_	_	_	_	_	_	_
32	-	_	_	_	_	_	_	_	_
33	Guérin	_	_	_	_	_	_	_	_
34	(	_	_	_	_	_	_	_	_
35	BCG	_	_	_	_	_	_	_	_
36	)	_	_	_	_	_	_	_	_
37	,	_	_	_	_	_	_	_	_
38	is	_	_	_	_	_	_	_	_
39	suboptimal	_	_	_	_	_	_	_	_
40	,	_	_	_	_	_	_	_	_
41	there	_	_	_	_	_	_	_	BeginSeg=Yes
42	is	_	_	_	_	_	_	_	_
43	a	_	_	_	_	_	_	_	_
44	strong	_	_	_	_	_	_	_	_
45	demand	_	_	_	_	_	_	_	_
46	to	_	_	_	_	_	_	_	BeginSeg=Yes
47	develop	_	_	_	_	_	_	_	_
48	new	_	_	_	_	_	_	_	_
49	tuberculosis	_	_	_	_	_	_	_	_
50	vaccines	_	_	_	_	_	_	_	_
51	.	_	_	_	_	_	_	_	_
52	As	_	_	_	_	_	_	_	BeginSeg=Yes
53	tuberculosis	_	_	_	_	_	_	_	_
54	is	_	_	_	_	_	_	_	_
55	an	_	_	_	_	_	_	_	_
56	airborne	_	_	_	_	_	_	_	_
57	disease	_	_	_	_	_	_	_	_
58	,	_	_	_	_	_	_	_	_
59	the	_	_	_	_	_	_	_	BeginSeg=Yes
60	intranasal	_	_	_	_	_	_	_	_
61	route	_	_	_	_	_	_	_	_
62	of	_	_	_	_	_	_	_	_
63	vaccination	_	_	_	_	_	_	_	_
64	might	_	_	_	_	_	_	_	_
65	be	_	_	_	_	_	_	_	_
66	preferable	_	_	_	_	_	_	_	_
67	.	_	_	_	_	_	_	_	_
68	Live	_	_	_	_	_	_	_	BeginSeg=Yes
69	influenza	_	_	_	_	_	_	_	_
70	virus	_	_	_	_	_	_	_	_
71	vaccines	_	_	_	_	_	_	_	_
72	might	_	_	_	_	_	_	_	_
73	be	_	_	_	_	_	_	_	_
74	considered	_	_	_	_	_	_	_	_
75	as	_	_	_	_	_	_	_	_
76	potential	_	_	_	_	_	_	_	_
77	vectors	_	_	_	_	_	_	_	_
78	for	_	_	_	_	_	_	_	_
79	mucosal	_	_	_	_	_	_	_	_
80	immunization	_	_	_	_	_	_	_	_
81	against	_	_	_	_	_	_	_	_
82	various	_	_	_	_	_	_	_	_
83	viral	_	_	_	_	_	_	_	_
84	or	_	_	_	_	_	_	_	_
85	bacterial	_	_	_	_	_	_	_	_
86	pathogens	_	_	_	_	_	_	_	_
87	,	_	_	_	_	_	_	_	_
88	including	_	_	_	_	_	_	_	BeginSeg=Yes
89	M.	_	_	_	_	_	_	_	_
90	tuberculosis	_	_	_	_	_	_	_	_
91	.	_	_	_	_	_	_	_	_
92	We	_	_	_	_	_	_	_	BeginSeg=Yes
93	generated	_	_	_	_	_	_	_	_
94	several	_	_	_	_	_	_	_	_
95	subtypes	_	_	_	_	_	_	_	_
96	of	_	_	_	_	_	_	_	_
97	attenuated	_	_	_	_	_	_	_	_
98	recombinant	_	_	_	_	_	_	_	_
99	influenza	_	_	_	_	_	_	_	_
100	A	_	_	_	_	_	_	_	_
101	viruses	_	_	_	_	_	_	_	_
102	expressing	_	_	_	_	_	_	_	BeginSeg=Yes
103	the	_	_	_	_	_	_	_	_
104	6-kDa	_	_	_	_	_	_	_	_
105	early	_	_	_	_	_	_	_	_
106	secretory	_	_	_	_	_	_	_	_
107	antigenic	_	_	_	_	_	_	_	_
108	target	_	_	_	_	_	_	_	_
109	protein	_	_	_	_	_	_	_	_
110	(	_	_	_	_	_	_	_	_
111	ESAT-6	_	_	_	_	_	_	_	_
112	)	_	_	_	_	_	_	_	_
113	of	_	_	_	_	_	_	_	_
114	M.	_	_	_	_	_	_	_	_
115	tuberculosis	_	_	_	_	_	_	_	_
116	from	_	_	_	_	_	_	_	_
117	the	_	_	_	_	_	_	_	_
118	NS1	_	_	_	_	_	_	_	_
119	reading	_	_	_	_	_	_	_	_
120	frame	_	_	_	_	_	_	_	_
121	.	_	_	_	_	_	_	_	_
122	We	_	_	_	_	_	_	_	BeginSeg=Yes
123	were	_	_	_	_	_	_	_	_
124	able	_	_	_	_	_	_	_	_
125	to	_	_	_	_	_	_	_	_
126	demonstrate	_	_	_	_	_	_	_	_
127	the	_	_	_	_	_	_	_	_
128	potency	_	_	_	_	_	_	_	_
129	of	_	_	_	_	_	_	_	_
130	influenza	_	_	_	_	_	_	_	_
131	virus	_	_	_	_	_	_	_	_
132	NS	_	_	_	_	_	_	_	_
133	vectors	_	_	_	_	_	_	_	_
134	to	_	_	_	_	_	_	_	BeginSeg=Yes
135	induce	_	_	_	_	_	_	_	_
136	an	_	_	_	_	_	_	_	_
137	M.	_	_	_	_	_	_	_	_
138	tuberculosisspecific	_	_	_	_	_	_	_	_
139	Th1	_	_	_	_	_	_	_	_
140	immune	_	_	_	_	_	_	_	_
141	response	_	_	_	_	_	_	_	_
142	in	_	_	_	_	_	_	_	_
143	mice	_	_	_	_	_	_	_	_
144	.	_	_	_	_	_	_	_	_
145	Moreover	_	_	_	_	_	_	_	BeginSeg=Yes
146	,	_	_	_	_	_	_	_	_
147	intranasal	_	_	_	_	_	_	_	_
148	immunization	_	_	_	_	_	_	_	_
149	of	_	_	_	_	_	_	_	_
150	mice	_	_	_	_	_	_	_	_
151	and	_	_	_	_	_	_	_	_
152	guinea	_	_	_	_	_	_	_	_
153	pigs	_	_	_	_	_	_	_	_
154	with	_	_	_	_	_	_	_	_
155	such	_	_	_	_	_	_	_	_
156	vectors	_	_	_	_	_	_	_	_
157	induced	_	_	_	_	_	_	_	_
158	protection	_	_	_	_	_	_	_	_
159	against	_	_	_	_	_	_	_	_
160	mycobacterial	_	_	_	_	_	_	_	_
161	challenge	_	_	_	_	_	_	_	_
162	,	_	_	_	_	_	_	_	_
163	similar	_	_	_	_	_	_	_	_
164	to	_	_	_	_	_	_	_	_
165	that	_	_	_	_	_	_	_	_
166	induced	_	_	_	_	_	_	_	BeginSeg=Yes
167	by	_	_	_	_	_	_	_	_
168	BCG	_	_	_	_	_	_	_	_
169	vaccination	_	_	_	_	_	_	_	_
170	.	_	_	_	_	_	_	_	_

# newdoc_id = f72abb1b0683ec97335167e3e3b8c2790531654e
1	With	_	_	_	_	_	_	_	BeginSeg=Yes
2	rabbit	_	_	_	_	_	_	_	_
3	patients	_	_	_	_	_	_	_	_
4	,	_	_	_	_	_	_	_	_
5	as	_	_	_	_	_	_	_	_
6	in	_	_	_	_	_	_	_	_
7	other	_	_	_	_	_	_	_	_
8	species	_	_	_	_	_	_	_	_
9	,	_	_	_	_	_	_	_	_
10	analyzing	_	_	_	_	_	_	_	_
11	blood	_	_	_	_	_	_	_	_
12	and	_	_	_	_	_	_	_	_
13	urine	_	_	_	_	_	_	_	_
14	samples	_	_	_	_	_	_	_	_
15	can	_	_	_	_	_	_	_	_
16	be	_	_	_	_	_	_	_	_
17	useful	_	_	_	_	_	_	_	_
18	and	_	_	_	_	_	_	_	_
19	informative	_	_	_	_	_	_	_	_
20	,	_	_	_	_	_	_	_	_
21	although	_	_	_	_	_	_	_	BeginSeg=Yes
22	interpretation	_	_	_	_	_	_	_	_
23	of	_	_	_	_	_	_	_	_
24	the	_	_	_	_	_	_	_	_
25	results	_	_	_	_	_	_	_	_
26	is	_	_	_	_	_	_	_	_
27	sometimes	_	_	_	_	_	_	_	_
28	challenging	_	_	_	_	_	_	_	_
29	.	_	_	_	_	_	_	_	_
30	This	_	_	_	_	_	_	_	BeginSeg=Yes
31	article	_	_	_	_	_	_	_	_
32	summarizes	_	_	_	_	_	_	_	_
33	the	_	_	_	_	_	_	_	_
34	interpretation	_	_	_	_	_	_	_	_
35	of	_	_	_	_	_	_	_	_
36	laboratory	_	_	_	_	_	_	_	_
37	results	_	_	_	_	_	_	_	_
38	from	_	_	_	_	_	_	_	_
39	rabbits	_	_	_	_	_	_	_	_
40	.	_	_	_	_	_	_	_	_
41	Hematological	_	_	_	_	_	_	_	BeginSeg=Yes
42	parameters	_	_	_	_	_	_	_	_
43	can	_	_	_	_	_	_	_	_
44	yield	_	_	_	_	_	_	_	_
45	information	_	_	_	_	_	_	_	_
46	about	_	_	_	_	_	_	_	_
47	the	_	_	_	_	_	_	_	_
48	red	_	_	_	_	_	_	_	_
49	blood	_	_	_	_	_	_	_	_
50	cell	_	_	_	_	_	_	_	_
51	population	_	_	_	_	_	_	_	_
52	and	_	_	_	_	_	_	_	_
53	leukocyte	_	_	_	_	_	_	_	_
54	response	_	_	_	_	_	_	_	_
55	to	_	_	_	_	_	_	_	_
56	stress	_	_	_	_	_	_	_	_
57	and	_	_	_	_	_	_	_	_
58	pathogens	_	_	_	_	_	_	_	_
59	.	_	_	_	_	_	_	_	_
60	Biochemistry	_	_	_	_	_	_	_	BeginSeg=Yes
61	evaluation	_	_	_	_	_	_	_	_
62	can	_	_	_	_	_	_	_	_
63	be	_	_	_	_	_	_	_	_
64	used	_	_	_	_	_	_	_	_
65	to	_	_	_	_	_	_	_	BeginSeg=Yes
66	investigate	_	_	_	_	_	_	_	_
67	liver	_	_	_	_	_	_	_	_
68	,	_	_	_	_	_	_	_	_
69	kidney	_	_	_	_	_	_	_	_
70	,	_	_	_	_	_	_	_	_
71	and	_	_	_	_	_	_	_	_
72	other	_	_	_	_	_	_	_	_
73	organ	_	_	_	_	_	_	_	_
74	function	_	_	_	_	_	_	_	_
75	,	_	_	_	_	_	_	_	_
76	and	_	_	_	_	_	_	_	BeginSeg=Yes
77	urinalysis	_	_	_	_	_	_	_	_
78	results	_	_	_	_	_	_	_	_
79	may	_	_	_	_	_	_	_	_
80	yield	_	_	_	_	_	_	_	_
81	additional	_	_	_	_	_	_	_	_
82	information	_	_	_	_	_	_	_	_
83	about	_	_	_	_	_	_	_	_
84	kidney	_	_	_	_	_	_	_	_
85	function	_	_	_	_	_	_	_	_
86	and	_	_	_	_	_	_	_	_
87	electrolyte	_	_	_	_	_	_	_	_
88	imbalances	_	_	_	_	_	_	_	_
89	.	_	_	_	_	_	_	_	_
90	Serological	_	_	_	_	_	_	_	BeginSeg=Yes
91	tests	_	_	_	_	_	_	_	_
92	are	_	_	_	_	_	_	_	_
93	available	_	_	_	_	_	_	_	_
94	for	_	_	_	_	_	_	_	_
95	several	_	_	_	_	_	_	_	_
96	pathogens	_	_	_	_	_	_	_	_
97	of	_	_	_	_	_	_	_	_
98	rabbits	_	_	_	_	_	_	_	_
99	,	_	_	_	_	_	_	_	_
100	including	_	_	_	_	_	_	_	BeginSeg=Yes
101	Encephalitozoon	_	_	_	_	_	_	_	_
102	cuniculi	_	_	_	_	_	_	_	_
103	,	_	_	_	_	_	_	_	_
104	although	_	_	_	_	_	_	_	BeginSeg=Yes
105	the	_	_	_	_	_	_	_	_
106	significance	_	_	_	_	_	_	_	_
107	of	_	_	_	_	_	_	_	_
108	positive	_	_	_	_	_	_	_	_
109	results	_	_	_	_	_	_	_	_
110	and	_	_	_	_	_	_	_	_
111	antibody	_	_	_	_	_	_	_	_
112	titers	_	_	_	_	_	_	_	_
113	is	_	_	_	_	_	_	_	_
114	not	_	_	_	_	_	_	_	_
115	clear	_	_	_	_	_	_	_	_
116	.	_	_	_	_	_	_	_	_
117	Serum	_	_	_	_	_	_	_	BeginSeg=Yes
118	protein	_	_	_	_	_	_	_	_
119	electrophoresis	_	_	_	_	_	_	_	_
120	aids	_	_	_	_	_	_	_	_
121	the	_	_	_	_	_	_	_	_
122	understanding	_	_	_	_	_	_	_	_
123	of	_	_	_	_	_	_	_	_
124	protein	_	_	_	_	_	_	_	_
125	disorders	_	_	_	_	_	_	_	_
126	and	_	_	_	_	_	_	_	_
127	the	_	_	_	_	_	_	_	_
128	immune	_	_	_	_	_	_	_	_
129	response	_	_	_	_	_	_	_	_
130	to	_	_	_	_	_	_	_	_
131	acute	_	_	_	_	_	_	_	_
132	and	_	_	_	_	_	_	_	_
133	chronic	_	_	_	_	_	_	_	_
134	inflammation	_	_	_	_	_	_	_	_
135	.	_	_	_	_	_	_	_	_

# newdoc_id = f849d3e71f4d2eae8a1e39802195bc9c06fc30ae
1	Background	_	_	_	_	_	_	_	BeginSeg=Yes
2	:	_	_	_	_	_	_	_	_
3	Viral	_	_	_	_	_	_	_	BeginSeg=Yes
4	respiratory	_	_	_	_	_	_	_	_
5	infection	_	_	_	_	_	_	_	_
6	(	_	_	_	_	_	_	_	_
7	VRI	_	_	_	_	_	_	_	_
8	)	_	_	_	_	_	_	_	_
9	is	_	_	_	_	_	_	_	_
10	a	_	_	_	_	_	_	_	_
11	common	_	_	_	_	_	_	_	_
12	contraindication	_	_	_	_	_	_	_	_
13	to	_	_	_	_	_	_	_	_
14	elective	_	_	_	_	_	_	_	_
15	surgery	_	_	_	_	_	_	_	_
16	.	_	_	_	_	_	_	_	_
17	Asymptomatic	_	_	_	_	_	_	_	BeginSeg=Yes
18	shedding	_	_	_	_	_	_	_	_
19	among	_	_	_	_	_	_	_	_
20	pediatric	_	_	_	_	_	_	_	_
21	surgery	_	_	_	_	_	_	_	_
22	patients	_	_	_	_	_	_	_	_
23	(	_	_	_	_	_	_	_	_
24	PSPs	_	_	_	_	_	_	_	_
25	)	_	_	_	_	_	_	_	_
26	could	_	_	_	_	_	_	_	_
27	potentially	_	_	_	_	_	_	_	_
28	lead	_	_	_	_	_	_	_	_
29	to	_	_	_	_	_	_	_	_
30	progression	_	_	_	_	_	_	_	_
31	of	_	_	_	_	_	_	_	_
32	symptomatic	_	_	_	_	_	_	_	_
33	diseases	_	_	_	_	_	_	_	_
34	and	_	_	_	_	_	_	_	BeginSeg=Yes
35	cause	_	_	_	_	_	_	_	_
36	outbreaks	_	_	_	_	_	_	_	_
37	of	_	_	_	_	_	_	_	_
38	respiratory	_	_	_	_	_	_	_	_
39	diseases	_	_	_	_	_	_	_	_
40	.	_	_	_	_	_	_	_	_
41	The	_	_	_	_	_	_	_	BeginSeg=Yes
42	aim	_	_	_	_	_	_	_	_
43	of	_	_	_	_	_	_	_	_
44	this	_	_	_	_	_	_	_	_
45	study	_	_	_	_	_	_	_	_
46	is	_	_	_	_	_	_	_	_
47	to	_	_	_	_	_	_	_	_
48	investigate	_	_	_	_	_	_	_	_
49	the	_	_	_	_	_	_	_	_
50	incidence	_	_	_	_	_	_	_	_
51	of	_	_	_	_	_	_	_	_
52	infection	_	_	_	_	_	_	_	_
53	among	_	_	_	_	_	_	_	_
54	mild	_	_	_	_	_	_	_	_
55	symptomatic	_	_	_	_	_	_	_	_
56	PSP	_	_	_	_	_	_	_	_
57	group	_	_	_	_	_	_	_	_
58	and	_	_	_	_	_	_	_	_
59	asymptomatic	_	_	_	_	_	_	_	_
60	PSP	_	_	_	_	_	_	_	_
61	group	_	_	_	_	_	_	_	_
62	after	_	_	_	_	_	_	_	_
63	surgical	_	_	_	_	_	_	_	_
64	procedure	_	_	_	_	_	_	_	_
65	.	_	_	_	_	_	_	_	_
66	Methods	_	_	_	_	_	_	_	BeginSeg=Yes
67	:	_	_	_	_	_	_	_	_
68	We	_	_	_	_	_	_	_	BeginSeg=Yes
69	collected	_	_	_	_	_	_	_	_
70	the	_	_	_	_	_	_	_	_
71	induced	_	_	_	_	_	_	_	_
72	sputum	_	_	_	_	_	_	_	_
73	from	_	_	_	_	_	_	_	_
74	enrolled	_	_	_	_	_	_	_	_
75	1629	_	_	_	_	_	_	_	_
76	children	_	_	_	_	_	_	_	_
77	(	_	_	_	_	_	_	_	BeginSeg=Yes
78	under	_	_	_	_	_	_	_	_
79	18	_	_	_	_	_	_	_	_
80	years	_	_	_	_	_	_	_	_
81	of	_	_	_	_	_	_	_	_
82	age	_	_	_	_	_	_	_	_
83	)	_	_	_	_	_	_	_	_
84	with	_	_	_	_	_	_	_	BeginSeg=Yes
85	no	_	_	_	_	_	_	_	_
86	respiratory	_	_	_	_	_	_	_	_
87	symptom	_	_	_	_	_	_	_	_
88	prior	_	_	_	_	_	_	_	_
89	to	_	_	_	_	_	_	_	_
90	pediatric	_	_	_	_	_	_	_	_
91	surgery	_	_	_	_	_	_	_	_
92	between	_	_	_	_	_	_	_	_
93	March	_	_	_	_	_	_	_	_
94	2017	_	_	_	_	_	_	_	_
95	and	_	_	_	_	_	_	_	_
96	February	_	_	_	_	_	_	_	_
97	2019	_	_	_	_	_	_	_	_
98	.	_	_	_	_	_	_	_	_
99	We	_	_	_	_	_	_	_	BeginSeg=Yes
100	tested	_	_	_	_	_	_	_	_
101	16	_	_	_	_	_	_	_	_
102	different	_	_	_	_	_	_	_	_
103	respiratory	_	_	_	_	_	_	_	_
104	virus	_	_	_	_	_	_	_	_
105	infections	_	_	_	_	_	_	_	_
106	in	_	_	_	_	_	_	_	_
107	post	_	_	_	_	_	_	_	_
108	-	_	_	_	_	_	_	_	_
109	surgery	_	_	_	_	_	_	_	_
110	mild	_	_	_	_	_	_	_	_
111	symptomatic	_	_	_	_	_	_	_	_
112	PSP	_	_	_	_	_	_	_	_
113	group	_	_	_	_	_	_	_	_
114	and	_	_	_	_	_	_	_	_
115	asymptomatic	_	_	_	_	_	_	_	_
116	PSP	_	_	_	_	_	_	_	_
117	group	_	_	_	_	_	_	_	_
118	using	_	_	_	_	_	_	_	BeginSeg=Yes
119	a	_	_	_	_	_	_	_	_
120	quantitative	_	_	_	_	_	_	_	_
121	real	_	_	_	_	_	_	_	_
122	-	_	_	_	_	_	_	_	_
123	time	_	_	_	_	_	_	_	_
124	reverse	_	_	_	_	_	_	_	_
125	transcriptase	_	_	_	_	_	_	_	_
126	polymerase	_	_	_	_	_	_	_	_
127	chain	_	_	_	_	_	_	_	_
128	reaction	_	_	_	_	_	_	_	_
129	(	_	_	_	_	_	_	_	_
130	qRT	_	_	_	_	_	_	_	_
131	-	_	_	_	_	_	_	_	_
132	PCR	_	_	_	_	_	_	_	_
133	)	_	_	_	_	_	_	_	_
134	assay	_	_	_	_	_	_	_	_
135	panel	_	_	_	_	_	_	_	_
136	.	_	_	_	_	_	_	_	_
137	We	_	_	_	_	_	_	_	BeginSeg=Yes
138	analyzed	_	_	_	_	_	_	_	_
139	symptom	_	_	_	_	_	_	_	_
140	data	_	_	_	_	_	_	_	_
141	and	_	_	_	_	_	_	_	_
142	quantitative	_	_	_	_	_	_	_	_
143	viral	_	_	_	_	_	_	_	_
144	load	_	_	_	_	_	_	_	_
145	to	_	_	_	_	_	_	_	BeginSeg=Yes
146	investigate	_	_	_	_	_	_	_	_
147	the	_	_	_	_	_	_	_	_
148	association	_	_	_	_	_	_	_	_
149	between	_	_	_	_	_	_	_	_
150	viruses	_	_	_	_	_	_	_	_
151	,	_	_	_	_	_	_	_	_
152	symptoms	_	_	_	_	_	_	_	_
153	and	_	_	_	_	_	_	_	_
154	viral	_	_	_	_	_	_	_	_
155	quantity	_	_	_	_	_	_	_	_
156	in	_	_	_	_	_	_	_	_
157	qRT	_	_	_	_	_	_	_	_
158	-	_	_	_	_	_	_	_	_
159	PCR	_	_	_	_	_	_	_	_
160	-	_	_	_	_	_	_	_	_
161	positive	_	_	_	_	_	_	_	_
162	PSPs	_	_	_	_	_	_	_	_
163	.	_	_	_	_	_	_	_	_
164	Results	_	_	_	_	_	_	_	BeginSeg=Yes
165	:	_	_	_	_	_	_	_	_
166	Out	_	_	_	_	_	_	_	BeginSeg=Yes
167	of	_	_	_	_	_	_	_	_
168	1629	_	_	_	_	_	_	_	_
169	children	_	_	_	_	_	_	_	_
170	enrolled	_	_	_	_	_	_	_	_
171	,	_	_	_	_	_	_	_	_
172	a	_	_	_	_	_	_	_	_
173	total	_	_	_	_	_	_	_	_
174	of	_	_	_	_	_	_	_	_
175	204	_	_	_	_	_	_	_	_
176	respiratory	_	_	_	_	_	_	_	_
177	viruses	_	_	_	_	_	_	_	_
178	were	_	_	_	_	_	_	_	_
179	present	_	_	_	_	_	_	_	_
180	in	_	_	_	_	_	_	_	_
181	171	_	_	_	_	_	_	_	_
182	(	_	_	_	_	_	_	_	BeginSeg=Yes
183	10.50	_	_	_	_	_	_	_	_
184	%	_	_	_	_	_	_	_	_
185	)	_	_	_	_	_	_	_	_
186	PSPs	_	_	_	_	_	_	_	BeginSeg=Yes
187	including	_	_	_	_	_	_	_	BeginSeg=Yes
188	47	_	_	_	_	_	_	_	_
189	patients	_	_	_	_	_	_	_	_
190	with	_	_	_	_	_	_	_	_
191	mild	_	_	_	_	_	_	_	_
192	symptoms	_	_	_	_	_	_	_	_
193	and	_	_	_	_	_	_	_	_
194	124	_	_	_	_	_	_	_	_
195	with	_	_	_	_	_	_	_	_
196	no	_	_	_	_	_	_	_	_
197	symptoms	_	_	_	_	_	_	_	_
198	after	_	_	_	_	_	_	_	_
199	surgery	_	_	_	_	_	_	_	_
200	.	_	_	_	_	_	_	_	_
201	Commonly	_	_	_	_	_	_	_	BeginSeg=Yes
202	detected	_	_	_	_	_	_	_	_
203	viruses	_	_	_	_	_	_	_	_
204	were	_	_	_	_	_	_	_	_
205	human	_	_	_	_	_	_	_	_
206	rhino	_	_	_	_	_	_	_	_
207	/	_	_	_	_	_	_	_	_
208	enterovirus	_	_	_	_	_	_	_	_
209	(	_	_	_	_	_	_	_	BeginSeg=Yes
210	HRV	_	_	_	_	_	_	_	_
211	/	_	_	_	_	_	_	_	_
212	EV	_	_	_	_	_	_	_	_
213	,	_	_	_	_	_	_	_	_
214	42.19	_	_	_	_	_	_	_	_
215	%	_	_	_	_	_	_	_	_
216	)	_	_	_	_	_	_	_	_
217	,	_	_	_	_	_	_	_	_
218	parainfluenza	_	_	_	_	_	_	_	BeginSeg=Yes
219	virus	_	_	_	_	_	_	_	_
220	3	_	_	_	_	_	_	_	_
221	(	_	_	_	_	_	_	_	BeginSeg=Yes
222	PIV3	_	_	_	_	_	_	_	_
223	,	_	_	_	_	_	_	_	_
224	24.48	_	_	_	_	_	_	_	_
225	%	_	_	_	_	_	_	_	_
226	)	_	_	_	_	_	_	_	_
227	,	_	_	_	_	_	_	_	_
228	coronavirus	_	_	_	_	_	_	_	BeginSeg=Yes
229	(	_	_	_	_	_	_	_	BeginSeg=Yes
230	CoV	_	_	_	_	_	_	_	_
231	NL63	_	_	_	_	_	_	_	_
232	,	_	_	_	_	_	_	_	_
233	OC43	_	_	_	_	_	_	_	_
234	,	_	_	_	_	_	_	_	_
235	HKU1	_	_	_	_	_	_	_	_
236	,	_	_	_	_	_	_	_	_
237	11.46	_	_	_	_	_	_	_	_
238	%	_	_	_	_	_	_	_	_
239	)	_	_	_	_	_	_	_	_
240	,	_	_	_	_	_	_	_	_
241	and	_	_	_	_	_	_	_	BeginSeg=Yes
242	respiratory	_	_	_	_	_	_	_	_
243	syncytial	_	_	_	_	_	_	_	_
244	virus	_	_	_	_	_	_	_	_
245	(	_	_	_	_	_	_	_	BeginSeg=Yes
246	RSV	_	_	_	_	_	_	_	_
247	,	_	_	_	_	_	_	_	_
248	9.9	_	_	_	_	_	_	_	_
249	%	_	_	_	_	_	_	_	_
250	)	_	_	_	_	_	_	_	_
251	.	_	_	_	_	_	_	_	_
252	PIV3	_	_	_	_	_	_	_	BeginSeg=Yes
253	infection	_	_	_	_	_	_	_	_
254	with	_	_	_	_	_	_	_	_
255	a	_	_	_	_	_	_	_	_
256	higher	_	_	_	_	_	_	_	_
257	viral	_	_	_	_	_	_	_	_
258	load	_	_	_	_	_	_	_	_
259	was	_	_	_	_	_	_	_	_
260	frequently	_	_	_	_	_	_	_	_
261	found	_	_	_	_	_	_	_	_
262	in	_	_	_	_	_	_	_	_
263	PSPs	_	_	_	_	_	_	_	_
264	presenting	_	_	_	_	_	_	_	BeginSeg=Yes
265	with	_	_	_	_	_	_	_	_
266	mild	_	_	_	_	_	_	_	_
267	symptoms	_	_	_	_	_	_	_	_
268	,	_	_	_	_	_	_	_	_
269	progressing	_	_	_	_	_	_	_	BeginSeg=Yes
270	to	_	_	_	_	_	_	_	_
271	pneumonia	_	_	_	_	_	_	_	_
272	with	_	_	_	_	_	_	_	_
273	radiographic	_	_	_	_	_	_	_	_
274	evidence	_	_	_	_	_	_	_	_
275	after	_	_	_	_	_	_	_	_
276	surgery	_	_	_	_	_	_	_	_
277	.	_	_	_	_	_	_	_	_
278	HRV	_	_	_	_	_	_	_	BeginSeg=Yes
279	/	_	_	_	_	_	_	_	_
280	EV	_	_	_	_	_	_	_	_
281	were	_	_	_	_	_	_	_	_
282	the	_	_	_	_	_	_	_	_
283	most	_	_	_	_	_	_	_	_
284	commonly	_	_	_	_	_	_	_	_
285	detected	_	_	_	_	_	_	_	_
286	pathogens	_	_	_	_	_	_	_	_
287	in	_	_	_	_	_	_	_	_
288	both	_	_	_	_	_	_	_	_
289	asymptomatic	_	_	_	_	_	_	_	_
290	and	_	_	_	_	_	_	_	_
291	mild	_	_	_	_	_	_	_	_
292	symptomatic	_	_	_	_	_	_	_	_
293	PSPs	_	_	_	_	_	_	_	_
294	.	_	_	_	_	_	_	_	_
295	CoV	_	_	_	_	_	_	_	BeginSeg=Yes
296	(	_	_	_	_	_	_	_	_
297	OC43	_	_	_	_	_	_	_	_
298	,	_	_	_	_	_	_	_	_
299	HKU1	_	_	_	_	_	_	_	_
300	)	_	_	_	_	_	_	_	_
301	infections	_	_	_	_	_	_	_	_
302	with	_	_	_	_	_	_	_	_
303	a	_	_	_	_	_	_	_	_
304	higher	_	_	_	_	_	_	_	_
305	viral	_	_	_	_	_	_	_	_
306	load	_	_	_	_	_	_	_	_
307	were	_	_	_	_	_	_	_	_
308	mostly	_	_	_	_	_	_	_	_
309	observed	_	_	_	_	_	_	_	_
310	in	_	_	_	_	_	_	_	_
311	asymptomatic	_	_	_	_	_	_	_	_
312	PSPs	_	_	_	_	_	_	_	_
313	progressing	_	_	_	_	_	_	_	_
314	to	_	_	_	_	_	_	_	_
315	alveolar	_	_	_	_	_	_	_	_
316	or	_	_	_	_	_	_	_	_
317	interstitial	_	_	_	_	_	_	_	_
318	infiltration	_	_	_	_	_	_	_	_
319	.	_	_	_	_	_	_	_	_
320	Conclusions	_	_	_	_	_	_	_	BeginSeg=Yes
321	:	_	_	_	_	_	_	_	_
322	Our	_	_	_	_	_	_	_	BeginSeg=Yes
323	study	_	_	_	_	_	_	_	_
324	suggested	_	_	_	_	_	_	_	_
325	that	_	_	_	_	_	_	_	BeginSeg=Yes
326	PIV3	_	_	_	_	_	_	_	_
327	is	_	_	_	_	_	_	_	_
328	a	_	_	_	_	_	_	_	_
329	new	_	_	_	_	_	_	_	_
330	risk	_	_	_	_	_	_	_	_
331	factor	_	_	_	_	_	_	_	_
332	for	_	_	_	_	_	_	_	_
333	VRI	_	_	_	_	_	_	_	_
334	in	_	_	_	_	_	_	_	_
335	PSPs	_	_	_	_	_	_	_	_
336	.	_	_	_	_	_	_	_	_
337	Employing	_	_	_	_	_	_	_	BeginSeg=Yes
338	a	_	_	_	_	_	_	_	_
339	more	_	_	_	_	_	_	_	_
340	comprehensive	_	_	_	_	_	_	_	_
341	,	_	_	_	_	_	_	_	_
342	sensitive	_	_	_	_	_	_	_	_
343	and	_	_	_	_	_	_	_	_
344	quantitative	_	_	_	_	_	_	_	_
345	method	_	_	_	_	_	_	_	_
346	should	_	_	_	_	_	_	_	_
347	be	_	_	_	_	_	_	_	_
348	considered	_	_	_	_	_	_	_	_
349	for	_	_	_	_	_	_	_	_
350	preoperative	_	_	_	_	_	_	_	_
351	testing	_	_	_	_	_	_	_	_
352	of	_	_	_	_	_	_	_	_
353	respiratory	_	_	_	_	_	_	_	_
354	viruses	_	_	_	_	_	_	_	_
355	in	_	_	_	_	_	_	_	BeginSeg=Yes
356	order	_	_	_	_	_	_	_	_
357	to	_	_	_	_	_	_	_	_
358	guide	_	_	_	_	_	_	_	_
359	optimal	_	_	_	_	_	_	_	_
360	surgical	_	_	_	_	_	_	_	_
361	timing	_	_	_	_	_	_	_	_
362	.	_	_	_	_	_	_	_	_

# newdoc_id = faffbac0e2a22d215556feec30516c1a6ccdb283
1	The	_	_	_	_	_	_	_	BeginSeg=Yes
2	computational	_	_	_	_	_	_	_	_
3	search	_	_	_	_	_	_	_	_
4	of	_	_	_	_	_	_	_	_
5	chemical	_	_	_	_	_	_	_	_
6	libraries	_	_	_	_	_	_	_	_
7	has	_	_	_	_	_	_	_	_
8	been	_	_	_	_	_	_	_	_
9	used	_	_	_	_	_	_	_	_
10	as	_	_	_	_	_	_	_	_
11	a	_	_	_	_	_	_	_	_
12	powerful	_	_	_	_	_	_	_	_
13	tool	_	_	_	_	_	_	_	_
14	for	_	_	_	_	_	_	_	_
15	the	_	_	_	_	_	_	_	_
16	rapid	_	_	_	_	_	_	_	_
17	discovery	_	_	_	_	_	_	_	_
18	of	_	_	_	_	_	_	_	_
19	candidate	_	_	_	_	_	_	_	_
20	compounds	_	_	_	_	_	_	_	_
21	.	_	_	_	_	_	_	_	_
22	To	_	_	_	_	_	_	_	BeginSeg=Yes
23	find	_	_	_	_	_	_	_	_
24	small	_	_	_	_	_	_	_	_
25	molecules	_	_	_	_	_	_	_	_
26	with	_	_	_	_	_	_	_	_
27	anti	_	_	_	_	_	_	_	_
28	-	_	_	_	_	_	_	_	_
29	feline	_	_	_	_	_	_	_	_
30	infectious	_	_	_	_	_	_	_	_
31	peritonitis	_	_	_	_	_	_	_	_
32	virus	_	_	_	_	_	_	_	_
33	(	_	_	_	_	_	_	_	_
34	FIPV	_	_	_	_	_	_	_	_
35	)	_	_	_	_	_	_	_	_
36	properties	_	_	_	_	_	_	_	_
37	,	_	_	_	_	_	_	_	_
38	we	_	_	_	_	_	_	_	BeginSeg=Yes
39	utilized	_	_	_	_	_	_	_	_
40	a	_	_	_	_	_	_	_	_
41	virtual	_	_	_	_	_	_	_	_
42	screening	_	_	_	_	_	_	_	_
43	technique	_	_	_	_	_	_	_	_
44	to	_	_	_	_	_	_	_	BeginSeg=Yes
45	identify	_	_	_	_	_	_	_	_
46	the	_	_	_	_	_	_	_	_
47	active	_	_	_	_	_	_	_	_
48	site	_	_	_	_	_	_	_	_
49	on	_	_	_	_	_	_	_	_
50	the	_	_	_	_	_	_	_	_
51	viral	_	_	_	_	_	_	_	_
52	protease	_	_	_	_	_	_	_	_
53	for	_	_	_	_	_	_	_	_
54	the	_	_	_	_	_	_	_	_
55	binding	_	_	_	_	_	_	_	_
56	of	_	_	_	_	_	_	_	_
57	the	_	_	_	_	_	_	_	_
58	available	_	_	_	_	_	_	_	_
59	natural	_	_	_	_	_	_	_	_
60	compounds	_	_	_	_	_	_	_	_
61	.	_	_	_	_	_	_	_	_
62	The	_	_	_	_	_	_	_	BeginSeg=Yes
63	protease	_	_	_	_	_	_	_	_
64	3CL	_	_	_	_	_	_	_	_
65	(	_	_	_	_	_	_	_	_
66	3CL	_	_	_	_	_	_	_	_
67	pro	_	_	_	_	_	_	_	_
68	)	_	_	_	_	_	_	_	_
69	plays	_	_	_	_	_	_	_	_
70	an	_	_	_	_	_	_	_	_
71	important	_	_	_	_	_	_	_	_
72	role	_	_	_	_	_	_	_	_
73	in	_	_	_	_	_	_	_	_
74	the	_	_	_	_	_	_	_	_
75	replication	_	_	_	_	_	_	_	_
76	cycle	_	_	_	_	_	_	_	_
77	of	_	_	_	_	_	_	_	_
78	FIPV	_	_	_	_	_	_	_	_
79	and	_	_	_	_	_	_	_	_
80	other	_	_	_	_	_	_	_	_
81	viruses	_	_	_	_	_	_	_	_
82	within	_	_	_	_	_	_	_	_
83	the	_	_	_	_	_	_	_	_
84	family	_	_	_	_	_	_	_	_
85	Coronaviridae	_	_	_	_	_	_	_	_
86	.	_	_	_	_	_	_	_	_
87	The	_	_	_	_	_	_	_	BeginSeg=Yes
88	15	_	_	_	_	_	_	_	_
89	best	_	_	_	_	_	_	_	_
90	-	_	_	_	_	_	_	_	_
91	ranked	_	_	_	_	_	_	_	_
92	candidate	_	_	_	_	_	_	_	_
93	consensus	_	_	_	_	_	_	_	_
94	compounds	_	_	_	_	_	_	_	_
95	,	_	_	_	_	_	_	_	_
96	based	_	_	_	_	_	_	_	BeginSeg=Yes
97	on	_	_	_	_	_	_	_	_
98	three	_	_	_	_	_	_	_	_
99	docking	_	_	_	_	_	_	_	_
100	tools	_	_	_	_	_	_	_	_
101	,	_	_	_	_	_	_	_	_
102	were	_	_	_	_	_	_	_	BeginSeg=Yes
103	evaluated	_	_	_	_	_	_	_	_
104	for	_	_	_	_	_	_	_	_
105	further	_	_	_	_	_	_	_	_
106	assays	_	_	_	_	_	_	_	_
107	.	_	_	_	_	_	_	_	_
108	The	_	_	_	_	_	_	_	BeginSeg=Yes
109	protease	_	_	_	_	_	_	_	_
110	inhibitor	_	_	_	_	_	_	_	_
111	assay	_	_	_	_	_	_	_	_
112	on	_	_	_	_	_	_	_	_
113	recombinant	_	_	_	_	_	_	_	_
114	FIPV	_	_	_	_	_	_	_	_
115	3CL	_	_	_	_	_	_	_	_
116	pro	_	_	_	_	_	_	_	_
117	was	_	_	_	_	_	_	_	_
118	performed	_	_	_	_	_	_	_	_
119	to	_	_	_	_	_	_	_	BeginSeg=Yes
120	screen	_	_	_	_	_	_	_	_
121	the	_	_	_	_	_	_	_	_
122	inhibitory	_	_	_	_	_	_	_	_
123	effect	_	_	_	_	_	_	_	_
124	of	_	_	_	_	_	_	_	_
125	the	_	_	_	_	_	_	_	_
126	candidate	_	_	_	_	_	_	_	_
127	compounds	_	_	_	_	_	_	_	_
128	with	_	_	_	_	_	_	_	_
129	IC	_	_	_	_	_	_	_	_
130	50	_	_	_	_	_	_	_	_
131	ranging	_	_	_	_	_	_	_	BeginSeg=Yes
132	from	_	_	_	_	_	_	_	_
133	6.36	_	_	_	_	_	_	_	_
134	±	_	_	_	_	_	_	_	_
135	2.15	_	_	_	_	_	_	_	_
136	to	_	_	_	_	_	_	_	_
137	78.40	_	_	_	_	_	_	_	_
138	±	_	_	_	_	_	_	_	_
139	2.60	_	_	_	_	_	_	_	_
140	μM.	_	_	_	_	_	_	_	_
141	As	_	_	_	_	_	_	_	BeginSeg=Yes
142	determined	_	_	_	_	_	_	_	_
143	by	_	_	_	_	_	_	_	_
144	the	_	_	_	_	_	_	_	_
145	cell	_	_	_	_	_	_	_	_
146	-	_	_	_	_	_	_	_	_
147	based	_	_	_	_	_	_	_	_
148	assay	_	_	_	_	_	_	_	_
149	,	_	_	_	_	_	_	_	_
150	the	_	_	_	_	_	_	_	BeginSeg=Yes
151	compounds	_	_	_	_	_	_	_	_
152	NSC345647	_	_	_	_	_	_	_	_
153	,	_	_	_	_	_	_	_	_
154	NSC87511	_	_	_	_	_	_	_	_
155	,	_	_	_	_	_	_	_	_
156	and	_	_	_	_	_	_	_	_
157	NSC343256	_	_	_	_	_	_	_	_
158	showed	_	_	_	_	_	_	_	_
159	better	_	_	_	_	_	_	_	_
160	EC	_	_	_	_	_	_	_	_
161	50	_	_	_	_	_	_	_	_
162	values	_	_	_	_	_	_	_	_
163	than	_	_	_	_	_	_	_	_
164	the	_	_	_	_	_	_	_	_
165	broad	_	_	_	_	_	_	_	_
166	-	_	_	_	_	_	_	_	_
167	spectrum	_	_	_	_	_	_	_	_
168	antiviral	_	_	_	_	_	_	_	_
169	drug	_	_	_	_	_	_	_	_
170	ribavirin	_	_	_	_	_	_	_	_
171	and	_	_	_	_	_	_	_	_
172	the	_	_	_	_	_	_	_	_
173	protease	_	_	_	_	_	_	_	_
174	inhibitor	_	_	_	_	_	_	_	_
175	lopinavir	_	_	_	_	_	_	_	_
176	,	_	_	_	_	_	_	_	_
177	under	_	_	_	_	_	_	_	_
178	all	_	_	_	_	_	_	_	_
179	the	_	_	_	_	_	_	_	_
180	test	_	_	_	_	_	_	_	_
181	conditions	_	_	_	_	_	_	_	_
182	including	_	_	_	_	_	_	_	BeginSeg=Yes
183	pre	_	_	_	_	_	_	_	_
184	-	_	_	_	_	_	_	_	_
185	viral	_	_	_	_	_	_	_	_
186	entry	_	_	_	_	_	_	_	_
187	,	_	_	_	_	_	_	_	_
188	post	_	_	_	_	_	_	_	_
189	-	_	_	_	_	_	_	_	_
190	viral	_	_	_	_	_	_	_	_
191	entry	_	_	_	_	_	_	_	_
192	,	_	_	_	_	_	_	_	_
193	and	_	_	_	_	_	_	_	_
194	prophylactic	_	_	_	_	_	_	_	_
195	activity	_	_	_	_	_	_	_	_
196	.	_	_	_	_	_	_	_	_
197	The	_	_	_	_	_	_	_	BeginSeg=Yes
198	NSC87511	_	_	_	_	_	_	_	_
199	particularly	_	_	_	_	_	_	_	_
200	yielded	_	_	_	_	_	_	_	_
201	the	_	_	_	_	_	_	_	_
202	best	_	_	_	_	_	_	_	_
203	selective	_	_	_	_	_	_	_	_
204	index	_	_	_	_	_	_	_	_
205	(	_	_	_	_	_	_	_	BeginSeg=Yes
206	>	_	_	_	_	_	_	_	_
207	4	_	_	_	_	_	_	_	_
208	;	_	_	_	_	_	_	_	_
209	range	_	_	_	_	_	_	_	_
210	of	_	_	_	_	_	_	_	_
211	SI	_	_	_	_	_	_	_	_
212	=	_	_	_	_	_	_	_	_
213	13.80	_	_	_	_	_	_	_	_
214	-	_	_	_	_	_	_	_	_
215	22.90	_	_	_	_	_	_	_	_
216	)	_	_	_	_	_	_	_	_
217	.	_	_	_	_	_	_	_	_
218	These	_	_	_	_	_	_	_	BeginSeg=Yes
219	results	_	_	_	_	_	_	_	_
220	indicated	_	_	_	_	_	_	_	_
221	that	_	_	_	_	_	_	_	BeginSeg=Yes
222	the	_	_	_	_	_	_	_	_
223	natural	_	_	_	_	_	_	_	_
224	small	_	_	_	_	_	_	_	_
225	-	_	_	_	_	_	_	_	_
226	molecular	_	_	_	_	_	_	_	_
227	compounds	_	_	_	_	_	_	_	_
228	specifically	_	_	_	_	_	_	_	_
229	targeted	_	_	_	_	_	_	_	_
230	the	_	_	_	_	_	_	_	_
231	3CL	_	_	_	_	_	_	_	_
232	pro	_	_	_	_	_	_	_	_
233	of	_	_	_	_	_	_	_	_
234	FIPV	_	_	_	_	_	_	_	_
235	and	_	_	_	_	_	_	_	BeginSeg=Yes
236	inhibited	_	_	_	_	_	_	_	_
237	its	_	_	_	_	_	_	_	_
238	replication	_	_	_	_	_	_	_	_
239	.	_	_	_	_	_	_	_	_
240	Structural	_	_	_	_	_	_	_	BeginSeg=Yes
241	modification	_	_	_	_	_	_	_	_
242	of	_	_	_	_	_	_	_	_
243	these	_	_	_	_	_	_	_	_
244	compounds	_	_	_	_	_	_	_	_
245	may	_	_	_	_	_	_	_	_
246	generate	_	_	_	_	_	_	_	_
247	a	_	_	_	_	_	_	_	_
248	higher	_	_	_	_	_	_	_	_
249	anti	_	_	_	_	_	_	_	_
250	-	_	_	_	_	_	_	_	_
251	viral	_	_	_	_	_	_	_	_
252	potency	_	_	_	_	_	_	_	_
253	for	_	_	_	_	_	_	_	_
254	the	_	_	_	_	_	_	_	_
255	further	_	_	_	_	_	_	_	_
256	development	_	_	_	_	_	_	_	_
257	of	_	_	_	_	_	_	_	_
258	a	_	_	_	_	_	_	_	_
259	novel	_	_	_	_	_	_	_	_
260	therapy	_	_	_	_	_	_	_	_
261	against	_	_	_	_	_	_	_	_
262	FIP	_	_	_	_	_	_	_	_
263	.	_	_	_	_	_	_	_	_

# newdoc_id = fb824a8c9ca3c15f49dffa5e22fbfdc1b1fec4ac
1	As	_	_	_	_	_	_	_	BeginSeg=Yes
2	Sun	_	_	_	_	_	_	_	_
3	Tzu	_	_	_	_	_	_	_	_
4	wrote	_	_	_	_	_	_	_	_
5	in	_	_	_	_	_	_	_	_
6	The	_	_	_	_	_	_	_	_
7	Art	_	_	_	_	_	_	_	_
8	of	_	_	_	_	_	_	_	_
9	War	_	_	_	_	_	_	_	_
10	,	_	_	_	_	_	_	_	_
11	"	_	_	_	_	_	_	_	BeginSeg=Yes
12	All	_	_	_	_	_	_	_	_
13	warfare	_	_	_	_	_	_	_	_
14	is	_	_	_	_	_	_	_	_
15	based	_	_	_	_	_	_	_	_
16	on	_	_	_	_	_	_	_	_
17	deception	_	_	_	_	_	_	_	_
18	"	_	_	_	_	_	_	_	_
19	.	_	_	_	_	_	_	_	_
20	He	_	_	_	_	_	_	_	BeginSeg=Yes
21	could	_	_	_	_	_	_	_	_
22	have	_	_	_	_	_	_	_	_
23	easily	_	_	_	_	_	_	_	_
24	been	_	_	_	_	_	_	_	_
25	describing	_	_	_	_	_	_	_	_
26	the	_	_	_	_	_	_	_	_
27	ancient	_	_	_	_	_	_	_	_
28	battle	_	_	_	_	_	_	_	_
29	between	_	_	_	_	_	_	_	_
30	virus	_	_	_	_	_	_	_	_
31	and	_	_	_	_	_	_	_	_
32	host	_	_	_	_	_	_	_	_
33	rather	_	_	_	_	_	_	_	_
34	than	_	_	_	_	_	_	_	_
35	on	_	_	_	_	_	_	_	_
36	the	_	_	_	_	_	_	_	_
37	lore	_	_	_	_	_	_	_	_
38	of	_	_	_	_	_	_	_	_
39	Chinese	_	_	_	_	_	_	_	_
40	warfare	_	_	_	_	_	_	_	_
41	.	_	_	_	_	_	_	_	_
42	A	_	_	_	_	_	_	_	BeginSeg=Yes
43	virus	_	_	_	_	_	_	_	_
44	must	_	_	_	_	_	_	_	_
45	infect	_	_	_	_	_	_	_	_
46	,	_	_	_	_	_	_	_	_
47	replicate	_	_	_	_	_	_	_	BeginSeg=Yes
48	and	_	_	_	_	_	_	_	BeginSeg=Yes
49	spread	_	_	_	_	_	_	_	_
50	for	_	_	_	_	_	_	_	BeginSeg=Yes
51	it	_	_	_	_	_	_	_	_
52	to	_	_	_	_	_	_	_	_
53	survive	_	_	_	_	_	_	_	_
54	;	_	_	_	_	_	_	_	_
55	the	_	_	_	_	_	_	_	BeginSeg=Yes
56	host	_	_	_	_	_	_	_	_
57	attempting	_	_	_	_	_	_	_	_
58	to	_	_	_	_	_	_	_	_
59	thwart	_	_	_	_	_	_	_	_
60	it	_	_	_	_	_	_	_	_
61	at	_	_	_	_	_	_	_	_
62	every	_	_	_	_	_	_	_	_
63	step	_	_	_	_	_	_	_	_
64	of	_	_	_	_	_	_	_	_
65	the	_	_	_	_	_	_	_	_
66	way	_	_	_	_	_	_	_	_
67	.	_	_	_	_	_	_	_	_
68	This	_	_	_	_	_	_	_	BeginSeg=Yes
69	ancient	_	_	_	_	_	_	_	_
70	battle	_	_	_	_	_	_	_	_
71	has	_	_	_	_	_	_	_	_
72	been	_	_	_	_	_	_	_	_
73	waged	_	_	_	_	_	_	_	_
74	for	_	_	_	_	_	_	_	_
75	millions	_	_	_	_	_	_	_	_
76	of	_	_	_	_	_	_	_	_
77	years	_	_	_	_	_	_	_	_
78	and	_	_	_	_	_	_	_	BeginSeg=Yes
79	has	_	_	_	_	_	_	_	_
80	spawned	_	_	_	_	_	_	_	_
81	an	_	_	_	_	_	_	_	_
82	innumerable	_	_	_	_	_	_	_	_
83	number	_	_	_	_	_	_	_	_
84	of	_	_	_	_	_	_	_	_
85	viruses	_	_	_	_	_	_	_	_
86	,	_	_	_	_	_	_	_	_
87	each	_	_	_	_	_	_	_	_
88	with	_	_	_	_	_	_	_	_
89	their	_	_	_	_	_	_	_	_
90	own	_	_	_	_	_	_	_	_
91	unique	_	_	_	_	_	_	_	_
92	ways	_	_	_	_	_	_	_	_
93	of	_	_	_	_	_	_	_	BeginSeg=Yes
94	trying	_	_	_	_	_	_	_	_
95	to	_	_	_	_	_	_	_	_
96	outsmart	_	_	_	_	_	_	_	_
97	the	_	_	_	_	_	_	_	_
98	host	_	_	_	_	_	_	_	_
99	.	_	_	_	_	_	_	_	_
100	Some	_	_	_	_	_	_	_	BeginSeg=Yes
101	viruses	_	_	_	_	_	_	_	_
102	encode	_	_	_	_	_	_	_	_
103	proteins	_	_	_	_	_	_	_	_
104	that	_	_	_	_	_	_	_	BeginSeg=Yes
105	directly	_	_	_	_	_	_	_	_
106	inhibit	_	_	_	_	_	_	_	_
107	/	_	_	_	_	_	_	_	_
108	degrade	_	_	_	_	_	_	_	_
109	/	_	_	_	_	_	_	_	_
110	alter	_	_	_	_	_	_	_	_
111	host	_	_	_	_	_	_	_	_
112	pathways	_	_	_	_	_	_	_	_
113	and	_	_	_	_	_	_	_	BeginSeg=Yes
114	some	_	_	_	_	_	_	_	_
115	simply	_	_	_	_	_	_	_	_
116	have	_	_	_	_	_	_	_	_
117	evolved	_	_	_	_	_	_	_	_
118	ways	_	_	_	_	_	_	_	_
119	to	_	_	_	_	_	_	_	BeginSeg=Yes
120	hide	_	_	_	_	_	_	_	_
121	from	_	_	_	_	_	_	_	_
122	the	_	_	_	_	_	_	_	_
123	hosts	_	_	_	_	_	_	_	_
124	detection	_	_	_	_	_	_	_	_
125	system	_	_	_	_	_	_	_	_
126	.	_	_	_	_	_	_	_	_
127	The	_	_	_	_	_	_	_	BeginSeg=Yes
128	host	_	_	_	_	_	_	_	_
129	is	_	_	_	_	_	_	_	_
130	not	_	_	_	_	_	_	_	_
131	passive	_	_	_	_	_	_	_	_
132	in	_	_	_	_	_	_	_	_
133	this	_	_	_	_	_	_	_	_
134	battle	_	_	_	_	_	_	_	_
135	.	_	_	_	_	_	_	_	_
136	It	_	_	_	_	_	_	_	BeginSeg=Yes
137	has	_	_	_	_	_	_	_	_
138	evolved	_	_	_	_	_	_	_	_
139	complex	_	_	_	_	_	_	_	_
140	pathways	_	_	_	_	_	_	_	_
141	and	_	_	_	_	_	_	_	_
142	redundant	_	_	_	_	_	_	_	_
143	mechanisms	_	_	_	_	_	_	_	_
144	to	_	_	_	_	_	_	_	BeginSeg=Yes
145	respond	_	_	_	_	_	_	_	_
146	to	_	_	_	_	_	_	_	_
147	viral	_	_	_	_	_	_	_	_
148	interlopers	_	_	_	_	_	_	_	_
149	.	_	_	_	_	_	_	_	_

# newdoc_id = fcc503a22ab18a67222842a84aa2ba08e0e4865e
1	It	_	_	_	_	_	_	_	BeginSeg=Yes
2	is	_	_	_	_	_	_	_	_
3	a	_	_	_	_	_	_	_	_
4	much	_	_	_	_	_	_	_	_
5	desirable	_	_	_	_	_	_	_	_
6	skill	_	_	_	_	_	_	_	_
7	among	_	_	_	_	_	_	_	_
8	physicians	_	_	_	_	_	_	_	_
9	that	_	_	_	_	_	_	_	_
10	clinical	_	_	_	_	_	_	_	_
11	practice	_	_	_	_	_	_	_	_
12	should	_	_	_	_	_	_	_	_
13	be	_	_	_	_	_	_	_	_
14	guided	_	_	_	_	_	_	_	_
15	by	_	_	_	_	_	_	_	_
16	ethical	_	_	_	_	_	_	_	_
17	norms	_	_	_	_	_	_	_	_
18	.	_	_	_	_	_	_	_	_
19	The	_	_	_	_	_	_	_	BeginSeg=Yes
20	dissection	_	_	_	_	_	_	_	_
21	room	_	_	_	_	_	_	_	_
22	experience	_	_	_	_	_	_	_	_
23	provides	_	_	_	_	_	_	_	_
24	an	_	_	_	_	_	_	_	_
25	opportunity	_	_	_	_	_	_	_	_
26	for	_	_	_	_	_	_	_	BeginSeg=Yes
27	nurturing	_	_	_	_	_	_	_	_
28	the	_	_	_	_	_	_	_	_
29	principles	_	_	_	_	_	_	_	_
30	of	_	_	_	_	_	_	_	_
31	ethical	_	_	_	_	_	_	_	_
32	practice	_	_	_	_	_	_	_	_
33	among	_	_	_	_	_	_	_	_
34	medical	_	_	_	_	_	_	_	_
35	students	_	_	_	_	_	_	_	_
36	early	_	_	_	_	_	_	_	_
37	in	_	_	_	_	_	_	_	_
38	the	_	_	_	_	_	_	_	_
39	curriculum	_	_	_	_	_	_	_	_
40	.	_	_	_	_	_	_	_	_
41	When	_	_	_	_	_	_	_	BeginSeg=Yes
42	the	_	_	_	_	_	_	_	_
43	exercise	_	_	_	_	_	_	_	_
44	of	_	_	_	_	_	_	_	_
45	human	_	_	_	_	_	_	_	_
46	dissection	_	_	_	_	_	_	_	_
47	is	_	_	_	_	_	_	_	_
48	followed	_	_	_	_	_	_	_	_
49	within	_	_	_	_	_	_	_	_
50	the	_	_	_	_	_	_	_	_
51	boundaries	_	_	_	_	_	_	_	_
52	of	_	_	_	_	_	_	_	_
53	ethics	_	_	_	_	_	_	_	_
54	it	_	_	_	_	_	_	_	BeginSeg=Yes
55	effectively	_	_	_	_	_	_	_	_
56	props	_	_	_	_	_	_	_	_
57	an	_	_	_	_	_	_	_	_
58	ideal	_	_	_	_	_	_	_	_
59	example	_	_	_	_	_	_	_	_
60	for	_	_	_	_	_	_	_	_
61	the	_	_	_	_	_	_	_	_
62	young	_	_	_	_	_	_	_	_
63	minds	_	_	_	_	_	_	_	_
64	to	_	_	_	_	_	_	_	BeginSeg=Yes
65	emulate	_	_	_	_	_	_	_	_
66	in	_	_	_	_	_	_	_	_
67	the	_	_	_	_	_	_	_	_
68	future	_	_	_	_	_	_	_	_
69	.	_	_	_	_	_	_	_	_
70	Hence	_	_	_	_	_	_	_	BeginSeg=Yes
71	in	_	_	_	_	_	_	_	_
72	every	_	_	_	_	_	_	_	_
73	stage	_	_	_	_	_	_	_	_
74	of	_	_	_	_	_	_	_	_
75	dissection	_	_	_	_	_	_	_	_
76	room	_	_	_	_	_	_	_	_
77	activity	_	_	_	_	_	_	_	_
78	precious	_	_	_	_	_	_	_	_
79	human	_	_	_	_	_	_	_	_
80	body	_	_	_	_	_	_	_	_
81	needs	_	_	_	_	_	_	_	_
82	to	_	_	_	_	_	_	_	_
83	be	_	_	_	_	_	_	_	_
84	handled	_	_	_	_	_	_	_	_
85	in	_	_	_	_	_	_	_	_
86	an	_	_	_	_	_	_	_	_
87	ethical	_	_	_	_	_	_	_	_
88	manner	_	_	_	_	_	_	_	_
89	so	_	_	_	_	_	_	_	BeginSeg=Yes
90	as	_	_	_	_	_	_	_	_
91	to	_	_	_	_	_	_	_	_
92	set	_	_	_	_	_	_	_	_
93	a	_	_	_	_	_	_	_	_
94	standard	_	_	_	_	_	_	_	_
95	for	_	_	_	_	_	_	_	_
96	the	_	_	_	_	_	_	_	_
97	students	_	_	_	_	_	_	_	_
98	The	_	_	_	_	_	_	_	BeginSeg=Yes
99	present	_	_	_	_	_	_	_	_
100	review	_	_	_	_	_	_	_	_
101	is	_	_	_	_	_	_	_	_
102	an	_	_	_	_	_	_	_	_
103	attempt	_	_	_	_	_	_	_	_
104	to	_	_	_	_	_	_	_	BeginSeg=Yes
105	collate	_	_	_	_	_	_	_	_
106	the	_	_	_	_	_	_	_	_
107	recommendations	_	_	_	_	_	_	_	_
108	documented	_	_	_	_	_	_	_	BeginSeg=Yes
109	by	_	_	_	_	_	_	_	_
110	researchers	_	_	_	_	_	_	_	_
111	as	_	_	_	_	_	_	_	_
112	per	_	_	_	_	_	_	_	_
113	ethical	_	_	_	_	_	_	_	_
114	guidelines	_	_	_	_	_	_	_	_
115	in	_	_	_	_	_	_	_	_
116	the	_	_	_	_	_	_	_	_
117	context	_	_	_	_	_	_	_	_
118	of	_	_	_	_	_	_	_	_
119	human	_	_	_	_	_	_	_	_
120	dissection	_	_	_	_	_	_	_	_
121	.	_	_	_	_	_	_	_	_
122	The	_	_	_	_	_	_	_	BeginSeg=Yes
123	review	_	_	_	_	_	_	_	_
124	highlights	_	_	_	_	_	_	_	_
125	on	_	_	_	_	_	_	_	_
126	the	_	_	_	_	_	_	_	_
127	ethical	_	_	_	_	_	_	_	_
128	norms	_	_	_	_	_	_	_	_
129	which	_	_	_	_	_	_	_	BeginSeg=Yes
130	needs	_	_	_	_	_	_	_	_
131	to	_	_	_	_	_	_	_	_
132	be	_	_	_	_	_	_	_	_
133	adhered	_	_	_	_	_	_	_	_
134	to	_	_	_	_	_	_	_	_
135	while	_	_	_	_	_	_	_	BeginSeg=Yes
136	receiving	_	_	_	_	_	_	_	_
137	the	_	_	_	_	_	_	_	_
138	human	_	_	_	_	_	_	_	_
139	body	_	_	_	_	_	_	_	_
140	of	_	_	_	_	_	_	_	_
141	a	_	_	_	_	_	_	_	_
142	donor	_	_	_	_	_	_	_	_
143	and	_	_	_	_	_	_	_	_
144	during	_	_	_	_	_	_	_	_
145	preservation	_	_	_	_	_	_	_	_
146	of	_	_	_	_	_	_	_	_
147	the	_	_	_	_	_	_	_	_
148	same	_	_	_	_	_	_	_	_
149	.	_	_	_	_	_	_	_	_
150	It	_	_	_	_	_	_	_	BeginSeg=Yes
151	reflects	_	_	_	_	_	_	_	_
152	on	_	_	_	_	_	_	_	_
153	ideal	_	_	_	_	_	_	_	_
154	ethical	_	_	_	_	_	_	_	_
155	behaviour	_	_	_	_	_	_	_	_
156	in	_	_	_	_	_	_	_	_
157	the	_	_	_	_	_	_	_	_
158	dissection	_	_	_	_	_	_	_	_
159	room	_	_	_	_	_	_	_	_
160	during	_	_	_	_	_	_	_	_
161	the	_	_	_	_	_	_	_	_
162	act	_	_	_	_	_	_	_	_
163	of	_	_	_	_	_	_	_	_
164	dissection	_	_	_	_	_	_	_	_
165	and	_	_	_	_	_	_	_	BeginSeg=Yes
166	finally	_	_	_	_	_	_	_	_
167	emphasize	_	_	_	_	_	_	_	_
168	on	_	_	_	_	_	_	_	_
169	the	_	_	_	_	_	_	_	_
170	respectful	_	_	_	_	_	_	_	_
171	disposal	_	_	_	_	_	_	_	_
172	of	_	_	_	_	_	_	_	_
173	the	_	_	_	_	_	_	_	_
174	human	_	_	_	_	_	_	_	_
175	remains	_	_	_	_	_	_	_	_
176	in	_	_	_	_	_	_	_	_
177	an	_	_	_	_	_	_	_	_
178	ethical	_	_	_	_	_	_	_	_
179	manner	_	_	_	_	_	_	_	_
180	.	_	_	_	_	_	_	_	_
181	The	_	_	_	_	_	_	_	BeginSeg=Yes
182	intended	_	_	_	_	_	_	_	_
183	purpose	_	_	_	_	_	_	_	_
184	of	_	_	_	_	_	_	_	_
185	this	_	_	_	_	_	_	_	_
186	article	_	_	_	_	_	_	_	_
187	is	_	_	_	_	_	_	_	_
188	to	_	_	_	_	_	_	_	_
189	support	_	_	_	_	_	_	_	_
190	uniform	_	_	_	_	_	_	_	_
191	adoption	_	_	_	_	_	_	_	_
192	of	_	_	_	_	_	_	_	_
193	the	_	_	_	_	_	_	_	_
194	recommendations	_	_	_	_	_	_	_	_
195	for	_	_	_	_	_	_	_	_
196	ethical	_	_	_	_	_	_	_	_
197	handling	_	_	_	_	_	_	_	_
198	of	_	_	_	_	_	_	_	_
199	human	_	_	_	_	_	_	_	_
200	bodies	_	_	_	_	_	_	_	_
201	used	_	_	_	_	_	_	_	BeginSeg=Yes
202	in	_	_	_	_	_	_	_	_
203	anatomical	_	_	_	_	_	_	_	_
204	dissection	_	_	_	_	_	_	_	_
205	.	_	_	_	_	_	_	_	_
